Citrus Sinensis ID: 001847
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
ID ![]() | Alignment graph ![]() | Length ![]() |
Definition ![]() |
RBH(Q2H) ![]() |
RBH(H2Q) ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 1005 | 2.2.26 [Sep-21-2011] | |||||||
| O48963 | 996 | Phototropin-1 OS=Arabidop | yes | no | 0.974 | 0.982 | 0.730 | 0.0 | |
| Q2QYY8 | 921 | Phototropin-1A OS=Oryza s | yes | no | 0.897 | 0.979 | 0.633 | 0.0 | |
| Q2RBR1 | 921 | Phototropin-1B OS=Oryza s | yes | no | 0.897 | 0.979 | 0.632 | 0.0 | |
| P93025 | 915 | Phototropin-2 OS=Arabidop | no | no | 0.839 | 0.922 | 0.613 | 0.0 | |
| Q9ST27 | 907 | Phototropin-2 OS=Oryza sa | no | no | 0.789 | 0.874 | 0.65 | 0.0 | |
| Q9LFA2 | 934 | Serine/threonine-protein | no | no | 0.329 | 0.354 | 0.457 | 7e-94 | |
| Q0DCT8 | 589 | Protein kinase G11A OS=Or | no | no | 0.377 | 0.643 | 0.428 | 1e-92 | |
| A2YBX5 | 589 | Protein kinase G11A OS=Or | N/A | no | 0.377 | 0.643 | 0.428 | 2e-92 | |
| P15792 | 609 | Protein kinase PVPK-1 OS= | N/A | no | 0.329 | 0.543 | 0.45 | 2e-91 | |
| Q05999 | 578 | Serine/threonine-protein | no | no | 0.337 | 0.586 | 0.435 | 6e-87 |
| >sp|O48963|PHOT1_ARATH Phototropin-1 OS=Arabidopsis thaliana GN=PHOT1 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 1464 bits (3789), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 741/1014 (73%), Positives = 838/1014 (82%), Gaps = 35/1014 (3%)
Query: 8 EKSPKQSSKACESPLSRDSRGSLEVFNPSTFSTRPTNPVFRPQP-TWQTWMEQRES---P 63
E + K S+K L RD+RGSLEVFNPST TRP NPVFRP+P WQ + R + P
Sbjct: 2 EPTEKPSTKPSSRTLPRDTRGSLEVFNPSTQLTRPDNPVFRPEPPAWQNLSDPRGTSPQP 61
Query: 64 EPEHAKLNSKSSRAEE----ITSWMALKDPAPQKPSLPPLIQKMTNDQEKSTVTKQLSGE 119
P+ S R+++ TSWMALKDP+P+ S +K+ ++
Sbjct: 62 RPQQEPAPSNPVRSDQEIAVTTSWMALKDPSPETIS------------KKTITAEKPQKS 109
Query: 120 AGAAAQRAAEWGLVLKTDTETGKPQAVVARTSGG--DDPNGKPGTSRRNSNNSVRSSGEM 177
A AA QRAAEWGLVLKTDT+TGKPQ V R SGG +DPNGK TS+RNS NS RSSGEM
Sbjct: 110 AVAAEQRAAEWGLVLKTDTKTGKPQGVGVRNSGGTENDPNGKKTTSQRNSQNSCRSSGEM 169
Query: 178 SDEG--GKEKGLPRVSDIVKDALSTFQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEV 235
SD G G+PRVS+ +KDALSTFQQTFVVSDATKPDYPIMYASAGFF MTGYTSKEV
Sbjct: 170 SDGDVPGGRSGIPRVSEDLKDALSTFQQTFVVSDATKPDYPIMYASAGFFNMTGYTSKEV 229
Query: 236 VGRNCRFLQGAGTDPEDVAKIRETLQNGQSYCGRLLNYKKDGTPFWNLLTIAPIKDDEGK 295
VGRNCRFLQG+GTD +++AKIRETL G +YCGR+LNYKKDGT FWNLLTIAPIKD+ GK
Sbjct: 230 VGRNCRFLQGSGTDADELAKIRETLAAGNNYCGRILNYKKDGTSFWNLLTIAPIKDESGK 289
Query: 296 VLKFIGMQVEVSKHTEGAKDKMLRPNGLPESLIRYDARQKEMATSSVTELVQAMKKPRSL 355
VLKFIGMQVEVSKHTEGAK+K LRPNGLPESLIRYDARQK+MAT+SVTELV+A+K+PR+L
Sbjct: 290 VLKFIGMQVEVSKHTEGAKEKALRPNGLPESLIRYDARQKDMATNSVTELVEAVKRPRAL 349
Query: 356 SESTNRPPIIRKSEGGVEEERAGALGRRKSENVPPPRRNSYGGGCRTSMQRISEVPEKKK 415
SESTN P + KSE +E RR SENV P R + GGG R SMQRI+E+PEKK
Sbjct: 350 SESTNLHPFMTKSES---DELPKKPARRMSENVVPSGRRNSGGGRRNSMQRINEIPEKKS 406
Query: 416 QKSGRRSFMGLIGRKSQSTDDHDSFENEIIMEG--DDDYESDDERPDSVDDKVRQKEMRK 473
+KS SFMG I +KS+S D+ S ++ I G DD+ DERP+SVDDKVRQKEMRK
Sbjct: 407 RKSSL-SFMG-IKKKSESLDE--SIDDGFIEYGEEDDEISDRDERPESVDDKVRQKEMRK 462
Query: 474 GIDLATTLERIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDP 533
GIDLATTLERIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETD
Sbjct: 463 GIDLATTLERIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDL 522
Query: 534 ATVRKIRAAIDNQTDVTVQLINYTKSGKKFWNLFHLQPMRDQKGEVQYFIGVQLDGSEHL 593
TV+KIR AIDNQT+VTVQLINYTKSGKKFWN+FHLQPMRDQKGEVQYFIGVQLDGS+H+
Sbjct: 523 TTVKKIRNAIDNQTEVTVQLINYTKSGKKFWNIFHLQPMRDQKGEVQYFIGVQLDGSKHV 582
Query: 594 EPLRNSIPEATAEESEKLVKQTAENVNEAVKELPDANLTPEDLWANHSKVVHPKPHRKDS 653
EP+RN I E +E E LVK+TA N++EAV+ELPDAN+TPEDLWANHSKVVH KPHRKDS
Sbjct: 583 EPVRNVIEETAVKEGEDLVKKTAVNIDEAVRELPDANMTPEDLWANHSKVVHCKPHRKDS 642
Query: 654 PPWKAIQKILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNR 713
PPW AIQK+L+SGE I L+HF+P+KPLGSGDTGSVHLVEL G+ Q FAMKAMDK VMLNR
Sbjct: 643 PPWIAIQKVLESGEPIGLKHFKPVKPLGSGDTGSVHLVELVGTDQLFAMKAMDKAVMLNR 702
Query: 714 NKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKE 773
NKVHRA AEREILD+LDHPF+PALYASFQTKTH+CLITDY PGGELF+LLDRQP KVLKE
Sbjct: 703 NKVHRARAEREILDLLDHPFLPALYASFQTKTHICLITDYYPGGELFMLLDRQPRKVLKE 762
Query: 774 DAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLP 833
DAVRFYAA+VVVALEYLHCQGIIYRDLKPENVL+QGNG +SL+DFDLSCLTSCKPQLL+P
Sbjct: 763 DAVRFYAAQVVVALEYLHCQGIIYRDLKPENVLIQGNGDISLSDFDLSCLTSCKPQLLIP 822
Query: 834 TTNE--KKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILL 891
+ +E KK++ K QQ P+FMAEPMRASNSFVGTEEYIAPEII+GAGHTSAVDWWALGIL+
Sbjct: 823 SIDEKKKKKQQKSQQTPIFMAEPMRASNSFVGTEEYIAPEIISGAGHTSAVDWWALGILM 882
Query: 892 YEMLYGYTPFRGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEG 951
YEMLYGYTPFRGKTRQKTF N+L KDLKFP+S P SL KQL++RLL RDPK RLG EG
Sbjct: 883 YEMLYGYTPFRGKTRQKTFTNVLQKDLKFPASIPASLQVKQLIFRLLQRDPKKRLGCFEG 942
Query: 952 ANEIKKHPFFKGVNWALVRCMNPPELDAPLFATDTEKEYKVVDPGMQDLQQNVF 1005
ANE+K+H FFKG+NWAL+RC NPPEL+ P+F+ + E KVVDP ++DLQ NVF
Sbjct: 943 ANEVKQHSFFKGINWALIRCTNPPELETPIFSGEAENGEKVVDPELEDLQTNVF 996
|
Protein kinase that acts as a blue-light photoreceptor in a signal-transduction pathway for photo-induced movements. Required for blue-light mediated mRNA destabilization. Mediates calcium spiking of extracellular origin in response to low rate of blue light. Mediates also rapid membrane depolarization and growth inhibition in response to blue light. Necessary for root phototropism. Involved in hypocotyl phototropism under low rate but not under high rate blue light. Contributes to the chloroplast accumulation but seems to be not required for chloroplast translocation. Regulates stomata opening and photomorphogenesis response of leaf tissue. Confers sensitivity to drought. Not involved in hypocotyl elongation inhibition, anthocyanin accumulation or cotyledon opening. Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q2QYY8|PHT1A_ORYSJ Phototropin-1A OS=Oryza sativa subsp. japonica GN=PHOT1A PE=1 SV=2 | Back alignment and function description |
|---|
Score = 1259 bits (3257), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 632/998 (63%), Positives = 756/998 (75%), Gaps = 96/998 (9%)
Query: 8 EKSPKQSSKACESPLSRDSRGSLEVFNPSTFSTRPTNPVFRPQPTWQTWMEQRESPEPEH 67
E+ +Q + + P RDSRGSLEVFNPS+ S+ FR
Sbjct: 14 ERKEQQQQRGYQLP--RDSRGSLEVFNPSSASS------FR------------------- 46
Query: 68 AKLNSKSSRAEEITSWMALKDPAPQKPSLPPLIQKMTNDQEKSTVTKQLSGEAGAAAQRA 127
+ ++ + + ++A+ D+E+ V Q QRA
Sbjct: 47 ----TAAAAPKSASPFLAIP------------------DREEDNVVAQ---------QRA 75
Query: 128 AEWGLVLKTDTETGKPQAVVARTSGGDDPNGKPGTSRRNSNNSVRSSGEMSDEGGKE-KG 186
AEWGLVL+TD TG PQ V AR S G S R+S E + + +
Sbjct: 76 AEWGLVLQTDHHTGLPQGVSARPSSG----------------SARTSSEDNPQQQQSAAA 119
Query: 187 LPRVSDIVKDALSTFQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGA 246
+PRVS+ ++ ALS FQQTFVVSDAT P++PIMYASAGFF MTGYTSKEVVGRNCRFLQG+
Sbjct: 120 IPRVSEELRAALSAFQQTFVVSDATHPNHPIMYASAGFFNMTGYTSKEVVGRNCRFLQGS 179
Query: 247 GTDPEDVAKIRETLQNGQSYCGRLLNYKKDGTPFWNLLTIAPIKDDEGKVLKFIGMQVEV 306
GTDP ++ KIR++L NG +YCGR+LNYKKDGTPFWNLLTIAPIKD++G++LKFIGMQVEV
Sbjct: 180 GTDPHEIDKIRQSLANGSNYCGRILNYKKDGTPFWNLLTIAPIKDEDGRLLKFIGMQVEV 239
Query: 307 SKHTEGAKDKMLRPNGLPESLIRYDARQKEMATSSVTELVQAMKKPRSLSESTNRPPIIR 366
SK+TEG KD ++RPNGL ESLI+YDARQK+ A SSV+EL+ A+K PRSLSES+N + R
Sbjct: 240 SKYTEGKKDTVVRPNGLSESLIKYDARQKDHARSSVSELLLALKNPRSLSESSNN-TLKR 298
Query: 367 KSEGGVEEERAGALGRRKSENVPPPRRNSYGGGCRTSMQRISEVPEK--KKQKSGRRSFM 424
KS+ + +R SE+ RRNS G R+S+Q+I+EVP++ + +KSG R+FM
Sbjct: 299 KSQESLSMSMTEVPSKRSSES--GSRRNSR-SGTRSSLQKINEVPDQGNRTRKSGLRAFM 355
Query: 425 GLIGRKSQSTDDHDSFENEIIMEGDDD--YESDDERPDSVDDKVRQKEMRKGIDLATTLE 482
G +G H S E ++ D+D +SDDERP+S +D+ R+KEMR+GIDLATTLE
Sbjct: 356 GFLGM------GHGSVEKNMLKPRDEDPLIDSDDERPESFEDEFRRKEMRRGIDLATTLE 409
Query: 483 RIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIRAA 542
RIEKNFVITDPRLPDNPIIFASDSFL+LTEY+REEILGRNCRFLQGPETD ATVRKIR A
Sbjct: 410 RIEKNFVITDPRLPDNPIIFASDSFLQLTEYNREEILGRNCRFLQGPETDRATVRKIRDA 469
Query: 543 IDNQTDVTVQLINYTKSGKKFWNLFHLQPMRDQKGEVQYFIGVQLDGSEHLEPLRNSIPE 602
IDNQ +VTVQLINYTKSGKKFWNLFHLQPMRDQKG+VQYFIGVQLDG+EH++ +
Sbjct: 470 IDNQAEVTVQLINYTKSGKKFWNLFHLQPMRDQKGDVQYFIGVQLDGTEHVQ-------D 522
Query: 603 ATAEESEKLVKQTAENVNEAVKELPDANLTPEDLWANHSKVVHPKPHRKDSPPWKAIQKI 662
A+E LVK+TA+N++EA KELPDANL PEDLWANHSKVV P PH KD+ W+AIQK+
Sbjct: 523 DAAKEGVVLVKKTADNIDEAAKELPDANLRPEDLWANHSKVVLPNPHMKDTASWRAIQKV 582
Query: 663 LDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAE 722
L+SGE I L+HFRP+KPLGSGDTGSVHLVEL +G+YFAMKAMDK +MLNRNKVHRA AE
Sbjct: 583 LESGESIGLKHFRPVKPLGSGDTGSVHLVELLNTGEYFAMKAMDKSIMLNRNKVHRATAE 642
Query: 723 REILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAE 782
R+ILD+LDHPF+P LYASFQTKTH+CLITDYCPGGELF+LLD QP KVL EDAVRFYAAE
Sbjct: 643 RQILDLLDHPFLPTLYASFQTKTHICLITDYCPGGELFVLLDNQPLKVLHEDAVRFYAAE 702
Query: 783 VVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRH 842
VVVALEYLHCQGIIYRDLKPEN+LL +GH+SLTDFDLSCLTSC+PQ+ LP ++K+
Sbjct: 703 VVVALEYLHCQGIIYRDLKPENILLHRDGHISLTDFDLSCLTSCRPQVFLPEDADEKKGR 762
Query: 843 KGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFR 902
K P+F AEPMRASNSFVGTEEYIAPEII GAGHTSAVDWWALGILLYEMLYGYTPFR
Sbjct: 763 KNGSYPIFFAEPMRASNSFVGTEEYIAPEIITGAGHTSAVDWWALGILLYEMLYGYTPFR 822
Query: 903 GKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFK 962
GKTRQ+TFANILHKD++FP+S SL A+QLMYRLLHRDP +RLGS+EGANEIK HPFF+
Sbjct: 823 GKTRQRTFANILHKDIRFPASISVSLAARQLMYRLLHRDPANRLGSYEGANEIKGHPFFR 882
Query: 963 GVNWALVRCMNPPELDAPLFATDTEKEYKVVDPGMQDL 1000
G+NW L+R PP+L+ PLF+ D ++ +V D+
Sbjct: 883 GINWPLIRATAPPKLEIPLFSKDDMEKKGLVTNNRTDM 920
|
Protein kinase that acts as a blue-light photoreceptor in a signal-transduction pathway for phototropic responses. Regulates a wide range of physiological activities in plants that maximize the efficiency of photosynthesis, such as chloroplast relocations, stomata opening, and leaf expansion. Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q2RBR1|PHT1B_ORYSJ Phototropin-1B OS=Oryza sativa subsp. japonica GN=PHOT1B PE=1 SV=2 | Back alignment and function description |
|---|
Score = 1258 bits (3255), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 631/998 (63%), Positives = 757/998 (75%), Gaps = 96/998 (9%)
Query: 8 EKSPKQSSKACESPLSRDSRGSLEVFNPSTFSTRPTNPVFRPQPTWQTWMEQRESPEPEH 67
E+ +Q + + P RDSRGSLEVFNPS+ S+ FR
Sbjct: 14 ERKEQQQQRGYQLP--RDSRGSLEVFNPSSASS------FR------------------- 46
Query: 68 AKLNSKSSRAEEITSWMALKDPAPQKPSLPPLIQKMTNDQEKSTVTKQLSGEAGAAAQRA 127
+ ++ + + ++A+ D+E+ V Q QRA
Sbjct: 47 ----TAAAAPKSASPFLAIP------------------DREEDNVVAQ---------QRA 75
Query: 128 AEWGLVLKTDTETGKPQAVVARTSGGDDPNGKPGTSRRNSNNSVRSSGEMSDEGGKE-KG 186
AEWGLVL+TD TG PQ V AR S G S R+S E + + +
Sbjct: 76 AEWGLVLQTDHHTGLPQGVSARPSSG----------------SARTSSEDNPQQQQSAAA 119
Query: 187 LPRVSDIVKDALSTFQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGA 246
+PRVS+ ++ ALS FQQTFVVSDAT P++PIMYASAGFF MTGYTSKEVVGRNCRFLQG+
Sbjct: 120 IPRVSEELRAALSVFQQTFVVSDATHPNHPIMYASAGFFNMTGYTSKEVVGRNCRFLQGS 179
Query: 247 GTDPEDVAKIRETLQNGQSYCGRLLNYKKDGTPFWNLLTIAPIKDDEGKVLKFIGMQVEV 306
GTDP ++ KIR++L NG +YCGR+LNYKKDGTPFWNLLTIAPIKD++G++LKFIGMQVEV
Sbjct: 180 GTDPHEIDKIRQSLANGSNYCGRILNYKKDGTPFWNLLTIAPIKDEDGRLLKFIGMQVEV 239
Query: 307 SKHTEGAKDKMLRPNGLPESLIRYDARQKEMATSSVTELVQAMKKPRSLSESTNRPPIIR 366
SK+TEG KD ++RPNGL ESLI+YDARQK+ A SSV+EL+ A+K PRSLSES+N + R
Sbjct: 240 SKYTEGKKDTVVRPNGLSESLIKYDARQKDHARSSVSELLLALKNPRSLSESSNN-TLKR 298
Query: 367 KSEGGVEEERAGALGRRKSENVPPPRRNSYGGGCRTSMQRISEVPEK--KKQKSGRRSFM 424
KS+ + + +R SE+ RRNS G R+S+Q+I+EVP++ + +KSG R+FM
Sbjct: 299 KSQESLSMSMSEVPSKRSSES--GSRRNSR-SGTRSSLQKINEVPDQVNRTRKSGLRAFM 355
Query: 425 GLIGRKSQSTDDHDSFENEIIMEGDDD--YESDDERPDSVDDKVRQKEMRKGIDLATTLE 482
G +G H S E ++ D+D +SDDERP+S +D+ R+KEMR+GIDLATTLE
Sbjct: 356 GFLGM------GHGSVEKNMLKPRDEDPLIDSDDERPESFEDEFRRKEMRRGIDLATTLE 409
Query: 483 RIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIRAA 542
RIEKNFVITDPRLPDNPIIFASDSFL+LTEY+REEILGRNCRFLQGPETD ATVRKIR A
Sbjct: 410 RIEKNFVITDPRLPDNPIIFASDSFLQLTEYNREEILGRNCRFLQGPETDRATVRKIRDA 469
Query: 543 IDNQTDVTVQLINYTKSGKKFWNLFHLQPMRDQKGEVQYFIGVQLDGSEHLEPLRNSIPE 602
IDNQ +VTVQLINYTKSGKKFWNLFHLQPMRDQKG+VQYFIGVQLDG+EH++ +
Sbjct: 470 IDNQAEVTVQLINYTKSGKKFWNLFHLQPMRDQKGDVQYFIGVQLDGTEHVQ-------D 522
Query: 603 ATAEESEKLVKQTAENVNEAVKELPDANLTPEDLWANHSKVVHPKPHRKDSPPWKAIQKI 662
A+E LVK+TA+N++EA KELPDANL P+DLWANHSKVV P PH KD+ W+AIQK+
Sbjct: 523 DAAKEGVVLVKKTADNIDEAAKELPDANLRPKDLWANHSKVVLPNPHMKDTASWRAIQKV 582
Query: 663 LDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAE 722
L+SGE I L+HFRP+KPLGSGDTGSVHLVEL +G+YFAMKAMDK +MLNRNKVHRA AE
Sbjct: 583 LESGESIGLKHFRPVKPLGSGDTGSVHLVELLNTGEYFAMKAMDKSIMLNRNKVHRATAE 642
Query: 723 REILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAE 782
R+ILD+LDHPF+P LYASFQTKTH+CLITDYCPGGELF+LLD QP KVL EDAVRFYAAE
Sbjct: 643 RQILDLLDHPFLPTLYASFQTKTHICLITDYCPGGELFVLLDNQPLKVLHEDAVRFYAAE 702
Query: 783 VVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRH 842
VVVALEYLHCQGIIYRDLKPEN+LL +GH+SLTDFDLSCLTSC+PQ+ LP ++K+
Sbjct: 703 VVVALEYLHCQGIIYRDLKPENILLHRDGHISLTDFDLSCLTSCRPQVFLPEDADEKKGR 762
Query: 843 KGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFR 902
K P+F AEPMRASNSFVGTEEYIAPEII GAGHTSAVDWWALGILLYEMLYGYTPFR
Sbjct: 763 KNGSYPIFFAEPMRASNSFVGTEEYIAPEIITGAGHTSAVDWWALGILLYEMLYGYTPFR 822
Query: 903 GKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFK 962
GKTRQ+TFANILHKD++FP+S SL A+QLMYRLLHRDP +RLGS+EGANEIK HPFF+
Sbjct: 823 GKTRQRTFANILHKDIRFPASISVSLAARQLMYRLLHRDPANRLGSYEGANEIKGHPFFR 882
Query: 963 GVNWALVRCMNPPELDAPLFATDTEKEYKVVDPGMQDL 1000
G+NW L+R PP+L+ PLF+ D ++ +V D+
Sbjct: 883 GINWPLIRATAPPKLEIPLFSKDDMEKKGLVTNNRTDM 920
|
Protein kinase that acts as a blue-light photoreceptor in a signal-transduction pathway for phototropic responses. Regulates a wide range of physiological activities in plants that maximize the efficiency of photosynthesis, such as chloroplast relocations, stomata opening, and leaf expansion. Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P93025|PHOT2_ARATH Phototropin-2 OS=Arabidopsis thaliana GN=PHOT2 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 1088 bits (2813), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 550/897 (61%), Positives = 658/897 (73%), Gaps = 53/897 (5%)
Query: 119 EAGAAAQRAAEWGLVLKTDTETGKPQAVVARTSGGDDPNGKPGTSRRNSNNSVRSSGEMS 178
++ +R AEWGL + V SG D + K + S N +
Sbjct: 62 DSAKITERTAEWGL------------SAVKPDSGDDGISFKLSSEVERSKN-MSRRSSEE 108
Query: 179 DEGGKEKGLPRVSDIVKDALSTFQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGR 238
+ PRVS +K ALST QQTFVVSDAT+P PI+YAS+GFF MTGY+SKE+VGR
Sbjct: 109 STSSESGAFPRVSQELKTALSTLQQTFVVSDATQPHCPIVYASSGFFTMTGYSSKEIVGR 168
Query: 239 NCRFLQGAGTDPEDVAKIRETLQNGQSYCGRLLNYKKDGTPFWNLLTIAPIKDDEGKVLK 298
NCRFLQG TD +VAKIR+ ++NG+SYCGRLLNYKKDGTPFWNLLT+ PIKDD+G +K
Sbjct: 169 NCRFLQGPDTDKNEVAKIRDCVKNGKSYCGRLLNYKKDGTPFWNLLTVTPIKDDQGNTIK 228
Query: 299 FIGMQVEVSKHTEGAKDKMLRPNGLPESLIRYDARQKEMATSSVTELVQAMKKPRS-LSE 357
FIGMQVEVSK+TEG DK LRPNGL +SLIRYDARQKE A S+TE+VQ ++ +S + E
Sbjct: 229 FIGMQVEVSKYTEGVNDKALRPNGLSKSLIRYDARQKEKALDSITEVVQTIRHRKSQVQE 288
Query: 358 STNRPPIIRKSEGGVEEERAGALGRRKSENVPPPRRNSYGGGCRTSMQRISEVPEKKKQK 417
S + +++ S P P R + R S+ K +
Sbjct: 289 SVSNDTMVKPD----------------SSTTPTPGRQT----------RQSDEASKSFRT 322
Query: 418 SGRRSFMGLIGRKSQSTDDHDSFENEIIMEGDDDYESDDE--RPDSVDDKVRQKEMRKGI 475
GR S G K +S+++ E+ + ME ++ S + + DS D R++++R+GI
Sbjct: 323 PGRVS--TPTGSKLKSSNNR--HEDLLRMEPEELMLSTEVIGQRDSWDLSDRERDIRQGI 378
Query: 476 DLATTLERIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPAT 535
DLATTLERIEKNFVI+DPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETD AT
Sbjct: 379 DLATTLERIEKNFVISDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDQAT 438
Query: 536 VRKIRAAIDNQTDVTVQLINYTKSGKKFWNLFHLQPMRDQKGEVQYFIGVQLDGSEHLEP 595
V+KIR AI +Q ++TVQLINYTKSGKKFWNLFHLQPMRDQKGE+QYFIGVQLDGS+H+EP
Sbjct: 439 VQKIRDAIRDQREITVQLINYTKSGKKFWNLFHLQPMRDQKGELQYFIGVQLDGSDHVEP 498
Query: 596 LRNSIPEATAEESEKLVKQTAENVNEAVKELPDANLTPEDLWANHSKVVHPKPHRKDSPP 655
L+N + E T +S KLVK TA NV+EAV+ELPDAN PEDLWA HSK V+P PH K+S
Sbjct: 499 LQNRLSERTEMQSSKLVKATATNVDEAVRELPDANTRPEDLWAAHSKPVYPLPHNKESTS 558
Query: 656 WKAIQKILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNK 715
WKAI+KI SGE + L HF+PIKPLGSGDTGSVHLVEL G+G+ +AMKAM+K +MLNRNK
Sbjct: 559 WKAIKKIQASGETVGLHHFKPIKPLGSGDTGSVHLVELKGTGELYAMKAMEKTMMLNRNK 618
Query: 716 VHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDA 775
HRAC EREI+ +LDHPF+P LYASFQT THVCLITD+CPGGELF LLDRQP K+L ED+
Sbjct: 619 AHRACIEREIISLLDHPFLPTLYASFQTSTHVCLITDFCPGGELFALLDRQPMKILTEDS 678
Query: 776 VRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTT 835
RFYAAEVV+ LEYLHC GI+YRDLKPEN+LL+ +GH+ L DFDLS +T+C PQL++P
Sbjct: 679 ARFYAAEVVIGLEYLHCLGIVYRDLKPENILLKKDGHIVLADFDLSFMTTCTPQLIIPAA 738
Query: 836 NEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEML 895
K+RR K Q P F+AEP SNSFVGTEEYIAPEII GAGHTSA+DWWALGILLYEML
Sbjct: 739 PSKRRRSKSQPLPTFVAEPSTQSNSFVGTEEYIAPEIITGAGHTSAIDWWALGILLYEML 798
Query: 896 YGYTPFRGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEI 955
YG TPFRGK RQKTFANILHKDL FPSS P SL +QL+ LL+RDP SRLGS GANEI
Sbjct: 799 YGRTPFRGKNRQKTFANILHKDLTFPSSIPVSLVGRQLINTLLNRDPSSRLGSKGGANEI 858
Query: 956 KKHPFFKGVNWALVRCMNPPELDAPLFATDTE---KEYKVVDPGM----QDLQQNVF 1005
K+H FF+G+NW L+R M+PP LDAPL + + K+ K D G+ DL ++F
Sbjct: 859 KQHAFFRGINWPLIRGMSPPPLDAPLSIIEKDPNAKDIKWEDDGVLVNSTDLDIDLF 915
|
Protein kinase that acts as a blue-light photoreceptor in a signal-transduction pathway for photo-induced movements. Mediates calcium spiking of extra- and intracellular origins in response to blue light. Involved in hypocotyl phototropism. Contributes to the chloroplast accumulation in low blue light and mediates their translocation (avoidance response) at high fluence. Regulates stomata opening and photomorphogenesis response of leaf tissue. Not involved in hypocotyl elongation inhibition, anthocyanin accumulation or cotyledon opening. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9ST27|PHOT2_ORYSJ Phototropin-2 OS=Oryza sativa subsp. japonica GN=PHOT2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 1067 bits (2760), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 520/800 (65%), Positives = 616/800 (77%), Gaps = 7/800 (0%)
Query: 187 LPRVSDIVKDALSTFQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGA 246
LPRVS +KDALS+ QQTFVVSDAT+PD PI+YAS GFF MTGY+ +EVVGRNCRFLQG
Sbjct: 86 LPRVSQELKDALSSLQQTFVVSDATRPDCPIIYASEGFFTMTGYSPREVVGRNCRFLQGP 145
Query: 247 GTDPEDVAKIRETLQNGQSYCGRLLNYKKDGTPFWNLLTIAPIKDDEGKVLKFIGMQVEV 306
TD +VAKIR+ +++G+S+CGRLLNY+KDG PFWNLLT+ PI+DD GKV+KFIGMQVEV
Sbjct: 146 DTDAAEVAKIRDAVKHGRSFCGRLLNYRKDGAPFWNLLTVTPIRDDNGKVIKFIGMQVEV 205
Query: 307 SKHTEGAKDKMLRPNGLPESLIRYDARQKEMATSSVTELVQAMKKPRSLSESTN----RP 362
SK+TEG DK +RPN LP SLIRYD RQK+ A SS+TE+VQ +K+PR + P
Sbjct: 206 SKYTEGLSDKRMRPNELPVSLIRYDERQKDKAMSSMTEVVQTVKQPRGARAPADAALLTP 265
Query: 363 PIIRKSEGGVEEERAGALGRRKSENVPPPRRNSYGGGCRTSMQRISEVPEKKKQKSGRRS 422
P + ++ A G S + R+S + +K SGR S
Sbjct: 266 PKMSDADKMAAMSPVVAPGTPSGGGGGAGSFKSPLWDLKKEESRLSRLASGRK--SGRSS 323
Query: 423 FMGL-IGRKSQSTDDHDSFENEIIMEGDDDYESDDERPDSVDDKVRQKEMRKGIDLATTL 481
MG IG++S E ER DS + R+K++R+GIDLATTL
Sbjct: 324 LMGFKIGKRSSVGSREAPAVVEEPAPAPPPAPEVVERTDSWERAEREKDIRQGIDLATTL 383
Query: 482 ERIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIRA 541
ERIEKNFVITDPR+PDNPIIFASDSFLELTEY+REEILGRNCRFLQGPETD TV KIR
Sbjct: 384 ERIEKNFVITDPRIPDNPIIFASDSFLELTEYTREEILGRNCRFLQGPETDQGTVDKIRE 443
Query: 542 AIDNQTDVTVQLINYTKSGKKFWNLFHLQPMRDQKGEVQYFIGVQLDGSEHLEPLRNSIP 601
AI Q ++TVQLINYTKSGKKFWNLFHLQPMRDQKGE+QYFIGVQLDGS+H+EPLRN +
Sbjct: 444 AIREQKEITVQLINYTKSGKKFWNLFHLQPMRDQKGELQYFIGVQLDGSDHVEPLRNRLS 503
Query: 602 EATAEESEKLVKQTAENVNEAVKELPDANLTPEDLWANHSKVVHPKPHRKDSPPWKAIQK 661
E T +S KLVK TAENV++AV+ELPDANL PEDLWA HS V PKPH++++P W AI+K
Sbjct: 504 ENTEIQSAKLVKATAENVDDAVRELPDANLRPEDLWAIHSMRVSPKPHKRNNPSWIAIEK 563
Query: 662 ILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACA 721
+ GE+I L+HF+P+KPLG GDTGSVHLVEL GSG+ FAMKAMDK VMLNRNKVHRAC
Sbjct: 564 ATNLGEKIGLKHFKPVKPLGCGDTGSVHLVELQGSGELFAMKAMDKSVMLNRNKVHRACI 623
Query: 722 EREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAA 781
EREI +LDHPF+P LY SFQT THVCLITD+CPGGELF +LDRQP K+ +E+ RFYAA
Sbjct: 624 EREIYALLDHPFLPTLYTSFQTPTHVCLITDFCPGGELFAVLDRQPMKIFREECARFYAA 683
Query: 782 EVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRR 841
EVV+ LEYLHC GIIYRDLKPEN+LLQ +GH+ LTDFDLS LT+ KP ++ +T+ K+RR
Sbjct: 684 EVVIGLEYLHCLGIIYRDLKPENILLQADGHIVLTDFDLSFLTTSKPHVIKNSTSLKRRR 743
Query: 842 HKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPF 901
+ P F++EP SNSFVGTEEYIAPE+I GAGHTSA+DWWALGILLYEMLYG TPF
Sbjct: 744 SQEFLPPTFVSEPSTPSNSFVGTEEYIAPEVITGAGHTSAIDWWALGILLYEMLYGRTPF 803
Query: 902 RGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFF 961
RGK R+KTF NILHKDL FPSS P SL AKQL++ LL RDP +R+GS+ GAN+IK+H FF
Sbjct: 804 RGKNRKKTFYNILHKDLTFPSSIPVSLAAKQLIHGLLQRDPSNRIGSNAGANDIKQHSFF 863
Query: 962 KGVNWALVRCMNPPELDAPL 981
+ +NW L+RCM+PPELD PL
Sbjct: 864 QDINWPLIRCMSPPELDVPL 883
|
Protein kinase that acts as a blue-light photoreceptor in a signal-transduction pathway for phototropic responses. Regulates a wide range of physiological activities in plants that maximize the efficiency of photosynthesis, such as chloroplast relocations, stomata opening, and leaf expansion. Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LFA2|KIPK_ARATH Serine/threonine-protein kinase KIPK OS=Arabidopsis thaliana GN=KIPK PE=1 SV=1 | Back alignment and function description |
|---|
Score = 345 bits (886), Expect = 7e-94, Method: Compositional matrix adjust.
Identities = 176/385 (45%), Positives = 232/385 (60%), Gaps = 54/385 (14%)
Query: 647 KPHRKDSPPWKAIQKILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMD 706
KPH W+AI+ I + L+HF +K LG GD G+V+L EL G+ FA+K MD
Sbjct: 511 KPHMSMDVRWEAIKHIKVQYGSLGLRHFNLLKKLGCGDIGTVYLAELIGTNCLFAIKVMD 570
Query: 707 KGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQ 766
+ R K RA AEREIL MLDHPF+P LYA F + CL+ +YCPGG+L +L +Q
Sbjct: 571 NEFLARRKKSPRAQAEREILKMLDHPFLPTLYAQFTSDNLSCLVMEYCPGGDLHVLRQKQ 630
Query: 767 PTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLS----- 821
+ E A RFY AE+++ALEYLH GIIYRDLKPEN+L++ +GH+ LTDFDLS
Sbjct: 631 LGRCFPEPAARFYVAEILLALEYLHMLGIIYRDLKPENILVREDGHIMLTDFDLSLRCAV 690
Query: 822 -------------------------------CLT--SCKPQLLLP--TTNEKKRR----- 841
C+T SC+ P ++N+++ R
Sbjct: 691 NPTLVRSNSPPGKDPARISGPYNTSNCIQPFCITEPSCQVSCFSPRLSSNQQQGRKPKRG 750
Query: 842 --------HKGQQNPVFMAEPMRA-SNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLY 892
H + P +AEP A SNSFVGT EY+APEII G GH +AVDWW G+LLY
Sbjct: 751 DHLSKTQQHLSRSLPQLVAEPTEARSNSFVGTHEYLAPEIIKGEGHGAAVDWWTFGVLLY 810
Query: 893 EMLYGYTPFRGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGA 952
E+LYG TPF+G +T AN++ ++LKFP S S AK L+ LL ++P++RLGS +G+
Sbjct: 811 ELLYGKTPFKGYNNDETLANVVLQNLKFPDSPLVSFQAKDLIRGLLVKEPENRLGSEKGS 870
Query: 953 NEIKKHPFFKGVNWALVRCMNPPEL 977
EIK+HPFF+G+NWAL+RC PPEL
Sbjct: 871 VEIKRHPFFEGLNWALIRCAIPPEL 895
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q0DCT8|G11A_ORYSJ Protein kinase G11A OS=Oryza sativa subsp. japonica GN=Os06g0291600 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 342 bits (876), Expect = 1e-92, Method: Compositional matrix adjust.
Identities = 185/432 (42%), Positives = 246/432 (56%), Gaps = 53/432 (12%)
Query: 603 ATAEESEKLV--KQTAENVNEAVKELPDANLTPEDLWANHSKVVHPKPHRKDSPPWKAIQ 660
A+A S +LV +T E + + P + D A S KPH+ + W+AIQ
Sbjct: 122 ASASGSARLVGRSETGERGFSSSRCRPSTSSDVSDESACSSISSVTKPHKANDSRWEAIQ 181
Query: 661 KILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRAC 720
I + L HF+ +K LG GD GSV+L EL G+ YFAMK MDK + +R K+ RA
Sbjct: 182 MIRTRDGILGLSHFKLLKKLGCGDIGSVYLSELSGTKSYFAMKVMDKASLASRKKLLRAQ 241
Query: 721 AEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYA 780
E+EIL LDHPF+P LY F+T CL+ ++CPGG+L L RQ K E AV+FY
Sbjct: 242 TEKEILQCLDHPFLPTLYTHFETDKFSCLVMEFCPGGDLHTLRQRQRGKYFPEQAVKFYV 301
Query: 781 AEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLL--------- 831
AE+++A+EYLH GIIYRDLKPENVL++ +GH+ L+DFDLS + P L+
Sbjct: 302 AEILLAMEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTLIRSSNPDAEA 361
Query: 832 --------------------------LPTT---------NEKKRRHKGQQN------PVF 850
PTT ++K R+ K + P
Sbjct: 362 LRKNNQAYCVQPACVEPSCMIQPSCATPTTCFGPRFFSKSKKDRKPKPEVVNQVSPWPEL 421
Query: 851 MAEPMRA-SNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKT 909
+AEP A S SFVGT EY+APEII G GH SAVDWW GI LYE+L+G TPF+G + T
Sbjct: 422 IAEPSDARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRAT 481
Query: 910 FANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVNWALV 969
N++ + L+FP S A+ L+ LL ++P+ RLG GA EIK+HPFF+GVNWAL+
Sbjct: 482 LFNVIGQPLRFPEYPVVSFSARDLIRGLLVKEPQQRLGCKRGATEIKQHPFFEGVNWALI 541
Query: 970 RCMNPPELDAPL 981
RC +PPE+ P+
Sbjct: 542 RCASPPEVPRPV 553
|
May play a role in the regulation of metabolism and signal transduction processes. Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|A2YBX5|G11A_ORYSI Protein kinase G11A OS=Oryza sativa subsp. indica GN=OsI_021818 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 341 bits (875), Expect = 2e-92, Method: Compositional matrix adjust.
Identities = 185/432 (42%), Positives = 246/432 (56%), Gaps = 53/432 (12%)
Query: 603 ATAEESEKLV--KQTAENVNEAVKELPDANLTPEDLWANHSKVVHPKPHRKDSPPWKAIQ 660
A+A S +LV +T E + + P + D A S KPH+ + W+AIQ
Sbjct: 122 ASASGSARLVGRSETGERGFSSSRCRPSTSSDVSDESACSSISSVTKPHKANDSRWEAIQ 181
Query: 661 KILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRAC 720
I + L HF+ +K LG GD GSV+L EL G+ YFAMK MDK + +R K+ RA
Sbjct: 182 MIRTRDGILGLSHFKLLKKLGCGDIGSVYLSELNGTKSYFAMKVMDKASLASRKKLLRAQ 241
Query: 721 AEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYA 780
E+EIL LDHPF+P LY F+T CL+ ++CPGG+L L RQ K E AV+FY
Sbjct: 242 TEKEILQCLDHPFLPTLYTHFETDKFSCLVMEFCPGGDLHTLRQRQRGKYFPEQAVKFYV 301
Query: 781 AEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLL--------- 831
AE+++A+EYLH GIIYRDLKPENVL++ +GH+ L+DFDLS + P L+
Sbjct: 302 AEILLAMEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTLIRSSNPDAEA 361
Query: 832 --------------------------LPTT---------NEKKRRHKGQQN------PVF 850
PTT ++K R+ K + P
Sbjct: 362 LRKNNQAYCVQPACVEPSCMIQPSCATPTTCFGPRFFSKSKKDRKPKPEVVNQVSPWPEL 421
Query: 851 MAEPMRA-SNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKT 909
+AEP A S SFVGT EY+APEII G GH SAVDWW GI LYE+L+G TPF+G + T
Sbjct: 422 IAEPSDARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRAT 481
Query: 910 FANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVNWALV 969
N++ + L+FP S A+ L+ LL ++P+ RLG GA EIK+HPFF+GVNWAL+
Sbjct: 482 LFNVIGQPLRFPEYPVVSFSARDLIRGLLVKEPQQRLGCKRGATEIKQHPFFEGVNWALI 541
Query: 970 RCMNPPELDAPL 981
RC +PPE+ P+
Sbjct: 542 RCASPPEVPRPV 553
|
May play a role in the regulation of metabolism and signal transduction processes. Oryza sativa subsp. indica (taxid: 39946) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P15792|KPK1_PHAVU Protein kinase PVPK-1 OS=Phaseolus vulgaris PE=2 SV=1 | Back alignment and function description |
|---|
Score = 337 bits (865), Expect = 2e-91, Method: Compositional matrix adjust.
Identities = 171/380 (45%), Positives = 223/380 (58%), Gaps = 49/380 (12%)
Query: 647 KPHRKDSPPWKAIQKILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMD 706
KPH+ + W+AIQ + + ++HFR +K LG GD GSV+L EL G+ FAMK M+
Sbjct: 202 KPHKANDIRWEAIQAVRTRDGMLEMRHFRLLKKLGCGDIGSVYLAELSGTRTSFAMKVMN 261
Query: 707 KGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQ 766
K + NR K+ RA EREIL LDHPF+P LY F+T+ CL+ ++CPGG+L L RQ
Sbjct: 262 KTELANRKKLLRAQTEREILQSLDHPFLPTLYTHFETEIFSCLVMEFCPGGDLHALRQRQ 321
Query: 767 PTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSC 826
P K E AVRFY AEV+++LEYLH GIIYRDLKPENVL++ +GH+ L+DFDLS S
Sbjct: 322 PGKYFSEHAVRFYVAEVLLSLEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCSV 381
Query: 827 KPQLLLPTTNEKKRRH-------------------------------------------- 842
P L+ + N + +
Sbjct: 382 SPTLVKSSNNLQTKSSGYCVQPSCIEPTCVMQPDCIKPSCFTPRFLSGKSKKDKKSKPKN 441
Query: 843 --KGQQNPV--FMAEPMRA-SNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYG 897
Q P+ +AEP A S SFVGT EY+APEII G GH SAVDWW GI LYE+L+G
Sbjct: 442 DMHNQVTPLPELIAEPTNARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFG 501
Query: 898 YTPFRGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKK 957
TPF+G + T N++ + L+FP S S A+ L+ LL ++P+ RL GA EIK+
Sbjct: 502 RTPFKGSANRATLFNVIGQPLRFPESPTVSFAARDLIRGLLVKEPQHRLAYRRGATEIKQ 561
Query: 958 HPFFKGVNWALVRCMNPPEL 977
HPFF+ VNWAL+RC PPE+
Sbjct: 562 HPFFQNVNWALIRCATPPEV 581
|
Phaseolus vulgaris (taxid: 3885) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q05999|KPK7_ARATH Serine/threonine-protein kinase AtPK7 OS=Arabidopsis thaliana GN=PK7 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 323 bits (827), Expect = 6e-87, Method: Compositional matrix adjust.
Identities = 169/388 (43%), Positives = 230/388 (59%), Gaps = 49/388 (12%)
Query: 647 KPHRKDSPP-WKAIQKILDS-GEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKA 704
KPHR ++ W AIQ++ G + + F+ IK LG GD G+V+L EL G+G FA+K
Sbjct: 153 KPHRDNNDKRWVAIQEVRSRVGSSLEAKDFKLIKKLGGGDIGNVYLAELIGTGVSFAVKV 212
Query: 705 MDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLD 764
M+K + R K+ RA E+EIL LDHPF+P LY+ F+T+ + CL+ ++CPGG+L L
Sbjct: 213 MEKAAIAARKKLVRAQTEKEILQSLDHPFLPTLYSHFETEMNSCLVMEFCPGGDLHSLRQ 272
Query: 765 RQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLT 824
+Q K E A RFY AEV++A+EYLH GIIYRDLKPENVL++ +GH+ L+DFDLS
Sbjct: 273 KQRGKYFPEQAARFYVAEVLLAMEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRC 332
Query: 825 SCKPQL----------------LLPTTNEK---------------------KRRHKGQQN 847
+ P L + PT ++ K +H+ + N
Sbjct: 333 AVSPTLVRFAAITLESKSSSYCIQPTCVDQSSCIVQPDCIQPVCFTPRFLSKGKHRKKSN 392
Query: 848 ---------PVFMAEPMRA-SNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYG 897
P +AEP A S SFVGT EY+APEII G GH SAVDWW GI LYE+L+G
Sbjct: 393 DMSRQIRPLPELIAEPTSARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFG 452
Query: 898 YTPFRGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKK 957
TPFRG + T N++ + L+FP S A+ L+ LL ++P+ RL GA EIK+
Sbjct: 453 ITPFRGGDNRATLFNVVGQPLRFPEHPNVSFAARDLIRGLLVKEPQHRLAYRRGATEIKQ 512
Query: 958 HPFFKGVNWALVRCMNPPELDAPLFATD 985
HPFF+ VNWAL+RC +PP++ P+ D
Sbjct: 513 HPFFQSVNWALIRCTSPPQIPQPVKPMD 540
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST 
Original result of BLAST against Nonredundant Database
GI ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 1005 | ||||||
| 225435157 | 1004 | PREDICTED: phototropin-1-like [Vitis vin | 0.988 | 0.989 | 0.797 | 0.0 | |
| 297746173 | 958 | unnamed protein product [Vitis vinifera] | 0.950 | 0.996 | 0.785 | 0.0 | |
| 224055599 | 977 | predicted protein [Populus trichocarpa] | 0.965 | 0.992 | 0.785 | 0.0 | |
| 401782496 | 1028 | phototropin 1 [Fragaria x ananassa] | 0.972 | 0.950 | 0.762 | 0.0 | |
| 255582071 | 1006 | serine/threonine protein kinase, putativ | 0.983 | 0.982 | 0.769 | 0.0 | |
| 350535803 | 1018 | phototropin-1 [Solanum lycopersicum] gi| | 0.970 | 0.957 | 0.738 | 0.0 | |
| 449460993 | 952 | PREDICTED: phototropin-1-like [Cucumis s | 0.876 | 0.925 | 0.806 | 0.0 | |
| 60099454 | 976 | phototropin [Phaseolus vulgaris] | 0.957 | 0.985 | 0.734 | 0.0 | |
| 356542583 | 977 | PREDICTED: phototropin-1-like [Glycine m | 0.958 | 0.985 | 0.738 | 0.0 | |
| 15231245 | 996 | non-specific serine/threonine protein ki | 0.974 | 0.982 | 0.730 | 0.0 |
| >gi|225435157|ref|XP_002281752.1| PREDICTED: phototropin-1-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 1635 bits (4234), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 810/1016 (79%), Positives = 892/1016 (87%), Gaps = 23/1016 (2%)
Query: 1 MREMDQSEKSPKQSSKACESPLSRDSRGSLEVFNPSTFSTRPTNPVFRPQPTWQTWMEQR 60
M D S KSP + PL RDSRGSLEVFNPST+STRPTN FRPQPTW++W E R
Sbjct: 1 MEASDDSAKSP-----SLIPPLPRDSRGSLEVFNPSTYSTRPTNQAFRPQPTWKSWAEPR 55
Query: 61 ESPEPEHA-KLNSKSSR-AEEITSWMALKDPAPQ------KPSLPPLIQKMTNDQEKSTV 112
+PE E + +L+SKS R A+EITSWMALK+P+P + S+ P + ++K T
Sbjct: 56 GTPEREGSPELSSKSGRSADEITSWMALKEPSPAPPLPLAQKSVSPAFNVQDDTRQKPTR 115
Query: 113 TKQLSGEAGAAAQRAAEWGLVLKTDTETGKPQAVVARTSGGDDPNGKPGTSRRNSNNSVR 172
QLSGE AAQRAAEWGL+LKTDTETGKPQ V RTSGGD+PN K GTSRRNS NSVR
Sbjct: 116 KTQLSGEVDNAAQRAAEWGLMLKTDTETGKPQGVAVRTSGGDEPNYKTGTSRRNSGNSVR 175
Query: 173 SSGEMSDEGG--KEKGLPRVSDIVKDALSTFQQTFVVSDATKPDYPIMYASAGFFKMTGY 230
SSGEMSDEGG K++ PRVS+ +KDALSTFQQTFVVSDATKPDYPI+YASAGFFKMTGY
Sbjct: 176 SSGEMSDEGGAGKDRAFPRVSEDLKDALSTFQQTFVVSDATKPDYPILYASAGFFKMTGY 235
Query: 231 TSKEVVGRNCRFLQGAGTDPEDVAKIRETLQNGQSYCGRLLNYKKDGTPFWNLLTIAPIK 290
TSKEV+GRNCRFLQG+GTDPEDVAKIRE L G SYCGRLLNYKKDGTPFWNLLTI+PIK
Sbjct: 236 TSKEVIGRNCRFLQGSGTDPEDVAKIREALHAGNSYCGRLLNYKKDGTPFWNLLTISPIK 295
Query: 291 DDEGKVLKFIGMQVEVSKHTEGAKDKMLRPNGLPESLIRYDARQKEMATSSVTELVQAMK 350
D+ G VLKFIGMQVEVSKHTEG+K+KM RPNGLPESLIRYDARQK+MAT+SV+ELVQA+K
Sbjct: 296 DENGNVLKFIGMQVEVSKHTEGSKEKMTRPNGLPESLIRYDARQKDMATNSVSELVQAVK 355
Query: 351 KPRSLSESTNRPPIIRKSEGGVEEERAGALGRRKSENVPPPRRNSYGGGCRTSMQRISEV 410
KPRSLSES++RP +RKSE G E+ER A GRR SE+V PPRRNS G R SMQRISE+
Sbjct: 356 KPRSLSESSDRP-FMRKSEDG-EQERPEAPGRRNSESVAPPRRNSQSGR-RASMQRISEL 412
Query: 411 PEKKKQKSGRRSFMGLIGRKSQSTDDHDSFENEIIMEGDDDYESDDERPDSVDDKVRQKE 470
PEKK +KS R SFM ++ RKSQ+ + F+ E++++ D DDERPDS+D+K RQ+E
Sbjct: 413 PEKKPRKSSRLSFMRIM-RKSQAHTEE--FDTEVLVD-DTSDSEDDERPDSIDNKTRQRE 468
Query: 471 MRKGIDLATTLERIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPE 530
MR+GIDLATTLERIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPE
Sbjct: 469 MRRGIDLATTLERIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPE 528
Query: 531 TDPATVRKIRAAIDNQTDVTVQLINYTKSGKKFWNLFHLQPMRDQKGEVQYFIGVQLDGS 590
TDPATVRKIR AIDNQTDVTVQLINYTKSGKKFWNLFHLQPMRDQKGEVQYFIGVQLDGS
Sbjct: 529 TDPATVRKIREAIDNQTDVTVQLINYTKSGKKFWNLFHLQPMRDQKGEVQYFIGVQLDGS 588
Query: 591 EHLEPLRNSIPEATAEESEKLVKQTAENVNEAVKELPDANLTPEDLWANHSKVVHPKPHR 650
EH+EPL N IPE+TA+ES KLVK+TAEN+++AV+ELPDANL PEDLW+NHSKVV PKPHR
Sbjct: 589 EHVEPLHNCIPESTAKESAKLVKETAENIDDAVRELPDANLKPEDLWSNHSKVVLPKPHR 648
Query: 651 KDSPPWKAIQKILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVM 710
K+S WKAIQKIL+ GEQI L+HFRP+KPLGSGDTGSVHLVELCG+G+YFAMKAMDK VM
Sbjct: 649 KESSAWKAIQKILEDGEQIGLKHFRPVKPLGSGDTGSVHLVELCGTGEYFAMKAMDKNVM 708
Query: 711 LNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKV 770
LNRNKVHRACAEREILDMLDHPF+PALYASFQTKTH+CLITDYCPGGELFLLLDRQPTKV
Sbjct: 709 LNRNKVHRACAEREILDMLDHPFLPALYASFQTKTHICLITDYCPGGELFLLLDRQPTKV 768
Query: 771 LKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQL 830
LKEDAVRFYAAEVVVALEYLHCQG+IYRDLKPENVLLQ +GHV+LTDFDLSCLTSCKPQL
Sbjct: 769 LKEDAVRFYAAEVVVALEYLHCQGVIYRDLKPENVLLQSSGHVALTDFDLSCLTSCKPQL 828
Query: 831 LLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGIL 890
L+P TNEKKR+HKGQQNP+FMAEPMRASNSFVGTEEYIAPEII GAGHTSAVDWWALGIL
Sbjct: 829 LMPNTNEKKRQHKGQQNPIFMAEPMRASNSFVGTEEYIAPEIITGAGHTSAVDWWALGIL 888
Query: 891 LYEMLYGYTPFRGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHE 950
LYEMLYGYTPFRGKTRQKTFANILHKDLKFPSS SL+AKQLMYRLLHRDPK+RLGS E
Sbjct: 889 LYEMLYGYTPFRGKTRQKTFANILHKDLKFPSSISVSLNAKQLMYRLLHRDPKNRLGSRE 948
Query: 951 GANEIKKHPFFKGVNWALVRCMNPPELDA-PLFATDTEKEYKVVDPGMQDLQQNVF 1005
GANEIK+HPFF+GVNWALVRCMNPPELDA PL TD EKE K VDP + DLQ N+F
Sbjct: 949 GANEIKRHPFFRGVNWALVRCMNPPELDAPPLETTDAEKEVKSVDPELLDLQTNIF 1004
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297746173|emb|CBI16229.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 1595 bits (4130), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 792/1008 (78%), Positives = 866/1008 (85%), Gaps = 53/1008 (5%)
Query: 1 MREMDQSEKSPKQSSKACESPLSRDSRGSLEVFNPSTFSTRPTNPVFRPQPTWQTWMEQR 60
M D S KSP + PL RDSRGSLEVFNPST+STRPTN FRPQPTW++W E R
Sbjct: 1 MEASDDSAKSP-----SLIPPLPRDSRGSLEVFNPSTYSTRPTNQAFRPQPTWKSWAEPR 55
Query: 61 ESPEPEHAKLNSKSSRAEEITSWMALKDPAPQKPSLPPLIQKMTNDQEKSTVTKQLSGEA 120
S A+EITSWMALK+P+ +KS
Sbjct: 56 RS--------------ADEITSWMALKEPS---------PAPPLPLAQKS---------- 82
Query: 121 GAAAQRAAEWGLVLKTDTETGKPQAVVARTSGGDDPNGKPGTSRRNSNNSVRSSGEMSDE 180
RAAEWGL+LKTDTETGKPQ V RTSGGD+PN K GTSRRNS NSVRSSGEMSDE
Sbjct: 83 -----RAAEWGLMLKTDTETGKPQGVAVRTSGGDEPNYKTGTSRRNSGNSVRSSGEMSDE 137
Query: 181 GG--KEKGLPRVSDIVKDALSTFQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGR 238
GG K++ PRVS+ +KDALSTFQQTFVVSDATKPDYPI+YASAGFFKMTGYTSKEV+GR
Sbjct: 138 GGAGKDRAFPRVSEDLKDALSTFQQTFVVSDATKPDYPILYASAGFFKMTGYTSKEVIGR 197
Query: 239 NCRFLQGAGTDPEDVAKIRETLQNGQSYCGRLLNYKKDGTPFWNLLTIAPIKDDEGKVLK 298
NCRFLQG+GTDPEDVAKIRE L G SYCGRLLNYKKDGTPFWNLLTI+PIKD+ G VLK
Sbjct: 198 NCRFLQGSGTDPEDVAKIREALHAGNSYCGRLLNYKKDGTPFWNLLTISPIKDENGNVLK 257
Query: 299 FIGMQVEVSKHTEGAKDKMLRPNGLPESLIRYDARQKEMATSSVTELVQAMKKPRSLSES 358
FIGMQVEVSKHTEG+K+KM RPNGLPESLIRYDARQK+MAT+SV+ELVQA+KKPRSLSES
Sbjct: 258 FIGMQVEVSKHTEGSKEKMTRPNGLPESLIRYDARQKDMATNSVSELVQAVKKPRSLSES 317
Query: 359 TNRPPIIRKSEGGVEEERAGALGRRKSENVPPPRRNSYGGGCRTSMQRISEVPEKKKQKS 418
++RP +RKSE G E+ER A GRR SE+V PPRRNS G R SMQRISE+PEKK +KS
Sbjct: 318 SDRP-FMRKSEDG-EQERPEAPGRRNSESVAPPRRNSQSGR-RASMQRISELPEKKPRKS 374
Query: 419 GRRSFMGLIGRKSQSTDDHDSFENEIIMEGDDDYESDDERPDSVDDKVRQKEMRKGIDLA 478
R SFM ++ RKSQ+ + F+ E++++ D DDERPDS+D+K RQ+EMR+GIDLA
Sbjct: 375 SRLSFMRIM-RKSQAHTEE--FDTEVLVD-DTSDSEDDERPDSIDNKTRQREMRRGIDLA 430
Query: 479 TTLERIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRK 538
TTLERIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRK
Sbjct: 431 TTLERIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRK 490
Query: 539 IRAAIDNQTDVTVQLINYTKSGKKFWNLFHLQPMRDQKGEVQYFIGVQLDGSEHLEPLRN 598
IR AIDNQTDVTVQLINYTKSGKKFWNLFHLQPMRDQKGEVQYFIGVQLDGSEH+EPL N
Sbjct: 491 IREAIDNQTDVTVQLINYTKSGKKFWNLFHLQPMRDQKGEVQYFIGVQLDGSEHVEPLHN 550
Query: 599 SIPEATAEESEKLVKQTAENVNEAVKELPDANLTPEDLWANHSKVVHPKPHRKDSPPWKA 658
IPE+TA+ES KLVK+TAEN+++AV+ELPDANL PEDLW+NHSKVV PKPHRK+S WKA
Sbjct: 551 CIPESTAKESAKLVKETAENIDDAVRELPDANLKPEDLWSNHSKVVLPKPHRKESSAWKA 610
Query: 659 IQKILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHR 718
IQKIL+ GEQI L+HFRP+KPLGSGDTGSVHLVELCG+G+YFAMKAMDK VMLNRNKVHR
Sbjct: 611 IQKILEDGEQIGLKHFRPVKPLGSGDTGSVHLVELCGTGEYFAMKAMDKNVMLNRNKVHR 670
Query: 719 ACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRF 778
ACAEREILDMLDHPF+PALYASFQTKTH+CLITDYCPGGELFLLLDRQPTKVLKEDAVRF
Sbjct: 671 ACAEREILDMLDHPFLPALYASFQTKTHICLITDYCPGGELFLLLDRQPTKVLKEDAVRF 730
Query: 779 YAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEK 838
YAAEVVVALEYLHCQG+IYRDLKPENVLLQ +GHV+LTDFDLSCLTSCKPQLL+P TNEK
Sbjct: 731 YAAEVVVALEYLHCQGVIYRDLKPENVLLQSSGHVALTDFDLSCLTSCKPQLLMPNTNEK 790
Query: 839 KRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGY 898
KR+HKGQQNP+FMAEPMRASNSFVGTEEYIAPEII GAGHTSAVDWWALGILLYEMLYGY
Sbjct: 791 KRQHKGQQNPIFMAEPMRASNSFVGTEEYIAPEIITGAGHTSAVDWWALGILLYEMLYGY 850
Query: 899 TPFRGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKH 958
TPFRGKTRQKTFANILHKDLKFPSS SL+AKQLMYRLLHRDPK+RLGS EGANEIK+H
Sbjct: 851 TPFRGKTRQKTFANILHKDLKFPSSISVSLNAKQLMYRLLHRDPKNRLGSREGANEIKRH 910
Query: 959 PFFKGVNWALVRCMNPPELDA-PLFATDTEKEYKVVDPGMQDLQQNVF 1005
PFF+GVNWALVRCMNPPELDA PL TD EKE K VDP + DLQ N+F
Sbjct: 911 PFFRGVNWALVRCMNPPELDAPPLETTDAEKEVKSVDPELLDLQTNIF 958
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224055599|ref|XP_002298559.1| predicted protein [Populus trichocarpa] gi|222845817|gb|EEE83364.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 1581 bits (4094), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 793/1009 (78%), Positives = 868/1009 (86%), Gaps = 39/1009 (3%)
Query: 4 MDQSEKSPKQSSKACESPLSRDSRGSLEVFNPST-FSTRPTNPVFRP-QPTWQTWMEQ-- 59
M+ ++KS KQSS PL RDSRGSLEVFNPS+ + RPTNP FR PTW++W++
Sbjct: 1 MEATDKSSKQSSGNV-PPLPRDSRGSLEVFNPSSAYLNRPTNPAFRSSNPTWKSWVDSSA 59
Query: 60 RESPEPEHAKLNSKSSRAEEITSWMALKDPAPQKPSLPPLIQKMTNDQEKSTVTKQLSGE 119
+ PEPE A + TSWMALKDP +KP +QLSGE
Sbjct: 60 KNEPEPEEAPIT---------TSWMALKDP--KKPK------------------QQLSGE 90
Query: 120 AGAAAQRAAEWGLVLKTDTETGKPQAVVARTSGGDDPNGKPGTSRRNSNNSVRSSGEMSD 179
G A +RAAEWGLVLKTD ETGKPQ V RTSGGDDPN KPGTSRR+SNNSVR+SGE+SD
Sbjct: 91 IGVATKRAAEWGLVLKTDDETGKPQGVSVRTSGGDDPNAKPGTSRRDSNNSVRNSGELSD 150
Query: 180 EGG--KEKGLPRVSDIVKDALSTFQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVG 237
+GG +PRVS+ +++ALSTFQQTFVVSDATKPDYPI+YASAGFFKMTGYTSKEV+G
Sbjct: 151 DGGTSNNSNIPRVSEDIRNALSTFQQTFVVSDATKPDYPILYASAGFFKMTGYTSKEVIG 210
Query: 238 RNCRFLQGAGTDPEDVAKIRETLQNGQSYCGRLLNYKKDGTPFWNLLTIAPIKDDEGKVL 297
RNCRFLQGAGTDPEDVAKIRE L+ +YCGRLLNYKKDG+PFWNLLTIAPIKDD GKVL
Sbjct: 211 RNCRFLQGAGTDPEDVAKIREALRGEGTYCGRLLNYKKDGSPFWNLLTIAPIKDDSGKVL 270
Query: 298 KFIGMQVEVSKHTEGAKDKMLRPNGLPESLIRYDARQKEMATSSVTELVQAMKKPRSLSE 357
KFIGM VEVSKHTEG+KDK LRPNGLP SLIRYDARQKEMATSSVTELVQA+ +PR+LSE
Sbjct: 271 KFIGMLVEVSKHTEGSKDKTLRPNGLPGSLIRYDARQKEMATSSVTELVQAVNRPRALSE 330
Query: 358 STNRPPIIRKSEGGVEEERAGALGRRKSENVPPPRRNSYGGGCRTSMQRISEVPEKKKQK 417
STNRP ++RKSEGG E ER GA+GRR SENV P RRNS+ G R SMQRISE+PEKK +K
Sbjct: 331 STNRP-LMRKSEGGGEGERKGAIGRRNSENVAPNRRNSHRG-TRNSMQRISELPEKKPRK 388
Query: 418 SGRRSFMGLIGRKSQSTDDHDSFENEIIMEGDDDYESDDERPDSVDDKVRQKEMRKGIDL 477
S R SFMGL+ + + S D+ + + + D + DD R DS+DDKVR+KEMRKGIDL
Sbjct: 389 SSRLSFMGLMRKSTHSNDESFDVGITLDDDFESDDDDDDARLDSLDDKVRKKEMRKGIDL 448
Query: 478 ATTLERIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVR 537
ATTLERIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVR
Sbjct: 449 ATTLERIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVR 508
Query: 538 KIRAAIDNQTDVTVQLINYTKSGKKFWNLFHLQPMRDQKGEVQYFIGVQLDGSEHLEPLR 597
KIR AIDNQTDVTVQLINYTKSGKKFWNLFHLQPMRDQKGEVQYFIGVQLDGSEH+EP
Sbjct: 509 KIREAIDNQTDVTVQLINYTKSGKKFWNLFHLQPMRDQKGEVQYFIGVQLDGSEHVEPRT 568
Query: 598 NSIPEATAEESEKLVKQTAENVNEAVKELPDANLTPEDLWANHSKVVHPKPHRKDSPPWK 657
NSIPEATA ESE+LVKQTAENV++A +ELPDAN+ PEDLWANHSKVV+PKPHRKDSP WK
Sbjct: 569 NSIPEATAIESEQLVKQTAENVDDAARELPDANMRPEDLWANHSKVVYPKPHRKDSPSWK 628
Query: 658 AIQKILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVH 717
AIQKIL+SGEQ+ L+HFRP+KPLGSGDTGSVHLVEL G+GQ+FAMK MDK MLNRNKVH
Sbjct: 629 AIQKILESGEQLGLKHFRPVKPLGSGDTGSVHLVELYGTGQFFAMKTMDKAAMLNRNKVH 688
Query: 718 RACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVR 777
RACAEREILDMLDHPF+PALYASFQTKTH+CLITDYCPGGELFLLLDRQP KVLKEDAVR
Sbjct: 689 RACAEREILDMLDHPFLPALYASFQTKTHICLITDYCPGGELFLLLDRQPKKVLKEDAVR 748
Query: 778 FYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNE 837
FYAAEVV+ALEYLHCQGIIYRDLKPENVLLQ NGHV+LTDFDLSCLTSCKPQLL+P+TNE
Sbjct: 749 FYAAEVVIALEYLHCQGIIYRDLKPENVLLQSNGHVALTDFDLSCLTSCKPQLLIPSTNE 808
Query: 838 KKRRHKGQQN-PVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY 896
KKR K QQ PVFMAEPMRASNSFVGTEEYIAPEII GAGHTSAVDWWALGILLYEMLY
Sbjct: 809 KKRHRKHQQAPPVFMAEPMRASNSFVGTEEYIAPEIITGAGHTSAVDWWALGILLYEMLY 868
Query: 897 GYTPFRGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIK 956
GYTPFRGKTRQKTFANILHKDLKFP S P SL+AKQLMYRLLHRDPK+RLGS EGAN+IK
Sbjct: 869 GYTPFRGKTRQKTFANILHKDLKFPGSIPVSLNAKQLMYRLLHRDPKNRLGSREGANDIK 928
Query: 957 KHPFFKGVNWALVRCMNPPELDAPLFATDTEKEYKVVDPGMQDLQQNVF 1005
+HPFFKGVNWALVRC+NPPEL+AP + EKE KVVDPGMQDLQ N+F
Sbjct: 929 RHPFFKGVNWALVRCLNPPELEAPFLESGEEKEAKVVDPGMQDLQTNIF 977
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|401782496|dbj|BAM36551.1| phototropin 1 [Fragaria x ananassa] | Back alignment and taxonomy information |
|---|
Score = 1541 bits (3990), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 779/1021 (76%), Positives = 855/1021 (83%), Gaps = 44/1021 (4%)
Query: 21 PLSRDSRGSLEVFNPSTFSTRPTNPV-FRPQ--PTWQTWMEQRES-----PEPEHAKLNS 72
PL RDSRGSLE+FNPS STRP +P FR TW+TW++ R++ S
Sbjct: 16 PLPRDSRGSLEIFNPS--STRPASPPPFRQSKPATWKTWLDPRDTLNPKPDPSPPPIPAS 73
Query: 73 KSSRAE-EITSWMALKD----------PAPQKPSLPPLIQKMTNDQEKSTVTKQLSGEAG 121
KS R + ITSWMALKD P+ Q PP IQ+ + V + + E G
Sbjct: 74 KSGRDDGTITSWMALKDFPPTPPPPSKPSKQSQQAPPYIQQQQTIS--AAVNDKSTPEHG 131
Query: 122 AAAQRAAEWGLVLKTDTETGKPQAVVARTSGG-DDPNGKPGTSRRNSNNSVRSSGEMSDE 180
AAQRAAEWGLVLKTDTETGKPQ V R SGG +DP+ KPGTSRRNSNNSVRSSGE+SD+
Sbjct: 132 DAAQRAAEWGLVLKTDTETGKPQGVTTRNSGGPEDPSHKPGTSRRNSNNSVRSSGELSDD 191
Query: 181 GGKEKG----LPRVSDIVKDALSTFQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVV 236
GG G PRVS+ +K+ LSTFQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEV+
Sbjct: 192 GGGGGGIGKGFPRVSEDLKNVLSTFQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVI 251
Query: 237 GRNCRFLQGAGTDPEDVAKIRETLQNGQSYCGRLLNYKKDGTPFWNLLTIAPIKDDEGKV 296
GRNCRFLQGA TDPEDVA++RE L SYCGRLLNYKKDGTPFWNLLTIAPIKD+ GKV
Sbjct: 252 GRNCRFLQGADTDPEDVAQLREALAKNTSYCGRLLNYKKDGTPFWNLLTIAPIKDETGKV 311
Query: 297 LKFIGMQVEVSKHTEGAKDKMLRPNGLPESLIRYDARQKEMATSSVTELVQAMKKPRSLS 356
LKFIGMQVEVSKHTEG+KDKMLRPNGLPESLIRYDARQKE AT SVTELVQA+++PRSLS
Sbjct: 312 LKFIGMQVEVSKHTEGSKDKMLRPNGLPESLIRYDARQKEKATHSVTELVQAVRRPRSLS 371
Query: 357 ESTNRPPIIRKSEGGVEEER---------AGALGRRKSENVPPPRRNSYGGGCRTSMQRI 407
ESTNRP RKS GG E + +L RR SE+V PPRRNS G SM I
Sbjct: 372 ESTNRP--FRKSGGGGRGEEVIEAHARPSSESLPRRNSESVAPPRRNSLGDA-NFSMHSI 428
Query: 408 SEVPEKKKQKSGRRSFMGLIGRKSQSTD--DHDSFENEIIMEGDDDYESDDERPDSVDDK 465
EVPEKK++K RRSFMG++ +KSQ+ + D D+F+ E D +DERP S+DDK
Sbjct: 429 KEVPEKKQKKPRRRSFMGIM-KKSQTQNQLDDDTFDEFGASEDVRDDSDNDERPMSLDDK 487
Query: 466 VRQKEMRKGIDLATTLERIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRF 525
VR+KEMRKG+DLATTLERIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRF
Sbjct: 488 VRKKEMRKGMDLATTLERIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRF 547
Query: 526 LQGPETDPATVRKIRAAIDNQTDVTVQLINYTKSGKKFWNLFHLQPMRDQKGEVQYFIGV 585
LQGPETDPATV+KIR AIDNQT+VTVQLINYTKSGKKFWN+FHLQPMRDQKGEVQYFIGV
Sbjct: 548 LQGPETDPATVKKIREAIDNQTEVTVQLINYTKSGKKFWNVFHLQPMRDQKGEVQYFIGV 607
Query: 586 QLDGSEHLEPLRNSIPEATAEESEKLVKQTAENVNEAVKELPDANLTPEDLWANHSKVVH 645
QLDGS+H+EPL+NSIPE A+ESEKLVK+TA NV+EA +ELPDAN+ PEDLW NHSKVVH
Sbjct: 608 QLDGSQHIEPLQNSIPEVAAKESEKLVKETAVNVDEAARELPDANMKPEDLWMNHSKVVH 667
Query: 646 PKPHRKDSPPWKAIQKILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAM 705
PKPHRKDSPPW AIQKILDSGEQI L+HF+PIKPLGSGDTGSVHLV+LCG+ QYFAMKAM
Sbjct: 668 PKPHRKDSPPWIAIQKILDSGEQIGLKHFKPIKPLGSGDTGSVHLVQLCGTDQYFAMKAM 727
Query: 706 DKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDR 765
DK +MLNRNKVHRACAEREILDMLDHPF+PALYASFQTKTHVCLITDY PGGELFLLLD
Sbjct: 728 DKNIMLNRNKVHRACAEREILDMLDHPFLPALYASFQTKTHVCLITDYYPGGELFLLLDT 787
Query: 766 QPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTS 825
QPTKVLKE++VRFY AEVVVALEYLHCQGIIYRDLKPENVLLQ NGHV+LTDFDLSCLTS
Sbjct: 788 QPTKVLKENSVRFYVAEVVVALEYLHCQGIIYRDLKPENVLLQSNGHVTLTDFDLSCLTS 847
Query: 826 CKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWW 885
CKPQLLLPT NEKKR HK Q +P+FMAEPMRASNSFVGTEEYIAPEII GAGH+SAVDWW
Sbjct: 848 CKPQLLLPTINEKKRHHKRQHDPIFMAEPMRASNSFVGTEEYIAPEIITGAGHSSAVDWW 907
Query: 886 ALGILLYEMLYGYTPFRGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSR 945
ALGIL+YEMLYGYTPFRGKTRQKTFANILHKDLKFP S P SL AKQLMYRLLHRDPK+R
Sbjct: 908 ALGILIYEMLYGYTPFRGKTRQKTFANILHKDLKFPGSIPASLQAKQLMYRLLHRDPKNR 967
Query: 946 LGSHEGANEIKKHPFFKGVNWALVRCMNPPELDAPLFA-TDTEKEYKVVDPGMQDLQQNV 1004
LGS EGANEIK+HPFF+GVNWALVRCMNPP+LD+PLF T+ EK K+VDP MQDLQ N+
Sbjct: 968 LGSLEGANEIKRHPFFRGVNWALVRCMNPPQLDSPLFGTTEAEKGAKLVDPEMQDLQTNI 1027
Query: 1005 F 1005
F
Sbjct: 1028 F 1028
|
Source: Fragaria x ananassa Species: Fragaria x ananassa Genus: Fragaria Family: Rosaceae Order: Rosales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255582071|ref|XP_002531832.1| serine/threonine protein kinase, putative [Ricinus communis] gi|223528528|gb|EEF30552.1| serine/threonine protein kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 1526 bits (3952), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 787/1023 (76%), Positives = 873/1023 (85%), Gaps = 35/1023 (3%)
Query: 1 MREMDQSEKSPKQSSKACESPLSRDSRGSLEVFNPSTFSTRPT-NPVFRPQPTWQTWMEQ 59
M +S S KQS +PL RD RGSLEVFNPS+ S+ + N +RP W+TW+E+
Sbjct: 1 MEPTGRSSSSNKQSPPVI-TPLPRDPRGSLEVFNPSSTSSTRSTNLAYRPNTNWKTWVEK 59
Query: 60 -RESPEPEHAKLNSKSSRAEEITSWMALKDPAPQKPSLPPLI-----QKMTNDQEKSTVT 113
+ P + KS RAEE T+WMA+KDPAP P+LP L Q + NDQ+K+ T
Sbjct: 60 PHDGPNTQSP---PKSGRAEEATTWMAIKDPAPS-PTLPLLSSPSHSQLIGNDQDKNPAT 115
Query: 114 KQLSGEAGAAAQRAAEWGLVLKTDTETGKPQAVVARTSGGDDPN-GKPGTSRRNSNNSVR 172
+LSGEA AA+RAAEWGLVLK +T+ GKPQ V R+SGGD+PN KPGTSRRNSNNSV+
Sbjct: 116 -ELSGEAEMAARRAAEWGLVLKPETQEGKPQVGV-RSSGGDEPNSNKPGTSRRNSNNSVQ 173
Query: 173 SSG-EMS-DEGGKE-KGLPRVSDIVKDALSTFQQTFVVSDATKPDYPIMYASAGFFKMTG 229
SSG ++S D+GGKE KG+PRVS+ +K+ALSTFQQTFVVSDATKPDYPIMYASAGFFKMTG
Sbjct: 174 SSGGDLSEDDGGKENKGIPRVSEDIKNALSTFQQTFVVSDATKPDYPIMYASAGFFKMTG 233
Query: 230 YTSKEVVGRNCRFLQGAGTDPEDVAKIRETLQNGQSYCGRLLNYKKDGTPFWNLLTIAPI 289
YTSKEV+GRNCRFLQGA TDPEDVAKIRE LQ+ SYCGRLLNYKKDGTPFWNLLTI+PI
Sbjct: 234 YTSKEVIGRNCRFLQGADTDPEDVAKIREALQSENSYCGRLLNYKKDGTPFWNLLTISPI 293
Query: 290 KDDEGKVLKFIGMQVEVSKHTEGAKDKMLRPNGLPESLIRYDARQKEMATSSVTELVQAM 349
KD+ GKVLK+IGMQVEVSK TEG+KDKMLRPNGLPESLIRYDARQKEMATSSVTELVQA+
Sbjct: 294 KDESGKVLKYIGMQVEVSKFTEGSKDKMLRPNGLPESLIRYDARQKEMATSSVTELVQAV 353
Query: 350 KKPRSLSESTNRPPIIRKSEGGVEEERAGALGRRKSENVPPPRRNSYGGGCRTSMQRISE 409
K+PRSLSE+T+RP ++RKSE G E+ER GALGRR SENVP RRNS GG R SMQ I+E
Sbjct: 354 KRPRSLSEATSRP-LMRKSESGGEDERKGALGRRNSENVPSNRRNSLGGA-RNSMQSINE 411
Query: 410 VPEKKKQKSGRRSFMGLIGRKSQSTDDHDSFENEIIMEGDDDYESDDE------RPDSVD 463
+PEKK +KS R SFMGL+ +KS + + DSF++ +I+ GDDD DDE RP+SVD
Sbjct: 412 LPEKKPRKSIRLSFMGLM-KKSSTQSNADSFDDALILNGDDDDVDDDEESEIDERPNSVD 470
Query: 464 DKVRQKEMRKGIDLATTLERIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNC 523
DKVR+KEMRKGIDLATTLERIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNC
Sbjct: 471 DKVRKKEMRKGIDLATTLERIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNC 530
Query: 524 RFLQGPETDPATVRKIRAAIDNQTDVTVQLINYTKSGKKFWNLFHLQPMRDQKGEVQYFI 583
RFLQGPETDPATVRKIR AIDNQTDVTVQLINYTKSGKKFWNLFHLQPMRDQKGEVQYFI
Sbjct: 531 RFLQGPETDPATVRKIREAIDNQTDVTVQLINYTKSGKKFWNLFHLQPMRDQKGEVQYFI 590
Query: 584 GVQLDGSEHLEPLRNSIPEATAEESEKLVKQTAENVNEAVKELPDANLTPEDLWANHSKV 643
GVQLDGSEH+EP N IPE TA+ESEKLVKQTAENV+EAV+ELPDAN PEDLWANHSK
Sbjct: 591 GVQLDGSEHVEPRSNCIPEETAQESEKLVKQTAENVDEAVRELPDANSKPEDLWANHSKA 650
Query: 644 VHPKPHRKDSPPWKAIQKILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMK 703
VH KPHRKD+P WKAIQKILD GE I L+HFRP+KPLGSGDTGSVHLVEL G+ +FAMK
Sbjct: 651 VHAKPHRKDTPSWKAIQKILDDGEPIGLKHFRPVKPLGSGDTGSVHLVELSGTDHHFAMK 710
Query: 704 AMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLL 763
AMDK VMLNRNKVHRACAEREILDMLDHPF+PALYASFQTKTH+CLITDYC GGELF+LL
Sbjct: 711 AMDKNVMLNRNKVHRACAEREILDMLDHPFLPALYASFQTKTHICLITDYCSGGELFMLL 770
Query: 764 DRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCL 823
DRQPTKVLKEDA RFYAAEVV+ALEYLHCQGIIYRDLKPENVLLQ +GHVSLTDFDLSCL
Sbjct: 771 DRQPTKVLKEDAARFYAAEVVIALEYLHCQGIIYRDLKPENVLLQSSGHVSLTDFDLSCL 830
Query: 824 TSCKPQLLLPTTNEKKR-RHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAV 882
TSCKPQLL+PT +EKK+ R QQ+P+FMAEPMRASNSFVGTEEYIAP +I
Sbjct: 831 TSCKPQLLIPTVDEKKKHRKHHQQDPIFMAEPMRASNSFVGTEEYIAPVLIFHF------ 884
Query: 883 DWWALGILLYEMLYGYTPFRGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDP 942
+A GILLYEMLYGYTPFRGKTRQKTFAN+LHKDLKFP S SLHAKQLMYRLLHRDP
Sbjct: 885 -IFATGILLYEMLYGYTPFRGKTRQKTFANVLHKDLKFPRSRQVSLHAKQLMYRLLHRDP 943
Query: 943 KSRLGSHEGANEIKKHPFFKGVNWALVRCMNPPELDAPLFATDTEKEYKVVDPGMQDLQQ 1002
K+RLGSHEGANEIK+HPFFKGVNWALVRCMNPPELD P+F + EKE K++DP + DLQ
Sbjct: 944 KNRLGSHEGANEIKRHPFFKGVNWALVRCMNPPELDTPIFENEAEKEAKLIDPELLDLQN 1003
Query: 1003 NVF 1005
NVF
Sbjct: 1004 NVF 1006
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|350535803|ref|NP_001234214.1| phototropin-1 [Solanum lycopersicum] gi|151176133|gb|ABN42185.2| phototropin-1 [Solanum lycopersicum] | Back alignment and taxonomy information |
|---|
Score = 1496 bits (3874), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 750/1016 (73%), Positives = 837/1016 (82%), Gaps = 41/1016 (4%)
Query: 21 PLSRDSRGSLEVFNPSTFSTRPTNPVFRPQPTWQTWM-----------------EQRESP 63
PL RD RGSLEVFNPST+S+R TNPVFR QP+W+ W EQ P
Sbjct: 13 PLPRDPRGSLEVFNPSTYSSRSTNPVFRSQPSWKNWTAADPITRSTIPETEEKTEQIAIP 72
Query: 64 EPEHAKLNSKSSRAEEITSWMALKDPAPQKPSLPPLIQKMTNDQEKSTVTKQLSGEAGAA 123
+ K+N + W L+ Q+ L L++ + +K E GAA
Sbjct: 73 QIRVTKMNKSL-----LHGWQLLR---LQRNWLLRLLKNQLPVVRRFN-SKAAVDEVGAA 123
Query: 124 AQRAAEWGLVLKTDTETGKPQAVVARTSGGDDPNGKPGTSRRNSNNSVRSSGEMSDEG-G 182
AQRAAEWGLVLKTD ETGK Q V RTSG DD NGK TSRR+S NS RSSGE SD+G G
Sbjct: 124 AQRAAEWGLVLKTDDETGKLQGVKVRTSG-DDTNGKTETSRRDSGNSGRSSGEFSDDGAG 182
Query: 183 KEKGLPRVSDIVKDALSTFQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCRF 242
KE+G+PRVS+ ++DALSTFQQTFVVSDATKPDYPI+YASAGFFKMTGYTSKEV+GRNCRF
Sbjct: 183 KERGIPRVSEDLRDALSTFQQTFVVSDATKPDYPILYASAGFFKMTGYTSKEVIGRNCRF 242
Query: 243 LQGAGTDPEDVAKIRETLQNGQSYCGRLLNYKKDGTPFWNLLTIAPIKDDEGKVLKFIGM 302
+QG+GTDPEDVA IRE LQ+G +YCGRLLNYKKDGTPFWNLLTIAPIKDD GKVLKFIGM
Sbjct: 243 MQGSGTDPEDVATIREALQSGSTYCGRLLNYKKDGTPFWNLLTIAPIKDDAGKVLKFIGM 302
Query: 303 QVEVSKHTEGAKDKMLRPNGLPESLIRYDARQKEMATSSVTELVQAMKKPR---SLSEST 359
QVEVSKHTEG+K+K +RPNGLPESLIRYD RQKEMA++SV EL++ +K PR +LSEST
Sbjct: 303 QVEVSKHTEGSKEKTVRPNGLPESLIRYDVRQKEMASNSVNELLEEIKNPRRARALSEST 362
Query: 360 N-RPPIIRKSEGGVEEERAGALGRRKSENVPPPRRNSYGGGCRTSM--QRISEVPEKKKQ 416
N RP +RKSEG E+ + N P RR+S+ G T+M ++I+EVPEKK +
Sbjct: 363 NNRPTFMRKSEGDQVEQDKQDTHKLNLVNKAPARRHSHAGTRTTTMKMEKINEVPEKKPK 422
Query: 417 KSGRRSFMGLIGRKSQSTDDHDS---FENEIIMEGDDDYESDDE---RPDSVDDKVRQKE 470
KS R SFMG++ +K ST FE + M+ DDD + + + RP SVDDKVR+KE
Sbjct: 423 KSARLSFMGIMKKKRSSTTMTTDDDDFEARMTMDNDDDDDDESDNDGRPVSVDDKVRKKE 482
Query: 471 MRKGIDLATTLERIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPE 530
MRKGIDLATTLERIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPE
Sbjct: 483 MRKGIDLATTLERIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPE 542
Query: 531 TDPATVRKIRAAIDNQTDVTVQLINYTKSGKKFWNLFHLQPMRDQKGEVQYFIGVQLDGS 590
TDPATV+KIR AIDNQTDVTVQLINYTK+GKKFWNLFHLQPMRDQKGEVQYFIGVQLDGS
Sbjct: 543 TDPATVKKIRQAIDNQTDVTVQLINYTKTGKKFWNLFHLQPMRDQKGEVQYFIGVQLDGS 602
Query: 591 EHLEPLRNSIPEATAEESEKLVKQTAENVNEAVKELPDANLTPEDLWANHSKVVHPKPHR 650
+H+EPL+NSIPE A ES KL+K+TA NV+EAV+ELPDAN PEDLW NHSKVV PKPHR
Sbjct: 603 QHVEPLQNSIPEDKATESAKLIKETAGNVDEAVRELPDANSKPEDLWRNHSKVVQPKPHR 662
Query: 651 KDSPPWKAIQKILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVM 710
KDSP WKAIQKIL+SGE I L+HF+PIKPLGSGDTGSVHLVELCG+ Q+FAMKAMDK +M
Sbjct: 663 KDSPSWKAIQKILESGEPIGLKHFKPIKPLGSGDTGSVHLVELCGTDQHFAMKAMDKSIM 722
Query: 711 LNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKV 770
LNRNKVHRACAEREILDMLDHPF+PALYASFQTKTH+CLITDY PGGELF+LLDRQ TKV
Sbjct: 723 LNRNKVHRACAEREILDMLDHPFLPALYASFQTKTHICLITDYYPGGELFMLLDRQQTKV 782
Query: 771 LKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQL 830
LKEDA RFYAAEVVVALEYLHCQGIIYRDLKPENVLLQ GHVSLTDFDLSCLTSCKPQL
Sbjct: 783 LKEDAARFYAAEVVVALEYLHCQGIIYRDLKPENVLLQSGGHVSLTDFDLSCLTSCKPQL 842
Query: 831 LLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGIL 890
L+P NEKK+ KGQ NP+FMAEPMRASNSFVGTEEYIAPEII GAGHTSAVDWWALGIL
Sbjct: 843 LVPEINEKKKHQKGQHNPIFMAEPMRASNSFVGTEEYIAPEIITGAGHTSAVDWWALGIL 902
Query: 891 LYEMLYGYTPFRGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHE 950
LYEMLYGYTPFRGKTRQKTF+NILHKDLKFP S +SLHAKQLMYRLLHRDPK+RLGS E
Sbjct: 903 LYEMLYGYTPFRGKTRQKTFSNILHKDLKFPGSIQSSLHAKQLMYRLLHRDPKNRLGSRE 962
Query: 951 GANEIKKHPFFKGVNWALVRCMNPPELD-APLFATDTEKEYKVVDPGMQDLQQNVF 1005
GANEIK+HPFF+GVNWAL+RCMNPP+LD AP T++EKE K ++P M+DLQ NVF
Sbjct: 963 GANEIKQHPFFRGVNWALIRCMNPPKLDSAPFLGTESEKEGKDINPEMEDLQTNVF 1018
|
Source: Solanum lycopersicum Species: Solanum lycopersicum Genus: Solanum Family: Solanaceae Order: Solanales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449460993|ref|XP_004148228.1| PREDICTED: phototropin-1-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 1476 bits (3820), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 734/910 (80%), Positives = 795/910 (87%), Gaps = 29/910 (3%)
Query: 119 EAGAAAQRAAEWGLVLKTDTETGKPQAVVARTSGGDDPNGKPGTSRRNSNNSVRSSG-EM 177
E G+AA RAAEWGLVLKTDTETGKPQ V RTSGGD+PN K SRR SNNSVRSSG EM
Sbjct: 49 EVGSAALRAAEWGLVLKTDTETGKPQGVGVRTSGGDEPNTKQENSRRTSNNSVRSSGDEM 108
Query: 178 SDEGGKEKGLPRVSDIVKDALSTFQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVG 237
S+EGG+E+G+PRVS+ +KDALSTFQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEV+G
Sbjct: 109 SEEGGRERGIPRVSEDLKDALSTFQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVIG 168
Query: 238 RNCRFLQGAGTDPEDVAKIRETLQNGQSYCGRLLNYKKDGTPFWNLLTIAPIKDDEGKVL 297
RNCRFLQGA TDPEDVAKIRE LQ G SYCGRLLNYKKDGTPFWNLLTI+PIKDD+GKVL
Sbjct: 169 RNCRFLQGADTDPEDVAKIREALQAGTSYCGRLLNYKKDGTPFWNLLTISPIKDDDGKVL 228
Query: 298 KFIGMQVEVSKHTEGAKDKMLRPNGLPESLIRYDARQKEMATSSVTELVQAMKKPRSLSE 357
K IGMQVEVSKHTEG KDKM+RPNGLPESLIRYDARQKEMATSSVTELVQA+K+PRSLSE
Sbjct: 229 KLIGMQVEVSKHTEGFKDKMVRPNGLPESLIRYDARQKEMATSSVTELVQAVKRPRSLSE 288
Query: 358 --------STNRPPIIRKSEGGVEEERAG----------ALGRRKSENVPPPRRNSYGGG 399
S NR + RKS GG G + RRKSE+ P GG
Sbjct: 289 YRPRALSESMNRR-LFRKSGGGGGGGEGGGKDEKDKLEPTMVRRKSESAAAPAGRRSQGG 347
Query: 400 CRTSMQRISEVPEKKKQKSGRRSFMGLIGRKSQSTDDHDSFENEIIMEGDDDYESDDE-- 457
R SMQRI+EVP+KK +KS RSFMG++ RKSQS + +SF+ I EG DD D+
Sbjct: 348 SRRSMQRINEVPDKKPKKSSHRSFMGIM-RKSQS-NVEESFD---IEEGSDDENESDDDV 402
Query: 458 RPDSVDDKVRQKEMRKGIDLATTLERIEKNFVITDPRLPDNPIIFASDSFLELTEYSREE 517
RPDSVDDKVRQ+EMRKGIDLATTLERIEKNFVITDPRLPDNPIIFASDSFLELTEYSREE
Sbjct: 403 RPDSVDDKVRQREMRKGIDLATTLERIEKNFVITDPRLPDNPIIFASDSFLELTEYSREE 462
Query: 518 ILGRNCRFLQGPETDPATVRKIRAAIDNQTDVTVQLINYTKSGKKFWNLFHLQPMRDQKG 577
ILGRNCRFLQGPETD TV+KIR AIDNQTDVTVQLINYTKSGKKFWNLFHLQPMRDQKG
Sbjct: 463 ILGRNCRFLQGPETDRTTVKKIRDAIDNQTDVTVQLINYTKSGKKFWNLFHLQPMRDQKG 522
Query: 578 EVQYFIGVQLDGSEHLEPLRNSIPEATAEESEKLVKQTAENVNEAVKELPDANLTPEDLW 637
EVQYFIGVQLDGS+H+EPL N I E+TA+E EKL+K+TAENV+ A +ELPDANLTPEDLW
Sbjct: 523 EVQYFIGVQLDGSQHVEPLSNCIAESTAKEGEKLIKETAENVDLAARELPDANLTPEDLW 582
Query: 638 ANHSKVVHPKPHRKDSPPWKAIQKILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSG 697
ANHSK+V PKPHRKDSP W+AIQKILD GEQI L+HF+P+KPLGSGDTGSVHLVELCG+
Sbjct: 583 ANHSKLVQPKPHRKDSPSWQAIQKILDGGEQIGLKHFKPVKPLGSGDTGSVHLVELCGTD 642
Query: 698 QYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGG 757
QYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPF+PALYASFQTKTHVCLITDYCPGG
Sbjct: 643 QYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFLPALYASFQTKTHVCLITDYCPGG 702
Query: 758 ELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTD 817
ELFLLLDRQPTKV+KEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQ NGHV+LTD
Sbjct: 703 ELFLLLDRQPTKVIKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQSNGHVALTD 762
Query: 818 FDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAG 877
FDLSCLTSCKPQLLLP NEKK++ K QQ P+FMAEPMRASNSFVGTEEYIAPEII GAG
Sbjct: 763 FDLSCLTSCKPQLLLPAANEKKKQSKTQQTPIFMAEPMRASNSFVGTEEYIAPEIITGAG 822
Query: 878 HTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRL 937
HTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANILHKDLKFP S SL+AKQL++RL
Sbjct: 823 HTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANILHKDLKFPRSISASLNAKQLIFRL 882
Query: 938 LHRDPKSRLGSHEGANEIKKHPFFKGVNWALVRCMNPPELDAPLF-ATDTEKEY-KVVDP 995
LHRDPK+RLGS EGA+EIK+HPFF+GVNWALVRCMNPPEL+APLF TD EK+ K D
Sbjct: 883 LHRDPKNRLGSREGASEIKRHPFFRGVNWALVRCMNPPELEAPLFQTTDGEKDANKASDF 942
Query: 996 GMQDLQQNVF 1005
++L+ +VF
Sbjct: 943 DPKELELSVF 952
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|60099454|dbj|BAD89966.1| phototropin [Phaseolus vulgaris] | Back alignment and taxonomy information |
|---|
Score = 1470 bits (3805), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 728/991 (73%), Positives = 818/991 (82%), Gaps = 29/991 (2%)
Query: 24 RDSRGSLEVFNPSTFSTRPTNPVFRP---QPTWQTWMEQRESPEPEHAKLNSKSSRAEEI 80
RD RGSLEVFNPS+ S PV P Q TW+TW++ R +PE + + +E+
Sbjct: 6 RDQRGSLEVFNPSSSSYSNEKPVISPLRTQSTWKTWVDSRVEEQPEKQQ---RGGGPDEV 62
Query: 81 T--SWMALKDPAPQKPSLPPLIQKMTNDQEKSTVTKQLSGEAGAAAQRAAEWGLVLKTDT 138
T SWMALKD P PS Q + V + E G AA+RAAEWGLVLKTDT
Sbjct: 63 TATSWMALKDSTPPPPS-----------QTLAAVLGEPPAEVGNAAKRAAEWGLVLKTDT 111
Query: 139 ETGKPQAVVARTSGGDDPNGK-PGTSRRNSNNSVRSSGEMSDEGGKEKG-LPRVSDIVKD 196
ETGKPQ V +TSGG++P K G SRR+S NSVRSSGE SD+G + +G +PRVS+ ++D
Sbjct: 112 ETGKPQGVAVQTSGGEEPGVKVTGGSRRDSGNSVRSSGESSDDGREYRGGIPRVSEDLRD 171
Query: 197 ALSTFQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKI 256
ALS FQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEV+GRNCRF+QGA TDP+DVAKI
Sbjct: 172 ALSAFQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVIGRNCRFMQGADTDPDDVAKI 231
Query: 257 RETLQNGQSYCGRLLNYKKDGTPFWNLLTIAPIKDDEGKVLKFIGMQVEVSKHTEGAKDK 316
RE LQ GQ+YCGRLLNYKKDGTPFWNLLTIAPIKD +G+VLKFIGMQVEVSKHTEG K+
Sbjct: 232 REALQTGQTYCGRLLNYKKDGTPFWNLLTIAPIKDHDGRVLKFIGMQVEVSKHTEGNKEN 291
Query: 317 MLRPNGLPESLIRYDARQKEMATSSVTELVQAMKKPRSLSESTNRPPIIRKSEGGVEEER 376
MLRPNGLPESLIRYDARQKE A SSV+EL+ A+++PR+LSES RP I + + G ++++
Sbjct: 292 MLRPNGLPESLIRYDARQKEKANSSVSELLLAVRRPRALSESGGRPLIRKSASGDDDQDK 351
Query: 377 AGALGRRKSENVPPPRRNSYGGGCRTSMQRISEVPEKKKQKSGRRSFMGLIGRKSQSTDD 436
RRKSE+V RR S+ G RTSM++I+E+PE K + S RRSFMG I RK+QS
Sbjct: 352 PEKSSRRKSESVASFRRKSHAGD-RTSMEKITEIPENKHKTSRRRSFMGFI-RKNQSK-- 407
Query: 437 HDSFENEIIMEGDDDYESDD-ERPDSVDDKVRQKEMRKGIDLATTLERIEKNFVITDPRL 495
SF +E ++EG + +D ER S D KV++KE RKG+DLATTLERIEKNFVITDPRL
Sbjct: 408 FGSFNDEAVIEGSSESSDEDGERSGSFDGKVQRKEKRKGLDLATTLERIEKNFVITDPRL 467
Query: 496 PDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIRAAIDNQTDVTVQLIN 555
PDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIR AID QTDVTVQLIN
Sbjct: 468 PDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIREAIDTQTDVTVQLIN 527
Query: 556 YTKSGKKFWNLFHLQPMRDQKGEVQYFIGVQLDGSEHLEPLRNSIPEATAEESEKLVKQT 615
YTK+GKKFWNLFHLQPMRDQKGEVQYFIGVQLDGS+H+EPL N I E TA+E EKLVK T
Sbjct: 528 YTKTGKKFWNLFHLQPMRDQKGEVQYFIGVQLDGSQHVEPLHNRIAENTAKEGEKLVKDT 587
Query: 616 AENVNEAVKELPDANLTPEDLWANHSKVVHPKPHRKDSPPWKAIQKILDSGEQINLQHFR 675
AENV++A++ELPDANL PEDLW NHSKVVHPKPHR+D WKAIQKIL+SGEQI L HF+
Sbjct: 588 AENVDDALRELPDANLKPEDLWMNHSKVVHPKPHRRDEAAWKAIQKILESGEQIGLNHFK 647
Query: 676 PIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVP 735
P+KPLGSGDTGSV+LVEL +GQYFAMKAM+KG+MLNRNKVHRAC EREILDMLDHPF+P
Sbjct: 648 PVKPLGSGDTGSVYLVELGETGQYFAMKAMEKGIMLNRNKVHRACTEREILDMLDHPFLP 707
Query: 736 ALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGI 795
ALYASFQTKTHVCLITDYC GGELFLLLDRQP KVL+EDAVRFYAAEVVVALEYLHCQGI
Sbjct: 708 ALYASFQTKTHVCLITDYCSGGELFLLLDRQPAKVLREDAVRFYAAEVVVALEYLHCQGI 767
Query: 796 IYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPM 855
IYRDLKPENVLLQ +GHVSLTDFDLSCLTSCKPQLL+P+ NEKK+ KG Q P+FMAEPM
Sbjct: 768 IYRDLKPENVLLQSSGHVSLTDFDLSCLTSCKPQLLVPSINEKKKAQKGHQPPIFMAEPM 827
Query: 856 RASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANILH 915
RASNSFVGTEEYIAPEII G+GH+SAVDWWALGILLYEM +GYTPFRGKTRQ+TF NILH
Sbjct: 828 RASNSFVGTEEYIAPEIITGSGHSSAVDWWALGILLYEMFFGYTPFRGKTRQRTFTNILH 887
Query: 916 KDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVNWALVRCMNPP 975
KDLKFP S S AKQLMYRLL+RDPKSRLGS EGANEIK HPFF+GVNWALVRC PP
Sbjct: 888 KDLKFPKSKQVSFSAKQLMYRLLNRDPKSRLGSREGANEIKNHPFFRGVNWALVRCTKPP 947
Query: 976 ELDAPLF-ATDTEKEYKVVDPGMQDLQQNVF 1005
ELDAPLF T EKE D +++ NVF
Sbjct: 948 ELDAPLFDTTRGEKEANFEDQVQEEM--NVF 976
|
Source: Phaseolus vulgaris Species: Phaseolus vulgaris Genus: Phaseolus Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356542583|ref|XP_003539746.1| PREDICTED: phototropin-1-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 1466 bits (3795), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 732/991 (73%), Positives = 828/991 (83%), Gaps = 28/991 (2%)
Query: 24 RDSRGSLEVFNPST-FST-RPTNPVFRPQPTWQTWMEQRESPEPEHAKLNSKSSRAEEIT 81
RD RGSLEVFNPS+ +ST + N R Q TW+TW++ E PE + + ++ T
Sbjct: 6 RDQRGSLEVFNPSSSYSTEKSVNSPVRVQSTWKTWID--ELPEQQQQQQCGGTNEVT-AT 62
Query: 82 SWMALKDPAPQKPSLPPLIQKMTNDQEKSTVTKQLSGEAGAAAQRAAEWGLVLKTDTETG 141
SWMALKD AP P+L ++ + + GE G AA+RAAEWGLVLKTDTETG
Sbjct: 63 SWMALKDSAPPPPTLAAVLGESLS---------AAVGEVGNAAKRAAEWGLVLKTDTETG 113
Query: 142 KPQAVVARTSGGDDPNGK-PGTSRRNSNNSVRSSGEMSDEGGKEKG-LPRVSDIVKDALS 199
KPQ V RTSGG++P+ K G SRR+S+NSVRSSGE SD+G + +G +PRVS+ ++DALS
Sbjct: 114 KPQGVKVRTSGGEEPSAKVTGGSRRDSSNSVRSSGESSDDGREYRGGIPRVSEDLRDALS 173
Query: 200 TFQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKIRET 259
FQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEV+GRNCRF+QGA TDP+DVAKIRE
Sbjct: 174 AFQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVIGRNCRFMQGADTDPDDVAKIREA 233
Query: 260 LQNGQSYCGRLLNYKKDGTPFWNLLTIAPIKDDEGKVLKFIGMQVEVSKHTEGAKDKMLR 319
LQ+G +YCGRLLNYKKDGTPFWNLLTIAPIKDD+G+VLKFIGMQVEVSKHTEGAK+KMLR
Sbjct: 234 LQSGSTYCGRLLNYKKDGTPFWNLLTIAPIKDDDGRVLKFIGMQVEVSKHTEGAKEKMLR 293
Query: 320 PNGLPESLIRYDARQKEMATSSVTELVQAMKKPRSLSESTNRPPIIRKSEGG--VEEERA 377
PNGLPESLIRYDARQKE A S+V+EL+ A+++PR+LSES RP +I+KS G +++
Sbjct: 294 PNGLPESLIRYDARQKEKANSTVSELLLAVRRPRALSESAGRP-MIKKSASGDDAQDKPP 352
Query: 378 GALGRRKSENVPPPRRNSYGGGCRTSMQRISEVPEKKKQKSGRRSFMGLIGRKSQSTDDH 437
RRKSE+V RR S+ G R+SM+RI+E+PEKK + S RRSFMG I RKSQS +
Sbjct: 353 EKSSRRKSESVASFRRKSHAGD-RSSMERITELPEKKHKSSRRRSFMGFI-RKSQS--NF 408
Query: 438 DSFENEIIMEGDDDYESDDE-RPDSVDDKVRQKEMRKGIDLATTLERIEKNFVITDPRLP 496
SF +E ++E + +D+ RP+S D KV++KE RKG+DLATTLERIEKNFVITDPRLP
Sbjct: 409 GSFNDEAVVENSSESSDEDDERPESFDGKVQKKEKRKGLDLATTLERIEKNFVITDPRLP 468
Query: 497 DNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIRAAIDNQTDVTVQLINY 556
DNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIR AIDNQTDVTVQLINY
Sbjct: 469 DNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIREAIDNQTDVTVQLINY 528
Query: 557 TKSGKKFWNLFHLQPMRDQKGEVQYFIGVQLDGSEHLEPLRNSIPEATAEESEKLVKQTA 616
TKSGKKFWNLFHLQPMRDQKGEVQYFIGVQLDGS+H+EPL N I + TA+E E+LVK TA
Sbjct: 529 TKSGKKFWNLFHLQPMRDQKGEVQYFIGVQLDGSQHVEPLHNRIADDTAKEGEQLVKDTA 588
Query: 617 ENVNEAVKELPDANLTPEDLWANHSKVVHPKPHRKDSPPWKAIQKILDSGEQINLQHFRP 676
ENV++A++ELPDAN+ PEDLW NHSKVVHPKPHR+D WKAIQ+IL+SGEQI L HFRP
Sbjct: 589 ENVDDALRELPDANMKPEDLWMNHSKVVHPKPHRRDEAAWKAIQQILNSGEQIGLNHFRP 648
Query: 677 IKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPA 736
+KPLGSGDTGSV+LVEL +G YFAMKAM+KGVMLNRNKVHRAC EREILDMLDHPF+PA
Sbjct: 649 VKPLGSGDTGSVYLVELGETGHYFAMKAMEKGVMLNRNKVHRACTEREILDMLDHPFLPA 708
Query: 737 LYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGII 796
LYASFQTKTHVCLITDYC GGELFLLLDRQP KVL+EDAVRFYAAEVVVALEYLHCQGII
Sbjct: 709 LYASFQTKTHVCLITDYCSGGELFLLLDRQPAKVLREDAVRFYAAEVVVALEYLHCQGII 768
Query: 797 YRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMR 856
YRDLKPENVLLQ +GHVSLTDFDLSCLTSCKPQLL+P NEKK+ KG P+FMAEPMR
Sbjct: 769 YRDLKPENVLLQSSGHVSLTDFDLSCLTSCKPQLLVPVINEKKKAQKGPHAPIFMAEPMR 828
Query: 857 ASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANILHK 916
ASNSFVGTEEYIAPEII G+GHTSAVDWWALGILLYEM YGYTPFRGKTRQ+TF NILHK
Sbjct: 829 ASNSFVGTEEYIAPEIITGSGHTSAVDWWALGILLYEMFYGYTPFRGKTRQRTFTNILHK 888
Query: 917 DLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVNWALVRCMNPPE 976
DLKFP S S AKQLMYRLL+RDPKSRLGS EGANEIK HPFF+GVNWALVRC PPE
Sbjct: 889 DLKFPKSKQVSFSAKQLMYRLLNRDPKSRLGSREGANEIKNHPFFRGVNWALVRCTKPPE 948
Query: 977 LDAPLFATDT--EKEYKVVDPGMQDLQQNVF 1005
LDAPL T EKE K + +D+ NVF
Sbjct: 949 LDAPLLETTEGGEKEAKFENQVQEDM--NVF 977
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|15231245|ref|NP_190164.1| non-specific serine/threonine protein kinase [Arabidopsis thaliana] gi|79314333|ref|NP_001030814.1| non-specific serine/threonine protein kinase [Arabidopsis thaliana] gi|25090817|sp|O48963.1|PHOT1_ARATH RecName: Full=Phototropin-1; AltName: Full=Non-phototropic hypocotyl protein 1; AltName: Full=Root phototropism protein 1 gi|13430612|gb|AAK25928.1|AF360218_1 putative nonphototropic hypocotyl 1 protein [Arabidopsis thaliana] gi|2832241|gb|AAC01753.1| nonphototropic hypocotyl 1 [Arabidopsis thaliana] gi|7019644|emb|CAB75791.1| nonphototropic hypocotyl 1 [Arabidopsis thaliana] gi|14532876|gb|AAK64120.1| putative nonphototropic hypocotyl 1 protein [Arabidopsis thaliana] gi|332644551|gb|AEE78072.1| non-specific serine/threonine protein kinase [Arabidopsis thaliana] gi|332644552|gb|AEE78073.1| non-specific serine/threonine protein kinase [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 1464 bits (3789), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 741/1014 (73%), Positives = 838/1014 (82%), Gaps = 35/1014 (3%)
Query: 8 EKSPKQSSKACESPLSRDSRGSLEVFNPSTFSTRPTNPVFRPQP-TWQTWMEQRES---P 63
E + K S+K L RD+RGSLEVFNPST TRP NPVFRP+P WQ + R + P
Sbjct: 2 EPTEKPSTKPSSRTLPRDTRGSLEVFNPSTQLTRPDNPVFRPEPPAWQNLSDPRGTSPQP 61
Query: 64 EPEHAKLNSKSSRAEE----ITSWMALKDPAPQKPSLPPLIQKMTNDQEKSTVTKQLSGE 119
P+ S R+++ TSWMALKDP+P+ S +K+ ++
Sbjct: 62 RPQQEPAPSNPVRSDQEIAVTTSWMALKDPSPETIS------------KKTITAEKPQKS 109
Query: 120 AGAAAQRAAEWGLVLKTDTETGKPQAVVARTSGG--DDPNGKPGTSRRNSNNSVRSSGEM 177
A AA QRAAEWGLVLKTDT+TGKPQ V R SGG +DPNGK TS+RNS NS RSSGEM
Sbjct: 110 AVAAEQRAAEWGLVLKTDTKTGKPQGVGVRNSGGTENDPNGKKTTSQRNSQNSCRSSGEM 169
Query: 178 SDEG--GKEKGLPRVSDIVKDALSTFQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEV 235
SD G G+PRVS+ +KDALSTFQQTFVVSDATKPDYPIMYASAGFF MTGYTSKEV
Sbjct: 170 SDGDVPGGRSGIPRVSEDLKDALSTFQQTFVVSDATKPDYPIMYASAGFFNMTGYTSKEV 229
Query: 236 VGRNCRFLQGAGTDPEDVAKIRETLQNGQSYCGRLLNYKKDGTPFWNLLTIAPIKDDEGK 295
VGRNCRFLQG+GTD +++AKIRETL G +YCGR+LNYKKDGT FWNLLTIAPIKD+ GK
Sbjct: 230 VGRNCRFLQGSGTDADELAKIRETLAAGNNYCGRILNYKKDGTSFWNLLTIAPIKDESGK 289
Query: 296 VLKFIGMQVEVSKHTEGAKDKMLRPNGLPESLIRYDARQKEMATSSVTELVQAMKKPRSL 355
VLKFIGMQVEVSKHTEGAK+K LRPNGLPESLIRYDARQK+MAT+SVTELV+A+K+PR+L
Sbjct: 290 VLKFIGMQVEVSKHTEGAKEKALRPNGLPESLIRYDARQKDMATNSVTELVEAVKRPRAL 349
Query: 356 SESTNRPPIIRKSEGGVEEERAGALGRRKSENVPPPRRNSYGGGCRTSMQRISEVPEKKK 415
SESTN P + KSE +E RR SENV P R + GGG R SMQRI+E+PEKK
Sbjct: 350 SESTNLHPFMTKSES---DELPKKPARRMSENVVPSGRRNSGGGRRNSMQRINEIPEKKS 406
Query: 416 QKSGRRSFMGLIGRKSQSTDDHDSFENEIIMEG--DDDYESDDERPDSVDDKVRQKEMRK 473
+KS SFMG I +KS+S D+ S ++ I G DD+ DERP+SVDDKVRQKEMRK
Sbjct: 407 RKSSL-SFMG-IKKKSESLDE--SIDDGFIEYGEEDDEISDRDERPESVDDKVRQKEMRK 462
Query: 474 GIDLATTLERIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDP 533
GIDLATTLERIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETD
Sbjct: 463 GIDLATTLERIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDL 522
Query: 534 ATVRKIRAAIDNQTDVTVQLINYTKSGKKFWNLFHLQPMRDQKGEVQYFIGVQLDGSEHL 593
TV+KIR AIDNQT+VTVQLINYTKSGKKFWN+FHLQPMRDQKGEVQYFIGVQLDGS+H+
Sbjct: 523 TTVKKIRNAIDNQTEVTVQLINYTKSGKKFWNIFHLQPMRDQKGEVQYFIGVQLDGSKHV 582
Query: 594 EPLRNSIPEATAEESEKLVKQTAENVNEAVKELPDANLTPEDLWANHSKVVHPKPHRKDS 653
EP+RN I E +E E LVK+TA N++EAV+ELPDAN+TPEDLWANHSKVVH KPHRKDS
Sbjct: 583 EPVRNVIEETAVKEGEDLVKKTAVNIDEAVRELPDANMTPEDLWANHSKVVHCKPHRKDS 642
Query: 654 PPWKAIQKILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNR 713
PPW AIQK+L+SGE I L+HF+P+KPLGSGDTGSVHLVEL G+ Q FAMKAMDK VMLNR
Sbjct: 643 PPWIAIQKVLESGEPIGLKHFKPVKPLGSGDTGSVHLVELVGTDQLFAMKAMDKAVMLNR 702
Query: 714 NKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKE 773
NKVHRA AEREILD+LDHPF+PALYASFQTKTH+CLITDY PGGELF+LLDRQP KVLKE
Sbjct: 703 NKVHRARAEREILDLLDHPFLPALYASFQTKTHICLITDYYPGGELFMLLDRQPRKVLKE 762
Query: 774 DAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLP 833
DAVRFYAA+VVVALEYLHCQGIIYRDLKPENVL+QGNG +SL+DFDLSCLTSCKPQLL+P
Sbjct: 763 DAVRFYAAQVVVALEYLHCQGIIYRDLKPENVLIQGNGDISLSDFDLSCLTSCKPQLLIP 822
Query: 834 TTNE--KKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILL 891
+ +E KK++ K QQ P+FMAEPMRASNSFVGTEEYIAPEII+GAGHTSAVDWWALGIL+
Sbjct: 823 SIDEKKKKKQQKSQQTPIFMAEPMRASNSFVGTEEYIAPEIISGAGHTSAVDWWALGILM 882
Query: 892 YEMLYGYTPFRGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEG 951
YEMLYGYTPFRGKTRQKTF N+L KDLKFP+S P SL KQL++RLL RDPK RLG EG
Sbjct: 883 YEMLYGYTPFRGKTRQKTFTNVLQKDLKFPASIPASLQVKQLIFRLLQRDPKKRLGCFEG 942
Query: 952 ANEIKKHPFFKGVNWALVRCMNPPELDAPLFATDTEKEYKVVDPGMQDLQQNVF 1005
ANE+K+H FFKG+NWAL+RC NPPEL+ P+F+ + E KVVDP ++DLQ NVF
Sbjct: 943 ANEVKQHSFFKGINWALIRCTNPPELETPIFSGEAENGEKVVDPELEDLQTNVF 996
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST 
Original result of BLAST against Gene Ontology (AMIGO)
ID ![]() |
Alignment graph ![]() |
Length ![]() |
Definition ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 1005 | ||||||
| TAIR|locus:2102674 | 996 | PHOT1 "phototropin 1" [Arabido | 0.973 | 0.981 | 0.714 | 0.0 | |
| UNIPROTKB|Q8H935 | 963 | Vfphot1a "Phototropin" [Vicia | 0.940 | 0.981 | 0.675 | 0.0 | |
| UNIPROTKB|Q2QYY8 | 921 | PHOT1A "Phototropin-1A" [Oryza | 0.793 | 0.865 | 0.702 | 0.0 | |
| UNIPROTKB|Q2RBR1 | 921 | PHOT1B "Phototropin-1B" [Oryza | 0.793 | 0.865 | 0.701 | 0.0 | |
| TAIR|locus:2155821 | 915 | PHOT2 "phototropin 2" [Arabido | 0.630 | 0.692 | 0.635 | 1.8e-287 | |
| UNIPROTKB|Q9ST27 | 907 | PHOT2 "Phototropin-2" [Oryza s | 0.806 | 0.894 | 0.630 | 9.5e-279 | |
| UNIPROTKB|Q5I6E9 | 700 | Adi3 "AvrPto-dependent Pto-int | 0.210 | 0.302 | 0.483 | 1.4e-93 | |
| TAIR|locus:2055017 | 765 | AT2G44830 [Arabidopsis thalian | 0.248 | 0.326 | 0.434 | 5.9e-91 | |
| TAIR|locus:2133837 | 506 | D6PKL1 "D6 protein kinase like | 0.202 | 0.403 | 0.495 | 4.4e-89 | |
| TAIR|locus:2174885 | 499 | AT5G40030 [Arabidopsis thalian | 0.197 | 0.396 | 0.505 | 1e-88 |
| TAIR|locus:2102674 PHOT1 "phototropin 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 3643 (1287.5 bits), Expect = 0., P = 0.
Identities = 725/1015 (71%), Positives = 815/1015 (80%)
Query: 8 EKSPKQSSKACESPLSRDSRGSLEVFNPSTFSTRPTNPVFRPQP-TWQTWMEQRES---P 63
E + K S+K L RD+RGSLEVFNPST TRP NPVFRP+P WQ + R + P
Sbjct: 2 EPTEKPSTKPSSRTLPRDTRGSLEVFNPSTQLTRPDNPVFRPEPPAWQNLSDPRGTSPQP 61
Query: 64 EPEHAKLNSKSSRAE-EI---TSWMALKDPAPQKPSLPPLIQKMTNDQEKSTVTKQLSXX 119
P+ S R++ EI TSWMALKDP+P+ I K T EK Q S
Sbjct: 62 RPQQEPAPSNPVRSDQEIAVTTSWMALKDPSPET------ISKKTITAEKP----QKSAV 111
Query: 120 XXXXXXXXXXWGLVLKTDTETGKPQAVVARTSGG--DDPNGKPGTXXXXXXXXXXXXGEM 177
WGLVLKTDT+TGKPQ V R SGG +DPNGK T GEM
Sbjct: 112 AAEQRAAE--WGLVLKTDTKTGKPQGVGVRNSGGTENDPNGKKTTSQRNSQNSCRSSGEM 169
Query: 178 SD---EGGKEKGLPRVSDIVKDALSTFQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKE 234
SD GG+ G+PRVS+ +KDALSTFQQTFVVSDATKPDYPIMYASAGFF MTGYTSKE
Sbjct: 170 SDGDVPGGRS-GIPRVSEDLKDALSTFQQTFVVSDATKPDYPIMYASAGFFNMTGYTSKE 228
Query: 235 VVGRNCRFLQGAGTDPEDVAKIRETLQNGQSYCGRLLNYKKDGTPFWNLLTIAPIKDDEG 294
VVGRNCRFLQG+GTD +++AKIRETL G +YCGR+LNYKKDGT FWNLLTIAPIKD+ G
Sbjct: 229 VVGRNCRFLQGSGTDADELAKIRETLAAGNNYCGRILNYKKDGTSFWNLLTIAPIKDESG 288
Query: 295 KVLKFIGMQVEVSKHTEGAKDKMLRPNGLPESLIRYDARQKEMATSSVTELVQAMKKPRS 354
KVLKFIGMQVEVSKHTEGAK+K LRPNGLPESLIRYDARQK+MAT+SVTELV+A+K+PR+
Sbjct: 289 KVLKFIGMQVEVSKHTEGAKEKALRPNGLPESLIRYDARQKDMATNSVTELVEAVKRPRA 348
Query: 355 LSESTNRPPIIRKSEGGVEEERAGALGRRKSENVPPPRRNSYGGGCRTSMQRISEVPEKK 414
LSESTN P + KSE +E RR SENV P R + GGG R SMQRI+E+PEKK
Sbjct: 349 LSESTNLHPFMTKSES---DELPKKPARRMSENVVPSGRRNSGGGRRNSMQRINEIPEKK 405
Query: 415 KQKSGRRSFMGLIGRKSQSTDDHDSFENEIIMXXXXXXXXXXXXXX--SVDDKVRQKEMR 472
+KS SFMG I +KS+S D+ S ++ I SVDDKVRQKEMR
Sbjct: 406 SRKSSL-SFMG-IKKKSESLDE--SIDDGFIEYGEEDDEISDRDERPESVDDKVRQKEMR 461
Query: 473 KGIDLATTLERIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETD 532
KGIDLATTLERIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETD
Sbjct: 462 KGIDLATTLERIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETD 521
Query: 533 PATVRKIRAAIDNQTDVTVQLINYTKSGKKFWNLFHLQPMRDQKGEVQYFIGVQLDGSEH 592
TV+KIR AIDNQT+VTVQLINYTKSGKKFWN+FHLQPMRDQKGEVQYFIGVQLDGS+H
Sbjct: 522 LTTVKKIRNAIDNQTEVTVQLINYTKSGKKFWNIFHLQPMRDQKGEVQYFIGVQLDGSKH 581
Query: 593 LEPLRNSIPEATAEESEKLVKQTAENVNEAVKELPDANLTPEDLWANHSKVVHPKPHRKD 652
+EP+RN I E +E E LVK+TA N++EAV+ELPDAN+TPEDLWANHSKVVH KPHRKD
Sbjct: 582 VEPVRNVIEETAVKEGEDLVKKTAVNIDEAVRELPDANMTPEDLWANHSKVVHCKPHRKD 641
Query: 653 SPPWKAIQKILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLN 712
SPPW AIQK+L+SGE I L+HF+P+KPLGSGDTGSVHLVEL G+ Q FAMKAMDK VMLN
Sbjct: 642 SPPWIAIQKVLESGEPIGLKHFKPVKPLGSGDTGSVHLVELVGTDQLFAMKAMDKAVMLN 701
Query: 713 RNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLK 772
RNKVHRA AEREILD+LDHPF+PALYASFQTKTH+CLITDY PGGELF+LLDRQP KVLK
Sbjct: 702 RNKVHRARAEREILDLLDHPFLPALYASFQTKTHICLITDYYPGGELFMLLDRQPRKVLK 761
Query: 773 EDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLL 832
EDAVRFYAA+VVVALEYLHCQGIIYRDLKPENVL+QGNG +SL+DFDLSCLTSCKPQLL+
Sbjct: 762 EDAVRFYAAQVVVALEYLHCQGIIYRDLKPENVLIQGNGDISLSDFDLSCLTSCKPQLLI 821
Query: 833 PTTNEKKRR--HKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGIL 890
P+ +EKK++ K QQ P+FMAEPMRASNSFVGTEEYIAPEII+GAGHTSAVDWWALGIL
Sbjct: 822 PSIDEKKKKKQQKSQQTPIFMAEPMRASNSFVGTEEYIAPEIISGAGHTSAVDWWALGIL 881
Query: 891 LYEMLYGYTPFRGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHE 950
+YEMLYGYTPFRGKTRQKTF N+L KDLKFP+S P SL KQL++RLL RDPK RLG E
Sbjct: 882 MYEMLYGYTPFRGKTRQKTFTNVLQKDLKFPASIPASLQVKQLIFRLLQRDPKKRLGCFE 941
Query: 951 GANEIKKHPFFKGVNWALVRCMNPPELDAPLFATDTEKEYKVVDPGMQDLQQNVF 1005
GANE+K+H FFKG+NWAL+RC NPPEL+ P+F+ + E KVVDP ++DLQ NVF
Sbjct: 942 GANEVKQHSFFKGINWALIRCTNPPELETPIFSGEAENGEKVVDPELEDLQTNVF 996
|
|
| UNIPROTKB|Q8H935 Vfphot1a "Phototropin" [Vicia faba (taxid:3906)] | Back alignment and assigned GO terms |
|---|
Score = 3296 (1165.3 bits), Expect = 0., Sum P(2) = 0.
Identities = 661/979 (67%), Positives = 744/979 (75%)
Query: 35 PSTFSTRPTNPVFRPQPTWQTWMEQ-RESPEPEHAKLNSKSSRAEEITSWM--ALKDPAP 91
P T R + VF P + +P P ++ SSR E + D P
Sbjct: 3 PFTRDHRGSLEVFNPSSSETNGTPNPNPNPNPSNSWNTGTSSRGTEAPPLRDSIISDEVP 62
Query: 92 QKPSLPPLIQKMTNDQEKSTVTKQLSXXXXXXXXXXXXWGLVLKTDTETGKPQAVVARTS 151
S L K T KS + ++ WGLVLKTD+ETGKPQ V R S
Sbjct: 63 TATSWMAL--KETTPSPKSGESGSVAEQRAAE------WGLVLKTDSETGKPQGVGVRGS 114
Query: 152 GGDDPNGKPGTXXXXXXXXXXXXGEMSDEGGKE-KGLPRVSDIVKDALSTFQQTFVVSDA 210
GG G GE SD+G + +G+PRVS+ ++DALS FQQTFVVSDA
Sbjct: 115 GGG------GGSRRDSNNSVRSSGESSDDGREGGRGIPRVSEDLRDALSAFQQTFVVSDA 168
Query: 211 TKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKIRETLQNGQSYCGRL 270
TKPDYPIMYASAGFF MTGYTSKEV+GRNCRF+QGA TDP DVAKIRE L G SYCGRL
Sbjct: 169 TKPDYPIMYASAGFFSMTGYTSKEVIGRNCRFMQGADTDPNDVAKIREALAAGTSYCGRL 228
Query: 271 LNYKKDGTPFWNLLTIAPIKDDEGKVLKFIGMQVEVSKHTEGAKDKMLRPNGLPESLIRY 330
LNYKKDGT FWNLLTIAPIKD+ GK+LK IGMQVEVSKHTEG K+KMLRPNGLPESLIRY
Sbjct: 229 LNYKKDGTTFWNLLTIAPIKDEHGKILKLIGMQVEVSKHTEGTKEKMLRPNGLPESLIRY 288
Query: 331 DARQKEMATSSVTELVQAM-KKPRSLSESTNRPPIIRKSEGGVEEE----RAGALGRRKS 385
DARQKE A SSVTELV+A+ K+PRSLSES NR P +K G + + + R+
Sbjct: 289 DARQKEKANSSVTELVEAVSKRPRSLSESANRLPFNKKPTNGSNDHATPPNSESSSRKSG 348
Query: 386 ENVPPPRRNSYGG-GCRTSMQRISEVPEKKKQKSGRRSFMGLIGRKSQSTDDHDSFENEI 444
+ RR S+ G G SM I+E+PE KS RRSFMG + RKS S ++ F +E
Sbjct: 349 STLRSFRRKSHSGAGNSNSMHPITELPENNN-KSRRRSFMGFM-RKSLSNNER--FNHEQ 404
Query: 445 IMXXXXXXXXXXXXXXSVDDKVRQKEMRKGIDLATTLERIEKNFVITDPRLPDNPIIFAS 504
++ + +++E RKG DLATTLERIEKNFVITDPRLPDNPIIFAS
Sbjct: 405 VIDRNSSEDEDRLDSFDEQNIAQKREKRKGFDLATTLERIEKNFVITDPRLPDNPIIFAS 464
Query: 505 DSFLELTEYSREEILGRNCRFLQGPETDPATVRKIRAAIDNQTDVTVQLINYTKSGKKFW 564
DSFLELTEYSREEILGRNCRFLQGPETDPATV+KIR AIDNQT+VTVQLINYTK+GKKFW
Sbjct: 465 DSFLELTEYSREEILGRNCRFLQGPETDPATVKKIRYAIDNQTEVTVQLINYTKTGKKFW 524
Query: 565 NLFHLQPMRDQKGEVQYFIGVQLDGSEHLEPLRNSIPEATAEESEKLVKQTAENVNEAVK 624
NLFHLQPMRDQKGEVQYFIGVQLDGS+H+EPL N I E TA+E E LVK+TAENV++A++
Sbjct: 525 NLFHLQPMRDQKGEVQYFIGVQLDGSQHVEPLHNGIAEDTAKEGENLVKKTAENVDDALR 584
Query: 625 ELPDANLTPEDLWANHSKVVHPKPHRKDSPPWKAIQKILDSGEQINLQHFRPIKPLGSGD 684
ELPDAN+ PEDLW NHSKVVHPKPHR++ W+AIQKI++SGEQI L+HF+PIKPLGSGD
Sbjct: 585 ELPDANMKPEDLWMNHSKVVHPKPHRREDSAWRAIQKIMESGEQIGLKHFKPIKPLGSGD 644
Query: 685 TGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTK 744
TGSVHLVELCG+ +FAMKAMDKGVM NRNKVHRAC EREILDMLDHPF+PALYASFQTK
Sbjct: 645 TGSVHLVELCGTDHHFAMKAMDKGVMPNRNKVHRACTEREILDMLDHPFLPALYASFQTK 704
Query: 745 THVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPEN 804
TH+CLITDYCPGGELF+LLDRQP KVLKEDAVRFYA EVVVALEYLHCQGIIYRDLKPEN
Sbjct: 705 THICLITDYCPGGELFMLLDRQPAKVLKEDAVRFYATEVVVALEYLHCQGIIYRDLKPEN 764
Query: 805 VLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGT 864
VLLQ GHVSLTDFDLSCLTSCKP+L++P+TN+KK KGQ P+FMAEPMRASNSFVGT
Sbjct: 765 VLLQSTGHVSLTDFDLSCLTSCKPELIVPSTNDKK---KGQHGPIFMAEPMRASNSFVGT 821
Query: 865 EEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANILHKDLKFPSST 924
EEYIAPEII G+GHT AVDWWALGILLYEM YGYTPFRGK RQ+TFANILHKDLK P S
Sbjct: 822 EEYIAPEIITGSGHTCAVDWWALGILLYEMFYGYTPFRGKNRQRTFANILHKDLKLPKSK 881
Query: 925 PTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVNWALVRCMNPPELDAPLFAT 984
SL AKQL+Y LL RDP SRLGS GAN+IK H FFKG+NWALVRC PPELDAPLF T
Sbjct: 882 QVSLSAKQLIYHLLQRDPTSRLGSKGGANDIKHHSFFKGINWALVRCTKPPELDAPLFDT 941
Query: 985 ---DTEKEYKVVDPGMQDL 1000
+ EK+ K VD G +D+
Sbjct: 942 NKEEKEKDDKYVDNGQEDM 960
|
|
| UNIPROTKB|Q2QYY8 PHOT1A "Phototropin-1A" [Oryza sativa Japonica Group (taxid:39947)] | Back alignment and assigned GO terms |
|---|
Score = 3002 (1061.8 bits), Expect = 0., Sum P(2) = 0.
Identities = 575/818 (70%), Positives = 675/818 (82%)
Query: 187 LPRVSDIVKDALSTFQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGA 246
+PRVS+ ++ ALS FQQTFVVSDAT P++PIMYASAGFF MTGYTSKEVVGRNCRFLQG+
Sbjct: 120 IPRVSEELRAALSAFQQTFVVSDATHPNHPIMYASAGFFNMTGYTSKEVVGRNCRFLQGS 179
Query: 247 GTDPEDVAKIRETLQNGQSYCGRLLNYKKDGTPFWNLLTIAPIKDDEGKVLKFIGMQVEV 306
GTDP ++ KIR++L NG +YCGR+LNYKKDGTPFWNLLTIAPIKD++G++LKFIGMQVEV
Sbjct: 180 GTDPHEIDKIRQSLANGSNYCGRILNYKKDGTPFWNLLTIAPIKDEDGRLLKFIGMQVEV 239
Query: 307 SKHTEGAKDKMLRPNGLPESLIRYDARQKEMATSSVTELVQAMKKPRSLSESTNRPPIIR 366
SK+TEG KD ++RPNGL ESLI+YDARQK+ A SSV+EL+ A+K PRSLSES+N + R
Sbjct: 240 SKYTEGKKDTVVRPNGLSESLIKYDARQKDHARSSVSELLLALKNPRSLSESSNNT-LKR 298
Query: 367 KSEGGVEEERAGALGRRKSENVPPPRRNSYGGGCRTSMQRISEVPEK--KKQKSGRRSFM 424
KS+ + +R SE+ RRNS G R+S+Q+I+EVP++ + +KSG R+FM
Sbjct: 299 KSQESLSMSMTEVPSKRSSES--GSRRNSRSG-TRSSLQKINEVPDQGNRTRKSGLRAFM 355
Query: 425 GLIGRKSQSTDDHDSFENEIIMXXXXXXXXXXXXXX--SVDDKVRQKEMRKGIDLATTLE 482
G +G H S E ++ S +D+ R+KEMR+GIDLATTLE
Sbjct: 356 GFLGM------GHGSVEKNMLKPRDEDPLIDSDDERPESFEDEFRRKEMRRGIDLATTLE 409
Query: 483 RIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIRAA 542
RIEKNFVITDPRLPDNPIIFASDSFL+LTEY+REEILGRNCRFLQGPETD ATVRKIR A
Sbjct: 410 RIEKNFVITDPRLPDNPIIFASDSFLQLTEYNREEILGRNCRFLQGPETDRATVRKIRDA 469
Query: 543 IDNQTDVTVQLINYTKSGKKFWNLFHLQPMRDQKGEVQYFIGVQLDGSEHLEPLRNSIPE 602
IDNQ +VTVQLINYTKSGKKFWNLFHLQPMRDQKG+VQYFIGVQLDG+EH++ +
Sbjct: 470 IDNQAEVTVQLINYTKSGKKFWNLFHLQPMRDQKGDVQYFIGVQLDGTEHVQ-------D 522
Query: 603 ATAEESEKLVKQTAENVNEAVKELPDANLTPEDLWANHSKVVHPKPHRKDSPPWKAIQKI 662
A+E LVK+TA+N++EA KELPDANL PEDLWANHSKVV P PH KD+ W+AIQK+
Sbjct: 523 DAAKEGVVLVKKTADNIDEAAKELPDANLRPEDLWANHSKVVLPNPHMKDTASWRAIQKV 582
Query: 663 LDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAE 722
L+SGE I L+HFRP+KPLGSGDTGSVHLVEL +G+YFAMKAMDK +MLNRNKVHRA AE
Sbjct: 583 LESGESIGLKHFRPVKPLGSGDTGSVHLVELLNTGEYFAMKAMDKSIMLNRNKVHRATAE 642
Query: 723 REILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAE 782
R+ILD+LDHPF+P LYASFQTKTH+CLITDYCPGGELF+LLD QP KVL EDAVRFYAAE
Sbjct: 643 RQILDLLDHPFLPTLYASFQTKTHICLITDYCPGGELFVLLDNQPLKVLHEDAVRFYAAE 702
Query: 783 VVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRH 842
VVVALEYLHCQGIIYRDLKPEN+LL +GH+SLTDFDLSCLTSC+PQ+ LP ++K+
Sbjct: 703 VVVALEYLHCQGIIYRDLKPENILLHRDGHISLTDFDLSCLTSCRPQVFLPEDADEKKGR 762
Query: 843 KGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFR 902
K P+F AEPMRASNSFVGTEEYIAPEII GAGHTSAVDWWALGILLYEMLYGYTPFR
Sbjct: 763 KNGSYPIFFAEPMRASNSFVGTEEYIAPEIITGAGHTSAVDWWALGILLYEMLYGYTPFR 822
Query: 903 GKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFK 962
GKTRQ+TFANILHKD++FP+S SL A+QLMYRLLHRDP +RLGS+EGANEIK HPFF+
Sbjct: 823 GKTRQRTFANILHKDIRFPASISVSLAARQLMYRLLHRDPANRLGSYEGANEIKGHPFFR 882
Query: 963 GVNWALVRCMNPPELDAPLFATDTEKEYKVVDPGMQDL 1000
G+NW L+R PP+L+ PLF+ D ++ +V D+
Sbjct: 883 GINWPLIRATAPPKLEIPLFSKDDMEKKGLVTNNRTDM 920
|
|
| UNIPROTKB|Q2RBR1 PHOT1B "Phototropin-1B" [Oryza sativa Japonica Group (taxid:39947)] | Back alignment and assigned GO terms |
|---|
Score = 2999 (1060.8 bits), Expect = 0., Sum P(2) = 0.
Identities = 574/818 (70%), Positives = 676/818 (82%)
Query: 187 LPRVSDIVKDALSTFQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGA 246
+PRVS+ ++ ALS FQQTFVVSDAT P++PIMYASAGFF MTGYTSKEVVGRNCRFLQG+
Sbjct: 120 IPRVSEELRAALSVFQQTFVVSDATHPNHPIMYASAGFFNMTGYTSKEVVGRNCRFLQGS 179
Query: 247 GTDPEDVAKIRETLQNGQSYCGRLLNYKKDGTPFWNLLTIAPIKDDEGKVLKFIGMQVEV 306
GTDP ++ KIR++L NG +YCGR+LNYKKDGTPFWNLLTIAPIKD++G++LKFIGMQVEV
Sbjct: 180 GTDPHEIDKIRQSLANGSNYCGRILNYKKDGTPFWNLLTIAPIKDEDGRLLKFIGMQVEV 239
Query: 307 SKHTEGAKDKMLRPNGLPESLIRYDARQKEMATSSVTELVQAMKKPRSLSESTNRPPIIR 366
SK+TEG KD ++RPNGL ESLI+YDARQK+ A SSV+EL+ A+K PRSLSES+N + R
Sbjct: 240 SKYTEGKKDTVVRPNGLSESLIKYDARQKDHARSSVSELLLALKNPRSLSESSNNT-LKR 298
Query: 367 KSEGGVEEERAGALGRRKSENVPPPRRNSYGGGCRTSMQRISEVPEK--KKQKSGRRSFM 424
KS+ + + +R SE+ RRNS G R+S+Q+I+EVP++ + +KSG R+FM
Sbjct: 299 KSQESLSMSMSEVPSKRSSES--GSRRNSRSG-TRSSLQKINEVPDQVNRTRKSGLRAFM 355
Query: 425 GLIGRKSQSTDDHDSFENEIIMXXXXXXXXXXXXXX--SVDDKVRQKEMRKGIDLATTLE 482
G +G H S E ++ S +D+ R+KEMR+GIDLATTLE
Sbjct: 356 GFLGM------GHGSVEKNMLKPRDEDPLIDSDDERPESFEDEFRRKEMRRGIDLATTLE 409
Query: 483 RIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIRAA 542
RIEKNFVITDPRLPDNPIIFASDSFL+LTEY+REEILGRNCRFLQGPETD ATVRKIR A
Sbjct: 410 RIEKNFVITDPRLPDNPIIFASDSFLQLTEYNREEILGRNCRFLQGPETDRATVRKIRDA 469
Query: 543 IDNQTDVTVQLINYTKSGKKFWNLFHLQPMRDQKGEVQYFIGVQLDGSEHLEPLRNSIPE 602
IDNQ +VTVQLINYTKSGKKFWNLFHLQPMRDQKG+VQYFIGVQLDG+EH++ +
Sbjct: 470 IDNQAEVTVQLINYTKSGKKFWNLFHLQPMRDQKGDVQYFIGVQLDGTEHVQ-------D 522
Query: 603 ATAEESEKLVKQTAENVNEAVKELPDANLTPEDLWANHSKVVHPKPHRKDSPPWKAIQKI 662
A+E LVK+TA+N++EA KELPDANL P+DLWANHSKVV P PH KD+ W+AIQK+
Sbjct: 523 DAAKEGVVLVKKTADNIDEAAKELPDANLRPKDLWANHSKVVLPNPHMKDTASWRAIQKV 582
Query: 663 LDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAE 722
L+SGE I L+HFRP+KPLGSGDTGSVHLVEL +G+YFAMKAMDK +MLNRNKVHRA AE
Sbjct: 583 LESGESIGLKHFRPVKPLGSGDTGSVHLVELLNTGEYFAMKAMDKSIMLNRNKVHRATAE 642
Query: 723 REILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAE 782
R+ILD+LDHPF+P LYASFQTKTH+CLITDYCPGGELF+LLD QP KVL EDAVRFYAAE
Sbjct: 643 RQILDLLDHPFLPTLYASFQTKTHICLITDYCPGGELFVLLDNQPLKVLHEDAVRFYAAE 702
Query: 783 VVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRH 842
VVVALEYLHCQGIIYRDLKPEN+LL +GH+SLTDFDLSCLTSC+PQ+ LP ++K+
Sbjct: 703 VVVALEYLHCQGIIYRDLKPENILLHRDGHISLTDFDLSCLTSCRPQVFLPEDADEKKGR 762
Query: 843 KGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFR 902
K P+F AEPMRASNSFVGTEEYIAPEII GAGHTSAVDWWALGILLYEMLYGYTPFR
Sbjct: 763 KNGSYPIFFAEPMRASNSFVGTEEYIAPEIITGAGHTSAVDWWALGILLYEMLYGYTPFR 822
Query: 903 GKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFK 962
GKTRQ+TFANILHKD++FP+S SL A+QLMYRLLHRDP +RLGS+EGANEIK HPFF+
Sbjct: 823 GKTRQRTFANILHKDIRFPASISVSLAARQLMYRLLHRDPANRLGSYEGANEIKGHPFFR 882
Query: 963 GVNWALVRCMNPPELDAPLFATDTEKEYKVVDPGMQDL 1000
G+NW L+R PP+L+ PLF+ D ++ +V D+
Sbjct: 883 GINWPLIRATAPPKLEIPLFSKDDMEKKGLVTNNRTDM 920
|
|
| TAIR|locus:2155821 PHOT2 "phototropin 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 2099 (743.9 bits), Expect = 1.8e-287, Sum P(3) = 1.8e-287
Identities = 418/658 (63%), Positives = 494/658 (75%)
Query: 348 AMKKPRSLSESTNRPPIIRKSEGGVEEERAG-ALGRRKSENVPPPRRNSYGGGCRTSMQR 406
A +K ++L T IR + V+E + + + S P P R + R
Sbjct: 262 ARQKEKALDSITEVVQTIRHRKSQVQESVSNDTMVKPDSSTTPTPGRQT----------R 311
Query: 407 ISEVPEKKKQKSGRRSFMGLIGRKSQSTDD-HDSF---ENEIIMXXXXXXXXXXXXXXSV 462
S+ K + GR S G K +S+++ H+ E E +M S
Sbjct: 312 QSDEASKSFRTPGRVSTP--TGSKLKSSNNRHEDLLRMEPEELMLSTEVIGQRD----SW 365
Query: 463 DDKVRQKEMRKGIDLATTLERIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRN 522
D R++++R+GIDLATTLERIEKNFVI+DPRLPDNPIIFASDSFLELTEYSREEILGRN
Sbjct: 366 DLSDRERDIRQGIDLATTLERIEKNFVISDPRLPDNPIIFASDSFLELTEYSREEILGRN 425
Query: 523 CRFLQGPETDPATVRKIRAAIDNQTDVTVQLINYTKSGKKFWNLFHLQPMRDQKGEVQYF 582
CRFLQGPETD ATV+KIR AI +Q ++TVQLINYTKSGKKFWNLFHLQPMRDQKGE+QYF
Sbjct: 426 CRFLQGPETDQATVQKIRDAIRDQREITVQLINYTKSGKKFWNLFHLQPMRDQKGELQYF 485
Query: 583 IGVQLDGSEHLEPLRNSIPEATAEESEKLVKQTAENVNEAVKELPDANLTPEDLWANHSK 642
IGVQLDGS+H+EPL+N + E T +S KLVK TA NV+EAV+ELPDAN PEDLWA HSK
Sbjct: 486 IGVQLDGSDHVEPLQNRLSERTEMQSSKLVKATATNVDEAVRELPDANTRPEDLWAAHSK 545
Query: 643 VVHPKPHRKDSPPWKAIQKILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAM 702
V+P PH K+S WKAI+KI SGE + L HF+PIKPLGSGDTGSVHLVEL G+G+ +AM
Sbjct: 546 PVYPLPHNKESTSWKAIKKIQASGETVGLHHFKPIKPLGSGDTGSVHLVELKGTGELYAM 605
Query: 703 KAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLL 762
KAM+K +MLNRNK HRAC EREI+ +LDHPF+P LYASFQT THVCLITD+CPGGELF L
Sbjct: 606 KAMEKTMMLNRNKAHRACIEREIISLLDHPFLPTLYASFQTSTHVCLITDFCPGGELFAL 665
Query: 763 LDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSC 822
LDRQP K+L ED+ RFYAAEVV+ LEYLHC GI+YRDLKPEN+LL+ +GH+ L DFDLS
Sbjct: 666 LDRQPMKILTEDSARFYAAEVVIGLEYLHCLGIVYRDLKPENILLKKDGHIVLADFDLSF 725
Query: 823 LTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAV 882
+T+C PQL++P K+RR K Q P F+AEP SNSFVGTEEYIAPEII GAGHTSA+
Sbjct: 726 MTTCTPQLIIPAAPSKRRRSKSQPLPTFVAEPSTQSNSFVGTEEYIAPEIITGAGHTSAI 785
Query: 883 DWWALGILLYEMLYGYTPFRGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDP 942
DWWALGILLYEMLYG TPFRGK RQKTFANILHKDL FPSS P SL +QL+ LL+RDP
Sbjct: 786 DWWALGILLYEMLYGRTPFRGKNRQKTFANILHKDLTFPSSIPVSLVGRQLINTLLNRDP 845
Query: 943 KSRLGSHEGANEIKKHPFFKGVNWALVRCMNPPELDAPLFATDTE---KEYKVVDPGM 997
SRLGS GANEIK+H FF+G+NW L+R M+PP LDAPL + + K+ K D G+
Sbjct: 846 SSRLGSKGGANEIKQHAFFRGINWPLIRGMSPPPLDAPLSIIEKDPNAKDIKWEDDGV 903
|
|
| UNIPROTKB|Q9ST27 PHOT2 "Phototropin-2" [Oryza sativa Japonica Group (taxid:39947)] | Back alignment and assigned GO terms |
|---|
Score = 2679 (948.1 bits), Expect = 9.5e-279, P = 9.5e-279
Identities = 523/830 (63%), Positives = 629/830 (75%)
Query: 175 GEMSDEGG----KEKGLPRVSDIVKDALSTFQQTFVVSDATKPDYPIMYASAGFFKMTGY 230
G+ S +GG LPRVS +KDALS+ QQTFVVSDAT+PD PI+YAS GFF MTGY
Sbjct: 70 GKSSVDGGVGRASHDSLPRVSQELKDALSSLQQTFVVSDATRPDCPIIYASEGFFTMTGY 129
Query: 231 TSKEVVGRNCRFLQGAGTDPEDVAKIRETLQNGQSYCGRLLNYKKDGTPFWNLLTIAPIK 290
+ +EVVGRNCRFLQG TD +VAKIR+ +++G+S+CGRLLNY+KDG PFWNLLT+ PI+
Sbjct: 130 SPREVVGRNCRFLQGPDTDAAEVAKIRDAVKHGRSFCGRLLNYRKDGAPFWNLLTVTPIR 189
Query: 291 DDEGKVLKFIGMQVEVSKHTEGAKDKMLRPNGLPESLIRYDARQKEMATSSVTELVQAMK 350
DD GKV+KFIGMQVEVSK+TEG DK +RPN LP SLIRYD RQK+ A SS+TE+VQ +K
Sbjct: 190 DDNGKVIKFIGMQVEVSKYTEGLSDKRMRPNELPVSLIRYDERQKDKAMSSMTEVVQTVK 249
Query: 351 KPRSLSESTNRPPIIRKSEGGVEEERAGALGRRKSENVPPPRRNSYGGGCRTSMQRISEV 410
+PR + + + ++ A+ S V P + GGG + + ++
Sbjct: 250 QPRGARAPADAALLTPPKMS--DADKMAAM----SPVVAPGTPSGGGGGAGSFKSPLWDL 303
Query: 411 PEKKKQ--------KSGRRSFMGL-IGRKSQSTDDHDSFENEIIMXXXXXXXXXXXXXXS 461
+++ + KSGR S MG IG++S E S
Sbjct: 304 KKEESRLSRLASGRKSGRSSLMGFKIGKRSSVGSREAPAVVEEPAPAPPPAPEVVERTDS 363
Query: 462 VDDKVRQKEMRKGIDLATTLERIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGR 521
+ R+K++R+GIDLATTLERIEKNFVITDPR+PDNPIIFASDSFLELTEY+REEILGR
Sbjct: 364 WERAEREKDIRQGIDLATTLERIEKNFVITDPRIPDNPIIFASDSFLELTEYTREEILGR 423
Query: 522 NCRFLQGPETDPATVRKIRAAIDNQTDVTVQLINYTKSGKKFWNLFHLQPMRDQKGEVQY 581
NCRFLQGPETD TV KIR AI Q ++TVQLINYTKSGKKFWNLFHLQPMRDQKGE+QY
Sbjct: 424 NCRFLQGPETDQGTVDKIREAIREQKEITVQLINYTKSGKKFWNLFHLQPMRDQKGELQY 483
Query: 582 FIGVQLDGSEHLEPLRNSIPEATAEESEKLVKQTAENVNEAVKELPDANLTPEDLWANHS 641
FIGVQLDGS+H+EPLRN + E T +S KLVK TAENV++AV+ELPDANL PEDLWA HS
Sbjct: 484 FIGVQLDGSDHVEPLRNRLSENTEIQSAKLVKATAENVDDAVRELPDANLRPEDLWAIHS 543
Query: 642 KVVHPKPHRKDSPPWKAIQKILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFA 701
V PKPH++++P W AI+K + GE+I L+HF+P+KPLG GDTGSVHLVEL GSG+ FA
Sbjct: 544 MRVSPKPHKRNNPSWIAIEKATNLGEKIGLKHFKPVKPLGCGDTGSVHLVELQGSGELFA 603
Query: 702 MKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFL 761
MKAMDK VMLNRNKVHRAC EREI +LDHPF+P LY SFQT THVCLITD+CPGGELF
Sbjct: 604 MKAMDKSVMLNRNKVHRACIEREIYALLDHPFLPTLYTSFQTPTHVCLITDFCPGGELFA 663
Query: 762 LLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLS 821
+LDRQP K+ +E+ RFYAAEVV+ LEYLHC GIIYRDLKPEN+LLQ +GH+ LTDFDLS
Sbjct: 664 VLDRQPMKIFREECARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQADGHIVLTDFDLS 723
Query: 822 CLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSA 881
LT+ KP ++ +T+ K+RR + P F++EP SNSFVGTEEYIAPE+I GAGHTSA
Sbjct: 724 FLTTSKPHVIKNSTSLKRRRSQEFLPPTFVSEPSTPSNSFVGTEEYIAPEVITGAGHTSA 783
Query: 882 VDWWALGILLYEMLYGYTPFRGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRD 941
+DWWALGILLYEMLYG TPFRGK R+KTF NILHKDL FPSS P SL AKQL++ LL RD
Sbjct: 784 IDWWALGILLYEMLYGRTPFRGKNRKKTFYNILHKDLTFPSSIPVSLAAKQLIHGLLQRD 843
Query: 942 PKSRLGSHEGANEIKKHPFFKGVNWALVRCMNPPELDAPLFATDTEKEYK 991
P +R+GS+ GAN+IK+H FF+ +NW L+RCM+PPELD PL E + K
Sbjct: 844 PSNRIGSNAGANDIKQHSFFQDINWPLIRCMSPPELDVPLKLIGKETQPK 893
|
|
| UNIPROTKB|Q5I6E9 Adi3 "AvrPto-dependent Pto-interacting protein 3" [Solanum lycopersicum (taxid:4081)] | Back alignment and assigned GO terms |
|---|
Score = 533 (192.7 bits), Expect = 1.4e-93, Sum P(3) = 1.4e-93
Identities = 103/213 (48%), Positives = 142/213 (66%)
Query: 629 ANLTPEDLWANHSKVVHPKPHRKDSPPWKAIQKILDSGEQINLQHFRPIKPLGSGDTGSV 688
+ L+ + W+N + + KPH+ + P WKAI I + + HF+ +K LG GD GSV
Sbjct: 264 SGLSDDSNWSNITGSAN-KPHKGNDPRWKAILAIRARDGILGMSHFKLLKRLGCGDIGSV 322
Query: 689 HLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVC 748
+L EL G+ YFAMK MDK + +R K+ RA EREIL +LDHPF+P LY F+T C
Sbjct: 323 YLSELSGTRCYFAMKVMDKASLASRKKLTRAQTEREILQLLDHPFLPTLYTHFETDRFSC 382
Query: 749 LITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQ 808
L+ +YCPGG+L L RQP K E A RFYAAEV++ALEYLH G++YRDLKPENVL++
Sbjct: 383 LVMEYCPGGDLHTLRQRQPGKHFSEYAARFYAAEVLLALEYLHMLGVVYRDLKPENVLVR 442
Query: 809 GNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRR 841
+GH+ L+DFDLS + P L+ ++++ +R
Sbjct: 443 DDGHIMLSDFDLSLRCAVSPTLIRISSDDPSKR 475
|
|
| TAIR|locus:2055017 AT2G44830 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 537 (194.1 bits), Expect = 5.9e-91, Sum P(2) = 5.9e-91
Identities = 110/253 (43%), Positives = 156/253 (61%)
Query: 606 EESEKLVKQTAENVNEAVKELPDAN-LTPEDLWANHSKVVHPKPHRKDSPPWKAIQKILD 664
+ S +V + E+ + D++ L+ E W+N + ++ KPH+ + P W AI I
Sbjct: 295 DRSISMVLDSFESTKTSASRASDSSGLSEESSWSNFTGSLN-KPHKGNDPWWNAILAIRT 353
Query: 665 SGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAERE 724
+ + HF+ +K LG GD GSV+L EL G+ +FA+K MDK + +R K++RA ER+
Sbjct: 354 RDGILGMSHFKLLKRLGCGDIGSVYLAELSGTRCHFAVKVMDKASLEDRKKLNRAQTERD 413
Query: 725 ILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVV 784
IL +LDHPF+P LY F+T CL+ +YCPGG+L L RQP K E A RFYAAEV+
Sbjct: 414 ILQLLDHPFLPTLYTHFETDRFSCLVMEYCPGGDLHTLRQRQPGKHFSEYAARFYAAEVL 473
Query: 785 VALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKG 844
+ALEYLH G++YRDLKPENVL++ +GH+ L+DFDLS + P L+ ++ RR
Sbjct: 474 LALEYLHMLGVVYRDLKPENVLVRDDGHIMLSDFDLSLRCAVSPTLIKTFDSDPSRRGAF 533
Query: 845 QQNPVFMAEPMRA 857
P M EP A
Sbjct: 534 CVQPACM-EPTSA 545
|
|
| TAIR|locus:2133837 D6PKL1 "D6 protein kinase like 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 528 (190.9 bits), Expect = 4.4e-89, Sum P(2) = 4.4e-89
Identities = 103/208 (49%), Positives = 138/208 (66%)
Query: 647 KPHRKDSPPWKAIQKILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMD 706
KPH+ + W+AIQ + + L HFR +K LG GD G+VHL EL G+ +FAMK MD
Sbjct: 96 KPHKANDVRWEAIQAVRTKHGVLGLNHFRLLKRLGCGDIGTVHLAELHGTRCFFAMKVMD 155
Query: 707 KGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQ 766
KG + +R K+ RA EREIL LDHPF+P LY+ F+T+ CL+ ++CPGG+L L RQ
Sbjct: 156 KGALASRKKLLRAQTEREILQCLDHPFLPTLYSHFETEKFSCLVMEFCPGGDLHTLRQRQ 215
Query: 767 PTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSC 826
P K E A +FY AEV++A+EYLH GIIYRDLKPENVL++ +GHV L+DFDLS +
Sbjct: 216 PGKRFSEQAAKFYVAEVLLAMEYLHMLGIIYRDLKPENVLVRDDGHVMLSDFDLSLRCTV 275
Query: 827 KPQLLLPTTNEKKRRHKGQQNPVFMAEP 854
P ++ T + GQ+N + A+P
Sbjct: 276 SPTVVRSTVLASE----GQKNSGYCAQP 299
|
|
| TAIR|locus:2174885 AT5G40030 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 520 (188.1 bits), Expect = 1.0e-88, Sum P(2) = 1.0e-88
Identities = 101/200 (50%), Positives = 138/200 (69%)
Query: 638 ANHSKVVHP-KPHRKDSPPWKAIQKILDS-GEQINLQHFRPIKPLGSGDTGSVHLVELCG 695
AN +V P KPH+ + W AIQ + S E + L HFR +K LG GD GSV+L EL
Sbjct: 76 ANFKRVFAPSKPHKGNDLRWDAIQNVKCSKNEDLGLGHFRLLKKLGCGDIGSVYLAELRE 135
Query: 696 SGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCP 755
G +FAMK MDKG+++ R K+ RA EREIL +LDHPF+P LY+ F+T+ CL+ ++C
Sbjct: 136 MGCFFAMKVMDKGMLIGRKKLVRAQTEREILGLLDHPFLPTLYSHFETEKFSCLLMEFCS 195
Query: 756 GGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSL 815
GG+L +L +QP K E A RFYA+EV++ALEYLH G++YRDLKPENV+++ +GH+ L
Sbjct: 196 GGDLHILRQKQPGKHFSELAARFYASEVLLALEYLHMMGVVYRDLKPENVMVREDGHIML 255
Query: 816 TDFDLSCLTSCKPQLLLPTT 835
+DFDLS + P L+ T+
Sbjct: 256 SDFDLSLQSFVSPTLIQSTS 275
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries 
Original result of BLAST against SWISS-PROT
ID ![]() | Name ![]() | Annotated EC number ![]() | Identity ![]() | Query coverage ![]() | Hit coverage ![]() | RBH(Q2H) ![]() | RBH(H2Q) ![]() |
| Q2QYY8 | PHT1A_ORYSJ | 2, ., 7, ., 1, 1, ., 1 | 0.6332 | 0.8975 | 0.9793 | yes | no |
| Q2RBR1 | PHT1B_ORYSJ | 2, ., 7, ., 1, 1, ., 1 | 0.6322 | 0.8975 | 0.9793 | yes | no |
| O48963 | PHOT1_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.7307 | 0.9741 | 0.9829 | yes | no |
EC Number Prediction by Ezypred Server 
Original result from Ezypred Server
Fail to connect to Ezypred Server
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING 
Original result from the STRING server
| Your Input: | |||||||||||
| gw1.I.2683.1 | hypothetical protein (971 aa) | ||||||||||
(Populus trichocarpa) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST 
Original result of RPS-BLAST against CDD database part I
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| Query | 1005 | |||
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 1e-180 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 1e-106 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 6e-91 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 7e-91 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 5e-89 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 5e-83 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 2e-81 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 8e-76 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 3e-74 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 4e-74 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 1e-73 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 3e-72 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 5e-72 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 6e-72 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 1e-71 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 3e-68 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 4e-68 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 4e-67 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 9e-67 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 2e-66 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 3e-66 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 3e-66 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 5e-66 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 7e-66 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 6e-65 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 1e-64 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 4e-63 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 3e-62 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 1e-61 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 2e-61 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 2e-61 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 7e-60 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 4e-59 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 7e-59 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 1e-58 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 2e-58 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 7e-58 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 9e-58 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 4e-57 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 6e-57 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 2e-55 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 4e-55 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 4e-55 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 5e-55 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 4e-54 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 3e-53 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 1e-52 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 3e-52 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 1e-51 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 3e-50 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 7e-50 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 1e-49 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 1e-49 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 5e-49 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 7e-49 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 8e-49 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 4e-48 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 1e-47 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 1e-47 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 2e-47 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 5e-47 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 3e-46 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 3e-45 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 7e-45 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 1e-44 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 5e-43 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 7e-43 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 5e-42 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 1e-41 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 2e-41 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 2e-41 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 2e-40 | |
| PRK13557 | 540 | PRK13557, PRK13557, histidine kinase; Provisional | 6e-39 | |
| PRK13559 | 361 | PRK13559, PRK13559, hypothetical protein; Provisio | 2e-38 | |
| PRK13559 | 361 | PRK13559, PRK13559, hypothetical protein; Provisio | 2e-36 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 4e-33 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 1e-31 | |
| PRK13558 | 665 | PRK13558, PRK13558, bacterio-opsin activator; Prov | 3e-31 | |
| PRK13558 | 665 | PRK13558, PRK13558, bacterio-opsin activator; Prov | 7e-31 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 1e-30 | |
| PRK13557 | 540 | PRK13557, PRK13557, histidine kinase; Provisional | 2e-30 | |
| pfam13426 | 101 | pfam13426, PAS_9, PAS domain | 2e-29 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 3e-29 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 4e-29 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 5e-29 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 8e-29 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 1e-28 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 1e-28 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 3e-27 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 3e-27 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 3e-27 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 1e-26 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 1e-26 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 2e-26 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 2e-26 | |
| pfam13426 | 101 | pfam13426, PAS_9, PAS domain | 3e-26 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 4e-26 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 1e-25 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 5e-24 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 7e-24 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 7e-24 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 8e-24 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 9e-24 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 3e-23 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 4e-23 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 5e-23 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 5e-23 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 6e-23 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 1e-22 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 2e-22 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 2e-22 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 2e-22 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 6e-22 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 8e-22 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 1e-21 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 1e-21 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 3e-21 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 3e-21 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 8e-21 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 9e-21 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 3e-20 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 3e-20 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 5e-20 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 3e-19 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 5e-19 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 1e-18 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 1e-18 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 3e-18 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 3e-18 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 3e-18 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 3e-18 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 4e-18 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 5e-18 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 5e-18 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 5e-18 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 1e-17 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 4e-17 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 6e-17 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 7e-17 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 1e-16 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 1e-16 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 2e-16 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 2e-16 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 4e-16 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 4e-16 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 5e-16 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 6e-16 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 8e-16 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 8e-16 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 9e-16 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 1e-15 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 2e-15 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 3e-15 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 3e-15 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 4e-15 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 4e-15 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 7e-15 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 7e-15 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 8e-15 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 9e-15 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 2e-14 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 2e-14 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 2e-14 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 3e-14 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 3e-14 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 3e-14 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 5e-14 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 5e-14 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 6e-14 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 2e-13 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 2e-13 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 3e-13 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 4e-13 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 6e-13 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 6e-13 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 1e-12 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 1e-12 | |
| TIGR02938 | 494 | TIGR02938, nifL_nitrog, nitrogen fixation negative | 2e-12 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 4e-12 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 4e-12 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 5e-12 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 5e-12 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 6e-12 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 7e-12 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 8e-12 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 8e-12 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 9e-12 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 9e-12 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 1e-11 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 1e-11 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 1e-11 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 1e-11 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 1e-11 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 2e-11 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 2e-11 | |
| cd00130 | 103 | cd00130, PAS, PAS domain; PAS motifs appear in arc | 2e-11 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 2e-11 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 2e-11 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 3e-11 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 3e-11 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 3e-11 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 3e-11 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 4e-11 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 4e-11 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 4e-11 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 4e-11 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 5e-11 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 5e-11 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 6e-11 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 6e-11 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 7e-11 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 8e-11 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 8e-11 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 9e-11 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 9e-11 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 1e-10 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 1e-10 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 1e-10 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 1e-10 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 2e-10 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 2e-10 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 2e-10 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 2e-10 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 3e-10 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 3e-10 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 3e-10 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 3e-10 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 3e-10 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 4e-10 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 4e-10 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 5e-10 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 5e-10 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 6e-10 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 9e-10 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 2e-09 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 2e-09 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 2e-09 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 3e-09 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 3e-09 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 5e-09 | |
| cd00130 | 103 | cd00130, PAS, PAS domain; PAS motifs appear in arc | 7e-09 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 8e-09 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 1e-08 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 1e-08 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 1e-08 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 1e-08 | |
| pfam08447 | 90 | pfam08447, PAS_3, PAS fold | 2e-08 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 2e-08 | |
| TIGR00229 | 124 | TIGR00229, sensory_box, PAS domain S-box | 2e-08 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 3e-08 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 3e-08 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 5e-08 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 5e-08 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 6e-08 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 7e-08 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 7e-08 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 8e-08 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 8e-08 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 9e-08 | |
| smart00086 | 43 | smart00086, PAC, Motif C-terminal to PAS motifs (l | 1e-07 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 1e-07 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 2e-07 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 2e-07 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 2e-07 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 2e-07 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 2e-07 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 2e-07 | |
| TIGR02938 | 494 | TIGR02938, nifL_nitrog, nitrogen fixation negative | 3e-07 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 3e-07 | |
| COG2202 | 232 | COG2202, AtoS, FOG: PAS/PAC domain [Signal transdu | 3e-07 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 4e-07 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 5e-07 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 5e-07 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 6e-07 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 7e-07 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 8e-07 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 1e-06 | |
| pfam00989 | 113 | pfam00989, PAS, PAS fold | 2e-06 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 2e-06 | |
| pfam00989 | 113 | pfam00989, PAS, PAS fold | 3e-06 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 3e-06 | |
| COG2202 | 232 | COG2202, AtoS, FOG: PAS/PAC domain [Signal transdu | 4e-06 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 4e-06 | |
| TIGR00229 | 124 | TIGR00229, sensory_box, PAS domain S-box | 5e-06 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 5e-06 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 6e-06 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 7e-06 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 1e-05 | |
| pfam08447 | 90 | pfam08447, PAS_3, PAS fold | 2e-05 | |
| smart00086 | 43 | smart00086, PAC, Motif C-terminal to PAS motifs (l | 2e-05 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 2e-05 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 2e-05 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 2e-05 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 2e-05 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 3e-05 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 7e-05 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 9e-05 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 1e-04 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 2e-04 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 2e-04 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 2e-04 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 3e-04 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 4e-04 | |
| cd08227 | 327 | cd08227, PK_STRAD_alpha, Pseudokinase domain of ST | 4e-04 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 7e-04 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 7e-04 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 0.001 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 0.001 | |
| PTZ00284 | 467 | PTZ00284, PTZ00284, protein kinase; Provisional | 0.001 | |
| PLN03224 | 507 | PLN03224, PLN03224, probable serine/threonine prot | 0.001 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 0.001 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 0.001 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 0.002 | |
| PHA02882 | 294 | PHA02882, PHA02882, putative serine/threonine kina | 0.002 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 0.002 | |
| smart00091 | 67 | smart00091, PAS, PAS domain | 0.002 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 0.004 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 525 bits (1354), Expect = e-180
Identities = 181/316 (57%), Positives = 223/316 (70%), Gaps = 2/316 (0%)
Query: 672 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDH 731
+HF+ IK LG GD G V LV L G+G+ FA+K +DK M+ RNKV R E+EIL LDH
Sbjct: 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDH 60
Query: 732 PFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLH 791
PF+P LYASFQT+T++CL+ DYCPGGELF LL RQP K L E+ RFYAAEV++ALEYLH
Sbjct: 61 PFLPTLYASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLH 120
Query: 792 CQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPT--TNEKKRRHKGQQNPV 849
GI+YRDLKPEN+LL +GH+ L+DFDLS + +P + ++ +
Sbjct: 121 LLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSET 180
Query: 850 FMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKT 909
F EP SNSFVGTEEYIAPE+I+G GH SAVDWW LGILLYEMLYG TPF+G R +T
Sbjct: 181 FSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNRDET 240
Query: 910 FANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVNWALV 969
F+NIL K++ FP S P S A+ L+ +LL +DP RLGS GA EIK+HPFF+GVNWAL+
Sbjct: 241 FSNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFFRGVNWALI 300
Query: 970 RCMNPPELDAPLFATD 985
R PP + P D
Sbjct: 301 RHTTPPIIPRPDDGID 316
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 331 bits (851), Expect = e-106
Identities = 123/282 (43%), Positives = 164/282 (58%), Gaps = 32/282 (11%)
Query: 680 LGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYA 739
LG G G V LV +G+ +AMK + K ++ R +V ER IL ++HPF+ L+
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHY 60
Query: 740 SFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRD 799
+FQT+ + L+ +Y PGGELF L ++ E+ RFYAAE+V+ALEYLH GIIYRD
Sbjct: 61 AFQTEEKLYLVLEYAPGGELFSHLSKE--GRFSEERARFYAAEIVLALEYLHSLGIIYRD 118
Query: 800 LKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASN 859
LKPEN+LL +GH+ LTDF L+ +E R N
Sbjct: 119 LKPENILLDADGHIKLTDFGLAK--------------------------ELSSEGSRT-N 151
Query: 860 SFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANILHKDLK 919
+F GT EY+APE++ G G+ AVDWW+LG+LLYEML G PF + R++ + IL L+
Sbjct: 152 TFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILKDPLR 211
Query: 920 FPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFF 961
FP S A+ L+ LL +DP RLGS GA EIK HPFF
Sbjct: 212 FPEF--LSPEARDLISGLLQKDPTKRLGSG-GAEEIKAHPFF 250
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 290 bits (744), Expect = 6e-91
Identities = 119/287 (41%), Positives = 169/287 (58%), Gaps = 22/287 (7%)
Query: 680 LGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYA 739
+ G G V L + +G +A+K + K M+ +N+V + ER+IL P+V LY
Sbjct: 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYY 60
Query: 740 SFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRD 799
SFQ K ++ L+ +Y PGG+L LL+ L ED R Y AE+V+ALEYLH GII+RD
Sbjct: 61 SFQGKKNLYLVMEYLPGGDLASLLEN--VGSLDEDVARIYIAEIVLALEYLHSNGIIHRD 118
Query: 800 LKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASN 859
LKP+N+L+ NGH+ LTDF LS + + Q+ L ++ +R
Sbjct: 119 LKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKR------------------ 160
Query: 860 SFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANILHKDLK 919
VGT +YIAPE+I G GH+ VDWW+LG +LYE L G PF G+T ++ F NIL+ ++
Sbjct: 161 -IVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIE 219
Query: 920 FPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVNW 966
+P S A L+ +LL DP+ RLG+ + EIK HPFFKG++W
Sbjct: 220 WPEDVEVSDEAIDLISKLLVPDPEKRLGA-KSIEEIKNHPFFKGIDW 265
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 291 bits (747), Expect = 7e-91
Identities = 121/296 (40%), Positives = 162/296 (54%), Gaps = 35/296 (11%)
Query: 672 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDH 731
F IK LG+G G V LV GSG+Y+A+K + K ++ +V E+ IL + H
Sbjct: 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRH 60
Query: 732 PFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLH 791
PF+ LY SFQ +++ L+ +Y PGGELF L + + E RFYAA+VV+ALEYLH
Sbjct: 61 PFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRK--SGRFPEPVARFYAAQVVLALEYLH 118
Query: 792 CQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFM 851
I+YRDLKPEN+LL +G++ +TDF + KR
Sbjct: 119 SLDIVYRDLKPENLLLDSDGYIKITDFGFA-----------------KRVKGRTY----- 156
Query: 852 AEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFA 911
+ GT EY+APEII G+ AVDWWALGIL+YEML GY PF + +
Sbjct: 157 --------TLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYE 208
Query: 912 NILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGS-HEGANEIKKHPFFKGVNW 966
IL ++FPS S AK L+ LL D RLG+ G N+IK HP+F G++W
Sbjct: 209 KILEGKVRFPS--FFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNHPWFAGIDW 262
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 284 bits (730), Expect = 5e-89
Identities = 104/290 (35%), Positives = 150/290 (51%), Gaps = 38/290 (13%)
Query: 674 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPF 733
+ ++ LG G G V+L +G+ A+K + K + + R E +IL L HP
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKI--KKDRERILREIKILKKLKHPN 58
Query: 734 VPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQ 793
+ LY F+ + + L+ +YC GG+LF LL ++ L ED RFY +++ ALEYLH +
Sbjct: 59 IVRLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRGR--LSEDEARFYLRQILSALEYLHSK 116
Query: 794 GIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAE 853
GI++RDLKPEN+LL +GHV L DF L+ +
Sbjct: 117 GIVHRDLKPENILLDEDGHVKLADFGLAR---------------------------QLDP 149
Query: 854 PMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGK-TRQKTFAN 912
+ +FVGT EY+APE++ G G+ AVD W+LG++LYE+L G PF G + F
Sbjct: 150 GEKL-TTFVGTPEYMAPEVLLGKGYGKAVDIWSLGVILYELLTGKPPFPGDDQLLELFKK 208
Query: 913 ILHKDLKFPSSTPT-SLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFF 961
I FP S AK L+ +LL +DP+ RL A E +HPFF
Sbjct: 209 IGKPKPPFPPPEWDISPEAKDLIRKLLVKDPEKRL----TAEEALQHPFF 254
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 272 bits (697), Expect = 5e-83
Identities = 131/313 (41%), Positives = 180/313 (57%), Gaps = 24/313 (7%)
Query: 674 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPF 733
F IK +G G G V LV +GQ +AMK + K M+ RN++ AER+IL D P+
Sbjct: 3 FEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPW 62
Query: 734 VPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQ 793
+ LY SFQ + H+ L+ +Y PGG+L LL R+ V E+ RFY AE+V+AL+ +H
Sbjct: 63 IVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIRK--DVFPEETARFYIAELVLALDSVHKL 120
Query: 794 GIIYRDLKPENVLLQGNGHVSLTDFDLS---------CLTSCKPQLLLPTTNEKKRRHKG 844
G I+RD+KP+N+L+ +GH+ L DF L LL N RR
Sbjct: 121 GFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDH 180
Query: 845 QQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGK 904
+Q V +NS VGT +YIAPE++ G + DWW+LG++LYEMLYG+ PF
Sbjct: 181 KQRRVR-------ANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSD 233
Query: 905 TRQKTFANILH--KDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFK 962
T Q+T+ I++ + L+FP P S A L+ RLL DP+ RLGS E EIK HPFFK
Sbjct: 234 TLQETYNKIINWKESLRFPPDPPVSPEAIDLICRLL-CDPEDRLGSFE---EIKSHPFFK 289
Query: 963 GVNWALVRCMNPP 975
G++W +R PP
Sbjct: 290 GIDWENLRETKPP 302
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 265 bits (680), Expect = 2e-81
Identities = 108/292 (36%), Positives = 162/292 (55%), Gaps = 18/292 (6%)
Query: 674 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLD-HP 732
F+ K +G G +V L + + + +A+K +DK ++ KV E+E+L L+ HP
Sbjct: 3 FKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHP 62
Query: 733 FVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHC 792
+ LY +FQ + ++ + +Y P GEL + + + L E RFYAAE+++ALEYLH
Sbjct: 63 GIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKYGS--LDEKCTRFYAAEILLALEYLHS 120
Query: 793 QGIIYRDLKPENVLLQGNGHVSLTDFDLSCL---TSCKPQLLLPTTNEKKRRHKGQQNPV 849
+GII+RDLKPEN+LL + H+ +TDF + + S TN + K ++
Sbjct: 121 KGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRF- 179
Query: 850 FMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKT 909
SFVGT EY++PE++ + D WALG ++Y+ML G PFRG T
Sbjct: 180 ---------ASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLT 230
Query: 910 FANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFF 961
F IL + FP + P AK L+ +LL DP+ RLG +EG +E+K HPFF
Sbjct: 231 FQKILKLEYSFPPNFP--PDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPFF 280
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 249 bits (638), Expect = 8e-76
Identities = 101/294 (34%), Positives = 145/294 (49%), Gaps = 40/294 (13%)
Query: 674 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPF 733
+ ++ LGSG G+V+ + G+G+ A+K + K K A E IL L HP
Sbjct: 1 YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKK-RSEKSKKDQTARREIRILRRLSHPN 59
Query: 734 VPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQ 793
+ L +F+ K H+ L+ +YC GG+LF L R L ED + A +++ LEYLH
Sbjct: 60 IVRLIDAFEDKDHLYLVMEYCEGGDLFDYLSRG--GPLSEDEAKKIALQILRGLEYLHSN 117
Query: 794 GIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAE 853
GII+RDLKPEN+LL NG V + DF L+ L
Sbjct: 118 GIIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSL---------------------- 155
Query: 854 PMRASNSFVGTEEYIAPEIIAGA-GHTSAVDWWALGILLYEMLYGYTPFRGKTR---QKT 909
+FVGT Y+APE++ G G+ VD W+LG++LYE+L G PF G+ +
Sbjct: 156 -----TTFVGTPWYMAPEVLLGGNGYGPKVDVWSLGVILYELLTGKPPFSGENILDQLQL 210
Query: 910 FANILHKDLKFPSSTPTSLH--AKQLMYRLLHRDPKSRLGSHEGANEIKKHPFF 961
IL L+F +S AK L+ + L++DP R A EI +HP+F
Sbjct: 211 IRRILGPPLEFDEPKWSSGSEEAKDLIKKCLNKDPSKRP----TAEEILQHPWF 260
|
Length = 260 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 245 bits (627), Expect = 3e-74
Identities = 112/293 (38%), Positives = 164/293 (55%), Gaps = 39/293 (13%)
Query: 680 LGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYA 739
LG G G V LV++ + FA+K + K ++ + +E+EIL+ +HPF+ LY
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60
Query: 740 SFQTKTHVCLITDYCPGGELF-LLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYR 798
+F+ K ++ ++ +YC GGEL+ +L DR + E RFY A VV+A EYLH +GIIYR
Sbjct: 61 TFKDKKYIYMLMEYCLGGELWTILRDR---GLFDEYTARFYIACVVLAFEYLHNRGIIYR 117
Query: 799 DLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRAS 858
DLKPEN+LL NG+V L DF + K K +
Sbjct: 118 DLKPENLLLDSNGYVKLVDFG--------------FAKKLKSGQK--------------T 149
Query: 859 NSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRG--KTRQKTFANILH- 915
+F GT EY+APEII G+ +VD+W+LGILLYE+L G PF + + + +IL
Sbjct: 150 WTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKG 209
Query: 916 -KDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHE-GANEIKKHPFFKGVNW 966
L+FP+ + AK L+ +LL R+P+ RLG+ + G +IKKH +F G +W
Sbjct: 210 NGKLEFPNYIDKA--AKDLIKQLLRRNPEERLGNLKGGIKDIKKHKWFNGFDW 260
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 244 bits (625), Expect = 4e-74
Identities = 113/293 (38%), Positives = 159/293 (54%), Gaps = 37/293 (12%)
Query: 677 IKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREIL-DMLDHPFVP 735
+KP+ G GSV+L + +G YFA+K + K M+ +N+V AER I+ + P+V
Sbjct: 1 LKPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVA 60
Query: 736 ALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGI 795
LY SFQ+K ++ L+ +Y GG+ L+ + L ED + Y AEVV+ +E LH +GI
Sbjct: 61 KLYYSFQSKDYLYLVMEYLNGGDCASLI--KTLGGLPEDWAKQYIAEVVLGVEDLHQRGI 118
Query: 796 IYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPM 855
I+RD+KPEN+L+ GH+ LTDF LS G +N
Sbjct: 119 IHRDIKPENLLIDQTGHLKLTDFGLS--------------------RNGLENK------- 151
Query: 856 RASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANILH 915
FVGT +Y+APE I G G DWW+LG +++E L+GY PF +T F NIL
Sbjct: 152 ----KFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILS 207
Query: 916 KDLKFPSSTPTSL--HAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVNW 966
+ + +P A L+ RLL DP RLG++ G EIK HPFFK +NW
Sbjct: 208 RRINWPEEVKEFCSPEAVDLINRLLCMDPAKRLGAN-GYQEIKSHPFFKSINW 259
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 245 bits (628), Expect = 1e-73
Identities = 121/343 (35%), Positives = 180/343 (52%), Gaps = 46/343 (13%)
Query: 678 KPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPA 736
K LG G G V L EL G+ + +A+K + K V+L + V E+ +L + HPF+
Sbjct: 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQ 60
Query: 737 LYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGII 796
L++ FQTK + + +Y GG+L + R E RFYAAE+V+ L++LH +GII
Sbjct: 61 LHSCFQTKDRLFFVMEYVNGGDLMFHIQRS--GRFDEPRARFYAAEIVLGLQFLHERGII 118
Query: 797 YRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMR 856
YRDLK +NVLL GH+ + DF + CK +L T
Sbjct: 119 YRDLKLDNVLLDSEGHIKIADFGM-----CKEGILGGVT--------------------- 152
Query: 857 ASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANILHK 916
+++F GT +YIAPEI++ + AVDWWALG+LLYEML G +PF G + F +IL
Sbjct: 153 -TSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILED 211
Query: 917 DLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHE-GANEIKKHPFFKGVNW-ALVRC-MN 973
++++P S AK ++ L ++P+ RLG G +IK HPFF+ ++W L R +
Sbjct: 212 EVRYPRW--LSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGHPFFREIDWDKLERKEIK 269
Query: 974 PP-------ELDAPLFATDTEKEYKVVDPG----MQDLQQNVF 1005
PP D F + KE V+ P ++++ Q F
Sbjct: 270 PPFKPKIKGRFDVSNFDDEFTKEKPVLTPPDEAIIRNIDQEEF 312
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 241 bits (618), Expect = 3e-72
Identities = 114/307 (37%), Positives = 167/307 (54%), Gaps = 37/307 (12%)
Query: 674 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLD--- 730
FR + LG G G V L E +G+ +A+KA+ KG ++ R++V E+ I + +
Sbjct: 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSER 60
Query: 731 HPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYL 790
HPF+ L+A FQT+ HVC + +Y GG+L + + V E FYAA VV+ L+YL
Sbjct: 61 HPFLVNLFACFQTEDHVCFVMEYAAGGDLMMHIHT---DVFSEPRAVFYAACVVLGLQYL 117
Query: 791 HCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVF 850
H I+YRDLK +N+LL G V + DF L CK
Sbjct: 118 HENKIVYRDLKLDNLLLDTEGFVKIADFGL-----CKEG--------------------- 151
Query: 851 MAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTF 910
M R S +F GT E++APE++ +T AVDWW LG+L+YEML G +PF G ++ F
Sbjct: 152 MGFGDRTS-TFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVF 210
Query: 911 ANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHE-GANEIKKHPFFKGVNW-AL 968
+I++ ++++P A +M RLL R+P+ RLGS E A ++KK PFF+ +NW L
Sbjct: 211 DSIVNDEVRYPRFLSRE--AISIMRRLLRRNPERRLGSGEKDAEDVKKQPFFRDINWDDL 268
Query: 969 VRCMNPP 975
+ P
Sbjct: 269 LARKIKP 275
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 242 bits (620), Expect = 5e-72
Identities = 129/335 (38%), Positives = 184/335 (54%), Gaps = 35/335 (10%)
Query: 674 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPF 733
F IK +G G G V LV+ +G +AMK + K ML + +V AER+IL D+P+
Sbjct: 3 FESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPW 62
Query: 734 VPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQ 793
V LY SFQ + ++ LI +Y PGG++ LL ++ T E+ RFY AE ++A++ +H
Sbjct: 63 VVKLYYSFQDENYLYLIMEYLPGGDMMTLLMKKDT--FTEEETRFYIAETILAIDSIHKL 120
Query: 794 GIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRR---HKGQQNPVF 850
G I+RD+KP+N+LL GH+ L+DF L C L E R F
Sbjct: 121 GYIHRDIKPDNLLLDAKGHIKLSDFGL-----CTG-LKKSHRTEFYRILSHALPSNFLDF 174
Query: 851 MAEPM----RASN----------SFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY 896
+++PM +A S VGT +YIAPE+ G+ DWW+LG+++YEML
Sbjct: 175 ISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLV 234
Query: 897 GYTPFRGKTRQKTFANILH--KDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANE 954
GY PF Q+T+ I++ + L+FP P S AK L+ RL + + RLG++ G NE
Sbjct: 235 GYPPFCSDNPQETYRKIINWKETLQFPDEVPLSPEAKDLIKRLC-CEAERRLGNN-GVNE 292
Query: 955 IKKHPFFKGVNWALVRCMNP---PELDAPLFATDT 986
IK HPFFKGV+W +R PEL + TDT
Sbjct: 293 IKSHPFFKGVDWEHIRERPAPIIPELKSI---TDT 324
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 241 bits (616), Expect = 6e-72
Identities = 136/334 (40%), Positives = 184/334 (55%), Gaps = 47/334 (14%)
Query: 677 IKPLGSGDTGSVHLVE-LCGS--GQYFAMKAMDKGVML-NRNKVHRACAEREILDMLDHP 732
+K LG G G V V + G+ G+ FAMK + K ++ N+ AER IL+ + HP
Sbjct: 1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHP 60
Query: 733 FVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHC 792
F+ L +FQT + LI +Y GGELF+ L+R+ + ED FY +E+ +ALE+LH
Sbjct: 61 FIVDLIYAFQTGGKLYLILEYLSGGELFMHLERE--GIFMEDTACFYLSEISLALEHLHQ 118
Query: 793 QGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMA 852
QGIIYRDLKPEN+LL GHV LTDF L CK + H+G
Sbjct: 119 QGIIYRDLKPENILLDAQGHVKLTDFGL-----CKESI-----------HEGT------- 155
Query: 853 EPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFAN 912
+++F GT EY+APEI+ +GH AVDWW+LG L+Y+ML G PF + R+KT
Sbjct: 156 ----VTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDK 211
Query: 913 ILHKDLKFPSS-TPTSLHAKQLMYRLLHRDPKSRLGSHEG-ANEIKKHPFFKGVNW--AL 968
IL L P TP A+ L+ +LL R+P SRLG+ G A E++ HPFF+ VNW L
Sbjct: 212 ILKGKLNLPPYLTP---EARDLLKKLLKRNPSSRLGAGPGDAAEVQSHPFFRHVNWDDLL 268
Query: 969 VRCMNPP-------ELDAPLFATDTEKEYKVVDP 995
R + PP E D F + ++ V P
Sbjct: 269 ARKVEPPFKPLLQSEEDVSQFDSKFTRQTPVDSP 302
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 239 bits (612), Expect = 1e-71
Identities = 122/305 (40%), Positives = 176/305 (57%), Gaps = 29/305 (9%)
Query: 674 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPF 733
F IK + +G G+V+LV + Q FAMK ++K ++ RN++ + ER+IL ++PF
Sbjct: 3 FETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPF 62
Query: 734 VPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQ 793
V +++ SF+TK H+C++ +Y GG+ LL L D R Y AE V+ALEYLH
Sbjct: 63 VVSMFCSFETKRHLCMVMEYVEGGDCATLLKNIGA--LPVDMARMYFAETVLALEYLHNY 120
Query: 794 GIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTN------EKKRRHKGQQN 847
GI++RDLKP+N+L+ GH+ LTDF LS K L+ TTN EK R
Sbjct: 121 GIVHRDLKPDNLLITSMGHIKLTDFGLS-----KIGLMSLTTNLYEGHIEKDTRE----- 170
Query: 848 PVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQ 907
F+ GT EYIAPE+I G+ VDWWA+GI+LYE L G PF G T +
Sbjct: 171 --FL------DKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPE 222
Query: 908 KTFANILHKDLKFPSS-TPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVNW 966
+ F ++ D+++P A+ L+ RLL ++P RLG+ GA E+K+H FF G++W
Sbjct: 223 ELFGQVISDDIEWPEGDEALPADAQDLISRLLRQNPLERLGTG-GAFEVKQHRFFLGLDW 281
Query: 967 -ALVR 970
L+R
Sbjct: 282 NGLLR 286
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 229 bits (586), Expect = 3e-68
Identities = 122/309 (39%), Positives = 170/309 (55%), Gaps = 44/309 (14%)
Query: 674 FRPIKPLGSGDTGSVHLVELCG---SGQYFAMKAMDKGVMLNRNKV-HRACAEREILDML 729
F ++ LG+G G V LV G +G+ +AMK + K ++ + K ER++L+ +
Sbjct: 2 FELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAV 61
Query: 730 DH-PFVPALYASFQTKTHVCLITDYCPGGELFL-LLDRQPTKVLKEDAVRFYAAEVVVAL 787
PF+ L+ +FQT T + LI DY GGELF L R+ E VR Y AE+V+AL
Sbjct: 62 RRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREH---FTESEVRVYIAEIVLAL 118
Query: 788 EYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQN 847
++LH GIIYRD+K EN+LL GHV LTDF LS
Sbjct: 119 DHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLS-------------------------- 152
Query: 848 PVFMAEPMRASNSFVGTEEYIAPEIIAG--AGHTSAVDWWALGILLYEMLYGYTPFR--- 902
F+AE + SF GT EY+APE+I G GH AVDWW+LG+L +E+L G +PF
Sbjct: 153 KEFLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDG 212
Query: 903 GKTRQKTFAN-ILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFF 961
+ Q + IL FP + S A+ + +LL +DPK RLG++ GA+EIK HPFF
Sbjct: 213 EQNSQSEISRRILKSKPPFPKT--MSAEARDFIQKLLEKDPKKRLGAN-GADEIKNHPFF 269
Query: 962 KGVNWALVR 970
+G++W +
Sbjct: 270 QGIDWDDLA 278
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 229 bits (585), Expect = 4e-68
Identities = 114/307 (37%), Positives = 160/307 (52%), Gaps = 37/307 (12%)
Query: 672 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDH 731
IK +G+G G VHLV S Y+A+K M ++ + E+ +L + H
Sbjct: 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSH 60
Query: 732 PFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLH 791
PF+ L+ + + + ++ +Y PGGELF L + + FYA+E+V ALEYLH
Sbjct: 61 PFIIRLFWTEHDQRFLYMLMEYVPGGELFSYL--RNSGRFSNSTGLFYASEIVCALEYLH 118
Query: 792 CQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFM 851
+ I+YRDLKPEN+LL GH+ LTDF + KK R +
Sbjct: 119 SKEIVYRDLKPENILLDKEGHIKLTDFGFA----------------KKLRDR-------- 154
Query: 852 AEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFA 911
+ + GT EY+APE+I GH AVDWWALGIL+YEML GY PF +
Sbjct: 155 ------TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYE 208
Query: 912 NILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHE-GANEIKKHPFFKGVNWALV- 969
IL L+FP L+AK L+ +LL D RLG+ + GA+++K H +FK V+W V
Sbjct: 209 KILAGKLEFPRH--LDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNHRWFKSVDWDDVP 266
Query: 970 -RCMNPP 975
R + PP
Sbjct: 267 QRKLKPP 273
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 225 bits (575), Expect = 4e-67
Identities = 100/292 (34%), Positives = 155/292 (53%), Gaps = 37/292 (12%)
Query: 673 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHP 732
HF ++ +G G G V +V+ + + FAMK M+K + + V ER IL L+HP
Sbjct: 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHP 60
Query: 733 FVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHC 792
F+ L+ SFQ + ++ L+ D GG+L L ++ E+ V+F+ E+V+ALEYLH
Sbjct: 61 FLVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQK--VKFSEEQVKFWICEIVLALEYLHS 118
Query: 793 QGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMA 852
+GII+RD+KP+N+LL GHV +TDF+++
Sbjct: 119 KGIIHRDIKPDNILLDEQGHVHITDFNIAT----------------------------KV 150
Query: 853 EPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKT--- 909
P + S GT Y+APE++ G++ AVDWW+LG+ YE L G P+RG +R
Sbjct: 151 TPDTLTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQI 210
Query: 910 FANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFF 961
A D+ +P++ T A + +LL RDP+ RLG + ++K HP+F
Sbjct: 211 RAKQETADVLYPATWSTE--AIDAINKLLERDPQKRLGDN--LKDLKNHPYF 258
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 226 bits (579), Expect = 9e-67
Identities = 114/301 (37%), Positives = 160/301 (53%), Gaps = 34/301 (11%)
Query: 678 KPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREIL-DMLDHPFVPA 736
K +G G G V L + G+++A+K + K +L + + AER +L + HPF+
Sbjct: 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVG 60
Query: 737 LYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGII 796
L+ SFQT + + DY GGELF L R+ + E RFYAAE+ AL YLH II
Sbjct: 61 LHYSFQTADKLYFVLDYVNGGELFFHLQRE--RSFPEPRARFYAAEIASALGYLHSLNII 118
Query: 797 YRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMR 856
YRDLKPEN+LL GHV LTDF L CK + E +
Sbjct: 119 YRDLKPENILLDSQGHVVLTDFGL-----CKEGI----------------------EHSK 151
Query: 857 ASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANILHK 916
+++F GT EY+APE++ + VDWW LG +LYEMLYG PF + + + NIL+K
Sbjct: 152 TTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNK 211
Query: 917 DLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVNWA--LVRCMNP 974
L+ + S+ A+ L+ LL +D RLG+ + EIK H FF +NW + + + P
Sbjct: 212 PLRLKPN--ISVSARHLLEGLLQKDRTKRLGAKDDFLEIKNHVFFSSINWDDLVNKKITP 269
Query: 975 P 975
P
Sbjct: 270 P 270
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 225 bits (575), Expect = 2e-66
Identities = 123/305 (40%), Positives = 177/305 (58%), Gaps = 38/305 (12%)
Query: 677 IKPLGSGDTGSVHLV-ELCG--SGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPF 733
+K LG G G V LV ++ G +GQ +AMK + K + R++V R ER+IL ++HPF
Sbjct: 1 LKVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRV-RTKMERDILAEVNHPF 59
Query: 734 VPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQ 793
+ L+ +FQT+ + LI D+ GG+LF L ++ + E+ V+FY AE+ +AL++LH
Sbjct: 60 IVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKE--VMFTEEDVKFYLAELALALDHLHSL 117
Query: 794 GIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAE 853
GIIYRDLKPEN+LL GH+ LTDF LS +EKK
Sbjct: 118 GIIYRDLKPENILLDEEGHIKLTDFGLS---------KESIDHEKK-------------- 154
Query: 854 PMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANI 913
+ SF GT EY+APE++ GHT + DWW+ G+L++EML G PF+GK R++T I
Sbjct: 155 ----AYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMI 210
Query: 914 LHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGS-HEGANEIKKHPFFKGVNWALV--R 970
L L P S A+ L+ L R+P +RLG+ +G EIK+HPFF ++W + R
Sbjct: 211 LKAKLGMPQF--LSPEAQSLLRALFKRNPANRLGAGPDGVEEIKRHPFFSTIDWNKLYRR 268
Query: 971 CMNPP 975
+ PP
Sbjct: 269 EIKPP 273
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 225 bits (576), Expect = 3e-66
Identities = 116/329 (35%), Positives = 162/329 (49%), Gaps = 50/329 (15%)
Query: 650 RKDSPPWKAIQKILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGV 709
+ D+ WK L F + LG+G G V + + G+G+Y+A+K + K
Sbjct: 9 KPDTSSWK-------------LSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKRE 55
Query: 710 MLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTK 769
+L +V E+ IL L HPF+ + SFQ + V + ++ GGELF L R+ +
Sbjct: 56 ILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLLEFVVGGELFTHL-RKAGR 114
Query: 770 VLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQ 829
D +FY AE+V+A EYLH + IIYRDLKPEN+LL GHV +TDF +
Sbjct: 115 -FPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFA-------- 165
Query: 830 LLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGI 889
KK + + + GT EY+APE+I GH AVDWW +G+
Sbjct: 166 --------KKVPDR--------------TFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGV 203
Query: 890 LLYEMLYGYTPFRGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGS- 948
LLYE + GY PF T + + IL LKFP+ A+ L+ LL D RLG+
Sbjct: 204 LLYEFIAGYPPFFDDTPFRIYEKILAGRLKFPNW--FDGRARDLVKGLLQTDHTKRLGTL 261
Query: 949 HEGANEIKKHPFFKGVNW--ALVRCMNPP 975
G ++K HP+F G NW R P
Sbjct: 262 KGGVADVKNHPYFHGANWDKLYARYYPAP 290
|
Length = 329 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 225 bits (575), Expect = 3e-66
Identities = 120/315 (38%), Positives = 170/315 (53%), Gaps = 34/315 (10%)
Query: 678 KPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPAL 737
K LG G G V LV +G+Y+AMK + K V++ +++V E +L HPF+ AL
Sbjct: 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTAL 60
Query: 738 YASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIY 797
SFQT +C + +Y GGELF L R+ +V ED RFY AE+V AL YLH ++Y
Sbjct: 61 KYSFQTHDRLCFVMEYANGGELFFHLSRE--RVFSEDRARFYGAEIVSALGYLHSCDVVY 118
Query: 798 RDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRA 857
RDLK EN++L +GH+ +TDF L CK + T
Sbjct: 119 RDLKLENLMLDKDGHIKITDFGL-----CKEGISDGAT---------------------- 151
Query: 858 SNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANILHKD 917
+F GT EY+APE++ + AVDWW LG+++YEM+ G PF + +K F IL ++
Sbjct: 152 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEE 211
Query: 918 LKFPSSTPTSLHAKQLMYRLLHRDPKSRL-GSHEGANEIKKHPFFKGVNW-ALVRCMNPP 975
++FP + S AK L+ LL +DPK RL G E A EI +H FF +NW +V+ P
Sbjct: 212 IRFPRT--LSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEHRFFASINWQDVVQKKLEP 269
Query: 976 ELDAPLFATDTEKEY 990
P ++T+ Y
Sbjct: 270 PFK-PQVTSETDTRY 283
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 224 bits (573), Expect = 5e-66
Identities = 113/301 (37%), Positives = 167/301 (55%), Gaps = 37/301 (12%)
Query: 678 KPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDM-LDHPFVPA 736
K LG G G V L EL G+ ++FA+KA+ K V+L + V ER +L + +HPF+
Sbjct: 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTH 60
Query: 737 LYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGII 796
L+ +FQTK H+ + +Y GG+L + Q + E RFYAAE++ L++LH +GII
Sbjct: 61 LFCTFQTKEHLFFVMEYLNGGDLMFHI--QSSGRFDEARARFYAAEIICGLQFLHKKGII 118
Query: 797 YRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMR 856
YRDLK +NVLL +GH+ + DF + CK +
Sbjct: 119 YRDLKLDNVLLDKDGHIKIADFGM-----CKENMNGEGK--------------------- 152
Query: 857 ASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANILHK 916
+++F GT +YIAPEI+ G + +VDWW+ G+LLYEML G +PF G+ + F +IL+
Sbjct: 153 -ASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILND 211
Query: 917 DLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVNWALV--RCMNP 974
FP S AK + +L RDP RLG +I++HPFF+G++W + R + P
Sbjct: 212 RPHFPRW--ISKEAKDCLSKLFERDPTKRLGV---DGDIRQHPFFRGIDWERLEKREIPP 266
Query: 975 P 975
P
Sbjct: 267 P 267
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 224 bits (572), Expect = 7e-66
Identities = 114/302 (37%), Positives = 171/302 (56%), Gaps = 36/302 (11%)
Query: 680 LGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREIL---DMLDHPFVPA 736
+G G G V+ V + + +AMK + K ++ + +V ER IL + + PF+
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60
Query: 737 LYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGII 796
L SFQT + + L+TDY GGELF L Q ED +FY AE+V+ALE+LH I+
Sbjct: 61 LKFSFQTDSDLYLVTDYMSGGELFWHL--QKEGRFSEDRAKFYIAELVLALEHLHKYDIV 118
Query: 797 YRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMR 856
YRDLKPEN+LL GH++L DF LS K L T N+
Sbjct: 119 YRDLKPENILLDATGHIALCDFGLS-----KANL---TDNK------------------- 151
Query: 857 ASNSFVGTEEYIAPEIIAG-AGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANILH 915
+N+F GT EY+APE++ G+T VD+W+LG+L++EM G++PF + Q+ + NI
Sbjct: 152 TTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAF 211
Query: 916 KDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVNWALV--RCMN 973
++FP + S +Q + LL+R+P+ RLG+H A E+K+HPFF ++W L+ + +
Sbjct: 212 GKVRFPKNV-LSDEGRQFVKGLLNRNPQHRLGAHRDAVELKEHPFFADIDWDLLSKKQIT 270
Query: 974 PP 975
PP
Sbjct: 271 PP 272
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 223 bits (570), Expect = 6e-65
Identities = 126/356 (35%), Positives = 179/356 (50%), Gaps = 52/356 (14%)
Query: 673 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHP 732
F IK +G G G V LV + +AMK + K +L RN+ AER+IL D+
Sbjct: 2 MFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNE 61
Query: 733 FVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHC 792
+V LY SFQ K ++ + DY PGG++ LL R + +ED RFY AE+ A+E +H
Sbjct: 62 WVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRL--GIFEEDLARFYIAELTCAIESVHK 119
Query: 793 QGIIYRDLKPENVLLQGNGHVSLTDFDL------------------------------SC 822
G I+RD+KP+N+L+ +GH+ LTDF L S
Sbjct: 120 MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSE 179
Query: 823 LTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAV 882
+ C+ + L +RR K Q ++S VGT YIAPE++ G+T
Sbjct: 180 IDRCRLKPL-------ERRRKRQHQRC-------LAHSLVGTPNYIAPEVLLRTGYTQLC 225
Query: 883 DWWALGILLYEMLYGYTPFRGKTRQKTFANILH--KDLKFPSSTPTSLHAKQLMYRLLHR 940
DWW++G++LYEML G PF T +T +++ L PS S A L+ RL
Sbjct: 226 DWWSVGVILYEMLVGQPPFLADTPAETQLKVINWETTLHIPSQAKLSREASDLILRLC-C 284
Query: 941 DPKSRLGSHEGANEIKKHPFFKGVNWA-LVRCMNPPELDAPLFATDTEKEYKVVDP 995
+ RLG + GA+EIK HPFFKG+++A L+R P + TDT + VDP
Sbjct: 285 GAEDRLGKN-GADEIKAHPFFKGIDFASLIRRQKAPYIPKITHPTDTSN-FDPVDP 338
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 220 bits (563), Expect = 1e-64
Identities = 132/340 (38%), Positives = 193/340 (56%), Gaps = 50/340 (14%)
Query: 674 FRPIKPLGSGDTGSVHLVELCG---SGQYFAMKAMDKGVMLNRNK-VHRACAEREILDML 729
F +K LG+G G V LV +G+ +AMK + K ++ + K V ER +L+ +
Sbjct: 2 FELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHV 61
Query: 730 -DHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALE 788
PF+ L+ +FQT+ + LI DY GGE+F L ++ ED VRFY+ E+++ALE
Sbjct: 62 RQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQR--DNFSEDEVRFYSGEIILALE 119
Query: 789 YLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNP 848
+LH GI+YRD+K EN+LL GHV LTDF LS
Sbjct: 120 HLHKLGIVYRDIKLENILLDSEGHVVLTDFGLS--------------------------K 153
Query: 849 VFMAEPMRASNSFVGTEEYIAPEIIAG-AGHTSAVDWWALGILLYEMLYGYTPFRGKTRQ 907
F++E + SF GT EY+APEII G GH AVDWW+LGIL++E+L G +PF + +
Sbjct: 154 EFLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGER 213
Query: 908 KTFANILHKDLKFPSSTPTSLH--AKQLMYRLLHRDPKSRLGS-HEGANEIKKHPFFKGV 964
T + + + LK P+ + A+ L+++LL +DPK RLG+ +GA+EIK+HPFFKG+
Sbjct: 214 NTQSEVSRRILKCDPPFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKGL 273
Query: 965 NWALV--RCMNPP-------ELDAPLFATDTEKEYKVVDP 995
+W + R +NPP ELD FA +E+ ++P
Sbjct: 274 DWEALALRKVNPPFRPSIRNELDVGNFA----EEFTNLEP 309
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 216 bits (552), Expect = 4e-63
Identities = 113/316 (35%), Positives = 173/316 (54%), Gaps = 36/316 (11%)
Query: 678 KPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPAL 737
K LG G G V LV +G+Y+AMK + K V++ +++V E +L HPF+ AL
Sbjct: 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 60
Query: 738 YASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIY 797
+FQT +C + +Y GGELF L R+ +V E+ RFY AE+V ALEYLH + ++Y
Sbjct: 61 KYAFQTHDRLCFVMEYANGGELFFHLSRE--RVFTEERARFYGAEIVSALEYLHSRDVVY 118
Query: 798 RDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRA 857
RD+K EN++L +GH+ +TDF L CK + ++ +
Sbjct: 119 RDIKLENLMLDKDGHIKITDFGL-----CKEGI----SDGATMK---------------- 153
Query: 858 SNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANILHKD 917
+F GT EY+APE++ + AVDWW LG+++YEM+ G PF + ++ F IL ++
Sbjct: 154 --TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEE 211
Query: 918 LKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSH-EGANEIKKHPFFKGVNW--ALVRCMNP 974
++FP + S AK L+ LL +DPK RLG A E+ +H FF +NW + + + P
Sbjct: 212 IRFPRT--LSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQDVVQKKLLP 269
Query: 975 PELDAPLFATDTEKEY 990
P P ++ + Y
Sbjct: 270 PF--KPQVTSEVDTRY 283
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 216 bits (551), Expect = 3e-62
Identities = 118/336 (35%), Positives = 181/336 (53%), Gaps = 28/336 (8%)
Query: 674 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPF 733
F +K +G G G V LV+ +G+ +AMK + K M ++++ AER++L D P+
Sbjct: 3 FHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPW 62
Query: 734 VPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQ 793
V +LY SFQ ++ LI ++ PGG+L +L + T ED RFY AE V+A+E +H
Sbjct: 63 VVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKYDT--FSEDVTRFYMAECVLAIEAVHKL 120
Query: 794 GIIYRDLKPENVLLQGNGHVSLTDFDLSC-----LTSCKPQLLLPTTNEKKRRHKGQQNP 848
G I+RD+KP+N+L+ GH+ L+DF LS S Q LL K R + +
Sbjct: 121 GFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLL-QGKSNKNRIDNRNSV 179
Query: 849 VFMAEPMRASN----------------SFVGTEEYIAPEIIAGAGHTSAVDWWALGILLY 892
+ + S+ S VGT +YIAPEI G+ DWW+LG +++
Sbjct: 180 AVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAIMF 239
Query: 893 EMLYGYTPFRGKTRQKTFANILH--KDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHE 950
E L G+ PF + +T+ I++ + L FP S+ A+ L+ RL+ + ++RLG
Sbjct: 240 ECLIGWPPFCSENSHETYRKIINWRETLYFPDDIHLSVEAEDLIRRLI-TNAENRLGRG- 297
Query: 951 GANEIKKHPFFKGVNWALVRCMNPPELDAPLFATDT 986
GA+EIK HPFF+GV+W +R + P + TDT
Sbjct: 298 GAHEIKSHPFFRGVDWDTIRQIRAPFIPQLKSITDT 333
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 212 bits (541), Expect = 1e-61
Identities = 116/290 (40%), Positives = 154/290 (53%), Gaps = 32/290 (11%)
Query: 678 KPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREIL-DMLDHPFVPA 736
K +G G G V L + G ++A+K + K +L + + + AER +L L HPF+
Sbjct: 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVG 60
Query: 737 LYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGII 796
L+ SFQT + + DY GGELF L R+ + E RFYAAEV A+ YLH II
Sbjct: 61 LHYSFQTAEKLYFVLDYVNGGELFFHLQRE--RCFLEPRARFYAAEVASAIGYLHSLNII 118
Query: 797 YRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMR 856
YRDLKPEN+LL GHV LTDF L CK + EP
Sbjct: 119 YRDLKPENILLDSQGHVVLTDFGL-----CKEGV----------------------EPEE 151
Query: 857 ASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANILHK 916
+++F GT EY+APE++ + VDWW LG +LYEMLYG PF + + + NILHK
Sbjct: 152 TTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHK 211
Query: 917 DLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVNW 966
L+ P + A L+ LLH+D + RLG+ EIK H FF +NW
Sbjct: 212 PLQLPGGKTVA--ACDLLVGLLHKDQRRRLGAKADFLEIKNHVFFSPINW 259
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 212 bits (540), Expect = 2e-61
Identities = 125/316 (39%), Positives = 174/316 (55%), Gaps = 36/316 (11%)
Query: 678 KPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPAL 737
K LG G G V LV SG+Y+AMK + K V++ +++V E +L HPF+ +L
Sbjct: 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSL 60
Query: 738 YASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIY 797
SFQTK +C + +Y GGELF L R+ +V ED RFY AE+V AL+YLH I+Y
Sbjct: 61 KYSFQTKDRLCFVMEYVNGGELFFHLSRE--RVFSEDRTRFYGAEIVSALDYLHSGKIVY 118
Query: 798 RDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRA 857
RDLK EN++L +GH+ +TDF L CK + T +
Sbjct: 119 RDLKLENLMLDKDGHIKITDFGL-----CKEGITDAATMK-------------------- 153
Query: 858 SNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANILHKD 917
+F GT EY+APE++ + AVDWW LG+++YEM+ G PF + +K F IL +D
Sbjct: 154 --TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMED 211
Query: 918 LKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSH-EGANEIKKHPFFKGVNWALV--RCMNP 974
+KFP + S AK L+ LL +DP RLG + A EI +H FF GVNW V + + P
Sbjct: 212 IKFPRT--LSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRHSFFTGVNWQDVYDKKLVP 269
Query: 975 PELDAPLFATDTEKEY 990
P P ++T+ Y
Sbjct: 270 PF--KPQVTSETDTRY 283
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 212 bits (541), Expect = 2e-61
Identities = 113/330 (34%), Positives = 166/330 (50%), Gaps = 50/330 (15%)
Query: 673 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHP 732
F+ + +G G G V L + +G+ A+K M K ++ N+V ER+IL
Sbjct: 2 DFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSE 61
Query: 733 FVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHC 792
++ L +FQ ++ L +Y PGG+ LL+ VL ED RFY AE+ A++ LH
Sbjct: 62 WLVKLLYAFQDDEYLYLAMEYVPGGDFRTLLNN--LGVLSEDHARFYMAEMFEAVDALHE 119
Query: 793 QGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMA 852
G I+RDLKPEN L+ +GH+ LTDF LS
Sbjct: 120 LGYIHRDLKPENFLIDASGHIKLTDFGLS------------------------------K 149
Query: 853 EPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFAN 912
+ +NS VG+ +Y+APE++ G G+ VD+W+LG +LYE L G+ PF G T +T+ N
Sbjct: 150 GIVTYANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWEN 209
Query: 913 ILH--KDLKFPSSTPT----SLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVNW 966
+ + + L+ P S A L+ +L++ DP R GS E +IK HPFFK V+W
Sbjct: 210 LKYWKETLQRPVYDDPRFNLSDEAWDLITKLIN-DPSRRFGSLE---DIKNHPFFKEVDW 265
Query: 967 ALVRCMNPP-------ELDAPLFATDTEKE 989
+R + PP E+D F D E E
Sbjct: 266 NELRELKPPFVPELESEIDTGYF-DDFENE 294
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 207 bits (527), Expect = 7e-60
Identities = 120/309 (38%), Positives = 167/309 (54%), Gaps = 34/309 (11%)
Query: 680 LGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYA 739
+G G G V V + + +A+K + K +++R++V AER +L ++ PF+ L
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60
Query: 740 SFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRD 799
SFQ+ + L+ + GGELF L R+ RFY AE++ ALE LH +IYRD
Sbjct: 61 SFQSPEKLYLVLAFINGGELFHHLQREGR--FDLSRARFYTAELLCALENLHKFNVIYRD 118
Query: 800 LKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASN 859
LKPEN+LL GH++L DF L CK L ++ K +N
Sbjct: 119 LKPENILLDYQGHIALCDFGL-----CK----LNMKDDDK------------------TN 151
Query: 860 SFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANILHKDLK 919
+F GT EY+APE++ G G+T AVDWW LG+LLYEML G PF + + + IL + L+
Sbjct: 152 TFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQEPLR 211
Query: 920 FPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVNWA--LVRCMNPPEL 977
FP AK L+ LL RDP RLG + GA EIK HPFF ++W L++ + PP
Sbjct: 212 FPDGFDRD--AKDLLIGLLSRDPTRRLGYN-GAQEIKNHPFFSQLSWKKLLMKGIQPPFK 268
Query: 978 DAPLFATDT 986
A A DT
Sbjct: 269 PAVSSAIDT 277
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 204 bits (520), Expect = 4e-59
Identities = 122/304 (40%), Positives = 173/304 (56%), Gaps = 38/304 (12%)
Query: 673 HFRPIKPLGSGDTGSVHLV-ELCG--SGQYFAMKAMDKGVMLNRNKV-HRACAEREILDM 728
+F +K LG+G G V LV ++ G SG+ +AMK + K ++ + K ER++L+
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 60
Query: 729 LDH-PFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVAL 787
+ PF+ L+ +FQT T + LI DY GGELF L ++ + KE V+ Y+ E+V+AL
Sbjct: 61 IRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQR--ERFKEQEVQIYSGEIVLAL 118
Query: 788 EYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQN 847
E+LH GIIYRD+K EN+LL NGHV LTDF LS
Sbjct: 119 EHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLS-------------------------- 152
Query: 848 PVFMAEPMRASNSFVGTEEYIAPEIIAG--AGHTSAVDWWALGILLYEMLYGYTPFRGKT 905
F + + + SF GT EY+AP+I+ G GH AVDWW++G+L+YE+L G +PF
Sbjct: 153 KEFHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDG 212
Query: 906 RQKTFANILHKDLKFPSSTPTSLH--AKQLMYRLLHRDPKSRLGSH-EGANEIKKHPFFK 962
+ + A I + LK P + AK ++ RLL +DPK RLG A+EIKKHPFF+
Sbjct: 213 EKNSQAEISRRILKSEPPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQ 272
Query: 963 GVNW 966
+NW
Sbjct: 273 KINW 276
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 204 bits (521), Expect = 7e-59
Identities = 121/317 (38%), Positives = 177/317 (55%), Gaps = 37/317 (11%)
Query: 678 KPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPAL 737
K LG G G V LV+ +G+Y+AMK + K V++ +++V E +L HPF+ AL
Sbjct: 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTAL 60
Query: 738 YASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQ-GII 796
SFQT +C + +Y GGELF L R+ +V ED RFY AE+V AL+YLH + ++
Sbjct: 61 KYSFQTHDRLCFVMEYANGGELFFHLSRE--RVFSEDRARFYGAEIVSALDYLHSEKNVV 118
Query: 797 YRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMR 856
YRDLK EN++L +GH+ +TDF L CK +G ++ M
Sbjct: 119 YRDLKLENLMLDKDGHIKITDFGL-----CK---------------EGIKDGATM----- 153
Query: 857 ASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANILHK 916
+F GT EY+APE++ + AVDWW LG+++YEM+ G PF + +K F IL +
Sbjct: 154 --KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILME 211
Query: 917 DLKFPSSTPTSLHAKQLMYRLLHRDPKSRL-GSHEGANEIKKHPFFKGVNWALV--RCMN 973
+++FP + S AK L+ LL +DPK RL G + A EI +H FF G+ W V + +
Sbjct: 212 EIRFPRT--LSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQHKFFAGIVWQDVYEKKLV 269
Query: 974 PPELDAPLFATDTEKEY 990
PP P ++T+ Y
Sbjct: 270 PPF--KPQVTSETDTRY 284
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 204 bits (520), Expect = 1e-58
Identities = 117/303 (38%), Positives = 161/303 (53%), Gaps = 33/303 (10%)
Query: 678 KPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREIL-DMLDHPFVPA 736
K +G G G V L + G+ +A+K + K ++LNR + AER +L + HPF+
Sbjct: 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVG 60
Query: 737 LYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGII 796
L+ SFQT + + D+ GGELF L R+ + E RFYAAE+ AL YLH I+
Sbjct: 61 LHYSFQTTEKLYFVLDFVNGGELFFHLQRERS--FPEPRARFYAAEIASALGYLHSINIV 118
Query: 797 YRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMR 856
YRDLKPEN+LL GHV LTDF L CK + T
Sbjct: 119 YRDLKPENILLDSQGHVVLTDFGL-----CKEGIAQSDT--------------------- 152
Query: 857 ASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANILHK 916
+ +F GT EY+APE+I + + VDWW LG +LYEMLYG PF + + + NILHK
Sbjct: 153 -TTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHK 211
Query: 917 DLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVNWA-LVRCMNPP 975
L SL A ++ LL +D + RLG+ E EI++HPFF+ ++W L + PP
Sbjct: 212 PLVLRPG--ASLTAWSILEELLEKDRQRRLGAKEDFLEIQEHPFFESLSWTDLEQKKIPP 269
Query: 976 ELD 978
+
Sbjct: 270 PFN 272
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 203 bits (519), Expect = 2e-58
Identities = 118/323 (36%), Positives = 177/323 (54%), Gaps = 41/323 (12%)
Query: 674 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRAC--AEREILDMLDH 731
F +K +G G G V +V++ +GQ +AMK ++K ML R + AC ER++L D
Sbjct: 3 FEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAET--ACFREERDVLVNGDR 60
Query: 732 PFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLH 791
++ L+ +FQ + ++ L+ DY GG+L LL + + L ED RFY AE+V+A++ +H
Sbjct: 61 RWITNLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDR-LPEDMARFYLAEMVLAIDSVH 119
Query: 792 CQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFM 851
G ++RD+KP+NVLL NGH+ L DF SCL +
Sbjct: 120 QLGYVHRDIKPDNVLLDKNGHIRLADFG-SCLR-------------------------LL 153
Query: 852 AEPMRASNSFVGTEEYIAPEIIA----GAGHTSA-VDWWALGILLYEMLYGYTPFRGKTR 906
A+ SN VGT +YI+PEI+ G G DWW+LG+ +YEMLYG TPF ++
Sbjct: 154 ADGTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESL 213
Query: 907 QKTFANIL-HKD-LKFPSSTP-TSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKG 963
+T+ I+ HK+ +FP S AK L+ RL+ P++RLG + G + K HPFF+G
Sbjct: 214 VETYGKIMNHKEHFQFPPDVTDVSEEAKDLIRRLICS-PETRLGRN-GLQDFKDHPFFEG 271
Query: 964 VNWALVRCMNPPELDAPLFATDT 986
++W +R P + TDT
Sbjct: 272 IDWDNIRNSTAPYVPEVSSPTDT 294
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 201 bits (513), Expect = 7e-58
Identities = 108/319 (33%), Positives = 177/319 (55%), Gaps = 40/319 (12%)
Query: 678 KPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPA 736
K LG G G V L EL G+ Q+FA+KA+ K V+L + V E+ +L + +HPF+
Sbjct: 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTH 60
Query: 737 LYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGII 796
LY +FQTK ++ + +Y GG+L + Q FYAAE++ L++LH +GI+
Sbjct: 61 LYCTFQTKENLFFVMEYLNGGDLMFHI--QSCHKFDLPRATFYAAEIICGLQFLHSKGIV 118
Query: 797 YRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMR 856
YRDLK +N+LL +GH+ + DF + CK +L + K
Sbjct: 119 YRDLKLDNILLDTDGHIKIADFGM-----CKENML----GDAK----------------- 152
Query: 857 ASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANILHK 916
+ +F GT +YIAPEI+ G + ++VDWW+ G+LLYEML G +PF G ++ F +I
Sbjct: 153 -TCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMD 211
Query: 917 DLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVNWALV--RCMNP 974
+ +P + AK ++ +L R+P+ RLG +I++HPFF+ ++W+ + R + P
Sbjct: 212 NPCYPRW--LTREAKDILVKLFVREPERRLGVK---GDIRQHPFFREIDWSALEEREIEP 266
Query: 975 ---PELDAPLFATDTEKEY 990
P++ + ++ +KE+
Sbjct: 267 PFKPKVKSANDCSNFDKEF 285
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 201 bits (513), Expect = 9e-58
Identities = 119/331 (35%), Positives = 169/331 (51%), Gaps = 44/331 (13%)
Query: 678 KPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDM-LDHPFVPA 736
K LG G G V L EL G+ + +A+K + K V+L + V E+ IL + HPF+ A
Sbjct: 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTA 60
Query: 737 LYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGII 796
L+ FQTK + + +Y GG+L + Q ++ E RFYAAEV +AL +LH G+I
Sbjct: 61 LHCCFQTKDRLFFVMEYVNGGDLMFQI--QRSRKFDEPRSRFYAAEVTLALMFLHRHGVI 118
Query: 797 YRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMR 856
YRDLK +N+LL GH L DF + CK +L
Sbjct: 119 YRDLKLDNILLDAEGHCKLADFGM-----CKEGIL----------------------NGV 151
Query: 857 ASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANILHK 916
+ +F GT +YIAPEI+ + +VDWWALG+L+YEM+ G PF F +ILH
Sbjct: 152 TTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHD 211
Query: 917 DLKFPSSTPTSLHAKQLMYRLLHRDPKSRLG---SHEGANEIKKHPFFKGVNWALV--RC 971
D+ +P S A ++ + ++P RLG S G + IK+HPFFK ++W L+ R
Sbjct: 212 DVLYP--VWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQHPFFKEIDWVLLEQRK 269
Query: 972 MNPP-------ELDAPLFATDTEKEYKVVDP 995
+ PP + D F D KE V+ P
Sbjct: 270 IKPPFKPKIKTKRDVNNFDQDFTKEEPVLTP 300
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 199 bits (507), Expect = 4e-57
Identities = 114/302 (37%), Positives = 167/302 (55%), Gaps = 39/302 (12%)
Query: 678 KPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPA 736
K LG G G V L EL G G+YFA+KA+ K V+L + V E+ +L + ++PF+
Sbjct: 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTH 60
Query: 737 LYASFQTKTHVCLITDYCPGGEL-FLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGI 795
LY +FQTK H+ + ++ GG+L F + D+ + + FYAAE+V L++LH +GI
Sbjct: 61 LYCTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDLYR---ATFYAAEIVCGLQFLHSKGI 117
Query: 796 IYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPM 855
IYRDLK +NV+L +GH+ + DF + CK + G
Sbjct: 118 IYRDLKLDNVMLDRDGHIKIADFGM-----CKENVF------------GDN--------- 151
Query: 856 RASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANILH 915
RAS +F GT +YIAPEI+ G +T +VDWW+ G+LLYEML G +PF G + F +I
Sbjct: 152 RAS-TFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRV 210
Query: 916 KDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVNWALV--RCMN 973
+P + +K ++ +L RDP RLG I+ HPFFK +NW + R ++
Sbjct: 211 DTPHYPRW--ITKESKDILEKLFERDPTRRLGV---VGNIRGHPFFKTINWTALEKRELD 265
Query: 974 PP 975
PP
Sbjct: 266 PP 267
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 200 bits (510), Expect = 6e-57
Identities = 119/313 (38%), Positives = 177/313 (56%), Gaps = 26/313 (8%)
Query: 674 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPF 733
F +K +G G G V LV+ +G +AMK + K ML + +V AER+IL D +
Sbjct: 3 FESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAW 62
Query: 734 VPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQ 793
V ++ SFQ K ++ LI ++ PGG++ LL ++ T L E+A +FY AE V+A++ +H
Sbjct: 63 VVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDT--LSEEATQFYIAETVLAIDAIHQL 120
Query: 794 GIIYRDLKPENVLLQGNGHVSLTDFDLSC-------------LTSCKPQ-LLLPTTNEKK 839
G I+RD+KP+N+LL GHV L+DF L LT P N K+
Sbjct: 121 GFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKR 180
Query: 840 RRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYT 899
+ ++N +A S VGT +YIAPE+ G+ DWW+LG+++YEML GY
Sbjct: 181 KAETWKKNRRQLAY------STVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP 234
Query: 900 PFRGKTRQKTFANILH--KDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKK 957
PF +T Q+T+ +++ + L FP P S AK L+ R D ++R+GS+ G EIK
Sbjct: 235 PFCSETPQETYRKVMNWKETLVFPPEVPISEKAKDLILRFC-TDSENRIGSN-GVEEIKS 292
Query: 958 HPFFKGVNWALVR 970
HPFF+GV+W +R
Sbjct: 293 HPFFEGVDWGHIR 305
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 195 bits (496), Expect = 2e-55
Identities = 108/301 (35%), Positives = 158/301 (52%), Gaps = 36/301 (11%)
Query: 680 LGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPALY 738
LG G G V L L SG+ +A+K + K V+L + V E+ IL + +HPF+ LY
Sbjct: 3 LGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLY 62
Query: 739 ASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYR 798
FQT + + ++ GG+L + Q ++ E RFYAAE+ AL +LH +GIIYR
Sbjct: 63 CCFQTPDRLFFVMEFVNGGDLMFHI--QKSRRFDEARARFYAAEITSALMFLHDKGIIYR 120
Query: 799 DLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRAS 858
DLK +NVLL GH L DF + CK + G + +
Sbjct: 121 DLKLDNVLLDHEGHCKLADFGM-----CKEGI-----------FNG-----------KTT 153
Query: 859 NSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANILHKDL 918
++F GT +YIAPEI+ + +VDWWA+G+LLYEML G+ PF + F IL+ ++
Sbjct: 154 STFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEV 213
Query: 919 KFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHE--GANEIKKHPFFKGVNWALV--RCMNP 974
+P T S A ++ + ++P RLGS G I +HPFFK ++W + R + P
Sbjct: 214 VYP--TWLSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILRHPFFKELDWEKLNRRQIEP 271
Query: 975 P 975
P
Sbjct: 272 P 272
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 192 bits (490), Expect = 4e-55
Identities = 96/302 (31%), Positives = 148/302 (49%), Gaps = 32/302 (10%)
Query: 680 LGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYA 739
LG G G V ++ +G+ +A K +DK + R A E++IL+ + F+ +L
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60
Query: 740 SFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRD 799
+F+TK +CL+ GG+L + E FYAA+++ LE+LH + I+YRD
Sbjct: 61 AFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRD 120
Query: 800 LKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASN 859
LKPENVLL +G+V ++D L+ KG +
Sbjct: 121 LKPENVLLDDHGNVRISDLGLAV------------------ELKGGKKI----------K 152
Query: 860 SFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANILHKDLK 919
GT Y+APE++ G + +VDW+ALG LYEM+ G +PFR + + + + L+
Sbjct: 153 GRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLE 212
Query: 920 FPSSTPTSL--HAKQLMYRLLHRDPKSRLGSHEG-ANEIKKHPFFKGVNWALVRC-MNPP 975
P AK L LL +DP+ RLG G A+E+++HP FK +NW + M P
Sbjct: 213 MAVEYPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVREHPLFKDLNWRRLEAGMLEP 272
Query: 976 EL 977
Sbjct: 273 PF 274
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 194 bits (494), Expect = 4e-55
Identities = 106/304 (34%), Positives = 155/304 (50%), Gaps = 40/304 (13%)
Query: 680 LGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYA 739
+G G G V +V +G +AMK M K V+L + V ER+IL + + P++P L
Sbjct: 9 VGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQY 68
Query: 740 SFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRD 799
+FQ K ++ L+ +Y PGG+L LL+R + ED +FY AE+V+A+ +H G ++RD
Sbjct: 69 AFQDKDNLYLVMEYQPGGDLLSLLNRYEDQ-FDEDMAQFYLAELVLAIHSVHQMGYVHRD 127
Query: 800 LKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASN 859
+KPENVL+ GH+ L DF + + A M S
Sbjct: 128 IKPENVLIDRTGHIKLADFGSAARLT--------------------------ANKMVNSK 161
Query: 860 SFVGTEEYIAPEII------AGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANI 913
VGT +YIAPE++ + DWW+LG++ YEM+YG +PF T KT+ NI
Sbjct: 162 LPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNI 221
Query: 914 L-HKD-LKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVNWALVRC 971
+ + LKFP S L+ LL K RLG +EG + HPFF ++W +R
Sbjct: 222 MNFQRFLKFPEDPKVSSDFLDLIQSLL-CGQKERLG-YEG---LCCHPFFSKIDWNNIRN 276
Query: 972 MNPP 975
PP
Sbjct: 277 SLPP 280
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 193 bits (493), Expect = 5e-55
Identities = 100/295 (33%), Positives = 151/295 (51%), Gaps = 33/295 (11%)
Query: 674 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHP- 732
F + LG G G V L E G+ + +A+K + K V++ + V E+ +L + P
Sbjct: 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPP 61
Query: 733 FVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHC 792
F+ L++ FQT + + +Y GG+L + Q KE FYAAE+ + L +LH
Sbjct: 62 FLTQLHSCFQTMDRLYFVMEYVNGGDLMYHI--QQVGKFKEPHAVFYAAEIAIGLFFLHS 119
Query: 793 QGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMA 852
+GIIYRDLK +NV+L GH+ + DF + CK + T
Sbjct: 120 KGIIYRDLKLDNVMLDAEGHIKIADFGM-----CKENIFGGKT----------------- 157
Query: 853 EPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFAN 912
+ +F GT +YIAPEIIA + +VDWWA G+LLYEML G PF G+ + F +
Sbjct: 158 -----TRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQS 212
Query: 913 ILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGS-HEGANEIKKHPFFKGVNW 966
I+ ++ +P S S A + LL + P RLG G +I++H FF+ ++W
Sbjct: 213 IMEHNVSYPKS--LSKEAVSICKGLLTKHPAKRLGCGPTGERDIREHAFFRRIDW 265
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 191 bits (486), Expect = 4e-54
Identities = 108/290 (37%), Positives = 151/290 (52%), Gaps = 32/290 (11%)
Query: 678 KPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREIL-DMLDHPFVPA 736
K +G G G V L +++A+K + K +L + + +ER +L + HPF+
Sbjct: 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVG 60
Query: 737 LYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGII 796
L+ SFQT + + DY GGELF L R+ + E RFYAAE+ AL YLH I+
Sbjct: 61 LHFSFQTADKLYFVLDYINGGELFYHLQRE--RCFLEPRARFYAAEIASALGYLHSLNIV 118
Query: 797 YRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMR 856
YRDLKPEN+LL GH+ LTDF L CK + E
Sbjct: 119 YRDLKPENILLDSQGHIVLTDFGL-----CKENI----------------------EHNG 151
Query: 857 ASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANILHK 916
+++F GT EY+APE++ + VDWW LG +LYEMLYG PF + + + NIL+K
Sbjct: 152 TTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNK 211
Query: 917 DLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVNW 966
L+ + S A+ L+ LL +D RLG+ + EIK H FF +NW
Sbjct: 212 PLQLKPNITNS--ARHLLEGLLQKDRTKRLGAKDDFMEIKNHIFFSPINW 259
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 188 bits (480), Expect = 3e-53
Identities = 106/310 (34%), Positives = 167/310 (53%), Gaps = 45/310 (14%)
Query: 680 LGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPALY 738
+G G V LVEL + + +AMK + K ++ + + E+ + + +HPF+ L+
Sbjct: 3 IGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLH 62
Query: 739 ASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYR 798
+ FQT++ + + ++ GG+L + RQ + L E+ RFY+AE+ +AL +LH +GIIYR
Sbjct: 63 SCFQTESRLFFVIEFVSGGDLMFHMQRQ--RKLPEEHARFYSAEISLALNFLHERGIIYR 120
Query: 799 DLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRAS 858
DLK +NVLL GH+ LTD+ + CK + P +
Sbjct: 121 DLKLDNVLLDAEGHIKLTDYGM-----CKEGI----------------------RPGDTT 153
Query: 859 NSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPF---------RGKTRQKT 909
++F GT YIAPEI+ G + +VDWWALG+L++EM+ G +PF T
Sbjct: 154 STFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYL 213
Query: 910 FANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSH--EGANEIKKHPFFKGVNWA 967
F IL K ++ P S S+ A ++ L++DPK RLG H G +IK HPFF+ ++W
Sbjct: 214 FQVILEKQIRIPRS--LSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSHPFFRNIDWD 271
Query: 968 LV--RCMNPP 975
L+ + + PP
Sbjct: 272 LLEQKQVLPP 281
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 188 bits (479), Expect = 1e-52
Identities = 109/327 (33%), Positives = 164/327 (50%), Gaps = 41/327 (12%)
Query: 657 KAIQKILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKV 716
KA +KI ++ + F IK +G G G V LV S Q +AMK + K M+ R+
Sbjct: 30 KAAEKITKL--RMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDS 87
Query: 717 HRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAV 776
ER+I+ + ++ L+ +FQ ++ ++ +Y PGG+L L+ + E
Sbjct: 88 AFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMVMEYMPGGDLVNLMSNYD---IPEKWA 144
Query: 777 RFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTN 836
RFY AEVV+AL+ +H G I+RD+KP+N+LL +GH+ L DF +C+
Sbjct: 145 RFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFG-TCMK------------ 191
Query: 837 EKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTS----AVDWWALGILLY 892
A M ++ VGT +YI+PE++ G DWW++G+ LY
Sbjct: 192 -------------MDANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLY 238
Query: 893 EMLYGYTPFRGKTRQKTFANIL-HKD-LKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHE 950
EML G TPF + T++ I+ HK+ L FP S AK L+ L D + RLG +
Sbjct: 239 EMLVGDTPFYADSLVGTYSKIMDHKNSLTFPDDIEISKQAKDLICAFL-TDREVRLGRN- 296
Query: 951 GANEIKKHPFFKG--VNWALVRCMNPP 975
G +EIK HPFFK + +R P
Sbjct: 297 GVDEIKSHPFFKNDQWTFDNIRETVAP 323
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 187 bits (476), Expect = 3e-52
Identities = 114/315 (36%), Positives = 174/315 (55%), Gaps = 26/315 (8%)
Query: 672 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDH 731
+ F +K +G G G V LV+ +G +AMK + K ML + +V AER+IL D
Sbjct: 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADS 60
Query: 732 PFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLH 791
+V ++ SFQ K ++ LI ++ PGG++ LL ++ T L E+ +FY AE V+A++ +H
Sbjct: 61 LWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDT--LTEEETQFYIAETVLAIDSIH 118
Query: 792 CQGIIYRDLKPENVLLQGNGHVSLTDFDLSC-------------LTSCKPQ-LLLPTTNE 837
G I+RD+KP+N+LL GHV L+DF L L P N
Sbjct: 119 QLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNS 178
Query: 838 KKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYG 897
K++ ++N +A S VGT +YIAPE+ G+ DWW+LG+++YEML G
Sbjct: 179 KRKAETWKRNRRQLA------FSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIG 232
Query: 898 YTPFRGKTRQKTFANILH--KDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEI 955
Y PF +T Q+T+ +++ + L FP P S AK L+ R + + R+G+ G EI
Sbjct: 233 YPPFCSETPQETYKKVMNWKETLIFPPEVPISEKAKDLILRFCC-EWEHRIGA-PGVEEI 290
Query: 956 KKHPFFKGVNWALVR 970
K +PFF+GV+W +R
Sbjct: 291 KTNPFFEGVDWEHIR 305
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 180 bits (458), Expect = 1e-51
Identities = 84/282 (29%), Positives = 123/282 (43%), Gaps = 69/282 (24%)
Query: 680 LGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYA 739
LG G G+V+L +G+ A+K + K + + + E EIL L+HP + LY
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKE--DSSSLLEELLREIEILKKLNHPNIVKLYG 58
Query: 740 SFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRD 799
F+ + H+ L+ +YC GG L LL K L ED + +++ LEYLH GII+RD
Sbjct: 59 VFEDENHLYLVMEYCEGGSLKDLLKENEGK-LSEDEILRILLQILEGLEYLHSNGIIHRD 117
Query: 800 LKPENVLLQ-GNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRAS 858
LKPEN+LL NG V L DF LS +
Sbjct: 118 LKPENILLDSDNGKVKLADFGLSK---------------------------LLTSDKSLL 150
Query: 859 NSFVGTEEYIAPEIIAGAGH-TSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANILHKD 917
+ VGT Y+APE++ G G+ + D W+LG++LYE+
Sbjct: 151 KTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL----------------------- 187
Query: 918 LKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHP 959
K L+ ++L +DP+ R A EI +H
Sbjct: 188 ----------PELKDLIRKMLQKDPEKRP----SAKEILEHL 215
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 180 bits (458), Expect = 3e-50
Identities = 108/310 (34%), Positives = 166/310 (53%), Gaps = 37/310 (11%)
Query: 674 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPF 733
F IK +G G G V +V++ + + +AMK ++K ML R + ER +L D +
Sbjct: 3 FEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQW 62
Query: 734 VPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQ 793
+ L+ +FQ + ++ L+ DY GG+L LL + + L ED RFY AE+V+A+ +H
Sbjct: 63 ITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDR-LPEDMARFYIAEMVLAIHSIHQL 121
Query: 794 GIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAE 853
++RD+KP+NVLL NGH+ L DF SCL +
Sbjct: 122 HYVHRDIKPDNVLLDMNGHIRLADFG-SCLK-------------------------MNQD 155
Query: 854 PMRASNSFVGTEEYIAPEIIA----GAG-HTSAVDWWALGILLYEMLYGYTPFRGKTRQK 908
S+ VGT +YI+PEI+ G G + DWW+LG+ +YEMLYG TPF ++ +
Sbjct: 156 GTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVE 215
Query: 909 TFANILHKD--LKFPSS-TPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVN 965
T+ I++ + +FPS T S AK L+ RL+ + RLG + G + KKH FF+G++
Sbjct: 216 TYGKIMNHEERFQFPSHITDVSEEAKDLIQRLICSRER-RLGQN-GIEDFKKHAFFEGID 273
Query: 966 WALVRCMNPP 975
W +R + P
Sbjct: 274 WENIRNLEAP 283
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 176 bits (450), Expect = 7e-50
Identities = 80/278 (28%), Positives = 132/278 (47%), Gaps = 37/278 (13%)
Query: 673 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAERE--ILDMLD 730
+ IK +G G G V+LV G+ + +K +D + N ++ R A E IL L+
Sbjct: 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEID---LSNMSEKEREDALNEVKILKKLN 57
Query: 731 HPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKV--LKEDAVRFYAAEVVVALE 788
HP + Y SF+ K +C++ +Y GG+L + +Q + E+ + + ++ +AL+
Sbjct: 58 HPNIIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALK 117
Query: 789 YLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNP 848
YLH + I++RD+KP+N+ L NG V L DF +S K +
Sbjct: 118 YLHSRKILHRDIKPQNIFLTSNGLVKLGDFGIS---------------------KVLSST 156
Query: 849 VFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQK 908
V +A + VGT Y++PE+ + D W+LG +LYE+ PF G+ +
Sbjct: 157 VDLA------KTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLE 210
Query: 909 TFANILHKDLK-FPSSTPTSLHAKQLMYRLLHRDPKSR 945
IL PS + L + L+ LL +DP+ R
Sbjct: 211 LALKILKGQYPPIPSQYSSEL--RNLVSSLLQKDPEER 246
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 178 bits (453), Expect = 1e-49
Identities = 105/306 (34%), Positives = 159/306 (51%), Gaps = 35/306 (11%)
Query: 674 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHP- 732
F + LG G G V L E G+ + +A+K + K V++ + V E+ +L + D P
Sbjct: 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPP 61
Query: 733 FVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHC 792
F+ L++ FQT + + +Y GG+L + Q KE FYAAE+ V L +LH
Sbjct: 62 FLTQLHSCFQTVDRLYFVMEYVNGGDLMYHI--QQVGKFKEPQAVFYAAEISVGLFFLHR 119
Query: 793 QGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMA 852
+GIIYRDLK +NV+L GH+ + DF + CK ++ T
Sbjct: 120 RGIIYRDLKLDNVMLDSEGHIKIADFGM-----CKEHMVDGVT----------------- 157
Query: 853 EPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFAN 912
+ +F GT +YIAPEIIA + +VDWWA G+LLYEML G PF G+ + F +
Sbjct: 158 -----TRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQS 212
Query: 913 ILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLG-SHEGANEIKKHPFFKGVNWALV-- 969
I+ ++ +P S S A + L+ + P RLG EG +I++H FF+ ++W +
Sbjct: 213 IMEHNVSYPKS--LSKEAVSICKGLMTKHPSKRLGCGPEGERDIREHAFFRRIDWDKLEN 270
Query: 970 RCMNPP 975
R + PP
Sbjct: 271 REIQPP 276
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 180 bits (457), Expect = 1e-49
Identities = 127/353 (35%), Positives = 181/353 (51%), Gaps = 44/353 (12%)
Query: 674 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPF 733
F IK LG G G V L + +AMK + K +L RN+V AER+IL D+ +
Sbjct: 3 FVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEW 62
Query: 734 VPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQ 793
V LY SFQ K ++ + DY PGG++ LL R + ED RFY AE+ A+E +H
Sbjct: 63 VVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRM--GIFPEDLARFYIAELTCAVESVHKM 120
Query: 794 GIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKG----QQNPV 849
G I+RD+KP+N+L+ +GH+ LTDF L C T++ K G Q +
Sbjct: 121 GFIHRDIKPDNILIDRDGHIKLTDFGL-CTG-------FRWTHDSKYYQSGDHVRQDSMD 172
Query: 850 FMAE--------------PM--RA--------SNSFVGTEEYIAPEIIAGAGHTSAVDWW 885
F E P+ RA ++S VGT YIAPE++ G+T DWW
Sbjct: 173 FSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWW 232
Query: 886 ALGILLYEMLYGYTPFRGKTRQKTFANIL--HKDLKFPSSTPTSLHAKQLMYRLLHRDPK 943
++G++LYEML G PF +T +T ++ L P S A L+ +L R P+
Sbjct: 233 SVGVILYEMLVGQPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIKLC-RGPE 291
Query: 944 SRLGSHEGANEIKKHPFFKGVNWAL-VRCMNPPELDAPLFATDTEKEYKVVDP 995
RLG + GA+EIK HPFFK ++++ +R + P + TDT + VDP
Sbjct: 292 DRLGKN-GADEIKAHPFFKTIDFSSDLRQQSAPYIPKITHPTDTSN-FDPVDP 342
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 176 bits (448), Expect = 5e-49
Identities = 105/302 (34%), Positives = 161/302 (53%), Gaps = 43/302 (14%)
Query: 680 LGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPALY 738
+G G V LV L + + +AMK + K ++ + + E+ + + +HPF+ L+
Sbjct: 3 IGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 62
Query: 739 ASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYR 798
+ FQT++ + + +Y GG+L + RQ + L E+ RFY+AE+ +AL YLH +GIIYR
Sbjct: 63 SCFQTESRLFFVIEYVNGGDLMFHMQRQ--RKLPEEHARFYSAEISLALNYLHERGIIYR 120
Query: 799 DLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRAS 858
DLK +NVLL GH+ LTD+ + CK L P +
Sbjct: 121 DLKLDNVLLDSEGHIKLTDYGM-----CKEGL----------------------RPGDTT 153
Query: 859 NSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPF---------RGKTRQKT 909
++F GT YIAPEI+ G + +VDWWALG+L++EM+ G +PF T
Sbjct: 154 STFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYL 213
Query: 910 FANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLG--SHEGANEIKKHPFFKGVNWA 967
F IL K ++ P S S+ A ++ L++DPK RLG G +I+ HPFF+ V+W
Sbjct: 214 FQVILEKQIRIPRS--LSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWD 271
Query: 968 LV 969
L+
Sbjct: 272 LM 273
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 176 bits (447), Expect = 7e-49
Identities = 106/308 (34%), Positives = 164/308 (53%), Gaps = 43/308 (13%)
Query: 680 LGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLD-HPFVPALY 738
+G G V LV L + Q +AMK + K ++ + + E+ + + +PF+ L+
Sbjct: 3 IGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLH 62
Query: 739 ASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYR 798
+ FQT + + L+ +Y GG+L + RQ + L E+ RFYAAE+ +AL +LH +GIIYR
Sbjct: 63 SCFQTTSRLFLVIEYVNGGDLMFHMQRQ--RKLPEEHARFYAAEICIALNFLHERGIIYR 120
Query: 799 DLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRAS 858
DLK +NVLL +GH+ LTD+ + CK L P +
Sbjct: 121 DLKLDNVLLDADGHIKLTDYGM-----CKEGL----------------------GPGDTT 153
Query: 859 NSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPF-------RGKTRQKTFA 911
++F GT YIAPEI+ G + +VDWWALG+L++EM+ G +PF T F
Sbjct: 154 STFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQ 213
Query: 912 NILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGS--HEGANEIKKHPFFKGVNWALV 969
IL K ++ P S+ A ++ L++DPK RLG G ++IK H FF+ ++W L+
Sbjct: 214 VILEKPIRIPRF--LSVKASHVLKGFLNKDPKERLGCQPQTGFSDIKSHTFFRSIDWDLL 271
Query: 970 --RCMNPP 975
+ + PP
Sbjct: 272 EKKQVTPP 279
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 176 bits (447), Expect = 8e-49
Identities = 116/326 (35%), Positives = 180/326 (55%), Gaps = 43/326 (13%)
Query: 672 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDH 731
+ F +K +G G G V +V+L + + FAMK ++K ML R + ER++L D+
Sbjct: 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDN 60
Query: 732 PFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLH 791
++ L+ +FQ + ++ L+ DY GG+L LL + + L ED RFY AE+V+A++ +H
Sbjct: 61 QWITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDR-LPEDMARFYLAEMVIAIDSVH 119
Query: 792 CQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFM 851
++RD+KP+N+L+ NGH+ L DF SCL M
Sbjct: 120 QLHYVHRDIKPDNILMDMNGHIRLADFG-SCLK-------------------------LM 153
Query: 852 AEPMRASNSFVGTEEYIAPEIIA----GAG-HTSAVDWWALGILLYEMLYGYTPFRGKTR 906
+ S+ VGT +YI+PEI+ G G + DWW+LG+ +YEMLYG TPF ++
Sbjct: 154 EDGTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESL 213
Query: 907 QKTFANIL-HKD-LKFPSS-TPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKG 963
+T+ I+ HK+ +FP+ T S AK L+ RL+ + RLG + G + K+HPFF G
Sbjct: 214 VETYGKIMNHKERFQFPAQVTDVSEDAKDLIRRLIC-SREHRLGQN-GIEDFKQHPFFTG 271
Query: 964 VNWALVR-CMNP--PELDAPLFATDT 986
++W +R C P PE+ +P TDT
Sbjct: 272 IDWDNIRNCEAPYIPEVSSP---TDT 294
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 172 bits (437), Expect = 4e-48
Identities = 105/310 (33%), Positives = 162/310 (52%), Gaps = 42/310 (13%)
Query: 680 LGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDML---DHPFVPA 736
+G G G V+ +G+ +AMK +DK + + A ER +L ++ D PF+
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61
Query: 737 LYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGII 796
+ +F T + I D GG+L L + V E +RFYAAE+++ LE++H + ++
Sbjct: 62 MSYAFHTPDKLSFILDLMNGGDLHYHLSQH--GVFSEAEMRFYAAEIILGLEHMHNRFVV 119
Query: 797 YRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMR 856
YRDLKP N+LL +GHV ++D L+C S KK+ H
Sbjct: 120 YRDLKPANILLDEHGHVRISDLGLACDFS------------KKKPH-------------- 153
Query: 857 ASNSFVGTEEYIAPEIIA-GAGHTSAVDWWALGILLYEMLYGYTPFRG-KTRQKTFAN-- 912
AS VGT Y+APE++ G + S+ DW++LG +L+++L G++PFR KT+ K +
Sbjct: 154 AS---VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRM 210
Query: 913 ILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSH-EGANEIKKHPFFKGVNWALVRC 971
L ++ P S S + L+ LL RD RLG GA E+K+HPFF+ ++W +V
Sbjct: 211 TLTMAVELPDS--FSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEHPFFRSLDWQMVFL 268
Query: 972 MN-PPELDAP 980
PP L P
Sbjct: 269 QKYPPPLIPP 278
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 172 bits (438), Expect = 1e-47
Identities = 101/295 (34%), Positives = 152/295 (51%), Gaps = 33/295 (11%)
Query: 674 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHP- 732
F + LG G G V L E G+ + +A+K + K V++ + V E+ +L + P
Sbjct: 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPP 61
Query: 733 FVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHC 792
F+ L++ FQT + + +Y GG+L + Q KE FYAAE+ + L +LH
Sbjct: 62 FLTQLHSCFQTMDRLYFVMEYVNGGDLMYQI--QQVGRFKEPHAVFYAAEIAIGLFFLHS 119
Query: 793 QGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMA 852
+GIIYRDLK +NV+L GH+ + DF + CK + T
Sbjct: 120 KGIIYRDLKLDNVMLDSEGHIKIADFGM-----CKENMWDGVT----------------- 157
Query: 853 EPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFAN 912
+ +F GT +YIAPEIIA + +VDWWA G+LLYEML G PF G+ + F +
Sbjct: 158 -----TKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQS 212
Query: 913 ILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLG-SHEGANEIKKHPFFKGVNW 966
I+ ++ +P S S A + L+ + P RLG EG +IK+H FF+ ++W
Sbjct: 213 IMEHNVAYPKS--MSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDW 265
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 173 bits (439), Expect = 1e-47
Identities = 102/320 (31%), Positives = 158/320 (49%), Gaps = 42/320 (13%)
Query: 650 RKDSPPWKAIQKILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQY--FAMKAMDK 707
+KDS K ++ ++ + F I+ LG+G G V L + + A+K +K
Sbjct: 12 KKDSDSTKEPKR----KNKMKYEDFNFIRTLGTGSFGRVILATY-KNEDFPPVAIKRFEK 66
Query: 708 GVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQP 767
++ + +V +ER+IL+ ++HPF LY SF+ ++++ L+ ++ GGE F L R
Sbjct: 67 SKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRN- 125
Query: 768 TKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCK 827
K D FYAA++V+ EYL I+YRDLKPEN+LL +G + +TDF + + +
Sbjct: 126 -KRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTR 184
Query: 828 PQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWAL 887
+ + GT EYIAPEI+ GH A DWW L
Sbjct: 185 ------------------------------TYTLCGTPEYIAPEILLNVGHGKAADWWTL 214
Query: 888 GILLYEMLYGYTPFRGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLG 947
GI +YE+L G PF + IL + FP + K LM +LL D R G
Sbjct: 215 GIFIYEILVGCPPFYANEPLLIYQKILEGIIYFPKFLDNN--CKHLMKKLLSHDLTKRYG 272
Query: 948 S-HEGANEIKKHPFFKGVNW 966
+ +GA +K+HP+F ++W
Sbjct: 273 NLKKGAQNVKEHPWFGNIDW 292
|
Length = 340 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 174 bits (441), Expect = 2e-47
Identities = 111/326 (34%), Positives = 167/326 (51%), Gaps = 46/326 (14%)
Query: 674 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPF 733
F IK LG G G V L + +AMK + K +LNRN+V AER+IL D+ +
Sbjct: 3 FVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEW 62
Query: 734 VPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQ 793
V LY SFQ K ++ + DY PGG++ LL R +V E RFY AE+ +A+E +H
Sbjct: 63 VVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRM--EVFPEVLARFYIAELTLAIESVHKM 120
Query: 794 GIIYRDLKPENVLLQGNGHVSLTDFDLSC------------------------------L 823
G I+RD+KP+N+L+ +GH+ LTDF L +
Sbjct: 121 GFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDV 180
Query: 824 TSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVD 883
++C+ L T ++ + Q+ +A +S VGT YIAPE++ G+T D
Sbjct: 181 SNCRCGDRLKTLEQRATK----QHQRCLA------HSLVGTPNYIAPEVLLRKGYTQLCD 230
Query: 884 WWALGILLYEMLYGYTPFRGKTRQKTFANILH--KDLKFPSSTPTSLHAKQLMYRLLHRD 941
WW++G++L+EML G PF T +T +++ L P S A L+ +L
Sbjct: 231 WWSVGVILFEMLVGQPPFLAPTPTETQLKVINWENTLHIPPQVKLSPEAVDLITKLCC-S 289
Query: 942 PKSRLGSHEGANEIKKHPFFKGVNWA 967
+ RLG + GA++IK HPFF V+++
Sbjct: 290 AEERLGRN-GADDIKAHPFFSEVDFS 314
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 169 bits (430), Expect = 5e-47
Identities = 94/296 (31%), Positives = 147/296 (49%), Gaps = 31/296 (10%)
Query: 674 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPF 733
FR + LG G G V ++ +G+ +A K ++K + R A E++IL+ ++ F
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRF 61
Query: 734 VPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQ 793
V +L +++TK +CL+ GG+L + E+ FYAAE+ LE LH +
Sbjct: 62 VVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRE 121
Query: 794 GIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAE 853
I+YRDLKPEN+LL GH+ ++D L+ + E
Sbjct: 122 RIVYRDLKPENILLDDYGHIRISDLGLAV-------------------------EIPEGE 156
Query: 854 PMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANI 913
+R VGT Y+APE++ +T + DWW LG L+YEM+ G +PFR + + +
Sbjct: 157 TIRGR---VGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEV 213
Query: 914 LHKDLKFPS--STPTSLHAKQLMYRLLHRDPKSRLGSH-EGANEIKKHPFFKGVNW 966
+ + S S A+ + +LL +DP RLG EGA E+K HPFF+ N+
Sbjct: 214 ERRVKEDQEEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAHPFFRTANF 269
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 170 bits (431), Expect = 3e-46
Identities = 107/316 (33%), Positives = 166/316 (52%), Gaps = 39/316 (12%)
Query: 657 KAIQKILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKV 716
K ++KI Q+ + + +K +G G G V LV S + +AMK + K M+ R+
Sbjct: 30 KIVRKI--RKLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDS 87
Query: 717 HRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAV 776
ER+I+ + P+V L+ +FQ ++ ++ +Y PGG+L L+ + E
Sbjct: 88 AFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYD---VPEKWA 144
Query: 777 RFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTN 836
+FY AEVV+AL+ +H G+I+RD+KP+N+LL +GH+ L DF +C+
Sbjct: 145 KFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFG-TCM------------- 190
Query: 837 EKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAG----HTSAVDWWALGILLY 892
K G M ++ VGT +YI+PE++ G + DWW++G+ L+
Sbjct: 191 --KMDETG----------MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLF 238
Query: 893 EMLYGYTPFRGKTRQKTFANIL-HKD-LKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHE 950
EML G TPF + T++ I+ HK+ L FP S HAK L+ L D + RLG +
Sbjct: 239 EMLVGDTPFYADSLVGTYSKIMDHKNSLNFPEDVEISKHAKNLICAFL-TDREVRLGRN- 296
Query: 951 GANEIKKHPFFKGVNW 966
G EIK+HPFFK W
Sbjct: 297 GVEEIKQHPFFKNDQW 312
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 164 bits (417), Expect = 3e-45
Identities = 100/314 (31%), Positives = 161/314 (51%), Gaps = 37/314 (11%)
Query: 674 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPF 733
FR + LG G G V ++ +G+ +A K ++K + R A E++IL+ ++ F
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQF 61
Query: 734 VPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQ 793
V L +++TK +CL+ GG+L + +E+ FYAAE++ LE LH +
Sbjct: 62 VVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRE 121
Query: 794 GIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAE 853
+YRDLKPEN+LL GH+ ++D L+ + +P + R
Sbjct: 122 NTVYRDLKPENILLDDYGHIRISDLGLA--------VKIPEGESIRGR------------ 161
Query: 854 PMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGK----TRQKT 909
VGT Y+APE++ +T + D+W LG L+YEM+ G +PFRG+ R++
Sbjct: 162 --------VGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEV 213
Query: 910 FANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHE-GANEIKKHPFFKGVNWAL 968
+L + + S S AK + LL +DPK RLG E GA E+K+HPFF+ +N+
Sbjct: 214 DRRVLETEEVY--SAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRHPFFRNMNFKR 271
Query: 969 VRC--MNPPELDAP 980
+ ++PP + P
Sbjct: 272 LEAGMLDPPFVPDP 285
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 163 bits (413), Expect = 7e-45
Identities = 103/311 (33%), Positives = 158/311 (50%), Gaps = 41/311 (13%)
Query: 680 LGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDML---DHPFVPA 736
+G G G V+ +G+ +AMK +DK + + A ER +L ++ D PF+
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61
Query: 737 LYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGII 796
+ +F T +C I D GG+L L + V E +RFYA E+++ LE++H + ++
Sbjct: 62 MTYAFHTPDKLCFILDLMNGGDLHYHLSQH--GVFSEKEMRFYATEIILGLEHMHNRFVV 119
Query: 797 YRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMR 856
YRDLKP N+LL +GHV ++D L+C S KK+ H
Sbjct: 120 YRDLKPANILLDEHGHVRISDLGLACDFS------------KKKPHAS------------ 155
Query: 857 ASNSFVGTEEYIAPEII-AGAGHTSAVDWWALGILLYEMLYGYTPFRG-KTRQKTFAN-- 912
VGT Y+APE++ G + S+ DW++LG +L+++L G++PFR KT+ K +
Sbjct: 156 -----VGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRM 210
Query: 913 ILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSH-EGANEIKKHPFFKGVNWALVRC 971
L +++ P S L K L+ LL RD RLG GA E+K+H FFKG++W V
Sbjct: 211 TLTVNVELPDSFSPEL--KSLLEGLLQRDVSKRLGCLGRGAQEVKEHVFFKGIDWQQVYL 268
Query: 972 MNPPELDAPLF 982
P P
Sbjct: 269 QKYPPPLIPPR 279
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 165 bits (419), Expect = 1e-44
Identities = 107/315 (33%), Positives = 163/315 (51%), Gaps = 39/315 (12%)
Query: 659 IQKILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHR 718
I KI D ++ + + +K +G G G V LV + + +AMK + K M+ R+
Sbjct: 32 INKIRDL--RMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAF 89
Query: 719 ACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRF 778
ER+I+ + P+V L+ +FQ ++ ++ +Y PGG+L L+ + E RF
Sbjct: 90 FWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYD---VPEKWARF 146
Query: 779 YAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEK 838
Y AEVV+AL+ +H G I+RD+KP+N+LL +GH+ L DF +C+ K
Sbjct: 147 YTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFG-TCMKMNK----------- 194
Query: 839 KRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAG----HTSAVDWWALGILLYEM 894
E M ++ VGT +YI+PE++ G + DWW++G+ LYEM
Sbjct: 195 --------------EGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEM 240
Query: 895 LYGYTPFRGKTRQKTFANIL-HKD-LKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGA 952
L G TPF + T++ I+ HK+ L FP S AK L+ L D + RLG + G
Sbjct: 241 LVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKEAKNLICAFL-TDREVRLGRN-GV 298
Query: 953 NEIKKHPFFKGVNWA 967
EIK+H FFK WA
Sbjct: 299 EEIKRHLFFKNDQWA 313
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 158 bits (400), Expect = 5e-43
Identities = 101/296 (34%), Positives = 153/296 (51%), Gaps = 31/296 (10%)
Query: 674 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPF 733
FR + LG G G V ++ +G+ +A K ++K + R A E++IL+ ++ F
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRF 61
Query: 734 VPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQ 793
V +L +++TK +CL+ GG+L + +E FYAAE+ LE LH +
Sbjct: 62 VVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQE 121
Query: 794 GIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAE 853
I+YRDLKPEN+LL +GH+ ++D L+ + +P K R
Sbjct: 122 RIVYRDLKPENILLDDHGHIRISDLGLA--------VHVPEGQTIKGR------------ 161
Query: 854 PMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPF--RGKTRQKTFA 911
VGT Y+APE++ +T + DWWALG LLYEM+ G +PF R K ++
Sbjct: 162 --------VGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEV 213
Query: 912 NILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSH-EGANEIKKHPFFKGVNW 966
L K+++ S S A+ L LL +DPK RLG GA E+K+HP FK +N+
Sbjct: 214 ERLVKEVQEEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEHPLFKQINF 269
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 156 bits (397), Expect = 7e-43
Identities = 79/289 (27%), Positives = 123/289 (42%), Gaps = 37/289 (12%)
Query: 673 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHP 732
F ++ +G G G V+ +G+ A+K + + K+ E +IL HP
Sbjct: 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIIN---EIQILKKCKHP 57
Query: 733 FVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHC 792
+ Y S+ K + ++ ++C GG L LL + L E + + E++ LEYLH
Sbjct: 58 NIVKYYGSYLKKDELWIVMEFCSGGSLKDLLKSTN-QTLTESQIAYVCKELLKGLEYLHS 116
Query: 793 QGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMA 852
GII+RD+K N+LL +G V L DF LS QL
Sbjct: 117 NGIIHRDIKAANILLTSDGEVKLIDFGLSA------QL---------------------- 148
Query: 853 EPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFAN 912
+A N+ VGT ++APE+I G + D W+LGI E+ G P+ K
Sbjct: 149 SDTKARNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFK 208
Query: 913 ILHKDL-KFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPF 960
I + S K + + L ++P+ R A ++ KHPF
Sbjct: 209 IATNGPPGLRNPEKWSDEFKDFLKKCLQKNPEKRP----TAEQLLKHPF 253
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 158 bits (399), Expect = 5e-42
Identities = 97/316 (30%), Positives = 150/316 (47%), Gaps = 42/316 (13%)
Query: 673 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHP 732
+R ++ LG G G V+L + A+K + K + +V R E +IL L+HP
Sbjct: 1 SYRILRKLGEGSFGEVYLAR---DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHP 57
Query: 733 -FVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTK-VLKEDAVRFYAAEVVVALEYL 790
+ LY FQ + + L+ +Y GG L LL + K L E F A+++ ALEYL
Sbjct: 58 PNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYL 117
Query: 791 HCQGIIYRDLKPENVLLQGNGH-VSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPV 849
H +GII+RD+KPEN+LL +G V L DF L+ L +P
Sbjct: 118 HSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLP---------------------DPG 156
Query: 850 FMAEPMRASNSFVGTEEYIAPEIIAGAGH---TSAVDWWALGILLYEMLYGYTPFRGKTR 906
+ ++ VGT Y+APE++ G +S+ D W+LGI LYE+L G PF G+
Sbjct: 157 STSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKN 216
Query: 907 QKTFANILHKDLKFPSST-----------PTSLHAKQLMYRLLHRDPKSRLGSHEG-ANE 954
+ L L+ P+ + S A L+ +LL +DPK+RL S +++
Sbjct: 217 SSATSQTLKIILELPTPSLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHD 276
Query: 955 IKKHPFFKGVNWALVR 970
+ H K + + +
Sbjct: 277 LLAHLKLKESDLSDLL 292
|
Length = 384 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 153 bits (389), Expect = 1e-41
Identities = 88/291 (30%), Positives = 147/291 (50%), Gaps = 33/291 (11%)
Query: 680 LGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYA 739
LG G G V V++ +G+ +A K +DK + ++ A E+EIL+ ++ PF+ L
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAY 60
Query: 740 SFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRD 799
+F++KTH+CL+ GG+L + + L+ + V Y+A++ + +LH I+YRD
Sbjct: 61 AFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRD 120
Query: 800 LKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASN 859
+KPENVLL G+ L+D L+ + L +R
Sbjct: 121 MKPENVLLDDQGNCRLSDLGLA--------VELKDGKTITQR------------------ 154
Query: 860 SFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGK----TRQKTFANILH 915
GT Y+APEI+ ++ VDW+A+G +YEM+ G TPF+ +++ L
Sbjct: 155 --AGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLE 212
Query: 916 KDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVNW 966
++KF T +K + L + P+ RLGS E ++ +KH FFK +N+
Sbjct: 213 DEVKFEHQNFTE-ESKDICRLFLAKKPEDRLGSREKNDDPRKHEFFKTINF 262
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 152 bits (387), Expect = 2e-41
Identities = 81/297 (27%), Positives = 126/297 (42%), Gaps = 47/297 (15%)
Query: 674 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACA---EREILDMLD 730
+ + LG G GSV+L +G+ A+K+++ L+ + A E IL L
Sbjct: 2 WTRGELLGRGSFGSVYLALDKDTGELMAVKSVE----LSGDSEEELEALEREIRILSSLQ 57
Query: 731 HPFVPALYASFQTKT--HVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALE 788
HP + Y S + + + + +Y GG L LL + L E +R Y +++ L
Sbjct: 58 HPNIVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKF--GKLPEPVIRKYTRQILEGLA 115
Query: 789 YLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNP 848
YLH GI++RD+K N+L+ +G V L DF + KR +
Sbjct: 116 YLHSNGIVHRDIKGANILVDSDGVVKLADFGCA-----------------KRLGDIETGE 158
Query: 849 VFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQK 908
+ S GT ++APE+I G + A D W+LG + EM G P+ +
Sbjct: 159 --------GTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPW---SELG 207
Query: 909 TFANILHKDLKFPSSTP----TSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFF 961
L+K S AK + + L RDPK R A+E+ +HPF
Sbjct: 208 NPMAALYKIGSSGEPPEIPEHLSEEAKDFLRKCLRRDPKKRP----TADELLQHPFL 260
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 153 bits (387), Expect = 2e-41
Identities = 95/315 (30%), Positives = 151/315 (47%), Gaps = 44/315 (13%)
Query: 680 LGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYA 739
LG G G V ++ +G+ +A K ++K + R A E+ IL + F+ +L
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAY 60
Query: 740 SFQTKTHVCLITDYCPGGEL----FLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGI 795
+FQTKT +CL+ GG+L + + + P E FY A+++ LE+LH + I
Sbjct: 61 AFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPG--FPEPRACFYTAQIISGLEHLHQRRI 118
Query: 796 IYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPM 855
IYRDLKPENVLL +G+V ++D L+ V + +
Sbjct: 119 IYRDLKPENVLLDNDGNVRISDLGLA---------------------------VELKDGQ 151
Query: 856 RASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRG---KTRQKTFAN 912
+ + GT ++APE++ G + +VD++ALG+ LYEM+ PFR K K
Sbjct: 152 SKTKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQ 211
Query: 913 -ILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGA-NEIKKHPFFKGVNWALVR 970
IL+ + +P S +K LL +DP+ RLG +G + ++ HP F+ +NW +
Sbjct: 212 RILNDSVTYPDK--FSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTHPLFRDLNWRQLE 269
Query: 971 CMNPPELDAPLFATD 985
P P F D
Sbjct: 270 AGMLP----PPFVPD 280
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 150 bits (380), Expect = 2e-40
Identities = 97/313 (30%), Positives = 152/313 (48%), Gaps = 35/313 (11%)
Query: 674 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPF 733
FR + LG G G V ++ +G+ +A K ++K + R A E+ IL+ ++ F
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRF 61
Query: 734 VPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQ 793
V +L +++TK +CL+ GG+L + E FYAAE+ LE L +
Sbjct: 62 VVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRE 121
Query: 794 GIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAE 853
I+YRDLKPEN+LL GH+ ++D L+ + +P + R
Sbjct: 122 RIVYRDLKPENILLDDRGHIRISDLGLA--------VQIPEGETVRGR------------ 161
Query: 854 PMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANI 913
VGT Y+APE+I +T + DWW LG L+YEM+ G +PFR K +++
Sbjct: 162 --------VGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFR-KRKERVKREE 212
Query: 914 LHKDLKFPSSTPT---SLHAKQLMYRLLHRDPKSRLG-SHEGANEIKKHPFFKGVNWALV 969
+ + +K + S AK + LL ++PK RLG GA +K+HP FK +N+ +
Sbjct: 213 VDRRVKEDQEEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQHPIFKNINFKRL 272
Query: 970 RC--MNPPELDAP 980
+ PP P
Sbjct: 273 EANMLEPPFCPDP 285
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|237425 PRK13557, PRK13557, histidine kinase; Provisional | Back alignment and domain information |
|---|
Score = 152 bits (387), Expect = 6e-39
Identities = 60/144 (41%), Positives = 84/144 (58%), Gaps = 3/144 (2%)
Query: 449 DDDYESDDERPDSVDD--KVRQKEMRKGIDLATTLERIEKNFVITDPRLPDNPIIFASDS 506
R SVD+ + R I A +E ++TDP PDNPI+FA+ +
Sbjct: 3 SPPEPRPHGRAPSVDESAAGDVSDHRSDIFFAA-VETTRMPMIVTDPNQPDNPIVFANRA 61
Query: 507 FLELTEYSREEILGRNCRFLQGPETDPATVRKIRAAIDNQTDVTVQLINYTKSGKKFWNL 566
FLE+T Y+ EEI+G NCRFLQGPETD ATV ++R AI + ++ +++NY K G FWN
Sbjct: 62 FLEMTGYAAEEIIGNNCRFLQGPETDRATVAEVRDAIAERREIATEILNYRKDGSSFWNA 121
Query: 567 FHLQPMRDQKGEVQYFIGVQLDGS 590
+ P+ + G++ YF G QLD S
Sbjct: 122 LFVSPVYNDAGDLVYFFGSQLDVS 145
|
Length = 540 |
| >gnl|CDD|237427 PRK13559, PRK13559, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 147 bits (372), Expect = 2e-38
Identities = 56/125 (44%), Positives = 76/125 (60%)
Query: 467 RQKEMRKGIDLATTLERIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFL 526
R G +E+ ITDP PD PI+ A+ +FL+LT Y+ EE++GRNCRFL
Sbjct: 35 RDFRGASGRLFEQAMEQTRMAMCITDPHQPDLPIVLANQAFLDLTGYAAEEVVGRNCRFL 94
Query: 527 QGPETDPATVRKIRAAIDNQTDVTVQLINYTKSGKKFWNLFHLQPMRDQKGEVQYFIGVQ 586
QG TDP V KIRAAI + ++ V+L+NY K G+ FWN HL P+ + G + YF G Q
Sbjct: 95 QGAATDPIAVAKIRAAIAAEREIVVELLNYRKDGEPFWNALHLGPVYGEDGRLLYFFGSQ 154
Query: 587 LDGSE 591
D ++
Sbjct: 155 WDVTD 159
|
Length = 361 |
| >gnl|CDD|237427 PRK13559, PRK13559, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 141 bits (357), Expect = 2e-36
Identities = 52/113 (46%), Positives = 72/113 (63%), Gaps = 3/113 (2%)
Query: 198 LSTFQQT---FVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVA 254
+QT ++D +PD PI+ A+ F +TGY ++EVVGRNCRFLQGA TDP VA
Sbjct: 46 EQAMEQTRMAMCITDPHQPDLPIVLANQAFLDLTGYAAEEVVGRNCRFLQGAATDPIAVA 105
Query: 255 KIRETLQNGQSYCGRLLNYKKDGTPFWNLLTIAPIKDDEGKVLKFIGMQVEVS 307
KIR + + LLNY+KDG PFWN L + P+ ++G++L F G Q +V+
Sbjct: 106 KIRAAIAAEREIVVELLNYRKDGEPFWNALHLGPVYGEDGRLLYFFGSQWDVT 158
|
Length = 361 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 128 bits (324), Expect = 4e-33
Identities = 87/289 (30%), Positives = 128/289 (44%), Gaps = 41/289 (14%)
Query: 680 LGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACA-EREILDMLDHPFVPALY 738
+G G G V+ +G+ A+K + + N K + A E ++L++L HP + Y
Sbjct: 8 IGGGTFGKVYTAVNLDTGELMAVKEIR--IQDNDPKTIKEIADEMKVLELLKHPNLVKYY 65
Query: 739 ASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYR 798
+ V + +YC GG L LL+ ++L E +R Y +++ L YLH GI++R
Sbjct: 66 GVEVHREKVYIFMEYCSGGTLEELLEH--GRILDEHVIRVYTLQLLEGLAYLHSHGIVHR 123
Query: 799 DLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRAS 858
D+KP N+ L NG + L DF C +L TT M E +
Sbjct: 124 DIKPANIFLDHNGVIKLGDF------GCAVKLKNNTTT--------------MGEEV--- 160
Query: 859 NSFVGTEEYIAPEIIAGA---GHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANILH 915
S GT Y+APE+I G GH A D W+LG ++ EM G P+ + F + H
Sbjct: 161 QSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNE--FQIMFH 218
Query: 916 KDLKFPSSTPTSLHAKQLMYRLLHR----DPKSRLGSHEGANEIKKHPF 960
P SL L R DPK R A+E+ +HPF
Sbjct: 219 VGAGHKPPIPDSLQLSPEGKDFLDRCLESDPKKRP----TASELLQHPF 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 124 bits (312), Expect = 1e-31
Identities = 76/277 (27%), Positives = 126/277 (45%), Gaps = 35/277 (12%)
Query: 674 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPF 733
F+ +K LG G GSV+ V+ Q++A+K +D G M ++ + A E IL ++HP
Sbjct: 2 FKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSM-SQKEREDAVNEIRILASVNHPN 60
Query: 734 VPALYASFQTKTHVCLITDYCPGGELFLLLDRQPT--KVLKEDAVRFYAAEVVVALEYLH 791
+ + +F +C++ +Y P G+L + ++ K++ E + +++ L+ LH
Sbjct: 61 IISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALH 120
Query: 792 CQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFM 851
Q I++RDLK N+LL N V + D +S + KK K Q
Sbjct: 121 EQKILHRDLKSANILLVANDLVKIGDLGISKVL-------------KKNMAKTQ------ 161
Query: 852 AEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFA 911
+GT Y+APE+ G ++ D W+LG LLYEM PF ++ Q
Sbjct: 162 ----------IGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRY 211
Query: 912 NILHKDLKFPSSTPT-SLHAKQLMYRLLHRDPKSRLG 947
+ K+P P S + + +L PK R
Sbjct: 212 KVQRG--KYPPIPPIYSQDLQNFIRSMLQVKPKLRPN 246
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|237426 PRK13558, PRK13558, bacterio-opsin activator; Provisional | Back alignment and domain information |
|---|
Score = 130 bits (329), Expect = 3e-31
Identities = 52/123 (42%), Positives = 73/123 (59%), Gaps = 5/123 (4%)
Query: 489 VITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIRAAIDNQTD 548
I D LPD P+I+ +D+F +T YS +E+LGRNCRFLQG +T+ V ++R AID +
Sbjct: 162 TIADATLPDEPLIYINDAFERITGYSPDEVLGRNCRFLQGEDTNEERVAELREAIDEERP 221
Query: 549 VTVQLINYTKSGKKFWNLFHLQPMRDQKGEVQYFIGVQLDGSEHLEPLRNSIPEATAEES 608
+V+L NY K G FWN + P+RD+ G V +++G Q D +E R A E
Sbjct: 222 TSVELRNYRKDGSTFWNQVDIAPIRDEDGTVTHYVGFQTDVTE-----RKEAELALQRER 276
Query: 609 EKL 611
KL
Sbjct: 277 RKL 279
|
Length = 665 |
| >gnl|CDD|237426 PRK13558, PRK13558, bacterio-opsin activator; Provisional | Back alignment and domain information |
|---|
Score = 129 bits (326), Expect = 7e-31
Identities = 48/106 (45%), Positives = 73/106 (68%)
Query: 206 VVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKIRETLQNGQS 265
++DAT PD P++Y + F ++TGY+ EV+GRNCRFLQG T+ E VA++RE + +
Sbjct: 162 TIADATLPDEPLIYINDAFERITGYSPDEVLGRNCRFLQGEDTNEERVAELREAIDEERP 221
Query: 266 YCGRLLNYKKDGTPFWNLLTIAPIKDDEGKVLKFIGMQVEVSKHTE 311
L NY+KDG+ FWN + IAPI+D++G V ++G Q +V++ E
Sbjct: 222 TSVELRNYRKDGSTFWNQVDIAPIRDEDGTVTHYVGFQTDVTERKE 267
|
Length = 665 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 121 bits (307), Expect = 1e-30
Identities = 78/296 (26%), Positives = 131/296 (44%), Gaps = 41/296 (13%)
Query: 673 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHP 732
+K LG G +G V+ V +G+ +A+K + + + E + L + P
Sbjct: 2 DLERVKVLGQGSSGVVYKVRHKPTGKIYALKKI-HVDG-DEEFRKQLLRELKTLRSCESP 59
Query: 733 FVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHC 792
+V Y +F + + ++ +Y GG L LL + + E + + A +++ L+YLH
Sbjct: 60 YVVKCYGAFYKEGEISIVLEYMDGGSLADLLKKVGK--IPEPVLAYIARQILKGLDYLHT 117
Query: 793 Q-GIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFM 851
+ II+RD+KP N+L+ G V + DF +S +L T ++
Sbjct: 118 KRHIIHRDIKPSNLLINSKGEVKIADFGISK--------VLENTLDQC------------ 157
Query: 852 AEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFA 911
N+FVGT Y++PE I G ++ A D W+LG+ L E G PF Q +F
Sbjct: 158 -------NTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFL-PPGQPSFF 209
Query: 912 NILHKDLKFPS----STPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKG 963
++ P + S + + L +DPK R A E+ +HPF K
Sbjct: 210 ELMQAICDGPPPSLPAEEFSPEFRDFISACLQKDPKKRP----SAAELLQHPFIKK 261
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|237425 PRK13557, PRK13557, histidine kinase; Provisional | Back alignment and domain information |
|---|
Score = 126 bits (319), Expect = 2e-30
Identities = 49/118 (41%), Positives = 79/118 (66%)
Query: 191 SDIVKDALSTFQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDP 250
SDI A+ T + +V+D +PD PI++A+ F +MTGY ++E++G NCRFLQG TD
Sbjct: 29 SDIFFAAVETTRMPMIVTDPNQPDNPIVFANRAFLEMTGYAAEEIIGNNCRFLQGPETDR 88
Query: 251 EDVAKIRETLQNGQSYCGRLLNYKKDGTPFWNLLTIAPIKDDEGKVLKFIGMQVEVSK 308
VA++R+ + + +LNY+KDG+ FWN L ++P+ +D G ++ F G Q++VS+
Sbjct: 89 ATVAEVRDAIAERREIATEILNYRKDGSSFWNALFVSPVYNDAGDLVYFFGSQLDVSR 146
|
Length = 540 |
| >gnl|CDD|222120 pfam13426, PAS_9, PAS domain | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 2e-29
Identities = 39/104 (37%), Positives = 60/104 (57%), Gaps = 3/104 (2%)
Query: 488 FVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIRAAIDNQT 547
++ DP D I++A+D+ L L Y+REE+LG++ R L GP D V ++R A+ N
Sbjct: 1 ILVLDP---DGRIVYANDAALRLLGYTREELLGKSIRDLFGPGDDEEAVARLREALRNGG 57
Query: 548 DVTVQLINYTKSGKKFWNLFHLQPMRDQKGEVQYFIGVQLDGSE 591
+V V+L K G+ F L P+RD+ GEV +G+ D +E
Sbjct: 58 EVEVELELRRKDGEPFPVLVSASPVRDEDGEVVGIVGILRDITE 101
|
Length = 101 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 117 bits (296), Expect = 3e-29
Identities = 75/247 (30%), Positives = 104/247 (42%), Gaps = 57/247 (23%)
Query: 728 MLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVAL 787
M D+P LY S T LI DY G+LF LL ++ L E V+ ++V AL
Sbjct: 65 MKDNPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKEGK--LSEAEVKKIIRQLVEAL 122
Query: 788 EYLHCQGIIYRDLKPENVLL-QGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQ 846
LH II+ D+K ENVL + + L D+ L CK G
Sbjct: 123 NDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGL-----CK--------------IIGTP 163
Query: 847 NPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRG--- 903
+ + GT +Y +PE I G + + DWWA+G+L YE+L G PF+
Sbjct: 164 S------------CYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDED 211
Query: 904 --------KTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEI 955
RQ K L F + S +A + +L + RL ++ NEI
Sbjct: 212 EELDLESLLKRQ-------QKKLPFIKN--VSKNANDFVQSMLKYNINYRLTNY---NEI 259
Query: 956 KKHPFFK 962
KHPF K
Sbjct: 260 IKHPFLK 266
|
Length = 267 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 117 bits (295), Expect = 4e-29
Identities = 80/300 (26%), Positives = 121/300 (40%), Gaps = 45/300 (15%)
Query: 673 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDM--LD 730
+ I+ +G G T V+ + + A+K +D L + + +E+ M +
Sbjct: 2 DYELIEVIGVGATAVVYAAICLPNNEKVAIKRID----LEKCQTSVDELRKEVQAMSQCN 57
Query: 731 HPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQ-PTKVLKEDAVRFYAAEVVVALEY 789
HP V Y SF + L+ Y GG L ++ P L E + EV+ LEY
Sbjct: 58 HPNVVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEY 117
Query: 790 LHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPV 849
LH G I+RD+K N+LL +G V + DF +S L +K R
Sbjct: 118 LHSNGQIHRDIKAGNILLGEDGSVKIADFGVSAS------LADGGDRTRKVRK------- 164
Query: 850 FMAEPMRASNSFVGTEEYIAPEIIA-GAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQK 908
+FVGT ++APE++ G+ D W+ GI E+ G P+ K
Sbjct: 165 ----------TFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMK 214
Query: 909 TFANILHKDLKFPSSTPT-------SLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFF 961
L D P S T S ++++ L +DP R A E+ KH FF
Sbjct: 215 VLMLTLQND---PPSLETGADYKKYSKSFRKMISLCLQKDPSKR----PTAEELLKHKFF 267
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 123 bits (311), Expect = 5e-29
Identities = 60/154 (38%), Positives = 92/154 (59%), Gaps = 2/154 (1%)
Query: 671 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLD 730
++ F +KP+ G G V+L + + +A+K + K M+N+N VH+ AER+ L +
Sbjct: 3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSK 62
Query: 731 HPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYL 790
PF+ LY S Q+ +V L+ +Y GG++ LL E+ Y +EV +AL+YL
Sbjct: 63 SPFIVHLYYSLQSANNVYLVMEYLIGGDVKSLL--HIYGYFDEEMAVKYISEVALALDYL 120
Query: 791 HCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLT 824
H GII+RDLKP+N+L+ GH+ LTDF LS +T
Sbjct: 121 HRHGIIHRDLKPDNMLISNEGHIKLTDFGLSKVT 154
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 116 bits (294), Expect = 8e-29
Identities = 84/308 (27%), Positives = 138/308 (44%), Gaps = 43/308 (13%)
Query: 658 AIQKILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVH 717
A++ I+ G+ L ++ ++ +G G +G V+ +G+ A+K M L +
Sbjct: 7 ALKDIVSEGDPREL--YKNLEKIGEGASGEVYKATDRATGKEVAIKKMR----LRKQNKE 60
Query: 718 RACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVR 777
E I+ HP + Y S+ + ++ +Y GG L ++ + + + E +
Sbjct: 61 LIINEILIMKDCKHPNIVDYYDSYLVGDELWVVMEYMDGGSLTDIITQNFVR-MNEPQIA 119
Query: 778 FYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNE 837
+ EV+ LEYLH Q +I+RD+K +N+LL +G V L DF + QL T E
Sbjct: 120 YVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAA------QL----TKE 169
Query: 838 KKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYG 897
K +R NS VGT ++APE+I + VD W+LGI+ EM G
Sbjct: 170 KSKR-----------------NSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEG 212
Query: 898 YTPFRGKTRQKTFANILHK---DLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANE 954
P+ + + I K LK P K + + L +DP+ R + E
Sbjct: 213 EPPYLREPPLRALFLITTKGIPPLKNPEKWSPEF--KDFLNKCLVKDPEKRPSAE----E 266
Query: 955 IKKHPFFK 962
+ +HPF K
Sbjct: 267 LLQHPFLK 274
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 115 bits (291), Expect = 1e-28
Identities = 75/300 (25%), Positives = 122/300 (40%), Gaps = 42/300 (14%)
Query: 672 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDH 731
+ LG+G++G V V +G+ A+K + + K + E +IL +
Sbjct: 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQK--QILRELDILHKCNS 58
Query: 732 PFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLH 791
P++ Y +F + + +Y GG L +L + E + A V+ L YLH
Sbjct: 59 PYIVGFYGAFYNNGDISICMEYMDGGSLDKILKEV-QGRIPERILGKIAVAVLKGLTYLH 117
Query: 792 CQ-GIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVF 850
+ II+RD+KP N+L+ G + L DF +S QL N
Sbjct: 118 EKHKIIHRDVKPSNILVNSRGQIKLCDFGVS------GQL----VNSL------------ 155
Query: 851 MAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQ-KT 909
+ +FVGT Y+APE I G ++ D W+LG+ L E+ G P+ +
Sbjct: 156 -------AKTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDG 208
Query: 910 FANILHKDLKFPS----STPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVN 965
+L + P S S + + L +DP+ R E+ +HPF K
Sbjct: 209 IFELLQYIVNEPPPRLPSGKFSPDFQDFVNLCLIKDPRER----PSYKELLEHPFIKKYE 264
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 115 bits (291), Expect = 1e-28
Identities = 88/298 (29%), Positives = 127/298 (42%), Gaps = 54/298 (18%)
Query: 674 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREI--LDMLDH 731
F ++ +G G G V+ + Q A+K +D L + ++EI L
Sbjct: 3 FTLLECIGKGSFGEVYKAIDKRTNQVVAIKVID----LEEAEDEIEDIQQEIQFLSQCRS 58
Query: 732 PFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLH 791
P++ Y SF + + +I +YC GG LL L E + F EV++ LEYLH
Sbjct: 59 PYITKYYGSFLKGSKLWIIMEYCGGGSCLDLLKPGK---LDETYIAFILREVLLGLEYLH 115
Query: 792 CQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFM 851
+G I+RD+K N+LL G V L DF +S QL T+ KR
Sbjct: 116 EEGKIHRDIKAANILLSEEGDVKLADFGVS------GQL---TSTMSKR----------- 155
Query: 852 AEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFA 911
N+FVGT ++APE+I +G+ D W+LGI E+ G P +
Sbjct: 156 -------NTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLF 208
Query: 912 NILHKDLKFPSSTPTSLHA-------KQLMYRLLHRDPKSRLGSHEGANEIKKHPFFK 962
I P + P SL K + L++DPK R A E+ KH F K
Sbjct: 209 LI-------PKNNPPSLEGNKFSKPFKDFVSLCLNKDPKERP----SAKELLKHKFIK 255
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 111 bits (280), Expect = 3e-27
Identities = 85/299 (28%), Positives = 130/299 (43%), Gaps = 55/299 (18%)
Query: 673 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNR--NKVHR-ACAEREILDML 729
H+ PI+ LG G G L K ++ L R K R A E IL +L
Sbjct: 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVN----LTRLSEKERRDALNEIVILSLL 56
Query: 730 DHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEY 789
HP + A Y F + + +Y GG L+ + RQ ++ +E+ V +Y ++V A+ Y
Sbjct: 57 QHPNIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSY 116
Query: 790 LHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPV 849
+H GI++RD+K N+ L G + L DF +S K +
Sbjct: 117 IHKAGILHRDIKTLNIFLTKAGLIKLGDFGIS---------------------KILGSEY 155
Query: 850 FMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKT 909
MAE + VGT Y++PE+ G + D WALG +LYE+L T ++T
Sbjct: 156 SMAE------TVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELL---------TLKRT 200
Query: 910 FA--NILHKDLKF------PSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPF 960
F N L+ +K P + S L++ LL +DP+ R A+E+ P
Sbjct: 201 FDATNPLNLVVKIVQGNYTPVVSVYSSELISLVHSLLQQDPEKR----PTADEVLDQPL 255
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 111 bits (280), Expect = 3e-27
Identities = 79/291 (27%), Positives = 129/291 (44%), Gaps = 51/291 (17%)
Query: 680 LGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACA---EREI--LDMLDHPFV 734
LGSG GSV+ G +FA+K + + + + + E+EI L L HP +
Sbjct: 8 LGSGSFGSVYEGLNLDDGDFFAVKEVS---LADDGQTGQEAVKQLEQEIALLSKLQHPNI 64
Query: 735 PALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQG 794
+ + + ++ + + PGG L LL + E +R Y ++++ LEYLH +
Sbjct: 65 VQYLGTEREEDNLYIFLELVPGGSLAKLLKK--YGSFPEPVIRLYTRQILLGLEYLHDRN 122
Query: 795 IIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEP 854
++RD+K N+L+ NG V L DF ++ K+
Sbjct: 123 TVHRDIKGANILVDTNGVVKLADFGMA----------------KQ------------VVE 154
Query: 855 MRASNSFVGTEEYIAPEIIAGAG-HTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANI 913
+ SF G+ ++APE+IA G + A D W+LG + EM G P+ ++ + A +
Sbjct: 155 FSFAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPW---SQLEGVAAV 211
Query: 914 LH----KDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPF 960
K+L P S AK + + L RDP R A E+ +HPF
Sbjct: 212 FKIGRSKELP-PIPDHLSDEAKDFILKCLQRDPSLRP----TAAELLEHPF 257
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 3e-27
Identities = 75/267 (28%), Positives = 119/267 (44%), Gaps = 31/267 (11%)
Query: 680 LGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYA 739
+G G G V V + +AMK +D M NR + A E +L LD ++ Y
Sbjct: 8 IGKGSFGVVFKVVRKADKRVYAMKQIDLSKM-NRREREEAIDEARVLAKLDSSYIIRYYE 66
Query: 740 SFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAV-RFYAAEVVVALEYLHCQGIIYR 798
SF K + ++ +Y G+L LL Q + L ED V RF+ ++++ L +LH + I++R
Sbjct: 67 SFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFF-IQILLGLAHLHSKKILHR 125
Query: 799 DLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRAS 858
D+K N+ L +V + D ++ +LL TN +
Sbjct: 126 DIKSLNLFLDAYDNVKIGDLGVA-------KLLSDNTN--------------------FA 158
Query: 859 NSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANILHKDL 918
N+ VGT Y++PE+ + D WALG++LYE G PF + I+
Sbjct: 159 NTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVF 218
Query: 919 KFPSSTPTSLHAKQLMYRLLHRDPKSR 945
P S S QL+ + L +D + R
Sbjct: 219 P-PVSQMYSQQLAQLIDQCLTKDYRQR 244
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 110 bits (275), Expect = 1e-26
Identities = 83/288 (28%), Positives = 137/288 (47%), Gaps = 43/288 (14%)
Query: 680 LGSGDTGSVHLVELCGSGQYFAMKAMDKGVM--LNRNKVHRACAEREILDMLDHPFVPAL 737
LG G G+V+LV+ + +K + + + LN N+ +A E ++L LDHP +
Sbjct: 8 LGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKF 67
Query: 738 YASFQTKTHVCLITDYCPGGELFLLLD--RQPTKVLKEDAVRFYAAEVVVALEYLHCQGI 795
+ASF + C+IT+YC G +L L+ + K L E+ V + ++++ + Y+H + I
Sbjct: 68 HASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRI 127
Query: 796 IYRDLKPENVLLQGNGHVSLTDFDLSCLT--SCKPQLLLPTTNEKKRRHKGQQNPVFMAE 853
++RDLK +N+ L+ N + + DF +S L SC L TT
Sbjct: 128 LHRDLKAKNIFLKNN-LLKIGDFGVSRLLMGSCD----LATT------------------ 164
Query: 854 PMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANI 913
F GT Y++PE + G+ S D W+LG +LYEM F G+ I
Sbjct: 165 -------FTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRI 217
Query: 914 LHKDL-KFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPF 960
+ P + L++ +M +L++DP R A EI ++PF
Sbjct: 218 VEGPTPSLPETYSRQLNS--IMQSMLNKDPSLRP----SAAEILRNPF 259
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 110 bits (276), Expect = 1e-26
Identities = 70/294 (23%), Positives = 128/294 (43%), Gaps = 44/294 (14%)
Query: 677 IKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPA 736
++ +G G G+V V G+ K +D G M + K + +E IL L HP +
Sbjct: 5 LETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEK-QQLVSEVNILRELKHPNIVR 63
Query: 737 LYASF--QTKTHVCLITDYCPGGELFLLLDR--QPTKVLKEDAVRFYAAEVVVALEYLHC 792
Y ++ + ++ +YC GG+L L+ + + K ++E+ + ++++AL H
Sbjct: 64 YYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHN 123
Query: 793 QG-----IIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQN 847
+ +++RDLKP N+ L N +V L DF L+ +L +
Sbjct: 124 RSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLA--------KILGHDS----------- 164
Query: 848 PVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQ 907
A ++VGT Y++PE + + D W+LG L+YE+ PF + +
Sbjct: 165 --SFA------KTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQL 216
Query: 908 KTFANILHKDLKFPSSTPT-SLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPF 960
+ + I K+ KF S +++ +L+ DP R E+ + P
Sbjct: 217 QLASKI--KEGKFRRIPYRYSSELNEVIKSMLNVDPDKR----PSTEELLQLPL 264
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 2e-26
Identities = 57/223 (25%), Positives = 100/223 (44%), Gaps = 32/223 (14%)
Query: 680 LGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRAC-AEREILDMLDHPFVPALY 738
+G G G V+ +G + A+K + + + + ++ E ++L L HP +
Sbjct: 8 IGRGAFGVVYKGLNLETGDFVAIKQIS--LEKIKEEALKSIMQEIDLLKNLKHPNIVKYI 65
Query: 739 ASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYR 798
S +T + +I +Y G L ++ + E V Y +V+ L YLH QG+I+R
Sbjct: 66 GSIETSDSLYIILEYAENGSLRQII--KKFGPFPESLVAVYVYQVLQGLAYLHEQGVIHR 123
Query: 799 DLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRAS 858
D+K N+L +G V L DF ++ + + +
Sbjct: 124 DIKAANILTTKDGVVKLADFGVA---------------------------TKLNDVSKDD 156
Query: 859 NSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPF 901
S VGT ++APE+I +G ++A D W+LG + E+L G P+
Sbjct: 157 ASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPY 199
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 2e-26
Identities = 80/278 (28%), Positives = 123/278 (44%), Gaps = 53/278 (19%)
Query: 688 VHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDH--PFVPALYASFQTKT 745
V LV + Q F +K + K +R + L ++ H P + L+ ++
Sbjct: 9 VLLVMDTRTQQTFILKGLRKSSEYSRER----------LTIIPHCVPNMVCLHKYIVSED 58
Query: 746 HVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENV 805
V L+ + GG+L+ + + + E+ V+ +AAE+VVAL+ LH +GI+ RDL P N+
Sbjct: 59 SVFLVLQHAEGGKLWSHISKFLN--IPEECVKRWAAEMVVALDALHREGIVCRDLNPNNI 116
Query: 806 LLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTE 865
LL GH+ LT F + + V E +
Sbjct: 117 LLDDRGHIQLTYF-------------------------SRWSEV---EDSCDGEAV--EN 146
Query: 866 EYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANI-LHKDLKFPSST 924
Y APE+ + T A DWW+LG +L+E+L G T + I H L P
Sbjct: 147 MYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHP-----SGINTHTTLNIPEW- 200
Query: 925 PTSLHAKQLMYRLLHRDPKSRLGSHE-GANEIKKHPFF 961
S A+ L+ +LL +P RLG+ G +IK HPFF
Sbjct: 201 -VSEEARSLLQQLLQFNPTERLGAGVAGVEDIKSHPFF 237
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|222120 pfam13426, PAS_9, PAS domain | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 3e-26
Identities = 37/104 (35%), Positives = 66/104 (63%), Gaps = 3/104 (2%)
Query: 205 FVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKIRETLQNGQ 264
+V D PD I+YA+ ++ GYT +E++G++ R L G G D E VA++RE L+NG
Sbjct: 1 ILVLD---PDGRIVYANDAALRLLGYTREELLGKSIRDLFGPGDDEEAVARLREALRNGG 57
Query: 265 SYCGRLLNYKKDGTPFWNLLTIAPIKDDEGKVLKFIGMQVEVSK 308
L +KDG PF L++ +P++D++G+V+ +G+ ++++
Sbjct: 58 EVEVELELRRKDGEPFPVLVSASPVRDEDGEVVGIVGILRDITE 101
|
Length = 101 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 109 bits (273), Expect = 4e-26
Identities = 86/311 (27%), Positives = 138/311 (44%), Gaps = 50/311 (16%)
Query: 658 AIQKILDSGEQ-INLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKV 716
A+Q ++D G+ L +F I G G TG V + +G+ A+K MD R +
Sbjct: 7 ALQLVVDPGDPRSYLDNFVKI---GEGSTGIVCIATDKSTGRQVAVKKMDL-----RKQQ 58
Query: 717 HRACAEREILDMLD--HPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKED 774
R E++ M D HP + +Y+S+ + ++ ++ GG L D + E+
Sbjct: 59 RRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGAL---TDIVTHTRMNEE 115
Query: 775 AVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPT 834
+ V+ AL +LH QG+I+RD+K +++LL +G V L+DF S
Sbjct: 116 QIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVS--------- 166
Query: 835 TNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEM 894
E RR S VGT ++APE+I+ + + VD W+LGI++ EM
Sbjct: 167 -KEVPRR-----------------KSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEM 208
Query: 895 LYGYTPFRGKTRQKTFANILHKDLKFPSSTPT---SLHAKQLMYRLLHRDPKSRLGSHEG 951
+ G P+ + + I +D P S + + R+L RDP R
Sbjct: 209 VDGEPPYFNEPPLQAMKRI--RDNLPPKLKNLHKVSPRLRSFLDRMLVRDPAQR----AT 262
Query: 952 ANEIKKHPFFK 962
A E+ HPF
Sbjct: 263 AAELLNHPFLA 273
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 1e-25
Identities = 74/316 (23%), Positives = 125/316 (39%), Gaps = 67/316 (21%)
Query: 677 IKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREI--LDMLDHPFV 734
+ +G G G V+ +G+ A+K + ++ A REI L L+HP +
Sbjct: 4 LGKIGEGTYGVVYKARDKLTGEIVAIKKIKLR---FESEGIPKTALREIKLLKELNHPNI 60
Query: 735 PALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQG 794
L F+ K + L+ ++ L+ DRQ + L E ++ Y +++ L + H G
Sbjct: 61 IKLLDVFRHKGDLYLVFEFMDTDLYKLIKDRQ--RGLPESLIKSYLYQLLQGLAFCHSHG 118
Query: 795 IIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEP 854
I++RDLKPEN+L+ G + L DF L+ +
Sbjct: 119 ILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTH--------------------- 157
Query: 855 MRASNSFVGTEEYIAPEIIAGA-GHTSAVDWWALGILLYEMLYGYTPFRGKTR------- 906
+V T Y APE++ G G+++ VD W++G + E+L F GK+
Sbjct: 158 ------YVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKI 211
Query: 907 ------------QKTFANILHKDLKFPSSTPTSLH---------AKQLMYRLLHRDPKSR 945
K + + FP L A L+ ++LH DP R
Sbjct: 212 FRTLGTPDPEVWPKFTSLARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKR 271
Query: 946 LGSHEGANEIKKHPFF 961
+ + + HP+F
Sbjct: 272 ITAEQAL----AHPYF 283
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 102 bits (257), Expect = 5e-24
Identities = 72/273 (26%), Positives = 110/273 (40%), Gaps = 71/273 (26%)
Query: 723 REI--LDMLDHPFVPALYASFQTKTHVCLITDYCPGGE--LFLLLDRQPTKVLKEDAVRF 778
REI L L HP + L T+ + L+ +YC + L LD++P L + ++
Sbjct: 47 REISLLKELKHPNIVKLLDVIHTERKLYLVFEYC---DMDLKKYLDKRPGP-LSPNLIKS 102
Query: 779 YAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLS-CLTSCKPQLLLPTTNE 837
+++ L Y H I++RDLKP+N+L+ +G + L DF L+
Sbjct: 103 IMYQLLRGLAYCHSHRILHRDLKPQNILINRDGVLKLADFGLARAFGI------------ 150
Query: 838 KKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGH-TSAVDWWALGILLYEMLY 896
P+R V T Y APEI+ G+ H ++AVD W++G + EM+
Sbjct: 151 ----------------PLRTYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMIT 194
Query: 897 GYTPFRGKTRQ----KTFANIL---------------HKDLKFPSSTPTSLH-------- 929
G F G + K F IL FP P L
Sbjct: 195 GKPLFPGDSEIDQLFKIF-QILGTPTEESWPGVTKLPDYKPTFPKFPPKDLEKVLPRLDP 253
Query: 930 -AKQLMYRLLHRDPKSRLGSHEGANEIKKHPFF 961
L+ ++L +P R+ A E KHP+F
Sbjct: 254 EGIDLLSKMLQYNPAKRI----SAKEALKHPYF 282
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 101 bits (255), Expect = 7e-24
Identities = 70/278 (25%), Positives = 117/278 (42%), Gaps = 42/278 (15%)
Query: 677 IKPLGSGDTGSVHLVELCGSGQYF----AMKAMDKGVML-NRNKVHRACAEREILDMLDH 731
K LG G G V+ L G G A+K + + + R E I+ LDH
Sbjct: 4 GKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLR---EARIMRKLDH 60
Query: 732 PFVPALYASFQTKTHVCLITDYCPGGEL--FLLLDRQPTKVLKEDAVRFYAAEVVVALEY 789
P + L + + ++ +Y PGG+L +L +P ++ D + F A ++ +EY
Sbjct: 61 PNIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLR-KNRPKELSLSDLLSF-ALQIARGMEY 118
Query: 790 LHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPV 849
L + I+RDL N L+ N V ++DF LS ++ + KG + P+
Sbjct: 119 LESKNFIHRDLAARNCLVGENLVVKISDFGLSRD----------LYDDDYYKVKGGKLPI 168
Query: 850 FMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEML-YGYTPFRGKTRQK 908
++APE + TS D W+ G+LL+E+ G P+ G + +
Sbjct: 169 R----------------WMAPESLKEGKFTSKSDVWSFGVLLWEIFTLGEEPYPGMSNAE 212
Query: 909 TFANILHKD-LKFPSSTPTSLHAKQLMYRLLHRDPKSR 945
+ L P + P L+ +LM + DP+ R
Sbjct: 213 VLEYLKKGYRLPKPPNCPPELY--KLMLQCWAEDPEDR 248
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 7e-24
Identities = 76/295 (25%), Positives = 129/295 (43%), Gaps = 51/295 (17%)
Query: 674 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPF 733
+ I+ +G G G VHL + +K + M +++ A E ++L +L HP
Sbjct: 2 YEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQM-TKDERLAAQNECQVLKLLSHPN 60
Query: 734 VPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQ 793
+ Y +F + ++ +Y PGG L + ++ +L ED + + ++++AL ++H +
Sbjct: 61 IIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTK 120
Query: 794 GIIYRDLKPENVLLQGNGH---VSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVF 850
I++RDLK +N+LL + H V + DF +S + S K
Sbjct: 121 LILHRDLKTQNILL--DKHKMVVKIGDFGISKILSSK----------------------- 155
Query: 851 MAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTF 910
+ + VGT YI+PE+ G + D WALG +LYE+ F
Sbjct: 156 -----SKAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEA------- 203
Query: 911 ANILHKDLKFPSST--PTSLH----AKQLMYRLLHRDPKSRLGSHEGANEIKKHP 959
AN+ LK S T P S +QL+ +L+ DP R ++I P
Sbjct: 204 ANLPALVLKIMSGTFAPISDRYSPDLRQLILSMLNLDPSKR----PQLSQIMAQP 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 8e-24
Identities = 63/230 (27%), Positives = 99/230 (43%), Gaps = 33/230 (14%)
Query: 674 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPF 733
F ++ LG G GSV+ +GQ A+K V+ + E IL D P+
Sbjct: 5 FDILEKLGEGSYGSVYKAIHKETGQVVAIK-----VVPVEEDLQEIIKEISILKQCDSPY 59
Query: 734 VPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQ 793
+ Y S+ T + ++ +YC G + ++ + K L E+ + + + LEYLH
Sbjct: 60 IVKYYGSYFKNTDLWIVMEYCGAGSVSDIM-KITNKTLTEEEIAAILYQTLKGLEYLHSN 118
Query: 794 GIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAE 853
I+RD+K N+LL G L DF +S GQ +
Sbjct: 119 KKIHRDIKAGNILLNEEGQAKLADFGVS----------------------GQLT-----D 151
Query: 854 PMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRG 903
M N+ +GT ++APE+I G+ + D W+LGI EM G P+
Sbjct: 152 TMAKRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSD 201
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 9e-24
Identities = 67/270 (24%), Positives = 125/270 (46%), Gaps = 32/270 (11%)
Query: 677 IKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPA 736
++ +G G G LV+ S Q +AMK + + + + V + E +L + HP + A
Sbjct: 5 LRVVGEGSFGRALLVQHVNSDQKYAMKEIR--LPKSSSAVEDSRKEAVLLAKMKHPNIVA 62
Query: 737 LYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGII 796
SF+ H+ ++ +YC GG+L + Q K+ ED + + ++ + ++++H + ++
Sbjct: 63 FKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVL 122
Query: 797 YRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMR 856
+RD+K +N+ L NG V L DF + L + P
Sbjct: 123 HRDIKSKNIFLTQNGKVKLGDFGSARL---------------------------LTSPGA 155
Query: 857 ASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANILHK 916
+ ++VGT Y+ PEI + + D W+LG +LYE+ PF+ + + +
Sbjct: 156 YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQG 215
Query: 917 DLK-FPSSTPTSLHAKQLMYRLLHRDPKSR 945
K PS L + L+ ++ R+P+SR
Sbjct: 216 SYKPLPSHYSYELRS--LIKQMFKRNPRSR 243
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 3e-23
Identities = 72/302 (23%), Positives = 122/302 (40%), Gaps = 69/302 (22%)
Query: 680 LGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYA 739
LG G G V+ + +G + A K + + ++ E +IL HP + LY
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKIIQIE---SEEELEDFMVEIDILSECKHPNIVGLYE 69
Query: 740 SFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRD 799
++ + + ++ ++C GG L ++ + + L E +R+ +++ AL +LH +I+RD
Sbjct: 70 AYFYENKLWILIEFCDGGALDSIML-ELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRD 128
Query: 800 LKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASN 859
LK N+LL +G V L DF +S + ++R
Sbjct: 129 LKAGNILLTLDGDVKLADFGVSAK----------NKSTLQKRD----------------- 161
Query: 860 SFVGTEEYIAPEIIA-----GAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANIL 914
+F+GT ++APE++A + D W+LGI L E+ P
Sbjct: 162 TFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPP-------------- 207
Query: 915 HKD-------LKFPSSTPTSLHA--------KQLMYRLLHRDPKSRLGSHEGANEIKKHP 959
H + LK S P +L + L +DP R A E+ KHP
Sbjct: 208 HHELNPMRVLLKILKSEPPTLDQPSKWSSSFNDFLKSCLVKDPDDRP----TAAELLKHP 263
Query: 960 FF 961
F
Sbjct: 264 FV 265
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 4e-23
Identities = 85/321 (26%), Positives = 147/321 (45%), Gaps = 48/321 (14%)
Query: 658 AIQKILDSGE-QINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKV 716
A++ ++D G+ + L+++ I G G TG V + SG+ A+K MD R +
Sbjct: 9 ALRMVVDQGDPRSLLENYIKI---GEGSTGIVCIAREKHSGRQVAVKMMDL-----RKQQ 60
Query: 717 HRACAEREILDMLD--HPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKED 774
R E++ M D H V +Y S+ + ++ ++ GG L ++ + L E+
Sbjct: 61 RRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQTR---LNEE 117
Query: 775 AVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPT 834
+ V+ AL YLH QG+I+RD+K +++LL +G V L+DF S
Sbjct: 118 QIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQIS--------- 168
Query: 835 TNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEM 894
+ KR+ S VGT ++APE+I+ + + VD W+LGI++ EM
Sbjct: 169 KDVPKRK------------------SLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEM 210
Query: 895 LYGYTPFRGKTRQKTFANILHK-DLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGAN 953
+ G P+ + + + K ++ S + + R+L R+P+ R A
Sbjct: 211 VDGEPPYFSDSPVQAMKRLRDSPPPKLKNAHKISPVLRDFLERMLTREPQER----ATAQ 266
Query: 954 EIKKHPFFKGVNWALVRCMNP 974
E+ HPF + L C+ P
Sbjct: 267 ELLDHPFL--LQTGLPECLVP 285
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 100 bits (249), Expect = 5e-23
Identities = 93/310 (30%), Positives = 138/310 (44%), Gaps = 50/310 (16%)
Query: 658 AIQKILDSGE-QINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKV 716
A+Q ++D G+ + L +F I G G TG V + + SG+ A+K MD R +
Sbjct: 8 ALQMVVDPGDPRTYLDNFIKI---GEGSTGIVCIATVKSSGKLVAVKKMDL-----RKQQ 59
Query: 717 HRACAEREILDMLD--HPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKED 774
R E++ M D H V +Y S+ + ++ ++ GG L D + E+
Sbjct: 60 RRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGAL---TDIVTHTRMNEE 116
Query: 775 AVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPT 834
+ V+ AL LH QG+I+RD+K +++LL +G V L+DF S
Sbjct: 117 QIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVS--------- 167
Query: 835 TNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEM 894
E RR S VGT ++APE+I+ + VD W+LGI++ EM
Sbjct: 168 -KEVPRR-----------------KSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEM 209
Query: 895 LYGYTPFRGKTRQKTFANI---LHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEG 951
+ G P+ + K I L LK SL K + RLL RDP R
Sbjct: 210 VDGEPPYFNEPPLKAMKMIRDNLPPKLKNLHKVSPSL--KGFLDRLLVRDPAQR----AT 263
Query: 952 ANEIKKHPFF 961
A E+ KHPF
Sbjct: 264 AAELLKHPFL 273
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 99.1 bits (247), Expect = 5e-23
Identities = 69/284 (24%), Positives = 129/284 (45%), Gaps = 33/284 (11%)
Query: 677 IKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPA 736
+K +G G G LV+ G+ + +K ++ M + + + E +L + HP +
Sbjct: 5 VKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKER-EESRKEVAVLSNMKHPNIVQ 63
Query: 737 LYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGII 796
SF+ ++ ++ DYC GG+L+ ++ Q + ED + + ++ +AL+++H + I+
Sbjct: 64 YQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKIL 123
Query: 797 YRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMR 856
+RD+K +N+ L +G + L DF ++ +L +T E R
Sbjct: 124 HRDIKSQNIFLTKDGTIKLGDFGIA--------RVLNSTVELAR---------------- 159
Query: 857 ASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANILHK 916
+ +GT Y++PEI + + D WALG +LYEM F + I+
Sbjct: 160 ---TCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRG 216
Query: 917 DLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPF 960
P S+ S + L+ +L R+P+ R N I + F
Sbjct: 217 SYP-PVSSHYSYDLRNLVSQLFKRNPRDR----PSVNSILEKNF 255
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 99.4 bits (248), Expect = 6e-23
Identities = 73/286 (25%), Positives = 127/286 (44%), Gaps = 46/286 (16%)
Query: 674 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREI-----LDM 728
++ ++ +G G G+V+ + +G+ A+K ++ L+ + +RE+ L
Sbjct: 3 YQRLELIGRGAYGAVYRGKHVPTGRVVALKIIN----LDTPDDDVSDIQREVALLSQLRQ 58
Query: 729 LDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALE 788
P + Y S+ + +I +Y GG + L+ P + E + EV+VAL+
Sbjct: 59 SQPPNITKYYGSYLKGPRLWIIMEYAEGGSVRTLMKAGP---IAEKYISVIIREVLVALK 115
Query: 789 YLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNP 848
Y+H G+I+RD+K N+L+ G+V L DF ++ L N KR
Sbjct: 116 YIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALL---------NQNSSKR-------- 158
Query: 849 VFMAEPMRASNSFVGTEEYIAPEIIA-GAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQ 907
++FVGT ++APE+I G + + D W+LGI +YEM G P+
Sbjct: 159 ----------STFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAF 208
Query: 908 KTFANILHKDLKFPSSTPTSLHAKQL---MYRLLHRDPKSRLGSHE 950
+ I P + ++K L + L +PK RL + E
Sbjct: 209 RAMMLIPKSK---PPRLEDNGYSKLLREFVAACLDEEPKERLSAEE 251
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 98.0 bits (245), Expect = 1e-22
Identities = 66/281 (23%), Positives = 111/281 (39%), Gaps = 48/281 (17%)
Query: 677 IKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGV----MLNRNKVHRACAE--REILDM-- 728
K LG G G V+ G + L E E M
Sbjct: 4 GKKLGEGAFGEVYK------GTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKK 57
Query: 729 LDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALE 788
L HP + L + ++T+Y PGG+L L + K+ +D ++ A ++ +E
Sbjct: 58 LSHPNIVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQM-ALQIAKGME 116
Query: 789 YLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNP 848
YL + ++RDL N L+ N V ++DF LS + + +KR + P
Sbjct: 117 YLESKNFVHRDLAARNCLVTENLVVKISDFGLS-------RDIYEDDYYRKRGGG--KLP 167
Query: 849 VFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEML-YGYTPFRGKTRQ 907
+ ++APE + TS D W+ G+LL+E+ G P+ G + +
Sbjct: 168 IK----------------WMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNE 211
Query: 908 KTFANILHKD---LKFPSSTPTSLHAKQLMYRLLHRDPKSR 945
+ + +D L P + P L+ +LM + DP+ R
Sbjct: 212 EVLELL--EDGYRLPRPENCPDELY--ELMLQCWAYDPEDR 248
|
Length = 258 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 98.0 bits (244), Expect = 2e-22
Identities = 78/287 (27%), Positives = 124/287 (43%), Gaps = 34/287 (11%)
Query: 680 LGSGDTGSVHLVELCGSGQYFAMKAMD-KGVMLNRNKVHRA---CAEREI--LDMLDHPF 733
+GSG GSV+L SG+ A+K ++ V + R+ REI L L H
Sbjct: 8 IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67
Query: 734 VPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQ 793
+ S H+ + +Y PGG + LL+ +E VR + +++ L YLH +
Sbjct: 68 IVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGA--FEETLVRNFVRQILKGLNYLHNR 125
Query: 794 GIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAE 853
GII+RD+K N+L+ G + ++DF +S +L + + K +
Sbjct: 126 GIIHRDIKGANILVDNKGGIKISDFGIS------KKLEANSLSTKTNGAR---------- 169
Query: 854 PMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANI 913
S G+ ++APE++ +T D W+LG L+ EML G PF T+ + I
Sbjct: 170 -----PSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKI 224
Query: 914 LHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPF 960
S +S A + + D R A E+ KHPF
Sbjct: 225 GENASPEIPSNISS-EAIDFLEKTFEIDHNKR----PTAAELLKHPF 266
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 97.6 bits (244), Expect = 2e-22
Identities = 69/278 (24%), Positives = 116/278 (41%), Gaps = 43/278 (15%)
Query: 677 IKPLGSGDTGSVHLVELCGSGQYF----AMKAMDKGVML-NRNKVHRACAEREILDMLDH 731
K LG G G V+ +L G G A+K + + + R E I+ LDH
Sbjct: 4 GKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLR---EARIMRKLDH 60
Query: 732 PFVPALYASFQTKTHVCLITDYCPGGEL--FLLLDRQPTKVLKEDAVRFYAAEVVVALEY 789
P V L + + ++ +Y GG+L +L R+ L + +A ++ +EY
Sbjct: 61 PNVVKLLGVCTEEEPLYIVMEYMEGGDLLSYL---RKNRPKLSLSDLLSFALQIARGMEY 117
Query: 790 LHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPV 849
L + I+RDL N L+ N V ++DF LS ++ R +G + P+
Sbjct: 118 LESKNFIHRDLAARNCLVGENLVVKISDFGLSRD----------LYDDDYYRKRGGKLPI 167
Query: 850 FMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEML-YGYTPFRGKTRQK 908
++APE + TS D W+ G+LL+E+ G P+ G + ++
Sbjct: 168 R----------------WMAPESLKEGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEE 211
Query: 909 TFANILHKD-LKFPSSTPTSLHAKQLMYRLLHRDPKSR 945
+ + L P + P L+ LM + DP+ R
Sbjct: 212 VLEYLKNGYRLPQPPNCPPELY--DLMLQCWAEDPEDR 247
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 97.5 bits (243), Expect = 2e-22
Identities = 76/292 (26%), Positives = 124/292 (42%), Gaps = 34/292 (11%)
Query: 671 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLD 730
L +F+ K +G G V+ G+ A+K + M++ E ++L LD
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD 60
Query: 731 HPFVPALYASFQTKTHVCLITDYCPGGELFLLLD--RQPTKVLKEDAVRFYAAEVVVALE 788
HP V ASF + ++ + G+L ++ ++ +++ E + Y ++ ALE
Sbjct: 61 HPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALE 120
Query: 789 YLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNP 848
++H + I++RD+KP NV + G V L D L S K TT
Sbjct: 121 HMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSK------TT------------- 161
Query: 849 VFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQ- 907
A++S VGT Y++PE I G+ D W+LG LLYEM +PF G
Sbjct: 162 --------AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL 213
Query: 908 -KTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGS---HEGANEI 955
I D + S + L+ R ++ DP+ R + A E+
Sbjct: 214 YSLCKKIEKCDYPPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEM 265
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 6e-22
Identities = 51/126 (40%), Positives = 74/126 (58%), Gaps = 5/126 (3%)
Query: 862 VGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANILHKDLKFP 921
+GT +Y+APE++ G H AVDWWALG+ L+E L G PF +T Q+ F NIL++D+ +P
Sbjct: 541 LGTPDYLAPELLLGKPHGPAVDWWALGVCLFEFLTGIPPFNDETPQQVFQNILNRDIPWP 600
Query: 922 SSTPT-SLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVNWALVRCMNPPELDAP 980
S++A+ + LL DP R G E+K+HP F GV+W ++ P + P
Sbjct: 601 EGEEKLSVNAQNAIEILLTMDPTKR----AGLKELKQHPLFHGVDWENLQNQTMPFIPQP 656
Query: 981 LFATDT 986
TDT
Sbjct: 657 DDETDT 662
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 96.6 bits (241), Expect = 8e-22
Identities = 80/314 (25%), Positives = 124/314 (39%), Gaps = 68/314 (21%)
Query: 680 LGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYA 739
+G G G V + +G+ A+K + L ++A E + L HP+V L
Sbjct: 8 IGEGAHGIVFKAKDRETGETVALKKV-ALRRLEGGIPNQALREIKALQACQHPYVVKLLD 66
Query: 740 SFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRD 799
F + L+ +Y P +L D + + L E V+ Y ++ + Y+H GI++RD
Sbjct: 67 VFPHGSGFVLVMEYMPSDLSEVLRDEE--RPLPEAQVKSYMRMLLKGVAYMHANGIMHRD 124
Query: 800 LKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASN 859
LKP N+L+ +G + + DF L+ L S E R +
Sbjct: 125 LKPANLLISADGVLKIADFGLARLFS--------------------------EEEPRLYS 158
Query: 860 SFVGTEEYIAPEIIAGAGH-TSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANILH--- 915
V T Y APE++ GA VD WA+G + E+L G F G+ + A +
Sbjct: 159 HQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLG 218
Query: 916 ----------KDL------------------KFPSSTPTSLHAKQLMYRLLHRDPKSRLG 947
L FP ++P +L L+ LL DP RL
Sbjct: 219 TPNEETWPGLTSLPDYNKITFPESKPIPLEEIFPDASPEALD---LLKGLLVYDPSKRL- 274
Query: 948 SHEGANEIKKHPFF 961
A E +HP+F
Sbjct: 275 ---SAAEALRHPYF 285
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 95.4 bits (238), Expect = 1e-21
Identities = 65/231 (28%), Positives = 100/231 (43%), Gaps = 42/231 (18%)
Query: 671 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMK--AMDKGVMLNRNKVHRACAEREILDM 728
+ + I+ +GSG G V+ +G+ A+K ++ G + E +L
Sbjct: 2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPG-----DDFEIIQQEISMLKE 56
Query: 729 LDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLD--RQPTKVLKEDAVRFYAAEVVVA 786
HP + A + S+ + + ++ +YC GG L + R P L E + + E +
Sbjct: 57 CRHPNIVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTRGP---LSELQIAYVCRETLKG 113
Query: 787 LEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQ 846
L YLH G I+RD+K N+LL +G V L DF +S QL T KR
Sbjct: 114 LAYLHETGKIHRDIKGANILLTEDGDVKLADFGVSA------QL---TATIAKR------ 158
Query: 847 NPVFMAEPMRASNSFVGTEEYIAPEIIA---GAGHTSAVDWWALGILLYEM 894
SF+GT ++APE+ A G+ D WALGI E+
Sbjct: 159 ------------KSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIEL 197
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 95.4 bits (237), Expect = 1e-21
Identities = 71/291 (24%), Positives = 129/291 (44%), Gaps = 38/291 (13%)
Query: 674 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREI--LDMLDH 731
+ IK +G G G ++L + ++ +K +D M + K +++E+ L + H
Sbjct: 2 YEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEK---EASKKEVILLAKMKH 58
Query: 732 PFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLH 791
P + +ASFQ + ++ +YC GG+L ++RQ + ED + + ++ + L+++H
Sbjct: 59 PNIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIH 118
Query: 792 CQGIIYRDLKPENVLLQGNGHVS-LTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVF 850
+ I++RD+K +N+ L NG V+ L DF ++
Sbjct: 119 DRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQ--------------------------- 151
Query: 851 MAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTF 910
+ + M + + VGT Y++PEI + + D W+LG +LYE+ PF G +
Sbjct: 152 LNDSMELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLV 211
Query: 911 ANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFF 961
I P S S + L+ +L P+ R I K PF
Sbjct: 212 LKICQGYFA-PISPNFSRDLRSLISQLFKVSPRDR----PSITSILKRPFL 257
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 94.9 bits (237), Expect = 3e-21
Identities = 87/322 (27%), Positives = 133/322 (41%), Gaps = 73/322 (22%)
Query: 674 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAERE---ILDMLD 730
++ IK LG G GSV+L +G+ A+K M K RE + + +
Sbjct: 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKF----YSWEECMNLREVKSLRKLNE 56
Query: 731 HPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYL 790
HP + L F+ + + +Y G L+ L+ + K E +R +++ L ++
Sbjct: 57 HPNIVKLKEVFRENDELYFVFEYMEG-NLYQLMKDRKGKPFSESVIRSIIYQILQGLAHI 115
Query: 791 HCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVF 850
H G +RDLKPEN+L+ G V + DF L+ +P P T+
Sbjct: 116 HKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRP----PYTD-------------- 157
Query: 851 MAEPMRASNSFVGTEEYIAPEII-AGAGHTSAVDWWALGILLYEMLYGYTP-FRGKTR-- 906
+V T Y APEI+ ++S VD WALG ++ E LY P F G +
Sbjct: 158 ----------YVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAE-LYTLRPLFPGSSEID 206
Query: 907 --QKTFANIL----------HKDL------KFPSSTPTSLH---------AKQLMYRLLH 939
K + +L L +FP PTSLH A L+ +L
Sbjct: 207 QLYKICS-VLGTPTKQDWPEGYKLASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLR 265
Query: 940 RDPKSRLGSHEGANEIKKHPFF 961
DPK R A++ +HP+F
Sbjct: 266 WDPKKRP----TASQALQHPYF 283
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 94.9 bits (236), Expect = 3e-21
Identities = 72/288 (25%), Positives = 125/288 (43%), Gaps = 49/288 (17%)
Query: 672 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDH 731
+ I LG+G+ GSV V+ +G A K + G + K + E +I+
Sbjct: 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRK--QILRELQIMHECRS 62
Query: 732 PFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKV--LKEDAVRFYAAEVVVALEY 789
P++ + Y +F + ++C+ ++ G L DR K + + + A VV L Y
Sbjct: 63 PYIVSFYGAFLNENNICMCMEFMDCGSL----DRIYKKGGPIPVEILGKIAVAVVEGLTY 118
Query: 790 LH-CQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNP 848
L+ I++RD+KP N+L+ G + L DF +S +L+ N
Sbjct: 119 LYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVS------GELI---------------NS 157
Query: 849 VFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPF------- 901
+ +++FVGT Y++PE I G +T D W+LGI + E+ G PF
Sbjct: 158 I--------ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDD 209
Query: 902 RGKTRQKTFANILHKDLKFPSST-PTSL---HAKQLMYRLLHRDPKSR 945
G+ ++L + ++ P P+S + + L +DP R
Sbjct: 210 DGQDDPMGILDLLQQIVQEPPPRLPSSDFPEDLRDFVDACLLKDPTER 257
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 93.4 bits (233), Expect = 8e-21
Identities = 74/329 (22%), Positives = 125/329 (37%), Gaps = 83/329 (25%)
Query: 674 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRA------CAEREI-- 725
+ I +G G G V+ +G+ A+K + ++ A REI
Sbjct: 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKI---------RMENEKEGFPITAIREIKL 51
Query: 726 LDMLDHPFVPALY---ASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAE 782
L L HP + L S + + ++ +Y +L LLD K E ++ Y +
Sbjct: 52 LQKLRHPNIVRLKEIVTSKGKGS-IYMVFEYMDH-DLTGLLDSPEVK-FTESQIKCYMKQ 108
Query: 783 VVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRH 842
++ L+YLH GI++RD+K N+L+ +G + L DF L+ R +
Sbjct: 109 LLEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLA------------------RPY 150
Query: 843 KGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGH-TSAVDWWALGILLYEMLYGYTPF 901
+ + + + V T Y PE++ GA VD W++G +L E+ G F
Sbjct: 151 TKRNSADY--------TNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIF 202
Query: 902 RGKTRQKTFANILH-------------------KDLKFPSSTPTSL----------HAKQ 932
+G T + I ++LK L A
Sbjct: 203 QGSTELEQLEKIFELCGSPTDENWPGVSKLPWFENLKPKKPYKRRLREFFKHLIDPSALD 262
Query: 933 LMYRLLHRDPKSRLGSHEGANEIKKHPFF 961
L+ +LL DPK R+ + + H +F
Sbjct: 263 LLDKLLTLDPKKRISADQALQ----HEYF 287
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 93.0 bits (232), Expect = 9e-21
Identities = 65/281 (23%), Positives = 116/281 (41%), Gaps = 43/281 (15%)
Query: 678 KPLGSGDTGSVHLVELCGSGQYF---AMKAMDKGVMLNRNKVHRACAEREILDMLDHPFV 734
K LG G G V+ +L G A+K + + + + E ++ L HP V
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKED--ASEEERKDFLKEARVMKKLGHPNV 58
Query: 735 PALYASFQTKTHVCLITDYCPGGEL--FLLLDRQPTKVLKEDAVRF-----YAAEVVVAL 787
L + + L+ +Y GG+L +L R ++ + +A ++ +
Sbjct: 59 VRLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGM 118
Query: 788 EYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQN 847
EYL + ++RDL N L+ + V ++DF LS + + +++ G+
Sbjct: 119 EYLASKKFVHRDLAARNCLVGEDLVVKISDFGLS--------RDVYDDDYYRKKTGGK-- 168
Query: 848 PVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEML-YGYTPFRGKTR 906
P+R ++APE + TS D W+ G+LL+E+ G TP+ G +
Sbjct: 169 -----LPIR----------WMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSN 213
Query: 907 QKTFANILHKD--LKFPSSTPTSLHAKQLMYRLLHRDPKSR 945
++ + K L P P L+ +LM DP+ R
Sbjct: 214 EEVLEYL-RKGYRLPKPEYCPDELY--ELMLSCWQLDPEDR 251
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 91.9 bits (229), Expect = 3e-20
Identities = 71/325 (21%), Positives = 126/325 (38%), Gaps = 87/325 (26%)
Query: 680 LGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREI-----LDMLDHPFV 734
+G G G+V+ +G++ A+K + V L+ + + REI L+ +HP +
Sbjct: 7 IGEGAYGTVYKARDLNTGRFVALKKVR--VPLSEEGIPLSTL-REIALLKQLESFEHPNI 63
Query: 735 PALYASFQTK-----THVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEY 789
L + L+ ++ +L L + P L + ++ +++ +++
Sbjct: 64 VRLLDVCHGPRTDRELKLTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDF 122
Query: 790 LHCQGIIYRDLKPENVLLQGNGHVSLTDFDL-------SCLTSCKPQLLLPTTNEKKRRH 842
LH I++RDLKP+N+L+ +G V + DF L LTS
Sbjct: 123 LHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMALTSV---------------- 166
Query: 843 KGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTP-F 901
V T Y APE++ + + + VD W++G + E+ + P F
Sbjct: 167 -------------------VVTLWYRAPEVLLQSSYATPVDMWSVGCIFAEL-FRRRPLF 206
Query: 902 RGKTR----QKTF------------ANILHKDLKFPSSTPTSL---------HAKQLMYR 936
RG + K F N+ FPS TP S L+ +
Sbjct: 207 RGTSEADQLDKIFDVIGLPSEEEWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKK 266
Query: 937 LLHRDPKSRLGSHEGANEIKKHPFF 961
+L +P R+ + E HP+F
Sbjct: 267 MLTFNPHKRISAFEALQ----HPYF 287
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 91.6 bits (228), Expect = 3e-20
Identities = 68/248 (27%), Positives = 106/248 (42%), Gaps = 57/248 (22%)
Query: 674 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREI---LDML- 729
F ++ +G G G V+ +GQ A+K MD E EI ++L
Sbjct: 8 FELVEVIGEGTYGKVYKARHKKTGQLVAIKIMD----------IIEDEEEEIKEEYNILR 57
Query: 730 ---DHPFVPALYASFQTKTHVC------LITDYCPGGELFLLLD--RQPTKVLKEDAVRF 778
+HP + Y +F K L+ + C GG + L+ R+ K LKE+ + +
Sbjct: 58 KYSNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAY 117
Query: 779 YAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEK 838
E + L YLH +I+RD+K +N+LL N V L DF +S L +T +
Sbjct: 118 ILRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVSA--------QLDSTLGR 169
Query: 839 KRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIA-----GAGHTSAVDWWALGILLYE 893
+ N+F+GT ++APE+IA A + + D W+LGI E
Sbjct: 170 R-------------------NTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIE 210
Query: 894 MLYGYTPF 901
+ G P
Sbjct: 211 LADGKPPL 218
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 91.2 bits (227), Expect = 5e-20
Identities = 74/281 (26%), Positives = 114/281 (40%), Gaps = 65/281 (23%)
Query: 714 NKVHRACAEREI--LDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVL 771
++ + A RE+ L L H + L +F+ K + L+ +Y L LL+ P L
Sbjct: 40 DEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFEYVER-TLLELLEASPGG-L 97
Query: 772 KEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLL 831
DAVR Y +++ A+ Y H II+RD+KPEN+L+ +G + L DF + +P
Sbjct: 98 PPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPA-- 155
Query: 832 LPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAG-HTSAVDWWALGIL 890
+V T Y APE++ G + VD WA+G +
Sbjct: 156 ------------------------SPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCI 191
Query: 891 LYEMLYGYTPFRGKT------------------RQKTF-ANILHKDLKFPS-STPTSLHA 930
+ E+L G F G + Q+ F +N + FP S P SL
Sbjct: 192 MAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAGVAFPEPSQPESLER 251
Query: 931 K----------QLMYRLLHRDPKSRLGSHEGANEIKKHPFF 961
+ + L DPK RL E+ +HP+F
Sbjct: 252 RYPGKVSSPALDFLKACLRMDPKERLTCD----ELLQHPYF 288
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 88.9 bits (220), Expect = 3e-19
Identities = 78/300 (26%), Positives = 126/300 (42%), Gaps = 51/300 (17%)
Query: 677 IKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPA 736
I LG G G V+ + +G A K ++ + ++ E EIL +HP++
Sbjct: 17 IGELGDGAFGKVYKAKNKETGALAAAKVIETK---SEEELEDYMVEIEILATCNHPYIVK 73
Query: 737 LYASFQTKTHVCLITDYCPGGE---LFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQ 793
L +F + ++ ++CPGG + L LDR L E ++ +++ AL+YLH
Sbjct: 74 LLGAFYWDGKLWIMIEFCPGGAVDAIMLELDRG----LTEPQIQVICRQMLEALQYLHSM 129
Query: 794 GIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAE 853
II+RDLK NVLL +G + L DF +S +RR
Sbjct: 130 KIIHRDLKAGNVLLTLDGDIKLADFGVSA----------KNVKTLQRR------------ 167
Query: 854 PMRASNSFVGTEEYIAPEII-----AGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQK 908
+SF+GT ++APE++ + D W+LGI L EM P +
Sbjct: 168 -----DSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMR 222
Query: 909 TFANILHKD---LKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVN 965
I + L PS S+ + + L + P++R A ++ +HPF V
Sbjct: 223 VLLKIAKSEPPTLSQPSK--WSMEFRDFLKTALDKHPETR----PSAAQLLEHPFVSSVT 276
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 87.8 bits (217), Expect = 5e-19
Identities = 66/235 (28%), Positives = 106/235 (45%), Gaps = 29/235 (12%)
Query: 671 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLD 730
L +FR K +G G V+ G A+K + +++ E ++L L+
Sbjct: 1 LANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLN 60
Query: 731 HPFVPALYASFQTKTHVCLITDYCPGGELFLLLD--RQPTKVLKEDAVRFYAAEVVVALE 788
HP V YASF + ++ + G+L ++ ++ +++ E V Y ++ ALE
Sbjct: 61 HPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALE 120
Query: 789 YLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNP 848
++H + +++RD+KP NV + G V L D L S K TT
Sbjct: 121 HMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSK------TT------------- 161
Query: 849 VFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRG 903
A++S VGT Y++PE I G+ D W+LG LLYEM +PF G
Sbjct: 162 --------AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYG 208
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 87.2 bits (216), Expect = 1e-18
Identities = 83/298 (27%), Positives = 129/298 (43%), Gaps = 55/298 (18%)
Query: 680 LGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYA 739
LG G+ GSV+ V +G AMK + + L+ +K ++ E +IL P++ Y
Sbjct: 9 LGKGNYGSVYKVLHRPTGVTMAMKEIR--LELDESKFNQIIMELDILHKAVSPYIVDFYG 66
Query: 740 SFQTKTHVCLITDYCPGGELFLLLD-RQPTKVLKEDAVRFYAAEVVVALEYLHCQ-GIIY 797
+F + V + +Y G L L T+ + ED +R VV L++L + II+
Sbjct: 67 AFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIH 126
Query: 798 RDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLL--LPTTNEKKRRHKGQQNPVFMAEPM 855
RD+KP NVL+ GNG V L DF +S L+ L TN
Sbjct: 127 RDVKPTNVLVNGNGQVKLCDFGVS------GNLVASLAKTN------------------- 161
Query: 856 RASNSFVGTEEYIAPEIIAGAG------HTSAVDWWALGILLYEMLYGYTPFRGKTRQKT 909
+G + Y+APE I G +T D W+LG+ + EM G P+ +T
Sbjct: 162 ------IGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANI 215
Query: 910 FAN---ILHKDLKFPSSTPT--SLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFK 962
FA I+ D P + P+ S A+ + + L++ P R + HP+
Sbjct: 216 FAQLSAIVDGD---PPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLE----HPWLV 266
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 87.0 bits (215), Expect = 1e-18
Identities = 84/329 (25%), Positives = 139/329 (42%), Gaps = 56/329 (17%)
Query: 658 AIQKILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVH 717
A+Q ++ G+ ++ +G G TG V + +G+ A+K MD R +
Sbjct: 10 ALQLVVSPGDP--REYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDL-----RKQQR 62
Query: 718 RACAEREILDMLD--HPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDA 775
R E++ M D H V +Y S+ + ++ ++ GG L D + E+
Sbjct: 63 RELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGAL---TDIVTHTRMNEEQ 119
Query: 776 VRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTT 835
+ V+ AL YLH QG+I+RD+K +++LL +G + L+DF S
Sbjct: 120 IATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVS---------- 169
Query: 836 NEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEML 895
E +R S VGT ++APE+I+ + + VD W+LGI++ EM+
Sbjct: 170 KEVPKR-----------------KSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMI 212
Query: 896 YGYTPFRGKTRQKTFANI---LHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGA 952
G P+ + + I L +K + L + +L R+P R A
Sbjct: 213 DGEPPYFNEPPLQAMRRIRDNLPPRVKDSHKVSSVLRG--FLDLMLVREPSQR----ATA 266
Query: 953 NEIKKHPFFKGVNWALVRCMNPPELDAPL 981
E+ +HPF K PP PL
Sbjct: 267 QELLQHPFLK--------LAGPPSCIVPL 287
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 85.6 bits (212), Expect = 3e-18
Identities = 70/286 (24%), Positives = 114/286 (39%), Gaps = 32/286 (11%)
Query: 678 KPLGSGDTGSVHLVELCGSGQYFAMKAM--DKGVMLNRNKVHRACAEREILDMLDHPFVP 735
K LG G G V+L +G+ A+K + D + +V+ E ++L L H +
Sbjct: 8 KLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIV 67
Query: 736 ALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGI 795
Y + + + +Y PGG + L + L E R Y +++ +EYLH I
Sbjct: 68 QYYGCLRDDETLSIFMEYMPGGSVKDQL--KAYGALTETVTRKYTRQILEGVEYLHSNMI 125
Query: 796 IYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPM 855
++RD+K N+L G+V L DF S KR + M
Sbjct: 126 VHRDIKGANILRDSAGNVKLGDFGAS-----------------KRLQTICSSGTGM---- 164
Query: 856 RASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANILH 915
S GT +++PE+I+G G+ D W++G + EML P+ I
Sbjct: 165 ---KSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIAT 221
Query: 916 KDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFF 961
+ + S A+ + R + K R A E+ +H F
Sbjct: 222 QPTNPQLPSHVSPDARNFLRRTFVENAKKR----PSAEELLRHFFV 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 85.4 bits (211), Expect = 3e-18
Identities = 70/272 (25%), Positives = 123/272 (45%), Gaps = 34/272 (12%)
Query: 677 IKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAERE--ILDMLDHPFV 734
++ +G G G V LV G+ + +K ++ + N ++ R AE+E +L L HP +
Sbjct: 5 VRVVGKGSYGEVSLVRHRTDGKQYVIKKLN---LRNASRRERKAAEQEAQLLSQLKHPNI 61
Query: 735 PALYASFQTKTHVCLIT-DYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQ 793
A S++ + + I +C GG+L+ L Q K+L E+ V + ++ +AL+YLH +
Sbjct: 62 VAYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEK 121
Query: 794 GIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAE 853
I++RDLK +NV L + + D ++ + +N MA
Sbjct: 122 HILHRDLKTQNVFLTRTNIIKVGDLGIA---------------------RVLENQCDMA- 159
Query: 854 PMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANI 913
++ +GT Y++PE+ + + D WALG +YEM F K I
Sbjct: 160 -----STLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRI 214
Query: 914 LHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSR 945
+ L P S +L+ +L + P+ R
Sbjct: 215 IEGKLP-PMPKDYSPELGELIATMLSKRPEKR 245
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 86.1 bits (214), Expect = 3e-18
Identities = 83/327 (25%), Positives = 129/327 (39%), Gaps = 80/327 (24%)
Query: 674 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNK-VHRACAEREI--LDMLD 730
+ K LG G V+ +G+ A+K + G ++ A REI L L
Sbjct: 2 YEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFT-ALREIKLLQELK 60
Query: 731 HPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEV------- 783
HP + L F K+++ L+ ++ D + KV+K+ ++ A++
Sbjct: 61 HPNIIGLLDVFGHKSNINLVFEFMET-------DLE--KVIKDKSIVLTPADIKSYMLMT 111
Query: 784 VVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHK 843
+ LEYLH I++RDLKP N+L+ +G + L DF L+
Sbjct: 112 LRGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLAR--------------------- 150
Query: 844 GQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGH-TSAVDWWALGILLYEMLYGYTPF- 901
P R V T Y APE++ GA H VD W++G + E+L PF
Sbjct: 151 ------SFGSPNRKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLR-VPFL 203
Query: 902 RGKT--RQ--KTFANI-------------LHKDLKFPSSTPTSLH---------AKQLMY 935
G + Q K F + L ++F PT L A L+
Sbjct: 204 PGDSDIDQLGKIFEALGTPTEENWPGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQ 263
Query: 936 RLLHRDPKSRLGSHEGANEIKKHPFFK 962
RLL +P R+ A + +HP+F
Sbjct: 264 RLLTLNPNKRI----TARQALEHPYFS 286
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 85.7 bits (212), Expect = 3e-18
Identities = 76/298 (25%), Positives = 126/298 (42%), Gaps = 58/298 (19%)
Query: 680 LGSGDTGSVHLVELCGSGQYFAMKA--MDKGVMLNRNKVHRACAEREILDMLDHPFVPAL 737
LG G+ G+V+ + + A+K +D V L + + +E EIL D P++
Sbjct: 9 LGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIM----SELEILYKCDSPYIIGF 64
Query: 738 YASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIY 797
Y +F + + + T++ GG L + + P VL AV VV L YL I++
Sbjct: 65 YGAFFVENRISICTEFMDGGSLDVY-RKIPEHVLGRIAV-----AVVKGLTYLWSLKILH 118
Query: 798 RDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRA 857
RD+KP N+L+ G V L DF +S QL+ N +
Sbjct: 119 RDVKPSNMLVNTRGQVKLCDFGVS------TQLV---------------NSI-------- 149
Query: 858 SNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTF------- 910
+ ++VGT Y+APE I+G + D W+LGI E+ G P+ + +
Sbjct: 150 AKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLL 209
Query: 911 ANILHKDLKFPSSTPTSLHAKQLMY---RLLHRDPKSRLGSHEGANEIKKHPFFKGVN 965
I+ +D P P +++ ++ + + + PK R + HPF N
Sbjct: 210 QCIVDED---PPVLPVGQFSEKFVHFITQCMRKQPKERP----APENLMDHPFIVQYN 260
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 85.6 bits (212), Expect = 4e-18
Identities = 70/236 (29%), Positives = 98/236 (41%), Gaps = 55/236 (23%)
Query: 680 LGSGDTGSVHLVELCGSGQYFAMKAM--DKGVMLNRNKVHRACAEREILDMLDHPFVPAL 737
LG G GSV L +G FA+K + D L + + E EI P++
Sbjct: 9 LGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILR----ELEINKSCKSPYIVKY 64
Query: 738 YASF--QTKTHVCLITDYCPGGELFLLLDRQPTKVLK------EDAVRFYAAEVVVALEY 789
Y +F ++ + + + +YC GG L D KV K E + A V+ L Y
Sbjct: 65 YGAFLDESSSSIGIAMEYCEGGSL----DSIYKKVKKRGGRIGEKVLGKIAESVLKGLSY 120
Query: 790 LHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPV 849
LH + II+RD+KP N+LL G V L DF +S G+
Sbjct: 121 LHSRKIIHRDIKPSNILLTRKGQVKLCDFGVS----------------------GE---- 154
Query: 850 FMAEPMRASNS----FVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPF 901
NS F GT Y+APE I G ++ D W+LG+ L E+ PF
Sbjct: 155 -------LVNSLAGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPF 203
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 85.7 bits (212), Expect = 5e-18
Identities = 74/296 (25%), Positives = 126/296 (42%), Gaps = 50/296 (16%)
Query: 674 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMD------KGVMLNRNKVHRACAEREILD 727
+ + +G G +G+V+ +GQ A+K M+ K +++N V R I++
Sbjct: 21 YTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVN 80
Query: 728 MLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVAL 787
LD S+ + ++ +Y GG L D + E + E + AL
Sbjct: 81 YLD---------SYLVGDELWVVMEYLAGGSL---TDVVTETCMDEGQIAAVCRECLQAL 128
Query: 788 EYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQN 847
E+LH +I+RD+K +N+LL +G V LTDF C T E+ +R
Sbjct: 129 EFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGF-CAQ---------ITPEQSKR------ 172
Query: 848 PVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQ 907
++ VGT ++APE++ + VD W+LGI+ EM+ G P+ +
Sbjct: 173 -----------STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPL 221
Query: 908 KTFANI-LHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFK 962
+ I + + + S + + R L D + R A E+ +HPF K
Sbjct: 222 RALYLIATNGTPELQNPEKLSAIFRDFLNRCLEMDVEKRG----SAKELLQHPFLK 273
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 88.2 bits (218), Expect = 5e-18
Identities = 87/342 (25%), Positives = 152/342 (44%), Gaps = 50/342 (14%)
Query: 615 TAENVNEAVKELPDANLTPEDLWANHSKVVHPKPHRK--DSPPWKAIQKILDSGEQINLQ 672
+AE +N+ K P T E+ + + + P+ ++K D P + + + + E
Sbjct: 12 SAELLNQYAKYFPHVLFTSEEAFEKYCADLDPEAYKKCVDLPEGEEVPESNNPRE----- 66
Query: 673 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNK-VHRACAEREILDMLDH 731
H + L + + V GS K + K VMLN + A +E L DH
Sbjct: 67 HMYVLTTLVGRNPTTAAFVATRGSDP--KEKVVAKFVMLNDERQAAYARSELHCLAACDH 124
Query: 732 PFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKED--------AVRFYAAEV 783
+ + F++ + LI +Y GG+L ++Q + LKE + FY ++
Sbjct: 125 FGIVKHFDDFKSDDKLLLIMEYGSGGDL----NKQIKQRLKEHLPFQEYEVGLLFY--QI 178
Query: 784 VVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHK 843
V+AL+ +H + +++RDLK N+ L G + L DF S K
Sbjct: 179 VLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFS---------------------K 217
Query: 844 GQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRG 903
+ V + ++SF GT Y+APE+ ++ D W+LG++LYE+L + PF+G
Sbjct: 218 QYSDSV----SLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKG 273
Query: 904 KTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSR 945
++++ +L+ P P S K L+ LL ++P R
Sbjct: 274 PSQREIMQQVLYGKYD-PFPCPVSSGMKALLDPLLSKNPALR 314
|
Length = 478 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 86.2 bits (214), Expect = 5e-18
Identities = 79/334 (23%), Positives = 132/334 (39%), Gaps = 89/334 (26%)
Query: 672 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVH--RACAEREILDML 729
++ + P+GSG G V +G+ A+K + + ++ +H R E +L +
Sbjct: 15 DRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPF---QSAIHAKRTYRELRLLKHM 71
Query: 730 DHP--------FVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAA 781
DH F PA +S + V L+T G +L ++ Q L +D ++F
Sbjct: 72 DHENVIGLLDVFTPA--SSLEDFQDVYLVTHLM-GADLNNIVKCQ---KLSDDHIQFLVY 125
Query: 782 EVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRR 841
+++ L+Y+H GII+RDLKP N+ + + + + DF L+ R
Sbjct: 126 QILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLA-------------------R 166
Query: 842 HKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGH-TSAVDWWALGILLYEMLYGYTP 900
H + M +V T Y APEI+ H VD W++G ++ E+L G T
Sbjct: 167 HT--------DDEM---TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTL 215
Query: 901 FRG------------------------------KTRQKTFANILHKDLK--FPSSTPTSL 928
F G + ++ + KD K F + P
Sbjct: 216 FPGSDHIDQLKRIMNLVGTPDEELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPL-- 273
Query: 929 HAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFK 962
A L+ ++L DP R+ A E HP+
Sbjct: 274 -AIDLLEKMLVLDPDKRI----TAAEALAHPYLA 302
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 83.7 bits (207), Expect = 1e-17
Identities = 76/298 (25%), Positives = 129/298 (43%), Gaps = 52/298 (17%)
Query: 680 LGSGDTGSVHLVELCGSGQYFAMK-------AMDKGVMLNRNKVHRACAEREILDMLDHP 732
+G G G V+L +G+ A+K + ++ V +E E L LDH
Sbjct: 9 IGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHL 68
Query: 733 FVPALYASFQTK-THVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLH 791
+ Y F+T ++ + +Y PGG + L R + +E VRF+ +V+ L YLH
Sbjct: 69 NIVQ-YLGFETTEEYLSIFLEYVPGGSIGSCL-RTYGR-FEEQLVRFFTEQVLEGLAYLH 125
Query: 792 CQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFM 851
+GI++RDLK +N+L+ +G ++DF +S K+ N
Sbjct: 126 SKGILHRDLKADNLLVDADGICKISDFGIS-----------------KKSDDIYDN---- 164
Query: 852 AEPMRASNSFVGTEEYIAPEII--AGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKT 909
+ S G+ ++APE+I G+++ VD W+LG ++ EM G P+ + ++
Sbjct: 165 ----DQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPW---SDEEA 217
Query: 910 FANI--LHKDLKFPSSTP-----TSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPF 960
A + L P P S A + +P +R A E+ +HPF
Sbjct: 218 IAAMFKLGNKRSAPPIPPDVSMNLSPVALDFLNACFTINPDNR----PTARELLQHPF 271
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 82.9 bits (205), Expect = 4e-17
Identities = 65/232 (28%), Positives = 106/232 (45%), Gaps = 42/232 (18%)
Query: 674 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLN-RNKVHRACAEREILDMLDHP 732
F + LG+G+ G V V SG A K + + RN++ R E ++L + P
Sbjct: 3 FEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIR---ELKVLHECNSP 59
Query: 733 FVPALYASFQTKTHVCLITDYCPGGELFLLLD---RQPTKVLKEDAVRFYAAEVVVALEY 789
++ Y +F + + + ++ GG L +L R P +L + ++ V+ L Y
Sbjct: 60 YIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPENILGKISI-----AVLRGLTY 114
Query: 790 LHCQ-GIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNP 848
L + I++RD+KP N+L+ G + L DF +S GQ
Sbjct: 115 LREKHKIMHRDVKPSNILVNSRGEIKLCDFGVS----------------------GQ--- 149
Query: 849 VFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTP 900
+ + M +NSFVGT Y++PE + G +T D W+LG+ L EM G P
Sbjct: 150 --LIDSM--ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYP 197
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 82.0 bits (202), Expect = 6e-17
Identities = 78/293 (26%), Positives = 126/293 (43%), Gaps = 49/293 (16%)
Query: 674 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPF 733
F ++ +G G G V+ + + A+K +D + +++ E +L D P+
Sbjct: 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIID--LEEAEDEIEDIQQEITVLSQCDSPY 63
Query: 734 VPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQ 793
+ Y S+ T + +I +Y GG LL P L+E + E++ L+YLH +
Sbjct: 64 ITRYYGSYLKGTKLWIIMEYLGGGSALDLLKPGP---LEETYIATILREILKGLDYLHSE 120
Query: 794 GIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAE 853
I+RD+K NVLL G V L DF ++ QL T + KR
Sbjct: 121 RKIHRDIKAANVLLSEQGDVKLADFGVA------GQL---TDTQIKR------------- 158
Query: 854 PMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANI 913
N+FVGT ++APE+I + + D W+LGI E+ G P + I
Sbjct: 159 -----NTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLI 213
Query: 914 LHKDLKFPSSTPTSLHA------KQLMYRLLHRDPKSRLGSHEGANEIKKHPF 960
P ++P +L K+ + L++DP+ R A E+ KH F
Sbjct: 214 -------PKNSPPTLEGQYSKPFKEFVEACLNKDPRFR----PTAKELLKHKF 255
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 81.7 bits (201), Expect = 7e-17
Identities = 72/245 (29%), Positives = 106/245 (43%), Gaps = 47/245 (19%)
Query: 722 EREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAA 781
E +L D P+V Y S+ T + +I +Y GG LL+ P L E +
Sbjct: 52 EITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGP---LDETQIATILR 108
Query: 782 EVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRR 841
E++ L+YLH + I+RD+K NVLL +G V L DF ++ QL T + KR
Sbjct: 109 EILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVA------GQL---TDTQIKR- 158
Query: 842 HKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPF 901
N+FVGT ++APE+I + + S D W+LGI E+ G P
Sbjct: 159 -----------------NTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPH 201
Query: 902 RGKTRQKTFANILHKDLKFPSSTPTSLHA------KQLMYRLLHRDPKSRLGSHEGANEI 955
K I P + P +L K+ + L+++P R A E+
Sbjct: 202 SELHPMKVLFLI-------PKNNPPTLEGNYSKPLKEFVEACLNKEPSFR----PTAKEL 250
Query: 956 KKHPF 960
KH F
Sbjct: 251 LKHKF 255
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 81.3 bits (200), Expect = 1e-16
Identities = 79/300 (26%), Positives = 128/300 (42%), Gaps = 52/300 (17%)
Query: 672 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLD- 730
+ F I+ +GSG G V+ +G+ A+K V+ A ++EI+ M D
Sbjct: 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIK-----VIKLEPGEDFAVVQQEIIMMKDC 63
Query: 731 -HPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEY 789
H + A + S+ + + + ++C GG L + T L E + + + E + L Y
Sbjct: 64 KHSNIVAYFGSYLRRDKLWICMEFCGGGSLQDIY--HVTGPLSESQIAYVSRETLQGLYY 121
Query: 790 LHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPV 849
LH +G ++RD+K N+LL NGHV L DF +S + T K++
Sbjct: 122 LHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQIT--------ATIAKRK--------- 164
Query: 850 FMAEPMRASNSFVGTEEYIAPEIIA---GAGHTSAVDWWALGILLYEM------LYGYTP 900
SF+GT ++APE+ A G+ D WA+GI E+ ++ P
Sbjct: 165 ----------SFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHP 214
Query: 901 FRGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPF 960
R T +N LK S H + L ++PK R A ++ +HPF
Sbjct: 215 MRALFLM-TKSNFQPPKLKDKMKWSNSFH--HFVKMALTKNPKKR----PTAEKLLQHPF 267
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 80.8 bits (199), Expect = 1e-16
Identities = 62/235 (26%), Positives = 104/235 (44%), Gaps = 29/235 (12%)
Query: 671 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLD 730
L +F+ K +G G V+ + A+K + M++ E ++L L+
Sbjct: 1 LANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLN 60
Query: 731 HPFVPALYASFQTKTHVCLITDYCPGGELFLLLD--RQPTKVLKEDAVRFYAAEVVVALE 788
HP V SF + ++ + G+L ++ ++ +++ E V Y ++ A+E
Sbjct: 61 HPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVE 120
Query: 789 YLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNP 848
++H + +++RD+KP NV + G V L D L S K TT
Sbjct: 121 HMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSK------TT------------- 161
Query: 849 VFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRG 903
A++S VGT Y++PE I G+ D W+LG LLYEM +PF G
Sbjct: 162 --------AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYG 208
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 81.2 bits (201), Expect = 2e-16
Identities = 76/326 (23%), Positives = 128/326 (39%), Gaps = 69/326 (21%)
Query: 674 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKG--VMLNRNKVHRACAEREILDMLDH 731
++PI+ +GSG G V SG+ A+K + V + R E +IL H
Sbjct: 7 YKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLR---ELKILRHFKH 63
Query: 732 PFVPALYASFQTK----THVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVAL 787
+ A+ + V ++ D ++ QP L E+ +R++ +++ L
Sbjct: 64 DNIIAIRDILRPPGADFKDVYVVMDLMESDLHHIIHSDQP---LTEEHIRYFLYQLLRGL 120
Query: 788 EYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQN 847
+Y+H +I+RDLKP N+L+ + + + DF ++ S P E K
Sbjct: 121 KYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPT-------EHKY------- 166
Query: 848 PVFMAEPMRASNSFVGTEEYIAPEII-AGAGHTSAVDWWALGILLYEMLYGYTPFRGKTR 906
FM E +V T Y APE++ + +T+A+D W++G + EML F GK
Sbjct: 167 --FMTE-------YVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNY 217
Query: 907 QKTFANIL-------HKDLK-------------FPSSTPTSLH---------AKQLMYRL 937
IL + L P P A L+ ++
Sbjct: 218 VHQLKLILSVLGSPSEEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQM 277
Query: 938 LHRDPKSRLGSHEGANEIKKHPFFKG 963
L DP+ R+ + +HPF
Sbjct: 278 LQFDPEERI----TVEQALQHPFLAQ 299
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 80.1 bits (197), Expect = 2e-16
Identities = 72/242 (29%), Positives = 102/242 (42%), Gaps = 41/242 (16%)
Query: 722 EREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAA 781
E +L D P+V Y S+ T + +I +Y GG LL P E +
Sbjct: 52 EITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYLGGGSALDLLRAGP---FDEFQIATMLK 108
Query: 782 EVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRR 841
E++ L+YLH + I+RD+K NVLL G V L DF ++ QL T + KR
Sbjct: 109 EILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVA------GQL---TDTQIKR- 158
Query: 842 HKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPF 901
N+FVGT ++APE+I + + S D W+LGI E+ G P
Sbjct: 159 -----------------NTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPN 201
Query: 902 RGKTRQKTFANILHKDLKFPSSTPT---SLHAKQLMYRLLHRDPKSRLGSHEGANEIKKH 958
+ I K T T S K+ + L++DP R A E+ KH
Sbjct: 202 SDMHPMRVLFLI----PKNNPPTLTGEFSKPFKEFIDACLNKDPSFR----PTAKELLKH 253
Query: 959 PF 960
F
Sbjct: 254 KF 255
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 80.3 bits (199), Expect = 4e-16
Identities = 60/224 (26%), Positives = 93/224 (41%), Gaps = 56/224 (25%)
Query: 769 KVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKP 828
+L++ R+ +++ AL+Y+H +I+RDLKP N+LL + V L DF L+ S
Sbjct: 102 NILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELE 161
Query: 829 QLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGH-TSAVDWWAL 887
+ +NPV + + +V T Y APEI+ G+ T VD W++
Sbjct: 162 E--------------NPENPV-LTD-------YVATRWYRAPEILLGSTRYTKGVDMWSV 199
Query: 888 GILLYEMLYGYTPFRGKTRQKTFANIL-------HKDL-------------KFPSSTPTS 927
G +L EML G F G + I+ +D+ PS
Sbjct: 200 GCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIESIKSPFAATMLDSLPSRPRKP 259
Query: 928 LH---------AKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFK 962
L A L+ +LL +P RL A E +HP+
Sbjct: 260 LDELLPKASDDALDLLKKLLVFNPNKRL----TAEEALEHPYVA 299
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 4e-16
Identities = 66/240 (27%), Positives = 105/240 (43%), Gaps = 43/240 (17%)
Query: 674 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPF 733
F ++ +G+G G V+ +GQ A+K MD + ++ E +L H
Sbjct: 18 FELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMD----VTEDEEEEIKLEINMLKKYSHHR 73
Query: 734 -VPALYASFQTKT------HVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVA 786
+ Y +F K+ + L+ ++C G + L+ LKED + + E++
Sbjct: 74 NIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRG 133
Query: 787 LEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQ 846
L +LH +I+RD+K +NVLL N V L DF +S QL R G++
Sbjct: 134 LAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSA------QL---------DRTVGRR 178
Query: 847 NPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAV-----DWWALGILLYEMLYGYTPF 901
N+F+GT ++APE+IA + A D W+LGI EM G P
Sbjct: 179 ------------NTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPL 226
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 79.4 bits (195), Expect = 5e-16
Identities = 75/291 (25%), Positives = 125/291 (42%), Gaps = 52/291 (17%)
Query: 680 LGSGDTGSVHLVELCGSGQYFAMKAMD------KGVMLNRNKVHRACAEREILDMLDHPF 733
+G G +G+V+ +GQ A+K M+ K +++N V R I++ LD
Sbjct: 27 IGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLD--- 83
Query: 734 VPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQ 793
S+ + ++ +Y GG L D + E + E + AL++LH
Sbjct: 84 ------SYLVGDELWVVMEYLAGGSL---TDVVTETCMDEGQIAAVCRECLQALDFLHSN 134
Query: 794 GIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAE 853
+I+RD+K +N+LL +G V LTDF T E+ +R
Sbjct: 135 QVIHRDIKSDNILLGMDGSVKLTDFGFCA----------QITPEQSKR------------ 172
Query: 854 PMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANI 913
++ VGT ++APE++ + VD W+LGI+ EM+ G P+ + + +
Sbjct: 173 -----STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY-L 226
Query: 914 LHKDLKFPSSTPTSLHA--KQLMYRLLHRDPKSRLGSHEGANEIKKHPFFK 962
+ + P L A + + R L D R GS A E+ +HPF K
Sbjct: 227 IATNGTPELQNPERLSAVFRDFLNRCLEMDVDRR-GS---AKELLQHPFLK 273
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 80.3 bits (198), Expect = 6e-16
Identities = 82/329 (24%), Positives = 137/329 (41%), Gaps = 60/329 (18%)
Query: 646 PKPHRKDSPPWKAIQKILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAM 705
P P S + +L + +GSG G+V+ V +G+ +A+K +
Sbjct: 48 PPPSSSSSSSSSSSASGSAPSAAKSLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVI 107
Query: 706 ----DKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFL 761
+ V R ++ C E EIL ++HP V + F + ++ ++ GG L
Sbjct: 108 YGNHEDTV---RRQI---CREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSL-- 159
Query: 762 LLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLS 821
+ T + E + A +++ + YLH + I++RD+KP N+L+ +V + DF +S
Sbjct: 160 ----EGTHIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVS 215
Query: 822 CLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEII-----AGA 876
+ +A+ M NS VGT Y++PE I GA
Sbjct: 216 RI---------------------------LAQTMDPCNSSVGTIAYMSPERINTDLNHGA 248
Query: 877 GHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFAN----ILHKDLKFPSSTPT-SLHAK 931
A D W+LG+ + E G PF G RQ +A+ I P + T S +
Sbjct: 249 YDGYAGDIWSLGVSILEFYLGRFPF-GVGRQGDWASLMCAICMSQP--PEAPATASREFR 305
Query: 932 QLMYRLLHRDPKSRLGSHEGANEIKKHPF 960
+ L R+P R A ++ +HPF
Sbjct: 306 HFISCCLQREPAKRW----SAMQLLQHPF 330
|
Length = 353 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 78.6 bits (194), Expect = 8e-16
Identities = 80/319 (25%), Positives = 126/319 (39%), Gaps = 72/319 (22%)
Query: 677 IKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREI--LDMLDHPFV 734
+ +G G G V +GQ A+K K V + V + A REI L L HP +
Sbjct: 6 LSKIGEGSYGVVFKCRNRETGQIVAIK---KFVESEDDPVIKKIALREIRMLKQLKHPNL 62
Query: 735 PALYASFQTKTHVCLITDYCPGGELFLL--LDRQPTKVLKEDAVRFYAAEVVVALEYLHC 792
L F+ K + L+ +YC + +L L++ P V E ++ + + A+ + H
Sbjct: 63 VNLIEVFRRKRKLHLVFEYC---DHTVLNELEKNPRGV-PEHLIKKIIWQTLQAVNFCHK 118
Query: 793 QGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMA 852
I+RD+KPEN+L+ G + L DF + ++L
Sbjct: 119 HNCIHRDVKPENILITKQGQIKLCDFGFA-------RILTG------------------- 152
Query: 853 EPMRASNSFVGTEEYIAPEIIAG-AGHTSAVDWWALGILLYEMLYGYTPFRGKTR----- 906
P +V T Y APE++ G + VD WA+G + E+L G + GK+
Sbjct: 153 -PGDDYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLY 211
Query: 907 --QKTFANIL--H----------KDLKFPSSTP----------TSLHAKQLMYRLLHRDP 942
+KT +++ H K L P S A + L DP
Sbjct: 212 LIRKTLGDLIPRHQQIFSTNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDP 271
Query: 943 KSRLGSHEGANEIKKHPFF 961
RL E+ +HP+F
Sbjct: 272 TERLSC----EELLEHPYF 286
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 78.4 bits (193), Expect = 8e-16
Identities = 70/285 (24%), Positives = 114/285 (40%), Gaps = 32/285 (11%)
Query: 680 LGSGDTGSVHLVELCGSGQYFAMK--AMDKGVMLNRNKVHRACAER-EILDMLDHPFVPA 736
LG G G+V+ L GQ A+K +D +L K + E ++L L H +
Sbjct: 8 LGKGAYGTVYC-GLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQ 66
Query: 737 LYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGII 796
+ + + ++ PGG + +L+R L E Y +++ + YLH ++
Sbjct: 67 YLGTCLDDNTISIFMEFVPGGSISSILNR--FGPLPEPVFCKYTKQILDGVAYLHNNCVV 124
Query: 797 YRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMR 856
+RD+K NV+L NG + L DF C +L + M + M
Sbjct: 125 HRDIKGNNVMLMPNGIIKLIDF------GCARRLAWVGLHGTHSN---------MLKSMH 169
Query: 857 ASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTR-QKTFANILH 915
GT ++APE+I +G+ D W++G ++EM G P R F H
Sbjct: 170 ------GTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAH 223
Query: 916 KDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPF 960
+ L S A + L RD R A ++ +H F
Sbjct: 224 RGLMPRLPDSFSAAAIDFVTSCLTRDQHER----PSALQLLRHDF 264
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 81.1 bits (200), Expect = 9e-16
Identities = 81/287 (28%), Positives = 127/287 (44%), Gaps = 53/287 (18%)
Query: 680 LGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYA 739
LGSG TG+V + G+ FA+K +D M + +RA AE L D + +
Sbjct: 40 LGSGATGTVLCAKRVSDGEPFAVKVVDMEGM-SEADKNRAQAEVCCLLNCDFFSIVKCHE 98
Query: 740 SFQTK--------THVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAE-------VV 784
F K + L+ DY G+L RQ K + F E V+
Sbjct: 99 DFAKKDPRNPENVLMIALVLDYANAGDL-----RQEIKSRAKTNRTFREHEAGLLFIQVL 153
Query: 785 VALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKG 844
+A+ ++H + +I+RD+K N+LL NG V L DF S + + T ++ R
Sbjct: 154 LAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAA-------TVSDDVGR--- 203
Query: 845 QQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGK 904
+F GT Y+APEI ++ D ++LG+LLYE+L PF G+
Sbjct: 204 ---------------TFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGE 248
Query: 905 TRQKTFANILHKDL--KF-PSSTPTSLHAKQLMYRLLHRDPKSRLGS 948
++ ++HK L ++ P S ++++ LL DPK R S
Sbjct: 249 NMEE----VMHKTLAGRYDPLPPSISPEMQEIVTALLSSDPKRRPSS 291
|
Length = 496 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 78.4 bits (193), Expect = 1e-15
Identities = 65/290 (22%), Positives = 116/290 (40%), Gaps = 36/290 (12%)
Query: 680 LGSGDTGSVHLVELCGSGQYFAMKAMD--KGVMLNRNKVHRAC-AEREILDMLDHPFVPA 736
LG+G S + +G A+K + + + +V A E ++ L+HP +
Sbjct: 8 LGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIR 67
Query: 737 LYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGII 796
+ + +H L ++ GG + LL + KE + Y +++ L YLH II
Sbjct: 68 MLGATCEDSHFNLFVEWMAGGSVSHLLSK--YGAFKEAVIINYTEQLLRGLSYLHENQII 125
Query: 797 YRDLKPENVLLQGNGH-VSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPM 855
+RD+K N+L+ G + + DF + + L +GQ
Sbjct: 126 HRDVKGANLLIDSTGQRLRIADFG----AAAR----LAAKGTGAGEFQGQ---------- 167
Query: 856 RASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANILH 915
+GT ++APE++ G + + D W++G ++ EM P+ + A I
Sbjct: 168 -----LLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFK 222
Query: 916 -KDLKFPSSTPTSLH--AKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFK 962
S P L + + R L P+ R + E+ KHP F+
Sbjct: 223 IASATTAPSIPEHLSPGLRDVTLRCLELQPEDR----PPSRELLKHPVFR 268
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 77.7 bits (192), Expect = 2e-15
Identities = 74/329 (22%), Positives = 126/329 (38%), Gaps = 88/329 (26%)
Query: 674 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDML---D 730
++ + +G G V + +G+Y+A+K M K + + + REI +
Sbjct: 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKK----HFKSLEQVNNLREIQALRRLSP 56
Query: 731 HPFVPALYASFQTKTHVCLITDYCPGGELFLLLD----------RQPTKVLKEDAVRFYA 780
HP + L + L +F L+D ++P L E V+ Y
Sbjct: 57 HPNILRLIEVLFDRKTGRLAL-------VFELMDMNLYELIKGRKRP---LPEKRVKSYM 106
Query: 781 AEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKR 840
+++ +L+++H GI +RD+KPEN+L++ + + L DF KP P T
Sbjct: 107 YQLLKSLDHMHRNGIFHRDIKPENILIKDD-ILKLADFGSCRGIYSKP----PYT----- 156
Query: 841 RHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAG-HTSAVDWWALGILLYEMLYGYT 899
++ T Y APE + G + +D WA+G + +E+L +
Sbjct: 157 -------------------EYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFP 197
Query: 900 PFRGKTR------------------QKTFANILHKDLKFPSSTPTSL-----HAKQ---- 932
F G K F H + FPS T L +A
Sbjct: 198 LFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMNYNFPSKKGTGLRKLLPNASAEGLD 257
Query: 933 LMYRLLHRDPKSRLGSHEGANEIKKHPFF 961
L+ +LL DP R+ + + HP+F
Sbjct: 258 LLKKLLAYDPDERITAKQALR----HPYF 282
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 78.2 bits (193), Expect = 3e-15
Identities = 84/356 (23%), Positives = 135/356 (37%), Gaps = 79/356 (22%)
Query: 674 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPF 733
P +P+G G G V V G+ A+K M V N R E ++L H
Sbjct: 2 VEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPN-VFQNLVSCKRVFRELKMLCFFKHDN 60
Query: 734 V--------PALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVV 785
V P F+ + ++T+ +++ QP L D V+ + +++
Sbjct: 61 VLSALDILQPPHIDPFE---EIYVVTELMQSDLHKIIVSPQP---LSSDHVKVFLYQILR 114
Query: 786 ALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQ 845
L+YLH GI++RD+KP N+L+ N + + DF L+ + +H Q
Sbjct: 115 GLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLA-----------RVEEPDESKHMTQ 163
Query: 846 QNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGH-TSAVDWWALGILLYEMLYGYTPFR-- 902
+ V T+ Y APEI+ G+ H TSAVD W++G + E+L F+
Sbjct: 164 E---------------VVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQ 208
Query: 903 ---------------------GKTRQKTFANILHKDLKFPS-------STPTSLHAKQLM 934
+ A+IL K PS S+ + A L+
Sbjct: 209 SPIQQLDLITDLLGTPSLEAMRSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLL 268
Query: 935 YRLLHRDPKSRLGSHEGANEIKKHPFFKGVNWALVRCMNP---PELDAPLFATDTE 987
R+L DP R+ A + HP+ CM ++ +D E
Sbjct: 269 CRMLVFDPDKRI----SAADALAHPYLDEGRLRYHTCMCKCCYTTSGGRVYTSDFE 320
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 78.0 bits (193), Expect = 3e-15
Identities = 75/342 (21%), Positives = 131/342 (38%), Gaps = 97/342 (28%)
Query: 673 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVH--RACAEREILDMLD 730
+ +KP+GSG G V +G+ A+K K + + + R E ++L L
Sbjct: 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIK---KISNVFDDLIDAKRILREIKLLRHLR 57
Query: 731 HP--------FVPALYASFQTKTHVCLITDYCPGGELFLLLD-----RQPTKVLKEDAVR 777
H P F V ++T+ + D + P + L +D ++
Sbjct: 58 HENIIGLLDILRPPSPEDFND---VYIVTEL-------METDLHKVIKSP-QPLTDDHIQ 106
Query: 778 FYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNE 837
++ +++ L+YLH +I+RDLKP N+L+ N + + DF L+
Sbjct: 107 YFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLA---------------- 150
Query: 838 KKRRHKGQQ--NPVFMAEPMRASNSFVGTEEYIAPEIIAGAGH-TSAVDWWALGILLYEM 894
R F+ E +V T Y APE++ + T A+D W++G + E+
Sbjct: 151 ---RGVDPDEDEKGFLTE-------YVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAEL 200
Query: 895 LYGYTPFRGKT-----------------------RQKTFANIL-------HKDL--KFPS 922
L F G+ + N L K L FP
Sbjct: 201 LTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITSEKARNYLKSLPKKPKKPLSKLFPG 260
Query: 923 STPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGV 964
++P ++ L+ ++L DPK R+ A+E HP+ +
Sbjct: 261 ASPEAID---LLEKMLVFDPKKRI----TADEALAHPYLAQL 295
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 77.1 bits (189), Expect = 4e-15
Identities = 74/291 (25%), Positives = 125/291 (42%), Gaps = 52/291 (17%)
Query: 680 LGSGDTGSVHLVELCGSGQYFAMKAMD------KGVMLNRNKVHRACAEREILDMLDHPF 733
+G G +G+V+ +GQ A++ M+ K +++N V R I++ LD
Sbjct: 28 IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLD--- 84
Query: 734 VPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQ 793
S+ + ++ +Y GG L D + E + E + ALE+LH
Sbjct: 85 ------SYLVGDELWVVMEYLAGGSL---TDVVTETCMDEGQIAAVCRECLQALEFLHSN 135
Query: 794 GIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAE 853
+I+RD+K +N+LL +G V LTDF T E+ +R
Sbjct: 136 QVIHRDIKSDNILLGMDGSVKLTDFGFCA----------QITPEQSKR------------ 173
Query: 854 PMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANI 913
++ VGT ++APE++ + VD W+LGI+ EM+ G P+ + + +
Sbjct: 174 -----STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALY-L 227
Query: 914 LHKDLKFPSSTPTSLHA--KQLMYRLLHRDPKSRLGSHEGANEIKKHPFFK 962
+ + P L A + + R L D + R GS A E+ +H F K
Sbjct: 228 IATNGTPELQNPEKLSAIFRDFLNRCLDMDVEKR-GS---AKELLQHQFLK 274
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 77.1 bits (189), Expect = 4e-15
Identities = 74/286 (25%), Positives = 122/286 (42%), Gaps = 42/286 (14%)
Query: 680 LGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYA 739
+G G +G+V +GQ A+K ++ + + K E ++ L +P +
Sbjct: 27 IGQGASGTVFTAIDVATGQEVAIKQIN---LQKQPKKELIINEILVMKELKNPNIVNFLD 83
Query: 740 SFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRD 799
SF + ++ +Y GG L D + E + E + ALE+LH +I+RD
Sbjct: 84 SFLVGDELFVVMEYLAGGSL---TDVVTETCMDEAQIAAVCRECLQALEFLHANQVIHRD 140
Query: 800 LKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASN 859
+K +NVLL +G V LTDF T E+ +R +
Sbjct: 141 IKSDNVLLGMDGSVKLTDFGFCA----------QITPEQSKR-----------------S 173
Query: 860 SFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANILHK--- 916
+ VGT ++APE++ + VD W+LGI+ EM+ G P+ + + I
Sbjct: 174 TMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTP 233
Query: 917 DLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFK 962
+L+ P + + R L D + R GS A E+ +HPF K
Sbjct: 234 ELQNPEKLSPIF--RDFLNRCLEMDVEKR-GS---AKELLQHPFLK 273
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 75.9 bits (187), Expect = 7e-15
Identities = 74/302 (24%), Positives = 122/302 (40%), Gaps = 65/302 (21%)
Query: 673 HFRPIKPLGSGDTGSVHLVELC-------GSGQYFAMKAMDKGVMLNR--NKVHRACAER 723
H + IK LG G G V ELC +G+ A+K LN + HR+ ER
Sbjct: 5 HLKFIKQLGEGHFGKV---ELCRYDPLGDNTGEQVAVK------SLNHSGEEQHRSDFER 55
Query: 724 EILDM--LDHPFVPAL--YASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFY 779
EI + LDH + + LI +Y P G L L R ++ + + F
Sbjct: 56 EIEILRTLDHENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLF- 114
Query: 780 AAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKK 839
++++ ++YL Q I+RDL N+L++ V ++DF L+ +LP +
Sbjct: 115 SSQICKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLA--------KVLPEDKDYY 166
Query: 840 RRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEML-YG- 897
+ ++P+F + APE + + +SA D W+ G+ LYE+ YG
Sbjct: 167 YVKEPGESPIF----------------WYAPECLRTSKFSSASDVWSFGVTLYELFTYGD 210
Query: 898 ------------YTPFRGKTRQKTFANILH--KDLKFPSSTPTSLHAKQLMYRLLHRDPK 943
+G+ +L + L P S P ++ LM +P+
Sbjct: 211 PSQSPPAEFLRMIGIAQGQMIVTRLLELLKEGERLPRPPSCPDEVY--DLMKLCWEAEPQ 268
Query: 944 SR 945
R
Sbjct: 269 DR 270
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 7e-15
Identities = 62/229 (27%), Positives = 107/229 (46%), Gaps = 36/229 (15%)
Query: 674 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLN-RNKVHRACAEREILDMLDHP 732
F I LG+G+ G V V+ SG A K + + RN++ R E ++L + P
Sbjct: 7 FERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIR---ELQVLHECNSP 63
Query: 733 FVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHC 792
++ Y +F + + + ++ GG L +L + K + E+ + + V+ L YL
Sbjct: 64 YIVGFYGAFYSDGEISICMEHMDGGSLDQVL--KEAKRIPEEILGKVSIAVLRGLAYLRE 121
Query: 793 Q-GIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFM 851
+ I++RD+KP N+L+ G + L DF +S GQ +
Sbjct: 122 KHQIMHRDVKPSNILVNSRGEIKLCDFGVS----------------------GQ-----L 154
Query: 852 AEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTP 900
+ M +NSFVGT Y++PE + G ++ D W++G+ L E+ G P
Sbjct: 155 IDSM--ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYP 201
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 75.6 bits (186), Expect = 8e-15
Identities = 63/235 (26%), Positives = 100/235 (42%), Gaps = 42/235 (17%)
Query: 680 LGSGDTGSVHLVELCGSGQ-YFAMK-------AMDKGVMLNRNKVHRACAEREIL-DMLD 730
LGSG G V+ V +GQ A+K A K + +E I+ + L
Sbjct: 8 LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLR 67
Query: 731 HPFVPALYASFQTKTHVCLITDY---CPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVAL 787
HP + Y +F + ++ D P GE F L ++ + E+ + ++V+AL
Sbjct: 68 HPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSL-KEKKQRFTEERIWNIFVQMVLAL 126
Query: 788 EYLHCQG-IIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQ 846
YLH + I++RDL P N++L + V++TDF L+ + K +
Sbjct: 127 RYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGLA-------------------KQKQPE 167
Query: 847 NPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPF 901
+ + S VGT Y PEI+ + D WA G +LY+M PF
Sbjct: 168 SKL---------TSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPF 213
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 9e-15
Identities = 81/322 (25%), Positives = 133/322 (41%), Gaps = 69/322 (21%)
Query: 674 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVH----RACAEREILDML 729
+ P+ +G G G+V+ SG + A+K++ V N + + R A + L+
Sbjct: 2 YEPVAEIGVGAYGTVYKARDPHSGHFVALKSVR--VQTNEDGLPLSTVREVALLKRLEAF 59
Query: 730 DHPFVPALY---ASFQT--KTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVV 784
DHP + L A+ +T +T V L+ ++ +L LD+ P L + ++ + +
Sbjct: 60 DHPNIVRLMDVCATSRTDRETKVTLVFEHV-DQDLRTYLDKVPPPGLPAETIKDLMRQFL 118
Query: 785 VALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKG 844
L++LH I++RDLKPEN+L+ G V L DF L+ + SC+ L
Sbjct: 119 RGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIYSCQMAL-------------- 164
Query: 845 QQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGK 904
PV V T Y APE++ + + + VD W++G + EM F G
Sbjct: 165 --TPV------------VVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGN 210
Query: 905 TRQ----KTFANI-LHKDLKFPSSTPTSLHA--------------------KQLMYRLLH 939
+ K F I L + +P A QL+ +L
Sbjct: 211 SEADQLGKIFDLIGLPPEDDWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLT 270
Query: 940 RDPKSRLGSHEGANEIKKHPFF 961
+P R+ A +HPFF
Sbjct: 271 FNPHKRI----SAFRALQHPFF 288
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 74.7 bits (184), Expect = 2e-14
Identities = 58/224 (25%), Positives = 86/224 (38%), Gaps = 67/224 (29%)
Query: 771 LKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQL 830
L E VR Y +++ +E+ H II+RD+KPEN+L+ +G V L DF +
Sbjct: 97 LDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFA--------- 147
Query: 831 LLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAG-AGHTSAVDWWALGI 889
+A P +V T Y APE++ G + AVD WA+G
Sbjct: 148 ------------------RTLAAPGEVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGC 189
Query: 890 LLYEMLYGYTPFRGKT------------------------RQKTFANILHKDLK------ 919
L+ EML G F G + + FA + ++K
Sbjct: 190 LVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGMRLPEVKEIEPLE 249
Query: 920 --FPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFF 961
FP + L L + L DP R S +++ H FF
Sbjct: 250 KRFPKLSGLVL---DLAKQCLRIDPDDRPSS----SQLLHHEFF 286
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 75.1 bits (185), Expect = 2e-14
Identities = 86/384 (22%), Positives = 144/384 (37%), Gaps = 108/384 (28%)
Query: 673 HFRPIKPLGSGDTGSVHLVELCGS--GQYFAMK----AMDKGVMLNRNKVHRACAEREIL 726
+ IK LG G G V + + A+K K ++ R A RE+
Sbjct: 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKR-------ALREL- 52
Query: 727 DMLDHPFVPALYASFQTKTH---VCL----ITDYCPGGELFL---LLDRQPTKVLK---- 772
L F + H CL I EL+L L++ ++++
Sbjct: 53 -KLLRHF----------RGHKNITCLYDMDIVFPGNFNELYLYEELMEADLHQIIRSGQP 101
Query: 773 -EDA-VRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQL 830
DA + + +++ L+Y+H +++RDLKP N+L+ + + + DF L+ S P
Sbjct: 102 LTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSENP-- 159
Query: 831 LLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEI-IAGAGHTSAVDWWALGI 889
+N FM E +V T Y APEI ++ +T A+D W++G
Sbjct: 160 --------------GENAGFMTE-------YVATRWYRAPEIMLSFQSYTKAIDVWSVGC 198
Query: 890 LLYEMLYGYTPFRGKTRQKTFANILH----------------------KDL------KFP 921
+L E+L F+GK IL + L F
Sbjct: 199 ILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSRIGSPKAQNYIRSLPNIPKKPFE 258
Query: 922 SSTPTSLH-AKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVNWALVRCMNPPELDAP 980
S P + A L+ +LL DP R+ E +HP+ L +P D P
Sbjct: 259 SIFPNANPLALDLLEKLLAFDPTKRISVEEAL----EHPY-------LAIWHDPD--DEP 305
Query: 981 LFATDTEKEYKVVDPGMQDLQQNV 1004
+ + ++ D M++L+ +
Sbjct: 306 VCQKPFDFSFESED-SMEELRDMI 328
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 74.7 bits (184), Expect = 2e-14
Identities = 77/332 (23%), Positives = 124/332 (37%), Gaps = 66/332 (19%)
Query: 670 NLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREI--LD 727
L+ + + LG G G V+ +G+ A+K K +M N A REI L
Sbjct: 6 KLRDYEILGKLGEGTFGEVYKARQIKTGRVVALK---KILMHNEKDGFPITALREIKILK 62
Query: 728 MLDHPFVPAL------YASFQTKTHVC--LITDYCPGGELFLLLDRQPTKVLKEDAVRFY 779
L HP V L + ++T Y +L LL+ K L E ++ Y
Sbjct: 63 KLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYM-DHDLSGLLENPSVK-LTESQIKCY 120
Query: 780 AAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCL-TSCKPQLLLPTTNEK 838
+++ + YLH I++RD+K N+L+ G + + DF L+ P
Sbjct: 121 MLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNP-------- 172
Query: 839 KRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGA-GHTSAVDWWALGILLYEMLYG 897
+ R + V T Y PE++ G +T+AVD W +G + EM
Sbjct: 173 -------KGGGGGGT--RKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTR 223
Query: 898 YTPFRGKT---------------RQKTFANI-----LHKDLKFPSSTPT--SLHAKQ--- 932
+GK+ ++T+ F + T K
Sbjct: 224 RPILQGKSDIDQLHLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPE 283
Query: 933 ---LMYRLLHRDPKSRLGSHEGANEIKKHPFF 961
L+ +LL DP RL A++ +HP+F
Sbjct: 284 GLDLLSKLLSLDPYKRL----TASDALEHPYF 311
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 74.7 bits (184), Expect = 3e-14
Identities = 73/279 (26%), Positives = 108/279 (38%), Gaps = 78/279 (27%)
Query: 723 REI--LDMLDHPFVPALYASFQTK--THVCLITDYCPGGELFLLLDRQPTKVLKEDAVRF 778
REI L L HP + L K + L+ +YC +L LLD PT E V+
Sbjct: 55 REITLLLNLRHPNIVELKEVVVGKHLDSIFLVMEYCEQ-DLASLLDNMPTP-FSESQVKC 112
Query: 779 YAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEK 838
+++ L+YLH II+RDLK N+LL G + + DF L+ + + P
Sbjct: 113 LMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPK---- 168
Query: 839 KRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGA-GHTSAVDWWALGILLYEMLYG 897
V T Y APE++ G +T+A+D WA+G +L E+L
Sbjct: 169 -----------------------VVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAH 205
Query: 898 YTPFRGKT----------------------------------RQKTFANILHKDLKFPSS 923
GK+ ++ + N+ H KFP
Sbjct: 206 KPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLPLVGKFTLPKQPYNNLKH---KFPWL 262
Query: 924 TPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFK 962
+ L +L+ LL DPK R A E + +FK
Sbjct: 263 SEAGL---RLLNFLLMYDPKKRA----TAEEALESSYFK 294
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 73.7 bits (181), Expect = 3e-14
Identities = 72/278 (25%), Positives = 112/278 (40%), Gaps = 39/278 (14%)
Query: 680 LGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYA 739
LG G G V+ + A+K + + +H E + L H +
Sbjct: 16 LGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHE---EIALHSYLKHRNIVQYLG 72
Query: 740 SFQTKTHVCLITDYCPGGELFLLLDRQ--PTKVLKEDAVRFYAAEVVVALEYLHCQGIIY 797
S + + PGG L LL + P K E + FY +++ L+YLH I++
Sbjct: 73 SDSENGFFKIFMEQVPGGSLSALLRSKWGPLKD-NEQTIIFYTKQILEGLKYLHDNQIVH 131
Query: 798 RDLKPENVLLQG-NGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMR 856
RD+K +NVL+ +G V ++DF S +R G NP
Sbjct: 132 RDIKGDNVLVNTYSGVVKISDFGTS------------------KRLAG-INPC------- 165
Query: 857 ASNSFVGTEEYIAPEIIAGA--GHTSAVDWWALGILLYEMLYGYTPFR--GKTRQKTFAN 912
+ +F GT +Y+APE+I G+ + D W+LG + EM G PF G+ + F
Sbjct: 166 -TETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKV 224
Query: 913 ILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHE 950
+ K S AK + R DP R +H+
Sbjct: 225 GMFKIHP-EIPESLSAEAKNFILRCFEPDPDKRASAHD 261
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 73.6 bits (180), Expect = 3e-14
Identities = 71/291 (24%), Positives = 115/291 (39%), Gaps = 35/291 (12%)
Query: 674 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAM--DKGVMLNRNKVHRACAEREILDMLDH 731
+R K LG G G V+L +G+ A K + D +V E ++L L H
Sbjct: 4 WRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQH 63
Query: 732 PFVPALYASFQTKTH--VCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEY 789
+ Y + + + + +Y PGG + L + L E R Y +++ + Y
Sbjct: 64 ERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQL--KAYGALTESVTRKYTRQILEGMSY 121
Query: 790 LHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPV 849
LH I++RD+K N+L G+V L DF S K Q
Sbjct: 122 LHSNMIVHRDIKGANILRDSAGNVKLGDFGAS---------------------KRLQTIC 160
Query: 850 FMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKT 909
+R S GT +++PE+I+G G+ D W+LG + EML P+
Sbjct: 161 MSGTGIR---SVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAA 217
Query: 910 FANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPF 960
I + + S HA+ + + + + R A E+ +HPF
Sbjct: 218 IFKIATQPTNPQLPSHISEHARDFLGCIF-VEARHR----PSAEELLRHPF 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 5e-14
Identities = 61/270 (22%), Positives = 114/270 (42%), Gaps = 34/270 (12%)
Query: 677 IKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPA 736
+K LGSG G VHL + G A+K + +G M + + A +++ L HP +
Sbjct: 9 LKELGSGQFGVVHLGKWRGKID-VAIKMIREGAMSEDDFIEEA----KVMMKLSHPNLVQ 63
Query: 737 LYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGII 796
LY + + ++T+Y G L L + L + + ++V A+EYL G I
Sbjct: 64 LYGVCTKQRPIFIVTEYMANGCLLNYLRERK-GKLGTEWLLDMCSDVCEAMEYLESNGFI 122
Query: 797 YRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMR 856
+RDL N L+ + V ++DF L+ + +L +++ +G + PV
Sbjct: 123 HRDLAARNCLVGEDNVVKVSDFGLA-------RYVL---DDQYTSSQGTKFPV------- 165
Query: 857 ASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY-GYTPFRGKTRQKTFANILH 915
++ PE+ + +S D W+ G+L++E+ G P+ + + ++
Sbjct: 166 ---------KWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESV-S 215
Query: 916 KDLKFPSSTPTSLHAKQLMYRLLHRDPKSR 945
+ +MY H P+ R
Sbjct: 216 AGYRLYRPKLAPTEVYTIMYSCWHEKPEDR 245
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 76.3 bits (188), Expect = 5e-14
Identities = 76/294 (25%), Positives = 125/294 (42%), Gaps = 31/294 (10%)
Query: 671 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLD 730
+Q + I+ +G G G V+L + A+K + + + N R E +I L
Sbjct: 1 MQRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLI 60
Query: 731 HPFVPALYASFQTKTHVCLITDYCPGGELFLLLD--RQPTKVLKEDAVRFYAA------- 781
HP + +Y+ V Y G L LL Q + KE A +
Sbjct: 61 HPGIVPVYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFH 120
Query: 782 EVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRR 841
++ +EY+H +G+++RDLKP+N+LL G V + D+ + + + LL ++
Sbjct: 121 KICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDE--- 177
Query: 842 HKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPF 901
M VGT +Y+APE + G + + D +ALG++LY+ML P+
Sbjct: 178 ------RNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPY 231
Query: 902 RGKTRQKTFANILHKD-LKFPSST------PTSLHAKQLMYRLLHRDPKSRLGS 948
R K +K I ++D + P P L Q+ + L DP R S
Sbjct: 232 RRKKGRK----ISYRDVILSPIEVAPYREIPPFL--SQIAMKALAVDPAERYSS 279
|
Length = 932 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 72.8 bits (178), Expect = 6e-14
Identities = 63/240 (26%), Positives = 103/240 (42%), Gaps = 43/240 (17%)
Query: 674 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPF 733
F ++ +G+G G V+ +GQ A+K MD + ++ E +L H
Sbjct: 8 FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMD----VTGDEEEEIKQEINMLKKYSHHR 63
Query: 734 -VPALYASFQTKT------HVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVA 786
+ Y +F K + L+ ++C G + L+ LKE+ + + E++
Sbjct: 64 NIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRG 123
Query: 787 LEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQ 846
L +LH +I+RD+K +NVLL N V L DF +S + R G++
Sbjct: 124 LSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSA---------------QLDRTVGRR 168
Query: 847 NPVFMAEPMRASNSFVGTEEYIAPEIIA-----GAGHTSAVDWWALGILLYEMLYGYTPF 901
N+F+GT ++APE+IA A + D W+LGI EM G P
Sbjct: 169 ------------NTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPL 216
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 2e-13
Identities = 74/295 (25%), Positives = 121/295 (41%), Gaps = 51/295 (17%)
Query: 677 IKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPA 736
I LG G G V+ + +G A K +D + ++ E +IL DHP +
Sbjct: 10 IGELGDGAFGKVYKAQNKETGVLAAAKVIDTK---SEEELEDYMVEIDILASCDHPNIVK 66
Query: 737 LYASFQTKTHVCLITDYCPGGEL---FLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQ 793
L +F + ++ ++ ++C GG + L L+R L E +R + + AL YLH
Sbjct: 67 LLDAFYYENNLWILIEFCAGGAVDAVMLELERP----LTEPQIRVVCKQTLEALNYLHEN 122
Query: 794 GIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAE 853
II+RDLK N+L +G + L DF +S T +RR
Sbjct: 123 KIIHRDLKAGNILFTLDGDIKLADFGVSA----------KNTRTIQRR------------ 160
Query: 854 PMRASNSFVGTEEYIAPEII-----AGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQK 908
+SF+GT ++APE++ + D W+LGI L EM P +
Sbjct: 161 -----DSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMR 215
Query: 909 TFANILHKD---LKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPF 960
I + L PS + K + + L ++ +R ++ +HPF
Sbjct: 216 VLLKIAKSEPPTLAQPSRWSSEF--KDFLKKCLEKNVDARW----TTTQLLQHPF 264
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 71.4 bits (175), Expect = 2e-13
Identities = 76/323 (23%), Positives = 126/323 (39%), Gaps = 75/323 (23%)
Query: 674 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAM-----DKGVMLNRNKVHRACAEREI--L 726
F+ ++ +G G G V+ +G+ A+K + +GV + A REI L
Sbjct: 2 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGV--------PSTAIREISLL 53
Query: 727 DMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVA 786
L+HP + L T+ + L+ ++ +L +D P + ++ Y +++
Sbjct: 54 KELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASPLSGIPLPLIKSYLFQLLQG 112
Query: 787 LEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQ 846
L + H +++RDLKP+N+L+ G + L DF L+ R G
Sbjct: 113 LAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLA-------------------RAFGV- 152
Query: 847 NPVFMAEPMRASNSFVGTEEYIAPEIIAGAG-HTSAVDWWALGILLYEMLYGYTPFRGKT 905
P+R V T Y APEI+ G +++AVD W+LG + EM+ F G +
Sbjct: 153 -------PVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDS 205
Query: 906 RQKTFANILH----------------KDLK--FPSSTPTSLH---------AKQLMYRLL 938
I D K FP + L+ ++L
Sbjct: 206 EIDQLFRIFRTLGTPDEVVWPGVTSLPDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQML 265
Query: 939 HRDPKSRLGSHEGANEIKKHPFF 961
H DP R+ + HPFF
Sbjct: 266 HYDPNKRISAKAALA----HPFF 284
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 3e-13
Identities = 69/262 (26%), Positives = 117/262 (44%), Gaps = 48/262 (18%)
Query: 674 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLN-RNKVHRACAEREILDMLDHP 732
F I LG+G+ G V V SG A K + + RN++ R E ++L + P
Sbjct: 7 FEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIR---ELQVLHECNSP 63
Query: 733 FVPALYASFQTKTHVCLITDYCPGGELFLLLDRQ---PTKVLKEDAVRFYAAEVVVALEY 789
++ Y +F + + + ++ GG L +L + P ++L + ++ V+ L Y
Sbjct: 64 YIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSI-----AVIKGLTY 118
Query: 790 LHCQ-GIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNP 848
L + I++RD+KP N+L+ G + L DF +S GQ
Sbjct: 119 LREKHKIMHRDVKPSNILVNSRGEIKLCDFGVS----------------------GQ--- 153
Query: 849 VFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPF---RGKT 905
+ + M +NSFVGT Y++PE + G ++ D W++G+ L EM G P K
Sbjct: 154 --LIDSM--ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKE 209
Query: 906 RQKTFANILHKDLKFPSSTPTS 927
+ F + D P+ + TS
Sbjct: 210 LELMFGCPVEGD---PAESETS 228
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 70.9 bits (173), Expect = 4e-13
Identities = 68/291 (23%), Positives = 112/291 (38%), Gaps = 42/291 (14%)
Query: 674 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPF 733
F ++ +G G G+V+ + + A+K M + K E + L + HP
Sbjct: 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPN 86
Query: 734 VPALYASFQTKTHVCLITDYCPGGELFLL-LDRQPTKVLKEDAVRFYAAEVVVALEYLHC 792
+ + L+ +YC G LL + ++P + ++ A+ A + L YLH
Sbjct: 87 SIEYKGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQ---GLAYLHS 143
Query: 793 QGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMA 852
+I+RD+K N+LL G V L DF + + S
Sbjct: 144 HNMIHRDIKAGNILLTEPGQVKLADFGSASIAS--------------------------- 176
Query: 853 EPMRASNSFVGTEEYIAPEIIAG---AGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKT 909
+NSFVGT ++APE+I + VD W+LGI E+ P
Sbjct: 177 ----PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA 232
Query: 910 FANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPF 960
+I + S S + + + L + P+ R S E+ KH F
Sbjct: 233 LYHIAQNESPTLQSNEWSDYFRNFVDSCLQKIPQDRPTS----EELLKHMF 279
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 6e-13
Identities = 85/357 (23%), Positives = 144/357 (40%), Gaps = 93/357 (26%)
Query: 671 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLD 730
L+ ++ +KP+GSG G V G A+K + + N+ RA E +L ++
Sbjct: 20 LKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQ-NQTHAKRAYRELVLLKCVN 78
Query: 731 HPFVPALYASFQTKTHVCLITDYCPGGELFL---LLDRQPTKV----LKEDAVRFYAAEV 783
H + +L F + + D ++L L+D +V L + + + ++
Sbjct: 79 HKNIISLLNVFTPQKSLEEFQD------VYLVMELMDANLCQVIHMELDHERMSYLLYQM 132
Query: 784 VVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHK 843
+ +++LH GII+RDLKP N++++ + + + DF L+ T+C TN
Sbjct: 133 LCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA-RTAC--------TN------- 176
Query: 844 GQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRG 903
FM P +V T Y APE+I G G+ VD W++G ++ E++ G F+G
Sbjct: 177 ------FMMTP------YVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQG 224
Query: 904 KTR----------------------QKTFANI--------------LHKDLKFPSSTP-- 925
Q T N L D FPS +
Sbjct: 225 TDHIDQWNKVIEQLGTPSAEFMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERD 284
Query: 926 --TSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVNWALVRCMNPPELDAP 980
+ A+ L+ ++L DP R+ E HP+ W +P E +AP
Sbjct: 285 KLKTSQARDLLSKMLVIDPDKRISVDEALR----HPYIT--VW-----YDPAEAEAP 330
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 6e-13
Identities = 71/322 (22%), Positives = 137/322 (42%), Gaps = 73/322 (22%)
Query: 674 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDM--LDH 731
F+ ++ LG G +V+ +G+ A+K + L+ + + A REI M L H
Sbjct: 2 FKQLEKLGEGTYATVYKGRNRTTGEIVALKE----IHLDAEEGTPSTAIREISLMKELKH 57
Query: 732 PFVPALYASFQTKTHVCLITDYCPGGELFLLLD-RQPTKVLKEDAVRFYAAEVVVALEYL 790
+ L+ T+ + L+ +Y +L +D L + V+ + +++ + +
Sbjct: 58 ENIVRLHDVIHTENKLMLVFEYMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFC 116
Query: 791 HCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVF 850
H +++RDLKP+N+L+ G + L DF L+ R G
Sbjct: 117 HENRVLHRDLKPQNLLINKRGELKLADFGLA-------------------RAFGI----- 152
Query: 851 MAEPMRASNSFVGTEEYIAPEIIAGA-GHTSAVDWWALGILLYEMLYGYTPFRGKTR--- 906
P+ ++ V T Y AP+++ G+ +++++D W++G ++ EM+ G F G
Sbjct: 153 ---PVNTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQ 209
Query: 907 -------------------------QKTFANILHKDLK--FPSSTPTSLHAKQLMYRLLH 939
+ TF +DL+ FP + P + L++RLL
Sbjct: 210 LLKIFRIMGTPTESTWPGISQLPEYKPTFPRYPPQDLQQLFPHADPLGI---DLLHRLLQ 266
Query: 940 RDPKSRLGSHEGANEIKKHPFF 961
+P+ R+ +H+ HP+F
Sbjct: 267 LNPELRISAHDALQ----HPWF 284
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 69.4 bits (170), Expect = 1e-12
Identities = 72/297 (24%), Positives = 119/297 (40%), Gaps = 51/297 (17%)
Query: 674 FRPIKPLGSGDTGSVH----LVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILD-- 727
IK LGSG G+V+ + E A+K + R + A +EILD
Sbjct: 9 LEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVL-------REETSPK-ANKEILDEA 60
Query: 728 ----MLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLD--RQPTKVLKEDAVRFYAA 781
+DHP V L + LIT P G L LD R + + +
Sbjct: 61 YVMASVDHPHVVRLLGICLSSQV-QLITQLMPLGCL---LDYVRNHKDNIGSQYLLNWCV 116
Query: 782 EVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRR 841
++ + YL + +++RDL NVL++ HV +TDF L+ L +EK+
Sbjct: 117 QIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLD---------VDEKEYH 167
Query: 842 HKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYE-MLYGYTP 900
+G + P+ +++A E I +T D W+ G+ ++E M +G P
Sbjct: 168 AEGGKVPI----------------KWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKP 211
Query: 901 FRGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKK 957
+ G ++L K + P ++ ++ + D +SR E NE K
Sbjct: 212 YEGI-PAVEIPDLLEKGERLPQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSK 267
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 69.5 bits (170), Expect = 1e-12
Identities = 72/293 (24%), Positives = 110/293 (37%), Gaps = 42/293 (14%)
Query: 672 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDH 731
+ F ++ +G G G+V+ + + A+K M + K E L L H
Sbjct: 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRH 74
Query: 732 PFVPALYASFQTKTHVCLITDYCPGGELFLL-LDRQPTKVLKEDAVRFYAAEVVVALEYL 790
P + + L+ +YC G +L + ++P L+E + + L YL
Sbjct: 75 PNTIEYKGCYLREHTAWLVMEYCLGSASDILEVHKKP---LQEVEIAAICHGALQGLAYL 131
Query: 791 HCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVF 850
H I+RD+K N+LL G V L DF + L S
Sbjct: 132 HSHERIHRDIKAGNILLTEPGTVKLADFGSASLVS------------------------- 166
Query: 851 MAEPMRASNSFVGTEEYIAPEIIAG--AGH-TSAVDWWALGILLYEMLYGYTPFRGKTRQ 907
+NSFVGT ++APE+I G VD W+LGI E+ P
Sbjct: 167 ------PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM 220
Query: 908 KTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPF 960
+I D SS S + + + L + P+ R S E+ KH F
Sbjct: 221 SALYHIAQNDSPTLSSNDWSDYFRNFVDSCLQKIPQDRPSSE----ELLKHRF 269
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|131984 TIGR02938, nifL_nitrog, nitrogen fixation negative regulator NifL | Back alignment and domain information |
|---|
Score = 70.7 bits (173), Expect = 2e-12
Identities = 31/92 (33%), Positives = 56/92 (60%)
Query: 217 IMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKIRETLQNGQSYCGRLLNYKKD 276
I+YA+ F ++TGYT +E++G+N L T PE + +L + + G+LLN +KD
Sbjct: 26 ILYANDAFTRITGYTKEEIIGKNESVLSNHTTPPEVYQALWGSLAEQKPWAGKLLNRRKD 85
Query: 277 GTPFWNLLTIAPIKDDEGKVLKFIGMQVEVSK 308
G + LT+AP+ ++ G+ F+GM ++++
Sbjct: 86 GELYLAELTVAPVLNEAGETTHFLGMHRDITE 117
|
NifL is a modulator of the nitrogen fixation positive regulator protein NifA, and is therefore a negative regulator. It binds NifA. NifA and NifL are encoded by adjacent genes [Central intermediary metabolism, Nitrogen fixation, Regulatory functions, Protein interactions]. Length = 494 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 4e-12
Identities = 70/279 (25%), Positives = 118/279 (42%), Gaps = 39/279 (13%)
Query: 674 FRPIKPLGSGDTGSVHLVELCGSGQYF----AMKAMDKGVMLNRNKVHRACAEREILDML 729
F+ IK LGSG G+V+ G+ A+K + + NK E ++ +
Sbjct: 9 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANK--EILDEAYVMASV 66
Query: 730 DHPFVPALYASFQTKTHVCLITDYCPGGELFLLLD--RQPTKVLKEDAVRFYAAEVVVAL 787
D+P V L T T V LIT P G LLD R+ + + + ++ +
Sbjct: 67 DNPHVCRLLGICLTST-VQLITQLMPFG---CLLDYVREHKDNIGSQYLLNWCVQIAKGM 122
Query: 788 EYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQN 847
YL + +++RDL NVL++ HV +TDF L+ L +EK+ +G +
Sbjct: 123 NYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLL---------GADEKEYHAEGGKV 173
Query: 848 PVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYE-MLYGYTPFRGKTR 906
P+ +++A E I +T D W+ G+ ++E M +G P+ G
Sbjct: 174 PI----------------KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG-IP 216
Query: 907 QKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSR 945
++IL K + P ++ +M + D SR
Sbjct: 217 ASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSR 255
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.5 bits (168), Expect = 4e-12
Identities = 43/138 (31%), Positives = 70/138 (50%), Gaps = 25/138 (18%)
Query: 768 TKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCK 827
T+ L D ++++ +++ L+Y+H +++RDLKP N+LL N + + DF L+ +
Sbjct: 100 TQHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIAD-- 157
Query: 828 PQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEI-IAGAGHTSAVDWWA 886
P + H G F+ E +V T Y APEI + G+T A+D W+
Sbjct: 158 -----PEHD-----HTG-----FLTE-------YVATRWYRAPEIMLNSKGYTKAIDIWS 195
Query: 887 LGILLYEMLYGYTPFRGK 904
+G +L EML F GK
Sbjct: 196 VGCILAEMLSNRPLFPGK 213
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 5e-12
Identities = 82/310 (26%), Positives = 123/310 (39%), Gaps = 69/310 (22%)
Query: 677 IKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVP 735
I+ +G G G V+ V G A+K +D + AE IL L +HP V
Sbjct: 27 IETIGKGTYGKVYKVTNKKDGSLAAVKILDP----ISDVDEEIEAEYNILQSLPNHPNVV 82
Query: 736 ALYASFQTKTHVCLITDYCPGGELFLLLDR----QPTKVLK----------EDAVRFYAA 781
Y F D GG+L+L+L+ T+++K E + +
Sbjct: 83 KFYGMFYK-------ADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILY 135
Query: 782 EVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRR 841
++ L++LH II+RD+K N+LL G V L DF +S QL T+ + RR
Sbjct: 136 GALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSA------QL----TSTRLRR 185
Query: 842 HKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIA-----GAGHTSAVDWWALGILLYEMLY 896
N+ VGT ++APE+IA + + D W+LGI E+
Sbjct: 186 -----------------NTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGD 228
Query: 897 GYTPFRGKTRQKTFANILHKDLKFPSS-TPTSLHAKQLMYRLLHRDPKSRLGSHE---GA 952
G P KT K P + PT LH ++ H + + E
Sbjct: 229 GDPPLFDMHPVKTL-------FKIPRNPPPTLLHPEKWCRSFNHFISQCLIKDFEARPSV 281
Query: 953 NEIKKHPFFK 962
+ +HPF K
Sbjct: 282 THLLEHPFIK 291
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 5e-12
Identities = 62/240 (25%), Positives = 108/240 (45%), Gaps = 40/240 (16%)
Query: 671 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDM-- 728
L+ ++ +KP+GSG G V + A+K + + +N+ H A RE++ M
Sbjct: 23 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPF---QNQTHAKRAYRELVLMKC 79
Query: 729 LDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKV----LKEDAVRFYAAEVV 784
++H + L F + + D EL +D +V L + + + +++
Sbjct: 80 VNHKNIIGLLNVFTPQKSLEEFQDVYIVMEL---MDANLCQVIQMELDHERMSYLLYQML 136
Query: 785 VALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKG 844
+++LH GII+RDLKP N++++ + + + DF L+ R G
Sbjct: 137 CGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA-------------------RTAG 177
Query: 845 QQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGK 904
FM P +V T Y APE+I G G+ VD W++G ++ EM+ G F G
Sbjct: 178 TS---FMMTP------YVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGT 228
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 68.2 bits (166), Expect = 6e-12
Identities = 85/356 (23%), Positives = 145/356 (40%), Gaps = 91/356 (25%)
Query: 671 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDM-- 728
L+ ++ +KP+GSG G V + A+K + + +N+ H A RE++ M
Sbjct: 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPF---QNQTHAKRAYRELVLMKC 72
Query: 729 LDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKV----LKEDAVRFYAAEVV 784
++H + +L F + + D EL +D +V L + + + +++
Sbjct: 73 VNHKNIISLLNVFTPQKSLEEFQDVYLVMEL---MDANLCQVIQMELDHERMSYLLYQML 129
Query: 785 VALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKG 844
+++LH GII+RDLKP N++++ + + + DF L+ R G
Sbjct: 130 CGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA-------------------RTAG 170
Query: 845 QQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRG- 903
FM P +V T Y APE+I G G+ VD W++G ++ EM+ F G
Sbjct: 171 TS---FMMTP------YVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGR 221
Query: 904 ---------------------KTRQKTFANIL-----HKDLKFPSSTPTSL--------- 928
K Q T N + + L FP P SL
Sbjct: 222 DYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNK 281
Query: 929 ----HAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVNWALVRCMNPPELDAP 980
A+ L+ ++L DP R+ +E +HP+ W +P E++AP
Sbjct: 282 LKASQARDLLSKMLVIDPAKRI----SVDEALQHPYIN--VW-----YDPAEVEAP 326
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 7e-12
Identities = 57/215 (26%), Positives = 90/215 (41%), Gaps = 61/215 (28%)
Query: 776 VRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGH-VSLTDFDLSCLTSCKPQLLLPT 834
V+ Y+ ++ AL Y+H + I +RDLKP+N+L+ N H + L DF
Sbjct: 172 VKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDF---------------- 215
Query: 835 TNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGA-GHTSAVDWWALGILLYE 893
K GQ+ S S++ + Y APE++ GA +T+ +D W+LG ++ E
Sbjct: 216 -GSAKNLLAGQR-----------SVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAE 263
Query: 894 MLYGYTPFRGKTRQKTFANIL-----------------HKDLKFPSSTPTSLH------- 929
M+ GY F G++ I+ + D+KFP P L
Sbjct: 264 MILGYPIFSGQSSVDQLVRIIQVLGTPTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGT 323
Query: 930 ---AKQLMYRLLHRDPKSRLGSHEGANEIKKHPFF 961
A + + L +P RL E + PFF
Sbjct: 324 PDDAINFISQFLKYEPLKRLNPIEALAD----PFF 354
|
Length = 440 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 66.3 bits (162), Expect = 8e-12
Identities = 67/277 (24%), Positives = 106/277 (38%), Gaps = 47/277 (16%)
Query: 684 DTGSVHLVELCGSGQY-------------FAMKAMDKGVMLNRNKVHRACAEREILDMLD 730
D S+ L+ G+GQ+ A+K + G M AE +I+ L
Sbjct: 4 DRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTM----DPKDFLAEAQIMKKLR 59
Query: 731 HPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYL 790
HP + LYA + + ++T+ G L L + LK + AA+V + YL
Sbjct: 60 HPKLIQLYAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYL 119
Query: 791 HCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVF 850
Q I+RDL NVL+ N + DF L+ + + + R G + P+
Sbjct: 120 EAQNYIHRDLAARNVLVGENNICKVADFGLARVIK---------EDIYEARE-GAKFPI- 168
Query: 851 MAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEML-YGYTPFRGKTRQKT 909
++ APE + D W+ GILL E++ YG P+ G T +
Sbjct: 169 ---------------KWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEV 213
Query: 910 FANILHK-DLKFPSSTPTSLHAKQLMYRLLHRDPKSR 945
+ + P P L+ +M DP R
Sbjct: 214 LQQVDQGYRMPCPPGCPKELY--DIMLDCWKEDPDDR 248
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 66.7 bits (163), Expect = 8e-12
Identities = 56/206 (27%), Positives = 87/206 (42%), Gaps = 44/206 (21%)
Query: 766 QPTKVLKEDAVRFYAAEVVVALEYLHCQ-GIIYRDLKPENVLLQGNGHVSLTDFDLSCLT 824
+ ED + A +V ALEYLH + +I+RD+KP NVL+ NG V L DF +S
Sbjct: 95 DKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGIS--- 151
Query: 825 SCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAV-- 882
L + +A+ + A G + Y+APE I +
Sbjct: 152 ---GYL----VDS-------------VAKTIDA-----GCKPYMAPERINPELNQKGYDV 186
Query: 883 --DWWALGILLYEMLYGYTPFRGKTRQKTFANILHKDLKFPSST----PTSLHAKQLMYR 936
D W+LGI + E+ G P+ KT L + ++ PS S + + +
Sbjct: 187 KSDVWSLGITMIELATGRFPY---DSWKTPFQQLKQVVEEPSPQLPAEKFSPEFQDFVNK 243
Query: 937 LLHRDPKSRLGSHEGANEIKKHPFFK 962
L ++ K R E+ +HPFF+
Sbjct: 244 CLKKNYKER----PNYPELLQHPFFE 265
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 9e-12
Identities = 62/233 (26%), Positives = 103/233 (44%), Gaps = 44/233 (18%)
Query: 670 NLQH-FRPIKPLGSGDTGSVHLVELCGSGQYFAMK--AMDKGVMLNRNKVHRACAEREIL 726
N QH + I+ +GSG G V+ +G+ A+K ++ G + ++EI
Sbjct: 6 NPQHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDF-------SLIQQEIF 58
Query: 727 DMLD--HPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVV 784
+ + H + A + S+ ++ + + +YC GG L + T L E + + E +
Sbjct: 59 MVKECKHCNIVAYFGSYLSREKLWICMEYCGGGSLQDIY--HVTGPLSELQIAYVCRETL 116
Query: 785 VALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKG 844
L YLH +G ++RD+K N+LL NG V L DF ++ T KR+
Sbjct: 117 QGLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVAAKI---------TATIAKRK--- 164
Query: 845 QQNPVFMAEPMRASNSFVGTEEYIAPEIIA---GAGHTSAVDWWALGILLYEM 894
SF+GT ++APE+ A G+ D WA+GI E+
Sbjct: 165 ---------------SFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 9e-12
Identities = 67/270 (24%), Positives = 112/270 (41%), Gaps = 62/270 (22%)
Query: 722 EREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAA 781
E ++L L + L +F+ + + L+ +Y + LL+ P V + VR Y
Sbjct: 50 ELKMLRTLKQENIVELKEAFRRRGKLYLVFEYVEK-NMLELLEEMPNGVPP-EKVRSYIY 107
Query: 782 EVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRR 841
+++ A+ + H I++RD+KPEN+L+ N + L DF + R
Sbjct: 108 QLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFA-------------------R 148
Query: 842 HKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPF 901
+ + + E +V T Y +PE++ GA + AVD W++G +L E+ G F
Sbjct: 149 NLSEGSNANYTE-------YVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLF 201
Query: 902 RGK-------TRQKT------------FANILHKDLKFPSST-PTSLHAK---------- 931
G+ T QK ++N L+FP+ P SL +
Sbjct: 202 PGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHGLRFPAVNHPQSLERRYLGILSGVLL 261
Query: 932 QLMYRLLHRDPKSRLGSHEGANEIKKHPFF 961
LM LL +P R + + N HP F
Sbjct: 262 DLMKNLLKLNPTDRYLTEQCLN----HPAF 287
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 65.9 bits (161), Expect = 1e-11
Identities = 61/238 (25%), Positives = 100/238 (42%), Gaps = 30/238 (12%)
Query: 722 EREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAA 781
E EIL DHP + L K + ++ + PGG L L R+ L + +
Sbjct: 42 EAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLLTFL-RKKKNRLTVKKLLQMSL 100
Query: 782 EVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRR 841
+ +EYL + I+RDL N L+ N + ++DF +S + + T +
Sbjct: 101 DAAAGMEYLESKNCIHRDLAARNCLVGENNVLKISDFGMS-----REEEGGIYTVSDGLK 155
Query: 842 HKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEML-YGYTP 900
Q P+ ++ APE + +TS D W+ GILL+E G TP
Sbjct: 156 ----QIPI----------------KWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTP 195
Query: 901 FRGKTRQKTFANILHK-DLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKK 957
+ G + Q+T I + P P ++ +LM + DP++R E NE++
Sbjct: 196 YPGMSNQQTRERIESGYRMPAPQLCPEEIY--RLMLQCWAYDPENRPSFSEIYNELQI 251
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 66.0 bits (161), Expect = 1e-11
Identities = 63/269 (23%), Positives = 107/269 (39%), Gaps = 36/269 (13%)
Query: 680 LGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYA 739
LG G G V+ A+K + + M +V E ++ + HP + L
Sbjct: 14 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIKHPNLVQLLG 69
Query: 740 SFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRD 799
+ +IT++ G L L + + + + A ++ A+EYL + I+RD
Sbjct: 70 VCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRD 129
Query: 800 LKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASN 859
L N L+ N V + DF LS L T + H G + P+
Sbjct: 130 LAARNCLVGENHLVKVADFGLSRL----------MTGDTYTAHAGAKFPI---------- 169
Query: 860 SFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEM-LYGYTPFRGKTRQKTFANILHKDL 918
++ APE +A + D WA G+LL+E+ YG +P+ G + + +L K
Sbjct: 170 ------KWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVY-ELLEKGY 222
Query: 919 KF--PSSTPTSLHAKQLMYRLLHRDPKSR 945
+ P P ++ +LM +P R
Sbjct: 223 RMERPEGCPPKVY--ELMRACWQWNPSDR 249
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 1e-11
Identities = 77/329 (23%), Positives = 130/329 (39%), Gaps = 71/329 (21%)
Query: 674 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVH--RACAEREILDMLDH 731
++ + P+GSG GSV +G A+K + + ++ +H R E +L + H
Sbjct: 19 YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF---QSIIHAKRTYRELRLLKHMKH 75
Query: 732 P--------FVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEV 783
F PA S + V L+T + G +L ++ Q L +D V+F ++
Sbjct: 76 ENVIGLLDVFTPA--RSLEEFNDVYLVT-HLMGADLNNIVKCQK---LTDDHVQFLIYQI 129
Query: 784 VVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHK 843
+ L+Y+H II+RDLKP N+ + + + + DF L+ RH
Sbjct: 130 LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA-------------------RHT 170
Query: 844 GQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGH-TSAVDWWALGILLYEMLYGYTPFR 902
+ +V T Y APEI+ H VD W++G ++ E+L G T F
Sbjct: 171 DDE-----------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFP 219
Query: 903 GKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFK 962
G + L L+ + L ++ S N I+
Sbjct: 220 GTDH----IDQLKLILRLVGTPGAEL--------------LKKISSESARNYIQSLTQMP 261
Query: 963 GVNWALVRC-MNPPELD--APLFATDTEK 988
+N+A V NP +D + D++K
Sbjct: 262 KMNFANVFIGANPLAVDLLEKMLVLDSDK 290
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 66.6 bits (163), Expect = 1e-11
Identities = 65/316 (20%), Positives = 115/316 (36%), Gaps = 59/316 (18%)
Query: 681 GSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYAS 740
D VHL + + A+K ++ ++ + E L HP + S
Sbjct: 9 CFEDLMIVHLAKHKPTNTLVAVKKINLDSC-SKEDLKLLQQEIITSRQLQHPNILPYVTS 67
Query: 741 FQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDL 800
F + + +++ G LL + L E A+ F +V+ AL+Y+H +G I+R +
Sbjct: 68 FIVDSELYVVSPLMAYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSV 127
Query: 801 KPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNS 860
K ++LL G+G V L+ S KR+ P + +
Sbjct: 128 KASHILLSGDGKVVLSGLRYSV----------SMIKHGKRQRVVHDFPKSSVKNL----- 172
Query: 861 FVGTEEYIAPEIIAG--AGHTSAVDWWALGILLYEMLYGYTPF-------------RGKT 905
+++PE++ G+ D +++GI E+ G+ PF RG
Sbjct: 173 -----PWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTV 227
Query: 906 R----QKTF----ANILHKDLKFPSSTPT-----------SLHAKQLMYRLLHRDPKSRL 946
+ T+ ++ S H Q + L RDP+SR
Sbjct: 228 PCLLDKSTYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESR- 286
Query: 947 GSHEGANEIKKHPFFK 962
A+++ H FFK
Sbjct: 287 ---PSASQLLNHSFFK 299
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 1e-11
Identities = 59/233 (25%), Positives = 100/233 (42%), Gaps = 30/233 (12%)
Query: 673 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAM--DKGVMLNRNKVHRACAEREILDMLD 730
++R K LG G G V+L +G+ A+K + D +V+ E ++L L
Sbjct: 3 NWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLR 62
Query: 731 HPFVPALYASFQ--TKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALE 788
H + Y + + + + +Y PGG + L + L E+ R Y +++ +
Sbjct: 63 HDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQL--KAYGALTENVTRRYTRQILQGVS 120
Query: 789 YLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNP 848
YLH I++RD+K N+L G+V L DF S KR
Sbjct: 121 YLHSNMIVHRDIKGANILRDSAGNVKLGDFGAS-----------------KRIQT----- 158
Query: 849 VFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPF 901
+ M+ S GT +++PE+I+G G+ D W++ + EML P+
Sbjct: 159 ICMSGT--GIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPW 209
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 65.7 bits (160), Expect = 2e-11
Identities = 73/282 (25%), Positives = 121/282 (42%), Gaps = 45/282 (15%)
Query: 680 LGSGDTGSVHLVELC---GSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPA 736
LG G+ GSV +L GS Q A+K M K + + + + E + DHP V
Sbjct: 7 LGKGEFGSVREAQLKSEDGSFQKVAVK-MLKADIFSSSDIEEFLREAACMKEFDHPNVIK 65
Query: 737 LYA-SFQTKTHVCL-----ITDYCPGGEL--FLLLDR---QPTKVLKEDAVRFYAAEVVV 785
L S +++ L I + G+L FLL+ R +P + + VRF ++
Sbjct: 66 LIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRF-MIDIAS 124
Query: 786 ALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQ 845
+EYL + I+RDL N +L N V + DF LS KK
Sbjct: 125 GMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGLS----------------KK------ 162
Query: 846 QNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYE-MLYGYTPFRGK 904
++ + R + +++A E +A +T+ D WA G+ ++E M G TP+ G
Sbjct: 163 ---IYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGV 219
Query: 905 TRQKTFANILHKD-LKFPSSTPTSLHAKQLMYRLLHRDPKSR 945
+ + ++ + LK P ++ +LM + +PK R
Sbjct: 220 ENSEIYNYLIKGNRLKQPPDCLEDVY--ELMCQCWSPEPKCR 259
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 65.4 bits (160), Expect = 2e-11
Identities = 64/274 (23%), Positives = 108/274 (39%), Gaps = 38/274 (13%)
Query: 678 KPLGSGDTGSVHL-VELCGSGQYF--AMKAMDKGVMLNRNKVHRACAEREILDMLDHPFV 734
K LG G+ GSV V L SG+ A+K + + + K E ++ LDHP +
Sbjct: 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKK--EFLREASVMAQLDHPCI 58
Query: 735 PALYASFQTKTHVCLITDYCPGGELF-LLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQ 793
L + + + L+ + P G L L R+ V ++ A +V + + YL +
Sbjct: 59 VRLIGVCKGEP-LMLVMELAPLGPLLKYLKKRREIPVSD---LKELAHQVAMGMAYLESK 114
Query: 794 GIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAE 853
++RDL NVLL ++DF +S L ++ R + P+
Sbjct: 115 HFVHRDLAARNVLLVNRHQAKISDFGMS--------RALGAGSDYYRATTAGRWPL---- 162
Query: 854 PMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEML-YGYTPFRGKTRQKTFAN 912
++ APE I +S D W+ G+ L+E YG P+ + A
Sbjct: 163 ------------KWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAM 210
Query: 913 ILH-KDLKFPSSTPTSLHAKQLMYRLLHRDPKSR 945
+ + L P P ++ +M P+ R
Sbjct: 211 LESGERLPRPEECPQEIY--SIMLSCWKYRPEDR 242
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|238075 cd00130, PAS, PAS domain; PAS motifs appear in archaea, eubacteria and eukarya | Back alignment and domain information |
|---|
Score = 61.5 bits (149), Expect = 2e-11
Identities = 29/101 (28%), Positives = 49/101 (48%), Gaps = 3/101 (2%)
Query: 488 FVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIRAAIDNQT 547
++ D D I++A+ + +L YS EE++G++ L PE ++ +
Sbjct: 5 VIVLDL---DGRILYANPAAEQLLGYSPEELIGKSLLDLIHPEDREELRERLENLLSGGE 61
Query: 548 DVTVQLINYTKSGKKFWNLFHLQPMRDQKGEVQYFIGVQLD 588
VT+++ K G W L L P+RD+ GEV +GV D
Sbjct: 62 PVTLEVRLRRKDGSVIWVLVSLTPIRDEGGEVIGLLGVVRD 102
|
Probably the most surprising identification of a PAS domain was that in EAG-like K+-channels. PAS domains have been found to bind ligands, and to act as sensors for light and oxygen in signal transduction. Length = 103 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 65.9 bits (161), Expect = 2e-11
Identities = 74/293 (25%), Positives = 117/293 (39%), Gaps = 48/293 (16%)
Query: 680 LGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDM-LDHPFVPALY 738
+GSG G V+ + +G A+K M + N+ + R + +++ D P++ Y
Sbjct: 23 IGSGTCGQVYKMRFKKTGHVMAVKQMRRTG--NKEENKRILMDLDVVLKSHDCPYIVKCY 80
Query: 739 ASFQTKTHVCLITDYCPGGELFLLLDR--QPTKVLKEDAVRFYAAEVVVALEYL-HCQGI 795
F T + V I L LL R P + ED + +V AL YL G+
Sbjct: 81 GYFITDSDV-FICMELMSTCLDKLLKRIQGP---IPEDILGKMTVAIVKALHYLKEKHGV 136
Query: 796 IYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPM 855
I+RD+KP N+LL +G+V L DF +S + +
Sbjct: 137 IHRDVKPSNILLDASGNVKLCDFGISG---------------------------RLVDSK 169
Query: 856 RASNSFVGTEEYIAPEIIAGAGHTSA----VDWWALGILLYEMLYGYTPFRG-KTRQKTF 910
+ S G Y+APE I D W+LGI L E+ G P++ KT +
Sbjct: 170 AKTRS-AGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVL 228
Query: 911 ANILHKDL-KFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFK 962
IL ++ P + S + L +D + R E+ +HPF +
Sbjct: 229 TKILQEEPPSLPPNEGFSPDFCSFVDLCLTKDHRKR----PKYRELLQHPFIR 277
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 66.5 bits (162), Expect = 2e-11
Identities = 75/308 (24%), Positives = 125/308 (40%), Gaps = 59/308 (19%)
Query: 674 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPF 733
+R +K +GSG G+V +G A+K + + + RA E +L + H
Sbjct: 17 YRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQ-SELFAKRAYRELRLLKHMKHEN 75
Query: 734 VPALYASFQTKTHVCLITDY---CP--GGELFLLLDRQPTKVLKEDAVRFYAAEVVVALE 788
V L F + D+ P G +L L+ + L ED ++F +++ L+
Sbjct: 76 VIGLLDVFTPDLSLDRFHDFYLVMPFMGTDLGKLMKHEK---LSEDRIQFLVYQMLKGLK 132
Query: 789 YLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNP 848
Y+H GII+RDLKP N+ + + + + DF L+ R +
Sbjct: 133 YIHAAGIIHRDLKPGNLAVNEDCELKILDFGLA-------------------RQTDSE-- 171
Query: 849 VFMAEPMRASNSFVGTEEYIAPEIIAGAGH-TSAVDWWALGILLYEMLYGYTPFRGKTRQ 907
+V T Y APE+I H T VD W++G ++ EML G F+G
Sbjct: 172 ---------MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHL 222
Query: 908 KTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVNWA 967
I+ + TP+ ++ +L S + N +KK P F+ ++
Sbjct: 223 DQLMEIMKV-----TGTPS-------------KEFVQKLQSEDAKNYVKKLPRFRKKDFR 264
Query: 968 -LVRCMNP 974
L+ NP
Sbjct: 265 SLLPNANP 272
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 3e-11
Identities = 58/245 (23%), Positives = 109/245 (44%), Gaps = 43/245 (17%)
Query: 672 QHFRPIKPLGSGDTGSVHLV-ELCGSGQYFAMKAM-----DKGVMLNRNKVHRACAEREI 725
Q + + +G G G V +L G++ A+K + ++G+ L+ R A
Sbjct: 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLS---TIREVAVLRH 57
Query: 726 LDMLDHPFVPALY-----ASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYA 780
L+ +HP V L+ + +T + L+ ++ +L LD+ P + + ++
Sbjct: 58 LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPEPGVPTETIKDMM 116
Query: 781 AEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKR 840
+++ L++LH +++RDLKP+N+L+ +G + L DF L+ + S
Sbjct: 117 FQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYS--------------- 161
Query: 841 RHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTP 900
F A S V T Y APE++ + + + VD W++G + EM
Sbjct: 162 ---------FQM----ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPL 208
Query: 901 FRGKT 905
FRG +
Sbjct: 209 FRGSS 213
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 67.6 bits (165), Expect = 3e-11
Identities = 62/250 (24%), Positives = 100/250 (40%), Gaps = 54/250 (21%)
Query: 730 DHPFVPALYASFQTKTHVC-----------LITDYCPGGELFLLLDRQPTKVLKE----- 773
D P A F+ +T +C L + P G LF + + P + L+E
Sbjct: 14 DAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYVPGRTLREVLAAD 73
Query: 774 ------DAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNG---HVSLTDFDLSCLT 824
+ R +V+ AL H QGI++RDLKP+N+++ G H + DF +
Sbjct: 74 GALPAGETGRL-MLQVLDALACAHNQGIVHRDLKPQNIMVSQTGVRPHAKVLDFGIGT-- 130
Query: 825 SCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDW 884
LLP + + + +GT Y APE + G T D
Sbjct: 131 ------LLPGVRDADVAT------------LTRTTEVLGTPTYCAPEQLRGEPVTPNSDL 172
Query: 885 WALGILLYEMLYGYTPFRGKTRQKTFANILHKDLK-FPSSTPTSLHAK---QLMYRLLHR 940
+A G++ E L G +G + A IL++ L S P + Q++ + L++
Sbjct: 173 YAWGLIFLECLTGQRVVQG----ASVAEILYQQLSPVDVSLPPWIAGHPLGQVLRKALNK 228
Query: 941 DPKSRLGSHE 950
DP+ R S
Sbjct: 229 DPRQRAASAP 238
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 66.1 bits (161), Expect = 3e-11
Identities = 67/286 (23%), Positives = 107/286 (37%), Gaps = 53/286 (18%)
Query: 674 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPF 733
+ IK L G G V + G +K KG L E +L ++HP
Sbjct: 68 YTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKGTTL---------IEAMLLQNVNHPS 118
Query: 734 VPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQ 793
V + + + C++ + +L+ L ++ + + A+ ++ L YLH Q
Sbjct: 119 VIRMKDTLVSGAITCMVLPHY-SSDLYTYLTKRSRPLPIDQALIIEKQ-ILEGLRYLHAQ 176
Query: 794 GIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAE 853
II+RD+K EN+ + V + D + Q PV
Sbjct: 177 RIIHRDVKTENIFINDVDQVCIGDLGAA------------------------QFPV--VA 210
Query: 854 PMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEML-YGYTPFRGK-TRQKTFA 911
P GT E APE++A + S D W+ GI+L+EML Y T F + + +
Sbjct: 211 PAFLG--LAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYV 268
Query: 912 NILHKDL------------KFPSSTPTSLHAKQLMYRLLHRDPKSR 945
H L +FP + L + Y L R P +R
Sbjct: 269 KSCHSHLLKIISTLKVHPEEFPRDPGSRLVRGFIEYASLERQPYTR 314
|
Length = 357 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 3e-11
Identities = 73/274 (26%), Positives = 114/274 (41%), Gaps = 59/274 (21%)
Query: 677 IKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVH----RACAEREILDML-DH 731
I+ +G G G V V +G A+K +D +H AE IL L DH
Sbjct: 23 IETIGKGTYGKVFKVLNKKNGSKAAVKILDP--------IHDIDEEIEAEYNILKALSDH 74
Query: 732 PFVPALYASFQTKT-----HVCLITDYCPGGELFLLLD--RQPTKVLKEDAVRFYAAEVV 784
P V Y + K + L+ + C GG + L+ + + ++E + + E +
Sbjct: 75 PNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEAL 134
Query: 785 VALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKG 844
+ L++LH I+RD+K N+LL G V L DF +S QL T+ + RR
Sbjct: 135 MGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSA------QL----TSTRLRR--- 181
Query: 845 QQNPVFMAEPMRASNSFVGTEEYIAPEIIA-----GAGHTSAVDWWALGILLYEMLYGYT 899
N+ VGT ++APE+IA + + + D W+LGI E+ G
Sbjct: 182 --------------NTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDP 227
Query: 900 PFRGKTRQKTFANILHKDLKFPSSTPTSLHAKQL 933
P + K P + P +LH +L
Sbjct: 228 PLADLHPMRAL-------FKIPRNPPPTLHQPEL 254
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.0 bits (159), Expect = 4e-11
Identities = 52/224 (23%), Positives = 81/224 (36%), Gaps = 77/224 (34%)
Query: 787 LEYLHCQGIIYRDLKPENVLLQGNGH----VSLTDFDLSCLTSCKPQLLLPTTNEKKRRH 842
+ YLH +++RDLKP N+L+ G G V + D L+ L + + L
Sbjct: 121 VHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLA---------- 170
Query: 843 KGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGH-TSAVDWWALGILLYEMLYGYTPF 901
+PV V T Y APE++ GA H T A+D WA+G + E+L F
Sbjct: 171 --DLDPV------------VVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIF 216
Query: 902 RGKTRQKTFANILHKD-----------------------------------LKFPSS--- 923
+G+ + +N +D +PS+
Sbjct: 217 KGREAKIKKSNPFQRDQLERIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLA 276
Query: 924 ------TPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFF 961
L+ +LL DP R+ + E HP+F
Sbjct: 277 KWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALE----HPYF 316
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 65.5 bits (160), Expect = 4e-11
Identities = 78/335 (23%), Positives = 133/335 (39%), Gaps = 94/335 (28%)
Query: 674 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPF 733
+ PIKP+G G G V + + + A+K + NR R E ++L LDH
Sbjct: 7 YVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIAN-AFDNRIDAKRTLREIKLLRHLDHEN 65
Query: 734 V--------PALYASFQTKTHVCLITDYCPGGELFLLLDR------QPTKVLKEDAVRFY 779
V P +F V ++ + L+D + ++ L +D +++
Sbjct: 66 VIAIKDIMPPPHREAFND---VYIVYE---------LMDTDLHQIIRSSQTLSDDHCQYF 113
Query: 780 AAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKK 839
+++ L+Y+H +++RDLKP N+LL N + + DF L+ TS K
Sbjct: 114 LYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGD---------- 163
Query: 840 RRHKGQQNPVFMAEPMRASNSFVGTEEYIAPE-IIAGAGHTSAVDWWALGILLYEMLYGY 898
FM E +V T Y APE ++ + +T+A+D W++G + E+L
Sbjct: 164 ----------FMTE-------YVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRK 206
Query: 899 TPFRGK---TRQKTFANIL----HKDL-------------------------KFPSSTPT 926
F GK + K +L +DL FP + P
Sbjct: 207 PLFPGKDYVHQLKLITELLGSPSEEDLGFIRNEKARRYIRSLPYTPRQSFARLFPHANPL 266
Query: 927 SLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFF 961
++ L+ ++L DP R+ E HP+
Sbjct: 267 AI---DLLEKMLVFDPSKRITVEEALA----HPYL 294
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.7 bits (158), Expect = 4e-11
Identities = 65/275 (23%), Positives = 112/275 (40%), Gaps = 65/275 (23%)
Query: 719 ACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRF 778
A E +L L H + L+ TK + L+ +Y +L +D L VR
Sbjct: 50 AIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEYLDT-DLKQYMDDCGG-GLSMHNVRL 107
Query: 779 YAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEK 838
+ +++ L Y H + +++RDLKP+N+L+ G + L DF L+
Sbjct: 108 FLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLA----------------- 150
Query: 839 KRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGA-GHTSAVDWWALGILLYEMLYG 897
R K + P + ++ V T Y P+++ G+ +++++D W +G + YEM G
Sbjct: 151 --RAK--------SVPSKTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATG 200
Query: 898 YTPFRGKT----------------RQKTFANILH----KDLKFPSSTPTSL--------- 928
F G T ++T+ + K FP P L
Sbjct: 201 RPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPEFKPYSFPFYPPRPLINHAPRLDR 260
Query: 929 --HAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFF 961
H ++L + L +PK R+ + E KHP+F
Sbjct: 261 IPHGEELALKFLQYEPKKRISAAEAM----KHPYF 291
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 65.1 bits (158), Expect = 4e-11
Identities = 65/276 (23%), Positives = 103/276 (37%), Gaps = 38/276 (13%)
Query: 674 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPF 733
F ++ +G G G+V+ + + A+K M + K E L L HP
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 734 VPALYASFQTKTHVCLITDYCPGGELFLL-LDRQPTKVLKEDAVRFYAAEVVVALEYLHC 792
+ + L+ +YC G LL + ++P + ++ AV A + L YLH
Sbjct: 77 TIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQ---GLAYLHS 133
Query: 793 QGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMA 852
+I+RD+K N+LL G V L DF A
Sbjct: 134 HNMIHRDVKAGNILLSEPGLVKLGDFG-------------------------------SA 162
Query: 853 EPMRASNSFVGTEEYIAPEIIAG---AGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKT 909
M +N FVGT ++APE+I + VD W+LGI E+ P
Sbjct: 163 SIMAPANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA 222
Query: 910 FANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSR 945
+I + S S + + + L + P+ R
Sbjct: 223 LYHIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDR 258
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 64.5 bits (157), Expect = 5e-11
Identities = 61/234 (26%), Positives = 97/234 (41%), Gaps = 43/234 (18%)
Query: 672 QHFRPIKPLGSGDTGSVHLVELC------GSGQYFAMKAMDKGVMLNRNKVHRACAEREI 725
++ + I+ LG G G V L C G+G+ A+K + + + + + ++EI
Sbjct: 4 RYLKKIRVLGEGHFGKVSL--YCYDPANDGTGEMVAVKTLKREC----GQQNTSGWKKEI 57
Query: 726 --LDMLDHPFVPALYA--SFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAA 781
L L H + S Q + LI +Y P G L D P L + +A
Sbjct: 58 NILKTLYHENIVKYKGCCSEQGGKGLQLIMEYVPLGSL---RDYLPKHKLNLAQLLLFAQ 114
Query: 782 EVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRR 841
++ + YLH Q I+RDL NVLL + V + DF L+ +P +E R
Sbjct: 115 QICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLA--------KAVPEGHEYYRV 166
Query: 842 HKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEML 895
+ +PVF + A E + + A D W+ G+ LYE+L
Sbjct: 167 REDGDSPVF----------------WYAVECLKENKFSYASDVWSFGVTLYELL 204
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 5e-11
Identities = 59/245 (24%), Positives = 102/245 (41%), Gaps = 45/245 (18%)
Query: 674 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPF 733
+ ++PLG G G V + A+K K V+ + V A E +I+ LDH
Sbjct: 7 YMDLRPLGCGSNGLVFSAVDSDCDKRVAVK---KIVLTDPQSVKHALREIKIIRRLDHDN 63
Query: 734 VPALY-------------ASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYA 780
+ +Y T+ + I +L +L++ P L E+ R +
Sbjct: 64 IVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLEQGP---LSEEHARLFM 120
Query: 781 AEVVVALEYLHCQGIIYRDLKPENVLLQGNGHV-SLTDFDLSCLTSCKPQLLLPTTNEKK 839
+++ L+Y+H +++RDLKP NV + V + DF L+ + +
Sbjct: 121 YQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGDFGLARIV------------DPH 168
Query: 840 RRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGH-TSAVDWWALGILLYEMLYGY 898
HKG +++E + T+ Y +P ++ + T A+D WA G + EML G
Sbjct: 169 YSHKG-----YLSEGLV-------TKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 216
Query: 899 TPFRG 903
F G
Sbjct: 217 PLFAG 221
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 6e-11
Identities = 69/280 (24%), Positives = 122/280 (43%), Gaps = 38/280 (13%)
Query: 669 INLQHFRPIKPLGSGDTGSVHLVELCGSGQY-FAMKAMDKGVMLNRNKVHRACAEREILD 727
IN +K LGSG G VHL + Q A+KA+++G M + + A +++
Sbjct: 1 INPSELTFMKELGSGQFGVVHLGKW--RAQIKVAIKAINEGAMSEEDFIEEA----KVMM 54
Query: 728 MLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVAL 787
L HP + LY + + ++T++ G L L RQ L +D + +V +
Sbjct: 55 KLSHPKLVQLYGVCTQQKPLYIVTEFMENGCLLNYL-RQRQGKLSKDMLLSMCQDVCEGM 113
Query: 788 EYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQN 847
EYL I+RDL N L+ G V ++DF ++ + +L +++ G +
Sbjct: 114 EYLERNSFIHRDLAARNCLVSSTGVVKVSDFGMT-------RYVL---DDEYTSSSGAKF 163
Query: 848 PVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY-GYTPFRGKTR 906
PV ++ PE+ + ++S D W+ G+L++E+ G PF K+
Sbjct: 164 PV----------------KWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSN 207
Query: 907 QKTFANILHKD-LKFPSSTPTSLHAKQLMYRLLHRDPKSR 945
+ I L P +++ ++MY H P+ R
Sbjct: 208 YEVVEMISRGFRLYRPKLASMTVY--EVMYSCWHEKPEGR 245
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 63.6 bits (155), Expect = 6e-11
Identities = 53/230 (23%), Positives = 91/230 (39%), Gaps = 39/230 (16%)
Query: 722 EREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAA 781
E + L L H + +L+A V +IT+ G L L +VL ++ A
Sbjct: 52 EVQALKRLRHKHLISLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMAC 111
Query: 782 EVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRR 841
+V + YL Q I+RDL N+L+ + + DF L+ L
Sbjct: 112 QVAEGMAYLEEQNSIHRDLAARNILVGEDLVCKVADFGLARLI----------------- 154
Query: 842 HKGQQNPVFMAE----PMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEML-Y 896
+ V+++ P + + APE + ++ D W+ GILLYEM Y
Sbjct: 155 ----KEDVYLSSDKKIPYK----------WTAPEAASHGTFSTKSDVWSFGILLYEMFTY 200
Query: 897 GYTPFRGKTRQKTFANILHK-DLKFPSSTPTSLHAKQLMYRLLHRDPKSR 945
G P+ G + + I + P+ P ++ ++M +P+ R
Sbjct: 201 GQVPYPGMNNHEVYDQITAGYRMPCPAKCPQEIY--KIMLECWAAEPEDR 248
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 64.5 bits (157), Expect = 7e-11
Identities = 80/319 (25%), Positives = 122/319 (38%), Gaps = 72/319 (22%)
Query: 677 IKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPA 736
+K +GSG GSV +G+ A+K + + + RA E +L + H V
Sbjct: 20 LKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQ-SEIFAKRAYRELTLLKHMQHENVIG 78
Query: 737 LYASFQTKTHVCLITD-YCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGI 795
L F + D Y + L + L ED V++ +++ L+Y+H GI
Sbjct: 79 LLDVFTSAVSGDEFQDFYLVMPYMQTDLQKIMGHPLSEDKVQYLVYQMLCGLKYIHSAGI 138
Query: 796 IYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPM 855
I+RDLKP N+ + + + + DF L+ RH +
Sbjct: 139 IHRDLKPGNLAVNEDCELKILDFGLA-------------------RHADAE--------- 170
Query: 856 RASNSFVGTEEYIAPEIIAGAGH-TSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANIL 914
+V T Y APE+I H VD W++G ++ EML G T F+GK IL
Sbjct: 171 --MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQIL 228
Query: 915 ------------------------------HKDLK--FPSSTPTSLHAKQLMYRLLHRDP 942
KD FP ++P A L+ ++L D
Sbjct: 229 KVTGVPGPEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASP---QAVDLLEKMLELDV 285
Query: 943 KSRLGSHEGANEIKKHPFF 961
RL A E +HP+F
Sbjct: 286 DKRL----TATEALEHPYF 300
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 63.6 bits (155), Expect = 8e-11
Identities = 60/241 (24%), Positives = 102/241 (42%), Gaps = 58/241 (24%)
Query: 672 QHFRPIKPLGSGDTGSVHLVELC-------GSGQYFAMKAMDKGVMLNRNKVHRACAERE 724
+H + I+ LG G+ GSV ELC +G+ A+K + + R E E
Sbjct: 4 RHLKFIQQLGKGNFGSV---ELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFER---EIE 57
Query: 725 ILDMLDHPFVPALYASFQTKTHVC---------LITDYCPGGELFLLLDRQPTKVLKEDA 775
IL L H + Y VC L+ +Y P G L L + ++ D
Sbjct: 58 ILKSLQHDNI-VKYKG------VCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERL---DH 107
Query: 776 VRF--YAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLP 833
+ YA+++ +EYL + ++RDL N+L++ V + DF L+ +LP
Sbjct: 108 RKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLT--------KVLP 159
Query: 834 TTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYE 893
E + + ++P+F + APE + + + A D W+ G++LYE
Sbjct: 160 QDKEYYKVREPGESPIF----------------WYAPESLTESKFSVASDVWSFGVVLYE 203
Query: 894 M 894
+
Sbjct: 204 L 204
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 63.4 bits (154), Expect = 8e-11
Identities = 76/277 (27%), Positives = 111/277 (40%), Gaps = 42/277 (15%)
Query: 678 KPLGSGDTGSVHLVELCGSGQ---YFAMKAMDKGVMLNRNKVHRA-CAEREILDMLDHPF 733
K +G+G+ G V L G+ A+K + G K R +E I+ DHP
Sbjct: 10 KVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYT---EKQRRDFLSEASIMGQFDHPN 66
Query: 734 VPALYASFQTKTHVCLITDYCPGGELFLLL---DRQPTKVLKEDAVRFYAAEVVVALEYL 790
+ L V ++T+Y G L L D Q T + +R A+ ++YL
Sbjct: 67 IIHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIAS----GMKYL 122
Query: 791 HCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVF 850
G ++RDL N+L+ N ++DF LS + P+ T K
Sbjct: 123 SDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKI----------- 171
Query: 851 MAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYE-MLYGYTPFRGKTRQKT 909
P+R + APE IA TSA D W+ GI+++E M YG P+ + Q
Sbjct: 172 ---PIR----------WTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDV 218
Query: 910 FANILHK-DLKFPSSTPTSLHAKQLMYRLLHRDPKSR 945
I L P P +LH QLM +D R
Sbjct: 219 IKAIEEGYRLPAPMDCPAALH--QLMLDCWQKDRNER 253
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 9e-11
Identities = 65/248 (26%), Positives = 110/248 (44%), Gaps = 56/248 (22%)
Query: 671 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDM-- 728
L+ ++ +KP+GSG G V +GQ A+K + + +N H A RE++ M
Sbjct: 15 LKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPF---QNVTHAKRAYRELVLMKL 71
Query: 729 LDHP--------FVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKV----LKEDAV 776
++H F P S + V L+ + L+D +V L + +
Sbjct: 72 VNHKNIIGLLNVFTPQ--KSLEEFQDVYLVME---------LMDANLCQVIQMDLDHERM 120
Query: 777 RFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTN 836
+ +++ +++LH GII+RDLKP N++++ + + + DF L+
Sbjct: 121 SYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA--------------- 165
Query: 837 EKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY 896
R G FM P +V T Y APE+I G G+ VD W++G ++ EM+
Sbjct: 166 ----RTAGTS---FMMTP------YVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIR 212
Query: 897 GYTPFRGK 904
G F G
Sbjct: 213 GTVLFPGT 220
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 63.9 bits (156), Expect = 9e-11
Identities = 75/336 (22%), Positives = 116/336 (34%), Gaps = 87/336 (25%)
Query: 674 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAERE--ILDMLDH 731
+ + +G G G V + Q A+K K +M N + A RE IL +L H
Sbjct: 14 YEKLAKIGQGTFGEVFKARHKKTKQIVALK---KVLMENEKEGFPITALREIKILQLLKH 70
Query: 732 PFVPALYASFQT--------KTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEV 783
V L +T K L+ ++C + +L V+F +E+
Sbjct: 71 ENVVNLIEICRTKATPYNRYKGSFYLVFEFC---------EHDLAGLLSNKNVKFTLSEI 121
Query: 784 -------VVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTN 836
+ L Y+H I++RD+K N+L+ +G + L DF L+ S N
Sbjct: 122 KKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLARAFSLS-------KN 174
Query: 837 EKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTS-AVDWWALGILLYEML 895
K R+ + V T Y PE++ G +D W G ++ EM
Sbjct: 175 SKPNRYTNR----------------VVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMW 218
Query: 896 YGYTPFRGKTRQKTFANI-------------------LHKDLKFPSSTP----------- 925
+G T Q I L K ++ P
Sbjct: 219 TRSPIMQGNTEQHQLTLISQLCGSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYV 278
Query: 926 TSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFF 961
HA L+ +LL DP R+ + N H FF
Sbjct: 279 KDPHALDLIDKLLVLDPAKRIDADTALN----HDFF 310
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 1e-10
Identities = 69/272 (25%), Positives = 113/272 (41%), Gaps = 38/272 (13%)
Query: 677 IKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPA 736
+K LG+G G V + A+K++ +G M AE ++ L HP +
Sbjct: 11 VKKLGAGQFGEVWM-GYYNGHTKVAIKSLKQGSM----SPEAFLAEANLMKQLQHPRLVR 65
Query: 737 LYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGII 796
LYA T+ + +IT+Y G L L L + + AA++ + ++ + I
Sbjct: 66 LYAVV-TQEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYI 124
Query: 797 YRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMR 856
+RDL+ N+L+ + DF L+ L NE R +G + P+
Sbjct: 125 HRDLRAANILVSETLCCKIADFGLARLIE---------DNEYTAR-EGAKFPI------- 167
Query: 857 ASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEML-YGYTPFRGKTRQKTFANILH 915
++ APE I T D W+ GILL E++ YG P+ G T + N L
Sbjct: 168 ---------KWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQN-LE 217
Query: 916 KDLKF--PSSTPTSLHAKQLMYRLLHRDPKSR 945
+ + P + P L+ +LM P+ R
Sbjct: 218 RGYRMPRPDNCPEELY--ELMRLCWKEKPEER 247
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 63.6 bits (155), Expect = 1e-10
Identities = 56/229 (24%), Positives = 96/229 (41%), Gaps = 67/229 (29%)
Query: 771 LKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQL 830
L + +F+ +++ AL+Y+H + +RDLKP+N+L + + + DF L+ +
Sbjct: 100 LTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADCKLKICDFGLA-----RVAF 154
Query: 831 L-LPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAG--AGHTSAVDWWAL 887
PT +F + +V T Y APE+ + +T A+D W++
Sbjct: 155 NDTPTA-------------IFWTD-------YVATRWYRAPELCGSFFSKYTPAIDIWSI 194
Query: 888 GILLYEMLYGYTPFRGKT--------------------------RQKTFANILHKDL--- 918
G + E+L G F GK + + + + + K
Sbjct: 195 GCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVRNEKARRYLSSMRKKQPVP 254
Query: 919 ---KFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGV 964
KFP++ P +L +L+ RLL DPK R A E P+FKG+
Sbjct: 255 FSQKFPNADPLAL---RLLERLLAFDPKDR----PTAEEALADPYFKGL 296
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 63.2 bits (153), Expect = 1e-10
Identities = 53/231 (22%), Positives = 101/231 (43%), Gaps = 32/231 (13%)
Query: 674 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPF 733
+ ++ LG G +V+ + +G+ A+K + + A E +L L H
Sbjct: 7 YEKLEKLGEGSYATVYKGKSKVNGKLVALKVIR--LQEEEGTPFTAIREASLLKGLKHAN 64
Query: 734 VPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQ 793
+ L+ TK + L+ +Y +L +D+ P L + V+ + +++ L Y+H +
Sbjct: 65 IVLLHDIIHTKETLTLVFEYV-HTDLCQYMDKHPGG-LHPENVKLFLFQLLRGLSYIHQR 122
Query: 794 GIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAE 853
I++RDLKP+N+L+ G + L DF L+ S
Sbjct: 123 YILHRDLKPQNLLISDTGELKLADFGLARAKSV--------------------------- 155
Query: 854 PMRASNSFVGTEEYIAPEIIAGAG-HTSAVDWWALGILLYEMLYGYTPFRG 903
P ++ V T Y P+++ G+ +++ +D W +G + EM+ G F G
Sbjct: 156 PSHTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPG 206
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 1e-10
Identities = 72/272 (26%), Positives = 118/272 (43%), Gaps = 38/272 (13%)
Query: 677 IKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPA 736
IK LG+G G V + G+ + A+K + G M + + A +I+ L H +
Sbjct: 11 IKKLGNGQFGEVWMGTWNGNTK-VAVKTLKPGTMSPESFLEEA----QIMKKLRHDKLVQ 65
Query: 737 LYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGII 796
LYA ++ + ++T+Y G L L + LK + AA+V + Y+ I
Sbjct: 66 LYAVV-SEEPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYI 124
Query: 797 YRDLKPENVLLQGNGHV-SLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPM 855
+RDL+ N+L+ G+G V + DF L+ L NE R +G + P+
Sbjct: 125 HRDLRSANILV-GDGLVCKIADFGLARLIE---------DNEYTAR-QGAKFPI------ 167
Query: 856 RASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY-GYTPFRGKTRQKTFANIL 914
++ APE T D W+ GILL E++ G P+ G ++ +
Sbjct: 168 ----------KWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVE 217
Query: 915 HK-DLKFPSSTPTSLHAKQLMYRLLHRDPKSR 945
+ P P SLH +LM + +DP+ R
Sbjct: 218 RGYRMPCPQDCPISLH--ELMLQCWKKDPEER 247
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 2e-10
Identities = 66/281 (23%), Positives = 105/281 (37%), Gaps = 38/281 (13%)
Query: 674 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPF 733
F + +G G G+V+ + + A+K M K E + L L HP
Sbjct: 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPN 82
Query: 734 VPALYASFQTKTHVCLITDYCPGGELFLL-LDRQPTKVLKEDAVRFYAAEVVVALEYLHC 792
+ + L+ +YC G LL + ++P + ++ A+ A + L YLH
Sbjct: 83 TIEYKGCYLKEHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQ---GLAYLHS 139
Query: 793 QGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMA 852
+I+RD+K N+LL G V L DF + +S
Sbjct: 140 HNMIHRDIKAGNILLTEPGQVKLADFGSASKSS--------------------------- 172
Query: 853 EPMRASNSFVGTEEYIAPEIIAG---AGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKT 909
+NSFVGT ++APE+I + VD W+LGI E+ P
Sbjct: 173 ----PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA 228
Query: 910 FANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHE 950
+I D S + + + L + P+ R S E
Sbjct: 229 LYHIAQNDSPTLQSNEWTDSFRGFVDYCLQKIPQERPASAE 269
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 62.4 bits (152), Expect = 2e-10
Identities = 70/286 (24%), Positives = 113/286 (39%), Gaps = 59/286 (20%)
Query: 678 KPLGSGDTGSVHLVELCGSGQYF---AMKAMDKGVMLNRNKVHRACAEREILDMLDHPFV 734
K LG G G V E SG A+K + + + E I+ LDH +
Sbjct: 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLK--EAAIMHSLDHENL 58
Query: 735 PALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRF--------YAAEVVVA 786
LY T + ++T+ P G L LDR L++DA+ YA ++
Sbjct: 59 IRLYGVVLTHP-LMMVTELAPLGSL---LDR-----LRKDALGHFLISTLCDYAVQIANG 109
Query: 787 LEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQ 846
+ YL + I+RDL N+LL + V + DF L + + +
Sbjct: 110 MRYLESKRFIHRDLAARNILLASDDKVKIGDFGLM-----------------RALPQNED 152
Query: 847 NPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEML-YGYTPFRGKT 905
+ V M E ++ + + APE + + A D W G+ L+EM YG P+ G +
Sbjct: 153 HYV-MEEHLKVPFA------WCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLS 205
Query: 906 RQKTFANILHK------DLKFPSSTPTSLHAKQLMYRLLHRDPKSR 945
+ IL K L+ P + P ++ +M + +P R
Sbjct: 206 G----SQILKKIDKEGERLERPEACPQDIY--NVMLQCWAHNPADR 245
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 62.3 bits (152), Expect = 2e-10
Identities = 66/274 (24%), Positives = 108/274 (39%), Gaps = 47/274 (17%)
Query: 687 SVHLVELCGSGQY-------------FAMKAMDKGVMLNRNKVHRACAEREILDMLDHPF 733
S+ L G+GQ+ A+K + G M E +I+ L H
Sbjct: 7 SLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTM----SPEAFLQEAQIMKKLRHDK 62
Query: 734 VPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQ 793
+ LYA + + ++T+Y G L L K L+ + AA++ + YL +
Sbjct: 63 LVQLYAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESR 122
Query: 794 GIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAE 853
I+RDL N+L+ N + DF L+ L +E R G + P+
Sbjct: 123 NYIHRDLAARNILVGENLVCKIADFGLARLIE---------DDEYTARE-GAKFPI---- 168
Query: 854 PMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEML-YGYTPFRGKTRQKTFAN 912
++ APE T D W+ GILL E++ YG P+ G T ++
Sbjct: 169 ------------KWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQ 216
Query: 913 I-LHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSR 945
+ + P + P L+ LM + +DP+ R
Sbjct: 217 VERGYRMPRPPNCPEELY--DLMLQCWDKDPEER 248
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 62.2 bits (151), Expect = 2e-10
Identities = 73/280 (26%), Positives = 115/280 (41%), Gaps = 50/280 (17%)
Query: 680 LGSGDTGSVHLVELCGSG---QYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPA 736
+G+G+ G V L G + A+K + G + + +E I+ DHP +
Sbjct: 12 IGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRR--DFLSEASIMGQFDHPNIIH 69
Query: 737 LYASFQTKTHVCLITDYCPGGEL--FLLL-DRQPTKVLKEDAVRFYAAEVVVALEYLHCQ 793
L V +IT++ G L FL D Q T + +R AA ++YL
Sbjct: 70 LEGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAA----GMKYLSEM 125
Query: 794 GIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAE 853
++RDL N+L+ N ++DF LS + +P + +
Sbjct: 126 NYVHRDLAARNILVNSNLVCKVSDFGLS-----------------RFLEDDTSDPTYTSS 168
Query: 854 -----PMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYE-MLYGYTPFRGKTRQ 907
P+R + APE IA TSA D W+ GI+++E M YG P+ + Q
Sbjct: 169 LGGKIPIR----------WTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQ 218
Query: 908 KTFANILHKDLKFPS--STPTSLHAKQLMYRLLHRDPKSR 945
N + +D + P PT+LH QLM +D +R
Sbjct: 219 DVI-NAIEQDYRLPPPMDCPTALH--QLMLDCWQKDRNAR 255
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 3e-10
Identities = 78/291 (26%), Positives = 122/291 (41%), Gaps = 59/291 (20%)
Query: 678 KPLGSGDTGSVHLVELC---GSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFV 734
K LG G+ GSV +L GS A+K M K + +++ +E + DHP V
Sbjct: 5 KILGEGEFGSVMEGQLSQDDGSQLKVAVKTM-KLDIHTYSEIEEFLSEAACMKDFDHPNV 63
Query: 735 PALY------ASFQTKTHVCLITDYCPGGEL--FLLLDR---QPTKVLKEDAVRFYAAEV 783
L +S Q +I + G+L FLL R P K+ + ++F ++
Sbjct: 64 MKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKF-MVDI 122
Query: 784 VVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKK---- 839
+ +EYL + I+RDL N +L+ + V + DF LS KK
Sbjct: 123 ALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLS----------------KKIYSG 166
Query: 840 ---RRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEML- 895
R+ + + PV ++IA E +A +TS D WA G+ ++E+
Sbjct: 167 DYYRQGRIAKMPV----------------KWIAIESLADRVYTSKSDVWAFGVTMWEIAT 210
Query: 896 YGYTPFRGKTRQKTFANILHKD-LKFPSSTPTSLHAKQLMYRLLHRDPKSR 945
G TP+ G + + + H + LK P L+ LMY DPK R
Sbjct: 211 RGQTPYPGVENHEIYDYLRHGNRLKQPEDCLDELYD--LMYSCWRADPKDR 259
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 3e-10
Identities = 63/240 (26%), Positives = 103/240 (42%), Gaps = 34/240 (14%)
Query: 668 QINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILD 727
+I + + +K LG+G G V + S + A+K + G M V E ++
Sbjct: 2 EIPRESIKLVKKLGAGQFGEVWMGYYNNSTK-VAVKTLKPGTM----SVQAFLEEANLMK 56
Query: 728 MLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQP-TKVLKEDAVRFYAAEVVVA 786
L H + LYA + + +IT+Y G L L KVL + F +A++
Sbjct: 57 TLQHDKLVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDF-SAQIAEG 115
Query: 787 LEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQ 846
+ Y+ + I+RDL+ NVL+ + + DF L+ + NE R +G +
Sbjct: 116 MAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIE---------DNEYTAR-EGAK 165
Query: 847 NPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEML-YGYTPFRGKT 905
P+ ++ APE I T D W+ GILLYE++ YG P+ G +
Sbjct: 166 FPI----------------KWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMS 209
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.9 bits (151), Expect = 3e-10
Identities = 58/230 (25%), Positives = 100/230 (43%), Gaps = 44/230 (19%)
Query: 674 FRPIKPLGSGDTGSVHLVELCGSGQYFAMK-----AMDKGVMLNRNKVHRACAEREI--L 726
++ ++ +G G G V+ +G+ A+K D+GV + A REI L
Sbjct: 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGV--------PSTAIREISLL 52
Query: 727 DMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVA 786
L+HP + L ++ + L+ ++ +L +D P L ++ Y +++
Sbjct: 53 KELNHPNIVRLLDVVHSENKLYLVFEFL-DLDLKKYMDSSPLTGLDPPLIKSYLYQLLQG 111
Query: 787 LEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQ 846
+ Y H +++RDLKP+N+L+ G + L DF L+ R G
Sbjct: 112 IAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLA-------------------RAFGV- 151
Query: 847 NPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTS-AVDWWALGILLYEML 895
P+R V T Y APEI+ G+ S VD W++G + EM+
Sbjct: 152 -------PVRTYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMV 194
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 3e-10
Identities = 50/183 (27%), Positives = 76/183 (41%), Gaps = 41/183 (22%)
Query: 722 EREILDMLDHPFVPALYASFQTKTHVCLI-----TD-YCPGGELFLLLDRQPTKVLKEDA 775
E IL ++HP + L +F CLI TD YC L ++ + A
Sbjct: 133 EAHILRAINHPSIIQLKGTFTYNKFTCLILPRYKTDLYC------YLAAKRNIAICDILA 186
Query: 776 VRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTT 835
+ V+ A++YLH II+RD+K EN+ + G V L DF +C P
Sbjct: 187 IE---RSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAAC---------FPVD 234
Query: 836 NEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEML 895
+ + + GT APE++A + AVD W+ GI+L+EM
Sbjct: 235 INANKYY-----------------GWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMA 277
Query: 896 YGY 898
+
Sbjct: 278 TCH 280
|
Length = 391 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 3e-10
Identities = 63/279 (22%), Positives = 110/279 (39%), Gaps = 76/279 (27%)
Query: 719 ACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKE----- 773
A E +L L H + L+ T+ + L+ +Y LD+ + L +
Sbjct: 51 AIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY---------LDKDLKQYLDDCGNSI 101
Query: 774 --DAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLL 831
V+ + +++ L Y H + +++RDLKP+N+L+ G + L DF L+ S
Sbjct: 102 NMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSI----- 156
Query: 832 LPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGA-GHTSAVDWWALGIL 890
P + ++ V T Y P+I+ G+ +++ +D W +G +
Sbjct: 157 ----------------------PTKTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCI 194
Query: 891 LYEMLYGYTPFRGKT---------------RQKTFANILH----KDLKFPSSTPTSLHAK 931
YEM G F G T ++T+ IL K +P LH
Sbjct: 195 FYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKSYNYPKYRADCLHNH 254
Query: 932 ---------QLMYRLLHRDPKSRLGSHEGANEIKKHPFF 961
+L+ +LL + + R+ A E KHP+F
Sbjct: 255 APRLDSDGAELLSKLLQFEGRKRI----SAEEAMKHPYF 289
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 4e-10
Identities = 59/233 (25%), Positives = 100/233 (42%), Gaps = 30/233 (12%)
Query: 673 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAM--DKGVMLNRNKVHRACAEREILDMLD 730
++R K LG G G V+L +G+ A+K + D +V+ E ++L L
Sbjct: 3 NWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLL 62
Query: 731 HPFVPALYASFQ--TKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALE 788
H + Y + + + + ++ PGG + L + L E+ R Y +++ +
Sbjct: 63 HERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQL--KSYGALTENVTRKYTRQILEGVS 120
Query: 789 YLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNP 848
YLH I++RD+K N+L G+V L DF S K Q
Sbjct: 121 YLHSNMIVHRDIKGANILRDSVGNVKLGDFGAS---------------------KRLQTI 159
Query: 849 VFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPF 901
M+ S GT +++PE+I+G G+ D W++G + EML P+
Sbjct: 160 CLSGTGMK---SVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPW 209
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 63.0 bits (153), Expect = 4e-10
Identities = 48/174 (27%), Positives = 76/174 (43%), Gaps = 31/174 (17%)
Query: 722 EREILDMLDHPFVPALYASFQTKTHVCLITDYCPG--GELFLLLDRQPTKVLKEDAVRFY 779
E +L L HP V AL CL+ P +L+ L + + L V
Sbjct: 210 EARLLRRLSHPAVLALLDVRVVGGLTCLVL---PKYRSDLYTYLGARL-RPLGLAQVTAV 265
Query: 780 AAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKK 839
A +++ A++Y+H +GII+RD+K ENVL+ G + L DF +C
Sbjct: 266 ARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFA--------------- 310
Query: 840 RRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYE 893
P GT + APE++AG +T +VD W+ G++++E
Sbjct: 311 --RGSWSTPFHYG--------IAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFE 354
|
Length = 461 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 61.3 bits (149), Expect = 5e-10
Identities = 67/300 (22%), Positives = 114/300 (38%), Gaps = 52/300 (17%)
Query: 668 QINLQHFRPIKPLGSGDTGSVHLVELCG-----SGQYFAMKAMDKGVMLN-RNKVHRACA 721
+I L R ++ LG G G V+ EL G S A+K + + + + +
Sbjct: 1 EIPLSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQ--- 57
Query: 722 EREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGEL--FLLL------------DRQP 767
E E++ L HP + L + C++ +Y G+L FL+ D
Sbjct: 58 EAELMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETV 117
Query: 768 TKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCK 827
L A ++ +EYL ++RDL N L+ V ++DF LS
Sbjct: 118 KSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGLTVKISDFGLSRD---- 173
Query: 828 PQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWAL 887
++ A+ R + + ++ PE I T+ D W+
Sbjct: 174 ---------------------IYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSF 212
Query: 888 GILLYEML-YGYTPFRGKTRQKTFANILHKD-LKFPSSTPTSLHAKQLMYRLLHRDPKSR 945
G++L+E+ YG P+ G + Q+ I + L P P ++A LM + P R
Sbjct: 213 GVVLWEIFSYGLQPYYGFSNQEVIEMIRSRQLLPCPEDCPARVYA--LMIECWNEIPARR 270
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 61.7 bits (150), Expect = 5e-10
Identities = 73/331 (22%), Positives = 119/331 (35%), Gaps = 61/331 (18%)
Query: 672 QHFRPI-KPLGSGDTGSVHLVELCGSGQYFAMKAM-----DKGVMLNRNKVHRA----CA 721
+ + LG G G V +G+ A+K + V +R V
Sbjct: 8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTT 67
Query: 722 EREILDM--LDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKV-LKEDAVRF 778
RE+ M + H + L + + L+ D +L ++DR K+ L E V+
Sbjct: 68 LRELKIMNEIKHENIMGLVDVYVEGDFINLVMDIM-ASDLKKVVDR---KIRLTESQVKC 123
Query: 779 YAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEK 838
+++ L LH ++RDL P N+ + G + DF L+ P T ++
Sbjct: 124 ILLQILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPP--YSDTLSKD 181
Query: 839 KRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAG-HTSAVDWWALGILLYEMLYG 897
+ + S V T Y APE++ GA + AVD W++G + E+L G
Sbjct: 182 ET-----------MQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTG 230
Query: 898 YTPFRGKTRQKTFANILH-----------KDLKFPSSTPTSLHAKQ-------------- 932
F G+ I + K P T + +
Sbjct: 231 KPLFPGENEIDQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAI 290
Query: 933 -LMYRLLHRDPKSRLGSHEGANEIKKHPFFK 962
L+ LL +P R+ A E KH +FK
Sbjct: 291 DLLQSLLKLNPLERI----SAKEALKHEYFK 317
|
Length = 335 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 62.2 bits (151), Expect = 6e-10
Identities = 59/235 (25%), Positives = 95/235 (40%), Gaps = 48/235 (20%)
Query: 677 IKPLGSGDTGSVHLVELCGSGQY--FAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFV 734
+ L G G V + G Q +KA+ G R E +IL + H +
Sbjct: 97 LSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGGKTPGR--------EIDILKTISHRAI 148
Query: 735 PALYASFQTKTHVCLITDY--CPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHC 792
L +++ K+ VC++ C +LF +DR L++ ++ AL YLH
Sbjct: 149 INLIHAYRWKSTVCMVMPKYKC---DLFTYVDRSGPLPLEQ--AITIQRRLLEALAYLHG 203
Query: 793 QGIIYRDLKPENVLLQGNGHVSLTDFDLSC-LTSC--KPQLLLPTTNEKKRRHKGQQNPV 849
+GII+RD+K EN+ L + L DF +C L + PQ
Sbjct: 204 RGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQ-------------------- 243
Query: 850 FMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGK 904
+ GT E +PE++A + + D W+ G++L+EM GK
Sbjct: 244 --------CYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGK 290
|
Length = 392 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 60.5 bits (147), Expect = 9e-10
Identities = 78/324 (24%), Positives = 127/324 (39%), Gaps = 76/324 (23%)
Query: 674 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAM-----DKGVMLNRNKVHRACAEREI--L 726
+ I+ +G G G V+ +GQ AMK + ++GV + A REI L
Sbjct: 2 YTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGV--------PSTAIREISLL 53
Query: 727 DMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPT-KVLKEDAVRFYAAEVVV 785
L HP + L ++ + LI ++ +L LD P + + + V+ Y +++
Sbjct: 54 KELQHPNIVCLQDVLMQESRLYLIFEFL-SMDLKKYLDSLPKGQYMDAELVKSYLYQILQ 112
Query: 786 ALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQ 845
+ + H + +++RDLKP+N+L+ G + L DF L+ R G
Sbjct: 113 GILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLA-------------------RAFGI 153
Query: 846 QNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSA-VDWWALGILLYEMLYGYTPFRGK 904
P+R V T Y APE++ G+ S VD W++G + EM F G
Sbjct: 154 --------PVRVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGD 205
Query: 905 TRQKTFANILH----------------KDLK--FPSSTPTSLHAK---------QLMYRL 937
+ I D K FP SL + L+ ++
Sbjct: 206 SEIDQLFRIFRILGTPTEDVWPGVTSLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKM 265
Query: 938 LHRDPKSRLGSHEGANEIKKHPFF 961
L DP R+ A + HP+F
Sbjct: 266 LIYDPAKRI----SAKKALNHPYF 285
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 2e-09
Identities = 76/327 (23%), Positives = 126/327 (38%), Gaps = 87/327 (26%)
Query: 677 IKPLGSGDTGSVHLVELCGSGQYFAMKAM----DKGVMLNRNKVHRACAEREILDMLDHP 732
++ LG G +V+ +GQ A+K + ++GV A E +L L H
Sbjct: 10 LEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFT------AIREASLLKGLKHA 63
Query: 733 FVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHC 792
+ L+ TK + + +Y +L + + P L VR + +++ L Y+H
Sbjct: 64 NIVLLHDIIHTKETLTFVFEYMHT-DLAQYMIQHPGG-LHPYNVRLFMFQLLRGLAYIHG 121
Query: 793 QGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMA 852
Q I++RDLKP+N+L+ G + L DF L+ R K +
Sbjct: 122 QHILHRDLKPQNLLISYLGELKLADFGLA-------------------RAK--------S 154
Query: 853 EPMRASNSFVGTEEYIAPEIIAGA-GHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFA 911
P + +S V T Y P+++ GA ++SA+D W G + EML G F G +
Sbjct: 155 IPSQTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPG------VS 208
Query: 912 NILHKDLK--------------------------FPSSTPTSLH-----------AKQLM 934
++ + K F P L A+ L
Sbjct: 209 DVFEQLEKIWTVLGVPTEDTWPGVSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLA 268
Query: 935 YRLLHRDPKSRLGSHEGANEIKKHPFF 961
++L PK R+ A + HP+F
Sbjct: 269 SQMLMMFPKDRI----SAQDALLHPYF 291
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 60.1 bits (145), Expect = 2e-09
Identities = 56/212 (26%), Positives = 89/212 (41%), Gaps = 37/212 (17%)
Query: 719 ACAEREILDMLDHPFVPALYASF--QTKTHVCLITDYCPGGELFLLLDRQPTKV------ 770
AC E +L L HP V AL F + V L+ DY ++ + +K
Sbjct: 45 ACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQ 104
Query: 771 LKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGN----GHVSLTDFDLSCLTSC 826
L V+ +++ + YLH +++RDLKP N+L+ G G V + D + L +
Sbjct: 105 LPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFN- 163
Query: 827 KPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGH-TSAVDWW 885
+P+ +P+ + V T Y APE++ GA H T A+D W
Sbjct: 164 --------------------SPL---KPLADLDPVVVTFWYRAPELLLGARHYTKAIDIW 200
Query: 886 ALGILLYEMLYGYTPFRGKTRQKTFANILHKD 917
A+G + E+L F + +N H D
Sbjct: 201 AIGCIFAELLTSEPIFHCRQEDIKTSNPFHHD 232
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 2e-09
Identities = 63/279 (22%), Positives = 113/279 (40%), Gaps = 36/279 (12%)
Query: 669 INLQHFRPIKPLGSGDTGSVHLVELCGSGQY-FAMKAMDKGVMLNRNKVHRACAEREILD 727
I+ + +K LG+G G V + GQY A+K + +G M + A +++
Sbjct: 1 IDPKDLTFLKELGTGQFGVVKYGKW--RGQYDVAIKMIKEGSMSEDEFIEEA----KVMM 54
Query: 728 MLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVAL 787
L H + LY + + ++T+Y G L L R+ K + + +V +
Sbjct: 55 KLSHEKLVQLYGVCTKQRPIYIVTEYMSNGCLLNYL-REHGKRFQPSQLLEMCKDVCEGM 113
Query: 788 EYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQN 847
YL + I+RDL N L+ G V ++DF LS + +L +++ G +
Sbjct: 114 AYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLS-------RYVL---DDEYTSSVGSKF 163
Query: 848 PVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEML-YGYTPFRGKTR 906
PV + PE++ + +S D WA G+L++E+ G P+
Sbjct: 164 PV----------------RWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNN 207
Query: 907 QKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSR 945
+T + + L+ S +MY H + R
Sbjct: 208 SETVEKVS-QGLRLYRPHLASEKVYAIMYSCWHEKAEER 245
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 59.5 bits (144), Expect = 3e-09
Identities = 74/319 (23%), Positives = 127/319 (39%), Gaps = 74/319 (23%)
Query: 677 IKPLGSGDTGSVHLVELCGSGQYFAMKAMDK--GVMLNRNKVHRACAEREILDMLDHPFV 734
++P+G G G V +GQ A+K + K + + +R E ++L L H +
Sbjct: 15 LQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYR---ELKLLKHLRHENI 71
Query: 735 PALYASF-QTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQ 793
+L F + +T+ G +L LL +P L++ ++++ +++ L+Y+H
Sbjct: 72 ISLSDIFISPLEDIYFVTELL-GTDLHRLLTSRP---LEKQFIQYFLYQILRGLKYVHSA 127
Query: 794 GIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAE 853
G+++RDLKP N+L+ N + + DF L+ + PQ+
Sbjct: 128 GVVHRDLKPSNILINENCDLKICDFGLARIQD--PQM----------------------- 162
Query: 854 PMRASNSFVGTEEYIAPEI-IAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFAN 912
+V T Y APEI + + VD W+ G + EML G F GK F+
Sbjct: 163 -----TGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSI 217
Query: 913 IL----------------HKDLKFPSSTP-------------TSLHAKQLMYRLLHRDPK 943
I L+F S P A L+ ++L DP+
Sbjct: 218 ITDLLGTPPDDVINTICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQ 277
Query: 944 SRLGSHEGANEIKKHPFFK 962
R+ + E HP+
Sbjct: 278 KRISAAEAL----AHPYLA 292
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 3e-09
Identities = 62/243 (25%), Positives = 103/243 (42%), Gaps = 50/243 (20%)
Query: 672 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVH--RACAEREILDML 729
+ ++ + P+GSG GSV Q A+K + + ++ +H R E +L +
Sbjct: 15 ERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPF---QSLIHARRTYRELRLLKHM 71
Query: 730 DHP--------FVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAA 781
H F PA S + V L+T+ G +L ++ Q L ++ V+F
Sbjct: 72 KHENVIGLLDVFTPA--TSIENFNEVYLVTNLM-GADLNNIVKCQK---LSDEHVQFLIY 125
Query: 782 EVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRR 841
+++ L+Y+H GII+RDLKP NV + + + + DF L+
Sbjct: 126 QLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQAD---------------- 169
Query: 842 HKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGH-TSAVDWWALGILLYEMLYGYTP 900
+ M +V T Y APEI+ H VD W++G ++ E+L G
Sbjct: 170 -----------DEM---TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKAL 215
Query: 901 FRG 903
F G
Sbjct: 216 FPG 218
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 58.5 bits (142), Expect = 5e-09
Identities = 56/207 (27%), Positives = 79/207 (38%), Gaps = 50/207 (24%)
Query: 769 KVLKEDAVRFYAAEVVVALEYLHCQ-GIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCK 827
V+ E+ + A V AL YL + II+RD+KP N+LL NG++ L DF +S
Sbjct: 102 SVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGIS------ 155
Query: 828 PQLLLPTTNEKKRRHKGQ-QNPVFMAEPMRASNSFVGTEEYIAPEIIA---GAGHTSAVD 883
GQ + + A G Y+APE I G+ D
Sbjct: 156 ----------------GQLVDSI-------AKTRDAGCRPYMAPERIDPSARDGYDVRSD 192
Query: 884 WWALGILLYEMLYGYTPFRG------KTRQ--KTFANILHKDLKFPSSTPTSLHAKQLMY 935
W+LGI LYE+ G P+ + Q K IL + S +
Sbjct: 193 VWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKGDPPILSNSEEREFSPSF----VNFIN 248
Query: 936 RLLHRDPKSRLGSHEGANEIKKHPFFK 962
L +D R E+ +HPF K
Sbjct: 249 LCLIKDESKR----PKYKELLEHPFIK 271
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|238075 cd00130, PAS, PAS domain; PAS motifs appear in archaea, eubacteria and eukarya | Back alignment and domain information |
|---|
Score = 53.8 bits (129), Expect = 7e-09
Identities = 27/94 (28%), Positives = 55/94 (58%), Gaps = 8/94 (8%)
Query: 217 IMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKIRETLQN----GQSYCGRLLN 272
I+YA+ ++ GY+ +E++G++ L PED ++RE L+N G+ +
Sbjct: 14 ILYANPAAEQLLGYSPEELIGKSLLDL----IHPEDREELRERLENLLSGGEPVTLEVRL 69
Query: 273 YKKDGTPFWNLLTIAPIKDDEGKVLKFIGMQVEV 306
+KDG+ W L+++ PI+D+ G+V+ +G+ ++
Sbjct: 70 RRKDGSVIWVLVSLTPIRDEGGEVIGLLGVVRDI 103
|
Probably the most surprising identification of a PAS domain was that in EAG-like K+-channels. PAS domains have been found to bind ligands, and to act as sensors for light and oxygen in signal transduction. Length = 103 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 57.4 bits (139), Expect = 8e-09
Identities = 52/234 (22%), Positives = 92/234 (39%), Gaps = 37/234 (15%)
Query: 669 INLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDM 728
IN + + +G G+ G V L + GQ A+K + + AE ++
Sbjct: 3 INSKELKLGATIGKGEFGDVMLGDY--RGQKVAVKCLKD----DSTAAQAFLAEASVMTT 56
Query: 729 LDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALE 788
L HP + L + ++T+Y G L L + V+ +A +V +E
Sbjct: 57 LRHPNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGME 116
Query: 789 YLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNP 848
YL + ++RDL NVL+ + ++DF L+ E + + P
Sbjct: 117 YLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLA--------------KEASQGQDSGKLP 162
Query: 849 VFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEML-YGYTPF 901
V ++ APE + ++ D W+ GILL+E+ +G P+
Sbjct: 163 V----------------KWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPY 200
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 57.8 bits (139), Expect = 1e-08
Identities = 55/212 (25%), Positives = 88/212 (41%), Gaps = 37/212 (17%)
Query: 719 ACAEREILDMLDHPFVPALYASF--QTKTHVCLITDYCPGGELFLLLDRQPTKV------ 770
AC E +L L HP V +L F V L+ DY ++ + +K
Sbjct: 45 ACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQ 104
Query: 771 LKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGN----GHVSLTDFDLSCLTSC 826
L V+ +++ + YLH +++RDLKP N+L+ G G V + D + L +
Sbjct: 105 LPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFN- 163
Query: 827 KPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGH-TSAVDWW 885
+P+ +P+ + V T Y APE++ GA H T A+D W
Sbjct: 164 --------------------SPL---KPLADLDPVVVTFWYRAPELLLGARHYTKAIDIW 200
Query: 886 ALGILLYEMLYGYTPFRGKTRQKTFANILHKD 917
A+G + E+L F + +N H D
Sbjct: 201 AIGCIFAELLTSEPIFHCRQEDIKTSNPYHHD 232
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 1e-08
Identities = 64/268 (23%), Positives = 110/268 (41%), Gaps = 36/268 (13%)
Query: 680 LGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYA 739
LG G G V + G+ + A+K + G M + A +++ L H + LYA
Sbjct: 14 LGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFLQEA----QVMKKLRHEKLVQLYA 68
Query: 740 SFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRD 799
++ + ++T+Y G L L + K L+ + AA++ + Y+ ++RD
Sbjct: 69 VV-SEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRD 127
Query: 800 LKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASN 859
L+ N+L+ N + DF L+ L NE R +G + P+
Sbjct: 128 LRAANILVGENLVCKVADFGLARLIE---------DNEYTAR-QGAKFPI---------- 167
Query: 860 SFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY-GYTPFRGKTRQKTFANILHK-D 917
++ APE T D W+ GILL E+ G P+ G ++ +
Sbjct: 168 ------KWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYR 221
Query: 918 LKFPSSTPTSLHAKQLMYRLLHRDPKSR 945
+ P P SLH LM + ++P+ R
Sbjct: 222 MPCPPECPESLH--DLMCQCWRKEPEER 247
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 1e-08
Identities = 62/283 (21%), Positives = 120/283 (42%), Gaps = 44/283 (15%)
Query: 669 INLQHFRPIKPLGSGDTGSVHLVELCGSGQY---FAMKAMDKGVMLNRNKVHRACAEREI 725
I+ ++ +GSG G V L G A+K + +G M + + A ++
Sbjct: 1 IHPSELTLVQEIGSGQFGLVWL----GYWLEKRKVAIKTIREGAMSEEDFIEEA----QV 52
Query: 726 LDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVV 785
+ L HP + LY ++ +CL+ ++ G L L Q K +E + +V
Sbjct: 53 MMKLSHPKLVQLYGVCTERSPICLVFEFMEHGCLSDYLRAQRGKFSQE-TLLGMCLDVCE 111
Query: 786 ALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQ 845
+ YL +I+RDL N L+ N V ++DF ++ + +L +++ G
Sbjct: 112 GMAYLESSNVIHRDLAARNCLVGENQVVKVSDFGMT-------RFVL---DDQYTSSTGT 161
Query: 846 QNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY-GYTPFRGK 904
+ PV ++ +PE+ + + ++S D W+ G+L++E+ G TP+ +
Sbjct: 162 KFPV----------------KWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENR 205
Query: 905 TRQKTFANIL--HKDLKFPSSTPTSLHAKQLMYRLLHRDPKSR 945
+ + I + K P S++ +LM P+ R
Sbjct: 206 SNSEVVETINAGFRLYK-PRLASQSVY--ELMQHCWKERPEDR 245
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 1e-08
Identities = 60/275 (21%), Positives = 108/275 (39%), Gaps = 62/275 (22%)
Query: 719 ACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRF 778
A E +L L H + L+ T + L+ +Y +L +D ++ V+
Sbjct: 51 AIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEYL-DKDLKQYMD-DCGNIMSMHNVKI 108
Query: 779 YAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEK 838
+ +++ L Y H + +++RDLKP+N+L+ G + L DF L+ S
Sbjct: 109 FLYQILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSV------------ 156
Query: 839 KRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAG-HTSAVDWWALGILLYEMLYG 897
P + ++ V T Y P+++ G+ +++ +D W +G + +EM G
Sbjct: 157 ---------------PTKTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASG 201
Query: 898 YTPFRGKTRQKTFANILH-------------------KDLKFPSSTPTSL--HAK----- 931
F G T + I K+ FP P L HA
Sbjct: 202 RPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFKNYNFPKYKPQPLINHAPRLDTE 261
Query: 932 --QLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGV 964
+L+ + L + K R+ A E KH +F+ +
Sbjct: 262 GIELLTKFLQYESKKRI----SAEEAMKHAYFRSL 292
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|219844 pfam08447, PAS_3, PAS fold | Back alignment and domain information |
|---|
Score = 52.0 bits (125), Expect = 2e-08
Identities = 29/90 (32%), Positives = 43/90 (47%), Gaps = 7/90 (7%)
Query: 217 IMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKIRETLQ-----NGQSYCGRLL 271
I+Y S F ++ GYT +E+ +L PED ++R LQ G+ Y G
Sbjct: 1 IIYWSPRFEEILGYTPEELKSSYEGWLDL--VHPEDRERVRRALQEFSLKKGEPYSGEYR 58
Query: 272 NYKKDGTPFWNLLTIAPIKDDEGKVLKFIG 301
+KDG W PI+D+ GK ++ IG
Sbjct: 59 IRRKDGEYRWVEARGRPIRDENGKPVRVIG 88
|
The PAS fold corresponds to the structural domain that has previously been defined as PAS and PAC motifs. The PAS fold appears in archaea, eubacteria and eukarya. Length = 90 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 2e-08
Identities = 61/272 (22%), Positives = 108/272 (39%), Gaps = 62/272 (22%)
Query: 719 ACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRF 778
A E +L L H + L+ T+ + L+ +Y +L LD ++ V+
Sbjct: 50 AIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEYLDS-DLKQYLD-NCGNLMSMHNVKI 107
Query: 779 YAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEK 838
+ +++ L Y H + I++RDLKP+N+L+ G + L DF L+ S
Sbjct: 108 FMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLARAKSV------------ 155
Query: 839 KRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAG-HTSAVDWWALGILLYEMLYG 897
P + ++ V T Y P+++ G+ +++ +D W +G +LYEM G
Sbjct: 156 ---------------PTKTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATG 200
Query: 898 YTPFRGKTRQKTF-------------------ANILHKDLKFPSSTPTSL--HAKQ---- 932
F G T ++ +N + FP L HA +
Sbjct: 201 RPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFRSYLFPQYRAQPLINHAPRLDTD 260
Query: 933 ---LMYRLLHRDPKSRLGSHEGANEIKKHPFF 961
L+ LL + KSR+ + +H +F
Sbjct: 261 GIDLLSSLLLYETKSRISAEAAL----RHSYF 288
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|232884 TIGR00229, sensory_box, PAS domain S-box | Back alignment and domain information |
|---|
Score = 53.1 bits (128), Expect = 2e-08
Identities = 22/96 (22%), Positives = 42/96 (43%), Gaps = 2/96 (2%)
Query: 500 IIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIRAAIDNQTDVTVQLINY-TK 558
I++ + +F E+ YS EE++GRN L E +I ++ + + + K
Sbjct: 25 ILYVNPAFEEIFGYSAEELIGRNVLELIPEEDREEVRERIERRLEGEREPVSEERRVRRK 84
Query: 559 SGKKFWNLFHLQPMRDQKGEVQYFIGVQLDGSEHLE 594
G + W + P+R G +G+ D +E +
Sbjct: 85 DGSEIWVEVSVSPIRTN-GGELGVVGIVRDITERKQ 119
|
The PAS domain was previously described. This sensory box, or S-box domain occupies the central portion of the PAS domain but is more widely distributed. It is often tandemly repeated. Known prosthetic groups bound in the S-box domain include heme in the oxygen sensor FixL, FAD in the redox potential sensor NifL, and a 4-hydroxycinnamyl chromophore in photoactive yellow protein. Proteins containing the domain often contain other regulatory domains such as response regulator or sensor histidine kinase domains. Other S-box proteins include phytochromes and the aryl hydrocarbon receptor nuclear translocator [Regulatory functions, Small molecule interactions]. Length = 124 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 3e-08
Identities = 42/189 (22%), Positives = 82/189 (43%), Gaps = 28/189 (14%)
Query: 721 AEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYA 780
+E IL DHP + L + + ++ + PGG+ L ++ ++ + V+F A
Sbjct: 41 SEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKF-A 99
Query: 781 AEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKR 840
+ + YL + I+RDL N L+ N + ++DF +S
Sbjct: 100 LDAAAGMAYLESKNCIHRDLAARNCLVGENNVLKISDFGMS------------------- 140
Query: 841 RHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEML-YGYT 899
+ + + ++ + ++ ++ APE + ++S D W+ GILL+E G
Sbjct: 141 --RQEDDGIYSSSGLKQI-----PIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVC 193
Query: 900 PFRGKTRQK 908
P+ G T Q+
Sbjct: 194 PYPGMTNQQ 202
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 55.9 bits (135), Expect = 3e-08
Identities = 70/321 (21%), Positives = 125/321 (38%), Gaps = 77/321 (23%)
Query: 677 IKPLGSGDTGSVHLVELCGSGQYFAMKAM-----DKGVMLNRNKVHRACAEREI--LDML 729
++ +G G G+V + + + A+K + D+GV + A REI L L
Sbjct: 5 LEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSS--------ALREICLLKEL 56
Query: 730 DHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEY 789
H + LY + + L+ +YC +L D + + V+ + +++ L +
Sbjct: 57 KHKNIVRLYDVLHSDKKLTLVFEYC-DQDLKKYFDSCNGDI-DPEIVKSFMFQLLKGLAF 114
Query: 790 LHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPV 849
H +++RDLKP+N+L+ NG + L DF L+ R G
Sbjct: 115 CHSHNVLHRDLKPQNLLINKNGELKLADFGLA-------------------RAFGI---- 151
Query: 850 FMAEPMRASNSFVGTEEYIAPEIIAGA-GHTSAVDWWALGILLYEMLYGYTP-FRGKTRQ 907
P+R ++ V T Y P+++ GA +++++D W+ G + E+ P F G
Sbjct: 152 ----PVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVD 207
Query: 908 KTFANI-----------------LHKDLKFPSSTPTSLHA----------KQLMYRLLHR 940
I L +P T+ + L+ LL
Sbjct: 208 DQLKRIFRLLGTPTEESWPGVSKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVC 267
Query: 941 DPKSRLGSHEGANEIKKHPFF 961
+P R+ A E +HP+F
Sbjct: 268 NPVQRI----SAEEALQHPYF 284
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 55.1 bits (132), Expect = 5e-08
Identities = 67/268 (25%), Positives = 110/268 (41%), Gaps = 36/268 (13%)
Query: 680 LGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYA 739
LG G G V + G+ + A+K + G M+ + A +I+ L H + LYA
Sbjct: 14 LGQGCFGEVWMGTWNGTTK-VAIKTLKPGTMMPEAFLQEA----QIMKKLRHDKLVPLYA 68
Query: 740 SFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRD 799
++ + ++T++ G L L K LK + AA++ + Y+ I+RD
Sbjct: 69 VV-SEEPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRD 127
Query: 800 LKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASN 859
L+ N+L+ N + DF L+ L NE R +G + P+
Sbjct: 128 LRAANILVGDNLVCKIADFGLARLIE---------DNEYTAR-QGAKFPI---------- 167
Query: 860 SFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY-GYTPFRGKTRQKTFANILHK-D 917
++ APE T D W+ GILL E++ G P+ G ++ +
Sbjct: 168 ------KWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGYR 221
Query: 918 LKFPSSTPTSLHAKQLMYRLLHRDPKSR 945
+ P P SLH +LM +DP R
Sbjct: 222 MPCPQGCPESLH--ELMKLCWKKDPDER 247
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 55.1 bits (132), Expect = 5e-08
Identities = 63/286 (22%), Positives = 104/286 (36%), Gaps = 48/286 (16%)
Query: 678 KPLGSGDTGSVHLVE---LCGSGQ--YFAMKAMDKGVMLNRNKVHRACAEREILDMLDHP 732
+ LG G G V L E LC A+K + R HR E E+L L H
Sbjct: 11 RELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHR---EAELLTNLQHE 67
Query: 733 FVPALYASFQTKTHVCLITDYCPGGEL-----------FLLLDRQPTKVLKEDAVRFYAA 781
+ Y + ++ +Y G+L L+ + L + + A
Sbjct: 68 HIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQ 127
Query: 782 EVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRR 841
++ + YL Q ++RDL N L+ N V + DF
Sbjct: 128 QIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDF----------------------- 164
Query: 842 HKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEML-YGYTP 900
G V+ + R + ++ PE I T+ D W+LG++L+E+ YG P
Sbjct: 165 --GMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQP 222
Query: 901 FRGKTRQKTFANILH-KDLKFPSSTPTSLHAKQLMYRLLHRDPKSR 945
+ + + I + L+ P + P ++ LM R+P R
Sbjct: 223 WYQLSNNEVIECITQGRVLQRPRTCPKEVY--DLMLGCWQREPHMR 266
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 6e-08
Identities = 63/293 (21%), Positives = 114/293 (38%), Gaps = 55/293 (18%)
Query: 673 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVM---LNRNKVHRACAE-REILDM 728
+ + I LG G+ G V L + G + + V+ L + K +E R LDM
Sbjct: 6 NLQEITTLGRGEFGEVFLAKAKGI----EEEGGETLVLVKALQKTKDENLQSEFRRELDM 61
Query: 729 ---LDHPFVPALYASFQTKTHVCLITDYCPGGEL--FLLLDR--------QPTKVLKEDA 775
L H V L + +I +Y G+L FL + P ++ A
Sbjct: 62 FRKLSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVA 121
Query: 776 VRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTT 835
+ ++ + +++L ++RDL N L+ V + S L+ K
Sbjct: 122 L---CTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKV-----SLLSLSK-------D 166
Query: 836 NEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEML 895
+K + + P+R ++APE + ++ D W+ G+L++E+
Sbjct: 167 VYNSEYYKLRNALI----PLR----------WLAPEAVQEDDFSTKSDVWSFGVLMWEVF 212
Query: 896 -YGYTPFRGKTRQKTFANILHKDLKF--PSSTPTSLHAKQLMYRLLHRDPKSR 945
G PF G + ++ + L+ P P+ L+ +LM R +PK R
Sbjct: 213 TQGELPFYGLSDEEVLNRLQAGKLELPVPEGCPSRLY--KLMTRCWAVNPKDR 263
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 54.7 bits (132), Expect = 7e-08
Identities = 60/227 (26%), Positives = 95/227 (41%), Gaps = 32/227 (14%)
Query: 721 AEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYA 780
E I+ DHP + L T+ V ++ + P GEL L L ++ Y+
Sbjct: 56 QEAYIMRQFDHPHIVKLIGVI-TENPVWIVMELAPLGELRSYLQVNKYS-LDLASLILYS 113
Query: 781 AEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKR 840
++ AL YL + ++RD+ NVL+ V L DF LS + L + K
Sbjct: 114 YQLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLS-------RYLEDESYYKAS 166
Query: 841 RHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEML-YGYT 899
+ K P++ ++APE I TSA D W G+ ++E+L G
Sbjct: 167 KGK---------LPIK----------WMAPESINFRRFTSASDVWMFGVCMWEILMLGVK 207
Query: 900 PFRGKTRQKTFANILHKD-LKFPSSTPTSLHAKQLMYRLLHRDPKSR 945
PF+G I + + L P + P +L++ LM + DP R
Sbjct: 208 PFQGVKNNDVIGRIENGERLPMPPNCPPTLYS--LMTKCWAYDPSKR 252
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 54.7 bits (132), Expect = 7e-08
Identities = 58/233 (24%), Positives = 87/233 (37%), Gaps = 42/233 (18%)
Query: 721 AEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYA 780
E I+ DHP + L V +IT+Y G L L K V
Sbjct: 54 TEASIMGQFDHPNIIRLEGVVTKSRPVMIITEYMENGSLDKFLRENDGKFTVGQLVGM-L 112
Query: 781 AEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKR 840
+ ++YL ++RDL N+L+ N ++DF LS
Sbjct: 113 RGIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLS------------------- 153
Query: 841 RHKGQQNPVFMAE----PMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYE-ML 895
R + + P+R + APE IA TSA D W+ GI+++E M
Sbjct: 154 RRLEDSEATYTTKGGKIPIR----------WTAPEAIAYRKFTSASDVWSFGIVMWEVMS 203
Query: 896 YGYTPFRGKTRQKTFANILHKD---LKFPSSTPTSLHAKQLMYRLLHRDPKSR 945
YG P+ + Q + +D L P P++L+ QLM +D R
Sbjct: 204 YGERPYWDMSNQDVIKAV--EDGYRLPPPMDCPSALY--QLMLDCWQKDRNER 252
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 8e-08
Identities = 55/248 (22%), Positives = 93/248 (37%), Gaps = 53/248 (21%)
Query: 722 EREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDR-----QPTKVLKEDAV 776
E ++ DHP + L +CL+ +Y G+L L Q + +
Sbjct: 58 EAALMAEFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSA 117
Query: 777 RFY---------------AAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLS 821
R A +V + YL + ++RDL N L+ N V + DF LS
Sbjct: 118 RKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLS 177
Query: 822 CLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSA 881
+N ++ A+ +AS + ++ PE I +T+
Sbjct: 178 ------------------------RN-IYSADYYKASENDAIPIRWMPPESIFYNRYTTE 212
Query: 882 VDWWALGILLYEML-YGYTPFRGKTRQKTFANILHKD---LKFPSSTPTSLHAKQLMYRL 937
D WA G++L+E+ YG P+ G ++ + +D L P + P L+ LM
Sbjct: 213 SDVWAYGVVLWEIFSYGMQPYYGMAHEEVIYYV--RDGNVLSCPDNCPLELYN--LMRLC 268
Query: 938 LHRDPKSR 945
+ P R
Sbjct: 269 WSKLPSDR 276
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 8e-08
Identities = 65/281 (23%), Positives = 111/281 (39%), Gaps = 44/281 (15%)
Query: 669 INLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDM 728
+N++ + ++ +G G+ G V L G Y K K + N AE ++
Sbjct: 3 LNMKELKLLQTIGKGEFGDVML------GDYRGNKVAVKCIK-NDATAQAFLAEASVMTQ 55
Query: 729 LDHP-FVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVAL 787
L H V L + K + ++T+Y G L L + VL D + ++ +V A+
Sbjct: 56 LRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAM 115
Query: 788 EYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQN 847
EYL ++RDL NVL+ + ++DF L T E +
Sbjct: 116 EYLEANNFVHRDLAARNVLVSEDNVAKVSDFGL--------------TKEASSTQDTGKL 161
Query: 848 PVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEML-YGYTPFRGKTR 906
PV ++ APE + ++ D W+ GILL+E+ +G P+ +
Sbjct: 162 PV----------------KWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYP-RIP 204
Query: 907 QKTFANILHKDLKF--PSSTPTSLHAKQLMYRLLHRDPKSR 945
K + K K P P ++ +M + H D +R
Sbjct: 205 LKDVVPRVEKGYKMDAPDGCPPVVY--DVMKQCWHLDAATR 243
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 9e-08
Identities = 67/280 (23%), Positives = 114/280 (40%), Gaps = 44/280 (15%)
Query: 678 KPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRA-----CAEREILDML-DH 731
K LG+G G V VE G + M V + + H + +E +I+ L +H
Sbjct: 41 KTLGAGAFGKV--VEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNH 98
Query: 732 PFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLH 791
+ L + + +IT+YC G+L L R+ L + + ++ +V + +L
Sbjct: 99 ENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLA 158
Query: 792 CQGIIYRDLKPENVLLQGNGHVS-LTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVF 850
+ I+RDL NVLL +G + + DF L+ R N V
Sbjct: 159 SKNCIHRDLAARNVLLT-HGKIVKICDFGLA------------------RDIMNDSNYVV 199
Query: 851 MAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEML-YGYTPFRGKTRQKT 909
N+ + +++APE I +T D W+ GILL+E+ G P+ G
Sbjct: 200 ------KGNARLPV-KWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSK 252
Query: 910 FANILHKDLKFPSSTPTSLHAKQLMYRLLHR----DPKSR 945
F ++ + + + P HA +Y ++ DP R
Sbjct: 253 FYKLIKEGYRM--AQPE--HAPAEIYDIMKTCWDADPLKR 288
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|197509 smart00086, PAC, Motif C-terminal to PAS motifs (likely to contribute to PAS structural domain) | Back alignment and domain information |
|---|
Score = 48.7 bits (117), Expect = 1e-07
Identities = 16/42 (38%), Positives = 22/42 (52%)
Query: 550 TVQLINYTKSGKKFWNLFHLQPMRDQKGEVQYFIGVQLDGSE 591
TV+ K G W L P+RD+ GEV+ +GV D +E
Sbjct: 1 TVEYRLRRKDGSYIWVLVSASPIRDEDGEVEGILGVVRDITE 42
|
PAC motif occurs C-terminal to a subset of all known PAS motifs. It is proposed to contribute to the PAS domain fold. Length = 43 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 1e-07
Identities = 69/315 (21%), Positives = 114/315 (36%), Gaps = 68/315 (21%)
Query: 672 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMK---AMDKGVML-----------NRNKVH 717
H + LG G G VHL E+ ++ + KG L N+N +
Sbjct: 5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARN 64
Query: 718 RACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGEL--FL----LLDRQ----- 766
E +IL L P + L + +C+IT+Y G+L FL L D++
Sbjct: 65 DFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGND 124
Query: 767 ------PTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDL 820
+ ++ A ++ ++YL ++RDL N L+ N + + DF
Sbjct: 125 AVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVHRDLATRNCLVGENLTIKIADF-- 182
Query: 821 SCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTS 880
G ++ + R V ++A E I T+
Sbjct: 183 -----------------------GMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTT 219
Query: 881 AVDWWALGILLYEMLY--GYTPFRGKTRQKTFANI--LHKD------LKFPSSTPTSLHA 930
A D WA G+ L+E+L P+ T ++ N +D L P P L+
Sbjct: 220 ASDVWAFGVTLWEILMLCKEQPYGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLY- 278
Query: 931 KQLMYRLLHRDPKSR 945
+LM + RD + R
Sbjct: 279 -ELMLQCWSRDCRER 292
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 53.8 bits (129), Expect = 2e-07
Identities = 66/294 (22%), Positives = 113/294 (38%), Gaps = 41/294 (13%)
Query: 672 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVM--LNRNKVHRACAEREILDML 729
R +K LGSG G+VH G + K + R + L
Sbjct: 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSL 66
Query: 730 DHPFVPALY-----ASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVV 784
DH ++ L AS Q L+T P G L + RQ L + + ++
Sbjct: 67 DHAYIVRLLGICPGASLQ------LVTQLSPLGSLLDHV-RQHRDSLDPQRLLNWCVQIA 119
Query: 785 VALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKG 844
+ YL +++R+L N+LL+ + V + DF ++ LL P ++KK +
Sbjct: 120 KGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVA-------DLLYP--DDKKYFYSE 170
Query: 845 QQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEML-YGYTPFRG 903
+ P+ +++A E I +T D W+ G+ ++EM+ YG P+ G
Sbjct: 171 HKTPI----------------KWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAG 214
Query: 904 KTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKK 957
R ++L K + ++ +M + D R E ANE +
Sbjct: 215 -MRPHEVPDLLEKGERLAQPQICTIDVYMVMVKCWMIDENVRPTFKELANEFTR 267
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 53.4 bits (129), Expect = 2e-07
Identities = 50/207 (24%), Positives = 77/207 (37%), Gaps = 62/207 (29%)
Query: 786 ALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQ 845
+ +LH I++RDLK N+LL G + + DF L+ R +
Sbjct: 118 GVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLA------------------REY--- 156
Query: 846 QNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGH-TSAVDWWALGILLYEMLYGYTPFRGK 904
P++ V T Y APE++ GA ++A+D W++G + E+L F GK
Sbjct: 157 ------GSPLKPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGK 210
Query: 905 ----TRQKTF--------------ANILH-KDLKFPSSTPTSLHAK-----------QLM 934
K F + + K F L K L+
Sbjct: 211 SEIDQLNKIFKLLGTPTEKIWPGFSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLL 270
Query: 935 YRLLHRDPKSRLGSHEGANEIKKHPFF 961
RLL DP R+ + + KHP+F
Sbjct: 271 NRLLTYDPAKRISAEDAL----KHPYF 293
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 53.3 bits (128), Expect = 2e-07
Identities = 46/225 (20%), Positives = 84/225 (37%), Gaps = 59/225 (26%)
Query: 765 RQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHV-SLTDFDLSCL 823
R P + L ++ + +++ + + H G+++RDLKP+N+L+ + + D L
Sbjct: 101 RGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRA 160
Query: 824 TSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGH-TSAV 882
S P+++ + T Y APE++ G+ H ++ V
Sbjct: 161 FSI---------------------------PVKSYTHEIVTLWYRAPEVLLGSTHYSTPV 193
Query: 883 DWWALGILLYEMLYGYTPFRGKTRQKTFANILH-------------KDLK----FPSSTP 925
D W++G + EM F G + + +I L+ FP P
Sbjct: 194 DIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVWPGVSKLRDWHEFPQWKP 253
Query: 926 TSL---------HAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFF 961
L L+ ++L DP R+ A HP+F
Sbjct: 254 QDLSRAVPDLSPEGLDLLQKMLRYDPAKRI----SAKAALTHPYF 294
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 2e-07
Identities = 71/283 (25%), Positives = 116/283 (40%), Gaps = 44/283 (15%)
Query: 678 KPLGSGDTGSVHLVELCGSGQYF--AMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVP 735
K LG G+ GSV +L A+K M K + R+++ +E + DHP V
Sbjct: 5 KTLGEGEFGSVMEGQLNQDDSILKVAVKTM-KIAICTRSEMEDFLSEAVCMKEFDHPNVM 63
Query: 736 ALYA-SFQTKTH-----VCLITDYCPGGEL--FLLLDR---QPTKVLKEDAVRFYAAEVV 784
L QT +I + G+L FLL R P + + V+F ++
Sbjct: 64 RLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKF-MTDIA 122
Query: 785 VALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKG 844
+EYL + I+RDL N +L N +V + DF LS + R+ +
Sbjct: 123 SGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSKKI---------YNGDYYRQGRI 173
Query: 845 QQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEM-LYGYTPFRG 903
+ PV ++IA E +A +T+ D W+ G+ ++E+ G TP+ G
Sbjct: 174 AKMPV----------------KWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPG 217
Query: 904 KTRQKTFANILHKD-LKFPSSTPTSLHAKQLMYRLLHRDPKSR 945
+ + + + LK P L++ LM +PK R
Sbjct: 218 VENSEIYDYLRQGNRLKQPPDCLDGLYS--LMSSCWLLNPKDR 258
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 2e-07
Identities = 33/114 (28%), Positives = 57/114 (50%), Gaps = 26/114 (22%)
Query: 782 EVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRR 841
+++ A+EY+H + +I+RD+K EN+ L +G + L DF + +P E++
Sbjct: 275 QLLCAVEYIHDKKLIHRDIKLENIFLNCDGKIVLGDFGTA----------MPFEKEREAF 324
Query: 842 HKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEML 895
G +VGT +PEI+AG G+ D W+ G++L +ML
Sbjct: 325 DYG----------------WVGTVATNSPEILAGDGYCEITDIWSCGLILLDML 362
|
Length = 501 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 2e-07
Identities = 67/290 (23%), Positives = 119/290 (41%), Gaps = 37/290 (12%)
Query: 674 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAE----REILDML 729
+ +K LGSG G+V+ G+ + K +LN +A E I+ +
Sbjct: 9 LKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIK--ILNETTGPKANVEFMDEALIMASM 66
Query: 730 DHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEY 789
DHP + L + T + L+T P G L + + + + + ++ + Y
Sbjct: 67 DHPHLVRLLGVCLSPT-IQLVTQLMPHGCLLDYVHEHKDNIGSQLLLN-WCVQIAKGMMY 124
Query: 790 LHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPV 849
L + +++RDL NVL++ HV +TDF L+ L +EK+ G + P+
Sbjct: 125 LEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLE---------GDEKEYNADGGKMPI 175
Query: 850 FMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYE-MLYGYTPFRG-KTRQ 907
+++A E I T D W+ G+ ++E M +G P+ G TR+
Sbjct: 176 ----------------KWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTRE 219
Query: 908 KTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKK 957
++L K + P ++ +M + D SR E A E +
Sbjct: 220 --IPDLLEKGERLPQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSR 267
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|131984 TIGR02938, nifL_nitrog, nitrogen fixation negative regulator NifL | Back alignment and domain information |
|---|
Score = 53.8 bits (129), Expect = 3e-07
Identities = 26/92 (28%), Positives = 51/92 (55%)
Query: 500 IIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIRAAIDNQTDVTVQLINYTKS 559
I++A+D+F +T Y++EEI+G+N L T P + + ++ Q +L+N K
Sbjct: 26 ILYANDAFTRITGYTKEEIIGKNESVLSNHTTPPEVYQALWGSLAEQKPWAGKLLNRRKD 85
Query: 560 GKKFWNLFHLQPMRDQKGEVQYFIGVQLDGSE 591
G+ + + P+ ++ GE +F+G+ D +E
Sbjct: 86 GELYLAELTVAPVLNEAGETTHFLGMHRDITE 117
|
NifL is a modulator of the nitrogen fixation positive regulator protein NifA, and is therefore a negative regulator. It binds NifA. NifA and NifL are encoded by adjacent genes [Central intermediary metabolism, Nitrogen fixation, Regulatory functions, Protein interactions]. Length = 494 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 3e-07
Identities = 48/241 (19%), Positives = 90/241 (37%), Gaps = 44/241 (18%)
Query: 722 EREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGEL--FLLLDRQPTKV--------- 770
E ++ L HP + L + VC++ +Y G+L FL++ + V
Sbjct: 57 EASLMAELHHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGT 116
Query: 771 ----LKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSC 826
L A ++ +EYL +++DL N+L+ HV ++D LS
Sbjct: 117 VKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQLHVKISDLGLS----- 171
Query: 827 KPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWA 886
++ A+ R + ++ PE I +S D W+
Sbjct: 172 --------------------REIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWS 211
Query: 887 LGILLYEML-YGYTPFRGKTRQKTFANILHKD-LKFPSSTPTSLHAKQLMYRLLHRDPKS 944
G++L+E+ +G P+ G + Q+ + + L P +++ LM P
Sbjct: 212 FGVVLWEIFSFGLQPYYGFSNQEVIEMVRKRQLLPCSEDCPPRMYS--LMTECWQEGPSR 269
Query: 945 R 945
R
Sbjct: 270 R 270
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|225112 COG2202, AtoS, FOG: PAS/PAC domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Score = 52.2 bits (123), Expect = 3e-07
Identities = 32/119 (26%), Positives = 50/119 (42%), Gaps = 7/119 (5%)
Query: 476 DLATTLERIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPAT 535
L LE + D D I++A+ + EL YS EE LGR L PE +
Sbjct: 113 RLRALLEASPDGIWVLDE---DGRILYANPAAEELLGYSPEEELGRGLSDLIHPEDEERR 169
Query: 536 VRK--IRAAIDNQTDVTVQLINYTKSGKK-FWNLFHLQPMRDQKGEVQYFIGVQLDGSE 591
+ A + ++ K G++ W L + P+RD GE+ +G+ D +E
Sbjct: 170 ELELARALAEGRGGPLEIEYRVRRKDGERVRWILSRISPVRDD-GEIVGVVGIARDITE 227
|
Length = 232 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 4e-07
Identities = 67/290 (23%), Positives = 113/290 (38%), Gaps = 48/290 (16%)
Query: 668 QINLQHFRPIKPLGSGDTGSVHLVELCGSGQY---FAMKAMDKGVMLNRNKVHRACAERE 724
+I+ H K +G+G+ G V L G+ A+K + G + +E
Sbjct: 1 EIHPSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPG--YTEKQRQDFLSEAS 58
Query: 725 ILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVV 784
I+ H + L +IT+Y G L K L++ F + ++V
Sbjct: 59 IMGQFSHHNIIRLEGVVTKFKPAMIITEYMENGAL--------DKYLRDHDGEFSSYQLV 110
Query: 785 -------VALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNE 837
++YL ++RDL N+L+ N ++DF LS + P+ T+
Sbjct: 111 GMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGG 170
Query: 838 KKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYE-MLY 896
K P+R + APE IA TSA D W+ GI+++E M +
Sbjct: 171 KI--------------PIR----------WTAPEAIAYRKFTSASDVWSFGIVMWEVMSF 206
Query: 897 GYTPFRGKTRQKTFANILHK-DLKFPSSTPTSLHAKQLMYRLLHRDPKSR 945
G P+ + + I L P P++++ QLM + +D R
Sbjct: 207 GERPYWDMSNHEVMKAINDGFRLPAPMDCPSAVY--QLMLQCWQQDRARR 254
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 5e-07
Identities = 66/275 (24%), Positives = 112/275 (40%), Gaps = 46/275 (16%)
Query: 678 KPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPAL 737
K LG+G G V + A+K M G M V AE ++ L H + L
Sbjct: 12 KKLGAGQFGEVWMATY-NKHTKVAVKTMKPGSM----SVEAFLAEANVMKTLQHDKLVKL 66
Query: 738 YASFQTKTHVCLITDYCPGGELFLLL-----DRQPTKVLKEDAVRFYAAEVVVALEYLHC 792
+A TK + +IT++ G L L +QP L + ++A++ + ++
Sbjct: 67 HAVV-TKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLID-----FSAQIAEGMAFIEQ 120
Query: 793 QGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMA 852
+ I+RDL+ N+L+ + + DF L+ + NE R +G + P+
Sbjct: 121 RNYIHRDLRAANILVSASLVCKIADFGLARVIE---------DNEYTAR-EGAKFPI--- 167
Query: 853 EPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEML-YGYTPFRGKTRQKTFA 911
++ APE I T D W+ GILL E++ YG P+ G + +
Sbjct: 168 -------------KWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIR 214
Query: 912 NILHK-DLKFPSSTPTSLHAKQLMYRLLHRDPKSR 945
+ + P + P L+ +M R P+ R
Sbjct: 215 ALERGYRMPRPENCPEELY--NIMMRCWKNRPEER 247
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 52.2 bits (125), Expect = 5e-07
Identities = 68/293 (23%), Positives = 109/293 (37%), Gaps = 55/293 (18%)
Query: 677 IKPLGSGDTGSVHLVELC-------GSGQYFAMKAMDKGVMLNRNKVHRACAEREILDML 729
I+ LG G G V ELC +G+ A+K++ N + E EIL L
Sbjct: 9 IRDLGEGHFGKV---ELCRYDPEGDNTGEQVAVKSLKPES--GGNHIADLKKEIEILRNL 63
Query: 730 DHPFVPALYASFQTK---THVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVA 786
H + Y T+ + LI ++ P G L L R K+ + ++ YA ++
Sbjct: 64 YHENI-VKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLK-YAVQICKG 121
Query: 787 LEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQ 846
++YL + ++RDL NVL++ V + DF L+ + T E
Sbjct: 122 MDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLT--------KAIETDKEYYTVKDDLD 173
Query: 847 NPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY----GYTPF- 901
+PVF + APE + + A D W+ G+ LYE+L +P
Sbjct: 174 SPVF----------------WYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMT 217
Query: 902 ---------RGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSR 945
G+ +L + + P QLM + P R
Sbjct: 218 LFLKMIGPTHGQMTVTRLVRVLEEGKRLPRPPNCPEEVYQLMRKCWEFQPSKR 270
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 51.8 bits (124), Expect = 6e-07
Identities = 58/239 (24%), Positives = 91/239 (38%), Gaps = 48/239 (20%)
Query: 680 LGSGDTGSVHLVELCGSGQY----FAMKAMDKGVMLNRNKVHRACA----------EREI 725
LG G G VHL E G ++ F++ +L K+ R A E +I
Sbjct: 13 LGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKI 72
Query: 726 LDMLDHPFVPALYASFQTKTHVCLITDYCPGGEL--FLLLDRQPTKVLKEDAV------- 776
+ L P + L A T +C+IT+Y G+L FL K D V
Sbjct: 73 MSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTL 132
Query: 777 RFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTN 836
F A ++ ++YL ++RDL N L+ N + + DF +S
Sbjct: 133 IFMATQIASGMKYLSSLNFVHRDLATRNCLVGKNYTIKIADFGMS--------------- 177
Query: 837 EKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEML 895
++ + R V +++ E I T+A D WA G+ L+E+L
Sbjct: 178 ----------RNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEIL 226
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 7e-07
Identities = 61/259 (23%), Positives = 110/259 (42%), Gaps = 40/259 (15%)
Query: 680 LGSGDTGSVHLVELCGSGQY-FAMKAMDKGVMLNRNKVHRAC-----AEREILDMLDHPF 733
LGSG+ G V G Y K +D + + +N+ ++ E EI+ LD+P+
Sbjct: 3 LGSGNFGCVK------KGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPY 56
Query: 734 VPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQ 793
+ + + + + L+ + GG L L + ++ + V +V + ++YL +
Sbjct: 57 IVRMIGVCEAEA-LMLVMEMASGGPLNKFLSGKKDEITVSNVVELMH-QVSMGMKYLEGK 114
Query: 794 GIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAE 853
++RDL NVLL + ++DF LS + L + K R G+
Sbjct: 115 NFVHRDLAARNVLLVNQHYAKISDFGLS-------KALGADDSYYKARSAGKW------- 160
Query: 854 PMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEML-YGYTPFRGKTRQKTFAN 912
P++ + APE I +S D W+ GI ++E YG P++ + +
Sbjct: 161 PLK----------WYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSF 210
Query: 913 ILH-KDLKFPSSTPTSLHA 930
I K L P+ P ++A
Sbjct: 211 IEQGKRLDCPAECPPEMYA 229
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 8e-07
Identities = 64/279 (22%), Positives = 114/279 (40%), Gaps = 39/279 (13%)
Query: 674 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDM----- 728
+ +K LGSG G+V+ G+ + K +L N +A +EILD
Sbjct: 9 LKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIK--VLRENTSPKA--NKEILDEAYVMA 64
Query: 729 -LDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVAL 787
+ P+V L T T V L+T P G L + ++ +D + + ++ +
Sbjct: 65 GVGSPYVCRLLGICLTST-VQLVTQLMPYGCLLDYVRENKDRIGSQDLLN-WCVQIAKGM 122
Query: 788 EYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQN 847
YL +++RDL NVL++ HV +TDF L+ L +E + G +
Sbjct: 123 SYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARLLD---------IDETEYHADGGKV 173
Query: 848 PVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYE-MLYGYTPFRGKTR 906
P+ +++A E I T D W+ G+ ++E M +G P+ G
Sbjct: 174 PI----------------KWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDG-IP 216
Query: 907 QKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSR 945
+ ++L K + P ++ +M + D + R
Sbjct: 217 AREIPDLLEKGERLPQPPICTIDVYMIMVKCWMIDSECR 255
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 51.1 bits (122), Expect = 1e-06
Identities = 50/246 (20%), Positives = 91/246 (36%), Gaps = 47/246 (19%)
Query: 672 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKA---MDKGVML---------NRNKVHRA 719
Q R + LG G G VHL E G ++ A + V++ + +
Sbjct: 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDF 64
Query: 720 CAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQP--TKVLKEDAVR 777
E +I+ L +P + L + +C+IT+Y G+L L ++ + + +
Sbjct: 65 LKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIP 124
Query: 778 --------FYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQ 829
+ A ++ ++YL ++RDL N L+ + + + DF
Sbjct: 125 SVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVGNHYTIKIADF----------- 173
Query: 830 LLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGI 889
G ++ + R V ++A E I T+A D WA G+
Sbjct: 174 --------------GMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGV 219
Query: 890 LLYEML 895
L+EM
Sbjct: 220 TLWEMF 225
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|216228 pfam00989, PAS, PAS fold | Back alignment and domain information |
|---|
Score = 47.4 bits (113), Expect = 2e-06
Identities = 23/87 (26%), Positives = 46/87 (52%), Gaps = 1/87 (1%)
Query: 217 IMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKIRETLQNGQSYCGRLLNYK-K 275
I+Y +A ++ G + +EV+G++ L D E +R+ L G+ G ++++
Sbjct: 23 ILYVNAAAEELLGLSREEVIGKSLLDLIPEDDDAEVAELLRQALLQGEESRGFEVSFRVP 82
Query: 276 DGTPFWNLLTIAPIKDDEGKVLKFIGM 302
DG P + +P++D G+V F+G+
Sbjct: 83 DGRPRHVEVRASPVRDAGGEVRGFLGV 109
|
The PAS fold corresponds to the structural domain that has previously been defined as PAS and PAC motifs. The PAS fold appears in archaea, eubacteria and eukarya. Length = 113 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 50.4 bits (121), Expect = 2e-06
Identities = 58/286 (20%), Positives = 109/286 (38%), Gaps = 46/286 (16%)
Query: 677 IKPLGSGDTGSVH--LVELCGSGQYF---AMKAM-DKGVMLNRNKVHRACAEREILDMLD 730
I+ LG G G V+ L + G+ A+K + + M R + E ++ +
Sbjct: 11 IRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEF---LNEASVMKEFN 67
Query: 731 HPFVPALYASFQTKTHVCLITDYCPGGELFLLL------DRQPTKVLKEDAVRFY--AAE 782
V L T ++ + G+L L + +F AAE
Sbjct: 68 CHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAE 127
Query: 783 VVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRH 842
+ + YL + ++RDL N ++ + V + DF ++ + T+ ++
Sbjct: 128 IADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIGDFGMT--------RDIYETDYYRKGG 179
Query: 843 KGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEML-YGYTPF 901
KG P+R ++APE + T+ D W+ G++L+EM P+
Sbjct: 180 KG-------LLPVR----------WMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPY 222
Query: 902 RGKTRQKTFANILHKD-LKFPSSTPTSLHAKQLMYRLLHRDPKSRL 946
+G + ++ ++ L P + P L +LM +PK R
Sbjct: 223 QGLSNEEVLKFVIDGGHLDLPENCPDKLL--ELMRMCWQYNPKMRP 266
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|216228 pfam00989, PAS, PAS fold | Back alignment and domain information |
|---|
Score = 46.6 bits (111), Expect = 3e-06
Identities = 23/90 (25%), Positives = 42/90 (46%), Gaps = 1/90 (1%)
Query: 500 IIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIRAAIDNQTDVTVQLINY-TK 558
I++ + + EL SREE++G++ L + D +R A+ + +++
Sbjct: 23 ILYVNAAAEELLGLSREEVIGKSLLDLIPEDDDAEVAELLRQALLQGEESRGFEVSFRVP 82
Query: 559 SGKKFWNLFHLQPMRDQKGEVQYFIGVQLD 588
G+ P+RD GEV+ F+GV D
Sbjct: 83 DGRPRHVEVRASPVRDAGGEVRGFLGVLRD 112
|
The PAS fold corresponds to the structural domain that has previously been defined as PAS and PAC motifs. The PAS fold appears in archaea, eubacteria and eukarya. Length = 113 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 50.1 bits (120), Expect = 3e-06
Identities = 60/295 (20%), Positives = 108/295 (36%), Gaps = 61/295 (20%)
Query: 678 KPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDML-------- 729
KPLG G G V E + ++ + + E+++ D++
Sbjct: 18 KPLGEGAFGQVVKAE------AVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKM 71
Query: 730 --DHPFVPALYASFQTKTHVCLITDYCPGGEL--FL------------LLDRQPTKVLKE 773
H + L + + ++ +Y G L FL R P + L +
Sbjct: 72 IGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQ 131
Query: 774 DAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHV-SLTDFDLSCLTSCKPQLLL 832
+ +A +V +E+L + I+RDL NVL+ HV + DF L+
Sbjct: 132 KDLVSFAYQVARGMEFLASKKCIHRDLAARNVLV-TEDHVMKIADFGLARDIHH------ 184
Query: 833 PTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLY 892
+ R+ + PV +++APE + +T D W+ G+LL+
Sbjct: 185 ---IDYYRKTTNGRLPV----------------KWMAPEALFDRVYTHQSDVWSFGVLLW 225
Query: 893 E-MLYGYTPFRGKTRQKTFANILH-KDLKFPSSTPTSLHAKQLMYRLLHRDPKSR 945
E G +P+ G ++ F + ++ P + L+ LM H P R
Sbjct: 226 EIFTLGGSPYPGIPVEELFKLLKEGYRMEKPQNCTQELYH--LMRDCWHEVPSQR 278
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|225112 COG2202, AtoS, FOG: PAS/PAC domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Score = 49.1 bits (115), Expect = 4e-06
Identities = 19/97 (19%), Positives = 41/97 (42%), Gaps = 2/97 (2%)
Query: 213 PDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKIRETLQ--NGQSYCGRL 270
D I+YA+ ++ GY+ +E +GR L + ++ L G
Sbjct: 130 EDGRILYANPAAEELLGYSPEEELGRGLSDLIHPEDEERRELELARALAEGRGGPLEIEY 189
Query: 271 LNYKKDGTPFWNLLTIAPIKDDEGKVLKFIGMQVEVS 307
+KDG +L+ D+G+++ +G+ +++
Sbjct: 190 RVRRKDGERVRWILSRISPVRDDGEIVGVVGIARDIT 226
|
Length = 232 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 4e-06
Identities = 41/168 (24%), Positives = 69/168 (41%), Gaps = 26/168 (15%)
Query: 779 YAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEK 838
Y+ +V +E+L + I+RDL N+LL N V + DF L+ P +
Sbjct: 184 YSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYV------- 236
Query: 839 KRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEML-YG 897
R + P+ +++APE I +T D W+ G+LL+E+ G
Sbjct: 237 --RKGDARLPL----------------KWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLG 278
Query: 898 YTPFRGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSR 945
+P+ G + F L + + + T+ Q M H +P R
Sbjct: 279 ASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQR 326
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|232884 TIGR00229, sensory_box, PAS domain S-box | Back alignment and domain information |
|---|
Score = 46.5 bits (111), Expect = 5e-06
Identities = 22/94 (23%), Positives = 46/94 (48%), Gaps = 2/94 (2%)
Query: 217 IMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKIRETLQNGQSYCGRLLNYK-K 275
I+Y + F ++ GY+++E++GRN L E +I L+ + + K
Sbjct: 25 ILYVNPAFEEIFGYSAEELIGRNVLELIPEEDREEVRERIERRLEGEREPVSEERRVRRK 84
Query: 276 DGTPFWNLLTIAPIKDDEGKVLKFIGMQVEVSKH 309
DG+ W ++++PI G L +G+ ++++
Sbjct: 85 DGSEIWVEVSVSPI-RTNGGELGVVGIVRDITER 117
|
The PAS domain was previously described. This sensory box, or S-box domain occupies the central portion of the PAS domain but is more widely distributed. It is often tandemly repeated. Known prosthetic groups bound in the S-box domain include heme in the oxygen sensor FixL, FAD in the redox potential sensor NifL, and a 4-hydroxycinnamyl chromophore in photoactive yellow protein. Proteins containing the domain often contain other regulatory domains such as response regulator or sensor histidine kinase domains. Other S-box proteins include phytochromes and the aryl hydrocarbon receptor nuclear translocator [Regulatory functions, Small molecule interactions]. Length = 124 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 5e-06
Identities = 67/308 (21%), Positives = 120/308 (38%), Gaps = 56/308 (18%)
Query: 678 KPLGSGDTGSV---HLVELCGSGQY--FAMKAMDKGVMLNRNKVHRACAEREILDMLDHP 732
K LG G+ G V L G Y A+K + + + +++ +E +L ++HP
Sbjct: 6 KTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENA--SSSELRDLLSEFNLLKQVNHP 63
Query: 733 FVPALYASFQTKTHVCLITDYCPGGEL--FLLLDRQ------------PTKVLKEDAVRF 778
V LY + + LI +Y G L FL R+ + L R
Sbjct: 64 HVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERA 123
Query: 779 YAAEVVVALEYLHCQGIIY--------RDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQL 830
+++ + +G+ Y RDL NVL+ + ++DF LS +
Sbjct: 124 LTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSY 183
Query: 831 LLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGIL 890
+ +R KG+ PV +++A E + +T+ D W+ G+L
Sbjct: 184 V--------KRSKGRI-PV----------------KWMAIESLFDHIYTTQSDVWSFGVL 218
Query: 891 LYEML-YGYTPFRGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSH 949
L+E++ G P+ G ++ F N+L + S LM ++P R
Sbjct: 219 LWEIVTLGGNPYPGIAPERLF-NLLKTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFA 277
Query: 950 EGANEIKK 957
+ + E++K
Sbjct: 278 DISKELEK 285
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 50.1 bits (119), Expect = 6e-06
Identities = 72/288 (25%), Positives = 122/288 (42%), Gaps = 40/288 (13%)
Query: 664 DSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAER 723
D GE L + IK +G+G G V LV+ + ++F KA+ + R K + E
Sbjct: 6 DDGES-RLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREK-SQLVIEV 63
Query: 724 EILDMLDHPFVPALYASFQTKTH--VCLITDYCPGGELFLLLDRQPTKVLK------EDA 775
++ L H + F K + + ++ ++C G+ L R K K E A
Sbjct: 64 NVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGD----LSRNIQKCYKMFGKIEEHA 119
Query: 776 VRFYAAEVVVALEYLH-------CQGIIYRDLKPENVLLQ-GNGHVSLTDFDLSCLTSCK 827
+ +++ AL Y H + +++RDLKP+N+ L G H+ + L +
Sbjct: 120 IVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNG-R 178
Query: 828 PQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEII--AGAGHTSAVDWW 885
P + K E M ++S VGT Y +PE++ + D W
Sbjct: 179 PIAKIGDFGLSKN---------IGIESM--AHSCVGTPYYWSPELLLHETKSYDDKSDMW 227
Query: 886 ALGILLYEMLYGYTPFRGKTRQKTFANILHKDLKFPSSTPTSLHAKQL 933
ALG ++YE+ G TPF + F+ ++ +LK P +K+L
Sbjct: 228 ALGCIIYELCSGKTPFH---KANNFSQLI-SELKRGPDLPIKGKSKEL 271
|
Length = 1021 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 48.8 bits (116), Expect = 7e-06
Identities = 40/168 (23%), Positives = 69/168 (41%), Gaps = 26/168 (15%)
Query: 779 YAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEK 838
Y+ +V +E+L + I+RDL N+LL N V + DF L+ P +
Sbjct: 179 YSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYV------- 231
Query: 839 KRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEML-YG 897
R + P+ +++APE I +T+ D W+ G+LL+E+ G
Sbjct: 232 --RKGSARLPL----------------KWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLG 273
Query: 898 YTPFRGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSR 945
+P+ G + F L + + + ++M DPK R
Sbjct: 274 ASPYPGVQINEEFCQRLKDGTRMRAPENATPEIYRIMLACWQGDPKER 321
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 1e-05
Identities = 64/294 (21%), Positives = 108/294 (36%), Gaps = 51/294 (17%)
Query: 678 KPLGSGDTGSVHLVEL-----CGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHP 732
+ LG G G V L E A+KA+ + R R E E+L L H
Sbjct: 11 RELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQR---EAELLTNLQHE 67
Query: 733 FVPALYASFQTKTHVCLITDYCPGGEL-----------FLLLDRQPTKVLKE---DAVRF 778
+ Y + ++ +Y G+L +L+D QP + E +
Sbjct: 68 HIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLH 127
Query: 779 YAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEK 838
A+++ + YL Q ++RDL N L+ N V + DF
Sbjct: 128 IASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDF-------------------- 167
Query: 839 KRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEML-YG 897
G V+ + R + ++ PE I T+ D W+ G++L+E+ YG
Sbjct: 168 -----GMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYG 222
Query: 898 YTPFRGKTRQKTFANILH-KDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHE 950
P+ + + I + L+ P P ++ +M R+P+ RL E
Sbjct: 223 KQPWFQLSNTEVIECITQGRVLERPRVCPKEVY--DIMLGCWQREPQQRLNIKE 274
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|219844 pfam08447, PAS_3, PAS fold | Back alignment and domain information |
|---|
Score = 43.5 bits (103), Expect = 2e-05
Identities = 24/90 (26%), Positives = 39/90 (43%), Gaps = 5/90 (5%)
Query: 500 IIFASDSFLELTEYSREEILGRNCRFLQG--PETDPATVRKI--RAAIDNQTDVTVQLIN 555
II+ S F E+ Y+ EE+ +L PE D VR+ ++ + +
Sbjct: 1 IIYWSPRFEEILGYTPEELKSSYEGWLDLVHPE-DRERVRRALQEFSLKKGEPYSGEYRI 59
Query: 556 YTKSGKKFWNLFHLQPMRDQKGEVQYFIGV 585
K G+ W +P+RD+ G+ IGV
Sbjct: 60 RRKDGEYRWVEARGRPIRDENGKPVRVIGV 89
|
The PAS fold corresponds to the structural domain that has previously been defined as PAS and PAC motifs. The PAS fold appears in archaea, eubacteria and eukarya. Length = 90 |
| >gnl|CDD|197509 smart00086, PAC, Motif C-terminal to PAS motifs (likely to contribute to PAS structural domain) | Back alignment and domain information |
|---|
Score = 42.6 bits (101), Expect = 2e-05
Identities = 11/36 (30%), Positives = 25/36 (69%)
Query: 272 NYKKDGTPFWNLLTIAPIKDDEGKVLKFIGMQVEVS 307
+KDG+ W L++ +PI+D++G+V +G+ +++
Sbjct: 6 LRRKDGSYIWVLVSASPIRDEDGEVEGILGVVRDIT 41
|
PAC motif occurs C-terminal to a subset of all known PAS motifs. It is proposed to contribute to the PAS domain fold. Length = 43 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 2e-05
Identities = 62/300 (20%), Positives = 112/300 (37%), Gaps = 52/300 (17%)
Query: 668 QINLQHFRPIKPLGSGDTGSVHLVELCGSG-----QYFAMKAM-DKGVMLNRNKVHRACA 721
+INL R ++ LG G V+ L G+ Q A+K + DK R +
Sbjct: 1 EINLSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAM 60
Query: 722 EREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGEL--FLLL------------DRQP 767
R L HP + L + + +I YC +L FL++ D+
Sbjct: 61 MRS---RLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTV 117
Query: 768 TKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCK 827
L+ ++ +E+L ++++DL NVL+ +V ++D L
Sbjct: 118 KSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDKLNVKISDLGLF------ 171
Query: 828 PQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWAL 887
V+ A+ + + + +++PE I + D W+
Sbjct: 172 -------------------REVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSY 212
Query: 888 GILLYEML-YGYTPFRGKTRQKTFANILHKD-LKFPSSTPTSLHAKQLMYRLLHRDPKSR 945
G++L+E+ YG P+ G + Q I ++ L P P ++ LM + P R
Sbjct: 213 GVVLWEVFSYGLQPYCGYSNQDVIEMIRNRQVLPCPDDCPAWVYT--LMLECWNEFPSRR 270
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 2e-05
Identities = 52/226 (23%), Positives = 90/226 (39%), Gaps = 30/226 (13%)
Query: 722 EREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAA 781
E IL HP + L K + ++ + GG+ L + ++ ++ ++
Sbjct: 43 EARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQM-VE 101
Query: 782 EVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRR 841
+EYL + I+RDL N L+ + ++DF +S + + +T K
Sbjct: 102 NAAAGMEYLESKHCIHRDLAARNCLVTEKNVLKISDFGMS---REEEDGVYASTGGMK-- 156
Query: 842 HKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEML-YGYTP 900
Q PV ++ APE + ++S D W+ GILL+E G P
Sbjct: 157 ----QIPV----------------KWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVP 196
Query: 901 FRGKTRQKTFANILHK-DLKFPSSTPTSLHAKQLMYRLLHRDPKSR 945
+ + Q+T I L P P +++ +LM R DP R
Sbjct: 197 YANLSNQQTREAIEQGVRLPCPELCPDAVY--RLMERCWEYDPGQR 240
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 2e-05
Identities = 62/293 (21%), Positives = 113/293 (38%), Gaps = 46/293 (15%)
Query: 669 INLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDM 728
+NLQ + +G G+ G+V E +GQ A+K + V E ++
Sbjct: 3 LNLQKLTLGEIIGEGEFGAVLQGEY--TGQKVAVKNIKCDVT-----AQAFLEETAVMTK 55
Query: 729 LDHP-FVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVAL 787
L H V L ++ + + G L L + ++ + ++ +V +
Sbjct: 56 LHHKNLVRLLGVILHNGLYI--VMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGM 113
Query: 788 EYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQN 847
EYL + +++RDL N+L+ +G ++DF L+
Sbjct: 114 EYLESKKLVHRDLAARNILVSEDGVAKVSDFGLA-------------------------- 147
Query: 848 PVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEML-YGYTPFRGKTR 906
M NS + + + APE + +S D W+ G+LL+E+ YG P+ K
Sbjct: 148 ---RVGSMGVDNSKLPVK-WTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYP-KMS 202
Query: 907 QKTFANILHKDLKF--PSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKK 957
K + K + P P ++ LM +PK R H+ +++K
Sbjct: 203 LKEVKECVEKGYRMEPPEGCPADVYV--LMTSCWETEPKKRPSFHKLREKLEK 253
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 47.1 bits (112), Expect = 2e-05
Identities = 34/122 (27%), Positives = 56/122 (45%), Gaps = 29/122 (23%)
Query: 776 VRFYAAEVVVALEYLHCQGIIYRDLKPENVLL-QGNGHVSLTDFDLSCLTSCKPQLLLPT 834
++ Y +++ + Y H +++RDLKP+N+L+ + + L DF L+
Sbjct: 104 IKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLA------------- 150
Query: 835 TNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSA-VDWWALGILLYE 893
R G P+R V T Y APEI+ G+ H S VD W++G + E
Sbjct: 151 ------RAFGI--------PVRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAE 196
Query: 894 ML 895
M+
Sbjct: 197 MV 198
|
Length = 294 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 46.1 bits (109), Expect = 3e-05
Identities = 55/235 (23%), Positives = 99/235 (42%), Gaps = 43/235 (18%)
Query: 678 KPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLN--RNKVHRACAEREIL------DML 729
LGSG+ G+V + MK +K V + +N + + E+L L
Sbjct: 1 GELGSGNFGTV-------KKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQL 53
Query: 730 DHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEY 789
D+P++ + + ++ + L+ + G L L Q K + E + +V + ++Y
Sbjct: 54 DNPYIVRMIGICEAESWM-LVMELAELGPLNKFL--QKNKHVTEKNITELVHQVSMGMKY 110
Query: 790 LHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPV 849
L ++RDL NVLL + ++DF LS + L N K + G+
Sbjct: 111 LEETNFVHRDLAARNVLLVTQHYAKISDFGLS-------KALGADENYYKAKTHGKW--- 160
Query: 850 FMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEML-YGYTPFRG 903
P++ + APE + +S D W+ G+L++E YG P++G
Sbjct: 161 ----PVK----------WYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKG 201
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 45.5 bits (108), Expect = 7e-05
Identities = 31/123 (25%), Positives = 54/123 (43%), Gaps = 27/123 (21%)
Query: 773 EDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLL 832
ED ++ + +++ L Y H + ++RD+K N+LL G + L DF L+ L
Sbjct: 115 EDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLARL--------- 165
Query: 833 PTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAG-HTSAVDWWALGILL 891
+ +E R + V T Y PE++ G + A+D W+ G +L
Sbjct: 166 -----------------YNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCIL 208
Query: 892 YEM 894
E+
Sbjct: 209 GEL 211
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 45.1 bits (107), Expect = 9e-05
Identities = 62/290 (21%), Positives = 100/290 (34%), Gaps = 50/290 (17%)
Query: 677 IKPLGSGDTGSVHLVELC-----GSGQYFAMKAMDKGVMLN--RNKVHRACAEREILDML 729
+ LG G G V L E + A+K + K N R R E E+L
Sbjct: 10 KRELGEGAFGKVFLGECYHLEPENDKELVAVKTL-KETASNDARKDFER---EAELLTNF 65
Query: 730 DHPFVPALYASFQTKTHVCLITDYCPGGEL------------FLLLDRQPTKVLKEDAVR 777
H + Y ++ +Y G+L FL P L +
Sbjct: 66 QHENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLL 125
Query: 778 FYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNE 837
A ++ + YL Q ++RDL N L+ + V + DF +S
Sbjct: 126 QIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLVVKIGDFGMS---------------- 169
Query: 838 KKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEML-Y 896
V+ + R + ++ PE I T+ D W+ G++L+E+ Y
Sbjct: 170 ---------RDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTY 220
Query: 897 GYTPFRGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRL 946
G P+ G + ++ I L T S +M RDP+ R+
Sbjct: 221 GKQPWYGLSNEEVIECITQGRLLQRPRTCPS-EVYDIMLGCWKRDPQQRI 269
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 1e-04
Identities = 53/208 (25%), Positives = 92/208 (44%), Gaps = 49/208 (23%)
Query: 717 HRACA-EREILDML-DHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKED 774
HR A E E+L L HP + L + + + ++ L +Y P G L L + ++VL+ D
Sbjct: 51 HRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRK--SRVLETD 108
Query: 775 ----------------AVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDF 818
+ +AA+V ++YL + I+RDL N+L+ N + DF
Sbjct: 109 PAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADF 168
Query: 819 DLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGH 878
LS +GQ+ V++ + M ++A E + + +
Sbjct: 169 GLS---------------------RGQE--VYVKKTMGRL-----PVRWMAIESLNYSVY 200
Query: 879 TSAVDWWALGILLYEML-YGYTPFRGKT 905
T+ D W+ G+LL+E++ G TP+ G T
Sbjct: 201 TTNSDVWSYGVLLWEIVSLGGTPYCGMT 228
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 2e-04
Identities = 53/244 (21%), Positives = 97/244 (39%), Gaps = 33/244 (13%)
Query: 687 SVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREIL--DMLDHPFVPALYASFQTK 744
SV+L +G ++ D + N + H + E++ HP + + F T
Sbjct: 15 SVYLARHTPTGTLVTVRITD---LENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTG 71
Query: 745 THVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPEN 804
+ + +I+ + G LL + + E + + L YLH G I+R++K +
Sbjct: 72 SWLWVISPFMAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASH 131
Query: 805 VLLQGNGHVSLTDFD-LSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVG 863
+L+ G+G VSL+ L L GQ+ V P
Sbjct: 132 ILISGDGLVSLSGLSHLYSLV-----------------RNGQKAKVVYDFP----QFSTS 170
Query: 864 TEEYIAPEIIAG--AGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANILHKDLKFP 921
+++PE++ G+ D +++GI E+ G PF+ R + +L + LK P
Sbjct: 171 VLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQ----MLLQKLKGP 226
Query: 922 SSTP 925
+P
Sbjct: 227 PYSP 230
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 42.4 bits (100), Expect = 2e-04
Identities = 30/149 (20%), Positives = 58/149 (38%), Gaps = 15/149 (10%)
Query: 677 IKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDH--PFV 734
IK L G T V+L+ + +K R E IL +L V
Sbjct: 3 IKLLKGGLTNRVYLLGTKDED--YVLK--INPSREKGADRER---EVAILQLLARKGLPV 55
Query: 735 PALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQG 794
P + AS ++ L+ ++ G L + + + + ++ AE++ L L
Sbjct: 56 PKVLASGESDGWSYLLMEWIEGETLDEVSEEEKEDIAEQ------LAELLAKLHQLPLLV 109
Query: 795 IIYRDLKPENVLLQGNGHVSLTDFDLSCL 823
+ + DL P N+L+ + + D++ +
Sbjct: 110 LCHGDLHPGNILVDDGKILGIIDWEYAGY 138
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 44.1 bits (104), Expect = 2e-04
Identities = 39/168 (23%), Positives = 70/168 (41%), Gaps = 26/168 (15%)
Query: 779 YAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEK 838
Y+ +V +E+L + I+RDL N+LL N V + DF L+ P +
Sbjct: 178 YSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYV------- 230
Query: 839 KRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEML-YG 897
R + P+ +++APE I +T+ D W+ G+LL+E+ G
Sbjct: 231 --RKGDARLPL----------------KWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLG 272
Query: 898 YTPFRGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSR 945
+P+ G + F L + + + + +M H +P+ R
Sbjct: 273 ASPYPGVQIDEEFCRRLKEGTRMRAPEYATPEIYSIMLDCWHNNPEDR 320
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 3e-04
Identities = 52/209 (24%), Positives = 93/209 (44%), Gaps = 51/209 (24%)
Query: 717 HRACA-EREILDML-DHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKED 774
HR A E E+L L HP + L + + + ++ + +Y P G L L + ++VL+ D
Sbjct: 46 HRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIAIEYAPYGNLLDFLRK--SRVLETD 103
Query: 775 A-----------------VRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTD 817
++F A++V ++YL + I+RDL NVL+ N + D
Sbjct: 104 PAFAKEHGTASTLTSQQLLQF-ASDVATGMQYLSEKQFIHRDLAARNVLVGENLASKIAD 162
Query: 818 FDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAG 877
F LS +G++ V++ + M ++A E + +
Sbjct: 163 FGLS---------------------RGEE--VYVKKTMGRL-----PVRWMAIESLNYSV 194
Query: 878 HTSAVDWWALGILLYEML-YGYTPFRGKT 905
+T+ D W+ G+LL+E++ G TP+ G T
Sbjct: 195 YTTKSDVWSFGVLLWEIVSLGGTPYCGMT 223
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 4e-04
Identities = 46/213 (21%), Positives = 82/213 (38%), Gaps = 46/213 (21%)
Query: 738 YASFQTKTHVCLITDYCP----GGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQ 793
YA ++ + Y P L++ P L + ++ +V +E+L +
Sbjct: 201 YADIESSNYESPYDQYLPSAPERTRRDTLINESP--ALSYMDLVGFSYQVANGMEFLASK 258
Query: 794 GIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAE 853
++RDL NVL+ V + DF L+ +
Sbjct: 259 NCVHRDLAARNVLICEGKLVKICDFGLA------------------------------RD 288
Query: 854 PMRASN-----SFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEML-YGYTPFRGKTRQ 907
MR SN S +++APE I +T+ D W+ GILL+E+ G TP+
Sbjct: 289 IMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMN 348
Query: 908 KTFANILHKDLKFPSSTPTSLHAKQLMYRLLHR 940
+ F N + + + + P HA +Y ++ +
Sbjct: 349 EQFYNAIKRGYRM--AKPA--HASDEIYEIMQK 377
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Score = 43.4 bits (102), Expect = 4e-04
Identities = 47/224 (20%), Positives = 95/224 (42%), Gaps = 23/224 (10%)
Query: 681 GSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYAS 740
G D +V+L +G+Y ++ ++ N V E + + +HP + A+
Sbjct: 9 GFEDLMTVNLARYKPTGEYVTVRRINLEACTN-EMVTFLQGELHVSKLFNHPNIVPYRAT 67
Query: 741 FQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDL 800
F + ++T + G L+ + E A+ + V+ AL+Y+H G ++R +
Sbjct: 68 FIADNELWVVTSFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSV 127
Query: 801 KPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNS 860
K ++L+ +G V L+ +N H GQ+ V P +
Sbjct: 128 KASHILISVDGKVYLSGL---------------RSNLSMINH-GQRLRVVHDFPKYS--- 168
Query: 861 FVGTEEYIAPEIIAG--AGHTSAVDWWALGILLYEMLYGYTPFR 902
V +++PE++ G+ + D +++GI E+ G+ PF+
Sbjct: 169 -VKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFK 211
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 7e-04
Identities = 44/192 (22%), Positives = 78/192 (40%), Gaps = 26/192 (13%)
Query: 755 PGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVS 814
E+ LL ++ L + + +V +E+L + ++RDL NVLL V
Sbjct: 218 NDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLLAQGKIVK 277
Query: 815 LTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIA 874
+ DF L+ ++ KG F+ P++ ++APE I
Sbjct: 278 ICDFGLA----------RDIMHDSNYVSKGS---TFL--PVK----------WMAPESIF 312
Query: 875 GAGHTSAVDWWALGILLYEML-YGYTPFRGKTRQKTFANILHKDLKFPSSTPTSLHAKQL 933
+T+ D W+ GILL+E+ G TP+ G TF N + + + +
Sbjct: 313 DNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFYNKIKSGYRMAKPDHATQEVYDI 372
Query: 934 MYRLLHRDPKSR 945
M + + +P+ R
Sbjct: 373 MVKCWNSEPEKR 384
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 42.4 bits (99), Expect = 7e-04
Identities = 54/209 (25%), Positives = 92/209 (44%), Gaps = 51/209 (24%)
Query: 717 HRACA-EREILDML-DHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKED 774
HR A E E+L L HP + L + + + ++ L +Y P G L L + ++VL+ D
Sbjct: 39 HRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRK--SRVLETD 96
Query: 775 A-----------------VRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTD 817
+ F AA+V ++YL + I+RDL N+L+ N + D
Sbjct: 97 PAFAIANSTASTLSSQQLLHF-AADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIAD 155
Query: 818 FDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAG 877
F LS +GQ+ V++ + M ++A E + +
Sbjct: 156 FGLS---------------------RGQE--VYVKKTMGRL-----PVRWMAIESLNYSV 187
Query: 878 HTSAVDWWALGILLYEML-YGYTPFRGKT 905
+T+ D W+ G+LL+E++ G TP+ G T
Sbjct: 188 YTTNSDVWSYGVLLWEIVSLGGTPYCGMT 216
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 41.9 bits (99), Expect = 0.001
Identities = 66/320 (20%), Positives = 109/320 (34%), Gaps = 78/320 (24%)
Query: 668 QINLQHFRPIKPLGSGDTGSVHLVELCGSGQY----------------FAMKAMDKGVML 711
+ Q ++ LG G G VHL E G + A+K +
Sbjct: 1 EFPRQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDA-- 58
Query: 712 NRNKVHRACAERE--ILDMLDHPFVPALYASFQTKTHVCLITDYCPGGEL--FLLLDRQP 767
+ R +E IL L P + L +C+I +Y G+L FL
Sbjct: 59 --SDNAREDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAE 116
Query: 768 TKVLKEDA-------VRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDL 820
T L ++ + + A ++ + YL ++RDL N L+ N + + DF +
Sbjct: 117 TSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNCLVGKNYTIKIADFGM 176
Query: 821 SCLTSCKPQLLLPTTNE--KKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGH 878
S ++ Q P+R ++A E +
Sbjct: 177 S--------------RNLYSSDYYRVQGRAPL---PIR----------WMAWESVLLGKF 209
Query: 879 TSAVDWWALGILLYEMLYGYT-----PFRGKTRQKTFANILHKD--------LKFPSSTP 925
T+ D WA G+ L+E+ T P+ T Q+ N H L P + P
Sbjct: 210 TTKSDVWAFGVTLWEI---LTLCREQPYEHLTDQQVIENAGHFFRDDGRQIYLPRPPNCP 266
Query: 926 TSLHAKQLMYRLLHRDPKSR 945
++ +LM RD + R
Sbjct: 267 KDIY--ELMLECWRRDEEDR 284
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 41.7 bits (98), Expect = 0.001
Identities = 64/295 (21%), Positives = 112/295 (37%), Gaps = 48/295 (16%)
Query: 668 QINLQHFRPIKPLGSGDTGSVHLVELCG-----SGQYFAMKAMDKGVMLNRNKVHRACAE 722
++ ++ LG G G V+ G A+K + + + E
Sbjct: 2 EVPRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPE--SCSEQDESDFLME 59
Query: 723 REILDMLDHP-FVPALYASFQTKTHVCLITDYCPGGEL--FLLLDR----QPTKVLKEDA 775
I+ +H V + SF+ L+ + GG+L FL +R +P+ + +D
Sbjct: 60 ALIMSKFNHQNIVRLIGVSFERLPRFILL-ELMAGGDLKSFLRENRPRPERPSSLTMKDL 118
Query: 776 VRFYAAEVVVALEYLHCQGIIYRDLKPENVLL--QGNGHVS-LTDFDLSCLTSCKPQLLL 832
+ F A +V +YL I+RD+ N LL +G G V+ + DF
Sbjct: 119 L-FCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADF-------------- 163
Query: 833 PTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLY 892
G ++ A R + +++ PE TS D W+ G+LL+
Sbjct: 164 -----------GMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLW 212
Query: 893 EML-YGYTPFRGKTRQKTFANI-LHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSR 945
E+ GY P+ G+T Q+ + L P P ++ ++M P+ R
Sbjct: 213 EIFSLGYMPYPGRTNQEVMEFVTGGGRLDPPKGCPGPVY--RIMTDCWQHTPEDR 265
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 0.001
Identities = 50/184 (27%), Positives = 73/184 (39%), Gaps = 67/184 (36%)
Query: 785 VALEYLHCQ-GIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHK 843
VAL+Y H + +++ DLKPEN+L++ S T D P TN R
Sbjct: 242 VALDYFHTELHLMHTDLKPENILME----TSDTVVD-------------PVTN----RA- 279
Query: 844 GQQNPVFMAEPMR--------------ASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGI 889
+P R + + V T Y +PE++ G G + D W++G
Sbjct: 280 ------LPPDPCRVRICDLGGCCDERHSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGC 333
Query: 890 LLYEMLYGYTPFRGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPK---SRL 946
++YE+ YT GK T N+ H LH LM + L R P R
Sbjct: 334 IIYEL---YT---GKLLYDTHDNLEH------------LH---LMEKTLGRLPSEWAGRC 372
Query: 947 GSHE 950
G+ E
Sbjct: 373 GTEE 376
|
Length = 467 |
| >gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 42.4 bits (99), Expect = 0.001
Identities = 17/37 (45%), Positives = 26/37 (70%)
Query: 782 EVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDF 818
+V+ L LH GI++RD+KPEN+L+ +G V + DF
Sbjct: 317 QVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDF 353
|
Length = 507 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 0.001
Identities = 60/287 (20%), Positives = 106/287 (36%), Gaps = 52/287 (18%)
Query: 680 LGSGDTGSVHLVELCGS------GQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPF 733
LG G G V L E C + A+KA+ + R R E E+L +L H
Sbjct: 13 LGEGAFGKVFLAE-CHNLLPEQDKMLVAVKALKEASESARQDFQR---EAELLTVLQHQH 68
Query: 734 VPALYASFQTKTHVCLITDYCPGGEL--FL--------LLDR---QPTKVLKEDAVRFYA 780
+ Y + ++ +Y G+L FL +L L + A
Sbjct: 69 IVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIA 128
Query: 781 AEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKR 840
+++ + YL ++RDL N L+ V + DF
Sbjct: 129 SQIASGMVYLASLHFVHRDLATRNCLVGQGLVVKIGDF---------------------- 166
Query: 841 RHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEML-YGYT 899
G ++ + R + ++ PE I T+ D W+ G++L+E+ YG
Sbjct: 167 ---GMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQ 223
Query: 900 PFRGKTRQKTFANILH-KDLKFPSSTPTSLHAKQLMYRLLHRDPKSR 945
P+ + + I ++L+ P + P ++A +M R+P+ R
Sbjct: 224 PWYQLSNTEAIECITQGRELERPRTCPPEVYA--IMQGCWQREPQQR 268
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 0.001
Identities = 60/254 (23%), Positives = 101/254 (39%), Gaps = 46/254 (18%)
Query: 678 KPLGSGDTGSVHLVELCGSGQYFAMKAMDKGV-MLNRNKVHRACA----EREILDML-DH 731
KPLG G G V + E G + +A+ V ML + + + E E++ M+ H
Sbjct: 21 KPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 80
Query: 732 PFVPALYASFQTKTHVCLITDYCPGGEL--FLLLDRQPTKVLKEDAVRF----------- 778
+ L + + +I +Y G L +L R P D R
Sbjct: 81 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLV 140
Query: 779 -YAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNE 837
+V +EYL Q I+RDL NVL+ N + + DF L+ + +
Sbjct: 141 SCTYQVARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLA--------RDVNNIDY 192
Query: 838 KKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEML-Y 896
K+ G+ PV +++APE + +T D W+ G+L++E+
Sbjct: 193 YKKTTNGRL-PV----------------KWMAPEALFDRVYTHQSDVWSFGVLMWEIFTL 235
Query: 897 GYTPFRGKTRQKTF 910
G +P+ G ++ F
Sbjct: 236 GGSPYPGIPVEELF 249
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 41.0 bits (96), Expect = 0.002
Identities = 63/285 (22%), Positives = 109/285 (38%), Gaps = 47/285 (16%)
Query: 680 LGSGDTGSVH---LVELCGSG---QYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPF 733
LGSG G V+ ++ G G A+K + KG K E ++ +HP
Sbjct: 3 LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKK--EFLKEAHLMSNFNHPN 60
Query: 734 VPALYASFQTKTHVCLITDYCPGGELFLLL-----DRQPTKVLKEDAVRFYAAEVVVALE 788
+ L +I + GG+L L +R +L + +V
Sbjct: 61 IVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCV 120
Query: 789 YLHCQGIIYRDLKPENVLLQGNGH-----VSLTDFDLSCLTSCKPQLLLPTTNEKKRRHK 843
YL I+RDL N L+ G+ V + DF L+ + ++ ++ +
Sbjct: 121 YLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLA--------RDIYKSDYYRKEGE 172
Query: 844 GQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEML-YGYTPFR 902
G P+R ++APE + T+ D W+ G+L++E+L G P+
Sbjct: 173 GLL-------PVR----------WMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYP 215
Query: 903 GKTRQKTFANILHKD-LKFPSSTPTSLHAKQLMYRLLHRDPKSRL 946
Q+ ++ L+ P + P ++ QLM +DP R
Sbjct: 216 ALNNQEVLQHVTAGGRLQKPENCPDKIY--QLMTNCWAQDPSERP 258
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Score = 40.7 bits (95), Expect = 0.002
Identities = 25/96 (26%), Positives = 45/96 (46%), Gaps = 11/96 (11%)
Query: 729 LDHPFVPALYA--SFQTKT----HVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAE 782
+DH +P Y SF+ + L E+F + + K++K +
Sbjct: 80 IDHLGIPKYYGCGSFKRCRMYYRFILLEKLVENTKEIFKRIKCKNKKLIKNIMK-----D 134
Query: 783 VVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDF 818
++ LEY+H GI + D+KPEN+++ GN + D+
Sbjct: 135 MLTTLEYIHEHGISHGDIKPENIMVDGNNRGYIIDY 170
|
Length = 294 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 41.2 bits (96), Expect = 0.002
Identities = 62/254 (24%), Positives = 105/254 (41%), Gaps = 46/254 (18%)
Query: 678 KPLGSGDTGSVHLVELCGSGQYFAMKAMDKGV-MLNRNKVHR----ACAEREILDML-DH 731
KPLG G G V + E G + K + V ML + + +E E++ M+ H
Sbjct: 18 KPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKH 77
Query: 732 PFVPALYASFQTKTHVCLITDYCPGGEL--FLLLDRQP-------TKVLKEDAVRFY--- 779
+ L + + ++ +Y G L +L R P T L E+ + F
Sbjct: 78 KNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLV 137
Query: 780 --AAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNE 837
A +V +EYL Q I+RDL NVL+ + + + DF L+ + +
Sbjct: 138 SCAYQVARGMEYLASQKCIHRDLAARNVLVTEDNVMKIADFGLA--------RDVHNIDY 189
Query: 838 KKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEML-Y 896
K+ G+ PV +++APE + +T D W+ G+LL+E+
Sbjct: 190 YKKTTNGRL-PV----------------KWMAPEALFDRVYTHQSDVWSFGVLLWEIFTL 232
Query: 897 GYTPFRGKTRQKTF 910
G +P+ G ++ F
Sbjct: 233 GGSPYPGIPVEELF 246
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|214512 smart00091, PAS, PAS domain | Back alignment and domain information |
|---|
Score = 37.0 bits (86), Expect = 0.002
Identities = 15/49 (30%), Positives = 28/49 (57%), Gaps = 4/49 (8%)
Query: 217 IMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKIRETLQNGQS 265
I+YA+ ++ GY+ +E++G++ L PED +++E LQ S
Sbjct: 23 ILYANPAAEELLGYSPEELIGKSLLEL----IHPEDRERVQEALQRLLS 67
|
PAS motifs appear in archaea, eubacteria and eukarya. Probably the most surprising identification of a PAS domain was that in EAG-like K+-channels. Length = 67 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 40.1 bits (94), Expect = 0.004
Identities = 33/145 (22%), Positives = 60/145 (41%), Gaps = 45/145 (31%)
Query: 767 PTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLS----- 821
P + + V A ++ + YLH +G+I++D+ N ++ V +TD LS
Sbjct: 111 PQALSTQQLVHM-AIQIACGMSYLHKRGVIHKDIAARNCVIDEELQVKITDNALSRDLFP 169
Query: 822 ----CLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAG 877
CL NE + P++ ++A E +
Sbjct: 170 MDYHCLGD----------NENR--------------PVK----------WMALESLVNKE 195
Query: 878 HTSAVDWWALGILLYEML-YGYTPF 901
++SA D W+ G+LL+E++ G TP+
Sbjct: 196 YSSASDVWSFGVLLWELMTLGQTPY 220
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
Conserved Domains Detected by HHsearch 
Original result of HHsearch against CDD database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 1005 | |||
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 100.0 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 99.98 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 99.98 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 99.97 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 99.97 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.97 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.97 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 99.97 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 99.97 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.97 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.97 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 99.97 | |
| PRK13560 | 807 | hypothetical protein; Provisional | 99.97 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.97 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.96 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.96 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.96 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.96 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.96 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.95 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.95 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 99.95 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 99.95 | |
| PRK09776 | 1092 | putative diguanylate cyclase; Provisional | 99.95 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.94 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.93 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.93 | |
| TIGR02040 | 442 | PpsR-CrtJ transcriptional regulator PpsR. This mod | 99.92 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.92 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.91 | |
| PRK13560 | 807 | hypothetical protein; Provisional | 99.91 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.91 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.91 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.9 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.89 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.88 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.88 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.88 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.87 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.87 | |
| PRK11359 | 799 | cyclic-di-GMP phosphodiesterase; Provisional | 99.85 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.85 | |
| TIGR02938 | 494 | nifL_nitrog nitrogen fixation negative regulator N | 99.84 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.82 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.82 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.81 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.78 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.78 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.78 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.75 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.74 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.73 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.69 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.66 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.65 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.64 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.63 | |
| PF13426 | 104 | PAS_9: PAS domain; PDB: 3ULF_B 3UE6_E 2Z6D_B 2Z6C_ | 99.62 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.62 | |
| PF13426 | 104 | PAS_9: PAS domain; PDB: 3ULF_B 3UE6_E 2Z6D_B 2Z6C_ | 99.6 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.59 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.59 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.56 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.55 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.53 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.5 | |
| PF08448 | 110 | PAS_4: PAS fold; InterPro: IPR013656 The PAS fold | 99.49 | |
| PF00989 | 113 | PAS: PAS fold; InterPro: IPR013767 PAS domains are | 99.48 | |
| PF08448 | 110 | PAS_4: PAS fold; InterPro: IPR013656 The PAS fold | 99.47 | |
| PRK09776 | 1092 | putative diguanylate cyclase; Provisional | 99.46 | |
| PF00989 | 113 | PAS: PAS fold; InterPro: IPR013767 PAS domains are | 99.45 | |
| PRK13559 | 361 | hypothetical protein; Provisional | 99.42 | |
| PRK13557 | 540 | histidine kinase; Provisional | 99.4 | |
| PRK13559 | 361 | hypothetical protein; Provisional | 99.39 | |
| PRK11091 | 779 | aerobic respiration control sensor protein ArcB; P | 99.39 | |
| PRK13557 | 540 | histidine kinase; Provisional | 99.39 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.39 | |
| PRK11091 | 779 | aerobic respiration control sensor protein ArcB; P | 99.37 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.34 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.31 | |
| PRK13558 | 665 | bacterio-opsin activator; Provisional | 99.27 | |
| TIGR02040 | 442 | PpsR-CrtJ transcriptional regulator PpsR. This mod | 99.26 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.26 | |
| PRK10060 | 663 | RNase II stability modulator; Provisional | 99.26 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.23 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.22 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.21 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.2 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.2 | |
| PRK13558 | 665 | bacterio-opsin activator; Provisional | 99.18 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.17 | |
| TIGR02938 | 494 | nifL_nitrog nitrogen fixation negative regulator N | 99.13 | |
| PRK10060 | 663 | RNase II stability modulator; Provisional | 99.12 | |
| TIGR00229 | 124 | sensory_box PAS domain S-box. The PAS domain was p | 99.12 | |
| PRK11359 | 799 | cyclic-di-GMP phosphodiesterase; Provisional | 99.07 | |
| PF08447 | 91 | PAS_3: PAS fold; InterPro: IPR013655 The PAS fold | 99.04 | |
| TIGR00229 | 124 | sensory_box PAS domain S-box. The PAS domain was p | 99.02 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 99.0 | |
| PF08447 | 91 | PAS_3: PAS fold; InterPro: IPR013655 The PAS fold | 98.96 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 98.95 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.87 | |
| COG3829 | 560 | RocR Transcriptional regulator containing PAS, AAA | 98.84 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.83 | |
| cd00130 | 103 | PAS PAS domain; PAS motifs appear in archaea, euba | 98.79 | |
| PRK11073 | 348 | glnL nitrogen regulation protein NR(II); Provision | 98.79 | |
| cd00130 | 103 | PAS PAS domain; PAS motifs appear in archaea, euba | 98.77 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.76 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.75 | |
| PRK11360 | 607 | sensory histidine kinase AtoS; Provisional | 98.73 | |
| TIGR02966 | 333 | phoR_proteo phosphate regulon sensor kinase PhoR. | 98.72 | |
| TIGR02966 | 333 | phoR_proteo phosphate regulon sensor kinase PhoR. | 98.68 | |
| PRK11073 | 348 | glnL nitrogen regulation protein NR(II); Provision | 98.67 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.64 | |
| PRK11360 | 607 | sensory histidine kinase AtoS; Provisional | 98.64 | |
| KOG0501 | 971 | consensus K+-channel KCNQ [Inorganic ion transport | 98.64 | |
| PF13596 | 106 | PAS_10: PAS domain; PDB: 3CAX_A 2QKP_D. | 98.64 | |
| PF12860 | 115 | PAS_7: PAS fold | 98.58 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.57 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.57 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.54 | |
| KOG0501 | 971 | consensus K+-channel KCNQ [Inorganic ion transport | 98.51 | |
| PF13596 | 106 | PAS_10: PAS domain; PDB: 3CAX_A 2QKP_D. | 98.49 | |
| PF12860 | 115 | PAS_7: PAS fold | 98.47 |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-52 Score=443.18 Aligned_cols=336 Identities=54% Similarity=0.967 Sum_probs=292.4
Q ss_pred CCCCCCCCCchhhHHhhc-ccccccccCCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHH
Q 001847 646 PKPHRKDSPPWKAIQKIL-DSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAERE 724 (1005)
Q Consensus 646 ~~~~~~~~~~~~~~~~~~-~~~~~i~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~ 724 (1005)
..||.....-|..+..+- ..+..+..++|++++.||.|.-|+||+|....++..+|+|++.+..+.......+...|.+
T Consensus 50 ~kph~~~d~~w~a~~~~~~~~~~~l~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~e 129 (459)
T KOG0610|consen 50 NKPHKGNDVRWEAISSIRNSKDGSLGLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTERE 129 (459)
T ss_pred CCCCCCCchhhhhhccccccCCCccCHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHH
Confidence 446666556677766555 4667788999999999999999999999999999999999999998888888999999999
Q ss_pred HHHhCCCCCcceEEEEEEeCCeEEEEEeccCCCchhhHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCc
Q 001847 725 ILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPEN 804 (1005)
Q Consensus 725 il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~N 804 (1005)
||..++||+++.+|..|+...+.|++||||+||+|..++++++++.+++..++.|+..++.||+|||-.|||+|||||+|
T Consensus 130 IL~~lDHPFlPTLYa~fet~~~~cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPEN 209 (459)
T KOG0610|consen 130 ILSLLDHPFLPTLYASFETDKYSCLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPEN 209 (459)
T ss_pred HHHhcCCCccchhhheeeccceeEEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcce
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred EEEecCCcEEEEeccCCcccCCCCCCCCCcc----------------------hhh-hhc---ccCC--CCCccccccc-
Q 001847 805 VLLQGNGHVSLTDFDLSCLTSCKPQLLLPTT----------------------NEK-KRR---HKGQ--QNPVFMAEPM- 855 (1005)
Q Consensus 805 ILi~~~g~vkL~DFG~a~~~~~~~~~~~~~~----------------------~~~-~~~---~~~~--~~~~~~~~~~- 855 (1005)
|||.++|++.|+||.++..+...+....... ... ++. .... ..+..+..+.
T Consensus 210 ILvredGHIMLsDFDLS~~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~ 289 (459)
T KOG0610|consen 210 ILVREDGHIMLSDFDLSLRCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTG 289 (459)
T ss_pred eEEecCCcEEeeeccccccCCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCC
Confidence 9999999999999999976644333221100 000 000 0000 0011222333
Q ss_pred ccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhCCCCCCCCCCCCHHHHHHHH
Q 001847 856 RASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMY 935 (1005)
Q Consensus 856 ~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlGvll~eLltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~Ll~ 935 (1005)
..+.+++||-.|+|||++.+..++.++|-|+||+++|||++|..||.|.+..+.+.+|+.....+|.....+..++|||+
T Consensus 290 ~RSnSFVGThEYlAPEvI~G~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~l~Fp~~~~vs~~akDLIr 369 (459)
T KOG0610|consen 290 ARSNSFVGTHEYLAPEVIRGEGHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQPLKFPEEPEVSSAAKDLIR 369 (459)
T ss_pred ccccccccccccccceeeecCCCCchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCCCcCCCCCcchhHHHHHHH
Confidence 45678899999999999999999999999999999999999999999999999999999999999999889999999999
Q ss_pred HccccCcCccCCChhcHHHHHcCCCCCCCChhhhhhcCCCCCCCCC
Q 001847 936 RLLHRDPKSRLGSHEGANEIKKHPFFKGVNWALVRCMNPPELDAPL 981 (1005)
Q Consensus 936 ~~L~~dP~~Rpt~~~~a~elL~hpff~~~~~~~~~~~~~~~~~~p~ 981 (1005)
++|.+||.+|+.....|.+|.+||||++++|+++++..||+++.|.
T Consensus 370 ~LLvKdP~kRlg~~rGA~eIK~HpFF~gVnWaLir~~~PP~iP~~~ 415 (459)
T KOG0610|consen 370 KLLVKDPSKRLGSKRGAAEIKRHPFFEGVNWALIRCARPPEIPKPV 415 (459)
T ss_pred HHhccChhhhhccccchHHhhcCccccCCChhheeccCCCcCCCcc
Confidence 9999999999999999999999999999999999999999986654
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-50 Score=440.46 Aligned_cols=319 Identities=42% Similarity=0.719 Sum_probs=269.7
Q ss_pred ccccCCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeE
Q 001847 668 QINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHV 747 (1005)
Q Consensus 668 ~i~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 747 (1005)
.+..++|+++++||+|+||.||+|+-+.||.+||+|++++..+........+..|..+|...++|+||+++..|++..++
T Consensus 137 r~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~L 216 (550)
T KOG0605|consen 137 RLSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYL 216 (550)
T ss_pred cCCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCee
Confidence 34578999999999999999999999999999999999999888889999999999999999999999999999999999
Q ss_pred EEEEeccCCCchhhHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCC
Q 001847 748 CLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCK 827 (1005)
Q Consensus 748 ~lV~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~ 827 (1005)
||||||++||++..+|.+. +.|+++.+++++.+++.|+..||+.|+|||||||+|+|||..|++||+|||++.-....
T Consensus 217 YLiMEylPGGD~mTLL~~~--~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~ 294 (550)
T KOG0605|consen 217 YLIMEYLPGGDMMTLLMRK--DTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKK 294 (550)
T ss_pred EEEEEecCCccHHHHHHhc--CcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecCCCCEeeccccccchhhhh
Confidence 9999999999999999874 56999999999999999999999999999999999999999999999999998544332
Q ss_pred CCCCCCcchhhh--hcc--cCCCCC----------------cccccccccccccccCCcccccccccCCCCCChhhHHHH
Q 001847 828 PQLLLPTTNEKK--RRH--KGQQNP----------------VFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWAL 887 (1005)
Q Consensus 828 ~~~~~~~~~~~~--~~~--~~~~~~----------------~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSl 887 (1005)
............ ... .....+ .+.-.......+.+|||.|+|||++.+..|+..+|.|||
T Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSL 374 (550)
T KOG0605|consen 295 HRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSL 374 (550)
T ss_pred hhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHHH
Confidence 221100000000 000 000000 000112223445799999999999999999999999999
Q ss_pred HHHHHHHHcCCCCCCCCChHHHHHHHHhCC--CCCCCCCCCCHHHHHHHHHccccCcCccCCChhcHHHHHcCCCCCCCC
Q 001847 888 GILLYEMLYGYTPFRGKTRQKTFANILHKD--LKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVN 965 (1005)
Q Consensus 888 Gvll~eLltG~~Pf~~~~~~~~~~~i~~~~--~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~hpff~~~~ 965 (1005)
|||+||||.|.+||.+.+..+.+.+|+... +.+|....++.+++|||.+||+ ||++|+. ...++||.+||||++++
T Consensus 375 G~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~~~~~s~eA~DLI~rll~-d~~~RLG-~~G~~EIK~HPfF~~v~ 452 (550)
T KOG0605|consen 375 GCIMYEMLVGYPPFCSETPQETYRKIVNWRETLKFPEEVDLSDEAKDLITRLLC-DPENRLG-SKGAEEIKKHPFFKGVD 452 (550)
T ss_pred HHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCCcCcccHHHHHHHHHHhc-CHHHhcC-cccHHHHhcCCccccCC
Confidence 999999999999999999999999999765 7888888899999999999999 9999998 55699999999999999
Q ss_pred hhhhhhcCCCCCCCCCCCCcccccccc
Q 001847 966 WALVRCMNPPELDAPLFATDTEKEYKV 992 (1005)
Q Consensus 966 ~~~~~~~~~~~~~~p~~~~~~~~~~~~ 992 (1005)
|..++...+| .+|.+....+-.|+.
T Consensus 453 W~~l~~~~ap--fvP~v~~~~DT~yFd 477 (550)
T KOG0605|consen 453 WDHLREMPAP--FVPQVNSELDTQYFD 477 (550)
T ss_pred cchhhcCCCC--CCCCCCCcccccccc
Confidence 9999888877 458877766666664
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-49 Score=423.59 Aligned_cols=277 Identities=45% Similarity=0.796 Sum_probs=249.9
Q ss_pred cccCCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEE
Q 001847 669 INLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVC 748 (1005)
Q Consensus 669 i~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~ 748 (1005)
+..++|++++.||.|+||+||+|+.+.+++.||+|++++..+...........|..||..++||+||.++..|++...+|
T Consensus 22 ~~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLy 101 (357)
T KOG0598|consen 22 VGPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLY 101 (357)
T ss_pred CChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEE
Confidence 45679999999999999999999999999999999999988877778888999999999999999999999999999999
Q ss_pred EEEeccCCCchhhHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCC
Q 001847 749 LITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKP 828 (1005)
Q Consensus 749 lV~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~ 828 (1005)
+|+||+.||.|+-.|+++ +.+++..++.|+..|+.||.|||++|||||||||+|||++.+|+++|+|||+++..-
T Consensus 102 lVld~~~GGeLf~hL~~e--g~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~--- 176 (357)
T KOG0598|consen 102 LVLDYLNGGELFYHLQRE--GRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDEQGHIKLTDFGLCKEDL--- 176 (357)
T ss_pred EEEeccCCccHHHHHHhc--CCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecCCCcEEEeccccchhcc---
Confidence 999999999999999875 559999999999999999999999999999999999999999999999999996421
Q ss_pred CCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHcCCCCCCCCChHH
Q 001847 829 QLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQK 908 (1005)
Q Consensus 829 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlGvll~eLltG~~Pf~~~~~~~ 908 (1005)
.......++|||+.|||||++.+.+|+..+|-||||+++|+|++|.+||.+.+...
T Consensus 177 ------------------------~~~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~ 232 (357)
T KOG0598|consen 177 ------------------------KDGDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKK 232 (357)
T ss_pred ------------------------cCCCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHH
Confidence 11223456899999999999999999999999999999999999999999999999
Q ss_pred HHHHHHhCCCCCCCCCCCCHHHHHHHHHccccCcCccCCChhcHHHHHcCCCCCCCChhhhhhcCCC
Q 001847 909 TFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVNWALVRCMNPP 975 (1005)
Q Consensus 909 ~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~hpff~~~~~~~~~~~~~~ 975 (1005)
.+.+|.++....+.. ..+.++++||.++|..||.+|......+.++.+||||+.++|..+.....+
T Consensus 233 ~~~~I~~~k~~~~p~-~ls~~ardll~~LL~rdp~~RLg~~~d~~~ik~HpfF~~inW~~l~~k~l~ 298 (357)
T KOG0598|consen 233 MYDKILKGKLPLPPG-YLSEEARDLLKKLLKRDPRQRLGGPGDAEEIKRHPFFKGINWEKLLAKKLS 298 (357)
T ss_pred HHHHHhcCcCCCCCc-cCCHHHHHHHHHHhccCHHHhcCCCCChHHhhcCcccccCCHHHHHhcCCC
Confidence 999999987433322 268899999999999999999865566999999999999999988444443
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-49 Score=436.48 Aligned_cols=286 Identities=39% Similarity=0.674 Sum_probs=257.5
Q ss_pred ccCCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCeEE
Q 001847 670 NLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPALYASFQTKTHVC 748 (1005)
Q Consensus 670 ~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~~ 748 (1005)
...+|.+.+.||+|+|++|++|+++.+++.||||++.+..+......+.+..|..+|.+| +||.|++++-.|.+...+|
T Consensus 71 ~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLY 150 (604)
T KOG0592|consen 71 TPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLY 150 (604)
T ss_pred ChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceE
Confidence 356899999999999999999999999999999999887776677778888999999999 8999999999999999999
Q ss_pred EEEeccCCCchhhHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCC
Q 001847 749 LITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKP 828 (1005)
Q Consensus 749 lV~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~ 828 (1005)
+|+||+++|+|.+++.+. +.+++.-.+.++.||+.||+|||++|||||||||+|||++.||++||.|||.|..+....
T Consensus 151 FvLe~A~nGdll~~i~K~--Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~dmhikITDFGsAK~l~~~~ 228 (604)
T KOG0592|consen 151 FVLEYAPNGDLLDLIKKY--GSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDKDGHIKITDFGSAKILSPSQ 228 (604)
T ss_pred EEEEecCCCcHHHHHHHh--CcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCCCcEEEeeccccccCChhh
Confidence 999999999999999875 669999999999999999999999999999999999999999999999999998876543
Q ss_pred CCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHcCCCCCCCCChHH
Q 001847 829 QLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQK 908 (1005)
Q Consensus 829 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlGvll~eLltG~~Pf~~~~~~~ 908 (1005)
...- .+...........+++||..|.+||+|.....++.+|||+|||+||+|+.|.+||.+.+...
T Consensus 229 ~~~~--------------~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Neyl 294 (604)
T KOG0592|consen 229 KSQE--------------NPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYL 294 (604)
T ss_pred cccc--------------CccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHH
Confidence 3210 00111111112367999999999999999999999999999999999999999999999999
Q ss_pred HHHHHHhCCCCCCCCCCCCHHHHHHHHHccccCcCccCCChhcHHHHHcCCCCCCCChhhhhhcCCCCC
Q 001847 909 TFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVNWALVRCMNPPEL 977 (1005)
Q Consensus 909 ~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~hpff~~~~~~~~~~~~~~~~ 977 (1005)
++++|+.-...++.. .+..+.+||+++|..||..|++ +.+|.+||||.+++|..++...||++
T Consensus 295 iFqkI~~l~y~fp~~--fp~~a~dLv~KLLv~dp~~Rlt----~~qIk~HpFF~~Vdw~nlw~~~PP~l 357 (604)
T KOG0592|consen 295 IFQKIQALDYEFPEG--FPEDARDLIKKLLVRDPSDRLT----SQQIKAHPFFEGVDWENLWQQTPPKL 357 (604)
T ss_pred HHHHHHHhcccCCCC--CCHHHHHHHHHHHccCcccccc----HHHHhhCcccccCChhhhhhcCCCcc
Confidence 999999998888875 5789999999999999999999 99999999999999999999999987
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-48 Score=416.45 Aligned_cols=262 Identities=28% Similarity=0.464 Sum_probs=235.2
Q ss_pred ccccCCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC-e
Q 001847 668 QINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKT-H 746 (1005)
Q Consensus 668 ~i~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~-~ 746 (1005)
.+...+.+.++.||+|+.|+||+|.|+.|++.+|+|.+.. ..+....+++.+|+++++.++|||||.+|++|..++ .
T Consensus 75 ~i~~~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~--~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~ 152 (364)
T KOG0581|consen 75 GISLSDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILL--NIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEE 152 (364)
T ss_pred ccCHHHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecc--cCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCce
Confidence 4556789999999999999999999999999999999953 346677889999999999999999999999999998 5
Q ss_pred EEEEEeccCCCchhhHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHH-cCcccCCCCCCcEEEecCCcEEEEeccCCcccC
Q 001847 747 VCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHC-QGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTS 825 (1005)
Q Consensus 747 ~~lV~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~-~gIvHrDLkP~NILi~~~g~vkL~DFG~a~~~~ 825 (1005)
++|+||||++|+|.+++... +.+++..+..++.++++||.|||. .+||||||||+|||+++.|.|||||||.+....
T Consensus 153 isI~mEYMDgGSLd~~~k~~--g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lv 230 (364)
T KOG0581|consen 153 ISICMEYMDGGSLDDILKRV--GRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILV 230 (364)
T ss_pred EEeehhhcCCCCHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCCCEEeccccccHHhh
Confidence 99999999999999999875 569999999999999999999996 899999999999999999999999999986543
Q ss_pred CCCCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHcCCCCCCCC-
Q 001847 826 CKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGK- 904 (1005)
Q Consensus 826 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlGvll~eLltG~~Pf~~~- 904 (1005)
.. ..++++||..|||||.+.+..|+.++||||||++++|+++|++||...
T Consensus 231 nS-----------------------------~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~ 281 (364)
T KOG0581|consen 231 NS-----------------------------IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPN 281 (364)
T ss_pred hh-----------------------------hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcC
Confidence 11 356789999999999999999999999999999999999999999874
Q ss_pred ----ChHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHccccCcCccCCChhcHHHHHcCCCCCCCCh
Q 001847 905 ----TRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVNW 966 (1005)
Q Consensus 905 ----~~~~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~hpff~~~~~ 966 (1005)
...+.+..|+.+..+......+|+++.+||..||++||.+|++ ++||++|||+++...
T Consensus 282 ~~~~~~~~Ll~~Iv~~ppP~lP~~~fS~ef~~FV~~CL~Kdp~~R~s----~~qLl~Hpfi~~~~~ 343 (364)
T KOG0581|consen 282 PPYLDIFELLCAIVDEPPPRLPEGEFSPEFRSFVSCCLRKDPSERPS----AKQLLQHPFIKKFED 343 (364)
T ss_pred CCCCCHHHHHHHHhcCCCCCCCcccCCHHHHHHHHHHhcCCcccCCC----HHHHhcCHHHhhccc
Confidence 5678888888876554444468999999999999999999999 999999999997543
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-48 Score=400.50 Aligned_cols=275 Identities=45% Similarity=0.836 Sum_probs=254.5
Q ss_pred cccCCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEE
Q 001847 669 INLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVC 748 (1005)
Q Consensus 669 i~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~ 748 (1005)
..+++|+.++.||.|+||+|.+++++.+|.+||+|++.+..+......+...+|..+|+.+.||+++++++.|.+.+.+|
T Consensus 41 ~~l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~ly 120 (355)
T KOG0616|consen 41 YSLQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLY 120 (355)
T ss_pred cchhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEE
Confidence 45679999999999999999999999999999999999988878888888999999999999999999999999999999
Q ss_pred EEEeccCCCchhhHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCC
Q 001847 749 LITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKP 828 (1005)
Q Consensus 749 lV~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~ 828 (1005)
+||||++||.|+.++++. +.+++..++.++.||+.||+|||+++|++|||||+|||+|++|.+||+|||+|+...
T Consensus 121 mvmeyv~GGElFS~Lrk~--~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~--- 195 (355)
T KOG0616|consen 121 MVMEYVPGGELFSYLRKS--GRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQNGHIKITDFGFAKRVS--- 195 (355)
T ss_pred EEEeccCCccHHHHHHhc--CCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeeccCCcEEEEeccceEEec---
Confidence 999999999999999875 569999999999999999999999999999999999999999999999999996643
Q ss_pred CCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHcCCCCCCCCChHH
Q 001847 829 QLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQK 908 (1005)
Q Consensus 829 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlGvll~eLltG~~Pf~~~~~~~ 908 (1005)
....+.||||.|+|||++...+++.++|-||||+++|||+.|.+||...+...
T Consensus 196 ---------------------------~rT~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~ 248 (355)
T KOG0616|consen 196 ---------------------------GRTWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQ 248 (355)
T ss_pred ---------------------------CcEEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHH
Confidence 12457899999999999999999999999999999999999999999999999
Q ss_pred HHHHHHhCCCCCCCCCCCCHHHHHHHHHccccCcCccCCCh-hcHHHHHcCCCCCCCChhhh--hhcCCCCC
Q 001847 909 TFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSH-EGANEIKKHPFFKGVNWALV--RCMNPPEL 977 (1005)
Q Consensus 909 ~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~-~~a~elL~hpff~~~~~~~~--~~~~~~~~ 977 (1005)
++.+|+.+...+|.. .+.++++||.++|+.|-.+|.... +..+++..||||++++|..+ +..++|-.
T Consensus 249 iY~KI~~~~v~fP~~--fs~~~kdLl~~LL~vD~t~R~gnlknG~~dIk~H~wF~~v~W~~i~~r~ie~P~~ 318 (355)
T KOG0616|consen 249 IYEKILEGKVKFPSY--FSSDAKDLLKKLLQVDLTKRFGNLKNGVEDIKNHPWFKGVDWEAILQRKIEPPFE 318 (355)
T ss_pred HHHHHHhCcccCCcc--cCHHHHHHHHHHHhhhhHhhhcCcCCCccccccCcccccccHHHHhhccccCCCC
Confidence 999999999999876 688999999999999999996654 47899999999999999988 55556644
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-49 Score=423.26 Aligned_cols=261 Identities=33% Similarity=0.507 Sum_probs=229.2
Q ss_pred cCCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccC----hHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCe
Q 001847 671 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLN----RNKVHRACAEREILDMLDHPFVPALYASFQTKTH 746 (1005)
Q Consensus 671 ~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~----~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~ 746 (1005)
.+.|.+.+.||+|+||.|-+|..+.||+.||||++++..... ......+.+|++||++|+||+||+++++|...+.
T Consensus 171 ~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds 250 (475)
T KOG0615|consen 171 NDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDS 250 (475)
T ss_pred cceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCc
Confidence 478999999999999999999999999999999998765543 2244557799999999999999999999999999
Q ss_pred EEEEEeccCCCchhhHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecC---CcEEEEeccCCcc
Q 001847 747 VCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGN---GHVSLTDFDLSCL 823 (1005)
Q Consensus 747 ~~lV~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~~~---g~vkL~DFG~a~~ 823 (1005)
.||||||+.||+|++.+-.+ +.+.+...+.+++||+.||.|||++||+||||||+|||++.+ -.+||.|||+|+.
T Consensus 251 ~YmVlE~v~GGeLfd~vv~n--k~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKItDFGlAK~ 328 (475)
T KOG0615|consen 251 SYMVLEYVEGGELFDKVVAN--KYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKITDFGLAKV 328 (475)
T ss_pred eEEEEEEecCccHHHHHHhc--cccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEecccchhhc
Confidence 99999999999999999775 458899999999999999999999999999999999999876 6799999999976
Q ss_pred cCCCCCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCC---CChhhHHHHHHHHHHHHcCCCC
Q 001847 824 TSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGH---TSAVDWWALGILLYEMLYGYTP 900 (1005)
Q Consensus 824 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~---~~~sDIwSlGvll~eLltG~~P 900 (1005)
.+. .....++||||.|.|||++..... ..++|||||||+||-+++|.+|
T Consensus 329 ~g~----------------------------~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pP 380 (475)
T KOG0615|consen 329 SGE----------------------------GSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPP 380 (475)
T ss_pred ccc----------------------------ceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCC
Confidence 531 122457899999999999977643 3378999999999999999999
Q ss_pred CCCCChHH-HHHHHHhCCCCCC--CCCCCCHHHHHHHHHccccCcCccCCChhcHHHHHcCCCCCCCC
Q 001847 901 FRGKTRQK-TFANILHKDLKFP--SSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVN 965 (1005)
Q Consensus 901 f~~~~~~~-~~~~i~~~~~~~~--~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~hpff~~~~ 965 (1005)
|.+..... ..+.|.++...+. .+..++.++.+||.+||..||++||+ +.++|+||||+..+
T Consensus 381 FS~~~~~~sl~eQI~~G~y~f~p~~w~~Iseea~dlI~~mL~VdP~~R~s----~~eaL~hpW~~~~~ 444 (475)
T KOG0615|consen 381 FSEEYTDPSLKEQILKGRYAFGPLQWDRISEEALDLINWMLVVDPENRPS----ADEALNHPWFKDAP 444 (475)
T ss_pred cccccCCccHHHHHhcCcccccChhhhhhhHHHHHHHHHhhEeCcccCcC----HHHHhcChhhhccc
Confidence 98876554 7788888877654 45668999999999999999999999 99999999999754
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-48 Score=435.77 Aligned_cols=256 Identities=33% Similarity=0.576 Sum_probs=241.0
Q ss_pred CCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEE
Q 001847 672 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLIT 751 (1005)
Q Consensus 672 ~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~ 751 (1005)
.+|...+.||+|+|+.||.+++..+|..||+|++.+..+......+++.+|++|.++|+|||||+++++|++.+++|||+
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 57999999999999999999999999999999999988888889999999999999999999999999999999999999
Q ss_pred eccCCCchhhHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCCCCC
Q 001847 752 DYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLL 831 (1005)
Q Consensus 752 E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~~ 831 (1005)
|+|..++|..+++++ +.+++..++.+++||+.||.|||+++|+|||||..|||++++.+|||+|||+|.....+
T Consensus 98 ELC~~~sL~el~Krr--k~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~---- 171 (592)
T KOG0575|consen 98 ELCHRGSLMELLKRR--KPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYD---- 171 (592)
T ss_pred EecCCccHHHHHHhc--CCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecCcCcEEecccceeeeecCc----
Confidence 999999999999854 66999999999999999999999999999999999999999999999999999765422
Q ss_pred CCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHcCCCCCCCCChHHHHH
Q 001847 832 LPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFA 911 (1005)
Q Consensus 832 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlGvll~eLltG~~Pf~~~~~~~~~~ 911 (1005)
.....+.||||.|+|||++....++..+||||+||++|.|++|++||...+-.+.+.
T Consensus 172 -----------------------~Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~ 228 (592)
T KOG0575|consen 172 -----------------------GERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYN 228 (592)
T ss_pred -----------------------ccccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHH
Confidence 233457899999999999999999999999999999999999999999999999999
Q ss_pred HHHhCCCCCCCCCCCCHHHHHHHHHccccCcCccCCChhcHHHHHcCCCCC
Q 001847 912 NILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFK 962 (1005)
Q Consensus 912 ~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~hpff~ 962 (1005)
+|...+...|. .++.++++||.+||+.||.+||| +.++|.|+||+
T Consensus 229 ~Ik~~~Y~~P~--~ls~~A~dLI~~lL~~~P~~Rps----l~~vL~h~Ff~ 273 (592)
T KOG0575|consen 229 KIKLNEYSMPS--HLSAEAKDLIRKLLRPNPSERPS----LDEVLDHPFFK 273 (592)
T ss_pred HHHhcCccccc--ccCHHHHHHHHHHhcCCcccCCC----HHHHhcCHhhh
Confidence 99999888887 47899999999999999999999 99999999994
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-46 Score=419.55 Aligned_cols=289 Identities=40% Similarity=0.751 Sum_probs=259.2
Q ss_pred cccccCCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCC
Q 001847 667 EQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPALYASFQTKT 745 (1005)
Q Consensus 667 ~~i~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~ 745 (1005)
..+..++|+++++||.|+||+|+++..+.+++.||||++++..+...+.......|..|+... +||+++.++.+|+...
T Consensus 363 ~~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~ 442 (694)
T KOG0694|consen 363 GPLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKE 442 (694)
T ss_pred CcccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCC
Confidence 367889999999999999999999999999999999999999998999999999999999888 5999999999999999
Q ss_pred eEEEEEeccCCCchhhHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccC
Q 001847 746 HVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTS 825 (1005)
Q Consensus 746 ~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~~~g~vkL~DFG~a~~~~ 825 (1005)
++|+||||+.||++.... ..+.+++..++.|+..|+.||.|||++||||||||.+|||+|.+|++||+|||+++..-
T Consensus 443 ~l~fvmey~~Ggdm~~~~---~~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m 519 (694)
T KOG0694|consen 443 HLFFVMEYVAGGDLMHHI---HTDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTEGHVKIADFGLCKEGM 519 (694)
T ss_pred eEEEEEEecCCCcEEEEE---ecccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEcccCcEEecccccccccC
Confidence 999999999999954433 34569999999999999999999999999999999999999999999999999995421
Q ss_pred CCCCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHcCCCCCCCCC
Q 001847 826 CKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKT 905 (1005)
Q Consensus 826 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlGvll~eLltG~~Pf~~~~ 905 (1005)
......+++||||.|||||++.+..|+.++|-|||||+||+|+.|+.||.|++
T Consensus 520 ---------------------------~~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gdd 572 (694)
T KOG0694|consen 520 ---------------------------GQGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDD 572 (694)
T ss_pred ---------------------------CCCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCC
Confidence 11234678999999999999999999999999999999999999999999999
Q ss_pred hHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHccccCcCccCCCh-hcHHHHHcCCCCCCCChhhhhhcCCCCCCCCCCCC
Q 001847 906 RQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSH-EGANEIKKHPFFKGVNWALVRCMNPPELDAPLFAT 984 (1005)
Q Consensus 906 ~~~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~-~~a~elL~hpff~~~~~~~~~~~~~~~~~~p~~~~ 984 (1005)
..+.+..|+..+..+|.. ++.++.++++++|..+|++|+.+- ..+.+|.+||||+.++|.++..++-+....|....
T Consensus 573 Eee~FdsI~~d~~~yP~~--ls~ea~~il~~ll~k~p~kRLG~~e~d~~~i~~hpFFr~i~w~~L~~r~i~PPf~P~i~~ 650 (694)
T KOG0694|consen 573 EEEVFDSIVNDEVRYPRF--LSKEAIAIMRRLLRKNPEKRLGSGERDAEDIKKHPFFRSIDWDDLLNRRIKPPFVPTIKG 650 (694)
T ss_pred HHHHHHHHhcCCCCCCCc--ccHHHHHHHHHHhccCcccccCCCCCCchhhhhCCccccCCHHHHhhccCCCCCCcccCC
Confidence 999999999999988877 688999999999999999999963 34789999999999999999555544446677665
Q ss_pred ccc
Q 001847 985 DTE 987 (1005)
Q Consensus 985 ~~~ 987 (1005)
+.+
T Consensus 651 ~~D 653 (694)
T KOG0694|consen 651 PED 653 (694)
T ss_pred hhh
Confidence 544
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-46 Score=382.70 Aligned_cols=260 Identities=27% Similarity=0.457 Sum_probs=221.8
Q ss_pred cCCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEE
Q 001847 671 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLI 750 (1005)
Q Consensus 671 ~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV 750 (1005)
++.|+.+..+|+|+||+||+|+++.||+.||||.+... ..++...+-..+|+++|++|+|+|+|.++++|.....+++|
T Consensus 1 MekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Es-edd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLV 79 (396)
T KOG0593|consen 1 MEKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVES-EDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLV 79 (396)
T ss_pred CcHHhhhhccccCcceEEEEeccCCcccEEEEEeeccC-CccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEE
Confidence 35799999999999999999999999999999998754 33455556668999999999999999999999999999999
Q ss_pred EeccCCCchhhHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCCCC
Q 001847 751 TDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQL 830 (1005)
Q Consensus 751 ~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~ 830 (1005)
+||| .-++.+-+.+.+.+ ++.+.++.++.|++.|+.|+|++++|||||||+||||+.+|.+||||||+|+.....
T Consensus 80 FE~~-dhTvL~eLe~~p~G-~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~p--- 154 (396)
T KOG0593|consen 80 FEYC-DHTVLHELERYPNG-VPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQNGVVKLCDFGFARTLSAP--- 154 (396)
T ss_pred eeec-chHHHHHHHhccCC-CCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEecCCcEEeccchhhHhhcCC---
Confidence 9999 55555556655444 899999999999999999999999999999999999999999999999999765421
Q ss_pred CCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccC-CCCCChhhHHHHHHHHHHHHcCCCCCCCCChHHH
Q 001847 831 LLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAG-AGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKT 909 (1005)
Q Consensus 831 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~sDIwSlGvll~eLltG~~Pf~~~~~~~~ 909 (1005)
......++.|.+|+|||.+.+ .+|+.++||||+||++.||++|.+.|+|.+..++
T Consensus 155 ------------------------gd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQ 210 (396)
T KOG0593|consen 155 ------------------------GDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQ 210 (396)
T ss_pred ------------------------cchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHH
Confidence 122344678999999999988 6899999999999999999999999999998888
Q ss_pred HHHHHhC-------------------CCCCCC----------CCCCCHHHHHHHHHccccCcCccCCChhcHHHHHcCCC
Q 001847 910 FANILHK-------------------DLKFPS----------STPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPF 960 (1005)
Q Consensus 910 ~~~i~~~-------------------~~~~~~----------~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~hpf 960 (1005)
+..|... .+.+|. .+..+.-+.+|+++||..||++|++ .+++|.|+|
T Consensus 211 Ly~I~ktLG~L~prhq~iF~~N~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~s----c~qll~H~y 286 (396)
T KOG0593|consen 211 LYLIRKTLGNLIPRHQSIFSSNPFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLS----CEQLLHHPY 286 (396)
T ss_pred HHHHHHHHcccCHHHHHHhccCCceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCcccccc----HHHHhcChH
Confidence 7777541 111221 1335567789999999999999999 999999999
Q ss_pred CCCC
Q 001847 961 FKGV 964 (1005)
Q Consensus 961 f~~~ 964 (1005)
|.++
T Consensus 287 Fd~~ 290 (396)
T KOG0593|consen 287 FDGF 290 (396)
T ss_pred HHHH
Confidence 9664
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-44 Score=386.15 Aligned_cols=259 Identities=29% Similarity=0.507 Sum_probs=228.7
Q ss_pred cCCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEE
Q 001847 671 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLI 750 (1005)
Q Consensus 671 ~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV 750 (1005)
.++|.+.+.||+|+|++||+++++.++..||||.+.+..+ .+...+.+..|+++|+.++|||||.+++++...+.+|+|
T Consensus 9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l-~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lV 87 (429)
T KOG0595|consen 9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKL-NKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLV 87 (429)
T ss_pred cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhcc-CHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEE
Confidence 4689999999999999999999999999999999987643 556677888999999999999999999999999999999
Q ss_pred EeccCCCchhhHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecC------CcEEEEeccCCccc
Q 001847 751 TDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGN------GHVSLTDFDLSCLT 824 (1005)
Q Consensus 751 ~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~~~------g~vkL~DFG~a~~~ 824 (1005)
||||.||+|.+|+++. +.+++..++.++.||+.||++||+++||||||||.|||++.+ -.+||.|||+|+.+
T Consensus 88 MEyC~gGDLs~yi~~~--~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L 165 (429)
T KOG0595|consen 88 MEYCNGGDLSDYIRRR--GRLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFL 165 (429)
T ss_pred EEeCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccchhhhC
Confidence 9999999999999875 459999999999999999999999999999999999999865 35899999999765
Q ss_pred CCCCCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHcCCCCCCCC
Q 001847 825 SCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGK 904 (1005)
Q Consensus 825 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlGvll~eLltG~~Pf~~~ 904 (1005)
. +.....+.||+|.|||||++....|+.|+|+||+|++||+|++|+.||...
T Consensus 166 ~----------------------------~~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~ 217 (429)
T KOG0595|consen 166 Q----------------------------PGSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAE 217 (429)
T ss_pred C----------------------------chhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCcccc
Confidence 4 223456789999999999999999999999999999999999999999999
Q ss_pred ChHHHHHHHHhCCCCCCCC-CCCCHHHHHHHHHccccCcCccCCChhcHHHHHcCCCCCCC
Q 001847 905 TRQKTFANILHKDLKFPSS-TPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGV 964 (1005)
Q Consensus 905 ~~~~~~~~i~~~~~~~~~~-~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~hpff~~~ 964 (1005)
+..+....+.++.-..+.. ...+..+.+|+...|+.+|..|.+ ..+-+.|+++..-
T Consensus 218 t~~eL~~~~~k~~~~~~~~~~~~s~~~~~Ll~~ll~~~~~~~~~----~~~~~~~~~l~~~ 274 (429)
T KOG0595|consen 218 TPKELLLYIKKGNEIVPVLPAELSNPLRELLISLLQRNPKDRIS----FEDFFDHPFLAAN 274 (429)
T ss_pred CHHHHHHHHhccccccCchhhhccCchhhhhhHHHhcCccccCc----hHHhhhhhhcccC
Confidence 9999888777665443332 224555678999999999999999 7888899988763
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-45 Score=373.55 Aligned_cols=257 Identities=28% Similarity=0.460 Sum_probs=224.1
Q ss_pred ccCCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceEEE-EEEeCCe-E
Q 001847 670 NLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYA-SFQTKTH-V 747 (1005)
Q Consensus 670 ~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~-~~~~~~~-~ 747 (1005)
....|++++.||.|+||.||+|.+..+|+.+|.|.+..+ ..+......+..|+.+|++|+|||||++++ .|..+.. +
T Consensus 17 ~l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~-~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evl 95 (375)
T KOG0591|consen 17 TLADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFG-MMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVL 95 (375)
T ss_pred cHHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchh-hccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhh
Confidence 456899999999999999999999999999999999854 456677788999999999999999999998 5655555 8
Q ss_pred EEEEeccCCCchhhHHhh--CCCCCCCHHHHHHHHHHHHHHHHHHHH--cC--cccCCCCCCcEEEecCCcEEEEeccCC
Q 001847 748 CLITDYCPGGELFLLLDR--QPTKVLKEDAVRFYAAEVVVALEYLHC--QG--IIYRDLKPENVLLQGNGHVSLTDFDLS 821 (1005)
Q Consensus 748 ~lV~E~~~ggsL~~~l~~--~~~~~l~~~~i~~i~~qil~aL~~LH~--~g--IvHrDLkP~NILi~~~g~vkL~DFG~a 821 (1005)
+||||||.+|+|..++++ ...+.+++..++.++.||+.||..+|. .+ |+||||||.||+++.+|.+||+|||++
T Consensus 96 nivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~ 175 (375)
T KOG0591|consen 96 NIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLG 175 (375)
T ss_pred HHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhH
Confidence 999999999999999974 345679999999999999999999999 45 999999999999999999999999999
Q ss_pred cccCCCCCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHcCCCCC
Q 001847 822 CLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPF 901 (1005)
Q Consensus 822 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlGvll~eLltG~~Pf 901 (1005)
+..+.+ .....+++|||+||+||.+.+.+|+.+|||||+||++|||+.-++||
T Consensus 176 r~l~s~---------------------------~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF 228 (375)
T KOG0591|consen 176 RFLSSK---------------------------TTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPF 228 (375)
T ss_pred hHhcch---------------------------hHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCc
Confidence 765422 12245689999999999999999999999999999999999999999
Q ss_pred CCCChHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHccccCcCccCCChhcHHH
Q 001847 902 RGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANE 954 (1005)
Q Consensus 902 ~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~e 954 (1005)
.|.+-.+.-.+|.+++.+......+|..+..||..|+..||+.||+..+.+.+
T Consensus 229 ~g~n~~~L~~KI~qgd~~~~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~d 281 (375)
T KOG0591|consen 229 YGDNLLSLCKKIEQGDYPPLPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQD 281 (375)
T ss_pred ccccHHHHHHHHHcCCCCCCcHHHhhhHHHHHHHHHccCCcccCCCcchHHHH
Confidence 99988888889998876533334578899999999999999999984333333
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-44 Score=393.78 Aligned_cols=256 Identities=33% Similarity=0.542 Sum_probs=234.1
Q ss_pred CCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEE
Q 001847 672 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLIT 751 (1005)
Q Consensus 672 ~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~ 751 (1005)
++|.+.+.||+|+||.||+++.+.+.+.||+|.+.+... .....+.+.+|++|++.++||||+.++++|+...++|+|+
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr-~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVt 80 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGR-NEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVT 80 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCC-chHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEe
Confidence 589999999999999999999999999999999987533 3345678899999999999999999999999999999999
Q ss_pred eccCCCchhhHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCCCCC
Q 001847 752 DYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLL 831 (1005)
Q Consensus 752 E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~~ 831 (1005)
||+.| +|+.++... +.++++.++.++.+++.||.|||+++|.|||+||.|||+..+|++|+||||+|+.++....
T Consensus 81 e~a~g-~L~~il~~d--~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t~-- 155 (808)
T KOG0597|consen 81 EYAVG-DLFTILEQD--GKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNTS-- 155 (808)
T ss_pred hhhhh-hHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecCCCceeechhhhhhhcccCce--
Confidence 99955 999999875 5599999999999999999999999999999999999999999999999999987653222
Q ss_pred CCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHcCCCCCCCCChHHHHH
Q 001847 832 LPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFA 911 (1005)
Q Consensus 832 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlGvll~eLltG~~Pf~~~~~~~~~~ 911 (1005)
.-....|||.|||||++.+.+|+..+|.|||||++||+++|++||.........+
T Consensus 156 -------------------------vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~ 210 (808)
T KOG0597|consen 156 -------------------------VLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARSITQLVK 210 (808)
T ss_pred -------------------------eeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHHHHHHHH
Confidence 2245679999999999999999999999999999999999999999998889999
Q ss_pred HHHhCCCCCCCCCCCCHHHHHHHHHccccCcCccCCChhcHHHHHcCCCCCCC
Q 001847 912 NILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGV 964 (1005)
Q Consensus 912 ~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~hpff~~~ 964 (1005)
.|......+|. ..+..+.+||+++|.+||.+|++ +.+++.|||.++.
T Consensus 211 ~I~~d~v~~p~--~~S~~f~nfl~gLL~kdP~~Rlt----W~~Ll~HpF~k~~ 257 (808)
T KOG0597|consen 211 SILKDPVKPPS--TASSSFVNFLQGLLIKDPAQRLT----WTDLLGHPFWKGK 257 (808)
T ss_pred HHhcCCCCCcc--cccHHHHHHHHHHhhcChhhccc----HHHHhcChHHhhh
Confidence 99999888887 47889999999999999999999 9999999999984
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-44 Score=399.17 Aligned_cols=264 Identities=31% Similarity=0.533 Sum_probs=239.3
Q ss_pred cCCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEE
Q 001847 671 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLI 750 (1005)
Q Consensus 671 ~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV 750 (1005)
.+.|++.+.||.|+.|.|-+|++..||+.+|||++.+...........+.+|+-||+.+.||||+++|+++.++.++|+|
T Consensus 11 iGpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylv 90 (786)
T KOG0588|consen 11 IGPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLV 90 (786)
T ss_pred ccceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEE
Confidence 45789999999999999999999999999999999887555666678899999999999999999999999999999999
Q ss_pred EeccCCCchhhHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCCCC
Q 001847 751 TDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQL 830 (1005)
Q Consensus 751 ~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~ 830 (1005)
.||++||.|++++-.. +.+++..+..+++||+.||.|+|..+|+||||||+|+|++..+++||+|||+|.....
T Consensus 91 lEyv~gGELFdylv~k--G~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~---- 164 (786)
T KOG0588|consen 91 LEYVPGGELFDYLVRK--GPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDVKNNIKIADFGMASLEVP---- 164 (786)
T ss_pred EEecCCchhHHHHHhh--CCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhcccCEeeeccceeecccC----
Confidence 9999999999999875 5699999999999999999999999999999999999999999999999999955321
Q ss_pred CCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCC-CChhhHHHHHHHHHHHHcCCCCCCCCChHHH
Q 001847 831 LLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGH-TSAVDWWALGILLYEMLYGYTPFRGKTRQKT 909 (1005)
Q Consensus 831 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~-~~~sDIwSlGvll~eLltG~~Pf~~~~~~~~ 909 (1005)
...-.+.||+|.|.|||++.+.+| +.++||||.|||||.|++|++||.+++....
T Consensus 165 ------------------------gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~L 220 (786)
T KOG0588|consen 165 ------------------------GKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVL 220 (786)
T ss_pred ------------------------CccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHH
Confidence 122346799999999999999887 4699999999999999999999999999999
Q ss_pred HHHHHhCCCCCCCCCCCCHHHHHHHHHccccCcCccCCChhcHHHHHcCCCCCCCChhhhh
Q 001847 910 FANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVNWALVR 970 (1005)
Q Consensus 910 ~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~hpff~~~~~~~~~ 970 (1005)
+.++.++.+..|. .++.++++||.+||..||+.|+| .++|++|||+.+..-....
T Consensus 221 LlKV~~G~f~MPs--~Is~eaQdLLr~ml~VDp~~RiT----~~eI~kHP~l~g~~~~~~~ 275 (786)
T KOG0588|consen 221 LLKVQRGVFEMPS--NISSEAQDLLRRMLDVDPSTRIT----TEEILKHPFLSGYTSLPSS 275 (786)
T ss_pred HHHHHcCcccCCC--cCCHHHHHHHHHHhccCcccccc----HHHHhhCchhhcCCCCChh
Confidence 9999999888874 58999999999999999999999 9999999999987555443
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-44 Score=388.96 Aligned_cols=263 Identities=28% Similarity=0.469 Sum_probs=226.1
Q ss_pred cccCCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCC-CCCcceEEEEEEeCC-e
Q 001847 669 INLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLD-HPFVPALYASFQTKT-H 746 (1005)
Q Consensus 669 i~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~il~~l~-hpnIv~l~~~~~~~~-~ 746 (1005)
+.+++|.++++||.|+||.||+|+.+.++..||||.+++... .-+.+ .-++|++.|++|+ ||||+++.+++.+.+ .
T Consensus 7 ~~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~-s~ee~-~nLREvksL~kln~hpniikL~Evi~d~~~~ 84 (538)
T KOG0661|consen 7 IFMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFY-SWEEC-MNLREVKSLRKLNPHPNIIKLKEVIRDNDRI 84 (538)
T ss_pred hHHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhc-cHHHH-HHHHHHHHHHhcCCCCcchhhHHHhhccCce
Confidence 346799999999999999999999999999999999987533 22222 2357999999998 999999999999887 9
Q ss_pred EEEEEeccCCCchhhHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCC
Q 001847 747 VCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSC 826 (1005)
Q Consensus 747 ~~lV~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~~~g~vkL~DFG~a~~~~~ 826 (1005)
+|+||||| ..+|+++++.+ ...+++..++.|+.||++||+|+|++|+.||||||+|||+..+..+||+|||+|+....
T Consensus 85 L~fVfE~M-d~NLYqLmK~R-~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~S 162 (538)
T KOG0661|consen 85 LYFVFEFM-DCNLYQLMKDR-NRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISGNDVIKIADFGLAREVRS 162 (538)
T ss_pred EeeeHHhh-hhhHHHHHhhc-CCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEecccceeEeccccccccccc
Confidence 99999999 89999999877 67899999999999999999999999999999999999999999999999999977543
Q ss_pred CCCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccC-CCCCChhhHHHHHHHHHHHHcCCCCCCCCC
Q 001847 827 KPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAG-AGHTSAVDWWALGILLYEMLYGYTPFRGKT 905 (1005)
Q Consensus 827 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~sDIwSlGvll~eLltG~~Pf~~~~ 905 (1005)
.+ ....++.|.+|+|||+|.. ..|+.+.|||++||+++|+++-++.|.|.+
T Consensus 163 kp----------------------------PYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~s 214 (538)
T KOG0661|consen 163 KP----------------------------PYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGAS 214 (538)
T ss_pred CC----------------------------CcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCc
Confidence 21 2234688999999999865 567889999999999999999999999999
Q ss_pred hHHHHHHHHh--C-----------------CCCCCCC---------CCCCHHHHHHHHHccccCcCccCCChhcHHHHHc
Q 001847 906 RQKTFANILH--K-----------------DLKFPSS---------TPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKK 957 (1005)
Q Consensus 906 ~~~~~~~i~~--~-----------------~~~~~~~---------~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~ 957 (1005)
..+++.+|.. + ++.+|.. +..+.++.+||.+||.|||.+||| |.++|+
T Consensus 215 E~Dqi~KIc~VLGtP~~~~~~eg~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpT----A~~al~ 290 (538)
T KOG0661|consen 215 EIDQIYKICEVLGTPDKDSWPEGYNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPT----ASQALQ 290 (538)
T ss_pred HHHHHHHHHHHhCCCccccchhHHHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCcc----HHHHhc
Confidence 8888887754 1 2223321 336778999999999999999999 999999
Q ss_pred CCCCCCCChh
Q 001847 958 HPFFKGVNWA 967 (1005)
Q Consensus 958 hpff~~~~~~ 967 (1005)
||||+.....
T Consensus 291 ~pffq~~~~~ 300 (538)
T KOG0661|consen 291 HPFFQVGRAS 300 (538)
T ss_pred Cccccccccc
Confidence 9999975444
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-43 Score=395.12 Aligned_cols=262 Identities=34% Similarity=0.614 Sum_probs=233.6
Q ss_pred cccCCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccCh--HHHHHHHHHHHHHHhCC-CCCcceEEEEEEeCC
Q 001847 669 INLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNR--NKVHRACAEREILDMLD-HPFVPALYASFQTKT 745 (1005)
Q Consensus 669 i~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~--~~~~~~~~E~~il~~l~-hpnIv~l~~~~~~~~ 745 (1005)
...+.|.+.+.||+|+||+|+.+.+..++..||+|++.+...... .....+.+|+.+++.+. ||||+++++++....
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~ 93 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT 93 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence 346799999999999999999999999999999998776422211 23456668999999998 999999999999999
Q ss_pred eEEEEEeccCCCchhhHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecC-CcEEEEeccCCccc
Q 001847 746 HVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGN-GHVSLTDFDLSCLT 824 (1005)
Q Consensus 746 ~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~~~-g~vkL~DFG~a~~~ 824 (1005)
.+|+||||+.||+|++++.. .+.+.+..++.+++||+.||+|||++||+||||||+|||++.+ +++||+|||++...
T Consensus 94 ~~~ivmEy~~gGdL~~~i~~--~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~~ 171 (370)
T KOG0583|consen 94 KIYIVMEYCSGGDLFDYIVN--KGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNEGNLKLSDFGLSAIS 171 (370)
T ss_pred eEEEEEEecCCccHHHHHHH--cCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCCCCEEEecccccccc
Confidence 99999999999999999987 3569999999999999999999999999999999999999999 99999999999664
Q ss_pred CCCCCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCC-CC-ChhhHHHHHHHHHHHHcCCCCCC
Q 001847 825 SCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAG-HT-SAVDWWALGILLYEMLYGYTPFR 902 (1005)
Q Consensus 825 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~-~~-~~sDIwSlGvll~eLltG~~Pf~ 902 (1005)
. .......+.+||+.|+|||++.+.. |+ .++||||+|++||.|++|+.||.
T Consensus 172 ~---------------------------~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~ 224 (370)
T KOG0583|consen 172 P---------------------------GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFD 224 (370)
T ss_pred C---------------------------CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCC
Confidence 2 0112345679999999999998876 64 69999999999999999999999
Q ss_pred CCChHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHccccCcCccCCChhcHHHHHcCCCCCCC
Q 001847 903 GKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGV 964 (1005)
Q Consensus 903 ~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~hpff~~~ 964 (1005)
..+....+..|..+...+|.... +.++.+|+.+||..||.+|++ +.+++.||||+..
T Consensus 225 d~~~~~l~~ki~~~~~~~p~~~~-S~~~~~Li~~mL~~~P~~R~t----~~~i~~h~w~~~~ 281 (370)
T KOG0583|consen 225 DSNVPNLYRKIRKGEFKIPSYLL-SPEARSLIEKMLVPDPSTRIT----LLEILEHPWFQKE 281 (370)
T ss_pred CccHHHHHHHHhcCCccCCCCcC-CHHHHHHHHHHcCCCcccCCC----HHHHhhChhhccC
Confidence 99999999999999999988755 999999999999999999999 9999999999974
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-43 Score=387.03 Aligned_cols=289 Identities=26% Similarity=0.379 Sum_probs=236.4
Q ss_pred ccCCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeC--CeE
Q 001847 670 NLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTK--THV 747 (1005)
Q Consensus 670 ~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~--~~~ 747 (1005)
..+.|+.+++||+|+||.||+|++..+|+.||+|.++... .+.....-..+||.||++|+||||+++.+..... ..+
T Consensus 115 ~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~-~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~si 193 (560)
T KOG0600|consen 115 RADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDN-EKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSI 193 (560)
T ss_pred chHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeeccc-CCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceE
Confidence 4578999999999999999999999999999999998753 3445556678899999999999999999998876 689
Q ss_pred EEEEeccCCCchhhHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCC
Q 001847 748 CLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCK 827 (1005)
Q Consensus 748 ~lV~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~ 827 (1005)
|||+||| .-+|..++.. +.-.+++.+++.||+||+.||+|||++||.|||||.+||||+.+|.+||+|||+|.....+
T Consensus 194 YlVFeYM-dhDL~GLl~~-p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~ 271 (560)
T KOG0600|consen 194 YLVFEYM-DHDLSGLLSS-PGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILIDNNGVLKIADFGLARFYTPS 271 (560)
T ss_pred EEEEecc-cchhhhhhcC-CCcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEcCCCCEEeccccceeeccCC
Confidence 9999999 6688887764 3456999999999999999999999999999999999999999999999999999765432
Q ss_pred CCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCC-CCCChhhHHHHHHHHHHHHcCCCCCCCCCh
Q 001847 828 PQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGA-GHTSAVDWWALGILLYEMLYGYTPFRGKTR 906 (1005)
Q Consensus 828 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~sDIwSlGvll~eLltG~~Pf~~~~~ 906 (1005)
.. ....+.+.|.+|+|||.|.+. .|+..+|+||.||||.||+.|++.|.|.+.
T Consensus 272 ~~--------------------------~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tE 325 (560)
T KOG0600|consen 272 GS--------------------------APYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTE 325 (560)
T ss_pred CC--------------------------cccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccH
Confidence 21 123456889999999999885 689999999999999999999999999999
Q ss_pred HHHHHHHHhC--C--------CCCCC-----------------CCCCCHHHHHHHHHccccCcCccCCChhcHHHHHcCC
Q 001847 907 QKTFANILHK--D--------LKFPS-----------------STPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHP 959 (1005)
Q Consensus 907 ~~~~~~i~~~--~--------~~~~~-----------------~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~hp 959 (1005)
.+++..|.+- . ..+|. ...++....+|+..||+.||.+|.| |.++|+|+
T Consensus 326 veQl~kIfklcGSP~e~~W~~~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~t----A~~aL~se 401 (560)
T KOG0600|consen 326 VEQLHKIFKLCGSPTEDYWPVSKLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGT----ASSALQSE 401 (560)
T ss_pred HHHHHHHHHHhCCCChhccccccCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCcccccc----HHHHhcCc
Confidence 9999988751 0 01110 1224567789999999999999999 99999999
Q ss_pred CCCCCChhhhhhcCCCCCCCCCCCCccccccccCCchh
Q 001847 960 FFKGVNWALVRCMNPPELDAPLFATDTEKEYKVVDPGM 997 (1005)
Q Consensus 960 ff~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~ 997 (1005)
||+.-..+ .+...+|..-+.-+.+.+..++.+
T Consensus 402 yF~t~p~~------~~p~~Lp~y~~s~E~~~K~r~e~~ 433 (560)
T KOG0600|consen 402 YFTTEPLP------CDPSSLPKYPPSHELDAKRRREQK 433 (560)
T ss_pred ccccCCCC------CCcccCCCCCcchhHHHHHHHHHh
Confidence 99643222 222345666665555555554443
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-43 Score=354.71 Aligned_cols=272 Identities=26% Similarity=0.460 Sum_probs=229.0
Q ss_pred CCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEE
Q 001847 672 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLIT 751 (1005)
Q Consensus 672 ~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~ 751 (1005)
.+|..++.||+|.||.||+|++..+|+.||||.++.....+. -.....+|++.|+.++|+||+.++++|...+.+.||+
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdG-i~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVf 80 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDG-INRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVF 80 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccC-ccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEE
Confidence 479999999999999999999999999999999987633222 2345678999999999999999999999999999999
Q ss_pred eccCCCchhhHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCCCCC
Q 001847 752 DYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLL 831 (1005)
Q Consensus 752 E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~~ 831 (1005)
||| ..+|...++.. ...++..+++.|+.++++||+|||++.|+||||||+|+||+++|.+||+|||+|+.......
T Consensus 81 Efm-~tdLe~vIkd~-~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~-- 156 (318)
T KOG0659|consen 81 EFM-PTDLEVVIKDK-NIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNR-- 156 (318)
T ss_pred Eec-cccHHHHhccc-ccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCCCcEEeecccchhccCCCCc--
Confidence 999 78999998754 45699999999999999999999999999999999999999999999999999977653322
Q ss_pred CCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCC-CCCChhhHHHHHHHHHHHHcCCCCCCCCChHHHH
Q 001847 832 LPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGA-GHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTF 910 (1005)
Q Consensus 832 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~sDIwSlGvll~eLltG~~Pf~~~~~~~~~ 910 (1005)
.....+-|.+|+|||.+.+. .|+..+||||.||++.||+-|.+.|.|.+..+++
T Consensus 157 -------------------------~~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL 211 (318)
T KOG0659|consen 157 -------------------------IQTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQL 211 (318)
T ss_pred -------------------------ccccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHH
Confidence 12233789999999999885 6788999999999999999999999999999988
Q ss_pred HHHHhC--C---CCCCC---------------------CCCCCHHHHHHHHHccccCcCccCCChhcHHHHHcCCCCCCC
Q 001847 911 ANILHK--D---LKFPS---------------------STPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGV 964 (1005)
Q Consensus 911 ~~i~~~--~---~~~~~---------------------~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~hpff~~~ 964 (1005)
..|.+- . -.||. .+..+.++.+|+.+||..||.+|++ +.|+|+|+||+..
T Consensus 212 ~~If~~LGTP~~~~WP~~~~lpdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rit----a~qaL~~~yf~~~ 287 (318)
T KOG0659|consen 212 SKIFRALGTPTPDQWPEMTSLPDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRIT----ASQALKHPYFKSL 287 (318)
T ss_pred HHHHHHcCCCCcccCccccccccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhccc----HHHHhcchhhhcC
Confidence 888651 1 11111 1234667889999999999999999 9999999999985
Q ss_pred ChhhhhhcCCCCCCCCC
Q 001847 965 NWALVRCMNPPELDAPL 981 (1005)
Q Consensus 965 ~~~~~~~~~~~~~~~p~ 981 (1005)
..... +.++++|.
T Consensus 288 P~pt~----~~~lp~p~ 300 (318)
T KOG0659|consen 288 PLPTP----PSKLPIPS 300 (318)
T ss_pred CCCCC----hhhCcCCc
Confidence 44433 44444443
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-43 Score=380.67 Aligned_cols=267 Identities=34% Similarity=0.569 Sum_probs=227.7
Q ss_pred ccccCCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccC-----------hHHHHHHHHHHHHHHhCCCCCcce
Q 001847 668 QINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLN-----------RNKVHRACAEREILDMLDHPFVPA 736 (1005)
Q Consensus 668 ~i~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~-----------~~~~~~~~~E~~il~~l~hpnIv~ 736 (1005)
...+++|++++.||+|.||.|-+|++..+++.||||++.+..... ....+++.+||.||++|.|||||+
T Consensus 93 ~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~ 172 (576)
T KOG0585|consen 93 RKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVK 172 (576)
T ss_pred ceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeE
Confidence 344679999999999999999999999999999999997642211 122468889999999999999999
Q ss_pred EEEEEEe--CCeEEEEEeccCCCchhhHHhhCCCCC-CCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcE
Q 001847 737 LYASFQT--KTHVCLITDYCPGGELFLLLDRQPTKV-LKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHV 813 (1005)
Q Consensus 737 l~~~~~~--~~~~~lV~E~~~ggsL~~~l~~~~~~~-l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~~~g~v 813 (1005)
++++..+ .+.+|||+|||..|.+...-. .+. +++.+++.|+++++.||+|||.+|||||||||+|+|++++|++
T Consensus 173 LiEvLDDP~s~~~YlVley~s~G~v~w~p~---d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~~~g~V 249 (576)
T KOG0585|consen 173 LIEVLDDPESDKLYLVLEYCSKGEVKWCPP---DKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLSSDGTV 249 (576)
T ss_pred EEEeecCcccCceEEEEEeccCCccccCCC---CcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEcCCCcE
Confidence 9999975 468999999998887754432 334 8999999999999999999999999999999999999999999
Q ss_pred EEEeccCCcccCCCCCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCC----CCChhhHHHHHH
Q 001847 814 SLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAG----HTSAVDWWALGI 889 (1005)
Q Consensus 814 kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~----~~~~sDIwSlGv 889 (1005)
||+|||.+........ ...+ ..-...+|||.|+|||.+.+.. .+.+.||||+||
T Consensus 250 KIsDFGVs~~~~~~~~---~~~d-------------------~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGV 307 (576)
T KOG0585|consen 250 KISDFGVSNEFPQGSD---EGSD-------------------DQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGV 307 (576)
T ss_pred EeeccceeeecccCCc---cccH-------------------HHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhh
Confidence 9999999865422100 0000 1112258999999999987732 355899999999
Q ss_pred HHHHHHcCCCCCCCCChHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHccccCcCccCCChhcHHHHHcCCCCCC
Q 001847 890 LLYEMLYGYTPFRGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKG 963 (1005)
Q Consensus 890 ll~eLltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~hpff~~ 963 (1005)
+||.|++|+.||.+....+.+.+|+...+.+|....+...+++||.+||++||++|++ +.++..|||...
T Consensus 308 TLYCllfG~~PF~~~~~~~l~~KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~----l~~ik~Hpwvt~ 377 (576)
T KOG0585|consen 308 TLYCLLFGQLPFFDDFELELFDKIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRIT----LPDIKLHPWVTR 377 (576)
T ss_pred hHHHhhhccCCcccchHHHHHHHHhcCcccCCCcccccHHHHHHHHHHhhcChhheee----hhhheecceecc
Confidence 9999999999999999999999999999999999888999999999999999999999 999999999986
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-42 Score=384.67 Aligned_cols=278 Identities=39% Similarity=0.694 Sum_probs=238.9
Q ss_pred CCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEE
Q 001847 672 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLIT 751 (1005)
Q Consensus 672 ~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~ 751 (1005)
++|++++.||+|+||.||+|.+..+++.||+|++.............+.+|+.+++.++||||+++++++.+.+.+|+||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 37999999999999999999999999999999987653333445567888999999999999999999999999999999
Q ss_pred eccCCCchhhHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCCCCC
Q 001847 752 DYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLL 831 (1005)
Q Consensus 752 E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~~ 831 (1005)
||+.+++|.+++... +.+++..+..++.||+.||+|||++||+||||||+|||++.+|.+||+|||++.....
T Consensus 81 e~~~~~~L~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~----- 153 (291)
T cd05612 81 EYVPGGELFSYLRNS--GRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRD----- 153 (291)
T ss_pred eCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEEecCcchhccC-----
Confidence 999999999999764 4589999999999999999999999999999999999999999999999998854321
Q ss_pred CCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHcCCCCCCCCChHHHHH
Q 001847 832 LPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFA 911 (1005)
Q Consensus 832 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlGvll~eLltG~~Pf~~~~~~~~~~ 911 (1005)
.....+|++.|+|||++.+..++.++|||||||++|+|++|+.||.+.+....+.
T Consensus 154 -------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~ 208 (291)
T cd05612 154 -------------------------RTWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYE 208 (291)
T ss_pred -------------------------CcccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 1123468999999999998889999999999999999999999999988888888
Q ss_pred HHHhCCCCCCCCCCCCHHHHHHHHHccccCcCccCCCh-hcHHHHHcCCCCCCCChhhhhhcCCCCCCCCCCC
Q 001847 912 NILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSH-EGANEIKKHPFFKGVNWALVRCMNPPELDAPLFA 983 (1005)
Q Consensus 912 ~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~-~~a~elL~hpff~~~~~~~~~~~~~~~~~~p~~~ 983 (1005)
.+......++.. .+..+.+||.+||..||.+|++.. ..++++++||||+.++|..+....-.....|-++
T Consensus 209 ~i~~~~~~~~~~--~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~~~~~~~~~~~~~~~~p~~~ 279 (291)
T cd05612 209 KILAGKLEFPRH--LDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNHRWFKSVDWDDVPQRKLKPPIVPKVS 279 (291)
T ss_pred HHHhCCcCCCcc--CCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcCccccCCCHHHHhcCCCCCCEeCCCC
Confidence 888887766654 578899999999999999999532 3499999999999999998754443333345443
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=375.03 Aligned_cols=273 Identities=26% Similarity=0.395 Sum_probs=237.1
Q ss_pred cccccccCCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeC
Q 001847 665 SGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTK 744 (1005)
Q Consensus 665 ~~~~i~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~ 744 (1005)
.+++++.+.|++...||.|..++||+|+...++.+||||++..+... .....+.+|+..++.++||||+.++.+|..+
T Consensus 19 ~~~p~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~--~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~ 96 (516)
T KOG0582|consen 19 KEFPLNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCN--NDLDALRKEVQTMSLIDHPNIVTYHCSFVVD 96 (516)
T ss_pred ccCCCCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhh--hhHHHHHHHHHHhhhcCCCCcceEEEEEEec
Confidence 45567889999999999999999999999999999999999866443 3378889999999999999999999999999
Q ss_pred CeEEEEEeccCCCchhhHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCccc
Q 001847 745 THVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLT 824 (1005)
Q Consensus 745 ~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~~~g~vkL~DFG~a~~~ 824 (1005)
..+|+||.||.+|++.++++..-...+++..+..|++++++||.|||++|.||||||+.||||+++|.|||+|||.+..+
T Consensus 97 ~~LWvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l 176 (516)
T KOG0582|consen 97 SELWVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDSDGTVKLADFGVSASL 176 (516)
T ss_pred ceeEEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcCCCcEEEcCceeeeee
Confidence 99999999999999999998755555999999999999999999999999999999999999999999999999998655
Q ss_pred CCCCCCCCCcchhhhhcccCCCCCcccccccccc-cccccCCcccccccccC--CCCCChhhHHHHHHHHHHHHcCCCCC
Q 001847 825 SCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRAS-NSFVGTEEYIAPEIIAG--AGHTSAVDWWALGILLYEMLYGYTPF 901 (1005)
Q Consensus 825 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~gt~~y~aPE~l~~--~~~~~~sDIwSlGvll~eLltG~~Pf 901 (1005)
-.... ..... .++.||++|||||++.. ..|+.|+||||||++..||++|+.||
T Consensus 177 ~~~G~------------------------R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf 232 (516)
T KOG0582|consen 177 FDSGD------------------------RQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPF 232 (516)
T ss_pred cccCc------------------------eeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCc
Confidence 32110 01111 67799999999999755 46788999999999999999999999
Q ss_pred CCCChHHHHHHHHhCCCCCCCC--------CCCCHHHHHHHHHccccCcCccCCChhcHHHHHcCCCCCCCChh
Q 001847 902 RGKTRQKTFANILHKDLKFPSS--------TPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVNWA 967 (1005)
Q Consensus 902 ~~~~~~~~~~~i~~~~~~~~~~--------~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~hpff~~~~~~ 967 (1005)
....+.+.+..-+++.++.+.. ...+..+..+|..||.+||.+||| +.++|+|+||+...-.
T Consensus 233 ~k~pPmkvLl~tLqn~pp~~~t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRpt----AskLlkh~FFk~~k~~ 302 (516)
T KOG0582|consen 233 SKYPPMKVLLLTLQNDPPTLLTSGLDKDEDKKFSKSFREMIALCLVKDPSKRPT----ASKLLKHAFFKKAKSK 302 (516)
T ss_pred ccCChHHHHHHHhcCCCCCcccccCChHHhhhhcHHHHHHHHHHhhcCcccCCC----HHHHhccHHHhhccch
Confidence 9998888887777777654432 335667899999999999999999 9999999999986543
|
|
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-44 Score=359.97 Aligned_cols=261 Identities=30% Similarity=0.484 Sum_probs=232.2
Q ss_pred cccCCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEE
Q 001847 669 INLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVC 748 (1005)
Q Consensus 669 i~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~ 748 (1005)
+..+.|.+.+.||+|.|+.||++.+..+|+.+|+|++.-..+. ....+.+.+|+.|.+.|+||||+++++.+...+..|
T Consensus 8 ~f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~-~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~y 86 (355)
T KOG0033|consen 8 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLS-ARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHY 86 (355)
T ss_pred ccchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhc-cccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeE
Confidence 3457899999999999999999999999999999988765443 336788999999999999999999999999999999
Q ss_pred EEEeccCCCchhhHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecC---CcEEEEeccCCcccC
Q 001847 749 LITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGN---GHVSLTDFDLSCLTS 825 (1005)
Q Consensus 749 lV~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~~~---g~vkL~DFG~a~~~~ 825 (1005)
+|+|+|.|++|..-+-.+ ..+++..+-.+++||+++|.|+|.+||||||+||.|+++.+. .-+||+|||+|...+
T Consensus 87 lvFe~m~G~dl~~eIV~R--~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~ 164 (355)
T KOG0033|consen 87 LVFDLVTGGELFEDIVAR--EFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVN 164 (355)
T ss_pred EEEecccchHHHHHHHHH--HHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEEEeC
Confidence 999999999997555433 458999999999999999999999999999999999999753 359999999996543
Q ss_pred CCCCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHcCCCCCCCCC
Q 001847 826 CKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKT 905 (1005)
Q Consensus 826 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlGvll~eLltG~~Pf~~~~ 905 (1005)
+ .......+|||+|||||++...+++..+|||+.|++||-|+.|++||.+.+
T Consensus 165 ~----------------------------g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~ 216 (355)
T KOG0033|consen 165 D----------------------------GEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDED 216 (355)
T ss_pred C----------------------------ccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCcc
Confidence 1 123346789999999999999999999999999999999999999999999
Q ss_pred hHHHHHHHHhCCCCCCC--CCCCCHHHHHHHHHccccCcCccCCChhcHHHHHcCCCCCCC
Q 001847 906 RQKTFANILHKDLKFPS--STPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGV 964 (1005)
Q Consensus 906 ~~~~~~~i~~~~~~~~~--~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~hpff~~~ 964 (1005)
....++.|+++..+++. +..+++++++|+.+||..||.+|+| +.|+|+|||+.+.
T Consensus 217 ~~rlye~I~~g~yd~~~~~w~~is~~Ak~LvrrML~~dP~kRIt----a~EAL~HpWi~~r 273 (355)
T KOG0033|consen 217 QHRLYEQIKAGAYDYPSPEWDTVTPEAKSLIRRMLTVNPKKRIT----ADEALKHPWICNR 273 (355)
T ss_pred HHHHHHHHhccccCCCCcccCcCCHHHHHHHHHHhccChhhhcc----HHHHhCCchhcch
Confidence 99999999998776654 6788999999999999999999999 9999999999974
|
|
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-42 Score=391.30 Aligned_cols=286 Identities=35% Similarity=0.678 Sum_probs=242.9
Q ss_pred ccccCCccccccccccCcEEEEEEEEcCCC-eEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCe
Q 001847 668 QINLQHFRPIKPLGSGDTGSVHLVELCGSG-QYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTH 746 (1005)
Q Consensus 668 ~i~~~~y~~~~~LG~G~~g~Vy~a~~~~~~-~~valK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~ 746 (1005)
.+..++|.+++.||.|+||.||+|.+..++ ..||+|.+.............+.+|+.+++.++||||+++++++...+.
T Consensus 26 ~~~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~ 105 (340)
T PTZ00426 26 KMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESY 105 (340)
T ss_pred CCChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCE
Confidence 355679999999999999999999986655 6899999876544444556678899999999999999999999999999
Q ss_pred EEEEEeccCCCchhhHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCC
Q 001847 747 VCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSC 826 (1005)
Q Consensus 747 ~~lV~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~~~g~vkL~DFG~a~~~~~ 826 (1005)
+|+||||+.+++|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||++.....
T Consensus 106 ~~lv~Ey~~~g~L~~~i~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~ 183 (340)
T PTZ00426 106 LYLVLEFVIGGEFFTFLRRN--KRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDT 183 (340)
T ss_pred EEEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEecCCCCeecCC
Confidence 99999999999999999765 4589999999999999999999999999999999999999999999999999854321
Q ss_pred CCCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCh
Q 001847 827 KPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTR 906 (1005)
Q Consensus 827 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlGvll~eLltG~~Pf~~~~~ 906 (1005)
......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+.
T Consensus 184 ------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~ 233 (340)
T PTZ00426 184 ------------------------------RTYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEP 233 (340)
T ss_pred ------------------------------CcceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCH
Confidence 01235799999999999988889999999999999999999999999888
Q ss_pred HHHHHHHHhCCCCCCCCCCCCHHHHHHHHHccccCcCccCCC-hhcHHHHHcCCCCCCCChhhhhhcCCCCCCCCCCCCc
Q 001847 907 QKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGS-HEGANEIKKHPFFKGVNWALVRCMNPPELDAPLFATD 985 (1005)
Q Consensus 907 ~~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~-~~~a~elL~hpff~~~~~~~~~~~~~~~~~~p~~~~~ 985 (1005)
...+..+..+...++.. .+..+.+||.+||..||.+|++. .+.++++++||||++++|..+....-+....|.+...
T Consensus 234 ~~~~~~i~~~~~~~p~~--~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~hp~f~~~~~~~~~~~~~~~~~~p~~~~~ 311 (340)
T PTZ00426 234 LLIYQKILEGIIYFPKF--LDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEHPWFGNIDWVSLLHKNVEVPYKPKYKNV 311 (340)
T ss_pred HHHHHHHhcCCCCCCCC--CCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcCCCcCCCCHHHHHhCCCCCCcCCCCCCC
Confidence 88888888877665543 67889999999999999999732 1339999999999999999875444333445666554
Q ss_pred cc
Q 001847 986 TE 987 (1005)
Q Consensus 986 ~~ 987 (1005)
..
T Consensus 312 ~~ 313 (340)
T PTZ00426 312 FD 313 (340)
T ss_pred cc
Confidence 43
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-42 Score=389.05 Aligned_cols=267 Identities=40% Similarity=0.773 Sum_probs=236.3
Q ss_pred ccCCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEE
Q 001847 670 NLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCL 749 (1005)
Q Consensus 670 ~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l 749 (1005)
..++|++.+.||+|+||.||+|.+..+++.||+|++.............+.+|+.+++.++||||+++++++...+.+|+
T Consensus 16 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 95 (329)
T PTZ00263 16 KLSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYF 95 (329)
T ss_pred CchheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEE
Confidence 45789999999999999999999999999999999986544444456678899999999999999999999999999999
Q ss_pred EEeccCCCchhhHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCCC
Q 001847 750 ITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQ 829 (1005)
Q Consensus 750 V~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~ 829 (1005)
||||+.+++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++.....
T Consensus 96 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~--- 170 (329)
T PTZ00263 96 LLEFVVGGELFTHLRKA--GRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPD--- 170 (329)
T ss_pred EEcCCCCChHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECCCCCEEEeeccCceEcCC---
Confidence 99999999999999764 4589999999999999999999999999999999999999999999999999854321
Q ss_pred CCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHcCCCCCCCCChHHH
Q 001847 830 LLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKT 909 (1005)
Q Consensus 830 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlGvll~eLltG~~Pf~~~~~~~~ 909 (1005)
.....+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+....
T Consensus 171 ---------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~ 223 (329)
T PTZ00263 171 ---------------------------RTFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRI 223 (329)
T ss_pred ---------------------------CcceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHHH
Confidence 11235799999999999998899999999999999999999999999888888
Q ss_pred HHHHHhCCCCCCCCCCCCHHHHHHHHHccccCcCccCCC-hhcHHHHHcCCCCCCCChhhhh
Q 001847 910 FANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGS-HEGANEIKKHPFFKGVNWALVR 970 (1005)
Q Consensus 910 ~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~-~~~a~elL~hpff~~~~~~~~~ 970 (1005)
+..+..+...++.. ++..+.+||.+||+.||.+|++. .+.++++++||||++.+|..+.
T Consensus 224 ~~~i~~~~~~~p~~--~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~hp~f~~~~~~~~~ 283 (329)
T PTZ00263 224 YEKILAGRLKFPNW--FDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNHPYFHGANWDKLY 283 (329)
T ss_pred HHHHhcCCcCCCCC--CCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCccCCCCHHHHH
Confidence 88888877666543 67889999999999999999974 2458999999999999999874
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-42 Score=387.18 Aligned_cols=263 Identities=43% Similarity=0.774 Sum_probs=228.1
Q ss_pred ccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEEeccCCC
Q 001847 678 KPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGG 757 (1005)
Q Consensus 678 ~~LG~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg 757 (1005)
+.||+|+||.||+|.+..+|+.||+|++++...........+.+|+.+++.++||||++++++|...+.+|+||||+.++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 46899999999999999999999999998754444555667788999999999999999999999999999999999999
Q ss_pred chhhHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCCCCCCCcchh
Q 001847 758 ELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNE 837 (1005)
Q Consensus 758 sL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~ 837 (1005)
+|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++......
T Consensus 81 ~L~~~l~~~--~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~---------- 148 (323)
T cd05571 81 ELFFHLSRE--RVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISD---------- 148 (323)
T ss_pred cHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccC----------
Confidence 999998764 45899999999999999999999999999999999999999999999999988432100
Q ss_pred hhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhCC
Q 001847 838 KKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANILHKD 917 (1005)
Q Consensus 838 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlGvll~eLltG~~Pf~~~~~~~~~~~i~~~~ 917 (1005)
.......+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+.......+....
T Consensus 149 -----------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~ 211 (323)
T cd05571 149 -----------------GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEE 211 (323)
T ss_pred -----------------CCcccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHcCC
Confidence 011234579999999999999889999999999999999999999999888777777777776
Q ss_pred CCCCCCCCCCHHHHHHHHHccccCcCccCCChh-cHHHHHcCCCCCCCChhhhhh
Q 001847 918 LKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHE-GANEIKKHPFFKGVNWALVRC 971 (1005)
Q Consensus 918 ~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~-~a~elL~hpff~~~~~~~~~~ 971 (1005)
..++. .++.++.+||.+||..||.+||+... .+.++++||||+.++|..+..
T Consensus 212 ~~~p~--~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h~~f~~~~~~~~~~ 264 (323)
T cd05571 212 IRFPR--TLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEHRFFASINWQDVVQ 264 (323)
T ss_pred CCCCC--CCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcCCCcCCCCHHHHHh
Confidence 66554 46889999999999999999993221 299999999999999998853
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-43 Score=389.39 Aligned_cols=267 Identities=27% Similarity=0.459 Sum_probs=236.8
Q ss_pred hHHhhcccccccccCCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceE
Q 001847 658 AIQKILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPAL 737 (1005)
Q Consensus 658 ~~~~~~~~~~~i~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l 737 (1005)
.++.++..+.+. ..|.....||+|+.|.||.+....+++.||+|.+.... ....+-+++|+.+|+..+|+|||.+
T Consensus 261 ~l~~v~~~~dP~--~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~---Q~~keLilnEi~Vm~~~~H~NiVnf 335 (550)
T KOG0578|consen 261 KLKRVVSQGDPR--SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRK---QPKKELLLNEILVMRDLHHPNIVNF 335 (550)
T ss_pred HhheeccCCChh--hhhcchhhhccccccceeeeeeccCCceEEEEEEEecc---CCchhhhHHHHHHHHhccchHHHHH
Confidence 445566666664 48999999999999999999999999999999998653 3345678899999999999999999
Q ss_pred EEEEEeCCeEEEEEeccCCCchhhHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEe
Q 001847 738 YASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTD 817 (1005)
Q Consensus 738 ~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~~~g~vkL~D 817 (1005)
++.|...+.+|+|||||+||+|.+.+.. ..+++.++..+++.++.||+|||.+||+|||||.+|||++.+|.+||+|
T Consensus 336 l~Sylv~deLWVVMEym~ggsLTDvVt~---~~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~g~vKltD 412 (550)
T KOG0578|consen 336 LDSYLVGDELWVVMEYMEGGSLTDVVTK---TRMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTMDGSVKLTD 412 (550)
T ss_pred HHHhcccceeEEEEeecCCCchhhhhhc---ccccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEeccCCcEEEee
Confidence 9999999999999999999999999876 3499999999999999999999999999999999999999999999999
Q ss_pred ccCCcccCCCCCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHcC
Q 001847 818 FDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYG 897 (1005)
Q Consensus 818 FG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlGvll~eLltG 897 (1005)
||++..+... ...+.+.+|||+|||||+.....|++++||||||+++.||+-|
T Consensus 413 FGFcaqi~~~---------------------------~~KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveG 465 (550)
T KOG0578|consen 413 FGFCAQISEE---------------------------QSKRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEG 465 (550)
T ss_pred eeeeeccccc---------------------------cCccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcC
Confidence 9998654321 1134678999999999999999999999999999999999999
Q ss_pred CCCCCCCChHHHHHHHHh-CCCCCCCCCCCCHHHHHHHHHccccCcCccCCChhcHHHHHcCCCCCC
Q 001847 898 YTPFRGKTRQKTFANILH-KDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKG 963 (1005)
Q Consensus 898 ~~Pf~~~~~~~~~~~i~~-~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~hpff~~ 963 (1005)
++||...++...+..|.. +...+.....+|..+++||.+||+.|+++|++ |.+||+||||+.
T Consensus 466 EPPYlnE~PlrAlyLIa~ng~P~lk~~~klS~~~kdFL~~cL~~dv~~Ras----A~eLL~HpFl~~ 528 (550)
T KOG0578|consen 466 EPPYLNENPLRALYLIATNGTPKLKNPEKLSPELKDFLDRCLVVDVEQRAS----AKELLEHPFLKM 528 (550)
T ss_pred CCCccCCChHHHHHHHhhcCCCCcCCccccCHHHHHHHHHHhhcchhcCCC----HHHHhcChhhhh
Confidence 999998888777777664 56667777789999999999999999999999 999999999964
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-43 Score=350.80 Aligned_cols=261 Identities=36% Similarity=0.591 Sum_probs=242.8
Q ss_pred cccCCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEE
Q 001847 669 INLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVC 748 (1005)
Q Consensus 669 i~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~ 748 (1005)
...++|.+.+.||.|-||.||+++.++++-.+|+|++.+..+.......++.+|++|.+.|+||||+++|++|.+...+|
T Consensus 19 ~~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riy 98 (281)
T KOG0580|consen 19 WTLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIY 98 (281)
T ss_pred cchhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeE
Confidence 34679999999999999999999999999999999999887777777788999999999999999999999999999999
Q ss_pred EEEeccCCCchhhHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCC
Q 001847 749 LITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKP 828 (1005)
Q Consensus 749 lV~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~ 828 (1005)
+++||..+|+|+..++.+....+++.....++.|++.||.|+|.++||||||||+|+|++..|.+||+|||.+..
T Consensus 99 LilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~----- 173 (281)
T KOG0580|consen 99 LILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGSAGELKIADFGWSVH----- 173 (281)
T ss_pred EEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCCCCCeeccCCCceee-----
Confidence 999999999999999977677899999999999999999999999999999999999999999999999999843
Q ss_pred CCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHcCCCCCCCCChHH
Q 001847 829 QLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQK 908 (1005)
Q Consensus 829 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlGvll~eLltG~~Pf~~~~~~~ 908 (1005)
.++..+.+.|||..|.+||...+..++..+|+|++|++.|+++.|.+||...+..+
T Consensus 174 ------------------------~p~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~e 229 (281)
T KOG0580|consen 174 ------------------------APSNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSE 229 (281)
T ss_pred ------------------------cCCCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHH
Confidence 33455678999999999999999999999999999999999999999999999999
Q ss_pred HHHHHHhCCCCCCCCCCCCHHHHHHHHHccccCcCccCCChhcHHHHHcCCCCCCC
Q 001847 909 TFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGV 964 (1005)
Q Consensus 909 ~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~hpff~~~ 964 (1005)
.+.+|.+.++.+|. .++..+.+||.+||.++|.+|.. +.+++.|||+...
T Consensus 230 tYkrI~k~~~~~p~--~is~~a~dlI~~ll~~~p~~r~~----l~~v~~hpwI~a~ 279 (281)
T KOG0580|consen 230 TYKRIRKVDLKFPS--TISGGAADLISRLLVKNPIERLA----LTEVMDHPWIVAN 279 (281)
T ss_pred HHHHHHHccccCCc--ccChhHHHHHHHHhccCcccccc----HHHHhhhHHHHhc
Confidence 99999999888884 47899999999999999999999 9999999998753
|
|
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=384.34 Aligned_cols=278 Identities=37% Similarity=0.642 Sum_probs=238.2
Q ss_pred CCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEE
Q 001847 672 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLIT 751 (1005)
Q Consensus 672 ~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~ 751 (1005)
++|++++.||+|+||.||+|.+..+++.||+|++.+...........+.+|+.++..++||||+++++++...+.+|+||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 47999999999999999999999999999999998764444455667888999999999999999999999999999999
Q ss_pred eccCCCchhhHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCCCCC
Q 001847 752 DYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLL 831 (1005)
Q Consensus 752 E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~~ 831 (1005)
||+++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 81 e~~~g~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~----- 153 (333)
T cd05600 81 EYVPGGDFRTLLNNL--GVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT----- 153 (333)
T ss_pred eCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEEEeCcCCccccc-----
Confidence 999999999999764 4589999999999999999999999999999999999999999999999999854221
Q ss_pred CCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHcCCCCCCCCChHHHHH
Q 001847 832 LPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFA 911 (1005)
Q Consensus 832 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlGvll~eLltG~~Pf~~~~~~~~~~ 911 (1005)
......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+.+.
T Consensus 154 -------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~ 208 (333)
T cd05600 154 -------------------------YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWE 208 (333)
T ss_pred -------------------------ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHH
Confidence 1234579999999999998899999999999999999999999999888777776
Q ss_pred HHHhCC--CCCCCC----CCCCHHHHHHHHHccccCcCccCCChhcHHHHHcCCCCCCCChhhhhhcCCCCCCCCCCCCc
Q 001847 912 NILHKD--LKFPSS----TPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVNWALVRCMNPPELDAPLFATD 985 (1005)
Q Consensus 912 ~i~~~~--~~~~~~----~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~hpff~~~~~~~~~~~~~~~~~~p~~~~~ 985 (1005)
.+.... +..+.. ..++.++.+||.+||..+|.+||+ +.++++||||+.++|..+....+|- +|.+...
T Consensus 209 ~i~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~~~~rr~s----~~~ll~h~~~~~~~~~~~~~~~~~~--~~~~~~~ 282 (333)
T cd05600 209 NLKYWKETLQRPVYDDPRFNLSDEAWDLITKLINDPSRRFGS----LEDIKNHPFFKEVDWNELRELKPPF--VPELESE 282 (333)
T ss_pred HHHhccccccCCCCCccccccCHHHHHHHHHHhhChhhhcCC----HHHHHhCcccCCCCHHHHhhCCCCC--CCCCCCc
Confidence 665432 222222 145889999999999999999999 9999999999999999988656653 3655544
Q ss_pred cc
Q 001847 986 TE 987 (1005)
Q Consensus 986 ~~ 987 (1005)
..
T Consensus 283 ~~ 284 (333)
T cd05600 283 ID 284 (333)
T ss_pred ch
Confidence 43
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-41 Score=386.25 Aligned_cols=294 Identities=37% Similarity=0.652 Sum_probs=234.0
Q ss_pred CCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEE
Q 001847 672 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLIT 751 (1005)
Q Consensus 672 ~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~ 751 (1005)
++|++++.||+|+||.||+|.+..+++.||+|++.+...........+..|+.++..++|+||+++++++.....+|+||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 37999999999999999999999999999999998654444455567788999999999999999999999999999999
Q ss_pred eccCCCchhhHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCCCCC
Q 001847 752 DYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLL 831 (1005)
Q Consensus 752 E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~~ 831 (1005)
||++||+|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++..........
T Consensus 81 E~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~~ 158 (363)
T cd05628 81 EFLPGGDMMTLLMKK--DTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTE 158 (363)
T ss_pred cCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCCEEEeeccCccccccccccc
Confidence 999999999999764 459999999999999999999999999999999999999999999999999986543211100
Q ss_pred CCcc-hhhhhcccCCC--C-----CcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHcCCCCCCC
Q 001847 832 LPTT-NEKKRRHKGQQ--N-----PVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRG 903 (1005)
Q Consensus 832 ~~~~-~~~~~~~~~~~--~-----~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlGvll~eLltG~~Pf~~ 903 (1005)
.... ........... . ..............+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf~~ 238 (363)
T cd05628 159 FYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCS 238 (363)
T ss_pred ccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCCCC
Confidence 0000 00000000000 0 00000001112356899999999999998899999999999999999999999999
Q ss_pred CChHHHHHHHHhC--CCCCCCCCCCCHHHHHHHHHccccCcCcc---CCChhcHHHHHcCCCCCCCChhhhhhc
Q 001847 904 KTRQKTFANILHK--DLKFPSSTPTSLHAKQLMYRLLHRDPKSR---LGSHEGANEIKKHPFFKGVNWALVRCM 972 (1005)
Q Consensus 904 ~~~~~~~~~i~~~--~~~~~~~~~~s~~l~~Ll~~~L~~dP~~R---pt~~~~a~elL~hpff~~~~~~~~~~~ 972 (1005)
.+..+.+..+... ...++....++.++++||.+|+. +|.+| |+ +.++++||||++++|..++..
T Consensus 239 ~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~-~~~~r~~r~~----~~ei~~hp~f~~~~~~~~~~~ 307 (363)
T cd05628 239 ETPQETYKKVMNWKETLIFPPEVPISEKAKDLILRFCC-EWEHRIGAPG----VEEIKTNPFFEGVDWEHIRER 307 (363)
T ss_pred CCHHHHHHHHHcCcCcccCCCcCCCCHHHHHHHHHHcC-ChhhcCCCCC----HHHHhCCCCCCCCCHHHHHhC
Confidence 8888888888763 45566656678999999999876 55555 66 999999999999999998654
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-41 Score=374.73 Aligned_cols=275 Identities=33% Similarity=0.563 Sum_probs=227.1
Q ss_pred CccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEEe
Q 001847 673 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITD 752 (1005)
Q Consensus 673 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E 752 (1005)
.|++.+.||+|+||.||++.+..+++.||+|.+.............+.+|+.+++.++|+||+.+++++...+.+|+|||
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence 48889999999999999999999999999999876544333444567789999999999999999999999999999999
Q ss_pred ccCCCchhhHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCCCCCC
Q 001847 753 YCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLL 832 (1005)
Q Consensus 753 ~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~~~ 832 (1005)
|+++++|.+++.......+++..+..++.||+.||.|||++||+||||||+|||+++++.++|+|||++......
T Consensus 81 ~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~----- 155 (285)
T cd05631 81 IMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEG----- 155 (285)
T ss_pred ecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCC-----
Confidence 999999998886544456899999999999999999999999999999999999999999999999998543210
Q ss_pred CcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHcCCCCCCCCChHHHHHH
Q 001847 833 PTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFAN 912 (1005)
Q Consensus 833 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlGvll~eLltG~~Pf~~~~~~~~~~~ 912 (1005)
.......|++.|+|||++.+..++.++|||||||++|+|++|+.||.+.........
T Consensus 156 -----------------------~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~ 212 (285)
T cd05631 156 -----------------------ETVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREE 212 (285)
T ss_pred -----------------------CeecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHH
Confidence 011234689999999999998999999999999999999999999987654322222
Q ss_pred HHh--CCCCCCCCCCCCHHHHHHHHHccccCcCccCCCh-hcHHHHHcCCCCCCCChhhhhhcCCC
Q 001847 913 ILH--KDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSH-EGANEIKKHPFFKGVNWALVRCMNPP 975 (1005)
Q Consensus 913 i~~--~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~-~~a~elL~hpff~~~~~~~~~~~~~~ 975 (1005)
+.. ...........+..+.+||.+||+.||.+||+.. ..++++++||||.+++|..+...+.+
T Consensus 213 ~~~~~~~~~~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h~~~~~~~~~~~~~~~~~ 278 (285)
T cd05631 213 VDRRVKEDQEEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQHPIFKNINFKRLEANMLE 278 (285)
T ss_pred HHHHhhcccccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcCHhhcCCCHHHHHhCcCC
Confidence 211 1111222234688999999999999999999754 23899999999999999999665443
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-41 Score=388.39 Aligned_cols=307 Identities=38% Similarity=0.690 Sum_probs=241.3
Q ss_pred CCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEE
Q 001847 672 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLIT 751 (1005)
Q Consensus 672 ~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~ 751 (1005)
++|++++.||.|+||.||+|.+..+++.||||++.............+.+|+.++..++||||++++++|...+.+|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 47999999999999999999999999999999998654444455567788999999999999999999999999999999
Q ss_pred eccCCCchhhHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCCCCC
Q 001847 752 DYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLL 831 (1005)
Q Consensus 752 E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~~ 831 (1005)
||+.+++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.+|.++|+|||++..........
T Consensus 81 E~~~~g~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~ 158 (364)
T cd05599 81 EYLPGGDMMTLLMKK--DTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTE 158 (364)
T ss_pred CCCCCcHHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEeecccceecccccccc
Confidence 999999999998764 459999999999999999999999999999999999999999999999999986542211100
Q ss_pred -CCcchhhhhc---------c-cCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHcCCCC
Q 001847 832 -LPTTNEKKRR---------H-KGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTP 900 (1005)
Q Consensus 832 -~~~~~~~~~~---------~-~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlGvll~eLltG~~P 900 (1005)
.......... . .......+...........+||+.|+|||++....++.++|||||||++|+|++|..|
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~~P 238 (364)
T cd05599 159 FYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYPP 238 (364)
T ss_pred ccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCCCC
Confidence 0000000000 0 0000000000000012245799999999999988899999999999999999999999
Q ss_pred CCCCChHHHHHHHHhCC--CCCCCCCCCCHHHHHHHHHccccCcCccCCChhcHHHHHcCCCCCCCChhhhhhcCCCCCC
Q 001847 901 FRGKTRQKTFANILHKD--LKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVNWALVRCMNPPELD 978 (1005)
Q Consensus 901 f~~~~~~~~~~~i~~~~--~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~hpff~~~~~~~~~~~~~~~~~ 978 (1005)
|.+.+..+.+..+.... ..++....++..+.+||.+||. +|.+|++. ..+.++|+||||++++|..++...+|..
T Consensus 239 f~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~-~~~~~ll~h~~~~~~~~~~~~~~~~~~~- 315 (364)
T cd05599 239 FCSDNPQETYRKIINWKETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGN-NGVNEIKSHPFFKGVDWEHIRERPAPII- 315 (364)
T ss_pred CCCCCHHHHHHHHHcCCCccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCC-CCHHHHhcCCCcCCCCHHHHhhcCCCCC-
Confidence 99988887777776543 3445555678899999999997 99999975 4599999999999999998876555533
Q ss_pred CCCCCC
Q 001847 979 APLFAT 984 (1005)
Q Consensus 979 ~p~~~~ 984 (1005)
|.+..
T Consensus 316 -~~~~~ 320 (364)
T cd05599 316 -PELKS 320 (364)
T ss_pred -CCCCC
Confidence 54433
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-42 Score=373.44 Aligned_cols=262 Identities=32% Similarity=0.475 Sum_probs=218.1
Q ss_pred CCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC--eEEE
Q 001847 672 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKT--HVCL 749 (1005)
Q Consensus 672 ~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~--~~~l 749 (1005)
..|...+.||+|+||.||++.+..+|..+|+|.+... +....+.+.+|+.+|++++|||||++++...... .+++
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~---~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i 93 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELE---DSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNI 93 (313)
T ss_pred chhhhhccccCccceEEEEEEecCCCcceeeeeeecc---cchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEe
Confidence 4688899999999999999999999999999998765 2222677899999999999999999999755444 6899
Q ss_pred EEeccCCCchhhHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEec-CCcEEEEeccCCcccCCCC
Q 001847 750 ITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQG-NGHVSLTDFDLSCLTSCKP 828 (1005)
Q Consensus 750 V~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~~-~g~vkL~DFG~a~~~~~~~ 828 (1005)
+|||+++|+|.+++....+ .+++..++.+.+||++||+|||++|||||||||+|||++. +|.+||+|||++.......
T Consensus 94 ~mEy~~~GsL~~~~~~~g~-~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~ 172 (313)
T KOG0198|consen 94 FMEYAPGGSLSDLIKRYGG-KLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKG 172 (313)
T ss_pred eeeccCCCcHHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCCCCeEEeccCcccccccccc
Confidence 9999999999999998765 7999999999999999999999999999999999999999 7999999999986543200
Q ss_pred CCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCC-CCCChhhHHHHHHHHHHHHcCCCCCCC-CCh
Q 001847 829 QLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGA-GHTSAVDWWALGILLYEMLYGYTPFRG-KTR 906 (1005)
Q Consensus 829 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~sDIwSlGvll~eLltG~~Pf~~-~~~ 906 (1005)
..........||+.|||||++... ...+++|||||||++.||+||+.||.. ...
T Consensus 173 ------------------------~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~ 228 (313)
T KOG0198|consen 173 ------------------------TKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEE 228 (313)
T ss_pred ------------------------ccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcch
Confidence 011223456899999999999853 344599999999999999999999987 344
Q ss_pred HHHHHHHHhCCCCCCCCCCCCHHHHHHHHHccccCcCccCCChhcHHHHHcCCCCCCCC
Q 001847 907 QKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVN 965 (1005)
Q Consensus 907 ~~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~hpff~~~~ 965 (1005)
...+..+........-...++.++++||.+|+..+|++||| |.+||+|||.+.-.
T Consensus 229 ~~~~~~ig~~~~~P~ip~~ls~~a~~Fl~~C~~~~p~~Rpt----a~eLL~hpf~~~~~ 283 (313)
T KOG0198|consen 229 AEALLLIGREDSLPEIPDSLSDEAKDFLRKCFKRDPEKRPT----AEELLEHPFLKQNS 283 (313)
T ss_pred HHHHHHHhccCCCCCCCcccCHHHHHHHHHHhhcCcccCcC----HHHHhhChhhhccc
Confidence 44444555444211223347889999999999999999999 99999999998743
|
|
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=391.39 Aligned_cols=314 Identities=36% Similarity=0.676 Sum_probs=241.5
Q ss_pred CCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEE
Q 001847 672 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLIT 751 (1005)
Q Consensus 672 ~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~ 751 (1005)
++|++++.||+|+||.||++.+..+++.||||++.+...........+.+|+.+++.++||||++++++|...+.+|+||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 37999999999999999999999999999999987654434455667888999999999999999999999999999999
Q ss_pred eccCCCchhhHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCCCCC
Q 001847 752 DYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLL 831 (1005)
Q Consensus 752 E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~~ 831 (1005)
||+++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..........
T Consensus 81 E~~~gg~L~~~l~~~--~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~ 158 (377)
T cd05629 81 EFLPGGDLMTMLIKY--DTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSA 158 (377)
T ss_pred eCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEEeecccccccccccccc
Confidence 999999999998764 458999999999999999999999999999999999999999999999999985332111000
Q ss_pred -C----Ccchhhhh---cccCCCCCc------------ccccccccccccccCCcccccccccCCCCCChhhHHHHHHHH
Q 001847 832 -L----PTTNEKKR---RHKGQQNPV------------FMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILL 891 (1005)
Q Consensus 832 -~----~~~~~~~~---~~~~~~~~~------------~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlGvll 891 (1005)
+ ........ .......+. +...........+||+.|+|||++.+..++.++|||||||++
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil 238 (377)
T cd05629 159 YYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAIM 238 (377)
T ss_pred cccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecchhh
Confidence 0 00000000 000000000 000000011235799999999999988899999999999999
Q ss_pred HHHHcCCCCCCCCChHHHHHHHHh--CCCCCCCCCCCCHHHHHHHHHccccCcCccCCChhcHHHHHcCCCCCCCChhhh
Q 001847 892 YEMLYGYTPFRGKTRQKTFANILH--KDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVNWALV 969 (1005)
Q Consensus 892 ~eLltG~~Pf~~~~~~~~~~~i~~--~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~hpff~~~~~~~~ 969 (1005)
|+|++|..||.+.+..+.+..+.. ..+.++....++.++.+||.+||. +|.+|+.. ..+.++++||||++++|+.+
T Consensus 239 ~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-~~~~r~~r-~~~~~~l~hp~~~~~~~~~~ 316 (377)
T cd05629 239 FECLIGWPPFCSENSHETYRKIINWRETLYFPDDIHLSVEAEDLIRRLIT-NAENRLGR-GGAHEIKSHPFFRGVDWDTI 316 (377)
T ss_pred hhhhcCCCCCCCCCHHHHHHHHHccCCccCCCCCCCCCHHHHHHHHHHhc-CHhhcCCC-CCHHHHhcCCCcCCCCHHHH
Confidence 999999999998887777777765 334555555678899999999998 78876521 12999999999999999999
Q ss_pred hhcCCCCCCCCCCCCccccccc
Q 001847 970 RCMNPPELDAPLFATDTEKEYK 991 (1005)
Q Consensus 970 ~~~~~~~~~~p~~~~~~~~~~~ 991 (1005)
+...+|-. |.+.......|.
T Consensus 317 ~~~~~~~~--~~~~~~~~~~~~ 336 (377)
T cd05629 317 RQIRAPFI--PQLKSITDTSYF 336 (377)
T ss_pred ccCCCCcc--cCCCCccccccC
Confidence 77666643 555444443343
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-42 Score=355.36 Aligned_cols=271 Identities=42% Similarity=0.775 Sum_probs=249.2
Q ss_pred ccccCCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeE
Q 001847 668 QINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHV 747 (1005)
Q Consensus 668 ~i~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 747 (1005)
.+.+++|..++.||.|.||.|-+|+.+.+++.||+|++++..+-.+.....-..|-.+|+.++||++..+...|+..+.+
T Consensus 164 kvTm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drl 243 (516)
T KOG0690|consen 164 KVTMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRL 243 (516)
T ss_pred eeccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceE
Confidence 45678999999999999999999999999999999999999888888888888899999999999999999999999999
Q ss_pred EEEEeccCCCchhhHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCC
Q 001847 748 CLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCK 827 (1005)
Q Consensus 748 ~lV~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~ 827 (1005)
|+||||.+||.|+-.+.+. ..++++..+.+-..|+.||.|||+++||.||||.+|+|++.+|++||.|||+++..-.
T Consensus 244 CFVMeyanGGeLf~HLsre--r~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~- 320 (516)
T KOG0690|consen 244 CFVMEYANGGELFFHLSRE--RVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLDKDGHIKITDFGLCKEEIK- 320 (516)
T ss_pred EEEEEEccCceEeeehhhh--hcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheeccCCceEeeecccchhccc-
Confidence 9999999999999888764 5599999999999999999999999999999999999999999999999999854211
Q ss_pred CCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHcCCCCCCCCChH
Q 001847 828 PQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQ 907 (1005)
Q Consensus 828 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlGvll~eLltG~~Pf~~~~~~ 907 (1005)
......++||||.|+|||++....|+.++|-|.+|+++|+|++|++||...+..
T Consensus 321 --------------------------~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~ 374 (516)
T KOG0690|consen 321 --------------------------YGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHE 374 (516)
T ss_pred --------------------------ccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchh
Confidence 112346789999999999999999999999999999999999999999999999
Q ss_pred HHHHHHHhCCCCCCCCCCCCHHHHHHHHHccccCcCccCCCh-hcHHHHHcCCCCCCCChhhh
Q 001847 908 KTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSH-EGANEIKKHPFFKGVNWALV 969 (1005)
Q Consensus 908 ~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~-~~a~elL~hpff~~~~~~~~ 969 (1005)
..+..|+-..+.+|.. ++++++.|+..+|.+||.+|+..- +.|.++.+|+||..++|...
T Consensus 375 kLFeLIl~ed~kFPr~--ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~h~FF~~v~W~~~ 435 (516)
T KOG0690|consen 375 KLFELILMEDLKFPRT--LSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMRHRFFASVDWEAT 435 (516)
T ss_pred HHHHHHHhhhccCCcc--CCHHHHHHHHHHhhcChHhhcCCCchhHHHHHhhhhhccCCHHHH
Confidence 9999999999999875 789999999999999999999764 56999999999999999977
|
|
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-41 Score=379.93 Aligned_cols=263 Identities=44% Similarity=0.798 Sum_probs=227.2
Q ss_pred ccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEEeccCCC
Q 001847 678 KPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGG 757 (1005)
Q Consensus 678 ~~LG~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg 757 (1005)
+.||+|+||.||++.+..+++.||+|++.+...........+.+|+.+++.++||||+++++++...+.+|+||||++++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 46899999999999999999999999998765445556677888999999999999999999999999999999999999
Q ss_pred chhhHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCCCCCCCcchh
Q 001847 758 ELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNE 837 (1005)
Q Consensus 758 sL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~ 837 (1005)
+|..++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 81 ~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~---------- 148 (328)
T cd05593 81 ELFFHLSRE--RVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITD---------- 148 (328)
T ss_pred CHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCCCcEEEecCcCCccCCCc----------
Confidence 999888764 45899999999999999999999999999999999999999999999999988532110
Q ss_pred hhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhCC
Q 001847 838 KKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANILHKD 917 (1005)
Q Consensus 838 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlGvll~eLltG~~Pf~~~~~~~~~~~i~~~~ 917 (1005)
.......+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+.......+....
T Consensus 149 -----------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~~~~ 211 (328)
T cd05593 149 -----------------AATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMED 211 (328)
T ss_pred -----------------ccccccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhccCC
Confidence 011123579999999999988889999999999999999999999999888777777776666
Q ss_pred CCCCCCCCCCHHHHHHHHHccccCcCccCCCh-hcHHHHHcCCCCCCCChhhhhh
Q 001847 918 LKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSH-EGANEIKKHPFFKGVNWALVRC 971 (1005)
Q Consensus 918 ~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~-~~a~elL~hpff~~~~~~~~~~ 971 (1005)
..++. .++.++.+||.+||..||.+|++.. +.+.++++||||.+.+|..+..
T Consensus 212 ~~~p~--~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~~~~~~~~~~~~ 264 (328)
T cd05593 212 IKFPR--TLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRHSFFTGVNWQDVYD 264 (328)
T ss_pred ccCCC--CCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcCCCcCCCCHHHHHh
Confidence 65554 4688999999999999999998321 2299999999999999997743
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-41 Score=376.92 Aligned_cols=260 Identities=42% Similarity=0.740 Sum_probs=226.7
Q ss_pred ccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEEeccCCCch
Q 001847 680 LGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGEL 759 (1005)
Q Consensus 680 LG~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~ggsL 759 (1005)
||+|+||.||+|.+..+++.||+|.+.............+..|+.++++++||||+++++++...+..|+||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 69999999999999999999999999765444455567788899999999999999999999999999999999999999
Q ss_pred hhHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCCCCCCCcchhhh
Q 001847 760 FLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKK 839 (1005)
Q Consensus 760 ~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~ 839 (1005)
.+++... +.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 81 ~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~------------ 146 (312)
T cd05585 81 FHHLQRE--GRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKD------------ 146 (312)
T ss_pred HHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCCCcEEEEECcccccCccC------------
Confidence 9999764 45899999999999999999999999999999999999999999999999998532110
Q ss_pred hcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhCCCC
Q 001847 840 RRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANILHKDLK 919 (1005)
Q Consensus 840 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlGvll~eLltG~~Pf~~~~~~~~~~~i~~~~~~ 919 (1005)
.......+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+....+.+..+......
T Consensus 147 ---------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~ 211 (312)
T cd05585 147 ---------------DDKTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQEPLR 211 (312)
T ss_pred ---------------CCccccccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCC
Confidence 01123457999999999999988999999999999999999999999988888888888877665
Q ss_pred CCCCCCCCHHHHHHHHHccccCcCccCCChhcHHHHHcCCCCCCCChhhhhh
Q 001847 920 FPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVNWALVRC 971 (1005)
Q Consensus 920 ~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~hpff~~~~~~~~~~ 971 (1005)
++. .++..+.+||.+||..||.+||++.. +.++|+||||+..+|..+..
T Consensus 212 ~~~--~~~~~~~~li~~~L~~dp~~R~~~~~-~~e~l~hp~~~~~~~~~~~~ 260 (312)
T cd05585 212 FPD--GFDRDAKDLLIGLLSRDPTRRLGYNG-AQEIKNHPFFSQLSWKKLLM 260 (312)
T ss_pred CCC--cCCHHHHHHHHHHcCCCHHHcCCCCC-HHHHHcCCCcCCCCHHHHHh
Confidence 554 46889999999999999999986432 89999999999999987643
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=376.57 Aligned_cols=263 Identities=41% Similarity=0.777 Sum_probs=227.1
Q ss_pred ccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEEeccCCC
Q 001847 678 KPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGG 757 (1005)
Q Consensus 678 ~~LG~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg 757 (1005)
+.||+|+||.||++.+..+|+.||+|++.............+.+|+.+++.++||||++++++|...+.+|+||||++++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 46899999999999999999999999998764444455667788999999999999999999999999999999999999
Q ss_pred chhhHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCCCCCCCcchh
Q 001847 758 ELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNE 837 (1005)
Q Consensus 758 sL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~ 837 (1005)
+|..++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 81 ~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~---------- 148 (323)
T cd05595 81 ELFFHLSRE--RVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD---------- 148 (323)
T ss_pred cHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCCCCEEecccHHhccccCC----------
Confidence 999888764 45899999999999999999999999999999999999999999999999987432100
Q ss_pred hhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhCC
Q 001847 838 KKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANILHKD 917 (1005)
Q Consensus 838 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlGvll~eLltG~~Pf~~~~~~~~~~~i~~~~ 917 (1005)
........||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+.......+....
T Consensus 149 -----------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~~~ 211 (323)
T cd05595 149 -----------------GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEE 211 (323)
T ss_pred -----------------CCccccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhcCC
Confidence 011123579999999999998889999999999999999999999999888877777777776
Q ss_pred CCCCCCCCCCHHHHHHHHHccccCcCccCCCh-hcHHHHHcCCCCCCCChhhhhh
Q 001847 918 LKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSH-EGANEIKKHPFFKGVNWALVRC 971 (1005)
Q Consensus 918 ~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~-~~a~elL~hpff~~~~~~~~~~ 971 (1005)
..++. .++.++.+||.+||..||.+|++.. ..+.++++||||.+++|..+..
T Consensus 212 ~~~p~--~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h~~~~~~~~~~~~~ 264 (323)
T cd05595 212 IRFPR--TLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQDVVQ 264 (323)
T ss_pred CCCCC--CCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcCCCcCCCCHHHHHh
Confidence 66554 4688999999999999999998321 1399999999999999997743
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-41 Score=384.66 Aligned_cols=286 Identities=34% Similarity=0.601 Sum_probs=237.4
Q ss_pred ccccCCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeE
Q 001847 668 QINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHV 747 (1005)
Q Consensus 668 ~i~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 747 (1005)
.+..++|++++.||+|+||.||+|.+..+++.||+|++.+...........+.+|+.+++.++||||+++++++...+.+
T Consensus 39 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~ 118 (370)
T cd05596 39 RMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYL 118 (370)
T ss_pred CCCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence 34567999999999999999999999999999999999764333444455677899999999999999999999999999
Q ss_pred EEEEeccCCCchhhHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCC
Q 001847 748 CLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCK 827 (1005)
Q Consensus 748 ~lV~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~ 827 (1005)
|+||||+++|+|.+++... .+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||++......
T Consensus 119 ~lv~Ey~~gg~L~~~l~~~---~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~ 195 (370)
T cd05596 119 YMVMEYMPGGDLVNLMSNY---DIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDAN 195 (370)
T ss_pred EEEEcCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcCCCCEEEEeccceeeccCC
Confidence 9999999999999998653 4889999999999999999999999999999999999999999999999998543211
Q ss_pred CCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCC----CCCChhhHHHHHHHHHHHHcCCCCCCC
Q 001847 828 PQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGA----GHTSAVDWWALGILLYEMLYGYTPFRG 903 (1005)
Q Consensus 828 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~----~~~~~sDIwSlGvll~eLltG~~Pf~~ 903 (1005)
. .......+||+.|+|||++... .++.++|||||||++|+|++|+.||.+
T Consensus 196 ~--------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~ 249 (370)
T cd05596 196 G--------------------------MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYA 249 (370)
T ss_pred C--------------------------cccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCC
Confidence 0 0112345799999999998653 367899999999999999999999999
Q ss_pred CChHHHHHHHHhCC--CCCCCCCCCCHHHHHHHHHccccCcCc--cCCChhcHHHHHcCCCCCCCChhhhhhcCCCCCCC
Q 001847 904 KTRQKTFANILHKD--LKFPSSTPTSLHAKQLMYRLLHRDPKS--RLGSHEGANEIKKHPFFKGVNWALVRCMNPPELDA 979 (1005)
Q Consensus 904 ~~~~~~~~~i~~~~--~~~~~~~~~s~~l~~Ll~~~L~~dP~~--Rpt~~~~a~elL~hpff~~~~~~~~~~~~~~~~~~ 979 (1005)
.+....+..+.... +.++....++.++.+||.+||..+|.+ |++ +.++++||||+..+|............+
T Consensus 250 ~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s----~~ell~h~~~~~~~~~~~~~~~~~~~~~ 325 (370)
T cd05596 250 DSLVGTYSKIMDHKNSLTFPDDIEISKQAKDLICAFLTDREVRLGRNG----VDEIKSHPFFKNDQWTFDNIRETVAPVV 325 (370)
T ss_pred CCHHHHHHHHHcCCCcCCCCCcCCCCHHHHHHHHHHccChhhccCCCC----HHHHhcCcccCCCChhhHHhcCCCcCcc
Confidence 88888888887643 455665568999999999999999987 999 9999999999998887553333222234
Q ss_pred CCCCCcc
Q 001847 980 PLFATDT 986 (1005)
Q Consensus 980 p~~~~~~ 986 (1005)
|.+..+.
T Consensus 326 p~~~~~~ 332 (370)
T cd05596 326 PELSSDI 332 (370)
T ss_pred CcCCCcc
Confidence 5544433
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=383.39 Aligned_cols=296 Identities=36% Similarity=0.580 Sum_probs=231.7
Q ss_pred CccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEEe
Q 001847 673 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITD 752 (1005)
Q Consensus 673 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E 752 (1005)
.|++++.||+|+||+||+|.+..+++.||+|++.+...........+.+|+.+++.++||||+++++++...+.+|+|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 68999999999999999999999999999999987544455566778899999999999999999999999999999999
Q ss_pred ccCCCchhhHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCCCCCC
Q 001847 753 YCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLL 832 (1005)
Q Consensus 753 ~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~~~ 832 (1005)
|+++|+|.+++... ..+++..++.++.||+.||.|||+.||+||||||+|||++.+|.+||+|||++..........+
T Consensus 82 ~~~gg~L~~~l~~~--~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~~~ 159 (381)
T cd05626 82 YIPGGDMMSLLIRM--EVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKY 159 (381)
T ss_pred cCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCCCCEEEeeCcCCccccccccccc
Confidence 99999999998764 4589999999999999999999999999999999999999999999999998754321110000
Q ss_pred CcchhhhhcccCC--------------------CCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHH
Q 001847 833 PTTNEKKRRHKGQ--------------------QNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLY 892 (1005)
Q Consensus 833 ~~~~~~~~~~~~~--------------------~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlGvll~ 892 (1005)
............. ................+||+.|+|||++.+..++.++|||||||++|
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~il~ 239 (381)
T cd05626 160 YQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILF 239 (381)
T ss_pred ccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhhHHH
Confidence 0000000000000 00000000011123568999999999999888999999999999999
Q ss_pred HHHcCCCCCCCCChHHHHHHHHh--CCCCCCCCCCCCHHHHHHHHHcccc--CcCccCCChhcHHHHHcCCCCCCCChhh
Q 001847 893 EMLYGYTPFRGKTRQKTFANILH--KDLKFPSSTPTSLHAKQLMYRLLHR--DPKSRLGSHEGANEIKKHPFFKGVNWAL 968 (1005)
Q Consensus 893 eLltG~~Pf~~~~~~~~~~~i~~--~~~~~~~~~~~s~~l~~Ll~~~L~~--dP~~Rpt~~~~a~elL~hpff~~~~~~~ 968 (1005)
+|++|..||...+.......+.. .....+....++.++.+||.+||.. +|..|++ +.++++||||+.++|..
T Consensus 240 elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~----~~~~l~hp~f~~~~~~~ 315 (381)
T cd05626 240 EMLVGQPPFLAPTPTETQLKVINWENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNG----ADDIKAHPFFSEVDFSS 315 (381)
T ss_pred HHHhCCCCCcCCCHHHHHHHHHccccccCCCCCCCCCHHHHHHHHHHccCcccccCCCC----HHHHhcCcccCCCChhH
Confidence 99999999998877766666654 3345555556889999999996654 4555999 99999999999999987
Q ss_pred hhhcCC
Q 001847 969 VRCMNP 974 (1005)
Q Consensus 969 ~~~~~~ 974 (1005)
.....+
T Consensus 316 ~~~~~~ 321 (381)
T cd05626 316 DIRTQP 321 (381)
T ss_pred HhhcCC
Confidence 543333
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-41 Score=385.15 Aligned_cols=297 Identities=38% Similarity=0.634 Sum_probs=232.1
Q ss_pred CCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEE
Q 001847 672 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLIT 751 (1005)
Q Consensus 672 ~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~ 751 (1005)
++|++++.||+|+||.||+|.+..+++.||+|++.+...........+.+|+.+++.++|+||+++++.|..++.+|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence 37999999999999999999999999999999987654333444567788999999999999999999999999999999
Q ss_pred eccCCCchhhHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCCCCC
Q 001847 752 DYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLL 831 (1005)
Q Consensus 752 E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~~ 831 (1005)
||+++++|.+++... +.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++..........
T Consensus 81 E~~~~g~L~~~i~~~--~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~~ 158 (376)
T cd05598 81 DYIPGGDMMSLLIRL--GIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSK 158 (376)
T ss_pred eCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCCCCEEEEeCCCCcccccccccc
Confidence 999999999999764 458999999999999999999999999999999999999999999999999974322110000
Q ss_pred CCcchhhhhccc--------CCC----CC----cccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHH
Q 001847 832 LPTTNEKKRRHK--------GQQ----NP----VFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEML 895 (1005)
Q Consensus 832 ~~~~~~~~~~~~--------~~~----~~----~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlGvll~eLl 895 (1005)
........+... ... .+ .............+||+.|+|||++.+..++.++|||||||++|+|+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyell 238 (376)
T cd05598 159 YYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEML 238 (376)
T ss_pred ccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeeehh
Confidence 000000000000 000 00 00000011123468999999999999988999999999999999999
Q ss_pred cCCCCCCCCChHHHHHHHHhC--CCCCCCCCCCCHHHHHHHHHccccCcCccC---CChhcHHHHHcCCCCCCCChhhhh
Q 001847 896 YGYTPFRGKTRQKTFANILHK--DLKFPSSTPTSLHAKQLMYRLLHRDPKSRL---GSHEGANEIKKHPFFKGVNWALVR 970 (1005)
Q Consensus 896 tG~~Pf~~~~~~~~~~~i~~~--~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rp---t~~~~a~elL~hpff~~~~~~~~~ 970 (1005)
+|+.||.+....+....+... ....+....++..+.+||.+|+ .+|.+|+ + +.++++||||+.++|..+.
T Consensus 239 ~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t----~~ell~h~~~~~~~~~~~~ 313 (376)
T cd05598 239 VGQPPFLADTPAETQLKVINWETTLHIPSQAKLSREASDLILRLC-CGAEDRLGKNG----ADEIKAHPFFKGIDFASLI 313 (376)
T ss_pred hCCCCCCCCCHHHHHHHHhccCccccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCC----HHHHhCCCCcCCCCHHHHh
Confidence 999999988877766666543 2334444567889999999977 5999999 6 9999999999999999884
Q ss_pred -hcCCC
Q 001847 971 -CMNPP 975 (1005)
Q Consensus 971 -~~~~~ 975 (1005)
...+|
T Consensus 314 ~~~~~~ 319 (376)
T cd05598 314 RRQKAP 319 (376)
T ss_pred hcCCCC
Confidence 33344
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=382.27 Aligned_cols=297 Identities=37% Similarity=0.683 Sum_probs=236.0
Q ss_pred CCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEE
Q 001847 672 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLIT 751 (1005)
Q Consensus 672 ~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~ 751 (1005)
++|++++.||+|+||.||+|.+..+++.||+|++.............+..|+.++..++|++|++++++|...+.+|+||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 47999999999999999999999999999999998654444555677888999999999999999999999999999999
Q ss_pred eccCCCchhhHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCCCCC
Q 001847 752 DYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLL 831 (1005)
Q Consensus 752 E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~~ 831 (1005)
||++|++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.+|.++|+|||++..........
T Consensus 81 E~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~~ 158 (360)
T cd05627 81 EFLPGGDMMTLLMKK--DTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTE 158 (360)
T ss_pred eCCCCccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEeeccCCcccccccccc
Confidence 999999999998764 458999999999999999999999999999999999999999999999999986442211100
Q ss_pred CC------cchhhhh-cc-cCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHcCCCCCCC
Q 001847 832 LP------TTNEKKR-RH-KGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRG 903 (1005)
Q Consensus 832 ~~------~~~~~~~-~~-~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlGvll~eLltG~~Pf~~ 903 (1005)
.. ....... .. ...................+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf~~ 238 (360)
T cd05627 159 FYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCS 238 (360)
T ss_pred cccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCCCCC
Confidence 00 0000000 00 0000000000001112346899999999999999999999999999999999999999999
Q ss_pred CChHHHHHHHHhC--CCCCCCCCCCCHHHHHHHHHccccCcCccCCChhcHHHHHcCCCCCCCChhhhhhc
Q 001847 904 KTRQKTFANILHK--DLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVNWALVRCM 972 (1005)
Q Consensus 904 ~~~~~~~~~i~~~--~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~hpff~~~~~~~~~~~ 972 (1005)
.+....+..+... .+.++....++..+++||.+|+. ||.+|++.. .+.++++||||++++|..+...
T Consensus 239 ~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~-~p~~R~~~~-~~~ei~~hp~f~~~~~~~~~~~ 307 (360)
T cd05627 239 ETPQETYRKVMNWKETLVFPPEVPISEKAKDLILRFCT-DSENRIGSN-GVEEIKSHPFFEGVDWGHIRER 307 (360)
T ss_pred CCHHHHHHHHHcCCCceecCCCCCCCHHHHHHHHHhcc-ChhhcCCCC-CHHHHhcCCCCCCCCHHHHhcC
Confidence 8888877777753 34455555678899999999874 999999632 3899999999999999998654
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-40 Score=370.47 Aligned_cols=311 Identities=59% Similarity=1.016 Sum_probs=254.9
Q ss_pred CCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEE
Q 001847 672 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLIT 751 (1005)
Q Consensus 672 ~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~ 751 (1005)
++|++.+.||+|++|.||+|.+..+++.||+|.+.............+..|+++++.++|+||+++++.+......|+||
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 37999999999999999999999999999999998765444456678889999999999999999999999999999999
Q ss_pred eccCCCchhhHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCCCCC
Q 001847 752 DYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLL 831 (1005)
Q Consensus 752 E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~~ 831 (1005)
||+.+++|.+++.......+++..++.++.||+.||+|||+.|++|+||||+||+++.++.++|+|||++..........
T Consensus 81 e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~ 160 (316)
T cd05574 81 DYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPV 160 (316)
T ss_pred EecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcCCCCEEEeecchhhccccccccc
Confidence 99999999999987655679999999999999999999999999999999999999999999999999986543221110
Q ss_pred CCcchhhhhcc--cCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHcCCCCCCCCChHHH
Q 001847 832 LPTTNEKKRRH--KGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKT 909 (1005)
Q Consensus 832 ~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlGvll~eLltG~~Pf~~~~~~~~ 909 (1005)
........... ....................|+..|+|||++.+..++.++||||||+++|+|++|..||.+.+....
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~ 240 (316)
T cd05574 161 SKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNRDET 240 (316)
T ss_pred ccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCchHHH
Confidence 00000000000 0000000011112223456789999999999988889999999999999999999999998888777
Q ss_pred HHHHHhCCCCCCCCCCCCHHHHHHHHHccccCcCccCCChhcHHHHHcCCCCCCCChhhhhhcCCCCCCCCCC
Q 001847 910 FANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVNWALVRCMNPPELDAPLF 982 (1005)
Q Consensus 910 ~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~hpff~~~~~~~~~~~~~~~~~~p~~ 982 (1005)
+..+......++.....+..+.+||.+||..+|++||+++..++++|+||||++.+|..++-.-+|..+.|..
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (316)
T cd05574 241 FSNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFFRGVNWALIRHTTPPIIPRPDD 313 (316)
T ss_pred HHHHhcCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcCchhhcCChhhcccCCCCCCCCccc
Confidence 8778777777766656789999999999999999999999999999999999999999999888888766544
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-41 Score=380.01 Aligned_cols=279 Identities=37% Similarity=0.678 Sum_probs=237.7
Q ss_pred CCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEE
Q 001847 672 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLIT 751 (1005)
Q Consensus 672 ~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~ 751 (1005)
++|.+.+.||+|+||.||+|.+..+++.||+|+++............+..|+.+++.++|+||+++++++...+.+|+||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 37999999999999999999999999999999998764444455667788999999999999999999999999999999
Q ss_pred eccCCCchhhHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCCCCC
Q 001847 752 DYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLL 831 (1005)
Q Consensus 752 E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~~ 831 (1005)
||+++++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++........
T Consensus 81 e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~-- 157 (330)
T cd05601 81 EYQPGGDLLSLLNRYE-DQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKM-- 157 (330)
T ss_pred CCCCCCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECCCCCEEeccCCCCeECCCCCc--
Confidence 9999999999997652 4599999999999999999999999999999999999999999999999999854321110
Q ss_pred CCcchhhhhcccCCCCCcccccccccccccccCCccccccccc------CCCCCChhhHHHHHHHHHHHHcCCCCCCCCC
Q 001847 832 LPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIA------GAGHTSAVDWWALGILLYEMLYGYTPFRGKT 905 (1005)
Q Consensus 832 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~------~~~~~~~sDIwSlGvll~eLltG~~Pf~~~~ 905 (1005)
.......||+.|+|||++. ...++.++|||||||++|+|++|+.||....
T Consensus 158 ------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~ 213 (330)
T cd05601 158 ------------------------VNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGT 213 (330)
T ss_pred ------------------------eeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCC
Confidence 0112346899999999986 4556789999999999999999999999888
Q ss_pred hHHHHHHHHhCC--CCCCCCCCCCHHHHHHHHHccccCcCccCCChhcHHHHHcCCCCCCCChhhhhhcCCCCCCCCCCC
Q 001847 906 RQKTFANILHKD--LKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVNWALVRCMNPPELDAPLFA 983 (1005)
Q Consensus 906 ~~~~~~~i~~~~--~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~hpff~~~~~~~~~~~~~~~~~~p~~~ 983 (1005)
....+..+.... ..++.....+..+.+||.+||+ +|.+||+ ++++++||||+.++|..+....+|.. |.+.
T Consensus 214 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~ll~-~p~~R~t----~~~l~~h~~~~~~~~~~~~~~~~~~~--~~~~ 286 (330)
T cd05601 214 SAKTYNNIMNFQRFLKFPEDPKVSSDFLDLIQSLLC-GQKERLG----YEGLCCHPFFSKIDWNNIRNSLPPFV--PTLK 286 (330)
T ss_pred HHHHHHHHHcCCCccCCCCCCCCCHHHHHHHHHHcc-ChhhCCC----HHHHhCCCCcCCCCHHHHhhCCCCcc--CcCC
Confidence 877777776542 4455555678899999999998 9999999 99999999999999999987666543 5444
Q ss_pred C
Q 001847 984 T 984 (1005)
Q Consensus 984 ~ 984 (1005)
+
T Consensus 287 ~ 287 (330)
T cd05601 287 S 287 (330)
T ss_pred C
Confidence 3
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-42 Score=347.66 Aligned_cols=266 Identities=31% Similarity=0.517 Sum_probs=230.2
Q ss_pred cCCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccC-----hHHHHHHHHHHHHHHhC-CCCCcceEEEEEEeC
Q 001847 671 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLN-----RNKVHRACAEREILDML-DHPFVPALYASFQTK 744 (1005)
Q Consensus 671 ~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~-----~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~ 744 (1005)
...|...+.||.|..++|-++.++.+|+.+|+|++....... ....+.-..|+.||+++ .||+|+++.++|+.+
T Consensus 16 y~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~ 95 (411)
T KOG0599|consen 16 YAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESD 95 (411)
T ss_pred HhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCc
Confidence 457888899999999999999999999999999987532221 22334455799999998 899999999999999
Q ss_pred CeEEEEEeccCCCchhhHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCccc
Q 001847 745 THVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLT 824 (1005)
Q Consensus 745 ~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~~~g~vkL~DFG~a~~~ 824 (1005)
..+++|+|.|+.|.|++++... -.+++...+.||+||++|+.|||.++||||||||+|||++++-++||+|||+|+..
T Consensus 96 sF~FlVFdl~prGELFDyLts~--VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILlddn~~i~isDFGFa~~l 173 (411)
T KOG0599|consen 96 AFVFLVFDLMPRGELFDYLTSK--VTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDDNMNIKISDFGFACQL 173 (411)
T ss_pred chhhhhhhhcccchHHHHhhhh--eeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeeccccceEEeccceeecc
Confidence 9999999999999999999764 45999999999999999999999999999999999999999999999999999765
Q ss_pred CCCCCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccC------CCCCChhhHHHHHHHHHHHHcCC
Q 001847 825 SCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAG------AGHTSAVDWWALGILLYEMLYGY 898 (1005)
Q Consensus 825 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~------~~~~~~sDIwSlGvll~eLltG~ 898 (1005)
... ..-...||||+|+|||.+.. ..|+..+|+|++|+++|.|+.|+
T Consensus 174 ~~G----------------------------ekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGc 225 (411)
T KOG0599|consen 174 EPG----------------------------EKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGC 225 (411)
T ss_pred CCc----------------------------hhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCC
Confidence 421 12235799999999999843 45777999999999999999999
Q ss_pred CCCCCCChHHHHHHHHhCCCCCC--CCCCCCHHHHHHHHHccccCcCccCCChhcHHHHHcCCCCCCCChhhhh
Q 001847 899 TPFRGKTRQKTFANILHKDLKFP--SSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVNWALVR 970 (1005)
Q Consensus 899 ~Pf~~~~~~~~~~~i~~~~~~~~--~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~hpff~~~~~~~~~ 970 (1005)
+||......-.+..|+.+...+. .+..++...++||.+||+.||.+|+| ++++|.||||..+-....+
T Consensus 226 pPFwHRkQmlMLR~ImeGkyqF~speWadis~~~KdLIsrlLqVdp~~Rit----ake~LaHpff~q~~~~~~r 295 (411)
T KOG0599|consen 226 PPFWHRKQMLMLRMIMEGKYQFRSPEWADISATVKDLISRLLQVDPTKRIT----AKEALAHPFFIQIAQQQAR 295 (411)
T ss_pred CchhHHHHHHHHHHHHhcccccCCcchhhccccHHHHHHHHHeeCchhccc----HHHHhcChHHHHHHHhccc
Confidence 99999988888999999887664 45778899999999999999999999 9999999999765443333
|
|
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=374.93 Aligned_cols=265 Identities=38% Similarity=0.732 Sum_probs=226.9
Q ss_pred ccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCeEEEEEeccCC
Q 001847 678 KPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPALYASFQTKTHVCLITDYCPG 756 (1005)
Q Consensus 678 ~~LG~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~~lV~E~~~g 756 (1005)
+.||+|+||.||+|.+..+++.||+|++.+...........+..|..++..+ +||||+++++++...+.+|+||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 4689999999999999999999999999865433444556677888888876 799999999999999999999999999
Q ss_pred CchhhHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCCCCCCCcch
Q 001847 757 GELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTN 836 (1005)
Q Consensus 757 gsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~~~~~~~ 836 (1005)
++|..++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 81 g~L~~~i~~~--~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~--------- 149 (320)
T cd05590 81 GDLMFHIQKS--RRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFN--------- 149 (320)
T ss_pred chHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcC---------
Confidence 9999988764 45899999999999999999999999999999999999999999999999987432100
Q ss_pred hhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhC
Q 001847 837 EKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANILHK 916 (1005)
Q Consensus 837 ~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlGvll~eLltG~~Pf~~~~~~~~~~~i~~~ 916 (1005)
........||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+....+..+...
T Consensus 150 ------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~ 211 (320)
T cd05590 150 ------------------GKTTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILND 211 (320)
T ss_pred ------------------CCcccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcC
Confidence 01122357999999999999888999999999999999999999999998888888888877
Q ss_pred CCCCCCCCCCCHHHHHHHHHccccCcCccCCChh--cHHHHHcCCCCCCCChhhhhhcC
Q 001847 917 DLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHE--GANEIKKHPFFKGVNWALVRCMN 973 (1005)
Q Consensus 917 ~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~--~a~elL~hpff~~~~~~~~~~~~ 973 (1005)
...++. .++.++.+||.+||+.||.+||+... ..+++++||||+.++|..+....
T Consensus 212 ~~~~~~--~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~~~~h~~f~~~~~~~~~~~~ 268 (320)
T cd05590 212 EVVYPT--WLSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILRHPFFKELDWEKLNRRQ 268 (320)
T ss_pred CCCCCC--CCCHHHHHHHHHHcccCHHHCCCCCCCCCHHHHHcCCCcCCCCHHHHHhCC
Confidence 665554 36889999999999999999999432 23899999999999999875433
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=374.05 Aligned_cols=270 Identities=35% Similarity=0.692 Sum_probs=231.8
Q ss_pred CccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCC-CCcceEEEEEEeCCeEEEEE
Q 001847 673 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDH-PFVPALYASFQTKTHVCLIT 751 (1005)
Q Consensus 673 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~il~~l~h-pnIv~l~~~~~~~~~~~lV~ 751 (1005)
+|++++.||+|+||.||+|.+..+++.||+|++.+...........+..|+.++..+.| ++|+.++++|...+.+|+||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 48999999999999999999999999999999987544444556677889999999976 46889999999999999999
Q ss_pred eccCCCchhhHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCCCCC
Q 001847 752 DYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLL 831 (1005)
Q Consensus 752 E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~~ 831 (1005)
||+++++|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||++......
T Consensus 81 E~~~~g~L~~~~~~~--~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~---- 154 (324)
T cd05587 81 EYVNGGDLMYHIQQV--GKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFG---- 154 (324)
T ss_pred cCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCCCCEEEeecCcceecCCC----
Confidence 999999999998764 45899999999999999999999999999999999999999999999999987431100
Q ss_pred CCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHcCCCCCCCCChHHHHH
Q 001847 832 LPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFA 911 (1005)
Q Consensus 832 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlGvll~eLltG~~Pf~~~~~~~~~~ 911 (1005)
.......+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+....+.
T Consensus 155 -----------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~ 211 (324)
T cd05587 155 -----------------------GKTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQ 211 (324)
T ss_pred -----------------------CCceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 011234579999999999999889999999999999999999999999988888888
Q ss_pred HHHhCCCCCCCCCCCCHHHHHHHHHccccCcCccCCCh-hcHHHHHcCCCCCCCChhhhhhcC
Q 001847 912 NILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSH-EGANEIKKHPFFKGVNWALVRCMN 973 (1005)
Q Consensus 912 ~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~-~~a~elL~hpff~~~~~~~~~~~~ 973 (1005)
.+......++. .++..+.+|+.+||..||.+|++.. ....++++||||+.++|..+....
T Consensus 212 ~i~~~~~~~~~--~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~hp~~~~~~~~~~~~~~ 272 (324)
T cd05587 212 SIMEHNVSYPK--SLSKEAVSICKGLLTKHPAKRLGCGPTGERDIREHAFFRRIDWEKLERRE 272 (324)
T ss_pred HHHcCCCCCCC--CCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCCcCCCCHHHHHhCC
Confidence 88877665554 4688999999999999999999853 335899999999999999775443
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-42 Score=403.70 Aligned_cols=287 Identities=38% Similarity=0.687 Sum_probs=256.5
Q ss_pred ccccCCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeE
Q 001847 668 QINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHV 747 (1005)
Q Consensus 668 ~i~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 747 (1005)
++..++|.+++.||.|+||.|.+|+++.+++.||+|++.+-.+.......-|..|..+|...+++=|+.++..|.++.++
T Consensus 71 rl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~L 150 (1317)
T KOG0612|consen 71 RLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERYL 150 (1317)
T ss_pred hCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccce
Confidence 45678999999999999999999999999999999999987666667777888899999999999999999999999999
Q ss_pred EEEEeccCCCchhhHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCC
Q 001847 748 CLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCK 827 (1005)
Q Consensus 748 ~lV~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~ 827 (1005)
|+|||||+||+|..++.+.. .++++.+++|+..|+.||.-||+.|.|||||||+|||++.+|++||+|||.+-.+..+
T Consensus 151 YlVMdY~pGGDlltLlSk~~--~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~~GHikLADFGsClkm~~d 228 (1317)
T KOG0612|consen 151 YLVMDYMPGGDLLTLLSKFD--RLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKSGHIKLADFGSCLKMDAD 228 (1317)
T ss_pred EEEEecccCchHHHHHhhcC--CChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEecccCcEeeccchhHHhcCCC
Confidence 99999999999999998753 6999999999999999999999999999999999999999999999999988665432
Q ss_pred CCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccC-----CCCCChhhHHHHHHHHHHHHcCCCCCC
Q 001847 828 PQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAG-----AGHTSAVDWWALGILLYEMLYGYTPFR 902 (1005)
Q Consensus 828 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-----~~~~~~sDIwSlGvll~eLltG~~Pf~ 902 (1005)
. ...+...+|||-|++||+|.. +.|+..+|-||+||++|||++|..||.
T Consensus 229 G--------------------------~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFY 282 (1317)
T KOG0612|consen 229 G--------------------------TVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFY 282 (1317)
T ss_pred C--------------------------cEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcch
Confidence 2 234556789999999999943 457889999999999999999999999
Q ss_pred CCChHHHHHHHHhC--CCCCCCCCCCCHHHHHHHHHccccCcCccCCChhcHHHHHcCCCCCCCChhhhhhcCCCCCCCC
Q 001847 903 GKTRQKTFANILHK--DLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVNWALVRCMNPPELDAP 980 (1005)
Q Consensus 903 ~~~~~~~~~~i~~~--~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~hpff~~~~~~~~~~~~~~~~~~p 980 (1005)
..+-.+.|.+|+.- .+.+|....+|.++++||.++++ +|+.|.. +..+.++..||||.+++|.-+|...||-. |
T Consensus 283 adslveTY~KIm~hk~~l~FP~~~~VSeeakdLI~~ll~-~~e~RLg-rngiedik~HpFF~g~~W~~iR~~~pP~v--P 358 (1317)
T KOG0612|consen 283 ADSLVETYGKIMNHKESLSFPDETDVSEEAKDLIEALLC-DREVRLG-RNGIEDIKNHPFFEGIDWDNIRESVPPVV--P 358 (1317)
T ss_pred HHHHHHHHHHHhchhhhcCCCcccccCHHHHHHHHHHhc-Chhhhcc-cccHHHHHhCccccCCChhhhhhcCCCCC--C
Confidence 99999999999864 78888777799999999999998 7788987 56699999999999999999999999955 7
Q ss_pred CCCCcc
Q 001847 981 LFATDT 986 (1005)
Q Consensus 981 ~~~~~~ 986 (1005)
-++-|.
T Consensus 359 evssd~ 364 (1317)
T KOG0612|consen 359 EVSSDD 364 (1317)
T ss_pred cCCCCC
Confidence 655443
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-41 Score=357.68 Aligned_cols=261 Identities=27% Similarity=0.422 Sum_probs=222.5
Q ss_pred CCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceEEEEEEe-----CCe
Q 001847 672 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQT-----KTH 746 (1005)
Q Consensus 672 ~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-----~~~ 746 (1005)
..|..++.||.|+||.|+.+.++.+|..||+|.+... +......++..+|+++|+.++|+||+.+++.+.. -+.
T Consensus 22 ~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~-F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~D 100 (359)
T KOG0660|consen 22 RYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNP-FENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFND 100 (359)
T ss_pred ceecccccccCcceeeEEEEEEcCCCCEeehhhhhhh-hhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccce
Confidence 4666689999999999999999999999999988753 4566778899999999999999999999999875 457
Q ss_pred EEEEEeccCCCchhhHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCC
Q 001847 747 VCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSC 826 (1005)
Q Consensus 747 ~~lV~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~~~g~vkL~DFG~a~~~~~ 826 (1005)
+|+|+|+| +.+|...++.+ ..+++.+++.++.||++||+|+|+.||+||||||+|+|++.+..+||+|||+|+....
T Consensus 101 vYiV~elM-etDL~~iik~~--~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~ 177 (359)
T KOG0660|consen 101 VYLVFELM-ETDLHQIIKSQ--QDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNADCDLKICDFGLARYLDK 177 (359)
T ss_pred eEEehhHH-hhHHHHHHHcC--ccccHHHHHHHHHHHHHhcchhhcccccccccchhheeeccCCCEEeccccceeeccc
Confidence 99999999 89999999875 3499999999999999999999999999999999999999999999999999977643
Q ss_pred CCCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccC-CCCCChhhHHHHHHHHHHHHcCCCCCCCCC
Q 001847 827 KPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAG-AGHTSAVDWWALGILLYEMLYGYTPFRGKT 905 (1005)
Q Consensus 827 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~sDIwSlGvll~eLltG~~Pf~~~~ 905 (1005)
... ....+.++.|.+|+|||++.. ..|+...||||+||++.||++|++.|.|.+
T Consensus 178 ~~~-------------------------~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d 232 (359)
T KOG0660|consen 178 FFE-------------------------DGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKD 232 (359)
T ss_pred cCc-------------------------ccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCc
Confidence 200 112245688999999999754 578999999999999999999999999988
Q ss_pred hHHHHHHHHhC-----------------------CCCCC------CCCCCCHHHHHHHHHccccCcCccCCChhcHHHHH
Q 001847 906 RQKTFANILHK-----------------------DLKFP------SSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIK 956 (1005)
Q Consensus 906 ~~~~~~~i~~~-----------------------~~~~~------~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL 956 (1005)
...++..|+.- ....+ ..+..++.+.+|+.+||..||.+|+| ++++|
T Consensus 233 ~v~Ql~lI~~~lGtP~~e~l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRit----a~eAL 308 (359)
T KOG0660|consen 233 YVHQLQLILELLGTPSEEDLQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRIT----AEEAL 308 (359)
T ss_pred hHHHHHHHHHhcCCCCHHHHHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCC----HHHHh
Confidence 87777666441 11111 12456778999999999999999999 99999
Q ss_pred cCCCCCCCC
Q 001847 957 KHPFFKGVN 965 (1005)
Q Consensus 957 ~hpff~~~~ 965 (1005)
+||||..+.
T Consensus 309 ~hPYl~~~h 317 (359)
T KOG0660|consen 309 AHPYLAPYH 317 (359)
T ss_pred cChhhhhhc
Confidence 999999753
|
|
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=374.43 Aligned_cols=266 Identities=41% Similarity=0.773 Sum_probs=227.9
Q ss_pred ccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHH---HhCCCCCcceEEEEEEeCCeEEEE
Q 001847 674 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREIL---DMLDHPFVPALYASFQTKTHVCLI 750 (1005)
Q Consensus 674 y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~il---~~l~hpnIv~l~~~~~~~~~~~lV 750 (1005)
|++++.||+|+||.||+|.+..+++.||+|++++...........+..|+.++ +.++||||+++++++...+.+|+|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 78899999999999999999999999999999865433344455666676655 456899999999999999999999
Q ss_pred EeccCCCchhhHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCCCC
Q 001847 751 TDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQL 830 (1005)
Q Consensus 751 ~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~ 830 (1005)
|||+.+++|..++.. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 81 ~E~~~~~~L~~~~~~---~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~--- 154 (324)
T cd05589 81 MEYAAGGDLMMHIHT---DVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGF--- 154 (324)
T ss_pred EcCCCCCcHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCcEEeCcccCCccCCCC---
Confidence 999999999888754 35899999999999999999999999999999999999999999999999987432100
Q ss_pred CCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHcCCCCCCCCChHHHH
Q 001847 831 LLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTF 910 (1005)
Q Consensus 831 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlGvll~eLltG~~Pf~~~~~~~~~ 910 (1005)
.......+|++.|+|||.+.+..++.++|||||||++|+|++|+.||.+.+.....
T Consensus 155 ------------------------~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~ 210 (324)
T cd05589 155 ------------------------GDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVF 210 (324)
T ss_pred ------------------------CCcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 01123467999999999999888999999999999999999999999998888888
Q ss_pred HHHHhCCCCCCCCCCCCHHHHHHHHHccccCcCccCCChh-cHHHHHcCCCCCCCChhhhhh
Q 001847 911 ANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHE-GANEIKKHPFFKGVNWALVRC 971 (1005)
Q Consensus 911 ~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~-~a~elL~hpff~~~~~~~~~~ 971 (1005)
..+......++. .++..+.+||.+||..||.+||++.+ .+.++++||||+.++|.....
T Consensus 211 ~~i~~~~~~~p~--~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~~~f~~~~~~~~~~ 270 (324)
T cd05589 211 DSIVNDEVRYPR--FLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQPFFRDINWDDLLA 270 (324)
T ss_pred HHHHhCCCCCCC--CCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhCCCcCCCCHHHHHh
Confidence 888777665554 36888999999999999999996543 499999999999999997743
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-41 Score=382.25 Aligned_cols=305 Identities=41% Similarity=0.726 Sum_probs=244.8
Q ss_pred CCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEE
Q 001847 672 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLIT 751 (1005)
Q Consensus 672 ~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~ 751 (1005)
++|++++.||+|+||.||+|.+..+++.||+|++.............+..|+.++..++|+||+++++++...+.+|+||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 47999999999999999999999999999999998754444455667888999999999999999999999999999999
Q ss_pred eccCCCchhhHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCCCCC
Q 001847 752 DYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLL 831 (1005)
Q Consensus 752 E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~~ 831 (1005)
||+.+++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..........
T Consensus 81 e~~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~ 158 (350)
T cd05573 81 EYMPGGDLMNLLIRK--DVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDRE 158 (350)
T ss_pred cCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEeecCCCCccCcccCccc
Confidence 999999999999765 459999999999999999999999999999999999999999999999999986554322100
Q ss_pred CCcchhhhh--cccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHcCCCCCCCCChHHH
Q 001847 832 LPTTNEKKR--RHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKT 909 (1005)
Q Consensus 832 ~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlGvll~eLltG~~Pf~~~~~~~~ 909 (1005)
......... ......................||+.|+|||++.+..++.++|||||||++|+|++|+.||.+......
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~ 238 (350)
T cd05573 159 YYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQET 238 (350)
T ss_pred ccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCHHHH
Confidence 000000000 000000000000111123345799999999999999999999999999999999999999999888877
Q ss_pred HHHHHh--CCCCCCCCCCCCHHHHHHHHHccccCcCccCCChhcHHHHHcCCCCCCCChhhhhhcCCCCCCCCCCCC
Q 001847 910 FANILH--KDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVNWALVRCMNPPELDAPLFAT 984 (1005)
Q Consensus 910 ~~~i~~--~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~hpff~~~~~~~~~~~~~~~~~~p~~~~ 984 (1005)
...+.. ....++....++..+.+||.+||. ||.+|++. +.++++||||+.++|.......+|.. |.++.
T Consensus 239 ~~~i~~~~~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s---~~~ll~hp~~~~~~~~~~~~~~~~~~--~~~~~ 309 (350)
T cd05573 239 YNKIINWKESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGS---FEEIKSHPFFKGIDWENLRETKPPFV--PELSS 309 (350)
T ss_pred HHHHhccCCcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCC---HHHHhcCCCcCCCCHHHHhhCCCCcC--CCCCC
Confidence 777776 555566665678999999999998 99999985 88999999999999998876556544 55444
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-41 Score=351.51 Aligned_cols=263 Identities=23% Similarity=0.348 Sum_probs=222.7
Q ss_pred cCCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceEEEEEEe--CCeEE
Q 001847 671 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQT--KTHVC 748 (1005)
Q Consensus 671 ~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~--~~~~~ 748 (1005)
.+.|+.+..|++|+||.||+|+|+.|+..||+|.++.... .....---.+||.+|.+++|||||.+.++... -+.+|
T Consensus 75 v~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmeke-k~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy 153 (419)
T KOG0663|consen 75 VEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKE-KEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIY 153 (419)
T ss_pred HHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccc-cCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceee
Confidence 4689999999999999999999999999999999986532 22223345789999999999999999998764 46799
Q ss_pred EEEeccCCCchhhHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCC
Q 001847 749 LITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKP 828 (1005)
Q Consensus 749 lV~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~ 828 (1005)
+||||| .-+|..++.... .++...+++.++.|++.||+|||.+.|+||||||+|+|++..|.+||+|||+|+..+...
T Consensus 154 ~VMe~~-EhDLksl~d~m~-q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp~ 231 (419)
T KOG0663|consen 154 IVMEYV-EHDLKSLMETMK-QPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHKGILKIADFGLAREYGSPL 231 (419)
T ss_pred eeHHHH-HhhHHHHHHhcc-CCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeeccCCcEEecccchhhhhcCCc
Confidence 999999 678999988764 569999999999999999999999999999999999999999999999999997765321
Q ss_pred CCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCC-CCCChhhHHHHHHHHHHHHcCCCCCCCCChH
Q 001847 829 QLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGA-GHTSAVDWWALGILLYEMLYGYTPFRGKTRQ 907 (1005)
Q Consensus 829 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~sDIwSlGvll~eLltG~~Pf~~~~~~ 907 (1005)
......+.|.+|+|||.|.+. .|+.+.|+||+|||+.||+++++.|.|....
T Consensus 232 ---------------------------k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~ 284 (419)
T KOG0663|consen 232 ---------------------------KPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEI 284 (419)
T ss_pred ---------------------------ccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchH
Confidence 223456889999999999885 5888999999999999999999999999999
Q ss_pred HHHHHHHhC-----C--------------CCCCCC-----------CCCCHHHHHHHHHccccCcCccCCChhcHHHHHc
Q 001847 908 KTFANILHK-----D--------------LKFPSS-----------TPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKK 957 (1005)
Q Consensus 908 ~~~~~i~~~-----~--------------~~~~~~-----------~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~ 957 (1005)
+++.+|.+. . +.++.. ..++....+|+..+|.+||.+|.| |.+.|+
T Consensus 285 dQl~~If~llGtPte~iwpg~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~t----A~~~L~ 360 (419)
T KOG0663|consen 285 DQLDKIFKLLGTPSEAIWPGYSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRIT----AEDGLK 360 (419)
T ss_pred HHHHHHHHHhCCCccccCCCccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCcccccc----HHHhhc
Confidence 888888652 0 111110 114567789999999999999999 999999
Q ss_pred CCCCCCCChh
Q 001847 958 HPFFKGVNWA 967 (1005)
Q Consensus 958 hpff~~~~~~ 967 (1005)
|+||.....+
T Consensus 361 h~~F~e~P~p 370 (419)
T KOG0663|consen 361 HEYFRETPLP 370 (419)
T ss_pred ccccccCCCC
Confidence 9999985443
|
|
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-40 Score=382.40 Aligned_cols=293 Identities=38% Similarity=0.646 Sum_probs=231.8
Q ss_pred CccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEEe
Q 001847 673 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITD 752 (1005)
Q Consensus 673 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E 752 (1005)
.|++++.||+|+||.||+|.+..+++.||+|++.+...........+.+|+.+++.++|+||++++++|...+.+|+|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 68999999999999999999999999999999986544445556778899999999999999999999999999999999
Q ss_pred ccCCCchhhHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCCCCCC
Q 001847 753 YCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLL 832 (1005)
Q Consensus 753 ~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~~~ 832 (1005)
|+++|+|.+++.+. +.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++..........+
T Consensus 82 ~~~gg~L~~~l~~~--~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~~~ 159 (382)
T cd05625 82 YIPGGDMMSLLIRM--GIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKY 159 (382)
T ss_pred CCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEeECCCCccccccccccc
Confidence 99999999998764 4589999999999999999999999999999999999999999999999999753321111000
Q ss_pred Ccchhhhhccc----CC-CCC---------------cccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHH
Q 001847 833 PTTNEKKRRHK----GQ-QNP---------------VFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLY 892 (1005)
Q Consensus 833 ~~~~~~~~~~~----~~-~~~---------------~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlGvll~ 892 (1005)
....+..+... .. ..+ .............+||+.|+|||++.+..++.++|||||||++|
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvil~ 239 (382)
T cd05625 160 YQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILY 239 (382)
T ss_pred cccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechHHHH
Confidence 00000000000 00 000 00000011123468999999999999989999999999999999
Q ss_pred HHHcCCCCCCCCChHHHHHHHHhC--CCCCCCCCCCCHHHHHHHHHccccCcCccCCChhcHHHHHcCCCCCCCChhhh
Q 001847 893 EMLYGYTPFRGKTRQKTFANILHK--DLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVNWALV 969 (1005)
Q Consensus 893 eLltG~~Pf~~~~~~~~~~~i~~~--~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~hpff~~~~~~~~ 969 (1005)
+|++|+.||.+.+..+....+... ....+....++.++.+||.+|+ .+|.+|++ ...+.++++||||+.++|...
T Consensus 240 elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~-~~~~~ei~~hp~f~~~~~~~~ 316 (382)
T cd05625 240 EMLVGQPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIKLC-RGPEDRLG-KNGADEIKAHPFFKTIDFSSD 316 (382)
T ss_pred HHHhCCCCCCCCCHHHHHHHHHccCCCcCCCCcccCCHHHHHHHHHHc-cCHhHcCC-CCCHHHHhcCCCcCCcChHHH
Confidence 999999999988877777666653 3444555567889999999986 59999997 334899999999999999864
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=373.20 Aligned_cols=266 Identities=39% Similarity=0.747 Sum_probs=228.3
Q ss_pred ccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCeEEEEEeccCC
Q 001847 678 KPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPALYASFQTKTHVCLITDYCPG 756 (1005)
Q Consensus 678 ~~LG~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~~lV~E~~~g 756 (1005)
+.||+|+||.||+|.+..+++.||+|++.+...........+..|..++..+ +||||++++++|...+.+|+||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 4689999999999999999999999999875444445556677888888876 899999999999999999999999999
Q ss_pred CchhhHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCCCCCCCcch
Q 001847 757 GELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTN 836 (1005)
Q Consensus 757 gsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~~~~~~~ 836 (1005)
++|..++... ..+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||++......
T Consensus 81 ~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~--------- 149 (321)
T cd05591 81 GDLMFQIQRS--RKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILN--------- 149 (321)
T ss_pred CcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeecccceecccC---------
Confidence 9999988764 45899999999999999999999999999999999999999999999999988532110
Q ss_pred hhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhC
Q 001847 837 EKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANILHK 916 (1005)
Q Consensus 837 ~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlGvll~eLltG~~Pf~~~~~~~~~~~i~~~ 916 (1005)
........|++.|+|||++.+..++.++|||||||++|+|++|+.||.+.+....+..+...
T Consensus 150 ------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~~ 211 (321)
T cd05591 150 ------------------GVTTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHD 211 (321)
T ss_pred ------------------CccccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHcC
Confidence 01122456999999999999888999999999999999999999999999888888888877
Q ss_pred CCCCCCCCCCCHHHHHHHHHccccCcCccCCChh---cHHHHHcCCCCCCCChhhhhhcCC
Q 001847 917 DLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHE---GANEIKKHPFFKGVNWALVRCMNP 974 (1005)
Q Consensus 917 ~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~---~a~elL~hpff~~~~~~~~~~~~~ 974 (1005)
...++. .++.++.+||.+||..||.+|++..+ .+.++++||||..++|..+.....
T Consensus 212 ~~~~p~--~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~hp~~~~~~~~~~~~~~~ 270 (321)
T cd05591 212 DVLYPV--WLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQHPFFKEIDWVLLEQRKI 270 (321)
T ss_pred CCCCCC--CCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcCCccCCCCHHHHHhCCC
Confidence 665554 36789999999999999999994332 399999999999999998855443
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-40 Score=373.43 Aligned_cols=263 Identities=41% Similarity=0.749 Sum_probs=225.5
Q ss_pred ccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHH-HHHhCCCCCcceEEEEEEeCCeEEEEEeccCC
Q 001847 678 KPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAERE-ILDMLDHPFVPALYASFQTKTHVCLITDYCPG 756 (1005)
Q Consensus 678 ~~LG~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~-il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~g 756 (1005)
+.||+|+||.||++.+..+|+.||+|++.+...........+..|.. +++.++||||+++++++...+.+|+||||+.+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 46899999999999999999999999997654333344455555655 56788999999999999999999999999999
Q ss_pred CchhhHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCCCCCCCcch
Q 001847 757 GELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTN 836 (1005)
Q Consensus 757 gsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~~~~~~~ 836 (1005)
++|..++... ..+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++......
T Consensus 81 g~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~--------- 149 (323)
T cd05575 81 GELFFHLQRE--RSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEH--------- 149 (323)
T ss_pred CCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeccCCCcccccC---------
Confidence 9999998764 45899999999999999999999999999999999999999999999999987432100
Q ss_pred hhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhC
Q 001847 837 EKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANILHK 916 (1005)
Q Consensus 837 ~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlGvll~eLltG~~Pf~~~~~~~~~~~i~~~ 916 (1005)
.......+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+.+..+...
T Consensus 150 ------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~ 211 (323)
T cd05575 150 ------------------SKTTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNK 211 (323)
T ss_pred ------------------CCccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHcC
Confidence 01123457999999999999988999999999999999999999999998888888888776
Q ss_pred CCCCCCCCCCCHHHHHHHHHccccCcCccCCChhcHHHHHcCCCCCCCChhhhhh
Q 001847 917 DLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVNWALVRC 971 (1005)
Q Consensus 917 ~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~hpff~~~~~~~~~~ 971 (1005)
....+. ..+..+.+||.+||+.||.+||+..+.+.++++||||..++|..+..
T Consensus 212 ~~~~~~--~~~~~~~~li~~~l~~~p~~R~~~~~~~~~il~~~~~~~~~~~~~~~ 264 (323)
T cd05575 212 PLRLKP--NISVSARHLLEGLLQKDRTKRLGAKDDFLEIKNHVFFSSINWDDLVN 264 (323)
T ss_pred CCCCCC--CCCHHHHHHHHHHhhcCHHhCCCCCCCHHHHHcCCCcCCCCHHHHhh
Confidence 655443 46889999999999999999999887789999999999999988743
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=358.76 Aligned_cols=255 Identities=30% Similarity=0.551 Sum_probs=232.8
Q ss_pred cCCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEE
Q 001847 671 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLI 750 (1005)
Q Consensus 671 ~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV 750 (1005)
..+|++.+.||.|.||.|-+|.+...|+.||||.+++..+.+....-.+.+||+||..|+||||+.+|++|++.+.+.||
T Consensus 52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIviv 131 (668)
T KOG0611|consen 52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIV 131 (668)
T ss_pred hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEE
Confidence 46899999999999999999999999999999999999888888899999999999999999999999999999999999
Q ss_pred EeccCCCchhhHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCCCC
Q 001847 751 TDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQL 830 (1005)
Q Consensus 751 ~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~ 830 (1005)
|||..+|.|++|+... +.|++...+.+++||+.|+.|+|+++++|||||.+|||++.|+++||.|||++.......
T Consensus 132 MEYaS~GeLYDYiSer--~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~N~NiKIADFGLSNly~~~k-- 207 (668)
T KOG0611|consen 132 MEYASGGELYDYISER--GSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQNNNIKIADFGLSNLYADKK-- 207 (668)
T ss_pred EEecCCccHHHHHHHh--ccccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecCCCCeeeeccchhhhhcccc--
Confidence 9999999999999875 569999999999999999999999999999999999999999999999999985543221
Q ss_pred CCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCC-CChhhHHHHHHHHHHHHcCCCCCCCCChHHH
Q 001847 831 LLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGH-TSAVDWWALGILLYEMLYGYTPFRGKTRQKT 909 (1005)
Q Consensus 831 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~-~~~sDIwSlGvll~eLltG~~Pf~~~~~~~~ 909 (1005)
.-.++||+|.|.+||+..+.+| ++.+|.||||++||-|+.|..||+|.+....
T Consensus 208 --------------------------fLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~l 261 (668)
T KOG0611|consen 208 --------------------------FLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRL 261 (668)
T ss_pred --------------------------HHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHH
Confidence 2246899999999999999887 5689999999999999999999999999999
Q ss_pred HHHHHhCCCCCCCCCCCCHHHHHHHHHccccCcCccCCChhcHHHHHcCCCCC
Q 001847 910 FANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFK 962 (1005)
Q Consensus 910 ~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~hpff~ 962 (1005)
+..|..+...-|.. +..+..||+.||..||+.|.| +.++-.|=|+.
T Consensus 262 vrQIs~GaYrEP~~---PSdA~gLIRwmLmVNP~RRAT----ieDiAsHWWvN 307 (668)
T KOG0611|consen 262 VRQISRGAYREPET---PSDASGLIRWMLMVNPERRAT----IEDIASHWWVN 307 (668)
T ss_pred HHHhhcccccCCCC---CchHHHHHHHHHhcCcccchh----HHHHhhhheee
Confidence 99998886655543 446778999999999999999 99999998865
|
|
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=375.08 Aligned_cols=263 Identities=43% Similarity=0.785 Sum_probs=225.9
Q ss_pred ccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEEeccCCC
Q 001847 678 KPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGG 757 (1005)
Q Consensus 678 ~~LG~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg 757 (1005)
+.||+|+||.||+|.+..+++.||+|++.+...........+..|+.+++.++||||++++++|...+.+|+||||+.++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 46899999999999999999999999998765444555667788999999999999999999999999999999999999
Q ss_pred chhhHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHH-cCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCCCCCCCcch
Q 001847 758 ELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHC-QGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTN 836 (1005)
Q Consensus 758 sL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~-~gIvHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~~~~~~~ 836 (1005)
+|..++... ..+++..++.++.||+.||.|||+ +||+||||||+|||++.+|.+||+|||++......
T Consensus 81 ~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~--------- 149 (325)
T cd05594 81 ELFFHLSRE--RVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKD--------- 149 (325)
T ss_pred cHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCC---------
Confidence 999988764 458999999999999999999997 79999999999999999999999999987432100
Q ss_pred hhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhC
Q 001847 837 EKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANILHK 916 (1005)
Q Consensus 837 ~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlGvll~eLltG~~Pf~~~~~~~~~~~i~~~ 916 (1005)
........||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+.......+...
T Consensus 150 ------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~~ 211 (325)
T cd05594 150 ------------------GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILME 211 (325)
T ss_pred ------------------CcccccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHHHHHHhcC
Confidence 01112357999999999998888999999999999999999999999988877777777766
Q ss_pred CCCCCCCCCCCHHHHHHHHHccccCcCccCCCh-hcHHHHHcCCCCCCCChhhhhh
Q 001847 917 DLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSH-EGANEIKKHPFFKGVNWALVRC 971 (1005)
Q Consensus 917 ~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~-~~a~elL~hpff~~~~~~~~~~ 971 (1005)
...++. .++.++.+||.+||..||.+|++.. +.+.++++||||+++.|.....
T Consensus 212 ~~~~p~--~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~~~~~~~~~~~~ 265 (325)
T cd05594 212 EIRFPR--TLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQHKFFAGIVWQDVYE 265 (325)
T ss_pred CCCCCC--CCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcCCCcCCCCHHHHHh
Confidence 666554 3688999999999999999998321 1299999999999999997743
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=380.53 Aligned_cols=268 Identities=35% Similarity=0.660 Sum_probs=226.7
Q ss_pred cccCCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEE
Q 001847 669 INLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVC 748 (1005)
Q Consensus 669 i~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~ 748 (1005)
+..++|++++.||+|+||.||++.+..+++.||+|++.+...........+.+|+.+++.++||||+++++++..++.+|
T Consensus 40 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~ 119 (370)
T cd05621 40 MKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLY 119 (370)
T ss_pred CCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEE
Confidence 34578999999999999999999999999999999997644334444556778999999999999999999999999999
Q ss_pred EEEeccCCCchhhHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCC
Q 001847 749 LITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKP 828 (1005)
Q Consensus 749 lV~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~ 828 (1005)
+||||+++|+|.+++... .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 120 lv~Ey~~gg~L~~~l~~~---~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~~~ 196 (370)
T cd05621 120 MVMEYMPGGDLVNLMSNY---DVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETG 196 (370)
T ss_pred EEEcCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEEecccceecccCC
Confidence 999999999999999653 48899999999999999999999999999999999999999999999999985432110
Q ss_pred CCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCC----CCChhhHHHHHHHHHHHHcCCCCCCCC
Q 001847 829 QLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAG----HTSAVDWWALGILLYEMLYGYTPFRGK 904 (1005)
Q Consensus 829 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~----~~~~sDIwSlGvll~eLltG~~Pf~~~ 904 (1005)
.......+||+.|+|||++.... ++.++|||||||++|+|++|+.||.+.
T Consensus 197 --------------------------~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~ 250 (370)
T cd05621 197 --------------------------MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYAD 250 (370)
T ss_pred --------------------------ceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCC
Confidence 01123457999999999987643 678999999999999999999999998
Q ss_pred ChHHHHHHHHhCC--CCCCCCCCCCHHHHHHHHHccccCcCc--cCCChhcHHHHHcCCCCCCCChhhh
Q 001847 905 TRQKTFANILHKD--LKFPSSTPTSLHAKQLMYRLLHRDPKS--RLGSHEGANEIKKHPFFKGVNWALV 969 (1005)
Q Consensus 905 ~~~~~~~~i~~~~--~~~~~~~~~s~~l~~Ll~~~L~~dP~~--Rpt~~~~a~elL~hpff~~~~~~~~ 969 (1005)
+....+..+.... +.++....++..+++|+.+||..++.. |++ +.++++||||+...|...
T Consensus 251 ~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~----~~e~l~hp~~~~~~~~~~ 315 (370)
T cd05621 251 SLVGTYSKIMDHKNSLNFPEDVEISKHAKNLICAFLTDREVRLGRNG----VEEIKQHPFFKNDQWNWD 315 (370)
T ss_pred CHHHHHHHHHhCCcccCCCCcccCCHHHHHHHHHHccCchhccCCCC----HHHHhcCcccCCCCcChH
Confidence 8888888887643 455665567889999999999855543 778 999999999998666533
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-40 Score=370.72 Aligned_cols=271 Identities=35% Similarity=0.683 Sum_probs=232.6
Q ss_pred CccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCeEEEEE
Q 001847 673 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPALYASFQTKTHVCLIT 751 (1005)
Q Consensus 673 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~~lV~ 751 (1005)
+|++++.||+|+||.||+|.+..+++.||+|++.+..............|..++..+ .|++|+.+++++...+.+|+||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 488999999999999999999999999999999875443344455667788888777 5899999999999999999999
Q ss_pred eccCCCchhhHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCCCCC
Q 001847 752 DYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLL 831 (1005)
Q Consensus 752 E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~~ 831 (1005)
||+++|+|..++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 81 E~~~~g~L~~~~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~---- 154 (323)
T cd05616 81 EYVNGGDLMYQIQQV--GRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWD---- 154 (323)
T ss_pred cCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCCCcEEEccCCCceecCCC----
Confidence 999999999998764 45899999999999999999999999999999999999999999999999988532110
Q ss_pred CCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHcCCCCCCCCChHHHHH
Q 001847 832 LPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFA 911 (1005)
Q Consensus 832 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlGvll~eLltG~~Pf~~~~~~~~~~ 911 (1005)
.......+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+....+.
T Consensus 155 -----------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~ 211 (323)
T cd05616 155 -----------------------GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQ 211 (323)
T ss_pred -----------------------CCccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHH
Confidence 011224579999999999999999999999999999999999999999988888888
Q ss_pred HHHhCCCCCCCCCCCCHHHHHHHHHccccCcCccCCCh-hcHHHHHcCCCCCCCChhhhhhcCC
Q 001847 912 NILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSH-EGANEIKKHPFFKGVNWALVRCMNP 974 (1005)
Q Consensus 912 ~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~-~~a~elL~hpff~~~~~~~~~~~~~ 974 (1005)
.+......++. ..+.++.+|+.+||+.+|.+|++.. +...++++||||+.++|..+.....
T Consensus 212 ~i~~~~~~~p~--~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~~~~~~~~~~~~~~~ 273 (323)
T cd05616 212 SIMEHNVAYPK--SMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWEKLERKEV 273 (323)
T ss_pred HHHhCCCCCCC--cCCHHHHHHHHHHcccCHHhcCCCCCCCHHHHhcCCCcCCCCHHHHHhCCC
Confidence 88877766654 4688999999999999999999853 3468999999999999998854443
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-40 Score=372.35 Aligned_cols=259 Identities=33% Similarity=0.559 Sum_probs=235.3
Q ss_pred cCCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCC-CCCcceEEEEEEeCCeEEE
Q 001847 671 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLD-HPFVPALYASFQTKTHVCL 749 (1005)
Q Consensus 671 ~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~il~~l~-hpnIv~l~~~~~~~~~~~l 749 (1005)
...|.+.+.||.|.||.||+|.++.+|+.+|+|.+.+...........+.+|+.+|+++. ||||+.+++.|+....+++
T Consensus 34 ~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~l 113 (382)
T KOG0032|consen 34 KEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYL 113 (382)
T ss_pred cccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEE
Confidence 468999999999999999999999999999999998876655556788999999999998 9999999999999999999
Q ss_pred EEeccCCCchhhHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecC----CcEEEEeccCCcccC
Q 001847 750 ITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGN----GHVSLTDFDLSCLTS 825 (1005)
Q Consensus 750 V~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~~~----g~vkL~DFG~a~~~~ 825 (1005)
|||++.||.|++.+... .+++..+..+++|++.++.|||+.||+||||||+|+|+... +.+|++|||++....
T Consensus 114 vmEL~~GGeLfd~i~~~---~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~~ 190 (382)
T KOG0032|consen 114 VMELCEGGELFDRIVKK---HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFIK 190 (382)
T ss_pred EEEecCCchHHHHHHHc---cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCCCceEcc
Confidence 99999999999999876 39999999999999999999999999999999999999743 479999999996543
Q ss_pred CCCCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHcCCCCCCCCC
Q 001847 826 CKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKT 905 (1005)
Q Consensus 826 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlGvll~eLltG~~Pf~~~~ 905 (1005)
. .......+||+.|+|||++....++..+||||+|+++|.|++|..||.+.+
T Consensus 191 ~----------------------------~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~ 242 (382)
T KOG0032|consen 191 P----------------------------GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGET 242 (382)
T ss_pred C----------------------------CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCC
Confidence 2 123456799999999999999999999999999999999999999999999
Q ss_pred hHHHHHHHHhCCCCCC--CCCCCCHHHHHHHHHccccCcCccCCChhcHHHHHcCCCCCCC
Q 001847 906 RQKTFANILHKDLKFP--SSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGV 964 (1005)
Q Consensus 906 ~~~~~~~i~~~~~~~~--~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~hpff~~~ 964 (1005)
.......+..+++.+. .+..++..+++||..||..||..|++ +.++|+|||++..
T Consensus 243 ~~~~~~~i~~~~~~f~~~~w~~is~~akd~i~~ll~~dp~~R~t----a~~~L~HpWi~~~ 299 (382)
T KOG0032|consen 243 EFEIFLAILRGDFDFTSEPWDDISESAKDFIRKLLEFDPRKRLT----AAQALQHPWIKSI 299 (382)
T ss_pred hhHHHHHHHcCCCCCCCCCccccCHHHHHHHHHhcccCcccCCC----HHHHhcCccccCC
Confidence 9999999998877554 45678999999999999999999999 9999999999875
|
|
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-40 Score=371.41 Aligned_cols=265 Identities=38% Similarity=0.751 Sum_probs=222.4
Q ss_pred ccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCeEEEEEeccCC
Q 001847 678 KPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPALYASFQTKTHVCLITDYCPG 756 (1005)
Q Consensus 678 ~~LG~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~~lV~E~~~g 756 (1005)
+.||+|+||.||+|.+..+++.||+|++++...........+..|..++..+ +||||++++++|...+.+|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 4689999999999999999999999999876544555566788899999988 799999999999999999999999999
Q ss_pred CchhhHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCCCCCCCcch
Q 001847 757 GELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTN 836 (1005)
Q Consensus 757 gsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~~~~~~~ 836 (1005)
++|..++... +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 81 g~L~~~~~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~---------- 148 (329)
T cd05588 81 GDLMFHMQRQ--RKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIR---------- 148 (329)
T ss_pred CCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEECcCcccccccc----------
Confidence 9999888654 4599999999999999999999999999999999999999999999999998843110
Q ss_pred hhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHcCCCCCCCC---------ChH
Q 001847 837 EKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGK---------TRQ 907 (1005)
Q Consensus 837 ~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlGvll~eLltG~~Pf~~~---------~~~ 907 (1005)
........+||+.|+|||++.+..++.++|||||||++|+|++|+.||... ...
T Consensus 149 -----------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~ 211 (329)
T cd05588 149 -----------------PGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTED 211 (329)
T ss_pred -----------------CCCccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchH
Confidence 001123457999999999999988999999999999999999999999631 112
Q ss_pred HHHHHHHhCCCCCCCCCCCCHHHHHHHHHccccCcCccCCCh--hcHHHHHcCCCCCCCChhhhhhcC
Q 001847 908 KTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSH--EGANEIKKHPFFKGVNWALVRCMN 973 (1005)
Q Consensus 908 ~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~--~~a~elL~hpff~~~~~~~~~~~~ 973 (1005)
.....+......+|. .++..+.+||.+||..||.+|++.. ..+.++++||||..++|..+...+
T Consensus 212 ~~~~~~~~~~~~~p~--~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~hp~~~~~~~~~~~~~~ 277 (329)
T cd05588 212 YLFQVILEKQIRIPR--SLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSHPFFRNIDWDLLEQKQ 277 (329)
T ss_pred HHHHHHHcCCCCCCC--CCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcCCCCCCCCHHHHHhCC
Confidence 234445555555443 4688899999999999999999843 237899999999999999886543
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-40 Score=368.85 Aligned_cols=265 Identities=41% Similarity=0.804 Sum_probs=223.7
Q ss_pred ccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCeEEEEEeccCC
Q 001847 678 KPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPALYASFQTKTHVCLITDYCPG 756 (1005)
Q Consensus 678 ~~LG~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~~lV~E~~~g 756 (1005)
+.||+|+||.||+|.+..+++.||+|+++...............|..++..+ +||||+++++++...+.+|+||||++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 4689999999999999999999999999875443444455566677777654 899999999999999999999999999
Q ss_pred CchhhHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCCCCCCCcch
Q 001847 757 GELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTN 836 (1005)
Q Consensus 757 gsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~~~~~~~ 836 (1005)
++|..++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 81 g~L~~~~~~~--~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~--------- 149 (316)
T cd05592 81 GDLMFHIQSS--GRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNG--------- 149 (316)
T ss_pred CcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCC---------
Confidence 9999998764 45899999999999999999999999999999999999999999999999998532110
Q ss_pred hhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhC
Q 001847 837 EKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANILHK 916 (1005)
Q Consensus 837 ~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlGvll~eLltG~~Pf~~~~~~~~~~~i~~~ 916 (1005)
.......+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+.+..+...
T Consensus 150 ------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~ 211 (316)
T cd05592 150 ------------------EGKASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILND 211 (316)
T ss_pred ------------------CCccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcC
Confidence 01123457999999999999888999999999999999999999999998887777777665
Q ss_pred CCCCCCCCCCCHHHHHHHHHccccCcCccCCChhcHHHHHcCCCCCCCChhhhhhcCCCC
Q 001847 917 DLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVNWALVRCMNPPE 976 (1005)
Q Consensus 917 ~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~hpff~~~~~~~~~~~~~~~ 976 (1005)
...++. .++.++.+||.+||..||.+||+. ..++++||||+.++|..+.....+.
T Consensus 212 ~~~~~~--~~~~~~~~ll~~~l~~~P~~R~~~---~~~l~~h~~~~~~~~~~~~~~~~~~ 266 (316)
T cd05592 212 RPHFPR--WISKEAKDCLSKLFERDPTKRLGV---DGDIRQHPFFRGIDWERLEKREIPP 266 (316)
T ss_pred CCCCCC--CCCHHHHHHHHHHccCCHHHcCCC---hHHHHcCcccCCCCHHHHHhCCCCC
Confidence 544443 368889999999999999999982 3588999999999999886544443
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-40 Score=367.72 Aligned_cols=261 Identities=39% Similarity=0.767 Sum_probs=221.2
Q ss_pred ccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCeEEEEEeccCC
Q 001847 678 KPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPALYASFQTKTHVCLITDYCPG 756 (1005)
Q Consensus 678 ~~LG~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~~lV~E~~~g 756 (1005)
+.||+|+||.||+|.+..++..||+|+++...............|..++..+ +||||+++++++...+++|+||||+.+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 4689999999999999999999999999865432333445666788787755 899999999999999999999999999
Q ss_pred CchhhHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCCCCCCCcch
Q 001847 757 GELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTN 836 (1005)
Q Consensus 757 gsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~~~~~~~ 836 (1005)
++|..++... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.++|+|||++......
T Consensus 81 g~L~~~i~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--------- 149 (316)
T cd05620 81 GDLMFHIQDK--GRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFG--------- 149 (316)
T ss_pred CcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEeCccCCCeecccC---------
Confidence 9999998764 45899999999999999999999999999999999999999999999999987431100
Q ss_pred hhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhC
Q 001847 837 EKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANILHK 916 (1005)
Q Consensus 837 ~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlGvll~eLltG~~Pf~~~~~~~~~~~i~~~ 916 (1005)
.......+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+.......+...
T Consensus 150 ------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~~ 211 (316)
T cd05620 150 ------------------DNRASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVD 211 (316)
T ss_pred ------------------CCceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhC
Confidence 01123457999999999999989999999999999999999999999988887777777666
Q ss_pred CCCCCCCCCCCHHHHHHHHHccccCcCccCCChhcHHHHHcCCCCCCCChhhhhhc
Q 001847 917 DLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVNWALVRCM 972 (1005)
Q Consensus 917 ~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~hpff~~~~~~~~~~~ 972 (1005)
...++. .++.++.+||.+||..||.+||+. ..++++||||+.++|..+...
T Consensus 212 ~~~~~~--~~~~~~~~li~~~l~~dP~~R~~~---~~~~~~h~~f~~~~~~~~~~~ 262 (316)
T cd05620 212 TPHYPR--WITKESKDILEKLFERDPTRRLGV---VGNIRGHPFFKTINWTALEKR 262 (316)
T ss_pred CCCCCC--CCCHHHHHHHHHHccCCHHHcCCC---hHHHHcCCCcCCCCHHHHHhC
Confidence 555544 368899999999999999999992 358999999999999977443
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=367.82 Aligned_cols=270 Identities=36% Similarity=0.690 Sum_probs=231.6
Q ss_pred CccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCC-CCCcceEEEEEEeCCeEEEEE
Q 001847 673 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLD-HPFVPALYASFQTKTHVCLIT 751 (1005)
Q Consensus 673 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~il~~l~-hpnIv~l~~~~~~~~~~~lV~ 751 (1005)
+|++.+.||+|+||.||+|.+..+++.||+|++.+...........+..|..++..+. |++|+++++++...+.+|+||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 4788899999999999999999999999999998654434445566778888888885 578889999999999999999
Q ss_pred eccCCCchhhHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCCCCC
Q 001847 752 DYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLL 831 (1005)
Q Consensus 752 E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~~ 831 (1005)
||+++++|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 81 Ey~~~g~L~~~i~~~--~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~---- 154 (323)
T cd05615 81 EYVNGGDLMYHIQQV--GKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVD---- 154 (323)
T ss_pred cCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeccccccccCCC----
Confidence 999999999998764 45999999999999999999999999999999999999999999999999988532110
Q ss_pred CCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHcCCCCCCCCChHHHHH
Q 001847 832 LPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFA 911 (1005)
Q Consensus 832 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlGvll~eLltG~~Pf~~~~~~~~~~ 911 (1005)
........||+.|+|||++.+..++.++|||||||++|+|++|..||.+........
T Consensus 155 -----------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~ 211 (323)
T cd05615 155 -----------------------GVTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQ 211 (323)
T ss_pred -----------------------CccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 011223569999999999998889999999999999999999999999988888888
Q ss_pred HHHhCCCCCCCCCCCCHHHHHHHHHccccCcCccCCCh-hcHHHHHcCCCCCCCChhhhhhcC
Q 001847 912 NILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSH-EGANEIKKHPFFKGVNWALVRCMN 973 (1005)
Q Consensus 912 ~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~-~~a~elL~hpff~~~~~~~~~~~~ 973 (1005)
.+......++. ..+..+.+|+.+||..+|.+|++.. +...++++||||+.++|..+....
T Consensus 212 ~i~~~~~~~p~--~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~f~~~~~~~~~~~~ 272 (323)
T cd05615 212 SIMEHNVSYPK--SLSKEAVSICKGLMTKHPSKRLGCGPEGERDIREHAFFRRIDWDKLENRE 272 (323)
T ss_pred HHHhCCCCCCc--cCCHHHHHHHHHHcccCHhhCCCCCCCCHHHHhcCcccCCCCHHHHhcCC
Confidence 88877766554 3678899999999999999999854 347899999999999999885543
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=366.57 Aligned_cols=261 Identities=38% Similarity=0.769 Sum_probs=221.4
Q ss_pred ccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCeEEEEEeccCC
Q 001847 678 KPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPALYASFQTKTHVCLITDYCPG 756 (1005)
Q Consensus 678 ~~LG~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~~lV~E~~~g 756 (1005)
+.||+|+||.||+|.+..+++.||+|.++...............|..++..+ +||||+++++++...+.+|+||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 4689999999999999999999999999865432233445566777787764 999999999999999999999999999
Q ss_pred CchhhHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCCCCCCCcch
Q 001847 757 GELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTN 836 (1005)
Q Consensus 757 gsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~~~~~~~ 836 (1005)
++|..++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 81 g~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~--------- 149 (316)
T cd05619 81 GDLMFHIQSC--HKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLG--------- 149 (316)
T ss_pred CcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEccCCcceECCCC---------
Confidence 9999998764 45889999999999999999999999999999999999999999999999988432100
Q ss_pred hhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhC
Q 001847 837 EKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANILHK 916 (1005)
Q Consensus 837 ~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlGvll~eLltG~~Pf~~~~~~~~~~~i~~~ 916 (1005)
........||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+.+..+...
T Consensus 150 ------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~~ 211 (316)
T cd05619 150 ------------------DAKTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMD 211 (316)
T ss_pred ------------------CCceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC
Confidence 01112457899999999999888999999999999999999999999988877777777655
Q ss_pred CCCCCCCCCCCHHHHHHHHHccccCcCccCCChhcHH-HHHcCCCCCCCChhhhhhcC
Q 001847 917 DLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGAN-EIKKHPFFKGVNWALVRCMN 973 (1005)
Q Consensus 917 ~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~-elL~hpff~~~~~~~~~~~~ 973 (1005)
...++. ..+..+.+||.+||+.||.+||+ +. ++++||||+.++|..+....
T Consensus 212 ~~~~~~--~~~~~~~~li~~~l~~~P~~R~~----~~~~l~~h~~~~~~~~~~~~~~~ 263 (316)
T cd05619 212 NPCYPR--WLTREAKDILVKLFVREPERRLG----VKGDIRQHPFFREIDWSALEERE 263 (316)
T ss_pred CCCCCc--cCCHHHHHHHHHHhccCHhhcCC----ChHHHHcCcccCCCCHHHHHhCC
Confidence 544443 36788999999999999999999 64 89999999999999885543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-42 Score=369.72 Aligned_cols=258 Identities=27% Similarity=0.433 Sum_probs=228.8
Q ss_pred CCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEE
Q 001847 672 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLIT 751 (1005)
Q Consensus 672 ~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~ 751 (1005)
..|..+..||+|+||.||++.+..+++.||+|++.... .......+.+|+.+|.+++++||.++|+.|..+..++++|
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~--~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiM 90 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEE--AEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIM 90 (467)
T ss_pred cccccchhccccccceeeeeeeccccceEEEEEechhh--cchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHH
Confidence 46888899999999999999999999999999998643 4556788899999999999999999999999999999999
Q ss_pred eccCCCchhhHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCCCCC
Q 001847 752 DYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLL 831 (1005)
Q Consensus 752 E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~~ 831 (1005)
|||.||++.++++.. ..+.+..+..++++++.||.|||..+.+|||||+.|||+..+|.+||+|||++..+..
T Consensus 91 ey~~gGsv~~lL~~~--~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~----- 163 (467)
T KOG0201|consen 91 EYCGGGSVLDLLKSG--NILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSESGDVKLADFGVAGQLTN----- 163 (467)
T ss_pred HHhcCcchhhhhccC--CCCccceeeeehHHHHHHhhhhhhcceecccccccceeEeccCcEEEEecceeeeeec-----
Confidence 999999999999763 4458899999999999999999999999999999999999999999999999854321
Q ss_pred CCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHcCCCCCCCCChHHHHH
Q 001847 832 LPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFA 911 (1005)
Q Consensus 832 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlGvll~eLltG~~Pf~~~~~~~~~~ 911 (1005)
......+++|||.|||||++....|+.++||||||++.|||++|.+||....++..+.
T Consensus 164 ----------------------~~~rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlf 221 (467)
T KOG0201|consen 164 ----------------------TVKRRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLF 221 (467)
T ss_pred ----------------------hhhccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEE
Confidence 1223367899999999999998899999999999999999999999999888866666
Q ss_pred HHHhCCCCCCCCCCCCHHHHHHHHHccccCcCccCCChhcHHHHHcCCCCCCCC
Q 001847 912 NILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVN 965 (1005)
Q Consensus 912 ~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~hpff~~~~ 965 (1005)
.|-+..++.... ..+..+++|+..||.+||+.||+ |.+||+|+|++...
T Consensus 222 lIpk~~PP~L~~-~~S~~~kEFV~~CL~k~P~~Rps----A~~LLKh~FIk~a~ 270 (467)
T KOG0201|consen 222 LIPKSAPPRLDG-DFSPPFKEFVEACLDKNPEFRPS----AKELLKHKFIKRAK 270 (467)
T ss_pred eccCCCCCcccc-ccCHHHHHHHHHHhhcCcccCcC----HHHHhhhHHHHhcC
Confidence 665655554444 67888999999999999999999 99999999999844
|
|
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=375.12 Aligned_cols=268 Identities=36% Similarity=0.660 Sum_probs=226.8
Q ss_pred ccccCCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeE
Q 001847 668 QINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHV 747 (1005)
Q Consensus 668 ~i~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 747 (1005)
.+..++|++++.||+|+||.||+|.+..+++.||+|++.+...........+.+|+.+++.++||||+++++++...+.+
T Consensus 39 ~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~ 118 (371)
T cd05622 39 RMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYL 118 (371)
T ss_pred CcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEE
Confidence 34567999999999999999999999999999999998764333344455677899999999999999999999999999
Q ss_pred EEEEeccCCCchhhHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCC
Q 001847 748 CLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCK 827 (1005)
Q Consensus 748 ~lV~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~ 827 (1005)
|+||||+++++|.+++... .+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++......
T Consensus 119 ~lv~Ey~~gg~L~~~~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~~~ 195 (371)
T cd05622 119 YMVMEYMPGGDLVNLMSNY---DVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKE 195 (371)
T ss_pred EEEEcCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECCCCCEEEEeCCceeEcCcC
Confidence 9999999999999998653 3889999999999999999999999999999999999999999999999998543211
Q ss_pred CCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCC----CCChhhHHHHHHHHHHHHcCCCCCCC
Q 001847 828 PQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAG----HTSAVDWWALGILLYEMLYGYTPFRG 903 (1005)
Q Consensus 828 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~----~~~~sDIwSlGvll~eLltG~~Pf~~ 903 (1005)
. .......+||+.|+|||++.... ++.++|||||||++|+|++|..||.+
T Consensus 196 ~--------------------------~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~ 249 (371)
T cd05622 196 G--------------------------MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYA 249 (371)
T ss_pred C--------------------------cccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCC
Confidence 0 01123457999999999987543 67899999999999999999999999
Q ss_pred CChHHHHHHHHhCC--CCCCCCCCCCHHHHHHHHHccccCcCc---cCCChhcHHHHHcCCCCCCCChhhh
Q 001847 904 KTRQKTFANILHKD--LKFPSSTPTSLHAKQLMYRLLHRDPKS---RLGSHEGANEIKKHPFFKGVNWALV 969 (1005)
Q Consensus 904 ~~~~~~~~~i~~~~--~~~~~~~~~s~~l~~Ll~~~L~~dP~~---Rpt~~~~a~elL~hpff~~~~~~~~ 969 (1005)
.+....+..+.... +.++....++..+++||.+||. +|.. |++ +.++++|+||++.+|...
T Consensus 250 ~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~-~~~~r~~r~~----~~ei~~h~~~~~~~~~~~ 315 (371)
T cd05622 250 DSLVGTYSKIMNHKNSLTFPDDNDISKEAKNLICAFLT-DREVRLGRNG----VEEIKRHLFFKNDQWAWE 315 (371)
T ss_pred CCHHHHHHHHHcCCCcccCCCcCCCCHHHHHHHHHHcC-ChhhhcCCCC----HHHHhcCcccCCCChhHH
Confidence 88888888887643 4556656689999999999998 5555 556 999999999999766533
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=359.32 Aligned_cols=267 Identities=32% Similarity=0.565 Sum_probs=221.4
Q ss_pred ccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEEeccCCCch
Q 001847 680 LGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGEL 759 (1005)
Q Consensus 680 LG~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~ggsL 759 (1005)
||+|+||.||++.+..+|+.||+|.+................|+++++.++||||+++++++.....+|+||||+.|++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 69999999999999999999999998764333333344556799999999999999999999999999999999999999
Q ss_pred hhHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCCCCCCCcchhhh
Q 001847 760 FLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKK 839 (1005)
Q Consensus 760 ~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~ 839 (1005)
.+++.......++...+..++.||+.||.|||+.||+||||||+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~----------- 149 (277)
T cd05607 81 KYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK----------- 149 (277)
T ss_pred HHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCc-----------
Confidence 988866555568999999999999999999999999999999999999999999999999885432110
Q ss_pred hcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCh----HHHHHHHHh
Q 001847 840 RRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTR----QKTFANILH 915 (1005)
Q Consensus 840 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlGvll~eLltG~~Pf~~~~~----~~~~~~i~~ 915 (1005)
......|++.|+|||++.+..++.++|||||||++|+|++|+.||..... .........
T Consensus 150 -----------------~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~ 212 (277)
T cd05607 150 -----------------TITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLE 212 (277)
T ss_pred -----------------eeeccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhc
Confidence 01123689999999999888899999999999999999999999976432 222333333
Q ss_pred CCCCCCCCCCCCHHHHHHHHHccccCcCccCCChhcHHHHHcCCCCCCCChhhhhhcCCC
Q 001847 916 KDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVNWALVRCMNPP 975 (1005)
Q Consensus 916 ~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~hpff~~~~~~~~~~~~~~ 975 (1005)
..+... ...++.++.+||.+||+.||++||++.+.+.+++.||||+.++|..++....|
T Consensus 213 ~~~~~~-~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~~~h~~f~~~~~~~~~~~~~~ 271 (277)
T cd05607 213 DEVKFE-HQNFTEESKDICRLFLAKKPEDRLGSREKNDDPRKHEFFKTINFPRLEAGLIP 271 (277)
T ss_pred cccccc-cccCCHHHHHHHHHHhccCHhhCCCCccchhhhhcChhhcCCCHHHHhcCcCC
Confidence 333322 23468899999999999999999998777799999999999999988765444
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-40 Score=369.55 Aligned_cols=264 Identities=42% Similarity=0.740 Sum_probs=225.9
Q ss_pred ccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHH-HHHhCCCCCcceEEEEEEeCCeEEEEEeccCC
Q 001847 678 KPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAERE-ILDMLDHPFVPALYASFQTKTHVCLITDYCPG 756 (1005)
Q Consensus 678 ~~LG~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~-il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~g 756 (1005)
+.||+|+||.||+|.+..+|+.||+|++.+...........+..|.. +++.++||||+++++++...+..|+||||+.+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 46899999999999999999999999997654333344455555654 56778999999999999999999999999999
Q ss_pred CchhhHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCCCCCCCcch
Q 001847 757 GELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTN 836 (1005)
Q Consensus 757 gsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~~~~~~~ 836 (1005)
++|..++... ..+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++......
T Consensus 81 ~~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~--------- 149 (325)
T cd05604 81 GELFFHLQRE--RSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQ--------- 149 (325)
T ss_pred CCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEeecCCcccCCCC---------
Confidence 9999888754 45899999999999999999999999999999999999999999999999987432100
Q ss_pred hhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhC
Q 001847 837 EKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANILHK 916 (1005)
Q Consensus 837 ~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlGvll~eLltG~~Pf~~~~~~~~~~~i~~~ 916 (1005)
.......+|++.|+|||++.+..++.++|||||||++|+|++|..||...+..+.+..+...
T Consensus 150 ------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~~ 211 (325)
T cd05604 150 ------------------SDTTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHK 211 (325)
T ss_pred ------------------CCCcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHHHHHHHHcC
Confidence 01123457999999999999988999999999999999999999999998888888888776
Q ss_pred CCCCCCCCCCCHHHHHHHHHccccCcCccCCChhcHHHHHcCCCCCCCChhhhhhc
Q 001847 917 DLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVNWALVRCM 972 (1005)
Q Consensus 917 ~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~hpff~~~~~~~~~~~ 972 (1005)
....+. ..+..+.++|.+||..+|.+||+..+.+.++++||||+.++|..+...
T Consensus 212 ~~~~~~--~~~~~~~~ll~~ll~~~p~~R~~~~~~~~~i~~h~~f~~~~~~~~~~~ 265 (325)
T cd05604 212 PLVLRP--GASLTAWSILEELLEKDRQRRLGAKEDFLEIQEHPFFESLSWTDLEQK 265 (325)
T ss_pred CccCCC--CCCHHHHHHHHHHhccCHHhcCCCCCCHHHHhcCCCcCCCCHHHHHhC
Confidence 554433 468889999999999999999998888899999999999999887543
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=366.84 Aligned_cols=263 Identities=40% Similarity=0.766 Sum_probs=225.4
Q ss_pred ccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCeEEEEEeccCC
Q 001847 678 KPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPALYASFQTKTHVCLITDYCPG 756 (1005)
Q Consensus 678 ~~LG~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~~lV~E~~~g 756 (1005)
+.||+|+||.||+|.+..+++.||+|++++...........+..|+.++..+ +||||+++++++...+.+|+||||+.+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 4689999999999999999999999999876444445566777899999888 799999999999999999999999999
Q ss_pred CchhhHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCCCCCCCcch
Q 001847 757 GELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTN 836 (1005)
Q Consensus 757 gsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~~~~~~~ 836 (1005)
++|..++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 81 ~~L~~~~~~~--~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~--------- 149 (318)
T cd05570 81 GDLMFHIQRS--GRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILG--------- 149 (318)
T ss_pred CCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCCCcEEecccCCCeecCcC---------
Confidence 9999988764 45999999999999999999999999999999999999999999999999987431100
Q ss_pred hhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhC
Q 001847 837 EKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANILHK 916 (1005)
Q Consensus 837 ~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlGvll~eLltG~~Pf~~~~~~~~~~~i~~~ 916 (1005)
.......+|++.|+|||++.+..++.++|||||||++|+|++|+.||.+.+.......+...
T Consensus 150 ------------------~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~~~ 211 (318)
T cd05570 150 ------------------GVTTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILED 211 (318)
T ss_pred ------------------CCcccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHHcC
Confidence 01122356899999999999999999999999999999999999999988887777777776
Q ss_pred CCCCCCCCCCCHHHHHHHHHccccCcCccCCCh-hcHHHHHcCCCCCCCChhhhhh
Q 001847 917 DLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSH-EGANEIKKHPFFKGVNWALVRC 971 (1005)
Q Consensus 917 ~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~-~~a~elL~hpff~~~~~~~~~~ 971 (1005)
...++. .++..+.+||.+||..||.+||+.. ..+.++++||||+.++|.....
T Consensus 212 ~~~~~~--~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~~~~~~~~~~~~~~ 265 (318)
T cd05570 212 EVRYPR--WLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGHPFFREIDWDKLER 265 (318)
T ss_pred CCCCCC--cCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcCCCcCCCCHHHHHh
Confidence 665543 3688999999999999999999921 1129999999999999987643
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=365.99 Aligned_cols=259 Identities=28% Similarity=0.438 Sum_probs=219.9
Q ss_pred cccccCCccccccccccCcEEEEEEEEcCCCeE-EEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC
Q 001847 667 EQINLQHFRPIKPLGSGDTGSVHLVELCGSGQY-FAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKT 745 (1005)
Q Consensus 667 ~~i~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~-valK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~ 745 (1005)
+.++.....+.+.||.|+||+||++.+ .|.. +|+|++......... ...+.+|+.+|.+++|||||++++++....
T Consensus 36 ~~i~~~~l~~~~~iG~G~~g~V~~~~~--~g~~~vavK~~~~~~~~~~~-~~~f~~E~~il~~l~HpNIV~f~G~~~~~~ 112 (362)
T KOG0192|consen 36 EEIDPDELPIEEVLGSGSFGTVYKGKW--RGTDVVAVKIISDPDFDDES-RKAFRREASLLSRLRHPNIVQFYGACTSPP 112 (362)
T ss_pred eecChHHhhhhhhcccCCceeEEEEEe--CCceeEEEEEecchhcChHH-HHHHHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence 445666777788899999999999999 4445 999999876444433 779999999999999999999999999887
Q ss_pred -eEEEEEeccCCCchhhHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcC-cccCCCCCCcEEEecCC-cEEEEeccCCc
Q 001847 746 -HVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQG-IIYRDLKPENVLLQGNG-HVSLTDFDLSC 822 (1005)
Q Consensus 746 -~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~g-IvHrDLkP~NILi~~~g-~vkL~DFG~a~ 822 (1005)
..+|||||+++|+|.+++.......++...+..|+.||+.||.|||+++ ||||||||+|||++.++ ++||+|||+++
T Consensus 113 ~~~~iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr 192 (362)
T KOG0192|consen 113 GSLCIVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKGKTLKIADFGLSR 192 (362)
T ss_pred CceEEEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCCCEEEECCCccce
Confidence 7999999999999999998744567999999999999999999999999 99999999999999998 99999999996
Q ss_pred ccCCCCCCCCCcchhhhhcccCCCCCcccccccccccccccCCccccccccc--CCCCCChhhHHHHHHHHHHHHcCCCC
Q 001847 823 LTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIA--GAGHTSAVDWWALGILLYEMLYGYTP 900 (1005)
Q Consensus 823 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~--~~~~~~~sDIwSlGvll~eLltG~~P 900 (1005)
...... .......||+.|||||++. ...++.++||||||+++|||+||+.|
T Consensus 193 ~~~~~~---------------------------~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~P 245 (362)
T KOG0192|consen 193 EKVISK---------------------------TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIP 245 (362)
T ss_pred eecccc---------------------------ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCC
Confidence 543110 1223368999999999999 56899999999999999999999999
Q ss_pred CCCCChHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHccccCcCccCCChhcHHHH
Q 001847 901 FRGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEI 955 (1005)
Q Consensus 901 f~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~el 955 (1005)
|.+.........+.......+....++..+..|+..||..||..||++.+.+..+
T Consensus 246 f~~~~~~~~~~~v~~~~~Rp~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l 300 (362)
T KOG0192|consen 246 FEDLAPVQVASAVVVGGLRPPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRL 300 (362)
T ss_pred CCCCCHHHHHHHHHhcCCCCCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHH
Confidence 9999887777777655544444444788999999999999999999987654433
|
|
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=366.50 Aligned_cols=263 Identities=45% Similarity=0.802 Sum_probs=223.3
Q ss_pred cccccccCcEEEEEEEEc---CCCeEEEEEEeeccccc-ChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEEe
Q 001847 677 IKPLGSGDTGSVHLVELC---GSGQYFAMKAMDKGVML-NRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITD 752 (1005)
Q Consensus 677 ~~~LG~G~~g~Vy~a~~~---~~~~~valK~~~~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E 752 (1005)
++.||+|+||.||+|.+. .+++.||+|++...... .......+.+|+.+++.++||||++++++|..++.+|+|||
T Consensus 1 ~~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e 80 (323)
T cd05584 1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILE 80 (323)
T ss_pred CceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEe
Confidence 367999999999999874 46889999999764321 22334566789999999999999999999999999999999
Q ss_pred ccCCCchhhHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCCCCCC
Q 001847 753 YCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLL 832 (1005)
Q Consensus 753 ~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~~~ 832 (1005)
|+.+++|.+++... +.+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||++......
T Consensus 81 ~~~~~~L~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~----- 153 (323)
T cd05584 81 YLSGGELFMHLERE--GIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHE----- 153 (323)
T ss_pred CCCCchHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEeeCcCCeecccC-----
Confidence 99999999998764 45889999999999999999999999999999999999999999999999987432110
Q ss_pred CcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHcCCCCCCCCChHHHHHH
Q 001847 833 PTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFAN 912 (1005)
Q Consensus 833 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlGvll~eLltG~~Pf~~~~~~~~~~~ 912 (1005)
........|++.|+|||++.+..++.++|||||||++|+|++|+.||.+.+....+..
T Consensus 154 ----------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~ 211 (323)
T cd05584 154 ----------------------GTVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDK 211 (323)
T ss_pred ----------------------CCcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHH
Confidence 0112235799999999999888889999999999999999999999999888888888
Q ss_pred HHhCCCCCCCCCCCCHHHHHHHHHccccCcCccCCCh-hcHHHHHcCCCCCCCChhhhh
Q 001847 913 ILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSH-EGANEIKKHPFFKGVNWALVR 970 (1005)
Q Consensus 913 i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~-~~a~elL~hpff~~~~~~~~~ 970 (1005)
+..+...++. .++..+.+||.+||..+|++||+.. ..+.++++||||+..+|..+.
T Consensus 212 ~~~~~~~~~~--~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h~~~~~~~~~~~~ 268 (323)
T cd05584 212 ILKGKLNLPP--YLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSHPFFRHVNWDDLL 268 (323)
T ss_pred HHcCCCCCCC--CCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcCCCcCCCCHHHHh
Confidence 8877665554 3678899999999999999999322 229999999999999998774
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=359.81 Aligned_cols=275 Identities=33% Similarity=0.571 Sum_probs=225.4
Q ss_pred CccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEEe
Q 001847 673 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITD 752 (1005)
Q Consensus 673 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E 752 (1005)
.|++.+.||+|+||.||++.+..+++.||+|.+.............+.+|+.+++.++||||+.+++++...+.+|+|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 48899999999999999999998999999999876543333344566789999999999999999999999999999999
Q ss_pred ccCCCchhhHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCCCCCC
Q 001847 753 YCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLL 832 (1005)
Q Consensus 753 ~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~~~ 832 (1005)
|+.+++|.+++.......+++..+..++.|++.||.|||++||+|+||||+||++++++.++|+|||++.......
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~---- 156 (285)
T cd05605 81 LMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE---- 156 (285)
T ss_pred ccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCCCCEEEeeCCCceecCCCC----
Confidence 9999999988865544569999999999999999999999999999999999999999999999999885432110
Q ss_pred CcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHcCCCCCCCCChHHHHHH
Q 001847 833 PTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFAN 912 (1005)
Q Consensus 833 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlGvll~eLltG~~Pf~~~~~~~~~~~ 912 (1005)
......|++.|+|||++.+..++.++|||||||++|+|++|..||.+.........
T Consensus 157 ------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~ 212 (285)
T cd05605 157 ------------------------TIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREE 212 (285)
T ss_pred ------------------------ccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHH
Confidence 01234689999999999888889999999999999999999999987655433222
Q ss_pred HHhC--CCCCCCCCCCCHHHHHHHHHccccCcCccCCCh-hcHHHHHcCCCCCCCChhhhhhcCCC
Q 001847 913 ILHK--DLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSH-EGANEIKKHPFFKGVNWALVRCMNPP 975 (1005)
Q Consensus 913 i~~~--~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~-~~a~elL~hpff~~~~~~~~~~~~~~ 975 (1005)
+... .........++..+.+||.+||..||.+||+.. +.+.++++||||...+|..+.....+
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 278 (285)
T cd05605 213 VERRVKEDQEEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAHPFFRTANFKRLEAGMLE 278 (285)
T ss_pred HHHHhhhcccccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcCcCccCCCHHHHhhCCCC
Confidence 2211 111112234688899999999999999999322 12899999999999999988554443
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=367.01 Aligned_cols=274 Identities=37% Similarity=0.690 Sum_probs=226.1
Q ss_pred ccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCeEEEEEeccCC
Q 001847 678 KPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPALYASFQTKTHVCLITDYCPG 756 (1005)
Q Consensus 678 ~~LG~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~~lV~E~~~g 756 (1005)
+.||+|+||.||+|.+..+++.||+|++++...........+.+|+.++.++ +||+|+.+++++...+.+|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 4689999999999999999999999999876544455567788899999888 699999999999999999999999999
Q ss_pred CchhhHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCCCCCCCcch
Q 001847 757 GELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTN 836 (1005)
Q Consensus 757 gsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~~~~~~~ 836 (1005)
++|..++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++......
T Consensus 81 ~~L~~~~~~~--~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~--------- 149 (327)
T cd05617 81 GDLMFHMQRQ--RKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGP--------- 149 (327)
T ss_pred CcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCCCCEEEeccccceeccCC---------
Confidence 9999988764 45999999999999999999999999999999999999999999999999988432100
Q ss_pred hhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHcCCCCCCCC-------ChHHH
Q 001847 837 EKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGK-------TRQKT 909 (1005)
Q Consensus 837 ~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlGvll~eLltG~~Pf~~~-------~~~~~ 909 (1005)
.......+||+.|+|||++.+..++.++|||||||++|+|++|..||... .....
T Consensus 150 ------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~ 211 (327)
T cd05617 150 ------------------GDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYL 211 (327)
T ss_pred ------------------CCceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHH
Confidence 01123457999999999999989999999999999999999999999532 12233
Q ss_pred HHHHHhCCCCCCCCCCCCHHHHHHHHHccccCcCccCCCh--hcHHHHHcCCCCCCCChhhhhhcCCCCCCCCCC
Q 001847 910 FANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSH--EGANEIKKHPFFKGVNWALVRCMNPPELDAPLF 982 (1005)
Q Consensus 910 ~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~--~~a~elL~hpff~~~~~~~~~~~~~~~~~~p~~ 982 (1005)
...+......++. ..+..+.++|.+||..||.+|++.. ..+.++++||||+.++|..+.....+....|..
T Consensus 212 ~~~~~~~~~~~p~--~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h~~f~~~~~~~~~~~~~~~~~~~~~ 284 (327)
T cd05617 212 FQVILEKPIRIPR--FLSVKASHVLKGFLNKDPKERLGCQPQTGFSDIKSHTFFRSIDWDLLEKKQVTPPFKPQI 284 (327)
T ss_pred HHHHHhCCCCCCC--CCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHHcCCCCCCCCHHHHHhCCCCCCccCCC
Confidence 3444444444443 4678899999999999999999843 236799999999999999986655444334443
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=367.94 Aligned_cols=264 Identities=38% Similarity=0.741 Sum_probs=220.8
Q ss_pred ccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCeEEEEEeccCC
Q 001847 678 KPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPALYASFQTKTHVCLITDYCPG 756 (1005)
Q Consensus 678 ~~LG~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~~lV~E~~~g 756 (1005)
+.||+|+||.||+|.+..+++.||+|++.+...........+..|+.++.++ +||||+++++++...+.+|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 4689999999999999999999999999876555555666778899888877 899999999999999999999999999
Q ss_pred CchhhHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCCCCCCCcch
Q 001847 757 GELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTN 836 (1005)
Q Consensus 757 gsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~~~~~~~ 836 (1005)
++|..++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 81 ~~L~~~~~~~--~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~--------- 149 (329)
T cd05618 81 GDLMFHMQRQ--RKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP--------- 149 (329)
T ss_pred CCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCCEEEeeCCccccccCC---------
Confidence 9999888664 45999999999999999999999999999999999999999999999999988432100
Q ss_pred hhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHcCCCCCCC---------CChH
Q 001847 837 EKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRG---------KTRQ 907 (1005)
Q Consensus 837 ~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlGvll~eLltG~~Pf~~---------~~~~ 907 (1005)
.......+||+.|+|||++.+..++.++|||||||++|+|++|..||.. ....
T Consensus 150 ------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~ 211 (329)
T cd05618 150 ------------------GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTED 211 (329)
T ss_pred ------------------CCccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHH
Confidence 0112345799999999999998899999999999999999999999952 1112
Q ss_pred HHHHHHHhCCCCCCCCCCCCHHHHHHHHHccccCcCccCCCh--hcHHHHHcCCCCCCCChhhhhhc
Q 001847 908 KTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSH--EGANEIKKHPFFKGVNWALVRCM 972 (1005)
Q Consensus 908 ~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~--~~a~elL~hpff~~~~~~~~~~~ 972 (1005)
.....+......+|. ..+..+.+||.+||..||.+||+.. ..+.++++||||+.++|..+...
T Consensus 212 ~~~~~i~~~~~~~p~--~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~hp~f~~~~~~~~~~~ 276 (329)
T cd05618 212 YLFQVILEKQIRIPR--SLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWDLMEQK 276 (329)
T ss_pred HHHHHHhcCCCCCCC--CCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcCCCCCCCCHHHHHcC
Confidence 234445555555543 4678899999999999999999843 23689999999999999877543
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=358.44 Aligned_cols=267 Identities=33% Similarity=0.598 Sum_probs=219.3
Q ss_pred ccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEEeccCCCch
Q 001847 680 LGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGEL 759 (1005)
Q Consensus 680 LG~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~ggsL 759 (1005)
||+|+||+||++.+..+++.||+|.+.............+..|+.+++.++|+||++++++|...+.+|+||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 69999999999999999999999998765443444456677899999999999999999999999999999999999999
Q ss_pred hhHHhh--CCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCCCCCCCcchh
Q 001847 760 FLLLDR--QPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNE 837 (1005)
Q Consensus 760 ~~~l~~--~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~ 837 (1005)
..++.. .....+++..+..++.||+.||.|||++||+||||||+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~--------- 151 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQ--------- 151 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCccceecCCCC---------
Confidence 887743 223468999999999999999999999999999999999999999999999999885432110
Q ss_pred hhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHcCCCCCCCCChH----HHHHHH
Q 001847 838 KKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQ----KTFANI 913 (1005)
Q Consensus 838 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlGvll~eLltG~~Pf~~~~~~----~~~~~i 913 (1005)
.......|++.|+|||++.+..++.++|||||||++|+|++|+.||...... .....+
T Consensus 152 ------------------~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~ 213 (280)
T cd05608 152 ------------------SKTKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRI 213 (280)
T ss_pred ------------------ccccccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhh
Confidence 0112346899999999999999999999999999999999999999765432 222233
Q ss_pred HhCCCCCCCCCCCCHHHHHHHHHccccCcCccCCChh-cHHHHHcCCCCCCCChhhhhhcCCC
Q 001847 914 LHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHE-GANEIKKHPFFKGVNWALVRCMNPP 975 (1005)
Q Consensus 914 ~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~-~a~elL~hpff~~~~~~~~~~~~~~ 975 (1005)
......++ ..++..+.+|+.+||+.||++||++.+ .++++++||||+.++|..+.....|
T Consensus 214 ~~~~~~~~--~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h~~~~~~~~~~~~~~~~~ 274 (280)
T cd05608 214 LNDSVTYP--DKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTHPLFRDLNWRQLEAGMLP 274 (280)
T ss_pred cccCCCCc--ccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcChhhhcCCHhHHhhccCC
Confidence 33322222 347889999999999999999996543 4999999999999999987543333
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=367.02 Aligned_cols=263 Identities=40% Similarity=0.711 Sum_probs=223.7
Q ss_pred ccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHH-HHHHhCCCCCcceEEEEEEeCCeEEEEEeccCC
Q 001847 678 KPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAER-EILDMLDHPFVPALYASFQTKTHVCLITDYCPG 756 (1005)
Q Consensus 678 ~~LG~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~-~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~g 756 (1005)
+.||+|+||.||+|.+..+++.||+|++.+...........+..|. .+++.++||||+++++++...+.+|+||||+.+
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 4689999999999999999999999999764332223333444444 456788999999999999999999999999999
Q ss_pred CchhhHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCCCCCCCcch
Q 001847 757 GELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTN 836 (1005)
Q Consensus 757 gsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~~~~~~~ 836 (1005)
++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 81 ~~L~~~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~--------- 149 (325)
T cd05602 81 GELFYHLQRE--RCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEH--------- 149 (325)
T ss_pred CcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEEccCCCCcccccC---------
Confidence 9999998764 45889999999999999999999999999999999999999999999999998432110
Q ss_pred hhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhC
Q 001847 837 EKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANILHK 916 (1005)
Q Consensus 837 ~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlGvll~eLltG~~Pf~~~~~~~~~~~i~~~ 916 (1005)
.......+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+.+..+...
T Consensus 150 ------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~ 211 (325)
T cd05602 150 ------------------NGTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNK 211 (325)
T ss_pred ------------------CCCcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHhC
Confidence 01123457999999999999988999999999999999999999999988888887777766
Q ss_pred CCCCCCCCCCCHHHHHHHHHccccCcCccCCChhcHHHHHcCCCCCCCChhhhhh
Q 001847 917 DLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVNWALVRC 971 (1005)
Q Consensus 917 ~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~hpff~~~~~~~~~~ 971 (1005)
...++ ..++..+.+||.+||+.+|.+|++..+.+.++++|+||..++|..+..
T Consensus 212 ~~~~~--~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~i~~~~~~~~~~~~~~~~ 264 (325)
T cd05602 212 PLQLK--PNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKNHIFFSPINWDDLIN 264 (325)
T ss_pred CcCCC--CCCCHHHHHHHHHHcccCHHHCCCCCCCHHHHhcCcccCCCCHHHHHh
Confidence 55443 347889999999999999999999888889999999999999998743
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-40 Score=370.99 Aligned_cols=263 Identities=41% Similarity=0.744 Sum_probs=223.7
Q ss_pred ccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhC---CCCCcceEEEEEEeCCeEEEEEeccCC
Q 001847 680 LGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDML---DHPFVPALYASFQTKTHVCLITDYCPG 756 (1005)
Q Consensus 680 LG~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~il~~l---~hpnIv~l~~~~~~~~~~~lV~E~~~g 756 (1005)
||+|+||.||+|.+..+++.||+|++.+..............|..++..+ +||||+.++++|...+.+|+||||+.+
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 69999999999999999999999999765433334445556677777665 699999999999999999999999999
Q ss_pred CchhhHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCCCCCCCcch
Q 001847 757 GELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTN 836 (1005)
Q Consensus 757 gsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~~~~~~~ 836 (1005)
++|..++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.++|+|||++......
T Consensus 81 g~L~~~l~~~--~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~--------- 149 (330)
T cd05586 81 GELFWHLQKE--GRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLTD--------- 149 (330)
T ss_pred ChHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCC---------
Confidence 9999988764 45899999999999999999999999999999999999999999999999988432110
Q ss_pred hhhhcccCCCCCcccccccccccccccCCcccccccccCC-CCCChhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHh
Q 001847 837 EKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGA-GHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANILH 915 (1005)
Q Consensus 837 ~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~sDIwSlGvll~eLltG~~Pf~~~~~~~~~~~i~~ 915 (1005)
.......+||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+..+.+..+..
T Consensus 150 ------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~ 211 (330)
T cd05586 150 ------------------NKTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAF 211 (330)
T ss_pred ------------------CCCccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHc
Confidence 0112345799999999998764 478899999999999999999999999888888888877
Q ss_pred CCCCCCCCCCCCHHHHHHHHHccccCcCccCCChhcHHHHHcCCCCCCCChhhhhhc
Q 001847 916 KDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVNWALVRCM 972 (1005)
Q Consensus 916 ~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~hpff~~~~~~~~~~~ 972 (1005)
+...++.. .++..+.+||.+||..||.+||+..+.+.++++||||+..+|..+...
T Consensus 212 ~~~~~~~~-~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~h~~~~~~~~~~~~~~ 267 (330)
T cd05586 212 GKVRFPKN-VLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKEHPFFADIDWDLLSKK 267 (330)
T ss_pred CCCCCCCc-cCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhcCccccCCCHHHHHhC
Confidence 76666543 367889999999999999999987777999999999999999987543
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-39 Score=365.91 Aligned_cols=273 Identities=38% Similarity=0.678 Sum_probs=227.4
Q ss_pred CCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEE
Q 001847 672 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLIT 751 (1005)
Q Consensus 672 ~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~ 751 (1005)
++|++++.||+|+||.||++.+..+++.||+|++.+...........+.+|+.++..++|+||+.++++|...+.+|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 47999999999999999999999999999999997644434445566788999999999999999999999999999999
Q ss_pred eccCCCchhhHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCCCCC
Q 001847 752 DYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLL 831 (1005)
Q Consensus 752 E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~~ 831 (1005)
||+.+++|.+++... ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++........
T Consensus 81 e~~~g~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-- 157 (331)
T cd05597 81 DYYVGGDLLTLLSKF-EDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGT-- 157 (331)
T ss_pred ecCCCCcHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECCCCCEEEEECCceeecCCCCC--
Confidence 999999999999753 24589999999999999999999999999999999999999999999999998854321100
Q ss_pred CCcchhhhhcccCCCCCcccccccccccccccCCcccccccccC-----CCCCChhhHHHHHHHHHHHHcCCCCCCCCCh
Q 001847 832 LPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAG-----AGHTSAVDWWALGILLYEMLYGYTPFRGKTR 906 (1005)
Q Consensus 832 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-----~~~~~~sDIwSlGvll~eLltG~~Pf~~~~~ 906 (1005)
.......||+.|+|||++.. ..++.++|||||||++|+|++|+.||.+...
T Consensus 158 ------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~ 213 (331)
T cd05597 158 ------------------------VQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESL 213 (331)
T ss_pred ------------------------ccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCH
Confidence 01122469999999999863 3467799999999999999999999998887
Q ss_pred HHHHHHHHhCC--CCCCCC-CCCCHHHHHHHHHccccCcCc--cCCChhcHHHHHcCCCCCCCChhhhhhcCCC
Q 001847 907 QKTFANILHKD--LKFPSS-TPTSLHAKQLMYRLLHRDPKS--RLGSHEGANEIKKHPFFKGVNWALVRCMNPP 975 (1005)
Q Consensus 907 ~~~~~~i~~~~--~~~~~~-~~~s~~l~~Ll~~~L~~dP~~--Rpt~~~~a~elL~hpff~~~~~~~~~~~~~~ 975 (1005)
.+.+..+.... ..++.. ..++..+.+||.+||+.++.. |++ +.++++||||+.++|..+....+|
T Consensus 214 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~ll~~~~~r~~r~~----~~~~l~hp~~~~~~~~~~~~~~~~ 283 (331)
T cd05597 214 VETYGKIMNHKEHFQFPPDVTDVSEEAKDLIRRLICSPETRLGRNG----LQDFKDHPFFEGIDWDNIRNSTAP 283 (331)
T ss_pred HHHHHHHHcCCCcccCCCccCCCCHHHHHHHHHHccCcccccCCCC----HHHHhcCCCCCCCCHHHHhhCCCC
Confidence 77777776543 222222 346889999999999764433 667 999999999999999998776665
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=365.37 Aligned_cols=262 Identities=43% Similarity=0.760 Sum_probs=223.5
Q ss_pred ccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHH-HHHhCCCCCcceEEEEEEeCCeEEEEEeccCC
Q 001847 678 KPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAERE-ILDMLDHPFVPALYASFQTKTHVCLITDYCPG 756 (1005)
Q Consensus 678 ~~LG~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~-il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~g 756 (1005)
+.||+|+||.||+|.+..+++.||+|++.+...........+..|.. +++.++||||+++++++...+.+|+||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46899999999999999999999999997654333333445555554 67889999999999999999999999999999
Q ss_pred CchhhHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCCCCCCCcch
Q 001847 757 GELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTN 836 (1005)
Q Consensus 757 gsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~~~~~~~ 836 (1005)
++|...+... ..+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++......
T Consensus 81 ~~L~~~l~~~--~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~--------- 149 (321)
T cd05603 81 GELFFHLQRE--RCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEP--------- 149 (321)
T ss_pred CCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEccCCCCccCCCC---------
Confidence 9999888654 45899999999999999999999999999999999999999999999999987432100
Q ss_pred hhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhC
Q 001847 837 EKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANILHK 916 (1005)
Q Consensus 837 ~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlGvll~eLltG~~Pf~~~~~~~~~~~i~~~ 916 (1005)
.......+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+....+..+...
T Consensus 150 ------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~ 211 (321)
T cd05603 150 ------------------EETTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHK 211 (321)
T ss_pred ------------------CCccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHhcC
Confidence 01123457999999999998888999999999999999999999999998887777777776
Q ss_pred CCCCCCCCCCCHHHHHHHHHccccCcCccCCChhcHHHHHcCCCCCCCChhhhh
Q 001847 917 DLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVNWALVR 970 (1005)
Q Consensus 917 ~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~hpff~~~~~~~~~ 970 (1005)
...++. ..+..+.++|.+||+.+|.+|++....+.++++|+||..++|..+.
T Consensus 212 ~~~~~~--~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (321)
T cd05603 212 PLQLPG--GKTVAACDLLVGLLHKDQRRRLGAKADFLEIKNHVFFSPINWDDLY 263 (321)
T ss_pred CCCCCC--CCCHHHHHHHHHHccCCHhhcCCCCCCHHHHhCCCCcCCCCHHHHh
Confidence 655543 4678899999999999999999977778899999999999999774
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-40 Score=373.60 Aligned_cols=254 Identities=29% Similarity=0.495 Sum_probs=220.4
Q ss_pred CccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCC-C-----CCcceEEEEEEeCCe
Q 001847 673 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLD-H-----PFVPALYASFQTKTH 746 (1005)
Q Consensus 673 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~il~~l~-h-----pnIv~l~~~~~~~~~ 746 (1005)
+|.+++.||+|+||+|-+|.+.+|++.||||+++.. +....+...|+.+|..|+ | -|||+++++|...++
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~----k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~H 262 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNK----KRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNH 262 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccC----hHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccc
Confidence 899999999999999999999999999999999854 556677788999999996 4 389999999999999
Q ss_pred EEEEEeccCCCchhhHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecC--CcEEEEeccCCccc
Q 001847 747 VCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGN--GHVSLTDFDLSCLT 824 (1005)
Q Consensus 747 ~~lV~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~~~--g~vkL~DFG~a~~~ 824 (1005)
+|||+|.+ ..+|+++++.+....++...++.++.||+.||.+||+.||||+||||+|||+.+- ..|||+|||.|+..
T Consensus 263 lciVfELL-~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~ 341 (586)
T KOG0667|consen 263 LCIVFELL-STNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKRSRIKVIDFGSSCFE 341 (586)
T ss_pred eeeeehhh-hhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCcCceeEEeccccccc
Confidence 99999999 8999999998888889999999999999999999999999999999999999854 37999999999764
Q ss_pred CCCCCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHcCCCCCCCC
Q 001847 825 SCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGK 904 (1005)
Q Consensus 825 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlGvll~eLltG~~Pf~~~ 904 (1005)
.. ...+++.+..|+|||++.+.+|+.+.||||||||++||++|.+.|.|.
T Consensus 342 ~q------------------------------~vytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ 391 (586)
T KOG0667|consen 342 SQ------------------------------RVYTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGD 391 (586)
T ss_pred CC------------------------------cceeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCC
Confidence 31 112567899999999999999999999999999999999999999999
Q ss_pred ChHHHHHHHHhC--------------------C--------------------------------CCCC-CC-------C
Q 001847 905 TRQKTFANILHK--------------------D--------------------------------LKFP-SS-------T 924 (1005)
Q Consensus 905 ~~~~~~~~i~~~--------------------~--------------------------------~~~~-~~-------~ 924 (1005)
+..+++..|+.- . ...| .. .
T Consensus 392 ne~DQl~~I~e~lG~Pp~~mL~~~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~ 471 (586)
T KOG0667|consen 392 NEYDQLARIIEVLGLPPPKMLDTAKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLP 471 (586)
T ss_pred CHHHHHHHHHHHhCCCCHHHHHhccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcc
Confidence 988888877540 0 0001 00 0
Q ss_pred -CCCHHHHHHHHHccccCcCccCCChhcHHHHHcCCCCCCCC
Q 001847 925 -PTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVN 965 (1005)
Q Consensus 925 -~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~hpff~~~~ 965 (1005)
.....+.+||.+||.+||.+|+| ..++|+||||+...
T Consensus 472 ~~~~~~F~dflk~~L~~dP~~R~t----p~qal~Hpfl~~~~ 509 (586)
T KOG0667|consen 472 KADDKLFIDFLKRCLEWDPAERIT----PAQALNHPFLTGTS 509 (586)
T ss_pred cccHHHHHHHHHHHhccCchhcCC----HHHHhcCccccccc
Confidence 12235789999999999999999 99999999999643
|
|
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=347.53 Aligned_cols=262 Identities=27% Similarity=0.454 Sum_probs=221.9
Q ss_pred cCCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCC-cceEEEEEEeCC----
Q 001847 671 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPF-VPALYASFQTKT---- 745 (1005)
Q Consensus 671 ~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~il~~l~hpn-Iv~l~~~~~~~~---- 745 (1005)
...|..+++||+|+||+||+|.++.+|+.||+|.++..... ........+|+.+++.|+|+| |+.+++++...+
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~-EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~ 88 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEE-EGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRG 88 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccc-cCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccc
Confidence 45789999999999999999999999999999999865321 223445678999999999999 999999998877
Q ss_pred --eEEEEEeccCCCchhhHHhhCCC--CCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCC
Q 001847 746 --HVCLITDYCPGGELFLLLDRQPT--KVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLS 821 (1005)
Q Consensus 746 --~~~lV~E~~~ggsL~~~l~~~~~--~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~~~g~vkL~DFG~a 821 (1005)
.+++||||+ .-+|..++..... ..++...++.+++||+.||+|||++||+||||||.||||+++|.+||+|||+|
T Consensus 89 ~~~l~lvfe~~-d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~~G~lKlaDFGlA 167 (323)
T KOG0594|consen 89 IGKLYLVFEFL-DRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISSSGVLKLADFGLA 167 (323)
T ss_pred cceEEEEEEee-cccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECCCCcEeeeccchH
Confidence 899999999 8899999987542 35788999999999999999999999999999999999999999999999999
Q ss_pred cccCCCCCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCC-CCCChhhHHHHHHHHHHHHcCCCC
Q 001847 822 CLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGA-GHTSAVDWWALGILLYEMLYGYTP 900 (1005)
Q Consensus 822 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~sDIwSlGvll~eLltG~~P 900 (1005)
+.... +.......++|.+|+|||++.+. .|+...||||+||+++||++++..
T Consensus 168 ra~~i---------------------------p~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~L 220 (323)
T KOG0594|consen 168 RAFSI---------------------------PMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPL 220 (323)
T ss_pred HHhcC---------------------------CcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCC
Confidence 64331 22334566899999999999887 688899999999999999999999
Q ss_pred CCCCChHHHHHHHHhC--C---CC-------------CCCC----------CCCCHHHHHHHHHccccCcCccCCChhcH
Q 001847 901 FRGKTRQKTFANILHK--D---LK-------------FPSS----------TPTSLHAKQLMYRLLHRDPKSRLGSHEGA 952 (1005)
Q Consensus 901 f~~~~~~~~~~~i~~~--~---~~-------------~~~~----------~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a 952 (1005)
|.|.+..+++..|.+- . .. ++.. +..+....+++.+||+.+|.+|.+ +
T Consensus 221 FpG~se~~ql~~If~~lGtP~e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~S----a 296 (323)
T KOG0594|consen 221 FPGDSEIDQLFRIFRLLGTPNEKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRIS----A 296 (323)
T ss_pred CCCCcHHHHHHHHHHHcCCCCccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcC----H
Confidence 9999998888888651 1 11 1111 112347789999999999999999 9
Q ss_pred HHHHcCCCCCCCC
Q 001847 953 NEIKKHPFFKGVN 965 (1005)
Q Consensus 953 ~elL~hpff~~~~ 965 (1005)
+.+|.||||....
T Consensus 297 ~~al~h~yf~~~~ 309 (323)
T KOG0594|consen 297 KGALTHPYFSELP 309 (323)
T ss_pred HHHhcChhhcccc
Confidence 9999999999863
|
|
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=358.42 Aligned_cols=257 Identities=26% Similarity=0.383 Sum_probs=211.5
Q ss_pred CCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEE
Q 001847 672 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLIT 751 (1005)
Q Consensus 672 ~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~ 751 (1005)
++|++.+.||+|+||.||+|.+..+++.||+|.+..... .......+.+|+.+++.++||||+++++++...+.+|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 79 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEE-NEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVF 79 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccc-cccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEE
Confidence 479999999999999999999999999999999876422 2334566788999999999999999999999999999999
Q ss_pred eccCCCchhhHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCCCCC
Q 001847 752 DYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLL 831 (1005)
Q Consensus 752 E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~~ 831 (1005)
||+.++.+..+... ...+++..++.++.||+.||.|||+.||+||||||+||+++.++.+||+|||++........
T Consensus 80 e~~~~~~l~~~~~~--~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-- 155 (287)
T cd07848 80 EYVEKNMLELLEEM--PNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSN-- 155 (287)
T ss_pred ecCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccCccccccccc--
Confidence 99988776655433 24589999999999999999999999999999999999999999999999999855321100
Q ss_pred CCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHcCCCCCCCCChHHHHH
Q 001847 832 LPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFA 911 (1005)
Q Consensus 832 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlGvll~eLltG~~Pf~~~~~~~~~~ 911 (1005)
.......|++.|+|||++.+..++.++|||||||++|+|++|+.||.+.+......
T Consensus 156 ------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~ 211 (287)
T cd07848 156 ------------------------ANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLF 211 (287)
T ss_pred ------------------------ccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 01123468999999999988889999999999999999999999998876554443
Q ss_pred HHHhCC-------------------CCCCCC-----------CCCCHHHHHHHHHccccCcCccCCChhcHHHHHcCCCC
Q 001847 912 NILHKD-------------------LKFPSS-----------TPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFF 961 (1005)
Q Consensus 912 ~i~~~~-------------------~~~~~~-----------~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~hpff 961 (1005)
.+.... ..++.. ..++..+.+||.+||++||++||| ++++|+||||
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s----~~~~l~hp~f 287 (287)
T cd07848 212 TIQKVLGPLPAEQMKLFYSNPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYL----TEQCLNHPAF 287 (287)
T ss_pred HHHHhhCCCCHHHHHhhhccchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCC----HHHHhcCCCC
Confidence 332210 011110 125678999999999999999999 9999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-39 Score=365.18 Aligned_cols=271 Identities=44% Similarity=0.782 Sum_probs=220.6
Q ss_pred CccccccccccCcEEEEEEEEc---CCCeEEEEEEeeccccc-ChHHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCeE
Q 001847 673 HFRPIKPLGSGDTGSVHLVELC---GSGQYFAMKAMDKGVML-NRNKVHRACAEREILDML-DHPFVPALYASFQTKTHV 747 (1005)
Q Consensus 673 ~y~~~~~LG~G~~g~Vy~a~~~---~~~~~valK~~~~~~~~-~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~ 747 (1005)
+|++++.||+|+||.||+|.+. .+++.||+|++.+.... .......+..|+.+++.+ +|++|+.+++++...+.+
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 4899999999999999999874 46899999999764322 223445677899999999 599999999999999999
Q ss_pred EEEEeccCCCchhhHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCC
Q 001847 748 CLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCK 827 (1005)
Q Consensus 748 ~lV~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~ 827 (1005)
|+||||+.+++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++......
T Consensus 81 ~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~~ 158 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQR--DNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSE 158 (332)
T ss_pred EEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCCCCEEEeeCcCCcccccc
Confidence 9999999999999998764 45899999999999999999999999999999999999999999999999998543211
Q ss_pred CCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCC-CCCChhhHHHHHHHHHHHHcCCCCCCCC--
Q 001847 828 PQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGA-GHTSAVDWWALGILLYEMLYGYTPFRGK-- 904 (1005)
Q Consensus 828 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~sDIwSlGvll~eLltG~~Pf~~~-- 904 (1005)
. .......+||+.|+|||++.+. .++.++|||||||++|+|++|..||...
T Consensus 159 ~--------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~ 212 (332)
T cd05614 159 E--------------------------KERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGE 212 (332)
T ss_pred C--------------------------CCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCC
Confidence 0 0112245799999999998765 4788999999999999999999999643
Q ss_pred --ChHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHccccCcCccCCCh-hcHHHHHcCCCCCCCChhhhhhcC
Q 001847 905 --TRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSH-EGANEIKKHPFFKGVNWALVRCMN 973 (1005)
Q Consensus 905 --~~~~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~-~~a~elL~hpff~~~~~~~~~~~~ 973 (1005)
........+......++ ..++..+.+||.+||..||++||+.. +.++++++||||+..+|..+....
T Consensus 213 ~~~~~~~~~~~~~~~~~~~--~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~~~~~~~~~~ 282 (332)
T cd05614 213 RNTQSEVSRRILKCDPPFP--SFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKGLDWEALALRK 282 (332)
T ss_pred CCCHHHHHHHHhcCCCCCC--CCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcCCCcCCCCHHHHHhCC
Confidence 22333344444444333 34688999999999999999999532 238999999999999998875433
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-39 Score=358.25 Aligned_cols=256 Identities=25% Similarity=0.410 Sum_probs=212.1
Q ss_pred cCCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEE
Q 001847 671 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLI 750 (1005)
Q Consensus 671 ~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV 750 (1005)
+++|++++.||.|+||.||++.+..++..||+|.++... .......+.+|+.+++.++||||+++++++...+..|+|
T Consensus 4 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 81 (288)
T cd07871 4 LETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEH--EEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLV 81 (288)
T ss_pred cccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccc--cCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEE
Confidence 568999999999999999999999999999999987542 122234567899999999999999999999999999999
Q ss_pred EeccCCCchhhHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCCCC
Q 001847 751 TDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQL 830 (1005)
Q Consensus 751 ~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~ 830 (1005)
|||+. ++|.+++... ...++...++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++......
T Consensus 82 ~e~~~-~~l~~~l~~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~--- 156 (288)
T cd07871 82 FEYLD-SDLKQYLDNC-GNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLARAKSVP--- 156 (288)
T ss_pred EeCCC-cCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEECcCcceeeccCC---
Confidence 99995 5899888654 245889999999999999999999999999999999999999999999999988542210
Q ss_pred CCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccC-CCCCChhhHHHHHHHHHHHHcCCCCCCCCChHHH
Q 001847 831 LLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAG-AGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKT 909 (1005)
Q Consensus 831 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~sDIwSlGvll~eLltG~~Pf~~~~~~~~ 909 (1005)
........|++.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+.
T Consensus 157 ------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~ 212 (288)
T cd07871 157 ------------------------TKTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEE 212 (288)
T ss_pred ------------------------CccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 011123468999999999865 4678899999999999999999999988877666
Q ss_pred HHHHHhCC-------------------CCCCC---------CCCCCHHHHHHHHHccccCcCccCCChhcHHHHHcCCCC
Q 001847 910 FANILHKD-------------------LKFPS---------STPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFF 961 (1005)
Q Consensus 910 ~~~i~~~~-------------------~~~~~---------~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~hpff 961 (1005)
+..+.... ..++. ....+.++++||.+||++||.+||| ++++|+||||
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t----~~~~l~hp~f 288 (288)
T cd07871 213 LHLIFRLLGTPTEETWPGITSNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRIS----AEAALRHSYF 288 (288)
T ss_pred HHHHHHHhCCCChHHhhccccchhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCC----HHHHhcCCCC
Confidence 55543310 00111 1235778999999999999999999 9999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-40 Score=355.67 Aligned_cols=261 Identities=31% Similarity=0.497 Sum_probs=233.8
Q ss_pred CCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEE
Q 001847 672 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLIT 751 (1005)
Q Consensus 672 ~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~ 751 (1005)
+-|.+.+.||+|-|.+|.+|++.-+|..||||++.+..+.+ .....+++|...|+.++|||||++|+++.....+|||+
T Consensus 18 GLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~-~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiL 96 (864)
T KOG4717|consen 18 GLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDT-LSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLIL 96 (864)
T ss_pred eeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccch-hhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEE
Confidence 56999999999999999999999999999999999875543 44567888999999999999999999999999999999
Q ss_pred eccCCCchhhHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEe-cCCcEEEEeccCCcccCCCCCC
Q 001847 752 DYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQ-GNGHVSLTDFDLSCLTSCKPQL 830 (1005)
Q Consensus 752 E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~-~~g~vkL~DFG~a~~~~~~~~~ 830 (1005)
|+-.+|+|++|+.++.. .++++..++|+.||+.|+.|+|+..+|||||||+||.|- .-|-|||.|||++..+.
T Consensus 97 ELGD~GDl~DyImKHe~-Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~----- 170 (864)
T KOG4717|consen 97 ELGDGGDLFDYIMKHEE-GLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQ----- 170 (864)
T ss_pred EecCCchHHHHHHhhhc-cccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEeeecCceEeeeccccccCC-----
Confidence 99999999999987644 499999999999999999999999999999999998765 56999999999984322
Q ss_pred CCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCC-ChhhHHHHHHHHHHHHcCCCCCCCCChHHH
Q 001847 831 LLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHT-SAVDWWALGILLYEMLYGYTPFRGKTRQKT 909 (1005)
Q Consensus 831 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~-~~sDIwSlGvll~eLltG~~Pf~~~~~~~~ 909 (1005)
|...-.+.||+..|-|||+|.+..|+ +++|||||||+||-|++|++||...+..+.
T Consensus 171 -----------------------PG~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSET 227 (864)
T KOG4717|consen 171 -----------------------PGKKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSET 227 (864)
T ss_pred -----------------------CcchhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhh
Confidence 12234567999999999999998886 589999999999999999999999999999
Q ss_pred HHHHHhCCCCCCCCCCCCHHHHHHHHHccccCcCccCCChhcHHHHHcCCCCCCCChhh
Q 001847 910 FANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVNWAL 968 (1005)
Q Consensus 910 ~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~hpff~~~~~~~ 968 (1005)
+..|+......|.. .+.++++||..||..||.+|.+ +++|..|+|++..+-.+
T Consensus 228 LTmImDCKYtvPsh--vS~eCrdLI~sMLvRdPkkRAs----lEeI~s~~Wlq~~D~~~ 280 (864)
T KOG4717|consen 228 LTMIMDCKYTVPSH--VSKECRDLIQSMLVRDPKKRAS----LEEIVSTSWLQAGDRGL 280 (864)
T ss_pred hhhhhcccccCchh--hhHHHHHHHHHHHhcCchhhcc----HHHHhccccccCCCCCc
Confidence 99999988777765 7899999999999999999999 99999999999876443
|
|
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-39 Score=365.04 Aligned_cols=275 Identities=36% Similarity=0.643 Sum_probs=228.9
Q ss_pred CCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEE
Q 001847 672 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLIT 751 (1005)
Q Consensus 672 ~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~ 751 (1005)
++|++++.||+|+||.||++.+..+++.||+|++.+...........+..|+.++..++|++|+.+++++...+.+|+||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 37999999999999999999999999999999987543333444456778999999999999999999999999999999
Q ss_pred eccCCCchhhHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCCCCC
Q 001847 752 DYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLL 831 (1005)
Q Consensus 752 E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~~ 831 (1005)
||+.+|+|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 81 ey~~~g~L~~~l~~~~-~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~--- 156 (332)
T cd05623 81 DYYVGGDLLTLLSKFE-DRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDG--- 156 (332)
T ss_pred eccCCCcHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEeecchheecccCC---
Confidence 9999999999997632 358999999999999999999999999999999999999999999999999884321110
Q ss_pred CCcchhhhhcccCCCCCcccccccccccccccCCcccccccccC-----CCCCChhhHHHHHHHHHHHHcCCCCCCCCCh
Q 001847 832 LPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAG-----AGHTSAVDWWALGILLYEMLYGYTPFRGKTR 906 (1005)
Q Consensus 832 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-----~~~~~~sDIwSlGvll~eLltG~~Pf~~~~~ 906 (1005)
.......+||+.|+|||++.. ..++.++|||||||++|+|++|+.||.+.+.
T Consensus 157 -----------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~ 213 (332)
T cd05623 157 -----------------------TVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESL 213 (332)
T ss_pred -----------------------cceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCH
Confidence 011123479999999999863 4578899999999999999999999999888
Q ss_pred HHHHHHHHhCCC--CCCCC-CCCCHHHHHHHHHccccCcCc--cCCChhcHHHHHcCCCCCCCChhhhhhcCCCCC
Q 001847 907 QKTFANILHKDL--KFPSS-TPTSLHAKQLMYRLLHRDPKS--RLGSHEGANEIKKHPFFKGVNWALVRCMNPPEL 977 (1005)
Q Consensus 907 ~~~~~~i~~~~~--~~~~~-~~~s~~l~~Ll~~~L~~dP~~--Rpt~~~~a~elL~hpff~~~~~~~~~~~~~~~~ 977 (1005)
.+.+..+..... .++.. ..++..+.+||.+||+.++.. |++ +.++++||||.+++|..+.....|..
T Consensus 214 ~~~~~~i~~~~~~~~~p~~~~~~s~~~~~li~~ll~~~~~r~~r~~----~~~~~~h~~f~~~~~~~~~~~~~~~~ 285 (332)
T cd05623 214 VETYGKIMNHKERFQFPAQVTDVSEDAKDLIRRLICSREHRLGQNG----IEDFKQHPFFTGIDWDNIRNCEAPYI 285 (332)
T ss_pred HHHHHHHhCCCccccCCCccccCCHHHHHHHHHHccChhhhcCCCC----HHHHhCCCCcCCCCHHHHhhCCCCcc
Confidence 888887776532 23322 346889999999999765544 567 99999999999999999976665544
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-40 Score=366.55 Aligned_cols=262 Identities=25% Similarity=0.451 Sum_probs=236.7
Q ss_pred cCCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCe-EEE
Q 001847 671 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTH-VCL 749 (1005)
Q Consensus 671 ~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~-~~l 749 (1005)
++.|.+++.+|.|+||.++++.++..++.||+|.+.-.....+.. ....+|..+++++.|||||.+.+.|..++. +||
T Consensus 3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r-~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~I 81 (426)
T KOG0589|consen 3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPER-RSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCI 81 (426)
T ss_pred cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhh-HHHHHHHHHHHhccCCCeeeeccchhcCCceEEE
Confidence 568999999999999999999999999999999998765444433 467889999999999999999999998887 999
Q ss_pred EEeccCCCchhhHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCCC
Q 001847 750 ITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQ 829 (1005)
Q Consensus 750 V~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~ 829 (1005)
||+||+||+|.+.+.++.+..++++.+..|+.||+.||.|||+++|.|||||+.|||++.++.|||+|||+|+.+..+.
T Consensus 82 vm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~- 160 (426)
T KOG0589|consen 82 VMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPED- 160 (426)
T ss_pred EEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhccccCceeecchhhhhhcCCch-
Confidence 9999999999999998877889999999999999999999999999999999999999999999999999998765321
Q ss_pred CCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHcCCCCCCCCChHHH
Q 001847 830 LLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKT 909 (1005)
Q Consensus 830 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlGvll~eLltG~~Pf~~~~~~~~ 909 (1005)
....+++|||.|++||.+.+.+|+.++|||||||++|||++-+.+|.+.+-...
T Consensus 161 --------------------------~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~L 214 (426)
T KOG0589|consen 161 --------------------------SLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSEL 214 (426)
T ss_pred --------------------------hhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHH
Confidence 134578999999999999999999999999999999999999999999999999
Q ss_pred HHHHHhCCCCCCCCCCCCHHHHHHHHHccccCcCccCCChhcHHHHHcCCCCCCCC
Q 001847 910 FANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVN 965 (1005)
Q Consensus 910 ~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~hpff~~~~ 965 (1005)
+.+|.... -.|....++.++..+|..||+.+|..||+ +.+||.+|.+...-
T Consensus 215 i~ki~~~~-~~Plp~~ys~el~~lv~~~l~~~P~~RPs----a~~LL~~P~l~~~~ 265 (426)
T KOG0589|consen 215 ILKINRGL-YSPLPSMYSSELRSLVKSMLRKNPEHRPS----ALELLRRPHLLRYL 265 (426)
T ss_pred HHHHhhcc-CCCCCccccHHHHHHHHHHhhcCCccCCC----HHHHhhChhhhhHH
Confidence 99998876 33444557899999999999999999999 99999999888543
|
|
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-39 Score=360.19 Aligned_cols=261 Identities=25% Similarity=0.414 Sum_probs=210.0
Q ss_pred cCCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEE
Q 001847 671 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLI 750 (1005)
Q Consensus 671 ~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV 750 (1005)
.++|++++.||+|+||.||+|.+..+++.||+|++..... ......+.+|+.+++.++||||+++++++......|+|
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 81 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEE--EGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLV 81 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccc--cccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEE
Confidence 3689999999999999999999999999999999875421 22234567899999999999999999999999999999
Q ss_pred EeccCCCchhhHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCCCC
Q 001847 751 TDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQL 830 (1005)
Q Consensus 751 ~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~ 830 (1005)
|||+ +++|.+++... ...++...++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 82 ~e~~-~~~l~~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~--- 156 (303)
T cd07869 82 FEYV-HTDLCQYMDKH-PGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTGELKLADFGLARAKSVP--- 156 (303)
T ss_pred EECC-CcCHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECCCCcceeccCC---
Confidence 9999 57888877654 245889999999999999999999999999999999999999999999999988532211
Q ss_pred CCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccC-CCCCChhhHHHHHHHHHHHHcCCCCCCCCCh-HH
Q 001847 831 LLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAG-AGHTSAVDWWALGILLYEMLYGYTPFRGKTR-QK 908 (1005)
Q Consensus 831 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~sDIwSlGvll~eLltG~~Pf~~~~~-~~ 908 (1005)
........|++.|+|||++.+ ..++.++|||||||++|+|++|..||.+... ..
T Consensus 157 ------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~ 212 (303)
T cd07869 157 ------------------------SHTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQD 212 (303)
T ss_pred ------------------------CccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHH
Confidence 011123468999999999865 4578899999999999999999999987543 23
Q ss_pred HHHHHHhC--CC---CCC-------------------------CCCCCCHHHHHHHHHccccCcCccCCChhcHHHHHcC
Q 001847 909 TFANILHK--DL---KFP-------------------------SSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKH 958 (1005)
Q Consensus 909 ~~~~i~~~--~~---~~~-------------------------~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~h 958 (1005)
.+..+... .. .++ .....+..+.+||.+||+.||.+||| +.++|+|
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s----~~~~l~h 288 (303)
T cd07869 213 QLERIFLVLGTPNEDTWPGVHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLS----AQAALSH 288 (303)
T ss_pred HHHHHHHHhCCCChhhccchhhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccC----HHHHhcC
Confidence 33332210 00 000 00113457889999999999999999 9999999
Q ss_pred CCCCCCCh
Q 001847 959 PFFKGVNW 966 (1005)
Q Consensus 959 pff~~~~~ 966 (1005)
|||+.+++
T Consensus 289 ~~f~~~~~ 296 (303)
T cd07869 289 EYFSDLPP 296 (303)
T ss_pred cccccCCh
Confidence 99998754
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-39 Score=365.32 Aligned_cols=277 Identities=37% Similarity=0.659 Sum_probs=229.8
Q ss_pred CCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEE
Q 001847 672 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLIT 751 (1005)
Q Consensus 672 ~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~ 751 (1005)
++|++++.||+|+||.||++.+..+++.||+|++.+...........+.+|+.++..++|++|+.+++++...+..|+||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 47999999999999999999999999999999987643333444556778999999999999999999999999999999
Q ss_pred eccCCCchhhHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCCCCC
Q 001847 752 DYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLL 831 (1005)
Q Consensus 752 E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~~ 831 (1005)
||+.||+|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++........
T Consensus 81 Ey~~gg~L~~~l~~~~-~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~-- 157 (331)
T cd05624 81 DYYVGGDLLTLLSKFE-DRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGT-- 157 (331)
T ss_pred eCCCCCcHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcCCCCEEEEeccceeeccCCCc--
Confidence 9999999999997632 4589999999999999999999999999999999999999999999999999854321100
Q ss_pred CCcchhhhhcccCCCCCcccccccccccccccCCcccccccccC-----CCCCChhhHHHHHHHHHHHHcCCCCCCCCCh
Q 001847 832 LPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAG-----AGHTSAVDWWALGILLYEMLYGYTPFRGKTR 906 (1005)
Q Consensus 832 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-----~~~~~~sDIwSlGvll~eLltG~~Pf~~~~~ 906 (1005)
......+|++.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+.
T Consensus 158 ------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~ 213 (331)
T cd05624 158 ------------------------VQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESL 213 (331)
T ss_pred ------------------------eeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCH
Confidence 01123569999999999865 4567899999999999999999999998888
Q ss_pred HHHHHHHHhCC--CCCCCC-CCCCHHHHHHHHHccccCcCccCCChhcHHHHHcCCCCCCCChhhhhhcCCCCC
Q 001847 907 QKTFANILHKD--LKFPSS-TPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVNWALVRCMNPPEL 977 (1005)
Q Consensus 907 ~~~~~~i~~~~--~~~~~~-~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~hpff~~~~~~~~~~~~~~~~ 977 (1005)
.+.+..+.... ++++.. ..++..+.+||.+||+.++ +|+. ...++++++||||+.++|..++...+|..
T Consensus 214 ~~~~~~i~~~~~~~~~p~~~~~~~~~~~~li~~ll~~~~-~~~~-~~~~~~~~~h~~f~~~~~~~~~~~~~~~~ 285 (331)
T cd05624 214 VETYGKIMNHEERFQFPSHITDVSEEAKDLIQRLICSRE-RRLG-QNGIEDFKKHAFFEGIDWENIRNLEAPYI 285 (331)
T ss_pred HHHHHHHHcCCCcccCCCccccCCHHHHHHHHHHccCch-hhcC-CCCHHHHhcCCCcCCCCHHHHhhCCCCcc
Confidence 77777776643 333332 3468899999999999765 4432 12399999999999999999987776644
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=364.82 Aligned_cols=264 Identities=43% Similarity=0.774 Sum_probs=226.0
Q ss_pred cccccccCcEEEEEEEE---cCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEEec
Q 001847 677 IKPLGSGDTGSVHLVEL---CGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDY 753 (1005)
Q Consensus 677 ~~~LG~G~~g~Vy~a~~---~~~~~~valK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~ 753 (1005)
++.||+|+||.||++.+ ..+|+.||+|++..... .......+..|+.++++++||||+++++++...+.+|+||||
T Consensus 1 l~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 79 (318)
T cd05582 1 LKVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATL-KVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDF 79 (318)
T ss_pred CceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHh-hhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcC
Confidence 36799999999999987 35789999999986432 222345667899999999999999999999999999999999
Q ss_pred cCCCchhhHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCCCCCCC
Q 001847 754 CPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLP 833 (1005)
Q Consensus 754 ~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~~~~ 833 (1005)
+.+++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 80 ~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~------ 151 (318)
T cd05582 80 LRGGDLFTRLSKE--VMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDH------ 151 (318)
T ss_pred CCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCCCcEEEeeccCCcccCCC------
Confidence 9999999998764 45899999999999999999999999999999999999999999999999988543211
Q ss_pred cchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHH
Q 001847 834 TTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANI 913 (1005)
Q Consensus 834 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlGvll~eLltG~~Pf~~~~~~~~~~~i 913 (1005)
........|++.|+|||++.+..++.++|||||||++|+|++|+.||.+.+....+..+
T Consensus 152 ---------------------~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i 210 (318)
T cd05582 152 ---------------------EKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMI 210 (318)
T ss_pred ---------------------CCceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHHHHHH
Confidence 01122457999999999998888899999999999999999999999998888888888
Q ss_pred HhCCCCCCCCCCCCHHHHHHHHHccccCcCccCCChh-cHHHHHcCCCCCCCChhhhhhc
Q 001847 914 LHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHE-GANEIKKHPFFKGVNWALVRCM 972 (1005)
Q Consensus 914 ~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~-~a~elL~hpff~~~~~~~~~~~ 972 (1005)
......++. .++..+.+||.+||+.||.+||++.+ .+.++++||||+.++|..+...
T Consensus 211 ~~~~~~~p~--~~~~~~~~li~~~l~~~P~~R~~a~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (318)
T cd05582 211 LKAKLGMPQ--FLSPEAQSLLRALFKRNPANRLGAGPDGVEEIKRHPFFSTIDWNKLYRR 268 (318)
T ss_pred HcCCCCCCC--CCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhCCCCcCCCCHHHHHhc
Confidence 776665553 36888999999999999999999654 4789999999999999987543
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=360.69 Aligned_cols=262 Identities=24% Similarity=0.389 Sum_probs=218.5
Q ss_pred cccCCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEE
Q 001847 669 INLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVC 748 (1005)
Q Consensus 669 i~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~ 748 (1005)
+..++|++++.||+|+||.||++.+..++..+|+|.+.... .......+.+|+++++.++||||+++++++...+.++
T Consensus 2 l~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 79 (331)
T cd06649 2 LKDDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEIS 79 (331)
T ss_pred CCcccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeeccc--CHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEE
Confidence 44679999999999999999999999999999999987542 3344567889999999999999999999999999999
Q ss_pred EEEeccCCCchhhHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHc-CcccCCCCCCcEEEecCCcEEEEeccCCcccCCC
Q 001847 749 LITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQ-GIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCK 827 (1005)
Q Consensus 749 lV~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~-gIvHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~ 827 (1005)
+||||+++++|.+++... ..+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||++.....
T Consensus 80 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~- 156 (331)
T cd06649 80 ICMEHMDGGSLDQVLKEA--KRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID- 156 (331)
T ss_pred EEeecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCCcEEEccCcccccccc-
Confidence 999999999999999764 3489999999999999999999986 699999999999999999999999998843211
Q ss_pred CCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHcCCCCCCCCChH
Q 001847 828 PQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQ 907 (1005)
Q Consensus 828 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlGvll~eLltG~~Pf~~~~~~ 907 (1005)
.......|++.|+|||++.+..++.++|||||||++|+|++|+.||......
T Consensus 157 ----------------------------~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~ 208 (331)
T cd06649 157 ----------------------------SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAK 208 (331)
T ss_pred ----------------------------cccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 0112346899999999999888999999999999999999999999765543
Q ss_pred HHHHHHH----------------------------------------------hCCCCCCCCCCCCHHHHHHHHHccccC
Q 001847 908 KTFANIL----------------------------------------------HKDLKFPSSTPTSLHAKQLMYRLLHRD 941 (1005)
Q Consensus 908 ~~~~~i~----------------------------------------------~~~~~~~~~~~~s~~l~~Ll~~~L~~d 941 (1005)
+....+. ....+......++.++++||.+||.+|
T Consensus 209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~ 288 (331)
T cd06649 209 ELEAIFGRPVVDGEEGEPHSISPRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKN 288 (331)
T ss_pred HHHHHhcccccccccCCccccCcccccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCC
Confidence 3322111 111111111235778999999999999
Q ss_pred cCccCCChhcHHHHHcCCCCCCCChh
Q 001847 942 PKSRLGSHEGANEIKKHPFFKGVNWA 967 (1005)
Q Consensus 942 P~~Rpt~~~~a~elL~hpff~~~~~~ 967 (1005)
|++||| +.++++||||+.....
T Consensus 289 P~~Rpt----~~ell~h~~~~~~~~~ 310 (331)
T cd06649 289 PAERAD----LKMLMNHTFIKRSEVE 310 (331)
T ss_pred cccCCC----HHHHhcChHHhhcccc
Confidence 999999 9999999999875443
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-40 Score=351.97 Aligned_cols=273 Identities=36% Similarity=0.640 Sum_probs=239.4
Q ss_pred cccccCCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCe
Q 001847 667 EQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTH 746 (1005)
Q Consensus 667 ~~i~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~ 746 (1005)
+++..+.|+.-++||.|+||.||-|.-+.||+.||+|.+.+..+..+.......+|..||.++++++||.+-..|...+.
T Consensus 180 qpvt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~ 259 (591)
T KOG0986|consen 180 QPVTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDA 259 (591)
T ss_pred hhccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCc
Confidence 56778899999999999999999999999999999999987766666666777899999999999999999999999999
Q ss_pred EEEEEeccCCCchhhHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCC
Q 001847 747 VCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSC 826 (1005)
Q Consensus 747 ~~lV~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~~~g~vkL~DFG~a~~~~~ 826 (1005)
+|+||..|+||+|.-.+-......+++..++.++.+|+.||.+||+.+||.|||||+|||+|+.|+|+|+|+|+|..+..
T Consensus 260 LClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~ 339 (591)
T KOG0986|consen 260 LCLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLDDHGHVRISDLGLAVEIPE 339 (591)
T ss_pred eEEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeeccCCCeEeeccceEEecCC
Confidence 99999999999998877766556799999999999999999999999999999999999999999999999999976532
Q ss_pred CCCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCh
Q 001847 827 KPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTR 906 (1005)
Q Consensus 827 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlGvll~eLltG~~Pf~~~~~ 906 (1005)
. ......+||.+|||||++.+..|+...|-|||||+||+|+.|+.||.....
T Consensus 340 g----------------------------~~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~Ke 391 (591)
T KOG0986|consen 340 G----------------------------KPIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKE 391 (591)
T ss_pred C----------------------------CccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhh
Confidence 1 122344899999999999999999999999999999999999999976433
Q ss_pred H----HHHHHHHhCCCCCCCCCCCCHHHHHHHHHccccCcCccCCCh-hcHHHHHcCCCCCCCChhhh
Q 001847 907 Q----KTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSH-EGANEIKKHPFFKGVNWALV 969 (1005)
Q Consensus 907 ~----~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~-~~a~elL~hpff~~~~~~~~ 969 (1005)
. ++-..++.....++ ...|.++++|...+|++||.+|+..+ +.+.++.+||||+.++|..+
T Consensus 392 Kvk~eEvdrr~~~~~~ey~--~kFS~eakslc~~LL~Kdp~~RLGcrg~ga~evk~HpfFk~lnw~rl 457 (591)
T KOG0986|consen 392 KVKREEVDRRTLEDPEEYS--DKFSEEAKSLCEGLLTKDPEKRLGCRGEGAQEVKEHPFFKDLNWRRL 457 (591)
T ss_pred hhhHHHHHHHHhcchhhcc--cccCHHHHHHHHHHHccCHHHhccCCCcCcchhhhCcccccCCHhHH
Confidence 2 33333444444555 45799999999999999999999987 77999999999999999988
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=359.97 Aligned_cols=296 Identities=37% Similarity=0.623 Sum_probs=260.9
Q ss_pred ccccCCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeE
Q 001847 668 QINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHV 747 (1005)
Q Consensus 668 ~i~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 747 (1005)
++.+.+++++..||-|+||.|-+|........+|+|++++..+.+....+.+..|..||..+++|+||++|-.|.+..++
T Consensus 416 ~v~l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyv 495 (732)
T KOG0614|consen 416 QVKLSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYV 495 (732)
T ss_pred ccchhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhh
Confidence 34567889999999999999999998666667999999988777888888899999999999999999999999999999
Q ss_pred EEEEeccCCCchhhHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCC
Q 001847 748 CLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCK 827 (1005)
Q Consensus 748 ~lV~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~ 827 (1005)
|++||-|-||.|+..++.+ +.+.+...+.++..+++|++|||++|||+|||||+|+|++.+|.+||.|||+|+....
T Consensus 496 YmLmEaClGGElWTiLrdR--g~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~- 572 (732)
T KOG0614|consen 496 YMLMEACLGGELWTILRDR--GSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGS- 572 (732)
T ss_pred hhhHHhhcCchhhhhhhhc--CCcccchhhhhHHHHHHHHHHHHhcCceeccCChhheeeccCCceEEeehhhHHHhcc-
Confidence 9999999999999999875 5699999999999999999999999999999999999999999999999999976542
Q ss_pred CCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHcCCCCCCCCChH
Q 001847 828 PQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQ 907 (1005)
Q Consensus 828 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlGvll~eLltG~~Pf~~~~~~ 907 (1005)
.....++||||.|.|||++....++.++|.||||+++|||++|.+||.+.+++
T Consensus 573 ---------------------------g~KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpm 625 (732)
T KOG0614|consen 573 ---------------------------GRKTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPM 625 (732)
T ss_pred ---------------------------CCceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchH
Confidence 23356789999999999999999999999999999999999999999999999
Q ss_pred HHHHHHHhCCCCCCCCCCCCHHHHHHHHHccccCcCccCCC-hhcHHHHHcCCCCCCCChhhhhhcCCCCCCCCCCCCcc
Q 001847 908 KTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGS-HEGANEIKKHPFFKGVNWALVRCMNPPELDAPLFATDT 986 (1005)
Q Consensus 908 ~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~-~~~a~elL~hpff~~~~~~~~~~~~~~~~~~p~~~~~~ 986 (1005)
..+..|+++--.+.-+..+...+.+||++++..+|.+|+.+ ...+.+|.+|.||.+++|.-++...-|..-+|.++-++
T Consensus 626 ktYn~ILkGid~i~~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~Wf~gfdweglr~~~L~pPi~~~va~pt 705 (732)
T KOG0614|consen 626 KTYNLILKGIDKIEFPRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKHRWFEGFDWEGLRSRTLPPPIIPSVANPT 705 (732)
T ss_pred HHHHHHHhhhhhhhcccccchhHHHHHHHHHhcCcHhhhccccCChHHHHhhhhhhcCChhhhhhccCCCCccccCCCcc
Confidence 99999998743333334578889999999999999999985 35699999999999999998855544444468888887
Q ss_pred ccccccC
Q 001847 987 EKEYKVV 993 (1005)
Q Consensus 987 ~~~~~~~ 993 (1005)
+..|+-.
T Consensus 706 D~s~Fd~ 712 (732)
T KOG0614|consen 706 DVSNFDN 712 (732)
T ss_pred cchhccC
Confidence 7777643
|
|
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-38 Score=348.86 Aligned_cols=268 Identities=44% Similarity=0.803 Sum_probs=233.2
Q ss_pred CCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEE
Q 001847 672 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLIT 751 (1005)
Q Consensus 672 ~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~ 751 (1005)
++|++.+.||.|++|.||++.+..+++.+|+|.+.............+.+|++++++++||||+++++++...+.+|+||
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 37999999999999999999999999999999997654444555677889999999999999999999999999999999
Q ss_pred eccCCCchhhHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCCCCC
Q 001847 752 DYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLL 831 (1005)
Q Consensus 752 E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~~ 831 (1005)
||+++++|.+++... ..++...+..++.||+.||.|||++|++|+||+|+||+++.++.+||+|||++......
T Consensus 81 e~~~~~~L~~~~~~~--~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~---- 154 (290)
T cd05580 81 EYVPGGELFSHLRKS--GRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR---- 154 (290)
T ss_pred ecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEeeCCCccccCCC----
Confidence 999999999999765 45899999999999999999999999999999999999999999999999988543211
Q ss_pred CCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHcCCCCCCCCChHHHHH
Q 001847 832 LPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFA 911 (1005)
Q Consensus 832 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlGvll~eLltG~~Pf~~~~~~~~~~ 911 (1005)
.....|++.|+|||.+.+...+.++||||||+++|+|++|..||..........
T Consensus 155 --------------------------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~ 208 (290)
T cd05580 155 --------------------------TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYE 208 (290)
T ss_pred --------------------------CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 123468899999999988888889999999999999999999998887777777
Q ss_pred HHHhCCCCCCCCCCCCHHHHHHHHHccccCcCccCCCh-hcHHHHHcCCCCCCCChhhhhhcC
Q 001847 912 NILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSH-EGANEIKKHPFFKGVNWALVRCMN 973 (1005)
Q Consensus 912 ~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~-~~a~elL~hpff~~~~~~~~~~~~ 973 (1005)
.+..+...++.. .+..+.++|.+||..+|.+|++.. +.++++++||||+.++|..+....
T Consensus 209 ~~~~~~~~~~~~--~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 269 (290)
T cd05580 209 KILEGKVRFPSF--FSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNHPWFAGIDWIALLQRK 269 (290)
T ss_pred HHhcCCccCCcc--CCHHHHHHHHHHccCCHHHccCcccCCHHHHHcCcccccCCHHHHhhcc
Confidence 777666555543 578899999999999999999332 349999999999999999885433
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=358.94 Aligned_cols=321 Identities=37% Similarity=0.635 Sum_probs=256.3
Q ss_pred cccCCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEE
Q 001847 669 INLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVC 748 (1005)
Q Consensus 669 i~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~ 748 (1005)
++..-|..++.||-|+||.|.+|.-..|...||+|.+++..+..+.....+..|..||..-+++-||++|..|.+.+.+|
T Consensus 626 MdKSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLY 705 (1034)
T KOG0608|consen 626 MDKSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLY 705 (1034)
T ss_pred ccccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceE
Confidence 45567999999999999999999999999999999999887778888888889999999999999999999999999999
Q ss_pred EEEeccCCCchhhHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccC-CC
Q 001847 749 LITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTS-CK 827 (1005)
Q Consensus 749 lV~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~~~g~vkL~DFG~a~~~~-~~ 827 (1005)
+||+|++||++-.+|-+. +.++++++++++..|.+|++++|+.|+|||||||+|||||.+|++||.|||++.-+. ..
T Consensus 706 FVMdYIPGGDmMSLLIrm--gIFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTH 783 (1034)
T KOG0608|consen 706 FVMDYIPGGDMMSLLIRM--GIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH 783 (1034)
T ss_pred EEEeccCCccHHHHHHHh--ccCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEccCCceeeeeccccccceecc
Confidence 999999999999998775 569999999999999999999999999999999999999999999999999974321 11
Q ss_pred CCCCCCcchhhhhcccCCCCCcccc-c--------------ccccccccccCCcccccccccCCCCCChhhHHHHHHHHH
Q 001847 828 PQLLLPTTNEKKRRHKGQQNPVFMA-E--------------PMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLY 892 (1005)
Q Consensus 828 ~~~~~~~~~~~~~~~~~~~~~~~~~-~--------------~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlGvll~ 892 (1005)
...++.. ++..+.........+.. . ..-....++||+.|+|||++....++.-+|-||.||+||
T Consensus 784 dskYYq~-gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~ 862 (1034)
T KOG0608|consen 784 DSKYYQE-GDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILY 862 (1034)
T ss_pred ccccccC-CCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHH
Confidence 1222221 11111110000000000 0 001234578999999999999999999999999999999
Q ss_pred HHHcCCCCCCCCChHHHHHHHHh--CCCCCCCCCCCCHHHHHHHHHccccCcCccCCChhcHHHHHcCCCCCCCChhhhh
Q 001847 893 EMLYGYTPFRGKTRQKTFANILH--KDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVNWALVR 970 (1005)
Q Consensus 893 eLltG~~Pf~~~~~~~~~~~i~~--~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~hpff~~~~~~~~~ 970 (1005)
+|+.|++||...+..+...+++. ..+.++....++.++.+||.++++ +++.|+. +..+.++..||||++++|..+|
T Consensus 863 em~~g~~pf~~~tp~~tq~kv~nw~~~l~~~~~~~ls~e~~~li~kLc~-sad~RLG-kng~d~vKaHpfFkgIDfsslR 940 (1034)
T KOG0608|consen 863 EMLVGQPPFLADTPGETQYKVINWRNFLHIPYQGNLSKEALDLIQKLCC-SADSRLG-KNGADQVKAHPFFKGIDFSSLR 940 (1034)
T ss_pred HHhhCCCCccCCCCCcceeeeeehhhccccccccccCHHHHHHHHHHhc-Chhhhhc-ccchhhhhcCccccccchHhhh
Confidence 99999999998888777666654 345666677789999999998776 7899998 5568899999999999999999
Q ss_pred hcCCCCCCCCCCCCccccccccCCc
Q 001847 971 CMNPPELDAPLFATDTEKEYKVVDP 995 (1005)
Q Consensus 971 ~~~~~~~~~p~~~~~~~~~~~~~~~ 995 (1005)
....|=++.=.--||+.+ +..+|+
T Consensus 941 kq~ApYIP~ItHptDTSN-Fdpvdp 964 (1034)
T KOG0608|consen 941 KQRAPYIPRITHPTDTSN-FDPVDP 964 (1034)
T ss_pred hccCCcCccccCCCcccc-CCcCCc
Confidence 888775533233344443 444444
|
|
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=360.75 Aligned_cols=264 Identities=25% Similarity=0.396 Sum_probs=211.1
Q ss_pred CccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeC-----CeE
Q 001847 673 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTK-----THV 747 (1005)
Q Consensus 673 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~-----~~~ 747 (1005)
+|++.+.||+|+||.||+|.+..++..||+|.+.... ........+.+|+.+++.++||||+++++++... ..+
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 79 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVF-EHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDI 79 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhh-ccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceE
Confidence 5899999999999999999999999999999987532 2233445788999999999999999999987543 358
Q ss_pred EEEEeccCCCchhhHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCC
Q 001847 748 CLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCK 827 (1005)
Q Consensus 748 ~lV~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~ 827 (1005)
|+||||+ +++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 80 ~lv~e~~-~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~ 156 (338)
T cd07859 80 YVVFELM-ESDLHQVIKAN--DDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFND 156 (338)
T ss_pred EEEEecC-CCCHHHHHHhc--ccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEccCccccccccc
Confidence 9999999 67899888764 35899999999999999999999999999999999999999999999999998543211
Q ss_pred CCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccC--CCCCChhhHHHHHHHHHHHHcCCCCCCCCC
Q 001847 828 PQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAG--AGHTSAVDWWALGILLYEMLYGYTPFRGKT 905 (1005)
Q Consensus 828 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~--~~~~~~sDIwSlGvll~eLltG~~Pf~~~~ 905 (1005)
.. .........|++.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+
T Consensus 157 ~~------------------------~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~ 212 (338)
T cd07859 157 TP------------------------TAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKN 212 (338)
T ss_pred cC------------------------ccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCC
Confidence 00 0011133579999999999865 567889999999999999999999998765
Q ss_pred hHHHHHHHHh--------------------------CCCCCC---CCCCCCHHHHHHHHHccccCcCccCCChhcHHHHH
Q 001847 906 RQKTFANILH--------------------------KDLKFP---SSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIK 956 (1005)
Q Consensus 906 ~~~~~~~i~~--------------------------~~~~~~---~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL 956 (1005)
.......+.. ...+.+ .....+..+.+||.+||+.||++||+ +.++|
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt----~~e~l 288 (338)
T cd07859 213 VVHQLDLITDLLGTPSPETISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPT----AEEAL 288 (338)
T ss_pred hHHHHHHHHHHhCCCCHHHHHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCC----HHHHh
Confidence 4333221110 000000 11235678899999999999999999 99999
Q ss_pred cCCCCCCCChhh
Q 001847 957 KHPFFKGVNWAL 968 (1005)
Q Consensus 957 ~hpff~~~~~~~ 968 (1005)
+||||+.+....
T Consensus 289 ~hp~f~~~~~~~ 300 (338)
T cd07859 289 ADPYFKGLAKVE 300 (338)
T ss_pred cCchhhhcCccc
Confidence 999999876643
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-38 Score=348.32 Aligned_cols=273 Identities=34% Similarity=0.577 Sum_probs=226.1
Q ss_pred CccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEEe
Q 001847 673 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITD 752 (1005)
Q Consensus 673 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E 752 (1005)
.|+..+.||.|+||.||++.+..+++.||+|.+.............+.+|+.+++.++|+||+.+++++..++..|+|||
T Consensus 1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05632 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEE
Confidence 47788999999999999999999999999999876544333444567789999999999999999999999999999999
Q ss_pred ccCCCchhhHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCCCCCC
Q 001847 753 YCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLL 832 (1005)
Q Consensus 753 ~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~~~ 832 (1005)
|+.+++|.+++.......+++..+..++.|++.||.|||+.||+||||||+||++++++.++|+|||++......
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~----- 155 (285)
T cd05632 81 IMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEG----- 155 (285)
T ss_pred eccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCCCCEEEecCCcceecCCC-----
Confidence 999999998886544456999999999999999999999999999999999999999999999999988543211
Q ss_pred CcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHcCCCCCCCCChHHHHHH
Q 001847 833 PTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFAN 912 (1005)
Q Consensus 833 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlGvll~eLltG~~Pf~~~~~~~~~~~ 912 (1005)
.......|++.|+|||++.+..++.++|+|||||++|+|++|..||.+.........
T Consensus 156 -----------------------~~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~ 212 (285)
T cd05632 156 -----------------------ESIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREE 212 (285)
T ss_pred -----------------------CcccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 011234689999999999888899999999999999999999999987665443333
Q ss_pred HHhCC--CCCCCCCCCCHHHHHHHHHccccCcCccCCChhc-HHHHHcCCCCCCCChhhhhhcC
Q 001847 913 ILHKD--LKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEG-ANEIKKHPFFKGVNWALVRCMN 973 (1005)
Q Consensus 913 i~~~~--~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~-a~elL~hpff~~~~~~~~~~~~ 973 (1005)
+.... .........+..+.+|+.+||..||.+||+..+. +.+++.|+||+..+|..+...+
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 276 (285)
T cd05632 213 VDRRVLETEEVYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRHPFFRNMNFKRLEAGM 276 (285)
T ss_pred HHHhhhccccccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcChhhhcCCHHHHhcCc
Confidence 32211 1111223467789999999999999999997643 8899999999999999874433
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-40 Score=362.12 Aligned_cols=260 Identities=27% Similarity=0.435 Sum_probs=226.3
Q ss_pred CCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEE
Q 001847 672 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLIT 751 (1005)
Q Consensus 672 ~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~ 751 (1005)
+.|.++..||.|+||.||+|.++.++...|-|++.- .......++.-||+||..|+||+||++++.|...+.++|+.
T Consensus 32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIet---kseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwili 108 (1187)
T KOG0579|consen 32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIET---KSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILI 108 (1187)
T ss_pred HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcc---cchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEE
Confidence 468889999999999999999999998889998753 34567788889999999999999999999999999999999
Q ss_pred eccCCCchhhHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCCCCC
Q 001847 752 DYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLL 831 (1005)
Q Consensus 752 E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~~ 831 (1005)
|||.||-+..++-.- +..|++.++.-+++|++.||.|||+++|||||||..|||++-+|.++|.|||++....
T Consensus 109 EFC~GGAVDaimlEL-~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~------ 181 (1187)
T KOG0579|consen 109 EFCGGGAVDAIMLEL-GRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLDGDIRLADFGVSAKNK------ 181 (1187)
T ss_pred eecCCchHhHHHHHh-ccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEecCcEeeecccccccch------
Confidence 999988887776543 4569999999999999999999999999999999999999999999999999884321
Q ss_pred CCcchhhhhcccCCCCCcccccccccccccccCCccccccccc-----CCCCCChhhHHHHHHHHHHHHcCCCCCCCCCh
Q 001847 832 LPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIA-----GAGHTSAVDWWALGILLYEMLYGYTPFRGKTR 906 (1005)
Q Consensus 832 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~-----~~~~~~~sDIwSlGvll~eLltG~~Pf~~~~~ 906 (1005)
......+++.|||+|||||+.. ..+|++++||||||++|.+|.-+.+|-...+.
T Consensus 182 ---------------------~t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnp 240 (1187)
T KOG0579|consen 182 ---------------------STRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNP 240 (1187)
T ss_pred ---------------------hHHhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccch
Confidence 0112346789999999999874 35789999999999999999999999999999
Q ss_pred HHHHHHHHhCCCCCC-CCCCCCHHHHHHHHHccccCcCccCCChhcHHHHHcCCCCCCCCh
Q 001847 907 QKTFANILHKDLKFP-SSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVNW 966 (1005)
Q Consensus 907 ~~~~~~i~~~~~~~~-~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~hpff~~~~~ 966 (1005)
+..+-+|.+..++.. .+..-+..+.+||.+||.+||..||+ +.+||+||||++++-
T Consensus 241 MRVllKiaKSePPTLlqPS~Ws~~F~DfLk~cL~Knp~~Rp~----aaqll~Hpfv~~~~S 297 (1187)
T KOG0579|consen 241 MRVLLKIAKSEPPTLLQPSHWSRSFSDFLKRCLVKNPRNRPP----AAQLLKHPFVQNAPS 297 (1187)
T ss_pred HHHHHHHhhcCCCcccCcchhhhHHHHHHHHHHhcCCccCCC----HHHHhhCcccccCCc
Confidence 999988887765432 33345678999999999999999999 999999999997653
|
|
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=345.51 Aligned_cols=256 Identities=27% Similarity=0.468 Sum_probs=213.2
Q ss_pred CCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeC--C---e
Q 001847 672 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTK--T---H 746 (1005)
Q Consensus 672 ~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~--~---~ 746 (1005)
-.|...+.+|+|+||.||++....++..+|||.+-.+. . ---+|+.+|+.++|||||++.-+|... . +
T Consensus 24 i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~----r---~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~ 96 (364)
T KOG0658|consen 24 ISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDK----R---YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVY 96 (364)
T ss_pred EEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCC----C---cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhH
Confidence 36899999999999999999999999999999876441 1 223599999999999999999888632 2 4
Q ss_pred EEEEEeccCCCchhhHHhh--CCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecC-CcEEEEeccCCcc
Q 001847 747 VCLITDYCPGGELFLLLDR--QPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGN-GHVSLTDFDLSCL 823 (1005)
Q Consensus 747 ~~lV~E~~~ggsL~~~l~~--~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~~~-g~vkL~DFG~a~~ 823 (1005)
..+||||| .-+|..+++. ..+..++.-.++.++.||++||+|||+.||+||||||.|+|+|.+ |.+||||||.|+.
T Consensus 97 lnlVleym-P~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~ 175 (364)
T KOG0658|consen 97 LNLVLEYM-PETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPDTGVLKICDFGSAKV 175 (364)
T ss_pred HHHHHHhc-hHHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCCCCeEEeccCCccee
Confidence 56899999 7799988873 123558889999999999999999999999999999999999966 9999999999976
Q ss_pred cCCCCCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCC-CCCChhhHHHHHHHHHHHHcCCCCCC
Q 001847 824 TSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGA-GHTSAVDWWALGILLYEMLYGYTPFR 902 (1005)
Q Consensus 824 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~sDIwSlGvll~eLltG~~Pf~ 902 (1005)
.... ....++..|..|+|||.+.+. .|+.+.||||.||++.||+-|++.|.
T Consensus 176 L~~~----------------------------epniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFp 227 (364)
T KOG0658|consen 176 LVKG----------------------------EPNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFP 227 (364)
T ss_pred eccC----------------------------CCceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccC
Confidence 5421 233567899999999999885 68889999999999999999999999
Q ss_pred CCChHHHHHHHHhC-----------------CCCCC----------CCCCCCHHHHHHHHHccccCcCccCCChhcHHHH
Q 001847 903 GKTRQKTFANILHK-----------------DLKFP----------SSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEI 955 (1005)
Q Consensus 903 ~~~~~~~~~~i~~~-----------------~~~~~----------~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~el 955 (1005)
|.+...++..|.+- ...++ .....++++.+|+.++|.++|.+|.+ +.++
T Consensus 228 G~s~~dQL~eIik~lG~Pt~e~I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~----~~~~ 303 (364)
T KOG0658|consen 228 GDSSVDQLVEIIKVLGTPTREDIKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLS----ALEA 303 (364)
T ss_pred CCCHHHHHHHHHHHhCCCCHHHHhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCC----HHHH
Confidence 99888887777541 11111 11335778999999999999999999 9999
Q ss_pred HcCCCCCCCChh
Q 001847 956 KKHPFFKGVNWA 967 (1005)
Q Consensus 956 L~hpff~~~~~~ 967 (1005)
+.||||..+--.
T Consensus 304 l~h~fFdelr~~ 315 (364)
T KOG0658|consen 304 LAHPFFDELRDP 315 (364)
T ss_pred hcchhhHHhhCc
Confidence 999999975333
|
|
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-38 Score=348.69 Aligned_cols=270 Identities=35% Similarity=0.617 Sum_probs=223.1
Q ss_pred CccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEEe
Q 001847 673 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITD 752 (1005)
Q Consensus 673 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E 752 (1005)
.|+..+.||.|+||.||++.+..+++.||+|.+.............+.+|+.++++++|++|+.+++.+...+.+|+|||
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEE
Confidence 47888999999999999999999999999999876544344444567789999999999999999999999999999999
Q ss_pred ccCCCchhhHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCCCCCC
Q 001847 753 YCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLL 832 (1005)
Q Consensus 753 ~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~~~ 832 (1005)
|+.+++|.+++.......+++..+..++.|++.||.|||+.||+|+||||+||+++.++.++|+|||++.......
T Consensus 81 ~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~---- 156 (285)
T cd05630 81 LMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ---- 156 (285)
T ss_pred ecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeccceeecCCCc----
Confidence 9999999998865544568999999999999999999999999999999999999999999999999884422110
Q ss_pred CcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHcCCCCCCCCChH---HH
Q 001847 833 PTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQ---KT 909 (1005)
Q Consensus 833 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlGvll~eLltG~~Pf~~~~~~---~~ 909 (1005)
......|++.|+|||++.+..++.++|||||||++|+|++|+.||.+.... ..
T Consensus 157 ------------------------~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~ 212 (285)
T cd05630 157 ------------------------TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREE 212 (285)
T ss_pred ------------------------cccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHH
Confidence 112346899999999999888999999999999999999999999865432 22
Q ss_pred HHHHHhCCCCCCCCCCCCHHHHHHHHHccccCcCccCCCh-hcHHHHHcCCCCCCCChhhhhh
Q 001847 910 FANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSH-EGANEIKKHPFFKGVNWALVRC 971 (1005)
Q Consensus 910 ~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~-~~a~elL~hpff~~~~~~~~~~ 971 (1005)
...+... ........++..+.+|+.+||+.||.+||+.. ..+.++++||||+.++|..++.
T Consensus 213 ~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h~~~~~~~~~~~~~ 274 (285)
T cd05630 213 VERLVKE-VQEEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEHPLFKQINFKRLEA 274 (285)
T ss_pred HHhhhhh-hhhhcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcChhhhccCHHHHhc
Confidence 2222221 11112234678899999999999999999843 1378999999999999998865
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-38 Score=350.16 Aligned_cols=256 Identities=26% Similarity=0.440 Sum_probs=208.6
Q ss_pred CCccccccccccCcEEEEEEEEcC-CCeEEEEEEeecccccChHHHHHHHHHHHHHHhC---CCCCcceEEEEEE-----
Q 001847 672 QHFRPIKPLGSGDTGSVHLVELCG-SGQYFAMKAMDKGVMLNRNKVHRACAEREILDML---DHPFVPALYASFQ----- 742 (1005)
Q Consensus 672 ~~y~~~~~LG~G~~g~Vy~a~~~~-~~~~valK~~~~~~~~~~~~~~~~~~E~~il~~l---~hpnIv~l~~~~~----- 742 (1005)
++|++++.||+|+||.||+|.+.. +++.+|+|.++..... ........+|+.+++.+ +||||+++++++.
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~ 79 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGE-EGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 79 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCC-CCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCC
Confidence 379999999999999999999854 4788999998754322 22233455677777665 6999999999885
Q ss_pred eCCeEEEEEeccCCCchhhHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCc
Q 001847 743 TKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSC 822 (1005)
Q Consensus 743 ~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~~~g~vkL~DFG~a~ 822 (1005)
....+++||||+ +++|.+++.......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.
T Consensus 80 ~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~ 158 (290)
T cd07862 80 RETKLTLVFEHV-DQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLAR 158 (290)
T ss_pred CCCcEEEEEccC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcCCCCEEEccccceE
Confidence 345689999999 5689999876555568999999999999999999999999999999999999999999999999985
Q ss_pred ccCCCCCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHcCCCCCC
Q 001847 823 LTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFR 902 (1005)
Q Consensus 823 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlGvll~eLltG~~Pf~ 902 (1005)
..... .......|++.|+|||++.+..++.++|||||||++|+|++|++||.
T Consensus 159 ~~~~~----------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~ 210 (290)
T cd07862 159 IYSFQ----------------------------MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFR 210 (290)
T ss_pred eccCC----------------------------cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcC
Confidence 43211 11234568999999999988889999999999999999999999999
Q ss_pred CCChHHHHHHHHhCCC-----CCCC--------------------CCCCCHHHHHHHHHccccCcCccCCChhcHHHHHc
Q 001847 903 GKTRQKTFANILHKDL-----KFPS--------------------STPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKK 957 (1005)
Q Consensus 903 ~~~~~~~~~~i~~~~~-----~~~~--------------------~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~ 957 (1005)
+....+.+..+..... .++. ....+..+.+||.+||+.||++||+ +.++|+
T Consensus 211 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s----~~~~l~ 286 (290)
T cd07862 211 GSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRIS----AYSALS 286 (290)
T ss_pred CCCHHHHHHHHHHHhCCCChhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCC----HHHHhc
Confidence 8887777766654210 0000 1235677899999999999999999 999999
Q ss_pred CCCC
Q 001847 958 HPFF 961 (1005)
Q Consensus 958 hpff 961 (1005)
||||
T Consensus 287 hp~f 290 (290)
T cd07862 287 HPYF 290 (290)
T ss_pred CCCC
Confidence 9998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=347.78 Aligned_cols=302 Identities=38% Similarity=0.678 Sum_probs=243.1
Q ss_pred CCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEE
Q 001847 672 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLIT 751 (1005)
Q Consensus 672 ~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~ 751 (1005)
++|++++.||+|+||.||++.+..+++.|++|.+.............+.+|+.+++.++||||+++++.+...+.+|+||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 36999999999999999999999999999999987654434455667889999999999999999999999999999999
Q ss_pred eccCCCchhhHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCCCCC
Q 001847 752 DYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLL 831 (1005)
Q Consensus 752 E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~~ 831 (1005)
||+.|++|.+++... +.+++..+..++.|++.||.|||++|++|+||||+||+++.++.++|+|||++..........
T Consensus 81 e~~~g~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~~ 158 (305)
T cd05609 81 EYVEGGDCATLLKNI--GALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTN 158 (305)
T ss_pred ecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECCCCCEEEeeCCCccccCcCcccc
Confidence 999999999999764 458999999999999999999999999999999999999999999999999885422111100
Q ss_pred CCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHcCCCCCCCCChHHHHH
Q 001847 832 LPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFA 911 (1005)
Q Consensus 832 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlGvll~eLltG~~Pf~~~~~~~~~~ 911 (1005)
.... . ..............|+..|+|||.+....++.++|||||||++|+|++|..||.+....+...
T Consensus 159 ~~~~---------~---~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~ 226 (305)
T cd05609 159 LYEG---------H---IEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFG 226 (305)
T ss_pred cccc---------c---cccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 0000 0 000000011123467889999999988888999999999999999999999999888877777
Q ss_pred HHHhCCCCCCCCC-CCCHHHHHHHHHccccCcCccCCChhcHHHHHcCCCCCCCChhhhhhcCCCCCCCCCCCCcccccc
Q 001847 912 NILHKDLKFPSST-PTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVNWALVRCMNPPELDAPLFATDTEKEY 990 (1005)
Q Consensus 912 ~i~~~~~~~~~~~-~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~hpff~~~~~~~~~~~~~~~~~~p~~~~~~~~~~ 990 (1005)
.+.......+... ..+..+.+||.+||..+|++||++. .+.++|+||||...+|+.......+ -+|.+..-.+..|
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~-~~~~ll~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~ 303 (305)
T cd05609 227 QVISDDIEWPEGDEALPADAQDLISRLLRQNPLERLGTG-GAFEVKQHRFFLGLDWNGLLRQKAE--FIPQLESEDDTSY 303 (305)
T ss_pred HHHhcccCCCCccccCCHHHHHHHHHHhccChhhccCcc-CHHHHHhCccccCCCHHHHhhcCCC--CCCCCCCcccccc
Confidence 7776655554432 4688899999999999999999853 3789999999999999997654333 3466655555554
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-38 Score=364.60 Aligned_cols=254 Identities=24% Similarity=0.365 Sum_probs=206.8
Q ss_pred cccCCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEE
Q 001847 669 INLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVC 748 (1005)
Q Consensus 669 i~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~ 748 (1005)
+...+|++++.||+|+||.||+|.+..+++.||+|.... ..+.+|+.++++++||||++++++|......|
T Consensus 89 ~~~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~---------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ 159 (391)
T PHA03212 89 IEKAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR---------GGTATEAHILRAINHPSIIQLKGTFTYNKFTC 159 (391)
T ss_pred cccCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh---------hhhHHHHHHHHhCCCCCCCCEeEEEEECCeeE
Confidence 445789999999999999999999999999999996432 34678999999999999999999999999999
Q ss_pred EEEeccCCCchhhHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCC
Q 001847 749 LITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKP 828 (1005)
Q Consensus 749 lV~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~ 828 (1005)
+|||++ +++|..++... ..++...++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 160 lv~e~~-~~~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~ 236 (391)
T PHA03212 160 LILPRY-KTDLYCYLAAK--RNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDIN 236 (391)
T ss_pred EEEecC-CCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcCCCCEEEEeCCccccccccc
Confidence 999999 67888888654 348999999999999999999999999999999999999999999999999985421100
Q ss_pred CCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHcCCCCCCCCC---
Q 001847 829 QLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKT--- 905 (1005)
Q Consensus 829 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlGvll~eLltG~~Pf~~~~--- 905 (1005)
........||+.|+|||++.+..++.++|||||||++|+|++|..||.+..
T Consensus 237 --------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~ 290 (391)
T PHA03212 237 --------------------------ANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLD 290 (391)
T ss_pred --------------------------ccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCccccc
Confidence 011224579999999999998889999999999999999999998875422
Q ss_pred ----hHHHHHHHHhC--------------------------CCCCCC-------CCCCCHHHHHHHHHccccCcCccCCC
Q 001847 906 ----RQKTFANILHK--------------------------DLKFPS-------STPTSLHAKQLMYRLLHRDPKSRLGS 948 (1005)
Q Consensus 906 ----~~~~~~~i~~~--------------------------~~~~~~-------~~~~s~~l~~Ll~~~L~~dP~~Rpt~ 948 (1005)
....+..+... ....+. ....+.++.+||.+||++||.+|||
T Consensus 291 ~~~~~~~~l~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpt- 369 (391)
T PHA03212 291 GDCDSDRQIKLIIRRSGTHPNEFPIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPS- 369 (391)
T ss_pred ccCchhHHHHHHHHHhcCChhhcCcchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCC-
Confidence 11111111110 000000 0123557889999999999999999
Q ss_pred hhcHHHHHcCCCCCCC
Q 001847 949 HEGANEIKKHPFFKGV 964 (1005)
Q Consensus 949 ~~~a~elL~hpff~~~ 964 (1005)
+.++|+||||+.+
T Consensus 370 ---a~elL~hp~f~~~ 382 (391)
T PHA03212 370 ---AEALLDFAAFQDI 382 (391)
T ss_pred ---HHHHhcChhhccC
Confidence 9999999999874
|
|
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-38 Score=357.83 Aligned_cols=256 Identities=27% Similarity=0.418 Sum_probs=208.7
Q ss_pred cccCCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEE
Q 001847 669 INLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVC 748 (1005)
Q Consensus 669 i~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~ 748 (1005)
....+|+.++.||.|+||.||++.+..+++.||||++.... .......+.+|+.+++.++|+||+++++++...+.+|
T Consensus 71 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 148 (353)
T PLN00034 71 KSLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNH--EDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQ 148 (353)
T ss_pred CCHHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCC--cHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEE
Confidence 44678999999999999999999999999999999986542 3344567889999999999999999999999999999
Q ss_pred EEEeccCCCchhhHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCC
Q 001847 749 LITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKP 828 (1005)
Q Consensus 749 lV~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~ 828 (1005)
+||||+.+++|.... ..++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 149 lv~e~~~~~~L~~~~------~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~- 221 (353)
T PLN00034 149 VLLEFMDGGSLEGTH------IADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQT- 221 (353)
T ss_pred EEEecCCCCcccccc------cCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEcccccceecccc-
Confidence 999999999986532 2567888899999999999999999999999999999999999999999998543211
Q ss_pred CCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccC-----CCCCChhhHHHHHHHHHHHHcCCCCCCC
Q 001847 829 QLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAG-----AGHTSAVDWWALGILLYEMLYGYTPFRG 903 (1005)
Q Consensus 829 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-----~~~~~~sDIwSlGvll~eLltG~~Pf~~ 903 (1005)
........||..|+|||++.. ...+.++|||||||++|+|++|+.||..
T Consensus 222 --------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~ 275 (353)
T PLN00034 222 --------------------------MDPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGV 275 (353)
T ss_pred --------------------------cccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCC
Confidence 011223579999999998743 2334689999999999999999999974
Q ss_pred CChH---HHHHHHHhCCCCCCCCCCCCHHHHHHHHHccccCcCccCCChhcHHHHHcCCCCCCC
Q 001847 904 KTRQ---KTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGV 964 (1005)
Q Consensus 904 ~~~~---~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~hpff~~~ 964 (1005)
.... .....+... ........++.++.+||.+||..||++||+ +.++|+||||...
T Consensus 276 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt----~~ell~hp~~~~~ 334 (353)
T PLN00034 276 GRQGDWASLMCAICMS-QPPEAPATASREFRHFISCCLQREPAKRWS----AMQLLQHPFILRA 334 (353)
T ss_pred CCCccHHHHHHHHhcc-CCCCCCCccCHHHHHHHHHHccCChhhCcC----HHHHhcCcccccC
Confidence 3322 122222211 122223356889999999999999999999 9999999999985
|
|
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-38 Score=354.18 Aligned_cols=259 Identities=24% Similarity=0.400 Sum_probs=215.3
Q ss_pred cccCCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEE
Q 001847 669 INLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVC 748 (1005)
Q Consensus 669 i~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~ 748 (1005)
+..++|++.+.||.|+||.||++.+..++..+|+|.+.... .......+.+|+++++.++|+||++++++|...+.+|
T Consensus 2 l~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 79 (333)
T cd06650 2 LKDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEIS 79 (333)
T ss_pred cchhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeeccc--CHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEE
Confidence 45679999999999999999999999999999999887542 3344567889999999999999999999999999999
Q ss_pred EEEeccCCCchhhHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHc-CcccCCCCCCcEEEecCCcEEEEeccCCcccCCC
Q 001847 749 LITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQ-GIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCK 827 (1005)
Q Consensus 749 lV~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~-gIvHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~ 827 (1005)
+||||+.+++|.+++... +.+++..+..++.||+.||.|||+. +|+|+||||+|||++.+|.+||+|||++.....
T Consensus 80 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~- 156 (333)
T cd06650 80 ICMEHMDGGSLDQVLKKA--GRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID- 156 (333)
T ss_pred EEEecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhh-
Confidence 999999999999999764 4589999999999999999999985 799999999999999999999999998843211
Q ss_pred CCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHcCCCCCCCCChH
Q 001847 828 PQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQ 907 (1005)
Q Consensus 828 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlGvll~eLltG~~Pf~~~~~~ 907 (1005)
.......|++.|+|||++.+..++.++|||||||++|+|++|+.||......
T Consensus 157 ----------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~ 208 (333)
T cd06650 157 ----------------------------SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAK 208 (333)
T ss_pred ----------------------------hccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchh
Confidence 0112346899999999998888899999999999999999999999765443
Q ss_pred HHHHHH--------------------------------------------HhCCCCCCCCCCCCHHHHHHHHHccccCcC
Q 001847 908 KTFANI--------------------------------------------LHKDLKFPSSTPTSLHAKQLMYRLLHRDPK 943 (1005)
Q Consensus 908 ~~~~~i--------------------------------------------~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~ 943 (1005)
.....+ .....+.......+.++.+||.+||++||+
T Consensus 209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~ 288 (333)
T cd06650 209 ELELMFGCPVEGDPAESETSPRPRPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPA 288 (333)
T ss_pred HHHHHhcCcccCCccccccCcccCCccchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcc
Confidence 221111 111111111123567889999999999999
Q ss_pred ccCCChhcHHHHHcCCCCCCC
Q 001847 944 SRLGSHEGANEIKKHPFFKGV 964 (1005)
Q Consensus 944 ~Rpt~~~~a~elL~hpff~~~ 964 (1005)
+||+ +.++++||||+..
T Consensus 289 ~Rpt----~~ell~h~~~~~~ 305 (333)
T cd06650 289 ERAD----LKQLMVHAFIKRS 305 (333)
T ss_pred cCcC----HHHHhhCHHHhcC
Confidence 9999 9999999999864
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=339.82 Aligned_cols=256 Identities=26% Similarity=0.433 Sum_probs=223.8
Q ss_pred CccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEEe
Q 001847 673 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITD 752 (1005)
Q Consensus 673 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E 752 (1005)
-|.++.+||+|+||.||++.++.+|..+|+|.+... ...+.+..|+.|+.++++++||++|+.|.....+|||||
T Consensus 34 VFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~-----sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVME 108 (502)
T KOG0574|consen 34 VFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD-----TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVME 108 (502)
T ss_pred HHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc-----chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehh
Confidence 378999999999999999999999999999987643 457889999999999999999999999999999999999
Q ss_pred ccCCCchhhHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCCCCCC
Q 001847 753 YCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLL 832 (1005)
Q Consensus 753 ~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~~~ 832 (1005)
||..|++.+.++.+ .+.|++..+..+++..+.||.|||...-||||||..|||++.+|.+||.|||.+-.
T Consensus 109 YCGAGSiSDI~R~R-~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQ--------- 178 (502)
T KOG0574|consen 109 YCGAGSISDIMRAR-RKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTDGIAKLADFGVAGQ--------- 178 (502)
T ss_pred hcCCCcHHHHHHHh-cCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEcccchhhhhhccccch---------
Confidence 99999999999754 46799999999999999999999999999999999999999999999999999833
Q ss_pred CcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHcCCCCCCCCChHHHHHH
Q 001847 833 PTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFAN 912 (1005)
Q Consensus 833 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlGvll~eLltG~~Pf~~~~~~~~~~~ 912 (1005)
..+.....+++.|||.|||||++....|+.++||||||++..+|..|++||....+...+..
T Consensus 179 ------------------LTDTMAKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFM 240 (502)
T KOG0574|consen 179 ------------------LTDTMAKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFM 240 (502)
T ss_pred ------------------hhhhHHhhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeEe
Confidence 23344556788999999999999999999999999999999999999999988776555443
Q ss_pred HHhCCC-CCCCCCCCCHHHHHHHHHccccCcCccCCChhcHHHHHcCCCCCCCC
Q 001847 913 ILHKDL-KFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVN 965 (1005)
Q Consensus 913 i~~~~~-~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~hpff~~~~ 965 (1005)
|-.... .+.....-|.++.+|+++||.++|++|.| |-+|++|||+++..
T Consensus 241 IPT~PPPTF~KPE~WS~~F~DFi~~CLiK~PE~R~T----A~~L~~H~FiknA~ 290 (502)
T KOG0574|consen 241 IPTKPPPTFKKPEEWSSEFNDFIRSCLIKKPEERKT----ALRLCEHTFIKNAP 290 (502)
T ss_pred ccCCCCCCCCChHhhhhHHHHHHHHHhcCCHHHHHH----HHHHhhhhhhcCCC
Confidence 333222 22233334778999999999999999999 99999999999854
|
|
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-39 Score=356.01 Aligned_cols=254 Identities=26% Similarity=0.379 Sum_probs=232.1
Q ss_pred CccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEEe
Q 001847 673 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITD 752 (1005)
Q Consensus 673 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E 752 (1005)
.|.-++.||.|+||.||-+++..+...||||.+............++..|+..|+++.|||++.+.+||......|+|||
T Consensus 27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVME 106 (948)
T KOG0577|consen 27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVME 106 (948)
T ss_pred HHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHH
Confidence 58889999999999999999999999999999998766677888999999999999999999999999999999999999
Q ss_pred ccCCCchhhHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCCCCCC
Q 001847 753 YCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLL 832 (1005)
Q Consensus 753 ~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~~~ 832 (1005)
|| -|+-.+++... .+++.+-.+..|+.+.+.||+|||+.+.||||||..|||+++.|.|||+|||.|..+.
T Consensus 107 YC-lGSAsDlleVh-kKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~------- 177 (948)
T KOG0577|consen 107 YC-LGSASDLLEVH-KKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSEPGLVKLADFGSASIMA------- 177 (948)
T ss_pred HH-hccHHHHHHHH-hccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEecCCCeeeeccccchhhcC-------
Confidence 99 77888888754 3569999999999999999999999999999999999999999999999999986543
Q ss_pred CcchhhhhcccCCCCCcccccccccccccccCCcccccccccC---CCCCChhhHHHHHHHHHHHHcCCCCCCCCChHHH
Q 001847 833 PTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAG---AGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKT 909 (1005)
Q Consensus 833 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~---~~~~~~sDIwSlGvll~eLltG~~Pf~~~~~~~~ 909 (1005)
+.++++|||+|||||++.. +.|+-++||||||++..+|...++|+...+.+..
T Consensus 178 ------------------------PAnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSA 233 (948)
T KOG0577|consen 178 ------------------------PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA 233 (948)
T ss_pred ------------------------chhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHH
Confidence 3457899999999999854 5788899999999999999999999999999999
Q ss_pred HHHHHhCCCCCCCCCCCCHHHHHHHHHccccCcCccCCChhcHHHHHcCCCCCC
Q 001847 910 FANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKG 963 (1005)
Q Consensus 910 ~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~hpff~~ 963 (1005)
+.-|.+...+......-+..+.+|+..||++-|.+||| .+++|+|+|...
T Consensus 234 LYHIAQNesPtLqs~eWS~~F~~Fvd~CLqKipqeRpt----se~ll~H~fv~R 283 (948)
T KOG0577|consen 234 LYHIAQNESPTLQSNEWSDYFRNFVDSCLQKIPQERPT----SEELLKHRFVLR 283 (948)
T ss_pred HHHHHhcCCCCCCCchhHHHHHHHHHHHHhhCcccCCc----HHHHhhcchhcc
Confidence 99998887776666667889999999999999999999 999999999875
|
|
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=351.17 Aligned_cols=260 Identities=26% Similarity=0.427 Sum_probs=212.2
Q ss_pred cccCCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCeE
Q 001847 669 INLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPALYASFQTKTHV 747 (1005)
Q Consensus 669 i~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~ 747 (1005)
++...|++++.||+||.+.||+|...+ ...||+|.+... ..+......+.+|+.+|.+| .|.+|+++++|-..++++
T Consensus 358 Vkg~~Yeilk~iG~GGSSkV~kV~~s~-~~iyalkkv~~~-~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~l 435 (677)
T KOG0596|consen 358 VKGREYEILKQIGSGGSSKVFKVLNSD-KQIYALKKVVLL-EADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYL 435 (677)
T ss_pred ECcchhhHHHhhcCCCcceeeeeecCC-CcchhhhHHHHh-hcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceE
Confidence 567889999999999999999999844 445555554432 33667788999999999999 699999999999999999
Q ss_pred EEEEeccCCCchhhHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCC
Q 001847 748 CLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCK 827 (1005)
Q Consensus 748 ~lV~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~ 827 (1005)
|+||||- ..+|...|++.. ..++...++.|..|+|.|+.++|+.||||.||||.|+|+. .|.+||+|||.|..+..+
T Consensus 436 YmvmE~G-d~DL~kiL~k~~-~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLlV-kG~LKLIDFGIA~aI~~D 512 (677)
T KOG0596|consen 436 YMVMECG-DIDLNKILKKKK-SIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLLV-KGRLKLIDFGIANAIQPD 512 (677)
T ss_pred EEEeecc-cccHHHHHHhcc-CCCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEEE-eeeEEeeeechhcccCcc
Confidence 9999997 889999998653 4455568999999999999999999999999999999999 789999999999665433
Q ss_pred CCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCC-----------CCChhhHHHHHHHHHHHHc
Q 001847 828 PQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAG-----------HTSAVDWWALGILLYEMLY 896 (1005)
Q Consensus 828 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~-----------~~~~sDIwSlGvll~eLlt 896 (1005)
.. +-...+.+||+.||+||.+.... .+.++|||||||+||+|+.
T Consensus 513 TT-------------------------sI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvY 567 (677)
T KOG0596|consen 513 TT-------------------------SIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVY 567 (677)
T ss_pred cc-------------------------ceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHh
Confidence 22 22345678999999999996543 4568999999999999999
Q ss_pred CCCCCCCCC-hHHHHHHHHhC--CCCCCCCCCCCHHHHHHHHHccccCcCccCCChhcHHHHHcCCCCCC
Q 001847 897 GYTPFRGKT-RQKTFANILHK--DLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKG 963 (1005)
Q Consensus 897 G~~Pf~~~~-~~~~~~~i~~~--~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~hpff~~ 963 (1005)
|+.||.... ....+..|..- .+.+|..+.. .+++++++.||.+||.+||+ +.+||+|||++.
T Consensus 568 gktPf~~~~n~~aKl~aI~~P~~~Iefp~~~~~-~~li~~mK~CL~rdPkkR~s----i~eLLqhpFl~~ 632 (677)
T KOG0596|consen 568 GKTPFGQIINQIAKLHAITDPNHEIEFPDIPEN-DELIDVMKCCLARDPKKRWS----IPELLQHPFLQI 632 (677)
T ss_pred cCCchHHHHHHHHHHHhhcCCCccccccCCCCc-hHHHHHHHHHHhcCcccCCC----cHHHhcCccccc
Confidence 999997644 33334444443 3455554432 34999999999999999999 999999999996
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=353.97 Aligned_cols=255 Identities=25% Similarity=0.399 Sum_probs=218.6
Q ss_pred ccccccccCCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceEEEEEEe
Q 001847 664 DSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQT 743 (1005)
Q Consensus 664 ~~~~~i~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~ 743 (1005)
...+.+....+++++.||+|.||.||++.+.. ...+|+|.++.... ....+.+|+++|++|+|++||++++++..
T Consensus 198 ~d~wei~r~~l~l~~~LG~G~FG~V~~g~~~~-~~~vavk~ik~~~m----~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~ 272 (468)
T KOG0197|consen 198 RDPWEIPREELKLIRELGSGQFGEVWLGKWNG-STKVAVKTIKEGSM----SPEAFLREAQIMKKLRHEKLVKLYGVCTK 272 (468)
T ss_pred cCCeeecHHHHHHHHHhcCCccceEEEEEEcC-CCcccceEEecccc----ChhHHHHHHHHHHhCcccCeEEEEEEEec
Confidence 34556777889999999999999999999933 34799999887533 33567799999999999999999999999
Q ss_pred CCeEEEEEeccCCCchhhHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcc
Q 001847 744 KTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCL 823 (1005)
Q Consensus 744 ~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~~~g~vkL~DFG~a~~ 823 (1005)
+..+|||||||+.|+|.++++...+..+...+...++.||++|++||+++++|||||-..||||++++.|||+|||+|+.
T Consensus 273 ~~piyIVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~ 352 (468)
T KOG0197|consen 273 QEPIYIVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVDEDLVVKISDFGLARL 352 (468)
T ss_pred CCceEEEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeeccCceEEEcccccccc
Confidence 88999999999999999999986677899999999999999999999999999999999999999999999999999984
Q ss_pred cCCCCCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHc-CCCCCC
Q 001847 824 TSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY-GYTPFR 902 (1005)
Q Consensus 824 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlGvll~eLlt-G~~Pf~ 902 (1005)
..++.- . ....---...|.|||++....++.+|||||||++||||+| |+.||.
T Consensus 353 ~~d~~Y----------~----------------~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~ 406 (468)
T KOG0197|consen 353 IGDDEY----------T----------------ASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYP 406 (468)
T ss_pred cCCCce----------e----------------ecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCC
Confidence 332211 0 0111112446999999999999999999999999999997 999999
Q ss_pred CCChHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHccccCcCccCCChh
Q 001847 903 GKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHE 950 (1005)
Q Consensus 903 ~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~ 950 (1005)
+.+..+.+..+.++ ...|.+..++.++.+++..||..+|++||||..
T Consensus 407 ~msn~ev~~~le~G-yRlp~P~~CP~~vY~lM~~CW~~~P~~RPtF~~ 453 (468)
T KOG0197|consen 407 GMSNEEVLELLERG-YRLPRPEGCPDEVYELMKSCWHEDPEDRPTFET 453 (468)
T ss_pred CCCHHHHHHHHhcc-CcCCCCCCCCHHHHHHHHHHhhCCcccCCCHHH
Confidence 99999988777665 455666678999999999999999999999653
|
|
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=357.70 Aligned_cols=261 Identities=27% Similarity=0.407 Sum_probs=213.4
Q ss_pred CccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC-----eE
Q 001847 673 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKT-----HV 747 (1005)
Q Consensus 673 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~-----~~ 747 (1005)
+|++.+.||+|+||.||++.+..+++.||+|.+... .........+.+|+.+++.++|+||+++++++...+ .+
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 79 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNV-FQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEI 79 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEecccc-ccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceE
Confidence 478899999999999999999999999999988653 223345567889999999999999999999998776 79
Q ss_pred EEEEeccCCCchhhHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCC
Q 001847 748 CLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCK 827 (1005)
Q Consensus 748 ~lV~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~ 827 (1005)
|+||||+ +++|..++... ..++...++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 80 ~lv~e~~-~~~l~~~~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~ 156 (372)
T cd07853 80 YVVTELM-QSDLHKIIVSP--QPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPD 156 (372)
T ss_pred EEEeecc-ccCHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCCCCEEeccccceeecccC
Confidence 9999999 46788877553 45899999999999999999999999999999999999999999999999998543211
Q ss_pred CCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCC-CCCChhhHHHHHHHHHHHHcCCCCCCCCCh
Q 001847 828 PQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGA-GHTSAVDWWALGILLYEMLYGYTPFRGKTR 906 (1005)
Q Consensus 828 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~sDIwSlGvll~eLltG~~Pf~~~~~ 906 (1005)
.. .......+++.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+.
T Consensus 157 ~~--------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~ 210 (372)
T cd07853 157 ES--------------------------KHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSP 210 (372)
T ss_pred cc--------------------------ccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCH
Confidence 10 111234678999999998774 468899999999999999999999988776
Q ss_pred HHHHHHHHhC-----------------------CCCC-------CCCCCCCHHHHHHHHHccccCcCccCCChhcHHHHH
Q 001847 907 QKTFANILHK-----------------------DLKF-------PSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIK 956 (1005)
Q Consensus 907 ~~~~~~i~~~-----------------------~~~~-------~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL 956 (1005)
...+..+... .... ......+.++.+||.+||+.||.+||| +.++|
T Consensus 211 ~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t----~~e~l 286 (372)
T cd07853 211 IQQLDLITDLLGTPSLEAMRSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRIS----AADAL 286 (372)
T ss_pred HHHHHHHHHHcCCCCHHHHHHhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcC----HHHHh
Confidence 6555444321 1111 111234778899999999999999999 99999
Q ss_pred cCCCCCCCChh
Q 001847 957 KHPFFKGVNWA 967 (1005)
Q Consensus 957 ~hpff~~~~~~ 967 (1005)
+||||+...+.
T Consensus 287 ~hp~~~~~~~~ 297 (372)
T cd07853 287 AHPYLDEGRLR 297 (372)
T ss_pred cCHhhCCCcch
Confidence 99999986543
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=356.52 Aligned_cols=255 Identities=25% Similarity=0.484 Sum_probs=207.5
Q ss_pred cCCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC-----
Q 001847 671 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKT----- 745 (1005)
Q Consensus 671 ~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~----- 745 (1005)
.++|++++.||+|+||.||++.+..+|+.||+|.+.... ........+.+|+.+++.++||||++++++|...+
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 98 (359)
T cd07876 20 LKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPF-QNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF 98 (359)
T ss_pred hhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccc-cchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence 579999999999999999999999999999999987542 23344567788999999999999999999986543
Q ss_pred -eEEEEEeccCCCchhhHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCccc
Q 001847 746 -HVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLT 824 (1005)
Q Consensus 746 -~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~~~g~vkL~DFG~a~~~ 824 (1005)
.+|+||||+. ++|...+.. .++...+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||++...
T Consensus 99 ~~~~lv~e~~~-~~l~~~~~~----~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~ 173 (359)
T cd07876 99 QDVYLVMELMD-ANLCQVIHM----ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA 173 (359)
T ss_pred ceeEEEEeCCC-cCHHHHHhc----cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEecCCCcccc
Confidence 5799999995 566666543 3788999999999999999999999999999999999999999999999998542
Q ss_pred CCCCCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHcCCCCCCCC
Q 001847 825 SCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGK 904 (1005)
Q Consensus 825 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlGvll~eLltG~~Pf~~~ 904 (1005)
... .......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.
T Consensus 174 ~~~----------------------------~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~ 225 (359)
T cd07876 174 CTN----------------------------FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGT 225 (359)
T ss_pred ccC----------------------------ccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCC
Confidence 211 0112346899999999999988999999999999999999999999876
Q ss_pred ChHHHHHHHHh----------------------CCCCCC--------------C----CCCCCHHHHHHHHHccccCcCc
Q 001847 905 TRQKTFANILH----------------------KDLKFP--------------S----STPTSLHAKQLMYRLLHRDPKS 944 (1005)
Q Consensus 905 ~~~~~~~~i~~----------------------~~~~~~--------------~----~~~~s~~l~~Ll~~~L~~dP~~ 944 (1005)
+....+..+.. ....++ . ....+..+.+||.+||+.||.+
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~ 305 (359)
T cd07876 226 DHIDQWNKVIEQLGTPSAEFMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDK 305 (359)
T ss_pred CHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCccc
Confidence 65433322211 111110 0 0113567899999999999999
Q ss_pred cCCChhcHHHHHcCCCCCC
Q 001847 945 RLGSHEGANEIKKHPFFKG 963 (1005)
Q Consensus 945 Rpt~~~~a~elL~hpff~~ 963 (1005)
||| +.++|+||||..
T Consensus 306 R~t----~~e~l~hp~~~~ 320 (359)
T cd07876 306 RIS----VDEALRHPYITV 320 (359)
T ss_pred CCC----HHHHhcCchhhh
Confidence 999 999999999985
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=355.87 Aligned_cols=255 Identities=24% Similarity=0.461 Sum_probs=210.0
Q ss_pred cCCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeC------
Q 001847 671 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTK------ 744 (1005)
Q Consensus 671 ~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~------ 744 (1005)
.++|++++.||+|+||.||++.+..+++.||||.+.... ........+.+|+.+++.++||||+.+++++...
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~ 101 (364)
T cd07875 23 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPF-QNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 101 (364)
T ss_pred hcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccc-cCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence 578999999999999999999999999999999987542 2334456778899999999999999999987543
Q ss_pred CeEEEEEeccCCCchhhHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCccc
Q 001847 745 THVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLT 824 (1005)
Q Consensus 745 ~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~~~g~vkL~DFG~a~~~ 824 (1005)
..+|+||||+ +++|...+.. .++...+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus 102 ~~~~lv~e~~-~~~l~~~~~~----~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~ 176 (364)
T cd07875 102 QDVYIVMELM-DANLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA 176 (364)
T ss_pred CeEEEEEeCC-CCCHHHHHHh----cCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECCCCcEEEEeCCCcccc
Confidence 3579999999 4577777653 3788999999999999999999999999999999999999999999999998543
Q ss_pred CCCCCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHcCCCCCCCC
Q 001847 825 SCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGK 904 (1005)
Q Consensus 825 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlGvll~eLltG~~Pf~~~ 904 (1005)
... .......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.
T Consensus 177 ~~~----------------------------~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~ 228 (364)
T cd07875 177 GTS----------------------------FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGT 228 (364)
T ss_pred CCC----------------------------CcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCC
Confidence 211 0112346899999999999989999999999999999999999999887
Q ss_pred ChHHHHHHHHhCC----------------------CCC--------------CC----CCCCCHHHHHHHHHccccCcCc
Q 001847 905 TRQKTFANILHKD----------------------LKF--------------PS----STPTSLHAKQLMYRLLHRDPKS 944 (1005)
Q Consensus 905 ~~~~~~~~i~~~~----------------------~~~--------------~~----~~~~s~~l~~Ll~~~L~~dP~~ 944 (1005)
+....+..++... ..+ +. ....+..+++||.+||+.||.+
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~ 308 (364)
T cd07875 229 DHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASK 308 (364)
T ss_pred CHHHHHHHHHHhcCCCCHHHHHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCccc
Confidence 7766555544310 000 00 0112457889999999999999
Q ss_pred cCCChhcHHHHHcCCCCCC
Q 001847 945 RLGSHEGANEIKKHPFFKG 963 (1005)
Q Consensus 945 Rpt~~~~a~elL~hpff~~ 963 (1005)
||| +.++|+||||..
T Consensus 309 R~t----~~e~L~hp~~~~ 323 (364)
T cd07875 309 RIS----VDEALQHPYINV 323 (364)
T ss_pred CCC----HHHHhcCccccc
Confidence 999 999999999985
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=364.48 Aligned_cols=256 Identities=26% Similarity=0.419 Sum_probs=206.6
Q ss_pred cCCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeC------
Q 001847 671 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTK------ 744 (1005)
Q Consensus 671 ~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~------ 744 (1005)
..+|++++.||+|+||.||+|.+..+++.||||.+.... ....+|+.+++.++||||++++++|...
T Consensus 65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~-------~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~ 137 (440)
T PTZ00036 65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP-------QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNE 137 (440)
T ss_pred CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc-------chHHHHHHHHHhcCCCCCcceeeeEeecccccCC
Confidence 457999999999999999999999999999999886431 2234699999999999999999887432
Q ss_pred --CeEEEEEeccCCCchhhHHhh--CCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCC-cEEEEecc
Q 001847 745 --THVCLITDYCPGGELFLLLDR--QPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNG-HVSLTDFD 819 (1005)
Q Consensus 745 --~~~~lV~E~~~ggsL~~~l~~--~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~~~g-~vkL~DFG 819 (1005)
..+++||||++ ++|.+++.. .....+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||
T Consensus 138 ~~~~l~lvmE~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~~~vkL~DFG 216 (440)
T PTZ00036 138 KNIFLNVVMEFIP-QTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFG 216 (440)
T ss_pred CceEEEEEEecCC-ccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCCCceeeeccc
Confidence 25779999995 577776653 2345699999999999999999999999999999999999999664 79999999
Q ss_pred CCcccCCCCCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCC-CCCChhhHHHHHHHHHHHHcCC
Q 001847 820 LSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGA-GHTSAVDWWALGILLYEMLYGY 898 (1005)
Q Consensus 820 ~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~sDIwSlGvll~eLltG~ 898 (1005)
++...... .......||+.|+|||++.+. .++.++|||||||++|+|++|.
T Consensus 217 la~~~~~~----------------------------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~ 268 (440)
T PTZ00036 217 SAKNLLAG----------------------------QRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGY 268 (440)
T ss_pred cchhccCC----------------------------CCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCC
Confidence 98543211 111235789999999998764 6889999999999999999999
Q ss_pred CCCCCCChHHHHHHHHhC-----------------CCCCCC----------CCCCCHHHHHHHHHccccCcCccCCChhc
Q 001847 899 TPFRGKTRQKTFANILHK-----------------DLKFPS----------STPTSLHAKQLMYRLLHRDPKSRLGSHEG 951 (1005)
Q Consensus 899 ~Pf~~~~~~~~~~~i~~~-----------------~~~~~~----------~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~ 951 (1005)
+||.+....+.+..+.+. .+.++. ....+.++.+||.+||++||.+|||
T Consensus 269 ~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~t---- 344 (440)
T PTZ00036 269 PIFSGQSSVDQLVRIIQVLGTPTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLN---- 344 (440)
T ss_pred CCCCCCChHHHHHHHHHHhCCCCHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcC----
Confidence 999988776666555431 111111 1125678999999999999999999
Q ss_pred HHHHHcCCCCCCCCh
Q 001847 952 ANEIKKHPFFKGVNW 966 (1005)
Q Consensus 952 a~elL~hpff~~~~~ 966 (1005)
+.++|+||||..+..
T Consensus 345 a~e~l~hp~f~~~~~ 359 (440)
T PTZ00036 345 PIEALADPFFDDLRD 359 (440)
T ss_pred HHHHhCChhHHhhhc
Confidence 999999999987543
|
|
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=347.59 Aligned_cols=260 Identities=23% Similarity=0.417 Sum_probs=213.0
Q ss_pred ccCCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEE
Q 001847 670 NLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCL 749 (1005)
Q Consensus 670 ~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l 749 (1005)
...+|++++.||+|+||.||++.+..++..+|+|.++.... ......+.+|+.++++++||||+++++++...+..|+
T Consensus 4 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 81 (309)
T cd07872 4 KMETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHE--EGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTL 81 (309)
T ss_pred CCCceEEEEEecccCCEEEEEEEecCCCCeEEEEEeecccc--CCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEE
Confidence 35689999999999999999999999999999999875422 2223456689999999999999999999999999999
Q ss_pred EEeccCCCchhhHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCCC
Q 001847 750 ITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQ 829 (1005)
Q Consensus 750 V~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~ 829 (1005)
||||+. ++|.+++... ...++...++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 82 v~e~~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~- 158 (309)
T cd07872 82 VFEYLD-KDLKQYMDDC-GNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPT- 158 (309)
T ss_pred EEeCCC-CCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECccccceecCCCc-
Confidence 999995 5888887654 2458899999999999999999999999999999999999999999999999885422110
Q ss_pred CCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccC-CCCCChhhHHHHHHHHHHHHcCCCCCCCCChHH
Q 001847 830 LLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAG-AGHTSAVDWWALGILLYEMLYGYTPFRGKTRQK 908 (1005)
Q Consensus 830 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~sDIwSlGvll~eLltG~~Pf~~~~~~~ 908 (1005)
.......+++.|+|||.+.+ ..++.++|||||||++|+|++|+.||.+.+..+
T Consensus 159 --------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~ 212 (309)
T cd07872 159 --------------------------KTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVED 212 (309)
T ss_pred --------------------------cccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH
Confidence 01123457899999999865 457889999999999999999999998877655
Q ss_pred HHHHHHhC-------------------CCCCC---------CCCCCCHHHHHHHHHccccCcCccCCChhcHHHHHcCCC
Q 001847 909 TFANILHK-------------------DLKFP---------SSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPF 960 (1005)
Q Consensus 909 ~~~~i~~~-------------------~~~~~---------~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~hpf 960 (1005)
....+... ...++ ....++.++.+||.+||..||.+||| +.++|+|||
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t----~~e~l~h~~ 288 (309)
T cd07872 213 ELHLIFRLLGTPTEETWPGISSNDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRIS----AEEAMKHAY 288 (309)
T ss_pred HHHHHHHHhCCCCHHHHhhhcchhhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCC----HHHHhcChh
Confidence 54444321 00111 11235778999999999999999999 999999999
Q ss_pred CCCC
Q 001847 961 FKGV 964 (1005)
Q Consensus 961 f~~~ 964 (1005)
|+.+
T Consensus 289 ~~~~ 292 (309)
T cd07872 289 FRSL 292 (309)
T ss_pred hhhc
Confidence 9975
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=353.66 Aligned_cols=257 Identities=25% Similarity=0.460 Sum_probs=209.0
Q ss_pred ccCCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeC-----
Q 001847 670 NLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTK----- 744 (1005)
Q Consensus 670 ~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~----- 744 (1005)
..++|++++.||+|+||.||++.+..+++.||+|.+.... ........+.+|+.+++.++||||+++++++...
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 93 (355)
T cd07874 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPF-QNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEE 93 (355)
T ss_pred hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcc-cChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccc
Confidence 3579999999999999999999999999999999987642 2334456778899999999999999999988643
Q ss_pred -CeEEEEEeccCCCchhhHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcc
Q 001847 745 -THVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCL 823 (1005)
Q Consensus 745 -~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~~~g~vkL~DFG~a~~ 823 (1005)
..+|+||||+. ++|.+.+.. .++...+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..
T Consensus 94 ~~~~~lv~e~~~-~~l~~~~~~----~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~~~~~kl~Dfg~~~~ 168 (355)
T cd07874 94 FQDVYLVMELMD-ANLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART 168 (355)
T ss_pred cceeEEEhhhhc-ccHHHHHhh----cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEECCCCCEEEeeCccccc
Confidence 35799999994 567776653 388999999999999999999999999999999999999999999999999854
Q ss_pred cCCCCCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHcCCCCCCC
Q 001847 824 TSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRG 903 (1005)
Q Consensus 824 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlGvll~eLltG~~Pf~~ 903 (1005)
.... .......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+
T Consensus 169 ~~~~----------------------------~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~ 220 (355)
T cd07874 169 AGTS----------------------------FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPG 220 (355)
T ss_pred CCCc----------------------------cccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 3211 011234689999999999988899999999999999999999999988
Q ss_pred CChHHHHHHHHhC----------------------CCC-----CC-------------CCCCCCHHHHHHHHHccccCcC
Q 001847 904 KTRQKTFANILHK----------------------DLK-----FP-------------SSTPTSLHAKQLMYRLLHRDPK 943 (1005)
Q Consensus 904 ~~~~~~~~~i~~~----------------------~~~-----~~-------------~~~~~s~~l~~Ll~~~L~~dP~ 943 (1005)
.+....+..+... ... ++ .....+..+.+||.+||..||.
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~ 300 (355)
T cd07874 221 RDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPA 300 (355)
T ss_pred CCHHHHHHHHHHHhCCCCHHHHHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCch
Confidence 7655444332211 000 00 0011345788999999999999
Q ss_pred ccCCChhcHHHHHcCCCCCCC
Q 001847 944 SRLGSHEGANEIKKHPFFKGV 964 (1005)
Q Consensus 944 ~Rpt~~~~a~elL~hpff~~~ 964 (1005)
+||| +.++|+||||...
T Consensus 301 ~Rps----~~ell~hp~~~~~ 317 (355)
T cd07874 301 KRIS----VDEALQHPYINVW 317 (355)
T ss_pred hcCC----HHHHhcCcchhcc
Confidence 9999 9999999999854
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=343.45 Aligned_cols=255 Identities=28% Similarity=0.461 Sum_probs=206.1
Q ss_pred CccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhC---CCCCcceEEEEEEe-----C
Q 001847 673 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDML---DHPFVPALYASFQT-----K 744 (1005)
Q Consensus 673 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~il~~l---~hpnIv~l~~~~~~-----~ 744 (1005)
+|++++.||+|+||.||+|.+..+++.||+|.++..... ........+|+.+++.+ +||||+++++++.. .
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~ 79 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNE-DGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRE 79 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCC-CCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCC
Confidence 589999999999999999999999999999998754221 22223445666666655 79999999998864 3
Q ss_pred CeEEEEEeccCCCchhhHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCccc
Q 001847 745 THVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLT 824 (1005)
Q Consensus 745 ~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~~~g~vkL~DFG~a~~~ 824 (1005)
..+++||||+. ++|.+++.......+++..++.++.||+.||.|||++||+|+||||+|||++.++.+||+|||++...
T Consensus 80 ~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~kl~dfg~~~~~ 158 (288)
T cd07863 80 TKVTLVFEHVD-QDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIY 158 (288)
T ss_pred ceEEEEEcccc-cCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccCccccc
Confidence 46899999995 58988887654456899999999999999999999999999999999999999999999999988543
Q ss_pred CCCCCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHcCCCCCCCC
Q 001847 825 SCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGK 904 (1005)
Q Consensus 825 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlGvll~eLltG~~Pf~~~ 904 (1005)
... .......|++.|+|||++.+..++.++|||||||++|+|++|++||.+.
T Consensus 159 ~~~----------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~ 210 (288)
T cd07863 159 SCQ----------------------------MALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGN 210 (288)
T ss_pred cCc----------------------------ccCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCC
Confidence 211 0112346889999999998888999999999999999999999999887
Q ss_pred ChHHHHHHHHhCC-----CCCC--------------------CCCCCCHHHHHHHHHccccCcCccCCChhcHHHHHcCC
Q 001847 905 TRQKTFANILHKD-----LKFP--------------------SSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHP 959 (1005)
Q Consensus 905 ~~~~~~~~i~~~~-----~~~~--------------------~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~hp 959 (1005)
.....+..+.... ..++ ....++..+.+||.+||++||.+||| +.+++.||
T Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t----~~~~l~hp 286 (288)
T cd07863 211 SEADQLGKIFDLIGLPPEDDWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRIS----AFRALQHP 286 (288)
T ss_pred CHHHHHHHHHHHhCCCChhhCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCC----HHHHhcCC
Confidence 7665555543310 0000 01235677899999999999999999 99999999
Q ss_pred CC
Q 001847 960 FF 961 (1005)
Q Consensus 960 ff 961 (1005)
||
T Consensus 287 ~f 288 (288)
T cd07863 287 FF 288 (288)
T ss_pred CC
Confidence 98
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-37 Score=333.15 Aligned_cols=260 Identities=26% Similarity=0.382 Sum_probs=219.6
Q ss_pred CCccccccccccCcEEEEEEEEcCCCeEEEEEEeeccccc--ChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEE
Q 001847 672 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVML--NRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCL 749 (1005)
Q Consensus 672 ~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~~~~~~~~--~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l 749 (1005)
+.|.+.+.||+|++|.||++.+..+++.|++|.+...... .......+.+|+.++++++||||+++++++.....+|+
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 4689999999999999999999999999999998754221 12234577889999999999999999999999999999
Q ss_pred EEeccCCCchhhHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCCC
Q 001847 750 ITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQ 829 (1005)
Q Consensus 750 V~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~ 829 (1005)
||||+++++|.+++... ..++...++.++.||+.||.|||+.||+|+||+|+||+++.++.++|+|||++........
T Consensus 82 v~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~~ 159 (263)
T cd06625 82 FMEYMPGGSVKDQLKAY--GALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICS 159 (263)
T ss_pred EEEECCCCcHHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecccccc
Confidence 99999999999998764 4589999999999999999999999999999999999999999999999998854321100
Q ss_pred CCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHcCCCCCCCCChHHH
Q 001847 830 LLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKT 909 (1005)
Q Consensus 830 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlGvll~eLltG~~Pf~~~~~~~~ 909 (1005)
.........|+..|+|||++.+..++.++|||||||++|+|++|+.||........
T Consensus 160 ------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~ 215 (263)
T cd06625 160 ------------------------SGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAA 215 (263)
T ss_pred ------------------------ccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHH
Confidence 00011234678899999999988899999999999999999999999988776666
Q ss_pred HHHHHhCCCCCCCCCCCCHHHHHHHHHccccCcCccCCChhcHHHHHcCCCC
Q 001847 910 FANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFF 961 (1005)
Q Consensus 910 ~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~hpff 961 (1005)
...+.............+..+.+||.+||..+|.+||+ +.++++|+||
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt----~~~ll~~~~~ 263 (263)
T cd06625 216 IFKIATQPTNPQLPSHVSPDARNFLRRTFVENAKKRPS----AEELLRHFFV 263 (263)
T ss_pred HHHHhccCCCCCCCccCCHHHHHHHHHHhhcCcccCCC----HHHHhhCCCC
Confidence 66655544443334457889999999999999999999 9999999998
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=366.61 Aligned_cols=270 Identities=28% Similarity=0.409 Sum_probs=226.1
Q ss_pred cccCCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC---
Q 001847 669 INLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKT--- 745 (1005)
Q Consensus 669 i~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~--- 745 (1005)
...++|++.+.||+|+||.||++.+..+++.||||.+..... .......+.+|+.++..++|+||++++..+...+
T Consensus 29 ~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~ 107 (496)
T PTZ00283 29 EQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGM-SEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRN 107 (496)
T ss_pred ccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccC-CHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccC
Confidence 345799999999999999999999999999999999876533 3445567788999999999999999988775432
Q ss_pred -----eEEEEEeccCCCchhhHHhhC--CCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEec
Q 001847 746 -----HVCLITDYCPGGELFLLLDRQ--PTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDF 818 (1005)
Q Consensus 746 -----~~~lV~E~~~ggsL~~~l~~~--~~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~~~g~vkL~DF 818 (1005)
.+++||||+++|+|.+++... ....+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+||
T Consensus 108 ~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~~~~vkL~DF 187 (496)
T PTZ00283 108 PENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDF 187 (496)
T ss_pred cccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeCCCCEEEEec
Confidence 378999999999999998642 2346899999999999999999999999999999999999999999999999
Q ss_pred cCCcccCCCCCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHcCC
Q 001847 819 DLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGY 898 (1005)
Q Consensus 819 G~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlGvll~eLltG~ 898 (1005)
|++........ .......+||+.|+|||++.+..++.++|||||||++|+|++|+
T Consensus 188 Gls~~~~~~~~-------------------------~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~ 242 (496)
T PTZ00283 188 GFSKMYAATVS-------------------------DDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLK 242 (496)
T ss_pred ccCeecccccc-------------------------ccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCC
Confidence 99854321100 01123467999999999999988999999999999999999999
Q ss_pred CCCCCCChHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHccccCcCccCCChhcHHHHHcCCCCCCCChhhh
Q 001847 899 TPFRGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVNWALV 969 (1005)
Q Consensus 899 ~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~hpff~~~~~~~~ 969 (1005)
.||.+.+..+.+..+..+... +....++..+.+|+.+||+.||.+||+ +.++++|||++...-...
T Consensus 243 ~Pf~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~~L~~dP~~RPs----~~ell~~p~~~~~~~~~~ 308 (496)
T PTZ00283 243 RPFDGENMEEVMHKTLAGRYD-PLPPSISPEMQEIVTALLSSDPKRRPS----SSKLLNMPICKLFISGLL 308 (496)
T ss_pred CCCCCCCHHHHHHHHhcCCCC-CCCCCCCHHHHHHHHHHcccChhhCcC----HHHHHhCHHHHHhhhhHH
Confidence 999988887777777665443 223457889999999999999999999 999999999987544333
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=336.11 Aligned_cols=283 Identities=36% Similarity=0.697 Sum_probs=248.8
Q ss_pred cccccCCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCC
Q 001847 667 EQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPALYASFQTKT 745 (1005)
Q Consensus 667 ~~i~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~ 745 (1005)
..|...+|..+.+||.|+||.|.++..+.+...||||+++++.+-.....+--..|..+|... +-|.+++++.+|+.-+
T Consensus 344 d~i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmD 423 (683)
T KOG0696|consen 344 DRIKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMD 423 (683)
T ss_pred cceeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhh
Confidence 356778999999999999999999999999999999999998776666666666788888777 5689999999999999
Q ss_pred eEEEEEeccCCCchhhHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccC
Q 001847 746 HVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTS 825 (1005)
Q Consensus 746 ~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~~~g~vkL~DFG~a~~~~ 825 (1005)
.+|+||||++||+|--.+++- +.+.+..+..++..|+-||-+||++|||.||||.+|||++.+|++||.|||+++.--
T Consensus 424 RLyFVMEyvnGGDLMyhiQQ~--GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni 501 (683)
T KOG0696|consen 424 RLYFVMEYVNGGDLMYHIQQV--GKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENI 501 (683)
T ss_pred heeeEEEEecCchhhhHHHHh--cccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEeccCCceEeeecccccccc
Confidence 999999999999998777653 558899999999999999999999999999999999999999999999999985421
Q ss_pred CCCCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHcCCCCCCCCC
Q 001847 826 CKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKT 905 (1005)
Q Consensus 826 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlGvll~eLltG~~Pf~~~~ 905 (1005)
. ......++||||.|+|||++...+|+..+|-||+|++||||+.|++||.|.+
T Consensus 502 ~---------------------------~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeD 554 (683)
T KOG0696|consen 502 F---------------------------DGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGED 554 (683)
T ss_pred c---------------------------CCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCC
Confidence 1 1123467899999999999999999999999999999999999999999999
Q ss_pred hHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHccccCcCccCCCh-hcHHHHHcCCCCCCCChhhhhh--cCCCCCCCCCC
Q 001847 906 RQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSH-EGANEIKKHPFFKGVNWALVRC--MNPPELDAPLF 982 (1005)
Q Consensus 906 ~~~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~-~~a~elL~hpff~~~~~~~~~~--~~~~~~~~p~~ 982 (1005)
..+.+..|...+..+|.+ +|.++.++.+..|.+.|.+|+..- +.-.++..||||+.++|..++. .+||-. |..
T Consensus 555 E~elF~aI~ehnvsyPKs--lSkEAv~ickg~ltK~P~kRLGcg~~ge~di~~H~FFR~iDWek~E~~eiqPPfk--Pk~ 630 (683)
T KOG0696|consen 555 EDELFQAIMEHNVSYPKS--LSKEAVAICKGLLTKHPGKRLGCGPEGERDIREHPFFRRIDWEKLERREIQPPFK--PKI 630 (683)
T ss_pred HHHHHHHHHHccCcCccc--ccHHHHHHHHHHhhcCCccccCCCCccccchhhCcchhhccHHHHhhccCCCCCC--Ccc
Confidence 999999999999888876 689999999999999999998764 3346899999999999998854 455544 554
|
|
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=338.61 Aligned_cols=264 Identities=26% Similarity=0.445 Sum_probs=221.8
Q ss_pred cCCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEE
Q 001847 671 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLI 750 (1005)
Q Consensus 671 ~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV 750 (1005)
.+.|++++.||.|+||.||++.+..+++.+++|.+... .......+.+|+.+++.++|+||+++++++...+.+|+|
T Consensus 11 ~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 87 (292)
T cd06644 11 NEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETK---SEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIM 87 (292)
T ss_pred chhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccC---CHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEE
Confidence 46799999999999999999999999999999998754 345567788899999999999999999999999999999
Q ss_pred EeccCCCchhhHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCCCC
Q 001847 751 TDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQL 830 (1005)
Q Consensus 751 ~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~ 830 (1005)
|||+.+++|..++.... ..+++..+..++.||+.+|.|||+.|++|+||||+||+++.++.++|+|||++......
T Consensus 88 ~e~~~~~~l~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~--- 163 (292)
T cd06644 88 IEFCPGGAVDAIMLELD-RGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKT--- 163 (292)
T ss_pred EecCCCCcHHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcCCCCEEEccCccceecccc---
Confidence 99999999988875432 45899999999999999999999999999999999999999999999999987432110
Q ss_pred CCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccC-----CCCCChhhHHHHHHHHHHHHcCCCCCCCCC
Q 001847 831 LLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAG-----AGHTSAVDWWALGILLYEMLYGYTPFRGKT 905 (1005)
Q Consensus 831 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-----~~~~~~sDIwSlGvll~eLltG~~Pf~~~~ 905 (1005)
........+++.|+|||++.. ..++.++|||||||++|+|++|..||...+
T Consensus 164 ------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~ 219 (292)
T cd06644 164 ------------------------LQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELN 219 (292)
T ss_pred ------------------------ccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCcccc
Confidence 011223468889999999853 346778999999999999999999998877
Q ss_pred hHHHHHHHHhCCC-CCCCCCCCCHHHHHHHHHccccCcCccCCChhcHHHHHcCCCCCCCChhhh
Q 001847 906 RQKTFANILHKDL-KFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVNWALV 969 (1005)
Q Consensus 906 ~~~~~~~i~~~~~-~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~hpff~~~~~~~~ 969 (1005)
....+..+..... .......++..+.+||.+||..+|++||+ +.++++||||..++++..
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~----~~~il~~~~~~~~~~~~~ 280 (292)
T cd06644 220 PMRVLLKIAKSEPPTLSQPSKWSMEFRDFLKTALDKHPETRPS----AAQLLEHPFVSSVTSNRP 280 (292)
T ss_pred HHHHHHHHhcCCCccCCCCcccCHHHHHHHHHHhcCCcccCcC----HHHHhcCccccccccchh
Confidence 6665555554432 22223446788999999999999999999 999999999999888754
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-38 Score=318.14 Aligned_cols=261 Identities=27% Similarity=0.431 Sum_probs=221.9
Q ss_pred cccCCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCeE
Q 001847 669 INLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPALYASFQTKTHV 747 (1005)
Q Consensus 669 i~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~ 747 (1005)
.+.++.+.+..||+|+.|+||++..+.+|...|||.+.+. .+....++++..+.++... ++|+||+++++|..+..+
T Consensus 89 ~dindl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt--~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV 166 (391)
T KOG0983|consen 89 ADINDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRT--GNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDV 166 (391)
T ss_pred cChHHhhhHHhhcCCCccceEEEEEcccceEEEEEeeccc--CCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchH
Confidence 3456778889999999999999999999999999999875 3567778888888887666 599999999999999999
Q ss_pred EEEEeccCCCchhhHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHc-CcccCCCCCCcEEEecCCcEEEEeccCCcccCC
Q 001847 748 CLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQ-GIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSC 826 (1005)
Q Consensus 748 ~lV~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~-gIvHrDLkP~NILi~~~g~vkL~DFG~a~~~~~ 826 (1005)
++.||.| ...+..++++. .+++++..+-.+..-++.||.||-.+ ||+|||+||+|||++..|++||||||.+-.+.+
T Consensus 167 ~IcMelM-s~C~ekLlkri-k~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~GniKlCDFGIsGrlvd 244 (391)
T KOG0983|consen 167 FICMELM-STCAEKLLKRI-KGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVD 244 (391)
T ss_pred HHHHHHH-HHHHHHHHHHh-cCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCCCEEeecccccceeec
Confidence 9999999 66676666654 45699999999999999999999976 899999999999999999999999999855432
Q ss_pred CCCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccC---CCCCChhhHHHHHHHHHHHHcCCCCCCC
Q 001847 827 KPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAG---AGHTSAVDWWALGILLYEMLYGYTPFRG 903 (1005)
Q Consensus 827 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~---~~~~~~sDIwSlGvll~eLltG~~Pf~~ 903 (1005)
+ .......|-+.|||||.+.- ..|+.++||||||++++||+||+.||.+
T Consensus 245 S----------------------------kAhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~ 296 (391)
T KOG0983|consen 245 S----------------------------KAHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKG 296 (391)
T ss_pred c----------------------------cccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCC
Confidence 1 22334579999999999854 4678899999999999999999999988
Q ss_pred C-ChHHHHHHHHhCCCC-CCCCCCCCHHHHHHHHHccccCcCccCCChhcHHHHHcCCCCCCCC
Q 001847 904 K-TRQKTFANILHKDLK-FPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVN 965 (1005)
Q Consensus 904 ~-~~~~~~~~i~~~~~~-~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~hpff~~~~ 965 (1005)
. ...+.+.+++....+ ++.....|+.+.+|+..||++|+.+||. ..+||+|||+....
T Consensus 297 c~tdFe~ltkvln~ePP~L~~~~gFSp~F~~fv~~CL~kd~r~RP~----Y~~Ll~h~Fi~~ye 356 (391)
T KOG0983|consen 297 CKTDFEVLTKVLNEEPPLLPGHMGFSPDFQSFVKDCLTKDHRKRPK----YNKLLEHPFIKRYE 356 (391)
T ss_pred CCccHHHHHHHHhcCCCCCCcccCcCHHHHHHHHHHhhcCcccCcc----hHHHhcCcceeecc
Confidence 4 557778888876543 3444558999999999999999999999 99999999998743
|
|
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-37 Score=363.60 Aligned_cols=254 Identities=23% Similarity=0.380 Sum_probs=202.2
Q ss_pred ccCCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCC------CCcceEEEEEEe
Q 001847 670 NLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDH------PFVPALYASFQT 743 (1005)
Q Consensus 670 ~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~il~~l~h------pnIv~l~~~~~~ 743 (1005)
..++|++++.||+|+||.||+|.+..+++.||||+++.. .........|+.+++.+.| .+++.++++|..
T Consensus 127 ~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~----~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~ 202 (467)
T PTZ00284 127 STQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNV----PKYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQN 202 (467)
T ss_pred CCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecc----hhhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEc
Confidence 357899999999999999999999999999999998642 1222344557777766644 458889888875
Q ss_pred C-CeEEEEEeccCCCchhhHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHH-cCcccCCCCCCcEEEecCC----------
Q 001847 744 K-THVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHC-QGIIYRDLKPENVLLQGNG---------- 811 (1005)
Q Consensus 744 ~-~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~-~gIvHrDLkP~NILi~~~g---------- 811 (1005)
. .++|+||+++ |++|.+++... +.+++..++.++.||+.||.|||+ .|||||||||+|||++.++
T Consensus 203 ~~~~~~iv~~~~-g~~l~~~l~~~--~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~ 279 (467)
T PTZ00284 203 ETGHMCIVMPKY-GPCLLDWIMKH--GPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRA 279 (467)
T ss_pred CCceEEEEEecc-CCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCcccccccccc
Confidence 4 5789999999 88898888664 459999999999999999999998 5999999999999998765
Q ss_pred ------cEEEEeccCCcccCCCCCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHH
Q 001847 812 ------HVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWW 885 (1005)
Q Consensus 812 ------~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIw 885 (1005)
.+||+|||.+.... ......+||+.|+|||++.+..++.++|||
T Consensus 280 ~~~~~~~vkl~DfG~~~~~~------------------------------~~~~~~~gt~~Y~APE~~~~~~~~~~~Diw 329 (467)
T PTZ00284 280 LPPDPCRVRICDLGGCCDER------------------------------HSRTAIVSTRHYRSPEVVLGLGWMYSTDMW 329 (467)
T ss_pred cCCCCceEEECCCCccccCc------------------------------cccccccCCccccCcHHhhcCCCCcHHHHH
Confidence 49999999773211 112345799999999999999999999999
Q ss_pred HHHHHHHHHHcCCCCCCCCChHHHHHHHHhCCCCCC------------------------C----------------CCC
Q 001847 886 ALGILLYEMLYGYTPFRGKTRQKTFANILHKDLKFP------------------------S----------------STP 925 (1005)
Q Consensus 886 SlGvll~eLltG~~Pf~~~~~~~~~~~i~~~~~~~~------------------------~----------------~~~ 925 (1005)
||||++|+|++|+.||.+.+..+.+..+......++ . ...
T Consensus 330 SlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 409 (467)
T PTZ00284 330 SMGCIIYELYTGKLLYDTHDNLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVI 409 (467)
T ss_pred HHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhh
Confidence 999999999999999988776554443322100000 0 001
Q ss_pred CCHHHHHHHHHccccCcCccCCChhcHHHHHcCCCCCCC
Q 001847 926 TSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGV 964 (1005)
Q Consensus 926 ~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~hpff~~~ 964 (1005)
.+..+.+||.+||++||.+||| ++++|+||||...
T Consensus 410 ~~~~~~dli~~mL~~dP~~R~t----a~e~L~Hp~~~~~ 444 (467)
T PTZ00284 410 RDDLLCDLIYGLLHYDRQKRLN----ARQMTTHPYVLKY 444 (467)
T ss_pred chHHHHHHHHHhCCcChhhCCC----HHHHhcCcccccc
Confidence 1345779999999999999999 9999999999874
|
|
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-37 Score=337.38 Aligned_cols=264 Identities=34% Similarity=0.601 Sum_probs=218.1
Q ss_pred ccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEEeccCCCch
Q 001847 680 LGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGEL 759 (1005)
Q Consensus 680 LG~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~ggsL 759 (1005)
||+|+||.||+|.+..+|+.|++|.+.............+..|+++++.++||||+++++++...+..|+||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 69999999999999999999999998765433334455667899999999999999999999999999999999999999
Q ss_pred hhHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCCCCCCCcchhhh
Q 001847 760 FLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKK 839 (1005)
Q Consensus 760 ~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~ 839 (1005)
.+++.......+++..+..++.||+.||.|||++|++|+||+|+||+++.++.++|+|||.+......
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~------------ 148 (277)
T cd05577 81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGG------------ 148 (277)
T ss_pred HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEccCcchhhhccC------------
Confidence 99987655456999999999999999999999999999999999999999999999999987543210
Q ss_pred hcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhCCC-
Q 001847 840 RRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANILHKDL- 918 (1005)
Q Consensus 840 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlGvll~eLltG~~Pf~~~~~~~~~~~i~~~~~- 918 (1005)
.......++..|+|||++.+..++.++|||||||++|+|++|+.||...........+.....
T Consensus 149 ----------------~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~ 212 (277)
T cd05577 149 ----------------KKIKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLE 212 (277)
T ss_pred ----------------CccccccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhcccc
Confidence 011223578899999999888888999999999999999999999977544222222222111
Q ss_pred -CCCCCCCCCHHHHHHHHHccccCcCccCCChh-cHHHHHcCCCCCCCChhhhhh
Q 001847 919 -KFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHE-GANEIKKHPFFKGVNWALVRC 971 (1005)
Q Consensus 919 -~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~-~a~elL~hpff~~~~~~~~~~ 971 (1005)
........+..+.+||.+||+.+|.+||++.+ .+.++++||||+.++|..+..
T Consensus 213 ~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~h~~~~~~~~~~~~~ 267 (277)
T cd05577 213 MAVEYPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVREHPLFKDLNWRRLEA 267 (277)
T ss_pred ccccCCccCCHHHHHHHHHHccCChhHccCCCcccHHHHHhChhhhcCChhhhhc
Confidence 11222346889999999999999999997776 699999999999999988743
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-37 Score=364.17 Aligned_cols=261 Identities=25% Similarity=0.394 Sum_probs=222.2
Q ss_pred cCCccccccccccCcEEEEEEEEcCC-CeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEE
Q 001847 671 LQHFRPIKPLGSGDTGSVHLVELCGS-GQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCL 749 (1005)
Q Consensus 671 ~~~y~~~~~LG~G~~g~Vy~a~~~~~-~~~valK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l 749 (1005)
...|.+.+.||.|++|.||+|.+..+ +..+|+|.+... .......+..|+.+++.++||||++++++|...+.+|+
T Consensus 66 ~~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~---~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~l 142 (478)
T PTZ00267 66 EHMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLN---DERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLL 142 (478)
T ss_pred ceeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccC---CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEE
Confidence 34599999999999999999999777 788999976533 33444567789999999999999999999999999999
Q ss_pred EEeccCCCchhhHHhhC--CCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCC
Q 001847 750 ITDYCPGGELFLLLDRQ--PTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCK 827 (1005)
Q Consensus 750 V~E~~~ggsL~~~l~~~--~~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~ 827 (1005)
||||+++++|.+++... ....+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 143 v~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~ 222 (478)
T PTZ00267 143 IMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDS 222 (478)
T ss_pred EEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECCCCcEEEEeCcCceecCCc
Confidence 99999999999887532 2346899999999999999999999999999999999999999999999999998653211
Q ss_pred CCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHcCCCCCCCCChH
Q 001847 828 PQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQ 907 (1005)
Q Consensus 828 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlGvll~eLltG~~Pf~~~~~~ 907 (1005)
.. .......+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..
T Consensus 223 ~~-------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~ 277 (478)
T PTZ00267 223 VS-------------------------LDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQR 277 (478)
T ss_pred cc-------------------------cccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 00 01123467999999999999888999999999999999999999999988887
Q ss_pred HHHHHHHhCCCCCCCCCCCCHHHHHHHHHccccCcCccCCChhcHHHHHcCCCCCCC
Q 001847 908 KTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGV 964 (1005)
Q Consensus 908 ~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~hpff~~~ 964 (1005)
+.+..+..+... +....++..+.+||.+||..+|++||+ +.+++.|+|++.+
T Consensus 278 ~~~~~~~~~~~~-~~~~~~s~~~~~li~~~L~~dP~~Rps----~~~~l~~~~~~~~ 329 (478)
T PTZ00267 278 EIMQQVLYGKYD-PFPCPVSSGMKALLDPLLSKNPALRPT----TQQLLHTEFLKYV 329 (478)
T ss_pred HHHHHHHhCCCC-CCCccCCHHHHHHHHHHhccChhhCcC----HHHHHhCHHHHHH
Confidence 777777766543 222346889999999999999999999 9999999999754
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-37 Score=349.52 Aligned_cols=257 Identities=24% Similarity=0.345 Sum_probs=204.2
Q ss_pred cccccCCccccccccccCcEEEEEEEEc-----CCCeEEEEEEeecccccChHHHHHHHHHHHHHHhC-CCCCcceEEEE
Q 001847 667 EQINLQHFRPIKPLGSGDTGSVHLVELC-----GSGQYFAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPALYAS 740 (1005)
Q Consensus 667 ~~i~~~~y~~~~~LG~G~~g~Vy~a~~~-----~~~~~valK~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~ 740 (1005)
+++..++|++.+.||.|+||.||+|.+. .++..||+|.+.... .......+.+|+.++..+ +||||++++++
T Consensus 2 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~niv~~~~~ 79 (338)
T cd05102 2 WEFPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGA--TASEHKALMSELKILIHIGNHLNVVNLLGA 79 (338)
T ss_pred cccchhHceeeeEeccCCcceEEEEEEeccCCcccchhhheecccccc--chHHHHHHHHHHHHHHHhccCcceeeEEeE
Confidence 3456679999999999999999999852 345689999987532 233456788999999999 89999999998
Q ss_pred EEeC-CeEEEEEeccCCCchhhHHhhCC----------------------------------------------------
Q 001847 741 FQTK-THVCLITDYCPGGELFLLLDRQP---------------------------------------------------- 767 (1005)
Q Consensus 741 ~~~~-~~~~lV~E~~~ggsL~~~l~~~~---------------------------------------------------- 767 (1005)
+... +.+|+||||+++|+|.+++....
T Consensus 80 ~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (338)
T cd05102 80 CTKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNP 159 (338)
T ss_pred ecCCCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCccccc
Confidence 8754 46899999999999999987431
Q ss_pred --------CCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCCCCCCCcchhhh
Q 001847 768 --------TKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKK 839 (1005)
Q Consensus 768 --------~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~ 839 (1005)
...++...+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++........
T Consensus 160 ~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~---------- 229 (338)
T cd05102 160 PQETDDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPD---------- 229 (338)
T ss_pred chhccccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCCcEEEeecccccccccCcc----------
Confidence 12477888999999999999999999999999999999999999999999999854321110
Q ss_pred hcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHhCCC
Q 001847 840 RRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY-GYTPFRGKTRQKTFANILHKDL 918 (1005)
Q Consensus 840 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlGvll~eLlt-G~~Pf~~~~~~~~~~~i~~~~~ 918 (1005)
........+++.|+|||++.+..++.++|||||||++|+|++ |..||.+......+...+....
T Consensus 230 ---------------~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~ 294 (338)
T cd05102 230 ---------------YVRKGSARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGT 294 (338)
T ss_pred ---------------hhcccCCCCCccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcCC
Confidence 001122346788999999988889999999999999999996 9999987654444444443333
Q ss_pred CCCCCCCCCHHHHHHHHHccccCcCccCCChh
Q 001847 919 KFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHE 950 (1005)
Q Consensus 919 ~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~ 950 (1005)
........+..+.+|+.+||+.||.+||++.+
T Consensus 295 ~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~e 326 (338)
T cd05102 295 RMRAPENATPEIYRIMLACWQGDPKERPTFSA 326 (338)
T ss_pred CCCCCCCCCHHHHHHHHHHccCChhhCcCHHH
Confidence 33333457888999999999999999999443
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=351.82 Aligned_cols=255 Identities=27% Similarity=0.430 Sum_probs=209.4
Q ss_pred cCCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeC------
Q 001847 671 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTK------ 744 (1005)
Q Consensus 671 ~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~------ 744 (1005)
.++|++++.||.|+||.||+|.+..+++.||+|.+.... ........+.+|+.+++.++||||++++++|...
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07878 14 PERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPF-QSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENF 92 (343)
T ss_pred hhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchh-hhhHHHHHHHHHHHHHHhcCCCchhhhhhhhccccccccc
Confidence 368999999999999999999999999999999987542 2223445677899999999999999999887543
Q ss_pred CeEEEEEeccCCCchhhHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCccc
Q 001847 745 THVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLT 824 (1005)
Q Consensus 745 ~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~~~g~vkL~DFG~a~~~ 824 (1005)
...|++|+++ +++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus 93 ~~~~~~~~~~-~~~l~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~ 168 (343)
T cd07878 93 NEVYLVTNLM-GADLNNIVKC---QKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQA 168 (343)
T ss_pred CcEEEEeecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECCCCCEEEcCCccceec
Confidence 4579999998 8899888754 34999999999999999999999999999999999999999999999999998543
Q ss_pred CCCCCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccC-CCCCChhhHHHHHHHHHHHHcCCCCCCC
Q 001847 825 SCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAG-AGHTSAVDWWALGILLYEMLYGYTPFRG 903 (1005)
Q Consensus 825 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~sDIwSlGvll~eLltG~~Pf~~ 903 (1005)
.. ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+
T Consensus 169 ~~------------------------------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~ 218 (343)
T cd07878 169 DD------------------------------EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPG 218 (343)
T ss_pred CC------------------------------CcCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCC
Confidence 21 1123468999999999877 4678899999999999999999999987
Q ss_pred CChHHHHHHHHhCCC----------------------C-CCC------CCCCCHHHHHHHHHccccCcCccCCChhcHHH
Q 001847 904 KTRQKTFANILHKDL----------------------K-FPS------STPTSLHAKQLMYRLLHRDPKSRLGSHEGANE 954 (1005)
Q Consensus 904 ~~~~~~~~~i~~~~~----------------------~-~~~------~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~e 954 (1005)
.+....+..+..... + .+. ....+..+.+||.+||..||.+||| +.+
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s----~~e 294 (343)
T cd07878 219 NDYIDQLKRIMEVVGTPSPEVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRIS----ASE 294 (343)
T ss_pred CCHHHHHHHHHHHhCCCCHHHHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCC----HHH
Confidence 766554444432100 0 000 0124556889999999999999999 999
Q ss_pred HHcCCCCCCC
Q 001847 955 IKKHPFFKGV 964 (1005)
Q Consensus 955 lL~hpff~~~ 964 (1005)
+|+||||...
T Consensus 295 ll~hp~~~~~ 304 (343)
T cd07878 295 ALAHPYFSQY 304 (343)
T ss_pred HhcCcchhcc
Confidence 9999999874
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=329.55 Aligned_cols=256 Identities=28% Similarity=0.445 Sum_probs=221.3
Q ss_pred CccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEEe
Q 001847 673 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITD 752 (1005)
Q Consensus 673 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E 752 (1005)
+|.+.+.||+|++|.||++.+..+++.|++|.+..... .......+.+|+.+++.++||||+++++++...+..|+|||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKM-NRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVME 79 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhC-CHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEE
Confidence 47888999999999999999999999999999875432 34456778899999999999999999999999999999999
Q ss_pred ccCCCchhhHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCCCCCC
Q 001847 753 YCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLL 832 (1005)
Q Consensus 753 ~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~~~ 832 (1005)
|+++++|.+++.......++...+..++.||+.||.|||++|++|+||||+||+++.++.++|+|||++.......
T Consensus 80 ~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~---- 155 (256)
T cd08529 80 YAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNT---- 155 (256)
T ss_pred eCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCCCCEEEcccccceeccCcc----
Confidence 9999999999987545679999999999999999999999999999999999999999999999999875432110
Q ss_pred CcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHcCCCCCCCCChHHHHHH
Q 001847 833 PTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFAN 912 (1005)
Q Consensus 833 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlGvll~eLltG~~Pf~~~~~~~~~~~ 912 (1005)
.......|++.|+|||++.+..++.++|||||||++|+|++|+.||...+.......
T Consensus 156 -----------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~ 212 (256)
T cd08529 156 -----------------------NFANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILK 212 (256)
T ss_pred -----------------------chhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 111234688999999999888889999999999999999999999988887776776
Q ss_pred HHhCCCCCCCCCCCCHHHHHHHHHccccCcCccCCChhcHHHHHcCCCC
Q 001847 913 ILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFF 961 (1005)
Q Consensus 913 i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~hpff 961 (1005)
+..+...... ..++..+.++|.+||+.+|++||+ +.++++|||+
T Consensus 213 ~~~~~~~~~~-~~~~~~~~~~i~~~l~~~p~~Rp~----~~~ll~~~~~ 256 (256)
T cd08529 213 IIRGVFPPVS-QMYSQQLAQLIDQCLTKDYRQRPD----TFQLLRNPSL 256 (256)
T ss_pred HHcCCCCCCc-cccCHHHHHHHHHHccCCcccCcC----HHHHhhCCCC
Confidence 6665433222 256788999999999999999999 9999999996
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=329.37 Aligned_cols=256 Identities=25% Similarity=0.445 Sum_probs=217.7
Q ss_pred CccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceEEEEEEe-CCeEEEEE
Q 001847 673 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQT-KTHVCLIT 751 (1005)
Q Consensus 673 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~~lV~ 751 (1005)
+|++++.||.|++|.||++.+..+++.+|+|.+..... .......+.+|+.++++++|+|++++++.+.. ...+|++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~ 79 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNA-SRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVM 79 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhc-CHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEe
Confidence 58999999999999999999999999999999875422 33445667889999999999999999998864 45689999
Q ss_pred eccCCCchhhHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCCCCC
Q 001847 752 DYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLL 831 (1005)
Q Consensus 752 E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~~ 831 (1005)
||+++++|.+++.......+++.++..++.||+.||.|||++|++|+||||+||+++.++.++|+|||++.......
T Consensus 80 e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~--- 156 (257)
T cd08223 80 GFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQC--- 156 (257)
T ss_pred cccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecCCcEEEecccceEEecccC---
Confidence 99999999999976555668999999999999999999999999999999999999999999999999985432110
Q ss_pred CCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHcCCCCCCCCChHHHHH
Q 001847 832 LPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFA 911 (1005)
Q Consensus 832 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlGvll~eLltG~~Pf~~~~~~~~~~ 911 (1005)
.......|++.|+|||++.+..++.++|||||||++|+|++|+.||.+.+......
T Consensus 157 ------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~ 212 (257)
T cd08223 157 ------------------------DMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVY 212 (257)
T ss_pred ------------------------CccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHH
Confidence 11223468899999999998888999999999999999999999998877666666
Q ss_pred HHHhCCCCCCCCCCCCHHHHHHHHHccccCcCccCCChhcHHHHHcCCCC
Q 001847 912 NILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFF 961 (1005)
Q Consensus 912 ~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~hpff 961 (1005)
.+..+.... .....+..+.+|+.+||+.+|++||+ +.++++||||
T Consensus 213 ~~~~~~~~~-~~~~~~~~~~~li~~~l~~~p~~Rp~----~~~~l~~~~~ 257 (257)
T cd08223 213 RIIEGKLPP-MPKDYSPELGELIATMLSKRPEKRPS----VKSILRQPYI 257 (257)
T ss_pred HHHhcCCCC-CccccCHHHHHHHHHHhccCcccCCC----HHHHhcCCCC
Confidence 665554422 22347789999999999999999999 9999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=332.10 Aligned_cols=258 Identities=41% Similarity=0.746 Sum_probs=220.2
Q ss_pred ccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEEeccCCCch
Q 001847 680 LGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGEL 759 (1005)
Q Consensus 680 LG~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~ggsL 759 (1005)
||.|++|.||+|.+..+++.|++|.+.+...........+.+|+.+++.++||||+++++++..+..+|+||||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 69999999999999888999999999876544455667889999999999999999999999999999999999999999
Q ss_pred hhHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCCCCCCCcchhhh
Q 001847 760 FLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKK 839 (1005)
Q Consensus 760 ~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~ 839 (1005)
.+++... ..++...+..++.||+.||.|||++|++|+||+|+||+++.++.++|+|||.+.......
T Consensus 81 ~~~l~~~--~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~----------- 147 (262)
T cd05572 81 WTILRDR--GLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ----------- 147 (262)
T ss_pred HHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc-----------
Confidence 9999764 348999999999999999999999999999999999999999999999999885432110
Q ss_pred hcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHcCCCCCCCCC--hHHHHHHHHhCC
Q 001847 840 RRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKT--RQKTFANILHKD 917 (1005)
Q Consensus 840 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlGvll~eLltG~~Pf~~~~--~~~~~~~i~~~~ 917 (1005)
......|++.|++||.+....++.++|+||||+++|+|++|..||.... ....+..+..+.
T Consensus 148 -----------------~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~ 210 (262)
T cd05572 148 -----------------KTWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGN 210 (262)
T ss_pred -----------------ccccccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccC
Confidence 1123468889999999988888999999999999999999999998776 566666666433
Q ss_pred CCCCCCCCCCHHHHHHHHHccccCcCccCCCh-hcHHHHHcCCCCCCCChh
Q 001847 918 LKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSH-EGANEIKKHPFFKGVNWA 967 (1005)
Q Consensus 918 ~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~-~~a~elL~hpff~~~~~~ 967 (1005)
.........+..+.+||.+||..+|++||++. ..++++++||||++++|.
T Consensus 211 ~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~~~ 261 (262)
T cd05572 211 GKLEFPNYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKKHKWFNGFDWE 261 (262)
T ss_pred CCCCCCcccCHHHHHHHHHHccCChhhCcCCcccCHHHHhcChhhhCCCCC
Confidence 23332333478899999999999999999843 458999999999999885
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=344.21 Aligned_cols=265 Identities=21% Similarity=0.352 Sum_probs=209.3
Q ss_pred cccccccc--CcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEEec
Q 001847 676 PIKPLGSG--DTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDY 753 (1005)
Q Consensus 676 ~~~~LG~G--~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~ 753 (1005)
+++.||+| +|++||++.+..+|+.||+|.+..... .......+.+|+.+++.++||||++++++|..++..|+||||
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 80 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEAC-TNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSF 80 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhc-cHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEec
Confidence 56789999 789999999999999999999876432 233445677899999999999999999999999999999999
Q ss_pred cCCCchhhHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCCCCCCC
Q 001847 754 CPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLP 833 (1005)
Q Consensus 754 ~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~~~~ 833 (1005)
+++++|.+++.......+++..++.++.||+.||.|||++||+||||||+|||++.++.++++||+............
T Consensus 81 ~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~-- 158 (327)
T cd08227 81 MAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRL-- 158 (327)
T ss_pred cCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecCCcEEEcccchhhccccccccc--
Confidence 999999999976544568999999999999999999999999999999999999999999999998653321100000
Q ss_pred cchhhhhcccCCCCCcccccccccccccccCCcccccccccC--CCCCChhhHHHHHHHHHHHHcCCCCCCCCChHHHHH
Q 001847 834 TTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAG--AGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFA 911 (1005)
Q Consensus 834 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~--~~~~~~sDIwSlGvll~eLltG~~Pf~~~~~~~~~~ 911 (1005)
...........++..|+|||++.+ ..++.++|||||||++|+|++|+.||..........
T Consensus 159 ------------------~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~ 220 (327)
T cd08227 159 ------------------RVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLL 220 (327)
T ss_pred ------------------cccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHH
Confidence 000001122357788999999876 457889999999999999999999998655444333
Q ss_pred HHHhCCCCC--------------------------------------------CCCCCCCHHHHHHHHHccccCcCccCC
Q 001847 912 NILHKDLKF--------------------------------------------PSSTPTSLHAKQLMYRLLHRDPKSRLG 947 (1005)
Q Consensus 912 ~i~~~~~~~--------------------------------------------~~~~~~s~~l~~Ll~~~L~~dP~~Rpt 947 (1005)
.......+. +.....+..+.+||.+||+.||++|||
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt 300 (327)
T cd08227 221 EKLNGTVPCLLDTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPS 300 (327)
T ss_pred HHhcCCccccccccchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCC
Confidence 332221110 001124567899999999999999999
Q ss_pred ChhcHHHHHcCCCCCCCC
Q 001847 948 SHEGANEIKKHPFFKGVN 965 (1005)
Q Consensus 948 ~~~~a~elL~hpff~~~~ 965 (1005)
+.++++||||+.+.
T Consensus 301 ----~~ell~~p~f~~~~ 314 (327)
T cd08227 301 ----ASTLLNHSFFKQIK 314 (327)
T ss_pred ----HHHHhcChhhhhcc
Confidence 99999999999764
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=320.66 Aligned_cols=265 Identities=30% Similarity=0.482 Sum_probs=222.4
Q ss_pred cccc-ccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCeEEEEE
Q 001847 674 FRPI-KPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPALYASFQTKTHVCLIT 751 (1005)
Q Consensus 674 y~~~-~~LG~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~~lV~ 751 (1005)
|++. +.||+|+++.|-.+....+|+.||||++.+. ......++++|.+++.++ .|+||++++++|+++..+|+||
T Consensus 79 YkLt~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq---~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVf 155 (463)
T KOG0607|consen 79 YKLTSELLGEGAYASVQTCVSIQTGKEYAVKIIDKQ---PGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVF 155 (463)
T ss_pred HHhHHHHhcCccceeeeeeeeeccchhhhhhhhhcC---CchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEE
Confidence 4443 5699999999999999999999999999875 456678999999999999 7999999999999999999999
Q ss_pred eccCCCchhhHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCC---cEEEEeccCCcccCCCC
Q 001847 752 DYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNG---HVSLTDFDLSCLTSCKP 828 (1005)
Q Consensus 752 E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~~~g---~vkL~DFG~a~~~~~~~ 828 (1005)
|.|.||+|...+.++ ..+++..+..+.++|+.||.|||.+||.||||||+|||-.+.+ -+|||||.+..-+....
T Consensus 156 EKm~GGplLshI~~~--~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~ 233 (463)
T KOG0607|consen 156 EKMRGGPLLSHIQKR--KHFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNN 233 (463)
T ss_pred ecccCchHHHHHHHh--hhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeeccccccccccCC
Confidence 999999999999875 4599999999999999999999999999999999999998654 48999999874322111
Q ss_pred CCCCCcchhhhhcccCCCCCcccccccccccccccCCccccccccc-----CCCCCChhhHHHHHHHHHHHHcCCCCCCC
Q 001847 829 QLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIA-----GAGHTSAVDWWALGILLYEMLYGYTPFRG 903 (1005)
Q Consensus 829 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~-----~~~~~~~sDIwSlGvll~eLltG~~Pf~~ 903 (1005)
... +.....-.+.+|+..|||||+.. ...|+.++|.||||++||-|++|.+||.|
T Consensus 234 ~~s--------------------pastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG 293 (463)
T KOG0607|consen 234 DCS--------------------PASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVG 293 (463)
T ss_pred CCC--------------------CCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccC
Confidence 111 11112234568999999999862 24578899999999999999999999976
Q ss_pred CC---------------hHHHHHHHHhCCCCCCC--CCCCCHHHHHHHHHccccCcCccCCChhcHHHHHcCCCCCCCCh
Q 001847 904 KT---------------RQKTFANILHKDLKFPS--STPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVNW 966 (1005)
Q Consensus 904 ~~---------------~~~~~~~i~~~~~~~~~--~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~hpff~~~~~ 966 (1005)
.. ....+..|..+...+|. +..+|.++++|+..+|..++.+|.+ +.++++|||++.+-.
T Consensus 294 ~Cg~dCGWdrGe~Cr~CQ~~LFesIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rls----a~~vlnhPw~~~~~~ 369 (463)
T KOG0607|consen 294 HCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLS----AAQVLNHPWVQRCAP 369 (463)
T ss_pred ccCCcCCccCCCccHHHHHHHHHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhh----hhhccCCccccccch
Confidence 32 23667788888887775 4568899999999999999999999 999999999998644
Q ss_pred h
Q 001847 967 A 967 (1005)
Q Consensus 967 ~ 967 (1005)
+
T Consensus 370 e 370 (463)
T KOG0607|consen 370 E 370 (463)
T ss_pred h
Confidence 4
|
|
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=339.03 Aligned_cols=261 Identities=25% Similarity=0.412 Sum_probs=213.6
Q ss_pred ccCCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEE
Q 001847 670 NLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCL 749 (1005)
Q Consensus 670 ~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l 749 (1005)
..++|++++.||.|+||.||++.+..+++.||+|.+..... ......+.+|+.+++.++||||+++++++...+..|+
T Consensus 4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~l 81 (301)
T cd07873 4 KLETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHE--EGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTL 81 (301)
T ss_pred cccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccc--cCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEE
Confidence 35689999999999999999999999999999999875422 2223456789999999999999999999999999999
Q ss_pred EEeccCCCchhhHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCCC
Q 001847 750 ITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQ 829 (1005)
Q Consensus 750 V~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~ 829 (1005)
||||+. ++|.+++... ...+++..++.++.||+.||.|||++||+|+||||+||+++.++.++|+|||++.......
T Consensus 82 v~e~~~-~~l~~~l~~~-~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~- 158 (301)
T cd07873 82 VFEYLD-KDLKQYLDDC-GNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPT- 158 (301)
T ss_pred EEeccc-cCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECCCCcEEECcCcchhccCCCC-
Confidence 999995 6898888654 2458899999999999999999999999999999999999999999999999885422110
Q ss_pred CCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCC-CCCChhhHHHHHHHHHHHHcCCCCCCCCChHH
Q 001847 830 LLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGA-GHTSAVDWWALGILLYEMLYGYTPFRGKTRQK 908 (1005)
Q Consensus 830 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~sDIwSlGvll~eLltG~~Pf~~~~~~~ 908 (1005)
.......+++.|+|||++.+. .++.++|||||||++|+|++|++||.+.+..+
T Consensus 159 --------------------------~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~ 212 (301)
T cd07873 159 --------------------------KTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEE 212 (301)
T ss_pred --------------------------CcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 111233578899999998654 46789999999999999999999998877655
Q ss_pred HHHHHHhCC-------------------CCCCC---------CCCCCHHHHHHHHHccccCcCccCCChhcHHHHHcCCC
Q 001847 909 TFANILHKD-------------------LKFPS---------STPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPF 960 (1005)
Q Consensus 909 ~~~~i~~~~-------------------~~~~~---------~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~hpf 960 (1005)
....+.... ..++. ...++..+.+||.+||+.||.+||| +.++|+|||
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t----~~eil~h~~ 288 (301)
T cd07873 213 QLHFIFRILGTPTEETWPGILSNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRIS----AEEAMKHPY 288 (301)
T ss_pred HHHHHHHHcCCCChhhchhhhccccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcC----HHHHhcCcc
Confidence 544433210 01111 1235778899999999999999999 999999999
Q ss_pred CCCCC
Q 001847 961 FKGVN 965 (1005)
Q Consensus 961 f~~~~ 965 (1005)
|+.+.
T Consensus 289 f~~~~ 293 (301)
T cd07873 289 FHCLG 293 (301)
T ss_pred ccccc
Confidence 98764
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=332.17 Aligned_cols=258 Identities=30% Similarity=0.470 Sum_probs=221.2
Q ss_pred CCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEE
Q 001847 672 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLIT 751 (1005)
Q Consensus 672 ~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~ 751 (1005)
++|++.+.||.|++|.||++.+..++..+++|.+.... .......+.+|+.+++.++|+||+++++++.....+|+|+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 78 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEE--AEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIM 78 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccc--cchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEE
Confidence 47999999999999999999999999999999987542 2334566788999999999999999999999999999999
Q ss_pred eccCCCchhhHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCCCCC
Q 001847 752 DYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLL 831 (1005)
Q Consensus 752 E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~~ 831 (1005)
||+.+++|.+++... .+++..++.++.||+.||.|||+.+++|+||+|+||++++++.++|+|||++.......
T Consensus 79 e~~~~~~L~~~~~~~---~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~--- 152 (274)
T cd06609 79 EYCGGGSCLDLLKPG---KLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM--- 152 (274)
T ss_pred EeeCCCcHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEcccccceeecccc---
Confidence 999999999998763 58999999999999999999999999999999999999999999999999985543110
Q ss_pred CCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHcCCCCCCCCChHHHHH
Q 001847 832 LPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFA 911 (1005)
Q Consensus 832 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlGvll~eLltG~~Pf~~~~~~~~~~ 911 (1005)
.......+++.|+|||++.+..++.++|||||||++|+|++|..||...+......
T Consensus 153 ------------------------~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~ 208 (274)
T cd06609 153 ------------------------SKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLF 208 (274)
T ss_pred ------------------------cccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHHH
Confidence 11223468889999999988889999999999999999999999998777666555
Q ss_pred HHHhCCCCCCCCCCCCHHHHHHHHHccccCcCccCCChhcHHHHHcCCCCCCCC
Q 001847 912 NILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVN 965 (1005)
Q Consensus 912 ~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~hpff~~~~ 965 (1005)
.+.....+......++..+.+++.+||..+|++||+ ++++++||||+...
T Consensus 209 ~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~p~~Rpt----~~~il~~~~~~~~~ 258 (274)
T cd06609 209 LIPKNNPPSLEGNKFSKPFKDFVSLCLNKDPKERPS----AKELLKHKFIKKAK 258 (274)
T ss_pred HhhhcCCCCCcccccCHHHHHHHHHHhhCChhhCcC----HHHHhhChhhcCCC
Confidence 555543333232336788999999999999999999 99999999999753
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-37 Score=334.60 Aligned_cols=254 Identities=38% Similarity=0.627 Sum_probs=210.8
Q ss_pred ccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEEec
Q 001847 674 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDY 753 (1005)
Q Consensus 674 y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~ 753 (1005)
|++++.||+|+||+||++.+..+++.||+|++...... ........+|+.+++.++||||+++++++......++||||
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~-~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~ 79 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIE-EEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEY 79 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHH-HHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEecccccc-ccccchhhhhhhccccccccccccccccccccccccccccc
Confidence 78999999999999999999999999999999876322 22223345599999999999999999999999999999999
Q ss_pred cCCCchhhHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCCCCCCC
Q 001847 754 CPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLP 833 (1005)
Q Consensus 754 ~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~~~~ 833 (1005)
+.+++|.+++... ..++...+..++.||+.||.+||++|++|+||||+||+++.++.++|+|||.+.....
T Consensus 80 ~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~------- 150 (260)
T PF00069_consen 80 CPGGSLQDYLQKN--KPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDENGEVKLIDFGSSVKLSE------- 150 (260)
T ss_dssp ETTEBHHHHHHHH--SSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTTSEEEESSGTTTEESTS-------
T ss_pred ccccccccccccc--cccccccccccccccccccccccccccccccccccccccccccccccccccccccccc-------
Confidence 9999999999843 4589999999999999999999999999999999999999999999999999854210
Q ss_pred cchhhhhcccCCCCCcccccccccccccccCCccccccccc-CCCCCChhhHHHHHHHHHHHHcCCCCCCCCC---hHHH
Q 001847 834 TTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIA-GAGHTSAVDWWALGILLYEMLYGYTPFRGKT---RQKT 909 (1005)
Q Consensus 834 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~-~~~~~~~sDIwSlGvll~eLltG~~Pf~~~~---~~~~ 909 (1005)
.........+++.|+|||++. +...+.++||||||+++|+|++|..||.... ....
T Consensus 151 --------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~ 210 (260)
T PF00069_consen 151 --------------------NNENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEI 210 (260)
T ss_dssp --------------------TTSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHH
T ss_pred --------------------cccccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhh
Confidence 011223457899999999998 7888999999999999999999999998873 3333
Q ss_pred HHHHHhCCCCCCC--CCCCCHHHHHHHHHccccCcCccCCChhcHHHHHcCCCC
Q 001847 910 FANILHKDLKFPS--STPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFF 961 (1005)
Q Consensus 910 ~~~i~~~~~~~~~--~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~hpff 961 (1005)
+............ ....+..+.++|.+||+.||++||+ +.++++||||
T Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R~~----~~~l~~~~~~ 260 (260)
T PF00069_consen 211 IEKILKRPLPSSSQQSREKSEELRDLIKKMLSKDPEQRPS----AEELLKHPWF 260 (260)
T ss_dssp HHHHHHTHHHHHTTSHTTSHHHHHHHHHHHSSSSGGGSTT----HHHHHTSGGG
T ss_pred hhhcccccccccccccchhHHHHHHHHHHHccCChhHCcC----HHHHhcCCCC
Confidence 3333332211111 1112478999999999999999999 9999999998
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=332.55 Aligned_cols=252 Identities=26% Similarity=0.426 Sum_probs=209.6
Q ss_pred CccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEEe
Q 001847 673 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITD 752 (1005)
Q Consensus 673 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E 752 (1005)
+|++++.||+|+||.||++.+..+++.||+|.+.... .......+.+|+.++++++||||+++++++...+..++|||
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 79 (279)
T cd06619 2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDI--TVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTE 79 (279)
T ss_pred cchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCC--ChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEe
Confidence 6889999999999999999999999999999987542 23344678889999999999999999999999999999999
Q ss_pred ccCCCchhhHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCCCCCC
Q 001847 753 YCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLL 832 (1005)
Q Consensus 753 ~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~~~ 832 (1005)
|+++++|..+. .+++..+..++.||+.||.|||+.||+|+||||+|||++.++.++|+|||++......
T Consensus 80 ~~~~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~----- 148 (279)
T cd06619 80 FMDGGSLDVYR------KIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS----- 148 (279)
T ss_pred cCCCCChHHhh------cCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECCCCCEEEeeCCcceecccc-----
Confidence 99999986542 3788899999999999999999999999999999999999999999999988543210
Q ss_pred CcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCh------
Q 001847 833 PTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTR------ 906 (1005)
Q Consensus 833 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlGvll~eLltG~~Pf~~~~~------ 906 (1005)
......|++.|+|||++.+..++.++|+|||||++|+|++|..||.....
T Consensus 149 ------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~ 204 (279)
T cd06619 149 ------------------------IAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLM 204 (279)
T ss_pred ------------------------cccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccc
Confidence 11235789999999999988899999999999999999999999965321
Q ss_pred -HHHHHHHHhCCCCCCCCCCCCHHHHHHHHHccccCcCccCCChhcHHHHHcCCCCCCCC
Q 001847 907 -QKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVN 965 (1005)
Q Consensus 907 -~~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~hpff~~~~ 965 (1005)
......+.............+..+.+|+.+||+.+|.+||+ +.++++||||...+
T Consensus 205 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~----~~eil~~~~~~~~~ 260 (279)
T cd06619 205 PLQLLQCIVDEDPPVLPVGQFSEKFVHFITQCMRKQPKERPA----PENLMDHPFIVQYN 260 (279)
T ss_pred hHHHHHHHhccCCCCCCCCcCCHHHHHHHHHHhhCChhhCCC----HHHHhcCccccccc
Confidence 12222222222222222346778999999999999999999 99999999998753
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=331.73 Aligned_cols=255 Identities=27% Similarity=0.413 Sum_probs=212.3
Q ss_pred CCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhC-CCCCcceEEEEEEeC------
Q 001847 672 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPALYASFQTK------ 744 (1005)
Q Consensus 672 ~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~------ 744 (1005)
+.|++.+.||.|+||.||++.+..+++.+|+|.+.... .....+.+|+.+++++ +|+||++++++|...
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~----~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (272)
T cd06637 6 GIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG----DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD 81 (272)
T ss_pred hhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC----ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCC
Confidence 57999999999999999999999999999999986532 2235677899999998 799999999998752
Q ss_pred CeEEEEEeccCCCchhhHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCccc
Q 001847 745 THVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLT 824 (1005)
Q Consensus 745 ~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~~~g~vkL~DFG~a~~~ 824 (1005)
..+|+||||+.+++|.+++.......+++..+..++.|++.||+|||+++|+|+||||+||+++.++.++|+|||++...
T Consensus 82 ~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~~~~~~l~Dfg~~~~~ 161 (272)
T cd06637 82 DQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQL 161 (272)
T ss_pred cEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECCCCCEEEccCCCceec
Confidence 46899999999999999998755556899999999999999999999999999999999999999999999999998543
Q ss_pred CCCCCCCCCcchhhhhcccCCCCCcccccccccccccccCCccccccccc-----CCCCCChhhHHHHHHHHHHHHcCCC
Q 001847 825 SCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIA-----GAGHTSAVDWWALGILLYEMLYGYT 899 (1005)
Q Consensus 825 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~-----~~~~~~~sDIwSlGvll~eLltG~~ 899 (1005)
... ........|++.|+|||++. ...++.++|||||||++|+|++|..
T Consensus 162 ~~~---------------------------~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~ 214 (272)
T cd06637 162 DRT---------------------------VGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAP 214 (272)
T ss_pred ccc---------------------------cccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCC
Confidence 210 01123456899999999986 3357779999999999999999999
Q ss_pred CCCCCChHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHccccCcCccCCChhcHHHHHcCCCC
Q 001847 900 PFRGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFF 961 (1005)
Q Consensus 900 Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~hpff 961 (1005)
||...........+.............+..+.+|+.+||..+|.+||+ +.++++||||
T Consensus 215 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt----~~~il~~~~~ 272 (272)
T cd06637 215 PLCDMHPMRALFLIPRNPAPRLKSKKWSKKFQSFIESCLVKNHSQRPT----TEQLMKHPFI 272 (272)
T ss_pred CccccCHHHHHHHHhcCCCCCCCCCCcCHHHHHHHHHHcCCChhhCCC----HHHHhhCCCC
Confidence 998766555554444433333333456789999999999999999999 9999999998
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=333.60 Aligned_cols=259 Identities=27% Similarity=0.461 Sum_probs=220.2
Q ss_pred CCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEE
Q 001847 672 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLIT 751 (1005)
Q Consensus 672 ~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~ 751 (1005)
++|++++.||.|++|.||++.+..++..+|+|.+... .......+..|++++++++||||+++++++.....+|+||
T Consensus 5 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (280)
T cd06611 5 DIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIE---SEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILI 81 (280)
T ss_pred hHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeC---CHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEe
Confidence 5799999999999999999999889999999998643 4455667888999999999999999999999999999999
Q ss_pred eccCCCchhhHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCCCCC
Q 001847 752 DYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLL 831 (1005)
Q Consensus 752 E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~~ 831 (1005)
||+++++|..++... ...+++..++.++.|++.||.|||++||+|+||||+||+++.++.++|+|||++......
T Consensus 82 e~~~~~~L~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~---- 156 (280)
T cd06611 82 EFCDGGALDSIMLEL-ERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKST---- 156 (280)
T ss_pred eccCCCcHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECCCCCEEEccCccchhhccc----
Confidence 999999999998753 245899999999999999999999999999999999999999999999999987442210
Q ss_pred CCcchhhhhcccCCCCCcccccccccccccccCCcccccccccC-----CCCCChhhHHHHHHHHHHHHcCCCCCCCCCh
Q 001847 832 LPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAG-----AGHTSAVDWWALGILLYEMLYGYTPFRGKTR 906 (1005)
Q Consensus 832 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-----~~~~~~sDIwSlGvll~eLltG~~Pf~~~~~ 906 (1005)
........|++.|+|||.+.. ..++.++|||||||++|+|++|+.||.+...
T Consensus 157 -----------------------~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~ 213 (280)
T cd06611 157 -----------------------LQKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNP 213 (280)
T ss_pred -----------------------ccccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCH
Confidence 011223468999999999752 3466789999999999999999999988877
Q ss_pred HHHHHHHHhCCCC-CCCCCCCCHHHHHHHHHccccCcCccCCChhcHHHHHcCCCCCCCC
Q 001847 907 QKTFANILHKDLK-FPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVN 965 (1005)
Q Consensus 907 ~~~~~~i~~~~~~-~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~hpff~~~~ 965 (1005)
...+..+.....+ +......+..+.+||.+||..+|.+||+ +.++++||||....
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps----~~~il~~~~~~~~~ 269 (280)
T cd06611 214 MRVLLKILKSEPPTLDQPSKWSSSFNDFLKSCLVKDPDDRPT----AAELLKHPFVSDQS 269 (280)
T ss_pred HHHHHHHhcCCCCCcCCcccCCHHHHHHHHHHhccChhhCcC----HHHHhcChhhcccc
Confidence 6666666655332 2233456789999999999999999999 99999999999864
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=333.93 Aligned_cols=256 Identities=25% Similarity=0.406 Sum_probs=208.8
Q ss_pred CccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEEe
Q 001847 673 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITD 752 (1005)
Q Consensus 673 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E 752 (1005)
+|++++.||+|++|.||++.+..++..||+|.++.... .......+.+|+.++++++||||+++++++..++..|+|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESE-EEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFE 79 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccc-cCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEe
Confidence 48899999999999999999999999999999875422 22334567789999999999999999999999999999999
Q ss_pred ccCCCchhhHHhhCC-CCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCCCCC
Q 001847 753 YCPGGELFLLLDRQP-TKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLL 831 (1005)
Q Consensus 753 ~~~ggsL~~~l~~~~-~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~~ 831 (1005)
|+. ++|.+++.... ...+++..++.++.||+.||.|||++|++|+||||+||+++.+|.++|+|||++.......
T Consensus 80 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~--- 155 (285)
T cd07861 80 FLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV--- 155 (285)
T ss_pred cCC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCCCcEEECcccceeecCCCc---
Confidence 995 68888876533 2568999999999999999999999999999999999999999999999999985432110
Q ss_pred CCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCC-CCCChhhHHHHHHHHHHHHcCCCCCCCCChHHHH
Q 001847 832 LPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGA-GHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTF 910 (1005)
Q Consensus 832 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~sDIwSlGvll~eLltG~~Pf~~~~~~~~~ 910 (1005)
.......+++.|+|||++.+. .++.++|||||||++|+|++|+.||.+.......
T Consensus 156 ------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~ 211 (285)
T cd07861 156 ------------------------RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQL 211 (285)
T ss_pred ------------------------ccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHH
Confidence 111233578899999998654 4688999999999999999999999877654443
Q ss_pred HHHHhCCC------------------CC---------CCCCCCCHHHHHHHHHccccCcCccCCChhcHHHHHcCCCC
Q 001847 911 ANILHKDL------------------KF---------PSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFF 961 (1005)
Q Consensus 911 ~~i~~~~~------------------~~---------~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~hpff 961 (1005)
..+..... .. .....++.++.+||.+||..||.+||| +.+++.||||
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt----~~~ll~~~~~ 285 (285)
T cd07861 212 FRIFRILGTPTEDVWPGVTSLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRIS----AKKALNHPYF 285 (285)
T ss_pred HHHHHHhCCCChhhhhcchhhHHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCC----HHHHhcCCCC
Confidence 33221100 00 011236788899999999999999999 9999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-36 Score=331.61 Aligned_cols=260 Identities=35% Similarity=0.639 Sum_probs=205.5
Q ss_pred cccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHH---hCCCCCcceEEEEEEeCCeEEEEEeccC
Q 001847 679 PLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILD---MLDHPFVPALYASFQTKTHVCLITDYCP 755 (1005)
Q Consensus 679 ~LG~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~il~---~l~hpnIv~l~~~~~~~~~~~lV~E~~~ 755 (1005)
.||+|+||.||++.+..+++.+|+|.+.+.............++..+++ ..+||||+.+++++...+..|+||||+.
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 4899999999999999999999999987654333322233344444443 3479999999999999999999999999
Q ss_pred CCchhhHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCCCCCCCcc
Q 001847 756 GGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTT 835 (1005)
Q Consensus 756 ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~~~~~~ 835 (1005)
+++|.+++..+ +.+++..+..++.||+.||.|||++||+|+||||+|||++.++.++|+|||++......
T Consensus 81 ~~~L~~~i~~~--~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~-------- 150 (279)
T cd05633 81 GGDLHYHLSQH--GVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK-------- 150 (279)
T ss_pred CCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCCCCEEEccCCcceecccc--------
Confidence 99999988764 45999999999999999999999999999999999999999999999999988432210
Q ss_pred hhhhhcccCCCCCcccccccccccccccCCcccccccccC-CCCCChhhHHHHHHHHHHHHcCCCCCCCCCh--HHHHHH
Q 001847 836 NEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAG-AGHTSAVDWWALGILLYEMLYGYTPFRGKTR--QKTFAN 912 (1005)
Q Consensus 836 ~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~sDIwSlGvll~eLltG~~Pf~~~~~--~~~~~~ 912 (1005)
......|++.|+|||.+.. ..++.++|||||||++|+|++|..||.+... ......
T Consensus 151 ---------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~ 209 (279)
T cd05633 151 ---------------------KPHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDR 209 (279)
T ss_pred ---------------------CccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHH
Confidence 0112368999999999864 5678899999999999999999999975432 122222
Q ss_pred HHhCCCCCCCCCCCCHHHHHHHHHccccCcCccCCCh-hcHHHHHcCCCCCCCChhhhh
Q 001847 913 ILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSH-EGANEIKKHPFFKGVNWALVR 970 (1005)
Q Consensus 913 i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~-~~a~elL~hpff~~~~~~~~~ 970 (1005)
.. ...........+..+.+||.+||..||.+|++.. ..++++++||||++++|....
T Consensus 210 ~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h~~~~~~~~~~~~ 267 (279)
T cd05633 210 MT-LTVNVELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEHVFFKGIDWQQVY 267 (279)
T ss_pred Hh-hcCCcCCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhCccccCCCHhHHh
Confidence 21 1112222334688999999999999999999311 228999999999999999874
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=369.86 Aligned_cols=264 Identities=25% Similarity=0.388 Sum_probs=217.1
Q ss_pred cccCCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceEEEEEEe--CCe
Q 001847 669 INLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQT--KTH 746 (1005)
Q Consensus 669 i~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~--~~~ 746 (1005)
...++|++++.||.|+||.||+|.+..++..+|+|++..... .......+..|+.+++.++||||++++++|.. ...
T Consensus 10 ~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l-~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~ 88 (1021)
T PTZ00266 10 SRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGL-KEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQK 88 (1021)
T ss_pred cccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEecccc-CHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCE
Confidence 346799999999999999999999999999999999876532 33445678899999999999999999998854 457
Q ss_pred EEEEEeccCCCchhhHHhhC--CCCCCCHHHHHHHHHHHHHHHHHHHHc-------CcccCCCCCCcEEEec--------
Q 001847 747 VCLITDYCPGGELFLLLDRQ--PTKVLKEDAVRFYAAEVVVALEYLHCQ-------GIIYRDLKPENVLLQG-------- 809 (1005)
Q Consensus 747 ~~lV~E~~~ggsL~~~l~~~--~~~~l~~~~i~~i~~qil~aL~~LH~~-------gIvHrDLkP~NILi~~-------- 809 (1005)
+||||||+.+++|.+++... ....+++..++.|+.||+.||.|||+. +|||+||||+||||+.
T Consensus 89 lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i 168 (1021)
T PTZ00266 89 LYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKI 168 (1021)
T ss_pred EEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccc
Confidence 99999999999999998752 234699999999999999999999985 4999999999999964
Q ss_pred ---------CCcEEEEeccCCcccCCCCCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccC--CCC
Q 001847 810 ---------NGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAG--AGH 878 (1005)
Q Consensus 810 ---------~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~--~~~ 878 (1005)
.+.+||+|||++....... ......||+.|+|||++.+ ..+
T Consensus 169 ~~~~~n~ng~~iVKLsDFGlAr~l~~~s----------------------------~~~s~vGTp~YmAPEvL~ge~~~~ 220 (1021)
T PTZ00266 169 TAQANNLNGRPIAKIGDFGLSKNIGIES----------------------------MAHSCVGTPYYWSPELLLHETKSY 220 (1021)
T ss_pred cccccccCCCCceEEccCCccccccccc----------------------------cccccCCCccccCHHHHhccCCCC
Confidence 2358999999985432110 1123479999999999865 347
Q ss_pred CChhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHccccCcCccCCChhcHHHHHcC
Q 001847 879 TSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKH 958 (1005)
Q Consensus 879 ~~~sDIwSlGvll~eLltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~h 958 (1005)
+.++|||||||+||+|++|..||........+...+.....++. ...+..+.+||..||..+|.+||+ +.++|.|
T Consensus 221 s~KSDVWSLG~ILYELLTGk~PF~~~~~~~qli~~lk~~p~lpi-~~~S~eL~dLI~~~L~~dPeeRPS----a~QlL~h 295 (1021)
T PTZ00266 221 DDKSDMWALGCIIYELCSGKTPFHKANNFSQLISELKRGPDLPI-KGKSKELNILIKNLLNLSAKERPS----ALQCLGY 295 (1021)
T ss_pred CchhHHHHHHHHHHHHHHCCCCCCcCCcHHHHHHHHhcCCCCCc-CCCCHHHHHHHHHHhcCChhHCcC----HHHHhcc
Confidence 88999999999999999999999876665555455444333332 346789999999999999999999 9999999
Q ss_pred CCCCCCCh
Q 001847 959 PFFKGVNW 966 (1005)
Q Consensus 959 pff~~~~~ 966 (1005)
+||+.+..
T Consensus 296 ~~ik~i~~ 303 (1021)
T PTZ00266 296 QIIKNVGP 303 (1021)
T ss_pred HHHhhcCC
Confidence 99987644
|
|
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=351.59 Aligned_cols=262 Identities=25% Similarity=0.398 Sum_probs=211.7
Q ss_pred ccCCccccccccccCcEEEEEEEEc--CCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeE
Q 001847 670 NLQHFRPIKPLGSGDTGSVHLVELC--GSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHV 747 (1005)
Q Consensus 670 ~~~~y~~~~~LG~G~~g~Vy~a~~~--~~~~~valK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 747 (1005)
...+|++++.||.|+||.||+|... .+++.+++|.+... ....+|+.+++.++||||++++++|.....+
T Consensus 90 ~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~--------~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~ 161 (392)
T PHA03207 90 VRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG--------KTPGREIDILKTISHRAIINLIHAYRWKSTV 161 (392)
T ss_pred ccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc--------ccHHHHHHHHHhcCCCCccceeeeEeeCCEE
Confidence 3468999999999999999999864 34678999987643 2345799999999999999999999999999
Q ss_pred EEEEeccCCCchhhHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCC
Q 001847 748 CLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCK 827 (1005)
Q Consensus 748 ~lV~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~ 827 (1005)
|+|||++ +++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||++......
T Consensus 162 ~lv~e~~-~~~l~~~l~~~--~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~ 238 (392)
T PHA03207 162 CMVMPKY-KCDLFTYVDRS--GPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAH 238 (392)
T ss_pred EEEehhc-CCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEccCccccccCcc
Confidence 9999999 57888888543 55999999999999999999999999999999999999999999999999998553311
Q ss_pred CCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCh-
Q 001847 828 PQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTR- 906 (1005)
Q Consensus 828 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlGvll~eLltG~~Pf~~~~~- 906 (1005)
.. ........||+.|+|||++....++.++|||||||++|+|++|+.||.+...
T Consensus 239 ~~-------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~ 293 (392)
T PHA03207 239 PD-------------------------TPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVK 293 (392)
T ss_pred cc-------------------------cccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCC
Confidence 10 0112245799999999999988899999999999999999999999976432
Q ss_pred --HHHHHHHHhC----CCC-------------------------CCC---CCCCCHHHHHHHHHccccCcCccCCChhcH
Q 001847 907 --QKTFANILHK----DLK-------------------------FPS---STPTSLHAKQLMYRLLHRDPKSRLGSHEGA 952 (1005)
Q Consensus 907 --~~~~~~i~~~----~~~-------------------------~~~---~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a 952 (1005)
...+..+.+. ... .+. ....+.++.+||.+||..||++||+ +
T Consensus 294 ~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rps----a 369 (392)
T PHA03207 294 SSSSQLRSIIRCMQVHPLEFPQNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPS----A 369 (392)
T ss_pred CcHHHHHHHHHHhccCccccCCccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCC----H
Confidence 1222222210 000 000 0124567889999999999999999 9
Q ss_pred HHHHcCCCCCCCChhhhhh
Q 001847 953 NEIKKHPFFKGVNWALVRC 971 (1005)
Q Consensus 953 ~elL~hpff~~~~~~~~~~ 971 (1005)
.++|.||||+...|..++-
T Consensus 370 ~e~l~~p~f~~~~~~~~~~ 388 (392)
T PHA03207 370 QDILSLPLFTKEPINLLNI 388 (392)
T ss_pred HHHhhCchhhccchhhhcC
Confidence 9999999999988887643
|
|
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=329.95 Aligned_cols=265 Identities=45% Similarity=0.827 Sum_probs=225.0
Q ss_pred ccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEEeccCCCch
Q 001847 680 LGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGEL 759 (1005)
Q Consensus 680 LG~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~ggsL 759 (1005)
||.|+||.||++.+..+++.+++|.+.............+.+|+.++++++|+||+++++.+...+..|+||||+.+++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 68999999999999888999999999765444455667888999999999999999999999999999999999999999
Q ss_pred hhHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCCCCCCCcchhhh
Q 001847 760 FLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKK 839 (1005)
Q Consensus 760 ~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~ 839 (1005)
.+++.... .+++..+..++.||+.||.|||++|++|+||+|+||+++.++.++|+|||++...........
T Consensus 81 ~~~l~~~~--~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~------- 151 (265)
T cd05579 81 ASLLENVG--SLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINL------- 151 (265)
T ss_pred HHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCccccc-------
Confidence 99997643 589999999999999999999999999999999999999999999999998854321111000
Q ss_pred hcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhCCCC
Q 001847 840 RRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANILHKDLK 919 (1005)
Q Consensus 840 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlGvll~eLltG~~Pf~~~~~~~~~~~i~~~~~~ 919 (1005)
...........++..|++||.+.....+.++||||||+++|+|++|..||...........+..+...
T Consensus 152 ------------~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~ 219 (265)
T cd05579 152 ------------NDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIE 219 (265)
T ss_pred ------------ccccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCcC
Confidence 00011223456888999999998888889999999999999999999999988888777777776666
Q ss_pred CCCCCCCCHHHHHHHHHccccCcCccCCChhcHHHHHcCCCCCCCCh
Q 001847 920 FPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVNW 966 (1005)
Q Consensus 920 ~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~hpff~~~~~ 966 (1005)
++.....+..+.+|+.+||+.+|.+||++.. +.++|+||||+.++|
T Consensus 220 ~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~-~~~~l~~~~~~~~~~ 265 (265)
T cd05579 220 WPEDVEVSDEAIDLISKLLVPDPEKRLGAKS-IEEIKNHPFFKGIDW 265 (265)
T ss_pred CCccccCCHHHHHHHHHHhcCCHhhcCCCcc-HHHHhcCccccCCCC
Confidence 6665556889999999999999999999322 399999999999988
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-38 Score=316.28 Aligned_cols=266 Identities=24% Similarity=0.325 Sum_probs=216.1
Q ss_pred ccccCCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceEEEEEEe----
Q 001847 668 QINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQT---- 743 (1005)
Q Consensus 668 ~i~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~---- 743 (1005)
.|+.++|++.+.||+|||+.||+|++..++..||+|.+... .....+...+|++..++++||||++++++...
T Consensus 17 ~In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~---~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D 93 (302)
T KOG2345|consen 17 IINNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCH---SQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKD 93 (302)
T ss_pred EEcCceEEEeeeecCCCceeeeeecccCcccchhhheeecc---chHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhcc
Confidence 36789999999999999999999999999999999998765 35667888999999999999999999876532
Q ss_pred -CCeEEEEEeccCCCchhhHHhhC--CCCCCCHHHHHHHHHHHHHHHHHHHHcC--cccCCCCCCcEEEecCCcEEEEec
Q 001847 744 -KTHVCLITDYCPGGELFLLLDRQ--PTKVLKEDAVRFYAAEVVVALEYLHCQG--IIYRDLKPENVLLQGNGHVSLTDF 818 (1005)
Q Consensus 744 -~~~~~lV~E~~~ggsL~~~l~~~--~~~~l~~~~i~~i~~qil~aL~~LH~~g--IvHrDLkP~NILi~~~g~vkL~DF 818 (1005)
....||+++|+..|+|.+.+... .+..+++.++..|+.+|++||.+||... .+||||||.|||+++++.++|.||
T Consensus 94 ~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~~vl~D~ 173 (302)
T KOG2345|consen 94 GKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGLPVLMDL 173 (302)
T ss_pred CceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCceEEEec
Confidence 34599999999999999998753 3446999999999999999999999998 999999999999999999999999
Q ss_pred cCCcccCCCCCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCC---CCCChhhHHHHHHHHHHHH
Q 001847 819 DLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGA---GHTSAVDWWALGILLYEML 895 (1005)
Q Consensus 819 G~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~---~~~~~sDIwSlGvll~eLl 895 (1005)
|.+......-... . .............|..|+|||.+.-. ..+.++|||||||+||.|+
T Consensus 174 GS~~~a~i~i~~~---~---------------~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~m 235 (302)
T KOG2345|consen 174 GSATQAPIQIEGS---R---------------QALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMM 235 (302)
T ss_pred cCccccceEeech---H---------------HHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHH
Confidence 9886543211100 0 00011112234678999999998543 4577999999999999999
Q ss_pred cCCCCCCCCCh--HHHHHHHHhCCCCCCCCCCCCHHHHHHHHHccccCcCccCCChhcHHHHHcC
Q 001847 896 YGYTPFRGKTR--QKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKH 958 (1005)
Q Consensus 896 tG~~Pf~~~~~--~~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~h 958 (1005)
+|..||..... ....-.+....+.+|...+++..+.+||++||+.||.+||+ +.+++.+
T Consensus 236 f~~sPfe~~~~~GgSlaLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~----i~~ll~~ 296 (302)
T KOG2345|consen 236 FGESPFERIYQQGGSLALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPT----IPELLSK 296 (302)
T ss_pred HcCCcchHHhhcCCeEEEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCC----HHHHHHH
Confidence 99999953211 11222345567889998889999999999999999999999 7777653
|
|
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=328.10 Aligned_cols=256 Identities=43% Similarity=0.758 Sum_probs=214.6
Q ss_pred ccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHH-HhCCCCCcceEEEEEEeCCeEEEEEeccCC
Q 001847 678 KPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREIL-DMLDHPFVPALYASFQTKTHVCLITDYCPG 756 (1005)
Q Consensus 678 ~~LG~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~il-~~l~hpnIv~l~~~~~~~~~~~lV~E~~~g 756 (1005)
+.||.|+||.||+|.+..+++.||+|.+.+...........+..|..++ ...+|+|++++++++...+.+|+||||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 5789999999999999999999999998764332233334445555444 445899999999999999999999999999
Q ss_pred CchhhHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCCCCCCCcch
Q 001847 757 GELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTN 836 (1005)
Q Consensus 757 gsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~~~~~~~ 836 (1005)
++|.+++... ..+++..+..++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||++.....
T Consensus 82 ~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~---------- 149 (260)
T cd05611 82 GDCASLIKTL--GGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE---------- 149 (260)
T ss_pred CCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEeecccceeccc----------
Confidence 9999999764 4589999999999999999999999999999999999999999999999998743210
Q ss_pred hhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhC
Q 001847 837 EKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANILHK 916 (1005)
Q Consensus 837 ~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlGvll~eLltG~~Pf~~~~~~~~~~~i~~~ 916 (1005)
.....|++.|+|||.+.+..++.++||||||+++|+|++|..||...+.......+...
T Consensus 150 ---------------------~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~ 208 (260)
T cd05611 150 ---------------------NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSR 208 (260)
T ss_pred ---------------------cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhc
Confidence 12345788999999998887889999999999999999999999988887777777666
Q ss_pred CCCCCCC--CCCCHHHHHHHHHccccCcCccCCChhcHHHHHcCCCCCCCChh
Q 001847 917 DLKFPSS--TPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVNWA 967 (1005)
Q Consensus 917 ~~~~~~~--~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~hpff~~~~~~ 967 (1005)
...++.. ..++..+.++|.+||..+|++||++.. +++++.||||+.++|.
T Consensus 209 ~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~-~~~~l~~~~~~~~~~~ 260 (260)
T cd05611 209 RINWPEEVKEFCSPEAVDLINRLLCMDPAKRLGANG-YQEIKSHPFFKSINWD 260 (260)
T ss_pred ccCCCCcccccCCHHHHHHHHHHccCCHHHccCCCc-HHHHHcChHhhcCCCC
Confidence 5544432 246889999999999999999997322 6899999999999884
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-36 Score=336.26 Aligned_cols=256 Identities=27% Similarity=0.424 Sum_probs=212.6
Q ss_pred CCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEE
Q 001847 672 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLIT 751 (1005)
Q Consensus 672 ~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~ 751 (1005)
++|++++.||+|+||.||++.+..++..+++|.+.... .......+.+|++++++++||||++++++|..++.+|+||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 78 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEI--KPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICM 78 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEecccc--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEe
Confidence 36999999999999999999999999999999987532 3344567888999999999999999999999999999999
Q ss_pred eccCCCchhhHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHH-cCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCCCC
Q 001847 752 DYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHC-QGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQL 830 (1005)
Q Consensus 752 E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~-~gIvHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~ 830 (1005)
||+++++|.+++... ..+++..+..++.||+.||.|||+ .+++|+||||+|||++.++.++|+|||++.....
T Consensus 79 ey~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~---- 152 (308)
T cd06615 79 EHMDGGSLDQVLKKA--GRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID---- 152 (308)
T ss_pred eccCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCCcEEEccCCCcccccc----
Confidence 999999999999764 458999999999999999999997 5999999999999999999999999998743210
Q ss_pred CCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHcCCCCCCCCChHHHH
Q 001847 831 LLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTF 910 (1005)
Q Consensus 831 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlGvll~eLltG~~Pf~~~~~~~~~ 910 (1005)
.......|++.|+|||++.+..++.++|||||||++|+|++|..||...+.....
T Consensus 153 -------------------------~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~ 207 (308)
T cd06615 153 -------------------------SMANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELE 207 (308)
T ss_pred -------------------------cccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHH
Confidence 0112357899999999998888889999999999999999999999765543322
Q ss_pred HHHHhC------------------------------------CCCCCCCCCCCHHHHHHHHHccccCcCccCCChhcHHH
Q 001847 911 ANILHK------------------------------------DLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANE 954 (1005)
Q Consensus 911 ~~i~~~------------------------------------~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~e 954 (1005)
..+... ..+......++.++.+|+.+||..+|++||+ +.+
T Consensus 208 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt----~~~ 283 (308)
T cd06615 208 AMFGRPVSEGEAKESHRPVSGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERAD----LKE 283 (308)
T ss_pred HhhcCccccccccCCcccccCCCCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcC----HHH
Confidence 211110 0000001125678999999999999999999 999
Q ss_pred HHcCCCCCCC
Q 001847 955 IKKHPFFKGV 964 (1005)
Q Consensus 955 lL~hpff~~~ 964 (1005)
+++||||.+.
T Consensus 284 ll~~~~~~~~ 293 (308)
T cd06615 284 LTKHPFIKRA 293 (308)
T ss_pred HhcChhhhhc
Confidence 9999999863
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=318.25 Aligned_cols=253 Identities=27% Similarity=0.446 Sum_probs=213.3
Q ss_pred cCCcccc-ccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhC-CCCCcceEEEEEEe----C
Q 001847 671 LQHFRPI-KPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPALYASFQT----K 744 (1005)
Q Consensus 671 ~~~y~~~-~~LG~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~----~ 744 (1005)
.++|.+- ++||-|-.|.|-.|.++.|+..+|+|++... .+..+|.++--.. .|||||.++++|.+ .
T Consensus 60 tedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds--------~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~r 131 (400)
T KOG0604|consen 60 TEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS--------PKARREVELHWMASGHPHIVSIIDVYENSYQGR 131 (400)
T ss_pred hhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC--------HHHHhHhhhhhhhcCCCceEEeehhhhhhccCc
Confidence 3566665 5699999999999999999999999987532 3445677664444 79999999999875 4
Q ss_pred CeEEEEEeccCCCchhhHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEec---CCcEEEEeccCC
Q 001847 745 THVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQG---NGHVSLTDFDLS 821 (1005)
Q Consensus 745 ~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~~---~g~vkL~DFG~a 821 (1005)
..+.+|||.|+||.|++.++.+....+++..+..|++||..|+.|||+.+|.||||||+|+|++. |..+||+|||+|
T Consensus 132 kcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLtDfGFA 211 (400)
T KOG0604|consen 132 KCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLTDFGFA 211 (400)
T ss_pred eeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEecccccc
Confidence 57889999999999999999888888999999999999999999999999999999999999985 457999999999
Q ss_pred cccCCCCCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHcCCCCC
Q 001847 822 CLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPF 901 (1005)
Q Consensus 822 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlGvll~eLltG~~Pf 901 (1005)
+..... ..-.+.|-||+|.|||++-...|+..+|+||+||++|-|++|.+||
T Consensus 212 K~t~~~----------------------------~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPF 263 (400)
T KOG0604|consen 212 KETQEP----------------------------GDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPF 263 (400)
T ss_pred cccCCC----------------------------ccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcc
Confidence 653211 1223568899999999999999999999999999999999999999
Q ss_pred CCCCh----HHHHHHHHhCCCCCC--CCCCCCHHHHHHHHHccccCcCccCCChhcHHHHHcCCCCCC
Q 001847 902 RGKTR----QKTFANILHKDLKFP--SSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKG 963 (1005)
Q Consensus 902 ~~~~~----~~~~~~i~~~~~~~~--~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~hpff~~ 963 (1005)
..... .....+|..+...+| ++...|..++++|+++|..+|.+|+| +.+++.|||+.+
T Consensus 264 YS~hg~aispgMk~rI~~gqy~FP~pEWs~VSe~aKdlIR~LLkt~PteRlT----I~~~m~hpwi~~ 327 (400)
T KOG0604|consen 264 YSNHGLAISPGMKRRIRTGQYEFPEPEWSCVSEAAKDLIRKLLKTEPTERLT----IEEVMDHPWINQ 327 (400)
T ss_pred cccCCccCChhHHhHhhccCccCCChhHhHHHHHHHHHHHHHhcCCchhhee----HHHhhcCchhcc
Confidence 75433 234455665655554 55778999999999999999999999 999999999996
|
|
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=352.85 Aligned_cols=254 Identities=26% Similarity=0.376 Sum_probs=204.3
Q ss_pred ccCCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEE
Q 001847 670 NLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCL 749 (1005)
Q Consensus 670 ~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l 749 (1005)
...+|.+.+.||.|+||.||++.+..+++.||||.... ..+.+|+.++++++|+||+++++++...+..|+
T Consensus 167 ~~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~---------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~l 237 (461)
T PHA03211 167 AGLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY---------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCL 237 (461)
T ss_pred ccCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc---------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEE
Confidence 35689999999999999999999999999999996432 235679999999999999999999999999999
Q ss_pred EEeccCCCchhhHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCCC
Q 001847 750 ITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQ 829 (1005)
Q Consensus 750 V~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~ 829 (1005)
|||++ .++|..++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++........
T Consensus 238 v~e~~-~~~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~ 315 (461)
T PHA03211 238 VLPKY-RSDLYTYLGARL-RPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWS 315 (461)
T ss_pred EEEcc-CCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECCCCCEEEcccCCceecccccc
Confidence 99999 578888886542 3599999999999999999999999999999999999999999999999999865321100
Q ss_pred CCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCh---
Q 001847 830 LLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTR--- 906 (1005)
Q Consensus 830 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlGvll~eLltG~~Pf~~~~~--- 906 (1005)
........||+.|+|||++.+..++.++|||||||++|+|++|..|+.....
T Consensus 316 -------------------------~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~ 370 (461)
T PHA03211 316 -------------------------TPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDE 370 (461)
T ss_pred -------------------------cccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccc
Confidence 0011235799999999999998999999999999999999998765533211
Q ss_pred ----HHHHHHHHh-CCCC---C-----------------------------CCCCCCCHHHHHHHHHccccCcCccCCCh
Q 001847 907 ----QKTFANILH-KDLK---F-----------------------------PSSTPTSLHAKQLMYRLLHRDPKSRLGSH 949 (1005)
Q Consensus 907 ----~~~~~~i~~-~~~~---~-----------------------------~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~ 949 (1005)
...+.+++. .... + ......+..+.+||.+||+.||.+|||
T Consensus 371 ~~~~~~~l~~~i~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPs-- 448 (461)
T PHA03211 371 RRPYDAQILRIIRQAQVHVDEFPQHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPS-- 448 (461)
T ss_pred cCCcHHHHHHHHHhhccccccCCCCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcC--
Confidence 112222221 1110 0 111124557889999999999999999
Q ss_pred hcHHHHHcCCCCCC
Q 001847 950 EGANEIKKHPFFKG 963 (1005)
Q Consensus 950 ~~a~elL~hpff~~ 963 (1005)
+.++|+||||+.
T Consensus 449 --a~elL~hp~f~~ 460 (461)
T PHA03211 449 --AAELLRLPLFQS 460 (461)
T ss_pred --HHHHhhCcccCC
Confidence 999999999975
|
|
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-36 Score=330.24 Aligned_cols=257 Identities=26% Similarity=0.431 Sum_probs=216.4
Q ss_pred CccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEEe
Q 001847 673 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITD 752 (1005)
Q Consensus 673 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E 752 (1005)
-|++.+.||.|+||.||++.+..++..+++|.+... .......+.+|+++++.++||||+++++++...+..|+|||
T Consensus 6 ~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e 82 (282)
T cd06643 6 FWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTK---SEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIE 82 (282)
T ss_pred HHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCC---CHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEE
Confidence 378899999999999999999999999999998643 33455678889999999999999999999999999999999
Q ss_pred ccCCCchhhHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCCCCCC
Q 001847 753 YCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLL 832 (1005)
Q Consensus 753 ~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~~~ 832 (1005)
|+.+++|..++... ...+++..+..++.||+.||.|||+.|++|+||||+||+++.++.++|+|||++......
T Consensus 83 ~~~~~~l~~~~~~~-~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~----- 156 (282)
T cd06643 83 FCAGGAVDAVMLEL-ERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT----- 156 (282)
T ss_pred ecCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccCCCEEEcccccccccccc-----
Confidence 99999998887643 245899999999999999999999999999999999999999999999999988542210
Q ss_pred CcchhhhhcccCCCCCcccccccccccccccCCccccccccc-----CCCCCChhhHHHHHHHHHHHHcCCCCCCCCChH
Q 001847 833 PTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIA-----GAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQ 907 (1005)
Q Consensus 833 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~-----~~~~~~~sDIwSlGvll~eLltG~~Pf~~~~~~ 907 (1005)
........+++.|+|||++. ...++.++|||||||++|+|++|..||...+..
T Consensus 157 ----------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~ 214 (282)
T cd06643 157 ----------------------IQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPM 214 (282)
T ss_pred ----------------------ccccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHH
Confidence 01112346889999999984 344677999999999999999999999887776
Q ss_pred HHHHHHHhCCCC-CCCCCCCCHHHHHHHHHccccCcCccCCChhcHHHHHcCCCCCCC
Q 001847 908 KTFANILHKDLK-FPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGV 964 (1005)
Q Consensus 908 ~~~~~i~~~~~~-~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~hpff~~~ 964 (1005)
.....+...... ......++..+.+||.+||..+|.+||+ +.++++||||+..
T Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~----~~~il~~~~~~~~ 268 (282)
T cd06643 215 RVLLKIAKSEPPTLAQPSRWSSEFKDFLKKCLEKNVDARWT----TTQLLQHPFVTVN 268 (282)
T ss_pred HHHHHHhhcCCCCCCCccccCHHHHHHHHHHccCChhhCcC----HHHHhcCCCEecc
Confidence 666666554322 2223346788999999999999999999 9999999999964
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-36 Score=333.51 Aligned_cols=264 Identities=25% Similarity=0.417 Sum_probs=219.9
Q ss_pred hcccccccccCCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceEEEEE
Q 001847 662 ILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASF 741 (1005)
Q Consensus 662 ~~~~~~~i~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~ 741 (1005)
+...|... .+|++++.||+|++|.||++.+..++..|++|.+.... ......+.+|+.+++.+.|+||+++++.|
T Consensus 12 ~~~~~~~~--~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~---~~~~~~~~~e~~~l~~~~h~~v~~~~~~~ 86 (296)
T cd06654 12 IVSVGDPK--KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQ---QPKKELIINEILVMRENKNPNIVNYLDSY 86 (296)
T ss_pred ccccCCcc--cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCC---cchHHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence 34444443 58999999999999999999999999999999987543 22346678899999999999999999999
Q ss_pred EeCCeEEEEEeccCCCchhhHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCC
Q 001847 742 QTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLS 821 (1005)
Q Consensus 742 ~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~~~g~vkL~DFG~a 821 (1005)
......|+||||+++++|.+++.. ..++...+..++.||+.||.|||+.||+|+||||+||+++.++.++|+|||++
T Consensus 87 ~~~~~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~~~~kl~dfg~~ 163 (296)
T cd06654 87 LVGDELWVVMEYLAGGSLTDVVTE---TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFC 163 (296)
T ss_pred EeCCEEEEeecccCCCCHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEECccccc
Confidence 999999999999999999999865 34789999999999999999999999999999999999999999999999987
Q ss_pred cccCCCCCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHcCCCCC
Q 001847 822 CLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPF 901 (1005)
Q Consensus 822 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlGvll~eLltG~~Pf 901 (1005)
....... .......|++.|+|||.+.+..++.++|||||||++|+|++|+.||
T Consensus 164 ~~~~~~~---------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf 216 (296)
T cd06654 164 AQITPEQ---------------------------SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPY 216 (296)
T ss_pred hhccccc---------------------------cccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCC
Confidence 5432110 0112346889999999998888889999999999999999999999
Q ss_pred CCCChHHHHHHHHhCC-CCCCCCCCCCHHHHHHHHHccccCcCccCCChhcHHHHHcCCCCCCC
Q 001847 902 RGKTRQKTFANILHKD-LKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGV 964 (1005)
Q Consensus 902 ~~~~~~~~~~~i~~~~-~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~hpff~~~ 964 (1005)
...........+.... ........++..+.+|+.+||..+|++||+ +.++++||||...
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt----~~eil~~~~~~~~ 276 (296)
T cd06654 217 LNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLDMDVEKRGS----AKELLQHQFLKIA 276 (296)
T ss_pred CCCCHHHhHHHHhcCCCCCCCCccccCHHHHHHHHHHCcCCcccCcC----HHHHhhChhhhcc
Confidence 8876654443333322 222233446788999999999999999999 9999999999864
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-36 Score=324.19 Aligned_cols=256 Identities=28% Similarity=0.477 Sum_probs=222.7
Q ss_pred CccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEEe
Q 001847 673 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITD 752 (1005)
Q Consensus 673 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E 752 (1005)
+|++++.||.|+||.||.+.+..++..+++|.+..... .......+.+|+.++++++|+||+++++++...+.++++||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e 79 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRL-SEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEME 79 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeeccc-chhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEE
Confidence 58999999999999999999999999999999875432 33445678899999999999999999999999999999999
Q ss_pred ccCCCchhhHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCCCCCC
Q 001847 753 YCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLL 832 (1005)
Q Consensus 753 ~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~~~ 832 (1005)
|+++++|.+++.......+++..+..++.|++.+|.|||+.|++|+||+|+||+++.++.+||+|||++.......
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~---- 155 (256)
T cd08221 80 YANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEY---- 155 (256)
T ss_pred ecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCCCCEEECcCcceEEccccc----
Confidence 9999999999987645568999999999999999999999999999999999999999999999999885432111
Q ss_pred CcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHcCCCCCCCCChHHHHHH
Q 001847 833 PTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFAN 912 (1005)
Q Consensus 833 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlGvll~eLltG~~Pf~~~~~~~~~~~ 912 (1005)
.......|++.|+|||.+.+..++.++|+|||||++|+|++|..||......+....
T Consensus 156 -----------------------~~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~ 212 (256)
T cd08221 156 -----------------------SMAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVK 212 (256)
T ss_pred -----------------------ccccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHH
Confidence 012235689999999999888888999999999999999999999998888777777
Q ss_pred HHhCCCCCCCCCCCCHHHHHHHHHccccCcCccCCChhcHHHHHcCCCC
Q 001847 913 ILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFF 961 (1005)
Q Consensus 913 i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~hpff 961 (1005)
+..+.... .....+..+.+++.+||..+|.+||+ +.++++|+|+
T Consensus 213 ~~~~~~~~-~~~~~~~~~~~~i~~~l~~~p~~R~s----~~~ll~~~~l 256 (256)
T cd08221 213 IVQGNYTP-VVSVYSSELISLVHSLLQQDPEKRPT----ADEVLDQPLL 256 (256)
T ss_pred HHcCCCCC-CccccCHHHHHHHHHHcccCcccCCC----HHHHhhCcCC
Confidence 77665433 22456889999999999999999999 9999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-36 Score=332.21 Aligned_cols=244 Identities=18% Similarity=0.204 Sum_probs=205.9
Q ss_pred ccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceEEEEEEe----CCeEEEEEec
Q 001847 678 KPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQT----KTHVCLITDY 753 (1005)
Q Consensus 678 ~~LG~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~----~~~~~lV~E~ 753 (1005)
..||+|+++.||++.+ +|+.||+|.++............+.+|+.++++++||||+++++++.. ...+++||||
T Consensus 26 ~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey 103 (283)
T PHA02988 26 VLIKENDQNSIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEY 103 (283)
T ss_pred eEEeeCCceEEEEEEE--CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEe
Confidence 6789999999999998 789999999987544344445778899999999999999999999876 4578999999
Q ss_pred cCCCchhhHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHc-CcccCCCCCCcEEEecCCcEEEEeccCCcccCCCCCCCC
Q 001847 754 CPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQ-GIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLL 832 (1005)
Q Consensus 754 ~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~-gIvHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~~~ 832 (1005)
+++|+|.+++... ..++......++.|++.||.|||+. +++||||||+|||++.++.+||+|||++......
T Consensus 104 ~~~g~L~~~l~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~----- 176 (283)
T PHA02988 104 CTRGYLREVLDKE--KDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSP----- 176 (283)
T ss_pred CCCCcHHHHHhhC--CCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCCcEEEcccchHhhhccc-----
Confidence 9999999999764 4588899999999999999999985 9999999999999999999999999998543211
Q ss_pred CcchhhhhcccCCCCCcccccccccccccccCCcccccccccC--CCCCChhhHHHHHHHHHHHHcCCCCCCCCChHHHH
Q 001847 833 PTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAG--AGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTF 910 (1005)
Q Consensus 833 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~--~~~~~~sDIwSlGvll~eLltG~~Pf~~~~~~~~~ 910 (1005)
.....|++.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+.+
T Consensus 177 -------------------------~~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~ 231 (283)
T PHA02988 177 -------------------------PFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIY 231 (283)
T ss_pred -------------------------cccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHH
Confidence 112358899999999976 67889999999999999999999999988877777
Q ss_pred HHHHhCCCCCCCCCCCCHHHHHHHHHccccCcCccCCChhcHHHH
Q 001847 911 ANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEI 955 (1005)
Q Consensus 911 ~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~el 955 (1005)
..+.......+....++..+.+|+.+||+.||++|||+.+++..+
T Consensus 232 ~~i~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l 276 (283)
T PHA02988 232 DLIINKNNSLKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNL 276 (283)
T ss_pred HHHHhcCCCCCCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHH
Confidence 777666555444445788999999999999999999954444433
|
|
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-36 Score=326.03 Aligned_cols=261 Identities=28% Similarity=0.419 Sum_probs=215.9
Q ss_pred CccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccCh------HHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCe
Q 001847 673 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNR------NKVHRACAEREILDMLDHPFVPALYASFQTKTH 746 (1005)
Q Consensus 673 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~------~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~ 746 (1005)
+|.+.+.||.|++|.||+|.+..+++.+|+|.+........ .....+.+|+.+++.++||||+++++++...+.
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 47788999999999999999988899999998875433221 233567789999999999999999999999999
Q ss_pred EEEEEeccCCCchhhHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCC
Q 001847 747 VCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSC 826 (1005)
Q Consensus 747 ~~lV~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~~~g~vkL~DFG~a~~~~~ 826 (1005)
.++||||+++++|.+++... +.++...+..++.|++.||.|||++|++|+||+|+||++++++.++|+|||++.....
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNNY--GAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKGGIKISDFGISKKLEA 158 (267)
T ss_pred cEEEEEecCCCCHHHHHHhc--cCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcCCCCEEecccCCCccccc
Confidence 99999999999999999764 4588999999999999999999999999999999999999999999999999865431
Q ss_pred CCCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCh
Q 001847 827 KPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTR 906 (1005)
Q Consensus 827 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlGvll~eLltG~~Pf~~~~~ 906 (1005)
.... ...........|+..|+|||.+.+..++.++|+|||||++|+|++|+.||.+.+.
T Consensus 159 ~~~~---------------------~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~ 217 (267)
T cd06628 159 NSLS---------------------TKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQ 217 (267)
T ss_pred cccc---------------------CCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccH
Confidence 1100 0001112235688999999999888888999999999999999999999988766
Q ss_pred HHHHHHHHhCCCCCCCCCCCCHHHHHHHHHccccCcCccCCChhcHHHHHcCCCC
Q 001847 907 QKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFF 961 (1005)
Q Consensus 907 ~~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~hpff 961 (1005)
...+..+..... .......+..+.++|.+||+.+|.+||+ +.++++||||
T Consensus 218 ~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~p~~Rp~----~~~il~~~~~ 267 (267)
T cd06628 218 LQAIFKIGENAS-PEIPSNISSEAIDFLEKTFEIDHNKRPT----AAELLKHPFL 267 (267)
T ss_pred HHHHHHHhccCC-CcCCcccCHHHHHHHHHHccCCchhCcC----HHHHhhCCCC
Confidence 555555444211 1122346788999999999999999999 9999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-36 Score=328.62 Aligned_cols=254 Identities=26% Similarity=0.438 Sum_probs=212.2
Q ss_pred cCCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEE
Q 001847 671 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLI 750 (1005)
Q Consensus 671 ~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV 750 (1005)
.++|++.+.||+|+||.||+|.+..+++.||+|.++.. .......+.+|+.+++.++||||+++++++...+.+|+|
T Consensus 8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~---~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv 84 (267)
T cd06645 8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLE---PGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWIC 84 (267)
T ss_pred HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecC---chhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEE
Confidence 45899999999999999999999999999999998754 223345677899999999999999999999999999999
Q ss_pred EeccCCCchhhHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCCCC
Q 001847 751 TDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQL 830 (1005)
Q Consensus 751 ~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~ 830 (1005)
|||+.+++|.+++... +.+++..++.++.||+.||.|||++|++|+||||+||+++.++.++|+|||++......
T Consensus 85 ~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~--- 159 (267)
T cd06645 85 MEFCGGGSLQDIYHVT--GPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQITAT--- 159 (267)
T ss_pred EeccCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECcceeeeEccCc---
Confidence 9999999999998764 45899999999999999999999999999999999999999999999999987543211
Q ss_pred CCCcchhhhhcccCCCCCcccccccccccccccCCccccccccc---CCCCCChhhHHHHHHHHHHHHcCCCCCCCCChH
Q 001847 831 LLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIA---GAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQ 907 (1005)
Q Consensus 831 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~---~~~~~~~sDIwSlGvll~eLltG~~Pf~~~~~~ 907 (1005)
........|++.|+|||++. ...++.++|+|||||++|+|++|..||......
T Consensus 160 ------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~ 215 (267)
T cd06645 160 ------------------------IAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPM 215 (267)
T ss_pred ------------------------ccccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccch
Confidence 01112346899999999974 445778999999999999999999999766554
Q ss_pred HHHHHHHhCCCCCCC---CCCCCHHHHHHHHHccccCcCccCCChhcHHHHHcCCC
Q 001847 908 KTFANILHKDLKFPS---STPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPF 960 (1005)
Q Consensus 908 ~~~~~i~~~~~~~~~---~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~hpf 960 (1005)
.............+. ...++..+.+||.+||..+|++||+ +.++++|||
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~----~~~ll~~~~ 267 (267)
T cd06645 216 RALFLMTKSNFQPPKLKDKMKWSNSFHHFVKMALTKNPKKRPT----AEKLLQHPF 267 (267)
T ss_pred hhHHhhhccCCCCCcccccCCCCHHHHHHHHHHccCCchhCcC----HHHHhcCCC
Confidence 444443333332222 2245678999999999999999999 999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-36 Score=334.64 Aligned_cols=256 Identities=25% Similarity=0.419 Sum_probs=215.6
Q ss_pred CCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEE
Q 001847 672 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLIT 751 (1005)
Q Consensus 672 ~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~ 751 (1005)
.+|++++.||+|++|.||++.+..+++.||+|.+.... ......+.+|+.+++.++|+||+++++++...+..|+||
T Consensus 19 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~ 95 (297)
T cd06656 19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQ---QPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVM 95 (297)
T ss_pred hhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCc---cchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEee
Confidence 68999999999999999999999999999999987542 233456788999999999999999999999999999999
Q ss_pred eccCCCchhhHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCCCCC
Q 001847 752 DYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLL 831 (1005)
Q Consensus 752 E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~~ 831 (1005)
||+++++|.+++.. ..++...+..++.|++.+|.|||+.|++|+||||+|||++.++.++|+|||++.......
T Consensus 96 e~~~~~~L~~~~~~---~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~--- 169 (297)
T cd06656 96 EYLAGGSLTDVVTE---TCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ--- 169 (297)
T ss_pred cccCCCCHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEECcCccceEccCCc---
Confidence 99999999999865 348899999999999999999999999999999999999999999999999885432110
Q ss_pred CCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHcCCCCCCCCChHHHHH
Q 001847 832 LPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFA 911 (1005)
Q Consensus 832 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlGvll~eLltG~~Pf~~~~~~~~~~ 911 (1005)
.......+++.|+|||.+.+..++.++|+|||||++|+|++|..||.+.+......
T Consensus 170 ------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~ 225 (297)
T cd06656 170 ------------------------SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY 225 (297)
T ss_pred ------------------------cCcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchhee
Confidence 01123468899999999988888999999999999999999999998765543333
Q ss_pred HHHhC-CCCCCCCCCCCHHHHHHHHHccccCcCccCCChhcHHHHHcCCCCCCC
Q 001847 912 NILHK-DLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGV 964 (1005)
Q Consensus 912 ~i~~~-~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~hpff~~~ 964 (1005)
.+... ..........+..+.+|+.+||..+|++||+ +.++++||||+..
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps----~~~il~~~~~~~~ 275 (297)
T cd06656 226 LIATNGTPELQNPERLSAVFRDFLNRCLEMDVDRRGS----AKELLQHPFLKLA 275 (297)
T ss_pred eeccCCCCCCCCccccCHHHHHHHHHHccCChhhCcC----HHHHhcCchhccc
Confidence 22222 2222223346778899999999999999999 9999999999963
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-36 Score=326.90 Aligned_cols=261 Identities=28% Similarity=0.423 Sum_probs=219.7
Q ss_pred CCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEE
Q 001847 672 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLIT 751 (1005)
Q Consensus 672 ~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~ 751 (1005)
++|++.+.||.|+||.||++.+..++..+++|++..... ......+.+|+.+++.++|+||+++++.+...+..|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~ 78 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKC--QTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVM 78 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCc--chHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEE
Confidence 479999999999999999999988999999999875432 225677889999999999999999999999999999999
Q ss_pred eccCCCchhhHHhhCCC-CCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCCCC
Q 001847 752 DYCPGGELFLLLDRQPT-KVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQL 830 (1005)
Q Consensus 752 E~~~ggsL~~~l~~~~~-~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~ 830 (1005)
||+++++|.+++..... ..+++..++.++.||+.||.|||+.|++|+||+|+||++++++.++|+|||++.........
T Consensus 79 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~~ 158 (267)
T cd06610 79 PYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDR 158 (267)
T ss_pred eccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCccc
Confidence 99999999999976422 46899999999999999999999999999999999999999999999999988554321110
Q ss_pred CCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCC-CCCChhhHHHHHHHHHHHHcCCCCCCCCChHHH
Q 001847 831 LLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGA-GHTSAVDWWALGILLYEMLYGYTPFRGKTRQKT 909 (1005)
Q Consensus 831 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~sDIwSlGvll~eLltG~~Pf~~~~~~~~ 909 (1005)
.........|++.|+|||++... .++.++|+|||||++|+|++|+.||...+....
T Consensus 159 -----------------------~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~ 215 (267)
T cd06610 159 -----------------------TRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKV 215 (267)
T ss_pred -----------------------cccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhh
Confidence 00112345689999999998776 778899999999999999999999988777666
Q ss_pred HHHHHhCCCCCC-CC---CCCCHHHHHHHHHccccCcCccCCChhcHHHHHcCCCC
Q 001847 910 FANILHKDLKFP-SS---TPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFF 961 (1005)
Q Consensus 910 ~~~i~~~~~~~~-~~---~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~hpff 961 (1005)
+.+......... .. ..++..+.+|+.+||..||++||+ +.++++||||
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~----~~~ll~~p~~ 267 (267)
T cd06610 216 LMLTLQNDPPSLETGADYKKYSKSFRKMISLCLQKDPSKRPT----AEELLKHKFF 267 (267)
T ss_pred HHHHhcCCCCCcCCccccccccHHHHHHHHHHcCCChhhCcC----HHHHhhCCCC
Confidence 666665533221 11 246788999999999999999999 9999999998
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=346.30 Aligned_cols=252 Identities=25% Similarity=0.396 Sum_probs=200.8
Q ss_pred ccCCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEE
Q 001847 670 NLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCL 749 (1005)
Q Consensus 670 ~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l 749 (1005)
...+|++++.||+|+||.||+|.+..++..||+|+.... ....|+.++++++|+||+++++++...+..|+
T Consensus 64 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~---------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 134 (357)
T PHA03209 64 ASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG---------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCM 134 (357)
T ss_pred hhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc---------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEE
Confidence 345799999999999999999999999999999975433 23458999999999999999999999999999
Q ss_pred EEeccCCCchhhHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCCC
Q 001847 750 ITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQ 829 (1005)
Q Consensus 750 V~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~ 829 (1005)
||||+ .++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 135 v~e~~-~~~l~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~-- 210 (357)
T PHA03209 135 VLPHY-SSDLYTYLTKR-SRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVA-- 210 (357)
T ss_pred EEEcc-CCcHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEecCccccccccC--
Confidence 99999 66888888654 345899999999999999999999999999999999999999999999999988532110
Q ss_pred CCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHcCCCCC-CCCChH-
Q 001847 830 LLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPF-RGKTRQ- 907 (1005)
Q Consensus 830 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlGvll~eLltG~~Pf-~~~~~~- 907 (1005)
.......||+.|+|||++.+..++.++|||||||++|+|+++..|+ ......
T Consensus 211 --------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~ 264 (357)
T PHA03209 211 --------------------------PAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTP 264 (357)
T ss_pred --------------------------cccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcH
Confidence 0112356899999999999988999999999999999999754444 321110
Q ss_pred --------HHHHHHHhC----CCCCC----------------------------CCCCCCHHHHHHHHHccccCcCccCC
Q 001847 908 --------KTFANILHK----DLKFP----------------------------SSTPTSLHAKQLMYRLLHRDPKSRLG 947 (1005)
Q Consensus 908 --------~~~~~i~~~----~~~~~----------------------------~~~~~s~~l~~Ll~~~L~~dP~~Rpt 947 (1005)
..+..++.. ...++ .....+..+.+||.+||+.||.+|||
T Consensus 265 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpt 344 (357)
T PHA03209 265 EEYVKSCHSHLLKIISTLKVHPEEFPRDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPS 344 (357)
T ss_pred HHHHHHHHHHHHHHHHHhccChhhcCCCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcC
Confidence 111111110 00011 01123556778999999999999999
Q ss_pred ChhcHHHHHcCCCCCCC
Q 001847 948 SHEGANEIKKHPFFKGV 964 (1005)
Q Consensus 948 ~~~~a~elL~hpff~~~ 964 (1005)
+.++|+||||+.+
T Consensus 345 ----a~e~l~hp~f~~~ 357 (357)
T PHA03209 345 ----AEEILNYPMFAQL 357 (357)
T ss_pred ----HHHHhcCchhccC
Confidence 9999999999864
|
|
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-36 Score=330.95 Aligned_cols=256 Identities=28% Similarity=0.407 Sum_probs=212.1
Q ss_pred cCCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhC-CCCCcceEEEEEEe------
Q 001847 671 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPALYASFQT------ 743 (1005)
Q Consensus 671 ~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~------ 743 (1005)
.+.|++.+.||.|+||.||++.+..+++.+|+|.+... ......+..|+.+++++ +|+||+++++++..
T Consensus 15 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~----~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~ 90 (282)
T cd06636 15 AGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVT----EDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGH 90 (282)
T ss_pred hhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecC----hHHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCC
Confidence 35899999999999999999999999999999988643 23345677889999988 79999999999853
Q ss_pred CCeEEEEEeccCCCchhhHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcc
Q 001847 744 KTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCL 823 (1005)
Q Consensus 744 ~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~~~g~vkL~DFG~a~~ 823 (1005)
.+.+|++|||+.+++|.+++.......+++..+..++.||+.||.|||+.||+|+||+|+||+++.++.++|+|||++..
T Consensus 91 ~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~~~~~~l~dfg~~~~ 170 (282)
T cd06636 91 DDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQ 170 (282)
T ss_pred CCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCcchhh
Confidence 46789999999999999999876556689999999999999999999999999999999999999999999999998754
Q ss_pred cCCCCCCCCCcchhhhhcccCCCCCcccccccccccccccCCccccccccc-----CCCCCChhhHHHHHHHHHHHHcCC
Q 001847 824 TSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIA-----GAGHTSAVDWWALGILLYEMLYGY 898 (1005)
Q Consensus 824 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~-----~~~~~~~sDIwSlGvll~eLltG~ 898 (1005)
.... ........|++.|+|||.+. ...++.++|||||||++|+|++|.
T Consensus 171 ~~~~---------------------------~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~ 223 (282)
T cd06636 171 LDRT---------------------------VGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGA 223 (282)
T ss_pred hhcc---------------------------ccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCC
Confidence 3210 01112356899999999985 345677999999999999999999
Q ss_pred CCCCCCChHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHccccCcCccCCChhcHHHHHcCCCC
Q 001847 899 TPFRGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFF 961 (1005)
Q Consensus 899 ~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~hpff 961 (1005)
.||...........+............++..+.+||.+||..||.+||+ +.+||+||||
T Consensus 224 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~----~~ell~~~~~ 282 (282)
T cd06636 224 PPLCDMHPMRALFLIPRNPPPKLKSKKWSKKFIDFIEGCLVKNYLSRPS----TEQLLKHPFI 282 (282)
T ss_pred CCccccCHHhhhhhHhhCCCCCCcccccCHHHHHHHHHHhCCChhhCcC----HHHHhcCCCC
Confidence 9998766555544444333222223346789999999999999999999 9999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-36 Score=332.10 Aligned_cols=265 Identities=26% Similarity=0.436 Sum_probs=222.3
Q ss_pred hhcccccccccCCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceEEEE
Q 001847 661 KILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYAS 740 (1005)
Q Consensus 661 ~~~~~~~~i~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~ 740 (1005)
.+...|.. ..+|++++.||.|++|.||++.+..+++.+++|.+.... ......+.+|+.+++.++||||+.++++
T Consensus 10 ~~~~~~~~--~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~ 84 (296)
T cd06655 10 TIVSIGDP--KKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQK---QPKKELIINEILVMKELKNPNIVNFLDS 84 (296)
T ss_pred HHHhcCCC--cceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEeccc---CchHHHHHHHHHHHHhcCCCceeeeeee
Confidence 34444443 257999999999999999999999999999999886542 2334677889999999999999999999
Q ss_pred EEeCCeEEEEEeccCCCchhhHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccC
Q 001847 741 FQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDL 820 (1005)
Q Consensus 741 ~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~~~g~vkL~DFG~ 820 (1005)
+...+.+|+||||+.+++|..++... .+++..+..++.||+.||+|||+.|++|+||||+||+++.++.++|+|||+
T Consensus 85 ~~~~~~~~lv~e~~~~~~L~~~~~~~---~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~~~~~kl~dfg~ 161 (296)
T cd06655 85 FLVGDELFVVMEYLAGGSLTDVVTET---CMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGF 161 (296)
T ss_pred EecCceEEEEEEecCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCcc
Confidence 99999999999999999999988653 489999999999999999999999999999999999999999999999998
Q ss_pred CcccCCCCCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHcCCCC
Q 001847 821 SCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTP 900 (1005)
Q Consensus 821 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlGvll~eLltG~~P 900 (1005)
+....... .......|++.|+|||.+.+..++.++|||||||++|+|++|..|
T Consensus 162 ~~~~~~~~---------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~p 214 (296)
T cd06655 162 CAQITPEQ---------------------------SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPP 214 (296)
T ss_pred chhccccc---------------------------ccCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCC
Confidence 75432110 011234688999999999888889999999999999999999999
Q ss_pred CCCCChHHHHHHHHhCCC-CCCCCCCCCHHHHHHHHHccccCcCccCCChhcHHHHHcCCCCCCC
Q 001847 901 FRGKTRQKTFANILHKDL-KFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGV 964 (1005)
Q Consensus 901 f~~~~~~~~~~~i~~~~~-~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~hpff~~~ 964 (1005)
|.+.+.......+..... .+.....++..+.+||.+||..+|.+||+ +.++++||||+..
T Consensus 215 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt----~~~il~~~~~~~~ 275 (296)
T cd06655 215 YLNENPLRALYLIATNGTPELQNPEKLSPIFRDFLNRCLEMDVEKRGS----AKELLQHPFLKLA 275 (296)
T ss_pred CCCCCHHHHHHHHHhcCCcccCCcccCCHHHHHHHHHHhhcChhhCCC----HHHHhhChHhhhc
Confidence 988777655555443322 22233456788999999999999999999 9999999999864
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-36 Score=324.47 Aligned_cols=256 Identities=25% Similarity=0.471 Sum_probs=220.3
Q ss_pred CccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEEe
Q 001847 673 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITD 752 (1005)
Q Consensus 673 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E 752 (1005)
+|++++.||.|+||.||++.+..+++.|++|.+..... .......+.+|+.+++.++||||+++++++...+..|+|||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKM-SPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMD 79 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhC-ChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEe
Confidence 58999999999999999999999999999999875422 23345678889999999999999999999999999999999
Q ss_pred ccCCCchhhHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCCCCCC
Q 001847 753 YCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLL 832 (1005)
Q Consensus 753 ~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~~~ 832 (1005)
|+.+++|.+++.......+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++.......
T Consensus 80 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~---- 155 (256)
T cd08218 80 YCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTV---- 155 (256)
T ss_pred cCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEEeeccceeecCcch----
Confidence 9999999999876544568999999999999999999999999999999999999999999999999885432110
Q ss_pred CcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHcCCCCCCCCChHHHHHH
Q 001847 833 PTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFAN 912 (1005)
Q Consensus 833 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlGvll~eLltG~~Pf~~~~~~~~~~~ 912 (1005)
.......|++.|+|||++.+...+.++|+|||||++|+|++|..||......+....
T Consensus 156 -----------------------~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~ 212 (256)
T cd08218 156 -----------------------ELARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLK 212 (256)
T ss_pred -----------------------hhhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHH
Confidence 011123578899999999888888999999999999999999999988877777777
Q ss_pred HHhCCCCCCCCCCCCHHHHHHHHHccccCcCccCCChhcHHHHHcCCCC
Q 001847 913 ILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFF 961 (1005)
Q Consensus 913 i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~hpff 961 (1005)
+..+.... .....+..+.++|.+||+.+|++||+ +.++++||||
T Consensus 213 ~~~~~~~~-~~~~~~~~~~~li~~~l~~~p~~Rp~----~~~vl~~~~~ 256 (256)
T cd08218 213 IIRGSYPP-VSSHYSYDLRNLVSQLFKRNPRDRPS----VNSILEKNFI 256 (256)
T ss_pred HhcCCCCC-CcccCCHHHHHHHHHHhhCChhhCcC----HHHHhhCcCC
Confidence 76654432 23346788999999999999999999 9999999998
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-37 Score=318.34 Aligned_cols=276 Identities=37% Similarity=0.730 Sum_probs=240.7
Q ss_pred cccccccCCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhC-CCCCcceEEEEEEe
Q 001847 665 SGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPALYASFQT 743 (1005)
Q Consensus 665 ~~~~i~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~ 743 (1005)
+.+.+.+++|.++++||+|+|.+|.++++++|.+.||+|++++..+.+.+...-+..|..+..+- +||++|-++.+|..
T Consensus 243 ~~~~l~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqt 322 (593)
T KOG0695|consen 243 ISQGLGLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQT 322 (593)
T ss_pred cccccccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcc
Confidence 34556788999999999999999999999999999999999999888888888888888888776 79999999999999
Q ss_pred CCeEEEEEeccCCCchhhHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcc
Q 001847 744 KTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCL 823 (1005)
Q Consensus 744 ~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~~~g~vkL~DFG~a~~ 823 (1005)
+..+++|.||++||+|--.++++ ..+++++++.+...|..||.|||+.|||.||||.+|+|++..|++||.|+|+++.
T Consensus 323 esrlffvieyv~ggdlmfhmqrq--rklpeeharfys~ei~lal~flh~rgiiyrdlkldnvlldaeghikltdygmcke 400 (593)
T KOG0695|consen 323 ESRLFFVIEYVNGGDLMFHMQRQ--RKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKE 400 (593)
T ss_pred cceEEEEEEEecCcceeeehhhh--hcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEccCCceeecccchhhc
Confidence 99999999999999998777765 4599999999999999999999999999999999999999999999999999854
Q ss_pred cCCCCCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHcCCCCCC-
Q 001847 824 TSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFR- 902 (1005)
Q Consensus 824 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlGvll~eLltG~~Pf~- 902 (1005)
.- .+....+++||||.|+|||++.+..|+..+|-|+||+++++|+.|+.||.
T Consensus 401 ~l---------------------------~~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdi 453 (593)
T KOG0695|consen 401 GL---------------------------GPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDI 453 (593)
T ss_pred CC---------------------------CCCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcce
Confidence 21 22345678999999999999999999999999999999999999999994
Q ss_pred -------CCChHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHccccCcCccCCChh--cHHHHHcCCCCCCCChhhhhh
Q 001847 903 -------GKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHE--GANEIKKHPFFKGVNWALVRC 971 (1005)
Q Consensus 903 -------~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~--~a~elL~hpff~~~~~~~~~~ 971 (1005)
..+....++-|+.+.+.+|.+ +|-.+..+++..|.+||.+|+.-.. ...++..|+||+.++|..++-
T Consensus 454 vgm~n~d~ntedylfqvilekqiriprs--lsvkas~vlkgflnkdp~erlgc~~~~g~~dik~h~ffr~idwd~leq 529 (593)
T KOG0695|consen 454 VGMDNPDMNTEDYLFQVILEKQIRIPRS--LSVKASHVLKGFLNKDPKERLGCRPQTGFSDIKSHAFFRSIDWDLLEQ 529 (593)
T ss_pred ecCCCcccchhHHHHHHHhhhcccccce--eehhhHHHHHHhhcCCcHHhcCCCcccchhhhhcchhhhhCCHHHHhh
Confidence 122334456667777777765 4556678999999999999986542 478999999999999999843
|
|
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=329.75 Aligned_cols=271 Identities=18% Similarity=0.262 Sum_probs=217.5
Q ss_pred ccccCCccccccccccCcEEEEEEEEcC-----CCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceEEEEEE
Q 001847 668 QINLQHFRPIKPLGSGDTGSVHLVELCG-----SGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQ 742 (1005)
Q Consensus 668 ~i~~~~y~~~~~LG~G~~g~Vy~a~~~~-----~~~~valK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~ 742 (1005)
.+..++|++.+.||+|+||.||++.++. .+..||+|.+.... .......+.+|+.+++.++||||+++++++.
T Consensus 2 ~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~ 79 (288)
T cd05061 2 EVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESA--SLRERIEFLNEASVMKGFTCHHVVRLLGVVS 79 (288)
T ss_pred cccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcC--CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEc
Confidence 4566799999999999999999997642 35689999876432 2233456778999999999999999999999
Q ss_pred eCCeEEEEEeccCCCchhhHHhhCC--------CCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEE
Q 001847 743 TKTHVCLITDYCPGGELFLLLDRQP--------TKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVS 814 (1005)
Q Consensus 743 ~~~~~~lV~E~~~ggsL~~~l~~~~--------~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~~~g~vk 814 (1005)
..+..|+||||+.+++|.+++.... ...++...+..++.||+.||.|||++||+||||||+||+++.++.++
T Consensus 80 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~~~~~~~ 159 (288)
T cd05061 80 KGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVK 159 (288)
T ss_pred CCCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEcCCCcEE
Confidence 9999999999999999999997521 12356678899999999999999999999999999999999999999
Q ss_pred EEeccCCcccCCCCCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHH
Q 001847 815 LTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEM 894 (1005)
Q Consensus 815 L~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlGvll~eL 894 (1005)
|+|||++........ ........++..|+|||.+.+..++.++|||||||++|+|
T Consensus 160 L~Dfg~~~~~~~~~~-------------------------~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el 214 (288)
T cd05061 160 IGDFGMTRDIYETDY-------------------------YRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEI 214 (288)
T ss_pred ECcCCcccccccccc-------------------------ccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHH
Confidence 999998854321100 0011223456789999999888899999999999999999
Q ss_pred Hc-CCCCCCCCChHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHccccCcCccCCChhcHHHHHc--CCCCCCCCh
Q 001847 895 LY-GYTPFRGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKK--HPFFKGVNW 966 (1005)
Q Consensus 895 lt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~--hpff~~~~~ 966 (1005)
++ |..||.+....+....+...... ......+..+.+++.+||+.+|.+||++.++++.+.+ ||||.+++|
T Consensus 215 ~~~~~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~~~~~~ 288 (288)
T cd05061 215 TSLAEQPYQGLSNEQVLKFVMDGGYL-DQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFPEVSF 288 (288)
T ss_pred HhCCCCCCCCCCHHHHHHHHHcCCCC-CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcCCCCCCCCC
Confidence 98 88999887777766665544322 2223457889999999999999999996555555554 999999988
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=327.94 Aligned_cols=260 Identities=35% Similarity=0.640 Sum_probs=209.0
Q ss_pred cccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHH---HHHHhCCCCCcceEEEEEEeCCeEEEEEeccC
Q 001847 679 PLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAER---EILDMLDHPFVPALYASFQTKTHVCLITDYCP 755 (1005)
Q Consensus 679 ~LG~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~---~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~ 755 (1005)
.||+|+||.||++.+..+++.||+|.+.+..............|. .+++...||+|+.+++++...+.+|+||||+.
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 479999999999999999999999998765333222222233343 34455689999999999999999999999999
Q ss_pred CCchhhHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCCCCCCCcc
Q 001847 756 GGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTT 835 (1005)
Q Consensus 756 ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~~~~~~ 835 (1005)
|++|..++... ..+++..++.++.|++.||.|||+.+|+|+||||+||+++.++.++|+|||++......
T Consensus 81 g~~L~~~l~~~--~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~-------- 150 (278)
T cd05606 81 GGDLHYHLSQH--GVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK-------- 150 (278)
T ss_pred CCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCCCCEEEccCcCccccCcc--------
Confidence 99999988654 45999999999999999999999999999999999999999999999999988532210
Q ss_pred hhhhhcccCCCCCcccccccccccccccCCcccccccccCC-CCCChhhHHHHHHHHHHHHcCCCCCCCCC---hHHHHH
Q 001847 836 NEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGA-GHTSAVDWWALGILLYEMLYGYTPFRGKT---RQKTFA 911 (1005)
Q Consensus 836 ~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~sDIwSlGvll~eLltG~~Pf~~~~---~~~~~~ 911 (1005)
......|+..|+|||++.+. .++.++|||||||++|+|++|+.||.+.. ......
T Consensus 151 ---------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~ 209 (278)
T cd05606 151 ---------------------KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDR 209 (278)
T ss_pred ---------------------CCcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHH
Confidence 01234689999999998754 57889999999999999999999997753 222222
Q ss_pred HHHhCCCCCCCCCCCCHHHHHHHHHccccCcCccC-----CChhcHHHHHcCCCCCCCChhhhhhcCCC
Q 001847 912 NILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRL-----GSHEGANEIKKHPFFKGVNWALVRCMNPP 975 (1005)
Q Consensus 912 ~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rp-----t~~~~a~elL~hpff~~~~~~~~~~~~~~ 975 (1005)
.+......++ ...+..+.+++.+||..+|.+|| + +.++++||||+..+|+.+.....|
T Consensus 210 ~~~~~~~~~~--~~~s~~~~~li~~~l~~~p~~R~~~~~~~----~~~ll~~~~~~~~~~~~~~~~~~~ 272 (278)
T cd05606 210 MTLTMAVELP--DSFSPELRSLLEGLLQRDVNRRLGCLGRG----AQEVKEHPFFRSLDWQMVFLQKYP 272 (278)
T ss_pred HhhccCCCCC--CcCCHHHHHHHHHHhhcCHHhccCCCCCC----HHHHHhCccccCCCchHhhhcccC
Confidence 2222233333 23588999999999999999999 7 999999999999999988655444
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=330.58 Aligned_cols=263 Identities=24% Similarity=0.423 Sum_probs=216.4
Q ss_pred hcccccccccCCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCC-C-C----Ccc
Q 001847 662 ILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLD-H-P----FVP 735 (1005)
Q Consensus 662 ~~~~~~~i~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~il~~l~-h-p----nIv 735 (1005)
++..|.-+ ..+|.+++.+|+|.||.|-.+.|..++..+|||+++.- ....+...-|+++|.++. + | -++
T Consensus 80 v~~~gD~l-~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V----~kYreAa~iEi~vLqki~~~DP~g~~rcv 154 (415)
T KOG0671|consen 80 VYQVGDIL-TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNV----DKYREAALIEIEVLQKINESDPNGKFRCV 154 (415)
T ss_pred EEEecccc-ccceehhhhhcCCcccceEEEeecCCCceehHHHHHHH----HHHhhHHHHHHHHHHHHHhcCCCCceEEE
Confidence 45555544 68999999999999999999999999999999998743 233345556899999993 2 2 378
Q ss_pred eEEEEEEeCCeEEEEEeccCCCchhhHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEec------
Q 001847 736 ALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQG------ 809 (1005)
Q Consensus 736 ~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~~------ 809 (1005)
++.+||+..++.|||+|.+ |.++++++..+...+++..+++.++.||+.+|+|||+++++|.||||+|||+.+
T Consensus 155 ~m~~wFdyrghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~ 233 (415)
T KOG0671|consen 155 QMRDWFDYRGHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKT 233 (415)
T ss_pred eeehhhhccCceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEE
Confidence 8899999999999999999 899999999988889999999999999999999999999999999999999953
Q ss_pred --------------CCcEEEEeccCCcccCCCCCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccC
Q 001847 810 --------------NGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAG 875 (1005)
Q Consensus 810 --------------~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~ 875 (1005)
+-.|+|+|||.|.... ..+.+.+.|..|+|||++.+
T Consensus 234 ~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~------------------------------e~hs~iVsTRHYRAPEViLg 283 (415)
T KOG0671|consen 234 YNPKKKVCFIRPLKSTAIKVIDFGSATFDH------------------------------EHHSTIVSTRHYRAPEVILG 283 (415)
T ss_pred eccCCccceeccCCCcceEEEecCCcceec------------------------------cCcceeeeccccCCchheec
Confidence 2248999999884422 12356789999999999999
Q ss_pred CCCCChhhHHHHHHHHHHHHcCCCCCCCCChHHH---HHHHHh------------------CCCCCCCC-----------
Q 001847 876 AGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKT---FANILH------------------KDLKFPSS----------- 923 (1005)
Q Consensus 876 ~~~~~~sDIwSlGvll~eLltG~~Pf~~~~~~~~---~~~i~~------------------~~~~~~~~----------- 923 (1005)
-+++.++||||+||+|+||++|...|+..++.+. ++.|+. +.+.|+..
T Consensus 284 LGwS~pCDvWSiGCIL~ElytG~~LFqtHen~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~ 363 (415)
T KOG0671|consen 284 LGWSQPCDVWSIGCILVELYTGETLFQTHENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFE 363 (415)
T ss_pred cCcCCccCceeeeeEEEEeeccceecccCCcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhc
Confidence 9999999999999999999999999998776553 333322 11222211
Q ss_pred ------------CCCCHHHHHHHHHccccCcCccCCChhcHHHHHcCCCCCCC
Q 001847 924 ------------TPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGV 964 (1005)
Q Consensus 924 ------------~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~hpff~~~ 964 (1005)
......+.+||++||.+||.+|+| +.|+|.||||+..
T Consensus 364 ~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~RiT----l~EAL~HpFF~~~ 412 (415)
T KOG0671|consen 364 PCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPARRIT----LREALSHPFFARL 412 (415)
T ss_pred CCccHHHHhccCcHHHhHHHHHHHHHHccCcccccc----HHHHhcCHHhhcC
Confidence 011235789999999999999999 9999999999964
|
|
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-36 Score=327.06 Aligned_cols=254 Identities=25% Similarity=0.401 Sum_probs=210.9
Q ss_pred cCCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEE
Q 001847 671 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLI 750 (1005)
Q Consensus 671 ~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV 750 (1005)
..+|++.+.||+|+||.||++.+..+++.||+|++.... ......+.+|+.+++.++||||+++++++...+..|+|
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~---~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv 84 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEP---GDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWIC 84 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCc---cchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEE
Confidence 468999999999999999999999999999999987542 23345677899999999999999999999999999999
Q ss_pred EeccCCCchhhHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCCCC
Q 001847 751 TDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQL 830 (1005)
Q Consensus 751 ~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~ 830 (1005)
|||+.+++|.+++... ..+++..+..++.|++.||.|||+.||+|+||+|+||+++.++.++|+|||++......
T Consensus 85 ~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~--- 159 (267)
T cd06646 85 MEYCGGGSLQDIYHVT--GPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVAAKITAT--- 159 (267)
T ss_pred EeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEECcCccceeeccc---
Confidence 9999999999998754 45899999999999999999999999999999999999999999999999998543210
Q ss_pred CCCcchhhhhcccCCCCCcccccccccccccccCCccccccccc---CCCCCChhhHHHHHHHHHHHHcCCCCCCCCChH
Q 001847 831 LLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIA---GAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQ 907 (1005)
Q Consensus 831 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~---~~~~~~~sDIwSlGvll~eLltG~~Pf~~~~~~ 907 (1005)
........|++.|+|||.+. ...++.++|+|||||++|+|++|..||......
T Consensus 160 ------------------------~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~ 215 (267)
T cd06646 160 ------------------------IAKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPM 215 (267)
T ss_pred ------------------------ccccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchh
Confidence 01122346889999999984 344677999999999999999999999766544
Q ss_pred HHHHHHHhCCCCCCC---CCCCCHHHHHHHHHccccCcCccCCChhcHHHHHcCCC
Q 001847 908 KTFANILHKDLKFPS---STPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPF 960 (1005)
Q Consensus 908 ~~~~~i~~~~~~~~~---~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~hpf 960 (1005)
.....+....+..+. ....+..+.+||.+||..+|++||+ ++++|+|+|
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~----~~~il~~l~ 267 (267)
T cd06646 216 RALFLMSKSNFQPPKLKDKTKWSSTFHNFVKISLTKNPKKRPT----AERLLTHLF 267 (267)
T ss_pred hhheeeecCCCCCCCCccccccCHHHHHHHHHHhhCChhhCcC----HHHHhcCCC
Confidence 433333333332222 2345788999999999999999999 999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=328.83 Aligned_cols=256 Identities=27% Similarity=0.426 Sum_probs=209.7
Q ss_pred CCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEE
Q 001847 672 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLIT 751 (1005)
Q Consensus 672 ~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~ 751 (1005)
++|++.+.||+|++|.||++.+..+++.||+|.+..... .......+.+|+.+++.++|+||+++++++.....+++||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 79 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESED-DPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVF 79 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeeccc-CccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEE
Confidence 479999999999999999999998999999998875421 2223345678999999999999999999999999999999
Q ss_pred eccCCCchhhHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCCCCC
Q 001847 752 DYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLL 831 (1005)
Q Consensus 752 E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~~ 831 (1005)
||+++++|..++... ..+++..++.++.||+.+|.|||+.|++|+||||+||++++++.++|+|||++........
T Consensus 80 e~~~~~~l~~~~~~~--~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~-- 155 (286)
T cd07847 80 EYCDHTVLNELEKNP--RGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGD-- 155 (286)
T ss_pred eccCccHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcCCCcEEECccccceecCCCcc--
Confidence 999988888776543 3589999999999999999999999999999999999999999999999999855321110
Q ss_pred CCcchhhhhcccCCCCCcccccccccccccccCCcccccccccC-CCCCChhhHHHHHHHHHHHHcCCCCCCCCChHHHH
Q 001847 832 LPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAG-AGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTF 910 (1005)
Q Consensus 832 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~sDIwSlGvll~eLltG~~Pf~~~~~~~~~ 910 (1005)
......++..|+|||++.+ ..++.++|||||||++|+|++|..||.+....+..
T Consensus 156 -------------------------~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~ 210 (286)
T cd07847 156 -------------------------DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQL 210 (286)
T ss_pred -------------------------cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHH
Confidence 1123457889999999876 45678999999999999999999999887765554
Q ss_pred HHHHhCC-------------------CCCCC----------CCCCCHHHHHHHHHccccCcCccCCChhcHHHHHcCCCC
Q 001847 911 ANILHKD-------------------LKFPS----------STPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFF 961 (1005)
Q Consensus 911 ~~i~~~~-------------------~~~~~----------~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~hpff 961 (1005)
..+.... ...+. ....+..+.+||.+||..+|++||+ +.+++.||||
T Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~----~~eil~~~~f 286 (286)
T cd07847 211 YLIRKTLGDLIPRHQQIFSTNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLS----CEELLEHPYF 286 (286)
T ss_pred HHHHHHhCCCChHHhhhcccccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCC----HHHHhcCCCC
Confidence 4432210 00111 1235678899999999999999999 9999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=324.22 Aligned_cols=261 Identities=24% Similarity=0.354 Sum_probs=214.3
Q ss_pred CccccccccccCcEEEEEEEEcCCCeEEEEEEeeccccc---ChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEE
Q 001847 673 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVML---NRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCL 749 (1005)
Q Consensus 673 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~~~~~~~~---~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l 749 (1005)
+|++.+.||.|+||.||++.+ .++..+|+|.+...... .......+.+|+.+++.++|+||+++++++...+.+|+
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~-~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 79 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLT-NQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISI 79 (265)
T ss_pred CccccceEeccCCeEEEEEEE-cCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEE
Confidence 588999999999999999987 57889999988753211 22344668889999999999999999999999999999
Q ss_pred EEeccCCCchhhHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCCC
Q 001847 750 ITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQ 829 (1005)
Q Consensus 750 V~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~ 829 (1005)
||||+++++|.+++... ..+++..+..++.||+.||+|||+.||+|+||+|+||++++++.++|+|||++........
T Consensus 80 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 157 (265)
T cd06631 80 FMEFVPGGSISSILNRF--GPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGL 157 (265)
T ss_pred EEecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCCCeEEeccchhhHhhhhccc
Confidence 99999999999999764 3588999999999999999999999999999999999999999999999998854321100
Q ss_pred CCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHcCCCCCCCCChHHH
Q 001847 830 LLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKT 909 (1005)
Q Consensus 830 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlGvll~eLltG~~Pf~~~~~~~~ 909 (1005)
. ...........|+..|+|||++.+..++.++|+|||||++|+|++|..||...+....
T Consensus 158 ~---------------------~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~ 216 (265)
T cd06631 158 H---------------------GTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAA 216 (265)
T ss_pred c---------------------ccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHH
Confidence 0 0001112235689999999999888889999999999999999999999987665554
Q ss_pred HHHHHhCC-CCCCCCCCCCHHHHHHHHHccccCcCccCCChhcHHHHHcCCCC
Q 001847 910 FANILHKD-LKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFF 961 (1005)
Q Consensus 910 ~~~i~~~~-~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~hpff 961 (1005)
...+.... ........++..+.+||.+||..+|.+||+ +.++++||||
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~----~~~~l~~~~~ 265 (265)
T cd06631 217 MFYIGAHRGLMPRLPDSFSAAAIDFVTSCLTRDQHERPS----ALQLLRHDFL 265 (265)
T ss_pred HHHhhhccCCCCCCCCCCCHHHHHHHHHHhcCCcccCCC----HHHHhcCCCC
Confidence 44444332 222233457889999999999999999999 9999999997
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=327.55 Aligned_cols=257 Identities=30% Similarity=0.490 Sum_probs=213.3
Q ss_pred CccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEEe
Q 001847 673 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITD 752 (1005)
Q Consensus 673 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E 752 (1005)
+|++.+.||+|++|.||+|.+..++..|++|.+..... .......+.+|+.++++++||||+++++++......|+|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e 79 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRL-EGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVME 79 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccc-cchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEec
Confidence 58999999999999999999998999999999876532 23345678899999999999999999999999999999999
Q ss_pred ccCCCchhhHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCCCCCC
Q 001847 753 YCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLL 832 (1005)
Q Consensus 753 ~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~~~ 832 (1005)
|+ +++|.+++.... ..+++..++.++.||+.||.|||+.|++|+||||+||+++.++.++|+|||++........
T Consensus 80 ~~-~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~--- 154 (286)
T cd07832 80 YM-PSDLSEVLRDEE-RPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEP--- 154 (286)
T ss_pred cc-CCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCC---
Confidence 99 999999987543 5689999999999999999999999999999999999999999999999998855432110
Q ss_pred CcchhhhhcccCCCCCcccccccccccccccCCcccccccccCC-CCCChhhHHHHHHHHHHHHcCCCCCCCCChHHHHH
Q 001847 833 PTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGA-GHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFA 911 (1005)
Q Consensus 833 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~sDIwSlGvll~eLltG~~Pf~~~~~~~~~~ 911 (1005)
.......|+..|+|||.+.+. .++.++|||||||++|+|++|.+||.+......+.
T Consensus 155 -----------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~ 211 (286)
T cd07832 155 -----------------------RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLA 211 (286)
T ss_pred -----------------------CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHH
Confidence 111234688999999998654 45789999999999999999999998877666555
Q ss_pred HHHhCC-------------------CCCCC---------CCCCCHHHHHHHHHccccCcCccCCChhcHHHHHcCCCCC
Q 001847 912 NILHKD-------------------LKFPS---------STPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFK 962 (1005)
Q Consensus 912 ~i~~~~-------------------~~~~~---------~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~hpff~ 962 (1005)
.+...- ..++. ....+..+.+||.+||..+|++||+ ++++|+||||.
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~----~~~~l~h~~~~ 286 (286)
T cd07832 212 IVFRTLGTPNEETWPGLTSLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLS----AAEALRHPYFT 286 (286)
T ss_pred HHHHHcCCCChHHHhhccCcchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCC----HHHHhhCcCcC
Confidence 444310 00110 1234678899999999999999999 99999999994
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=334.68 Aligned_cols=251 Identities=26% Similarity=0.429 Sum_probs=192.5
Q ss_pred cccccccCcEEEEEEEEc--CCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceEEEEEEe--CCeEEEEEe
Q 001847 677 IKPLGSGDTGSVHLVELC--GSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQT--KTHVCLITD 752 (1005)
Q Consensus 677 ~~~LG~G~~g~Vy~a~~~--~~~~~valK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~--~~~~~lV~E 752 (1005)
.+.||+|+||.||+|.+. .+++.||+|.+.... ....+.+|+.+++.++||||++++++|.. ...+|+|||
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~-----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e 80 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG-----ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFD 80 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC-----CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEe
Confidence 367999999999999975 467899999886532 12346789999999999999999999854 467899999
Q ss_pred ccCCCchhhHHhhC-------CCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEe----cCCcEEEEeccCC
Q 001847 753 YCPGGELFLLLDRQ-------PTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQ----GNGHVSLTDFDLS 821 (1005)
Q Consensus 753 ~~~ggsL~~~l~~~-------~~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~----~~g~vkL~DFG~a 821 (1005)
|+ +++|.+++... ....+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||++
T Consensus 81 ~~-~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07868 81 YA-EHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred cc-CCCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence 99 56888887532 123589999999999999999999999999999999999994 5578999999998
Q ss_pred cccCCCCCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCC-CCCChhhHHHHHHHHHHHHcCCCC
Q 001847 822 CLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGA-GHTSAVDWWALGILLYEMLYGYTP 900 (1005)
Q Consensus 822 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~sDIwSlGvll~eLltG~~P 900 (1005)
........ +........||+.|+|||++.+. .++.++|||||||++|+|++|++|
T Consensus 160 ~~~~~~~~------------------------~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~ 215 (317)
T cd07868 160 RLFNSPLK------------------------PLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPI 215 (317)
T ss_pred eccCCCCc------------------------cccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCC
Confidence 65431110 01112345789999999998774 578899999999999999999999
Q ss_pred CCCCCh---------HHHHHHHHhCC-------------CC-------------CC----------CCCCCCHHHHHHHH
Q 001847 901 FRGKTR---------QKTFANILHKD-------------LK-------------FP----------SSTPTSLHAKQLMY 935 (1005)
Q Consensus 901 f~~~~~---------~~~~~~i~~~~-------------~~-------------~~----------~~~~~s~~l~~Ll~ 935 (1005)
|.+... ...+..+.... +. .. .....+..+.+||.
T Consensus 216 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~ 295 (317)
T cd07868 216 FHCRQEDIKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQ 295 (317)
T ss_pred ccCCcccccccccccHHHHHHHHHhcCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHH
Confidence 965332 11111111100 00 00 00123456889999
Q ss_pred HccccCcCccCCChhcHHHHHcCCCC
Q 001847 936 RLLHRDPKSRLGSHEGANEIKKHPFF 961 (1005)
Q Consensus 936 ~~L~~dP~~Rpt~~~~a~elL~hpff 961 (1005)
+||++||.+||| ++++|+||||
T Consensus 296 ~mL~~dP~~R~t----~~e~l~hp~f 317 (317)
T cd07868 296 KLLTMDPIKRIT----SEQAMQDPYF 317 (317)
T ss_pred HHhccCcccCCC----HHHHhcCCCC
Confidence 999999999999 9999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-36 Score=327.03 Aligned_cols=255 Identities=38% Similarity=0.725 Sum_probs=216.5
Q ss_pred CccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEEe
Q 001847 673 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITD 752 (1005)
Q Consensus 673 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E 752 (1005)
+|++.+.||.|+||.||+|.+..++..|++|.+.............+.+|+.++++++||||+++++++......|+|||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 48999999999999999999998999999999987654444567788999999999999999999999999999999999
Q ss_pred ccCCCchhhHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCCCCCC
Q 001847 753 YCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLL 832 (1005)
Q Consensus 753 ~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~~~ 832 (1005)
|+.+++|..++... ..+++..+..++.||+.||.|||++|++|+||+|+||++++++.++|+|||.+.......
T Consensus 81 ~~~~~~L~~~l~~~--~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~---- 154 (258)
T cd05578 81 LLLGGDLRYHLSQK--VKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT---- 154 (258)
T ss_pred CCCCCCHHHHHHhc--CCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCCCCEEEeecccccccCCCc----
Confidence 99999999999764 468999999999999999999999999999999999999999999999999875432110
Q ss_pred CcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCh--HHHH
Q 001847 833 PTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTR--QKTF 910 (1005)
Q Consensus 833 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlGvll~eLltG~~Pf~~~~~--~~~~ 910 (1005)
......|+..|+|||.+....++.++|+||||+++|+|++|..||..... ...+
T Consensus 155 ------------------------~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~ 210 (258)
T cd05578 155 ------------------------LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQI 210 (258)
T ss_pred ------------------------cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHH
Confidence 11234578899999999888889999999999999999999999987664 2323
Q ss_pred HHHHh-CCCCCCCCCCCCHHHHHHHHHccccCcCccCCChhcHHHHHcCCCC
Q 001847 911 ANILH-KDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFF 961 (1005)
Q Consensus 911 ~~i~~-~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~hpff 961 (1005)
..... .....+ ...+..+.++|.+||..||.+||++. ++++++||||
T Consensus 211 ~~~~~~~~~~~~--~~~~~~~~~~i~~~l~~~p~~R~~~~--~~~l~~~~~~ 258 (258)
T cd05578 211 RAKQETADVLYP--ATWSTEAIDAINKLLERDPQKRLGDN--LKDLKNHPYF 258 (258)
T ss_pred HHHhccccccCc--ccCcHHHHHHHHHHccCChhHcCCcc--HHHHhcCCCC
Confidence 23322 222222 34678999999999999999999932 3999999998
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=320.90 Aligned_cols=255 Identities=28% Similarity=0.476 Sum_probs=218.4
Q ss_pred CccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEEe
Q 001847 673 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITD 752 (1005)
Q Consensus 673 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E 752 (1005)
+|++.+.||+|++|.||++.+..++..+|+|.+..... .......+.+|+.+++.++||||+++++.+...+..++|||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQM-TKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVME 79 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEecccc-ccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEe
Confidence 58999999999999999999999999999999876533 33445778899999999999999999999999999999999
Q ss_pred ccCCCchhhHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecC-CcEEEEeccCCcccCCCCCCC
Q 001847 753 YCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGN-GHVSLTDFDLSCLTSCKPQLL 831 (1005)
Q Consensus 753 ~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~~~-g~vkL~DFG~a~~~~~~~~~~ 831 (1005)
|+++++|.+++.......+++..+..++.|++.+|.|||++|++|+||+|+||+++.+ +.++|+|||++......
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~---- 155 (256)
T cd08220 80 YAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSK---- 155 (256)
T ss_pred cCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCC----
Confidence 9999999999987555568999999999999999999999999999999999999865 46899999988543211
Q ss_pred CCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHcCCCCCCCCChHHHHH
Q 001847 832 LPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFA 911 (1005)
Q Consensus 832 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlGvll~eLltG~~Pf~~~~~~~~~~ 911 (1005)
.......|++.|+|||.+.+..++.++||||||+++|+|++|+.||.+.+......
T Consensus 156 ------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~ 211 (256)
T cd08220 156 ------------------------SKAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPALVL 211 (256)
T ss_pred ------------------------ccccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHHHH
Confidence 01123468889999999988888899999999999999999999998877766666
Q ss_pred HHHhCCCCCCCCCCCCHHHHHHHHHccccCcCccCCChhcHHHHHcCCCC
Q 001847 912 NILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFF 961 (1005)
Q Consensus 912 ~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~hpff 961 (1005)
.+...... +.....+..+.+|+.+||..+|++||| +.++++||||
T Consensus 212 ~~~~~~~~-~~~~~~~~~l~~li~~~l~~~p~~Rpt----~~~ll~~p~~ 256 (256)
T cd08220 212 KIMSGTFA-PISDRYSPDLRQLILSMLNLDPSKRPQ----LSQIMAQPIC 256 (256)
T ss_pred HHHhcCCC-CCCCCcCHHHHHHHHHHccCChhhCCC----HHHHhhCCCC
Confidence 66554332 222346888999999999999999999 9999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=323.16 Aligned_cols=259 Identities=26% Similarity=0.393 Sum_probs=210.8
Q ss_pred CccccccccccCcEEEEEEEEcCCCeEEEEEEeeccccc--ChHHHHHHHHHHHHHHhCCCCCcceEEEEEEe--CCeEE
Q 001847 673 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVML--NRNKVHRACAEREILDMLDHPFVPALYASFQT--KTHVC 748 (1005)
Q Consensus 673 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~~~~~~~~--~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~--~~~~~ 748 (1005)
.|++.+.||+|+||.||++.+..++..|++|.+...... .......+.+|+.+++.++||||+++++++.. ...++
T Consensus 3 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 82 (266)
T cd06651 3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLT 82 (266)
T ss_pred CccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEEE
Confidence 699999999999999999999999999999988754221 22345678889999999999999999998875 46789
Q ss_pred EEEeccCCCchhhHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCC
Q 001847 749 LITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKP 828 (1005)
Q Consensus 749 lV~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~ 828 (1005)
++|||+++++|.+++... ..++...++.++.||+.||.|||++||+|+||+|+||+++.++.++|+|||++.......
T Consensus 83 l~~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~~~ 160 (266)
T cd06651 83 IFMEYMPGGSVKDQLKAY--GALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTIC 160 (266)
T ss_pred EEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCCCcccccccc
Confidence 999999999999998764 348899999999999999999999999999999999999999999999999885432100
Q ss_pred CCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHcCCCCCCCCChHH
Q 001847 829 QLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQK 908 (1005)
Q Consensus 829 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlGvll~eLltG~~Pf~~~~~~~ 908 (1005)
. .........++..|+|||.+.+..++.++|||||||++|+|++|+.||.......
T Consensus 161 ~------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~ 216 (266)
T cd06651 161 M------------------------SGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMA 216 (266)
T ss_pred c------------------------cCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHH
Confidence 0 0001122458899999999988888999999999999999999999998776555
Q ss_pred HHHHHHhCCCCCCCCCCCCHHHHHHHHHccccCcCccCCChhcHHHHHcCCCCC
Q 001847 909 TFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFK 962 (1005)
Q Consensus 909 ~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~hpff~ 962 (1005)
....+.............+..+.+|+ +||..+|++||+ ++++++||||+
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~li-~~~~~~p~~Rp~----~~eil~hp~~~ 265 (266)
T cd06651 217 AIFKIATQPTNPQLPSHISEHARDFL-GCIFVEARHRPS----AEELLRHPFAQ 265 (266)
T ss_pred HHHHHhcCCCCCCCchhcCHHHHHHH-HHhcCChhhCcC----HHHHhcCcccc
Confidence 55444332221111223577788888 677789999999 99999999996
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-36 Score=331.31 Aligned_cols=255 Identities=23% Similarity=0.417 Sum_probs=205.1
Q ss_pred CccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEEe
Q 001847 673 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITD 752 (1005)
Q Consensus 673 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E 752 (1005)
+|++++.||.|+||.||+|.+..+|..|++|.+..... .......+.+|+.++++++||||+++++++...+.+|+|+|
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~-~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 79 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD-DEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFE 79 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccc-cccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEe
Confidence 48899999999999999999999999999999875422 22233566789999999999999999999999999999999
Q ss_pred ccCCCchhhHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCCCCCC
Q 001847 753 YCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLL 832 (1005)
Q Consensus 753 ~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~~~ 832 (1005)
|+. ++|.+++... ...+++..++.++.||+.||.|||++||+|+||||+||+++.++.++|+|||++.......
T Consensus 80 ~~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~---- 153 (284)
T cd07839 80 YCD-QDLKKYFDSC-NGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPV---- 153 (284)
T ss_pred cCC-CCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCCCcEEECccchhhccCCCC----
Confidence 995 6788777643 2458999999999999999999999999999999999999999999999999885432110
Q ss_pred CcchhhhhcccCCCCCcccccccccccccccCCcccccccccCC-CCCChhhHHHHHHHHHHHHcCCCCC-CCCChHHHH
Q 001847 833 PTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGA-GHTSAVDWWALGILLYEMLYGYTPF-RGKTRQKTF 910 (1005)
Q Consensus 833 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~sDIwSlGvll~eLltG~~Pf-~~~~~~~~~ 910 (1005)
.......+++.|+|||++.+. .++.++|||||||++|+|++|..|| .+.+..+.+
T Consensus 154 -----------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~ 210 (284)
T cd07839 154 -----------------------RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQL 210 (284)
T ss_pred -----------------------CCcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHH
Confidence 111234578899999998764 4688999999999999999988885 444444444
Q ss_pred HHHHhCC--------------CC---CC----------CCCCCCHHHHHHHHHccccCcCccCCChhcHHHHHcCCCC
Q 001847 911 ANILHKD--------------LK---FP----------SSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFF 961 (1005)
Q Consensus 911 ~~i~~~~--------------~~---~~----------~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~hpff 961 (1005)
..+.... .. ++ ....++.++.+||.+||..||.+||| ++++++||||
T Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t----~~~il~h~~f 284 (284)
T cd07839 211 KRIFRLLGTPTEESWPGVSKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRIS----AEEALQHPYF 284 (284)
T ss_pred HHHHHHhCCCChHHhHHhhhcccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCC----HHHHhcCCCC
Confidence 3332210 00 00 01235778899999999999999999 9999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=320.93 Aligned_cols=253 Identities=28% Similarity=0.451 Sum_probs=214.7
Q ss_pred CCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEE
Q 001847 672 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLIT 751 (1005)
Q Consensus 672 ~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~ 751 (1005)
++|++.+.||.|+||.||++.+..+++.|++|.+.... ....+.+|+.+++.++|+||+++++++......|+++
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~-----~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~ 77 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEE-----DLQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVM 77 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHH-----HHHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEE
Confidence 58999999999999999999998889999999987542 2578889999999999999999999999999999999
Q ss_pred eccCCCchhhHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCCCCC
Q 001847 752 DYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLL 831 (1005)
Q Consensus 752 E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~~ 831 (1005)
||+.+++|.+++... ...+++..++.++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||++.......
T Consensus 78 e~~~~~~L~~~l~~~-~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~--- 153 (256)
T cd06612 78 EYCGAGSVSDIMKIT-NKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTM--- 153 (256)
T ss_pred ecCCCCcHHHHHHhC-ccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECCCCcEEEcccccchhcccCc---
Confidence 999999999998653 2458999999999999999999999999999999999999999999999999985432110
Q ss_pred CCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHcCCCCCCCCChHHHHH
Q 001847 832 LPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFA 911 (1005)
Q Consensus 832 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlGvll~eLltG~~Pf~~~~~~~~~~ 911 (1005)
.......|+..|+|||++.+..++.++||||||+++|+|++|+.||..........
T Consensus 154 ------------------------~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~ 209 (256)
T cd06612 154 ------------------------AKRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIF 209 (256)
T ss_pred ------------------------cccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhh
Confidence 01123457889999999988888999999999999999999999998766654443
Q ss_pred HHHhCCC-CCCCCCCCCHHHHHHHHHccccCcCccCCChhcHHHHHcCCCC
Q 001847 912 NILHKDL-KFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFF 961 (1005)
Q Consensus 912 ~i~~~~~-~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~hpff 961 (1005)
.+..... .+.....++..+.+||.+||..+|++||+ +.++|+||||
T Consensus 210 ~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps----~~~il~~~~~ 256 (256)
T cd06612 210 MIPNKPPPTLSDPEKWSPEFNDFVKKCLVKDPEERPS----AIQLLQHPFI 256 (256)
T ss_pred hhccCCCCCCCchhhcCHHHHHHHHHHHhcChhhCcC----HHHHhcCCCC
Confidence 3332221 12222346778999999999999999999 9999999997
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=356.21 Aligned_cols=272 Identities=28% Similarity=0.382 Sum_probs=219.2
Q ss_pred cccCCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCC-CCCcceEEEE-EEe---
Q 001847 669 INLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLD-HPFVPALYAS-FQT--- 743 (1005)
Q Consensus 669 i~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~il~~l~-hpnIv~l~~~-~~~--- 743 (1005)
+...+++|.+.|.+|||+.||+|.+...|..||+|.+-.. +......+.+|+.+|++|+ |+|||.+++. ...
T Consensus 34 Vg~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~---de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~ 110 (738)
T KOG1989|consen 34 VGSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN---DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSS 110 (738)
T ss_pred ECCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC---CHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccC
Confidence 3456788999999999999999999888899999988643 6778889999999999995 9999999993 221
Q ss_pred ---CCeEEEEEeccCCCchhhHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcC--cccCCCCCCcEEEecCCcEEEEec
Q 001847 744 ---KTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQG--IIYRDLKPENVLLQGNGHVSLTDF 818 (1005)
Q Consensus 744 ---~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~g--IvHrDLkP~NILi~~~g~vkL~DF 818 (1005)
.-.++|+||||.||.|-++|..+....|++..+++|+.|+++||++||... |||||||-+||||+.+|+.|||||
T Consensus 111 ~~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g~~KLCDF 190 (738)
T KOG1989|consen 111 NNGVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADGNYKLCDF 190 (738)
T ss_pred CCceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCCCEEeCcc
Confidence 135789999999999999998655556999999999999999999999997 999999999999999999999999
Q ss_pred cCCcccCCCCCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccc---cCCCCCChhhHHHHHHHHHHHH
Q 001847 819 DLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEII---AGAGHTSAVDWWALGILLYEML 895 (1005)
Q Consensus 819 G~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l---~~~~~~~~sDIwSlGvll~eLl 895 (1005)
|.++..-.... ...+. .-........-|+.|+|||.+ .+.+.+.|+|||+|||+||.|+
T Consensus 191 GSatt~~~~~~----~~~e~--------------~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLC 252 (738)
T KOG1989|consen 191 GSATTKILSPT----SAQEV--------------NYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLC 252 (738)
T ss_pred cccccccCCCc----cHHHH--------------HHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHH
Confidence 99854321110 00000 000111223579999999986 5678899999999999999999
Q ss_pred cCCCCCCCCChHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHccccCcCccCCChhcHHHHH----cCCCCCCCC
Q 001847 896 YGYTPFRGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIK----KHPFFKGVN 965 (1005)
Q Consensus 896 tG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL----~hpff~~~~ 965 (1005)
+...||.+... -.|+.+.+.+|..+.++..+.+||..||+.||++||+.-++..++. .+.++.++.
T Consensus 253 y~t~PFe~sg~----laIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~~~~~~~~~ 322 (738)
T KOG1989|consen 253 YFTTPFEESGK----LAILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANKPCPIPDIY 322 (738)
T ss_pred HhCCCcCcCcc----eeEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcCCCCccccc
Confidence 99999977532 3577889999999999999999999999999999999544433332 344555443
|
|
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=321.71 Aligned_cols=254 Identities=28% Similarity=0.452 Sum_probs=216.0
Q ss_pred CCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEE
Q 001847 672 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLIT 751 (1005)
Q Consensus 672 ~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~ 751 (1005)
++|++.+.||.|+||.||+|.+..+++.+++|.+... .......+.+|+.++++++||||+++++++...+.+|++|
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~---~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~ 79 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLE---PGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVM 79 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcC---chhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEE
Confidence 5899999999999999999999889999999999754 2335677889999999999999999999999999999999
Q ss_pred eccCCCchhhHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCCCCC
Q 001847 752 DYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLL 831 (1005)
Q Consensus 752 E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~~ 831 (1005)
||+.+++|.+++... ...+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++......
T Consensus 80 e~~~~~~l~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~---- 154 (262)
T cd06613 80 EYCGGGSLQDIYQVT-RGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTAT---- 154 (262)
T ss_pred eCCCCCcHHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECCCCCEEECccccchhhhhh----
Confidence 999999999998764 245899999999999999999999999999999999999999999999999988543210
Q ss_pred CCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCC---CCCChhhHHHHHHHHHHHHcCCCCCCCCChHH
Q 001847 832 LPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGA---GHTSAVDWWALGILLYEMLYGYTPFRGKTRQK 908 (1005)
Q Consensus 832 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~---~~~~~sDIwSlGvll~eLltG~~Pf~~~~~~~ 908 (1005)
........++..|+|||.+... .++.++|||||||++|+|++|..||.+.....
T Consensus 155 -----------------------~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~ 211 (262)
T cd06613 155 -----------------------IAKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMR 211 (262)
T ss_pred -----------------------hhccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 0111234688899999998776 78889999999999999999999998877666
Q ss_pred HHHHHHhCCCCCCC---CCCCCHHHHHHHHHccccCcCccCCChhcHHHHHcCCC
Q 001847 909 TFANILHKDLKFPS---STPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPF 960 (1005)
Q Consensus 909 ~~~~i~~~~~~~~~---~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~hpf 960 (1005)
....+....+..+. ....+..+.+||.+||..+|..||+ +.+++.|+|
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt----~~~il~~~~ 262 (262)
T cd06613 212 ALFLISKSNFPPPKLKDKEKWSPVFHDFIKKCLTKDPKKRPT----ATKLLQHPF 262 (262)
T ss_pred HHHHHHhccCCCccccchhhhhHHHHHHHHHHcCCChhhCCC----HHHHhcCCC
Confidence 65555544332221 2234678899999999999999999 999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=325.39 Aligned_cols=257 Identities=28% Similarity=0.453 Sum_probs=216.2
Q ss_pred CCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEE
Q 001847 672 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLIT 751 (1005)
Q Consensus 672 ~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~ 751 (1005)
++|++.+.||.|++|.||++.+..+++.+++|.+.... .......+.+|+++++.+.||||+++++++...+..|++|
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 78 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEI--NEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICM 78 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEeccc--ChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEE
Confidence 36899999999999999999999999999999987653 2345567889999999999999999999999999999999
Q ss_pred eccCCCchhhHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHH-cCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCCCC
Q 001847 752 DYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHC-QGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQL 830 (1005)
Q Consensus 752 E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~-~gIvHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~ 830 (1005)
||+.+++|.+++.... ..+++..+..++.||+.+|+|||+ .|++|+||||+||+++.++.++|+|||.+......
T Consensus 79 e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~--- 154 (265)
T cd06605 79 EYMDGGSLDKILKEVQ-GRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNS--- 154 (265)
T ss_pred EecCCCcHHHHHHHcc-CCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCCCCEEEeecccchhhHHH---
Confidence 9999999999997643 568999999999999999999999 99999999999999999999999999987432110
Q ss_pred CCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHcCCCCCCCC-----C
Q 001847 831 LLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGK-----T 905 (1005)
Q Consensus 831 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlGvll~eLltG~~Pf~~~-----~ 905 (1005)
......++..|+|||.+.+..++.++|||||||++|+|++|..||... .
T Consensus 155 --------------------------~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~ 208 (265)
T cd06605 155 --------------------------LAKTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDG 208 (265)
T ss_pred --------------------------HhhcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccccccc
Confidence 001156888999999998888999999999999999999999999654 2
Q ss_pred hHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHccccCcCccCCChhcHHHHHcCCCCCCC
Q 001847 906 RQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGV 964 (1005)
Q Consensus 906 ~~~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~hpff~~~ 964 (1005)
.......+.............+..+.+||.+||..+|.+||+ +.+++.||||+..
T Consensus 209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt----~~~ll~~~~~~~~ 263 (265)
T cd06605 209 IFELLQYIVNEPPPRLPSGKFSPDFQDFVNLCLIKDPRERPS----YKELLEHPFIKKY 263 (265)
T ss_pred HHHHHHHHhcCCCCCCChhhcCHHHHHHHHHHcCCCchhCcC----HHHHhhCchhhcc
Confidence 233344444433222222226788999999999999999999 9999999999863
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=288.56 Aligned_cols=259 Identities=24% Similarity=0.427 Sum_probs=219.6
Q ss_pred CCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEE
Q 001847 672 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLIT 751 (1005)
Q Consensus 672 ~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~ 751 (1005)
..|..+++||+|.||+||++++..++..||+|.++.+.. +........+|+.+++.++|.|||++++....+..+-+|+
T Consensus 2 ~~ydkmekigegtygtvfkarn~~t~eivalkrvrlddd-degvpssalreicllkelkhknivrl~dvlhsdkkltlvf 80 (292)
T KOG0662|consen 2 QKYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDD-DEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVF 80 (292)
T ss_pred cchHHHHhhcCCcceeeEecccCCccceEEEEEEeccCC-CCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeH
Confidence 468889999999999999999999999999999986532 3344567788999999999999999999999999999999
Q ss_pred eccCCCchhhHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCCCCC
Q 001847 752 DYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLL 831 (1005)
Q Consensus 752 E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~~ 831 (1005)
||| ..+|..++..- .+.++.+.++.++.|+++||.|+|++++.||||||.|+||+.+|.+||.|||+++..+..
T Consensus 81 e~c-dqdlkkyfdsl-ng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~ngelkladfglarafgip---- 154 (292)
T KOG0662|consen 81 EFC-DQDLKKYFDSL-NGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRNGELKLADFGLARAFGIP---- 154 (292)
T ss_pred HHh-hHHHHHHHHhc-CCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccCCcEEecccchhhhcCCc----
Confidence 999 77898888754 356999999999999999999999999999999999999999999999999999765422
Q ss_pred CCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCC-CCChhhHHHHHHHHHHHH-cCCCCCCCCChHHH
Q 001847 832 LPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAG-HTSAVDWWALGILLYEML-YGYTPFRGKTRQKT 909 (1005)
Q Consensus 832 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~-~~~~sDIwSlGvll~eLl-tG~~Pf~~~~~~~~ 909 (1005)
.+-.+..+.|.+|++|.++.+.. |+...|+||.||++.|+. .|.+.|+|.+..++
T Consensus 155 -----------------------vrcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddq 211 (292)
T KOG0662|consen 155 -----------------------VRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQ 211 (292)
T ss_pred -----------------------eEeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHH
Confidence 12234457899999999998864 677899999999999999 59999999998888
Q ss_pred HHHHHhC-----CCCCCCC----------------------CCCCHHHHHHHHHccccCcCccCCChhcHHHHHcCCCCC
Q 001847 910 FANILHK-----DLKFPSS----------------------TPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFK 962 (1005)
Q Consensus 910 ~~~i~~~-----~~~~~~~----------------------~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~hpff~ 962 (1005)
+++|... .-.||.. +.++...++|++++|..+|.+|++ ++++++||||.
T Consensus 212 lkrif~~lg~p~ed~wps~t~lpdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qris----aeaalqhpyf~ 287 (292)
T KOG0662|consen 212 LKRIFRLLGTPTEDQWPSMTKLPDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRIS----AEAALQHPYFS 287 (292)
T ss_pred HHHHHHHhCCCccccCCccccCCCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccC----HHHHhcCcccc
Confidence 8888652 1112211 112334579999999999999999 99999999998
Q ss_pred CC
Q 001847 963 GV 964 (1005)
Q Consensus 963 ~~ 964 (1005)
..
T Consensus 288 d~ 289 (292)
T KOG0662|consen 288 DF 289 (292)
T ss_pred cc
Confidence 64
|
|
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=328.05 Aligned_cols=256 Identities=27% Similarity=0.454 Sum_probs=210.2
Q ss_pred CccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEEe
Q 001847 673 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITD 752 (1005)
Q Consensus 673 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E 752 (1005)
.|++++.||.|++|.||+|.+..+++.||||.+..... .......+.+|++++++++||||+++++++...+..|+|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE-TEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 79 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEcccccc-ccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEee
Confidence 48899999999999999999999999999998875422 22334577889999999999999999999999999999999
Q ss_pred ccCCCchhhHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCCCCCC
Q 001847 753 YCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLL 832 (1005)
Q Consensus 753 ~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~~~ 832 (1005)
|+. ++|..++.......+++..+..++.||+.||+|||+.|++|+||+|+||+++.++.+||+|||++.......
T Consensus 80 ~~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~---- 154 (284)
T cd07860 80 FLH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV---- 154 (284)
T ss_pred ccc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEeeccchhhcccCc----
Confidence 994 689888876555678999999999999999999999999999999999999999999999999875432110
Q ss_pred CcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCC-CCChhhHHHHHHHHHHHHcCCCCCCCCChHHHHH
Q 001847 833 PTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAG-HTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFA 911 (1005)
Q Consensus 833 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~-~~~~sDIwSlGvll~eLltG~~Pf~~~~~~~~~~ 911 (1005)
.......+++.|+|||++.+.. ++.++|||||||++|+|++|+.||.+.+......
T Consensus 155 -----------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~ 211 (284)
T cd07860 155 -----------------------RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLF 211 (284)
T ss_pred -----------------------cccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHH
Confidence 0112235688999999887644 5789999999999999999999998876655444
Q ss_pred HHHhCCC------------------CCCC---------CCCCCHHHHHHHHHccccCcCccCCChhcHHHHHcCCCC
Q 001847 912 NILHKDL------------------KFPS---------STPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFF 961 (1005)
Q Consensus 912 ~i~~~~~------------------~~~~---------~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~hpff 961 (1005)
.+..... .++. ...++.++.+||.+||+.||.+||+ +.++++||||
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt----~~~~l~~~~f 284 (284)
T cd07860 212 RIFRTLGTPDEVVWPGVTSLPDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRIS----AKAALAHPFF 284 (284)
T ss_pred HHHHHhCCCChhhhhhhhHHHHHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCC----HHHHhcCCCC
Confidence 4332100 0000 1235778899999999999999999 9999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-37 Score=340.95 Aligned_cols=248 Identities=27% Similarity=0.434 Sum_probs=209.8
Q ss_pred cccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEEeccCCCc
Q 001847 679 PLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGE 758 (1005)
Q Consensus 679 ~LG~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~ggs 758 (1005)
+||.|.||+||.++|..+...+|||.+... +....+.+..||.+-+.|+|.|||++++++..++++-|.||-++||+
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpek---dsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGS 658 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEK---DSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGS 658 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccc---cchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCc
Confidence 489999999999999999999999988643 44566788899999999999999999999999999999999999999
Q ss_pred hhhHHhhCCCCCC--CHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEe-cCCcEEEEeccCCcccCCCCCCCCCcc
Q 001847 759 LFLLLDRQPTKVL--KEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQ-GNGHVSLTDFDLSCLTSCKPQLLLPTT 835 (1005)
Q Consensus 759 L~~~l~~~~~~~l--~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~-~~g~vkL~DFG~a~~~~~~~~~~~~~~ 835 (1005)
|.++++... +++ ++..+..+.+||++||.|||.+.|||||||-+||||+ -.|.+||+|||.++...
T Consensus 659 LSsLLrskW-GPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLA---------- 727 (1226)
T KOG4279|consen 659 LSSLLRSKW-GPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLA---------- 727 (1226)
T ss_pred HHHHHHhcc-CCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEeeccceEEecccccchhhc----------
Confidence 999998653 456 7889999999999999999999999999999999997 57999999999885532
Q ss_pred hhhhhcccCCCCCcccccccccccccccCCcccccccccCC--CCCChhhHHHHHHHHHHHHcCCCCCCCCChHH-HHHH
Q 001847 836 NEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGA--GHTSAVDWWALGILLYEMLYGYTPFRGKTRQK-TFAN 912 (1005)
Q Consensus 836 ~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~--~~~~~sDIwSlGvll~eLltG~~Pf~~~~~~~-~~~~ 912 (1005)
+.+....++.||..|||||++..+ .|+.++|||||||++.||.||++||....... .+.+
T Consensus 728 -----------------ginP~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFk 790 (1226)
T KOG4279|consen 728 -----------------GINPCTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFK 790 (1226)
T ss_pred -----------------cCCccccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhh
Confidence 122334567899999999999765 57789999999999999999999997643322 2222
Q ss_pred H--HhCCCCCCCCCCCCHHHHHHHHHccccCcCccCCChhcHHHHHcCCCCCC
Q 001847 913 I--LHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKG 963 (1005)
Q Consensus 913 i--~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~hpff~~ 963 (1005)
+ .+..++.| ..++.+++.||.+|+.+||..||+ |++||+.||++.
T Consensus 791 VGmyKvHP~iP--eelsaeak~FilrcFepd~~~R~s----A~~LL~DpFlq~ 837 (1226)
T KOG4279|consen 791 VGMYKVHPPIP--EELSAEAKNFILRCFEPDPCDRPS----AKDLLQDPFLQH 837 (1226)
T ss_pred hcceecCCCCc--HHHHHHHHHHHHHHcCCCcccCcc----HHHhccCccccc
Confidence 2 12223333 346888999999999999999999 999999999985
|
|
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-35 Score=320.99 Aligned_cols=260 Identities=25% Similarity=0.367 Sum_probs=212.8
Q ss_pred CCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccc--cChHHHHHHHHHHHHHHhCCCCCcceEEEEEEe--CCeE
Q 001847 672 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVM--LNRNKVHRACAEREILDMLDHPFVPALYASFQT--KTHV 747 (1005)
Q Consensus 672 ~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~~~~~~~--~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~--~~~~ 747 (1005)
..|++.+.||+|+||.||++.+..++..|++|.+..... ........+.+|+.+++.++||||+++++++.. ...+
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 479999999999999999999999999999998864321 123445678889999999999999999999876 3578
Q ss_pred EEEEeccCCCchhhHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCC
Q 001847 748 CLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCK 827 (1005)
Q Consensus 748 ~lV~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~ 827 (1005)
++||||+++++|.+++... ..+++..+..++.||+.||.|||++|++|+||||+||+++.++.++|+|||++......
T Consensus 82 ~~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~~ 159 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSY--GALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTI 159 (265)
T ss_pred EEEEEecCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecCCCCEEECcCccccccccc
Confidence 8999999999999998764 34889999999999999999999999999999999999999999999999988543211
Q ss_pred CCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHcCCCCCCCCChH
Q 001847 828 PQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQ 907 (1005)
Q Consensus 828 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlGvll~eLltG~~Pf~~~~~~ 907 (1005)
.. .........|+..|+|||++.+..++.++|||||||++|+|++|+.||......
T Consensus 160 ~~------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~ 215 (265)
T cd06652 160 CL------------------------SGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAM 215 (265)
T ss_pred cc------------------------cccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchH
Confidence 00 001112346889999999998888899999999999999999999999877665
Q ss_pred HHHHHHHhCCCCCCCCCCCCHHHHHHHHHccccCcCccCCChhcHHHHHcCCCCC
Q 001847 908 KTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFK 962 (1005)
Q Consensus 908 ~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~hpff~ 962 (1005)
..+..+.............+..+.++|.+||. +|.+||+ ++++++|||+.
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~----~~~il~~~~~~ 265 (265)
T cd06652 216 AAIFKIATQPTNPVLPPHVSDHCRDFLKRIFV-EAKLRPS----ADELLRHTFVH 265 (265)
T ss_pred HHHHHHhcCCCCCCCchhhCHHHHHHHHHHhc-ChhhCCC----HHHHhcCcccC
Confidence 55555443322222223456788999999995 9999999 99999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=323.21 Aligned_cols=254 Identities=19% Similarity=0.268 Sum_probs=209.2
Q ss_pred cccCCccccccccccCcEEEEEEEEc---CCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC
Q 001847 669 INLQHFRPIKPLGSGDTGSVHLVELC---GSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKT 745 (1005)
Q Consensus 669 i~~~~y~~~~~LG~G~~g~Vy~a~~~---~~~~~valK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~ 745 (1005)
+...+|++.+.||+|+||.||++.+. ..+..+|+|.++... .......+.+|+.++++++||||+++++++...+
T Consensus 2 i~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 79 (266)
T cd05064 2 LDNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGC--SDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGN 79 (266)
T ss_pred CchHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCC--CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCC
Confidence 44568999999999999999999874 346789999987642 2334467888999999999999999999999999
Q ss_pred eEEEEEeccCCCchhhHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccC
Q 001847 746 HVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTS 825 (1005)
Q Consensus 746 ~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~~~g~vkL~DFG~a~~~~ 825 (1005)
.+|+||||+++++|.+++.... ..+++..++.++.||+.||+|||++|++||||||+|||++.++.++|+|||.+....
T Consensus 80 ~~~lv~e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~ 158 (266)
T cd05064 80 TMMIVTEYMSNGALDSFLRKHE-GQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDK 158 (266)
T ss_pred CcEEEEEeCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcCCCcEEECCCccccccc
Confidence 9999999999999999987643 458999999999999999999999999999999999999999999999999764321
Q ss_pred CCCCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHc-CCCCCCCC
Q 001847 826 CKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY-GYTPFRGK 904 (1005)
Q Consensus 826 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlGvll~eLlt-G~~Pf~~~ 904 (1005)
... ........++..|+|||.+.+..++.++|||||||++|++++ |..||.+.
T Consensus 159 ~~~--------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~ 212 (266)
T cd05064 159 SEA--------------------------IYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDM 212 (266)
T ss_pred ccc--------------------------hhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcC
Confidence 100 000112235678999999988889999999999999999775 99999988
Q ss_pred ChHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHccccCcCccCCChhcHHHHH
Q 001847 905 TRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIK 956 (1005)
Q Consensus 905 ~~~~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL 956 (1005)
........+..+ ...+....++..+.+++.+||+.+|.+||+ +.+|+
T Consensus 213 ~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~c~~~~p~~RP~----~~~i~ 259 (266)
T cd05064 213 SGQDVIKAVEDG-FRLPAPRNCPNLLHQLMLDCWQKERGERPR----FSQIH 259 (266)
T ss_pred CHHHHHHHHHCC-CCCCCCCCCCHHHHHHHHHHcCCCchhCCC----HHHHH
Confidence 777766665543 333444557888999999999999999999 55554
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=326.02 Aligned_cols=258 Identities=24% Similarity=0.389 Sum_probs=213.6
Q ss_pred cccCCccccccccccCcEEEEEEEEcCCC-----eEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceEEEEEEe
Q 001847 669 INLQHFRPIKPLGSGDTGSVHLVELCGSG-----QYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQT 743 (1005)
Q Consensus 669 i~~~~y~~~~~LG~G~~g~Vy~a~~~~~~-----~~valK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~ 743 (1005)
+...+|++++.||+|+||.||++.+...+ ..+++|.+.... .......+.+|+.+++.++||||+++++++..
T Consensus 2 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~--~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~ 79 (283)
T cd05048 2 IPLSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENA--EPKVQQEFRQEAELMSDLQHPNIVCLLGVCTK 79 (283)
T ss_pred CChHHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCC--CHHHHHHHHHHHHHHHhcCCcccceEEEEEcC
Confidence 34568999999999999999999986655 689999887542 33445678899999999999999999999999
Q ss_pred CCeEEEEEeccCCCchhhHHhhCCC--------------CCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEec
Q 001847 744 KTHVCLITDYCPGGELFLLLDRQPT--------------KVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQG 809 (1005)
Q Consensus 744 ~~~~~lV~E~~~ggsL~~~l~~~~~--------------~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~~ 809 (1005)
....|++|||+++++|.+++..... ..++...+..++.||+.||.|||++|++|+||||+||++++
T Consensus 80 ~~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~~~ 159 (283)
T cd05048 80 EQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGE 159 (283)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEEcC
Confidence 8999999999999999999875321 45788999999999999999999999999999999999999
Q ss_pred CCcEEEEeccCCcccCCCCCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHH
Q 001847 810 NGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGI 889 (1005)
Q Consensus 810 ~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlGv 889 (1005)
++.++|+|||++........ ........+++.|+|||.+....++.++|||||||
T Consensus 160 ~~~~~L~dfg~~~~~~~~~~-------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~ 214 (283)
T cd05048 160 GLTVKISDFGLSRDIYSADY-------------------------YRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGV 214 (283)
T ss_pred CCcEEECCCcceeecccccc-------------------------ccccCCCcccccccCHHHhccCcCchhhhHHHHHH
Confidence 99999999999854321110 01112335678999999998888999999999999
Q ss_pred HHHHHHc-CCCCCCCCChHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHccccCcCccCCChhcHHHHHcC
Q 001847 890 LLYEMLY-GYTPFRGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKH 958 (1005)
Q Consensus 890 ll~eLlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~h 958 (1005)
++|+|++ |..||.+....+....+..+.. .+....++..+.+|+.+||+.||.+||+ +.+++++
T Consensus 215 il~el~~~g~~p~~~~~~~~~~~~i~~~~~-~~~~~~~~~~~~~l~~~c~~~~p~~Rp~----~~~i~~~ 279 (283)
T cd05048 215 VLWEIFSYGLQPYYGFSNQEVIEMIRSRQL-LPCPEDCPARVYALMIECWNEIPARRPR----FKDIHTR 279 (283)
T ss_pred HHHHHHcCCCCCCCCCCHHHHHHHHHcCCc-CCCcccCCHHHHHHHHHHccCChhhCcC----HHHHHHH
Confidence 9999997 9999998887777666655433 2333457889999999999999999999 7776653
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-35 Score=359.68 Aligned_cols=151 Identities=39% Similarity=0.653 Sum_probs=138.9
Q ss_pred cCCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEE
Q 001847 671 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLI 750 (1005)
Q Consensus 671 ~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV 750 (1005)
+++|++++.||+|+||.||+|.+..+++.||||+++............+..|+.++..++|+||++++.++...+++|+|
T Consensus 3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lV 82 (669)
T cd05610 3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLV 82 (669)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEE
Confidence 46899999999999999999999989999999999876555556667888999999999999999999999999999999
Q ss_pred EeccCCCchhhHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcc
Q 001847 751 TDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCL 823 (1005)
Q Consensus 751 ~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~~~g~vkL~DFG~a~~ 823 (1005)
|||+.+++|.+++... +.+++..++.|+.||+.||.|||.+||+||||||+|||++.++.+||+|||++..
T Consensus 83 mEy~~g~~L~~li~~~--~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~~~g~vkL~DFGls~~ 153 (669)
T cd05610 83 MEYLIGGDVKSLLHIY--GYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNEGHIKLTDFGLSKV 153 (669)
T ss_pred EeCCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEcCCCCEEEEeCCCCcc
Confidence 9999999999998764 4588999999999999999999999999999999999999999999999999863
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=319.53 Aligned_cols=252 Identities=26% Similarity=0.476 Sum_probs=215.3
Q ss_pred CccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEEe
Q 001847 673 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITD 752 (1005)
Q Consensus 673 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E 752 (1005)
+|++.+.||.|+||.||++.+..+++.||+|.++... .......+.+|+.+++.++|+||+++++++...+.+|+|||
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 78 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPK--SSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVME 78 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCc--chHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEe
Confidence 5889999999999999999999999999999986532 23455677889999999999999999999999999999999
Q ss_pred ccCCCchhhHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCCCCCC
Q 001847 753 YCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLL 832 (1005)
Q Consensus 753 ~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~~~ 832 (1005)
|+++++|.+++.......+++..+..++.||+.||.|||++||+|+||||+||++++++.++|+|||.+......
T Consensus 79 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~----- 153 (255)
T cd08219 79 YCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSP----- 153 (255)
T ss_pred eCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCCCcEEEcccCcceeeccc-----
Confidence 999999999987655566899999999999999999999999999999999999999999999999988543211
Q ss_pred CcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHcCCCCCCCCChHHHHHH
Q 001847 833 PTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFAN 912 (1005)
Q Consensus 833 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlGvll~eLltG~~Pf~~~~~~~~~~~ 912 (1005)
........|++.|+|||++.+..++.++|+||||+++|+|++|..||...+.......
T Consensus 154 ----------------------~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~ 211 (255)
T cd08219 154 ----------------------GAYACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILK 211 (255)
T ss_pred ----------------------ccccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHHHHH
Confidence 0111234688999999999888899999999999999999999999998777666666
Q ss_pred HHhCCCCCCCCCCCCHHHHHHHHHccccCcCccCCChhcHHHHHcC
Q 001847 913 ILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKH 958 (1005)
Q Consensus 913 i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~h 958 (1005)
+..+.... .....+..+.+||.+||..||++||+ +.+++.-
T Consensus 212 ~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~Rp~----~~~il~~ 252 (255)
T cd08219 212 VCQGSYKP-LPSHYSYELRSLIKQMFKRNPRSRPS----ATTILSR 252 (255)
T ss_pred HhcCCCCC-CCcccCHHHHHHHHHHHhCCcccCCC----HHHHhhc
Confidence 65554332 22346788999999999999999999 7887764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-37 Score=337.09 Aligned_cols=250 Identities=26% Similarity=0.426 Sum_probs=214.4
Q ss_pred cccccCCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCe
Q 001847 667 EQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTH 746 (1005)
Q Consensus 667 ~~i~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~ 746 (1005)
|+|......-++.||+|+.|.||+++. .++.||||.++. .-..+|+-|++|+||||+.+.++|.....
T Consensus 119 WeiPFe~IsELeWlGSGaQGAVF~Grl--~netVAVKKV~e----------lkETdIKHLRkLkH~NII~FkGVCtqsPc 186 (904)
T KOG4721|consen 119 WEIPFEEISELEWLGSGAQGAVFLGRL--HNETVAVKKVRE----------LKETDIKHLRKLKHPNIITFKGVCTQSPC 186 (904)
T ss_pred ccCCHHHhhhhhhhccCcccceeeeec--cCceehhHHHhh----------hhhhhHHHHHhccCcceeeEeeeecCCce
Confidence 445555666678899999999999997 677899997652 22357889999999999999999999999
Q ss_pred EEEEEeccCCCchhhHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCC
Q 001847 747 VCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSC 826 (1005)
Q Consensus 747 ~~lV~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~~~g~vkL~DFG~a~~~~~ 826 (1005)
+|||||||..|-|..+|+.. ..++...+..|.++|+.|+.|||.+.|||||||.-||||+.+..|||+|||.++....
T Consensus 187 yCIiMEfCa~GqL~~VLka~--~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~ 264 (904)
T KOG4721|consen 187 YCIIMEFCAQGQLYEVLKAG--RPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISYDDVVKISDFGTSKELSD 264 (904)
T ss_pred eEEeeeccccccHHHHHhcc--CccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeeccceEEeccccchHhhhh
Confidence 99999999999999999864 5688999999999999999999999999999999999999999999999998855331
Q ss_pred CCCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCh
Q 001847 827 KPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTR 906 (1005)
Q Consensus 827 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlGvll~eLltG~~Pf~~~~~ 906 (1005)
. ...-+++||..|||||++...+.+.++|||||||+||||+||..||..-+.
T Consensus 265 ~----------------------------STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVds 316 (904)
T KOG4721|consen 265 K----------------------------STKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDS 316 (904)
T ss_pred h----------------------------hhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccch
Confidence 1 112357899999999999999999999999999999999999999988776
Q ss_pred HHHHHHHHhCCCCCCCCCCCCHHHHHHHHHccccCcCccCCChhcHHHHHcCCCCC
Q 001847 907 QKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFK 962 (1005)
Q Consensus 907 ~~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~hpff~ 962 (1005)
..++.-+-..-+.+|....++.-++=||+.||.-.|.+||+ ..++|.|-=+.
T Consensus 317 sAIIwGVGsNsL~LpvPstcP~GfklL~Kqcw~sKpRNRPS----Frqil~HldIa 368 (904)
T KOG4721|consen 317 SAIIWGVGSNSLHLPVPSTCPDGFKLLLKQCWNSKPRNRPS----FRQILLHLDIA 368 (904)
T ss_pred heeEEeccCCcccccCcccCchHHHHHHHHHHhcCCCCCcc----HHHHHHHHhhc
Confidence 66655554555667777778888999999999999999999 77888875333
|
|
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=323.61 Aligned_cols=256 Identities=28% Similarity=0.435 Sum_probs=211.8
Q ss_pred cCCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCC----
Q 001847 671 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPALYASFQTKT---- 745 (1005)
Q Consensus 671 ~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~---- 745 (1005)
.++|++.+.||.|++|.||+|.+..+++.+++|++.... .....+.+|+.+++++ +|+||+++++++....
T Consensus 5 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~----~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~ 80 (275)
T cd06608 5 TGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIE----DEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGN 80 (275)
T ss_pred hhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCc----hhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCc
Confidence 468999999999999999999998899999999987542 2345778899999999 7999999999997544
Q ss_pred --eEEEEEeccCCCchhhHHhhCC--CCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCC
Q 001847 746 --HVCLITDYCPGGELFLLLDRQP--TKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLS 821 (1005)
Q Consensus 746 --~~~lV~E~~~ggsL~~~l~~~~--~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~~~g~vkL~DFG~a 821 (1005)
.+|+||||+.+++|.+++.... ...+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++
T Consensus 81 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~~~~~~l~d~~~~ 160 (275)
T cd06608 81 DDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVS 160 (275)
T ss_pred ceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEccCCeEEECCCccc
Confidence 5899999999999999987532 456899999999999999999999999999999999999999999999999987
Q ss_pred cccCCCCCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCC-----CCCChhhHHHHHHHHHHHHc
Q 001847 822 CLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGA-----GHTSAVDWWALGILLYEMLY 896 (1005)
Q Consensus 822 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-----~~~~~sDIwSlGvll~eLlt 896 (1005)
...... ........|++.|+|||++... .++.++|||||||++|+|++
T Consensus 161 ~~~~~~---------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~ 213 (275)
T cd06608 161 AQLDST---------------------------LGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELAD 213 (275)
T ss_pred eecccc---------------------------hhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHh
Confidence 543210 0111234689999999987542 35678999999999999999
Q ss_pred CCCCCCCCChHHHHHHHHhCCCC-CCCCCCCCHHHHHHHHHccccCcCccCCChhcHHHHHcCCCC
Q 001847 897 GYTPFRGKTRQKTFANILHKDLK-FPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFF 961 (1005)
Q Consensus 897 G~~Pf~~~~~~~~~~~i~~~~~~-~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~hpff 961 (1005)
|+.||...........+...... .......+..+.+||.+||..||++||| +.++++|||+
T Consensus 214 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt----~~~ll~~~~~ 275 (275)
T cd06608 214 GKPPLCDMHPMRALFKIPRNPPPTLKSPENWSKKFNDFISECLIKNYEQRPF----MEELLEHPFI 275 (275)
T ss_pred CCCCccccchHHHHHHhhccCCCCCCchhhcCHHHHHHHHHHhhcChhhCcC----HHHHhcCCCC
Confidence 99999876665555555544322 2222235678999999999999999999 9999999996
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=329.95 Aligned_cols=268 Identities=28% Similarity=0.470 Sum_probs=221.1
Q ss_pred CCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEE
Q 001847 672 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLIT 751 (1005)
Q Consensus 672 ~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~ 751 (1005)
+.|.....||.|+||.||++.+..++..||||.+... .......+.+|+.+++.++|+||+++++.+...+..|+||
T Consensus 22 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~ 98 (292)
T cd06658 22 EYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLR---KQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVM 98 (292)
T ss_pred HHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecc---hHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEE
Confidence 3566677899999999999999889999999988643 2344566888999999999999999999999999999999
Q ss_pred eccCCCchhhHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCCCCC
Q 001847 752 DYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLL 831 (1005)
Q Consensus 752 E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~~ 831 (1005)
||+++++|.+++.. ..+++..+..++.||+.||.|||++||+||||||+||+++.++.++|+|||++......
T Consensus 99 e~~~~~~L~~~~~~---~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~---- 171 (292)
T cd06658 99 EFLEGGALTDIVTH---TRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKE---- 171 (292)
T ss_pred eCCCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEccCcchhhcccc----
Confidence 99999999998854 34889999999999999999999999999999999999999999999999987532211
Q ss_pred CCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHcCCCCCCCCChHHHHH
Q 001847 832 LPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFA 911 (1005)
Q Consensus 832 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlGvll~eLltG~~Pf~~~~~~~~~~ 911 (1005)
........|++.|+|||.+.+..++.++||||||+++|+|++|+.||........+.
T Consensus 172 -----------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~ 228 (292)
T cd06658 172 -----------------------VPKRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMR 228 (292)
T ss_pred -----------------------cccCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 011123468899999999988888999999999999999999999998877666555
Q ss_pred HHHhCC-CCCCCCCCCCHHHHHHHHHccccCcCccCCChhcHHHHHcCCCCCCCChhhhhhcCCCCCCCCCCCC
Q 001847 912 NILHKD-LKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVNWALVRCMNPPELDAPLFAT 984 (1005)
Q Consensus 912 ~i~~~~-~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~hpff~~~~~~~~~~~~~~~~~~p~~~~ 984 (1005)
.+.... ...+.....+..+.+|+.+||..||.+||| ++++++||||... .+|...+|++..
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt----~~~il~~~~~~~~--------~~~~~~~~~~~~ 290 (292)
T cd06658 229 RIRDNLPPRVKDSHKVSSVLRGFLDLMLVREPSQRAT----AQELLQHPFLKLA--------GPPSCIVPLMRQ 290 (292)
T ss_pred HHHhcCCCccccccccCHHHHHHHHHHccCChhHCcC----HHHHhhChhhhcc--------CCccccchhhhh
Confidence 443321 222233346788999999999999999999 9999999999963 344445565543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=337.23 Aligned_cols=255 Identities=26% Similarity=0.495 Sum_probs=208.7
Q ss_pred cCCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeC------
Q 001847 671 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTK------ 744 (1005)
Q Consensus 671 ~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~------ 744 (1005)
.++|++++.||+|+||.||++.+..+++.||+|.+.... ........+.+|+.++++++|+||++++++|...
T Consensus 15 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 93 (353)
T cd07850 15 LKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPF-QNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF 93 (353)
T ss_pred hcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccc-cChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence 478999999999999999999999999999999986542 2334456677899999999999999999988643
Q ss_pred CeEEEEEeccCCCchhhHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCccc
Q 001847 745 THVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLT 824 (1005)
Q Consensus 745 ~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~~~g~vkL~DFG~a~~~ 824 (1005)
...|+||||+ +++|.+.+... ++...+..++.||+.||+|||++||+||||||+||+++.++.+||+|||++...
T Consensus 94 ~~~~lv~e~~-~~~l~~~~~~~----l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~ 168 (353)
T cd07850 94 QDVYLVMELM-DANLCQVIQMD----LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA 168 (353)
T ss_pred CcEEEEEecc-CCCHHHHHhhc----CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCccceeC
Confidence 3579999999 56888887643 889999999999999999999999999999999999999999999999998543
Q ss_pred CCCCCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHcCCCCCCCC
Q 001847 825 SCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGK 904 (1005)
Q Consensus 825 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlGvll~eLltG~~Pf~~~ 904 (1005)
.... ......+++.|+|||.+.+..++.++|||||||++|+|++|+.||...
T Consensus 169 ~~~~----------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~ 220 (353)
T cd07850 169 GTSF----------------------------MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGT 220 (353)
T ss_pred CCCC----------------------------CCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCC
Confidence 2110 012245788999999999989999999999999999999999999877
Q ss_pred ChHHHHHHHHhC----------------------CC--------------CCCC-----CCCCCHHHHHHHHHccccCcC
Q 001847 905 TRQKTFANILHK----------------------DL--------------KFPS-----STPTSLHAKQLMYRLLHRDPK 943 (1005)
Q Consensus 905 ~~~~~~~~i~~~----------------------~~--------------~~~~-----~~~~s~~l~~Ll~~~L~~dP~ 943 (1005)
+....+..+... .. .++. ....+..+.+||.+||+.||.
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~ 300 (353)
T cd07850 221 DHIDQWNKIIEQLGTPSDEFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPE 300 (353)
T ss_pred CHHHHHHHHHHhcCCCCHHHHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChh
Confidence 655444433221 00 0000 012355688999999999999
Q ss_pred ccCCChhcHHHHHcCCCCCC
Q 001847 944 SRLGSHEGANEIKKHPFFKG 963 (1005)
Q Consensus 944 ~Rpt~~~~a~elL~hpff~~ 963 (1005)
+||+ +.++|.||||+.
T Consensus 301 ~R~t----~~eiL~~~~~~~ 316 (353)
T cd07850 301 KRIS----VDDALQHPYINV 316 (353)
T ss_pred hCcC----HHHHhcChhHhh
Confidence 9999 999999999984
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=326.03 Aligned_cols=258 Identities=25% Similarity=0.428 Sum_probs=215.3
Q ss_pred cccCCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEE
Q 001847 669 INLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVC 748 (1005)
Q Consensus 669 i~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~ 748 (1005)
+..++|++++.||+|+||.||++.+..+++.||+|++.... .......+.+|+++++.++||||+++++++...+.+|
T Consensus 2 l~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 79 (284)
T cd06620 2 LRNEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGA--KSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNIC 79 (284)
T ss_pred ccHHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecC--cchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEE
Confidence 34578999999999999999999998899999999887542 2344577889999999999999999999999999999
Q ss_pred EEEeccCCCchhhHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHH-cCcccCCCCCCcEEEecCCcEEEEeccCCcccCCC
Q 001847 749 LITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHC-QGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCK 827 (1005)
Q Consensus 749 lV~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~-~gIvHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~ 827 (1005)
+||||+++++|.+++... +.++...+..++.+++.+|.|||+ .|++|+||+|+||+++.++.++|+|||++......
T Consensus 80 lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~ 157 (284)
T cd06620 80 MCMEFMDCGSLDRIYKKG--GPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINS 157 (284)
T ss_pred EEEecCCCCCHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCCcEEEccCCcccchhhh
Confidence 999999999999998764 458999999999999999999997 59999999999999999999999999987432100
Q ss_pred CCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHcCCCCCCCCChH
Q 001847 828 PQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQ 907 (1005)
Q Consensus 828 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlGvll~eLltG~~Pf~~~~~~ 907 (1005)
......|+..|+|||++.+..++.++|||||||++|+|++|..||......
T Consensus 158 -----------------------------~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~ 208 (284)
T cd06620 158 -----------------------------IADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNID 208 (284)
T ss_pred -----------------------------ccCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchh
Confidence 012346899999999998888889999999999999999999999765431
Q ss_pred -----------HHHHHHHhCCCCCCCCCCCCHHHHHHHHHccccCcCccCCChhcHHHHHcCCCCCC
Q 001847 908 -----------KTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKG 963 (1005)
Q Consensus 908 -----------~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~hpff~~ 963 (1005)
.....+.............+..+.+|+.+||..||++||+ +.++++|+||..
T Consensus 209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt----~~e~~~~~~~~~ 271 (284)
T cd06620 209 DDGQDDPMGILDLLQQIVQEPPPRLPSSDFPEDLRDFVDACLLKDPTERPT----PQQLCAMPPFIQ 271 (284)
T ss_pred hhhhhhhhHHHHHHHHHhhccCCCCCchhcCHHHHHHHHHHhcCCcccCcC----HHHHhcCccccc
Confidence 2223333332222122236778999999999999999999 999999999975
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=329.89 Aligned_cols=264 Identities=28% Similarity=0.390 Sum_probs=213.3
Q ss_pred ccCCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeC--CeE
Q 001847 670 NLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTK--THV 747 (1005)
Q Consensus 670 ~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~--~~~ 747 (1005)
..++|++.+.||.|+||.||++.+..+|..||+|.++.... .........+|+.++++++|+||+++++++... +.+
T Consensus 5 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (309)
T cd07845 5 SVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNE-RDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSI 83 (309)
T ss_pred cccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccC-CCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeE
Confidence 35689999999999999999999999999999999875422 122223456799999999999999999998754 568
Q ss_pred EEEEeccCCCchhhHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCC
Q 001847 748 CLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCK 827 (1005)
Q Consensus 748 ~lV~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~ 827 (1005)
|+||||+. ++|.+++.... ..+++..+..++.||+.||.|||+.|++|+||||+||+++.++.+||+|||++......
T Consensus 84 ~lv~e~~~-~~l~~~l~~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~ 161 (309)
T cd07845 84 FLVMEYCE-QDLASLLDNMP-TPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLP 161 (309)
T ss_pred EEEEecCC-CCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccceeeecCCc
Confidence 99999994 58888876542 45899999999999999999999999999999999999999999999999998553211
Q ss_pred CCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccC-CCCCChhhHHHHHHHHHHHHcCCCCCCCCCh
Q 001847 828 PQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAG-AGHTSAVDWWALGILLYEMLYGYTPFRGKTR 906 (1005)
Q Consensus 828 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~sDIwSlGvll~eLltG~~Pf~~~~~ 906 (1005)
. .......+++.|+|||.+.+ ..++.++|||||||++|+|++|+.||.+.+.
T Consensus 162 ~---------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~ 214 (309)
T cd07845 162 A---------------------------KPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSE 214 (309)
T ss_pred c---------------------------CCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence 0 01112245788999999865 4578899999999999999999999998887
Q ss_pred HHHHHHHHhCC-------------------CCCCC---------CCCCCHHHHHHHHHccccCcCccCCChhcHHHHHcC
Q 001847 907 QKTFANILHKD-------------------LKFPS---------STPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKH 958 (1005)
Q Consensus 907 ~~~~~~i~~~~-------------------~~~~~---------~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~h 958 (1005)
...+..+.... ...+. ....+..+.+||.+||++||++||| +.++++|
T Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t----~~~il~h 290 (309)
T cd07845 215 IEQLDLIIQLLGTPNESIWPGFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRAT----AEEALES 290 (309)
T ss_pred HHHHHHHHHhcCCCChhhchhhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcC----HHHHhcC
Confidence 77766655421 00000 0124678899999999999999999 9999999
Q ss_pred CCCCCCChh
Q 001847 959 PFFKGVNWA 967 (1005)
Q Consensus 959 pff~~~~~~ 967 (1005)
|||+.....
T Consensus 291 ~~f~~~~~~ 299 (309)
T cd07845 291 SYFKEKPLP 299 (309)
T ss_pred hhhccCCCC
Confidence 999965444
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=342.01 Aligned_cols=253 Identities=25% Similarity=0.385 Sum_probs=215.7
Q ss_pred cccccccccCcEEEEEEEEcCCCeEEEEEEeecc-cccChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC--eEEEEE
Q 001847 675 RPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKG-VMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKT--HVCLIT 751 (1005)
Q Consensus 675 ~~~~~LG~G~~g~Vy~a~~~~~~~~valK~~~~~-~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~--~~~lV~ 751 (1005)
+....||+|+|-+||+|.|..+|..||--.++.. ....+....++..|+.+|+.|+||||+++|+++.+.. .+-+|+
T Consensus 43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iT 122 (632)
T KOG0584|consen 43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFIT 122 (632)
T ss_pred ehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeee
Confidence 4556799999999999999999988765444322 2345667799999999999999999999999998654 488999
Q ss_pred eccCCCchhhHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcC--cccCCCCCCcEEEecC-CcEEEEeccCCcccCCCC
Q 001847 752 DYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQG--IIYRDLKPENVLLQGN-GHVSLTDFDLSCLTSCKP 828 (1005)
Q Consensus 752 E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~g--IvHrDLkP~NILi~~~-g~vkL~DFG~a~~~~~~~ 828 (1005)
|+|..|+|+.|+++. +.++...++.|++||+.||.|||++. |||||||.+||||+.+ |.|||+|+|+|......
T Consensus 123 EL~TSGtLr~Y~kk~--~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s- 199 (632)
T KOG0584|consen 123 ELFTSGTLREYRKKH--RRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKS- 199 (632)
T ss_pred ecccCCcHHHHHHHh--ccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchhHHHHhhcc-
Confidence 999999999999885 45899999999999999999999984 9999999999999966 89999999999664321
Q ss_pred CCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHcCCCCCCCC-ChH
Q 001847 829 QLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGK-TRQ 907 (1005)
Q Consensus 829 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlGvll~eLltG~~Pf~~~-~~~ 907 (1005)
...+.+|||.|||||.+. ..|+..+||||||+.++||+|+.+||... +..
T Consensus 200 ----------------------------~aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~A 250 (632)
T KOG0584|consen 200 ----------------------------HAKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPA 250 (632)
T ss_pred ----------------------------ccceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHH
Confidence 123478999999999986 67899999999999999999999999875 556
Q ss_pred HHHHHHHhCCCCCCCCCCCCHHHHHHHHHccccCcCccCCChhcHHHHHcCCCCCCC
Q 001847 908 KTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGV 964 (1005)
Q Consensus 908 ~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~hpff~~~ 964 (1005)
.+|+++..+..+-.-...-++++++||.+||.. ...|++ +.+||+||||..-
T Consensus 251 QIYKKV~SGiKP~sl~kV~dPevr~fIekCl~~-~~~R~s----a~eLL~d~Ff~~d 302 (632)
T KOG0584|consen 251 QIYKKVTSGIKPAALSKVKDPEVREFIEKCLAT-KSERLS----AKELLKDPFFDED 302 (632)
T ss_pred HHHHHHHcCCCHHHhhccCCHHHHHHHHHHhcC-chhccC----HHHHhhChhhccc
Confidence 777777777555444444578999999999999 899999 9999999999974
|
|
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=341.04 Aligned_cols=256 Identities=22% Similarity=0.318 Sum_probs=206.5
Q ss_pred cccCCccccccccccCcEEEEEEEEcCC-----CeEEEEEEeecccccChHHHHHHHHHHHHHHhC-CCCCcceEEEEEE
Q 001847 669 INLQHFRPIKPLGSGDTGSVHLVELCGS-----GQYFAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPALYASFQ 742 (1005)
Q Consensus 669 i~~~~y~~~~~LG~G~~g~Vy~a~~~~~-----~~~valK~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~ 742 (1005)
+..++|++.+.||+|+||.||+|.+... +..||+|.++... .......+.+|+.+++.+ +|+||+++++++.
T Consensus 35 ~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~ 112 (374)
T cd05106 35 FPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASA--HTDEREALMSELKILSHLGQHKNIVNLLGACT 112 (374)
T ss_pred ccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCC--CHHHHHHHHHHHHHHHhhccCCceeeEeeEec
Confidence 4456899999999999999999987544 3579999987542 233456778899999999 8999999999999
Q ss_pred eCCeEEEEEeccCCCchhhHHhhCC-------------------------------------------------------
Q 001847 743 TKTHVCLITDYCPGGELFLLLDRQP------------------------------------------------------- 767 (1005)
Q Consensus 743 ~~~~~~lV~E~~~ggsL~~~l~~~~------------------------------------------------------- 767 (1005)
..+.+|+||||+.+|+|.+++....
T Consensus 113 ~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 192 (374)
T cd05106 113 HGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSS 192 (374)
T ss_pred CCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccc
Confidence 9999999999999999999885421
Q ss_pred -------------CCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCCCCCCCc
Q 001847 768 -------------TKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPT 834 (1005)
Q Consensus 768 -------------~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~~~~~ 834 (1005)
...++...+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++........
T Consensus 193 ~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~----- 267 (374)
T cd05106 193 QSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSN----- 267 (374)
T ss_pred ccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcc-----
Confidence 12478889999999999999999999999999999999999999999999999854321100
Q ss_pred chhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHH
Q 001847 835 TNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY-GYTPFRGKTRQKTFANI 913 (1005)
Q Consensus 835 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlGvll~eLlt-G~~Pf~~~~~~~~~~~i 913 (1005)
........+++.|+|||++....++.++|||||||++|+|++ |+.||........+...
T Consensus 268 --------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~ 327 (374)
T cd05106 268 --------------------YVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKM 327 (374)
T ss_pred --------------------eeeccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHH
Confidence 001112335678999999988889999999999999999997 99999876655555555
Q ss_pred HhCCCCCCCCCCCCHHHHHHHHHccccCcCccCCChhc
Q 001847 914 LHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEG 951 (1005)
Q Consensus 914 ~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~ 951 (1005)
.............+.++.+++.+||+.||.+||++.++
T Consensus 328 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~l 365 (374)
T cd05106 328 VKRGYQMSRPDFAPPEIYSIMKMCWNLEPTERPTFSQI 365 (374)
T ss_pred HHcccCccCCCCCCHHHHHHHHHHcCCChhhCcCHHHH
Confidence 55444444444467899999999999999999994443
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-35 Score=320.25 Aligned_cols=251 Identities=22% Similarity=0.310 Sum_probs=210.4
Q ss_pred cccCCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEE
Q 001847 669 INLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVC 748 (1005)
Q Consensus 669 i~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~ 748 (1005)
+...+|.+.+.||+|++|.||++.+..+++.+++|.+... ......+.+|+.+++.++|+||+++++++...+.++
T Consensus 3 ~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 78 (263)
T cd05052 3 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED----TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFY 78 (263)
T ss_pred CchHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC----chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcE
Confidence 4456799999999999999999999999999999998643 233467888999999999999999999999999999
Q ss_pred EEEeccCCCchhhHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCC
Q 001847 749 LITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKP 828 (1005)
Q Consensus 749 lV~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~ 828 (1005)
+||||+++++|.+++.......++...++.++.|++.||+|||++|++|+||||+||++++++.+||+|||++.......
T Consensus 79 lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~ 158 (263)
T cd05052 79 IITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT 158 (263)
T ss_pred EEEEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCcEEeCCCccccccccce
Confidence 99999999999999976555568999999999999999999999999999999999999999999999999985432110
Q ss_pred CCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCChH
Q 001847 829 QLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY-GYTPFRGKTRQ 907 (1005)
Q Consensus 829 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlGvll~eLlt-G~~Pf~~~~~~ 907 (1005)
. .......+++.|+|||.+.+..++.++|||||||++|+|++ |..||.+....
T Consensus 159 ~--------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~ 212 (263)
T cd05052 159 Y--------------------------TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS 212 (263)
T ss_pred e--------------------------eccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHH
Confidence 0 00112234668999999988889999999999999999998 99999887776
Q ss_pred HHHHHHHhCCCCCCCCCCCCHHHHHHHHHccccCcCccCCChh
Q 001847 908 KTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHE 950 (1005)
Q Consensus 908 ~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~ 950 (1005)
+....+... .........+..+.+||.+||..+|++||++.+
T Consensus 213 ~~~~~~~~~-~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ 254 (263)
T cd05052 213 QVYELLEKG-YRMERPEGCPPKVYELMRACWQWNPSDRPSFAE 254 (263)
T ss_pred HHHHHHHCC-CCCCCCCCCCHHHHHHHHHHccCCcccCCCHHH
Confidence 665555443 333334457889999999999999999999444
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=326.13 Aligned_cols=257 Identities=30% Similarity=0.454 Sum_probs=212.5
Q ss_pred CCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEE
Q 001847 672 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLIT 751 (1005)
Q Consensus 672 ~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~ 751 (1005)
++|++++.||+|+||.||++.+..++..||+|.+.... .......+.+|+.++++++|+||+++++++...+.+|+||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 78 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLEL--DESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCM 78 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeeccc--CHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEE
Confidence 36999999999999999999999899999999887532 3344567889999999999999999999999999999999
Q ss_pred eccCCCchhhHHhhCC-CCCCCHHHHHHHHHHHHHHHHHHHH-cCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCCC
Q 001847 752 DYCPGGELFLLLDRQP-TKVLKEDAVRFYAAEVVVALEYLHC-QGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQ 829 (1005)
Q Consensus 752 E~~~ggsL~~~l~~~~-~~~l~~~~i~~i~~qil~aL~~LH~-~gIvHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~ 829 (1005)
||+++++|..++.... ...+++..+..++.||+.||.|||+ .||+|+||||+||+++.++.++|+|||++......
T Consensus 79 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~-- 156 (286)
T cd06622 79 EYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS-- 156 (286)
T ss_pred eecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCCCEEEeecCCcccccCC--
Confidence 9999999998886531 2368999999999999999999997 59999999999999999999999999988432110
Q ss_pred CCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCC------CCChhhHHHHHHHHHHHHcCCCCCCC
Q 001847 830 LLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAG------HTSAVDWWALGILLYEMLYGYTPFRG 903 (1005)
Q Consensus 830 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~------~~~~sDIwSlGvll~eLltG~~Pf~~ 903 (1005)
......+++.|+|||.+.+.. ++.++|||||||++|+|++|+.||..
T Consensus 157 ---------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~ 209 (286)
T cd06622 157 ---------------------------LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPP 209 (286)
T ss_pred ---------------------------ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCC
Confidence 112335788999999985543 47799999999999999999999976
Q ss_pred CChHHHHHH---HHhCCCCCCCCCCCCHHHHHHHHHccccCcCccCCChhcHHHHHcCCCCCCC
Q 001847 904 KTRQKTFAN---ILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGV 964 (1005)
Q Consensus 904 ~~~~~~~~~---i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~hpff~~~ 964 (1005)
......... +.... .......++.++.+||.+||..+|++||+ +.+++.||||...
T Consensus 210 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rp~----~~~l~~~~~~~~~ 268 (286)
T cd06622 210 ETYANIFAQLSAIVDGD-PPTLPSGYSDDAQDFVAKCLNKIPNRRPT----YAQLLEHPWLVKY 268 (286)
T ss_pred cchhhHHHHHHHHhhcC-CCCCCcccCHHHHHHHHHHcccCcccCCC----HHHHhcChhhhhc
Confidence 554433332 22222 12222347889999999999999999999 9999999999875
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-35 Score=327.48 Aligned_cols=254 Identities=24% Similarity=0.345 Sum_probs=203.0
Q ss_pred cCCccccccccccCcEEEEEEEEcC----------------CCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCc
Q 001847 671 LQHFRPIKPLGSGDTGSVHLVELCG----------------SGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFV 734 (1005)
Q Consensus 671 ~~~y~~~~~LG~G~~g~Vy~a~~~~----------------~~~~valK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnI 734 (1005)
.++|++.+.||+|+||.||+|.+.. ++..||+|.+.... .......+.+|+.++.+++||||
T Consensus 4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~ni 81 (304)
T cd05096 4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDA--NKNARNDFLKEVKILSRLKDPNI 81 (304)
T ss_pred hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCC--CHHHHHHHHHHHHHHhhcCCCCe
Confidence 4689999999999999999998632 34579999987542 34445678899999999999999
Q ss_pred ceEEEEEEeCCeEEEEEeccCCCchhhHHhhCCC-----------------CCCCHHHHHHHHHHHHHHHHHHHHcCccc
Q 001847 735 PALYASFQTKTHVCLITDYCPGGELFLLLDRQPT-----------------KVLKEDAVRFYAAEVVVALEYLHCQGIIY 797 (1005)
Q Consensus 735 v~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~-----------------~~l~~~~i~~i~~qil~aL~~LH~~gIvH 797 (1005)
+++++++...+..|+||||+.+++|.+++..... ..++...+..++.||+.||.|||+.||+|
T Consensus 82 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~ivH 161 (304)
T cd05096 82 IRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVH 161 (304)
T ss_pred eEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCccc
Confidence 9999999999999999999999999999864311 23677889999999999999999999999
Q ss_pred CCCCCCcEEEecCCcEEEEeccCCcccCCCCCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCC
Q 001847 798 RDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAG 877 (1005)
Q Consensus 798 rDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~ 877 (1005)
|||||+|||++.++.+||+|||++....... .........++..|+|||++....
T Consensus 162 ~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~-------------------------~~~~~~~~~~~~~y~aPE~~~~~~ 216 (304)
T cd05096 162 RDLATRNCLVGENLTIKIADFGMSRNLYAGD-------------------------YYRIQGRAVLPIRWMAWECILMGK 216 (304)
T ss_pred cCcchhheEEcCCccEEECCCccceecccCc-------------------------eeEecCcCCCCccccCHHHHhcCC
Confidence 9999999999999999999999985432110 001122334678899999998888
Q ss_pred CCChhhHHHHHHHHHHHHc--CCCCCCCCChHHHHHHHHh---C---CCCCCCCCCCCHHHHHHHHHccccCcCccCCCh
Q 001847 878 HTSAVDWWALGILLYEMLY--GYTPFRGKTRQKTFANILH---K---DLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSH 949 (1005)
Q Consensus 878 ~~~~sDIwSlGvll~eLlt--G~~Pf~~~~~~~~~~~i~~---~---~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~ 949 (1005)
++.++|||||||++|+|++ +..||.+......+..+.. . .........++..+.+|+.+||..+|.+||+
T Consensus 217 ~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs-- 294 (304)
T cd05096 217 FTTASDVWAFGVTLWEILMLCKEQPYGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPS-- 294 (304)
T ss_pred CCchhhhHHHHHHHHHHHHccCCCCCCcCCHHHHHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcC--
Confidence 9999999999999999986 6778887666555444322 1 1112223456788999999999999999999
Q ss_pred hcHHHH
Q 001847 950 EGANEI 955 (1005)
Q Consensus 950 ~~a~el 955 (1005)
+.++
T Consensus 295 --~~~i 298 (304)
T cd05096 295 --FSDI 298 (304)
T ss_pred --HHHH
Confidence 6665
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=339.79 Aligned_cols=258 Identities=22% Similarity=0.323 Sum_probs=207.1
Q ss_pred cccCCccccccccccCcEEEEEEEE-----cCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhC-CCCCcceEEEEEE
Q 001847 669 INLQHFRPIKPLGSGDTGSVHLVEL-----CGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPALYASFQ 742 (1005)
Q Consensus 669 i~~~~y~~~~~LG~G~~g~Vy~a~~-----~~~~~~valK~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~ 742 (1005)
+..++|++.+.||+|+||.||+|.+ ..++..||+|+++... .......+.+|+.+++.+ +||||+++++++.
T Consensus 32 ~~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~ 109 (375)
T cd05104 32 FPRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSA--HLTEREALMSELKVLSYLGNHINIVNLLGACT 109 (375)
T ss_pred cchHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCc--CcHHHHHHHHHHHHHHHhcCCcceeeeeeeec
Confidence 4456899999999999999999975 3457789999987542 233446788899999999 8999999999999
Q ss_pred eCCeEEEEEeccCCCchhhHHhhCC-------------------------------------------------------
Q 001847 743 TKTHVCLITDYCPGGELFLLLDRQP------------------------------------------------------- 767 (1005)
Q Consensus 743 ~~~~~~lV~E~~~ggsL~~~l~~~~------------------------------------------------------- 767 (1005)
..+..|+||||+++|+|.+++....
T Consensus 110 ~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 189 (375)
T cd05104 110 VGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSV 189 (375)
T ss_pred cCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccccc
Confidence 9999999999999999999886421
Q ss_pred ------------------CCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCCC
Q 001847 768 ------------------TKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQ 829 (1005)
Q Consensus 768 ------------------~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~ 829 (1005)
...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++........
T Consensus 190 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~ 269 (375)
T cd05104 190 RSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSN 269 (375)
T ss_pred ccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECCCcEEEecCccceeccCccc
Confidence 12478888999999999999999999999999999999999999999999999854321110
Q ss_pred CCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCChHH
Q 001847 830 LLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY-GYTPFRGKTRQK 908 (1005)
Q Consensus 830 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlGvll~eLlt-G~~Pf~~~~~~~ 908 (1005)
........++..|+|||++.+..++.++|||||||++|+|++ |..||.+.....
T Consensus 270 -------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~ 324 (375)
T cd05104 270 -------------------------YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDS 324 (375)
T ss_pred -------------------------ccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchH
Confidence 001112335678999999999899999999999999999997 999998765544
Q ss_pred HHHHHHhCCCCCCCCCCCCHHHHHHHHHccccCcCccCCChhcHHHHHc
Q 001847 909 TFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKK 957 (1005)
Q Consensus 909 ~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~ 957 (1005)
.....+............+.++.+|+.+||..||++||+ +.++++
T Consensus 325 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs----~~eil~ 369 (375)
T cd05104 325 KFYKMIKEGYRMLSPECAPSEMYDIMKSCWDADPLKRPT----FKQIVQ 369 (375)
T ss_pred HHHHHHHhCccCCCCCCCCHHHHHHHHHHccCChhHCcC----HHHHHH
Confidence 444454443333333345788999999999999999999 555553
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=338.63 Aligned_cols=264 Identities=21% Similarity=0.276 Sum_probs=214.0
Q ss_pred cccccccCCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeC
Q 001847 665 SGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTK 744 (1005)
Q Consensus 665 ~~~~i~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~ 744 (1005)
..|.|......+...||+|.||+||++.+-++ ||||++.... ..+...+.|.+|..++++-+|.||+.+.+++...
T Consensus 385 ~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whGd---VAVK~Lnv~~-pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p 460 (678)
T KOG0193|consen 385 EEWEIPPEEVLLGERIGSGSFGTVYRGRWHGD---VAVKLLNVDD-PTPEQLQAFKNEVAVLKKTRHENILLFMGACMNP 460 (678)
T ss_pred cccccCHHHhhccceeccccccceeecccccc---eEEEEEecCC-CCHHHHHHHHHHHHHHhhcchhhheeeehhhcCC
Confidence 34566777888999999999999999999554 9999998763 3556889999999999999999999999999998
Q ss_pred CeEEEEEeccCCCchhhHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCccc
Q 001847 745 THVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLT 824 (1005)
Q Consensus 745 ~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~~~g~vkL~DFG~a~~~ 824 (1005)
.. .||+.+|+|.+|+.++.... ..+.....+.|++||++|+.|||.++|||+|||..|||+.++++|||+|||++...
T Consensus 461 ~~-AIiTqwCeGsSLY~hlHv~e-tkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk 538 (678)
T KOG0193|consen 461 PL-AIITQWCEGSSLYTHLHVQE-TKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHEDLKVKIGDFGLATVK 538 (678)
T ss_pred ce-eeeehhccCchhhhhccchh-hhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEccCCcEEEecccceeee
Confidence 87 99999999999999997653 56999999999999999999999999999999999999999999999999998432
Q ss_pred CCCCCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccC---CCCCChhhHHHHHHHHHHHHcCCCCC
Q 001847 825 SCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAG---AGHTSAVDWWALGILLYEMLYGYTPF 901 (1005)
Q Consensus 825 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~---~~~~~~sDIwSlGvll~eLltG~~Pf 901 (1005)
. .+ ..........|...|||||++.. .+|++.+|||||||++|||++|.+||
T Consensus 539 ~-------------~w------------~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPy 593 (678)
T KOG0193|consen 539 T-------------RW------------SGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPY 593 (678)
T ss_pred e-------------ee------------ccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCc
Confidence 1 00 01111223458889999999865 46888999999999999999999999
Q ss_pred CCCChHHHHHHHHhCCCCC---CCCCCCCHHHHHHHHHccccCcCccCCChhcHHHHHcCC
Q 001847 902 RGKTRQKTFANILHKDLKF---PSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHP 959 (1005)
Q Consensus 902 ~~~~~~~~~~~i~~~~~~~---~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~hp 959 (1005)
.......++..+-++.... .....++.++++|+..||.+++++||.+.+++..|+.++
T Consensus 594 si~~~dqIifmVGrG~l~pd~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~ 654 (678)
T KOG0193|consen 594 SIQNRDQIIFMVGRGYLMPDLSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELL 654 (678)
T ss_pred CCCChhheEEEecccccCccchhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhh
Confidence 9554444443333331111 122346778999999999999999999877666555443
|
|
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-35 Score=320.01 Aligned_cols=250 Identities=22% Similarity=0.349 Sum_probs=209.8
Q ss_pred ccccCCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeE
Q 001847 668 QINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHV 747 (1005)
Q Consensus 668 ~i~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 747 (1005)
.+..++|++++.||+|++|.||++.+ .++..|++|.+.... .....+.+|+.+++.++|+||+++++++...+..
T Consensus 2 ~~~~~~~~~~~~lg~g~~g~v~~~~~-~~~~~v~iK~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 76 (261)
T cd05072 2 EIPRESIKLVKKLGAGQFGEVWMGYY-NNSTKVAVKTLKPGT----MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPI 76 (261)
T ss_pred cCchHHeEEeeecCCcCCceEEEEEe-cCCceEEEEEccCCc----hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCc
Confidence 45667999999999999999999997 456779999876532 2356788899999999999999999999999999
Q ss_pred EEEEeccCCCchhhHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCC
Q 001847 748 CLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCK 827 (1005)
Q Consensus 748 ~lV~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~ 827 (1005)
|++|||+.+++|.+++.......++...+..++.||+.||.|||++|++|+||||+||+++.++.++|+|||++......
T Consensus 77 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~ 156 (261)
T cd05072 77 YIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDN 156 (261)
T ss_pred EEEEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecCCCcEEECCCccceecCCC
Confidence 99999999999999997765567899999999999999999999999999999999999999999999999998553211
Q ss_pred CCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCh
Q 001847 828 PQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY-GYTPFRGKTR 906 (1005)
Q Consensus 828 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlGvll~eLlt-G~~Pf~~~~~ 906 (1005)
.. .......++..|+|||++....++.++|||||||++|+|++ |..||.+...
T Consensus 157 ~~--------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~ 210 (261)
T cd05072 157 EY--------------------------TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSN 210 (261)
T ss_pred ce--------------------------eccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCH
Confidence 00 00112345678999999988888999999999999999998 9999988777
Q ss_pred HHHHHHHHhCCCCCCCCCCCCHHHHHHHHHccccCcCccCCCh
Q 001847 907 QKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSH 949 (1005)
Q Consensus 907 ~~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~ 949 (1005)
......+... ...+....++..+.+|+.+||..+|++||++.
T Consensus 211 ~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~ 252 (261)
T cd05072 211 SDVMSALQRG-YRMPRMENCPDELYDIMKTCWKEKAEERPTFD 252 (261)
T ss_pred HHHHHHHHcC-CCCCCCCCCCHHHHHHHHHHccCCcccCcCHH
Confidence 6666665543 34444455788999999999999999999933
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-35 Score=323.21 Aligned_cols=255 Identities=27% Similarity=0.469 Sum_probs=216.1
Q ss_pred CccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEEe
Q 001847 673 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITD 752 (1005)
Q Consensus 673 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E 752 (1005)
.|...+.||.|++|.||++.+..++..+++|.+... .......+.+|+.+++.++||||+++++++...+..|+|+|
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~---~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e 96 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLR---KQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVME 96 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEecc---chhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEe
Confidence 466668999999999999999889999999988643 23344567889999999999999999999999999999999
Q ss_pred ccCCCchhhHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCCCCCC
Q 001847 753 YCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLL 832 (1005)
Q Consensus 753 ~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~~~ 832 (1005)
|+.+++|.+++.. ..++...+..++.||+.||+|||++|++||||+|+||+++.++.++|+|||.+......
T Consensus 97 ~~~~~~L~~~~~~---~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~----- 168 (285)
T cd06648 97 FLEGGALTDIVTH---TRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKE----- 168 (285)
T ss_pred ccCCCCHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCCCcEEEcccccchhhccC-----
Confidence 9999999999876 34899999999999999999999999999999999999999999999999987432210
Q ss_pred CcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHcCCCCCCCCChHHHHHH
Q 001847 833 PTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFAN 912 (1005)
Q Consensus 833 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlGvll~eLltG~~Pf~~~~~~~~~~~ 912 (1005)
........|++.|+|||.+.+..++.++|||||||++|+|++|+.||...+.......
T Consensus 169 ----------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~ 226 (285)
T cd06648 169 ----------------------VPRRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKR 226 (285)
T ss_pred ----------------------CcccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHH
Confidence 0111234688999999999888889999999999999999999999988777666666
Q ss_pred HHhCCCCCCC-CCCCCHHHHHHHHHccccCcCccCCChhcHHHHHcCCCCCCC
Q 001847 913 ILHKDLKFPS-STPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGV 964 (1005)
Q Consensus 913 i~~~~~~~~~-~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~hpff~~~ 964 (1005)
+......... ...++..+.+|+.+||..+|++||+ +.++++||||+..
T Consensus 227 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt----~~~il~~~~~~~~ 275 (285)
T cd06648 227 IRDNLPPKLKNLHKVSPRLRSFLDRMLVRDPAQRAT----AAELLNHPFLAKA 275 (285)
T ss_pred HHhcCCCCCcccccCCHHHHHHHHHHcccChhhCcC----HHHHccCcccccC
Confidence 5554322222 2236788999999999999999999 9999999999874
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=321.57 Aligned_cols=261 Identities=23% Similarity=0.381 Sum_probs=212.2
Q ss_pred CccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccC---hHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEE
Q 001847 673 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLN---RNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCL 749 (1005)
Q Consensus 673 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~---~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l 749 (1005)
+|+..+.||+|++|.||++.+..+++.+|+|.+....... ......+.+|+.+++.++|+||+++++++...+..++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 4788899999999999999999999999999987542211 2245678899999999999999999999999999999
Q ss_pred EEeccCCCchhhHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCC-cEEEEeccCCcccCCCC
Q 001847 750 ITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNG-HVSLTDFDLSCLTSCKP 828 (1005)
Q Consensus 750 V~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~~~g-~vkL~DFG~a~~~~~~~ 828 (1005)
||||+.+++|.+++... ..+++..+..++.||+.||.|||++|++|+||+|+||+++.++ .++|+|||.+.......
T Consensus 81 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~~ 158 (268)
T cd06630 81 FVEWMAGGSVSHLLSKY--GAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKG 158 (268)
T ss_pred EEeccCCCcHHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccccccccccccc
Confidence 99999999999999764 4589999999999999999999999999999999999998776 69999999985432110
Q ss_pred CCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHcCCCCCCCCChHH
Q 001847 829 QLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQK 908 (1005)
Q Consensus 829 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlGvll~eLltG~~Pf~~~~~~~ 908 (1005)
. ..........|+..|+|||.+.+..++.++|+|||||++|+|++|..||.......
T Consensus 159 ~-----------------------~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~ 215 (268)
T cd06630 159 T-----------------------GAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSN 215 (268)
T ss_pred c-----------------------cCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcc
Confidence 0 00011223468899999999988888999999999999999999999997544322
Q ss_pred HHHHH---HhCCCCCCCCCCCCHHHHHHHHHccccCcCccCCChhcHHHHHcCCCCC
Q 001847 909 TFANI---LHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFK 962 (1005)
Q Consensus 909 ~~~~i---~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~hpff~ 962 (1005)
....+ .............+..+.+++.+||..+|.+||+ +.++++||||+
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~----~~~ll~~~~~~ 268 (268)
T cd06630 216 HLALIFKIASATTAPSIPEHLSPGLRDVTLRCLELQPEDRPP----SRELLKHPVFR 268 (268)
T ss_pred hHHHHHHHhccCCCCCCchhhCHHHHHHHHHHcCCCcccCcC----HHHHhcCcccC
Confidence 22222 2222222222346788999999999999999999 99999999985
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-36 Score=338.16 Aligned_cols=265 Identities=29% Similarity=0.485 Sum_probs=234.2
Q ss_pred ccccccCCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC
Q 001847 666 GEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKT 745 (1005)
Q Consensus 666 ~~~i~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~ 745 (1005)
..+.....|.+.+.||.|.|+.|.++.+..++..||||++.+..... .....+.+|+++|+.|+|||||+++.+.....
T Consensus 50 ~~~~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~-~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~ 128 (596)
T KOG0586|consen 50 DDSNSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNP-SKRQKLGREVDIMKSLNHPNIVKLFSVIETEA 128 (596)
T ss_pred cccccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccCh-HHHHHHHHHHHHHHhcCCcceeeeeeeeeecc
Confidence 34455678999999999999999999999999999999999875544 44455899999999999999999999999999
Q ss_pred eEEEEEeccCCCchhhHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccC
Q 001847 746 HVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTS 825 (1005)
Q Consensus 746 ~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~~~g~vkL~DFG~a~~~~ 825 (1005)
.+|+||||+.+|.+++|+.++ +.+.+..++.++.|++.|++|||+++|||||||++|||++.+-++||+|||++....
T Consensus 129 ~lylV~eya~~ge~~~yl~~~--gr~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~ 206 (596)
T KOG0586|consen 129 TLYLVMEYASGGELFDYLVKH--GRMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDENMNIKIADFGFSTFFD 206 (596)
T ss_pred eeEEEEEeccCchhHHHHHhc--ccchhhhhhhhhHHHHHHHHHHhhcceeccccchhhcccccccceeeeccccceeec
Confidence 999999999999999999876 447889999999999999999999999999999999999999999999999985433
Q ss_pred CCCCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCC-CChhhHHHHHHHHHHHHcCCCCCCCC
Q 001847 826 CKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGH-TSAVDWWALGILLYEMLYGYTPFRGK 904 (1005)
Q Consensus 826 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~-~~~sDIwSlGvll~eLltG~~Pf~~~ 904 (1005)
......+.||++.|.|||++.+..+ ++.+|+||||++||.|++|.+||.+.
T Consensus 207 ----------------------------~~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~ 258 (596)
T KOG0586|consen 207 ----------------------------YGLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQ 258 (596)
T ss_pred ----------------------------ccccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCc
Confidence 2233457899999999999988765 56999999999999999999999999
Q ss_pred ChHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHccccCcCccCCChhcHHHHHcCCCCCCCChh
Q 001847 905 TRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVNWA 967 (1005)
Q Consensus 905 ~~~~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~hpff~~~~~~ 967 (1005)
+-.+.-...+.+.+.++.. ++-++.+||+++|..+|.+|++ ++++..|.|.....-.
T Consensus 259 ~lk~Lr~rvl~gk~rIp~~--ms~dce~lLrk~lvl~Pskr~~----~dqim~~~W~n~~~~~ 315 (596)
T KOG0586|consen 259 NLKELRPRVLRGKYRIPFY--MSCDCEDLLRKFLVLNPSKRGP----CDQIMKDRWRNDLLEA 315 (596)
T ss_pred ccccccchheeeeecccce--eechhHHHHHHhhccCccccCC----HHHhhhhcccchhhhh
Confidence 8888877888877766655 5667899999999999999999 9999999999864433
|
|
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-35 Score=323.62 Aligned_cols=261 Identities=26% Similarity=0.391 Sum_probs=208.6
Q ss_pred CCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHH-HHhCCCCCcceEEEEEEeCCeEEEE
Q 001847 672 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREI-LDMLDHPFVPALYASFQTKTHVCLI 750 (1005)
Q Consensus 672 ~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~i-l~~l~hpnIv~l~~~~~~~~~~~lV 750 (1005)
++|++++.||+|+||.||++.+..+|+.||+|.+..... ......+..|+.+ ++.++||||+++++++...+.+|++
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv 78 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVN--SQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWIC 78 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCC--cHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEE
Confidence 479999999999999999999999999999999876422 1223445556654 6667999999999999999999999
Q ss_pred EeccCCCchhhHHhhC--CCCCCCHHHHHHHHHHHHHHHHHHHHc-CcccCCCCCCcEEEecCCcEEEEeccCCcccCCC
Q 001847 751 TDYCPGGELFLLLDRQ--PTKVLKEDAVRFYAAEVVVALEYLHCQ-GIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCK 827 (1005)
Q Consensus 751 ~E~~~ggsL~~~l~~~--~~~~l~~~~i~~i~~qil~aL~~LH~~-gIvHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~ 827 (1005)
|||+ .++|.+++... ....+++..++.++.||+.||.|||++ +++||||||+||+++.++.+||+|||++......
T Consensus 79 ~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~ 157 (283)
T cd06617 79 MEVM-DTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDS 157 (283)
T ss_pred hhhh-cccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecccccccccc
Confidence 9999 57888777542 234689999999999999999999997 9999999999999999999999999998543210
Q ss_pred CCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccC----CCCCChhhHHHHHHHHHHHHcCCCCCCC
Q 001847 828 PQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAG----AGHTSAVDWWALGILLYEMLYGYTPFRG 903 (1005)
Q Consensus 828 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~----~~~~~~sDIwSlGvll~eLltG~~Pf~~ 903 (1005)
.......|+..|+|||.+.+ ..++.++|+|||||++|+|++|+.||..
T Consensus 158 ----------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~ 209 (283)
T cd06617 158 ----------------------------VAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDS 209 (283)
T ss_pred ----------------------------cccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCc
Confidence 01122457889999998865 3457899999999999999999999965
Q ss_pred C-ChHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHccccCcCccCCChhcHHHHHcCCCCCCCChh
Q 001847 904 K-TRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVNWA 967 (1005)
Q Consensus 904 ~-~~~~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~hpff~~~~~~ 967 (1005)
. ...+.+..+............++.++.+||.+||..+|.+||+ +.++++||||......
T Consensus 210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~----~~~il~~~~~~~~~~~ 270 (283)
T cd06617 210 WKTPFQQLKQVVEEPSPQLPAEKFSPEFQDFVNKCLKKNYKERPN----YPELLQHPFFELHLSK 270 (283)
T ss_pred cccCHHHHHHHHhcCCCCCCccccCHHHHHHHHHHccCChhhCcC----HHHHhcCchhhhcccc
Confidence 3 3334444444433222222346788999999999999999999 9999999999986433
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-35 Score=318.87 Aligned_cols=258 Identities=29% Similarity=0.480 Sum_probs=219.4
Q ss_pred CCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEE
Q 001847 672 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLIT 751 (1005)
Q Consensus 672 ~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~ 751 (1005)
++|++.+.||.|++|.||+|.+..+++.|++|.+..... ......+.+|+.++..++|+||+++++++...+..++||
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 78 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGD--EEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVL 78 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcc--hHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEE
Confidence 368999999999999999999999999999999876532 245678889999999999999999999999999999999
Q ss_pred eccCCCchhhHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHH-cCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCCCC
Q 001847 752 DYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHC-QGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQL 830 (1005)
Q Consensus 752 E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~-~gIvHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~ 830 (1005)
||+++++|.+++... ..+++..+..++.||+.||.|||+ .|++|+||+|+||+++.++.++|+|||++.......
T Consensus 79 e~~~~~~L~~~l~~~--~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~-- 154 (264)
T cd06623 79 EYMDGGSLADLLKKV--GKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTL-- 154 (264)
T ss_pred EecCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCCCCEEEccCccceecccCC--
Confidence 999999999999764 458999999999999999999999 999999999999999999999999999885432111
Q ss_pred CCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHcCCCCCCCCC---hH
Q 001847 831 LLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKT---RQ 907 (1005)
Q Consensus 831 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlGvll~eLltG~~Pf~~~~---~~ 907 (1005)
.......++..|+|||.+....++.++|+||||+++|+|++|..||.... ..
T Consensus 155 -------------------------~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~ 209 (264)
T cd06623 155 -------------------------DQCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFF 209 (264)
T ss_pred -------------------------CcccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHH
Confidence 01123457889999999988888899999999999999999999997763 34
Q ss_pred HHHHHHHhCCCCCCCCCC-CCHHHHHHHHHccccCcCccCCChhcHHHHHcCCCCCCCC
Q 001847 908 KTFANILHKDLKFPSSTP-TSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVN 965 (1005)
Q Consensus 908 ~~~~~i~~~~~~~~~~~~-~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~hpff~~~~ 965 (1005)
.....+...... ..... ++..+.++|.+||..+|++||+ +.++++||||+.++
T Consensus 210 ~~~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~~p~~R~~----~~~ll~~~~~~~~~ 263 (264)
T cd06623 210 ELMQAICDGPPP-SLPAEEFSPEFRDFISACLQKDPKKRPS----AAELLQHPFIKKAD 263 (264)
T ss_pred HHHHHHhcCCCC-CCCcccCCHHHHHHHHHHccCChhhCCC----HHHHHhCHHHHhcc
Confidence 444444433322 22233 6788999999999999999999 99999999998764
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-35 Score=326.49 Aligned_cols=257 Identities=27% Similarity=0.383 Sum_probs=215.8
Q ss_pred CCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEE
Q 001847 672 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLIT 751 (1005)
Q Consensus 672 ~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~ 751 (1005)
..|++.+.||+|+||.||++.+..+++.||+|.+.............+.+|+.+++.++||||+++++++...+..|+||
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~ 94 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM 94 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence 46999999999999999999998899999999987554444555677889999999999999999999999999999999
Q ss_pred eccCCCchhhHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCCCCC
Q 001847 752 DYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLL 831 (1005)
Q Consensus 752 E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~~ 831 (1005)
||+. ++|.+++... ...+++..+..++.||+.||.|||+.||+|+||+|+||+++.++.++|+|||++.....
T Consensus 95 e~~~-g~l~~~~~~~-~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~----- 167 (307)
T cd06607 95 EYCL-GSASDILEVH-KKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSASLVSP----- 167 (307)
T ss_pred HhhC-CCHHHHHHHc-ccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECCCCCEEEeecCcceecCC-----
Confidence 9995 6777776543 24589999999999999999999999999999999999999999999999998744211
Q ss_pred CCcchhhhhcccCCCCCcccccccccccccccCCccccccccc---CCCCCChhhHHHHHHHHHHHHcCCCCCCCCChHH
Q 001847 832 LPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIA---GAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQK 908 (1005)
Q Consensus 832 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~---~~~~~~~sDIwSlGvll~eLltG~~Pf~~~~~~~ 908 (1005)
.....+++.|+|||++. ...++.++||||||+++|+|++|..||.+.+...
T Consensus 168 --------------------------~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~ 221 (307)
T cd06607 168 --------------------------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS 221 (307)
T ss_pred --------------------------CCCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHH
Confidence 11245788999999874 3457789999999999999999999998877666
Q ss_pred HHHHHHhCCCCCCCCCCCCHHHHHHHHHccccCcCccCCChhcHHHHHcCCCCCCCC
Q 001847 909 TFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVN 965 (1005)
Q Consensus 909 ~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~hpff~~~~ 965 (1005)
....+.............+..+.+||.+||..+|++||+ +.+++.||||....
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~----~~~il~~~~~~~~~ 274 (307)
T cd06607 222 ALYHIAQNDSPTLSSNDWSDYFRNFVDSCLQKIPQDRPS----SEELLKHRFVLRER 274 (307)
T ss_pred HHHHHhcCCCCCCCchhhCHHHHHHHHHHhcCChhhCcC----HHHHhcChhhcccC
Confidence 555554443322222345778999999999999999999 99999999998743
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-35 Score=321.71 Aligned_cols=258 Identities=28% Similarity=0.397 Sum_probs=217.5
Q ss_pred CCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEE
Q 001847 672 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLIT 751 (1005)
Q Consensus 672 ~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~ 751 (1005)
..|+.++.||.|+||.||++.+..++..+|+|.+.... .......+.+|+.+++.+.|+||+++++++...+..|+||
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEE--AEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIM 81 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccc--cHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence 36889999999999999999998899999999987542 2344577889999999999999999999999999999999
Q ss_pred eccCCCchhhHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCCCCC
Q 001847 752 DYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLL 831 (1005)
Q Consensus 752 E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~~ 831 (1005)
||+.+++|.+++.. ..++...+..++.|++.||.|||+++++|+||+|+||+++.++.++|+|||++.......
T Consensus 82 e~~~~~~L~~~i~~---~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~--- 155 (277)
T cd06640 82 EYLGGGSALDLLRA---GPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ--- 155 (277)
T ss_pred ecCCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCCCCEEEcccccceeccCCc---
Confidence 99999999999865 348899999999999999999999999999999999999999999999999985432110
Q ss_pred CCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHcCCCCCCCCChHHHHH
Q 001847 832 LPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFA 911 (1005)
Q Consensus 832 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlGvll~eLltG~~Pf~~~~~~~~~~ 911 (1005)
.......++..|+|||++.+..++.++|+|||||++|+|++|..||.+........
T Consensus 156 ------------------------~~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~ 211 (277)
T cd06640 156 ------------------------IKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLF 211 (277)
T ss_pred ------------------------cccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhh
Confidence 01123457889999999988888999999999999999999999998877665554
Q ss_pred HHHhCCCCCCCCCCCCHHHHHHHHHccccCcCccCCChhcHHHHHcCCCCCCCCh
Q 001847 912 NILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVNW 966 (1005)
Q Consensus 912 ~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~hpff~~~~~ 966 (1005)
.+.....+ ......+..+.+|+.+||..+|++||+ +.++++|+||.....
T Consensus 212 ~~~~~~~~-~~~~~~~~~~~~li~~~l~~~p~~Rp~----~~~il~~~~~~~~~~ 261 (277)
T cd06640 212 LIPKNNPP-TLTGEFSKPFKEFIDACLNKDPSFRPT----AKELLKHKFIVKNAK 261 (277)
T ss_pred hhhcCCCC-CCchhhhHHHHHHHHHHcccCcccCcC----HHHHHhChHhhhcch
Confidence 44333221 112235678899999999999999999 999999999987543
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-35 Score=315.94 Aligned_cols=255 Identities=30% Similarity=0.453 Sum_probs=214.2
Q ss_pred CccccccccccCcEEEEEEEEcCCCeEEEEEEeecccc--cChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEE
Q 001847 673 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVM--LNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLI 750 (1005)
Q Consensus 673 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~~~~~~~--~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV 750 (1005)
+|+..+.||+|++|.||++.+..++..|++|.+..... ........+.+|+.+++.++|+||+++++++.....+|++
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 47888999999999999999988899999999875422 1234557788999999999999999999999999999999
Q ss_pred EeccCCCchhhHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCCCC
Q 001847 751 TDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQL 830 (1005)
Q Consensus 751 ~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~ 830 (1005)
|||+++++|.+++... ..+++..+..++.||+.||+|||+.|++|+||+|+||+++.++.+||+|||++.......
T Consensus 81 ~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~-- 156 (258)
T cd06632 81 LELVPGGSLAKLLKKY--GSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFS-- 156 (258)
T ss_pred EEecCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccceeccccc--
Confidence 9999999999999764 358899999999999999999999999999999999999999999999999875432110
Q ss_pred CCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCC-CCChhhHHHHHHHHHHHHcCCCCCCCCChHHH
Q 001847 831 LLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAG-HTSAVDWWALGILLYEMLYGYTPFRGKTRQKT 909 (1005)
Q Consensus 831 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~-~~~~sDIwSlGvll~eLltG~~Pf~~~~~~~~ 909 (1005)
......|++.|++||.+.... ++.++|+|||||++|+|++|..||........
T Consensus 157 --------------------------~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~ 210 (258)
T cd06632 157 --------------------------FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAA 210 (258)
T ss_pred --------------------------cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHH
Confidence 112346889999999987766 88899999999999999999999987665555
Q ss_pred HHHHHhCCCCCCCCCCCCHHHHHHHHHccccCcCccCCChhcHHHHHcCCCC
Q 001847 910 FANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFF 961 (1005)
Q Consensus 910 ~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~hpff 961 (1005)
...+............++..+.+|+.+||..+|++||+ +.+++.|||+
T Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~----~~~~l~~~~~ 258 (258)
T cd06632 211 VFKIGRSKELPPIPDHLSDEAKDFILKCLQRDPSLRPT----AAELLEHPFV 258 (258)
T ss_pred HHHHHhcccCCCcCCCcCHHHHHHHHHHhhcCcccCcC----HHHHhcCCCC
Confidence 54444322111222346788999999999999999999 9999999996
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-35 Score=322.81 Aligned_cols=257 Identities=28% Similarity=0.386 Sum_probs=210.6
Q ss_pred cCCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhC-CCCCcceEEEEEEeC-----
Q 001847 671 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPALYASFQTK----- 744 (1005)
Q Consensus 671 ~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~----- 744 (1005)
.++|.+.+.||+|+||.||++.+..+++.+|+|.+.... .....+..|+.+++++ +|||++++++++...
T Consensus 21 ~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~----~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~ 96 (291)
T cd06639 21 TDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS----DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVG 96 (291)
T ss_pred CCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc----cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCC
Confidence 468999999999999999999999999999999986431 2235567789999998 899999999998753
Q ss_pred CeEEEEEeccCCCchhhHHhh--CCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCc
Q 001847 745 THVCLITDYCPGGELFLLLDR--QPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSC 822 (1005)
Q Consensus 745 ~~~~lV~E~~~ggsL~~~l~~--~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~~~g~vkL~DFG~a~ 822 (1005)
+..|+||||+++++|.+++.. .....+++..++.++.|++.||.|||+.|++|+||||+||+++.++.+||+|||++.
T Consensus 97 ~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~~~~~kl~dfg~~~ 176 (291)
T cd06639 97 GQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSA 176 (291)
T ss_pred CeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEeecccch
Confidence 368999999999999998863 223468999999999999999999999999999999999999999999999999885
Q ss_pred ccCCCCCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCC-----CCChhhHHHHHHHHHHHHcC
Q 001847 823 LTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAG-----HTSAVDWWALGILLYEMLYG 897 (1005)
Q Consensus 823 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~-----~~~~sDIwSlGvll~eLltG 897 (1005)
...... .......|+..|+|||.+.... ++.++|||||||++|+|++|
T Consensus 177 ~~~~~~---------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g 229 (291)
T cd06639 177 QLTSTR---------------------------LRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDG 229 (291)
T ss_pred hccccc---------------------------ccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhC
Confidence 432110 0112346888999999985432 57899999999999999999
Q ss_pred CCCCCCCChHHHHHHHHhCCCC-CCCCCCCCHHHHHHHHHccccCcCccCCChhcHHHHHcCCCCC
Q 001847 898 YTPFRGKTRQKTFANILHKDLK-FPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFK 962 (1005)
Q Consensus 898 ~~Pf~~~~~~~~~~~i~~~~~~-~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~hpff~ 962 (1005)
+.||........+..+...... .......+..+.+||.+||..+|++||+ +.++++||||+
T Consensus 230 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps----~~~il~~~~~~ 291 (291)
T cd06639 230 DPPLFDMHPVKTLFKIPRNPPPTLLHPEKWCRSFNHFISQCLIKDFEARPS----VTHLLEHPFIK 291 (291)
T ss_pred CCCCCCCcHHHHHHHHhcCCCCCCCcccccCHHHHHHHHHHhhcChhhCcC----HHHHhcCcccC
Confidence 9999887766665555544221 2222335678999999999999999999 99999999995
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=325.85 Aligned_cols=256 Identities=28% Similarity=0.415 Sum_probs=209.6
Q ss_pred CCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEE
Q 001847 672 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLIT 751 (1005)
Q Consensus 672 ~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~ 751 (1005)
++|++++.||+|+||.||+|.+..+++.||+|.+..... .......+.+|+++++.++||||+++++++...+..|+||
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 79 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESED-DKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVF 79 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccC-cchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEE
Confidence 369999999999999999999988999999998875432 2234456778999999999999999999999999999999
Q ss_pred eccCCCchhhHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCCCCC
Q 001847 752 DYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLL 831 (1005)
Q Consensus 752 E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~~ 831 (1005)
||+.+++|..+.... ..++...++.++.||+.||.|||+.|++|+||+|+||++++++.++|+|||++.......
T Consensus 80 e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~--- 154 (286)
T cd07846 80 EFVDHTVLDDLEKYP--NGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG--- 154 (286)
T ss_pred ecCCccHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCc---
Confidence 999988888776543 348999999999999999999999999999999999999999999999999885432110
Q ss_pred CCcchhhhhcccCCCCCcccccccccccccccCCcccccccccC-CCCCChhhHHHHHHHHHHHHcCCCCCCCCChHHHH
Q 001847 832 LPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAG-AGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTF 910 (1005)
Q Consensus 832 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~sDIwSlGvll~eLltG~~Pf~~~~~~~~~ 910 (1005)
.......++..|+|||++.+ ..++.++|||||||++|+|++|..||.+....+..
T Consensus 155 ------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~ 210 (286)
T cd07846 155 ------------------------EVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQL 210 (286)
T ss_pred ------------------------cccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHH
Confidence 11123467889999999875 34678999999999999999999999876654444
Q ss_pred HHHHhC-------------------CCCCCC----------CCCCCHHHHHHHHHccccCcCccCCChhcHHHHHcCCCC
Q 001847 911 ANILHK-------------------DLKFPS----------STPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFF 961 (1005)
Q Consensus 911 ~~i~~~-------------------~~~~~~----------~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~hpff 961 (1005)
..+... ....+. ...++..+.+|+.+||..+|++||+ +.++++||||
T Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~----~~~il~~~~~ 286 (286)
T cd07846 211 YHIIKCLGNLIPRHQEIFQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPS----SSQLLHHEFF 286 (286)
T ss_pred HHHHHHhCCCchhhHHHhccchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchh----HHHHhcCCCC
Confidence 333320 001110 1245778999999999999999999 9999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-35 Score=324.18 Aligned_cols=261 Identities=23% Similarity=0.367 Sum_probs=211.8
Q ss_pred CCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEE
Q 001847 672 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLIT 751 (1005)
Q Consensus 672 ~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~ 751 (1005)
++|++.+.||.|++|.||++.+..+++.||+|.+..... .......+.+|+.++++++||||+++++++......|+||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 80 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQE-DEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVF 80 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccc-cccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEE
Confidence 579999999999999999999998999999998865422 2233456778999999999999999999999999999999
Q ss_pred eccCCCchhhHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEec-CCcEEEEeccCCcccCCCCCC
Q 001847 752 DYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQG-NGHVSLTDFDLSCLTSCKPQL 830 (1005)
Q Consensus 752 E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~~-~g~vkL~DFG~a~~~~~~~~~ 830 (1005)
||+ +++|.+.+.......+++..++.++.||+.||.|||++|++|+||+|+||+++. ++.+||+|||++.......
T Consensus 81 e~~-~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~-- 157 (294)
T PLN00009 81 EYL-DLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPV-- 157 (294)
T ss_pred ecc-cccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEECCCCEEEEcccccccccCCCc--
Confidence 999 568888876654445788999999999999999999999999999999999985 5679999999885432110
Q ss_pred CCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCC-CCCChhhHHHHHHHHHHHHcCCCCCCCCChHHH
Q 001847 831 LLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGA-GHTSAVDWWALGILLYEMLYGYTPFRGKTRQKT 909 (1005)
Q Consensus 831 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~sDIwSlGvll~eLltG~~Pf~~~~~~~~ 909 (1005)
.......+++.|+|||++.+. .++.++|||||||++|+|++|+.||........
T Consensus 158 -------------------------~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~ 212 (294)
T PLN00009 158 -------------------------RTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDE 212 (294)
T ss_pred -------------------------cccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 011223578899999998664 568899999999999999999999988776655
Q ss_pred HHHHHhCC--C-------------------CCC------CCCCCCHHHHHHHHHccccCcCccCCChhcHHHHHcCCCCC
Q 001847 910 FANILHKD--L-------------------KFP------SSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFK 962 (1005)
Q Consensus 910 ~~~i~~~~--~-------------------~~~------~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~hpff~ 962 (1005)
+..+.... . .++ .....+..+.++|.+||..+|++||+ +.++++||||+
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps----~~~~l~~~~~~ 288 (294)
T PLN00009 213 LFKIFRILGTPNEETWPGVTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRIT----ARAALEHEYFK 288 (294)
T ss_pred HHHHHHHhCCCChhhccccccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcC----HHHHhcCchHh
Confidence 55443210 0 000 01235778899999999999999999 99999999999
Q ss_pred CCC
Q 001847 963 GVN 965 (1005)
Q Consensus 963 ~~~ 965 (1005)
.+.
T Consensus 289 ~~~ 291 (294)
T PLN00009 289 DLG 291 (294)
T ss_pred HHh
Confidence 753
|
|
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-35 Score=322.96 Aligned_cols=256 Identities=26% Similarity=0.384 Sum_probs=207.9
Q ss_pred cCCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhC-CCCCcceEEEEEE-----eC
Q 001847 671 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPALYASFQ-----TK 744 (1005)
Q Consensus 671 ~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~-----~~ 744 (1005)
.++|++++.||+|+||.||+|.+..+++.+|+|++.... .....+.+|+.+++.+ +|+||+++++++. ..
T Consensus 17 ~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~----~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~ 92 (286)
T cd06638 17 SDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH----DIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNG 92 (286)
T ss_pred ccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc----chHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCC
Confidence 568999999999999999999999999999999876431 1234567899999999 7999999999874 34
Q ss_pred CeEEEEEeccCCCchhhHHhh--CCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCc
Q 001847 745 THVCLITDYCPGGELFLLLDR--QPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSC 822 (1005)
Q Consensus 745 ~~~~lV~E~~~ggsL~~~l~~--~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~~~g~vkL~DFG~a~ 822 (1005)
+.+|+||||+++++|.+++.. .....+++..+..++.|++.||.|||+.+|+||||||+||+++.++.++|+|||++.
T Consensus 93 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~ 172 (286)
T cd06638 93 DQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSA 172 (286)
T ss_pred CeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECCCCCEEEccCCcee
Confidence 678999999999999998753 223458899999999999999999999999999999999999999999999999885
Q ss_pred ccCCCCCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccC-----CCCCChhhHHHHHHHHHHHHcC
Q 001847 823 LTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAG-----AGHTSAVDWWALGILLYEMLYG 897 (1005)
Q Consensus 823 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-----~~~~~~sDIwSlGvll~eLltG 897 (1005)
...... .......|++.|+|||++.. ..++.++|||||||++|+|++|
T Consensus 173 ~~~~~~---------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g 225 (286)
T cd06638 173 QLTSTR---------------------------LRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDG 225 (286)
T ss_pred ecccCC---------------------------CccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcC
Confidence 432110 01123468999999999853 3467899999999999999999
Q ss_pred CCCCCCCChHHHHHHHHhCC-CCCCCCCCCCHHHHHHHHHccccCcCccCCChhcHHHHHcCCCC
Q 001847 898 YTPFRGKTRQKTFANILHKD-LKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFF 961 (1005)
Q Consensus 898 ~~Pf~~~~~~~~~~~i~~~~-~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~hpff 961 (1005)
+.||........+..+.... .........+..+.+||.+||+.+|++||+ +.++++|+||
T Consensus 226 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps----~~ell~~~~~ 286 (286)
T cd06638 226 DPPLADLHPMRALFKIPRNPPPTLHQPELWSNEFNDFIRKCLTKDYEKRPT----VSDLLQHVFI 286 (286)
T ss_pred CCCCCCCchhHHHhhccccCCCcccCCCCcCHHHHHHHHHHccCCcccCCC----HHHHhhcccC
Confidence 99998776555444433322 112222335678999999999999999999 9999999997
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-35 Score=319.36 Aligned_cols=258 Identities=27% Similarity=0.428 Sum_probs=211.3
Q ss_pred CccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccC-------hHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC
Q 001847 673 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLN-------RNKVHRACAEREILDMLDHPFVPALYASFQTKT 745 (1005)
Q Consensus 673 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~-------~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~ 745 (1005)
+|.+.+.||.|++|.||++.+..+++.+|+|.++...... ....+.+..|+.+++.++|+||+++++++...+
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 5888999999999999999998899999999886431111 112356778999999999999999999999999
Q ss_pred eEEEEEeccCCCchhhHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccC
Q 001847 746 HVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTS 825 (1005)
Q Consensus 746 ~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~~~g~vkL~DFG~a~~~~ 825 (1005)
.+++||||+.+++|.+++... ..++...++.++.||+.||.|||++|++|+||+|+||+++.++.++|+|||++....
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~~~~~~l~d~~~~~~~~ 159 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTY--GRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGICKISDFGISKKSD 159 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcCCCeEEEeecccccccc
Confidence 999999999999999999765 458999999999999999999999999999999999999999999999999885432
Q ss_pred CCCCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCC--CCChhhHHHHHHHHHHHHcCCCCCCC
Q 001847 826 CKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAG--HTSAVDWWALGILLYEMLYGYTPFRG 903 (1005)
Q Consensus 826 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~--~~~~sDIwSlGvll~eLltG~~Pf~~ 903 (1005)
.... ........|+..|+|||.+.... ++.++|+||||+++|++++|..||..
T Consensus 160 ~~~~-------------------------~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~ 214 (272)
T cd06629 160 DIYD-------------------------NDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSD 214 (272)
T ss_pred cccc-------------------------ccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcC
Confidence 1100 00112346889999999987654 78899999999999999999999976
Q ss_pred CChHHHHHHHHhCC--CCCCC--CCCCCHHHHHHHHHccccCcCccCCChhcHHHHHcCCCC
Q 001847 904 KTRQKTFANILHKD--LKFPS--STPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFF 961 (1005)
Q Consensus 904 ~~~~~~~~~i~~~~--~~~~~--~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~hpff 961 (1005)
.........+.... ..++. ...++..+.+||.+||..+|++||+ +.++|+||||
T Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps----~~~il~~~~~ 272 (272)
T cd06629 215 EEAIAAMFKLGNKRSAPPIPPDVSMNLSPVALDFLNACFTINPDNRPT----ARELLQHPFI 272 (272)
T ss_pred cchHHHHHHhhccccCCcCCccccccCCHHHHHHHHHHhcCChhhCCC----HHHHhhCCCC
Confidence 65554444433222 12222 1345788999999999999999999 9999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-35 Score=321.71 Aligned_cols=257 Identities=27% Similarity=0.458 Sum_probs=213.7
Q ss_pred CccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCC---CCCcceEEEEEEeCCeEEE
Q 001847 673 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLD---HPFVPALYASFQTKTHVCL 749 (1005)
Q Consensus 673 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~il~~l~---hpnIv~l~~~~~~~~~~~l 749 (1005)
.|++++.||.|+||.||++.+..+++.|++|.+.... .......+.+|+.+++.+. |||++++++++......|+
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~l 79 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDT--PDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWI 79 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCC--CchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEE
Confidence 5888999999999999999999999999999987542 2334567788999999996 9999999999999999999
Q ss_pred EEeccCCCchhhHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCCC
Q 001847 750 ITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQ 829 (1005)
Q Consensus 750 V~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~ 829 (1005)
||||+++++|.+++... .+++..+..++.||+.||.|||+.||+|+||+|+||+++.++.++|+|||++.......
T Consensus 80 v~e~~~~~~L~~~~~~~---~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~- 155 (277)
T cd06917 80 IMEYAEGGSVRTLMKAG---PIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNS- 155 (277)
T ss_pred EEecCCCCcHHHHHHcc---CCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcCCCCEEEccCCceeecCCCc-
Confidence 99999999999998653 58999999999999999999999999999999999999999999999999885432110
Q ss_pred CCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccC-CCCCChhhHHHHHHHHHHHHcCCCCCCCCChHH
Q 001847 830 LLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAG-AGHTSAVDWWALGILLYEMLYGYTPFRGKTRQK 908 (1005)
Q Consensus 830 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~sDIwSlGvll~eLltG~~Pf~~~~~~~ 908 (1005)
.......|+..|+|||.+.+ ..++.++|+|||||++|+|++|..||.+.....
T Consensus 156 --------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~ 209 (277)
T cd06917 156 --------------------------SKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFR 209 (277)
T ss_pred --------------------------cccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhh
Confidence 11223468899999999865 446889999999999999999999998876655
Q ss_pred HHHHHHhCCCCCCCCCCCCHHHHHHHHHccccCcCccCCChhcHHHHHcCCCCCCCC
Q 001847 909 TFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVN 965 (1005)
Q Consensus 909 ~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~hpff~~~~ 965 (1005)
....+.....+.......+.++.+|+.+||..||++||+ +.++++|+||+...
T Consensus 210 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~----~~~il~~~~~~~~~ 262 (277)
T cd06917 210 AMMLIPKSKPPRLEDNGYSKLLREFVAACLDEEPKERLS----AEELLKSKWIKAHS 262 (277)
T ss_pred hhhccccCCCCCCCcccCCHHHHHHHHHHcCCCcccCcC----HHHHhhChHhhccc
Confidence 444333322221112236788999999999999999999 99999999998753
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=325.78 Aligned_cols=257 Identities=27% Similarity=0.402 Sum_probs=215.8
Q ss_pred CCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEE
Q 001847 672 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLIT 751 (1005)
Q Consensus 672 ~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~ 751 (1005)
..|+.++.||.|+||.||++.+..++..+|+|.+.... .......+.+|+.+++.++||||+++++++...+..|+||
T Consensus 4 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (277)
T cd06642 4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEE--AEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIM 81 (277)
T ss_pred HHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEecccc--chHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEE
Confidence 35888999999999999999998899999999987542 2334567889999999999999999999999999999999
Q ss_pred eccCCCchhhHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCCCCC
Q 001847 752 DYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLL 831 (1005)
Q Consensus 752 E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~~ 831 (1005)
||+.+++|.+++.. ..+++..++.++.||+.||.|||++|++|+||+|+||+++.++.++|+|||++.......
T Consensus 82 e~~~~~~L~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~--- 155 (277)
T cd06642 82 EYLGGGSALDLLKP---GPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ--- 155 (277)
T ss_pred EccCCCcHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCCCCEEEccccccccccCcc---
Confidence 99999999998864 358999999999999999999999999999999999999999999999999885432110
Q ss_pred CCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHcCCCCCCCCChHHHHH
Q 001847 832 LPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFA 911 (1005)
Q Consensus 832 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlGvll~eLltG~~Pf~~~~~~~~~~ 911 (1005)
.......|+..|+|||++.+..++.++|+|||||++|+|++|..||..........
T Consensus 156 ------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~ 211 (277)
T cd06642 156 ------------------------IKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLF 211 (277)
T ss_pred ------------------------hhhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHh
Confidence 01123467889999999988888999999999999999999999997766555444
Q ss_pred HHHhCCCCCCCCCCCCHHHHHHHHHccccCcCccCCChhcHHHHHcCCCCCCCC
Q 001847 912 NILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVN 965 (1005)
Q Consensus 912 ~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~hpff~~~~ 965 (1005)
.+...... ......+..+.+||.+||..+|++||+ +.++++||||..+.
T Consensus 212 ~~~~~~~~-~~~~~~~~~~~~li~~~l~~~p~~Rp~----~~~il~~~~~~~~~ 260 (277)
T cd06642 212 LIPKNSPP-TLEGQYSKPFKEFVEACLNKDPRFRPT----AKELLKHKFITRYT 260 (277)
T ss_pred hhhcCCCC-CCCcccCHHHHHHHHHHccCCcccCcC----HHHHHHhHHHHHHh
Confidence 43333221 112346778999999999999999999 99999999998644
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-35 Score=332.31 Aligned_cols=261 Identities=24% Similarity=0.358 Sum_probs=207.8
Q ss_pred cccccCCccccccccccCcEEEEEEEEcC-----CCeEEEEEEeecccccChHHHHHHHHHHHHHHhC-CCCCcceEEEE
Q 001847 667 EQINLQHFRPIKPLGSGDTGSVHLVELCG-----SGQYFAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPALYAS 740 (1005)
Q Consensus 667 ~~i~~~~y~~~~~LG~G~~g~Vy~a~~~~-----~~~~valK~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~ 740 (1005)
|++..++|++++.||.|+||.||+|.+.. +++.||+|.+.... .......+..|+.++.++ +|+||++++++
T Consensus 2 ~~~~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~E~~~~~~l~~h~niv~~~~~ 79 (337)
T cd05054 2 WEFPRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGA--TASEYKALMTELKILIHIGHHLNVVNLLGA 79 (337)
T ss_pred cccCHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCC--CHHHHHHHHHHHHHHHhhccCcchhheeee
Confidence 34556789999999999999999997543 35789999987532 233446677899999999 89999999998
Q ss_pred EEe-CCeEEEEEeccCCCchhhHHhhCCC---------------------------------------------------
Q 001847 741 FQT-KTHVCLITDYCPGGELFLLLDRQPT--------------------------------------------------- 768 (1005)
Q Consensus 741 ~~~-~~~~~lV~E~~~ggsL~~~l~~~~~--------------------------------------------------- 768 (1005)
+.. ...++++|||+++++|.+++.....
T Consensus 80 ~~~~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (337)
T cd05054 80 CTKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEED 159 (337)
T ss_pred EecCCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccc
Confidence 764 4678999999999999998864221
Q ss_pred --------CCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCCCCCCCcchhhhh
Q 001847 769 --------KVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKR 840 (1005)
Q Consensus 769 --------~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~ 840 (1005)
..++...+..++.||+.||.|||++||+||||||+|||++.++.++|+|||++........
T Consensus 160 ~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~----------- 228 (337)
T cd05054 160 EEGDELYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPD----------- 228 (337)
T ss_pred hhhhHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcc-----------
Confidence 2578999999999999999999999999999999999999999999999999865321110
Q ss_pred cccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHhCCCC
Q 001847 841 RHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY-GYTPFRGKTRQKTFANILHKDLK 919 (1005)
Q Consensus 841 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlGvll~eLlt-G~~Pf~~~~~~~~~~~i~~~~~~ 919 (1005)
........++..|+|||++.+..++.++|||||||++|+|++ |..||.+....+.+...+.....
T Consensus 229 --------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~ 294 (337)
T cd05054 229 --------------YVRKGDARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTR 294 (337)
T ss_pred --------------hhhccCCCCCccccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccCC
Confidence 001123456778999999999999999999999999999997 99999875544444444444333
Q ss_pred CCCCCCCCHHHHHHHHHccccCcCccCCChhcHHHHHcC
Q 001847 920 FPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKH 958 (1005)
Q Consensus 920 ~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~h 958 (1005)
.......+.++.+++.+||+.+|++||+ +.++++|
T Consensus 295 ~~~~~~~~~~~~~l~~~cl~~~p~~RPs----~~ell~~ 329 (337)
T cd05054 295 MRAPEYATPEIYSIMLDCWHNNPEDRPT----FSELVEI 329 (337)
T ss_pred CCCCccCCHHHHHHHHHHccCChhhCcC----HHHHHHH
Confidence 3333456788999999999999999999 6666653
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-35 Score=325.58 Aligned_cols=259 Identities=27% Similarity=0.407 Sum_probs=212.0
Q ss_pred CccccccccccCcEEEEEEEEcCCCeEEEEEEeeccccc--ChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEE
Q 001847 673 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVML--NRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLI 750 (1005)
Q Consensus 673 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~~~~~~~~--~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV 750 (1005)
+|++.+.||.|++|.||++.+..+++.|++|.+...... .......+..|+.+++.++|+||+++++++...+..|+|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 488899999999999999999889999999999865432 122345567899999999999999999999999999999
Q ss_pred EeccCCCchhhHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCCCC
Q 001847 751 TDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQL 830 (1005)
Q Consensus 751 ~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~ 830 (1005)
|||+ +++|.+++.... ..+++..+..++.||+.||.|||++|++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~e~~-~~~L~~~i~~~~-~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~-- 156 (298)
T cd07841 81 FEFM-ETDLEKVIKDKS-IVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPN-- 156 (298)
T ss_pred Eccc-CCCHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCCCCEEEccceeeeeccCCC--
Confidence 9999 999999997643 369999999999999999999999999999999999999999999999999985532110
Q ss_pred CCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccC-CCCCChhhHHHHHHHHHHHHcCCCCCCCCChHHH
Q 001847 831 LLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAG-AGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKT 909 (1005)
Q Consensus 831 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~sDIwSlGvll~eLltG~~Pf~~~~~~~~ 909 (1005)
.......+++.|+|||.+.+ ..++.++|||||||++|+|++|.+||.+......
T Consensus 157 -------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~ 211 (298)
T cd07841 157 -------------------------RKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQ 211 (298)
T ss_pred -------------------------ccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHH
Confidence 01122356788999999855 4568899999999999999999888887766555
Q ss_pred HHHHHhCCCC-----C------------------C---CCCCCCHHHHHHHHHccccCcCccCCChhcHHHHHcCCCCCC
Q 001847 910 FANILHKDLK-----F------------------P---SSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKG 963 (1005)
Q Consensus 910 ~~~i~~~~~~-----~------------------~---~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~hpff~~ 963 (1005)
+..+...-.. + + .....+..+.+||.+||.++|.+||+ +.+++.|+||++
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s----~~e~l~~~~~~~ 287 (298)
T cd07841 212 LGKIFEALGTPTEENWPGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRIT----ARQALEHPYFSN 287 (298)
T ss_pred HHHHHHHcCCCchhhhhhcccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcC----HHHHhhCccccC
Confidence 5444321000 0 0 01224678899999999999999999 999999999997
Q ss_pred C
Q 001847 964 V 964 (1005)
Q Consensus 964 ~ 964 (1005)
.
T Consensus 288 ~ 288 (298)
T cd07841 288 D 288 (298)
T ss_pred C
Confidence 4
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-35 Score=318.46 Aligned_cols=255 Identities=26% Similarity=0.377 Sum_probs=209.2
Q ss_pred CCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEE
Q 001847 672 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLIT 751 (1005)
Q Consensus 672 ~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~ 751 (1005)
++|++.+.||+|+||.||++.+..+++.||+|.+......+......+.+|+.+++.++||||+++++++...+..++||
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 57999999999999999999999999999999887644445556677889999999999999999999999999999999
Q ss_pred eccCCCchhhHHhhC--CCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCCC
Q 001847 752 DYCPGGELFLLLDRQ--PTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQ 829 (1005)
Q Consensus 752 E~~~ggsL~~~l~~~--~~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~ 829 (1005)
||+++++|.+++... ....+++..+..++.||+.||.|||++|++|+||||+||+++.++.++|+|||++.......
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~~- 160 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT- 160 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCCCCEEECccccceeccchh-
Confidence 999999999888632 23458899999999999999999999999999999999999999999999999885432110
Q ss_pred CCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCh--H
Q 001847 830 LLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTR--Q 907 (1005)
Q Consensus 830 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlGvll~eLltG~~Pf~~~~~--~ 907 (1005)
.......|++.|+|||.+.+..++.++||||||+++|+|++|+.||..... .
T Consensus 161 --------------------------~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~ 214 (267)
T cd08228 161 --------------------------TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLF 214 (267)
T ss_pred --------------------------HHHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHH
Confidence 011234688899999999888889999999999999999999999965432 2
Q ss_pred HHHHHHHhCCCCCCCCCCCCHHHHHHHHHccccCcCccCCChhcHHHHHc
Q 001847 908 KTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKK 957 (1005)
Q Consensus 908 ~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~ 957 (1005)
.....+.....+.......+..+.+|+.+||..+|++||+ +.++++
T Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~----~~~vl~ 260 (267)
T cd08228 215 SLCQKIEQCDYPPLPTEHYSEKLRELVSMCIYPDPDQRPD----IGYVHQ 260 (267)
T ss_pred HHHHHHhcCCCCCCChhhcCHHHHHHHHHHCCCCcccCcC----HHHHHH
Confidence 3333333322221112246678999999999999999999 666654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-35 Score=323.65 Aligned_cols=256 Identities=27% Similarity=0.444 Sum_probs=204.7
Q ss_pred cCCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEE
Q 001847 671 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLI 750 (1005)
Q Consensus 671 ~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV 750 (1005)
.+.|++.+.||+|++|.||++.+..+++.||+|.+...... .....+.+|+.+++.++|+||+++++++...+..|+|
T Consensus 4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 81 (291)
T cd07844 4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEE--GAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLV 81 (291)
T ss_pred ccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEeccccc--CCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEE
Confidence 46899999999999999999999889999999998754221 1223456799999999999999999999999999999
Q ss_pred EeccCCCchhhHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCCCC
Q 001847 751 TDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQL 830 (1005)
Q Consensus 751 ~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~ 830 (1005)
|||+. ++|.+++.... ..+++..++.++.||+.||.|||++||+|+||||+||+++.++.+||+|||++.......
T Consensus 82 ~e~~~-~~L~~~~~~~~-~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~-- 157 (291)
T cd07844 82 FEYLD-TDLKQYMDDCG-GGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPS-- 157 (291)
T ss_pred EecCC-CCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcCCCCEEECccccccccCCCC--
Confidence 99996 58998887543 358999999999999999999999999999999999999999999999999874321100
Q ss_pred CCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccC-CCCCChhhHHHHHHHHHHHHcCCCCCCCCC-hHH
Q 001847 831 LLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAG-AGHTSAVDWWALGILLYEMLYGYTPFRGKT-RQK 908 (1005)
Q Consensus 831 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~sDIwSlGvll~eLltG~~Pf~~~~-~~~ 908 (1005)
.......+++.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.. ..+
T Consensus 158 -------------------------~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~ 212 (291)
T cd07844 158 -------------------------KTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVED 212 (291)
T ss_pred -------------------------ccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHH
Confidence 01112346789999999875 457889999999999999999999997665 223
Q ss_pred HHHHHHhC-------------------CC--CCC-------CCCCCC--HHHHHHHHHccccCcCccCCChhcHHHHHcC
Q 001847 909 TFANILHK-------------------DL--KFP-------SSTPTS--LHAKQLMYRLLHRDPKSRLGSHEGANEIKKH 958 (1005)
Q Consensus 909 ~~~~i~~~-------------------~~--~~~-------~~~~~s--~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~h 958 (1005)
....+... .. ... .....+ ..+.++|.+||+.+|.+||+ +.++++|
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps----~~e~l~~ 288 (291)
T cd07844 213 QLHKIFRVLGTPTEETWPGVSSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRIS----AAEAMKH 288 (291)
T ss_pred HHHHHHHhcCCCChhhhhhhhhccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccC----HHHHhcC
Confidence 22222110 00 000 001223 67889999999999999999 9999999
Q ss_pred CCC
Q 001847 959 PFF 961 (1005)
Q Consensus 959 pff 961 (1005)
|||
T Consensus 289 ~~f 291 (291)
T cd07844 289 PYF 291 (291)
T ss_pred CCC
Confidence 998
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-35 Score=354.25 Aligned_cols=271 Identities=25% Similarity=0.332 Sum_probs=209.9
Q ss_pred CCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEE
Q 001847 672 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLIT 751 (1005)
Q Consensus 672 ~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~ 751 (1005)
++|++++.||+|+||.||+|.+..+++.||+|++............++.+|+.+++.++||||+++++++...+..|+||
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 68999999999999999999999999999999998654444455677889999999999999999999999999999999
Q ss_pred eccCCCchhhHHhhCC---------CCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCc
Q 001847 752 DYCPGGELFLLLDRQP---------TKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSC 822 (1005)
Q Consensus 752 E~~~ggsL~~~l~~~~---------~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~~~g~vkL~DFG~a~ 822 (1005)
||++|++|.+++.... ...++...+..++.||+.||+|||++||+||||||+|||++.+|.++|+|||++.
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~dg~vKLiDFGLAk 161 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAI 161 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcCCCCEEEEecCcce
Confidence 9999999999886421 1235667788999999999999999999999999999999999999999999996
Q ss_pred ccCCCCCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHcCCCCCC
Q 001847 823 LTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFR 902 (1005)
Q Consensus 823 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlGvll~eLltG~~Pf~ 902 (1005)
............ ... ...............+||+.|+|||++.+..++.++|||||||++|+|++|..||.
T Consensus 162 ~i~~~~~~~~~l-------~~~--~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~ 232 (932)
T PRK13184 162 FKKLEEEDLLDI-------DVD--ERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYR 232 (932)
T ss_pred eccccccccccc-------ccc--cccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCC
Confidence 542111100000 000 00000011112234679999999999999899999999999999999999999998
Q ss_pred CCChHHHHHHH-HhCCCCCCCCCCCCHHHHHHHHHccccCcCccCCChhc
Q 001847 903 GKTRQKTFANI-LHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEG 951 (1005)
Q Consensus 903 ~~~~~~~~~~i-~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~ 951 (1005)
........... ............++..+.+++.+||..||++|++..+.
T Consensus 233 ~~~~~ki~~~~~i~~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~ee 282 (932)
T PRK13184 233 RKKGRKISYRDVILSPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQE 282 (932)
T ss_pred CcchhhhhhhhhccChhhccccccCCHHHHHHHHHHccCChhhCcCHHHH
Confidence 75544332221 11111122223567889999999999999999985443
|
|
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=315.12 Aligned_cols=259 Identities=29% Similarity=0.536 Sum_probs=215.2
Q ss_pred CccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEEe
Q 001847 673 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITD 752 (1005)
Q Consensus 673 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E 752 (1005)
+|.+.+.||+|+||.||++.+..+++.|++|.++.... .......+.+|+.+++.++|+||+++++++...+.+++|+|
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e 79 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDN-DPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFME 79 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECccc-chHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEe
Confidence 58899999999999999999988999999999886532 24567888999999999999999999999999999999999
Q ss_pred ccCCCchhhHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCCCCCC
Q 001847 753 YCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLL 832 (1005)
Q Consensus 753 ~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~~~ 832 (1005)
|+.+++|.+++... ..+++..++.++.|++.||.|||+.||+|+||+|+||+++.++.+||+|||++..........
T Consensus 80 ~~~~~~L~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~- 156 (264)
T cd06626 80 YCSGGTLEELLEHG--RILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTM- 156 (264)
T ss_pred cCCCCcHHHHHhhc--CCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEcccccccccCCCCCcc-
Confidence 99999999998764 348899999999999999999999999999999999999999999999999986543221100
Q ss_pred CcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCC---CCChhhHHHHHHHHHHHHcCCCCCCCCChH-H
Q 001847 833 PTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAG---HTSAVDWWALGILLYEMLYGYTPFRGKTRQ-K 908 (1005)
Q Consensus 833 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~---~~~~sDIwSlGvll~eLltG~~Pf~~~~~~-~ 908 (1005)
........+++.|+|||++.+.. .+.++||||||+++|++++|+.||.+.... .
T Consensus 157 ----------------------~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~ 214 (264)
T cd06626 157 ----------------------GEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQ 214 (264)
T ss_pred ----------------------cccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHH
Confidence 00012356888999999998766 788999999999999999999999765332 2
Q ss_pred HHHHHHh-CCCCCCCCCCCCHHHHHHHHHccccCcCccCCChhcHHHHHcCCCC
Q 001847 909 TFANILH-KDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFF 961 (1005)
Q Consensus 909 ~~~~i~~-~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~hpff 961 (1005)
....+.. ....++.....+..+.+||.+||+.+|++||+ +.+++.|||+
T Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~----~~~i~~~~~~ 264 (264)
T cd06626 215 IMFHVGAGHKPPIPDSLQLSPEGKDFLDRCLESDPKKRPT----ASELLQHPFV 264 (264)
T ss_pred HHHHHhcCCCCCCCcccccCHHHHHHHHHHccCCcccCCC----HHHHhcCCCC
Confidence 2222222 22334444445888999999999999999999 9999999996
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=315.64 Aligned_cols=256 Identities=25% Similarity=0.472 Sum_probs=215.9
Q ss_pred CccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceEEEEEEe--CCeEEEE
Q 001847 673 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQT--KTHVCLI 750 (1005)
Q Consensus 673 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~--~~~~~lV 750 (1005)
+|++++.||.|+||.||+|.+..++..+|+|.+..... .......+..|+.+++.++|+||+++++++.. ....|++
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~ 79 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNM-TEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIV 79 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccC-CHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEE
Confidence 58899999999999999999999999999999876433 34455778889999999999999999998753 4578999
Q ss_pred EeccCCCchhhHHhhC--CCCCCCHHHHHHHHHHHHHHHHHHH-----HcCcccCCCCCCcEEEecCCcEEEEeccCCcc
Q 001847 751 TDYCPGGELFLLLDRQ--PTKVLKEDAVRFYAAEVVVALEYLH-----CQGIIYRDLKPENVLLQGNGHVSLTDFDLSCL 823 (1005)
Q Consensus 751 ~E~~~ggsL~~~l~~~--~~~~l~~~~i~~i~~qil~aL~~LH-----~~gIvHrDLkP~NILi~~~g~vkL~DFG~a~~ 823 (1005)
|||+++++|.+++... ....+++..++.++.||+.||.||| +.+++|+||+|+||+++.++.+||+|||++..
T Consensus 80 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~ 159 (265)
T cd08217 80 MEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKI 159 (265)
T ss_pred ehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEeccccccc
Confidence 9999999999998652 2356899999999999999999999 89999999999999999999999999999855
Q ss_pred cCCCCCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHcCCCCCCC
Q 001847 824 TSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRG 903 (1005)
Q Consensus 824 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlGvll~eLltG~~Pf~~ 903 (1005)
..... .......|++.|+|||.+....++.++|+||||+++|+|++|+.||..
T Consensus 160 ~~~~~---------------------------~~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~ 212 (265)
T cd08217 160 LGHDS---------------------------SFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTA 212 (265)
T ss_pred ccCCc---------------------------ccccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccC
Confidence 32111 001234689999999999888888999999999999999999999988
Q ss_pred CChHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHccccCcCccCCChhcHHHHHcCCCC
Q 001847 904 KTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFF 961 (1005)
Q Consensus 904 ~~~~~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~hpff 961 (1005)
.+.......+..+... ......+..+.+|+.+||..+|.+||+ +.++++|||+
T Consensus 213 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~~~l~~~p~~Rp~----~~~il~~~~~ 265 (265)
T cd08217 213 RNQLQLASKIKEGKFR-RIPYRYSSELNEVIKSMLNVDPDKRPS----TEELLQLPLI 265 (265)
T ss_pred cCHHHHHHHHhcCCCC-CCccccCHHHHHHHHHHccCCcccCCC----HHHHhhCCCC
Confidence 8766655555554332 222346788999999999999999999 9999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=320.23 Aligned_cols=259 Identities=28% Similarity=0.453 Sum_probs=211.5
Q ss_pred CCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceEEEEEEe--CCeEEE
Q 001847 672 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQT--KTHVCL 749 (1005)
Q Consensus 672 ~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~--~~~~~l 749 (1005)
++|+..+.||.|++|.||++.+..+++.+|+|.+.... .......+.+|++++++++||||++++++|.. .+.+|+
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 78 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDP--NPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGI 78 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCC--chHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEE
Confidence 46899999999999999999999999999999987542 23455778899999999999999999998864 347899
Q ss_pred EEeccCCCchhhHHhh--CCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCC
Q 001847 750 ITDYCPGGELFLLLDR--QPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCK 827 (1005)
Q Consensus 750 V~E~~~ggsL~~~l~~--~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~ 827 (1005)
||||+++++|.+++.. .....++...+..++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||++......
T Consensus 79 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~ 158 (287)
T cd06621 79 AMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNS 158 (287)
T ss_pred EEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecCCeEEEeecccccccccc
Confidence 9999999999988753 22355899999999999999999999999999999999999999999999999987432210
Q ss_pred CCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHcCCCCCCCC---
Q 001847 828 PQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGK--- 904 (1005)
Q Consensus 828 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlGvll~eLltG~~Pf~~~--- 904 (1005)
......++..|+|||.+.+..++.++|||||||++|+|++|+.||...
T Consensus 159 -----------------------------~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~ 209 (287)
T cd06621 159 -----------------------------LAGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEP 209 (287)
T ss_pred -----------------------------ccccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCC
Confidence 011235788899999998888999999999999999999999999765
Q ss_pred --ChHHHHHHHHhCCC-CCCCC----CCCCHHHHHHHHHccccCcCccCCChhcHHHHHcCCCCCCCC
Q 001847 905 --TRQKTFANILHKDL-KFPSS----TPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVN 965 (1005)
Q Consensus 905 --~~~~~~~~i~~~~~-~~~~~----~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~hpff~~~~ 965 (1005)
...+....+..... ..+.. ...+..+.+||.+||..+|.+||| +.++++||||+...
T Consensus 210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt----~~eil~~~~~~~~~ 273 (287)
T cd06621 210 PLGPIELLSYIVNMPNPELKDEPGNGIKWSEEFKDFIKQCLEKDPTRRPT----PWDMLEHPWIKAQM 273 (287)
T ss_pred CCChHHHHHHHhcCCchhhccCCCCCCchHHHHHHHHHHHcCCCcccCCC----HHHHHhCccccccc
Confidence 22333333333221 11111 123567899999999999999999 99999999998753
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-35 Score=321.79 Aligned_cols=279 Identities=37% Similarity=0.639 Sum_probs=225.7
Q ss_pred CCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCC-CCCcceEEEEEEeCCeEEEE
Q 001847 672 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLD-HPFVPALYASFQTKTHVCLI 750 (1005)
Q Consensus 672 ~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~il~~l~-hpnIv~l~~~~~~~~~~~lV 750 (1005)
++|.+.+.||+|++|.||++.+..+++.|++|++.............+..|..+++++. |+||+++++++...+..++|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 37999999999999999999999999999999987754444455577888999999998 99999999999999999999
Q ss_pred EeccCCCchhhHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCCCC
Q 001847 751 TDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQL 830 (1005)
Q Consensus 751 ~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~ 830 (1005)
|||+.+++|.+++... ..++...++.++.||+.||.|||++|++|+||+|+||+++.++.++|+|||++.........
T Consensus 81 ~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~~ 158 (280)
T cd05581 81 LEYAPNGELLQYIRKY--GSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSP 158 (280)
T ss_pred EcCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEecCCccccccCCcccc
Confidence 9999999999999875 35999999999999999999999999999999999999999999999999998654322111
Q ss_pred CCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHcCCCCCCCCChHHHH
Q 001847 831 LLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTF 910 (1005)
Q Consensus 831 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlGvll~eLltG~~Pf~~~~~~~~~ 910 (1005)
........ .................++..|+|||.+....++.++||||||++++++++|..||........+
T Consensus 159 ~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~ 231 (280)
T cd05581 159 ESNKGDAT-------NIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTF 231 (280)
T ss_pred ccCCCCCc-------cccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHHH
Confidence 00000000 00000011112334557889999999998888889999999999999999999999988776666
Q ss_pred HHHHhCCCCCCCCCCCCHHHHHHHHHccccCcCccCCChhcHHHHHcCCCC
Q 001847 911 ANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFF 961 (1005)
Q Consensus 911 ~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~hpff 961 (1005)
..+......++. ..+..+.+||.+||..+|.+||++.....++++||||
T Consensus 232 ~~~~~~~~~~~~--~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~~~~ 280 (280)
T cd05581 232 QKILKLEYSFPP--NFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPFF 280 (280)
T ss_pred HHHHhcCCCCCC--ccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcCCCC
Confidence 666655444443 4578899999999999999999933333999999998
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=322.59 Aligned_cols=258 Identities=26% Similarity=0.376 Sum_probs=217.7
Q ss_pred CccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEEe
Q 001847 673 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITD 752 (1005)
Q Consensus 673 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E 752 (1005)
-|...+.||+|+||.||++.+..++..|++|.+.............+.+|+.+++.++|||++++++++......|+|||
T Consensus 22 ~~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 101 (313)
T cd06633 22 IFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVME 101 (313)
T ss_pred HhhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEe
Confidence 37777889999999999999999999999999876544445556678889999999999999999999999999999999
Q ss_pred ccCCCchhhHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCCCCCC
Q 001847 753 YCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLL 832 (1005)
Q Consensus 753 ~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~~~ 832 (1005)
|+ .++|.+++... ...+++..+..++.||+.+|.|||++|++|+||+|+||+++.++.++|+|||++....
T Consensus 102 ~~-~~~l~~~l~~~-~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~------- 172 (313)
T cd06633 102 YC-LGSASDLLEVH-KKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASKSS------- 172 (313)
T ss_pred cC-CCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCCCCEEEeecCCCcccC-------
Confidence 99 56787777653 3458999999999999999999999999999999999999999999999999873211
Q ss_pred CcchhhhhcccCCCCCcccccccccccccccCCccccccccc---CCCCCChhhHHHHHHHHHHHHcCCCCCCCCChHHH
Q 001847 833 PTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIA---GAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKT 909 (1005)
Q Consensus 833 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~---~~~~~~~sDIwSlGvll~eLltG~~Pf~~~~~~~~ 909 (1005)
......|+..|+|||++. ...++.++|||||||++|+|++|..||...+....
T Consensus 173 ------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~ 228 (313)
T cd06633 173 ------------------------PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA 228 (313)
T ss_pred ------------------------CCCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHH
Confidence 112346888999999984 35577899999999999999999999988777666
Q ss_pred HHHHHhCCCCCCCCCCCCHHHHHHHHHccccCcCccCCChhcHHHHHcCCCCCCCChh
Q 001847 910 FANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVNWA 967 (1005)
Q Consensus 910 ~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~hpff~~~~~~ 967 (1005)
...+.....+.......+..+.+|+.+||+.+|.+||+ +.+++.||||+..+-+
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rp~----~~~~l~~~~~~~~~~~ 282 (313)
T cd06633 229 LYHIAQNDSPTLQSNEWTDSFRGFVDYCLQKIPQERPA----SAELLRHDFVRRDRPA 282 (313)
T ss_pred HHHHHhcCCCCCCccccCHHHHHHHHHHccCChhhCcC----HHHHhcCcccCCCchh
Confidence 66665554443333446778999999999999999999 9999999999976543
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=320.29 Aligned_cols=256 Identities=21% Similarity=0.309 Sum_probs=212.1
Q ss_pred ccCCccccccccccCcEEEEEEEEcC-----CCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeC
Q 001847 670 NLQHFRPIKPLGSGDTGSVHLVELCG-----SGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTK 744 (1005)
Q Consensus 670 ~~~~y~~~~~LG~G~~g~Vy~a~~~~-----~~~~valK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~ 744 (1005)
...+|.+.+.||+|+||.||++.+.. ++..||+|.++... .......+.+|+++++.++|+||+++++++...
T Consensus 3 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 80 (280)
T cd05049 3 QRDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETA--SNDARKDFEREAELLTNFQHENIVKFYGVCTEG 80 (280)
T ss_pred ChHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccC--CHHHHHHHHHHHHHHHhcCCCCchheeeEEecC
Confidence 35689999999999999999998743 36789999987542 233456888999999999999999999999999
Q ss_pred CeEEEEEeccCCCchhhHHhhCC------------CCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCc
Q 001847 745 THVCLITDYCPGGELFLLLDRQP------------TKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGH 812 (1005)
Q Consensus 745 ~~~~lV~E~~~ggsL~~~l~~~~------------~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~~~g~ 812 (1005)
...|+||||+++++|.+++.... ...+++..+..++.||+.||.|||++|++|+||||+||+++.++.
T Consensus 81 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~ 160 (280)
T cd05049 81 DPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLV 160 (280)
T ss_pred CCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEcCCCe
Confidence 99999999999999999997532 234788999999999999999999999999999999999999999
Q ss_pred EEEEeccCCcccCCCCCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHH
Q 001847 813 VSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLY 892 (1005)
Q Consensus 813 vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlGvll~ 892 (1005)
++|+|||++........ ........+++.|+|||++.+..++.++|||||||++|
T Consensus 161 ~kl~d~g~~~~~~~~~~-------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ 215 (280)
T cd05049 161 VKIGDFGMSRDVYTTDY-------------------------YRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLW 215 (280)
T ss_pred EEECCcccceecccCcc-------------------------eecCCCCcccceecChhhhccCCcchhhhHHHHHHHHH
Confidence 99999998854321100 00112234678899999999989999999999999999
Q ss_pred HHHc-CCCCCCCCChHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHccccCcCccCCChhcHHHHHc
Q 001847 893 EMLY-GYTPFRGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKK 957 (1005)
Q Consensus 893 eLlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~ 957 (1005)
+|++ |..||.+.........+..+....+ ....+..+.+|+.+||..||++||+ +.++++
T Consensus 216 e~~~~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~l~~~p~~Rp~----~~eil~ 276 (280)
T cd05049 216 EIFTYGKQPWYGLSNEEVIECITQGRLLQR-PRTCPSEVYDIMLGCWKRDPQQRIN----IKDIHE 276 (280)
T ss_pred HHHhcCCCCCCCCCHHHHHHHHHcCCcCCC-CCCCCHHHHHHHHHHcCCCcccCCC----HHHHHH
Confidence 9998 9999988887777777765544332 2357889999999999999999999 555553
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=315.85 Aligned_cols=256 Identities=27% Similarity=0.472 Sum_probs=216.7
Q ss_pred CccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEEe
Q 001847 673 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITD 752 (1005)
Q Consensus 673 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E 752 (1005)
+|.+.+.||.|+||.||++.+..++..+|+|.+..... .......+.+|+.+++.++|+||+++++++...+..|+|+|
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e 79 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKM-PVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVME 79 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhc-cchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEe
Confidence 48899999999999999999999999999999876432 22344567789999999999999999999999999999999
Q ss_pred ccCCCchhhHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCc-EEEEeccCCcccCCCCCCC
Q 001847 753 YCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGH-VSLTDFDLSCLTSCKPQLL 831 (1005)
Q Consensus 753 ~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~~~g~-vkL~DFG~a~~~~~~~~~~ 831 (1005)
|+.+++|.+++.......+++..+..++.||+.||.|||+.+++|+||||+||++++++. ++|+|||.+.......
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~--- 156 (257)
T cd08225 80 YCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSM--- 156 (257)
T ss_pred cCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCCCeEEecccccchhccCCc---
Confidence 999999999997755556899999999999999999999999999999999999998864 6999999885432110
Q ss_pred CCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHcCCCCCCCCChHHHHH
Q 001847 832 LPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFA 911 (1005)
Q Consensus 832 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlGvll~eLltG~~Pf~~~~~~~~~~ 911 (1005)
.......|++.|+|||++....++.++|+||||+++|+|++|..||...+......
T Consensus 157 ------------------------~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~ 212 (257)
T cd08225 157 ------------------------ELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVL 212 (257)
T ss_pred ------------------------ccccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHH
Confidence 01122358899999999988888999999999999999999999998877766666
Q ss_pred HHHhCCCCCCCCCCCCHHHHHHHHHccccCcCccCCChhcHHHHHcCCCC
Q 001847 912 NILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFF 961 (1005)
Q Consensus 912 ~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~hpff 961 (1005)
.+...... +.....+..+.++|.+||..+|++||+ +.++++||||
T Consensus 213 ~~~~~~~~-~~~~~~~~~~~~~i~~~l~~~p~~Rpt----~~~ll~~~~~ 257 (257)
T cd08225 213 KICQGYFA-PISPNFSRDLRSLISQLFKVSPRDRPS----ITSILKRPFL 257 (257)
T ss_pred HHhcccCC-CCCCCCCHHHHHHHHHHhccChhhCcC----HHHHhhCCCC
Confidence 55544332 223346788999999999999999999 9999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=313.14 Aligned_cols=256 Identities=31% Similarity=0.538 Sum_probs=220.2
Q ss_pred CccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEEe
Q 001847 673 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITD 752 (1005)
Q Consensus 673 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E 752 (1005)
+|++.+.||.|++|.||++.+..++..+++|.+..... .......+..|+++++.++|+|++++++.+......++|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e 79 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNM-SEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVME 79 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccC-ChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEE
Confidence 58899999999999999999988999999999876432 34556678889999999999999999999999999999999
Q ss_pred ccCCCchhhHHhhCC--CCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCCCC
Q 001847 753 YCPGGELFLLLDRQP--TKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQL 830 (1005)
Q Consensus 753 ~~~ggsL~~~l~~~~--~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~ 830 (1005)
|+++++|.+++.... ...++...+..++.||+.||.|||++|++|+||+|+||+++.++.++|+|||.+.......
T Consensus 80 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~-- 157 (258)
T cd08215 80 YADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV-- 157 (258)
T ss_pred ecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCCCcEEECCccceeecccCc--
Confidence 999999999997643 3569999999999999999999999999999999999999999999999999885432110
Q ss_pred CCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHcCCCCCCCCChHHHH
Q 001847 831 LLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTF 910 (1005)
Q Consensus 831 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlGvll~eLltG~~Pf~~~~~~~~~ 910 (1005)
.......|++.|+|||.+....++.++|+||||+++|+|++|+.||.........
T Consensus 158 -------------------------~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~ 212 (258)
T cd08215 158 -------------------------DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELA 212 (258)
T ss_pred -------------------------ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHHH
Confidence 1122346889999999998888899999999999999999999999887776666
Q ss_pred HHHHhCCCCCCCCCCCCHHHHHHHHHccccCcCccCCChhcHHHHHcCCCC
Q 001847 911 ANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFF 961 (1005)
Q Consensus 911 ~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~hpff 961 (1005)
..+....... .....+..+.+++.+||..+|++||+ +.++|+||||
T Consensus 213 ~~~~~~~~~~-~~~~~~~~~~~~i~~~l~~~p~~Rp~----~~~ll~~~~~ 258 (258)
T cd08215 213 LKILKGQYPP-IPSQYSSELRNLVSSLLQKDPEERPS----IAQILQSPFI 258 (258)
T ss_pred HHHhcCCCCC-CCCCCCHHHHHHHHHHcCCChhhCcC----HHHHhcCCCC
Confidence 6666554322 22356789999999999999999999 9999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=322.39 Aligned_cols=258 Identities=22% Similarity=0.381 Sum_probs=207.5
Q ss_pred CCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCC-CCCcceEEEEEEeCCe----
Q 001847 672 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLD-HPFVPALYASFQTKTH---- 746 (1005)
Q Consensus 672 ~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~il~~l~-hpnIv~l~~~~~~~~~---- 746 (1005)
++|++.+.||+|+||.||++.+..+++.||+|.+.... ........+.+|+.+++.+. |+||+++++++.....
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~-~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~ 79 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEM-DEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKP 79 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhc-cccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCc
Confidence 36999999999999999999999999999999886542 12223456778999999994 6999999999887655
Q ss_pred -EEEEEeccCCCchhhHHhhCC---CCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEec-CCcEEEEeccCC
Q 001847 747 -VCLITDYCPGGELFLLLDRQP---TKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQG-NGHVSLTDFDLS 821 (1005)
Q Consensus 747 -~~lV~E~~~ggsL~~~l~~~~---~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~~-~g~vkL~DFG~a 821 (1005)
.|+||||+.+ +|.+++.... ...+++..++.++.||+.||.|||++||+||||+|+||+++. ++.+||+|||++
T Consensus 80 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~~~~~kl~dfg~~ 158 (295)
T cd07837 80 SLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLG 158 (295)
T ss_pred eEEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEecCCCeEEEeecccc
Confidence 8999999965 7888876432 245899999999999999999999999999999999999998 889999999988
Q ss_pred cccCCCCCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccC-CCCCChhhHHHHHHHHHHHHcCCCC
Q 001847 822 CLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAG-AGHTSAVDWWALGILLYEMLYGYTP 900 (1005)
Q Consensus 822 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~sDIwSlGvll~eLltG~~P 900 (1005)
....... .......+++.|+|||++.+ ..++.++||||||+++|+|++|..|
T Consensus 159 ~~~~~~~---------------------------~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~ 211 (295)
T cd07837 159 RAFSIPV---------------------------KSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPL 211 (295)
T ss_pred eecCCCc---------------------------cccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCC
Confidence 5432110 01112356889999998865 4568899999999999999999999
Q ss_pred CCCCChHHHHHHHHhCCC-----C------------CCC---------CCCCCHHHHHHHHHccccCcCccCCChhcHHH
Q 001847 901 FRGKTRQKTFANILHKDL-----K------------FPS---------STPTSLHAKQLMYRLLHRDPKSRLGSHEGANE 954 (1005)
Q Consensus 901 f~~~~~~~~~~~i~~~~~-----~------------~~~---------~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~e 954 (1005)
|.+.+.......+..... . .+. ....+..+.+||.+||..||.+||+ +.+
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~----~~e 287 (295)
T cd07837 212 FPGDSELQQLLHIFKLLGTPTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRIS----AKA 287 (295)
T ss_pred CCCCCHHHHHHHHHHHhCCCChhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCC----HHH
Confidence 988777665555443100 0 000 1236778999999999999999999 999
Q ss_pred HHcCCCCC
Q 001847 955 IKKHPFFK 962 (1005)
Q Consensus 955 lL~hpff~ 962 (1005)
++.||||+
T Consensus 288 il~~~~~~ 295 (295)
T cd07837 288 ALTHPYFD 295 (295)
T ss_pred HhcCCCcC
Confidence 99999995
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-35 Score=324.77 Aligned_cols=257 Identities=28% Similarity=0.464 Sum_probs=216.1
Q ss_pred CCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEE
Q 001847 672 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLIT 751 (1005)
Q Consensus 672 ~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~ 751 (1005)
..|.....||.|+||.||++.+..+++.||+|.+.... ......+.+|+.+++.++||||+++++++..++..|+||
T Consensus 21 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~ 97 (297)
T cd06659 21 SLLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRK---QQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLM 97 (297)
T ss_pred hhHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecc---cchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEE
Confidence 35667778999999999999998899999999986532 223456788999999999999999999999999999999
Q ss_pred eccCCCchhhHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCCCCC
Q 001847 752 DYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLL 831 (1005)
Q Consensus 752 E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~~ 831 (1005)
||+++++|..++.. ..+++..++.++.||+.||.|||++|++|+||||+||+++.++.++|+|||++......
T Consensus 98 e~~~~~~L~~~~~~---~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~---- 170 (297)
T cd06659 98 EFLQGGALTDIVSQ---TRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKD---- 170 (297)
T ss_pred ecCCCCCHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccCCcEEEeechhHhhcccc----
Confidence 99999999988754 34899999999999999999999999999999999999999999999999987432211
Q ss_pred CCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHcCCCCCCCCChHHHHH
Q 001847 832 LPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFA 911 (1005)
Q Consensus 832 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlGvll~eLltG~~Pf~~~~~~~~~~ 911 (1005)
........|++.|+|||++.+..++.++|||||||++|+|++|+.||..........
T Consensus 171 -----------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~ 227 (297)
T cd06659 171 -----------------------VPKRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMK 227 (297)
T ss_pred -----------------------cccccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 011123568999999999988888999999999999999999999998877666655
Q ss_pred HHHhCCCC-CCCCCCCCHHHHHHHHHccccCcCccCCChhcHHHHHcCCCCCCCC
Q 001847 912 NILHKDLK-FPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVN 965 (1005)
Q Consensus 912 ~i~~~~~~-~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~hpff~~~~ 965 (1005)
.+...... +......+..+.++|.+||+.+|.+||+ +.++++||||....
T Consensus 228 ~~~~~~~~~~~~~~~~~~~l~~~i~~~l~~~P~~Rps----~~~ll~~~~~~~~~ 278 (297)
T cd06659 228 RLRDSPPPKLKNAHKISPVLRDFLERMLTREPQERAT----AQELLDHPFLLQTG 278 (297)
T ss_pred HHhccCCCCccccCCCCHHHHHHHHHHhcCCcccCcC----HHHHhhChhhccCC
Confidence 55433222 2223346788999999999999999999 99999999999753
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=317.46 Aligned_cols=252 Identities=29% Similarity=0.405 Sum_probs=208.0
Q ss_pred CCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEE
Q 001847 672 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLIT 751 (1005)
Q Consensus 672 ~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~ 751 (1005)
++|++.+.||.|++|.||++.+..++..++||.+.............+.+|+.+++.++|+||+++++++...+..+++|
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 57999999999999999999999999999999887654444555678889999999999999999999999999999999
Q ss_pred eccCCCchhhHHhhC--CCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCCC
Q 001847 752 DYCPGGELFLLLDRQ--PTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQ 829 (1005)
Q Consensus 752 E~~~ggsL~~~l~~~--~~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~ 829 (1005)
||+++++|.+++... ....+++..++.++.||+.||.|||++|++|+||||+||+++.++.++|+|||++.......
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~- 160 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT- 160 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEECcchhhhccccCC-
Confidence 999999999988642 23458999999999999999999999999999999999999999999999999875432110
Q ss_pred CCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCh--H
Q 001847 830 LLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTR--Q 907 (1005)
Q Consensus 830 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlGvll~eLltG~~Pf~~~~~--~ 907 (1005)
.......|+..|+|||.+.+..++.++|+||||+++|+|++|..||.+... .
T Consensus 161 --------------------------~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~ 214 (267)
T cd08229 161 --------------------------TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLY 214 (267)
T ss_pred --------------------------cccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHH
Confidence 011234688999999999888889999999999999999999999976533 2
Q ss_pred HHHHHHHhCCCCCCCCCCCCHHHHHHHHHccccCcCccCCChh
Q 001847 908 KTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHE 950 (1005)
Q Consensus 908 ~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~ 950 (1005)
.....+.....+.......+..+.+|+.+||..+|++|||+.+
T Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ 257 (267)
T cd08229 215 SLCKKIEQCDYPPLPSDHYSEELRQLVNMCINPDPEKRPDITY 257 (267)
T ss_pred HHhhhhhcCCCCCCCcccccHHHHHHHHHhcCCCcccCCCHHH
Confidence 3333333332222222346788999999999999999999443
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=319.89 Aligned_cols=258 Identities=28% Similarity=0.463 Sum_probs=220.1
Q ss_pred cCCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEE
Q 001847 671 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLI 750 (1005)
Q Consensus 671 ~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV 750 (1005)
.+.|.+.+.||+|++|.||++.+..++..+++|.+..... ....+.+|+.+++.++|+||+++++++...+..|+|
T Consensus 18 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 93 (286)
T cd06614 18 RELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ----NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVV 93 (286)
T ss_pred cccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch----hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEE
Confidence 4579999999999999999999988899999999875422 456778899999999999999999999999999999
Q ss_pred EeccCCCchhhHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCCCC
Q 001847 751 TDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQL 830 (1005)
Q Consensus 751 ~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~ 830 (1005)
+||+++++|.+++.... ..++...+..++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||++.......
T Consensus 94 ~e~~~~~~L~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~-- 170 (286)
T cd06614 94 MEYMDGGSLTDIITQNF-VRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEK-- 170 (286)
T ss_pred EeccCCCcHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcCCCCEEECccchhhhhccch--
Confidence 99999999999998753 369999999999999999999999999999999999999999999999999874432110
Q ss_pred CCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHcCCCCCCCCChHHHH
Q 001847 831 LLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTF 910 (1005)
Q Consensus 831 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlGvll~eLltG~~Pf~~~~~~~~~ 910 (1005)
.......+++.|++||.+.+..++.++|+|||||++|+|++|..||.........
T Consensus 171 -------------------------~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~ 225 (286)
T cd06614 171 -------------------------SKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRAL 225 (286)
T ss_pred -------------------------hhhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 0112345788999999998888899999999999999999999999887766555
Q ss_pred HHHHhCCCC-CCCCCCCCHHHHHHHHHccccCcCccCCChhcHHHHHcCCCCCCC
Q 001847 911 ANILHKDLK-FPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGV 964 (1005)
Q Consensus 911 ~~i~~~~~~-~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~hpff~~~ 964 (1005)
..+...... ......++..+.+||.+||+.+|.+||+ +.++++|+||+..
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt----~~~il~~~~~~~~ 276 (286)
T cd06614 226 FLITTKGIPPLKNPEKWSPEFKDFLNKCLVKDPEKRPS----AEELLQHPFLKKA 276 (286)
T ss_pred HHHHhcCCCCCcchhhCCHHHHHHHHHHhccChhhCcC----HHHHhhChHhhcc
Confidence 555443332 2222336788999999999999999999 9999999999984
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-35 Score=325.25 Aligned_cols=257 Identities=26% Similarity=0.425 Sum_probs=215.8
Q ss_pred cCCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEE
Q 001847 671 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLI 750 (1005)
Q Consensus 671 ~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV 750 (1005)
.++|++++.||+|+||.||++.+..++..|++|.+... .......+.+|+.+++.++||||+++++++...+..|+|
T Consensus 18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~---~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv 94 (293)
T cd06647 18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQ---QQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVV 94 (293)
T ss_pred hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccc---cchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEE
Confidence 36899999999999999999999888999999998643 223346778899999999999999999999999999999
Q ss_pred EeccCCCchhhHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCCCC
Q 001847 751 TDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQL 830 (1005)
Q Consensus 751 ~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~ 830 (1005)
+||+++++|.+++... .++...+..++.||+.||.|||++|++|+||+|+||+++.++.++|+|||++.......
T Consensus 95 ~e~~~~~~L~~~~~~~---~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~-- 169 (293)
T cd06647 95 MEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ-- 169 (293)
T ss_pred EecCCCCcHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcCCCCEEEccCcceecccccc--
Confidence 9999999999998753 47899999999999999999999999999999999999999999999999875432110
Q ss_pred CCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHcCCCCCCCCChHHHH
Q 001847 831 LLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTF 910 (1005)
Q Consensus 831 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlGvll~eLltG~~Pf~~~~~~~~~ 910 (1005)
.......|++.|++||.+....++.++|+|||||++|++++|..||...+.....
T Consensus 170 -------------------------~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~ 224 (293)
T cd06647 170 -------------------------SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRAL 224 (293)
T ss_pred -------------------------cccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhe
Confidence 0112346888999999998888889999999999999999999999876654443
Q ss_pred HHHHh-CCCCCCCCCCCCHHHHHHHHHccccCcCccCCChhcHHHHHcCCCCCCC
Q 001847 911 ANILH-KDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGV 964 (1005)
Q Consensus 911 ~~i~~-~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~hpff~~~ 964 (1005)
..+.. +...+......+..+.+||.+||..+|++||+ +.+++.|+||+..
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~----~~~il~h~~~~~~ 275 (293)
T cd06647 225 YLIATNGTPELQNPEKLSAIFRDFLNRCLEMDVEKRGS----AKELLQHPFLKIA 275 (293)
T ss_pred eehhcCCCCCCCCccccCHHHHHHHHHHccCChhhCcC----HHHHhcCHHHhcC
Confidence 33322 22223333345778999999999999999999 9999999999864
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=314.59 Aligned_cols=251 Identities=24% Similarity=0.373 Sum_probs=207.3
Q ss_pred ccCCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEE
Q 001847 670 NLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCL 749 (1005)
Q Consensus 670 ~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l 749 (1005)
+.++|++.+.||+|+||.||++.+. .+..+|+|.+.... .....+.+|+.+++.++||||+++++++...+.+|+
T Consensus 2 ~~~~~~~~~~lg~G~~~~vy~~~~~-~~~~~a~K~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~i 76 (256)
T cd05114 2 NPSELTFMKELGSGQFGVVHLGKWR-AQIKVAIKAINEGA----MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYI 76 (256)
T ss_pred CHHHcEEeeEecCCcCceEEEEEec-cCceEEEEecccCC----ccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEE
Confidence 3467999999999999999999884 45679999876442 123567889999999999999999999999999999
Q ss_pred EEeccCCCchhhHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCCC
Q 001847 750 ITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQ 829 (1005)
Q Consensus 750 V~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~ 829 (1005)
||||+++++|.+++.... ..+++..+..++.|++.||.|||++||+|+||||+||+++.++.+||+|||.+........
T Consensus 77 v~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~ 155 (256)
T cd05114 77 VTEFMENGCLLNYLRQRQ-GKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEY 155 (256)
T ss_pred EEEcCCCCcHHHHHHhCc-cCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcCCCeEEECCCCCccccCCCce
Confidence 999999999999987543 3589999999999999999999999999999999999999999999999998854321100
Q ss_pred CCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCChHH
Q 001847 830 LLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY-GYTPFRGKTRQK 908 (1005)
Q Consensus 830 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlGvll~eLlt-G~~Pf~~~~~~~ 908 (1005)
.......++..|+|||.+.+..++.++||||||+++|+|++ |+.||...+..+
T Consensus 156 --------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~ 209 (256)
T cd05114 156 --------------------------TSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYE 209 (256)
T ss_pred --------------------------eccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHH
Confidence 00112235668999999988888999999999999999999 999998888777
Q ss_pred HHHHHHhCCCCCCCCCCCCHHHHHHHHHccccCcCccCCChhcHHHHHc
Q 001847 909 TFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKK 957 (1005)
Q Consensus 909 ~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~ 957 (1005)
....+..+... ......+..+.+|+.+||..+|++||+ +.++++
T Consensus 210 ~~~~i~~~~~~-~~~~~~~~~~~~li~~c~~~~p~~Rps----~~~l~~ 253 (256)
T cd05114 210 VVEMISRGFRL-YRPKLASMTVYEVMYSCWHEKPEGRPT----FAELLR 253 (256)
T ss_pred HHHHHHCCCCC-CCCCCCCHHHHHHHHHHccCCcccCcC----HHHHHH
Confidence 77777665322 222345778999999999999999999 666654
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=351.16 Aligned_cols=268 Identities=24% Similarity=0.323 Sum_probs=199.4
Q ss_pred cCCccccccccccCcEEEEEEEEcCCC-eEEEEE--------------EeecccccChHHHHHHHHHHHHHHhCCCCCcc
Q 001847 671 LQHFRPIKPLGSGDTGSVHLVELCGSG-QYFAMK--------------AMDKGVMLNRNKVHRACAEREILDMLDHPFVP 735 (1005)
Q Consensus 671 ~~~y~~~~~LG~G~~g~Vy~a~~~~~~-~~valK--------------~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv 735 (1005)
.++|++++.||+|+||.||+|..+... ...+.| .+.+...........+.+|+.+++.++||||+
T Consensus 147 ~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv 226 (501)
T PHA03210 147 LAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENIL 226 (501)
T ss_pred hhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcC
Confidence 468999999999999999998864332 122222 11111111223445678899999999999999
Q ss_pred eEEEEEEeCCeEEEEEeccCCCchhhHHhhCC---CCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCc
Q 001847 736 ALYASFQTKTHVCLITDYCPGGELFLLLDRQP---TKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGH 812 (1005)
Q Consensus 736 ~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~---~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~~~g~ 812 (1005)
++++++...+..|+|++++ +++|..++.... ........++.++.||+.||.|||++|||||||||+|||++.++.
T Consensus 227 ~l~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl~~~~~ 305 (501)
T PHA03210 227 KIEEILRSEANTYMITQKY-DFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDGK 305 (501)
T ss_pred cEeEEEEECCeeEEEEecc-ccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCC
Confidence 9999999999999999999 667777765321 122446778889999999999999999999999999999999999
Q ss_pred EEEEeccCCcccCCCCCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHH
Q 001847 813 VSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLY 892 (1005)
Q Consensus 813 vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlGvll~ 892 (1005)
+||+|||++........ .......||+.|+|||++.+..++.++|||||||++|
T Consensus 306 vkL~DFGla~~~~~~~~--------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ 359 (501)
T PHA03210 306 IVLGDFGTAMPFEKERE--------------------------AFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILL 359 (501)
T ss_pred EEEEeCCCceecCcccc--------------------------cccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHH
Confidence 99999999865431110 1112357999999999999989999999999999999
Q ss_pred HHHcCCCCCCC-C--ChHHHHHHHHhCC----CCCC--------------------------CCCCCCHHHHHHHHHccc
Q 001847 893 EMLYGYTPFRG-K--TRQKTFANILHKD----LKFP--------------------------SSTPTSLHAKQLMYRLLH 939 (1005)
Q Consensus 893 eLltG~~Pf~~-~--~~~~~~~~i~~~~----~~~~--------------------------~~~~~s~~l~~Ll~~~L~ 939 (1005)
+|++|..++.+ . .....+..++... ..++ .....+..+.++|.+||+
T Consensus 360 ell~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~ 439 (501)
T PHA03210 360 DMLSHDFCPIGDGGGKPGKQLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLT 439 (501)
T ss_pred HHHHCCCCCccCCCCCHHHHHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhc
Confidence 99998765432 2 2222222222210 0000 011245567888999999
Q ss_pred cCcCccCCChhcHHHHHcCCCCCCCChhhh
Q 001847 940 RDPKSRLGSHEGANEIKKHPFFKGVNWALV 969 (1005)
Q Consensus 940 ~dP~~Rpt~~~~a~elL~hpff~~~~~~~~ 969 (1005)
+||.+||+ +.++|.||||.......+
T Consensus 440 ~DP~~Rps----a~elL~hp~f~~~~~~~~ 465 (501)
T PHA03210 440 FDWHLRPG----AAELLALPLFSAEEEEEI 465 (501)
T ss_pred cCcccCcC----HHHHhhChhhhcCCchHH
Confidence 99999999 999999999998765544
|
|
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=334.75 Aligned_cols=258 Identities=23% Similarity=0.308 Sum_probs=208.2
Q ss_pred cccccCCccccccccccCcEEEEEEEEcCC-----CeEEEEEEeecccccChHHHHHHHHHHHHHHhCC-CCCcceEEEE
Q 001847 667 EQINLQHFRPIKPLGSGDTGSVHLVELCGS-----GQYFAMKAMDKGVMLNRNKVHRACAEREILDMLD-HPFVPALYAS 740 (1005)
Q Consensus 667 ~~i~~~~y~~~~~LG~G~~g~Vy~a~~~~~-----~~~valK~~~~~~~~~~~~~~~~~~E~~il~~l~-hpnIv~l~~~ 740 (1005)
+.+..++|++.+.||.|+||.||++.+... +..||||.+.... .......+.+|+.+++.++ ||||++++++
T Consensus 32 ~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~ 109 (400)
T cd05105 32 WEFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTA--RSSEKQALMSELKIMTHLGPHLNIVNLLGA 109 (400)
T ss_pred eeccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCC--ChHHHHHHHHHHHHHHhcCCCCCeeeEEEE
Confidence 345578999999999999999999987433 3579999987542 2344567889999999996 9999999999
Q ss_pred EEeCCeEEEEEeccCCCchhhHHhhCC-----------------------------------------------------
Q 001847 741 FQTKTHVCLITDYCPGGELFLLLDRQP----------------------------------------------------- 767 (1005)
Q Consensus 741 ~~~~~~~~lV~E~~~ggsL~~~l~~~~----------------------------------------------------- 767 (1005)
+...+.+|+|||||++|+|.+++..+.
T Consensus 110 ~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 189 (400)
T cd05105 110 CTKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYV 189 (400)
T ss_pred EccCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccc
Confidence 999999999999999999998876421
Q ss_pred -----------------------------------------CCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEE
Q 001847 768 -----------------------------------------TKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVL 806 (1005)
Q Consensus 768 -----------------------------------------~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NIL 806 (1005)
...+++..+..++.||+.||.|||++||+|+||||+|||
T Consensus 190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~Nil 269 (400)
T cd05105 190 PMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVL 269 (400)
T ss_pred hhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHhEE
Confidence 124778888999999999999999999999999999999
Q ss_pred EecCCcEEEEeccCCcccCCCCCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHH
Q 001847 807 LQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWA 886 (1005)
Q Consensus 807 i~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwS 886 (1005)
++.++.+||+|||++........ ........+++.|+|||.+.+..++.++||||
T Consensus 270 l~~~~~~kL~DfGla~~~~~~~~-------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwS 324 (400)
T cd05105 270 LAQGKIVKICDFGLARDIMHDSN-------------------------YVSKGSTFLPVKWMAPESIFDNLYTTLSDVWS 324 (400)
T ss_pred EeCCCEEEEEeCCcceecccccc-------------------------ccccCCcCCCcceEChhhhcCCCCCchhhHHH
Confidence 99999999999999854321110 01112345778899999998888999999999
Q ss_pred HHHHHHHHHc-CCCCCCCCChHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHccccCcCccCCChhc
Q 001847 887 LGILLYEMLY-GYTPFRGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEG 951 (1005)
Q Consensus 887 lGvll~eLlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~ 951 (1005)
|||++|+|++ |..||............+......+....++..+.+|+.+||..+|++||++.++
T Consensus 325 lGvil~ellt~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l 390 (400)
T cd05105 325 YGILLWEIFSLGGTPYPGMIVDSTFYNKIKSGYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHL 390 (400)
T ss_pred HHHHHHHHHHCCCCCCcccchhHHHHHHHhcCCCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHH
Confidence 9999999996 9999987655444444444444444445578899999999999999999995553
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-35 Score=330.80 Aligned_cols=259 Identities=27% Similarity=0.421 Sum_probs=209.3
Q ss_pred cCCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeC-----C
Q 001847 671 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTK-----T 745 (1005)
Q Consensus 671 ~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~-----~ 745 (1005)
..+|++.+.||.|+||.||++.+..+++.||+|.+.... ........+.+|+.+++.++|+||+++++++... .
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~ 82 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAF-DNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFN 82 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccc-cccchhHHHHHHHHHHHhcCCCCccchHHheecccccccC
Confidence 358999999999999999999999999999999987542 2333445677899999999999999999987644 3
Q ss_pred eEEEEEeccCCCchhhHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccC
Q 001847 746 HVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTS 825 (1005)
Q Consensus 746 ~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~~~g~vkL~DFG~a~~~~ 825 (1005)
.+|+||||+ +++|.+++... ..+++..+..++.||+.||.|||++|++|+||||+||+++.++.+||+|||++....
T Consensus 83 ~~~lv~e~~-~~~L~~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~ 159 (337)
T cd07858 83 DVYIVYELM-DTDLHQIIRSS--QTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTS 159 (337)
T ss_pred cEEEEEeCC-CCCHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcCccccccC
Confidence 589999999 57898888654 459999999999999999999999999999999999999999999999999985432
Q ss_pred CCCCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccC-CCCCChhhHHHHHHHHHHHHcCCCCCCCC
Q 001847 826 CKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAG-AGHTSAVDWWALGILLYEMLYGYTPFRGK 904 (1005)
Q Consensus 826 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~sDIwSlGvll~eLltG~~Pf~~~ 904 (1005)
... .......++..|+|||.+.. ..++.++|||||||++|+|++|+.||.+.
T Consensus 160 ~~~---------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~ 212 (337)
T cd07858 160 EKG---------------------------DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGK 212 (337)
T ss_pred CCc---------------------------ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCC
Confidence 110 01123457889999998865 45788999999999999999999999876
Q ss_pred ChHHHHHHHHhC--C--------------------CC---C----CCCCCCCHHHHHHHHHccccCcCccCCChhcHHHH
Q 001847 905 TRQKTFANILHK--D--------------------LK---F----PSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEI 955 (1005)
Q Consensus 905 ~~~~~~~~i~~~--~--------------------~~---~----~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~el 955 (1005)
+.......+... . .. . .....++..+.+||.+||+.+|++||+ ++++
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps----~~el 288 (337)
T cd07858 213 DYVHQLKLITELLGSPSEEDLGFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRIT----VEEA 288 (337)
T ss_pred ChHHHHHHHHHHhCCCChHHhhhcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccC----HHHH
Confidence 544333222210 0 00 0 011346778899999999999999999 9999
Q ss_pred HcCCCCCCC
Q 001847 956 KKHPFFKGV 964 (1005)
Q Consensus 956 L~hpff~~~ 964 (1005)
++||||+.+
T Consensus 289 l~h~~~~~~ 297 (337)
T cd07858 289 LAHPYLASL 297 (337)
T ss_pred HcCcchhhh
Confidence 999999875
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=319.27 Aligned_cols=253 Identities=23% Similarity=0.329 Sum_probs=209.4
Q ss_pred cccCCccccccccccCcEEEEEEEE-----cCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceEEEEEEe
Q 001847 669 INLQHFRPIKPLGSGDTGSVHLVEL-----CGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQT 743 (1005)
Q Consensus 669 i~~~~y~~~~~LG~G~~g~Vy~a~~-----~~~~~~valK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~ 743 (1005)
|+.+.|.+.+.||+|+||.||++.+ ..++..+|+|.+... .......+.+|+.++++++||||+++++++..
T Consensus 2 ~~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 78 (288)
T cd05093 2 IKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA---SDNARKDFHREAELLTNLQHEHIVKFYGVCVE 78 (288)
T ss_pred CchHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCc---CHHHHHHHHHHHHHHHhCCCCCcceEEEEEec
Confidence 4457899999999999999999986 234567999988643 34456678899999999999999999999999
Q ss_pred CCeEEEEEeccCCCchhhHHhhCC-----------CCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCc
Q 001847 744 KTHVCLITDYCPGGELFLLLDRQP-----------TKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGH 812 (1005)
Q Consensus 744 ~~~~~lV~E~~~ggsL~~~l~~~~-----------~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~~~g~ 812 (1005)
.+.+|+||||+++++|.+++.... ...+++..+..++.||+.||+|||++|++||||||+|||+++++.
T Consensus 79 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~~~~~ 158 (288)
T cd05093 79 GDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLL 158 (288)
T ss_pred CCccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCc
Confidence 999999999999999999987432 124899999999999999999999999999999999999999999
Q ss_pred EEEEeccCCcccCCCCCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHH
Q 001847 813 VSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLY 892 (1005)
Q Consensus 813 vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlGvll~ 892 (1005)
++|+|||++........ ........+++.|+|||++.+..++.++|||||||++|
T Consensus 159 ~kl~dfg~~~~~~~~~~-------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~ 213 (288)
T cd05093 159 VKIGDFGMSRDVYSTDY-------------------------YRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLW 213 (288)
T ss_pred EEeccCCccccccCCce-------------------------eecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHH
Confidence 99999999854321110 00112234578899999998888899999999999999
Q ss_pred HHHc-CCCCCCCCChHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHccccCcCccCCChh
Q 001847 893 EMLY-GYTPFRGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHE 950 (1005)
Q Consensus 893 eLlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~ 950 (1005)
+|++ |..||...........+..+.... .....+..+.+|+.+||+.+|.+||++.+
T Consensus 214 ~l~t~g~~p~~~~~~~~~~~~i~~~~~~~-~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ 271 (288)
T cd05093 214 EIFTYGKQPWYQLSNNEVIECITQGRVLQ-RPRTCPKEVYDLMLGCWQREPHMRLNIKE 271 (288)
T ss_pred HHHhCCCCCCCCCCHHHHHHHHHcCCcCC-CCCCCCHHHHHHHHHHccCChhhCCCHHH
Confidence 9998 999998888777777776654322 22346788999999999999999999443
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=318.17 Aligned_cols=258 Identities=17% Similarity=0.231 Sum_probs=208.7
Q ss_pred cccCCccccccccccCcEEEEEEEEcC-----CCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceEEEEEEe
Q 001847 669 INLQHFRPIKPLGSGDTGSVHLVELCG-----SGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQT 743 (1005)
Q Consensus 669 i~~~~y~~~~~LG~G~~g~Vy~a~~~~-----~~~~valK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~ 743 (1005)
+..++|++.+.||+|+||.||++.+.. ++..+|+|.+.... .......+.+|+.+++.++||||+++++++..
T Consensus 3 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~--~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~ 80 (277)
T cd05062 3 VAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAA--SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQ 80 (277)
T ss_pred ccHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcC
Confidence 456789999999999999999998742 35679999886432 22344567889999999999999999999999
Q ss_pred CCeEEEEEeccCCCchhhHHhhCCC--------CCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEE
Q 001847 744 KTHVCLITDYCPGGELFLLLDRQPT--------KVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSL 815 (1005)
Q Consensus 744 ~~~~~lV~E~~~ggsL~~~l~~~~~--------~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~~~g~vkL 815 (1005)
....++||||+.+++|.+++..... ..++...+..++.|++.||.|||+.|++|+||||+||++++++.++|
T Consensus 81 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~~~~~~~l 160 (277)
T cd05062 81 GQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKI 160 (277)
T ss_pred CCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEcCCCCEEE
Confidence 9999999999999999999865321 23577889999999999999999999999999999999999999999
Q ss_pred EeccCCcccCCCCCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHH
Q 001847 816 TDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEML 895 (1005)
Q Consensus 816 ~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlGvll~eLl 895 (1005)
+|||++........ ........+++.|+|||++.+..++.++|||||||++|+|+
T Consensus 161 ~dfg~~~~~~~~~~-------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~ 215 (277)
T cd05062 161 GDFGMTRDIYETDY-------------------------YRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIA 215 (277)
T ss_pred CCCCCccccCCcce-------------------------eecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHH
Confidence 99998854321100 00011234578899999998888999999999999999999
Q ss_pred c-CCCCCCCCChHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHccccCcCccCCChhcHHHHHcC
Q 001847 896 Y-GYTPFRGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKH 958 (1005)
Q Consensus 896 t-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~h 958 (1005)
+ |..||.+.........+...... ......+..+.+|+.+||+.+|++||+ +.+++++
T Consensus 216 ~~~~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~p~~Rps----~~e~l~~ 274 (277)
T cd05062 216 TLAEQPYQGMSNEQVLRFVMEGGLL-DKPDNCPDMLFELMRMCWQYNPKMRPS----FLEIISS 274 (277)
T ss_pred cCCCCCCCCCCHHHHHHHHHcCCcC-CCCCCCCHHHHHHHHHHcCCChhhCcC----HHHHHHH
Confidence 8 78999888777766666554432 223346788999999999999999999 6666643
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=316.09 Aligned_cols=248 Identities=24% Similarity=0.327 Sum_probs=210.9
Q ss_pred CCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEE
Q 001847 672 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLIT 751 (1005)
Q Consensus 672 ~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~ 751 (1005)
.+|++++.||.|+||.||++.+.. +..+++|.+... .......+..|+.+++.++|+||+++++++......|+||
T Consensus 6 ~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 81 (261)
T cd05148 6 EEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSD---DLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIIT 81 (261)
T ss_pred HHHHHhhhhccCCCccEEEeEecC-CCcEEEEecccc---chhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEE
Confidence 479999999999999999999977 889999998754 2334557788999999999999999999999999999999
Q ss_pred eccCCCchhhHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCCCCC
Q 001847 752 DYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLL 831 (1005)
Q Consensus 752 E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~~ 831 (1005)
||+++++|.+++.......++...+..++.||+.||.|||++|++|+||||+||+++.++.+||+|||.+........
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~-- 159 (261)
T cd05148 82 ELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVY-- 159 (261)
T ss_pred eecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcCCceEEEccccchhhcCCccc--
Confidence 999999999999876566789999999999999999999999999999999999999999999999998854321100
Q ss_pred CCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCChHHHH
Q 001847 832 LPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY-GYTPFRGKTRQKTF 910 (1005)
Q Consensus 832 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlGvll~eLlt-G~~Pf~~~~~~~~~ 910 (1005)
......++..|++||.+....++.++||||||+++|+|++ |+.||.+....+.+
T Consensus 160 -------------------------~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~ 214 (261)
T cd05148 160 -------------------------LSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVY 214 (261)
T ss_pred -------------------------cccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHH
Confidence 0112235678999999988888999999999999999998 89999888777777
Q ss_pred HHHHhCCCCCCCCCCCCHHHHHHHHHccccCcCccCCChhc
Q 001847 911 ANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEG 951 (1005)
Q Consensus 911 ~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~ 951 (1005)
..+... ...+....++..+.+++.+||+.+|.+||++.++
T Consensus 215 ~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l 254 (261)
T cd05148 215 DQITAG-YRMPCPAKCPQEIYKIMLECWAAEPEDRPSFKAL 254 (261)
T ss_pred HHHHhC-CcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHH
Confidence 666643 3344445678899999999999999999994443
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=321.53 Aligned_cols=257 Identities=24% Similarity=0.367 Sum_probs=209.7
Q ss_pred cCCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeC--CeEE
Q 001847 671 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTK--THVC 748 (1005)
Q Consensus 671 ~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~--~~~~ 748 (1005)
.++|++.+.||.|+||.||+|.+..+++.+++|.++..... ......+.+|+.++++++||||+++++++... +..|
T Consensus 4 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~ 82 (293)
T cd07843 4 VDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEK-EGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIY 82 (293)
T ss_pred hhhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeecccc-ccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEE
Confidence 35899999999999999999999989999999999754322 22334567899999999999999999998877 8999
Q ss_pred EEEeccCCCchhhHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCC
Q 001847 749 LITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKP 828 (1005)
Q Consensus 749 lV~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~ 828 (1005)
+||||+. ++|.+++.... ..+++..++.++.||+.||.|||++|++|+||||+||+++.++.++|+|||++.......
T Consensus 83 lv~e~~~-~~L~~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~ 160 (293)
T cd07843 83 MVMEYVE-HDLKSLMETMK-QPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPL 160 (293)
T ss_pred EEehhcC-cCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCcEEEeecCceeeccCCc
Confidence 9999995 59988887543 358999999999999999999999999999999999999999999999999885433110
Q ss_pred CCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCC-CCChhhHHHHHHHHHHHHcCCCCCCCCChH
Q 001847 829 QLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAG-HTSAVDWWALGILLYEMLYGYTPFRGKTRQ 907 (1005)
Q Consensus 829 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~-~~~~sDIwSlGvll~eLltG~~Pf~~~~~~ 907 (1005)
.......+++.|+|||.+.+.. ++.++||||||+++|+|++|..||......
T Consensus 161 ---------------------------~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~ 213 (293)
T cd07843 161 ---------------------------KPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEI 213 (293)
T ss_pred ---------------------------cccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChH
Confidence 1112345788999999987643 578999999999999999999999887766
Q ss_pred HHHHHHHhCCC-------------------CC---------CCCCC--CCHHHHHHHHHccccCcCccCCChhcHHHHHc
Q 001847 908 KTFANILHKDL-------------------KF---------PSSTP--TSLHAKQLMYRLLHRDPKSRLGSHEGANEIKK 957 (1005)
Q Consensus 908 ~~~~~i~~~~~-------------------~~---------~~~~~--~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~ 957 (1005)
....++..... .+ ..... .+..+.+||.+||+.+|++||+ +.++|.
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t----~~ell~ 289 (293)
T cd07843 214 DQLNKIFKLLGTPTEKIWPGFSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRIS----AEDALK 289 (293)
T ss_pred HHHHHHHHHhCCCchHHHHHhhccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCC----HHHHhc
Confidence 55554432100 00 00111 3777899999999999999999 999999
Q ss_pred CCCC
Q 001847 958 HPFF 961 (1005)
Q Consensus 958 hpff 961 (1005)
||||
T Consensus 290 ~~~f 293 (293)
T cd07843 290 HPYF 293 (293)
T ss_pred CCCC
Confidence 9998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=319.75 Aligned_cols=256 Identities=27% Similarity=0.392 Sum_probs=203.1
Q ss_pred cCCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEE
Q 001847 671 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLI 750 (1005)
Q Consensus 671 ~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV 750 (1005)
.++|++++.||+|+||.||++.+..++..|++|.+..... ......+.+|+.+++.++|+||+++++++...+..|+|
T Consensus 4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv 81 (291)
T cd07870 4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTE--EGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFV 81 (291)
T ss_pred cceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCc--CCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEE
Confidence 3689999999999999999999999999999999875422 22233566899999999999999999999999999999
Q ss_pred EeccCCCchhhHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCCCC
Q 001847 751 TDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQL 830 (1005)
Q Consensus 751 ~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~ 830 (1005)
|||+ +++|.+++.... ..++...++.++.||+.||.|||+.||+|+||||+||+++.++.++|+|||++.......
T Consensus 82 ~e~~-~~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~-- 157 (291)
T cd07870 82 FEYM-HTDLAQYMIQHP-GGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPS-- 157 (291)
T ss_pred Eecc-cCCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcCCCcEEEeccccccccCCCC--
Confidence 9999 567777665432 347888899999999999999999999999999999999999999999999885422110
Q ss_pred CCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCC-CCCChhhHHHHHHHHHHHHcCCCCCCCCChH-H
Q 001847 831 LLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGA-GHTSAVDWWALGILLYEMLYGYTPFRGKTRQ-K 908 (1005)
Q Consensus 831 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~sDIwSlGvll~eLltG~~Pf~~~~~~-~ 908 (1005)
.......+++.|+|||.+.+. .++.++|||||||++|+|++|..||.+.... +
T Consensus 158 -------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~ 212 (291)
T cd07870 158 -------------------------QTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFE 212 (291)
T ss_pred -------------------------CCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHH
Confidence 011223578899999998754 4778999999999999999999999765432 2
Q ss_pred HHHHHHhC-C----------------------CCCC-------CCCCCCHHHHHHHHHccccCcCccCCChhcHHHHHcC
Q 001847 909 TFANILHK-D----------------------LKFP-------SSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKH 958 (1005)
Q Consensus 909 ~~~~i~~~-~----------------------~~~~-------~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~h 958 (1005)
.+..+... . ...+ .....+..+.+|+.+||..||.+||| +.+++.|
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t----~~~~l~h 288 (291)
T cd07870 213 QLEKIWTVLGVPTEDTWPGVSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRIS----AQDALLH 288 (291)
T ss_pred HHHHHHHHcCCCChhhhhhhhhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcC----HHHHhcC
Confidence 22222110 0 0000 00123567889999999999999999 9999999
Q ss_pred CCC
Q 001847 959 PFF 961 (1005)
Q Consensus 959 pff 961 (1005)
|||
T Consensus 289 ~~~ 291 (291)
T cd07870 289 PYF 291 (291)
T ss_pred CCC
Confidence 998
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=319.66 Aligned_cols=255 Identities=25% Similarity=0.419 Sum_probs=209.4
Q ss_pred ccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEEec
Q 001847 674 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDY 753 (1005)
Q Consensus 674 y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~ 753 (1005)
|++.+.||.|++|.||++.+..+|..||+|.+..... .......+.+|+.+++.++|||++++++++...+..|++|||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~ 79 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETE-DEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEF 79 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccc-cccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEec
Confidence 6788999999999999999999999999999875432 222335677899999999999999999999999999999999
Q ss_pred cCCCchhhHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCCCCCCC
Q 001847 754 CPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLP 833 (1005)
Q Consensus 754 ~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~~~~ 833 (1005)
+ +++|.+++.......+++..+..++.||+.||.|||+++++|+||+|+||+++.++.++|+|||.+.......
T Consensus 80 ~-~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~----- 153 (283)
T cd07835 80 L-DLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPV----- 153 (283)
T ss_pred c-CcCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCc-----
Confidence 9 5789999877654468999999999999999999999999999999999999999999999999985432110
Q ss_pred cchhhhhcccCCCCCcccccccccccccccCCcccccccccCC-CCCChhhHHHHHHHHHHHHcCCCCCCCCChHHHHHH
Q 001847 834 TTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGA-GHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFAN 912 (1005)
Q Consensus 834 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~sDIwSlGvll~eLltG~~Pf~~~~~~~~~~~ 912 (1005)
.......+++.|+|||++.+. .++.++||||||+++|+|++|+.||.+.+.......
T Consensus 154 ----------------------~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~ 211 (283)
T cd07835 154 ----------------------RTYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFR 211 (283)
T ss_pred ----------------------cccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 011223468899999988664 468899999999999999999999988766554444
Q ss_pred HHhCCC------------------CCC---------CCCCCCHHHHHHHHHccccCcCccCCChhcHHHHHcCCCC
Q 001847 913 ILHKDL------------------KFP---------SSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFF 961 (1005)
Q Consensus 913 i~~~~~------------------~~~---------~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~hpff 961 (1005)
+.+... .++ ....++..+.++|.+||+.+|.+||+ +.+++.||||
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt----~~~il~~~~~ 283 (283)
T cd07835 212 IFRTLGTPDEDVWPGVTSLPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRIS----AKAALQHPYF 283 (283)
T ss_pred HHHHhCCCChHHhhhhhhchhhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcC----HHHHhcCCCC
Confidence 332100 000 11345678899999999999999999 9999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=327.20 Aligned_cols=257 Identities=29% Similarity=0.475 Sum_probs=219.9
Q ss_pred cccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEEeccCC
Q 001847 677 IKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPG 756 (1005)
Q Consensus 677 ~~~LG~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~g 756 (1005)
.+.||+|.||+||-+.++++|+.||||++.+..+..+.. ..+.+|..||.++.||.||.+--.|+..+.+++|||.+.|
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqe-sqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~G 647 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQE-SQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHG 647 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchH-HHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcc
Confidence 378999999999999999999999999999876655444 7889999999999999999999999999999999999955
Q ss_pred CchhhHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecC---CcEEEEeccCCcccCCCCCCCCC
Q 001847 757 GELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGN---GHVSLTDFDLSCLTSCKPQLLLP 833 (1005)
Q Consensus 757 gsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~~~---g~vkL~DFG~a~~~~~~~~~~~~ 833 (1005)
+..+++-....+.|++...+.++.||+.||.|||-+||+|+||||+|||+.+. -.+||||||+|++++...
T Consensus 648 -DMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEks----- 721 (888)
T KOG4236|consen 648 -DMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKS----- 721 (888)
T ss_pred -hHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccceeecchhh-----
Confidence 55455544556779999999999999999999999999999999999999864 379999999998765321
Q ss_pred cchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHH
Q 001847 834 TTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANI 913 (1005)
Q Consensus 834 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlGvll~eLltG~~Pf~~~~~~~~~~~i 913 (1005)
-..+++|||.|+|||++....|+..-|+||.|+++|--++|..||..+. ++-..|
T Consensus 722 -----------------------FRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdE--dIndQI 776 (888)
T KOG4236|consen 722 -----------------------FRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDE--DINDQI 776 (888)
T ss_pred -----------------------hhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCcc--chhHHh
Confidence 1346799999999999999999999999999999999999999997653 344455
Q ss_pred HhCCCCCC--CCCCCCHHHHHHHHHccccCcCccCCChhcHHHHHcCCCCCCCC-hhhh
Q 001847 914 LHKDLKFP--SSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVN-WALV 969 (1005)
Q Consensus 914 ~~~~~~~~--~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~hpff~~~~-~~~~ 969 (1005)
....+-+| .+..++.++.+||..+|+..-.+|.+ +.+.|.|||+++.. |-++
T Consensus 777 QNAaFMyPp~PW~eis~~AidlIn~LLqVkm~kRys----vdk~lsh~Wlq~yq~w~DL 831 (888)
T KOG4236|consen 777 QNAAFMYPPNPWSEISPEAIDLINNLLQVKMRKRYS----VDKSLSHPWLQDYQTWLDL 831 (888)
T ss_pred hccccccCCCchhhcCHHHHHHHHHHHHHHHHHhcc----hHhhccchhhhcchHHHHH
Confidence 55544444 34568899999999999999999999 99999999999843 5555
|
|
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=316.90 Aligned_cols=248 Identities=31% Similarity=0.494 Sum_probs=200.2
Q ss_pred CCccccccc--cccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCeEE
Q 001847 672 QHFRPIKPL--GSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPALYASFQTKTHVC 748 (1005)
Q Consensus 672 ~~y~~~~~L--G~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~~ 748 (1005)
+.|.+.+.+ |+|+||.||++.++.++..+|+|.+....... .|+.+...+ +|+||++++++|...+..|
T Consensus 14 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~--------~e~~~~~~~~~h~~iv~~~~~~~~~~~~~ 85 (267)
T PHA03390 14 KNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA--------IEPMVHQLMKDNPNFIKLYYSVTTLKGHV 85 (267)
T ss_pred HhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch--------hhHHHHHHhhcCCCEEEEEEEEecCCeeE
Confidence 467777776 99999999999999999999999987542111 122222222 7999999999999999999
Q ss_pred EEEeccCCCchhhHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCC-cEEEEeccCCcccCCC
Q 001847 749 LITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNG-HVSLTDFDLSCLTSCK 827 (1005)
Q Consensus 749 lV~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~~~g-~vkL~DFG~a~~~~~~ 827 (1005)
+||||+++++|.+++... ..+++..+..++.||+.||.|||+.|++|+||||+||+++.++ .++|+|||++.....
T Consensus 86 iv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~- 162 (267)
T PHA03390 86 LIMDYIKDGDLFDLLKKE--GKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGT- 162 (267)
T ss_pred EEEEcCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCCCeEEEecCccceecCC-
Confidence 999999999999999765 3699999999999999999999999999999999999999988 999999998754321
Q ss_pred CCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHcCCCCCCCCChH
Q 001847 828 PQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQ 907 (1005)
Q Consensus 828 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlGvll~eLltG~~Pf~~~~~~ 907 (1005)
.....|+..|+|||++.+..++.++||||||+++|+|++|..||......
T Consensus 163 ------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~ 212 (267)
T PHA03390 163 ------------------------------PSCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDE 212 (267)
T ss_pred ------------------------------CccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcc
Confidence 11235788999999998888999999999999999999999999765433
Q ss_pred HH-HHHHHhC-CCCCCCCCCCCHHHHHHHHHccccCcCccCCChhcHHHHHcCCCCCC
Q 001847 908 KT-FANILHK-DLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKG 963 (1005)
Q Consensus 908 ~~-~~~i~~~-~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~hpff~~ 963 (1005)
.. ...+... ....+.....+..+.+||.+||+.+|.+||+. ++++|+||||++
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~---~~~~l~h~~~~~ 267 (267)
T PHA03390 213 ELDLESLLKRQQKKLPFIKNVSKNANDFVQSMLKYNINYRLTN---YNEIIKHPFLKI 267 (267)
T ss_pred hhhHHHHHHhhcccCCcccccCHHHHHHHHHHhccChhhCCch---HHHHhcCCcccC
Confidence 21 1111111 11122223578899999999999999999961 699999999974
|
|
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=314.27 Aligned_cols=250 Identities=25% Similarity=0.344 Sum_probs=207.9
Q ss_pred cccCCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEE
Q 001847 669 INLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVC 748 (1005)
Q Consensus 669 i~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~ 748 (1005)
+..++|++.+.||+|++|.||++.+. +++.||+|.++.... ....+.+|+.++++++|+||+++++++...+..|
T Consensus 3 ~~~~~~~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 77 (261)
T cd05068 3 IDRTSIQLLRKLGAGQFGEVWEGLWN-NTTPVAVKTLKPGTM----DPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIY 77 (261)
T ss_pred cchhheeeEEEecccCCccEEEEEec-CCeEEEEEeeCCCcc----cHHHHHHHHHHHHHCCCCCccceeEEEecCCCee
Confidence 44568999999999999999999974 457899999875422 2456778999999999999999999999999999
Q ss_pred EEEeccCCCchhhHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCC
Q 001847 749 LITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKP 828 (1005)
Q Consensus 749 lV~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~ 828 (1005)
+||||+.+++|.+++.......++...+..++.|++.||.|||++|++|+||||+||+++.++.++|+|||++.......
T Consensus 78 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~ 157 (261)
T cd05068 78 IVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDI 157 (261)
T ss_pred eeeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcCCCCEEECCcceEEEccCCc
Confidence 99999999999999976554568999999999999999999999999999999999999999999999999885543110
Q ss_pred CCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCChH
Q 001847 829 QLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY-GYTPFRGKTRQ 907 (1005)
Q Consensus 829 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlGvll~eLlt-G~~Pf~~~~~~ 907 (1005)
. ........+..|+|||++.+..++.++||||||+++|+|++ |+.||.+....
T Consensus 158 ~--------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~ 211 (261)
T cd05068 158 Y--------------------------EAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNA 211 (261)
T ss_pred c--------------------------cccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHH
Confidence 0 00111223468999999988888999999999999999998 99999888777
Q ss_pred HHHHHHHhCCCCCCCCCCCCHHHHHHHHHccccCcCccCCChh
Q 001847 908 KTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHE 950 (1005)
Q Consensus 908 ~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~ 950 (1005)
.....+... ...+.....+..+.+++.+||+.+|.+||++.+
T Consensus 212 ~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~ 253 (261)
T cd05068 212 EVLQQVDQG-YRMPCPPGCPKELYDIMLDCWKEDPDDRPTFET 253 (261)
T ss_pred HHHHHHHcC-CCCCCCCcCCHHHHHHHHHHhhcCcccCCCHHH
Confidence 666665443 333444557889999999999999999999433
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=324.36 Aligned_cols=250 Identities=26% Similarity=0.428 Sum_probs=190.4
Q ss_pred ccccccCcEEEEEEEEcC--CCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceEEEEEE--eCCeEEEEEec
Q 001847 678 KPLGSGDTGSVHLVELCG--SGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQ--TKTHVCLITDY 753 (1005)
Q Consensus 678 ~~LG~G~~g~Vy~a~~~~--~~~~valK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~--~~~~~~lV~E~ 753 (1005)
..||+|+||.||+|.+.. ++..||+|.+.... ....+.+|+.+++.++||||+++++++. ....+|+||||
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~-----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~ 81 (317)
T cd07867 7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG-----ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDY 81 (317)
T ss_pred eEeccCCCeeEEEEEecCCCccceEEEEEecCCC-----CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEee
Confidence 579999999999999754 56899999886532 1235678999999999999999999885 35678999999
Q ss_pred cCCCchhhHHhhC-------CCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE----ecCCcEEEEeccCCc
Q 001847 754 CPGGELFLLLDRQ-------PTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLL----QGNGHVSLTDFDLSC 822 (1005)
Q Consensus 754 ~~ggsL~~~l~~~-------~~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi----~~~g~vkL~DFG~a~ 822 (1005)
+ +++|.+++... ....+++..++.++.||+.||.|||+.||+||||||+|||+ +.++.+||+|||++.
T Consensus 82 ~-~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~ 160 (317)
T cd07867 82 A-EHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFAR 160 (317)
T ss_pred e-CCcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeecccee
Confidence 9 56888777521 12348899999999999999999999999999999999999 456799999999986
Q ss_pred ccCCCCCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCC-CCCChhhHHHHHHHHHHHHcCCCCC
Q 001847 823 LTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGA-GHTSAVDWWALGILLYEMLYGYTPF 901 (1005)
Q Consensus 823 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~sDIwSlGvll~eLltG~~Pf 901 (1005)
....... .........||+.|+|||++.+. .++.++|||||||++|+|++|++||
T Consensus 161 ~~~~~~~------------------------~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f 216 (317)
T cd07867 161 LFNSPLK------------------------PLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIF 216 (317)
T ss_pred ccCCCcc------------------------cccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCc
Confidence 5431110 01112345689999999998764 5788999999999999999999999
Q ss_pred CCCChH---------HHHHHHHhC--------------CCCC----------------------CCCCCCCHHHHHHHHH
Q 001847 902 RGKTRQ---------KTFANILHK--------------DLKF----------------------PSSTPTSLHAKQLMYR 936 (1005)
Q Consensus 902 ~~~~~~---------~~~~~i~~~--------------~~~~----------------------~~~~~~s~~l~~Ll~~ 936 (1005)
...... ..+..+... ...+ ......+..+.+||.+
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~ 296 (317)
T cd07867 217 HCRQEDIKTSNPFHHDQLDRIFSVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQK 296 (317)
T ss_pred ccccccccccccccHHHHHHHHHhcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHH
Confidence 653211 111111100 0000 0001234567899999
Q ss_pred ccccCcCccCCChhcHHHHHcCCCC
Q 001847 937 LLHRDPKSRLGSHEGANEIKKHPFF 961 (1005)
Q Consensus 937 ~L~~dP~~Rpt~~~~a~elL~hpff 961 (1005)
||+.||.+||| +.++|+||||
T Consensus 297 ~l~~dP~~R~t----~~e~l~hp~f 317 (317)
T cd07867 297 LLTMDPTKRIT----SEQALQDPYF 317 (317)
T ss_pred HhccCcccccC----HHHHhcCCCC
Confidence 99999999999 9999999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=319.92 Aligned_cols=257 Identities=29% Similarity=0.462 Sum_probs=210.2
Q ss_pred CCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEE
Q 001847 672 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLIT 751 (1005)
Q Consensus 672 ~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~ 751 (1005)
++|++.+.||+|++|.||+|.+..+++.|++|.++... ........+.+|+++++.++|+||+++++++...+..|+||
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~ 79 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESE-DDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVF 79 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhc-ccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEE
Confidence 37999999999999999999999999999999887542 23344567889999999999999999999999999999999
Q ss_pred eccCCCchhhHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCCCCC
Q 001847 752 DYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLL 831 (1005)
Q Consensus 752 E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~~ 831 (1005)
||+.++.+..+.... ..++...+..++.||+.||.|||+.|++|+||+|+||+++.++.+||+|||++........
T Consensus 80 e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~-- 155 (288)
T cd07833 80 EYVERTLLELLEASP--GGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPA-- 155 (288)
T ss_pred ecCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEEeeecccccCCCcc--
Confidence 999877666655443 4489999999999999999999999999999999999999999999999999855321110
Q ss_pred CCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCC-CCCChhhHHHHHHHHHHHHcCCCCCCCCChHHHH
Q 001847 832 LPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGA-GHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTF 910 (1005)
Q Consensus 832 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~sDIwSlGvll~eLltG~~Pf~~~~~~~~~ 910 (1005)
.......++..|+|||++.+. .++.++||||||+++|+|++|+.||.+.......
T Consensus 156 ------------------------~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~ 211 (288)
T cd07833 156 ------------------------SPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQL 211 (288)
T ss_pred ------------------------ccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 011234678899999999887 7888999999999999999999999876655444
Q ss_pred HHHHhC--C-----------------CCCC-----------CCCCCCHHHHHHHHHccccCcCccCCChhcHHHHHcCCC
Q 001847 911 ANILHK--D-----------------LKFP-----------SSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPF 960 (1005)
Q Consensus 911 ~~i~~~--~-----------------~~~~-----------~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~hpf 960 (1005)
..+... . ..++ ....++.++.+||.+||..+|++||+ ++++++|||
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps----~~~il~~~~ 287 (288)
T cd07833 212 YLIQKCLGPLPPSHQELFSSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLT----CDELLQHPY 287 (288)
T ss_pred HHHHHHhCCCCHHHhhhcccCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhccc----HHHHhcCCC
Confidence 333210 0 0000 01123778999999999999999999 999999999
Q ss_pred C
Q 001847 961 F 961 (1005)
Q Consensus 961 f 961 (1005)
|
T Consensus 288 f 288 (288)
T cd07833 288 F 288 (288)
T ss_pred C
Confidence 8
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=318.74 Aligned_cols=268 Identities=44% Similarity=0.769 Sum_probs=216.6
Q ss_pred CccccccccccCcEEEEEEEEc---CCCeEEEEEEeeccccc-ChHHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCeE
Q 001847 673 HFRPIKPLGSGDTGSVHLVELC---GSGQYFAMKAMDKGVML-NRNKVHRACAEREILDML-DHPFVPALYASFQTKTHV 747 (1005)
Q Consensus 673 ~y~~~~~LG~G~~g~Vy~a~~~---~~~~~valK~~~~~~~~-~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~ 747 (1005)
.|++.+.||.|+||.||+|.+. .+|..||+|++...... .......+.+|+.+++.+ +|+||+.++++|..+..+
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 4889999999999999999984 47899999998754322 223345677899999999 699999999999999999
Q ss_pred EEEEeccCCCchhhHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCC
Q 001847 748 CLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCK 827 (1005)
Q Consensus 748 ~lV~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~ 827 (1005)
|+||||+++++|.+++... ..+++..+..++.||+.||.|||+.|++||||+|+|||++.++.++|+|||++......
T Consensus 81 ~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~ 158 (290)
T cd05613 81 HLILDYINGGELFTHLSQR--ERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHED 158 (290)
T ss_pred EEEEecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECCCCCEEEeeCccceecccc
Confidence 9999999999999998764 45889999999999999999999999999999999999999999999999988543211
Q ss_pred CCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCC--CCCChhhHHHHHHHHHHHHcCCCCCCCCC
Q 001847 828 PQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGA--GHTSAVDWWALGILLYEMLYGYTPFRGKT 905 (1005)
Q Consensus 828 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~--~~~~~sDIwSlGvll~eLltG~~Pf~~~~ 905 (1005)
. ........|+..|+|||.+... .++.++||||||+++|+|++|..||....
T Consensus 159 ~--------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~ 212 (290)
T cd05613 159 E--------------------------VERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDG 212 (290)
T ss_pred c--------------------------ccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCC
Confidence 0 0111234688999999998653 46778999999999999999999996432
Q ss_pred h----HHHHHHHHhCCCCCCCCCCCCHHHHHHHHHccccCcCccCCCh-hcHHHHHcCCCCCCCChhhhh
Q 001847 906 R----QKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSH-EGANEIKKHPFFKGVNWALVR 970 (1005)
Q Consensus 906 ~----~~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~-~~a~elL~hpff~~~~~~~~~ 970 (1005)
. ......+......++ ..++..+.+|+.+||..+|.+||+.. ..+.+++.||||+.++|..+.
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~~~~~~ 280 (290)
T cd05613 213 EKNSQAEISRRILKSEPPYP--QEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKINWDDLA 280 (290)
T ss_pred ccccHHHHHHHhhccCCCCC--ccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcCcccccCCHHHHh
Confidence 2 233333333333333 33678899999999999999998432 349999999999999998773
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=317.38 Aligned_cols=254 Identities=28% Similarity=0.417 Sum_probs=215.1
Q ss_pred CccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEEe
Q 001847 673 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITD 752 (1005)
Q Consensus 673 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E 752 (1005)
-|++++.||.|+||.||++.+..++..+|+|.+.... .......+.+|+.+++.++||||+++++++..++..|+|||
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 82 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEE--AEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME 82 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEecccc--chHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEE
Confidence 4888999999999999999998899999999876432 23345678889999999999999999999999999999999
Q ss_pred ccCCCchhhHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCCCCCC
Q 001847 753 YCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLL 832 (1005)
Q Consensus 753 ~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~~~ 832 (1005)
|+.+++|..++.. ..++...+..++.|++.+|.|||+.|++|+||+|+||+++.++.++|+|||++.......
T Consensus 83 ~~~~~~l~~~i~~---~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~---- 155 (277)
T cd06641 83 YLGGGSALDLLEP---GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ---- 155 (277)
T ss_pred eCCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCCCCEEEeecccceecccch----
Confidence 9999999999864 348999999999999999999999999999999999999999999999999875432110
Q ss_pred CcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHcCCCCCCCCChHHHHHH
Q 001847 833 PTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFAN 912 (1005)
Q Consensus 833 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlGvll~eLltG~~Pf~~~~~~~~~~~ 912 (1005)
.......++..|+|||.+.+..++.++|+|||||++|+|++|..||...........
T Consensus 156 -----------------------~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~ 212 (277)
T cd06641 156 -----------------------IKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFL 212 (277)
T ss_pred -----------------------hhhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHH
Confidence 011234678899999999888888999999999999999999999987766555555
Q ss_pred HHhCCCCCCCCCCCCHHHHHHHHHccccCcCccCCChhcHHHHHcCCCCCC
Q 001847 913 ILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKG 963 (1005)
Q Consensus 913 i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~hpff~~ 963 (1005)
+.....+. ....++..+.+++.+||+.+|.+||+ +.++++||||..
T Consensus 213 ~~~~~~~~-~~~~~~~~~~~~i~~~l~~~p~~Rp~----~~~~l~~~~~~~ 258 (277)
T cd06641 213 IPKNNPPT-LEGNYSKPLKEFVEACLNKEPSFRPT----AKELLKHKFIVR 258 (277)
T ss_pred HhcCCCCC-CCcccCHHHHHHHHHHccCChhhCcC----HHHHHhCHHHhh
Confidence 44332221 22346788999999999999999999 999999999986
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-34 Score=320.49 Aligned_cols=255 Identities=26% Similarity=0.389 Sum_probs=217.6
Q ss_pred CCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEE
Q 001847 672 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLIT 751 (1005)
Q Consensus 672 ~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~ 751 (1005)
..|...+.||+|+||.||++.+..++..+|+|.+.............+.+|+.+++.++|+|++++++++...+..|+||
T Consensus 25 ~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 104 (317)
T cd06635 25 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVM 104 (317)
T ss_pred hhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEE
Confidence 35899999999999999999998899999999987654434455667889999999999999999999999999999999
Q ss_pred eccCCCchhhHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCCCCC
Q 001847 752 DYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLL 831 (1005)
Q Consensus 752 E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~~ 831 (1005)
||+. ++|.+++... ...+++..+..++.||+.||.|||++||+|+||+|+||+++.++.++|+|||++.....
T Consensus 105 e~~~-g~l~~~~~~~-~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~----- 177 (317)
T cd06635 105 EYCL-GSASDLLEVH-KKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIASP----- 177 (317)
T ss_pred eCCC-CCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECCCCCEEEecCCCccccCC-----
Confidence 9995 5777777543 34589999999999999999999999999999999999999999999999998743210
Q ss_pred CCcchhhhhcccCCCCCcccccccccccccccCCccccccccc---CCCCCChhhHHHHHHHHHHHHcCCCCCCCCChHH
Q 001847 832 LPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIA---GAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQK 908 (1005)
Q Consensus 832 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~---~~~~~~~sDIwSlGvll~eLltG~~Pf~~~~~~~ 908 (1005)
.....|++.|+|||++. ...++.++|||||||++|+|++|..||.......
T Consensus 178 --------------------------~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~ 231 (317)
T cd06635 178 --------------------------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS 231 (317)
T ss_pred --------------------------cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHH
Confidence 12345888999999974 3457889999999999999999999998877777
Q ss_pred HHHHHHhCCCCCCCCCCCCHHHHHHHHHccccCcCccCCChhcHHHHHcCCCCCC
Q 001847 909 TFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKG 963 (1005)
Q Consensus 909 ~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~hpff~~ 963 (1005)
....+.............+..+.+|+.+||+.+|.+||+ +.++++|+|+..
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt----~~~il~~~~~~~ 282 (317)
T cd06635 232 ALYHIAQNESPTLQSNEWSDYFRNFVDSCLQKIPQDRPT----SEELLKHMFVLR 282 (317)
T ss_pred HHHHHHhccCCCCCCccccHHHHHHHHHHccCCcccCcC----HHHHHhChhhhc
Confidence 677776665544444456788999999999999999999 999999999975
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=328.78 Aligned_cols=255 Identities=28% Similarity=0.433 Sum_probs=210.2
Q ss_pred cCCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC-----
Q 001847 671 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKT----- 745 (1005)
Q Consensus 671 ~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~----- 745 (1005)
.++|++++.||+|+||.||++.+..++..||+|.+.... ........+.+|+.+++.++||||+++++++....
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07880 14 PDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPF-QSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRF 92 (343)
T ss_pred ccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccc-cchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccccc
Confidence 468999999999999999999999999999999986532 23334456788999999999999999999987543
Q ss_pred -eEEEEEeccCCCchhhHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCccc
Q 001847 746 -HVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLT 824 (1005)
Q Consensus 746 -~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~~~g~vkL~DFG~a~~~ 824 (1005)
..|+||||+ +++|..++.. ..+++..++.++.||+.||.|||+.||+||||||+||+++.++.++|+|||++...
T Consensus 93 ~~~~lv~e~~-~~~l~~~~~~---~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~~~~~kl~dfg~~~~~ 168 (343)
T cd07880 93 HDFYLVMPFM-GTDLGKLMKH---EKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQT 168 (343)
T ss_pred ceEEEEEecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeccccccc
Confidence 468999999 8899888764 35899999999999999999999999999999999999999999999999988543
Q ss_pred CCCCCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccC-CCCCChhhHHHHHHHHHHHHcCCCCCCC
Q 001847 825 SCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAG-AGHTSAVDWWALGILLYEMLYGYTPFRG 903 (1005)
Q Consensus 825 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~sDIwSlGvll~eLltG~~Pf~~ 903 (1005)
.. ......+++.|+|||.+.+ ..++.++|+|||||++|+|++|..||.+
T Consensus 169 ~~------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~ 218 (343)
T cd07880 169 DS------------------------------EMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKG 218 (343)
T ss_pred cc------------------------------CccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 21 0122357889999999876 4578899999999999999999999988
Q ss_pred CChHHHHHHHHhCCCCCC-----------------------------CCCCCCHHHHHHHHHccccCcCccCCChhcHHH
Q 001847 904 KTRQKTFANILHKDLKFP-----------------------------SSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANE 954 (1005)
Q Consensus 904 ~~~~~~~~~i~~~~~~~~-----------------------------~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~e 954 (1005)
.+....+..+.......+ .....+..+.++|.+||+.||.+||| +.+
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t----~~~ 294 (343)
T cd07880 219 HDHLDQLMEIMKVTGTPSKEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRIT----AAE 294 (343)
T ss_pred CCHHHHHHHHHHhcCCCCHHHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCC----HHH
Confidence 766555544433211100 01245678899999999999999999 999
Q ss_pred HHcCCCCCCC
Q 001847 955 IKKHPFFKGV 964 (1005)
Q Consensus 955 lL~hpff~~~ 964 (1005)
++.||||+..
T Consensus 295 ~l~~~~~~~~ 304 (343)
T cd07880 295 ALAHPYFEEF 304 (343)
T ss_pred HhcCccHhhh
Confidence 9999999974
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=324.83 Aligned_cols=260 Identities=27% Similarity=0.441 Sum_probs=204.8
Q ss_pred CccccccccccCcEEEEEEEEcC--CCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeC--CeEE
Q 001847 673 HFRPIKPLGSGDTGSVHLVELCG--SGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTK--THVC 748 (1005)
Q Consensus 673 ~y~~~~~LG~G~~g~Vy~a~~~~--~~~~valK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~--~~~~ 748 (1005)
+|++.+.||+|++|.||+|.+.. ++..||+|.+.............+.+|+.+++.++||||+++++++... ..+|
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 58899999999999999999988 8999999999874322333446677899999999999999999999988 8899
Q ss_pred EEEeccCCCchhhHHhhC---CCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEec----CCcEEEEeccCC
Q 001847 749 LITDYCPGGELFLLLDRQ---PTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQG----NGHVSLTDFDLS 821 (1005)
Q Consensus 749 lV~E~~~ggsL~~~l~~~---~~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~~----~g~vkL~DFG~a 821 (1005)
+||||++ ++|.+++... ....+++..++.++.||+.||.|||++||+||||||+||+++. ++.+||+|||++
T Consensus 81 lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~~ 159 (316)
T cd07842 81 LLFDYAE-HDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLA 159 (316)
T ss_pred EEEeCCC-cCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccceEEECCCccc
Confidence 9999995 5677666432 1236899999999999999999999999999999999999999 899999999998
Q ss_pred cccCCCCCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCC-CCCChhhHHHHHHHHHHHHcCCCC
Q 001847 822 CLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGA-GHTSAVDWWALGILLYEMLYGYTP 900 (1005)
Q Consensus 822 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~sDIwSlGvll~eLltG~~P 900 (1005)
......... ........+++.|+|||++.+. .++.++|||||||++|+|++|+.|
T Consensus 160 ~~~~~~~~~------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~ 215 (316)
T cd07842 160 RLFNAPLKP------------------------LADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPI 215 (316)
T ss_pred cccCCCccc------------------------ccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCC
Confidence 654321110 1112335688999999988764 578899999999999999999999
Q ss_pred CCCCChHH---------HHHHHHh--------------------------CCCCCCC---------CCCCCHHHHHHHHH
Q 001847 901 FRGKTRQK---------TFANILH--------------------------KDLKFPS---------STPTSLHAKQLMYR 936 (1005)
Q Consensus 901 f~~~~~~~---------~~~~i~~--------------------------~~~~~~~---------~~~~s~~l~~Ll~~ 936 (1005)
|.+..... .+..++. ....++. ....+..+.++|.+
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ 295 (316)
T cd07842 216 FKGREAKIKKSNPFQRDQLERIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRK 295 (316)
T ss_pred CcCCcccccccchhHHHHHHHHHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHH
Confidence 97644321 1111110 0001110 01356678999999
Q ss_pred ccccCcCccCCChhcHHHHHcCCCC
Q 001847 937 LLHRDPKSRLGSHEGANEIKKHPFF 961 (1005)
Q Consensus 937 ~L~~dP~~Rpt~~~~a~elL~hpff 961 (1005)
||+.||.+||| +.++++||||
T Consensus 296 ~l~~~P~~Rps----~~eil~~~~f 316 (316)
T cd07842 296 LLEYDPTKRIT----AEEALEHPYF 316 (316)
T ss_pred HhcCCcccCcC----HHHHhcCCCC
Confidence 99999999999 9999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=324.55 Aligned_cols=254 Identities=24% Similarity=0.327 Sum_probs=206.2
Q ss_pred cccCCccccccccccCcEEEEEEEEcCCCe----EEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeC
Q 001847 669 INLQHFRPIKPLGSGDTGSVHLVELCGSGQ----YFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTK 744 (1005)
Q Consensus 669 i~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~----~valK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~ 744 (1005)
+...+|++++.||+|+||.||++.+..++. .||+|.+... ........+.+|+.+++.++||||+++++++...
T Consensus 4 ~~~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~ 81 (316)
T cd05108 4 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA--TSPKANKEILDEAYVMASVDNPHVCRLLGICLTS 81 (316)
T ss_pred cchhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEecccc--CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC
Confidence 345689999999999999999999866655 4899988643 2334456788899999999999999999988764
Q ss_pred CeEEEEEeccCCCchhhHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCccc
Q 001847 745 THVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLT 824 (1005)
Q Consensus 745 ~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~~~g~vkL~DFG~a~~~ 824 (1005)
..++|++|+.+|+|.+++.... ..++...+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++...
T Consensus 82 -~~~~v~e~~~~g~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~ 159 (316)
T cd05108 82 -TVQLITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLL 159 (316)
T ss_pred -CceeeeecCCCCCHHHHHHhcc-ccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEecCCCcEEEccccccccc
Confidence 5789999999999999997643 35888999999999999999999999999999999999999999999999998654
Q ss_pred CCCCCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHc-CCCCCCC
Q 001847 825 SCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY-GYTPFRG 903 (1005)
Q Consensus 825 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlGvll~eLlt-G~~Pf~~ 903 (1005)
...... .......++..|+|||++.+..++.++|||||||++|+|++ |..||.+
T Consensus 160 ~~~~~~-------------------------~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~ 214 (316)
T cd05108 160 GADEKE-------------------------YHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG 214 (316)
T ss_pred cCCCcc-------------------------eeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCC
Confidence 321110 00112234678999999998889999999999999999997 9999987
Q ss_pred CChHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHccccCcCccCCChhcH
Q 001847 904 KTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGA 952 (1005)
Q Consensus 904 ~~~~~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a 952 (1005)
....+. ..+......++....++..+.+++.+||..+|++||++.+++
T Consensus 215 ~~~~~~-~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~ 262 (316)
T cd05108 215 IPASEI-SSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELI 262 (316)
T ss_pred CCHHHH-HHHHhCCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHH
Confidence 765554 445555445555556788899999999999999999944433
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=316.84 Aligned_cols=258 Identities=19% Similarity=0.248 Sum_probs=210.6
Q ss_pred ccccCCccccccccccCcEEEEEEEEcCC-----CeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceEEEEEE
Q 001847 668 QINLQHFRPIKPLGSGDTGSVHLVELCGS-----GQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQ 742 (1005)
Q Consensus 668 ~i~~~~y~~~~~LG~G~~g~Vy~a~~~~~-----~~~valK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~ 742 (1005)
.+..++|++.+.||+|+||.||++.+... +..|++|.+.... .......+.+|+.+++.++|+||+++++++.
T Consensus 2 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~--~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~ 79 (277)
T cd05032 2 ELPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENA--SMRERIEFLNEASVMKEFNCHHVVRLLGVVS 79 (277)
T ss_pred ccchHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCcc--CHHHHHHHHHHHHHHHhCCCCceeEEEEEEc
Confidence 45677999999999999999999998644 4789999986542 2334456778999999999999999999999
Q ss_pred eCCeEEEEEeccCCCchhhHHhhCC--------CCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEE
Q 001847 743 TKTHVCLITDYCPGGELFLLLDRQP--------TKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVS 814 (1005)
Q Consensus 743 ~~~~~~lV~E~~~ggsL~~~l~~~~--------~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~~~g~vk 814 (1005)
.....|+||||+.+++|.+++.... ...+++..+..++.||+.||.|||++||+|+||||+|||++.++.+|
T Consensus 80 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~~~~~~k 159 (277)
T cd05032 80 TGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVK 159 (277)
T ss_pred CCCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEcCCCCEE
Confidence 9999999999999999999986432 22467889999999999999999999999999999999999999999
Q ss_pred EEeccCCcccCCCCCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHH
Q 001847 815 LTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEM 894 (1005)
Q Consensus 815 L~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlGvll~eL 894 (1005)
|+|||++........ ........++..|+|||.+....++.++|||||||++|+|
T Consensus 160 l~dfg~~~~~~~~~~-------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el 214 (277)
T cd05032 160 IGDFGMTRDIYETDY-------------------------YRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEM 214 (277)
T ss_pred ECCcccchhhccCcc-------------------------cccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHh
Confidence 999998854321100 0111233567889999999888889999999999999999
Q ss_pred Hc-CCCCCCCCChHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHccccCcCccCCChhcHHHHHc
Q 001847 895 LY-GYTPFRGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKK 957 (1005)
Q Consensus 895 lt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~ 957 (1005)
++ |..||.+.+.......+.... ........+..+.+|+.+||+.+|++||| +.++++
T Consensus 215 ~t~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rpt----~~~l~~ 273 (277)
T cd05032 215 ATLAEQPYQGLSNEEVLKFVIDGG-HLDLPENCPDKLLELMRMCWQYNPKMRPT----FLEIVS 273 (277)
T ss_pred hccCCCCCccCCHHHHHHHHhcCC-CCCCCCCCCHHHHHHHHHHcCCChhhCCC----HHHHHH
Confidence 98 999998877777666555332 22233346889999999999999999999 666553
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=327.29 Aligned_cols=260 Identities=25% Similarity=0.420 Sum_probs=207.0
Q ss_pred cCCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeC-----C
Q 001847 671 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTK-----T 745 (1005)
Q Consensus 671 ~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~-----~ 745 (1005)
.++|++.+.||+|+||.||++.+..+|+.||+|.+... ........+.+|+.+++.++|+||+++++++... .
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 81 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPF--EHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFN 81 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEeccc--ccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccc
Confidence 36899999999999999999999999999999998642 2233456677899999999999999999887643 3
Q ss_pred eEEEEEeccCCCchhhHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccC
Q 001847 746 HVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTS 825 (1005)
Q Consensus 746 ~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~~~g~vkL~DFG~a~~~~ 825 (1005)
.+|+||||+ +++|..++.. ..+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++....
T Consensus 82 ~~~lv~e~~-~~~l~~~~~~---~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~ 157 (336)
T cd07849 82 DVYIVQELM-ETDLYKLIKT---QHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIAD 157 (336)
T ss_pred eEEEEehhc-ccCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEECcccceeecc
Confidence 589999999 5688877754 358999999999999999999999999999999999999999999999999985432
Q ss_pred CCCCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccC-CCCCChhhHHHHHHHHHHHHcCCCCCCCC
Q 001847 826 CKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAG-AGHTSAVDWWALGILLYEMLYGYTPFRGK 904 (1005)
Q Consensus 826 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~sDIwSlGvll~eLltG~~Pf~~~ 904 (1005)
.... .........|++.|+|||.+.+ ..++.++|||||||++|+|++|+.||.+.
T Consensus 158 ~~~~------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~ 213 (336)
T cd07849 158 PEHD------------------------HTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGK 213 (336)
T ss_pred cccc------------------------ccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 1100 0001123568999999998754 46788999999999999999999999876
Q ss_pred ChHHHHHHHHhC----------------------CCCCCC-------CCCCCHHHHHHHHHccccCcCccCCChhcHHHH
Q 001847 905 TRQKTFANILHK----------------------DLKFPS-------STPTSLHAKQLMYRLLHRDPKSRLGSHEGANEI 955 (1005)
Q Consensus 905 ~~~~~~~~i~~~----------------------~~~~~~-------~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~el 955 (1005)
+.......+... ..+... ....+..+.+||.+||+.+|++||+ +.++
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt----~~e~ 289 (336)
T cd07849 214 DYLHQLNLILGVLGTPSQEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRIT----VEEA 289 (336)
T ss_pred CHHHHHHHHHHHcCCCCHHHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcC----HHHH
Confidence 544333222110 000000 1234667899999999999999999 9999
Q ss_pred HcCCCCCCC
Q 001847 956 KKHPFFKGV 964 (1005)
Q Consensus 956 L~hpff~~~ 964 (1005)
++||||+.+
T Consensus 290 l~hp~~~~~ 298 (336)
T cd07849 290 LAHPYLEQY 298 (336)
T ss_pred hcCcccccc
Confidence 999999975
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=316.60 Aligned_cols=251 Identities=27% Similarity=0.464 Sum_probs=202.3
Q ss_pred ccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhC-CCCCcceEEEEEEeC--CeEEEE
Q 001847 674 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPALYASFQTK--THVCLI 750 (1005)
Q Consensus 674 y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~--~~~~lV 750 (1005)
|++++.||+|+||.||++.+..+++.||+|.++.... ... ......|+.++.++ +|+||+++++++... +.+++|
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~-~~~-~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv 78 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFK-SLE-QVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALV 78 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccC-Cch-hhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEE
Confidence 7889999999999999999999999999999875422 222 22345788888888 599999999999987 899999
Q ss_pred EeccCCCchhhHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCCCC
Q 001847 751 TDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQL 830 (1005)
Q Consensus 751 ~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~ 830 (1005)
|||+. ++|.+.+.... ..+++..++.++.||+.||.|||+.|++|+||+|+||+++. +.+||+|||++.......
T Consensus 79 ~e~~~-~~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~-- 153 (282)
T cd07831 79 FELMD-MNLYELIKGRK-RPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD-DILKLADFGSCRGIYSKP-- 153 (282)
T ss_pred EecCC-ccHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcC-CCeEEEecccccccccCC--
Confidence 99995 57877776532 45899999999999999999999999999999999999999 999999999885432110
Q ss_pred CCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccC-CCCCChhhHHHHHHHHHHHHcCCCCCCCCChHHH
Q 001847 831 LLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAG-AGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKT 909 (1005)
Q Consensus 831 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~sDIwSlGvll~eLltG~~Pf~~~~~~~~ 909 (1005)
......+++.|+|||++.. ..++.++|||||||++|+|++|..||.+.+..+.
T Consensus 154 --------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~ 207 (282)
T cd07831 154 --------------------------PYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQ 207 (282)
T ss_pred --------------------------CcCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHH
Confidence 1112457889999998654 4567899999999999999999999988776554
Q ss_pred HHHHHhC------------------CCCCCC---------CCCCCHHHHHHHHHccccCcCccCCChhcHHHHHcCCCC
Q 001847 910 FANILHK------------------DLKFPS---------STPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFF 961 (1005)
Q Consensus 910 ~~~i~~~------------------~~~~~~---------~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~hpff 961 (1005)
+..+... ...++. ....+..+.+||.+||..+|++||+ +.++++||||
T Consensus 208 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~----~~~~l~~~~~ 282 (282)
T cd07831 208 IAKIHDVLGTPDAEVLKKFRKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERIT----AKQALRHPYF 282 (282)
T ss_pred HHHHHHHcCCCCHHHHHhhcccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccC----HHHHhhCCCC
Confidence 4444321 011111 1235788999999999999999999 9999999998
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=313.50 Aligned_cols=249 Identities=24% Similarity=0.384 Sum_probs=205.2
Q ss_pred ccccCCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeE
Q 001847 668 QINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHV 747 (1005)
Q Consensus 668 ~i~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 747 (1005)
.+..++|++++.||+|+||.||+|.+. .+..+|+|.+..... ....+.+|+.++++++|+|++++++++. ....
T Consensus 2 ~~~~~~~~~~~~ig~g~~~~v~~~~~~-~~~~~~~k~~~~~~~----~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~ 75 (260)
T cd05070 2 EIPRESLQLIKKLGNGQFGEVWMGTWN-GNTKVAVKTLKPGTM----SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPI 75 (260)
T ss_pred CCchHHhhhhheeccccCceEEEEEec-CCceeEEEEecCCCC----CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCc
Confidence 355678999999999999999999874 566799999876432 2356788999999999999999999875 4568
Q ss_pred EEEEeccCCCchhhHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCC
Q 001847 748 CLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCK 827 (1005)
Q Consensus 748 ~lV~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~ 827 (1005)
|++|||+.+++|.+++.......+++..++.++.||+.||.|||++|++|+||||+||++++++.++|+|||++......
T Consensus 76 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~ 155 (260)
T cd05070 76 YIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDN 155 (260)
T ss_pred EEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeCCceEEeCCceeeeeccCc
Confidence 99999999999999997655556899999999999999999999999999999999999999999999999998543211
Q ss_pred CCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCh
Q 001847 828 PQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY-GYTPFRGKTR 906 (1005)
Q Consensus 828 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlGvll~eLlt-G~~Pf~~~~~ 906 (1005)
.. .......++..|+|||.+.+..++.++||||||+++|+|++ |..||.+.+.
T Consensus 156 ~~--------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~ 209 (260)
T cd05070 156 EY--------------------------TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNN 209 (260)
T ss_pred cc--------------------------ccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCH
Confidence 00 01112235667999999988888999999999999999999 9999988777
Q ss_pred HHHHHHHHhCCCCCCCCCCCCHHHHHHHHHccccCcCccCCCh
Q 001847 907 QKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSH 949 (1005)
Q Consensus 907 ~~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~ 949 (1005)
.+....+... ...+.....+..+.+|+.+||..+|.+|||+.
T Consensus 210 ~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~ 251 (260)
T cd05070 210 REVLEQVERG-YRMPCPQDCPISLHELMLQCWKKDPEERPTFE 251 (260)
T ss_pred HHHHHHHHcC-CCCCCCCcCCHHHHHHHHHHcccCcccCcCHH
Confidence 7766666543 23333445678899999999999999999933
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=321.07 Aligned_cols=261 Identities=25% Similarity=0.361 Sum_probs=208.3
Q ss_pred cCCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCC-CCCcceEEEEEEeCCeEEE
Q 001847 671 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLD-HPFVPALYASFQTKTHVCL 749 (1005)
Q Consensus 671 ~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~il~~l~-hpnIv~l~~~~~~~~~~~l 749 (1005)
.++|...+.||+|+||.||++.+..+++.+|+|.+..... ......+.+|+.++.++. |+||+++++++...+..++
T Consensus 3 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~ 80 (288)
T cd06616 3 AEDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVD--EKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWI 80 (288)
T ss_pred HHHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccC--hHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEE
Confidence 3578888999999999999999999999999999875432 244567788999999995 9999999999999999999
Q ss_pred EEeccCCCchhhHHh---hCCCCCCCHHHHHHHHHHHHHHHHHHHHc-CcccCCCCCCcEEEecCCcEEEEeccCCcccC
Q 001847 750 ITDYCPGGELFLLLD---RQPTKVLKEDAVRFYAAEVVVALEYLHCQ-GIIYRDLKPENVLLQGNGHVSLTDFDLSCLTS 825 (1005)
Q Consensus 750 V~E~~~ggsL~~~l~---~~~~~~l~~~~i~~i~~qil~aL~~LH~~-gIvHrDLkP~NILi~~~g~vkL~DFG~a~~~~ 825 (1005)
+|||+ +++|.++.. ......+++..+..++.|++.||+|||+. |++||||||+||+++.++.++|+|||++....
T Consensus 81 ~~e~~-~~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~ 159 (288)
T cd06616 81 CMELM-DISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLV 159 (288)
T ss_pred EEecc-cCCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCCcEEEeecchhHHhc
Confidence 99999 456555432 22335699999999999999999999975 99999999999999999999999999885422
Q ss_pred CCCCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCC---CCCChhhHHHHHHHHHHHHcCCCCCC
Q 001847 826 CKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGA---GHTSAVDWWALGILLYEMLYGYTPFR 902 (1005)
Q Consensus 826 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~---~~~~~sDIwSlGvll~eLltG~~Pf~ 902 (1005)
.. .......|++.|+|||++... .++.++|||||||++|+|++|+.||.
T Consensus 160 ~~----------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~ 211 (288)
T cd06616 160 DS----------------------------IAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYP 211 (288)
T ss_pred cC----------------------------CccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCch
Confidence 10 011223578899999998766 67889999999999999999999997
Q ss_pred CCCh-HHHHHHHHhCCCC-CC--CCCCCCHHHHHHHHHccccCcCccCCChhcHHHHHcCCCCCCCCh
Q 001847 903 GKTR-QKTFANILHKDLK-FP--SSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVNW 966 (1005)
Q Consensus 903 ~~~~-~~~~~~i~~~~~~-~~--~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~hpff~~~~~ 966 (1005)
.... .+....+.....+ .+ ....++..+.+||.+||..+|++||+ ++++++||||+...+
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt----~~~i~~~~~~~~~~~ 275 (288)
T cd06616 212 KWNSVFDQLTQVVKGDPPILSNSEEREFSPSFVNFINLCLIKDESKRPK----YKELLEHPFIKDYEE 275 (288)
T ss_pred hcchHHHHHhhhcCCCCCcCCCcCCCccCHHHHHHHHHHccCChhhCcC----HHHHhcChhhhchhh
Confidence 6542 2222233222221 11 12246789999999999999999999 999999999987543
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-34 Score=320.43 Aligned_cols=256 Identities=22% Similarity=0.327 Sum_probs=209.6
Q ss_pred ccccCCccccccccccCcEEEEEEEEc-----CCCeEEEEEEeecccccChHHHHHHHHHHHHHHhC-CCCCcceEEEEE
Q 001847 668 QINLQHFRPIKPLGSGDTGSVHLVELC-----GSGQYFAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPALYASF 741 (1005)
Q Consensus 668 ~i~~~~y~~~~~LG~G~~g~Vy~a~~~-----~~~~~valK~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~ 741 (1005)
.+..++|.+.+.||+|+||.||++.+. .++..+|+|.++... .......+.+|+.+++++ +|+||+++++++
T Consensus 31 ~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~ 108 (302)
T cd05055 31 EFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTA--HSSEREALMSELKIMSHLGNHENIVNLLGAC 108 (302)
T ss_pred cccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccC--ChHHHHHHHHHHHHHHhccCCCCcceEEEEE
Confidence 355678999999999999999999862 345689999887542 233456788999999999 799999999999
Q ss_pred EeCCeEEEEEeccCCCchhhHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCC
Q 001847 742 QTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLS 821 (1005)
Q Consensus 742 ~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~~~g~vkL~DFG~a 821 (1005)
...+..|+||||+.+++|.+++.......+++..+..++.||+.||.|||++||+|+||||+|||++.++.++|+|||++
T Consensus 109 ~~~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~dfg~~ 188 (302)
T cd05055 109 TIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDFGLA 188 (302)
T ss_pred ecCCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEcCCCeEEECCCccc
Confidence 99999999999999999999997654445899999999999999999999999999999999999999999999999998
Q ss_pred cccCCCCCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHc-CCCC
Q 001847 822 CLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY-GYTP 900 (1005)
Q Consensus 822 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlGvll~eLlt-G~~P 900 (1005)
........ ........+++.|+|||.+.+..++.++|||||||++|+|++ |..|
T Consensus 189 ~~~~~~~~-------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p 243 (302)
T cd05055 189 RDIMNDSN-------------------------YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNP 243 (302)
T ss_pred ccccCCCc-------------------------eeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCC
Confidence 54321100 001122346788999999988889999999999999999998 9999
Q ss_pred CCCCChHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHccccCcCccCCChh
Q 001847 901 FRGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHE 950 (1005)
Q Consensus 901 f~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~ 950 (1005)
|.+.......................+..+.+|+.+||..+|++||++.+
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~e 293 (302)
T cd05055 244 YPGMPVDSKFYKLIKEGYRMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQ 293 (302)
T ss_pred cCCCCchHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHH
Confidence 98776655555555544444444456789999999999999999999443
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-34 Score=313.65 Aligned_cols=248 Identities=23% Similarity=0.354 Sum_probs=203.9
Q ss_pred cccCCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEE
Q 001847 669 INLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVC 748 (1005)
Q Consensus 669 i~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~ 748 (1005)
+..++|++.+.||+|+||.||++.+..+ ..+|+|.+..... ....+.+|+.+++.++||||+++++.+. ....|
T Consensus 3 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~-~~valK~~~~~~~----~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~ 76 (262)
T cd05071 3 IPRESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTM----SPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIY 76 (262)
T ss_pred CChHHeeEeeecCCCCCCcEEEEEecCC-ceEEEEecccCcc----CHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcE
Confidence 4456899999999999999999998655 4599999875321 2356788999999999999999998875 45689
Q ss_pred EEEeccCCCchhhHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCC
Q 001847 749 LITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKP 828 (1005)
Q Consensus 749 lV~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~ 828 (1005)
+||||+.+++|.+++.......++...+..++.|++.||+|||++|++|+||||+||+++.++.++|+|||.+.......
T Consensus 77 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~ 156 (262)
T cd05071 77 IVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE 156 (262)
T ss_pred EEEEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcCCCcEEeccCCceeeccccc
Confidence 99999999999999986544568999999999999999999999999999999999999999999999999885432110
Q ss_pred CCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCChH
Q 001847 829 QLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY-GYTPFRGKTRQ 907 (1005)
Q Consensus 829 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlGvll~eLlt-G~~Pf~~~~~~ 907 (1005)
. .......++..|+|||++.+..++.++|||||||++|+|++ |..||.+....
T Consensus 157 ~--------------------------~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~ 210 (262)
T cd05071 157 Y--------------------------TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR 210 (262)
T ss_pred c--------------------------ccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChH
Confidence 0 01112346778999999988889999999999999999999 89999887776
Q ss_pred HHHHHHHhCCCCCCCCCCCCHHHHHHHHHccccCcCccCCCh
Q 001847 908 KTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSH 949 (1005)
Q Consensus 908 ~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~ 949 (1005)
.....+... ...+....++..+.+|+.+||..+|++||++.
T Consensus 211 ~~~~~~~~~-~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~ 251 (262)
T cd05071 211 EVLDQVERG-YRMPCPPECPESLHDLMCQCWRKEPEERPTFE 251 (262)
T ss_pred HHHHHHhcC-CCCCCccccCHHHHHHHHHHccCCcccCCCHH
Confidence 666655443 23333455788899999999999999999933
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-34 Score=312.41 Aligned_cols=252 Identities=28% Similarity=0.405 Sum_probs=207.7
Q ss_pred CCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEE
Q 001847 672 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLIT 751 (1005)
Q Consensus 672 ~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~ 751 (1005)
++|++.+.||+|++|.||+|.+..+|+.|++|.++............+.+|++++++++|+||+++++++...+..++||
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 57999999999999999999998899999999987644444555678889999999999999999999999999999999
Q ss_pred eccCCCchhhHHhhC--CCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCCC
Q 001847 752 DYCPGGELFLLLDRQ--PTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQ 829 (1005)
Q Consensus 752 E~~~ggsL~~~l~~~--~~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~ 829 (1005)
||+++++|..++... ....++...+..++.||+.||.|||+.||+|+||+|+||+++.++.++|+|||++.......
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~- 160 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT- 160 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECCCCcEEEeccceeeeccCCC-
Confidence 999999999998642 23458999999999999999999999999999999999999999999999999875432110
Q ss_pred CCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCh--H
Q 001847 830 LLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTR--Q 907 (1005)
Q Consensus 830 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlGvll~eLltG~~Pf~~~~~--~ 907 (1005)
.......+++.|+|||.+.+..++.++|||||||++|+|++|+.||..... .
T Consensus 161 --------------------------~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~ 214 (267)
T cd08224 161 --------------------------TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLY 214 (267)
T ss_pred --------------------------cccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCccHH
Confidence 011234588899999999888889999999999999999999999965432 2
Q ss_pred HHHHHHHhCCCCCCCCCCCCHHHHHHHHHccccCcCccCCChh
Q 001847 908 KTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHE 950 (1005)
Q Consensus 908 ~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~ 950 (1005)
.....+..+..........+..+.++|.+||..+|++||++.+
T Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ 257 (267)
T cd08224 215 SLCKKIEKCDYPPLPADHYSEELRDLVSRCINPDPEKRPDISY 257 (267)
T ss_pred HHHhhhhcCCCCCCChhhcCHHHHHHHHHHcCCCcccCCCHHH
Confidence 3333333332221112246778999999999999999999433
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-34 Score=317.08 Aligned_cols=256 Identities=22% Similarity=0.345 Sum_probs=208.1
Q ss_pred ccCCccccccccccCcEEEEEEEEc----CCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC
Q 001847 670 NLQHFRPIKPLGSGDTGSVHLVELC----GSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKT 745 (1005)
Q Consensus 670 ~~~~y~~~~~LG~G~~g~Vy~a~~~----~~~~~valK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~ 745 (1005)
..++|++.+.||+|+||.||++.+. .++..+++|.+... ........+.+|+.+++.++||||+++++++...+
T Consensus 3 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 80 (283)
T cd05090 3 PLSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDI--NNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQ 80 (283)
T ss_pred ChhhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCC--CCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCC
Confidence 4568999999999999999999863 35678999998753 23344567888999999999999999999999999
Q ss_pred eEEEEEeccCCCchhhHHhhCC---------------CCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecC
Q 001847 746 HVCLITDYCPGGELFLLLDRQP---------------TKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGN 810 (1005)
Q Consensus 746 ~~~lV~E~~~ggsL~~~l~~~~---------------~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~~~ 810 (1005)
..|+||||+++++|.+++.... ...+++..+..++.||+.||.|||++|++|+||||+|||++.+
T Consensus 81 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili~~~ 160 (283)
T cd05090 81 PVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQ 160 (283)
T ss_pred ceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEEcCC
Confidence 9999999999999999985321 1247888999999999999999999999999999999999999
Q ss_pred CcEEEEeccCCcccCCCCCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHH
Q 001847 811 GHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGIL 890 (1005)
Q Consensus 811 g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlGvl 890 (1005)
+.+||+|||++........ ........++..|+|||++.+..++.++|||||||+
T Consensus 161 ~~~kl~dfg~~~~~~~~~~-------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i 215 (283)
T cd05090 161 LHVKISDLGLSREIYSADY-------------------------YRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVV 215 (283)
T ss_pred CcEEeccccccccccCCcc-------------------------eecccCCCccceecChHHhccCCCCchhhhHHHHHH
Confidence 9999999999854321110 011122345678999999988888999999999999
Q ss_pred HHHHHc-CCCCCCCCChHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHccccCcCccCCChhcHHHHHc
Q 001847 891 LYEMLY-GYTPFRGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKK 957 (1005)
Q Consensus 891 l~eLlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~ 957 (1005)
+|+|++ |..||.+.........+... ...+....++..+.+++.+||+.+|.+||+ +.++++
T Consensus 216 l~el~~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~----~~~i~~ 278 (283)
T cd05090 216 LWEIFSFGLQPYYGFSNQEVIEMVRKR-QLLPCSEDCPPRMYSLMTECWQEGPSRRPR----FKDIHT 278 (283)
T ss_pred HHHHHcCCCCCCCCCCHHHHHHHHHcC-CcCCCCCCCCHHHHHHHHHHcccCcccCcC----HHHHHH
Confidence 999998 99999887665555444433 333344457889999999999999999999 555554
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-34 Score=311.49 Aligned_cols=259 Identities=25% Similarity=0.365 Sum_probs=213.8
Q ss_pred CCccccccccccCcEEEEEEEEcCCCeEEEEEEeeccc--ccChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeC--CeE
Q 001847 672 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGV--MLNRNKVHRACAEREILDMLDHPFVPALYASFQTK--THV 747 (1005)
Q Consensus 672 ~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~~~~~~--~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~--~~~ 747 (1005)
..|++.+.||+|+||.||++.+..+++.|++|.+.... .........+.+|+.++++++|+||+++++++... +.+
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 36999999999999999999999999999999875431 12234556788999999999999999999998753 568
Q ss_pred EEEEeccCCCchhhHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCC
Q 001847 748 CLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCK 827 (1005)
Q Consensus 748 ~lV~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~ 827 (1005)
+++|||+++++|.+++... ..+++..+..++.||+.||.|||++|++|+||||+||+++.++.++|+|||++......
T Consensus 82 ~~v~e~~~~~~L~~~~~~~--~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~ 159 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKAY--GALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTI 159 (264)
T ss_pred EEEEEeCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECccccccccccc
Confidence 8999999999999998764 34889999999999999999999999999999999999999999999999988543210
Q ss_pred CCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHcCCCCCCCCChH
Q 001847 828 PQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQ 907 (1005)
Q Consensus 828 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlGvll~eLltG~~Pf~~~~~~ 907 (1005)
.. .........|+..|+|||.+.+..++.++|+|||||++|+|++|+.||......
T Consensus 160 ~~------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~ 215 (264)
T cd06653 160 CM------------------------SGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAM 215 (264)
T ss_pred cc------------------------cCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHH
Confidence 00 000112346889999999998888889999999999999999999999887666
Q ss_pred HHHHHHHhCCCCCCCCCCCCHHHHHHHHHccccCcCccCCChhcHHHHHcCCCC
Q 001847 908 KTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFF 961 (1005)
Q Consensus 908 ~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~hpff 961 (1005)
....++.............+..+.++|.+||. +|..||+ +.+++.|||.
T Consensus 216 ~~~~~~~~~~~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~----~~~~~~~~~~ 264 (264)
T cd06653 216 AAIFKIATQPTKPMLPDGVSDACRDFLKQIFV-EEKRRPT----AEFLLRHPFV 264 (264)
T ss_pred HHHHHHHcCCCCCCCCcccCHHHHHHHHHHhc-CcccCcc----HHHHhcCCCC
Confidence 66655554433322334577889999999999 5799999 9999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=318.15 Aligned_cols=270 Identities=41% Similarity=0.736 Sum_probs=216.9
Q ss_pred CccccccccccCcEEEEEEEEc---CCCeEEEEEEeeccccc-ChHHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCeE
Q 001847 673 HFRPIKPLGSGDTGSVHLVELC---GSGQYFAMKAMDKGVML-NRNKVHRACAEREILDML-DHPFVPALYASFQTKTHV 747 (1005)
Q Consensus 673 ~y~~~~~LG~G~~g~Vy~a~~~---~~~~~valK~~~~~~~~-~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~ 747 (1005)
.|++.+.||.|++|.||++.+. .++..||+|.+++.... .......+.+|+.++.++ +||||+.+++++......
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 4888999999999999999864 45788999998754322 223345677899999999 699999999999999999
Q ss_pred EEEEeccCCCchhhHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCC
Q 001847 748 CLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCK 827 (1005)
Q Consensus 748 ~lV~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~ 827 (1005)
|+||||+.+++|.+++... ..+++..++.++.|++.+|.|||+.|++|+||+|+||+++.++.++|+|||++......
T Consensus 81 ~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 158 (288)
T cd05583 81 HLILDYVNGGELFTHLYQR--EHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAE 158 (288)
T ss_pred EEEEecCCCCcHHHHHhhc--CCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEEECccccccccc
Confidence 9999999999999998754 45889999999999999999999999999999999999999999999999987543211
Q ss_pred CCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCC--CCChhhHHHHHHHHHHHHcCCCCCCCCC
Q 001847 828 PQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAG--HTSAVDWWALGILLYEMLYGYTPFRGKT 905 (1005)
Q Consensus 828 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~--~~~~sDIwSlGvll~eLltG~~Pf~~~~ 905 (1005)
. ........|++.|+|||.+.+.. .+.++||||||+++|+|++|..||....
T Consensus 159 ~--------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~ 212 (288)
T cd05583 159 E--------------------------EERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDG 212 (288)
T ss_pred c--------------------------ccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCc
Confidence 0 00112346889999999987654 6789999999999999999999996432
Q ss_pred ----hHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHccccCcCccCCChhcHHHHHcCCCCCCCChhhhhhcC
Q 001847 906 ----RQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVNWALVRCMN 973 (1005)
Q Consensus 906 ----~~~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~hpff~~~~~~~~~~~~ 973 (1005)
..+....+....... ...++..+.+||.+||+.+|++|||+.. +.++|+||||+.++|+.+...+
T Consensus 213 ~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~li~~~l~~~p~~R~t~~~-~~~~l~~~~~~~~~~~~~~~~~ 281 (288)
T cd05583 213 EQNSQSEISRRILKSKPPF--PKTMSAEARDFIQKLLEKDPKKRLGANG-ADEIKNHPFFQGIDWDDLAAKR 281 (288)
T ss_pred ccchHHHHHHHHHccCCCC--CcccCHHHHHHHHHHhcCCHhhccCcch-HHHHhcCcccccCCHHHHhhhc
Confidence 223333333333322 3346788999999999999999999543 7889999999999998774433
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=321.20 Aligned_cols=261 Identities=25% Similarity=0.360 Sum_probs=204.9
Q ss_pred cCCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC-----
Q 001847 671 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKT----- 745 (1005)
Q Consensus 671 ~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~----- 745 (1005)
.++|++++.||+|+||.||+|.+..+++.||+|.+..... .........+|+.++++++||||+++++++....
T Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 89 (310)
T cd07865 11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENE-KEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNR 89 (310)
T ss_pred hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCC-cCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccC
Confidence 4589999999999999999999999999999998865422 1222334567999999999999999999886543
Q ss_pred ---eEEEEEeccCCCchhhHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCc
Q 001847 746 ---HVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSC 822 (1005)
Q Consensus 746 ---~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~~~g~vkL~DFG~a~ 822 (1005)
..|+||||+ +++|.+++.... ..+++..++.++.||+.||.|||++|++|+||||+||+++.++.+||+|||++.
T Consensus 90 ~~~~~~lv~e~~-~~~l~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~ 167 (310)
T cd07865 90 YKGSFYLVFEFC-EHDLAGLLSNKN-VKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLAR 167 (310)
T ss_pred CCceEEEEEcCC-CcCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCCcEEECcCCCcc
Confidence 469999999 568888776542 358999999999999999999999999999999999999999999999999986
Q ss_pred ccCCCCCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCC-CCCChhhHHHHHHHHHHHHcCCCCC
Q 001847 823 LTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGA-GHTSAVDWWALGILLYEMLYGYTPF 901 (1005)
Q Consensus 823 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~sDIwSlGvll~eLltG~~Pf 901 (1005)
........ .........++..|+|||.+.+. .++.++||||||+++|+|++|..||
T Consensus 168 ~~~~~~~~-----------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~ 224 (310)
T cd07865 168 AFSLSKNS-----------------------KPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIM 224 (310)
T ss_pred cccCCccc-----------------------CCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCC
Confidence 54321110 00112234678899999988664 3678999999999999999999999
Q ss_pred CCCChHHHHHHHHh--CCC-----------------CCCC-----------CCCCCHHHHHHHHHccccCcCccCCChhc
Q 001847 902 RGKTRQKTFANILH--KDL-----------------KFPS-----------STPTSLHAKQLMYRLLHRDPKSRLGSHEG 951 (1005)
Q Consensus 902 ~~~~~~~~~~~i~~--~~~-----------------~~~~-----------~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~ 951 (1005)
.+.+.......+.. +.+ ..+. ....+..+.+||.+||..||.+||+
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t---- 300 (310)
T cd07865 225 QGNTEQHQLTLISQLCGSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRID---- 300 (310)
T ss_pred CCCCHHHHHHHHHHHhCCCChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccC----
Confidence 87765544333222 100 0000 0113456789999999999999999
Q ss_pred HHHHHcCCCC
Q 001847 952 ANEIKKHPFF 961 (1005)
Q Consensus 952 a~elL~hpff 961 (1005)
+.++|+||||
T Consensus 301 ~~e~l~h~~f 310 (310)
T cd07865 301 ADTALNHDFF 310 (310)
T ss_pred HHHHhcCCCC
Confidence 9999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=313.41 Aligned_cols=252 Identities=24% Similarity=0.371 Sum_probs=208.2
Q ss_pred ccccCCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeE
Q 001847 668 QINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHV 747 (1005)
Q Consensus 668 ~i~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 747 (1005)
.+..++|++++.||+|+||.||+|.+ .+++.||+|.+..... ....+.+|+.+++.++|+||+++++++. .+..
T Consensus 2 ~~~~~~~~~~~~ig~G~~g~v~~~~~-~~~~~~a~K~~~~~~~----~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~ 75 (260)
T cd05067 2 EVPRETLKLVKKLGAGQFGEVWMGYY-NGHTKVAIKSLKQGSM----SPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPI 75 (260)
T ss_pred ccchHHceeeeeeccCccceEEeeec-CCCceEEEEEecCCCC----cHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCc
Confidence 35667999999999999999999987 4567899998875432 2357788999999999999999998874 4568
Q ss_pred EEEEeccCCCchhhHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCC
Q 001847 748 CLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCK 827 (1005)
Q Consensus 748 ~lV~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~ 827 (1005)
|++|||+.+++|.+++.......++...+..++.|++.||+|||+.|++|+||||+||++++++.++|+|||++......
T Consensus 76 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~ 155 (260)
T cd05067 76 YIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETLCCKIADFGLARLIEDN 155 (260)
T ss_pred EEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcCCCCEEEccCcceeecCCC
Confidence 99999999999999987665567899999999999999999999999999999999999999999999999988543211
Q ss_pred CCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCh
Q 001847 828 PQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY-GYTPFRGKTR 906 (1005)
Q Consensus 828 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlGvll~eLlt-G~~Pf~~~~~ 906 (1005)
. ........++..|+|||++....++.++||||||+++|+|++ |+.||.+.+.
T Consensus 156 ~--------------------------~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~ 209 (260)
T cd05067 156 E--------------------------YTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTN 209 (260)
T ss_pred C--------------------------cccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCCh
Confidence 0 001112345678999999988888999999999999999998 9999988777
Q ss_pred HHHHHHHHhCCCCCCCCCCCCHHHHHHHHHccccCcCccCCChhcHHHHH
Q 001847 907 QKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIK 956 (1005)
Q Consensus 907 ~~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL 956 (1005)
......+... ...+.....+..+.+|+.+||..+|++||+ +++++
T Consensus 210 ~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~----~~~l~ 254 (260)
T cd05067 210 PEVIQNLERG-YRMPRPDNCPEELYELMRLCWKEKPEERPT----FEYLR 254 (260)
T ss_pred HHHHHHHHcC-CCCCCCCCCCHHHHHHHHHHccCChhhCCC----HHHHH
Confidence 6665555433 333444456789999999999999999999 55554
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=326.50 Aligned_cols=260 Identities=25% Similarity=0.391 Sum_probs=214.8
Q ss_pred CccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC-----eE
Q 001847 673 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKT-----HV 747 (1005)
Q Consensus 673 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~-----~~ 747 (1005)
+|++.+.||.|++|.||+|.+..++..|++|.+.... ........+.+|+.+++.++|+||+++++++.... .+
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~ 79 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVF-DDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDV 79 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeecccc-ccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccce
Confidence 5899999999999999999998889999999987642 23445567888999999999999999999988765 78
Q ss_pred EEEEeccCCCchhhHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCC
Q 001847 748 CLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCK 827 (1005)
Q Consensus 748 ~lV~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~ 827 (1005)
|+||||+. ++|.+++... ..+++..++.++.||+.||+|||++||+|+||||+|||++.++.++|+|||++......
T Consensus 80 ~lv~e~~~-~~l~~~l~~~--~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~ 156 (330)
T cd07834 80 YIVTELME-TDLHKVIKSP--QPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPD 156 (330)
T ss_pred EEEecchh-hhHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccCceEeeccc
Confidence 99999995 6898888654 36999999999999999999999999999999999999999999999999998654321
Q ss_pred CCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCC-CCCChhhHHHHHHHHHHHHcCCCCCCCCCh
Q 001847 828 PQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGA-GHTSAVDWWALGILLYEMLYGYTPFRGKTR 906 (1005)
Q Consensus 828 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~sDIwSlGvll~eLltG~~Pf~~~~~ 906 (1005)
... ........+++.|+|||.+.+. .++.++|||||||++|+|++|..||.+.+.
T Consensus 157 ~~~------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~ 212 (330)
T cd07834 157 EDE------------------------KGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDY 212 (330)
T ss_pred ccc------------------------cccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCH
Confidence 100 0112234678899999999887 788899999999999999999999988877
Q ss_pred HHHHHHHHhCCCCCC-----------------------------CCCCCCHHHHHHHHHccccCcCccCCChhcHHHHHc
Q 001847 907 QKTFANILHKDLKFP-----------------------------SSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKK 957 (1005)
Q Consensus 907 ~~~~~~i~~~~~~~~-----------------------------~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~ 957 (1005)
.+.+..+.......+ .....+..+.+||.+||+++|.+||+ +.++++
T Consensus 213 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt----~~~ll~ 288 (330)
T cd07834 213 IDQLNLIVEVLGTPSEEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRIT----ADEALA 288 (330)
T ss_pred HHHHHHHHHhcCCCChhHhhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCC----HHHHHh
Confidence 666555543211000 01225678899999999999999999 999999
Q ss_pred CCCCCCC
Q 001847 958 HPFFKGV 964 (1005)
Q Consensus 958 hpff~~~ 964 (1005)
||||+++
T Consensus 289 ~~~~~~~ 295 (330)
T cd07834 289 HPYLAQL 295 (330)
T ss_pred CccHHhh
Confidence 9999974
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-34 Score=317.02 Aligned_cols=255 Identities=24% Similarity=0.421 Sum_probs=208.2
Q ss_pred CccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEEe
Q 001847 673 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITD 752 (1005)
Q Consensus 673 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E 752 (1005)
+|++++.||.|++|.||++.+..+|..||+|.+..... ......+.+|+.++++++|+||+++++++...+..|+|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 78 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAE--EGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFE 78 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEeccccc--ccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEe
Confidence 48999999999999999999999999999999876432 2233556789999999999999999999999999999999
Q ss_pred ccCCCchhhHHhhCC-CCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCCCCC
Q 001847 753 YCPGGELFLLLDRQP-TKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLL 831 (1005)
Q Consensus 753 ~~~ggsL~~~l~~~~-~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~~ 831 (1005)
|+. ++|.+++.... ...+++..+..++.||+.||.|||+.|++|+||||+||++++++.++|+|||++.......
T Consensus 79 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~--- 154 (284)
T cd07836 79 YMD-KDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPV--- 154 (284)
T ss_pred cCC-ccHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCc---
Confidence 996 58888876532 2458999999999999999999999999999999999999999999999999885432110
Q ss_pred CCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCC-CCCChhhHHHHHHHHHHHHcCCCCCCCCChHHHH
Q 001847 832 LPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGA-GHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTF 910 (1005)
Q Consensus 832 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~sDIwSlGvll~eLltG~~Pf~~~~~~~~~ 910 (1005)
.......+++.|++||++.+. .++.++|||||||++|+|++|..||.+.+..+..
T Consensus 155 ------------------------~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~ 210 (284)
T cd07836 155 ------------------------NTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQL 210 (284)
T ss_pred ------------------------cccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHH
Confidence 111233578899999998664 4678999999999999999999999887766555
Q ss_pred HHHHhCC------------------CCCCC---------CCCCCHHHHHHHHHccccCcCccCCChhcHHHHHcCCCC
Q 001847 911 ANILHKD------------------LKFPS---------STPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFF 961 (1005)
Q Consensus 911 ~~i~~~~------------------~~~~~---------~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~hpff 961 (1005)
..+.... ...+. ....+..+.++|.+||+.||.+||+ +.++++||||
T Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~----~~~~l~~~~f 284 (284)
T cd07836 211 LKIFRIMGTPTESTWPGISQLPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRIS----AHDALQHPWF 284 (284)
T ss_pred HHHHHHhCCCChhhHHHHhcCchhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCC----HHHHhcCCCC
Confidence 5443210 00000 0124667889999999999999999 9999999998
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-34 Score=309.97 Aligned_cols=250 Identities=48% Similarity=0.864 Sum_probs=215.8
Q ss_pred ccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEEeccCCCch
Q 001847 680 LGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGEL 759 (1005)
Q Consensus 680 LG~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~ggsL 759 (1005)
||.|+||.||++.+..+++.+++|.+.............+..|+.+++.++|+||+++++.+..++.+|+||||+.+++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 69999999999999888999999999876555555677888999999999999999999999999999999999999999
Q ss_pred hhHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCCCCCCCcchhhh
Q 001847 760 FLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKK 839 (1005)
Q Consensus 760 ~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~ 839 (1005)
.+++... ..+++..+..++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~----------- 147 (250)
T cd05123 81 FSHLSKE--GRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEG----------- 147 (250)
T ss_pred HHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCCCcEEEeecCcceecccCC-----------
Confidence 9999765 358999999999999999999999999999999999999999999999999885432110
Q ss_pred hcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhCCCC
Q 001847 840 RRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANILHKDLK 919 (1005)
Q Consensus 840 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlGvll~eLltG~~Pf~~~~~~~~~~~i~~~~~~ 919 (1005)
.......++..|++||.+.+...+.++|+||||+++|+|++|..||...........+......
T Consensus 148 ----------------~~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~ 211 (250)
T cd05123 148 ----------------SRTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILKDPLR 211 (250)
T ss_pred ----------------CcccCCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCC
Confidence 1123456888999999998888889999999999999999999999887776666666664444
Q ss_pred CCCCCCCCHHHHHHHHHccccCcCccCCChhcHHHHHcCCCC
Q 001847 920 FPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFF 961 (1005)
Q Consensus 920 ~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~hpff 961 (1005)
++. ..+..+.+||.+||..||++||+... +.++++||||
T Consensus 212 ~~~--~~~~~l~~~i~~~l~~~p~~R~~~~~-~~~l~~~~~f 250 (250)
T cd05123 212 FPE--FLSPEARDLISGLLQKDPTKRLGSGG-AEEIKAHPFF 250 (250)
T ss_pred CCC--CCCHHHHHHHHHHhcCCHhhCCCccc-HHHHHhCCCC
Confidence 433 35788999999999999999999433 4999999998
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=328.67 Aligned_cols=266 Identities=26% Similarity=0.407 Sum_probs=211.8
Q ss_pred CCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceEEEEEEe----CCeE
Q 001847 672 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQT----KTHV 747 (1005)
Q Consensus 672 ~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~----~~~~ 747 (1005)
++|++.+.||.|++|.||++.+..++..||+|.+..... .......+.+|+.+++.++||||++++++|.. ...+
T Consensus 5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 83 (334)
T cd07855 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFD-VPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV 83 (334)
T ss_pred hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccc-cccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence 589999999999999999999999999999999875422 23345667789999999999999999998763 3578
Q ss_pred EEEEeccCCCchhhHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCC
Q 001847 748 CLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCK 827 (1005)
Q Consensus 748 ~lV~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~ 827 (1005)
|+||||+ +++|.+++... ..+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++......
T Consensus 84 ~lv~e~~-~~~l~~~~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~ 160 (334)
T cd07855 84 YVVMDLM-ESDLHHIIHSD--QPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSS 160 (334)
T ss_pred EEEEehh-hhhHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEecccccceeeccc
Confidence 9999999 56898888654 44899999999999999999999999999999999999999999999999998543211
Q ss_pred CCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccC-CCCCChhhHHHHHHHHHHHHcCCCCCCCCCh
Q 001847 828 PQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAG-AGHTSAVDWWALGILLYEMLYGYTPFRGKTR 906 (1005)
Q Consensus 828 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~sDIwSlGvll~eLltG~~Pf~~~~~ 906 (1005)
... .........|+..|+|||.+.. ..++.++|||||||++|+|++|+.||.+.+.
T Consensus 161 ~~~-----------------------~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~ 217 (334)
T cd07855 161 PTE-----------------------HKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNY 217 (334)
T ss_pred CcC-----------------------CCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCCh
Confidence 100 0011123468899999999865 4578899999999999999999999987665
Q ss_pred HHHHHHHHhC----------------------CCCCCC-------CCCCCHHHHHHHHHccccCcCccCCChhcHHHHHc
Q 001847 907 QKTFANILHK----------------------DLKFPS-------STPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKK 957 (1005)
Q Consensus 907 ~~~~~~i~~~----------------------~~~~~~-------~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~ 957 (1005)
...+..+... ...... ....+..+.+||.+||+.+|.+||+ +.+++.
T Consensus 218 ~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt----~~~~l~ 293 (334)
T cd07855 218 VHQLKLILSVLGSPSEEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERIT----VEQALQ 293 (334)
T ss_pred HHHHHHHHHHhCCChhHhhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcC----HHHHHh
Confidence 4433322211 000000 1235778999999999999999999 999999
Q ss_pred CCCCCCCChhh
Q 001847 958 HPFFKGVNWAL 968 (1005)
Q Consensus 958 hpff~~~~~~~ 968 (1005)
||||++.....
T Consensus 294 ~~~~~~~~~~~ 304 (334)
T cd07855 294 HPFLAQYHDPD 304 (334)
T ss_pred ChhhhhccCCc
Confidence 99999754433
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-34 Score=312.08 Aligned_cols=254 Identities=26% Similarity=0.383 Sum_probs=203.5
Q ss_pred CccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEEe
Q 001847 673 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITD 752 (1005)
Q Consensus 673 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E 752 (1005)
.+.....||+|+||.||++.+..++..|++|.+... .......+.+|+.+++.++|+||+++++++..++.+++|||
T Consensus 9 ~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 85 (268)
T cd06624 9 ENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPER---DSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFME 85 (268)
T ss_pred cCCceEEEecCCceEEEEeEecCCCcEEEEEEecCC---CHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEEe
Confidence 344446799999999999999889999999988654 23455678899999999999999999999999999999999
Q ss_pred ccCCCchhhHHhhCCCCCC--CHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEec-CCcEEEEeccCCcccCCCCC
Q 001847 753 YCPGGELFLLLDRQPTKVL--KEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQG-NGHVSLTDFDLSCLTSCKPQ 829 (1005)
Q Consensus 753 ~~~ggsL~~~l~~~~~~~l--~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~~-~g~vkL~DFG~a~~~~~~~~ 829 (1005)
|+.+++|.+++.... ..+ +...+..++.||+.||+|||++||+|+||||+||+++. ++.++|+|||++.......
T Consensus 86 ~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~- 163 (268)
T cd06624 86 QVPGGSLSALLRSKW-GPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGIN- 163 (268)
T ss_pred cCCCCCHHHHHHHhc-ccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCeEEEecchhheecccCC-
Confidence 999999999987542 234 78889999999999999999999999999999999986 6799999999875432100
Q ss_pred CCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCC--CCChhhHHHHHHHHHHHHcCCCCCCCCChH
Q 001847 830 LLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAG--HTSAVDWWALGILLYEMLYGYTPFRGKTRQ 907 (1005)
Q Consensus 830 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~--~~~~sDIwSlGvll~eLltG~~Pf~~~~~~ 907 (1005)
.......|++.|+|||++.... ++.++||||||+++|+|++|..||......
T Consensus 164 --------------------------~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~ 217 (268)
T cd06624 164 --------------------------PCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEP 217 (268)
T ss_pred --------------------------CccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccCh
Confidence 0111235788999999986643 678999999999999999999999764432
Q ss_pred HH-HHHHHhCCCCCCCCCCCCHHHHHHHHHccccCcCccCCChhcHHHHHcCCCC
Q 001847 908 KT-FANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFF 961 (1005)
Q Consensus 908 ~~-~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~hpff 961 (1005)
.. .................+.++.+|+.+||..+|.+||+ +.+++.||||
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt----~~~ll~~~~~ 268 (268)
T cd06624 218 QAAMFKVGMFKIHPEIPESLSAEAKNFILRCFEPDPDKRAS----AHDLLQDPFL 268 (268)
T ss_pred hhhHhhhhhhccCCCCCcccCHHHHHHHHHHcCCCchhCCC----HHHHHhCCCC
Confidence 21 11111111111122346788999999999999999999 9999999997
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=325.22 Aligned_cols=262 Identities=23% Similarity=0.320 Sum_probs=206.0
Q ss_pred cccccc--CcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEEeccC
Q 001847 678 KPLGSG--DTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCP 755 (1005)
Q Consensus 678 ~~LG~G--~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~ 755 (1005)
..||.| +||+||++.+..+|+.||+|++..... .....+.+.+|+.+++.++||||++++++|...+..|+||||+.
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~ 82 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENC-TEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMA 82 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEeccc
Confidence 456666 999999999999999999999875432 23445778889999999999999999999999999999999999
Q ss_pred CCchhhHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCCCCCCCcc
Q 001847 756 GGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTT 835 (1005)
Q Consensus 756 ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~~~~~~ 835 (1005)
+++|.+++.......+++..+..++.||+.||.|||++||+||||||+|||++.++.++++||+.+.........
T Consensus 83 ~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~----- 157 (328)
T cd08226 83 YGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQK----- 157 (328)
T ss_pred CCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcc-----
Confidence 999999988654456899999999999999999999999999999999999999999999999865322110000
Q ss_pred hhhhhcccCCCCCcccccccccccccccCCcccccccccCC--CCCChhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHH
Q 001847 836 NEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGA--GHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANI 913 (1005)
Q Consensus 836 ~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~--~~~~~sDIwSlGvll~eLltG~~Pf~~~~~~~~~~~i 913 (1005)
... .........++..|+|||++.+. .++.++|||||||++|+|++|..||.+..........
T Consensus 158 -----------~~~----~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~ 222 (328)
T cd08226 158 -----------AKV----VYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQK 222 (328)
T ss_pred -----------ccc----cccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHH
Confidence 000 00001112356679999998764 4678999999999999999999999877655544443
Q ss_pred HhCCCC---------------------------------------------CCCCCCCCHHHHHHHHHccccCcCccCCC
Q 001847 914 LHKDLK---------------------------------------------FPSSTPTSLHAKQLMYRLLHRDPKSRLGS 948 (1005)
Q Consensus 914 ~~~~~~---------------------------------------------~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~ 948 (1005)
+..... .+.....+..+.+||.+||+.||++|||
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt- 301 (328)
T cd08226 223 LKGPPYSPLDITTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPS- 301 (328)
T ss_pred hcCCCCCCccccccchhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCC-
Confidence 332111 1111224567899999999999999999
Q ss_pred hhcHHHHHcCCCCCCC
Q 001847 949 HEGANEIKKHPFFKGV 964 (1005)
Q Consensus 949 ~~~a~elL~hpff~~~ 964 (1005)
+.++|+||||+.+
T Consensus 302 ---a~e~l~~~~~~~~ 314 (328)
T cd08226 302 ---ASSLLSHAFFKQV 314 (328)
T ss_pred ---HHHHhhCHHHHHH
Confidence 9999999999864
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=312.61 Aligned_cols=251 Identities=22% Similarity=0.330 Sum_probs=207.8
Q ss_pred cCCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEE
Q 001847 671 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLI 750 (1005)
Q Consensus 671 ~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV 750 (1005)
..+|++.+.||+|+||.||++.+.. +..+|+|.+..... ....+.+|+.++++++||||+++++++.....+|+|
T Consensus 3 ~~~~~~~~~lg~G~~~~vy~~~~~~-~~~~aik~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 77 (256)
T cd05113 3 PKDLTFLKELGTGQFGVVKYGKWRG-QYDVAIKMIKEGSM----SEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIV 77 (256)
T ss_pred hHHeEEeeEecCcccceEEEEEecC-CCcEEEEEcCCCcc----cHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEE
Confidence 4579999999999999999998743 45699998875422 235678899999999999999999999998999999
Q ss_pred EeccCCCchhhHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCCCC
Q 001847 751 TDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQL 830 (1005)
Q Consensus 751 ~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~ 830 (1005)
|||+.+++|.+++.... ..+++..+..++.||+.||.|||+.|++|+||||+||+++.++.+||+|||.+.......
T Consensus 78 ~e~~~~~~l~~~i~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~-- 154 (256)
T cd05113 78 TEYMSNGCLLNYLREHG-KRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDE-- 154 (256)
T ss_pred EEcCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCCEEECCCccceecCCCc--
Confidence 99999999999987643 258999999999999999999999999999999999999999999999999875432110
Q ss_pred CCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCChHHH
Q 001847 831 LLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY-GYTPFRGKTRQKT 909 (1005)
Q Consensus 831 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlGvll~eLlt-G~~Pf~~~~~~~~ 909 (1005)
........++..|+|||.+.+..++.++|||||||++|+|++ |..||........
T Consensus 155 ------------------------~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~ 210 (256)
T cd05113 155 ------------------------YTSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSET 210 (256)
T ss_pred ------------------------eeecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHH
Confidence 001112235678999999988888999999999999999998 9999988777766
Q ss_pred HHHHHhCCCCCCCCCCCCHHHHHHHHHccccCcCccCCChhcHHHHHcC
Q 001847 910 FANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKH 958 (1005)
Q Consensus 910 ~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~h 958 (1005)
...+...... ......+..+.+++.+||..+|.+||+ +.+|+.+
T Consensus 211 ~~~~~~~~~~-~~~~~~~~~~~~li~~cl~~~p~~Rp~----~~~ll~~ 254 (256)
T cd05113 211 VEKVSQGLRL-YRPHLASEKVYAIMYSCWHEKAEERPT----FQQLLSS 254 (256)
T ss_pred HHHHhcCCCC-CCCCCCCHHHHHHHHHHcCCCcccCCC----HHHHHHh
Confidence 6666655333 223346788999999999999999999 7777754
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-34 Score=315.04 Aligned_cols=257 Identities=20% Similarity=0.298 Sum_probs=209.1
Q ss_pred ccCCccccccccccCcEEEEEEEEcC-----CCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeC
Q 001847 670 NLQHFRPIKPLGSGDTGSVHLVELCG-----SGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTK 744 (1005)
Q Consensus 670 ~~~~y~~~~~LG~G~~g~Vy~a~~~~-----~~~~valK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~ 744 (1005)
..+.|.+.+.||+|++|.||+|.+.. ++..|++|.+... ........+.+|+.+++.++|+||+++++++...
T Consensus 4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~--~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 81 (277)
T cd05036 4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPES--CSEQDESDFLMEALIMSKFNHQNIVRLIGVSFER 81 (277)
T ss_pred CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCC--CCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccC
Confidence 34679999999999999999999977 7789999987643 2233445688899999999999999999999988
Q ss_pred CeEEEEEeccCCCchhhHHhhCCC-----CCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCC---cEEEE
Q 001847 745 THVCLITDYCPGGELFLLLDRQPT-----KVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNG---HVSLT 816 (1005)
Q Consensus 745 ~~~~lV~E~~~ggsL~~~l~~~~~-----~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~~~g---~vkL~ 816 (1005)
+..|+||||+.+++|.+++..... ..+++..+..++.||+.||.|||++|++|+||||+||+++.++ .+||+
T Consensus 82 ~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~kl~ 161 (277)
T cd05036 82 LPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIA 161 (277)
T ss_pred CCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcceEec
Confidence 899999999999999999875421 2588999999999999999999999999999999999998765 59999
Q ss_pred eccCCcccCCCCCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHc
Q 001847 817 DFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY 896 (1005)
Q Consensus 817 DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlGvll~eLlt 896 (1005)
|||++........ ........++..|+|||++.+..++.++|||||||++|+|++
T Consensus 162 dfg~~~~~~~~~~-------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~ 216 (277)
T cd05036 162 DFGMARDIYRASY-------------------------YRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFS 216 (277)
T ss_pred cCccccccCCccc-------------------------eecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHc
Confidence 9999865421100 000112234568999999988889999999999999999996
Q ss_pred -CCCCCCCCChHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHccccCcCccCCChhcHHHHHcC
Q 001847 897 -GYTPFRGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKH 958 (1005)
Q Consensus 897 -G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~h 958 (1005)
|..||.+.+.......+... ........++..+.+|+.+||+.+|++||+ +.++++|
T Consensus 217 ~g~~pf~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~i~~cl~~~p~~Rps----~~~vl~~ 274 (277)
T cd05036 217 LGYMPYPGRTNQEVMEFVTGG-GRLDPPKGCPGPVYRIMTDCWQHTPEDRPN----FATILER 274 (277)
T ss_pred CCCCCCCCCCHHHHHHHHHcC-CcCCCCCCCCHHHHHHHHHHcCCCcccCcC----HHHHHHH
Confidence 99999987776665554433 222333456788999999999999999999 7777765
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=321.17 Aligned_cols=255 Identities=22% Similarity=0.327 Sum_probs=205.8
Q ss_pred cccCCccccccccccCcEEEEEEEEcCCCeE--EEEEEeecccccChHHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCC
Q 001847 669 INLQHFRPIKPLGSGDTGSVHLVELCGSGQY--FAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPALYASFQTKT 745 (1005)
Q Consensus 669 i~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~--valK~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~ 745 (1005)
+..++|++.+.||+|+||.||+|.+..++.. +++|.+... ........+.+|+.++.++ +|+||+++++++...+
T Consensus 4 ~~~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~--~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~ 81 (303)
T cd05088 4 LEWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY--ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRG 81 (303)
T ss_pred cchhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEeccc--CCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCC
Confidence 4456899999999999999999999777754 577766532 2334556778899999999 8999999999999999
Q ss_pred eEEEEEeccCCCchhhHHhhCC--------------CCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCC
Q 001847 746 HVCLITDYCPGGELFLLLDRQP--------------TKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNG 811 (1005)
Q Consensus 746 ~~~lV~E~~~ggsL~~~l~~~~--------------~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~~~g 811 (1005)
.+|+||||+++++|.+++.... ...++...++.++.||+.||+|||++||+||||||+|||++.++
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili~~~~ 161 (303)
T cd05088 82 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENY 161 (303)
T ss_pred CceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEecCCC
Confidence 9999999999999999987532 13578999999999999999999999999999999999999999
Q ss_pred cEEEEeccCCcccCCCCCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHH
Q 001847 812 HVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILL 891 (1005)
Q Consensus 812 ~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlGvll 891 (1005)
.+||+|||++...... .......++..|+|||++.+..++.++|||||||++
T Consensus 162 ~~kl~dfg~~~~~~~~----------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il 213 (303)
T cd05088 162 VAKIADFGLSRGQEVY----------------------------VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLL 213 (303)
T ss_pred cEEeCccccCcccchh----------------------------hhcccCCCcccccCHHHHhccCCcccccchhhhhHH
Confidence 9999999987421100 001112345679999999888889999999999999
Q ss_pred HHHHc-CCCCCCCCChHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHccccCcCccCCChhcHHHHHcC
Q 001847 892 YEMLY-GYTPFRGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKH 958 (1005)
Q Consensus 892 ~eLlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~h 958 (1005)
|+|++ |..||.+.+..+....+... .........+..+.+|+.+||+.+|++||+ +.+++++
T Consensus 214 ~ellt~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~----~~~il~~ 276 (303)
T cd05088 214 WEIVSLGGTPYCGMTCAELYEKLPQG-YRLEKPLNCDDEVYDLMRQCWREKPYERPS----FAQILVS 276 (303)
T ss_pred HHHHhcCCCCcccCChHHHHHHHhcC-CcCCCCCCCCHHHHHHHHHHcCCChhhCcC----HHHHHHH
Confidence 99998 99999887766665555332 222233346788999999999999999999 5555544
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-34 Score=318.84 Aligned_cols=261 Identities=21% Similarity=0.340 Sum_probs=212.5
Q ss_pred cccccccCCccccccccccCcEEEEEEEEcCC-----CeEEEEEEeecccccChHHHHHHHHHHHHHHhC-CCCCcceEE
Q 001847 665 SGEQINLQHFRPIKPLGSGDTGSVHLVELCGS-----GQYFAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPALY 738 (1005)
Q Consensus 665 ~~~~i~~~~y~~~~~LG~G~~g~Vy~a~~~~~-----~~~valK~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~ 738 (1005)
+...+..++|++.+.||+|+||.||++.+... ...+|+|.+.... .......+.+|+.+++++ +|+||++++
T Consensus 5 ~~~~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~i~~~~ 82 (293)
T cd05053 5 PEWELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINLL 82 (293)
T ss_pred cccccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCC--CHHHHHHHHHHHHHHHhhcCCCCeeeEE
Confidence 44556778999999999999999999998644 3789999987542 233446688899999999 899999999
Q ss_pred EEEEeCCeEEEEEeccCCCchhhHHhhC--------------CCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCc
Q 001847 739 ASFQTKTHVCLITDYCPGGELFLLLDRQ--------------PTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPEN 804 (1005)
Q Consensus 739 ~~~~~~~~~~lV~E~~~ggsL~~~l~~~--------------~~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~N 804 (1005)
+++...+.+|++|||+.+++|..++... ....++...+..++.||+.||.|||++||+|+||||+|
T Consensus 83 ~~~~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~N 162 (293)
T cd05053 83 GVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARN 162 (293)
T ss_pred EEEcCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceee
Confidence 9999999999999999999999998642 23568999999999999999999999999999999999
Q ss_pred EEEecCCcEEEEeccCCcccCCCCCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhH
Q 001847 805 VLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDW 884 (1005)
Q Consensus 805 ILi~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDI 884 (1005)
|+++.++.+||+|||++........ ........++..|+|||++.+..++.++||
T Consensus 163 il~~~~~~~kL~Dfg~~~~~~~~~~-------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di 217 (293)
T cd05053 163 VLVTEDHVMKIADFGLARDIHHIDY-------------------------YRKTTNGRLPVKWMAPEALFDRVYTHQSDV 217 (293)
T ss_pred EEEcCCCeEEeCccccccccccccc-------------------------eeccCCCCCCccccCHHHhccCCcCcccce
Confidence 9999999999999999854321100 001111234678999999988889999999
Q ss_pred HHHHHHHHHHHc-CCCCCCCCChHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHccccCcCccCCChhcHHHHHc
Q 001847 885 WALGILLYEMLY-GYTPFRGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKK 957 (1005)
Q Consensus 885 wSlGvll~eLlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~ 957 (1005)
|||||++|+|++ |..||.+....+....+... .........+..+.+|+.+||..+|++||| +.++++
T Consensus 218 ~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rps----~~eil~ 286 (293)
T cd05053 218 WSFGVLLWEIFTLGGSPYPGIPVEELFKLLKEG-YRMEKPQNCTQELYHLMRDCWHEVPSQRPT----FKQLVE 286 (293)
T ss_pred eehhhHHHHHhcCCCCCCCCCCHHHHHHHHHcC-CcCCCCCCCCHHHHHHHHHHcccCcccCcC----HHHHHH
Confidence 999999999997 99999887766666555444 233333456788999999999999999999 666654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-34 Score=317.60 Aligned_cols=255 Identities=30% Similarity=0.471 Sum_probs=213.5
Q ss_pred CccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEEe
Q 001847 673 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITD 752 (1005)
Q Consensus 673 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E 752 (1005)
.|.....||+|+||.||++.+..++..+|+|.+... .......+.+|+.+++.++|+||+++++++...++.|+|||
T Consensus 21 ~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 97 (292)
T cd06657 21 YLDNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLR---KQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVME 97 (292)
T ss_pred HhhhHHHcCCCCCeEEEEEEEcCCCeEEEEEEeccc---chhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEe
Confidence 344457799999999999999999999999987533 23345678889999999999999999999999999999999
Q ss_pred ccCCCchhhHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCCCCCC
Q 001847 753 YCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLL 832 (1005)
Q Consensus 753 ~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~~~ 832 (1005)
|+++++|.+++.. ..+++..+..++.|++.+|+|||+.|++|+||+|+||+++.++.++|+|||++......
T Consensus 98 ~~~~~~L~~~~~~---~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~----- 169 (292)
T cd06657 98 FLEGGALTDIVTH---TRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKE----- 169 (292)
T ss_pred cCCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEcccccceecccc-----
Confidence 9999999998754 34899999999999999999999999999999999999999999999999987433211
Q ss_pred CcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHcCCCCCCCCChHHHHHH
Q 001847 833 PTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFAN 912 (1005)
Q Consensus 833 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlGvll~eLltG~~Pf~~~~~~~~~~~ 912 (1005)
........|++.|+|||.+....++.++|+||||+++|+|++|..||.+.........
T Consensus 170 ----------------------~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~ 227 (292)
T cd06657 170 ----------------------VPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKM 227 (292)
T ss_pred ----------------------cccccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 0112235688999999999888888999999999999999999999988766555544
Q ss_pred HHhCC-CCCCCCCCCCHHHHHHHHHccccCcCccCCChhcHHHHHcCCCCCCC
Q 001847 913 ILHKD-LKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGV 964 (1005)
Q Consensus 913 i~~~~-~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~hpff~~~ 964 (1005)
+.... ..+......+..+.+++.+||..+|.+||+ +.++++||||...
T Consensus 228 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~R~~----~~~ll~~~~~~~~ 276 (292)
T cd06657 228 IRDNLPPKLKNLHKVSPSLKGFLDRLLVRDPAQRAT----AAELLKHPFLAKA 276 (292)
T ss_pred HHhhCCcccCCcccCCHHHHHHHHHHHhCCcccCcC----HHHHhcChHHhcc
Confidence 43321 122233446788999999999999999999 9999999999975
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-34 Score=307.85 Aligned_cols=257 Identities=30% Similarity=0.437 Sum_probs=215.4
Q ss_pred CccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeC--CeEEEE
Q 001847 673 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTK--THVCLI 750 (1005)
Q Consensus 673 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~--~~~~lV 750 (1005)
+|++.+.||+|++|.||++.+..+++.+++|.+..... .......+.+|+.++++++|+||+++++.+... ..+++|
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv 79 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGD-SEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIF 79 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeecccc-chHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEE
Confidence 48888999999999999999988999999999876532 245567888999999999999999999999988 899999
Q ss_pred EeccCCCchhhHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCCCC
Q 001847 751 TDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQL 830 (1005)
Q Consensus 751 ~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~ 830 (1005)
|||+.+++|.+++.... .+++..+..++.|++.+|.|||+.|++|+||+|+||+++.++.++|+|||.+.........
T Consensus 80 ~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~ 157 (260)
T cd06606 80 LEYVSGGSLSSLLKKFG--KLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETG 157 (260)
T ss_pred EEecCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEcccccEEeccccccc
Confidence 99999999999998653 6899999999999999999999999999999999999999999999999988554321100
Q ss_pred CCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHcCCCCCCCCC-hHHH
Q 001847 831 LLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKT-RQKT 909 (1005)
Q Consensus 831 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlGvll~eLltG~~Pf~~~~-~~~~ 909 (1005)
.......++..|+|||.+.....+.++||||||+++|+|++|..||.... ....
T Consensus 158 -------------------------~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~ 212 (260)
T cd06606 158 -------------------------EGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAA 212 (260)
T ss_pred -------------------------ccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHH
Confidence 01223468889999999988888999999999999999999999998765 2333
Q ss_pred HHHHHhCCCCCCCCCCCCHHHHHHHHHccccCcCccCCChhcHHHHHcCCCC
Q 001847 910 FANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFF 961 (1005)
Q Consensus 910 ~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~hpff 961 (1005)
...+.............+..+.+||.+||..+|++||+ +.++++||||
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~----~~~ll~~~~~ 260 (260)
T cd06606 213 LYKIGSSGEPPEIPEHLSEEAKDFLRKCLRRDPKKRPT----ADELLQHPFL 260 (260)
T ss_pred HHhccccCCCcCCCcccCHHHHHHHHHhCcCChhhCCC----HHHHhhCCCC
Confidence 33333222222223345789999999999999999999 9999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-34 Score=310.98 Aligned_cols=247 Identities=22% Similarity=0.382 Sum_probs=205.0
Q ss_pred ccccCCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceEEEEEE-eCCe
Q 001847 668 QINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQ-TKTH 746 (1005)
Q Consensus 668 ~i~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~-~~~~ 746 (1005)
.++..+|++.+.||+|+||.||++.. .+..+++|.++.. .....+.+|+.++++++|+|++++++++. ..+.
T Consensus 2 ~~~~~~~~~~~~lg~g~~~~v~~~~~--~~~~~~~k~~~~~-----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 74 (256)
T cd05082 2 ALNMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKND-----ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGG 74 (256)
T ss_pred CccHHhCeeeeeecccCCCeEEEEEE--cCCcEEEEEeCCC-----chHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCc
Confidence 46778999999999999999999987 4778999988643 23456788999999999999999998754 5567
Q ss_pred EEEEEeccCCCchhhHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCC
Q 001847 747 VCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSC 826 (1005)
Q Consensus 747 ~~lV~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~~~g~vkL~DFG~a~~~~~ 826 (1005)
.|+||||+++++|.+++.......+++..+..++.||+.||+|||++|++|+||||+||+++.++.+||+|||++.....
T Consensus 75 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~ 154 (256)
T cd05082 75 LYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS 154 (256)
T ss_pred eEEEEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcCCCcEEecCCccceeccc
Confidence 89999999999999999876555688999999999999999999999999999999999999999999999998743211
Q ss_pred CCCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCC
Q 001847 827 KPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY-GYTPFRGKT 905 (1005)
Q Consensus 827 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlGvll~eLlt-G~~Pf~~~~ 905 (1005)
. .....++..|+|||++.+..++.++|||||||++|+|++ |+.||....
T Consensus 155 ~------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~ 204 (256)
T cd05082 155 T------------------------------QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP 204 (256)
T ss_pred c------------------------------CCCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCC
Confidence 0 112234568999999988888999999999999999997 999998776
Q ss_pred hHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHccccCcCccCCChhcHHHHH
Q 001847 906 RQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIK 956 (1005)
Q Consensus 906 ~~~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL 956 (1005)
.......+... ........++..+.+|+.+||+.+|++||+ +.+++
T Consensus 205 ~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt----~~~l~ 250 (256)
T cd05082 205 LKDVVPRVEKG-YKMDAPDGCPPVVYDVMKQCWHLDAATRPS----FLQLR 250 (256)
T ss_pred HHHHHHHHhcC-CCCCCCCCCCHHHHHHHHHHhcCChhhCcC----HHHHH
Confidence 66655555443 222333457889999999999999999999 55554
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-34 Score=316.37 Aligned_cols=257 Identities=21% Similarity=0.325 Sum_probs=210.4
Q ss_pred cccCCccccccccccCcEEEEEEEEcCC-----CeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceEEEEEEe
Q 001847 669 INLQHFRPIKPLGSGDTGSVHLVELCGS-----GQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQT 743 (1005)
Q Consensus 669 i~~~~y~~~~~LG~G~~g~Vy~a~~~~~-----~~~valK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~ 743 (1005)
++..+|++++.||.|+||.||++.+..+ ++.+|+|.++... .......+..|+.++..++||||+++++++..
T Consensus 2 i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~ 79 (283)
T cd05091 2 INLSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKA--EGPLREEFKHEAMMRSRLQHPNIVCLLGVVTK 79 (283)
T ss_pred CCHHHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCC--CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcC
Confidence 3456899999999999999999997543 5789999987542 23344667889999999999999999999999
Q ss_pred CCeEEEEEeccCCCchhhHHhhC--------------CCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEec
Q 001847 744 KTHVCLITDYCPGGELFLLLDRQ--------------PTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQG 809 (1005)
Q Consensus 744 ~~~~~lV~E~~~ggsL~~~l~~~--------------~~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~~ 809 (1005)
....++++||+.+++|.+++... ....++...+..++.|++.||.|||++||+||||||+||++++
T Consensus 80 ~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~~~ 159 (283)
T cd05091 80 EQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFD 159 (283)
T ss_pred CCceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEecC
Confidence 99999999999999999998531 1234788889999999999999999999999999999999999
Q ss_pred CCcEEEEeccCCcccCCCCCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHH
Q 001847 810 NGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGI 889 (1005)
Q Consensus 810 ~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlGv 889 (1005)
++.+||+|||++........ ........+++.|+|||.+....++.++|||||||
T Consensus 160 ~~~~kl~Dfg~~~~~~~~~~-------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~ 214 (283)
T cd05091 160 KLNVKISDLGLFREVYAADY-------------------------YKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGV 214 (283)
T ss_pred CCceEecccccccccccchh-------------------------eeeccCccCCccccCHHHHhcCCCCcchhHHHHHH
Confidence 99999999998854321100 01112334678999999998888899999999999
Q ss_pred HHHHHHc-CCCCCCCCChHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHccccCcCccCCChhcHHHHHc
Q 001847 890 LLYEMLY-GYTPFRGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKK 957 (1005)
Q Consensus 890 ll~eLlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~ 957 (1005)
++|+|++ |..||.+....+....+...... +....++..+.+|+.+||+.+|.+||+ +++++.
T Consensus 215 ~l~el~~~g~~p~~~~~~~~~~~~i~~~~~~-~~~~~~~~~~~~li~~cl~~~p~~RP~----~~~i~~ 278 (283)
T cd05091 215 VLWEVFSYGLQPYCGYSNQDVIEMIRNRQVL-PCPDDCPAWVYTLMLECWNEFPSRRPR----FKDIHS 278 (283)
T ss_pred HHHHHHcCCCCCCCCCCHHHHHHHHHcCCcC-CCCCCCCHHHHHHHHHHhCCCcccCCC----HHHHHH
Confidence 9999998 88999888877777776665432 223357888999999999999999999 666654
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-34 Score=308.02 Aligned_cols=246 Identities=22% Similarity=0.326 Sum_probs=200.7
Q ss_pred ccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEEeccCCC
Q 001847 678 KPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGG 757 (1005)
Q Consensus 678 ~~LG~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg 757 (1005)
+.||+|+||.||++.+..+++.+|+|.+.... .......+.+|+++++.++||||+++++++......|+||||+.++
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 78 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETL--PPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGG 78 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccC--CHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCC
Confidence 46899999999999999999999999876432 3444567889999999999999999999999999999999999999
Q ss_pred chhhHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCCCCCCCcchh
Q 001847 758 ELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNE 837 (1005)
Q Consensus 758 sL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~ 837 (1005)
+|.+++... ...+++..++.++.|++.||.|||++||+|+||||+|||++.++.+||+|||++.........
T Consensus 79 ~L~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~------- 150 (252)
T cd05084 79 DFLTFLRTE-GPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYA------- 150 (252)
T ss_pred cHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCCCcEEECccccCccccccccc-------
Confidence 999998654 245899999999999999999999999999999999999999999999999988543210000
Q ss_pred hhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHhC
Q 001847 838 KKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY-GYTPFRGKTRQKTFANILHK 916 (1005)
Q Consensus 838 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlGvll~eLlt-G~~Pf~~~~~~~~~~~i~~~ 916 (1005)
.......++..|+|||.+.+..++.++|||||||++|+|++ |..||...........+...
T Consensus 151 ------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~~~ 212 (252)
T cd05084 151 ------------------STGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQG 212 (252)
T ss_pred ------------------ccCCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHHcC
Confidence 00011123457999999988888999999999999999997 99999776665554444432
Q ss_pred CCCCCCCCCCCHHHHHHHHHccccCcCccCCChhcHHHHH
Q 001847 917 DLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIK 956 (1005)
Q Consensus 917 ~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL 956 (1005)
...+.....+..+.+|+.+||..+|++||+ +.+++
T Consensus 213 -~~~~~~~~~~~~~~~li~~~l~~~p~~Rps----~~~~~ 247 (252)
T cd05084 213 -VRLPCPELCPDAVYRLMERCWEYDPGQRPS----FSTVH 247 (252)
T ss_pred -CCCCCcccCCHHHHHHHHHHcCCChhhCcC----HHHHH
Confidence 233334456889999999999999999999 55554
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-34 Score=311.15 Aligned_cols=250 Identities=23% Similarity=0.374 Sum_probs=206.0
Q ss_pred cCCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEE
Q 001847 671 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLI 750 (1005)
Q Consensus 671 ~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV 750 (1005)
..+|++.+.||+|+||.||++.+. ++..+|+|.+..... ....+.+|+.+++.++||||+++++++...+..|+|
T Consensus 3 ~~~~~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 77 (256)
T cd05059 3 PSELTFLKELGSGQFGVVHLGKWR-GKIDVAIKMIREGAM----SEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIV 77 (256)
T ss_pred hHHcchhhhhccCCCceEEEeEec-CCccEEEEEeccCCC----CHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEE
Confidence 357999999999999999999885 466899998865422 234577899999999999999999999999999999
Q ss_pred EeccCCCchhhHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCCCC
Q 001847 751 TDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQL 830 (1005)
Q Consensus 751 ~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~ 830 (1005)
|||+++++|.+++.... ..+++..+..++.||+.||+|||++|++|+||||+||+++.++.+||+|||++........
T Consensus 78 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~- 155 (256)
T cd05059 78 TEYMANGCLLNYLRERK-GKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQY- 155 (256)
T ss_pred EecCCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECCCCcEEECCcccceecccccc-
Confidence 99999999999987643 3589999999999999999999999999999999999999999999999998854321100
Q ss_pred CCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCChHHH
Q 001847 831 LLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY-GYTPFRGKTRQKT 909 (1005)
Q Consensus 831 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlGvll~eLlt-G~~Pf~~~~~~~~ 909 (1005)
.......++..|+|||.+.+..++.++||||||+++|+|++ |..||......+.
T Consensus 156 -------------------------~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~ 210 (256)
T cd05059 156 -------------------------TSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEV 210 (256)
T ss_pred -------------------------cccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHH
Confidence 00111124567999999988889999999999999999998 8999988777666
Q ss_pred HHHHHhCCCCCCCCCCCCHHHHHHHHHccccCcCccCCChhcHHHHHc
Q 001847 910 FANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKK 957 (1005)
Q Consensus 910 ~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~ 957 (1005)
...+... ...+.....+..+.+++.+||..+|++||+ +.++++
T Consensus 211 ~~~~~~~-~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt----~~~~l~ 253 (256)
T cd05059 211 VESVSAG-YRLYRPKLAPTEVYTIMYSCWHEKPEDRPA----FKKLLS 253 (256)
T ss_pred HHHHHcC-CcCCCCCCCCHHHHHHHHHHhcCChhhCcC----HHHHHH
Confidence 6655443 333333457889999999999999999999 666664
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-34 Score=311.16 Aligned_cols=254 Identities=22% Similarity=0.284 Sum_probs=209.4
Q ss_pred cCCccccccccccCcEEEEEEEEcCC---CeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeE
Q 001847 671 LQHFRPIKPLGSGDTGSVHLVELCGS---GQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHV 747 (1005)
Q Consensus 671 ~~~y~~~~~LG~G~~g~Vy~a~~~~~---~~~valK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 747 (1005)
.++|++.+.||+|+||.||+|.+..+ ...+|+|.++... .......+.+|+.+++.++||||+++++++...+..
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 80 (266)
T cd05033 3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGS--SDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPV 80 (266)
T ss_pred hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCC--ChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCce
Confidence 45799999999999999999998644 4579999887542 334456778899999999999999999999999999
Q ss_pred EEEEeccCCCchhhHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCC
Q 001847 748 CLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCK 827 (1005)
Q Consensus 748 ~lV~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~ 827 (1005)
|+||||+++++|.+++.... +.++...+..++.|++.||.|||++||+|+||||+||+++.++.++|+|||++......
T Consensus 81 ~iv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~ 159 (266)
T cd05033 81 MIITEYMENGSLDKFLREND-GKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDS 159 (266)
T ss_pred EEEEEcCCCCCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCCEEECccchhhccccc
Confidence 99999999999999987643 36899999999999999999999999999999999999999999999999998654311
Q ss_pred CCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCh
Q 001847 828 PQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY-GYTPFRGKTR 906 (1005)
Q Consensus 828 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlGvll~eLlt-G~~Pf~~~~~ 906 (1005)
... .......+++.|+|||.+....++.++||||||+++|+|++ |..||.....
T Consensus 160 ~~~-------------------------~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~ 214 (266)
T cd05033 160 EAT-------------------------YTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSN 214 (266)
T ss_pred ccc-------------------------eeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCH
Confidence 100 00111235678999999988889999999999999999997 9999988777
Q ss_pred HHHHHHHHhCCCCCCCCCCCCHHHHHHHHHccccCcCccCCChhcHHHHHc
Q 001847 907 QKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKK 957 (1005)
Q Consensus 907 ~~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~ 957 (1005)
......+... ...+.....+..+.+|+.+||+.+|++||+ +.++++
T Consensus 215 ~~~~~~~~~~-~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~----~~ei~~ 260 (266)
T cd05033 215 QDVIKAVEDG-YRLPPPMDCPSALYQLMLDCWQKDRNERPT----FSQIVS 260 (266)
T ss_pred HHHHHHHHcC-CCCCCCCCCCHHHHHHHHHHcCCCcccCcC----HHHHHH
Confidence 6666666543 233334457889999999999999999999 555554
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-34 Score=318.91 Aligned_cols=256 Identities=25% Similarity=0.367 Sum_probs=216.2
Q ss_pred CCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEE
Q 001847 672 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLIT 751 (1005)
Q Consensus 672 ~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~ 751 (1005)
..|...+.||.|+||.||++.+..++..+++|.+.............+.+|+.+++.++|+|++++++++...+..|+||
T Consensus 15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 94 (308)
T cd06634 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (308)
T ss_pred HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEE
Confidence 46888999999999999999999999999999987543334445567888999999999999999999999999999999
Q ss_pred eccCCCchhhHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCCCCC
Q 001847 752 DYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLL 831 (1005)
Q Consensus 752 E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~~ 831 (1005)
||+. ++|.+++... ...+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++.....
T Consensus 95 e~~~-~~l~~~~~~~-~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~----- 167 (308)
T cd06634 95 EYCL-GSASDLLEVH-KKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP----- 167 (308)
T ss_pred EccC-CCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECCCCcEEECCcccceeecC-----
Confidence 9995 6887777543 24589999999999999999999999999999999999999999999999998743211
Q ss_pred CCcchhhhhcccCCCCCcccccccccccccccCCcccccccccC---CCCCChhhHHHHHHHHHHHHcCCCCCCCCChHH
Q 001847 832 LPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAG---AGHTSAVDWWALGILLYEMLYGYTPFRGKTRQK 908 (1005)
Q Consensus 832 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~---~~~~~~sDIwSlGvll~eLltG~~Pf~~~~~~~ 908 (1005)
.....|++.|+|||.+.+ ..++.++|||||||++|+|++|..||.......
T Consensus 168 --------------------------~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~ 221 (308)
T cd06634 168 --------------------------ANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS 221 (308)
T ss_pred --------------------------cccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHH
Confidence 123457889999999753 456789999999999999999999998776666
Q ss_pred HHHHHHhCCCCCCCCCCCCHHHHHHHHHccccCcCccCCChhcHHHHHcCCCCCCC
Q 001847 909 TFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGV 964 (1005)
Q Consensus 909 ~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~hpff~~~ 964 (1005)
....+.....+.......+..+.+||.+||..+|++||+ +.++++|||+...
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~----~~~ll~~~~~~~~ 273 (308)
T cd06634 222 ALYHIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPT----SEVLLKHRFVLRE 273 (308)
T ss_pred HHHHHhhcCCCCcCcccccHHHHHHHHHHhhCCcccCCC----HHHHhhCcccccc
Confidence 555565555444444457788999999999999999999 9999999999974
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-34 Score=309.03 Aligned_cols=254 Identities=28% Similarity=0.452 Sum_probs=217.3
Q ss_pred CccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEEe
Q 001847 673 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITD 752 (1005)
Q Consensus 673 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E 752 (1005)
+|++.+.||.|++|.||++.+..+++.+++|.+..... .......+.+|+.+++.++|+||+++++++......|+|||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e 79 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSM-SQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVME 79 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhc-cHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEeh
Confidence 48899999999999999999999999999999876533 23445677789999999999999999999999999999999
Q ss_pred ccCCCchhhHHhhC--CCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCCCC
Q 001847 753 YCPGGELFLLLDRQ--PTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQL 830 (1005)
Q Consensus 753 ~~~ggsL~~~l~~~--~~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~ 830 (1005)
|+++++|..++... ....+++..+..++.||+.||.|||+.|++|+||+|+||+++.++.+||+|||++......
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~--- 156 (256)
T cd08530 80 YAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVANDLVKIGDLGISKVLKKN--- 156 (256)
T ss_pred hcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEecCCcEEEeeccchhhhccC---
Confidence 99999999998652 2245899999999999999999999999999999999999999999999999988543211
Q ss_pred CCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHcCCCCCCCCChHHHH
Q 001847 831 LLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTF 910 (1005)
Q Consensus 831 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlGvll~eLltG~~Pf~~~~~~~~~ 910 (1005)
......+++.|++||.+.+..++.++|+||||+++|+|++|+.||...+.....
T Consensus 157 --------------------------~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~ 210 (256)
T cd08530 157 --------------------------MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLR 210 (256)
T ss_pred --------------------------CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 111235788999999998888889999999999999999999999888776666
Q ss_pred HHHHhCCCCCCCCCCCCHHHHHHHHHccccCcCccCCChhcHHHHHcCCCC
Q 001847 911 ANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFF 961 (1005)
Q Consensus 911 ~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~hpff 961 (1005)
..+........ ....+.++.+++.+||..+|++||+ +.++++||++
T Consensus 211 ~~~~~~~~~~~-~~~~~~~~~~li~~~l~~~p~~Rp~----~~~~l~~p~~ 256 (256)
T cd08530 211 YKVQRGKYPPI-PPIYSQDLQNFIRSMLQVKPKLRPN----CDKILASPAV 256 (256)
T ss_pred HHHhcCCCCCC-chhhCHHHHHHHHHHcCCCcccCCC----HHHHhcCCCC
Confidence 66555443322 2356788999999999999999999 9999999985
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-34 Score=309.78 Aligned_cols=253 Identities=24% Similarity=0.355 Sum_probs=210.9
Q ss_pred ccccCCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeE
Q 001847 668 QINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHV 747 (1005)
Q Consensus 668 ~i~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 747 (1005)
.+..++|++.+.||.|+||.||++.+. .++.+++|.+.... .....+.+|+.+++.++|+||+++++++......
T Consensus 2 ~~~~~~~~i~~~ig~g~~~~v~~~~~~-~~~~~~vK~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 76 (261)
T cd05034 2 EIPRESLKLERKLGAGQFGEVWMGTWN-GTTKVAVKTLKPGT----MSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPI 76 (261)
T ss_pred ccchhheeeeeeeccCcceEEEEEEEc-CCceEEEEEecCCc----cCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCce
Confidence 356789999999999999999999974 55789999987542 2345688899999999999999999999998999
Q ss_pred EEEEeccCCCchhhHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCC
Q 001847 748 CLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCK 827 (1005)
Q Consensus 748 ~lV~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~ 827 (1005)
++||||+.+++|.+++.......++...+..++.||+.||.|||++|++|+||||+||++++++.++|+|||++......
T Consensus 77 ~~v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~ 156 (261)
T cd05034 77 YIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENLVCKIADFGLARLIEDD 156 (261)
T ss_pred EEEEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcCCCCEEECccccceeccch
Confidence 99999999999999998765567899999999999999999999999999999999999999999999999988543210
Q ss_pred CCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCh
Q 001847 828 PQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY-GYTPFRGKTR 906 (1005)
Q Consensus 828 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlGvll~eLlt-G~~Pf~~~~~ 906 (1005)
.. .......++..|+|||.+.+..++.++|||||||++|+|++ |+.||.+...
T Consensus 157 ~~--------------------------~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~ 210 (261)
T cd05034 157 EY--------------------------TAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTN 210 (261)
T ss_pred hh--------------------------hhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCH
Confidence 00 00011234568999999998888999999999999999998 9999988877
Q ss_pred HHHHHHHHhCCCCCCCCCCCCHHHHHHHHHccccCcCccCCChhcHHHHH
Q 001847 907 QKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIK 956 (1005)
Q Consensus 907 ~~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL 956 (1005)
......+... ...+.....+..+.+++.+||..+|++||+ +++++
T Consensus 211 ~~~~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~----~~~l~ 255 (261)
T cd05034 211 REVLEQVERG-YRMPRPPNCPEELYDLMLQCWDKDPEERPT----FEYLQ 255 (261)
T ss_pred HHHHHHHHcC-CCCCCCCCCCHHHHHHHHHHcccCcccCCC----HHHHH
Confidence 7777666543 333334446788999999999999999999 55554
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=305.12 Aligned_cols=252 Identities=31% Similarity=0.513 Sum_probs=213.7
Q ss_pred CccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEEe
Q 001847 673 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITD 752 (1005)
Q Consensus 673 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E 752 (1005)
.|.+.+.||+|++|.||++.+..++..+++|.+..... .....+.+|+.+++.++|+||+++++++......++++|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e 77 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK---EKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVME 77 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch---hHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEe
Confidence 48889999999999999999988899999999876532 355778899999999999999999999999999999999
Q ss_pred ccCCCchhhHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCCCCCC
Q 001847 753 YCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLL 832 (1005)
Q Consensus 753 ~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~~~ 832 (1005)
|+++++|.+++.... ..++...+..++.|++.+|.|||++|++|+||+|+||+++.++.++|+|||.+.......
T Consensus 78 ~~~~~~L~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~---- 152 (253)
T cd05122 78 FCSGGSLKDLLKSTN-QTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTK---- 152 (253)
T ss_pred cCCCCcHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccCCeEEEeeccccccccccc----
Confidence 999999999987643 458999999999999999999999999999999999999999999999999885432110
Q ss_pred CcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHcCCCCCCCCChHHHHHH
Q 001847 833 PTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFAN 912 (1005)
Q Consensus 833 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlGvll~eLltG~~Pf~~~~~~~~~~~ 912 (1005)
......++..|++||.+.+...+.++|+||||+++|+|++|..||...+.......
T Consensus 153 ------------------------~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~ 208 (253)
T cd05122 153 ------------------------ARNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFK 208 (253)
T ss_pred ------------------------cccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHH
Confidence 02235688899999999888888999999999999999999999987755444444
Q ss_pred HHhCCC-CCCCCCCCCHHHHHHHHHccccCcCccCCChhcHHHHHcCCC
Q 001847 913 ILHKDL-KFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPF 960 (1005)
Q Consensus 913 i~~~~~-~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~hpf 960 (1005)
+..... ..+.....+..+.++|.+||..||.+||+ +.++++|||
T Consensus 209 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t----~~~~l~~~~ 253 (253)
T cd05122 209 IATNGPPGLRNPEKWSDEFKDFLKKCLQKNPEKRPT----AEQLLKHPF 253 (253)
T ss_pred HHhcCCCCcCcccccCHHHHHHHHHHccCChhhCCC----HHHHhcCCC
Confidence 433222 22222223788999999999999999999 999999998
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-34 Score=324.58 Aligned_cols=259 Identities=24% Similarity=0.375 Sum_probs=206.5
Q ss_pred cCCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeC------
Q 001847 671 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTK------ 744 (1005)
Q Consensus 671 ~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~------ 744 (1005)
..+|++.+.||.|+||.||+|.+..+++.||+|.+.... ......+.+|+.+++.++||||+++++++...
T Consensus 4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~---~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (342)
T cd07854 4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTD---PQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTE 80 (342)
T ss_pred CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCC---CchHHHHHHHHHHHHhcCCCcchhhHhhhccccccccc
Confidence 368999999999999999999999999999999886542 24456678899999999999999999776543
Q ss_pred --------CeEEEEEeccCCCchhhHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEec-CCcEEE
Q 001847 745 --------THVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQG-NGHVSL 815 (1005)
Q Consensus 745 --------~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~~-~g~vkL 815 (1005)
...|+||||+. ++|.+++.. ..+++..++.++.||+.||.|||+.||+||||||+||+++. ++.++|
T Consensus 81 ~~~~~~~~~~~~lv~e~~~-~~L~~~~~~---~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~~~~~~kl 156 (342)
T cd07854 81 DVGSLTELNSVYIVQEYME-TDLANVLEQ---GPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKI 156 (342)
T ss_pred ccccccccceEEEEeeccc-ccHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCceEEE
Confidence 35899999995 689888764 34899999999999999999999999999999999999984 567899
Q ss_pred EeccCCcccCCCCCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccC-CCCCChhhHHHHHHHHHHH
Q 001847 816 TDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAG-AGHTSAVDWWALGILLYEM 894 (1005)
Q Consensus 816 ~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~sDIwSlGvll~eL 894 (1005)
+|||++........ .........++..|+|||.+.. ..++.++|||||||++|+|
T Consensus 157 ~dfg~~~~~~~~~~------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el 212 (342)
T cd07854 157 GDFGLARIVDPHYS------------------------HKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEM 212 (342)
T ss_pred CCcccceecCCccc------------------------cccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHH
Confidence 99998854321100 0001112357889999998754 4577899999999999999
Q ss_pred HcCCCCCCCCChHHHHHHHHhCCCC----------------------CC------CCCCCCHHHHHHHHHccccCcCccC
Q 001847 895 LYGYTPFRGKTRQKTFANILHKDLK----------------------FP------SSTPTSLHAKQLMYRLLHRDPKSRL 946 (1005)
Q Consensus 895 ltG~~Pf~~~~~~~~~~~i~~~~~~----------------------~~------~~~~~s~~l~~Ll~~~L~~dP~~Rp 946 (1005)
++|+.||.+.+.......+...... .+ .....+.++.+||.+||+.||.+||
T Consensus 213 ~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~ 292 (342)
T cd07854 213 LTGKPLFAGAHELEQMQLILESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRL 292 (342)
T ss_pred HhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhcc
Confidence 9999999877665555444322100 00 0123567889999999999999999
Q ss_pred CChhcHHHHHcCCCCCCC
Q 001847 947 GSHEGANEIKKHPFFKGV 964 (1005)
Q Consensus 947 t~~~~a~elL~hpff~~~ 964 (1005)
+ +.++|+||||+.+
T Consensus 293 t----~~ell~h~~~~~~ 306 (342)
T cd07854 293 T----AEEALMHPYMSCY 306 (342)
T ss_pred C----HHHHhCCCccccc
Confidence 9 9999999999864
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=305.56 Aligned_cols=254 Identities=27% Similarity=0.462 Sum_probs=217.4
Q ss_pred CccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEEe
Q 001847 673 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITD 752 (1005)
Q Consensus 673 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E 752 (1005)
+|++.+.||+|++|.||++.+..+++.|++|.+..... .......+.+|++++++++|+|++++++++...+..+++||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e 79 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKI-KEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILE 79 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEeccccc-CHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEe
Confidence 48899999999999999999988999999999987533 23456788899999999999999999999999999999999
Q ss_pred ccCCCchhhHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCCCCCC
Q 001847 753 YCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLL 832 (1005)
Q Consensus 753 ~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~~~ 832 (1005)
|+.+++|.+++... ..+++..+..++.|++.+|.|||++||+|+||+|+||+++.++.++|+|||++........
T Consensus 80 ~~~~~~L~~~~~~~--~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~--- 154 (254)
T cd06627 80 YAENGSLRQIIKKF--GPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSK--- 154 (254)
T ss_pred cCCCCcHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCCCCEEEeccccceecCCCcc---
Confidence 99999999998765 4589999999999999999999999999999999999999999999999999855431110
Q ss_pred CcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHcCCCCCCCCChHHHHHH
Q 001847 833 PTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFAN 912 (1005)
Q Consensus 833 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlGvll~eLltG~~Pf~~~~~~~~~~~ 912 (1005)
......++..|+|||.+.+...+.++||||||+++|+|++|..||...........
T Consensus 155 ------------------------~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~ 210 (254)
T cd06627 155 ------------------------DDASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFR 210 (254)
T ss_pred ------------------------cccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHH
Confidence 01234678899999999887788899999999999999999999987766555555
Q ss_pred HHhCCCCCCCCCCCCHHHHHHHHHccccCcCccCCChhcHHHHHcCCCC
Q 001847 913 ILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFF 961 (1005)
Q Consensus 913 i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~hpff 961 (1005)
+...... ......+..+.+++.+||..+|++||+ +.+++.||||
T Consensus 211 ~~~~~~~-~~~~~~~~~~~~~i~~~l~~~p~~R~~----~~~~l~~~~~ 254 (254)
T cd06627 211 IVQDDHP-PLPEGISPELKDFLMQCFQKDPNLRPT----AKQLLKHPWI 254 (254)
T ss_pred HhccCCC-CCCCCCCHHHHHHHHHHHhCChhhCcC----HHHHhcCCCC
Confidence 5433222 223346788999999999999999999 9999999997
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-35 Score=302.62 Aligned_cols=264 Identities=28% Similarity=0.459 Sum_probs=210.3
Q ss_pred cCCccccccccccCcEEEEEEEEcCCC----eEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceEEEEEEe-CC
Q 001847 671 LQHFRPIKPLGSGDTGSVHLVELCGSG----QYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQT-KT 745 (1005)
Q Consensus 671 ~~~y~~~~~LG~G~~g~Vy~a~~~~~~----~~valK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~ 745 (1005)
...|+++..||+|.||.||+|..+.++ +.||+|.++.....+ ......++|+.+++.++||||+.+..+|.. +.
T Consensus 23 l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~t-GiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~ 101 (438)
T KOG0666|consen 23 LFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGT-GISMSACREIALLRELKHPNVISLVKVFLSHDK 101 (438)
T ss_pred HHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCC-CcCHHHHHHHHHHHHhcCCcchhHHHHHhccCc
Confidence 458999999999999999999765553 378999987653222 223456789999999999999999999877 78
Q ss_pred eEEEEEeccCCCchhhHHhhC---CCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecC----CcEEEEec
Q 001847 746 HVCLITDYCPGGELFLLLDRQ---PTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGN----GHVSLTDF 818 (1005)
Q Consensus 746 ~~~lV~E~~~ggsL~~~l~~~---~~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~~~----g~vkL~DF 818 (1005)
.+++++||. .-+|++.++.+ ....++...++.|+.||+.|+.|||++-|+||||||.|||+..+ |.|||+||
T Consensus 102 ~v~l~fdYA-EhDL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VKIaDl 180 (438)
T KOG0666|consen 102 KVWLLFDYA-EHDLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVKIADL 180 (438)
T ss_pred eEEEEehhh-hhhHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeEeecc
Confidence 999999999 66888888742 23468999999999999999999999999999999999999988 89999999
Q ss_pred cCCcccCCCCCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCC-CCCChhhHHHHHHHHHHHHcC
Q 001847 819 DLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGA-GHTSAVDWWALGILLYEMLYG 897 (1005)
Q Consensus 819 G~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~sDIwSlGvll~eLltG 897 (1005)
|+++..... ..+....+.++.|.+|+|||.+.+. .|+++.|||+.||++.||++-
T Consensus 181 GlaR~~~~p------------------------lkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl 236 (438)
T KOG0666|consen 181 GLARLFNNP------------------------LKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTL 236 (438)
T ss_pred cHHHHhhcc------------------------ccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHcc
Confidence 999775422 2334455678899999999999886 578899999999999999999
Q ss_pred CCCCCCCC---------hHHHHHHHHh--C---CCCCCCC------------------------------CCCCHHHHHH
Q 001847 898 YTPFRGKT---------RQKTFANILH--K---DLKFPSS------------------------------TPTSLHAKQL 933 (1005)
Q Consensus 898 ~~Pf~~~~---------~~~~~~~i~~--~---~~~~~~~------------------------------~~~s~~l~~L 933 (1005)
++.|.+.. ....+.+|+. + .-.||.. ..-++...+|
T Consensus 237 ~PlF~g~E~k~~~~~Pfq~dQl~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~L 316 (438)
T KOG0666|consen 237 EPLFKGREEKIKTKNPFQHDQLDRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDL 316 (438)
T ss_pred CccccchhhhcccCCCchHHHHHHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHH
Confidence 99886522 1233444433 1 0111110 1123346799
Q ss_pred HHHccccCcCccCCChhcHHHHHcCCCCCCC
Q 001847 934 MYRLLHRDPKSRLGSHEGANEIKKHPFFKGV 964 (1005)
Q Consensus 934 l~~~L~~dP~~Rpt~~~~a~elL~hpff~~~ 964 (1005)
+.+||..||-+|+| ++++|+|+||+.-
T Consensus 317 L~klL~yDP~kRIt----a~qAleh~yF~~d 343 (438)
T KOG0666|consen 317 LQKLLTYDPIKRIT----AEQALEHPYFTED 343 (438)
T ss_pred HHHHhccCchhhcc----HHHHhcccccccC
Confidence 99999999999999 9999999999964
|
|
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-34 Score=315.95 Aligned_cols=257 Identities=25% Similarity=0.353 Sum_probs=208.8
Q ss_pred ccCCccccccccccCcEEEEEEEEcCCC----------------eEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCC
Q 001847 670 NLQHFRPIKPLGSGDTGSVHLVELCGSG----------------QYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPF 733 (1005)
Q Consensus 670 ~~~~y~~~~~LG~G~~g~Vy~a~~~~~~----------------~~valK~~~~~~~~~~~~~~~~~~E~~il~~l~hpn 733 (1005)
...+|++++.||+|+||.||+|.+..++ ..+|+|.+.... .......+.+|+.++++++|||
T Consensus 3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~e~~~l~~l~~~~ 80 (296)
T cd05051 3 PRQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDA--SDNAREDFLKEVKILSRLSDPN 80 (296)
T ss_pred chhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCcc--CHHHHHHHHHHHHHHHhcCCCC
Confidence 3568999999999999999999886543 568999987543 2345667888999999999999
Q ss_pred cceEEEEEEeCCeEEEEEeccCCCchhhHHhhCC---------CCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCc
Q 001847 734 VPALYASFQTKTHVCLITDYCPGGELFLLLDRQP---------TKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPEN 804 (1005)
Q Consensus 734 Iv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~---------~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~N 804 (1005)
|+++++++...+..+++|||+.+++|.+++.... ...+++..++.++.|++.||.|||++||+|+||||+|
T Consensus 81 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlkp~N 160 (296)
T cd05051 81 IARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRN 160 (296)
T ss_pred EeEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccchhc
Confidence 9999999999999999999999999999987643 1258999999999999999999999999999999999
Q ss_pred EEEecCCcEEEEeccCCcccCCCCCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhH
Q 001847 805 VLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDW 884 (1005)
Q Consensus 805 ILi~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDI 884 (1005)
|+++.++.++|+|||++....... .........+++.|+|||++....++.++||
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~-------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv 215 (296)
T cd05051 161 CLVGKNYTIKIADFGMSRNLYSSD-------------------------YYRVQGRAPLPIRWMAWESVLLGKFTTKSDV 215 (296)
T ss_pred eeecCCCceEEccccceeecccCc-------------------------ceeecCcCCCCceecCHHHhhcCCCCccchh
Confidence 999999999999999885432110 0011223456788999999988888999999
Q ss_pred HHHHHHHHHHHc--CCCCCCCCChHHHHHHHHhC------CCCCCCCCCCCHHHHHHHHHccccCcCccCCChhcHHHHH
Q 001847 885 WALGILLYEMLY--GYTPFRGKTRQKTFANILHK------DLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIK 956 (1005)
Q Consensus 885 wSlGvll~eLlt--G~~Pf~~~~~~~~~~~i~~~------~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL 956 (1005)
|||||++|+|++ |..||........+..+... ....+.....+.++.+|+.+||+.||.+||+ +.+++
T Consensus 216 ~slG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt----~~el~ 291 (296)
T cd05051 216 WAFGVTLWEILTLCREQPYEHLTDQQVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPT----FREIH 291 (296)
T ss_pred hhhHHHHHHHHhcCCCCCCCCcChHHHHHHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCC----HHHHH
Confidence 999999999997 78899877666665555432 1122233346789999999999999999999 66664
Q ss_pred c
Q 001847 957 K 957 (1005)
Q Consensus 957 ~ 957 (1005)
+
T Consensus 292 ~ 292 (296)
T cd05051 292 L 292 (296)
T ss_pred H
Confidence 3
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-34 Score=309.62 Aligned_cols=251 Identities=24% Similarity=0.343 Sum_probs=204.8
Q ss_pred cccCCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEE
Q 001847 669 INLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVC 748 (1005)
Q Consensus 669 i~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~ 748 (1005)
+..++|++...||+|++|.||++.+..+ ..+|+|.+.... .....+.+|+.+++.++|+|++++++++. .+..|
T Consensus 3 ~~~~~~~~~~~ig~g~~~~v~~~~~~~~-~~~~lK~~~~~~----~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~ 76 (260)
T cd05069 3 IPRESLRLDVKLGQGCFGEVWMGTWNGT-TKVAIKTLKPGT----MMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIY 76 (260)
T ss_pred CChHHeeeeeeecCcCCCeEEEEEEcCC-ceEEEEEcccCC----ccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcE
Confidence 4456899999999999999999998554 468999876532 22356778999999999999999998875 45689
Q ss_pred EEEeccCCCchhhHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCC
Q 001847 749 LITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKP 828 (1005)
Q Consensus 749 lV~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~ 828 (1005)
+||||+.+++|.+++.......++...+..++.||+.||.|||+.|++|+||||+||++++++.++|+|||.+.......
T Consensus 77 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~ 156 (260)
T cd05069 77 IVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNE 156 (260)
T ss_pred EEEEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCeEEECCCccceEccCCc
Confidence 99999999999999976555568999999999999999999999999999999999999999999999999985432110
Q ss_pred CCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCChH
Q 001847 829 QLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY-GYTPFRGKTRQ 907 (1005)
Q Consensus 829 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlGvll~eLlt-G~~Pf~~~~~~ 907 (1005)
........++..|+|||.+.+..++.++||||||+++|+|++ |..||.+....
T Consensus 157 --------------------------~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~ 210 (260)
T cd05069 157 --------------------------YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNR 210 (260)
T ss_pred --------------------------ccccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence 001112245678999999988888999999999999999999 99999888777
Q ss_pred HHHHHHHhCCCCCCCCCCCCHHHHHHHHHccccCcCccCCChhcHHHHH
Q 001847 908 KTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIK 956 (1005)
Q Consensus 908 ~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL 956 (1005)
.....+... ...+.....+..+.+|+.+||..+|++||+ +++++
T Consensus 211 ~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~----~~~i~ 254 (260)
T cd05069 211 EVLEQVERG-YRMPCPQGCPESLHELMKLCWKKDPDERPT----FEYIQ 254 (260)
T ss_pred HHHHHHHcC-CCCCCCcccCHHHHHHHHHHccCCcccCcC----HHHHH
Confidence 666655443 333333456788999999999999999999 55554
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-34 Score=326.53 Aligned_cols=278 Identities=27% Similarity=0.407 Sum_probs=220.4
Q ss_pred cCCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCe----
Q 001847 671 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTH---- 746 (1005)
Q Consensus 671 ~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~---- 746 (1005)
.++|++.+.||+|++|.||++.+..++..||+|.+.... ........+.+|+.+++.++|+||+++++++.....
T Consensus 14 ~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07851 14 PDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPF-QSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF 92 (343)
T ss_pred cCceEEEEEeccCCceEEEEEEECCCCcEEEEEeccccc-chhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence 468999999999999999999999999999999887542 233445667789999999999999999988866554
Q ss_pred --EEEEEeccCCCchhhHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCccc
Q 001847 747 --VCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLT 824 (1005)
Q Consensus 747 --~~lV~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~~~g~vkL~DFG~a~~~ 824 (1005)
.|+|+||+ +++|.+++.. ..+++..++.++.||+.||.|||++||+|+||||+||+++.++.++|+|||++...
T Consensus 93 ~~~~lv~e~~-~~~L~~~~~~---~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~~~~kL~dfg~~~~~ 168 (343)
T cd07851 93 QDVYLVTHLM-GADLNNIVKC---QKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARHT 168 (343)
T ss_pred ccEEEEEecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEccccccccc
Confidence 89999999 7899998865 35899999999999999999999999999999999999999999999999998543
Q ss_pred CCCCCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccC-CCCCChhhHHHHHHHHHHHHcCCCCCCC
Q 001847 825 SCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAG-AGHTSAVDWWALGILLYEMLYGYTPFRG 903 (1005)
Q Consensus 825 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~sDIwSlGvll~eLltG~~Pf~~ 903 (1005)
... .....+++.|+|||.+.+ ..++.++|||||||++|+|++|+.||.+
T Consensus 169 ~~~------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~ 218 (343)
T cd07851 169 DDE------------------------------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPG 218 (343)
T ss_pred ccc------------------------------ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCC
Confidence 210 123357888999999865 3577899999999999999999999988
Q ss_pred CChHHHHHHHHhCCCCC----------------------C-------CCCCCCHHHHHHHHHccccCcCccCCChhcHHH
Q 001847 904 KTRQKTFANILHKDLKF----------------------P-------SSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANE 954 (1005)
Q Consensus 904 ~~~~~~~~~i~~~~~~~----------------------~-------~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~e 954 (1005)
......+..+....... . .....+..+.+||.+||..+|.+||| +.+
T Consensus 219 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt----~~e 294 (343)
T cd07851 219 SDHIDQLKRIMNLVGTPDEELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRIT----AAE 294 (343)
T ss_pred CChHHHHHHHHHhcCCCCHHHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCC----HHH
Confidence 77766555544321000 0 01235778999999999999999999 999
Q ss_pred HHcCCCCCCCChhhhhhcCCCCCCCCCCCCccccccccC
Q 001847 955 IKKHPFFKGVNWALVRCMNPPELDAPLFATDTEKEYKVV 993 (1005)
Q Consensus 955 lL~hpff~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~ 993 (1005)
+++||||... ... .++...+++.++.......+
T Consensus 295 ll~h~~~~~~--~~~----~~~~~~~~~~~~~~~~~~~~ 327 (343)
T cd07851 295 ALAHPYLAEY--HDP----EDEPVAPPYDQSFESRDLTV 327 (343)
T ss_pred HhcCCCcccc--CCC----cccccccccCcchhhhhcCH
Confidence 9999999964 222 12222455555555544433
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-34 Score=319.69 Aligned_cols=256 Identities=24% Similarity=0.346 Sum_probs=201.0
Q ss_pred CcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEEeccCCCchhhHH
Q 001847 684 DTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLL 763 (1005)
Q Consensus 684 ~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l 763 (1005)
+++.||++.+..+++.||+|.+.... ........+.+|+.+++.++|+||++++++|...+..|++|||+++++|.+++
T Consensus 12 ~~~~v~~~~~~~~~~~~avK~~~~~~-~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~l 90 (314)
T cd08216 12 DLMIVHLAKHKPTNTLVAVKKINLDS-CSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCEDLL 90 (314)
T ss_pred CCceEEEEEecCCCCEEEEEEEeccc-cchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCHHHHH
Confidence 44556666666799999999997642 24456678999999999999999999999999999999999999999999999
Q ss_pred hhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCCCCCCCcchhhhhccc
Q 001847 764 DRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHK 843 (1005)
Q Consensus 764 ~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~~ 843 (1005)
.......+++..+..++.||+.||.|||++||+|+||||+||+++.+|.+||+|||.+..........
T Consensus 91 ~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~------------ 158 (314)
T cd08216 91 KTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQ------------ 158 (314)
T ss_pred HHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecCCceEEecCccceeeccccccc------------
Confidence 86545568999999999999999999999999999999999999999999999999885432111000
Q ss_pred CCCCCcccccccccccccccCCcccccccccCC--CCCChhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhCCCCC-
Q 001847 844 GQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGA--GHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANILHKDLKF- 920 (1005)
Q Consensus 844 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~--~~~~~sDIwSlGvll~eLltG~~Pf~~~~~~~~~~~i~~~~~~~- 920 (1005)
...........++..|+|||++... .++.++|||||||++|+|++|..||..............+....
T Consensus 159 --------~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~ 230 (314)
T cd08216 159 --------RVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCL 230 (314)
T ss_pred --------cccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccc
Confidence 0001112334678899999998663 47789999999999999999999998765544332222211100
Q ss_pred -------------------------------CCCCCCCHHHHHHHHHccccCcCccCCChhcHHHHHcCCCCCCC
Q 001847 921 -------------------------------PSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGV 964 (1005)
Q Consensus 921 -------------------------------~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~hpff~~~ 964 (1005)
......+.++.+|+.+||.+||++||+ ++++|+||||+.+
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt----~~~ll~~p~~~~~ 301 (314)
T cd08216 231 LDKSTYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPS----ASQLLNHSFFKQC 301 (314)
T ss_pred cccCchhhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcC----HHHHhcCchHhhh
Confidence 000112456789999999999999999 9999999999975
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-34 Score=313.38 Aligned_cols=254 Identities=24% Similarity=0.437 Sum_probs=207.4
Q ss_pred ccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhC---CCCCcceEEEEEEeCCe----
Q 001847 674 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDML---DHPFVPALYASFQTKTH---- 746 (1005)
Q Consensus 674 y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~il~~l---~hpnIv~l~~~~~~~~~---- 746 (1005)
|++.+.||.|+||.||++.+..+++.||+|.++.... .......+.+|+.+++++ +|+||+++++++...+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~ 79 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLS-EEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDREL 79 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccc-cchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCc
Confidence 7788999999999999999988899999999975432 222334556677777666 69999999999987776
Q ss_pred -EEEEEeccCCCchhhHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccC
Q 001847 747 -VCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTS 825 (1005)
Q Consensus 747 -~~lV~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~~~g~vkL~DFG~a~~~~ 825 (1005)
++++|||+. ++|.+++.......+++..++.++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||.+....
T Consensus 80 ~~~l~~e~~~-~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~~~~~~l~dfg~~~~~~ 158 (287)
T cd07838 80 KLTLVFEHVD-QDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYS 158 (287)
T ss_pred eeEEEehhcc-cCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEccCCCEEEeccCcceecc
Confidence 999999995 589988876544568999999999999999999999999999999999999999999999999885432
Q ss_pred CCCCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHcCCCCCCCCC
Q 001847 826 CKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKT 905 (1005)
Q Consensus 826 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlGvll~eLltG~~Pf~~~~ 905 (1005)
... ......++..|+|||++.+..++.++|||||||++|+|++|++||.+..
T Consensus 159 ~~~----------------------------~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~ 210 (287)
T cd07838 159 FEM----------------------------ALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTS 210 (287)
T ss_pred CCc----------------------------ccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCC
Confidence 110 0112347889999999998888999999999999999999999999887
Q ss_pred hHHHHHHHHhCC-----CCCC-----------C---------CCCCCHHHHHHHHHccccCcCccCCChhcHHHHHcCCC
Q 001847 906 RQKTFANILHKD-----LKFP-----------S---------STPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPF 960 (1005)
Q Consensus 906 ~~~~~~~i~~~~-----~~~~-----------~---------~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~hpf 960 (1005)
..+.+.++.... ..++ . ....+..+.+||.+||+.||.+||+ +.++++|||
T Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~----~~~il~~~~ 286 (287)
T cd07838 211 EADQLDKIFDVIGLPSEEEWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRIS----AFEALQHPY 286 (287)
T ss_pred hHHHHHHHHHHcCCCChHhcCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCC----HHHHhcCcC
Confidence 777666665421 0000 0 0123467789999999999999999 999999999
Q ss_pred C
Q 001847 961 F 961 (1005)
Q Consensus 961 f 961 (1005)
|
T Consensus 287 ~ 287 (287)
T cd07838 287 F 287 (287)
T ss_pred C
Confidence 8
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=310.68 Aligned_cols=253 Identities=24% Similarity=0.334 Sum_probs=204.6
Q ss_pred ccccccccccCcEEEEEEEEcCC---CeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCe----
Q 001847 674 FRPIKPLGSGDTGSVHLVELCGS---GQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTH---- 746 (1005)
Q Consensus 674 y~~~~~LG~G~~g~Vy~a~~~~~---~~~valK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~---- 746 (1005)
|++.+.||+|+||.||++.+..+ +..||+|.++... ........+.+|+.+++.++||||+++++++.....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 79 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDI-HTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKI 79 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCc-CCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccC
Confidence 67889999999999999997543 4789999987542 234455678899999999999999999998765443
Q ss_pred --EEEEEeccCCCchhhHHhhC----CCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccC
Q 001847 747 --VCLITDYCPGGELFLLLDRQ----PTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDL 820 (1005)
Q Consensus 747 --~~lV~E~~~ggsL~~~l~~~----~~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~~~g~vkL~DFG~ 820 (1005)
.+++|||+++++|..++... ....+++..+..++.||+.||.|||++|++|+||||+||++++++.+||+|||+
T Consensus 80 ~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~ 159 (273)
T cd05035 80 PKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGL 159 (273)
T ss_pred cccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECCCCeEEECCccc
Confidence 79999999999999888542 223589999999999999999999999999999999999999999999999999
Q ss_pred CcccCCCCCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHc-CCC
Q 001847 821 SCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY-GYT 899 (1005)
Q Consensus 821 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlGvll~eLlt-G~~ 899 (1005)
+........ ........++..|+|||.+....++.++|||||||++|+|++ |..
T Consensus 160 ~~~~~~~~~-------------------------~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~ 214 (273)
T cd05035 160 SKKIYSGDY-------------------------YRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQT 214 (273)
T ss_pred eeecccccc-------------------------ccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCC
Confidence 854321110 001112234678999999988888999999999999999998 999
Q ss_pred CCCCCChHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHccccCcCccCCChhcHHHHHc
Q 001847 900 PFRGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKK 957 (1005)
Q Consensus 900 Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~ 957 (1005)
||.+....+.+..+..+. ........+..+.+++.+||..||.+||+ +.++++
T Consensus 215 p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rp~----~~e~~~ 267 (273)
T cd05035 215 PYPGVENHEIYDYLRHGN-RLKQPEDCLDELYDLMYSCWRADPKDRPT----FTKLRE 267 (273)
T ss_pred CCCCCCHHHHHHHHHcCC-CCCCCcCCCHHHHHHHHHHcCCChhhCcC----HHHHHH
Confidence 998887777766665543 23333457889999999999999999999 555554
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=307.19 Aligned_cols=249 Identities=24% Similarity=0.370 Sum_probs=209.9
Q ss_pred ccccccCcEEEEEEEEcCC---CeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEEecc
Q 001847 678 KPLGSGDTGSVHLVELCGS---GQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYC 754 (1005)
Q Consensus 678 ~~LG~G~~g~Vy~a~~~~~---~~~valK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~ 754 (1005)
+.||+|+||.||+|.+... +..|++|.+..... ......+.+|+.+++.++|+||+++++++.....+++||||+
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 78 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDAS--EEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYM 78 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccc--hhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEec
Confidence 4689999999999999765 88999999886532 224678889999999999999999999999999999999999
Q ss_pred CCCchhhHHhhCC-------CCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCC
Q 001847 755 PGGELFLLLDRQP-------TKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCK 827 (1005)
Q Consensus 755 ~ggsL~~~l~~~~-------~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~ 827 (1005)
++++|.+++.... ...+++..+..++.||+.||+|||++|++|+||+|+||+++.++.++|+|||.+......
T Consensus 79 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~ 158 (262)
T cd00192 79 EGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDD 158 (262)
T ss_pred cCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECCCCcEEEcccccccccccc
Confidence 9999999997641 256899999999999999999999999999999999999999999999999998654321
Q ss_pred CCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCh
Q 001847 828 PQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY-GYTPFRGKTR 906 (1005)
Q Consensus 828 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlGvll~eLlt-G~~Pf~~~~~ 906 (1005)
.. ........+++.|+|||.+....++.++|||||||++|+|++ |..||.....
T Consensus 159 ~~-------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~ 213 (262)
T cd00192 159 DY-------------------------YRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSN 213 (262)
T ss_pred cc-------------------------cccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCH
Confidence 10 011233457889999999988888999999999999999998 6999998877
Q ss_pred HHHHHHHHhCCCCCCCCCCCCHHHHHHHHHccccCcCccCCChhcHHHHHcC
Q 001847 907 QKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKH 958 (1005)
Q Consensus 907 ~~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~h 958 (1005)
......+... ........++..+.+++.+||..+|.+||+ +.+++++
T Consensus 214 ~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rps----~~~l~~~ 260 (262)
T cd00192 214 EEVLEYLRKG-YRLPKPEYCPDELYELMLSCWQLDPEDRPT----FSELVER 260 (262)
T ss_pred HHHHHHHHcC-CCCCCCccCChHHHHHHHHHccCCcccCcC----HHHHHHh
Confidence 7766666653 233333456889999999999999999999 8888765
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-34 Score=314.90 Aligned_cols=256 Identities=21% Similarity=0.295 Sum_probs=209.3
Q ss_pred cCCccccccccccCcEEEEEEEEcC-----CCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC
Q 001847 671 LQHFRPIKPLGSGDTGSVHLVELCG-----SGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKT 745 (1005)
Q Consensus 671 ~~~y~~~~~LG~G~~g~Vy~a~~~~-----~~~~valK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~ 745 (1005)
..+|.+.+.||+|+||.||++.+.. ++..+++|.+... .......+.+|+.++++++|+||+++++++...+
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 80 (291)
T cd05094 4 RRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDP---TLAARKDFQREAELLTNLQHEHIVKFYGVCGDGD 80 (291)
T ss_pred hHHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCc---cHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCC
Confidence 4579999999999999999998633 4567899987643 2344467888999999999999999999999999
Q ss_pred eEEEEEeccCCCchhhHHhhCC--------------CCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCC
Q 001847 746 HVCLITDYCPGGELFLLLDRQP--------------TKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNG 811 (1005)
Q Consensus 746 ~~~lV~E~~~ggsL~~~l~~~~--------------~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~~~g 811 (1005)
..++||||+++++|.+++.... ...+++..++.++.||+.||+|||++||+||||||+||+++.++
T Consensus 81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~~~~~ 160 (291)
T cd05094 81 PLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANL 160 (291)
T ss_pred ceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCC
Confidence 9999999999999999987532 23488999999999999999999999999999999999999999
Q ss_pred cEEEEeccCCcccCCCCCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHH
Q 001847 812 HVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILL 891 (1005)
Q Consensus 812 ~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlGvll 891 (1005)
.++|+|||++........ ........+++.|+|||++.+..++.++|||||||++
T Consensus 161 ~~~l~dfg~a~~~~~~~~-------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il 215 (291)
T cd05094 161 LVKIGDFGMSRDVYSTDY-------------------------YRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVIL 215 (291)
T ss_pred cEEECCCCcccccCCCce-------------------------eecCCCCCcceeecChHHhccCCCCchhhHHHHHHHH
Confidence 999999999854321110 0111234567889999999888889999999999999
Q ss_pred HHHHc-CCCCCCCCChHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHccccCcCccCCChhcHHHH
Q 001847 892 YEMLY-GYTPFRGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEI 955 (1005)
Q Consensus 892 ~eLlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~el 955 (1005)
|+|++ |..||......+....+..+.... .....+..+.+|+.+||..+|++||++.++++.+
T Consensus 216 ~el~t~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l 279 (291)
T cd05094 216 WEIFTYGKQPWFQLSNTEVIECITQGRVLE-RPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKIL 279 (291)
T ss_pred HHHHhCCCCCCCCCCHHHHHHHHhCCCCCC-CCccCCHHHHHHHHHHcccChhhCcCHHHHHHHH
Confidence 99998 999998887777666665544332 2234678899999999999999999955544433
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=306.59 Aligned_cols=245 Identities=22% Similarity=0.339 Sum_probs=206.3
Q ss_pred cccCCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEE
Q 001847 669 INLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVC 748 (1005)
Q Consensus 669 i~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~ 748 (1005)
+...+|++.+.||.|+||.||++.+ .++.+|+|.+.... .....+.+|+.+++.++|+||+++++++...+..|
T Consensus 3 ~~~~~~~~~~~ig~g~~g~v~~~~~--~~~~v~iK~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 76 (256)
T cd05039 3 INSKELKLGATIGKGEFGDVMLGDY--RGQKVAVKCLKDDS----TAAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLY 76 (256)
T ss_pred cChhhccceeeeecCCCceEEEEEe--cCcEEEEEEeccch----hHHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeE
Confidence 4567899999999999999999987 47899999987542 14567889999999999999999999999899999
Q ss_pred EEEeccCCCchhhHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCC
Q 001847 749 LITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKP 828 (1005)
Q Consensus 749 lV~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~ 828 (1005)
+||||+++++|.+++.......+++..+..++.|++.||.|||++|++|+||||+||+++.++.++|+|||.+......
T Consensus 77 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~- 155 (256)
T cd05039 77 IVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQG- 155 (256)
T ss_pred EEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeCCCCEEEcccccccccccc-
Confidence 9999999999999998765456999999999999999999999999999999999999999999999999988543110
Q ss_pred CCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCChH
Q 001847 829 QLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY-GYTPFRGKTRQ 907 (1005)
Q Consensus 829 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlGvll~eLlt-G~~Pf~~~~~~ 907 (1005)
.....++..|+|||++....++.++||||||+++|+|++ |..||......
T Consensus 156 -----------------------------~~~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~ 206 (256)
T cd05039 156 -----------------------------QDSGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK 206 (256)
T ss_pred -----------------------------cccCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHH
Confidence 001234567999999988888999999999999999997 99999887766
Q ss_pred HHHHHHHhCCCCCCCCCCCCHHHHHHHHHccccCcCccCCChh
Q 001847 908 KTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHE 950 (1005)
Q Consensus 908 ~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~ 950 (1005)
.....+... .........+..+.+||.+||..+|++||++.+
T Consensus 207 ~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ 248 (256)
T cd05039 207 DVVPHVEKG-YRMEAPEGCPPEVYKVMKDCWELDPAKRPTFKQ 248 (256)
T ss_pred HHHHHHhcC-CCCCCccCCCHHHHHHHHHHhccChhhCcCHHH
Confidence 655544433 222233446789999999999999999999433
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=312.23 Aligned_cols=253 Identities=20% Similarity=0.299 Sum_probs=207.4
Q ss_pred cccCCccccccccccCcEEEEEEEEc-----CCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceEEEEEEe
Q 001847 669 INLQHFRPIKPLGSGDTGSVHLVELC-----GSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQT 743 (1005)
Q Consensus 669 i~~~~y~~~~~LG~G~~g~Vy~a~~~-----~~~~~valK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~ 743 (1005)
++..+|++.+.||+|+||.||++... .++..+++|.+... .......+.+|+++++.++|+||+++++++..
T Consensus 2 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 78 (280)
T cd05092 2 IKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA---SESARQDFQREAELLTVLQHQHIVRFYGVCTE 78 (280)
T ss_pred CChHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcC---CHHHHHHHHHHHHHHhcCCCCCCceEEEEEec
Confidence 34568999999999999999999752 34678999987643 34455678899999999999999999999999
Q ss_pred CCeEEEEEeccCCCchhhHHhhCCC-------------CCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecC
Q 001847 744 KTHVCLITDYCPGGELFLLLDRQPT-------------KVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGN 810 (1005)
Q Consensus 744 ~~~~~lV~E~~~ggsL~~~l~~~~~-------------~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~~~ 810 (1005)
.+..|++|||+.+++|.+++..... ..++...+..++.||+.||+|||++|++|+||||+|||++++
T Consensus 79 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~~~ 158 (280)
T cd05092 79 GRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQG 158 (280)
T ss_pred CCceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEEcCC
Confidence 9999999999999999999875421 347889999999999999999999999999999999999999
Q ss_pred CcEEEEeccCCcccCCCCCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHH
Q 001847 811 GHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGIL 890 (1005)
Q Consensus 811 g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlGvl 890 (1005)
+.+||+|||++........ ........+++.|+|||++.+..++.++|||||||+
T Consensus 159 ~~~kL~dfg~~~~~~~~~~-------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~i 213 (280)
T cd05092 159 LVVKIGDFGMSRDIYSTDY-------------------------YRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVV 213 (280)
T ss_pred CCEEECCCCceeEcCCCce-------------------------eecCCCccccccccCHHHhccCCcCchhhHHHHHHH
Confidence 9999999998854321100 001122345688999999988889999999999999
Q ss_pred HHHHHc-CCCCCCCCChHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHccccCcCccCCChh
Q 001847 891 LYEMLY-GYTPFRGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHE 950 (1005)
Q Consensus 891 l~eLlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~ 950 (1005)
+|+|++ |.+||...........+..+.. ......++..+.+||.+||+.||.+||++.+
T Consensus 214 l~el~~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ 273 (280)
T cd05092 214 LWEIFTYGKQPWYQLSNTEAIECITQGRE-LERPRTCPPEVYAIMQGCWQREPQQRMVIKD 273 (280)
T ss_pred HHHHHcCCCCCCccCCHHHHHHHHHcCcc-CCCCCCCCHHHHHHHHHHccCChhhCCCHHH
Confidence 999998 9999988777766666655432 2333457888999999999999999999433
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=327.77 Aligned_cols=263 Identities=23% Similarity=0.344 Sum_probs=225.3
Q ss_pred ccccccccCCccccccccccCcEEEEEEEEcCCCe---E-EEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceEEE
Q 001847 664 DSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQ---Y-FAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYA 739 (1005)
Q Consensus 664 ~~~~~i~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~---~-valK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~ 739 (1005)
...|++..++..+.+.||+|+||.||++..+..+. . ||+|..+............+.+|++++++++|||||++++
T Consensus 149 r~~Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yG 228 (474)
T KOG0194|consen 149 RQKWELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYG 228 (474)
T ss_pred ccccEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEE
Confidence 34566777788888999999999999999865422 3 8999988654556788899999999999999999999999
Q ss_pred EEEeCCeEEEEEeccCCCchhhHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEecc
Q 001847 740 SFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFD 819 (1005)
Q Consensus 740 ~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~~~g~vkL~DFG 819 (1005)
+......+++|||+|.||+|.++|++.+. .++..+...++.+.+.||+|||++++|||||-..|+|++.++.+||+|||
T Consensus 229 Va~~~~Pl~ivmEl~~gGsL~~~L~k~~~-~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~~~~~vKISDFG 307 (474)
T KOG0194|consen 229 VAVLEEPLMLVMELCNGGSLDDYLKKNKK-SLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYSKKGVVKISDFG 307 (474)
T ss_pred EEcCCCccEEEEEecCCCcHHHHHHhCCC-CCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheecCCCeEEeCccc
Confidence 99999999999999999999999998643 59999999999999999999999999999999999999999999999999
Q ss_pred CCcccCCCCCCCCCcchhhhhcccCCCCCccccccccccc-ccccCCcccccccccCCCCCChhhHHHHHHHHHHHHc-C
Q 001847 820 LSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASN-SFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY-G 897 (1005)
Q Consensus 820 ~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~gt~~y~aPE~l~~~~~~~~sDIwSlGvll~eLlt-G 897 (1005)
++..... . .... ..--...|+|||.+....++.++|||||||++||+++ |
T Consensus 308 Ls~~~~~---~-------------------------~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g 359 (474)
T KOG0194|consen 308 LSRAGSQ---Y-------------------------VMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENG 359 (474)
T ss_pred cccCCcc---e-------------------------eeccccccCcceecChhhhccCccccccchhheeeeEEeeeccC
Confidence 9854320 0 0000 1123568999999999999999999999999999998 8
Q ss_pred CCCCCCCChHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHccccCcCccCCChhcHHHH
Q 001847 898 YTPFRGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEI 955 (1005)
Q Consensus 898 ~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~el 955 (1005)
..||.+....+....+.......+.+...+..+..++.+|+..+|+.||++..+++.+
T Consensus 360 ~~Py~g~~~~~v~~kI~~~~~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l 417 (474)
T KOG0194|consen 360 AEPYPGMKNYEVKAKIVKNGYRMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKL 417 (474)
T ss_pred CCCCCCCCHHHHHHHHHhcCccCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHH
Confidence 8999999999999999777766666667788999999999999999999976654433
|
|
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=306.73 Aligned_cols=248 Identities=21% Similarity=0.290 Sum_probs=200.4
Q ss_pred cccccCcEEEEEEEE--cCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEEeccCC
Q 001847 679 PLGSGDTGSVHLVEL--CGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPG 756 (1005)
Q Consensus 679 ~LG~G~~g~Vy~a~~--~~~~~~valK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~g 756 (1005)
.||+|+||.||++.+ ..++..+|+|+++.. .........+.+|+.+++.++||||+++++++.. ...++||||+++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~-~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~e~~~~ 79 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKND-NNDPALKDELLREANVMQQLDNPYIVRMIGICEA-ESWMLVMELAEL 79 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCC-CCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCcEEEEecCCC
Confidence 589999999999965 456789999998754 2234456778899999999999999999998754 567999999999
Q ss_pred CchhhHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCCCCCCCcch
Q 001847 757 GELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTN 836 (1005)
Q Consensus 757 gsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~~~~~~~ 836 (1005)
++|.+++... ..+++..+..++.||+.||.|||++||+|+||||+||+++.++.+||+|||++.........
T Consensus 80 ~~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~------ 151 (257)
T cd05116 80 GPLNKFLQKN--KHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENY------ 151 (257)
T ss_pred CcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCCCeEEECCCccccccCCCCCe------
Confidence 9999999754 35899999999999999999999999999999999999999999999999998654321110
Q ss_pred hhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHh
Q 001847 837 EKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY-GYTPFRGKTRQKTFANILH 915 (1005)
Q Consensus 837 ~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlGvll~eLlt-G~~Pf~~~~~~~~~~~i~~ 915 (1005)
........+++.|+|||.+....++.++|||||||++|+|++ |..||...........+..
T Consensus 152 ------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~~ 213 (257)
T cd05116 152 ------------------YKAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIES 213 (257)
T ss_pred ------------------eeecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHC
Confidence 000111234678999999988888899999999999999997 9999988777666666554
Q ss_pred CCCCCCCCCCCCHHHHHHHHHccccCcCccCCChhcHHHH
Q 001847 916 KDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEI 955 (1005)
Q Consensus 916 ~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~el 955 (1005)
+. ..+.....+.++.+||.+||+.||++||++..+...|
T Consensus 214 ~~-~~~~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l 252 (257)
T cd05116 214 GE-RMECPQRCPPEMYDLMKLCWTYGVDERPGFAVVELRL 252 (257)
T ss_pred CC-CCCCCCCCCHHHHHHHHHHhccCchhCcCHHHHHHHH
Confidence 43 2333345788999999999999999999965544333
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=309.53 Aligned_cols=252 Identities=23% Similarity=0.331 Sum_probs=206.9
Q ss_pred cCCccccccccccCcEEEEEEEEcCCC---eEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeE
Q 001847 671 LQHFRPIKPLGSGDTGSVHLVELCGSG---QYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHV 747 (1005)
Q Consensus 671 ~~~y~~~~~LG~G~~g~Vy~a~~~~~~---~~valK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 747 (1005)
..+|++.+.||+|+||.||++.+..++ ..+|+|.++... .......+.+|+.+++.++||||+++++++...+.+
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 80 (267)
T cd05066 3 ASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGY--TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPV 80 (267)
T ss_pred HHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCC--CHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCcc
Confidence 468999999999999999999986444 379999887542 233456788899999999999999999999999999
Q ss_pred EEEEeccCCCchhhHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCC
Q 001847 748 CLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCK 827 (1005)
Q Consensus 748 ~lV~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~ 827 (1005)
|+||||+++++|.+++.... ..++...+..++.|++.||.|||+.|++|+||||+|||++.++.++|+|||++......
T Consensus 81 ~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~ 159 (267)
T cd05066 81 MIVTEYMENGSLDAFLRKHD-GQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD 159 (267)
T ss_pred EEEEEcCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEECCCCeEEeCCCCcccccccc
Confidence 99999999999999997653 45899999999999999999999999999999999999999999999999998654321
Q ss_pred CCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCh
Q 001847 828 PQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY-GYTPFRGKTR 906 (1005)
Q Consensus 828 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlGvll~eLlt-G~~Pf~~~~~ 906 (1005)
... ........++..|+|||.+.+..++.++|+|||||++|++++ |..||.+...
T Consensus 160 ~~~------------------------~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~ 215 (267)
T cd05066 160 PEA------------------------AYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSN 215 (267)
T ss_pred cce------------------------eeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCH
Confidence 100 000111233568999999988889999999999999999886 9999988777
Q ss_pred HHHHHHHHhCCCCCCCCCCCCHHHHHHHHHccccCcCccCCChh
Q 001847 907 QKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHE 950 (1005)
Q Consensus 907 ~~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~ 950 (1005)
.+....+... ...+.....+..+.+++.+||+.+|.+||++.+
T Consensus 216 ~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ 258 (267)
T cd05066 216 QDVIKAIEEG-YRLPAPMDCPAALHQLMLDCWQKDRNERPKFEQ 258 (267)
T ss_pred HHHHHHHhCC-CcCCCCCCCCHHHHHHHHHHcccCchhCCCHHH
Confidence 6666655544 334444557888999999999999999999444
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=305.91 Aligned_cols=248 Identities=22% Similarity=0.339 Sum_probs=206.0
Q ss_pred ccccccCcEEEEEEEEcC-CC--eEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEEecc
Q 001847 678 KPLGSGDTGSVHLVELCG-SG--QYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYC 754 (1005)
Q Consensus 678 ~~LG~G~~g~Vy~a~~~~-~~--~~valK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~ 754 (1005)
+.||+|++|.||++.+.. .+ ..+|+|.+...... .....+.+|+.++++++||||+++++.+.. ...++||||+
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~ 77 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS--DIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELA 77 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccH--HHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEec
Confidence 468999999999999855 33 36999998875432 566788899999999999999999999988 8899999999
Q ss_pred CCCchhhHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCCCCCCCc
Q 001847 755 PGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPT 834 (1005)
Q Consensus 755 ~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~~~~~ 834 (1005)
++++|.+++.......+++..++.++.|++.||.|||++|++|+||||+||+++.++.+||+|||++.........
T Consensus 78 ~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~---- 153 (257)
T cd05040 78 PLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDH---- 153 (257)
T ss_pred CCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecCCEEEeccccccccccccccc----
Confidence 9999999997754356899999999999999999999999999999999999999999999999998654321100
Q ss_pred chhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHH
Q 001847 835 TNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY-GYTPFRGKTRQKTFANI 913 (1005)
Q Consensus 835 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlGvll~eLlt-G~~Pf~~~~~~~~~~~i 913 (1005)
........++..|+|||++....++.++|||||||++|+|++ |+.||...+..+....+
T Consensus 154 --------------------~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~ 213 (257)
T cd05040 154 --------------------YVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKI 213 (257)
T ss_pred --------------------eecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence 011113457788999999988889999999999999999998 99999888777777766
Q ss_pred HhCCCCCCCCCCCCHHHHHHHHHccccCcCccCCChhcHHHHH
Q 001847 914 LHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIK 956 (1005)
Q Consensus 914 ~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL 956 (1005)
......++.....+..+.+++.+||..+|.+||+ +.+++
T Consensus 214 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps----~~~~~ 252 (257)
T cd05040 214 DKEGERLERPEACPQDIYNVMLQCWAHNPADRPT----FAALR 252 (257)
T ss_pred HhcCCcCCCCccCCHHHHHHHHHHCCCCcccCCC----HHHHH
Confidence 6544444444456789999999999999999999 55554
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=316.62 Aligned_cols=259 Identities=21% Similarity=0.298 Sum_probs=206.7
Q ss_pred cccccCCccccccccccCcEEEEEEEEcCC-------CeEEEEEEeecccccChHHHHHHHHHHHHHHhC-CCCCcceEE
Q 001847 667 EQINLQHFRPIKPLGSGDTGSVHLVELCGS-------GQYFAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPALY 738 (1005)
Q Consensus 667 ~~i~~~~y~~~~~LG~G~~g~Vy~a~~~~~-------~~~valK~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~ 738 (1005)
+.+..++|.+.+.||+|+||.||++.+... ...+|+|.+.... .......+..|+.+++.+ +|+||++++
T Consensus 13 ~~~~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~e~~~l~~l~~h~~i~~~~ 90 (307)
T cd05098 13 WEVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDA--TEKDLSDLISEMEMMKMIGKHKNIINLL 90 (307)
T ss_pred ceeehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCC--ChHHHHHHHHHHHHHHHhcCCCCEeeEE
Confidence 345567899999999999999999987432 3479999987542 233456788899999999 799999999
Q ss_pred EEEEeCCeEEEEEeccCCCchhhHHhhCC--------------CCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCc
Q 001847 739 ASFQTKTHVCLITDYCPGGELFLLLDRQP--------------TKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPEN 804 (1005)
Q Consensus 739 ~~~~~~~~~~lV~E~~~ggsL~~~l~~~~--------------~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~N 804 (1005)
+++...+..|+||||+.+++|.+++.... ...++...+..++.||+.||+|||++|++|+||||+|
T Consensus 91 ~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~N 170 (307)
T cd05098 91 GACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARN 170 (307)
T ss_pred EEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccHHh
Confidence 99999999999999999999999997542 1348889999999999999999999999999999999
Q ss_pred EEEecCCcEEEEeccCCcccCCCCCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhH
Q 001847 805 VLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDW 884 (1005)
Q Consensus 805 ILi~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDI 884 (1005)
|+++.++.+||+|||.+........ ........+++.|+|||++.+..++.++||
T Consensus 171 ill~~~~~~kL~dfg~a~~~~~~~~-------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv 225 (307)
T cd05098 171 VLVTEDNVMKIADFGLARDIHHIDY-------------------------YKKTTNGRLPVKWMAPEALFDRIYTHQSDV 225 (307)
T ss_pred eEEcCCCcEEECCCcccccccccch-------------------------hhccccCCCccceeChHHhccCCCCcHHHH
Confidence 9999999999999998854321000 000111234568999999988888999999
Q ss_pred HHHHHHHHHHHc-CCCCCCCCChHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHccccCcCccCCChhcHH
Q 001847 885 WALGILLYEMLY-GYTPFRGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGAN 953 (1005)
Q Consensus 885 wSlGvll~eLlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~ 953 (1005)
|||||++|+|++ |..||.+....+....+... .........+..+.+|+.+||..+|.+||++.++++
T Consensus 226 wslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~ 294 (307)
T cd05098 226 WSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEG-HRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE 294 (307)
T ss_pred HHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHcC-CCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHH
Confidence 999999999998 89999877665555544433 333333456889999999999999999999544433
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-34 Score=323.36 Aligned_cols=255 Identities=27% Similarity=0.421 Sum_probs=207.6
Q ss_pred cCCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeC------
Q 001847 671 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTK------ 744 (1005)
Q Consensus 671 ~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~------ 744 (1005)
.++|.+.+.||+|+||.||++.+..+++.||+|.+.... ........+.+|+.++++++|+||+++++++...
T Consensus 16 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~~ 94 (345)
T cd07877 16 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 94 (345)
T ss_pred cCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcc-hhhHHHHHHHHHHHHHHHcCCCcccceeeeeeeccccccc
Confidence 478999999999999999999999999999999987642 2233345677899999999999999999988643
Q ss_pred CeEEEEEeccCCCchhhHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCccc
Q 001847 745 THVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLT 824 (1005)
Q Consensus 745 ~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~~~g~vkL~DFG~a~~~ 824 (1005)
...|++++++ +++|.+++.. ..+++..++.++.||+.||.|||++||+|+||||+||+++.++.+||+|||++...
T Consensus 95 ~~~~lv~~~~-~~~L~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~dfg~~~~~ 170 (345)
T cd07877 95 NDVYLVTHLM-GADLNNIVKC---QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHT 170 (345)
T ss_pred ccEEEEehhc-ccCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcCCCCEEEecccccccc
Confidence 3578999988 8899888764 34899999999999999999999999999999999999999999999999988532
Q ss_pred CCCCCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccC-CCCCChhhHHHHHHHHHHHHcCCCCCCC
Q 001847 825 SCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAG-AGHTSAVDWWALGILLYEMLYGYTPFRG 903 (1005)
Q Consensus 825 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~sDIwSlGvll~eLltG~~Pf~~ 903 (1005)
.. ......+++.|+|||.+.+ ..++.++|||||||++|+|++|+.||..
T Consensus 171 ~~------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~ 220 (345)
T cd07877 171 DD------------------------------EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 220 (345)
T ss_pred cc------------------------------cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 11 1123467889999999866 4678899999999999999999999987
Q ss_pred CChHHHHHHHHhCCC-----------------------CCCC------CCCCCHHHHHHHHHccccCcCccCCChhcHHH
Q 001847 904 KTRQKTFANILHKDL-----------------------KFPS------STPTSLHAKQLMYRLLHRDPKSRLGSHEGANE 954 (1005)
Q Consensus 904 ~~~~~~~~~i~~~~~-----------------------~~~~------~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~e 954 (1005)
......+..+..... ..+. ....+..+.+||.+||+.||.+||+ +.+
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t----~~e 296 (345)
T cd07877 221 TDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRIT----AAQ 296 (345)
T ss_pred CCHHHHHHHHHHHhCCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCC----HHH
Confidence 665544443322110 0000 1134678899999999999999999 999
Q ss_pred HHcCCCCCCC
Q 001847 955 IKKHPFFKGV 964 (1005)
Q Consensus 955 lL~hpff~~~ 964 (1005)
++.||||++.
T Consensus 297 ~l~h~~f~~~ 306 (345)
T cd07877 297 ALAHAYFAQY 306 (345)
T ss_pred HhcChhhhhc
Confidence 9999999963
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=308.55 Aligned_cols=253 Identities=23% Similarity=0.294 Sum_probs=202.7
Q ss_pred ccccccccccCcEEEEEEEEcCCCe--EEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceEEEEEEe------CC
Q 001847 674 FRPIKPLGSGDTGSVHLVELCGSGQ--YFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQT------KT 745 (1005)
Q Consensus 674 y~~~~~LG~G~~g~Vy~a~~~~~~~--~valK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~------~~ 745 (1005)
|.+.+.||+|+||.||++.+..++. .+|+|.++.. .........+..|+.+++.++|+||+++++++.. ..
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~-~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 79 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIA-ICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYP 79 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccC-cCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCC
Confidence 3567889999999999999877664 6899988754 2344556778889999999999999999987642 23
Q ss_pred eEEEEEeccCCCchhhHHhhC----CCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCC
Q 001847 746 HVCLITDYCPGGELFLLLDRQ----PTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLS 821 (1005)
Q Consensus 746 ~~~lV~E~~~ggsL~~~l~~~----~~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~~~g~vkL~DFG~a 821 (1005)
..+++|||+.+++|.+++... ....+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||++
T Consensus 80 ~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~ 159 (272)
T cd05075 80 SPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLS 159 (272)
T ss_pred CcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEcCCCCEEECCCCcc
Confidence 578999999999999887421 2234889999999999999999999999999999999999999999999999998
Q ss_pred cccCCCCCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHc-CCCC
Q 001847 822 CLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY-GYTP 900 (1005)
Q Consensus 822 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlGvll~eLlt-G~~P 900 (1005)
........ ........+++.|++||.+.+..++.++|||||||++|+|++ |..|
T Consensus 160 ~~~~~~~~-------------------------~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p 214 (272)
T cd05075 160 KKIYNGDY-------------------------YRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTP 214 (272)
T ss_pred cccCcccc-------------------------eecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCC
Confidence 65421100 001122346778999999998889999999999999999998 8999
Q ss_pred CCCCChHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHccccCcCccCCChhcHHHHHc
Q 001847 901 FRGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKK 957 (1005)
Q Consensus 901 f~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~ 957 (1005)
|.+.........+..+.. .+.....+..+.++|.+||..+|++||+ +.++++
T Consensus 215 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~p~~Rps----~~~l~~ 266 (272)
T cd05075 215 YPGVENSEIYDYLRQGNR-LKQPPDCLDGLYSLMSSCWLLNPKDRPS----FETLRC 266 (272)
T ss_pred CCCCCHHHHHHHHHcCCC-CCCCCCCCHHHHHHHHHHcCCCcccCcC----HHHHHH
Confidence 988777766666655433 2233456788999999999999999999 555553
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=309.92 Aligned_cols=254 Identities=21% Similarity=0.316 Sum_probs=205.9
Q ss_pred cccCCccccccccccCcEEEEEEEEcCCCe----EEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeC
Q 001847 669 INLQHFRPIKPLGSGDTGSVHLVELCGSGQ----YFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTK 744 (1005)
Q Consensus 669 i~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~----~valK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~ 744 (1005)
+...+|++++.||.|+||.||+|.+..++. .||+|.+.... .......+.+|+.+++.+.|+||+.+++++..
T Consensus 4 l~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~- 80 (279)
T cd05109 4 LKETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENT--SPKANKEILDEAYVMAGVGSPYVCRLLGICLT- 80 (279)
T ss_pred cchhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCC--CHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-
Confidence 456789999999999999999999877765 48999887542 34445678889999999999999999998875
Q ss_pred CeEEEEEeccCCCchhhHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCccc
Q 001847 745 THVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLT 824 (1005)
Q Consensus 745 ~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~~~g~vkL~DFG~a~~~ 824 (1005)
...+++|+|+++|+|.+++.... ..+++..+..++.||+.||.|||++||+||||||+|||+++++.+||+|||++...
T Consensus 81 ~~~~l~~~~~~~g~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~ 159 (279)
T cd05109 81 STVQLVTQLMPYGCLLDYVRENK-DRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARLL 159 (279)
T ss_pred CCcEEEEEcCCCCCHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCCcEEECCCCceeec
Confidence 45789999999999999987542 45899999999999999999999999999999999999999999999999998654
Q ss_pred CCCCCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHc-CCCCCCC
Q 001847 825 SCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY-GYTPFRG 903 (1005)
Q Consensus 825 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlGvll~eLlt-G~~Pf~~ 903 (1005)
...... .......+++.|+|||.+.+..++.++|||||||++|+|++ |..||..
T Consensus 160 ~~~~~~-------------------------~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~ 214 (279)
T cd05109 160 DIDETE-------------------------YHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDG 214 (279)
T ss_pred ccccce-------------------------eecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Confidence 311110 00111235678999999988889999999999999999998 9999987
Q ss_pred CChHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHccccCcCccCCChhcHHHHH
Q 001847 904 KTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIK 956 (1005)
Q Consensus 904 ~~~~~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL 956 (1005)
.........+ ......+.....+..+.+++.+||..||++||+ +.+++
T Consensus 215 ~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~----~~~l~ 262 (279)
T cd05109 215 IPAREIPDLL-EKGERLPQPPICTIDVYMIMVKCWMIDSECRPR----FRELV 262 (279)
T ss_pred CCHHHHHHHH-HCCCcCCCCccCCHHHHHHHHHHcCCChhhCcC----HHHHH
Confidence 6665544433 333333444557889999999999999999999 55555
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=313.64 Aligned_cols=249 Identities=22% Similarity=0.308 Sum_probs=203.2
Q ss_pred CCccccccccccCcEEEEEEEEcCCCe--EEEEEEeecccccChHHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCeEE
Q 001847 672 QHFRPIKPLGSGDTGSVHLVELCGSGQ--YFAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPALYASFQTKTHVC 748 (1005)
Q Consensus 672 ~~y~~~~~LG~G~~g~Vy~a~~~~~~~--~valK~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~~ 748 (1005)
++|++.+.||.|+||.||++.+..++. .+++|.++.. ........+.+|+.++.++ +||||+++++++...+.+|
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~--~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~ 79 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEF--ASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLY 79 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEcccc--CCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcce
Confidence 479999999999999999999877664 4688877632 2334456788899999999 7999999999999999999
Q ss_pred EEEeccCCCchhhHHhhCC--------------CCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEE
Q 001847 749 LITDYCPGGELFLLLDRQP--------------TKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVS 814 (1005)
Q Consensus 749 lV~E~~~ggsL~~~l~~~~--------------~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~~~g~vk 814 (1005)
+||||+++++|.+++.... ...++...++.++.||+.||+|||++||+||||||+|||++.++.+|
T Consensus 80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~k 159 (297)
T cd05089 80 IAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLASK 159 (297)
T ss_pred EEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEECCCCeEE
Confidence 9999999999999986532 13488899999999999999999999999999999999999999999
Q ss_pred EEeccCCcccCCCCCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHH
Q 001847 815 LTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEM 894 (1005)
Q Consensus 815 L~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlGvll~eL 894 (1005)
|+|||++...... ........+..|+|||++....++.++|||||||++|+|
T Consensus 160 l~dfg~~~~~~~~----------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el 211 (297)
T cd05089 160 IADFGLSRGEEVY----------------------------VKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEI 211 (297)
T ss_pred ECCcCCCccccce----------------------------eccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHH
Confidence 9999987421100 000111234579999999888889999999999999999
Q ss_pred Hc-CCCCCCCCChHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHccccCcCccCCChhc
Q 001847 895 LY-GYTPFRGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEG 951 (1005)
Q Consensus 895 lt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~ 951 (1005)
++ |..||.+.........+..+ ...+....++..+.+|+.+||..+|.+||++.++
T Consensus 212 ~t~g~~pf~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i 268 (297)
T cd05089 212 VSLGGTPYCGMTCAELYEKLPQG-YRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQI 268 (297)
T ss_pred HcCCCCCCCCCCHHHHHHHHhcC-CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHH
Confidence 97 99999888777766666544 2223334578899999999999999999994443
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=306.40 Aligned_cols=250 Identities=22% Similarity=0.329 Sum_probs=206.2
Q ss_pred ccccCCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeE
Q 001847 668 QINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHV 747 (1005)
Q Consensus 668 ~i~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 747 (1005)
.+..++|++.+.||+|+||.||++.+. .+..+++|.+... ......+.+|+.+++.++|+||+++++++.. ...
T Consensus 2 ~~~~~~~~~~~~lg~g~~~~vy~~~~~-~~~~~~iK~~~~~----~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~ 75 (260)
T cd05073 2 EIPRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPG----SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPI 75 (260)
T ss_pred cccccceeEEeEecCccceEEEEEEec-CCccEEEEecCCC----hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCe
Confidence 456789999999999999999999864 4567999987653 2234678889999999999999999999887 778
Q ss_pred EEEEeccCCCchhhHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCC
Q 001847 748 CLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCK 827 (1005)
Q Consensus 748 ~lV~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~ 827 (1005)
+++|||+++++|.+++.......++...+..++.||+.||.|||+.|++|+||||+||+++.++.+||+|||.+......
T Consensus 76 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~ 155 (260)
T cd05073 76 YIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDN 155 (260)
T ss_pred EEEEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCCcceeeccCC
Confidence 99999999999999998765566889999999999999999999999999999999999999999999999988543211
Q ss_pred CCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCh
Q 001847 828 PQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY-GYTPFRGKTR 906 (1005)
Q Consensus 828 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlGvll~eLlt-G~~Pf~~~~~ 906 (1005)
.. .......++..|+|||++....++.++|+|||||++|++++ |..||.+.+.
T Consensus 156 ~~--------------------------~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~ 209 (260)
T cd05073 156 EY--------------------------TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSN 209 (260)
T ss_pred Cc--------------------------ccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCH
Confidence 00 00112235677999999988888899999999999999998 9999988776
Q ss_pred HHHHHHHHhCCCCCCCCCCCCHHHHHHHHHccccCcCccCCChh
Q 001847 907 QKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHE 950 (1005)
Q Consensus 907 ~~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~ 950 (1005)
......+... ...+.....+..+.+++.+||+.+|++||++.+
T Consensus 210 ~~~~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ 252 (260)
T cd05073 210 PEVIRALERG-YRMPRPENCPEELYNIMMRCWKNRPEERPTFEY 252 (260)
T ss_pred HHHHHHHhCC-CCCCCcccCCHHHHHHHHHHcccCcccCcCHHH
Confidence 6655554433 333444557789999999999999999999443
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-34 Score=323.32 Aligned_cols=256 Identities=30% Similarity=0.474 Sum_probs=207.5
Q ss_pred CCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeC------C
Q 001847 672 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTK------T 745 (1005)
Q Consensus 672 ~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~------~ 745 (1005)
++|.+.+.||.|+||.||+|.+..++..||+|.+..... .......+.+|+.+++.++||||+++++++... .
T Consensus 15 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 93 (342)
T cd07879 15 ERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQ-SEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ 93 (342)
T ss_pred cceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccc-cccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence 689999999999999999999988999999999875422 222345677899999999999999999998754 3
Q ss_pred eEEEEEeccCCCchhhHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccC
Q 001847 746 HVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTS 825 (1005)
Q Consensus 746 ~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~~~g~vkL~DFG~a~~~~ 825 (1005)
..|+||||+. .+|..++. ..+++..+..++.|++.||.|||+.|++||||||+||+++.++.++|+|||++....
T Consensus 94 ~~~lv~e~~~-~~l~~~~~----~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~~~~~kL~dfg~~~~~~ 168 (342)
T cd07879 94 DFYLVMPYMQ-TDLQKIMG----HPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLARHAD 168 (342)
T ss_pred eEEEEecccc-cCHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCCCCcCCC
Confidence 4699999994 57766652 248999999999999999999999999999999999999999999999999884321
Q ss_pred CCCCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccC-CCCCChhhHHHHHHHHHHHHcCCCCCCCC
Q 001847 826 CKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAG-AGHTSAVDWWALGILLYEMLYGYTPFRGK 904 (1005)
Q Consensus 826 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~sDIwSlGvll~eLltG~~Pf~~~ 904 (1005)
. ......+++.|+|||.+.+ ..++.++|||||||++|+|++|+.||.+.
T Consensus 169 ~------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~ 218 (342)
T cd07879 169 A------------------------------EMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGK 218 (342)
T ss_pred C------------------------------CCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCC
Confidence 1 1123467889999999876 45788999999999999999999999887
Q ss_pred ChHHHHHHHHhCC-----------------------CCCCC------CCCCCHHHHHHHHHccccCcCccCCChhcHHHH
Q 001847 905 TRQKTFANILHKD-----------------------LKFPS------STPTSLHAKQLMYRLLHRDPKSRLGSHEGANEI 955 (1005)
Q Consensus 905 ~~~~~~~~i~~~~-----------------------~~~~~------~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~el 955 (1005)
+....+..+.... ...+. ....+..+.+||.+||+.||.+||+ +.++
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~----~~e~ 294 (342)
T cd07879 219 DYLDQLTQILKVTGVPGPEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLT----ATEA 294 (342)
T ss_pred CHHHHHHHHHHhcCCCCHHHHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcC----HHHH
Confidence 6555444433210 00000 1235677899999999999999999 9999
Q ss_pred HcCCCCCCCChh
Q 001847 956 KKHPFFKGVNWA 967 (1005)
Q Consensus 956 L~hpff~~~~~~ 967 (1005)
+.||||+.+...
T Consensus 295 l~h~~f~~~~~~ 306 (342)
T cd07879 295 LEHPYFDSFRDA 306 (342)
T ss_pred hcCcchhhcccc
Confidence 999999998654
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=325.39 Aligned_cols=258 Identities=22% Similarity=0.290 Sum_probs=208.3
Q ss_pred cccccCCccccccccccCcEEEEEEEEc-----CCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCC-CCCcceEEEE
Q 001847 667 EQINLQHFRPIKPLGSGDTGSVHLVELC-----GSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLD-HPFVPALYAS 740 (1005)
Q Consensus 667 ~~i~~~~y~~~~~LG~G~~g~Vy~a~~~-----~~~~~valK~~~~~~~~~~~~~~~~~~E~~il~~l~-hpnIv~l~~~ 740 (1005)
+.+..++|.+.+.||+|+||.||+|.+. .+++.||+|++.... .......+.+|+.++.++. ||||++++++
T Consensus 32 ~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~~E~~~l~~l~~H~niv~~~~~ 109 (401)
T cd05107 32 WEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTA--RSSEKQALMSELKIMSHLGPHLNIVNLLGA 109 (401)
T ss_pred ceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCC--ChhHHHHHHHHHHHHHhcCCCCCeEEEEEE
Confidence 4566778999999999999999999963 345789999997542 2233456788999999997 9999999999
Q ss_pred EEeCCeEEEEEeccCCCchhhHHhhCCC----------------------------------------------------
Q 001847 741 FQTKTHVCLITDYCPGGELFLLLDRQPT---------------------------------------------------- 768 (1005)
Q Consensus 741 ~~~~~~~~lV~E~~~ggsL~~~l~~~~~---------------------------------------------------- 768 (1005)
+...+.+|+||||+.+|+|.+++.....
T Consensus 110 ~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 189 (401)
T cd05107 110 CTKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADY 189 (401)
T ss_pred EccCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCc
Confidence 9999999999999999999999864321
Q ss_pred --------------------------------------------CCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCc
Q 001847 769 --------------------------------------------KVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPEN 804 (1005)
Q Consensus 769 --------------------------------------------~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~N 804 (1005)
..++...+..++.||+.||.|||+.||+||||||+|
T Consensus 190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp~N 269 (401)
T cd05107 190 VPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARN 269 (401)
T ss_pred cchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCCcce
Confidence 236777889999999999999999999999999999
Q ss_pred EEEecCCcEEEEeccCCcccCCCCCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhH
Q 001847 805 VLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDW 884 (1005)
Q Consensus 805 ILi~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDI 884 (1005)
||++.++.+||+|||++........ ........+++.|+|||.+....++.++||
T Consensus 270 iLl~~~~~~kL~DfGla~~~~~~~~-------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv 324 (401)
T cd05107 270 VLICEGKLVKICDFGLARDIMRDSN-------------------------YISKGSTFLPLKWMAPESIFNNLYTTLSDV 324 (401)
T ss_pred EEEeCCCEEEEEecCcceecccccc-------------------------cccCCCcCCCCceeChHHhcCCCCCcHhHH
Confidence 9999999999999999854321100 001123357889999999988888999999
Q ss_pred HHHHHHHHHHHc-CCCCCCCCChHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHccccCcCccCCChhc
Q 001847 885 WALGILLYEMLY-GYTPFRGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEG 951 (1005)
Q Consensus 885 wSlGvll~eLlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~ 951 (1005)
|||||++|+|++ |..||......+.....+......+.....+.++.+|+.+||..+|.+||++.++
T Consensus 325 wslGvil~e~l~~g~~P~~~~~~~~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~el 392 (401)
T cd05107 325 WSFGILLWEIFTLGGTPYPELPMNEQFYNAIKRGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQL 392 (401)
T ss_pred HHHHHHHHHHHHcCCCCCCCCCchHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHH
Confidence 999999999997 8999987666555555555444433444568899999999999999999994433
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=319.14 Aligned_cols=274 Identities=25% Similarity=0.335 Sum_probs=212.4
Q ss_pred CCccc-cccccccCcEEEEEEEEcCCCeEEEEEEeecccccChH-----------HHHHHHHHHHHHHhCCCCCcceEEE
Q 001847 672 QHFRP-IKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRN-----------KVHRACAEREILDMLDHPFVPALYA 739 (1005)
Q Consensus 672 ~~y~~-~~~LG~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~-----------~~~~~~~E~~il~~l~hpnIv~l~~ 739 (1005)
++|.. .+.||.|+||.||++.+..+++.||+|.++........ ....+.+|+.+++.++|+||+++++
T Consensus 8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 87 (335)
T PTZ00024 8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD 87 (335)
T ss_pred cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence 56765 47799999999999999999999999998754322100 1124678999999999999999999
Q ss_pred EEEeCCeEEEEEeccCCCchhhHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEecc
Q 001847 740 SFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFD 819 (1005)
Q Consensus 740 ~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~~~g~vkL~DFG 819 (1005)
++...+..|+||||+. ++|.+++... ..+++..+..++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||
T Consensus 88 ~~~~~~~~~lv~e~~~-~~l~~~l~~~--~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~~~~~~kl~dfg 164 (335)
T PTZ00024 88 VYVEGDFINLVMDIMA-SDLKKVVDRK--IRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADFG 164 (335)
T ss_pred EEecCCcEEEEEeccc-cCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEECCCCCEEECCcc
Confidence 9999999999999995 6899988653 458999999999999999999999999999999999999999999999999
Q ss_pred CCcccCCCCCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCC-CCCChhhHHHHHHHHHHHHcCC
Q 001847 820 LSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGA-GHTSAVDWWALGILLYEMLYGY 898 (1005)
Q Consensus 820 ~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~sDIwSlGvll~eLltG~ 898 (1005)
++............... . ............+++.|+|||.+.+. .++.++|||||||++|+|++|.
T Consensus 165 ~~~~~~~~~~~~~~~~~---------~----~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~ 231 (335)
T PTZ00024 165 LARRYGYPPYSDTLSKD---------E----TMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGK 231 (335)
T ss_pred ceeeccccccccccccc---------c----cccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCC
Confidence 98654322111000000 0 00001111234578899999998764 4688999999999999999999
Q ss_pred CCCCCCChHHHHHHHHhCC--C---CCCC---------------------CCCCCHHHHHHHHHccccCcCccCCChhcH
Q 001847 899 TPFRGKTRQKTFANILHKD--L---KFPS---------------------STPTSLHAKQLMYRLLHRDPKSRLGSHEGA 952 (1005)
Q Consensus 899 ~Pf~~~~~~~~~~~i~~~~--~---~~~~---------------------~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a 952 (1005)
.||.+.+....+..+.... . .++. ....+..+.+||.+||..+|++||+ +
T Consensus 232 ~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s----~ 307 (335)
T PTZ00024 232 PLFPGENEIDQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERIS----A 307 (335)
T ss_pred CCCCCCCHHHHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccC----H
Confidence 9999887766665554310 0 0000 1234677899999999999999999 9
Q ss_pred HHHHcCCCCCCCC
Q 001847 953 NEIKKHPFFKGVN 965 (1005)
Q Consensus 953 ~elL~hpff~~~~ 965 (1005)
.++|.||||+...
T Consensus 308 ~~~l~~~~~~~~~ 320 (335)
T PTZ00024 308 KEALKHEYFKSDP 320 (335)
T ss_pred HHHhcCcccCCCC
Confidence 9999999999753
|
|
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=317.73 Aligned_cols=261 Identities=25% Similarity=0.381 Sum_probs=205.8
Q ss_pred CccccccccccCcEEEEEEEEcCC--CeEEEEEEeecccccChHHHHHHHHHHHHHHhC-CCCCcceEEEEEEe----CC
Q 001847 673 HFRPIKPLGSGDTGSVHLVELCGS--GQYFAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPALYASFQT----KT 745 (1005)
Q Consensus 673 ~y~~~~~LG~G~~g~Vy~a~~~~~--~~~valK~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~----~~ 745 (1005)
+|++.+.||+|+||.||++.+..+ +..||+|.+.... ........+.+|+.+++++ +||||+++++.+.. ..
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~ 79 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVF-SKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFN 79 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEecccc-ccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCC
Confidence 488999999999999999999888 8899999987532 2233456677899999999 69999999987543 24
Q ss_pred eEEEEEeccCCCchhhHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccC
Q 001847 746 HVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTS 825 (1005)
Q Consensus 746 ~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~~~g~vkL~DFG~a~~~~ 825 (1005)
.+|++|+|+ +++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||++....
T Consensus 80 ~~~~~~e~~-~~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~~~~~kl~Dfg~a~~~~ 156 (332)
T cd07857 80 ELYLYEELM-EADLHQIIRSG--QPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFS 156 (332)
T ss_pred cEEEEEecc-cCCHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcCCCCEEeCcCCCceecc
Confidence 688999999 57898888653 458999999999999999999999999999999999999999999999999986432
Q ss_pred CCCCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccC-CCCCChhhHHHHHHHHHHHHcCCCCCCCC
Q 001847 826 CKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAG-AGHTSAVDWWALGILLYEMLYGYTPFRGK 904 (1005)
Q Consensus 826 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~sDIwSlGvll~eLltG~~Pf~~~ 904 (1005)
..... .........|++.|+|||++.+ ..++.++|||||||++|+|++|..||.+.
T Consensus 157 ~~~~~-----------------------~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~ 213 (332)
T cd07857 157 ENPGE-----------------------NAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGK 213 (332)
T ss_pred ccccc-----------------------ccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCC
Confidence 11100 0011223578999999998765 46788999999999999999999999876
Q ss_pred ChHHHHHHHHhC----------------------------CCCCC-CCCCCCHHHHHHHHHccccCcCccCCChhcHHHH
Q 001847 905 TRQKTFANILHK----------------------------DLKFP-SSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEI 955 (1005)
Q Consensus 905 ~~~~~~~~i~~~----------------------------~~~~~-~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~el 955 (1005)
+....+..++.. ...+. .....+..+.+|+.+||+.||.+||+ +.++
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t----~~~l 289 (332)
T cd07857 214 DYVDQLNQILQVLGTPDEETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRIS----VEEA 289 (332)
T ss_pred CHHHHHHHHHHHhCCCCHHHHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCC----HHHH
Confidence 544433332211 00001 11235778999999999999999999 9999
Q ss_pred HcCCCCCCC
Q 001847 956 KKHPFFKGV 964 (1005)
Q Consensus 956 L~hpff~~~ 964 (1005)
+.||||+.+
T Consensus 290 l~~~~~~~~ 298 (332)
T cd07857 290 LEHPYLAIW 298 (332)
T ss_pred hcChhhhhh
Confidence 999999753
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=317.27 Aligned_cols=254 Identities=27% Similarity=0.447 Sum_probs=206.6
Q ss_pred cCCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceEEEEEEe-CCeEEE
Q 001847 671 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQT-KTHVCL 749 (1005)
Q Consensus 671 ~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~~l 749 (1005)
.++|++++.||.|+||.||++.+..+++.||+|.+.+.. ........+..|+.+++.++||||++++++|.. ....|+
T Consensus 9 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~l 87 (328)
T cd07856 9 TNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPF-STPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYF 87 (328)
T ss_pred ccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccc-cccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEEE
Confidence 468999999999999999999999999999999886542 223344667789999999999999999999865 567899
Q ss_pred EEeccCCCchhhHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCCC
Q 001847 750 ITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQ 829 (1005)
Q Consensus 750 V~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~ 829 (1005)
||||+ +++|..++.. ..++...+..++.||+.||.|||++||+|+||+|+||+++.++.++|+|||.+.....
T Consensus 88 v~e~~-~~~L~~~~~~---~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~--- 160 (328)
T cd07856 88 VTELL-GTDLHRLLTS---RPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLARIQDP--- 160 (328)
T ss_pred Eeehh-ccCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECCCCCEEeCccccccccCC---
Confidence 99999 7789888764 3478889999999999999999999999999999999999999999999998743210
Q ss_pred CCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccC-CCCCChhhHHHHHHHHHHHHcCCCCCCCCChHH
Q 001847 830 LLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAG-AGHTSAVDWWALGILLYEMLYGYTPFRGKTRQK 908 (1005)
Q Consensus 830 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~sDIwSlGvll~eLltG~~Pf~~~~~~~ 908 (1005)
......+++.|+|||.+.+ ..++.++|||||||++|+|++|+.||.+.....
T Consensus 161 ---------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~ 213 (328)
T cd07856 161 ---------------------------QMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVN 213 (328)
T ss_pred ---------------------------CcCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 0122357889999998765 567889999999999999999999998765533
Q ss_pred HHHHHHhC--------------------------CCCCC---CCCCCCHHHHHHHHHccccCcCccCCChhcHHHHHcCC
Q 001847 909 TFANILHK--------------------------DLKFP---SSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHP 959 (1005)
Q Consensus 909 ~~~~i~~~--------------------------~~~~~---~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~hp 959 (1005)
....+... ....+ ....++..+.++|.+||+.+|++||+ +.+++.||
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t----~~ell~~~ 289 (328)
T cd07856 214 QFSIITDLLGTPPDDVINTICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRIS----AAEALAHP 289 (328)
T ss_pred HHHHHHHHhCCCCHHHHHhccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCC----HHHHhcCC
Confidence 22221110 00011 01235678999999999999999999 99999999
Q ss_pred CCCC
Q 001847 960 FFKG 963 (1005)
Q Consensus 960 ff~~ 963 (1005)
||..
T Consensus 290 ~~~~ 293 (328)
T cd07856 290 YLAP 293 (328)
T ss_pred cccc
Confidence 9985
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-34 Score=310.13 Aligned_cols=250 Identities=30% Similarity=0.448 Sum_probs=202.2
Q ss_pred cccccccccCcEEEEEEEEc----CCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEE
Q 001847 675 RPIKPLGSGDTGSVHLVELC----GSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLI 750 (1005)
Q Consensus 675 ~~~~~LG~G~~g~Vy~a~~~----~~~~~valK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV 750 (1005)
.+.+.||.|.||.||+|.+. ..+..|+||.+... ........+.+|++++++++||||+++++++...+..++|
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~--~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv 79 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPS--SSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLV 79 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTT--SSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEE
T ss_pred EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccc--cccccceeeeeccccccccccccccccccccccccccccc
Confidence 35678999999999999997 34678999999542 2344578899999999999999999999999988889999
Q ss_pred EeccCCCchhhHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCCCC
Q 001847 751 TDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQL 830 (1005)
Q Consensus 751 ~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~ 830 (1005)
|||+++|+|.+++.......++...+..|+.||+.||.|||+++++|++|+|+||++++++.+||+|||++........
T Consensus 80 ~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~- 158 (259)
T PF07714_consen 80 MEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSK- 158 (259)
T ss_dssp EE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSS-
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc-
Confidence 9999999999999886456699999999999999999999999999999999999999999999999999855421100
Q ss_pred CCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCChHHH
Q 001847 831 LLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY-GYTPFRGKTRQKT 909 (1005)
Q Consensus 831 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlGvll~eLlt-G~~Pf~~~~~~~~ 909 (1005)
........+...|+|||.+....++.++||||||+++|||++ |+.||...+..+.
T Consensus 159 ------------------------~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~ 214 (259)
T PF07714_consen 159 ------------------------YKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEI 214 (259)
T ss_dssp ------------------------EEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHH
T ss_pred ------------------------cccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 011223356778999999988889999999999999999999 7899998888887
Q ss_pred HHHHHhCCCCCCCCCCCCHHHHHHHHHccccCcCccCCChhcHHHHH
Q 001847 910 FANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIK 956 (1005)
Q Consensus 910 ~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL 956 (1005)
...+.... ..+....++..+.++|..||..+|++||+ +.+++
T Consensus 215 ~~~~~~~~-~~~~~~~~~~~~~~li~~C~~~~p~~RPs----~~~i~ 256 (259)
T PF07714_consen 215 IEKLKQGQ-RLPIPDNCPKDIYSLIQQCWSHDPEKRPS----FQEIL 256 (259)
T ss_dssp HHHHHTTE-ETTSBTTSBHHHHHHHHHHT-SSGGGS------HHHHH
T ss_pred cccccccc-cceeccchhHHHHHHHHHHcCCChhhCcC----HHHHH
Confidence 77774443 33334457889999999999999999999 55554
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=313.58 Aligned_cols=253 Identities=24% Similarity=0.341 Sum_probs=202.3
Q ss_pred cCCccccccccccCcEEEEEEEEcCC--------------CeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcce
Q 001847 671 LQHFRPIKPLGSGDTGSVHLVELCGS--------------GQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPA 736 (1005)
Q Consensus 671 ~~~y~~~~~LG~G~~g~Vy~a~~~~~--------------~~~valK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~ 736 (1005)
.++|++.+.||+|+||.||+|.+..+ ...||+|.++... .......+.+|++++++++|+||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~ei~~l~~l~h~~i~~ 81 (295)
T cd05097 4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADV--TKTARNDFLKEIKIMSRLKNPNIIR 81 (295)
T ss_pred hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCC--CHHHHHHHHHHHHHHHhCCCCCcCe
Confidence 46899999999999999999987543 2358999987542 2344567889999999999999999
Q ss_pred EEEEEEeCCeEEEEEeccCCCchhhHHhhCC----------CCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEE
Q 001847 737 LYASFQTKTHVCLITDYCPGGELFLLLDRQP----------TKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVL 806 (1005)
Q Consensus 737 l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~----------~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NIL 806 (1005)
+++++...+..|+||||+.+++|.+++.... ...++...+..++.||+.||.|||++|++|+||||+||+
T Consensus 82 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil 161 (295)
T cd05097 82 LLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCL 161 (295)
T ss_pred EEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccChhhEE
Confidence 9999999999999999999999999986431 123678899999999999999999999999999999999
Q ss_pred EecCCcEEEEeccCCcccCCCCCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHH
Q 001847 807 LQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWA 886 (1005)
Q Consensus 807 i~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwS 886 (1005)
++.++.+||+|||++....... .........+++.|+|||++....++.++||||
T Consensus 162 l~~~~~~kl~dfg~~~~~~~~~-------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwS 216 (295)
T cd05097 162 VGNHYTIKIADFGMSRNLYSGD-------------------------YYRIQGRAVLPIRWMAWESILLGKFTTASDVWA 216 (295)
T ss_pred EcCCCcEEecccccccccccCc-------------------------ceeccCcCcCceeecChhhhccCCcCchhhHHH
Confidence 9999999999999885432110 001112234577899999998888999999999
Q ss_pred HHHHHHHHHc--CCCCCCCCChHHHHHHHHh------CCCCCCCCCCCCHHHHHHHHHccccCcCccCCChh
Q 001847 887 LGILLYEMLY--GYTPFRGKTRQKTFANILH------KDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHE 950 (1005)
Q Consensus 887 lGvll~eLlt--G~~Pf~~~~~~~~~~~i~~------~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~ 950 (1005)
|||++|+|++ |..||...........+.. ...........+..+.+|+.+||..+|++||++.+
T Consensus 217 lG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~ 288 (295)
T cd05097 217 FGVTLWEMFTLCKEQPYSLLSDEQVIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNK 288 (295)
T ss_pred HHHHHHHHHHcCCCCCCcccChHHHHHHHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHH
Confidence 9999999987 7789987766655544432 11112223346788999999999999999999444
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=313.88 Aligned_cols=256 Identities=21% Similarity=0.306 Sum_probs=207.5
Q ss_pred ccccCCccccccccccCcEEEEEEEEc-------CCCeEEEEEEeecccccChHHHHHHHHHHHHHHhC-CCCCcceEEE
Q 001847 668 QINLQHFRPIKPLGSGDTGSVHLVELC-------GSGQYFAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPALYA 739 (1005)
Q Consensus 668 ~i~~~~y~~~~~LG~G~~g~Vy~a~~~-------~~~~~valK~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~ 739 (1005)
.+..++|.+.+.||+|+||.||++.+. ..+..+|+|.+.... .......+.+|+.+++.+ +||||+++++
T Consensus 11 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~i~~~~~ 88 (304)
T cd05101 11 EFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINLLG 88 (304)
T ss_pred cccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeeccccc--chHHHHHHHHHHHHHHhhccCCCchheeE
Confidence 355678999999999999999999753 234579999887532 234456788999999999 8999999999
Q ss_pred EEEeCCeEEEEEeccCCCchhhHHhhCC--------------CCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcE
Q 001847 740 SFQTKTHVCLITDYCPGGELFLLLDRQP--------------TKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENV 805 (1005)
Q Consensus 740 ~~~~~~~~~lV~E~~~ggsL~~~l~~~~--------------~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NI 805 (1005)
++...+.+|+||||+.+++|.+++.... ...++...+..++.||+.||.|||++|++|+||||+||
T Consensus 89 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Ni 168 (304)
T cd05101 89 ACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNV 168 (304)
T ss_pred EEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeecccccceE
Confidence 9999999999999999999999987532 13477888999999999999999999999999999999
Q ss_pred EEecCCcEEEEeccCCcccCCCCCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHH
Q 001847 806 LLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWW 885 (1005)
Q Consensus 806 Li~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIw 885 (1005)
+++.++.+||+|||++........ ........+++.|+|||++.+..++.++|||
T Consensus 169 li~~~~~~kl~D~g~~~~~~~~~~-------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~ 223 (304)
T cd05101 169 LVTENNVMKIADFGLARDVNNIDY-------------------------YKKTTNGRLPVKWMAPEALFDRVYTHQSDVW 223 (304)
T ss_pred EEcCCCcEEECCCccceecccccc-------------------------cccccCCCCCceeeCchhhccCCCCchhhHH
Confidence 999999999999999865421110 0011123456789999999888889999999
Q ss_pred HHHHHHHHHHc-CCCCCCCCChHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHccccCcCccCCChhc
Q 001847 886 ALGILLYEMLY-GYTPFRGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEG 951 (1005)
Q Consensus 886 SlGvll~eLlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~ 951 (1005)
|||+++|+|++ |..||.+....+....+.... .......++..+.+|+.+||..+|.+||++.++
T Consensus 224 slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~ 289 (304)
T cd05101 224 SFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGH-RMDKPANCTNELYMMMRDCWHAIPSHRPTFKQL 289 (304)
T ss_pred HHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCC-cCCCCCCCCHHHHHHHHHHcccChhhCCCHHHH
Confidence 99999999998 889998877766666554432 223334578899999999999999999994443
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=309.23 Aligned_cols=256 Identities=21% Similarity=0.315 Sum_probs=213.6
Q ss_pred cCCccccccccccCcEEEEEEEEcC-----CCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC
Q 001847 671 LQHFRPIKPLGSGDTGSVHLVELCG-----SGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKT 745 (1005)
Q Consensus 671 ~~~y~~~~~LG~G~~g~Vy~a~~~~-----~~~~valK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~ 745 (1005)
..+|++++.||.|+||.||++..+. +.+.+++|.+.... .......+.+|+.++++++|+||+++++++...+
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 81 (275)
T cd05046 4 RSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTK--DENLQSEFRRELDMFRKLSHKNVVRLLGLCREAE 81 (275)
T ss_pred hHhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCcc--chHHHHHHHHHHHHHHhcCCcceeeeEEEECCCC
Confidence 4689999999999999999999754 34679999876431 2234567889999999999999999999999989
Q ss_pred eEEEEEeccCCCchhhHHhhCCC-------CCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEec
Q 001847 746 HVCLITDYCPGGELFLLLDRQPT-------KVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDF 818 (1005)
Q Consensus 746 ~~~lV~E~~~ggsL~~~l~~~~~-------~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~~~g~vkL~DF 818 (1005)
..|+||||+++++|.+++..... ..+++..+..++.||+.||.|||++||+|+||||+||+++.++.++|+||
T Consensus 82 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~~~ 161 (275)
T cd05046 82 PHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKVSLL 161 (275)
T ss_pred cceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeCCCcEEEccc
Confidence 99999999999999999976431 15899999999999999999999999999999999999999999999999
Q ss_pred cCCcccCCCCCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHc-C
Q 001847 819 DLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY-G 897 (1005)
Q Consensus 819 G~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlGvll~eLlt-G 897 (1005)
|++....... ........+++.|+|||.+.+...+.++||||||+++|+|++ |
T Consensus 162 ~~~~~~~~~~--------------------------~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~ 215 (275)
T cd05046 162 SLSKDVYNSE--------------------------YYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQG 215 (275)
T ss_pred ccccccCccc--------------------------ccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCC
Confidence 9874321110 011123356778999999988888899999999999999998 8
Q ss_pred CCCCCCCChHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHccccCcCccCCChhcHHHHHcC
Q 001847 898 YTPFRGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKH 958 (1005)
Q Consensus 898 ~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~h 958 (1005)
..||.+.........+..+...++....++..+.+++.+||+.+|.+||+ +.+++.+
T Consensus 216 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~----~~~~l~~ 272 (275)
T cd05046 216 ELPFYGLSDEEVLNRLQAGKLELPVPEGCPSRLYKLMTRCWAVNPKDRPS----FSELVSA 272 (275)
T ss_pred CCCccccchHHHHHHHHcCCcCCCCCCCCCHHHHHHHHHHcCCCcccCCC----HHHHHHH
Confidence 89998877777777776666666666668889999999999999999999 7777653
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=311.02 Aligned_cols=253 Identities=21% Similarity=0.303 Sum_probs=206.8
Q ss_pred ccCCccccccccccCcEEEEEEEEcC-----CCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeC
Q 001847 670 NLQHFRPIKPLGSGDTGSVHLVELCG-----SGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTK 744 (1005)
Q Consensus 670 ~~~~y~~~~~LG~G~~g~Vy~a~~~~-----~~~~valK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~ 744 (1005)
..++|++++.||.|+||.||+|.+.. ++..+|+|.+.... .......+.+|+.+++.++||||+++++++...
T Consensus 3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~ 80 (288)
T cd05050 3 PRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMAEFDHPNIVKLLGVCAVG 80 (288)
T ss_pred ChHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCc--CHHHHHHHHHHHHHHHhcCCCchheEEEEEcCC
Confidence 45689999999999999999999753 57899999987542 234456788899999999999999999999999
Q ss_pred CeEEEEEeccCCCchhhHHhhCC--------------------CCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCc
Q 001847 745 THVCLITDYCPGGELFLLLDRQP--------------------TKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPEN 804 (1005)
Q Consensus 745 ~~~~lV~E~~~ggsL~~~l~~~~--------------------~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~N 804 (1005)
...|+||||+++++|.+++.... ...+++..+..++.||+.||.|||++|++||||||+|
T Consensus 81 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p~n 160 (288)
T cd05050 81 KPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRN 160 (288)
T ss_pred CccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccccHhh
Confidence 99999999999999999986421 1247888899999999999999999999999999999
Q ss_pred EEEecCCcEEEEeccCCcccCCCCCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhH
Q 001847 805 VLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDW 884 (1005)
Q Consensus 805 ILi~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDI 884 (1005)
|+++.++.++|+|||++........ ........+++.|+|||.+.+..++.++||
T Consensus 161 il~~~~~~~~l~dfg~~~~~~~~~~-------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv 215 (288)
T cd05050 161 CLVGENMVVKIADFGLSRNIYSADY-------------------------YKASENDAIPIRWMPPESIFYNRYTTESDV 215 (288)
T ss_pred eEecCCCceEECccccceecccCcc-------------------------ccccCCCccChhhcCHHHHhcCCCCchhHH
Confidence 9999999999999998754321100 011112234667999999988889999999
Q ss_pred HHHHHHHHHHHc-CCCCCCCCChHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHccccCcCccCCChh
Q 001847 885 WALGILLYEMLY-GYTPFRGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHE 950 (1005)
Q Consensus 885 wSlGvll~eLlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~ 950 (1005)
|||||++|+|++ |..||.+....+....+..+... +.....+..+.+|+.+||+.+|++||++.+
T Consensus 216 ~slG~il~el~~~~~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~~p~~Rpt~~e 281 (288)
T cd05050 216 WAYGVVLWEIFSYGMQPYYGMAHEEVIYYVRDGNVL-SCPDNCPLELYNLMRLCWSKLPSDRPSFAS 281 (288)
T ss_pred HHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCC-CCCCCCCHHHHHHHHHHcccCcccCCCHHH
Confidence 999999999997 88999888777766666555432 223346788999999999999999999444
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=312.25 Aligned_cols=254 Identities=28% Similarity=0.499 Sum_probs=210.1
Q ss_pred ccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEEec
Q 001847 674 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDY 753 (1005)
Q Consensus 674 y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~ 753 (1005)
|++++.||.|++|.||++.+..+++.+++|.+..... .......+.+|+.++++++|+||+++++++..++.+|+||||
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 79 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFE-SEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEF 79 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccc-cchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEec
Confidence 6788999999999999999988999999999876532 223456778899999999999999999999999999999999
Q ss_pred cCCCchhhHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCCCCCCC
Q 001847 754 CPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLP 833 (1005)
Q Consensus 754 ~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~~~~ 833 (1005)
+. ++|.+++.... ..+++..+..++.||+.||.|||+.||+|+||||+||+++.++.++|+|||.+.......
T Consensus 80 ~~-~~l~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~----- 152 (283)
T cd05118 80 MD-TDLYKLIKDRQ-RGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPV----- 152 (283)
T ss_pred cC-CCHHHHHHhhc-ccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc-----
Confidence 95 58888876642 468999999999999999999999999999999999999999999999999885432111
Q ss_pred cchhhhhcccCCCCCcccccccccccccccCCcccccccccCC-CCCChhhHHHHHHHHHHHHcCCCCCCCCChHHHHHH
Q 001847 834 TTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGA-GHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFAN 912 (1005)
Q Consensus 834 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~sDIwSlGvll~eLltG~~Pf~~~~~~~~~~~ 912 (1005)
.......++..|+|||.+.+. ..+.++||||||+++|+|++|+.||.+.+..+.+..
T Consensus 153 ----------------------~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~ 210 (283)
T cd05118 153 ----------------------RPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFK 210 (283)
T ss_pred ----------------------ccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 011223578899999998776 678899999999999999999999988776655544
Q ss_pred HHhCC-------------------CCCCC---------CCCCCHHHHHHHHHccccCcCccCCChhcHHHHHcCCCC
Q 001847 913 ILHKD-------------------LKFPS---------STPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFF 961 (1005)
Q Consensus 913 i~~~~-------------------~~~~~---------~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~hpff 961 (1005)
+...- ..++. ....+..+.+||.+||..||.+||+ +.+++.||||
T Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~----~~~ll~~~~~ 283 (283)
T cd05118 211 IFRTLGTPDPEVWPKFTSLARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRIT----AEQALAHPYF 283 (283)
T ss_pred HHHHcCCCchHhcccchhhhhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcC----HHHHhhCCCC
Confidence 43210 00000 1235678999999999999999999 9999999997
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=320.56 Aligned_cols=259 Identities=25% Similarity=0.373 Sum_probs=203.4
Q ss_pred cccCCccccccccccCcEEEEEEEE-----cCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhC-CCCCcceEEEEEE
Q 001847 669 INLQHFRPIKPLGSGDTGSVHLVEL-----CGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPALYASFQ 742 (1005)
Q Consensus 669 i~~~~y~~~~~LG~G~~g~Vy~a~~-----~~~~~~valK~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~ 742 (1005)
+..++|++.+.||.|+||.||+|.+ ..+++.||||.++... .......+.+|+.++..+ +|+||+++++++.
T Consensus 4 ~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~ 81 (343)
T cd05103 4 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLGACT 81 (343)
T ss_pred cchhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCC--ChHHHHHHHHHHHHHHhccCCccHhhhcceee
Confidence 3456899999999999999999985 3457899999987542 233456788899999999 6899999999876
Q ss_pred e-CCeEEEEEeccCCCchhhHHhhCC------------------------------------------------------
Q 001847 743 T-KTHVCLITDYCPGGELFLLLDRQP------------------------------------------------------ 767 (1005)
Q Consensus 743 ~-~~~~~lV~E~~~ggsL~~~l~~~~------------------------------------------------------ 767 (1005)
. ...+++||||+.+|+|.+++....
T Consensus 82 ~~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (343)
T cd05103 82 KPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDV 161 (343)
T ss_pred cCCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccc
Confidence 4 456899999999999999986421
Q ss_pred -----------CCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCCCCCCCcch
Q 001847 768 -----------TKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTN 836 (1005)
Q Consensus 768 -----------~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~~~~~~~ 836 (1005)
...++...+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.........
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~------ 235 (343)
T cd05103 162 EEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDY------ 235 (343)
T ss_pred hhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCCCcEEEEecccccccccCcch------
Confidence 123677888999999999999999999999999999999999999999999998543211100
Q ss_pred hhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHh
Q 001847 837 EKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY-GYTPFRGKTRQKTFANILH 915 (1005)
Q Consensus 837 ~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlGvll~eLlt-G~~Pf~~~~~~~~~~~i~~ 915 (1005)
.......+++.|+|||.+.+..++.++|||||||++|+|++ |..||.+..........+.
T Consensus 236 -------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~ 296 (343)
T cd05103 236 -------------------VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLK 296 (343)
T ss_pred -------------------hhcCCCCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHh
Confidence 01112235678999999988888999999999999999996 9999987654333333333
Q ss_pred CCCCCCCCCCCCHHHHHHHHHccccCcCccCCChhcHHHHHcC
Q 001847 916 KDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKH 958 (1005)
Q Consensus 916 ~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~h 958 (1005)
.....+.....+..+.+++..||+.+|++||+ +.++++|
T Consensus 297 ~~~~~~~~~~~~~~~~~~~~~cl~~~p~~Rps----~~eil~~ 335 (343)
T cd05103 297 EGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPT----FSELVEH 335 (343)
T ss_pred ccCCCCCCCCCCHHHHHHHHHHccCChhhCcC----HHHHHHH
Confidence 33333333346778999999999999999999 7777654
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-33 Score=304.06 Aligned_cols=246 Identities=22% Similarity=0.325 Sum_probs=199.3
Q ss_pred ccccccCcEEEEEEEEcCCC---eEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEEecc
Q 001847 678 KPLGSGDTGSVHLVELCGSG---QYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYC 754 (1005)
Q Consensus 678 ~~LG~G~~g~Vy~a~~~~~~---~~valK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~ 754 (1005)
+.||+|+||.||+|.+..++ ..+|+|.+...... .....+.+|+.+++.++|+||+++++++. ....++||||+
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~ 77 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIA--AGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELA 77 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccch--HHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeC
Confidence 46899999999999875554 78999998765332 44567888999999999999999999876 45689999999
Q ss_pred CCCchhhHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCCCCCCCc
Q 001847 755 PGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPT 834 (1005)
Q Consensus 755 ~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~~~~~ 834 (1005)
.+++|.+++.... .+++..+..++.|++.+|.|||..|++|+||||+|||++.++.+||+|||++.........
T Consensus 78 ~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~---- 151 (257)
T cd05060 78 PLGPLLKYLKKRR--EIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDY---- 151 (257)
T ss_pred CCCcHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCCCcEEeccccccceeecCCcc----
Confidence 9999999997653 5899999999999999999999999999999999999999999999999998654311110
Q ss_pred chhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHH
Q 001847 835 TNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY-GYTPFRGKTRQKTFANI 913 (1005)
Q Consensus 835 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlGvll~eLlt-G~~Pf~~~~~~~~~~~i 913 (1005)
........++..|+|||.+....++.++|||||||++|+|++ |..||...+..+....+
T Consensus 152 --------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~ 211 (257)
T cd05060 152 --------------------YRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAML 211 (257)
T ss_pred --------------------cccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHH
Confidence 000111224567999999988889999999999999999997 99999887776665555
Q ss_pred HhCCCCCCCCCCCCHHHHHHHHHccccCcCccCCChhcHH
Q 001847 914 LHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGAN 953 (1005)
Q Consensus 914 ~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~ 953 (1005)
.... ..+.....+..+.+||.+||..+|.+||++.++++
T Consensus 212 ~~~~-~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~ 250 (257)
T cd05060 212 ESGE-RLPRPEECPQEIYSIMLSCWKYRPEDRPTFSELES 250 (257)
T ss_pred HcCC-cCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 4442 33344456788999999999999999999544333
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=312.68 Aligned_cols=262 Identities=27% Similarity=0.420 Sum_probs=210.8
Q ss_pred cccccCCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCC
Q 001847 667 EQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPALYASFQTKT 745 (1005)
Q Consensus 667 ~~i~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~ 745 (1005)
..+..+.|++.+.||+|++|.||++.+..+++.||+|.++... .......+..|+.++..+ +|+||+++++++....
T Consensus 10 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~--~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~ 87 (296)
T cd06618 10 YPADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTG--NKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDS 87 (296)
T ss_pred ccCCcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccC--ChHHHHHHHHHHHHHHhccCCCchHhhheeeecCC
Confidence 3466789999999999999999999998889999999987542 223345566677766666 5999999999999999
Q ss_pred eEEEEEeccCCCchhhHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHH-cCcccCCCCCCcEEEecCCcEEEEeccCCccc
Q 001847 746 HVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHC-QGIIYRDLKPENVLLQGNGHVSLTDFDLSCLT 824 (1005)
Q Consensus 746 ~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~-~gIvHrDLkP~NILi~~~g~vkL~DFG~a~~~ 824 (1005)
..|++|||+ +++|.+++.... ..+++..+..++.||+.||.|||+ .||+||||+|+||++++++.+||+|||++...
T Consensus 88 ~~~~v~e~~-~~~l~~l~~~~~-~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~ 165 (296)
T cd06618 88 DVFICMELM-STCLDKLLKRIQ-GPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRL 165 (296)
T ss_pred eEEEEeecc-CcCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCCCEEECccccchhc
Confidence 999999999 567777766532 368999999999999999999997 59999999999999999999999999987543
Q ss_pred CCCCCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCC----CCChhhHHHHHHHHHHHHcCCCC
Q 001847 825 SCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAG----HTSAVDWWALGILLYEMLYGYTP 900 (1005)
Q Consensus 825 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~----~~~~sDIwSlGvll~eLltG~~P 900 (1005)
.... ......+++.|+|||.+.+.. ++.++||||||+++|+|++|+.|
T Consensus 166 ~~~~----------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p 217 (296)
T cd06618 166 VDSK----------------------------AKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFP 217 (296)
T ss_pred cCCC----------------------------cccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCC
Confidence 2110 011224778999999986553 67899999999999999999999
Q ss_pred CCCCCh-HHHHHHHHhCCCC-CCCCCCCCHHHHHHHHHccccCcCccCCChhcHHHHHcCCCCCCC
Q 001847 901 FRGKTR-QKTFANILHKDLK-FPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGV 964 (1005)
Q Consensus 901 f~~~~~-~~~~~~i~~~~~~-~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~hpff~~~ 964 (1005)
|..... .+.+..+...... .+....++..+.+|+.+||..||.+||+ +.++++||||+..
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~----~~~il~~~~~~~~ 279 (296)
T cd06618 218 YKNCKTEFEVLTKILQEEPPSLPPNEGFSPDFCSFVDLCLTKDHRKRPK----YRELLQHPFIRRY 279 (296)
T ss_pred CCcchhHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHHccCChhhCCC----HHHHhcChhhhcc
Confidence 976433 3445555544322 2233346788999999999999999999 9999999999863
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-33 Score=307.49 Aligned_cols=257 Identities=23% Similarity=0.324 Sum_probs=209.2
Q ss_pred cCCccccccccccCcEEEEEEEEcCCCe---EEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeE
Q 001847 671 LQHFRPIKPLGSGDTGSVHLVELCGSGQ---YFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHV 747 (1005)
Q Consensus 671 ~~~y~~~~~LG~G~~g~Vy~a~~~~~~~---~valK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 747 (1005)
...|++.+.||.|+||.||+|.+..+++ .|++|.+.... .......+..|+.+++.++||||+++++++......
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~ 80 (269)
T cd05065 3 VSCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGY--TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPV 80 (269)
T ss_pred hHHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCC--CHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCce
Confidence 4579999999999999999999977664 69999987542 344557788999999999999999999999999999
Q ss_pred EEEEeccCCCchhhHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCC
Q 001847 748 CLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCK 827 (1005)
Q Consensus 748 ~lV~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~ 827 (1005)
++||||+.+++|.+++.... +.++...++.++.|++.||.|||++|++|+||||+||+++.++.++|+|||++......
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~ 159 (269)
T cd05065 81 MIITEFMENGALDSFLRQND-GQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 159 (269)
T ss_pred EEEEecCCCCcHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEcCCCcEEECCCccccccccC
Confidence 99999999999999987543 45899999999999999999999999999999999999999999999999988543211
Q ss_pred CCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCh
Q 001847 828 PQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY-GYTPFRGKTR 906 (1005)
Q Consensus 828 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlGvll~eLlt-G~~Pf~~~~~ 906 (1005)
.... .........++..|+|||.+....++.++|||||||++|++++ |..||.....
T Consensus 160 ~~~~----------------------~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~ 217 (269)
T cd05065 160 TSDP----------------------TYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN 217 (269)
T ss_pred cccc----------------------ccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCH
Confidence 1000 0000011112457999999988889999999999999999886 9999988777
Q ss_pred HHHHHHHHhCCCCCCCCCCCCHHHHHHHHHccccCcCccCCChhcHHHHHc
Q 001847 907 QKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKK 957 (1005)
Q Consensus 907 ~~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~ 957 (1005)
......+. .....+....++..+.+++.+||..+|++||+ +.+++.
T Consensus 218 ~~~~~~i~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~----~~~i~~ 263 (269)
T cd05065 218 QDVINAIE-QDYRLPPPMDCPTALHQLMLDCWQKDRNARPK----FGQIVS 263 (269)
T ss_pred HHHHHHHH-cCCcCCCcccCCHHHHHHHHHHcCCChhhCcC----HHHHHH
Confidence 66666554 33444444557888999999999999999999 566553
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=310.22 Aligned_cols=255 Identities=27% Similarity=0.434 Sum_probs=208.6
Q ss_pred ccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeC--CeEEEEE
Q 001847 674 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTK--THVCLIT 751 (1005)
Q Consensus 674 y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~--~~~~lV~ 751 (1005)
|++++.||.|++|.||++.+..+++.+|+|.+.... ........+.+|+.+++.++|+|++++++++... +..|+||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 79 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMEN-EKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVF 79 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEeccc-ccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEe
Confidence 778899999999999999999899999999998653 2333445677899999999999999999999987 8999999
Q ss_pred eccCCCchhhHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCCCCC
Q 001847 752 DYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLL 831 (1005)
Q Consensus 752 E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~~ 831 (1005)
||+. ++|..++.... ..+++..++.++.||+.||+|||+.|++|+||+|+||++++++.++|+|||++........
T Consensus 80 e~~~-~~l~~~~~~~~-~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~-- 155 (287)
T cd07840 80 EYMD-HDLTGLLDSPE-VKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNS-- 155 (287)
T ss_pred cccc-ccHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCCCCEEEccccceeeccCCCc--
Confidence 9995 58888886542 4689999999999999999999999999999999999999999999999998854432110
Q ss_pred CCcchhhhhcccCCCCCcccccccccccccccCCcccccccccC-CCCCChhhHHHHHHHHHHHHcCCCCCCCCChHHHH
Q 001847 832 LPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAG-AGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTF 910 (1005)
Q Consensus 832 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~sDIwSlGvll~eLltG~~Pf~~~~~~~~~ 910 (1005)
.......++..|+|||.+.+ ..++.++||||||+++|+|++|+.||...+.....
T Consensus 156 ------------------------~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~ 211 (287)
T cd07840 156 ------------------------ADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQL 211 (287)
T ss_pred ------------------------ccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHH
Confidence 01122356788999998765 45688999999999999999999999887766555
Q ss_pred HHHHhCCC-----CCCC-----------------------CCC-CCHHHHHHHHHccccCcCccCCChhcHHHHHcCCCC
Q 001847 911 ANILHKDL-----KFPS-----------------------STP-TSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFF 961 (1005)
Q Consensus 911 ~~i~~~~~-----~~~~-----------------------~~~-~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~hpff 961 (1005)
..+..... .++. ... ++..+.+++.+||..+|.+||+ ++++++||||
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~----~~~~l~~~~~ 287 (287)
T cd07840 212 EKIFELCGSPTDENWPGVSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRIS----ADQALQHEYF 287 (287)
T ss_pred HHHHHHhCCCchhhccccccchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcC----HHHHhhCcCC
Confidence 55443100 0000 011 2778899999999999999999 9999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-33 Score=308.28 Aligned_cols=252 Identities=20% Similarity=0.292 Sum_probs=200.8
Q ss_pred ccCCccccccccccCcEEEEEEEEcCCCe----EEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC
Q 001847 670 NLQHFRPIKPLGSGDTGSVHLVELCGSGQ----YFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKT 745 (1005)
Q Consensus 670 ~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~----~valK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~ 745 (1005)
..++|++++.||.|+||.||++.+..++. .+++|.+... ........+..|+.+++.++||||+++++++.. .
T Consensus 5 ~~~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~ 81 (279)
T cd05111 5 KETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDR--SGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-A 81 (279)
T ss_pred CHhhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccc--cchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-C
Confidence 45689999999999999999999977765 4677776432 123344667788889999999999999998754 5
Q ss_pred eEEEEEeccCCCchhhHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccC
Q 001847 746 HVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTS 825 (1005)
Q Consensus 746 ~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~~~g~vkL~DFG~a~~~~ 825 (1005)
..++++||+.+++|.+++.... ..+++..+..++.||+.||.|||++|++|+||||+||+++.++.+||+|||++....
T Consensus 82 ~~~~i~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~ 160 (279)
T cd05111 82 SLQLVTQLSPLGSLLDHVRQHR-DSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVADLLY 160 (279)
T ss_pred ccEEEEEeCCCCcHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEEcCCccceecc
Confidence 5789999999999999997542 458999999999999999999999999999999999999999999999999985432
Q ss_pred CCCCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHc-CCCCCCCC
Q 001847 826 CKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY-GYTPFRGK 904 (1005)
Q Consensus 826 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlGvll~eLlt-G~~Pf~~~ 904 (1005)
..... .......++..|+|||.+.+..++.++|||||||++|+|++ |..||.+.
T Consensus 161 ~~~~~-------------------------~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~ 215 (279)
T cd05111 161 PDDKK-------------------------YFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGM 215 (279)
T ss_pred CCCcc-------------------------cccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCC
Confidence 11100 01122456778999999988889999999999999999998 99999887
Q ss_pred ChHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHccccCcCccCCChhc
Q 001847 905 TRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEG 951 (1005)
Q Consensus 905 ~~~~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~ 951 (1005)
........+ ......+....++..+.+++.+||..+|++||++.++
T Consensus 216 ~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~c~~~~p~~Rps~~el 261 (279)
T cd05111 216 RPHEVPDLL-EKGERLAQPQICTIDVYMVMVKCWMIDENVRPTFKEL 261 (279)
T ss_pred CHHHHHHHH-HCCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHH
Confidence 665544333 3323333333467788999999999999999994443
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-33 Score=306.21 Aligned_cols=254 Identities=22% Similarity=0.301 Sum_probs=207.6
Q ss_pred ccCCccccccccccCcEEEEEEEEcCCCe---EEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCe
Q 001847 670 NLQHFRPIKPLGSGDTGSVHLVELCGSGQ---YFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTH 746 (1005)
Q Consensus 670 ~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~---~valK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~ 746 (1005)
..+.|...+.||+|+||.||+|.+..++. .+++|.+.... .......+.+|+++++.++|+||+++++++...+.
T Consensus 3 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (268)
T cd05063 3 HPSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGY--TEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKP 80 (268)
T ss_pred ChHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccC--CHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCC
Confidence 34578999999999999999999876554 79999886542 23345678889999999999999999999999999
Q ss_pred EEEEEeccCCCchhhHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCC
Q 001847 747 VCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSC 826 (1005)
Q Consensus 747 ~~lV~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~~~g~vkL~DFG~a~~~~~ 826 (1005)
.|+||||+++++|.+++.... ..++...+..++.|++.||.|||+.|++|+||||+||+++.++.+||+|||++.....
T Consensus 81 ~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~ 159 (268)
T cd05063 81 AMIITEYMENGALDKYLRDHD-GEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLED 159 (268)
T ss_pred cEEEEEcCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcCCCcEEECCCccceeccc
Confidence 999999999999999987543 4589999999999999999999999999999999999999999999999998854321
Q ss_pred CCCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCC
Q 001847 827 KPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY-GYTPFRGKT 905 (1005)
Q Consensus 827 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlGvll~eLlt-G~~Pf~~~~ 905 (1005)
.... .........++.|+|||++....++.++|||||||++|+|++ |..||...+
T Consensus 160 ~~~~------------------------~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~ 215 (268)
T cd05063 160 DPEG------------------------TYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMS 215 (268)
T ss_pred cccc------------------------ceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCC
Confidence 1100 000111223567999999988888999999999999999997 999998877
Q ss_pred hHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHccccCcCccCCChhc
Q 001847 906 RQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEG 951 (1005)
Q Consensus 906 ~~~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~ 951 (1005)
..+....+... ...+.....+..+.+|+.+||..+|++||++.++
T Consensus 216 ~~~~~~~i~~~-~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i 260 (268)
T cd05063 216 NHEVMKAINDG-FRLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDI 260 (268)
T ss_pred HHHHHHHHhcC-CCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHH
Confidence 76666666543 3444445578899999999999999999994443
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=315.60 Aligned_cols=268 Identities=26% Similarity=0.376 Sum_probs=207.4
Q ss_pred cCCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeC------
Q 001847 671 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTK------ 744 (1005)
Q Consensus 671 ~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~------ 744 (1005)
.++|++.+.||.|+||.||++.+..++..+|+|.+......+ .......+|+++++.++||||+++++++...
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 85 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKD-GFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKR 85 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCC-CcchhHHHHHHHHHhcCCCCccchhhheecccccccc
Confidence 579999999999999999999999999999999987543212 1223566899999999999999999887543
Q ss_pred --CeEEEEEeccCCCchhhHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCc
Q 001847 745 --THVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSC 822 (1005)
Q Consensus 745 --~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~~~g~vkL~DFG~a~ 822 (1005)
..+|+||||+. ++|...+... ...+++..++.++.||+.||.|||++||+|+||||+||++++++.++|+|||++.
T Consensus 86 ~~~~~~lv~~~~~-~~l~~~~~~~-~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~ 163 (311)
T cd07866 86 KRGSVYMVTPYMD-HDLSGLLENP-SVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLAR 163 (311)
T ss_pred cCceEEEEEecCC-cCHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECcCccch
Confidence 35799999994 5676666543 3469999999999999999999999999999999999999999999999999986
Q ss_pred ccCCCCCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCC-CCCChhhHHHHHHHHHHHHcCCCCC
Q 001847 823 LTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGA-GHTSAVDWWALGILLYEMLYGYTPF 901 (1005)
Q Consensus 823 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~sDIwSlGvll~eLltG~~Pf 901 (1005)
.......... ..............+++.|+|||.+.+. .++.++|||||||++|+|++|++||
T Consensus 164 ~~~~~~~~~~----------------~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~ 227 (311)
T cd07866 164 PYDGPPPNPK----------------GGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPIL 227 (311)
T ss_pred hccCCCcccc----------------cCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCC
Confidence 5432211100 0000011122345788999999988654 5788999999999999999999999
Q ss_pred CCCChHHHHHHHHhCCCC-----C------C---------C--------CCCCCHHHHHHHHHccccCcCccCCChhcHH
Q 001847 902 RGKTRQKTFANILHKDLK-----F------P---------S--------STPTSLHAKQLMYRLLHRDPKSRLGSHEGAN 953 (1005)
Q Consensus 902 ~~~~~~~~~~~i~~~~~~-----~------~---------~--------~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~ 953 (1005)
.+.+.......+...... + + . ....+..+.+||.+||..||.+||| +.
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t----~~ 303 (311)
T cd07866 228 QGKSDIDQLHLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLT----AS 303 (311)
T ss_pred CCCCHHHHHHHHHHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcC----HH
Confidence 887776655544321000 0 0 0 0123457889999999999999999 99
Q ss_pred HHHcCCCC
Q 001847 954 EIKKHPFF 961 (1005)
Q Consensus 954 elL~hpff 961 (1005)
+++.||||
T Consensus 304 ell~~~~f 311 (311)
T cd07866 304 DALEHPYF 311 (311)
T ss_pred HHhcCCCC
Confidence 99999998
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=313.73 Aligned_cols=258 Identities=24% Similarity=0.348 Sum_probs=207.5
Q ss_pred cCCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC-----
Q 001847 671 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKT----- 745 (1005)
Q Consensus 671 ~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~----- 745 (1005)
.++|++.+.||+|+||.||++.+..+++.||+|.++.... .......+.+|+.+++.++||||+++++++....
T Consensus 6 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~ 84 (302)
T cd07864 6 VDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNE-KEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDF 84 (302)
T ss_pred hhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeeccc-ccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhc
Confidence 5689999999999999999999998999999999875422 2223346678999999999999999999887654
Q ss_pred -----eEEEEEeccCCCchhhHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccC
Q 001847 746 -----HVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDL 820 (1005)
Q Consensus 746 -----~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~~~g~vkL~DFG~ 820 (1005)
.+|+||||+++ +|..++... ...+++..++.++.||+.||+|||+.||+|+||||+||++++++.+||+|||.
T Consensus 85 ~~~~~~~~lv~e~~~~-~l~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~kl~dfg~ 162 (302)
T cd07864 85 KKDKGAFYLVFEYMDH-DLMGLLESG-LVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGL 162 (302)
T ss_pred cccCCcEEEEEcccCc-cHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCcEEeCcccc
Confidence 79999999965 777776654 34589999999999999999999999999999999999999999999999998
Q ss_pred CcccCCCCCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCC-CCCChhhHHHHHHHHHHHHcCCC
Q 001847 821 SCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGA-GHTSAVDWWALGILLYEMLYGYT 899 (1005)
Q Consensus 821 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~sDIwSlGvll~eLltG~~ 899 (1005)
+........ .......+++.|+|||.+.+. .++.++|||||||++|+|++|++
T Consensus 163 ~~~~~~~~~--------------------------~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~ 216 (302)
T cd07864 163 ARLYNSEES--------------------------RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKP 216 (302)
T ss_pred cccccCCcc--------------------------cccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCC
Confidence 854321110 011123467889999988653 46889999999999999999999
Q ss_pred CCCCCChHHHHHHHHhC---CCC--C-----------------------CCCCCCCHHHHHHHHHccccCcCccCCChhc
Q 001847 900 PFRGKTRQKTFANILHK---DLK--F-----------------------PSSTPTSLHAKQLMYRLLHRDPKSRLGSHEG 951 (1005)
Q Consensus 900 Pf~~~~~~~~~~~i~~~---~~~--~-----------------------~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~ 951 (1005)
||........+..+... ... + .....++..+.+||.+||..+|.+||+
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~---- 292 (302)
T cd07864 217 IFQANQELAQLELISRLCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCT---- 292 (302)
T ss_pred CCCCCChHHHHHHHHHHhCCCChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCC----
Confidence 99877665555444331 100 0 011235778999999999999999999
Q ss_pred HHHHHcCCCC
Q 001847 952 ANEIKKHPFF 961 (1005)
Q Consensus 952 a~elL~hpff 961 (1005)
+.+++.||||
T Consensus 293 ~~~il~~~~~ 302 (302)
T cd07864 293 AEEALNSPWL 302 (302)
T ss_pred HHHHhcCCCC
Confidence 9999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-33 Score=309.84 Aligned_cols=251 Identities=21% Similarity=0.311 Sum_probs=203.4
Q ss_pred CccccccccccCcEEEEEEEEcC-----CCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeE
Q 001847 673 HFRPIKPLGSGDTGSVHLVELCG-----SGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHV 747 (1005)
Q Consensus 673 ~y~~~~~LG~G~~g~Vy~a~~~~-----~~~~valK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 747 (1005)
+|++.+.||+|+||.||++.+.. ....+++|.+.... .......+.+|+.+++.++||||+++++.+...+..
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 78 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENA--SSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPL 78 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCC--CHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCc
Confidence 48899999999999999999743 23578899886542 234456788999999999999999999999999999
Q ss_pred EEEEeccCCCchhhHHhhC----------------------CCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcE
Q 001847 748 CLITDYCPGGELFLLLDRQ----------------------PTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENV 805 (1005)
Q Consensus 748 ~lV~E~~~ggsL~~~l~~~----------------------~~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NI 805 (1005)
+++|||+.+++|.+++... ....++...+..++.|++.||.|||++|++||||||+||
T Consensus 79 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp~ni 158 (290)
T cd05045 79 LLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNV 158 (290)
T ss_pred EEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhhheE
Confidence 9999999999999987642 113478899999999999999999999999999999999
Q ss_pred EEecCCcEEEEeccCCcccCCCCCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHH
Q 001847 806 LLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWW 885 (1005)
Q Consensus 806 Li~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIw 885 (1005)
|+++++.+||+|||++......... .......++..|+|||.+.+..++.++|||
T Consensus 159 ll~~~~~~kl~dfg~~~~~~~~~~~-------------------------~~~~~~~~~~~y~apE~~~~~~~~~~~Di~ 213 (290)
T cd05045 159 LVAEGRKMKISDFGLSRDVYEEDSY-------------------------VKRSKGRIPVKWMAIESLFDHIYTTQSDVW 213 (290)
T ss_pred EEcCCCcEEeccccccccccCccch-------------------------hcccCCCCCccccCHHHHccCCcchHhHHH
Confidence 9999999999999998543211100 011123456789999999888889999999
Q ss_pred HHHHHHHHHHc-CCCCCCCCChHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHccccCcCccCCChhc
Q 001847 886 ALGILLYEMLY-GYTPFRGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEG 951 (1005)
Q Consensus 886 SlGvll~eLlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~ 951 (1005)
|||+++|+|++ |..||.+.........+ ......+.....+..+.+|+.+||+.+|.+||++.++
T Consensus 214 slG~~l~el~t~g~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i 279 (290)
T cd05045 214 SFGVLLWEIVTLGGNPYPGIAPERLFNLL-KTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADI 279 (290)
T ss_pred HHHHHHHHHHhcCCCCCCCCCHHHHHHHH-hCCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHH
Confidence 99999999998 99999887766655443 3334444445578899999999999999999994443
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=335.39 Aligned_cols=255 Identities=24% Similarity=0.363 Sum_probs=220.2
Q ss_pred cccCCccccccccccCcEEEEEEEEc-----CCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceEEEEEEe
Q 001847 669 INLQHFRPIKPLGSGDTGSVHLVELC-----GSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQT 743 (1005)
Q Consensus 669 i~~~~y~~~~~LG~G~~g~Vy~a~~~-----~~~~~valK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~ 743 (1005)
+.....+..+.||+|+||+||+++.. .....||||.++... +.....+|.+|++++..++|||||++++++..
T Consensus 483 i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a--~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~ 560 (774)
T KOG1026|consen 483 IPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKA--ENQARQDFRREAELLAELQHPNIVRLLGVCRE 560 (774)
T ss_pred echhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccc--cHHHHHHHHHHHHHHHhccCCCeEEEEEEEcc
Confidence 44567888899999999999999873 234679999998653 44467899999999999999999999999999
Q ss_pred CCeEEEEEeccCCCchhhHHhhC--------C----CCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCC
Q 001847 744 KTHVCLITDYCPGGELFLLLDRQ--------P----TKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNG 811 (1005)
Q Consensus 744 ~~~~~lV~E~~~ggsL~~~l~~~--------~----~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~~~g 811 (1005)
++.+|+|+|||..|+|.++|... . ...|+..+...|+.||+.|+.||-++.+|||||-..|+||.++-
T Consensus 561 ~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCLVge~l 640 (774)
T KOG1026|consen 561 GDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCLVGENL 640 (774)
T ss_pred CCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhceeccce
Confidence 99999999999999999999742 1 12388999999999999999999999999999999999999999
Q ss_pred cEEEEeccCCcccCCCCCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHH
Q 001847 812 HVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILL 891 (1005)
Q Consensus 812 ~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlGvll 891 (1005)
.|||+|||+++..... ++. +....-.-..+|||||.+....++.+||||||||+|
T Consensus 641 ~VKIsDfGLsRdiYss---------DYY----------------k~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvL 695 (774)
T KOG1026|consen 641 VVKISDFGLSRDIYSS---------DYY----------------KVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVL 695 (774)
T ss_pred EEEecccccchhhhhh---------hhh----------------cccCCceeeeecCCHHHhhcCcccchhhhhhhhhhh
Confidence 9999999999654311 011 111122346789999999999999999999999999
Q ss_pred HHHHc-CCCCCCCCChHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHccccCcCccCCChhc
Q 001847 892 YEMLY-GYTPFRGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEG 951 (1005)
Q Consensus 892 ~eLlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~ 951 (1005)
||+++ |.-||.+....+.+..|..+.. ++.+..++.++.+|+..||+.+|.+||++.++
T Consensus 696 WEIFsyG~QPy~glSn~EVIe~i~~g~l-L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI 755 (774)
T KOG1026|consen 696 WEIFSYGKQPYYGLSNQEVIECIRAGQL-LSCPENCPTEVYSLMLECWNENPKRRPSFKEI 755 (774)
T ss_pred hhhhccccCcccccchHHHHHHHHcCCc-ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHH
Confidence 99996 9999999999999999999988 88888899999999999999999999997663
|
|
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=319.21 Aligned_cols=263 Identities=28% Similarity=0.426 Sum_probs=210.1
Q ss_pred cCCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhC-CCCCcceEEEEEEeC--CeE
Q 001847 671 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPALYASFQTK--THV 747 (1005)
Q Consensus 671 ~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~--~~~ 747 (1005)
.++|++.+.||+|+||.||++.+..++..+|+|.+.... ........+..|+.+++++ +|+||+++++++... ...
T Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~-~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~ 84 (337)
T cd07852 6 LRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAF-RNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI 84 (337)
T ss_pred hhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeecccc-CcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence 468999999999999999999998899999999886532 2233445677899999999 999999999998653 468
Q ss_pred EEEEeccCCCchhhHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCC
Q 001847 748 CLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCK 827 (1005)
Q Consensus 748 ~lV~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~ 827 (1005)
|+||||+. ++|..++... .+++..++.++.||+.||.|||++||+|+||||+||+++.++.+||+|||++......
T Consensus 85 ~lv~e~~~-~~L~~~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~~ 160 (337)
T cd07852 85 YLVFEYME-TDLHAVIRAN---ILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSEL 160 (337)
T ss_pred EEEecccc-cCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccchhccccc
Confidence 99999995 6998888653 5888999999999999999999999999999999999999999999999988654221
Q ss_pred CCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccC-CCCCChhhHHHHHHHHHHHHcCCCCCCCCCh
Q 001847 828 PQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAG-AGHTSAVDWWALGILLYEMLYGYTPFRGKTR 906 (1005)
Q Consensus 828 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~sDIwSlGvll~eLltG~~Pf~~~~~ 906 (1005)
.... .........|++.|+|||.+.+ ..++.++|||||||++|+|++|+.||.+...
T Consensus 161 ~~~~----------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~ 218 (337)
T cd07852 161 EENP----------------------ENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTST 218 (337)
T ss_pred cccc----------------------cCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCCh
Confidence 1100 0011223568999999998765 4567899999999999999999999987665
Q ss_pred HHHHHHHHhCCCC----------------------------C-CCCCCCCHHHHHHHHHccccCcCccCCChhcHHHHHc
Q 001847 907 QKTFANILHKDLK----------------------------F-PSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKK 957 (1005)
Q Consensus 907 ~~~~~~i~~~~~~----------------------------~-~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~ 957 (1005)
......+...... . ......+.++.+||.+||+.+|++||+ +.++++
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps----~~~il~ 294 (337)
T cd07852 219 LNQLEKIIEVIGPPSAEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLT----AEEALE 294 (337)
T ss_pred HHHHHHHHHHhCCCCHHHHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccC----HHHHhh
Confidence 5444333221100 0 001225778999999999999999999 999999
Q ss_pred CCCCCCC
Q 001847 958 HPFFKGV 964 (1005)
Q Consensus 958 hpff~~~ 964 (1005)
||||+.+
T Consensus 295 ~~~~~~~ 301 (337)
T cd07852 295 HPYVAQF 301 (337)
T ss_pred Chhhhhh
Confidence 9999986
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-33 Score=308.25 Aligned_cols=250 Identities=23% Similarity=0.345 Sum_probs=195.2
Q ss_pred CCc-cccccccccCcEEEEEEEE----cCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceEEEEEEe--C
Q 001847 672 QHF-RPIKPLGSGDTGSVHLVEL----CGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQT--K 744 (1005)
Q Consensus 672 ~~y-~~~~~LG~G~~g~Vy~a~~----~~~~~~valK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~--~ 744 (1005)
++| ++++.||.|+||+||++.. ..++..+|+|.++... .......+.+|+.+++.++||||+++++++.. .
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 80 (283)
T cd05080 3 KRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKREC--GQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGG 80 (283)
T ss_pred hhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEecccc--ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCC
Confidence 345 9999999999999988653 3567899999987542 22345677889999999999999999998765 3
Q ss_pred CeEEEEEeccCCCchhhHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCccc
Q 001847 745 THVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLT 824 (1005)
Q Consensus 745 ~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~~~g~vkL~DFG~a~~~ 824 (1005)
..+|+||||+.+++|.+++... .+++..++.++.|++.||.|||++||+|+||||+|||++.++.++|+|||++...
T Consensus 81 ~~~~lv~e~~~~~~l~~~~~~~---~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~ 157 (283)
T cd05080 81 KGLQLIMEYVPLGSLRDYLPKH---KLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAV 157 (283)
T ss_pred ceEEEEecCCCCCCHHHHHHHc---CCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEcCCCcEEEeeccccccc
Confidence 4689999999999999998763 4899999999999999999999999999999999999999999999999998543
Q ss_pred CCCCCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHcCCCCCCCC
Q 001847 825 SCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGK 904 (1005)
Q Consensus 825 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlGvll~eLltG~~Pf~~~ 904 (1005)
...... ........++..|+|||.+.+..++.++|||||||++|+|++|+.||...
T Consensus 158 ~~~~~~------------------------~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~ 213 (283)
T cd05080 158 PEGHEY------------------------YRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSP 213 (283)
T ss_pred CCcchh------------------------hccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCC
Confidence 211100 00111224566799999998888899999999999999999999998643
Q ss_pred ChH--------------HHHHHHHhCCCCCCCCCCCCHHHHHHHHHccccCcCccCCChh
Q 001847 905 TRQ--------------KTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHE 950 (1005)
Q Consensus 905 ~~~--------------~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~ 950 (1005)
... .............+....++..+.+|+.+||..+|++||++.+
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~ 273 (283)
T cd05080 214 PKKFEEMIGPKQGQMTVVRLIELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRS 273 (283)
T ss_pred cchhhhhhcccccccchhhhhhhhhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHH
Confidence 211 0111111122222333456789999999999999999999443
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-33 Score=313.02 Aligned_cols=255 Identities=22% Similarity=0.308 Sum_probs=205.4
Q ss_pred ccccCCccccccccccCcEEEEEEEEcC-------CCeEEEEEEeecccccChHHHHHHHHHHHHHHhC-CCCCcceEEE
Q 001847 668 QINLQHFRPIKPLGSGDTGSVHLVELCG-------SGQYFAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPALYA 739 (1005)
Q Consensus 668 ~i~~~~y~~~~~LG~G~~g~Vy~a~~~~-------~~~~valK~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~ 739 (1005)
.+..++|.+.+.||+|+||.||+|.+.. ....+|+|.++... .......+.+|+.+++.+ +||||+++++
T Consensus 8 ~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~ 85 (314)
T cd05099 8 EFPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNA--TDKDLADLISEMELMKLIGKHKNIINLLG 85 (314)
T ss_pred cccHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCC--ChHHHHHHHHHHHHHHhccCCCCeeeEEE
Confidence 3445689999999999999999998632 34579999887532 234456788899999999 6999999999
Q ss_pred EEEeCCeEEEEEeccCCCchhhHHhhCC--------------CCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcE
Q 001847 740 SFQTKTHVCLITDYCPGGELFLLLDRQP--------------TKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENV 805 (1005)
Q Consensus 740 ~~~~~~~~~lV~E~~~ggsL~~~l~~~~--------------~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NI 805 (1005)
++...+.+|+||||+.+++|.+++.... ...++...+..++.||+.||.|||++|++|+||||+||
T Consensus 86 ~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Ni 165 (314)
T cd05099 86 VCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNV 165 (314)
T ss_pred EEccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeeccccceeE
Confidence 9999899999999999999999997532 23488899999999999999999999999999999999
Q ss_pred EEecCCcEEEEeccCCcccCCCCCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHH
Q 001847 806 LLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWW 885 (1005)
Q Consensus 806 Li~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIw 885 (1005)
|++.++.+||+|||++........ ........+++.|+|||++.+..++.++|||
T Consensus 166 ll~~~~~~kL~Dfg~~~~~~~~~~-------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diw 220 (314)
T cd05099 166 LVTEDNVMKIADFGLARGVHDIDY-------------------------YKKTSNGRLPVKWMAPEALFDRVYTHQSDVW 220 (314)
T ss_pred EEcCCCcEEEcccccccccccccc-------------------------ccccccCCCCccccCHHHHccCCcCccchhh
Confidence 999999999999999854321100 0001112245679999999888889999999
Q ss_pred HHHHHHHHHHc-CCCCCCCCChHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHccccCcCccCCChh
Q 001847 886 ALGILLYEMLY-GYTPFRGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHE 950 (1005)
Q Consensus 886 SlGvll~eLlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~ 950 (1005)
||||++|+|++ |..||.+......+..+..... ......++..+.+|+.+||..+|.+||++.+
T Consensus 221 slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ 285 (314)
T cd05099 221 SFGILMWEIFTLGGSPYPGIPVEELFKLLREGHR-MDKPSNCTHELYMLMRECWHAVPTQRPTFKQ 285 (314)
T ss_pred HHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC-CCCCCCCCHHHHHHHHHHcCCCcccCcCHHH
Confidence 99999999998 9999988777666666554432 2223456788999999999999999999443
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=307.33 Aligned_cols=256 Identities=29% Similarity=0.466 Sum_probs=211.1
Q ss_pred CccccccccccCcEEEEEEEEcCCCeEEEEEEeeccccc--ChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEE
Q 001847 673 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVML--NRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLI 750 (1005)
Q Consensus 673 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~~~~~~~~--~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV 750 (1005)
+|.+.+.||+|+||.||++.+..++..+++|+++..... .......+..|+.+++.++||||+++++++......|+|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 588999999999999999999887777777776643221 223344566789999999999999999999999999999
Q ss_pred EeccCCCchhhHHhh--CCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCC
Q 001847 751 TDYCPGGELFLLLDR--QPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKP 828 (1005)
Q Consensus 751 ~E~~~ggsL~~~l~~--~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~ 828 (1005)
|||+++++|.+++.. .....+++..++.++.|++.||.|||++|++|+||+|+||++++ +.++|+|||.+......
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~~- 158 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMGS- 158 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEeec-CCEeecccCceeecCCC-
Confidence 999999999988864 23356899999999999999999999999999999999999984 67999999987543211
Q ss_pred CCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHcCCCCCCCCChHH
Q 001847 829 QLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQK 908 (1005)
Q Consensus 829 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlGvll~eLltG~~Pf~~~~~~~ 908 (1005)
........|++.|+|||.+.+..++.++|+||||+++|+|++|..||.......
T Consensus 159 --------------------------~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~ 212 (260)
T cd08222 159 --------------------------CDLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLS 212 (260)
T ss_pred --------------------------cccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHH
Confidence 011223457889999999988888889999999999999999999998777666
Q ss_pred HHHHHHhCCCCCCCCCCCCHHHHHHHHHccccCcCccCCChhcHHHHHcCCCC
Q 001847 909 TFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFF 961 (1005)
Q Consensus 909 ~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~hpff 961 (1005)
....+.....+. ....++..+.++|.+||..+|++||+ +.++++||||
T Consensus 213 ~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~p~~Rp~----~~~il~~~~~ 260 (260)
T cd08222 213 VVLRIVEGPTPS-LPETYSRQLNSIMQSMLNKDPSLRPS----AAEILRNPFI 260 (260)
T ss_pred HHHHHHcCCCCC-CcchhcHHHHHHHHHHhcCChhhCcC----HHHHhhCCCC
Confidence 666665543322 22356788999999999999999999 9999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=353.50 Aligned_cols=261 Identities=28% Similarity=0.480 Sum_probs=220.5
Q ss_pred CCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEE
Q 001847 672 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLIT 751 (1005)
Q Consensus 672 ~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~ 751 (1005)
-+++....||.|.||.||.|.+..+|...|+|-++.... .......+.+|..++..++|||+|+++++-.....++|.|
T Consensus 1235 ~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~-~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFM 1313 (1509)
T KOG4645|consen 1235 FRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDS-DHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFM 1313 (1509)
T ss_pred eeeccccccCCcceeeeEEeecCCccchhhhhhhhcCcc-ccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHH
Confidence 357777889999999999999999999999998876533 2455667788999999999999999999999999999999
Q ss_pred eccCCCchhhHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCCCCC
Q 001847 752 DYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLL 831 (1005)
Q Consensus 752 E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~~ 831 (1005)
|||.+|+|.+++... +..++...+.+..|++.|++|||+.|||||||||.||+++.+|.+|++|||.|..........
T Consensus 1314 EyC~~GsLa~ll~~g--ri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~~ 1391 (1509)
T KOG4645|consen 1314 EYCEGGSLASLLEHG--RIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQTM 1391 (1509)
T ss_pred HHhccCcHHHHHHhc--chhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecCCcEEeecccceeEecCchhcC
Confidence 999999999999764 458888899999999999999999999999999999999999999999999997654332111
Q ss_pred CCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCC---CCCChhhHHHHHHHHHHHHcCCCCCCCCCh-H
Q 001847 832 LPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGA---GHTSAVDWWALGILLYEMLYGYTPFRGKTR-Q 907 (1005)
Q Consensus 832 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~---~~~~~sDIwSlGvll~eLltG~~Pf~~~~~-~ 907 (1005)
. ..-....||+.|||||++.+. ...-+.|||||||++.||+||+.||...+. .
T Consensus 1392 ~-----------------------~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~ 1448 (1509)
T KOG4645|consen 1392 P-----------------------GELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEW 1448 (1509)
T ss_pred C-----------------------HHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchh
Confidence 0 122357899999999999764 456699999999999999999999987655 4
Q ss_pred HHHHHHHhCC-CCCCCCCCCCHHHHHHHHHccccCcCccCCChhcHHHHHcCCCCCCC
Q 001847 908 KTFANILHKD-LKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGV 964 (1005)
Q Consensus 908 ~~~~~i~~~~-~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~hpff~~~ 964 (1005)
.++..+-.+. +++|.. ++.+..+||..||..||..|.+ +.|||.|.|-+..
T Consensus 1449 aIMy~V~~gh~Pq~P~~--ls~~g~dFle~Cl~~dP~~Rw~----~~qlle~~f~~~~ 1500 (1509)
T KOG4645|consen 1449 AIMYHVAAGHKPQIPER--LSSEGRDFLEHCLEQDPKMRWT----ASQLLEHAFGKSC 1500 (1509)
T ss_pred HHHhHHhccCCCCCchh--hhHhHHHHHHHHHhcCchhhhH----HHHHHHhhccccc
Confidence 4444444443 344444 8999999999999999999999 8899999998864
|
|
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-33 Score=310.58 Aligned_cols=256 Identities=25% Similarity=0.354 Sum_probs=202.9
Q ss_pred cCCccccccccccCcEEEEEEEEcC----------------CCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCc
Q 001847 671 LQHFRPIKPLGSGDTGSVHLVELCG----------------SGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFV 734 (1005)
Q Consensus 671 ~~~y~~~~~LG~G~~g~Vy~a~~~~----------------~~~~valK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnI 734 (1005)
.++|++.+.||+|+||.||++.+.. ++..+|+|.+.... .......+.+|+.+++.++|+||
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~--~~~~~~~~~~E~~~l~~l~~~~i 81 (296)
T cd05095 4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDA--NKNARNDFLKEIKIMSRLKDPNI 81 (296)
T ss_pred hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCCc
Confidence 3579999999999999999986532 34578999887542 33445678899999999999999
Q ss_pred ceEEEEEEeCCeEEEEEeccCCCchhhHHhhCCC---------CCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcE
Q 001847 735 PALYASFQTKTHVCLITDYCPGGELFLLLDRQPT---------KVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENV 805 (1005)
Q Consensus 735 v~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~---------~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NI 805 (1005)
+++++++...+..|+||||+.+++|.+++..... ..++...+..++.||+.||.|||++|++|+||||+||
T Consensus 82 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp~Ni 161 (296)
T cd05095 82 IRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNC 161 (296)
T ss_pred ceEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCChheE
Confidence 9999999999999999999999999999875321 2367788999999999999999999999999999999
Q ss_pred EEecCCcEEEEeccCCcccCCCCCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHH
Q 001847 806 LLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWW 885 (1005)
Q Consensus 806 Li~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIw 885 (1005)
|++.++.++|+|||++........ ........+++.|++||......++.++|||
T Consensus 162 li~~~~~~~l~dfg~~~~~~~~~~-------------------------~~~~~~~~~~~~~~~pe~~~~~~~~~~~Diw 216 (296)
T cd05095 162 LVGKNYTIKIADFGMSRNLYSGDY-------------------------YRIQGRAVLPIRWMSWESILLGKFTTASDVW 216 (296)
T ss_pred EEcCCCCEEeccCcccccccCCcc-------------------------eeccCcCcCccccCCHHHHhcCCccchhhhh
Confidence 999999999999999854321100 0111223456789999998888899999999
Q ss_pred HHHHHHHHHHc--CCCCCCCCChHHHHHHHHh------CCCCCCCCCCCCHHHHHHHHHccccCcCccCCChhcHH
Q 001847 886 ALGILLYEMLY--GYTPFRGKTRQKTFANILH------KDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGAN 953 (1005)
Q Consensus 886 SlGvll~eLlt--G~~Pf~~~~~~~~~~~i~~------~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~ 953 (1005)
||||++|+|++ |..||......+.+..... .....+....++..+.+|+.+||+.||.+||++.++++
T Consensus 217 SlG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~ 292 (296)
T cd05095 217 AFGVTLWEILTLCKEQPYSQLSDEQVIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHA 292 (296)
T ss_pred HHHHHHHHHHHhCCCCCccccChHHHHHHHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 99999999997 7889977666554443321 11223333456788999999999999999999544333
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-33 Score=303.85 Aligned_cols=242 Identities=21% Similarity=0.348 Sum_probs=201.5
Q ss_pred ccCCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEE
Q 001847 670 NLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCL 749 (1005)
Q Consensus 670 ~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l 749 (1005)
..++|++.+.||+|+||.||++.. +++.+|+|.++... ....+.+|+.+++.++||||+++++++... ..|+
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~--~~~~~~iK~~~~~~-----~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~ 75 (254)
T cd05083 4 NLQKLTLGEIIGEGEFGAVLQGEY--TGQKVAVKNIKCDV-----TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYI 75 (254)
T ss_pred cHHHceeeeeeccCCCCceEeccc--CCCceEEEeecCcc-----hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEE
Confidence 456899999999999999999875 78889999886532 235678899999999999999999998764 4799
Q ss_pred EEeccCCCchhhHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCCC
Q 001847 750 ITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQ 829 (1005)
Q Consensus 750 V~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~ 829 (1005)
||||+.+++|.+++.......++...+..++.|++.||.|||++|++||||||+||+++.++.++|+|||.+......
T Consensus 76 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~-- 153 (254)
T cd05083 76 VMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMG-- 153 (254)
T ss_pred EEECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCcEEECCCccceecccc--
Confidence 999999999999998765556899999999999999999999999999999999999999999999999987432100
Q ss_pred CCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCChHH
Q 001847 830 LLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY-GYTPFRGKTRQK 908 (1005)
Q Consensus 830 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlGvll~eLlt-G~~Pf~~~~~~~ 908 (1005)
......+..|+|||.+.+..++.++|+|||||++|+|++ |+.||......+
T Consensus 154 ----------------------------~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~ 205 (254)
T cd05083 154 ----------------------------VDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKE 205 (254)
T ss_pred ----------------------------CCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHH
Confidence 011233567999999988888999999999999999997 999998887766
Q ss_pred HHHHHHhCCCCCCCCCCCCHHHHHHHHHccccCcCccCCChh
Q 001847 909 TFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHE 950 (1005)
Q Consensus 909 ~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~ 950 (1005)
....+..+ ........++..+.+|+.+||..+|++||++.+
T Consensus 206 ~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ 246 (254)
T cd05083 206 VKECVEKG-YRMEPPEGCPADVYVLMTSCWETEPKKRPSFHK 246 (254)
T ss_pred HHHHHhCC-CCCCCCCcCCHHHHHHHHHHcCCChhhCcCHHH
Confidence 65555443 333333457889999999999999999999443
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-33 Score=301.61 Aligned_cols=244 Identities=21% Similarity=0.290 Sum_probs=196.5
Q ss_pred cccccCcEEEEEEEEc--CCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEEeccCC
Q 001847 679 PLGSGDTGSVHLVELC--GSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPG 756 (1005)
Q Consensus 679 ~LG~G~~g~Vy~a~~~--~~~~~valK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~g 756 (1005)
.||+|+||.||++.+. .++..+|+|.+.... .......+.+|+.++++++|+||+++++++.. ...++||||+++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~--~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~-~~~~lv~e~~~~ 78 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNEN--EKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA-EALMLVMEMASG 78 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEccccc--ChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC-CCeEEEEEeCCC
Confidence 3899999999999774 445679999887542 33445678899999999999999999998754 578999999999
Q ss_pred CchhhHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCCCCCCCcch
Q 001847 757 GELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTN 836 (1005)
Q Consensus 757 gsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~~~~~~~ 836 (1005)
++|.+++... ...+++..+..++.||+.||.|||++|++|+||||+||+++.++.+||+|||++..........
T Consensus 79 ~~L~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~----- 152 (257)
T cd05115 79 GPLNKFLSGK-KDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYY----- 152 (257)
T ss_pred CCHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCCCcEEeccCCccccccCCccce-----
Confidence 9999998653 2458999999999999999999999999999999999999999999999999885432111100
Q ss_pred hhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHh
Q 001847 837 EKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY-GYTPFRGKTRQKTFANILH 915 (1005)
Q Consensus 837 ~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlGvll~eLlt-G~~Pf~~~~~~~~~~~i~~ 915 (1005)
.......+++.|+|||.+....++.++|||||||++|+|++ |..||.+.........+..
T Consensus 153 -------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~ 213 (257)
T cd05115 153 -------------------KARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQ 213 (257)
T ss_pred -------------------eccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHC
Confidence 00111224578999999988888999999999999999996 9999988877776655554
Q ss_pred CCCCCCCCCCCCHHHHHHHHHccccCcCccCCChhc
Q 001847 916 KDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEG 951 (1005)
Q Consensus 916 ~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~ 951 (1005)
+. ........+.++.++|.+||..+|++||++.++
T Consensus 214 ~~-~~~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i 248 (257)
T cd05115 214 GK-RLDCPAECPPEMYALMKDCWIYKWEDRPNFAKV 248 (257)
T ss_pred CC-CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHH
Confidence 43 222334568899999999999999999995553
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-33 Score=315.97 Aligned_cols=262 Identities=21% Similarity=0.309 Sum_probs=209.2
Q ss_pred ccccccCCccccccccccCcEEEEEEEEcCC-------CeEEEEEEeecccccChHHHHHHHHHHHHHHhC-CCCCcceE
Q 001847 666 GEQINLQHFRPIKPLGSGDTGSVHLVELCGS-------GQYFAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPAL 737 (1005)
Q Consensus 666 ~~~i~~~~y~~~~~LG~G~~g~Vy~a~~~~~-------~~~valK~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l 737 (1005)
.+.+...+|++.+.||+|+||.||+|.+... +..+|+|.+... ........+.+|+.+++++ +||||+++
T Consensus 6 ~~~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~~l~~h~~iv~~ 83 (334)
T cd05100 6 KWELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDD--ATDKDLSDLVSEMEMMKMIGKHKNIINL 83 (334)
T ss_pred ccccCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccc--cCHHHHHHHHHHHHHHHhhcCCCCeeee
Confidence 3456667899999999999999999987432 236899987743 2334456788999999999 89999999
Q ss_pred EEEEEeCCeEEEEEeccCCCchhhHHhhCC--------------CCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCC
Q 001847 738 YASFQTKTHVCLITDYCPGGELFLLLDRQP--------------TKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPE 803 (1005)
Q Consensus 738 ~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~--------------~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~ 803 (1005)
++++...+.+|++|||+++++|.+++.... ...++...+..++.||+.||.|||++|++||||||+
T Consensus 84 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp~ 163 (334)
T cd05100 84 LGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAAR 163 (334)
T ss_pred eEEEccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeeccccccc
Confidence 999999999999999999999999987532 224778889999999999999999999999999999
Q ss_pred cEEEecCCcEEEEeccCCcccCCCCCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhh
Q 001847 804 NVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVD 883 (1005)
Q Consensus 804 NILi~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sD 883 (1005)
|||++.++.+||+|||++........ ........++..|+|||++.+..++.++|
T Consensus 164 Nill~~~~~~kL~Dfg~~~~~~~~~~-------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~D 218 (334)
T cd05100 164 NVLVTEDNVMKIADFGLARDVHNIDY-------------------------YKKTTNGRLPVKWMAPEALFDRVYTHQSD 218 (334)
T ss_pred eEEEcCCCcEEECCcccceecccccc-------------------------cccccCCCcCceEcCHHHhccCCcCchhh
Confidence 99999999999999998854321100 00111223456799999999888999999
Q ss_pred HHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHccccCcCccCCChhcHHHH
Q 001847 884 WWALGILLYEMLY-GYTPFRGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEI 955 (1005)
Q Consensus 884 IwSlGvll~eLlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~el 955 (1005)
||||||++|+|++ |..||.+....+....+.... ..+.....+..+.+|+.+||..+|.+||++.+++..+
T Consensus 219 i~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l 290 (334)
T cd05100 219 VWSFGVLLWEIFTLGGSPYPGIPVEELFKLLKEGH-RMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDL 290 (334)
T ss_pred hHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCC-CCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHH
Confidence 9999999999998 899998887777666555432 2233345678899999999999999999944443333
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-33 Score=306.16 Aligned_cols=255 Identities=22% Similarity=0.372 Sum_probs=199.9
Q ss_pred cCCccccccccccCcEEEEEEEE----cCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceEEEEEEe--C
Q 001847 671 LQHFRPIKPLGSGDTGSVHLVEL----CGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQT--K 744 (1005)
Q Consensus 671 ~~~y~~~~~LG~G~~g~Vy~a~~----~~~~~~valK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~--~ 744 (1005)
..+|++++.||+|+||.||++.. ..++..|++|.+... .......+.+|+.+++.++||||+++++++.. .
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 79 (284)
T cd05081 3 ERHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHS---TAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGR 79 (284)
T ss_pred cccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccC---CHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCC
Confidence 35899999999999999999984 456889999998654 34455678899999999999999999998753 3
Q ss_pred CeEEEEEeccCCCchhhHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCccc
Q 001847 745 THVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLT 824 (1005)
Q Consensus 745 ~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~~~g~vkL~DFG~a~~~ 824 (1005)
..+|+||||+++++|.+++.... ..+++..+..++.||+.||+|||++||+|+||||+||+++.++.++|+|||++...
T Consensus 80 ~~~~lv~e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~ 158 (284)
T cd05081 80 RNLRLVMEYLPYGSLRDYLQKHR-ERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLTKVL 158 (284)
T ss_pred CceEEEEEecCCCCHHHHHHhcC-cCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEECCCCeEEECCCcccccc
Confidence 56899999999999999987542 35899999999999999999999999999999999999999999999999998654
Q ss_pred CCCCCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHcCCCCCCCC
Q 001847 825 SCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGK 904 (1005)
Q Consensus 825 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlGvll~eLltG~~Pf~~~ 904 (1005)
....... .......++..|+|||++.+..++.++|||||||++|+|++|..|+...
T Consensus 159 ~~~~~~~------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~ 214 (284)
T cd05081 159 PQDKEYY------------------------KVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSP 214 (284)
T ss_pred cCCCcce------------------------eecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCc
Confidence 3211100 0011122445699999998888899999999999999999987775432
Q ss_pred ChH---------------HHHHHHHhCCCCCCCCCCCCHHHHHHHHHccccCcCccCCChhcHHHHHc
Q 001847 905 TRQ---------------KTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKK 957 (1005)
Q Consensus 905 ~~~---------------~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~ 957 (1005)
... ..+..++.....++....++..+.+|+.+||..+|++||| +.++++
T Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt----~~ei~~ 278 (284)
T cd05081 215 PAEFMRMMGNDKQGQMIVYHLIELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPS----FSELAL 278 (284)
T ss_pred chhhhhhcccccccccchHHHHHHHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCC----HHHHHH
Confidence 211 1111233333344444557789999999999999999999 555543
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-34 Score=306.88 Aligned_cols=268 Identities=28% Similarity=0.465 Sum_probs=223.5
Q ss_pred ccCCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccC----hHHHHHHHHHHHHHHhCCCCCcceEEEEEE-eC
Q 001847 670 NLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLN----RNKVHRACAEREILDMLDHPFVPALYASFQ-TK 744 (1005)
Q Consensus 670 ~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~----~~~~~~~~~E~~il~~l~hpnIv~l~~~~~-~~ 744 (1005)
..++|-++..||.|+|+.||++.|....+++|+|+-.....-. ....+...+|..|-+.|+||.||++|++|. +.
T Consensus 461 Ln~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDt 540 (775)
T KOG1151|consen 461 LNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDT 540 (775)
T ss_pred hHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeecc
Confidence 3578999999999999999999999999999999876432211 223445578999999999999999999997 56
Q ss_pred CeEEEEEeccCCCchhhHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHc--CcccCCCCCCcEEEecC---CcEEEEecc
Q 001847 745 THVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQ--GIIYRDLKPENVLLQGN---GHVSLTDFD 819 (1005)
Q Consensus 745 ~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~--gIvHrDLkP~NILi~~~---g~vkL~DFG 819 (1005)
+.+|-|+|||+|.+|.-|++.+ +.+++..++.|+.||+.||.||... -|||-||||.|||+.+. |.+||.|||
T Consensus 541 dsFCTVLEYceGNDLDFYLKQh--klmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITDFG 618 (775)
T KOG1151|consen 541 DSFCTVLEYCEGNDLDFYLKQH--KLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITDFG 618 (775)
T ss_pred ccceeeeeecCCCchhHHHHhh--hhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeeecc
Confidence 7899999999999999999875 5699999999999999999999987 59999999999999743 679999999
Q ss_pred CCcccCCCCCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCC----CCCChhhHHHHHHHHHHHH
Q 001847 820 LSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGA----GHTSAVDWWALGILLYEML 895 (1005)
Q Consensus 820 ~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~----~~~~~sDIwSlGvll~eLl 895 (1005)
++++++++.... .......+...||.+|++||.+.-+ ..+.++||||.||++|.++
T Consensus 619 LSKIMdddSy~~--------------------vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQCl 678 (775)
T KOG1151|consen 619 LSKIMDDDSYNS--------------------VDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCL 678 (775)
T ss_pred hhhhccCCccCc--------------------ccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhh
Confidence 999987654321 2233455667899999999998544 4577999999999999999
Q ss_pred cCCCCCCCCChH-HHHH--HHH-hCCCCCCCCCCCCHHHHHHHHHccccCcCccCCChhcHHHHHcCCCCCC
Q 001847 896 YGYTPFRGKTRQ-KTFA--NIL-HKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKG 963 (1005)
Q Consensus 896 tG~~Pf~~~~~~-~~~~--~i~-~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~hpff~~ 963 (1005)
.|+-||...... .++. .|+ .....+|..+..+.++++||++||.+.-+.|.. +.+|-.||||..
T Consensus 679 YGrKPFGhnqsQQdILqeNTIlkAtEVqFP~KPvVsseAkaFIRRCLaYRKeDR~D----V~qLA~dpyllP 746 (775)
T KOG1151|consen 679 YGRKPFGHNQSQQDILQENTILKATEVQFPPKPVVSSEAKAFIRRCLAYRKEDRID----VQQLACDPYLLP 746 (775)
T ss_pred ccCCCCCCchhHHHHHhhhchhcceeccCCCCCccCHHHHHHHHHHHHhhhhhhhh----HHHHccCccccc
Confidence 999999765432 2222 222 345678888889999999999999999999999 999999999986
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-34 Score=321.01 Aligned_cols=244 Identities=34% Similarity=0.520 Sum_probs=207.3
Q ss_pred ccCCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCeEE
Q 001847 670 NLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPALYASFQTKTHVC 748 (1005)
Q Consensus 670 ~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~~ 748 (1005)
....|.+...+|.|+|+.|-.+.+..+++.+++|++.+.. .+..+|+.++... +||||+++++.+....+.|
T Consensus 320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~-------~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~ 392 (612)
T KOG0603|consen 320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA-------DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIY 392 (612)
T ss_pred cchhhccccccCCCCccceeeeeccccccchhheeccccc-------cccccccchhhhhcCCCcceeecceecCCceee
Confidence 3678999999999999999999999999999999997651 2334566565555 8999999999999999999
Q ss_pred EEEeccCCCchhhHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-ecCCcEEEEeccCCcccCCC
Q 001847 749 LITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLL-QGNGHVSLTDFDLSCLTSCK 827 (1005)
Q Consensus 749 lV~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi-~~~g~vkL~DFG~a~~~~~~ 827 (1005)
+|||++.|+-|.+.+...+. +. ..+..|+.+|+.+|.|||.+|||||||||+|||+ ++.|+++|+|||.++....+
T Consensus 393 ~v~e~l~g~ell~ri~~~~~--~~-~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~ 469 (612)
T KOG0603|consen 393 LVMELLDGGELLRRIRSKPE--FC-SEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS 469 (612)
T ss_pred eeehhccccHHHHHHHhcch--hH-HHHHHHHHHHHHHHHHHHhcCeeecCCChhheeecCCCCcEEEEEechhhhCchh
Confidence 99999999988888776432 33 6777899999999999999999999999999999 58899999999998653311
Q ss_pred CCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHcCCCCCCCCChH
Q 001847 828 PQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQ 907 (1005)
Q Consensus 828 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlGvll~eLltG~~Pf~~~~~~ 907 (1005)
..+.+-|..|.|||++....++.++|+||||++||+|++|+.||......
T Consensus 470 ------------------------------~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~ 519 (612)
T KOG0603|consen 470 ------------------------------CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG 519 (612)
T ss_pred ------------------------------hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch
Confidence 12346789999999999999999999999999999999999999876655
Q ss_pred -HHHHHHHhCCCCCCCCCCCCHHHHHHHHHccccCcCccCCChhcHHHHHcCCCC
Q 001847 908 -KTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFF 961 (1005)
Q Consensus 908 -~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~hpff 961 (1005)
+++..+..+.+. ..+|..+++||++||+.||.+|++ +.+++.||||
T Consensus 520 ~ei~~~i~~~~~s----~~vS~~AKdLl~~LL~~dP~~Rl~----~~~i~~h~w~ 566 (612)
T KOG0603|consen 520 IEIHTRIQMPKFS----ECVSDEAKDLLQQLLQVDPALRLG----ADEIGAHPWF 566 (612)
T ss_pred HHHHHhhcCCccc----cccCHHHHHHHHHhccCChhhCcC----hhhhccCcch
Confidence 444444333332 457999999999999999999999 9999999999
|
|
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-33 Score=301.28 Aligned_cols=250 Identities=21% Similarity=0.337 Sum_probs=205.8
Q ss_pred cCCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEE
Q 001847 671 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLI 750 (1005)
Q Consensus 671 ~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV 750 (1005)
..+|++.+.||.|+||.||++.+. .+..+++|.+..... ....+.+|++++++++||||+++++++......|+|
T Consensus 3 ~~~~~~~~~ig~g~~g~v~~~~~~-~~~~~~~k~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v 77 (256)
T cd05112 3 PSELTLVQEIGSGQFGLVWLGYWL-EKRKVAIKTIREGAM----SEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLV 77 (256)
T ss_pred hhHeEEEeeecCcccceEEEEEEe-CCCeEEEEECCCCCC----CHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEE
Confidence 457999999999999999999884 467899998875432 234677899999999999999999999999999999
Q ss_pred EeccCCCchhhHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCCCC
Q 001847 751 TDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQL 830 (1005)
Q Consensus 751 ~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~ 830 (1005)
|||+.+++|.+++.... ..+++..++.++.|++.+|+|||+.|++|+||||+||+++.++.++|+|||++.......
T Consensus 78 ~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~-- 154 (256)
T cd05112 78 FEFMEHGCLSDYLRAQR-GKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQ-- 154 (256)
T ss_pred EEcCCCCcHHHHHHhCc-cCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcCCCeEEECCCcceeecccCc--
Confidence 99999999999987543 358899999999999999999999999999999999999999999999999875432110
Q ss_pred CCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCChHHH
Q 001847 831 LLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY-GYTPFRGKTRQKT 909 (1005)
Q Consensus 831 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlGvll~eLlt-G~~Pf~~~~~~~~ 909 (1005)
........++..|+|||.+.+..++.++||||||+++|+|++ |..||........
T Consensus 155 ------------------------~~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~ 210 (256)
T cd05112 155 ------------------------YTSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEV 210 (256)
T ss_pred ------------------------ccccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHH
Confidence 001112235678999999988888999999999999999998 9999988777666
Q ss_pred HHHHHhCCCCCCCCCCCCHHHHHHHHHccccCcCccCCChhcHHHHHc
Q 001847 910 FANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKK 957 (1005)
Q Consensus 910 ~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~ 957 (1005)
...+..... .......+..+.+|+.+||..+|++||+ +.++++
T Consensus 211 ~~~~~~~~~-~~~~~~~~~~~~~l~~~~l~~~p~~Rp~----~~~~l~ 253 (256)
T cd05112 211 VETINAGFR-LYKPRLASQSVYELMQHCWKERPEDRPS----FSLLLH 253 (256)
T ss_pred HHHHhCCCC-CCCCCCCCHHHHHHHHHHcccChhhCCC----HHHHHH
Confidence 666654422 2222346788999999999999999999 666664
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=304.43 Aligned_cols=255 Identities=22% Similarity=0.301 Sum_probs=207.7
Q ss_pred ccCCccccccccccCcEEEEEEEEcCCCe----EEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC
Q 001847 670 NLQHFRPIKPLGSGDTGSVHLVELCGSGQ----YFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKT 745 (1005)
Q Consensus 670 ~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~----~valK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~ 745 (1005)
...+|++.+.||+|+||.||++.+..+|. .+++|.+.... .......+.+|+.+++.++|+||+++++++.. .
T Consensus 5 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~ 81 (279)
T cd05057 5 KETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREET--SPKANKEILDEAYVMASVDHPHVVRLLGICLS-S 81 (279)
T ss_pred CHHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCC--CHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-C
Confidence 35689999999999999999999876654 68999876542 24455678889999999999999999999887 7
Q ss_pred eEEEEEeccCCCchhhHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccC
Q 001847 746 HVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTS 825 (1005)
Q Consensus 746 ~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~~~g~vkL~DFG~a~~~~ 825 (1005)
..++||||+.+++|.+++.... ..+++..+..++.||+.||+|||++|++|+||||+||+++.++.+||+|||++....
T Consensus 82 ~~~~v~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~ 160 (279)
T cd05057 82 QVQLITQLMPLGCLLDYVRNHK-DNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLD 160 (279)
T ss_pred ceEEEEecCCCCcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEcCCCeEEECCCccccccc
Confidence 8899999999999999987643 348999999999999999999999999999999999999999999999999986543
Q ss_pred CCCCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHc-CCCCCCCC
Q 001847 826 CKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY-GYTPFRGK 904 (1005)
Q Consensus 826 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlGvll~eLlt-G~~Pf~~~ 904 (1005)
..... .......++..|+|||.+....++.++|||||||++|++++ |..||.+.
T Consensus 161 ~~~~~-------------------------~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~ 215 (279)
T cd05057 161 VDEKE-------------------------YHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGI 215 (279)
T ss_pred Ccccc-------------------------eecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCC
Confidence 11100 00011224568999999988888999999999999999998 99999888
Q ss_pred ChHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHccccCcCccCCChhcHHH
Q 001847 905 TRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANE 954 (1005)
Q Consensus 905 ~~~~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~e 954 (1005)
...+....+..+ ...+.....+..+.+++.+||..+|..||++.+.++.
T Consensus 216 ~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~ 264 (279)
T cd05057 216 PAVEIPDLLEKG-ERLPQPPICTIDVYMVLVKCWMIDAESRPTFKELINE 264 (279)
T ss_pred CHHHHHHHHhCC-CCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence 776665555543 3334444567889999999999999999995544333
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-33 Score=307.46 Aligned_cols=255 Identities=22% Similarity=0.339 Sum_probs=201.2
Q ss_pred CCccccccccccCcEEEEEEEE----cCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeC--C
Q 001847 672 QHFRPIKPLGSGDTGSVHLVEL----CGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTK--T 745 (1005)
Q Consensus 672 ~~y~~~~~LG~G~~g~Vy~a~~----~~~~~~valK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~--~ 745 (1005)
.-|++++.||+|+||.||++.. ..++..||+|.++... .......+.+|+.+++.++||||+++++++... .
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES--GGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGN 81 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccc--cHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCC
Confidence 4589999999999999999984 4568899999987542 234456788999999999999999999988765 5
Q ss_pred eEEEEEeccCCCchhhHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccC
Q 001847 746 HVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTS 825 (1005)
Q Consensus 746 ~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~~~g~vkL~DFG~a~~~~ 825 (1005)
..++||||++|++|.+++.... ..++...+..++.||+.||+|||++|++||||||+||+++.++.++|+|||++....
T Consensus 82 ~~~lv~e~~~g~~L~~~l~~~~-~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~ 160 (284)
T cd05079 82 GIKLIMEFLPSGSLKEYLPRNK-NKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIE 160 (284)
T ss_pred ceEEEEEccCCCCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEcCCCCEEECCCccccccc
Confidence 7899999999999999986542 358999999999999999999999999999999999999999999999999985432
Q ss_pred CCCCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHcCCCCCCCCC
Q 001847 826 CKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKT 905 (1005)
Q Consensus 826 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlGvll~eLltG~~Pf~~~~ 905 (1005)
..... ........++..|+|||++.+..++.++|||||||++|+|++++.|+....
T Consensus 161 ~~~~~------------------------~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~ 216 (284)
T cd05079 161 TDKEY------------------------YTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPM 216 (284)
T ss_pred cCccc------------------------eeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCcccc
Confidence 11100 001123456778999999988888999999999999999999876653211
Q ss_pred --------------hHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHccccCcCccCCChhcHHHHHc
Q 001847 906 --------------RQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKK 957 (1005)
Q Consensus 906 --------------~~~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~ 957 (1005)
...............+....++..+.+|+.+||+.+|++||+ +.++++
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt----~~~il~ 278 (284)
T cd05079 217 TLFLKMIGPTHGQMTVTRLVRVLEEGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTT----FQNLIE 278 (284)
T ss_pred chhhhhcccccccccHHHHHHHHHcCccCCCCCCCCHHHHHHHHHHccCCcccCcC----HHHHHH
Confidence 111111222233334444557889999999999999999999 666654
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-33 Score=307.05 Aligned_cols=253 Identities=30% Similarity=0.479 Sum_probs=205.9
Q ss_pred ccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCC-CCCcceEEEEEEeCCeEEEEEe
Q 001847 674 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLD-HPFVPALYASFQTKTHVCLITD 752 (1005)
Q Consensus 674 y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~il~~l~-hpnIv~l~~~~~~~~~~~lV~E 752 (1005)
|++.+.||+|++|.||+|.+..+++.+++|.+..... . .......+|+..++++. |+||+++++++..++..|+|||
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~-~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e 78 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFY-S-WEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFE 78 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhcc-c-hhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEe
Confidence 6788999999999999999988899999998875422 1 22234456888999998 9999999999999999999999
Q ss_pred ccCCCchhhHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCCCCCC
Q 001847 753 YCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLL 832 (1005)
Q Consensus 753 ~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~~~ 832 (1005)
|+ +++|.+++.......++...+..++.||+.+|.|||++|++|+||+|+||+++.++.++|+|||.+......
T Consensus 79 ~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~----- 152 (283)
T cd07830 79 YM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSR----- 152 (283)
T ss_pred cC-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCCEEEeecccceeccCC-----
Confidence 99 889999887765456899999999999999999999999999999999999999999999999988543211
Q ss_pred CcchhhhhcccCCCCCcccccccccccccccCCcccccccccC-CCCCChhhHHHHHHHHHHHHcCCCCCCCCChHHHHH
Q 001847 833 PTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAG-AGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFA 911 (1005)
Q Consensus 833 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~sDIwSlGvll~eLltG~~Pf~~~~~~~~~~ 911 (1005)
.......++..|+|||++.. ..++.++|+||||+++|+|++|+.||........+.
T Consensus 153 -----------------------~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~ 209 (283)
T cd07830 153 -----------------------PPYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLY 209 (283)
T ss_pred -----------------------CCcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHH
Confidence 01122457889999998754 456889999999999999999999998776655544
Q ss_pred HHHhCC-----------------C--CCCC---------CCCCCHHHHHHHHHccccCcCccCCChhcHHHHHcCCCC
Q 001847 912 NILHKD-----------------L--KFPS---------STPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFF 961 (1005)
Q Consensus 912 ~i~~~~-----------------~--~~~~---------~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~hpff 961 (1005)
.+...- . .++. ....+..+.+||.+||+.+|++||+ +++++.||||
T Consensus 210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt----~~ei~~~~~~ 283 (283)
T cd07830 210 KICSVLGTPTKQDWPEGYKLASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPT----ASQALQHPYF 283 (283)
T ss_pred HHHHhcCCCChhhhhhHhhhhccccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCC----HHHHhhCCCC
Confidence 433210 0 0000 0123567899999999999999999 9999999997
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-33 Score=307.16 Aligned_cols=254 Identities=28% Similarity=0.469 Sum_probs=209.7
Q ss_pred ccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEEec
Q 001847 674 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDY 753 (1005)
Q Consensus 674 y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~ 753 (1005)
|++.+.||+|++|.||++.+..+++.|++|.+.... ........+..|+.+++.++|+||+++++++...+..++||||
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 79 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDN-EEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEY 79 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEecccc-ccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecC
Confidence 677889999999999999999999999999998653 2233446677899999999999999999999999999999999
Q ss_pred cCCCchhhHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCCCCCCC
Q 001847 754 CPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLP 833 (1005)
Q Consensus 754 ~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~~~~ 833 (1005)
+. ++|.+++.... ..+++..+..++.|++.||.|||++||+|+||+|+||+++.++.++|+|||.+.......
T Consensus 80 ~~-~~l~~~i~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~----- 152 (282)
T cd07829 80 CD-MDLKKYLDKRP-GPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPL----- 152 (282)
T ss_pred cC-cCHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCCCCEEEecCCcccccCCCc-----
Confidence 96 68999997643 359999999999999999999999999999999999999999999999999885432110
Q ss_pred cchhhhhcccCCCCCcccccccccccccccCCcccccccccCC-CCCChhhHHHHHHHHHHHHcCCCCCCCCChHHHHHH
Q 001847 834 TTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGA-GHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFAN 912 (1005)
Q Consensus 834 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~sDIwSlGvll~eLltG~~Pf~~~~~~~~~~~ 912 (1005)
.......++..|+|||.+... .++.++|||||||++|+|++|..||.+......+..
T Consensus 153 ----------------------~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~ 210 (282)
T cd07829 153 ----------------------RTYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFK 210 (282)
T ss_pred ----------------------cccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHH
Confidence 011223467789999998776 788899999999999999999999988776655554
Q ss_pred HHhC------------------CCCCCC---------CCCCCHHHHHHHHHccccCcCccCCChhcHHHHHcCCCC
Q 001847 913 ILHK------------------DLKFPS---------STPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFF 961 (1005)
Q Consensus 913 i~~~------------------~~~~~~---------~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~hpff 961 (1005)
+... ...++. ....+..+.++|.+||..+|.+||+ +.+++.||||
T Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~----~~~~l~~p~~ 282 (282)
T cd07829 211 IFQILGTPTEESWPGVTKLPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRIS----AKEALKHPYF 282 (282)
T ss_pred HHHHhCCCcHHHHHhhcccccccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCC----HHHHhhCcCC
Confidence 4321 000110 1124668999999999999999999 9999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-34 Score=337.99 Aligned_cols=273 Identities=28% Similarity=0.425 Sum_probs=208.9
Q ss_pred ccCCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceEEEEEEe------
Q 001847 670 NLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQT------ 743 (1005)
Q Consensus 670 ~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~------ 743 (1005)
...+|+.+..||+||||.||+|+++-+|+.||||.+.... .......+.+|+.++.+|+|||||+++..+.+
T Consensus 477 Y~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~--s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~ 554 (1351)
T KOG1035|consen 477 YLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKA--SDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELT 554 (1351)
T ss_pred HhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCch--HHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccc
Confidence 3568999999999999999999999999999999987653 56667889999999999999999999843210
Q ss_pred --------------------------------------------------------------------------------
Q 001847 744 -------------------------------------------------------------------------------- 743 (1005)
Q Consensus 744 -------------------------------------------------------------------------------- 743 (1005)
T Consensus 555 ~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS 634 (1351)
T KOG1035|consen 555 VLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTS 634 (1351)
T ss_pred cccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccccc
Confidence
Q ss_pred -------------------------C--------CeEEEEEeccCCCchhhHHhhCCCCCCCHHHHHHHHHHHHHHHHHH
Q 001847 744 -------------------------K--------THVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYL 790 (1005)
Q Consensus 744 -------------------------~--------~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~L 790 (1005)
+ ..+||-||||+..+|.+++..+.... .....+.++++|++||+|+
T Consensus 635 ~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~-~~d~~wrLFreIlEGLaYI 713 (1351)
T KOG1035|consen 635 DSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS-QRDEAWRLFREILEGLAYI 713 (1351)
T ss_pred ccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch-hhHHHHHHHHHHHHHHHHH
Confidence 0 12799999999999999998764321 4678899999999999999
Q ss_pred HHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCCCCCCCcchhhhhcccCCCCCccccc-ccccccccccCCcccc
Q 001847 791 HCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAE-PMRASNSFVGTEEYIA 869 (1005)
Q Consensus 791 H~~gIvHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~gt~~y~a 869 (1005)
|++|||||||||.|||+++++.|||+|||+|....-.... ............+ +....++.+||..|+|
T Consensus 714 H~~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~----------~d~~~~~~~~~~g~~~~~~Ts~VGTalYvA 783 (1351)
T KOG1035|consen 714 HDQGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLES----------IDQDLSFSTNRAGSNDGDLTSQVGTALYVA 783 (1351)
T ss_pred HhCceeeccCCcceeEEcCCCCeeecccccchhhhhhhhh----------HhhccCccccccCCCCcccccccceeeeec
Confidence 9999999999999999999999999999999652100000 0000000011111 2224567799999999
Q ss_pred cccccCCC---CCChhhHHHHHHHHHHHHcCCCCCCCC-ChHHHHHHHHhCCCCCCCC--CCCCHHHHHHHHHccccCcC
Q 001847 870 PEIIAGAG---HTSAVDWWALGILLYEMLYGYTPFRGK-TRQKTFANILHKDLKFPSS--TPTSLHAKQLMYRLLHRDPK 943 (1005)
Q Consensus 870 PE~l~~~~---~~~~sDIwSlGvll~eLltG~~Pf~~~-~~~~~~~~i~~~~~~~~~~--~~~s~~l~~Ll~~~L~~dP~ 943 (1005)
||++.+.. |+.|+|+||||++++||+. ||... .....+..+..+.++.+.. .+.-+.-..+|.+||+.||.
T Consensus 784 PEll~~~~~~~Yn~KiDmYSLGIVlFEM~y---PF~TsMERa~iL~~LR~g~iP~~~~f~~~~~~~e~slI~~Ll~hdP~ 860 (1351)
T KOG1035|consen 784 PELLSDTSSNKYNSKIDMYSLGIVLFEMLY---PFGTSMERASILTNLRKGSIPEPADFFDPEHPEEASLIRWLLSHDPS 860 (1351)
T ss_pred HHHhcccccccccchhhhHHHHHHHHHHhc---cCCchHHHHHHHHhcccCCCCCCcccccccchHHHHHHHHHhcCCCc
Confidence 99997754 8899999999999999984 56543 2234444444455555511 11223456899999999999
Q ss_pred ccCCChhcHHHHHcCCCCC
Q 001847 944 SRLGSHEGANEIKKHPFFK 962 (1005)
Q Consensus 944 ~Rpt~~~~a~elL~hpff~ 962 (1005)
+||| |.+||++.||-
T Consensus 861 kRPt----A~eLL~s~llp 875 (1351)
T KOG1035|consen 861 KRPT----ATELLNSELLP 875 (1351)
T ss_pred cCCC----HHHHhhccCCC
Confidence 9999 99999999998
|
|
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=299.63 Aligned_cols=251 Identities=24% Similarity=0.369 Sum_probs=209.3
Q ss_pred ccccccccccCcEEEEEEEEcCCC----eEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEE
Q 001847 674 FRPIKPLGSGDTGSVHLVELCGSG----QYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCL 749 (1005)
Q Consensus 674 y~~~~~LG~G~~g~Vy~a~~~~~~----~~valK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l 749 (1005)
+.+.+.||.|+||.||++.+...+ ..+|+|.+.... .......+..|+.+++.++|+||+++++++...+..|+
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 78 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDA--DEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMI 78 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCC--ChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEE
Confidence 456789999999999999997766 899999986542 22256788889999999999999999999999999999
Q ss_pred EEeccCCCchhhHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCCC
Q 001847 750 ITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQ 829 (1005)
Q Consensus 750 V~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~ 829 (1005)
+|||+++++|.+++.......+++..+..++.||+.||.|||+.|++|+||||+||++++++.++|+|||++........
T Consensus 79 i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~ 158 (258)
T smart00219 79 VMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDY 158 (258)
T ss_pred EEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEccCCeEEEcccCCceecccccc
Confidence 99999999999999765333389999999999999999999999999999999999999999999999999855431100
Q ss_pred CCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCChHH
Q 001847 830 LLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY-GYTPFRGKTRQK 908 (1005)
Q Consensus 830 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlGvll~eLlt-G~~Pf~~~~~~~ 908 (1005)
. ......+++.|+|||.+....++.++|||||||++|+|++ |..||...+...
T Consensus 159 ~--------------------------~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~ 212 (258)
T smart00219 159 Y--------------------------KKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEE 212 (258)
T ss_pred c--------------------------ccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence 0 0001226789999999988888999999999999999998 899998877777
Q ss_pred HHHHHHhCCCCCCCCCCCCHHHHHHHHHccccCcCccCCChhcHHHHHc
Q 001847 909 TFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKK 957 (1005)
Q Consensus 909 ~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~ 957 (1005)
....+...... ......+..+.+++.+||..+|++||| +.++++
T Consensus 213 ~~~~~~~~~~~-~~~~~~~~~~~~~i~~~l~~~p~~Rpt----~~~ll~ 256 (258)
T smart00219 213 VLEYLKKGYRL-PKPENCPPEIYKLMLQCWAEDPEDRPT----FSELVE 256 (258)
T ss_pred HHHHHhcCCCC-CCCCcCCHHHHHHHHHHCcCChhhCcC----HHHHHh
Confidence 77666655432 233347889999999999999999999 777765
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-32 Score=296.94 Aligned_cols=245 Identities=23% Similarity=0.349 Sum_probs=199.3
Q ss_pred ccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEEeccCCC
Q 001847 678 KPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGG 757 (1005)
Q Consensus 678 ~~LG~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg 757 (1005)
+.||+|+||.||++.. .++..+|+|.++... .......+.+|+.+++.++||||+++++++...+..++||||++++
T Consensus 1 ~~ig~g~~g~vy~~~~-~~~~~~a~K~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 77 (250)
T cd05085 1 ELLGKGNFGEVFKGTL-KDKTPVAVKTCKEDL--PQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGG 77 (250)
T ss_pred CccCCCCCceEEEEEe-cCCcEEEEEecCCcC--CHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCC
Confidence 3689999999999986 468899999887542 2334456888999999999999999999999999999999999999
Q ss_pred chhhHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCCCCCCCcchh
Q 001847 758 ELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNE 837 (1005)
Q Consensus 758 sL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~ 837 (1005)
+|.+++.... ..+++..+..++.|++.+|.|||++|++|+||||+||+++.++.++|+|||++.......
T Consensus 78 ~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~--------- 147 (250)
T cd05085 78 DFLSFLRKKK-DELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGI--------- 147 (250)
T ss_pred cHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCCCeEEECCCccceeccccc---------
Confidence 9999987543 358899999999999999999999999999999999999999999999999885322100
Q ss_pred hhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHhC
Q 001847 838 KKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY-GYTPFRGKTRQKTFANILHK 916 (1005)
Q Consensus 838 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlGvll~eLlt-G~~Pf~~~~~~~~~~~i~~~ 916 (1005)
........+++.|+|||++....++.++||||||+++|++++ |..||.+.........+...
T Consensus 148 -----------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~~~ 210 (250)
T cd05085 148 -----------------YSSSGLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKG 210 (250)
T ss_pred -----------------cccCCCCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHcC
Confidence 000111234567999999988888999999999999999998 99999887776666555443
Q ss_pred CCCCCCCCCCCHHHHHHHHHccccCcCccCCChhcHH
Q 001847 917 DLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGAN 953 (1005)
Q Consensus 917 ~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~ 953 (1005)
. .......++..+.+|+.+||..+|++||++.++++
T Consensus 211 ~-~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 246 (250)
T cd05085 211 Y-RMSCPQKCPDDVYKVMQRCWDYKPENRPKFSELQK 246 (250)
T ss_pred C-CCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 2 22233456789999999999999999999444333
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=298.06 Aligned_cols=246 Identities=26% Similarity=0.365 Sum_probs=201.8
Q ss_pred ccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEEeccCCC
Q 001847 678 KPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGG 757 (1005)
Q Consensus 678 ~~LG~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg 757 (1005)
+.||.|++|.||++.+.. ++.|++|.+..... ......+.+|+.++++++|+||+++++++......++||||+.++
T Consensus 1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~ 77 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLP--PDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGG 77 (251)
T ss_pred CccccCCCceEEEEEEeC-CCcEEEEeccccCC--HHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCC
Confidence 468999999999999977 99999998876532 235567889999999999999999999999999999999999999
Q ss_pred chhhHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCCCCCCCcchh
Q 001847 758 ELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNE 837 (1005)
Q Consensus 758 sL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~ 837 (1005)
+|.+++.... ..++...+..++.+++.+|.|||++|++|+||||+||+++.++.++|+|||++.........
T Consensus 78 ~l~~~l~~~~-~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~------- 149 (251)
T cd05041 78 SLLTFLRKKK-NRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYT------- 149 (251)
T ss_pred cHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCCCcEEEeeccccccccCCcce-------
Confidence 9999986542 35889999999999999999999999999999999999999999999999988543210000
Q ss_pred hhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHhC
Q 001847 838 KKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY-GYTPFRGKTRQKTFANILHK 916 (1005)
Q Consensus 838 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlGvll~eLlt-G~~Pf~~~~~~~~~~~i~~~ 916 (1005)
.......++..|+|||.+.+..++.++|||||||++|+|++ |..||...........+...
T Consensus 150 ------------------~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~~~ 211 (251)
T cd05041 150 ------------------VSDGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESG 211 (251)
T ss_pred ------------------eccccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHhcC
Confidence 00011234567999999988888999999999999999998 89999877765555544432
Q ss_pred CCCCCCCCCCCHHHHHHHHHccccCcCccCCChhcHHHHHc
Q 001847 917 DLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKK 957 (1005)
Q Consensus 917 ~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~ 957 (1005)
...+.....+..+.+|+.+||..+|.+||+ +.++++
T Consensus 212 -~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~----~~ell~ 247 (251)
T cd05041 212 -YRMPAPQLCPEEIYRLMLQCWAYDPENRPS----FSEIYN 247 (251)
T ss_pred -CCCCCCccCCHHHHHHHHHHhccChhhCcC----HHHHHH
Confidence 333333456789999999999999999999 777664
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=303.64 Aligned_cols=255 Identities=19% Similarity=0.213 Sum_probs=207.1
Q ss_pred cccCCccccccccccCcEEEEEEEEcC----CCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceEEEEEEe-
Q 001847 669 INLQHFRPIKPLGSGDTGSVHLVELCG----SGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQT- 743 (1005)
Q Consensus 669 i~~~~y~~~~~LG~G~~g~Vy~a~~~~----~~~~valK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~- 743 (1005)
+..++|++.+.||+|+||.||++.+.. ++..+++|.+... ........+.+|+.+++.++|+||+++++++..
T Consensus 3 ~~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~--~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~ 80 (280)
T cd05043 3 ISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDH--ASEIQVTLLLQESCLLYGLSHQNILPILHVCIED 80 (280)
T ss_pred cchhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCC--CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecC
Confidence 456789999999999999999999865 3578999987643 244556778899999999999999999998665
Q ss_pred CCeEEEEEeccCCCchhhHHhhCCC------CCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEe
Q 001847 744 KTHVCLITDYCPGGELFLLLDRQPT------KVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTD 817 (1005)
Q Consensus 744 ~~~~~lV~E~~~ggsL~~~l~~~~~------~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~~~g~vkL~D 817 (1005)
+...+++++|+.+++|.+++..... ..++...+..++.||+.||+|||++|++|+||||+||++++++.+||+|
T Consensus 81 ~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~~~~~kl~d 160 (280)
T cd05043 81 GEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQVKITD 160 (280)
T ss_pred CCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcCCCcEEECC
Confidence 5778999999999999999875322 4589999999999999999999999999999999999999999999999
Q ss_pred ccCCcccCCCCCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHc-
Q 001847 818 FDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY- 896 (1005)
Q Consensus 818 FG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlGvll~eLlt- 896 (1005)
||++..+...... .......++..|+|||++.+..++.++|||||||++|++++
T Consensus 161 ~g~~~~~~~~~~~-------------------------~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~ 215 (280)
T cd05043 161 NALSRDLFPMDYH-------------------------CLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTL 215 (280)
T ss_pred CCCcccccCCceE-------------------------EeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcC
Confidence 9998643211100 00112245678999999988889999999999999999998
Q ss_pred CCCCCCCCChHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHccccCcCccCCChhc
Q 001847 897 GYTPFRGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEG 951 (1005)
Q Consensus 897 G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~ 951 (1005)
|+.||...+.......+.. ...++....++..+.+++.+||+.+|++||++.++
T Consensus 216 g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~ 269 (280)
T cd05043 216 GQTPYVEIDPFEMAAYLKD-GYRLAQPINCPDELFAVMACCWALDPEERPSFSQL 269 (280)
T ss_pred CCCCcCcCCHHHHHHHHHc-CCCCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHH
Confidence 9999988776665544433 33334444567889999999999999999994443
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=302.10 Aligned_cols=252 Identities=24% Similarity=0.335 Sum_probs=204.9
Q ss_pred ccCCccccccccccCcEEEEEEEEcCC---CeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCe
Q 001847 670 NLQHFRPIKPLGSGDTGSVHLVELCGS---GQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTH 746 (1005)
Q Consensus 670 ~~~~y~~~~~LG~G~~g~Vy~a~~~~~---~~~valK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~ 746 (1005)
...+|.+.+.||.|+||.||++.+... ...+++|...... .......+.+|+.+++.++||||+++++++.. ..
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~--~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~ 80 (270)
T cd05056 4 QREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCT--SPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NP 80 (270)
T ss_pred chhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcC--CHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CC
Confidence 346799999999999999999987544 4578999876542 24455678899999999999999999998875 55
Q ss_pred EEEEEeccCCCchhhHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCC
Q 001847 747 VCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSC 826 (1005)
Q Consensus 747 ~~lV~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~~~g~vkL~DFG~a~~~~~ 826 (1005)
.|+||||+++++|.+++.... ..++...+..++.||+.||.|||+.|++|+||||+||+++.++.++|+|||++.....
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~ 159 (270)
T cd05056 81 VWIVMELAPLGELRSYLQVNK-YSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLED 159 (270)
T ss_pred cEEEEEcCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEecCCCeEEccCceeeeccc
Confidence 789999999999999997643 3589999999999999999999999999999999999999999999999998854321
Q ss_pred CCCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCC
Q 001847 827 KPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY-GYTPFRGKT 905 (1005)
Q Consensus 827 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlGvll~eLlt-G~~Pf~~~~ 905 (1005)
... .......+++.|+|||.+....++.++|||||||++|+|++ |..||.+..
T Consensus 160 ~~~--------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~ 213 (270)
T cd05056 160 ESY--------------------------YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVK 213 (270)
T ss_pred ccc--------------------------eecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCC
Confidence 100 00112234568999999988888999999999999999985 999998887
Q ss_pred hHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHccccCcCccCCChhcHHHHH
Q 001847 906 RQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIK 956 (1005)
Q Consensus 906 ~~~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL 956 (1005)
..+....+..+. ..+....++..+.+|+.+||..+|++||+ +.+++
T Consensus 214 ~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~~P~~Rpt----~~~~~ 259 (270)
T cd05056 214 NNDVIGRIENGE-RLPMPPNCPPTLYSLMTKCWAYDPSKRPR----FTELK 259 (270)
T ss_pred HHHHHHHHHcCC-cCCCCCCCCHHHHHHHHHHcCCChhhCcC----HHHHH
Confidence 776666555443 22334457889999999999999999999 55554
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-33 Score=315.75 Aligned_cols=252 Identities=26% Similarity=0.326 Sum_probs=198.0
Q ss_pred cCCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC-eEEE
Q 001847 671 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKT-HVCL 749 (1005)
Q Consensus 671 ~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~-~~~l 749 (1005)
.+.|.....||+|+||.||++.... |..+|||.+....... ..++.+|+.++.+++|||+|++++||.+.+ ..+|
T Consensus 74 T~~Fs~~~~ig~Ggfg~VYkG~l~~-~~~vAVK~~~~~~~~~---~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~~~~~L 149 (361)
T KOG1187|consen 74 TNNFSESNLIGEGGFGTVYKGVLSD-GTVVAVKRLSSNSGQG---EREFLNEVEILSRLRHPNLVKLLGYCLEGGEHRLL 149 (361)
T ss_pred HhCCchhcceecCCCeEEEEEEECC-CCEEEEEEecCCCCcc---hhHHHHHHHHHhcCCCcCcccEEEEEecCCceEEE
Confidence 3678888999999999999999844 4899999877543211 455999999999999999999999999988 5999
Q ss_pred EEeccCCCchhhHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcC---cccCCCCCCcEEEecCCcEEEEeccCCcccCC
Q 001847 750 ITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQG---IIYRDLKPENVLLQGNGHVSLTDFDLSCLTSC 826 (1005)
Q Consensus 750 V~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~g---IvHrDLkP~NILi~~~g~vkL~DFG~a~~~~~ 826 (1005)
|+|||++|+|.+.+.......+++..+..|+.+++.||+|||... ||||||||+|||+|.+..+||+|||+|.....
T Consensus 150 VYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsDFGLa~~~~~ 229 (361)
T KOG1187|consen 150 VYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSDFGLAKLGPE 229 (361)
T ss_pred EEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccCccCcccCCc
Confidence 999999999999997654327899999999999999999999853 99999999999999999999999999954321
Q ss_pred -CCCCCCCcchhhhhcccCCCCCccccccccccccc-ccCCcccccccccCCCCCChhhHHHHHHHHHHHHcCCCCCCCC
Q 001847 827 -KPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSF-VGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGK 904 (1005)
Q Consensus 827 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~gt~~y~aPE~l~~~~~~~~sDIwSlGvll~eLltG~~Pf~~~ 904 (1005)
... .... .||.+|++||++..+..+.++||||||++|+||++|+.+....
T Consensus 230 ~~~~----------------------------~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~ 281 (361)
T KOG1187|consen 230 GDTS----------------------------VSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQS 281 (361)
T ss_pred cccc----------------------------eeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCC
Confidence 100 0111 7999999999998888999999999999999999999887643
Q ss_pred C---h---HHHHHHHHh-CCC------CCCCCCCCC-----HHHHHHHHHccccCcCccCCChhcHHHH
Q 001847 905 T---R---QKTFANILH-KDL------KFPSSTPTS-----LHAKQLMYRLLHRDPKSRLGSHEGANEI 955 (1005)
Q Consensus 905 ~---~---~~~~~~i~~-~~~------~~~~~~~~s-----~~l~~Ll~~~L~~dP~~Rpt~~~~a~el 955 (1005)
. . .+-....+. +.+ .+.. ...+ ..+..+...|++.+|..||++.+++..+
T Consensus 282 ~~~~~~~l~~w~~~~~~~~~~~eiiD~~l~~-~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L 349 (361)
T KOG1187|consen 282 RPRGELSLVEWAKPLLEEGKLREIVDPRLKE-GEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKEL 349 (361)
T ss_pred CCcccccHHHHHHHHHHCcchhheeCCCccC-CCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHH
Confidence 2 1 111111111 111 1110 1122 2356788999999999999977765555
|
|
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-32 Score=300.96 Aligned_cols=244 Identities=23% Similarity=0.329 Sum_probs=196.8
Q ss_pred ccccccCcEEEEEEEEcCCCe--EEEEEEeecccccChHHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCeEEEEEecc
Q 001847 678 KPLGSGDTGSVHLVELCGSGQ--YFAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPALYASFQTKTHVCLITDYC 754 (1005)
Q Consensus 678 ~~LG~G~~g~Vy~a~~~~~~~--~valK~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~~lV~E~~ 754 (1005)
+.||+|+||.||++.+..++. .+++|.++.. ........+.+|+.++.++ +||||+++++++...+.+|+||||+
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~ 78 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY--ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYA 78 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEcccc--CCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeC
Confidence 358999999999999987775 4688877642 2334456788899999999 8999999999999999999999999
Q ss_pred CCCchhhHHhhCC--------------CCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccC
Q 001847 755 PGGELFLLLDRQP--------------TKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDL 820 (1005)
Q Consensus 755 ~ggsL~~~l~~~~--------------~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~~~g~vkL~DFG~ 820 (1005)
++++|.+++.... ...++...+..++.|++.||+|||++|++|+||||+||+++.++.+||+|||+
T Consensus 79 ~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~~~~~kl~dfgl 158 (270)
T cd05047 79 PHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGL 158 (270)
T ss_pred CCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcCCCeEEECCCCC
Confidence 9999999987532 12478999999999999999999999999999999999999999999999998
Q ss_pred CcccCCCCCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHc-CCC
Q 001847 821 SCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY-GYT 899 (1005)
Q Consensus 821 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlGvll~eLlt-G~~ 899 (1005)
+...... ........++.|+|||++....++.++|||||||++|+|++ |..
T Consensus 159 ~~~~~~~----------------------------~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~ 210 (270)
T cd05047 159 SRGQEVY----------------------------VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGT 210 (270)
T ss_pred ccccchh----------------------------hhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCC
Confidence 7321100 00011223567999999988888999999999999999996 999
Q ss_pred CCCCCChHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHccccCcCccCCChhcH
Q 001847 900 PFRGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGA 952 (1005)
Q Consensus 900 Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a 952 (1005)
||.+.+.......+... .........+..+.+|+.+||..+|.+||++.+++
T Consensus 211 pf~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il 262 (270)
T cd05047 211 PYCGMTCAELYEKLPQG-YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQIL 262 (270)
T ss_pred CccccCHHHHHHHHhCC-CCCCCCCcCCHHHHHHHHHHcccChhhCCCHHHHH
Confidence 99887766666555443 22223334678899999999999999999944433
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-33 Score=303.35 Aligned_cols=238 Identities=20% Similarity=0.305 Sum_probs=190.4
Q ss_pred ccccccCcEEEEEEEEcCCCe-------EEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEE
Q 001847 678 KPLGSGDTGSVHLVELCGSGQ-------YFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLI 750 (1005)
Q Consensus 678 ~~LG~G~~g~Vy~a~~~~~~~-------~valK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV 750 (1005)
+.||.|+||.||++.+...+. .+++|.+... .......+..|..+++.++||||+++++++......++|
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv 77 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKS---HRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMV 77 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcch---hHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEE
Confidence 368999999999999865543 4888877543 234456778899999999999999999999998999999
Q ss_pred EeccCCCchhhHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCc--------EEEEeccCCc
Q 001847 751 TDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGH--------VSLTDFDLSC 822 (1005)
Q Consensus 751 ~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~~~g~--------vkL~DFG~a~ 822 (1005)
|||+.+++|..++.... ..+++..+..++.||+.||+|||++||+||||||+||+++.++. ++++|||.+.
T Consensus 78 ~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~ 156 (258)
T cd05078 78 QEYVKFGSLDTYLKKNK-NLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISI 156 (258)
T ss_pred EecCCCCcHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEeccccccc
Confidence 99999999999997643 35899999999999999999999999999999999999987765 6999999874
Q ss_pred ccCCCCCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCC-CCCChhhHHHHHHHHHHHHcCC-CC
Q 001847 823 LTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGA-GHTSAVDWWALGILLYEMLYGY-TP 900 (1005)
Q Consensus 823 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~sDIwSlGvll~eLltG~-~P 900 (1005)
... ......+++.|+|||++.+. .++.++|||||||++|+|++|. .|
T Consensus 157 ~~~-------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~ 205 (258)
T cd05078 157 TVL-------------------------------PKEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKP 205 (258)
T ss_pred ccC-------------------------------CchhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCC
Confidence 321 01224578899999999764 4788999999999999999984 66
Q ss_pred CCCCChHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHccccCcCccCCChhcHHHHHc
Q 001847 901 FRGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKK 957 (1005)
Q Consensus 901 f~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~ 957 (1005)
|......... ........++. ..+.++.+||.+||+.+|++||+ ++++++
T Consensus 206 ~~~~~~~~~~-~~~~~~~~~~~--~~~~~~~~li~~~l~~~p~~Rps----~~~il~ 255 (258)
T cd05078 206 LSALDSQKKL-QFYEDRHQLPA--PKWTELANLINQCMDYEPDFRPS----FRAIIR 255 (258)
T ss_pred hhhccHHHHH-HHHHccccCCC--CCcHHHHHHHHHHhccChhhCCC----HHHHHH
Confidence 6555444332 23333333332 35678999999999999999999 777665
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-33 Score=299.08 Aligned_cols=233 Identities=32% Similarity=0.476 Sum_probs=189.4
Q ss_pred cCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEEeccCCCchhhH
Q 001847 683 GDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLL 762 (1005)
Q Consensus 683 G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~ 762 (1005)
|.++.||+|.+..+++.||+|.+.... ....+...+....||||+++++++...+.+|+||||+.+++|.++
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~--------~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~ 75 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS--------EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSH 75 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh--------hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHH
Confidence 899999999999999999999987642 222344445556799999999999999999999999999999999
Q ss_pred HhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCCCCCCCcchhhhhcc
Q 001847 763 LDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRH 842 (1005)
Q Consensus 763 l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~ 842 (1005)
+... ..+++..+..++.||+.||.|||++||+|+||||+||+++.++.++|+|||.+......
T Consensus 76 l~~~--~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~--------------- 138 (237)
T cd05576 76 ISKF--LNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS--------------- 138 (237)
T ss_pred HHHh--cCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEecccchhccccc---------------
Confidence 8764 34899999999999999999999999999999999999999999999999976432210
Q ss_pred cCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhCCCCCCC
Q 001847 843 KGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANILHKDLKFPS 922 (1005)
Q Consensus 843 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlGvll~eLltG~~Pf~~~~~~~~~~~i~~~~~~~~~ 922 (1005)
.....++..|+|||.+....++.++|+||+||++|+|++|..||...... ......+..
T Consensus 139 ---------------~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~------~~~~~~~~~ 197 (237)
T cd05576 139 ---------------CDGEAVENMYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSG------INTHTTLNI 197 (237)
T ss_pred ---------------cccCCcCccccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchh------cccccccCC
Confidence 11234567799999998888899999999999999999999887543211 011111112
Q ss_pred CCCCCHHHHHHHHHccccCcCccCCCh-hcHHHHHcCCCC
Q 001847 923 STPTSLHAKQLMYRLLHRDPKSRLGSH-EGANEIKKHPFF 961 (1005)
Q Consensus 923 ~~~~s~~l~~Ll~~~L~~dP~~Rpt~~-~~a~elL~hpff 961 (1005)
...++..+.+||.+||+.||.+||+.. ..++++++||||
T Consensus 198 ~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h~~~ 237 (237)
T cd05576 198 PEWVSEEARSLLQQLLQFNPTERLGAGVAGVEDIKSHPFF 237 (237)
T ss_pred cccCCHHHHHHHHHHccCCHHHhcCCCccchHHHHcCCCC
Confidence 233678899999999999999999953 236999999998
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=306.89 Aligned_cols=256 Identities=22% Similarity=0.340 Sum_probs=204.2
Q ss_pred cccCCccccccccccCcEEEEEEEEcCCCe----EEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeC
Q 001847 669 INLQHFRPIKPLGSGDTGSVHLVELCGSGQ----YFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTK 744 (1005)
Q Consensus 669 i~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~----~valK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~ 744 (1005)
+...+|+.++.||+|+||.||++.+..++. .+|+|.+.... .......+.+|+.+++.++||||+++++++...
T Consensus 4 ~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~ 81 (303)
T cd05110 4 LKETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETT--GPKANVEFMDEALIMASMDHPHLVRLLGVCLSP 81 (303)
T ss_pred cchhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC
Confidence 345689999999999999999999877765 56888876432 233344678899999999999999999988754
Q ss_pred CeEEEEEeccCCCchhhHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCccc
Q 001847 745 THVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLT 824 (1005)
Q Consensus 745 ~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~~~g~vkL~DFG~a~~~ 824 (1005)
..++++||+++|+|.+++... ...+++..+..++.||+.||.|||++||+|+||||+||+++.++.+||+|||++...
T Consensus 82 -~~~~v~e~~~~g~l~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~ 159 (303)
T cd05110 82 -TIQLVTQLMPHGCLLDYVHEH-KDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLL 159 (303)
T ss_pred -CceeeehhcCCCCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeecCCCceEEccccccccc
Confidence 467999999999999998754 235889999999999999999999999999999999999999999999999998654
Q ss_pred CCCCCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHc-CCCCCCC
Q 001847 825 SCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY-GYTPFRG 903 (1005)
Q Consensus 825 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlGvll~eLlt-G~~Pf~~ 903 (1005)
...... .......++..|+|||.+.+..++.++|||||||++|+|++ |..||.+
T Consensus 160 ~~~~~~-------------------------~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~ 214 (303)
T cd05110 160 EGDEKE-------------------------YNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDG 214 (303)
T ss_pred cCcccc-------------------------cccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 211100 01112345778999999988889999999999999999997 9999987
Q ss_pred CChHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHccccCcCccCCChhcHHH
Q 001847 904 KTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANE 954 (1005)
Q Consensus 904 ~~~~~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~e 954 (1005)
...... ..++.....++.....+..+.+++.+||..+|++||++.+++..
T Consensus 215 ~~~~~~-~~~~~~~~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~ 264 (303)
T cd05110 215 IPTREI-PDLLEKGERLPQPPICTIDVYMVMVKCWMIDADSRPKFKELAAE 264 (303)
T ss_pred CCHHHH-HHHHHCCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 655443 34444444444445567889999999999999999995554443
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=301.82 Aligned_cols=245 Identities=22% Similarity=0.304 Sum_probs=198.0
Q ss_pred ccccccCcEEEEEEEEcCCC------eEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEE
Q 001847 678 KPLGSGDTGSVHLVELCGSG------QYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLIT 751 (1005)
Q Consensus 678 ~~LG~G~~g~Vy~a~~~~~~------~~valK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~ 751 (1005)
+.||.|+||.||++.+.... ..+++|.+.... .......+.+|+.+++.++||||+++++++...+..|+||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 78 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGA--TDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIM 78 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhccc--chhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEE
Confidence 36899999999999986543 789999886542 2234567888999999999999999999999999999999
Q ss_pred eccCCCchhhHHhhC-----CCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCC-----cEEEEeccCC
Q 001847 752 DYCPGGELFLLLDRQ-----PTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNG-----HVSLTDFDLS 821 (1005)
Q Consensus 752 E~~~ggsL~~~l~~~-----~~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~~~g-----~vkL~DFG~a 821 (1005)
||+++++|.+++... ....++...+..++.||+.||.|||+++++|+||||+||+++.++ .++|+|||++
T Consensus 79 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~ 158 (269)
T cd05044 79 ELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLA 158 (269)
T ss_pred eccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECCcccc
Confidence 999999999998753 223478899999999999999999999999999999999999887 8999999998
Q ss_pred cccCCCCCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHc-CCCC
Q 001847 822 CLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY-GYTP 900 (1005)
Q Consensus 822 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlGvll~eLlt-G~~P 900 (1005)
........ ........++..|+|||++.+..++.++|||||||++|+|++ |..|
T Consensus 159 ~~~~~~~~-------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p 213 (269)
T cd05044 159 RDIYKSDY-------------------------YRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQP 213 (269)
T ss_pred cccccccc-------------------------cccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCC
Confidence 54321100 001122345678999999998889999999999999999998 9999
Q ss_pred CCCCChHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHccccCcCccCCChh
Q 001847 901 FRGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHE 950 (1005)
Q Consensus 901 f~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~ 950 (1005)
|...+..+....+.... ........+..+.+||.+||..+|.+||++.+
T Consensus 214 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ 262 (269)
T cd05044 214 YPALNNQEVLQHVTAGG-RLQKPENCPDKIYQLMTNCWAQDPSERPTFDR 262 (269)
T ss_pred CcccCHHHHHHHHhcCC-ccCCcccchHHHHHHHHHHcCCCcccCCCHHH
Confidence 98877766555544332 22333446788999999999999999999433
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-32 Score=299.35 Aligned_cols=250 Identities=24% Similarity=0.352 Sum_probs=205.8
Q ss_pred CccccccccccCcEEEEEEEEcC-CCeEEEEEEeecccc-------cChHHHHHHHHHHHHHHh-CCCCCcceEEEEEEe
Q 001847 673 HFRPIKPLGSGDTGSVHLVELCG-SGQYFAMKAMDKGVM-------LNRNKVHRACAEREILDM-LDHPFVPALYASFQT 743 (1005)
Q Consensus 673 ~y~~~~~LG~G~~g~Vy~a~~~~-~~~~valK~~~~~~~-------~~~~~~~~~~~E~~il~~-l~hpnIv~l~~~~~~ 743 (1005)
.|++.+.||+|+||.||++.+.. +++.+|+|.+..... ........+.+|+.++.+ ++||||+++++++..
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 48899999999999999999977 678999998864321 123344567788888865 699999999999999
Q ss_pred CCeEEEEEeccCCCchhhHHhh--CCCCCCCHHHHHHHHHHHHHHHHHHHH-cCcccCCCCCCcEEEecCCcEEEEeccC
Q 001847 744 KTHVCLITDYCPGGELFLLLDR--QPTKVLKEDAVRFYAAEVVVALEYLHC-QGIIYRDLKPENVLLQGNGHVSLTDFDL 820 (1005)
Q Consensus 744 ~~~~~lV~E~~~ggsL~~~l~~--~~~~~l~~~~i~~i~~qil~aL~~LH~-~gIvHrDLkP~NILi~~~g~vkL~DFG~ 820 (1005)
.+..|+||||+.+++|.+++.. .....+++..++.++.|++.+|.|||+ .|++|+||+|+||++++++.++|+|||.
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~~~~l~dfg~ 160 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGL 160 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCCcEEEecccc
Confidence 9999999999999999988753 223468999999999999999999996 6899999999999999999999999999
Q ss_pred CcccCCCCCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHcCCCC
Q 001847 821 SCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTP 900 (1005)
Q Consensus 821 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlGvll~eLltG~~P 900 (1005)
+....... ......|+..|++||.+.+..++.++|+||||+++|+|++|+.|
T Consensus 161 ~~~~~~~~----------------------------~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p 212 (269)
T cd08528 161 AKQKQPES----------------------------KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPP 212 (269)
T ss_pred eeeccccc----------------------------ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCc
Confidence 85432110 11234688899999999888889999999999999999999999
Q ss_pred CCCCChHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHccccCcCccCCChh
Q 001847 901 FRGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHE 950 (1005)
Q Consensus 901 f~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~ 950 (1005)
|...........+.............+..+.+||.+||+.||++||++.+
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e 262 (269)
T cd08528 213 FYSTNMLSLATKIVEAVYEPLPEGMYSEDVTDVITSCLTPDAEARPDIIQ 262 (269)
T ss_pred ccccCHHHHHHHHhhccCCcCCcccCCHHHHHHHHHHCCCCCccCCCHHH
Confidence 98877766666665554433233356789999999999999999999444
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-33 Score=335.11 Aligned_cols=257 Identities=21% Similarity=0.336 Sum_probs=216.2
Q ss_pred ccCCccccccccccCcEEEEEEEEcCCC-----eEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeC
Q 001847 670 NLQHFRPIKPLGSGDTGSVHLVELCGSG-----QYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTK 744 (1005)
Q Consensus 670 ~~~~y~~~~~LG~G~~g~Vy~a~~~~~~-----~~valK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~ 744 (1005)
......+.+.||+|+||.||.+....-. ..||+|.+.+. .+.....+|.+|..+|+.++|||||++++++...
T Consensus 690 ~~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~--~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~ 767 (1025)
T KOG1095|consen 690 PRKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRL--SSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDS 767 (1025)
T ss_pred ChhheEeeeeeccccccceEEEEEecCCCCccceEEEEEecccc--CCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCC
Confidence 3456778899999999999999985443 34899988764 4677888999999999999999999999999999
Q ss_pred CeEEEEEeccCCCchhhHHhhC-----CCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEecc
Q 001847 745 THVCLITDYCPGGELFLLLDRQ-----PTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFD 819 (1005)
Q Consensus 745 ~~~~lV~E~~~ggsL~~~l~~~-----~~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~~~g~vkL~DFG 819 (1005)
...+|++|||+||+|..+++.. ....++...+..++.||++|+.||+++++|||||-..|+|++....|||+|||
T Consensus 768 ~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~~r~VKIaDFG 847 (1025)
T KOG1095|consen 768 GPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLDERRVVKIADFG 847 (1025)
T ss_pred CCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeecccCcEEEcccc
Confidence 9999999999999999999864 12458999999999999999999999999999999999999999999999999
Q ss_pred CCcccCCCCCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHc-CC
Q 001847 820 LSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY-GY 898 (1005)
Q Consensus 820 ~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlGvll~eLlt-G~ 898 (1005)
+|+.+....- .+ ....-.-...|||||.+....++.++|||||||+|||+++ |.
T Consensus 848 lArDiy~~~y----------yr---------------~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~ 902 (1025)
T KOG1095|consen 848 LARDIYDKDY----------YR---------------KHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGA 902 (1025)
T ss_pred hhHhhhhchh----------ee---------------ccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCC
Confidence 9974321110 00 0011123458999999999999999999999999999997 99
Q ss_pred CCCCCCChHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHccccCcCccCCChhcHHH
Q 001847 899 TPFRGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANE 954 (1005)
Q Consensus 899 ~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~e 954 (1005)
.||.+.++.+.+...+.+. .++....++..+.+++..||+.+|++||+|...+++
T Consensus 903 ~PY~~~~n~~v~~~~~~gg-RL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q 957 (1025)
T KOG1095|consen 903 TPYPSRSNFEVLLDVLEGG-RLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQ 957 (1025)
T ss_pred CCCCCcchHHHHHHHHhCC-ccCCCCCCChHHHHHHHHHccCChhhCccHHHHHhh
Confidence 9999999998888676655 555566688889999999999999999997655553
|
|
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-32 Score=297.65 Aligned_cols=245 Identities=21% Similarity=0.315 Sum_probs=189.8
Q ss_pred ccccccCcEEEEEEEEcC--CCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEEeccC
Q 001847 678 KPLGSGDTGSVHLVELCG--SGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCP 755 (1005)
Q Consensus 678 ~~LG~G~~g~Vy~a~~~~--~~~~valK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~ 755 (1005)
+.||+|+||.||++.... ....+++|.+.... .......+.+|+.+++.++|+||+++++++.....+|+||||+.
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~ 78 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASA--TPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCP 78 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccC--ChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCC
Confidence 368999999999997533 34578888776432 23344567889999999999999999999999999999999999
Q ss_pred CCchhhHHhhCCC---CCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCCCCCC
Q 001847 756 GGELFLLLDRQPT---KVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLL 832 (1005)
Q Consensus 756 ggsL~~~l~~~~~---~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~~~ 832 (1005)
+++|.+++..... ...+...+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++........
T Consensus 79 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~--- 155 (269)
T cd05042 79 LGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDY--- 155 (269)
T ss_pred CCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCCCcEEEeccccccccccchh---
Confidence 9999999876422 2346788899999999999999999999999999999999999999999998743211100
Q ss_pred CcchhhhhcccCCCCCcccccccccccccccCCcccccccccC-------CCCCChhhHHHHHHHHHHHHc-CCCCCCCC
Q 001847 833 PTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAG-------AGHTSAVDWWALGILLYEMLY-GYTPFRGK 904 (1005)
Q Consensus 833 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-------~~~~~~sDIwSlGvll~eLlt-G~~Pf~~~ 904 (1005)
........+++.|+|||++.. ..++.++|||||||++|+|++ |..||...
T Consensus 156 ----------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~ 213 (269)
T cd05042 156 ----------------------YITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDL 213 (269)
T ss_pred ----------------------eeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcC
Confidence 001123346778999998743 345779999999999999998 88899887
Q ss_pred ChHHHHHHHHhC-CCCCCC---CCCCCHHHHHHHHHccccCcCccCCChh
Q 001847 905 TRQKTFANILHK-DLKFPS---STPTSLHAKQLMYRLLHRDPKSRLGSHE 950 (1005)
Q Consensus 905 ~~~~~~~~i~~~-~~~~~~---~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~ 950 (1005)
...+........ ...++. ....+..+.+++..|+ .||++||++.+
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~ 262 (269)
T cd05042 214 SDEQVLKQVVREQDIKLPKPQLDLKYSDRWYEVMQFCW-LDPETRPTAEE 262 (269)
T ss_pred CHHHHHHHHhhccCccCCCCcccccCCHHHHHHHHHHh-cCcccccCHHH
Confidence 776666555443 222222 2346778888999998 59999999333
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-32 Score=295.26 Aligned_cols=249 Identities=19% Similarity=0.268 Sum_probs=195.0
Q ss_pred ccccccCcEEEEEEEEcC---CCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceEEEEEE-eCCeEEEEEec
Q 001847 678 KPLGSGDTGSVHLVELCG---SGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQ-TKTHVCLITDY 753 (1005)
Q Consensus 678 ~~LG~G~~g~Vy~a~~~~---~~~~valK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~-~~~~~~lV~E~ 753 (1005)
+.||+|+||.||+|.+.. .+..+|+|.+... ........+.+|+.+++.++||||+++++++. .++..++||||
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~--~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~ 78 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRI--TDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPY 78 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCcc--CCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEec
Confidence 468999999999998743 3467999987542 23445667888999999999999999999765 45678999999
Q ss_pred cCCCchhhHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCCCCCCC
Q 001847 754 CPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLP 833 (1005)
Q Consensus 754 ~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~~~~ 833 (1005)
+.+++|.+++.... ..++...+..++.||+.||.|||+.|++|+||||+|||+++++.+||+|||++.........
T Consensus 79 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~--- 154 (262)
T cd05058 79 MKHGDLRNFIRSET-HNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYY--- 154 (262)
T ss_pred CCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCccccccccCCcce---
Confidence 99999999987543 34677888899999999999999999999999999999999999999999998543211100
Q ss_pred cchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHH
Q 001847 834 TTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY-GYTPFRGKTRQKTFAN 912 (1005)
Q Consensus 834 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlGvll~eLlt-G~~Pf~~~~~~~~~~~ 912 (1005)
.........+++.|+|||.+....++.++|||||||++|+|++ |.+||...+.......
T Consensus 155 --------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~ 214 (262)
T cd05058 155 --------------------SVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVY 214 (262)
T ss_pred --------------------eecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Confidence 0011122346778999999988888999999999999999999 5667777666665555
Q ss_pred HHhCCCCCCCCCCCCHHHHHHHHHccccCcCccCCChhcHHHHHc
Q 001847 913 ILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKK 957 (1005)
Q Consensus 913 i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~ 957 (1005)
+..+. ..+.....+..+.+++.+||..+|++||+ +.++++
T Consensus 215 ~~~~~-~~~~~~~~~~~~~~li~~cl~~~p~~Rp~----~~~il~ 254 (262)
T cd05058 215 LLQGR-RLLQPEYCPDPLYEVMLSCWHPKPEMRPT----FSELVS 254 (262)
T ss_pred HhcCC-CCCCCCcCCHHHHHHHHHHcCCChhhCCC----HHHHHH
Confidence 54442 22223345778999999999999999999 555543
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-32 Score=300.91 Aligned_cols=257 Identities=23% Similarity=0.335 Sum_probs=204.8
Q ss_pred cCCccccccccccCcEEEEEEEEc----CCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceEEEEEEe--C
Q 001847 671 LQHFRPIKPLGSGDTGSVHLVELC----GSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQT--K 744 (1005)
Q Consensus 671 ~~~y~~~~~LG~G~~g~Vy~a~~~----~~~~~valK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~--~ 744 (1005)
...|++.+.||+|+||.||++.+. .++..+|+|.+...... .....+.+|+.+++.+.|+||+++++++.. .
T Consensus 3 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~--~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~ 80 (284)
T cd05038 3 KRHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEE--QHRSDFEREIEILRTLDHENIVKYKGVCEKPGG 80 (284)
T ss_pred hhhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccch--HHHHHHHHHHHHHHhCCCCChheEEeeeecCCC
Confidence 357899999999999999999864 34789999998765321 356788899999999999999999999877 5
Q ss_pred CeEEEEEeccCCCchhhHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCccc
Q 001847 745 THVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLT 824 (1005)
Q Consensus 745 ~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~~~g~vkL~DFG~a~~~ 824 (1005)
...|+||||+++++|.+++.... ..++...+..++.||+.||+|||++|++|+||||+||+++.++.++|+|||.+...
T Consensus 81 ~~~~lv~e~~~~~~l~~~l~~~~-~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 159 (284)
T cd05038 81 RSLRLIMEYLPSGSLRDYLQRHR-DQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVL 159 (284)
T ss_pred CceEEEEecCCCCCHHHHHHhCc-cccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEccccccccc
Confidence 68999999999999999997653 25899999999999999999999999999999999999999999999999998654
Q ss_pred CCCCCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHcCCCCCCCC
Q 001847 825 SCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGK 904 (1005)
Q Consensus 825 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlGvll~eLltG~~Pf~~~ 904 (1005)
...... ........++..|++||.+....++.++|||||||++|+|++|..||...
T Consensus 160 ~~~~~~------------------------~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~ 215 (284)
T cd05038 160 PEDKDY------------------------YYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSP 215 (284)
T ss_pred ccCCcc------------------------eeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccc
Confidence 311110 00011123456799999998888899999999999999999999998653
Q ss_pred Ch--------------HHHHHHHHhCCCCCCCCCCCCHHHHHHHHHccccCcCccCCChhcHHH
Q 001847 905 TR--------------QKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANE 954 (1005)
Q Consensus 905 ~~--------------~~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~e 954 (1005)
.. .......+......+....++..+.+|+.+||..+|.+||++.+++++
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~ 279 (284)
T cd05038 216 PAEFLRMIGIAQGQMIVTRLLELLKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILI 279 (284)
T ss_pred cchhccccccccccccHHHHHHHHHcCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHH
Confidence 22 122233344444455455567889999999999999999994444333
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-32 Score=296.78 Aligned_cols=247 Identities=22% Similarity=0.318 Sum_probs=191.1
Q ss_pred ccccccCcEEEEEEEEc--CCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEEeccC
Q 001847 678 KPLGSGDTGSVHLVELC--GSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCP 755 (1005)
Q Consensus 678 ~~LG~G~~g~Vy~a~~~--~~~~~valK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~ 755 (1005)
+.||+|+||.||++... .++..+++|.++... .......+.+|+.+++.++||||+++++++.....+|+||||++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 78 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSA--SVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCP 78 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCC--ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCC
Confidence 36899999999999864 345789999887542 22334567889999999999999999999999899999999999
Q ss_pred CCchhhHHhhCC---CCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCCCCCC
Q 001847 756 GGELFLLLDRQP---TKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLL 832 (1005)
Q Consensus 756 ggsL~~~l~~~~---~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~~~ 832 (1005)
+++|.+++.... ....+...+..++.|++.||.|||++|++|+||||+||+++.++.++|+|||++........
T Consensus 79 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~--- 155 (269)
T cd05087 79 LGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDY--- 155 (269)
T ss_pred CCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEECCccccccccCcce---
Confidence 999999987532 12456778889999999999999999999999999999999999999999998853221100
Q ss_pred CcchhhhhcccCCCCCcccccccccccccccCCcccccccccCC-------CCCChhhHHHHHHHHHHHHc-CCCCCCCC
Q 001847 833 PTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGA-------GHTSAVDWWALGILLYEMLY-GYTPFRGK 904 (1005)
Q Consensus 833 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-------~~~~~sDIwSlGvll~eLlt-G~~Pf~~~ 904 (1005)
........+++.|+|||++... .++.++|||||||++|+|++ |..||...
T Consensus 156 ----------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~ 213 (269)
T cd05087 156 ----------------------YVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHL 213 (269)
T ss_pred ----------------------eecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCC
Confidence 0111234578889999998542 34679999999999999996 99999876
Q ss_pred ChHHHHHHHHh-CCCCCCCC---CCCCHHHHHHHHHccccCcCccCCChhcHHHHH
Q 001847 905 TRQKTFANILH-KDLKFPSS---TPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIK 956 (1005)
Q Consensus 905 ~~~~~~~~i~~-~~~~~~~~---~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL 956 (1005)
...+....... .....+.. ...+..+.+++.+|+ .+|++||+ +.+|+
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~-~~P~~Rpt----~~~l~ 264 (269)
T cd05087 214 SDEQVLTYTVREQQLKLPKPRLKLPLSDRWYEVMQFCW-LQPEQRPS----AEEVH 264 (269)
T ss_pred ChHHHHHHHhhcccCCCCCCccCCCCChHHHHHHHHHh-cCcccCCC----HHHHH
Confidence 66554433332 22222221 235678899999998 68999999 55554
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-33 Score=278.10 Aligned_cols=253 Identities=25% Similarity=0.408 Sum_probs=208.9
Q ss_pred ccCCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCC-CCCcceEEEEEEeC--Ce
Q 001847 670 NLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLD-HPFVPALYASFQTK--TH 746 (1005)
Q Consensus 670 ~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~il~~l~-hpnIv~l~~~~~~~--~~ 746 (1005)
..++|++++.+|+|.+|.||.+.+..++..++||++++ -..+.+.+|++||..|. ||||+++++...+. ..
T Consensus 36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKP------VkkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~Skt 109 (338)
T KOG0668|consen 36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKP------VKKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKT 109 (338)
T ss_pred ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeech------HHHHHHHHHHHHHHhccCCCCeeehhhhhcCccccC
Confidence 35789999999999999999999999999999998874 35678899999999995 99999999998764 46
Q ss_pred EEEEEeccCCCchhhHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecC-CcEEEEeccCCcccC
Q 001847 747 VCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGN-GHVSLTDFDLSCLTS 825 (1005)
Q Consensus 747 ~~lV~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~~~-g~vkL~DFG~a~~~~ 825 (1005)
..+|+||+++.+...+... ++...++.++.+|+.||.|+|++||+|||+||.|++|+.. -.++|+|+|+|....
T Consensus 110 paLiFE~v~n~Dfk~ly~t-----l~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYH 184 (338)
T KOG0668|consen 110 PSLIFEYVNNTDFKQLYPT-----LTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH 184 (338)
T ss_pred chhHhhhhccccHHHHhhh-----hchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeechhhceeeeeecchHhhcC
Confidence 7899999999998888755 8889999999999999999999999999999999999954 579999999996543
Q ss_pred CCCCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccC-CCCCChhhHHHHHHHHHHHHcCCCCCC-C
Q 001847 826 CKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAG-AGHTSAVDWWALGILLYEMLYGYTPFR-G 903 (1005)
Q Consensus 826 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~sDIwSlGvll~eLltG~~Pf~-~ 903 (1005)
+. ..-+..+.+..|-.||.+.. ..+++.-|+|||||++..|++.+.||. |
T Consensus 185 p~----------------------------~eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG 236 (338)
T KOG0668|consen 185 PG----------------------------KEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHG 236 (338)
T ss_pred CC----------------------------ceeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCC
Confidence 21 12234567888999999866 457889999999999999999888874 5
Q ss_pred CChHHHHHHHHhC-------------CC----------------CCC-----CC-CCCCHHHHHHHHHccccCcCccCCC
Q 001847 904 KTRQKTFANILHK-------------DL----------------KFP-----SS-TPTSLHAKQLMYRLLHRDPKSRLGS 948 (1005)
Q Consensus 904 ~~~~~~~~~i~~~-------------~~----------------~~~-----~~-~~~s~~l~~Ll~~~L~~dP~~Rpt~ 948 (1005)
.++.+++.+|.+- .+ +|. .. .-.++++.+||.++|..|.++|+|
T Consensus 237 ~dN~DQLVkIakVLGt~el~~Yl~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlT- 315 (338)
T KOG0668|consen 237 HDNYDQLVKIAKVLGTDELYAYLNKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLT- 315 (338)
T ss_pred CCCHHHHHHHHHHhChHHHHHHHHHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccc-
Confidence 5555555555320 01 111 11 124678999999999999999999
Q ss_pred hhcHHHHHcCCCCCCCC
Q 001847 949 HEGANEIKKHPFFKGVN 965 (1005)
Q Consensus 949 ~~~a~elL~hpff~~~~ 965 (1005)
|+|++.||||..+-
T Consensus 316 ---akEam~HpyF~~~~ 329 (338)
T KOG0668|consen 316 ---AKEAMAHPYFAPVR 329 (338)
T ss_pred ---hHHHhcCchHHHHH
Confidence 99999999999753
|
|
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-32 Score=296.78 Aligned_cols=253 Identities=23% Similarity=0.342 Sum_probs=201.1
Q ss_pred ccccccccccCcEEEEEEEEc---CCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC-----
Q 001847 674 FRPIKPLGSGDTGSVHLVELC---GSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKT----- 745 (1005)
Q Consensus 674 y~~~~~LG~G~~g~Vy~a~~~---~~~~~valK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~----- 745 (1005)
|++.+.||+|+||.||+|.+. .+++.+|||.+.... ........+.+|+.+++.++||||+++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 79 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADI-FSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRL 79 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEecccc-CChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCcc
Confidence 678899999999999999864 357899999987643 23445677889999999999999999999886432
Q ss_pred -eEEEEEeccCCCchhhHHhhC----CCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccC
Q 001847 746 -HVCLITDYCPGGELFLLLDRQ----PTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDL 820 (1005)
Q Consensus 746 -~~~lV~E~~~ggsL~~~l~~~----~~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~~~g~vkL~DFG~ 820 (1005)
..+++++|+.+++|.+++... ....++...++.++.||+.||+|||++||+|+||||+||+++.++.+||+|||+
T Consensus 80 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~~~~~kl~dfg~ 159 (273)
T cd05074 80 PIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGL 159 (273)
T ss_pred cceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcCCCCEEECcccc
Confidence 347899999999998887432 112478899999999999999999999999999999999999999999999998
Q ss_pred CcccCCCCCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHc-CCC
Q 001847 821 SCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY-GYT 899 (1005)
Q Consensus 821 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlGvll~eLlt-G~~ 899 (1005)
+........ ........+++.|++||.+....++.++|||||||++|+|++ |+.
T Consensus 160 ~~~~~~~~~-------------------------~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~ 214 (273)
T cd05074 160 SKKIYSGDY-------------------------YRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQT 214 (273)
T ss_pred cccccCCcc-------------------------eecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCC
Confidence 864321110 001112345678999999988888999999999999999998 899
Q ss_pred CCCCCChHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHccccCcCccCCChhcHHHHHc
Q 001847 900 PFRGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKK 957 (1005)
Q Consensus 900 Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~ 957 (1005)
||.+.........+.... ........+..+.+++.+||..+|++||+ +.++++
T Consensus 215 p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~~~l~~~p~~Rps----~~~~~~ 267 (273)
T cd05074 215 PYAGVENSEIYNYLIKGN-RLKQPPDCLEDVYELMCQCWSPEPKCRPS----FQHLRD 267 (273)
T ss_pred CCCCCCHHHHHHHHHcCC-cCCCCCCCCHHHHHHHHHHcCCChhhCcC----HHHHHH
Confidence 998877766665555442 22223346788999999999999999999 555543
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-32 Score=297.52 Aligned_cols=238 Identities=19% Similarity=0.296 Sum_probs=188.3
Q ss_pred cccccCcEEEEEEEEcCC------------------------CeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCc
Q 001847 679 PLGSGDTGSVHLVELCGS------------------------GQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFV 734 (1005)
Q Consensus 679 ~LG~G~~g~Vy~a~~~~~------------------------~~~valK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnI 734 (1005)
.||+|+||.||++....+ ...+++|.+... .......+.+|+.+++.++||||
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~---~~~~~~~~~~~~~~~~~l~h~ni 78 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPS---HRDIALAFFETASLMSQVSHIHL 78 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChH---HHHHHHHHHHHHHHHhcCCCCCe
Confidence 689999999999975322 235888887643 22344567888999999999999
Q ss_pred ceEEEEEEeCCeEEEEEeccCCCchhhHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCC---
Q 001847 735 PALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNG--- 811 (1005)
Q Consensus 735 v~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~~~g--- 811 (1005)
+++++++......|+||||+++++|..++... ...+++..+..++.||+.||.|||++||+||||||+|||++..+
T Consensus 79 v~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~~~~ 157 (274)
T cd05076 79 AFVHGVCVRGSENIMVEEFVEHGPLDVCLRKE-KGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLAE 157 (274)
T ss_pred eeEEEEEEeCCceEEEEecCCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccCccc
Confidence 99999999999999999999999999888653 34588999999999999999999999999999999999998644
Q ss_pred ----cEEEEeccCCcccCCCCCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccC-CCCCChhhHHH
Q 001847 812 ----HVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAG-AGHTSAVDWWA 886 (1005)
Q Consensus 812 ----~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~sDIwS 886 (1005)
.++|+|||.+..... .....++..|+|||.+.+ ..++.++||||
T Consensus 158 ~~~~~~kl~d~g~~~~~~~-------------------------------~~~~~~~~~~~aPe~~~~~~~~~~~~Dv~s 206 (274)
T cd05076 158 GTSPFIKLSDPGVSFTALS-------------------------------REERVERIPWIAPECVPGGNSLSTAADKWS 206 (274)
T ss_pred CccceeeecCCcccccccc-------------------------------ccccccCCcccCchhhcCCCCCCcHHHHHH
Confidence 489999998743210 011246778999998865 55788999999
Q ss_pred HHHHHHHHH-cCCCCCCCCChHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHccccCcCccCCChhcHHHHHcC
Q 001847 887 LGILLYEML-YGYTPFRGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKH 958 (1005)
Q Consensus 887 lGvll~eLl-tG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~h 958 (1005)
|||++|+|+ +|..||.+....+.. .........+. ..+..+.+||.+||+.+|++||+ +.++|++
T Consensus 207 lG~~l~el~~~g~~p~~~~~~~~~~-~~~~~~~~~~~--~~~~~~~~li~~cl~~~p~~Rps----~~~il~~ 272 (274)
T cd05076 207 FGTTLLEICFDGEVPLKERTPSEKE-RFYEKKHRLPE--PSCKELATLISQCLTYEPTQRPS----FRTILRD 272 (274)
T ss_pred HHHHHHHHHhCCCCCccccChHHHH-HHHHhccCCCC--CCChHHHHHHHHHcccChhhCcC----HHHHHHh
Confidence 999999985 799999876654432 23333222332 24567899999999999999999 7777654
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-32 Score=294.71 Aligned_cols=239 Identities=21% Similarity=0.304 Sum_probs=189.0
Q ss_pred ccccccCcEEEEEEEEcC------------CCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC
Q 001847 678 KPLGSGDTGSVHLVELCG------------SGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKT 745 (1005)
Q Consensus 678 ~~LG~G~~g~Vy~a~~~~------------~~~~valK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~ 745 (1005)
+.||.|+||.||++.... ....+++|.+... .......+..|+.+++.++||||+++++++....
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~---~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~ 77 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPS---HRDISLAFFETASMMRQVSHKHIVLLYGVCVRDV 77 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChh---hhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCC
Confidence 368999999999998532 2335888887643 2334456778899999999999999999999988
Q ss_pred eEEEEEeccCCCchhhHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCc-------EEEEec
Q 001847 746 HVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGH-------VSLTDF 818 (1005)
Q Consensus 746 ~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~~~g~-------vkL~DF 818 (1005)
..++||||+++++|..++... ...+++..+..++.||+.||.|||++||+||||||+|||++.++. ++++||
T Consensus 78 ~~~lv~e~~~~~~l~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~ 156 (262)
T cd05077 78 ENIMVEEFVEFGPLDLFMHRK-SDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDP 156 (262)
T ss_pred CCEEEEecccCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeEeCCC
Confidence 999999999999998887654 345899999999999999999999999999999999999987664 899999
Q ss_pred cCCcccCCCCCCCCCcchhhhhcccCCCCCcccccccccccccccCCccccccccc-CCCCCChhhHHHHHHHHHHHH-c
Q 001847 819 DLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIA-GAGHTSAVDWWALGILLYEML-Y 896 (1005)
Q Consensus 819 G~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~-~~~~~~~sDIwSlGvll~eLl-t 896 (1005)
|++..... .....++..|+|||.+. ...++.++|||||||++|+|+ .
T Consensus 157 g~~~~~~~-------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~ 205 (262)
T cd05077 157 GIPITVLS-------------------------------RQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYN 205 (262)
T ss_pred CCCccccC-------------------------------cccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhC
Confidence 98743210 11235788899999986 456788999999999999998 5
Q ss_pred CCCCCCCCChHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHccccCcCccCCChhcHHHHHcC
Q 001847 897 GYTPFRGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKH 958 (1005)
Q Consensus 897 G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~h 958 (1005)
|..||......+. ......... ...+.+.++.+||.+||+.||.+||+ +.+|+++
T Consensus 206 ~~~p~~~~~~~~~-~~~~~~~~~--~~~~~~~~~~~li~~cl~~dp~~Rp~----~~~il~~ 260 (262)
T cd05077 206 GEIPLKDKTLAEK-ERFYEGQCM--LVTPSCKELADLMTHCMNYDPNQRPF----FRAIMRD 260 (262)
T ss_pred CCCCCCCcchhHH-HHHHhcCcc--CCCCChHHHHHHHHHHcCCChhhCcC----HHHHHHh
Confidence 8888876554333 223233222 22234578899999999999999999 6777654
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-32 Score=298.57 Aligned_cols=143 Identities=29% Similarity=0.431 Sum_probs=126.6
Q ss_pred hcccccccccCCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCC-----C---CC
Q 001847 662 ILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLD-----H---PF 733 (1005)
Q Consensus 662 ~~~~~~~i~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~il~~l~-----h---pn 733 (1005)
.+..|+.++..+|.+.++||+|-|++||+|+|..+.++||+|+++.. ....+....||++|+++. | .+
T Consensus 68 pV~IGD~F~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA----qhYtEaAlDEIklL~~v~~~Dp~~~~~~~ 143 (590)
T KOG1290|consen 68 PVRIGDVFNGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA----QHYTEAALDEIKLLQQVREGDPNDPGKKC 143 (590)
T ss_pred eeeccccccCceEEEEEeccccccceeEEEeeccCCeEEEEEEEehh----hHHHHHHHHHHHHHHHHHhcCCCCCCCce
Confidence 35567788889999999999999999999999999999999999864 455667788999999983 2 37
Q ss_pred cceEEEEEEe----CCeEEEEEeccCCCchhhHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHc-CcccCCCCCCcEEEe
Q 001847 734 VPALYASFQT----KTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQ-GIIYRDLKPENVLLQ 808 (1005)
Q Consensus 734 Iv~l~~~~~~----~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~-gIvHrDLkP~NILi~ 808 (1005)
||++++.|.. +.++|+|+|+. |.+|..++.....+.++...++.|++|||.||.|||.. ||||.||||+|||+.
T Consensus 144 VV~LlD~FkhsGpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl~ 222 (590)
T KOG1290|consen 144 VVQLLDHFKHSGPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLLC 222 (590)
T ss_pred eeeeeccceecCCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeeee
Confidence 9999999974 56999999999 99999999987777899999999999999999999965 999999999999995
Q ss_pred c
Q 001847 809 G 809 (1005)
Q Consensus 809 ~ 809 (1005)
.
T Consensus 223 ~ 223 (590)
T KOG1290|consen 223 S 223 (590)
T ss_pred c
Confidence 3
|
|
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-32 Score=293.33 Aligned_cols=236 Identities=19% Similarity=0.260 Sum_probs=189.2
Q ss_pred ccccccCcEEEEEEEEcCCC----------eEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeE
Q 001847 678 KPLGSGDTGSVHLVELCGSG----------QYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHV 747 (1005)
Q Consensus 678 ~~LG~G~~g~Vy~a~~~~~~----------~~valK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 747 (1005)
+.||+|+||.||++.+..++ ..+++|.+.... .....+.+|+.+++.++||||+++++++.. ...
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~ 75 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDH----RDSLAFFETASLMSQLSHKHLVKLYGVCVR-DEN 75 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccch----hhHHHHHHHHHHHHcCCCcchhheeeEEec-CCc
Confidence 46899999999999997776 357888765432 115678889999999999999999999888 778
Q ss_pred EEEEeccCCCchhhHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCC-------cEEEEeccC
Q 001847 748 CLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNG-------HVSLTDFDL 820 (1005)
Q Consensus 748 ~lV~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~~~g-------~vkL~DFG~ 820 (1005)
++||||+.+++|.+++..... .++...+..++.||+.||.|||++||+|+||||+|||++.++ .+||+|||+
T Consensus 76 ~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~ 154 (259)
T cd05037 76 IMVEEYVKFGPLDVFLHREKN-NVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGI 154 (259)
T ss_pred EEEEEcCCCCcHHHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEEeCCCCc
Confidence 999999999999999976532 589999999999999999999999999999999999999887 799999998
Q ss_pred CcccCCCCCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCC--CCCChhhHHHHHHHHHHHHc-C
Q 001847 821 SCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGA--GHTSAVDWWALGILLYEMLY-G 897 (1005)
Q Consensus 821 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~--~~~~~sDIwSlGvll~eLlt-G 897 (1005)
+..... .....++..|+|||++... .++.++|||||||++|+|++ |
T Consensus 155 a~~~~~-------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~ 203 (259)
T cd05037 155 PITVLS-------------------------------REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNG 203 (259)
T ss_pred cccccc-------------------------------ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCC
Confidence 854321 1123466789999999776 78889999999999999998 6
Q ss_pred CCCCCCCChHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHccccCcCccCCChhcHHHHHc
Q 001847 898 YTPFRGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKK 957 (1005)
Q Consensus 898 ~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~ 957 (1005)
..||...+......... .....+. .....+.+|+.+||..+|.+||+ +.++++
T Consensus 204 ~~p~~~~~~~~~~~~~~-~~~~~~~--~~~~~~~~li~~~l~~~p~~Rpt----~~~il~ 256 (259)
T cd05037 204 EEPLSTLSSSEKERFYQ-DQHRLPM--PDCAELANLINQCWTYDPTKRPS----FRAILR 256 (259)
T ss_pred CCCcccCCchhHHHHHh-cCCCCCC--CCchHHHHHHHHHhccChhhCCC----HHHHHH
Confidence 88887665433322222 2111111 22368899999999999999999 666654
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-34 Score=287.39 Aligned_cols=264 Identities=25% Similarity=0.376 Sum_probs=212.7
Q ss_pred ccCCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceEEEEEEe------
Q 001847 670 NLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQT------ 743 (1005)
Q Consensus 670 ~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~------ 743 (1005)
..+.|..+..||+|.||.||+|+.+.+|+.||+|++.-. ...........+|+++|..|+|+|++.+++.+..
T Consensus 15 ~~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlme-neKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~ 93 (376)
T KOG0669|consen 15 EVSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLME-NEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTN 93 (376)
T ss_pred cchHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHh-ccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcc
Confidence 457899999999999999999999999999999865432 1122233456789999999999999988877642
Q ss_pred --CCeEEEEEeccCCCchhhHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCC
Q 001847 744 --KTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLS 821 (1005)
Q Consensus 744 --~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~~~g~vkL~DFG~a 821 (1005)
...+|+||.+| ..+|..++... ...++...++.++++++.||.|+|.+.|+|||+||.|+||+.+|.+||.|||++
T Consensus 94 r~r~t~ylVf~~c-ehDLaGlLsn~-~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~dgilklADFGla 171 (376)
T KOG0669|consen 94 RDRATFYLVFDFC-EHDLAGLLSNR-KVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITKDGILKLADFGLA 171 (376)
T ss_pred cccceeeeeHHHh-hhhHHHHhcCc-cccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcCCceEEeeccccc
Confidence 34589999999 66888888643 345999999999999999999999999999999999999999999999999999
Q ss_pred cccCCCCCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCC-CCCChhhHHHHHHHHHHHHcCCCC
Q 001847 822 CLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGA-GHTSAVDWWALGILLYEMLYGYTP 900 (1005)
Q Consensus 822 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~sDIwSlGvll~eLltG~~P 900 (1005)
+..+.......|. ....+.|.+|++||.+.+. .++++.|||+.||++.+|.++.+.
T Consensus 172 r~fs~~~n~~kpr-----------------------ytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspi 228 (376)
T KOG0669|consen 172 RAFSTSKNVVKPR-----------------------YTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPI 228 (376)
T ss_pred cceecccccCCCC-----------------------cccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCcc
Confidence 7655433222111 2345679999999999875 688999999999999999999999
Q ss_pred CCCCChHHHHHHHHh--CCC---CCCC----------------------------CCCCCHHHHHHHHHccccCcCccCC
Q 001847 901 FRGKTRQKTFANILH--KDL---KFPS----------------------------STPTSLHAKQLMYRLLHRDPKSRLG 947 (1005)
Q Consensus 901 f~~~~~~~~~~~i~~--~~~---~~~~----------------------------~~~~s~~l~~Ll~~~L~~dP~~Rpt 947 (1005)
|.+.+....+..|.. +.+ -||. ...-+.++.+|+.+||..||.+|++
T Consensus 229 mqgnteqqql~~Is~LcGs~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ 308 (376)
T KOG0669|consen 229 MQGNTEQQQLHLISQLCGSITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRID 308 (376)
T ss_pred ccCChHHHHHHHHHHHhccCCcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcc
Confidence 999988877776643 211 1111 0112346779999999999999999
Q ss_pred ChhcHHHHHcCCCCCC
Q 001847 948 SHEGANEIKKHPFFKG 963 (1005)
Q Consensus 948 ~~~~a~elL~hpff~~ 963 (1005)
+.++|+|.||..
T Consensus 309 ----ad~alnh~~F~k 320 (376)
T KOG0669|consen 309 ----ADQALNHDFFWK 320 (376)
T ss_pred ----hHhhhchhhhhc
Confidence 999999999986
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=307.29 Aligned_cols=257 Identities=27% Similarity=0.407 Sum_probs=211.5
Q ss_pred cccCCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCC------CCcceEEEEEE
Q 001847 669 INLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDH------PFVPALYASFQ 742 (1005)
Q Consensus 669 i~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~il~~l~h------pnIv~l~~~~~ 742 (1005)
+...+|.+....|.|-||+|..|.+...|..||||++....+ -.+.-+.|++||++|.. -|+++++..|.
T Consensus 429 ~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~----M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~ 504 (752)
T KOG0670|consen 429 LLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEV----MHKTGLKELEILKKLNDADPEDKFHCLRLFRHFK 504 (752)
T ss_pred hhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchH----HhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhh
Confidence 346899999999999999999999999999999999986532 23344679999999953 48999999999
Q ss_pred eCCeEEEEEeccCCCchhhHHhhC-CCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecC-CcEEEEeccC
Q 001847 743 TKTHVCLITDYCPGGELFLLLDRQ-PTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGN-GHVSLTDFDL 820 (1005)
Q Consensus 743 ~~~~~~lV~E~~~ggsL~~~l~~~-~~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~~~-g~vkL~DFG~ 820 (1005)
..+++|||||-+ .-+|.+++++- ..-.|....++.|+.||+.||..|-.+||+|.||||+|||++.+ ..+||||||.
T Consensus 505 hknHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVNE~k~iLKLCDfGS 583 (752)
T KOG0670|consen 505 HKNHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVNESKNILKLCDFGS 583 (752)
T ss_pred hcceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEeccCcceeeeccCcc
Confidence 999999999999 88999999853 22348889999999999999999999999999999999999965 6799999999
Q ss_pred CcccCCCCCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHcCCCC
Q 001847 821 SCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTP 900 (1005)
Q Consensus 821 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlGvll~eLltG~~P 900 (1005)
|...+.. .-..+..+..|.|||++.+.+|++..|+||.||+||||+||+..
T Consensus 584 A~~~~en-----------------------------eitPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIl 634 (752)
T KOG0670|consen 584 ASFASEN-----------------------------EITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKIL 634 (752)
T ss_pred ccccccc-----------------------------cccHHHHHHhccCcceeecCcccCCccceeeceeeEEeecccee
Confidence 8543321 12335667789999999999999999999999999999999999
Q ss_pred CCCCChHHHHHHHHhCCCCCCC---------------------------------------------------CCCC---
Q 001847 901 FRGKTRQKTFANILHKDLKFPS---------------------------------------------------STPT--- 926 (1005)
Q Consensus 901 f~~~~~~~~~~~i~~~~~~~~~---------------------------------------------------~~~~--- 926 (1005)
|+|.++..++.-.+.-..++|. ...+
T Consensus 635 FpG~TNN~MLrl~me~KGk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~de 714 (752)
T KOG0670|consen 635 FPGRTNNQMLRLFMELKGKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDE 714 (752)
T ss_pred cCCCCcHHHHHHHHHhcCCCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCch
Confidence 9998877666544331111110 0001
Q ss_pred ----CHHHHHHHHHccccCcCccCCChhcHHHHHcCCCCCC
Q 001847 927 ----SLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKG 963 (1005)
Q Consensus 927 ----s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~hpff~~ 963 (1005)
-..+.+||.+||..||++|.| +.++|+||||+.
T Consensus 715 q~~~~~~~rdLLdkml~LdP~KRit----~nqAL~HpFi~~ 751 (752)
T KOG0670|consen 715 QPKIVQQLRDLLDKMLILDPEKRIT----VNQALKHPFITE 751 (752)
T ss_pred hHHHHHHHHHHHHHHhccChhhcCC----HHHHhcCCcccC
Confidence 125679999999999999999 999999999974
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-33 Score=289.56 Aligned_cols=253 Identities=26% Similarity=0.478 Sum_probs=212.2
Q ss_pred cCCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeC------
Q 001847 671 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTK------ 744 (1005)
Q Consensus 671 ~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~------ 744 (1005)
..+|.-++.+|.|+- .|..+.|.-+++++|+|.+... .......++.++|..++..+.|+||++++.+|...
T Consensus 16 ~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~p-f~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~ 93 (369)
T KOG0665|consen 16 PKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRP-FQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEF 93 (369)
T ss_pred eeeeeeecccCCCCc-eEEecchhhccCceehhhhcCc-cccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHH
Confidence 358999999999999 7889999999999999988776 33445567888999999999999999999999754
Q ss_pred CeEEEEEeccCCCchhhHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCccc
Q 001847 745 THVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLT 824 (1005)
Q Consensus 745 ~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~~~g~vkL~DFG~a~~~ 824 (1005)
..+|+||||| ..+|...+... ++...+..++.|++.|+.|||+.||+||||||+||++..++.+||.|||+|...
T Consensus 94 ~e~y~v~e~m-~~nl~~vi~~e----lDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~~~~lKi~dfg~ar~e 168 (369)
T KOG0665|consen 94 QEVYLVMELM-DANLCQVILME----LDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNSDCTLKILDFGLARTE 168 (369)
T ss_pred HhHHHHHHhh-hhHHHHHHHHh----cchHHHHHHHHHHHHHHHHHHhcceeecccCcccceecchhheeeccchhhccc
Confidence 3689999999 88898887632 778899999999999999999999999999999999999999999999999653
Q ss_pred CCCCCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHcCCCCCCCC
Q 001847 825 SCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGK 904 (1005)
Q Consensus 825 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlGvll~eLltG~~Pf~~~ 904 (1005)
..+ ...+.++.|..|.|||++.+..+...+||||+||++.+|++|+..|.|.
T Consensus 169 ~~~----------------------------~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~ 220 (369)
T KOG0665|consen 169 DTD----------------------------FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGK 220 (369)
T ss_pred Ccc----------------------------cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCc
Confidence 321 1234568899999999999999999999999999999999999999987
Q ss_pred ChHHHHHHHHhC------------------------------------CCCCCCC----CCCCHHHHHHHHHccccCcCc
Q 001847 905 TRQKTFANILHK------------------------------------DLKFPSS----TPTSLHAKQLMYRLLHRDPKS 944 (1005)
Q Consensus 905 ~~~~~~~~i~~~------------------------------------~~~~~~~----~~~s~~l~~Ll~~~L~~dP~~ 944 (1005)
+....+.++... +..|+.. ......+.+|+.+||..||++
T Consensus 221 d~idQ~~ki~~~lgtpd~~F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~ 300 (369)
T KOG0665|consen 221 DHIDQWNKIIEQLGTPDPSFMKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEK 300 (369)
T ss_pred hHHHHHHHHHHHhcCCCHHHHHHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhh
Confidence 776666555431 0011111 112346789999999999999
Q ss_pred cCCChhcHHHHHcCCCCC
Q 001847 945 RLGSHEGANEIKKHPFFK 962 (1005)
Q Consensus 945 Rpt~~~~a~elL~hpff~ 962 (1005)
|.+ ++++|+||||+
T Consensus 301 Ris----v~daL~HPY~~ 314 (369)
T KOG0665|consen 301 RIS----VDDALRHPYIK 314 (369)
T ss_pred ccc----HHHHhcCCeee
Confidence 999 99999999999
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-32 Score=316.17 Aligned_cols=260 Identities=28% Similarity=0.409 Sum_probs=222.2
Q ss_pred cCCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhC-CCCCcceEEEEEEe-----C
Q 001847 671 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPALYASFQT-----K 744 (1005)
Q Consensus 671 ~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~-----~ 744 (1005)
.+.|++...||.|.+|.||+++++.+++..|+|+...... .-..+..|.+|++.+ .|||++.++++|.. +
T Consensus 18 ~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d----~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~ 93 (953)
T KOG0587|consen 18 ADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTED----EEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNG 93 (953)
T ss_pred CCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCcc----ccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCC
Confidence 4679999999999999999999999999999999876532 224566788888888 79999999999863 5
Q ss_pred CeEEEEEeccCCCchhhHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCccc
Q 001847 745 THVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLT 824 (1005)
Q Consensus 745 ~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~~~g~vkL~DFG~a~~~ 824 (1005)
+.+|||||||.|||.-++++.-.+..+.+..+.-|++.++.||.+||.+.++|||||-.|||++.+|.|||+|||++...
T Consensus 94 DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~e~~VKLvDFGvSaQl 173 (953)
T KOG0587|consen 94 DQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTENAEVKLVDFGVSAQL 173 (953)
T ss_pred CeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEeccCcEEEeeeeeeeee
Confidence 78999999999999999998766778999999999999999999999999999999999999999999999999998543
Q ss_pred CCCCCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCC-----CCCChhhHHHHHHHHHHHHcCCC
Q 001847 825 SCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGA-----GHTSAVDWWALGILLYEMLYGYT 899 (1005)
Q Consensus 825 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-----~~~~~sDIwSlGvll~eLltG~~ 899 (1005)
. ......++.+|||+|||||++... .|+..+|+||||++..||.-|.+
T Consensus 174 d---------------------------sT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~P 226 (953)
T KOG0587|consen 174 D---------------------------STVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAP 226 (953)
T ss_pred e---------------------------cccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCC
Confidence 2 233455678999999999998543 45679999999999999999999
Q ss_pred CCCCCChHHHHHHHHhCCCCCC-CCCCCCHHHHHHHHHccccCcCccCCChhcHHHHHcCCCCCCCC
Q 001847 900 PFRGKTRQKTFANILHKDLKFP-SSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVN 965 (1005)
Q Consensus 900 Pf~~~~~~~~~~~i~~~~~~~~-~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~hpff~~~~ 965 (1005)
|+....+...+..|-+...+.. .+..-+.++.+||..||.+|-++||+ ..++|+|||++.-.
T Consensus 227 Pl~DmHPmraLF~IpRNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~----~~~ll~hpFi~e~~ 289 (953)
T KOG0587|consen 227 PLCDMHPMRALFLIPRNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPS----TEELLKHPFITEQP 289 (953)
T ss_pred CccCcchhhhhccCCCCCCccccchhhHHHHHHHHHHHHHhhccccCcc----hhhhccCCcccccc
Confidence 9988888777666655543322 23344678899999999999999999 99999999999533
|
|
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-31 Score=297.09 Aligned_cols=259 Identities=16% Similarity=0.171 Sum_probs=189.3
Q ss_pred cccCCccccccccccCcEEEEEEEEcCC---CeEEEEEEeecccccChHH--------HHHHHHHHHHHHhCCCCCcceE
Q 001847 669 INLQHFRPIKPLGSGDTGSVHLVELCGS---GQYFAMKAMDKGVMLNRNK--------VHRACAEREILDMLDHPFVPAL 737 (1005)
Q Consensus 669 i~~~~y~~~~~LG~G~~g~Vy~a~~~~~---~~~valK~~~~~~~~~~~~--------~~~~~~E~~il~~l~hpnIv~l 737 (1005)
+...+|++.+.||+|+||.||+|.+..+ +..+++|+........... ......+...+..+.|++|+.+
T Consensus 9 i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~ 88 (294)
T PHA02882 9 ITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKY 88 (294)
T ss_pred cCCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcE
Confidence 4457899999999999999999999777 6677888643221100000 0111223344556789999999
Q ss_pred EEEEEeCC----eEEEEEeccCCCchhhHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcE
Q 001847 738 YASFQTKT----HVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHV 813 (1005)
Q Consensus 738 ~~~~~~~~----~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~~~g~v 813 (1005)
++++.... ..+++++++ ..++.+++... ...++..+..++.||+.||.|||+++|+||||||+|||++.++.+
T Consensus 89 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~~~~~~ 165 (294)
T PHA02882 89 YGCGSFKRCRMYYRFILLEKL-VENTKEIFKRI--KCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNRG 165 (294)
T ss_pred EEeeeEecCCceEEEEEEehh-ccCHHHHHHhh--ccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCcE
Confidence 98765443 457888888 55777776553 236788899999999999999999999999999999999999999
Q ss_pred EEEeccCCcccCCCCCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHH
Q 001847 814 SLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYE 893 (1005)
Q Consensus 814 kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlGvll~e 893 (1005)
+|+|||+|.......... ...........||+.|+|||++.+..++.++|||||||++|+
T Consensus 166 ~l~DFGla~~~~~~~~~~--------------------~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~e 225 (294)
T PHA02882 166 YIIDYGIASHFIIHGKHI--------------------EYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLK 225 (294)
T ss_pred EEEEcCCceeeccCCccc--------------------ccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHH
Confidence 999999986543211100 000111233469999999999999999999999999999999
Q ss_pred HHcCCCCCCCCCh-HHH--------HHHHHhCCCCCCCCCCCCHHHHHHHHHccccCcCccCCChhcHHHHHc
Q 001847 894 MLYGYTPFRGKTR-QKT--------FANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKK 957 (1005)
Q Consensus 894 LltG~~Pf~~~~~-~~~--------~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~ 957 (1005)
|++|..||.+... ... +..+....... ...+..+.+++..|+..+|++||+ +.++++
T Consensus 226 l~~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~rp~----~~~l~~ 291 (294)
T PHA02882 226 WAGIKLPWKGFGHNGNLIHAAKCDFIKRLHEGKIKI---KNANKFIYDFIECVTKLSYEEKPD----YDALIK 291 (294)
T ss_pred HHhCCCCCCccccchHHHHHhHHHHHHHhhhhhhcc---CCCCHHHHHHHHHHHhCCCCCCCC----HHHHHH
Confidence 9999999987632 221 12222222222 234678999999999999999999 666553
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=286.80 Aligned_cols=264 Identities=24% Similarity=0.362 Sum_probs=214.3
Q ss_pred cccCCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHH-HHhCCCCCcceEEEEEEeCCeE
Q 001847 669 INLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREI-LDMLDHPFVPALYASFQTKTHV 747 (1005)
Q Consensus 669 i~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~i-l~~l~hpnIv~l~~~~~~~~~~ 747 (1005)
+..+..+-+..||.|+||+|++..++.+|+..|||.++.... .....++..|.+. ++.-++||||++|+....++.-
T Consensus 61 F~~~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~--~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdc 138 (361)
T KOG1006|consen 61 FTSDNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNI--EKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDC 138 (361)
T ss_pred cccchHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccc--hHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCce
Confidence 344567778899999999999999999999999999987532 3344566667665 4555899999999999888889
Q ss_pred EEEEeccCCCchhhHHhh---CCCCCCCHHHHHHHHHHHHHHHHHHHHc-CcccCCCCCCcEEEecCCcEEEEeccCCcc
Q 001847 748 CLITDYCPGGELFLLLDR---QPTKVLKEDAVRFYAAEVVVALEYLHCQ-GIIYRDLKPENVLLQGNGHVSLTDFDLSCL 823 (1005)
Q Consensus 748 ~lV~E~~~ggsL~~~l~~---~~~~~l~~~~i~~i~~qil~aL~~LH~~-gIvHrDLkP~NILi~~~g~vkL~DFG~a~~ 823 (1005)
||.||+| ..+|..+.+. .....+++.-+-.|..-.+.||.||-.. +||||||||+|||++..|.+||||||.+-.
T Consensus 139 WiCMELM-d~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G~vKLCDFGIcGq 217 (361)
T KOG1006|consen 139 WICMELM-DISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHGDVKLCDFGICGQ 217 (361)
T ss_pred eeeHHHH-hhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCCCEeeecccchHh
Confidence 9999999 7777655442 1234589999999999999999999965 899999999999999999999999998743
Q ss_pred cCCCCCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccC--CCCCChhhHHHHHHHHHHHHcCCCCC
Q 001847 824 TSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAG--AGHTSAVDWWALGILLYEMLYGYTPF 901 (1005)
Q Consensus 824 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~--~~~~~~sDIwSlGvll~eLltG~~Pf 901 (1005)
... +.....-+|-..|||||.+.. ..++.+||+||||++|||++||.+||
T Consensus 218 Lv~----------------------------SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPy 269 (361)
T KOG1006|consen 218 LVD----------------------------SIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPY 269 (361)
T ss_pred HHH----------------------------HHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCc
Confidence 321 112233468899999999854 35788999999999999999999999
Q ss_pred CCC-ChHHHHHHHHhCCCCCCCC----CCCCHHHHHHHHHccccCcCccCCChhcHHHHHcCCCCCCCChh
Q 001847 902 RGK-TRQKTFANILHKDLKFPSS----TPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVNWA 967 (1005)
Q Consensus 902 ~~~-~~~~~~~~i~~~~~~~~~~----~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~hpff~~~~~~ 967 (1005)
.+- +..+++..++.+.++.... ...+..+.+||.-||.+|-..||. ..+|+++||++-...+
T Consensus 270 r~w~svfeql~~Vv~gdpp~l~~~~~~~~~s~~~~~fintCl~Kd~~~Rpk----y~~Lk~~~fyr~y~~~ 336 (361)
T KOG1006|consen 270 RKWDSVFEQLCQVVIGDPPILLFDKECVHYSFSMVRFINTCLIKDRSDRPK----YDDLKKFPFYRMYAVE 336 (361)
T ss_pred chHHHHHHHHHHHHcCCCCeecCcccccccCHHHHHHHHHHhhcccccCcc----hhhhhcCchhhhhhhc
Confidence 874 4467788888887665433 236888999999999999999999 9999999999975433
|
|
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.4e-31 Score=290.78 Aligned_cols=248 Identities=18% Similarity=0.301 Sum_probs=191.6
Q ss_pred ccccccCcEEEEEEEEcCC--CeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEEeccC
Q 001847 678 KPLGSGDTGSVHLVELCGS--GQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCP 755 (1005)
Q Consensus 678 ~~LG~G~~g~Vy~a~~~~~--~~~valK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~ 755 (1005)
+.||+|+||.||++..... ...+++|.+.... .......+.+|+.+++.++||||+++++.+......|+||||+.
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 78 (268)
T cd05086 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANA--SSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCE 78 (268)
T ss_pred CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCC--ChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCC
Confidence 3589999999999976333 3456777765432 23345678889999999999999999999999999999999999
Q ss_pred CCchhhHHhhCC--CCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCCCCCCC
Q 001847 756 GGELFLLLDRQP--TKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLP 833 (1005)
Q Consensus 756 ggsL~~~l~~~~--~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~~~~ 833 (1005)
+++|.+++.... ...++...++.++.||+.||.|||+++++|+||||+|||++.++.++|+|||++........
T Consensus 79 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~---- 154 (268)
T cd05086 79 LGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDY---- 154 (268)
T ss_pred CCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCCccEEecccccccccCcchh----
Confidence 999999987532 23467778889999999999999999999999999999999999999999998743211100
Q ss_pred cchhhhhcccCCCCCcccccccccccccccCCcccccccccC-------CCCCChhhHHHHHHHHHHHHc-CCCCCCCCC
Q 001847 834 TTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAG-------AGHTSAVDWWALGILLYEMLY-GYTPFRGKT 905 (1005)
Q Consensus 834 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-------~~~~~~sDIwSlGvll~eLlt-G~~Pf~~~~ 905 (1005)
........++..|+|||++.. ..++.++|||||||++|+|++ |..||....
T Consensus 155 ---------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~ 213 (268)
T cd05086 155 ---------------------IETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLS 213 (268)
T ss_pred ---------------------hhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCC
Confidence 011123567889999999743 234678999999999999996 677898777
Q ss_pred hHHHHHHHHhCC-CCCC---CCCCCCHHHHHHHHHccccCcCccCCChhcHHHHHc
Q 001847 906 RQKTFANILHKD-LKFP---SSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKK 957 (1005)
Q Consensus 906 ~~~~~~~i~~~~-~~~~---~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~ 957 (1005)
..+.+..+..+. ...+ .....+..+.+++..|| .+|++||+ +.++++
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~-~~P~~Rp~----~~~i~~ 264 (268)
T cd05086 214 DREVLNHVIKDQQVKLFKPQLELPYSERWYEVLQFCW-LSPEKRAT----AEEVHR 264 (268)
T ss_pred HHHHHHHHHhhcccccCCCccCCCCcHHHHHHHHHHh-hCcccCCC----HHHHHH
Confidence 776666655442 2211 12346778899999999 68999999 666543
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.7e-32 Score=305.49 Aligned_cols=258 Identities=21% Similarity=0.292 Sum_probs=219.0
Q ss_pred cCCccccccccccCcEEEEEEEEcCC-C--eEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeE
Q 001847 671 LQHFRPIKPLGSGDTGSVHLVELCGS-G--QYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHV 747 (1005)
Q Consensus 671 ~~~y~~~~~LG~G~~g~Vy~a~~~~~-~--~~valK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 747 (1005)
....++.+.||+|+||+|+++.+... | ..||||+++...... ...+|.+|+.+|.+|+|+|++++|++..+ ..+
T Consensus 109 ee~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~--~mddflrEas~M~~L~H~hliRLyGvVl~-qp~ 185 (1039)
T KOG0199|consen 109 EEQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNA--IMDDFLREASHMLKLQHPHLIRLYGVVLD-QPA 185 (1039)
T ss_pred HHHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccch--hHHHHHHHHHHHHhccCcceeEEeeeecc-chh
Confidence 34667888999999999999998543 3 368999998764432 67899999999999999999999999887 667
Q ss_pred EEEEeccCCCchhhHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCC
Q 001847 748 CLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCK 827 (1005)
Q Consensus 748 ~lV~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~ 827 (1005)
.+|||+++.|+|.+.|.+.....|....+..|+.||+.||.||..+++|||||-..|||+..-..|||+|||+.+..+..
T Consensus 186 mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllasprtVKI~DFGLmRaLg~n 265 (1039)
T KOG0199|consen 186 MMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLASPRTVKICDFGLMRALGEN 265 (1039)
T ss_pred hHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheecccceeeeecccceeccCCC
Confidence 89999999999999999866778999999999999999999999999999999999999999999999999999776543
Q ss_pred CCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCh
Q 001847 828 PQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY-GYTPFRGKTR 906 (1005)
Q Consensus 828 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlGvll~eLlt-G~~Pf~~~~~ 906 (1005)
...+ .......-...|+|||.|....++.++|+|+|||+||||++ |+.||.|...
T Consensus 266 ed~Y------------------------vm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g 321 (1039)
T KOG0199|consen 266 EDMY------------------------VMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRG 321 (1039)
T ss_pred Ccce------------------------EecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCH
Confidence 3221 11122234567999999999999999999999999999996 9999999999
Q ss_pred HHHHHHHHhCCCCCCCCCCCCHHHHHHHHHccccCcCccCCChhcHHHHH
Q 001847 907 QKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIK 956 (1005)
Q Consensus 907 ~~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL 956 (1005)
..++++|- ..-.++....++..+.+++..||..+|++||+|..+.++.+
T Consensus 322 ~qIL~~iD-~~erLpRPk~csedIY~imk~cWah~paDRptFsair~~~~ 370 (1039)
T KOG0199|consen 322 IQILKNID-AGERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDLV 370 (1039)
T ss_pred HHHHHhcc-ccccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHhHH
Confidence 99888887 44456666678999999999999999999999655443433
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-31 Score=297.09 Aligned_cols=263 Identities=22% Similarity=0.305 Sum_probs=222.6
Q ss_pred ccccccCCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC
Q 001847 666 GEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKT 745 (1005)
Q Consensus 666 ~~~i~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~ 745 (1005)
.|.+...+.....+||.|.||.||.+.+++....+|||.++.+. -..+.|+.|+.+|+.++|||+|+++++|..+.
T Consensus 261 kWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDt----MeveEFLkEAAvMKeikHpNLVqLLGVCT~Ep 336 (1157)
T KOG4278|consen 261 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT----MEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEP 336 (1157)
T ss_pred hhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcc----hhHHHHHHHHHHHHhhcCccHHHHhhhhccCC
Confidence 45566677778899999999999999999999999999988653 35688999999999999999999999999999
Q ss_pred eEEEEEeccCCCchhhHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccC
Q 001847 746 HVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTS 825 (1005)
Q Consensus 746 ~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~~~g~vkL~DFG~a~~~~ 825 (1005)
.+|||+|||..|+|.+|++......++.-.+..++.||..|+.||..+++|||||-..|+|+..+..||+.|||+++.+.
T Consensus 337 PFYIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVgEnhiVKvADFGLsRlMt 416 (1157)
T KOG4278|consen 337 PFYIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHIVKVADFGLSRLMT 416 (1157)
T ss_pred CeEEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhccccccceEEeeccchhhhhc
Confidence 99999999999999999997666667777888899999999999999999999999999999999999999999998875
Q ss_pred CCCCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHc-CCCCCCCC
Q 001847 826 CKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY-GYTPFRGK 904 (1005)
Q Consensus 826 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlGvll~eLlt-G~~Pf~~~ 904 (1005)
.+.- ..+...--...|.|||.|....++.++|||+|||+|||+.| |-.||.|.
T Consensus 417 gDTY--------------------------TAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGi 470 (1157)
T KOG4278|consen 417 GDTY--------------------------TAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGI 470 (1157)
T ss_pred CCce--------------------------ecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCc
Confidence 3311 11111223457999999999999999999999999999996 99999998
Q ss_pred ChHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHccccCcCccCCChhcHHHHHcCCC
Q 001847 905 TRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPF 960 (1005)
Q Consensus 905 ~~~~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~hpf 960 (1005)
+....+. ++...+.......+++....|+..||.++|..||+|++ +.+.++.-|
T Consensus 471 dlSqVY~-LLEkgyRM~~PeGCPpkVYeLMraCW~WsPsDRPsFae-iHqafEtmf 524 (1157)
T KOG4278|consen 471 DLSQVYG-LLEKGYRMDGPEGCPPKVYELMRACWNWSPSDRPSFAE-IHQAFETMF 524 (1157)
T ss_pred cHHHHHH-HHhccccccCCCCCCHHHHHHHHHHhcCCcccCccHHH-HHHHHHHHh
Confidence 8777664 45555555566678999999999999999999999876 344444333
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-31 Score=294.48 Aligned_cols=254 Identities=22% Similarity=0.325 Sum_probs=208.4
Q ss_pred cccCCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEE
Q 001847 669 INLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVC 748 (1005)
Q Consensus 669 i~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~ 748 (1005)
+..+...++++||+|.||.|.+|.- ..+..||+|.++... .......+..|+++|.+|+||||+.++++|..++.+|
T Consensus 535 fPRs~L~~~ekiGeGqFGEVhLCev-eg~lkVAVK~Lr~~a--~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePic 611 (807)
T KOG1094|consen 535 FPRSRLRFKEKIGEGQFGEVHLCEV-EGPLKVAVKILRPDA--TKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLC 611 (807)
T ss_pred cchhheehhhhhcCcccceeEEEEe-cCceEEEEeecCccc--chhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchH
Confidence 3446778899999999999999987 346899999998764 3455688999999999999999999999999999999
Q ss_pred EEEeccCCCchhhHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCC
Q 001847 749 LITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKP 828 (1005)
Q Consensus 749 lV~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~ 828 (1005)
+|+|||++|+|.+++..+....+.......|+.||+.||+||.+.++|||||.+.|+|++.++++||+|||+++......
T Consensus 612 mI~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~ 691 (807)
T KOG1094|consen 612 MITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGD 691 (807)
T ss_pred HHHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceeecCcccEEecCcccccccccCC
Confidence 99999999999999987643334556677799999999999999999999999999999999999999999996543111
Q ss_pred CCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHH--cCCCCCCCCCh
Q 001847 829 QLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEML--YGYTPFRGKTR 906 (1005)
Q Consensus 829 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlGvll~eLl--tG~~Pf~~~~~ 906 (1005)
. .+.....+-...|||||.+..++++.++|+|+||+++||++ +..-||...+.
T Consensus 692 y-------------------------y~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~ 746 (807)
T KOG1094|consen 692 Y-------------------------YRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTD 746 (807)
T ss_pred c-------------------------eeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhH
Confidence 0 01122334567899999999999999999999999999987 57889988877
Q ss_pred HHHHHHHHhC-----C-CCCCCCCCCCHHHHHHHHHccccCcCccCCChh
Q 001847 907 QKTFANILHK-----D-LKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHE 950 (1005)
Q Consensus 907 ~~~~~~i~~~-----~-~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~ 950 (1005)
.....+.-.- . .-++.+.-++..+.+++..||..+..+||++.+
T Consensus 747 e~vven~~~~~~~~~~~~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~ 796 (807)
T KOG1094|consen 747 EQVVENAGEFFRDQGRQVVLSRPPACPQGLYELMLRCWRRESEQRPSFEQ 796 (807)
T ss_pred HHHHHhhhhhcCCCCcceeccCCCcCcHHHHHHHHHHhchhhhcCCCHHH
Confidence 7666554321 1 112233457788999999999999999999443
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5e-33 Score=281.99 Aligned_cols=281 Identities=27% Similarity=0.442 Sum_probs=220.0
Q ss_pred CccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC-----eE
Q 001847 673 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKT-----HV 747 (1005)
Q Consensus 673 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~-----~~ 747 (1005)
+.+..+.||.|+||+||.+.|..+|+.|++|.+..- ...-...+++++|+++|...+|.||+..++.....+ .+
T Consensus 54 Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnv-fq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEi 132 (449)
T KOG0664|consen 54 DIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNV-FQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQEL 132 (449)
T ss_pred cCCCCCcccccceeEEEeccCCCCccchhHhhcchH-HHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHH
Confidence 456678899999999999999999999999988643 445567789999999999999999999988876543 46
Q ss_pred EEEEeccCCCchhhHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCC
Q 001847 748 CLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCK 827 (1005)
Q Consensus 748 ~lV~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~ 827 (1005)
|+++|+| ..+|...+-. ...++.+.++-++.||++||+|||+.||.||||||.|+|+++|..+||||||+++.-..+
T Consensus 133 YV~TELm-QSDLHKIIVS--PQ~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d 209 (449)
T KOG0664|consen 133 YVLTELM-QSDLHKIIVS--PQALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNSNCILKICDFGLARTWDQR 209 (449)
T ss_pred HHHHHHH-Hhhhhheecc--CCCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEeccCceEEecccccccccchh
Confidence 8899999 7788777643 356999999999999999999999999999999999999999999999999999654322
Q ss_pred CCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCC-CCCChhhHHHHHHHHHHHHcCCCCCCCCCh
Q 001847 828 PQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGA-GHTSAVDWWALGILLYEMLYGYTPFRGKTR 906 (1005)
Q Consensus 828 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~sDIwSlGvll~eLltG~~Pf~~~~~ 906 (1005)
.. ......+.|-+|+|||++.+. .|+.+.||||.||++.||+..+..|...++
T Consensus 210 ~~--------------------------~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~P 263 (449)
T KOG0664|consen 210 DR--------------------------LNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGP 263 (449)
T ss_pred hh--------------------------hhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccCh
Confidence 11 112234678899999999885 578899999999999999999999988777
Q ss_pred HHHHHHHHh-----------------------CCCCCCCCC---------CCCHHHHHHHHHccccCcCccCCChhcHHH
Q 001847 907 QKTFANILH-----------------------KDLKFPSST---------PTSLHAKQLMYRLLHRDPKSRLGSHEGANE 954 (1005)
Q Consensus 907 ~~~~~~i~~-----------------------~~~~~~~~~---------~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~e 954 (1005)
.+.+..|.. +....|+.. .-..+...++.+||..||++|++ ..+
T Consensus 264 iqQL~lItdLLGTPs~EaMr~ACEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris----~~~ 339 (449)
T KOG0664|consen 264 IEQLQMIIDLLGTPSQEAMKYACEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRIS----VEE 339 (449)
T ss_pred HHHHHHHHHHhCCCcHHHHHHHhhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCccccc----Hhh
Confidence 666554422 222222211 12236678999999999999999 999
Q ss_pred HHcCCCCCCCChhhh-----hhcCCCCCCCCCCCCccc
Q 001847 955 IKKHPFFKGVNWALV-----RCMNPPELDAPLFATDTE 987 (1005)
Q Consensus 955 lL~hpff~~~~~~~~-----~~~~~~~~~~p~~~~~~~ 987 (1005)
++.|+|+...-+.-+ .|+..+-.+...|..+++
T Consensus 340 A~~~~~~~e~R~r~~sCmC~~~~tt~~~~~r~f~~~~~ 377 (449)
T KOG0664|consen 340 ALQHRYLEEGRLRFHSCMCSCCYTKPNMPSRLFAQDLD 377 (449)
T ss_pred hcccccccccceeeeeeeEeeeccCCCcchhhhccccC
Confidence 999999988655533 444444443334444443
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=4e-31 Score=316.95 Aligned_cols=263 Identities=17% Similarity=0.215 Sum_probs=180.8
Q ss_pred ccCCccccccccccCcEEEEEEEEcCC----CeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceEEEE-----
Q 001847 670 NLQHFRPIKPLGSGDTGSVHLVELCGS----GQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYAS----- 740 (1005)
Q Consensus 670 ~~~~y~~~~~LG~G~~g~Vy~a~~~~~----~~~valK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~----- 740 (1005)
..++|.+.+.||+|+||.||+|.+..+ +..||+|.+..... ......+ .++...+.++..+...
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~-----~e~~~~e--~l~~~~~~~~~~~~~~~~~~~ 202 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA-----VEIWMNE--RVRRACPNSCADFVYGFLEPV 202 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch-----hHHHHHH--HHHhhchhhHHHHHHhhhccc
Confidence 457999999999999999999999888 89999998764211 1111111 1122222222222111
Q ss_pred -EEeCCeEEEEEeccCCCchhhHHhhCCCC------------------CCCHHHHHHHHHHHHHHHHHHHHcCcccCCCC
Q 001847 741 -FQTKTHVCLITDYCPGGELFLLLDRQPTK------------------VLKEDAVRFYAAEVVVALEYLHCQGIIYRDLK 801 (1005)
Q Consensus 741 -~~~~~~~~lV~E~~~ggsL~~~l~~~~~~------------------~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLk 801 (1005)
.......++||||+.+++|.+++...... ......+..++.||+.||.|||++||+|||||
T Consensus 203 ~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHRDLK 282 (566)
T PLN03225 203 SSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDVK 282 (566)
T ss_pred ccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeCcCC
Confidence 23556799999999999999998653210 11234567899999999999999999999999
Q ss_pred CCcEEEec-CCcEEEEeccCCcccCCCCCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCC---
Q 001847 802 PENVLLQG-NGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAG--- 877 (1005)
Q Consensus 802 P~NILi~~-~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~--- 877 (1005)
|+|||++. ++.+||+|||+|....... .......++++.|+|||.+....
T Consensus 283 P~NILl~~~~~~~KL~DFGlA~~l~~~~--------------------------~~~~~~~~~t~~Y~APE~~~~~~~~~ 336 (566)
T PLN03225 283 PQNIIFSEGSGSFKIIDLGAAADLRVGI--------------------------NYIPKEFLLDPRYAAPEQYIMSTQTP 336 (566)
T ss_pred HHHEEEeCCCCcEEEEeCCCcccccccc--------------------------ccCCcccccCCCccChHHhhccCCCC
Confidence 99999995 5899999999996432110 01123457899999999764322
Q ss_pred -------------------CCChhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHh-CCCCC-----------------
Q 001847 878 -------------------HTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANILH-KDLKF----------------- 920 (1005)
Q Consensus 878 -------------------~~~~sDIwSlGvll~eLltG~~Pf~~~~~~~~~~~i~~-~~~~~----------------- 920 (1005)
++.++|||||||+||+|+++..++.. ....+..++. ....+
T Consensus 337 ~~~~~~~~~~~sp~l~~~~~~~k~DVwSlGviL~el~~~~~~~~~--~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 414 (566)
T PLN03225 337 SAPSAPVATALSPVLWQLNLPDRFDIYSAGLIFLQMAFPNLRSDS--NLIQFNRQLKRNDYDLVAWRKLVEPRASPDLRR 414 (566)
T ss_pred CCccccccccccchhccccCCCCcccHHHHHHHHHHHhCcCCCch--HHHHHHHHHHhcCCcHHHHHHhhccccchhhhh
Confidence 23356999999999999997766532 2222222111 11000
Q ss_pred --CCCCCCCHHHHHHHHHccccCcCccCCChhcHHHHHcCCCCCCCChhhhhh
Q 001847 921 --PSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVNWALVRC 971 (1005)
Q Consensus 921 --~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~hpff~~~~~~~~~~ 971 (1005)
......+..+++||.+||++||.+||| +.++|+||||++..+..+..
T Consensus 415 ~~~~~d~~~~~~~dLi~~mL~~dP~kR~t----a~e~L~Hpff~~~~~~~~~~ 463 (566)
T PLN03225 415 GFEVLDLDGGAGWELLKSMMRFKGRQRIS----AKAALAHPYFDREGLLGLSV 463 (566)
T ss_pred hhhhccccchHHHHHHHHHccCCcccCCC----HHHHhCCcCcCCCCcccccc
Confidence 000112334568999999999999999 99999999999987765533
|
|
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-31 Score=305.89 Aligned_cols=245 Identities=31% Similarity=0.449 Sum_probs=194.5
Q ss_pred CCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeC------C
Q 001847 672 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTK------T 745 (1005)
Q Consensus 672 ~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~------~ 745 (1005)
..+..-+.||.|+||.||+++++.+|+.+|||.+.... .....+...+|+++|++++|+|||+++++-... .
T Consensus 13 y~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~--~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~ 90 (732)
T KOG4250|consen 13 YLWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKES--SLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTR 90 (732)
T ss_pred cceeehhhhcCCccceeeeecccccccchhHHhhhhhc--ccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccc
Confidence 34566688999999999999999999999999998754 345567888999999999999999999876543 3
Q ss_pred eEEEEEeccCCCchhhHHhhC-CCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEec--CC--cEEEEeccC
Q 001847 746 HVCLITDYCPGGELFLLLDRQ-PTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQG--NG--HVSLTDFDL 820 (1005)
Q Consensus 746 ~~~lV~E~~~ggsL~~~l~~~-~~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~~--~g--~vkL~DFG~ 820 (1005)
...+|||||.||+|..++..- ....|++..++.++..+..||.|||++|||||||||.||++-. +| .-||+|||.
T Consensus 91 ~~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~ 170 (732)
T KOG4250|consen 91 LPVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGA 170 (732)
T ss_pred cceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeeecccc
Confidence 578999999999999999742 1234999999999999999999999999999999999999853 34 379999999
Q ss_pred CcccCCCCCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccC-CCCCChhhHHHHHHHHHHHHcCCC
Q 001847 821 SCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAG-AGHTSAVDWWALGILLYEMLYGYT 899 (1005)
Q Consensus 821 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~sDIwSlGvll~eLltG~~ 899 (1005)
|+..+++. ...+++||+.|++||.+.. ..++..+|.|||||++|+++||..
T Consensus 171 Arel~d~s----------------------------~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~l 222 (732)
T KOG4250|consen 171 ARELDDNS----------------------------LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGEL 222 (732)
T ss_pred cccCCCCC----------------------------eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCC
Confidence 97654322 3457899999999999985 778889999999999999999999
Q ss_pred CCCCCCh----HHHHHHHHhC---------------CCC----CCCCCCCCH----HHHHHHHHccccCcCccC
Q 001847 900 PFRGKTR----QKTFANILHK---------------DLK----FPSSTPTSL----HAKQLMYRLLHRDPKSRL 946 (1005)
Q Consensus 900 Pf~~~~~----~~~~~~i~~~---------------~~~----~~~~~~~s~----~l~~Ll~~~L~~dP~~Rp 946 (1005)
||..... .+....+..+ .+. +|.+..++. .+...+..+|.++|.+|-
T Consensus 223 PF~p~~~pk~~~~~~~~~~tkkp~~v~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~ 296 (732)
T KOG4250|consen 223 PFIPFGGPKNNKEIMWHIITKKPSGVAIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRG 296 (732)
T ss_pred CCCcCCCccccchhhhhhhccCCCceeEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhC
Confidence 9954222 2333333321 111 122222222 345688999999999998
|
|
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.7e-31 Score=293.96 Aligned_cols=248 Identities=22% Similarity=0.346 Sum_probs=209.5
Q ss_pred CCccccccccccCcEEEEEEEEcCC----CeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeE
Q 001847 672 QHFRPIKPLGSGDTGSVHLVELCGS----GQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHV 747 (1005)
Q Consensus 672 ~~y~~~~~LG~G~~g~Vy~a~~~~~----~~~valK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 747 (1005)
....+.+.||.|.||.||++....- .--||||.-+.+. ++...+.|..|..+|+.++||||+++++++.+. .+
T Consensus 389 e~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~--t~d~tekflqEa~iMrnfdHphIikLIGv~~e~-P~ 465 (974)
T KOG4257|consen 389 ELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDC--TPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQ-PM 465 (974)
T ss_pred hhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCC--ChhhHHHHHHHHHHHHhCCCcchhheeeeeecc-ce
Confidence 3445567899999999999987322 3358899887654 455688999999999999999999999998874 58
Q ss_pred EEEEeccCCCchhhHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCC
Q 001847 748 CLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCK 827 (1005)
Q Consensus 748 ~lV~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~ 827 (1005)
|||||+++-|.|..|++.+. ..++...+..++.||+.||+|||+.++|||||-..|||+.+..-|||+|||+++.+.++
T Consensus 466 WivmEL~~~GELr~yLq~nk-~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~ 544 (974)
T KOG4257|consen 466 WIVMELAPLGELREYLQQNK-DSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSSPQCVKLADFGLSRYLEDD 544 (974)
T ss_pred eEEEecccchhHHHHHHhcc-ccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecCcceeeecccchhhhcccc
Confidence 99999999999999998764 46999999999999999999999999999999999999999999999999999887644
Q ss_pred CCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCh
Q 001847 828 PQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY-GYTPFRGKTR 906 (1005)
Q Consensus 828 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlGvll~eLlt-G~~Pf~~~~~ 906 (1005)
.-. ..+...-...|||||.+.-..++.++|||-||+.+||+++ |.-||.+-.+
T Consensus 545 ~yY--------------------------kaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkN 598 (974)
T KOG4257|consen 545 AYY--------------------------KASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKN 598 (974)
T ss_pred chh--------------------------hccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccc
Confidence 221 1112234567999999999999999999999999999985 9999999888
Q ss_pred HHHHHHHHhCCCCCCCCCCCCHHHHHHHHHccccCcCccCCChh
Q 001847 907 QKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHE 950 (1005)
Q Consensus 907 ~~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~ 950 (1005)
.+.+..+-++. .+|.++.+++.+..|+.+||.++|.+||++.+
T Consensus 599 sDVI~~iEnGe-RlP~P~nCPp~LYslmskcWayeP~kRPrfte 641 (974)
T KOG4257|consen 599 SDVIGHIENGE-RLPCPPNCPPALYSLMSKCWAYEPSKRPRFTE 641 (974)
T ss_pred cceEEEecCCC-CCCCCCCCChHHHHHHHHHhccCcccCCcHHH
Confidence 77776665553 45666678999999999999999999999865
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.4e-30 Score=276.19 Aligned_cols=242 Identities=43% Similarity=0.719 Sum_probs=203.0
Q ss_pred CcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEEeccCCCchhhHH
Q 001847 684 DTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLL 763 (1005)
Q Consensus 684 ~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l 763 (1005)
+||.||++.+..+++.+++|++........ ...+.+|+.++++++|+||+++++++......+++|||+.+++|..++
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~ 78 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKK--RERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLL 78 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccH--HHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHH
Confidence 589999999988899999999876532221 578889999999999999999999999999999999999988999998
Q ss_pred hhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCCCCCCCcchhhhhccc
Q 001847 764 DRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHK 843 (1005)
Q Consensus 764 ~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~~ 843 (1005)
..... ++...+..++.+++.++.|||+.|++|+||+|+||+++.++.++|+|||.+.......
T Consensus 79 ~~~~~--~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~--------------- 141 (244)
T smart00220 79 KKRGR--LSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG--------------- 141 (244)
T ss_pred HhccC--CCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCCCcEEEccccceeeecccc---------------
Confidence 76432 8899999999999999999999999999999999999999999999999985543110
Q ss_pred CCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHcCCCCCCC-CChHHHHHHHHhCCCCCCC
Q 001847 844 GQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRG-KTRQKTFANILHKDLKFPS 922 (1005)
Q Consensus 844 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlGvll~eLltG~~Pf~~-~~~~~~~~~i~~~~~~~~~ 922 (1005)
......++..|++||.+....++.++||||||+++|+|++|..||.. .........+.........
T Consensus 142 -------------~~~~~~~~~~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~ 208 (244)
T smart00220 142 -------------LLTTFVGTPEYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPP 208 (244)
T ss_pred -------------ccccccCCcCCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCcc
Confidence 12234678899999999888888999999999999999999999987 4444444444333333322
Q ss_pred CCC-CCHHHHHHHHHccccCcCccCCChhcHHHHHcCCCC
Q 001847 923 STP-TSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFF 961 (1005)
Q Consensus 923 ~~~-~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~hpff 961 (1005)
... ++..+.+++.+||..+|++||+ +.++++||||
T Consensus 209 ~~~~~~~~~~~~i~~~l~~~p~~Rp~----~~~~~~~~~~ 244 (244)
T smart00220 209 PEWKISPEAKDLIRKLLVKDPEKRLT----AEEALQHPFF 244 (244)
T ss_pred ccccCCHHHHHHHHHHccCCchhccC----HHHHhhCCCC
Confidence 222 6788999999999999999999 9999999997
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.5e-30 Score=300.36 Aligned_cols=266 Identities=18% Similarity=0.200 Sum_probs=190.2
Q ss_pred ccccCCccccccccccCcEEEEEEEEc----------------CCCeEEEEEEeecccccChH-----------HHHHHH
Q 001847 668 QINLQHFRPIKPLGSGDTGSVHLVELC----------------GSGQYFAMKAMDKGVMLNRN-----------KVHRAC 720 (1005)
Q Consensus 668 ~i~~~~y~~~~~LG~G~~g~Vy~a~~~----------------~~~~~valK~~~~~~~~~~~-----------~~~~~~ 720 (1005)
.+..++|++.++||+|+||.||++.+. ..++.||||.+......... ..+...
T Consensus 141 r~~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~ 220 (507)
T PLN03224 141 RWSSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGM 220 (507)
T ss_pred CccccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhH
Confidence 345779999999999999999999752 23567999998643211000 011223
Q ss_pred HHHHHHHhCCCCC-----cceEEEEEEe--------CCeEEEEEeccCCCchhhHHhhCCC-------------------
Q 001847 721 AEREILDMLDHPF-----VPALYASFQT--------KTHVCLITDYCPGGELFLLLDRQPT------------------- 768 (1005)
Q Consensus 721 ~E~~il~~l~hpn-----Iv~l~~~~~~--------~~~~~lV~E~~~ggsL~~~l~~~~~------------------- 768 (1005)
.|+.++.++.|.+ ++.++++|.. .+..++||||+.+++|.+++.....
T Consensus 221 vE~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~ 300 (507)
T PLN03224 221 VEAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDN 300 (507)
T ss_pred HHHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhh
Confidence 4666777776554 3666666643 3568999999999999998864211
Q ss_pred ---CCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCCCCCCCcchhhhhcccCC
Q 001847 769 ---KVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQ 845 (1005)
Q Consensus 769 ---~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~ 845 (1005)
..++...++.++.||+.+|.|||+.+|+||||||+|||++.++.+||+|||++........
T Consensus 301 ~~~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~---------------- 364 (507)
T PLN03224 301 MPQDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGIN---------------- 364 (507)
T ss_pred cccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCCCcEEEEeCcCccccccCCc----------------
Confidence 1245677889999999999999999999999999999999999999999999854321100
Q ss_pred CCCcccccccccccccccCCcccccccccCCCC----------------------CChhhHHHHHHHHHHHHcCCC-CCC
Q 001847 846 QNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGH----------------------TSAVDWWALGILLYEMLYGYT-PFR 902 (1005)
Q Consensus 846 ~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~----------------------~~~sDIwSlGvll~eLltG~~-Pf~ 902 (1005)
.......+++.|+|||.+..... ..+.||||+||++|+|++|.. ||.
T Consensus 365 ----------~~~~~g~~tp~Y~aPE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~ 434 (507)
T PLN03224 365 ----------FNPLYGMLDPRYSPPEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVA 434 (507)
T ss_pred ----------cCccccCCCcceeChhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCcc
Confidence 00111235889999999854321 124699999999999999886 665
Q ss_pred CCChH-----------HHHHHHHhCCCCCCCCCCCCHHHHHHHHHccccCc---CccCCChhcHHHHHcCCCCCC
Q 001847 903 GKTRQ-----------KTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDP---KSRLGSHEGANEIKKHPFFKG 963 (1005)
Q Consensus 903 ~~~~~-----------~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP---~~Rpt~~~~a~elL~hpff~~ 963 (1005)
+.... .....+......++.....+..+++|+.+||..+| .+|+| +.++|+||||..
T Consensus 435 ~~~~f~~~~~~~~~~~~~~r~~~~~~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlS----a~eaL~Hp~f~~ 505 (507)
T PLN03224 435 NIRLFNTELRQYDNDLNRWRMYKGQKYDFSLLDRNKEAGWDLACKLITKRDQANRGRLS----VGQALSHRFFLP 505 (507)
T ss_pred chhhhhhHHhhccchHHHHHhhcccCCCcccccccChHHHHHHHHHhccCCCCcccCCC----HHHHhCCCCcCC
Confidence 32111 11112222344555555678899999999999876 68999 999999999963
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-31 Score=304.56 Aligned_cols=266 Identities=24% Similarity=0.340 Sum_probs=226.6
Q ss_pred ccccccCCccccccccccCcEEEEEEEEcCCCe---EEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceEEEEEE
Q 001847 666 GEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQ---YFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQ 742 (1005)
Q Consensus 666 ~~~i~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~---~valK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~ 742 (1005)
-..|+.....+.++||.|.||.||++..+..|+ .||||.++... ......+|+.|+.||-+.+||||+++.++..
T Consensus 623 akEId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~Gy--tekqrrdFL~EAsIMGQFdHPNIIrLEGVVT 700 (996)
T KOG0196|consen 623 AKEIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGY--TEKQRRDFLSEASIMGQFDHPNIIRLEGVVT 700 (996)
T ss_pred hhhcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCc--cHHHHhhhhhhhhhcccCCCCcEEEEEEEEe
Confidence 345666778889999999999999999977764 68999998764 3445678999999999999999999999999
Q ss_pred eCCeEEEEEeccCCCchhhHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCc
Q 001847 743 TKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSC 822 (1005)
Q Consensus 743 ~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~~~g~vkL~DFG~a~ 822 (1005)
....+.||+|||++|+|..+|+.+.+ .++.-++..+++.|+.|++||-++|.|||||-..|||++++-.+|++|||+++
T Consensus 701 ks~PvMIiTEyMENGsLDsFLR~~DG-qftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVNsnLvCKVsDFGLSR 779 (996)
T KOG0196|consen 701 KSKPVMIITEYMENGSLDSFLRQNDG-QFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVNSNLVCKVSDFGLSR 779 (996)
T ss_pred cCceeEEEhhhhhCCcHHHHHhhcCC-ceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeeccceEEEecccccee
Confidence 99999999999999999999988754 48889999999999999999999999999999999999999999999999998
Q ss_pred ccCCCCCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHH-cCCCCC
Q 001847 823 LTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEML-YGYTPF 901 (1005)
Q Consensus 823 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlGvll~eLl-tG~~Pf 901 (1005)
...+++...+.+. .-.-...|.|||.+...+++.+|||||+|+++||.+ +|..||
T Consensus 780 vledd~~~~ytt~------------------------GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPY 835 (996)
T KOG0196|consen 780 VLEDDPEAAYTTL------------------------GGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPY 835 (996)
T ss_pred ecccCCCcccccc------------------------CCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcc
Confidence 7765542221111 011245799999999999999999999999999987 599999
Q ss_pred CCCChHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHccccCcCccCCChhc---HHHHHcCC
Q 001847 902 RGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEG---ANEIKKHP 959 (1005)
Q Consensus 902 ~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~---a~elL~hp 959 (1005)
...++++.+..|.++ ..+|.+..++..+.+|+..||++|-.+||.|.++ +..+++.|
T Consensus 836 WdmSNQdVIkaIe~g-yRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrnP 895 (996)
T KOG0196|consen 836 WDMSNQDVIKAIEQG-YRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRNP 895 (996)
T ss_pred cccchHHHHHHHHhc-cCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcCc
Confidence 999999988877665 5667777789999999999999999999997654 33445554
|
|
| >PRK13560 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.7e-30 Score=326.50 Aligned_cols=412 Identities=12% Similarity=0.088 Sum_probs=303.9
Q ss_pred ccccccccccccccccccchHHHHHHHHHhcCCeEEEEeCCCCCCcEEEccHHHHHHcCCChhhhcCCCCCcCCCCCCCh
Q 001847 171 VRSSGEMSDEGGKEKGLPRVSDIVKDALSTFQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDP 250 (1005)
Q Consensus 171 ~~~~~dit~~~~~e~~L~~~~~~l~~ile~~~~~i~i~D~~~~dg~I~~vN~a~~~l~Gys~eEllG~~~~~l~~~~~~~ 250 (1005)
.....|||++++++++|+++++.|+.++++++++++++|. +|+|+++|+++++++||+.+|++|+++..+.++....
T Consensus 183 ~g~~~DIT~rk~ae~~l~~~~~~l~~l~e~~~~~i~~~d~---~g~i~~~N~~~~~~~G~~~~e~~g~~~~~~~~~~~~~ 259 (807)
T PRK13560 183 DGFAEDITERKRAEERIDEALHFLQQLLDNIADPAFWKDE---DAKVFGCNDAACLACGFRREEIIGMSIHDFAPAQPAD 259 (807)
T ss_pred EEEEEccchHHHHHHHHHHHHHHHHHHHhhCCCeEEEEcC---CCCEEEEhHHHHHHhCCCHHHHcCCcchhcCCcchhH
Confidence 3455899999999999999999999999999999999998 7889999999999999999999999998887766544
Q ss_pred HHHHHHHHHHHcCCcEEEEEEEEecCCcEEEEEEEe--eeeecCCCCEEEEEEEEeccchhhHHHHHhhcCCCCCchhhh
Q 001847 251 EDVAKIRETLQNGQSYCGRLLNYKKDGTPFWNLLTI--APIKDDEGKVLKFIGMQVEVSKHTEGAKDKMLRPNGLPESLI 328 (1005)
Q Consensus 251 ~~~~~i~~~l~~g~~~~~e~~~~~kdG~~~wv~~~~--~pi~d~~G~v~~~v~~~~DITerk~~E~~L~~~~~~l~~~l~ 328 (1005)
.........+..+.....+.+++++||+.+|+.+.+ .|+.+.+|.+.+++++++|||++|++|++|+.+.+
T Consensus 260 ~~~~~~~~~~~~~~~~~~e~~~~~~dG~~~~~~~~~~~~~~~~~~g~~~g~~~~~~DITerk~~e~~L~~se~------- 332 (807)
T PRK13560 260 DYQEADAAKFDADGSQIIEAEFQNKDGRTRPVDVIFNHAEFDDKENHCAGLVGAITDISGRRAAERELLEKED------- 332 (807)
T ss_pred HHHHHHHHHhccCCceEEEEEEEcCCCCEEEEEEEecceEEEcCCCCEEEEEEEEEechHHHHHHHHHHHHHH-------
Confidence 443445556667777778888999999999776654 55678999999999999999999999999874211
Q ss_pred hHHHHHHHHhhhhHHHHHHH-ccCCCCcccCCCCCccc-ccCCCCchhhhcccccCCCCCCCCCCCCCC---------CC
Q 001847 329 RYDARQKEMATSSVTELVQA-MKKPRSLSESTNRPPII-RKSEGGVEEERAGALGRRKSENVPPPRRNS---------YG 397 (1005)
Q Consensus 329 ~~~~~~~~~~~~~~~~l~~~-~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~---------~~ 397 (1005)
+...+... -......+.......++ ..+...+|++..++.|+......|...... ..
T Consensus 333 ------------~l~~l~~~~~~~i~~~d~~g~i~~~nn~~~~~~~G~~~~e~~g~~~~~~~~~~~~~~~~~~~~~~~~~ 400 (807)
T PRK13560 333 ------------MLRAIIEAAPIAAIGLDADGNICFVNNNAAERMLGWSAAEVMGKPLPGMDPELNEEFWCGDFQEWYPD 400 (807)
T ss_pred ------------HHHHHHHhCcccEEEEcCCCCEEEecCHHHHHHhCCCHHHHcCCCccccChhhhhhhhhchhhhcCCc
Confidence 11111111 11222233333333333 335668899999999988766554311100 00
Q ss_pred CCc-----------ccccccccccchhhccccCCcccccccccccccCCCCCCccccccccCCCCCCCCCCCCCchhhHH
Q 001847 398 GGC-----------RTSMQRISEVPEKKKQKSGRRSFMGLIGRKSQSTDDHDSFENEIIMEGDDDYESDDERPDSVDDKV 466 (1005)
Q Consensus 398 ~~~-----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~er~~ 466 (1005)
+.. ................++|...|+...+.+..+.++.......+ ..|+|+|++
T Consensus 401 ~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~g~~~~~~~~~~p~~d~~g~~~~~~~~-------------~~DITerk~ 467 (807)
T PRK13560 401 GRPMAFDACPMAKTIKGGKIFDGQEVLIEREDDGPADCSAYAEPLHDADGNIIGAIAL-------------LVDITERKQ 467 (807)
T ss_pred CCcchhhhhhHHHHHhcCCcccCceEEEEcCCCCeEEEEEEEeeeECCCCCEEEEEEE-------------eehhhhHHH
Confidence 000 11111222334455667788888888888887777765544333 689999999
Q ss_pred HHHHHhhcccHHHHHHhccccEEEEcCCCCCCCEEeecHHHHHHcCCChhhhcCCC--CCccCCCCCCHHHHHHHHHHHh
Q 001847 467 RQKEMRKGIDLATTLERIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRN--CRFLQGPETDPATVRKIRAAID 544 (1005)
Q Consensus 467 ~e~~l~~~~~l~~i~e~~~~~I~i~D~~G~d~~i~~vN~a~~~l~Gy~~eEllG~~--~~~l~~~~~~~~~~~~i~~~l~ 544 (1005)
.|+++++ .+.++++++.+++.++..+ +..+.+|.....++||+++++++.. +..+++|++.......+...+.
T Consensus 468 ~E~~L~~---~~~~~e~~~~~i~~~~~~~--~~~~~~~~~~~~~~G~~~~e~~~~~~~~~~~~~p~d~~~~~~~~~~~~~ 542 (807)
T PRK13560 468 VEEQLLL---ANLIVENSPLVLFRWKAEE--GWPVELVSKNITQFGYEPDEFISGKRMFAAIIHPADLEQVAAEVAEFAA 542 (807)
T ss_pred HHHHHHH---HHHHHhcCCceEEEEecCC--CceEEEecchhhhcCCCHHHhhcccchHhhhcChhhHHHHHHHHHHHHh
Confidence 9999987 6789999999999887652 2245555666788999999998633 5567788887777777766665
Q ss_pred cC-CcEEEEEEEEecCCcEEEEEEEEeeeeCCCCCEEEEEEEEecCccCccccccCCchhhHHHHHHHHHHHhhhhhhhh
Q 001847 545 NQ-TDVTVQLINYTKSGKKFWNLFHLQPMRDQKGEVQYFIGVQLDGSEHLEPLRNSIPEATAEESEKLVKQTAENVNEAV 623 (1005)
Q Consensus 545 ~~-~~~~~e~~~~~kdG~~~wv~~~~~pi~d~~G~v~~~vgi~~DITerK~~e~~~~~~~~~~e~~~l~~~~~~~v~~~v 623 (1005)
.+ ..+..++++.++||..+|+.....|++|.+|.+.+++|+++|||++|++|+++ +++++++..++..++|.+++.+
T Consensus 543 ~g~~~~~~e~r~~~~dG~~~w~~~~~~~~~d~~G~~~~~~g~~~DITerK~aE~~L--~~a~~~~~~~l~~isHelrnpL 620 (807)
T PRK13560 543 QGVDRFEQEYRILGKGGAVCWIDDQSAAERDEEGQISHFEGIVIDISERKHAEEKI--KAALTEKEVLLKEIHHRVKNNL 620 (807)
T ss_pred cCCccceeEEEEEcCCCCEEEEEecceeeeCCCCCEEEEEEEEechHHHHHHHHHH--HHHHHHHHHHHHHhHHHHhChH
Confidence 55 45788999999999999999999999999999999999999999999965443 3455666666666666666654
Q ss_pred c
Q 001847 624 K 624 (1005)
Q Consensus 624 ~ 624 (1005)
.
T Consensus 621 ~ 621 (807)
T PRK13560 621 Q 621 (807)
T ss_pred H
Confidence 3
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.97 E-value=9e-31 Score=283.18 Aligned_cols=293 Identities=24% Similarity=0.344 Sum_probs=212.7
Q ss_pred hHHhhcccccccccCCccccccccccCcEEEEEEEEcC---CCeEEEEEEeecccccChHHHHHHHHHHHHHHhC-CCCC
Q 001847 658 AIQKILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCG---SGQYFAMKAMDKGVMLNRNKVHRACAEREILDML-DHPF 733 (1005)
Q Consensus 658 ~~~~~~~~~~~i~~~~y~~~~~LG~G~~g~Vy~a~~~~---~~~~valK~~~~~~~~~~~~~~~~~~E~~il~~l-~hpn 733 (1005)
++.++......+ ...|+++.+||+|.|++||++.+.. ..+++|+|.+.... ...++.+|+++|..+ .+.|
T Consensus 23 e~~~l~q~~p~~-~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts-----~p~ri~~El~~L~~~gG~~n 96 (418)
T KOG1167|consen 23 EIEQLRQDIPFI-SNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS-----SPSRILNELEMLYRLGGSDN 96 (418)
T ss_pred HHHHHHhhhhhh-hhhhhhhccccccchhhhhhhhHhhhccccceEeeeeccccc-----CchHHHHHHHHHHHhccchh
Confidence 344444444443 4689999999999999999999977 78899999887543 356789999999999 7999
Q ss_pred cceEEEEEEeCCeEEEEEeccCCCchhhHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEec-CCc
Q 001847 734 VPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQG-NGH 812 (1005)
Q Consensus 734 Iv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~~-~g~ 812 (1005)
|+.+.+++..++.+++||||++.....++... ++...++.+++.++.||.++|++|||||||||+|||++. .+.
T Consensus 97 i~~~~~~~rnnd~v~ivlp~~~H~~f~~l~~~-----l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t~r 171 (418)
T KOG1167|consen 97 IIKLNGCFRNNDQVAIVLPYFEHDRFRDLYRS-----LSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRTQR 171 (418)
T ss_pred hhcchhhhccCCeeEEEecccCccCHHHHHhc-----CCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccccccCC
Confidence 99999999999999999999999999998865 788999999999999999999999999999999999985 478
Q ss_pred EEEEeccCCcccCCCCCC-----------CC-CcchhhhhcccCCCCC-ccc----ccccccccccccCCcccccccccC
Q 001847 813 VSLTDFDLSCLTSCKPQL-----------LL-PTTNEKKRRHKGQQNP-VFM----AEPMRASNSFVGTEEYIAPEIIAG 875 (1005)
Q Consensus 813 vkL~DFG~a~~~~~~~~~-----------~~-~~~~~~~~~~~~~~~~-~~~----~~~~~~~~~~~gt~~y~aPE~l~~ 875 (1005)
-.|+|||+|-........ .. ...+.......+...+ ... ...........||++|+|||++..
T Consensus 172 g~LvDFgLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k 251 (418)
T KOG1167|consen 172 GVLVDFGLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFR 251 (418)
T ss_pred ceEEechhHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhh
Confidence 999999998521111000 00 0000000000000000 000 011123345689999999999877
Q ss_pred C-CCCChhhHHHHHHHHHHHHcCCCCCCCCCh-HHHHHHHH--------------hCC---------------------C
Q 001847 876 A-GHTSAVDWWALGILLYEMLYGYTPFRGKTR-QKTFANIL--------------HKD---------------------L 918 (1005)
Q Consensus 876 ~-~~~~~sDIwSlGvll~eLltG~~Pf~~~~~-~~~~~~i~--------------~~~---------------------~ 918 (1005)
. .+++++||||.|++++.++++.+||..... ...+..+. .+. +
T Consensus 252 ~~~QttaiDiws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~ 331 (418)
T KOG1167|consen 252 CPRQTTAIDIWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETL 331 (418)
T ss_pred ccCcCCccceeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhcc
Confidence 5 578899999999999999999999953211 11111100 011 0
Q ss_pred C----CC----------CCCCCCHHHHHHHHHccccCcCccCCChhcHHHHHcCCCCCCCC
Q 001847 919 K----FP----------SSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVN 965 (1005)
Q Consensus 919 ~----~~----------~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~hpff~~~~ 965 (1005)
. .+ .....+..+.+|+.+||..||.+|+| |+++|+||||...+
T Consensus 332 ~~~~~~~~~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRit----AEeALkHpFF~~~~ 388 (418)
T KOG1167|consen 332 HIESIYKSRQPNTEREIGSDVFPALLLDLLDKCLELNPQKRIT----AEDALKHPFFDEAD 388 (418)
T ss_pred ChhhcccccccceeeccccccccHHHHHHHHHHccCChhhccc----HHHHhcCcCCcchh
Confidence 0 00 00113447889999999999999999 99999999999643
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.7e-30 Score=251.17 Aligned_cols=226 Identities=26% Similarity=0.387 Sum_probs=185.8
Q ss_pred cccccccCCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhC-CCCCcceEEEEEEe
Q 001847 665 SGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPALYASFQT 743 (1005)
Q Consensus 665 ~~~~i~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~ 743 (1005)
.+-.+..+....+..||+|++|.|-+.++..+|...|+|.+.... +....+++.+|+.+..+. .+|++|.+++.+..
T Consensus 39 ~~~eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tv--n~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~r 116 (282)
T KOG0984|consen 39 RNFEVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATV--NSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFR 116 (282)
T ss_pred CccccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhc--ChHHHHHHHHhhhhhccCCCCCeEEEeehhhhc
Confidence 334455567777889999999999999999999999999998653 344556778888876665 89999999999999
Q ss_pred CCeEEEEEeccCCCchhhHHhh--CCCCCCCHHHHHHHHHHHHHHHHHHHHc-CcccCCCCCCcEEEecCCcEEEEeccC
Q 001847 744 KTHVCLITDYCPGGELFLLLDR--QPTKVLKEDAVRFYAAEVVVALEYLHCQ-GIIYRDLKPENVLLQGNGHVSLTDFDL 820 (1005)
Q Consensus 744 ~~~~~lV~E~~~ggsL~~~l~~--~~~~~l~~~~i~~i~~qil~aL~~LH~~-gIvHrDLkP~NILi~~~g~vkL~DFG~ 820 (1005)
...++|.||.| ..+|..+.++ ..++.+++..+-+|+..++.||.|||++ .+||||+||+||||+.+|++|+||||.
T Consensus 117 egdvwIcME~M-~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~GqVKiCDFGI 195 (282)
T KOG0984|consen 117 EGDVWICMELM-DTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDGQVKICDFGI 195 (282)
T ss_pred cccEEEeHHHh-hhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCCcEEEccccc
Confidence 99999999999 7788766543 2456799999999999999999999976 999999999999999999999999999
Q ss_pred CcccCCCCCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccC----CCCCChhhHHHHHHHHHHHHc
Q 001847 821 SCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAG----AGHTSAVDWWALGILLYEMLY 896 (1005)
Q Consensus 821 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~----~~~~~~sDIwSlGvll~eLlt 896 (1005)
+-+..++- ..+.-.|-..|||||.+.. ..|+.++||||||+++.||.+
T Consensus 196 sG~L~dSi----------------------------Akt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~ 247 (282)
T KOG0984|consen 196 SGYLVDSI----------------------------AKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAI 247 (282)
T ss_pred ceeehhhh----------------------------HHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhh
Confidence 85543211 1122467889999999844 367889999999999999999
Q ss_pred CCCCCCC-CChHHHHHHHHhCCCCCC
Q 001847 897 GYTPFRG-KTRQKTFANILHKDLKFP 921 (1005)
Q Consensus 897 G~~Pf~~-~~~~~~~~~i~~~~~~~~ 921 (1005)
+++||.. .++.+++..++....+..
T Consensus 248 lr~PY~~w~tpF~qLkqvVeep~P~L 273 (282)
T KOG0984|consen 248 LRFPYESWGTPFQQLKQVVEEPSPQL 273 (282)
T ss_pred ccccccccCCHHHHHHHHhcCCCCCC
Confidence 9999965 577888888887755443
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.8e-30 Score=295.42 Aligned_cols=252 Identities=28% Similarity=0.408 Sum_probs=200.1
Q ss_pred CccccccccccCcEE-EEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCeEEEE
Q 001847 673 HFRPIKPLGSGDTGS-VHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPALYASFQTKTHVCLI 750 (1005)
Q Consensus 673 ~y~~~~~LG~G~~g~-Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~~lV 750 (1005)
-|.-.+++|.|+.|+ ||++.. .|+.||||.+-.. ......+|+.+|+.- .||||++++..-.+....||.
T Consensus 510 ~~~~~eilG~Gs~Gt~Vf~G~y--e~R~VAVKrll~e------~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIa 581 (903)
T KOG1027|consen 510 FFSPKEILGYGSNGTVVFRGVY--EGREVAVKRLLEE------FFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIA 581 (903)
T ss_pred eeccHHHcccCCCCcEEEEEee--CCceehHHHHhhH------hHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEE
Confidence 355567789999875 799987 7889999977543 345667899999988 699999999888889999999
Q ss_pred EeccCCCchhhHHhhC-CC-CCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEec---CC--cEEEEeccCCcc
Q 001847 751 TDYCPGGELFLLLDRQ-PT-KVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQG---NG--HVSLTDFDLSCL 823 (1005)
Q Consensus 751 ~E~~~ggsL~~~l~~~-~~-~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~~---~g--~vkL~DFG~a~~ 823 (1005)
.|.| ..+|.+++... .. .....-..+.++.|++.||++||+.+||||||||.||||+. ++ .++|+|||+++.
T Consensus 582 lELC-~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKk 660 (903)
T KOG1027|consen 582 LELC-ACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKK 660 (903)
T ss_pred ehHh-hhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEecccccccc
Confidence 9999 88999999863 11 11111345778899999999999999999999999999986 33 689999999977
Q ss_pred cCCCCCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHcC-CCCCC
Q 001847 824 TSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYG-YTPFR 902 (1005)
Q Consensus 824 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlGvll~eLltG-~~Pf~ 902 (1005)
...+...+ .......||.+|+|||++.....+.++|||||||++|+.++| ..||.
T Consensus 661 l~~~~sS~------------------------~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFG 716 (903)
T KOG1027|consen 661 LAGGKSSF------------------------SRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFG 716 (903)
T ss_pred cCCCcchh------------------------hcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCC
Confidence 65433211 124556899999999999998888899999999999999985 89996
Q ss_pred CCChHHHHHHHHhCCCCCCCCCCC-CHHHHHHHHHccccCcCccCCChhcHHHHHcCCCCCC
Q 001847 903 GKTRQKTFANILHKDLKFPSSTPT-SLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKG 963 (1005)
Q Consensus 903 ~~~~~~~~~~i~~~~~~~~~~~~~-s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~hpff~~ 963 (1005)
.... .-.+|+.+...+...... +.++.+||.+||.++|..||+ |.++|.||||=.
T Consensus 717 d~~~--R~~NIl~~~~~L~~L~~~~d~eA~dLI~~ml~~dP~~RPs----a~~VL~HPlFW~ 772 (903)
T KOG1027|consen 717 DSLE--RQANILTGNYTLVHLEPLPDCEAKDLISRMLNPDPQLRPS----ATDVLNHPLFWD 772 (903)
T ss_pred chHH--hhhhhhcCccceeeeccCchHHHHHHHHHhcCCCcccCCC----HHHHhCCCccCC
Confidence 5433 334667665544332211 127899999999999999999 999999999954
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.9e-29 Score=285.82 Aligned_cols=253 Identities=23% Similarity=0.296 Sum_probs=211.9
Q ss_pred CccccccccccCcEEEEEEEEcCCCe----EEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEE
Q 001847 673 HFRPIKPLGSGDTGSVHLVELCGSGQ----YFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVC 748 (1005)
Q Consensus 673 ~y~~~~~LG~G~~g~Vy~a~~~~~~~----~valK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~ 748 (1005)
..+..++||+|+||+||++.+...|+ +||+|++... ........+..|+.+|.+|+|||++++++++.... +.
T Consensus 697 elkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~--t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~q 773 (1177)
T KOG1025|consen 697 ELKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEF--TSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQ 773 (1177)
T ss_pred hhhhhceeccccceeEEeeeEecCCceecceeEEEEeecc--CCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HH
Confidence 46677899999999999999965554 6888888754 23455678899999999999999999999988765 88
Q ss_pred EEEeccCCCchhhHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCC
Q 001847 749 LITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKP 828 (1005)
Q Consensus 749 lV~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~ 828 (1005)
||++|++.|+|.++++.++ ..+.......|..||++||.|||.+++|||||-..|||+.+-..+|+.|||+++....+.
T Consensus 774 lvtq~mP~G~LlDyvr~hr-~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~ 852 (1177)
T KOG1025|consen 774 LVTQLMPLGCLLDYVREHR-DNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDE 852 (1177)
T ss_pred HHHHhcccchHHHHHHHhh-ccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeecCCCeEEEEecchhhccCccc
Confidence 9999999999999998753 558889999999999999999999999999999999999999999999999998765443
Q ss_pred CCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCChH
Q 001847 829 QLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY-GYTPFRGKTRQ 907 (1005)
Q Consensus 829 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlGvll~eLlt-G~~Pf~~~~~~ 907 (1005)
..+ ......-.+.|||-|.+....++.++|||||||++|||+| |..||.+....
T Consensus 853 ~ey-------------------------~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~ 907 (1177)
T KOG1025|consen 853 KEY-------------------------SAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAE 907 (1177)
T ss_pred ccc-------------------------cccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHH
Confidence 221 1111224567999999999999999999999999999996 99999988766
Q ss_pred HHHHHHHhCCCCCCCCCCCCHHHHHHHHHccccCcCccCCChhcHHHH
Q 001847 908 KTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEI 955 (1005)
Q Consensus 908 ~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~el 955 (1005)
++- ++++..-.++.++.++.++..++.+||..|+..||++++.+.++
T Consensus 908 eI~-dlle~geRLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~f 954 (1177)
T KOG1025|consen 908 EIP-DLLEKGERLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEF 954 (1177)
T ss_pred Hhh-HHHhccccCCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHH
Confidence 654 45544445777788899999999999999999999987765554
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.3e-29 Score=278.72 Aligned_cols=203 Identities=31% Similarity=0.498 Sum_probs=176.8
Q ss_pred ccCCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHH-----HHHHHHHHHHHHhCC---CCCcceEEEEE
Q 001847 670 NLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNK-----VHRACAEREILDMLD---HPFVPALYASF 741 (1005)
Q Consensus 670 ~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~-----~~~~~~E~~il~~l~---hpnIv~l~~~~ 741 (1005)
+..+|..++.||+|+||.|++|.++.+...|+||.+.+..+..... ...+--||.||..|+ |+||++++++|
T Consensus 559 k~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfF 638 (772)
T KOG1152|consen 559 KFSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFF 638 (772)
T ss_pred ccccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhhee
Confidence 3457999999999999999999999999999999998764432221 223446999999996 99999999999
Q ss_pred EeCCeEEEEEecc-CCCchhhHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccC
Q 001847 742 QTKTHVCLITDYC-PGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDL 820 (1005)
Q Consensus 742 ~~~~~~~lV~E~~-~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~~~g~vkL~DFG~ 820 (1005)
++++++||+||.. +|.+|++++... ..+++...+.|++|++.|+++||+.||||||||-+|++++++|-+||+|||.
T Consensus 639 Eddd~yyl~te~hg~gIDLFd~IE~k--p~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd~~g~~klidfgs 716 (772)
T KOG1152|consen 639 EDDDYYYLETEVHGEGIDLFDFIEFK--PRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVDSNGFVKLIDFGS 716 (772)
T ss_pred ecCCeeEEEecCCCCCcchhhhhhcc--CccchHHHHHHHHHHHhccccccccCceecccccccEEEecCCeEEEeeccc
Confidence 9999999999998 477999999875 4499999999999999999999999999999999999999999999999999
Q ss_pred CcccCCCCCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCC-CChhhHHHHHHHHHHHHcCCC
Q 001847 821 SCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGH-TSAVDWWALGILLYEMLYGYT 899 (1005)
Q Consensus 821 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~-~~~sDIwSlGvll~eLltG~~ 899 (1005)
|.... +.+.+.++||..|.|||++.+.+| +..-|||+||++||.++....
T Consensus 717 aa~~k-----------------------------sgpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivyken 767 (772)
T KOG1152|consen 717 AAYTK-----------------------------SGPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKEN 767 (772)
T ss_pred hhhhc-----------------------------CCCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccC
Confidence 85532 233467899999999999998876 568899999999999999999
Q ss_pred CCCC
Q 001847 900 PFRG 903 (1005)
Q Consensus 900 Pf~~ 903 (1005)
||..
T Consensus 768 pyyn 771 (772)
T KOG1152|consen 768 PYYN 771 (772)
T ss_pred CCcC
Confidence 9864
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-29 Score=285.36 Aligned_cols=286 Identities=26% Similarity=0.392 Sum_probs=233.7
Q ss_pred cCCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEE
Q 001847 671 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLI 750 (1005)
Q Consensus 671 ~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV 750 (1005)
.++|.++..+|+|++|.||+++|+.+++..|+|+++.. ......-+.+|+-+++-++||||+.+++.|...+.+++.
T Consensus 14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLe---p~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwic 90 (829)
T KOG0576|consen 14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLE---PGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWIC 90 (829)
T ss_pred ccchhheeeecCCcccchhhhcccccCchhhheeeecc---CCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEE
Confidence 46899999999999999999999999999999999854 345566778899999999999999999999999999999
Q ss_pred EeccCCCchhhHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCCCC
Q 001847 751 TDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQL 830 (1005)
Q Consensus 751 ~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~ 830 (1005)
||||.||+|.+.-.- .+++++.++..+++..++||+|||+.|-+|||||-.||++++.|.+||.|||.+..+.
T Consensus 91 MEycgggslQdiy~~--TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd~gDvklaDfgvsaqit----- 163 (829)
T KOG0576|consen 91 MEYCGGGSLQDIYHV--TGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDEGDVKLADFGVSAQIT----- 163 (829)
T ss_pred EEecCCCcccceeee--cccchhHHHHHHHhhhhccchhhhcCCcccccccccceeecccCceeecccCchhhhh-----
Confidence 999999999987643 5779999999999999999999999999999999999999999999999999884432
Q ss_pred CCCcchhhhhcccCCCCCcccccccccccccccCCcccccccc---cCCCCCChhhHHHHHHHHHHHHcCCCCCCCCChH
Q 001847 831 LLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEII---AGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQ 907 (1005)
Q Consensus 831 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l---~~~~~~~~sDIwSlGvll~eLltG~~Pf~~~~~~ 907 (1005)
.....+.++.|||+|||||+. ....|...+|||++|++..++..-++|.....++
T Consensus 164 ----------------------ati~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpm 221 (829)
T KOG0576|consen 164 ----------------------ATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPM 221 (829)
T ss_pred ----------------------hhhhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchH
Confidence 112234567899999999986 3456888999999999999999888888777777
Q ss_pred HHHHHHHhCCCCCCCC---CCCCHHHHHHHHHccccCcCccCCChhcHHHHHcCCCCCCCCh-----hhhhhcCCCCCCC
Q 001847 908 KTFANILHKDLKFPSS---TPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVNW-----ALVRCMNPPELDA 979 (1005)
Q Consensus 908 ~~~~~i~~~~~~~~~~---~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~hpff~~~~~-----~~~~~~~~~~~~~ 979 (1005)
.....+-+..++.|.. ..-+..+-+|++.+|.++|.+||+ ++.+|.|||...--- .++-..+.|-..+
T Consensus 222 r~l~LmTkS~~qpp~lkDk~kws~~fh~fvK~altknpKkRpt----aeklL~h~fvs~~l~~rl~~eLLdK~n~P~~~v 297 (829)
T KOG0576|consen 222 RALFLMTKSGFQPPTLKDKTKWSEFFHNFVKGALTKNPKKRPT----AEKLLQHPFVSQTLSRRLAIELLDKVNNPNPVV 297 (829)
T ss_pred HHHHHhhccCCCCCcccCCccchHHHHHHHHHHhcCCCccCCC----hhhheeceeeccchhhHHHHHHHHHccCCCCcc
Confidence 6666665655544432 334667889999999999999999 999999999987421 1233334444444
Q ss_pred CCCCCcccccccc
Q 001847 980 PLFATDTEKEYKV 992 (1005)
Q Consensus 980 p~~~~~~~~~~~~ 992 (1005)
..+-.+.--+|..
T Consensus 298 ~~~~d~~~E~~~~ 310 (829)
T KOG0576|consen 298 RYLEDYDGEDYLW 310 (829)
T ss_pred cccccCCcccccc
Confidence 5544444444433
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.1e-28 Score=311.83 Aligned_cols=238 Identities=20% Similarity=0.306 Sum_probs=183.6
Q ss_pred CccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEEe
Q 001847 673 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITD 752 (1005)
Q Consensus 673 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E 752 (1005)
.|.....||+|+||.||++.+..++..||+|.+..... ....|++++++++||||+++++++...+..|+|||
T Consensus 691 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-------~~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~E 763 (968)
T PLN00113 691 SLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS-------IPSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHE 763 (968)
T ss_pred hCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc-------ccHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEe
Confidence 56777889999999999999988999999998864321 11235788999999999999999999999999999
Q ss_pred ccCCCchhhHHhhCCCCCCCHHHHHHHHHHHHHHHHHHH---HcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCCC
Q 001847 753 YCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLH---CQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQ 829 (1005)
Q Consensus 753 ~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH---~~gIvHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~ 829 (1005)
|+++|+|.+++.. +++..+..++.||+.||+||| +.+|+||||||+||+++.++..++. ||.+....
T Consensus 764 y~~~g~L~~~l~~-----l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~---- 833 (968)
T PLN00113 764 YIEGKNLSEVLRN-----LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLC---- 833 (968)
T ss_pred CCCCCcHHHHHhc-----CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccc----
Confidence 9999999999953 788999999999999999999 6699999999999999988887775 66442210
Q ss_pred CCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHcCCCCCCCCChH-H
Q 001847 830 LLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQ-K 908 (1005)
Q Consensus 830 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlGvll~eLltG~~Pf~~~~~~-~ 908 (1005)
......|++.|+|||++.+..++.++|||||||++|||++|+.||...... .
T Consensus 834 ---------------------------~~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~ 886 (968)
T PLN00113 834 ---------------------------TDTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHG 886 (968)
T ss_pred ---------------------------cCCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCC
Confidence 011236789999999999888999999999999999999999998542110 0
Q ss_pred HHHHHHh---CC--------CCCCCC----CCCCHHHHHHHHHccccCcCccCCChhcHHH
Q 001847 909 TFANILH---KD--------LKFPSS----TPTSLHAKQLMYRLLHRDPKSRLGSHEGANE 954 (1005)
Q Consensus 909 ~~~~i~~---~~--------~~~~~~----~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~e 954 (1005)
......+ .. ...... .....++.+++.+||+.+|++||++.++++.
T Consensus 887 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~ 947 (968)
T PLN00113 887 SIVEWARYCYSDCHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKT 947 (968)
T ss_pred cHHHHHHHhcCccchhheeCccccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHH
Confidence 0111110 00 000001 1112356789999999999999995554443
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.3e-27 Score=284.91 Aligned_cols=263 Identities=25% Similarity=0.351 Sum_probs=211.8
Q ss_pred cccccCCccccccccccCcEEEEEEEEcC-------CCeEEEEEEeecccccChHHHHHHHHHHHHHHhC-CCCCcceEE
Q 001847 667 EQINLQHFRPIKPLGSGDTGSVHLVELCG-------SGQYFAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPALY 738 (1005)
Q Consensus 667 ~~i~~~~y~~~~~LG~G~~g~Vy~a~~~~-------~~~~valK~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~ 738 (1005)
+.+......+.+.||+|+||.|+++.... ....||||.++.... ......+..|+++|+.+ .|+||+.++
T Consensus 291 ~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~--~~~~~~~~~El~~m~~~g~H~niv~ll 368 (609)
T KOG0200|consen 291 WEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENAS--SSEKKDLMSELNVLKELGKHPNIVNLL 368 (609)
T ss_pred eeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccC--cHHHHHHHHHHHHHHHhcCCcchhhhe
Confidence 34555556677799999999999998531 145789999886543 36678899999999999 699999999
Q ss_pred EEEEeCCeEEEEEeccCCCchhhHHhhCC-------C-------CCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCc
Q 001847 739 ASFQTKTHVCLITDYCPGGELFLLLDRQP-------T-------KVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPEN 804 (1005)
Q Consensus 739 ~~~~~~~~~~lV~E~~~ggsL~~~l~~~~-------~-------~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~N 804 (1005)
+++...+.+++|+||+..|+|..+++... . ..++...+..++.||+.|+.||++.++|||||-..|
T Consensus 369 G~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAaRN 448 (609)
T KOG0200|consen 369 GACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLAARN 448 (609)
T ss_pred eeeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhhhhh
Confidence 99999999999999999999999998754 0 138899999999999999999999999999999999
Q ss_pred EEEecCCcEEEEeccCCcccCCCCCCCCCcchhhhhcccCCCCCcccccccccccccc--cCCcccccccccCCCCCChh
Q 001847 805 VLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFV--GTEEYIAPEIIAGAGHTSAV 882 (1005)
Q Consensus 805 ILi~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--gt~~y~aPE~l~~~~~~~~s 882 (1005)
||+..+..+||+|||+++....+.... ...-. -...|||||.+....++.++
T Consensus 449 VLi~~~~~~kIaDFGlar~~~~~~~y~--------------------------~~~~~~~LP~kWmApEsl~~~~ft~kS 502 (609)
T KOG0200|consen 449 VLITKNKVIKIADFGLARDHYNKDYYR--------------------------TKSSAGTLPVKWMAPESLFDRVFTSKS 502 (609)
T ss_pred EEecCCCEEEEccccceeccCCCCceE--------------------------ecCCCCccceeecCHHHhccCcccccc
Confidence 999999999999999996533221110 00001 23459999999999999999
Q ss_pred hHHHHHHHHHHHHc-CCCCCCCCC-hHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHccccCcCccCCChhcHHHHHcC
Q 001847 883 DWWALGILLYEMLY-GYTPFRGKT-RQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKH 958 (1005)
Q Consensus 883 DIwSlGvll~eLlt-G~~Pf~~~~-~~~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~h 958 (1005)
||||||++||||++ |..||.+.. ..+.+. .++.......+..++.++.++++.||+.+|++||++.+....+-.|
T Consensus 503 DVWSfGI~L~EifsLG~~PYp~~~~~~~l~~-~l~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~ 579 (609)
T KOG0200|consen 503 DVWSFGILLWEIFTLGGTPYPGIPPTEELLE-FLKEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKH 579 (609)
T ss_pred hhhHHHHHHHHHhhCCCCCCCCCCcHHHHHH-HHhcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHH
Confidence 99999999999997 999999865 445544 4444444444445688999999999999999999988766665554
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.7e-27 Score=256.46 Aligned_cols=243 Identities=23% Similarity=0.356 Sum_probs=185.1
Q ss_pred CCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHh--CCCCCcceEEEEEEeC----C
Q 001847 672 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDM--LDHPFVPALYASFQTK----T 745 (1005)
Q Consensus 672 ~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~il~~--l~hpnIv~l~~~~~~~----~ 745 (1005)
.+..+.+.||+|-||.||++.+ .|..||||+|... .....++|.+|... |+|+||+.+++.=..+ .
T Consensus 211 rqI~L~e~IGkGRyGEVwrG~w--rGe~VAVKiF~sr------dE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~T 282 (513)
T KOG2052|consen 211 RQIVLQEIIGKGRFGEVWRGRW--RGEDVAVKIFSSR------DERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWT 282 (513)
T ss_pred heeEEEEEecCccccceeeccc--cCCceEEEEeccc------chhhhhhHHHHHHHHHhccchhhhhhhccccCCCceE
Confidence 5678889999999999999999 6779999999753 23456677777655 5999999998764432 2
Q ss_pred eEEEEEeccCCCchhhHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHc--------CcccCCCCCCcEEEecCCcEEEEe
Q 001847 746 HVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQ--------GIIYRDLKPENVLLQGNGHVSLTD 817 (1005)
Q Consensus 746 ~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~--------gIvHrDLkP~NILi~~~g~vkL~D 817 (1005)
.+|||++|.+.|||+|||.+. .++.+....++..++.||++||.. .|+|||||..|||+.++|.+-|+|
T Consensus 283 QLwLvTdYHe~GSL~DyL~r~---tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IAD 359 (513)
T KOG2052|consen 283 QLWLVTDYHEHGSLYDYLNRN---TVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIAD 359 (513)
T ss_pred EEEEeeecccCCcHHHHHhhc---cCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEee
Confidence 689999999999999999874 388999999999999999999974 399999999999999999999999
Q ss_pred ccCCcccCCCCCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCC------CChhhHHHHHHHH
Q 001847 818 FDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGH------TSAVDWWALGILL 891 (1005)
Q Consensus 818 FG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~------~~~sDIwSlGvll 891 (1005)
+|+|.....+.... ....+..+||..|||||+|...-. ...+||||||+++
T Consensus 360 LGLAv~h~~~t~~i-----------------------di~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVl 416 (513)
T KOG2052|consen 360 LGLAVRHDSDTDTI-----------------------DIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVL 416 (513)
T ss_pred ceeeEEecccCCcc-----------------------cCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHH
Confidence 99997655432211 112345689999999999965421 2379999999999
Q ss_pred HHHHc----------CCCCCCCC----ChHHHHHHHHh---CCCCCCCCCCCCH---HHHHHHHHccccCcCccCCC
Q 001847 892 YEMLY----------GYTPFRGK----TRQKTFANILH---KDLKFPSSTPTSL---HAKQLMYRLLHRDPKSRLGS 948 (1005)
Q Consensus 892 ~eLlt----------G~~Pf~~~----~~~~~~~~i~~---~~~~~~~~~~~s~---~l~~Ll~~~L~~dP~~Rpt~ 948 (1005)
||++. -++||.+- ...+.+.+++- -++..|....-.+ .+-++++.||..+|..|.|+
T Consensus 417 WEiarRc~~ggi~eey~~Pyyd~Vp~DPs~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltA 493 (513)
T KOG2052|consen 417 WEIARRCESGGIVEEYQLPYYDVVPSDPSFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTA 493 (513)
T ss_pred HHHHHHhhcCCEehhhcCCcccCCCCCCCHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHH
Confidence 99984 34677542 22344444432 2233333222222 34578999999999999993
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.5e-27 Score=260.34 Aligned_cols=244 Identities=23% Similarity=0.354 Sum_probs=188.0
Q ss_pred ccCCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhC--CCCCcceEEEEEEeCC--
Q 001847 670 NLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDML--DHPFVPALYASFQTKT-- 745 (1005)
Q Consensus 670 ~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~il~~l--~hpnIv~l~~~~~~~~-- 745 (1005)
+....+++..||+|.||.||++.. +++.||||++... ....+.+|..|.+.. +|+||++++++-+-..
T Consensus 208 ~l~pl~l~eli~~Grfg~V~KaqL--~~~~VAVKifp~~------~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~ 279 (534)
T KOG3653|consen 208 ELDPLQLLELIGRGRFGCVWKAQL--DNRLVAVKIFPEQ------EKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTAD 279 (534)
T ss_pred cCCchhhHHHhhcCccceeehhhc--cCceeEEEecCHH------HHHHHHhHHHHHhccCccchhHHHhhchhccCCcc
Confidence 356778889999999999999998 6689999998643 456778888887664 8999999998766444
Q ss_pred --eEEEEEeccCCCchhhHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHc---------CcccCCCCCCcEEEecCCcEE
Q 001847 746 --HVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQ---------GIIYRDLKPENVLLQGNGHVS 814 (1005)
Q Consensus 746 --~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~---------gIvHrDLkP~NILi~~~g~vk 814 (1005)
.++||++|.+.|+|.+||+.+ .+++.....++..+++||+|||+. .|+|||||..|||+.+|+++.
T Consensus 280 ~~eywLVt~fh~kGsL~dyL~~n---tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTcc 356 (534)
T KOG3653|consen 280 RMEYWLVTEFHPKGSLCDYLKAN---TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCC 356 (534)
T ss_pred ccceeEEeeeccCCcHHHHHHhc---cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEE
Confidence 789999999999999999875 389999999999999999999973 499999999999999999999
Q ss_pred EEeccCCcccCCCCCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCC-CC-----ChhhHHHHH
Q 001847 815 LTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAG-HT-----SAVDWWALG 888 (1005)
Q Consensus 815 L~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~-~~-----~~sDIwSlG 888 (1005)
|+|||+|...... .+.......+||..|||||+|.+.. +. .+.||||+|
T Consensus 357 IaDFGLAl~~~p~-------------------------~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamg 411 (534)
T KOG3653|consen 357 IADFGLALRLEPG-------------------------KPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMG 411 (534)
T ss_pred eeccceeEEecCC-------------------------CCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHH
Confidence 9999999665311 1122334478999999999996642 11 378999999
Q ss_pred HHHHHHHcCCCC------------CC---C--CChHHHHHHHHh--CCCCCCCCCC---CCHHHHHHHHHccccCcCccC
Q 001847 889 ILLYEMLYGYTP------------FR---G--KTRQKTFANILH--KDLKFPSSTP---TSLHAKQLMYRLLHRDPKSRL 946 (1005)
Q Consensus 889 vll~eLltG~~P------------f~---~--~~~~~~~~~i~~--~~~~~~~~~~---~s~~l~~Ll~~~L~~dP~~Rp 946 (1005)
.+||||++.... |. | .+..+....+++ .++.++.... --..+.+.+..||..||+.|+
T Consensus 412 LVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARL 491 (534)
T KOG3653|consen 412 LVLWEIASRCTDADPGPVPEYQLPFEAEVGNHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARL 491 (534)
T ss_pred HHHHHHHhhcccccCCCCCcccCchhHHhcCCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhh
Confidence 999999974432 22 1 112222222232 3344443311 223567899999999999999
Q ss_pred CCh
Q 001847 947 GSH 949 (1005)
Q Consensus 947 t~~ 949 (1005)
|+-
T Consensus 492 TA~ 494 (534)
T KOG3653|consen 492 TAG 494 (534)
T ss_pred hhH
Confidence 954
|
|
| >PRK09776 putative diguanylate cyclase; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.3e-27 Score=310.85 Aligned_cols=380 Identities=15% Similarity=0.137 Sum_probs=272.3
Q ss_pred ccccccccccchHHHHHHHHHhcCCeEEEEeCCCCCCcEEEccHHHHHHcCCChhhhcCCCCCcCCCCCCChHHHHHHHH
Q 001847 179 DEGGKEKGLPRVSDIVKDALSTFQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKIRE 258 (1005)
Q Consensus 179 ~~~~~e~~L~~~~~~l~~ile~~~~~i~i~D~~~~dg~I~~vN~a~~~l~Gys~eEllG~~~~~l~~~~~~~~~~~~i~~ 258 (1005)
.++..++.|++++++++.++++++++|+++|. +|+|+++|+++++++||+.+|++|+++..+.++++.......+..
T Consensus 270 ~~r~~~~~l~~~e~r~~~l~e~~~~~i~~~d~---dG~i~~~N~~~~~l~G~~~~el~g~~~~~~~~~~d~~~~~~~~~~ 346 (1092)
T PRK09776 270 AFRAERKHISESETRFRNAMEYSAIGMALVGT---EGQWLQVNKALCQFLGYSQEELRGLTFQQLTWPEDLNKDLQQVEK 346 (1092)
T ss_pred HHHHHHHHHHHHHHHHHHHHHhCCceEEEEcC---CCcEEehhHHHHHHhCCCHHHHccCCceeccCcchhHhHHHHHHH
Confidence 34445667889999999999999999999998 888999999999999999999999998888777766555555555
Q ss_pred HHHcC-CcEEEEEEEEecCCcEEEEEEEeeeeecCCCCEEEEEEEEeccchhhHHHHHhhcCCCCCchhhhhHHHHHHHH
Q 001847 259 TLQNG-QSYCGRLLNYKKDGTPFWNLLTIAPIKDDEGKVLKFIGMQVEVSKHTEGAKDKMLRPNGLPESLIRYDARQKEM 337 (1005)
Q Consensus 259 ~l~~g-~~~~~e~~~~~kdG~~~wv~~~~~pi~d~~G~v~~~v~~~~DITerk~~E~~L~~~~~~l~~~l~~~~~~~~~~ 337 (1005)
.+..+ ..+..+.+..++||+.+|+..+..++++.+|.+.+++++++|||++|++|++++...+
T Consensus 347 ~~~~~~~~~~~e~~~~~~dG~~~~~~~~~~~~~~~~g~~~~~i~~~~DITerk~~e~~l~~~~~---------------- 410 (1092)
T PRK09776 347 LLSGEINSYSMEKRYYRRDGEVVWALLAVSLVRDTDGTPLYFIAQIEDINELKRTEQVNERLME---------------- 410 (1092)
T ss_pred HHcCCccceeeeeEEEcCCCCEEEEEEEEEEEECCCCCEeeehhhHHhhHHHHHHHHHHHHHHH----------------
Confidence 54443 3467888999999999999999999999999999999999999999999988773111
Q ss_pred hhhhHHHHHHH-ccCCCCcccCCCCCcccccCCCCchhhhcccccCCCCCCCCCCCCCCCCC---Ccccccccccccchh
Q 001847 338 ATSSVTELVQA-MKKPRSLSESTNRPPIIRKSEGGVEEERAGALGRRKSENVPPPRRNSYGG---GCRTSMQRISEVPEK 413 (1005)
Q Consensus 338 ~~~~~~~l~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~ 413 (1005)
+...+... -...+..+.......+|......+|++.++..+...-..+-++....... ............+.+
T Consensus 411 ---~~~~~~~~~~~~i~~~d~~~~~~~~n~~~~~l~G~~~~~~~~~~~~~~~~~p~d~~~~~~~~~~~~~~~~~~~~e~r 487 (1092)
T PRK09776 411 ---RITLANEAGGIGIWEWDLKPNIISWDKRMFELYEIPPHIKPTWQVWYACLHPEDRQRVEKEIRDALQGRSPFKLEFR 487 (1092)
T ss_pred ---HHHHHHHhcCceEEEEecCCCeEeeCHHHHHHhCCCcccCCCHHHHHHhcCHhHHHHHHHHHHHHHhcCCCeeEEEE
Confidence 11111111 11222333333344445444444555443322211000000000000000 000011122345566
Q ss_pred hccccCCcccccccccccccCCCCCCccccccccCCCCCCCCCCCCCchhhHHHHHHHhhc-ccHHHHHHhccccEEEEc
Q 001847 414 KKQKSGRRSFMGLIGRKSQSTDDHDSFENEIIMEGDDDYESDDERPDSVDDKVRQKEMRKG-IDLATTLERIEKNFVITD 492 (1005)
Q Consensus 414 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~er~~~e~~l~~~-~~l~~i~e~~~~~I~i~D 492 (1005)
...++| ..|+...+.+..+.++.......+ ..|+|+|++.++++++. ..++.++++++++|+++|
T Consensus 488 ~~~~dG-~~w~~~~~~~~~d~~G~~~~~ig~-------------~~DITerk~~e~~L~~~~~~l~~~l~~~~~~i~~~D 553 (1092)
T PRK09776 488 IVVKDG-VRHIRALANRVLNKDGEVERLLGI-------------NMDMTEVRQLNEALFQEKERLHITLDSIGEAVVCTD 553 (1092)
T ss_pred EEcCCc-eEEEEEeeEEEECCCCCEEEEEee-------------eeehhHHHHHHHHHHHHHHHHHHHHhccccEEEEEC
Confidence 678888 888888887777766665443333 68999999999999877 679999999999999999
Q ss_pred CCCCCCCEEeecHHHHHHcCCChhhhcCCCCCccCCCC--CCHHHHHHHHHHHhcCCc--EEEEEEEEecCCcEEEEEEE
Q 001847 493 PRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPE--TDPATVRKIRAAIDNQTD--VTVQLINYTKSGKKFWNLFH 568 (1005)
Q Consensus 493 ~~G~d~~i~~vN~a~~~l~Gy~~eEllG~~~~~l~~~~--~~~~~~~~i~~~l~~~~~--~~~e~~~~~kdG~~~wv~~~ 568 (1005)
.+|. |+++|+++++++||+.+|++|+++..+.+.. ........+......... ...+....++||..+|+..+
T Consensus 554 ~~g~---i~~~N~a~~~l~G~~~~e~iG~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~G~~~~~~~~ 630 (1092)
T PRK09776 554 MAMK---VTFMNPVAEKMTGWTQEEALGVPLLTVLHITFGDNGPLMENIYSCLTSRSAAYLEQDVVLHCRSGGSYDVHYS 630 (1092)
T ss_pred CCCe---EEEEcHHHHHHhCCCHHHHcCCCHHHHcccccCCcchhhHHHHHHHhcCCCccccceEEEEeCCCcEEEEEEE
Confidence 9888 9999999999999999999999966554322 122222334444444433 56677889999999999999
Q ss_pred EeeeeCCCCCEEEEEEEEecCccCccccc
Q 001847 569 LQPMRDQKGEVQYFIGVQLDGSEHLEPLR 597 (1005)
Q Consensus 569 ~~pi~d~~G~v~~~vgi~~DITerK~~e~ 597 (1005)
..|+++.+|++.+++++++|||++|+.++
T Consensus 631 ~~pi~~~~g~~~g~v~~~~DITe~k~~e~ 659 (1092)
T PRK09776 631 ITPLSTLDGENIGSVLVIQDVTESRKMLR 659 (1092)
T ss_pred eeeeecCCCCEEEEEEEEEecchHHHHHH
Confidence 99999999999999999999999998543
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.4e-25 Score=234.07 Aligned_cols=213 Identities=39% Similarity=0.646 Sum_probs=184.3
Q ss_pred ccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEEeccCCCch
Q 001847 680 LGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGEL 759 (1005)
Q Consensus 680 LG~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~ggsL 759 (1005)
||+|++|.||++.+..+++.+++|.+....... ....+.+|+.+++.+.|++|+++++++......+++|||+.+++|
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~--~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l 78 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS--LLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSL 78 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchh--HHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcH
Confidence 689999999999998889999999987653211 346788999999999999999999999999999999999988999
Q ss_pred hhHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEec-CCcEEEEeccCCcccCCCCCCCCCcchhh
Q 001847 760 FLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQG-NGHVSLTDFDLSCLTSCKPQLLLPTTNEK 838 (1005)
Q Consensus 760 ~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~~-~g~vkL~DFG~a~~~~~~~~~~~~~~~~~ 838 (1005)
.+++.... ..++...+..++.+++.+|.+||+.|++|+||+|.||+++. ++.++|+|||.+........
T Consensus 79 ~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~--------- 148 (215)
T cd00180 79 KDLLKENE-GKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS--------- 148 (215)
T ss_pred HHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc---------
Confidence 99987642 35899999999999999999999999999999999999999 89999999998854321110
Q ss_pred hhcccCCCCCcccccccccccccccCCcccccccccCC-CCCChhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhCC
Q 001847 839 KRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGA-GHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANILHKD 917 (1005)
Q Consensus 839 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~sDIwSlGvll~eLltG~~Pf~~~~~~~~~~~i~~~~ 917 (1005)
......+...|++||.+... ..+.+.|+|+||+++++|
T Consensus 149 ------------------~~~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l----------------------- 187 (215)
T cd00180 149 ------------------LLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL----------------------- 187 (215)
T ss_pred ------------------hhhcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH-----------------------
Confidence 12234578899999998776 778899999999999999
Q ss_pred CCCCCCCCCCHHHHHHHHHccccCcCccCCChhcHHHHHcCC
Q 001847 918 LKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHP 959 (1005)
Q Consensus 918 ~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~hp 959 (1005)
..+.+++.+||..+|++||+ +.++++|+
T Consensus 188 ----------~~~~~~l~~~l~~~p~~R~~----~~~l~~~~ 215 (215)
T cd00180 188 ----------PELKDLIRKMLQKDPEKRPS----AKEILEHL 215 (215)
T ss_pred ----------HHHHHHHHHHhhCCcccCcC----HHHHhhCC
Confidence 46889999999999999999 89998875
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.93 E-value=6e-25 Score=233.20 Aligned_cols=215 Identities=37% Similarity=0.610 Sum_probs=179.9
Q ss_pred ccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEEec
Q 001847 674 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDY 753 (1005)
Q Consensus 674 y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~ 753 (1005)
|.+.+.||.|++|.||++.+..+++.+++|.+...... .....+.+|+..++.++|+|++++++++......++++||
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~ 78 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE--KQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEY 78 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch--HHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEec
Confidence 67788999999999999999888999999998865322 2567888899999999999999999999998999999999
Q ss_pred cCCCchhhHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCCCCCCC
Q 001847 754 CPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLP 833 (1005)
Q Consensus 754 ~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~~~~ 833 (1005)
+.+++|.+++...... ++...+..++.+++.+|.+||+.+++|+||+|+||+++.++.++|+|||.+.......
T Consensus 79 ~~~~~L~~~~~~~~~~-~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~----- 152 (225)
T smart00221 79 CEGGDLFDYLRKKGGK-LSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDL----- 152 (225)
T ss_pred cCCCCHHHHHHhcccC-CCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcc-----
Confidence 9999999999764321 7899999999999999999999999999999999999999999999999885532111
Q ss_pred cchhhhhcccCCCCCcccccccccccccccCCcccccccc-cCCCCCChhhHHHHHHHHHHHHcCCCCCCC-CChH-HHH
Q 001847 834 TTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEII-AGAGHTSAVDWWALGILLYEMLYGYTPFRG-KTRQ-KTF 910 (1005)
Q Consensus 834 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l-~~~~~~~~sDIwSlGvll~eLltG~~Pf~~-~~~~-~~~ 910 (1005)
........++..|++||.+ ....++.++|+|+||+++|+|++|+.||.. .... ...
T Consensus 153 ---------------------~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~~~~~~~~~~ 211 (225)
T smart00221 153 ---------------------AALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSGEGEFTSLLS 211 (225)
T ss_pred ---------------------cccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccccchhHHHHH
Confidence 0011234678889999998 666777899999999999999999999977 4444 555
Q ss_pred HHHHhCC
Q 001847 911 ANILHKD 917 (1005)
Q Consensus 911 ~~i~~~~ 917 (1005)
..+..+.
T Consensus 212 ~~~~~~~ 218 (225)
T smart00221 212 DVWSFGV 218 (225)
T ss_pred HHHhcCC
Confidence 5555554
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.2e-26 Score=234.32 Aligned_cols=255 Identities=23% Similarity=0.329 Sum_probs=193.9
Q ss_pred cCCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhC-CCCCcceEEEE-EEeCCeEE
Q 001847 671 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPALYAS-FQTKTHVC 748 (1005)
Q Consensus 671 ~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~-~~~~~~~~ 748 (1005)
.+.|.+.+.||+|.||.+.+|+++.++..+|+|.+.... -...++.+|...---| .|.||+.-|+. |+..+.++
T Consensus 23 ~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~----tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~Yv 98 (378)
T KOG1345|consen 23 EDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQ----TTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYV 98 (378)
T ss_pred hhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcch----hhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEE
Confidence 368999999999999999999999999999999988753 3456677776554444 58899987764 67778889
Q ss_pred EEEeccCCCchhhHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEec--CCcEEEEeccCCcccCC
Q 001847 749 LITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQG--NGHVSLTDFDLSCLTSC 826 (1005)
Q Consensus 749 lV~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~~--~g~vkL~DFG~a~~~~~ 826 (1005)
+++||++.|+|..-+... .+-+...+.++.|+++|+.|||++++||||||.+||||-. ...+||||||.+...+.
T Consensus 99 F~qE~aP~gdL~snv~~~---GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~ 175 (378)
T KOG1345|consen 99 FVQEFAPRGDLRSNVEAA---GIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGT 175 (378)
T ss_pred EeeccCccchhhhhcCcc---cccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCCccEEEeeecccccccCc
Confidence 999999999998877653 3788899999999999999999999999999999999953 35899999999855431
Q ss_pred CCCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCC-----CCCChhhHHHHHHHHHHHHcCCCCC
Q 001847 827 KPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGA-----GHTSAVDWWALGILLYEMLYGYTPF 901 (1005)
Q Consensus 827 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-----~~~~~sDIwSlGvll~eLltG~~Pf 901 (1005)
.- ...-.+..|.+||.+... ...+.+|||.||+++|.+++|++||
T Consensus 176 tV------------------------------~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PW 225 (378)
T KOG1345|consen 176 TV------------------------------KYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPW 225 (378)
T ss_pred ee------------------------------hhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcc
Confidence 10 112345678999986432 3467899999999999999999999
Q ss_pred CCCC----hHHHHHHHHhCC-CCCCC-CCCCCHHHHHHHHHccccCcCccCCChhcHHHHHcCCCCCC
Q 001847 902 RGKT----RQKTFANILHKD-LKFPS-STPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKG 963 (1005)
Q Consensus 902 ~~~~----~~~~~~~i~~~~-~~~~~-~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~hpff~~ 963 (1005)
.... ....+....++. +..|. ....+..+.+++++-|..+|+.|-...+ ++......|...
T Consensus 226 Qka~~~d~~Y~~~~~w~~rk~~~~P~~F~~fs~~a~r~Fkk~lt~~~~drcki~~-~kk~rk~~w~E~ 292 (378)
T KOG1345|consen 226 QKASIMDKPYWEWEQWLKRKNPALPKKFNPFSEKALRLFKKSLTPRFKDRCKIWT-AKKMRKCLWKEK 292 (378)
T ss_pred hhhhccCchHHHHHHHhcccCccCchhhcccCHHHHHHHHHhcCCcccccchhHH-HHHHHHHHHHHh
Confidence 7532 223344444443 33333 2457889999999999999999944222 445555555443
|
|
| >TIGR02040 PpsR-CrtJ transcriptional regulator PpsR | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.8e-25 Score=259.82 Aligned_cols=359 Identities=13% Similarity=0.038 Sum_probs=225.0
Q ss_pred HHhcCCeEEEEeCCCCCCcEEEccHHHHHHcCCChhhhcCCCCCcCCCCCCChHHHHHHHHHHHcCC-cEEEEEEEEecC
Q 001847 198 LSTFQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKIRETLQNGQ-SYCGRLLNYKKD 276 (1005)
Q Consensus 198 le~~~~~i~i~D~~~~dg~I~~vN~a~~~l~Gys~eEllG~~~~~l~~~~~~~~~~~~i~~~l~~g~-~~~~e~~~~~kd 276 (1005)
+++++|+++++|. +|+|++||.+++.++||+.+|++|+++..+++++........+...+..+. .+..+..+..++
T Consensus 2 ~~~~~d~~~~~d~---~g~i~~~n~~~~~~~g~~~~el~G~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~ 78 (442)
T TIGR02040 2 LATAADVTLLLDA---EGVVREVAANPHHPSFEQLSEWEGRRWEEIVTAESVEKFELRLSEALRTGRGAVRVELNHIDPS 78 (442)
T ss_pred CcccCcEEEEECC---CCcEEEEEECCCcccccccccCCCCcHhHhhCcchHHHHHHHHHHHhccCCCcceEeeccCCCC
Confidence 5788999999999 777999999999999999999999999888887665555555656666654 455666666677
Q ss_pred CcEEEEEEEeeeeecCCCCEEEEEEEEeccchhhHHHHHhhcCCCCCchhhhhHHHHHHHHhhhhHHHHHHHc-cCCCCc
Q 001847 277 GTPFWNLLTIAPIKDDEGKVLKFIGMQVEVSKHTEGAKDKMLRPNGLPESLIRYDARQKEMATSSVTELVQAM-KKPRSL 355 (1005)
Q Consensus 277 G~~~wv~~~~~pi~d~~G~v~~~v~~~~DITerk~~E~~L~~~~~~l~~~l~~~~~~~~~~~~~~~~~l~~~~-~~~~~~ 355 (1005)
|..+|+.++..++.+ + .+++++.+|||++++.+.+|...... ++.+.......+++...+.... ..+.-.
T Consensus 79 g~~~~~~~~~~~~~~--~--~~~~~i~rDi~~~~~~~~~l~~~~~~-----~e~~~~~l~~~e~r~~~l~e~~~~~i~~~ 149 (442)
T TIGR02040 79 SFELPMRFILVRLGA--D--RGVLALGRDLRAVAELQQQLVAAQQA-----MERDYWTLREMETRYRVVLEVSSDAVLLV 149 (442)
T ss_pred CCccCeEEEEEEeCC--C--CeEEEEecccHHHHHHHHHHHHHHHH-----HHHHHHHHHHHHHHHHHHHhhCCceEEEE
Confidence 777788777777644 2 26688999999988876554210000 0000001111112222222222 222333
Q ss_pred cc-CCCCCcccccCCCCchhhhcccccCCCCCCCCCCCCCCCCC---CcccccccccccchhhccccCCccccccccccc
Q 001847 356 SE-STNRPPIIRKSEGGVEEERAGALGRRKSENVPPPRRNSYGG---GCRTSMQRISEVPEKKKQKSGRRSFMGLIGRKS 431 (1005)
Q Consensus 356 ~~-~~~~~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 431 (1005)
+. .-....+|..+...+|++.++++|++..++++......... .....+. . .........+...| .+.+...
T Consensus 150 d~~~g~i~~~N~a~~~l~G~~~~el~g~~~~~~~~~~~~~~~~~~l~~~~~~g~-~--~~~~~~~~~~~~~~-~~~~~~~ 225 (442)
T TIGR02040 150 DMSTGRIVEANSAAAALLGGVGQSLVGRAFPQEFEGRRREELMLTLRNVRATGS-A--APVRILLRRSQKRL-LVVVSVF 225 (442)
T ss_pred ECCCCEEEEEcHHHHHHhCcCHHHHcCCCHHHhCCHHHHHHHHHHHHHHHhcCC-C--cceEEEEcCCCeEE-EEEEEEE
Confidence 32 23344577778888999999999999888775421110000 0000000 0 01111111111111 1111111
Q ss_pred ccCCCCCCccccccccCCCCCCCCCCCCCchhhHHHHHHHhhcccHHHHHHhccccEEEEcCCCCCCCEEeecHHHHHHc
Q 001847 432 QSTDDHDSFENEIIMEGDDDYESDDERPDSVDDKVRQKEMRKGIDLATTLERIEKNFVITDPRLPDNPIIFASDSFLELT 511 (1005)
Q Consensus 432 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~er~~~e~~l~~~~~l~~i~e~~~~~I~i~D~~G~d~~i~~vN~a~~~l~ 511 (1005)
.. ++...++. ...|++++++.+++++ ..|+.+|++++++|+++|.+|. |+++|++|++++
T Consensus 226 ~~-~~~~~~l~--------------~~~dit~~~~~e~~~~--~~~~~l~e~~~d~I~v~D~~G~---I~~~N~a~~~l~ 285 (442)
T TIGR02040 226 RQ-DGESLFLC--------------QLSPAGATQPVGDELS--ENLARLYHEAPDAIVFSDADGT---IRGANEAFLELT 285 (442)
T ss_pred Ee-CCceEEEE--------------EEcccchhhhhhHHHH--HHHHHHHHhCCceEEEEcCCCc---EEehhHHHHHHh
Confidence 11 11111111 2345677776665553 2599999999999999999888 999999999999
Q ss_pred CCC-hhhhcCCCCCccCCCCCCHHHHHHHHHHHhcCCcEEEEEEEEecCCcEEEEEEEEeeeeCCCCCEEEEEEEEecCc
Q 001847 512 EYS-REEILGRNCRFLQGPETDPATVRKIRAAIDNQTDVTVQLINYTKSGKKFWNLFHLQPMRDQKGEVQYFIGVQLDGS 590 (1005)
Q Consensus 512 Gy~-~eEllG~~~~~l~~~~~~~~~~~~i~~~l~~~~~~~~e~~~~~kdG~~~wv~~~~~pi~d~~G~v~~~vgi~~DIT 590 (1005)
||+ .++++|+++..+.++.... ....+......+.....+..+.++||+.+|+.++..|+.+..+ ..++++++|||
T Consensus 286 G~~~~~~l~G~~~~~~~~~~~~~-~~~~~~~~~~~g~~~~~~~~~~~~~G~~~~ve~s~~~i~~~~~--~~~~~v~rDIT 362 (442)
T TIGR02040 286 DSSSLEAVRGRTLDRWLGRGGVD-LRVLLSNVRRTGQVRLYATTLTGEFGAQTEVEISAAWVDQGER--PLIVLVIRDIS 362 (442)
T ss_pred CCCChHHHcCCCHHHHhCCCccc-HHHHHHHHhhcCceEEEEEEEEcCCCCEEEEEEEEEEeccCCc--eEEEEEEecch
Confidence 997 5789999976665543222 2222333334444455677888999999999999999986554 46789999999
Q ss_pred cCccc
Q 001847 591 EHLEP 595 (1005)
Q Consensus 591 erK~~ 595 (1005)
+||+.
T Consensus 363 eR~~~ 367 (442)
T TIGR02040 363 RRLTM 367 (442)
T ss_pred hhccC
Confidence 99986
|
This model represents the transcriptional regulator PpsR which is strictly associated with photosynthetic proteobacteria and found in photosynthetic operons. PpsR has been reported to be a repressor. These proteins contain a Helix-Turn_Helix motif of the "fis" type (pfam02954). |
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.4e-25 Score=280.38 Aligned_cols=227 Identities=19% Similarity=0.269 Sum_probs=154.5
Q ss_pred CCC-CCcceEEEEEE-------eCCeEEEEEeccCCCchhhHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCC
Q 001847 729 LDH-PFVPALYASFQ-------TKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDL 800 (1005)
Q Consensus 729 l~h-pnIv~l~~~~~-------~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDL 800 (1005)
+.| +||+.++++|. ....++++|||+ +++|.+++... ...++...++.++.||+.||.|||++||+||||
T Consensus 29 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrDl 106 (793)
T PLN00181 29 LSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNP-DRSVDAFECFHVFRQIVEIVNAAHSQGIVVHNV 106 (793)
T ss_pred hhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcc-cccccHHHHHHHHHHHHHHHHHHHhCCeeeccC
Confidence 344 57777777772 334678899998 77999999753 345999999999999999999999999999999
Q ss_pred CCCcEEEecCCcEEEEeccCCcccCCCCCCCCCcch-hhhhcccCCC-CC-----cccccc-cccccccccCCccccccc
Q 001847 801 KPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTN-EKKRRHKGQQ-NP-----VFMAEP-MRASNSFVGTEEYIAPEI 872 (1005)
Q Consensus 801 kP~NILi~~~g~vkL~DFG~a~~~~~~~~~~~~~~~-~~~~~~~~~~-~~-----~~~~~~-~~~~~~~~gt~~y~aPE~ 872 (1005)
||+||||+..|.+|++|||++.....+........+ +..+...... .. .....+ .......+||+.|+|||+
T Consensus 107 KP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~ 186 (793)
T PLN00181 107 RPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEE 186 (793)
T ss_pred CchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChhh
Confidence 999999988788888888776543221110000000 0000000000 00 000000 011223578999999999
Q ss_pred ccCCCCCChhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHccccCcCccCCChhcH
Q 001847 873 IAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGA 952 (1005)
Q Consensus 873 l~~~~~~~~sDIwSlGvll~eLltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a 952 (1005)
+.+..++.++|||||||+||||++|..|+.... ..+..+.....+ +..........+++.+||.++|.+||+ +
T Consensus 187 ~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~--~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~L~~~P~~Rps----~ 259 (793)
T PLN00181 187 DNGSSSNCASDVYRLGVLLFELFCPVSSREEKS--RTMSSLRHRVLP-PQILLNWPKEASFCLWLLHPEPSCRPS----M 259 (793)
T ss_pred hccCCCCchhhhhhHHHHHHHHhhCCCchhhHH--HHHHHHHHhhcC-hhhhhcCHHHHHHHHHhCCCChhhCcC----h
Confidence 999999999999999999999999988875422 122222222111 111122445678999999999999999 9
Q ss_pred HHHHcCCCCCCC
Q 001847 953 NEIKKHPFFKGV 964 (1005)
Q Consensus 953 ~elL~hpff~~~ 964 (1005)
.++|+||||...
T Consensus 260 ~eil~h~~~~~~ 271 (793)
T PLN00181 260 SELLQSEFINEP 271 (793)
T ss_pred HHHhhchhhhhh
Confidence 999999999864
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=4.3e-24 Score=227.23 Aligned_cols=254 Identities=17% Similarity=0.159 Sum_probs=203.1
Q ss_pred cccCCccccccccccCcEEEEEEEEcCCC-----eEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceEEEEEE-
Q 001847 669 INLQHFRPIKPLGSGDTGSVHLVELCGSG-----QYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQ- 742 (1005)
Q Consensus 669 i~~~~y~~~~~LG~G~~g~Vy~a~~~~~~-----~~valK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~- 742 (1005)
+...++++...+.+|.||.||.+.+.+.+ +.+.+|.++... .+-....+..|..++..+.|||+..+.++..
T Consensus 281 v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~A--S~iQv~~~L~es~lly~~sH~nll~V~~V~ie 358 (563)
T KOG1024|consen 281 VQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHA--SQIQVNLLLQESMLLYGASHPNLLSVLGVSIE 358 (563)
T ss_pred hhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcc--cHHHHHHHHHHHHHHhcCcCCCccceeEEEee
Confidence 44567889999999999999999775443 235566655432 3455678888999999999999999988765
Q ss_pred eCCeEEEEEeccCCCchhhHHhhC------CCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEE
Q 001847 743 TKTHVCLITDYCPGGELFLLLDRQ------PTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLT 816 (1005)
Q Consensus 743 ~~~~~~lV~E~~~ggsL~~~l~~~------~~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~~~g~vkL~ 816 (1005)
+....++++.++.-|+|..++... ..+.++..++..++.|++.|++|||+.||||.||-..|.+|++.-++||+
T Consensus 359 ~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvIdd~LqVklt 438 (563)
T KOG1024|consen 359 DYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVIDDQLQVKLT 438 (563)
T ss_pred ccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcceehhheeEEec
Confidence 456788999999999999999732 22347778888999999999999999999999999999999999999999
Q ss_pred eccCCcccCCCCCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHc
Q 001847 817 DFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY 896 (1005)
Q Consensus 817 DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlGvll~eLlt 896 (1005)
|=.+++..=+ .++ .-..+...-...||+||.+....++.++|+||||++||||++
T Consensus 439 DsaLSRDLFP------~DY-------------------hcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmt 493 (563)
T KOG1024|consen 439 DSALSRDLFP------GDY-------------------HCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMT 493 (563)
T ss_pred cchhccccCc------ccc-------------------cccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHh
Confidence 9998853211 000 001122234567999999999999999999999999999997
Q ss_pred -CCCCCCCCChHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHccccCcCccCCChh
Q 001847 897 -GYTPFRGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHE 950 (1005)
Q Consensus 897 -G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~ 950 (1005)
|+.||...++.+...-+..+ ..+..+.+++.++..++..||...|++||++.+
T Consensus 494 lg~~PyaeIDPfEm~~ylkdG-yRlaQP~NCPDeLf~vMacCWallpeeRPsf~Q 547 (563)
T KOG1024|consen 494 LGKLPYAEIDPFEMEHYLKDG-YRLAQPFNCPDELFTVMACCWALLPEERPSFSQ 547 (563)
T ss_pred cCCCCccccCHHHHHHHHhcc-ceecCCCCCcHHHHHHHHHHHhcCcccCCCHHH
Confidence 99999999988876655544 455556678999999999999999999999543
|
|
| >PRK13560 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=9.5e-24 Score=267.97 Aligned_cols=379 Identities=10% Similarity=0.043 Sum_probs=264.7
Q ss_pred cccccccccccchHHHH-HHHHHhcCCeEEEEeCCCCCCcE--EEccHHHHHHcCCChhhhcCCC--CCcCCCCCCChHH
Q 001847 178 SDEGGKEKGLPRVSDIV-KDALSTFQQTFVVSDATKPDYPI--MYASAGFFKMTGYTSKEVVGRN--CRFLQGAGTDPED 252 (1005)
Q Consensus 178 t~~~~~e~~L~~~~~~l-~~ile~~~~~i~i~D~~~~dg~I--~~vN~a~~~l~Gys~eEllG~~--~~~l~~~~~~~~~ 252 (1005)
+.|+.++.+|+++++.+ +.+++++|+++++++..+ +|.+ .+++.++..++||...++++.. +..+.+|++....
T Consensus 53 ~~r~~~~~~l~~~~e~~~r~l~~~~p~~i~~~~~~~-~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~p~d~~~~ 131 (807)
T PRK13560 53 DARAIAEAEAQDCREQCERNLKANIPGGMFLFALDG-DGTFSFPSLLDANGELAAIAKHDLMADKGLLAMLIGGDDGDFF 131 (807)
T ss_pred hHHHHHHHHHHHHHHHHHHHHHhcCCceEEEEEEcC-ccccccceeeccchhHHHhcCcccCCccchhhhhcCCCcchhh
Confidence 34566788888888888 999999999999998732 3443 3478888888898888877543 3345666655433
Q ss_pred H-------HHHHHHHHcCCcEEEEEEEEecCCcEEEEEEEeeeeecCCCCEEEEEEEEeccchhhHHHHHhhcCCCCCch
Q 001847 253 V-------AKIRETLQNGQSYCGRLLNYKKDGTPFWNLLTIAPIKDDEGKVLKFIGMQVEVSKHTEGAKDKMLRPNGLPE 325 (1005)
Q Consensus 253 ~-------~~i~~~l~~g~~~~~e~~~~~kdG~~~wv~~~~~pi~d~~G~v~~~v~~~~DITerk~~E~~L~~~~~~l~~ 325 (1005)
+ +.+..++..+.....+++++++||+ |+.....|.++.+|.+ .+.|+++|||++|++|++|+.+.+
T Consensus 132 ~~~~~~~~~~~~~~~~~~~~~~~e~r~~~~dg~--~~~~~~~~~~~~~g~~-~~~g~~~DIT~rk~ae~~l~~~~~---- 204 (807)
T PRK13560 132 FANPFRSAETIAMALQSDDWQEEEGHFRCGDGR--FIDCCLRFERHAHADD-QVDGFAEDITERKRAEERIDEALH---- 204 (807)
T ss_pred hhChhhHHHHHHHHhccCcccceEEEEEeCCcc--EEEEEeeeeecCCCce-EEEEEEEccchHHHHHHHHHHHHH----
Confidence 3 2333344455556678888999996 6677788888888876 689999999999999988773111
Q ss_pred hhhhHHHHHHHHhhhhHHHHHH-HccCCCCcccCCCCCcccccCCCCchhhhcccccCCCCCCCCCCCCCCCCC--Cccc
Q 001847 326 SLIRYDARQKEMATSSVTELVQ-AMKKPRSLSESTNRPPIIRKSEGGVEEERAGALGRRKSENVPPPRRNSYGG--GCRT 402 (1005)
Q Consensus 326 ~l~~~~~~~~~~~~~~~~~l~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~--~~~~ 402 (1005)
....+.. .-......+..-..+.+|......+|++.++++|++..++.|......... ....
T Consensus 205 ---------------~l~~l~e~~~~~i~~~d~~g~i~~~N~~~~~~~G~~~~e~~g~~~~~~~~~~~~~~~~~~~~~~~ 269 (807)
T PRK13560 205 ---------------FLQQLLDNIADPAFWKDEDAKVFGCNDAACLACGFRREEIIGMSIHDFAPAQPADDYQEADAAKF 269 (807)
T ss_pred ---------------HHHHHHhhCCCeEEEEcCCCCEEEEhHHHHHHhCCCHHHHcCCcchhcCCcchhHHHHHHHHHHh
Confidence 1111111 112223345555667788889999999999999999999887633221100 0000
Q ss_pred ccccccccchhhccccCCcccccccc--cccccCCCCCCccccccccCCCCCCCCCCCCCchhhHHHHHHHhhc-ccHHH
Q 001847 403 SMQRISEVPEKKKQKSGRRSFMGLIG--RKSQSTDDHDSFENEIIMEGDDDYESDDERPDSVDDKVRQKEMRKG-IDLAT 479 (1005)
Q Consensus 403 ~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~er~~~e~~l~~~-~~l~~ 479 (1005)
.......++.....++|+..|+.+.. .+..+.++....... ...|+|+|++.+++++++ ..|+.
T Consensus 270 ~~~~~~~~e~~~~~~dG~~~~~~~~~~~~~~~~~~g~~~g~~~-------------~~~DITerk~~e~~L~~se~~l~~ 336 (807)
T PRK13560 270 DADGSQIIEAEFQNKDGRTRPVDVIFNHAEFDDKENHCAGLVG-------------AITDISGRRAAERELLEKEDMLRA 336 (807)
T ss_pred ccCCceEEEEEEEcCCCCEEEEEEEecceEEEcCCCCEEEEEE-------------EEEechHHHHHHHHHHHHHHHHHH
Confidence 11112234455667788877554443 333343433332222 367999999999999877 67999
Q ss_pred HHHhccccEEEEcCCCCCCCEEee-cHHHHHHcCCChhhhcCCCCCccCCCCCCHH---------------H--HHHHHH
Q 001847 480 TLERIEKNFVITDPRLPDNPIIFA-SDSFLELTEYSREEILGRNCRFLQGPETDPA---------------T--VRKIRA 541 (1005)
Q Consensus 480 i~e~~~~~I~i~D~~G~d~~i~~v-N~a~~~l~Gy~~eEllG~~~~~l~~~~~~~~---------------~--~~~i~~ 541 (1005)
++++++++|+++|.+|. ++++ |+++++++||+.++++|+++..+.+...... . ...+..
T Consensus 337 l~~~~~~~i~~~d~~g~---i~~~nn~~~~~~~G~~~~e~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 413 (807)
T PRK13560 337 IIEAAPIAAIGLDADGN---ICFVNNNAAERMLGWSAAEVMGKPLPGMDPELNEEFWCGDFQEWYPDGRPMAFDACPMAK 413 (807)
T ss_pred HHHhCcccEEEEcCCCC---EEEecCHHHHHHhCCCHHHHcCCCccccChhhhhhhhhchhhhcCCcCCcchhhhhhHHH
Confidence 99999999999999888 9987 6788889999999999998655433221111 0 011233
Q ss_pred HHhcCCcE-EEEEEEEecCCcEEEEEEEEeeeeCCCCCEEEEEEEEecCccCccc
Q 001847 542 AIDNQTDV-TVQLINYTKSGKKFWNLFHLQPMRDQKGEVQYFIGVQLDGSEHLEP 595 (1005)
Q Consensus 542 ~l~~~~~~-~~e~~~~~kdG~~~wv~~~~~pi~d~~G~v~~~vgi~~DITerK~~ 595 (1005)
.+..+..+ ..++...+++|..+|+.....|++|.+|.+.+++++++|||++|+.
T Consensus 414 ~~~~~~~~~~~e~~~~~~~g~~~~~~~~~~p~~d~~g~~~~~~~~~~DITerk~~ 468 (807)
T PRK13560 414 TIKGGKIFDGQEVLIEREDDGPADCSAYAEPLHDADGNIIGAIALLVDITERKQV 468 (807)
T ss_pred HHhcCCcccCceEEEEcCCCCeEEEEEEEeeeECCCCCEEEEEEEeehhhhHHHH
Confidence 35555543 3578888999999999999999999999999999999999999995
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=4.6e-24 Score=214.16 Aligned_cols=274 Identities=20% Similarity=0.254 Sum_probs=221.2
Q ss_pred ccccCCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCC-CCCcceEEEEEEeCCe
Q 001847 668 QINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLD-HPFVPALYASFQTKTH 746 (1005)
Q Consensus 668 ~i~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~il~~l~-hpnIv~l~~~~~~~~~ 746 (1005)
-+..+.|+++++||+|+||.+|++....+|..||||+=+... ...++..|..+.+.|. ...|+.+..++.+..+
T Consensus 11 ~iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a-----~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~y 85 (341)
T KOG1163|consen 11 LIVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKA-----KHPQLLYESKVYRILQGGVGIPHIRHYGTEKDY 85 (341)
T ss_pred heeccceEEEEeecCCchhheeeeeeccCCceEEEEeecccC-----CCcchhHHHHHHHHhccCCCCchhhhhcccccc
Confidence 456789999999999999999999999999999999765432 2335667899999995 4788999999999999
Q ss_pred EEEEEeccCCCchhhHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecC---CcEEEEeccCCcc
Q 001847 747 VCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGN---GHVSLTDFDLSCL 823 (1005)
Q Consensus 747 ~~lV~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~~~---g~vkL~DFG~a~~ 823 (1005)
-.+||++. |.+|.+++.-.. ..++...+..++-|++.-++|+|.+++|||||||+|+|+.-+ ..+.|+|||+|+.
T Consensus 86 nvlVMdLL-GPsLEdLfnfC~-R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKk 163 (341)
T KOG1163|consen 86 NVLVMDLL-GPSLEDLFNFCS-RRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKK 163 (341)
T ss_pred ceeeeecc-CccHHHHHHHHh-hhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEeccchhh
Confidence 99999999 999999997542 458999999999999999999999999999999999999743 4689999999965
Q ss_pred cCCCCCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHcCCCCCCC
Q 001847 824 TSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRG 903 (1005)
Q Consensus 824 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlGvll~eLltG~~Pf~~ 903 (1005)
..+.. ...+.+.+......||..|.+-..+.+...+.+.|+=|+|.+|.++..|.+||.+
T Consensus 164 y~d~~--------------------t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQg 223 (341)
T KOG1163|consen 164 YRDIR--------------------TRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQG 223 (341)
T ss_pred hcccc--------------------ccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccc
Confidence 43211 1124456677788999999999999888889999999999999999999999988
Q ss_pred C---ChHHHHHHHHhCCCCCCC---CCCCCHHHHHHHHHccccCcCccCCChhcHHHHH-------cCCCCCCCChhhh
Q 001847 904 K---TRQKTFANILHKDLKFPS---STPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIK-------KHPFFKGVNWALV 969 (1005)
Q Consensus 904 ~---~~~~~~~~i~~~~~~~~~---~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL-------~hpff~~~~~~~~ 969 (1005)
. +....+++|....+..+. ....+.++...+..|-..--++-|.... +.++. +|.+=--.+|..+
T Consensus 224 lka~tk~QKyEkI~EkK~s~~ie~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~y-lrqlFriLfr~ln~~~d~iyDW~~l 301 (341)
T KOG1163|consen 224 LKAATKKQKYEKISEKKMSTPIEVLCKGFPAEFAMYLNYCRGLGFEEKPDYMY-LRQLFRILFRTLNHQYDYIYDWTML 301 (341)
T ss_pred cchhhHHHHHHHHHHhhcCCCHHHHhCCCcHHHHHHHHHHhhcCCCCCCcHHH-HHHHHHHHHhhccccCCeEeeHHHH
Confidence 4 445667777776665553 3457888999999998888888887543 34443 3333334678866
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.6e-23 Score=219.24 Aligned_cols=256 Identities=21% Similarity=0.274 Sum_probs=205.5
Q ss_pred ccccccCCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhC-CCCCcceEEEEEEeC
Q 001847 666 GEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPALYASFQTK 744 (1005)
Q Consensus 666 ~~~i~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~ 744 (1005)
+..+..-.|++.++||+|+||.++.+.+.-++.+||||.=.. +...-++..|....+.| ..+.|+.++-+..++
T Consensus 22 ~~~~VG~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPr-----kS~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG 96 (449)
T KOG1165|consen 22 GVLMVGPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPR-----KSEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEG 96 (449)
T ss_pred CceEecccceeccccccCcceeeecccccccCceEEEEeccc-----cCCcchHHHHHHHHHHHcCCCCCCceeeecccc
Confidence 344667799999999999999999999999999999996432 23345677788888888 679999999888888
Q ss_pred CeEEEEEeccCCCchhhHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecC-----CcEEEEecc
Q 001847 745 THVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGN-----GHVSLTDFD 819 (1005)
Q Consensus 745 ~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~~~-----g~vkL~DFG 819 (1005)
.+-.||+|+. |.+|.|++.-.. ..++...+..++.|++.-++|+|++++|.|||||+|+||..- ..+.++|||
T Consensus 97 ~~NiLVidLL-GPSLEDLFD~Cg-R~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFG 174 (449)
T KOG1165|consen 97 KYNILVIDLL-GPSLEDLFDLCG-RRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFG 174 (449)
T ss_pred chhhhhhhhh-CcCHHHHHHHhc-CcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEecc
Confidence 8999999999 999999998763 569999999999999999999999999999999999999743 358999999
Q ss_pred CCcccCCCCCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHcCCC
Q 001847 820 LSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYT 899 (1005)
Q Consensus 820 ~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlGvll~eLltG~~ 899 (1005)
+|+...+... -.+.|.+...++.||..||+-....+...+.+.|+=|||-++++++.|.+
T Consensus 175 mAK~YrDp~T--------------------kqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsL 234 (449)
T KOG1165|consen 175 MAKEYRDPKT--------------------KQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSL 234 (449)
T ss_pred chhhhcCccc--------------------cccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCC
Confidence 9976532211 13556788889999999999999999999999999999999999999999
Q ss_pred CCCC---CChHHHHHHHHhCCCCCCC---CCCCCHHHHHHHHHccccCcCccCCC
Q 001847 900 PFRG---KTRQKTFANILHKDLKFPS---STPTSLHAKQLMYRLLHRDPKSRLGS 948 (1005)
Q Consensus 900 Pf~~---~~~~~~~~~i~~~~~~~~~---~~~~s~~l~~Ll~~~L~~dP~~Rpt~ 948 (1005)
||.| .+..+.+++|-...-..+. ..+++.++...+...-..+-.+-|..
T Consensus 235 PWQGLKA~tnK~kYeKIGe~Kr~T~i~~Lc~g~P~efa~Yl~yvR~L~F~E~PDY 289 (449)
T KOG1165|consen 235 PWQGLKADTNKEKYEKIGETKRSTPIEVLCEGFPEEFATYLRYVRRLDFFETPDY 289 (449)
T ss_pred ccccccCcchHHHHHHhccccccCCHHHHHhcCHHHHHHHHHHHHhcCcccCCCH
Confidence 9987 4455666666433222221 13345566666665556666666664
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=7.7e-25 Score=248.64 Aligned_cols=262 Identities=41% Similarity=0.700 Sum_probs=220.1
Q ss_pred cccccCcEEEEEEEE---cCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCC-CCCcceEEEEEEeCCeEEEEEecc
Q 001847 679 PLGSGDTGSVHLVEL---CGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLD-HPFVPALYASFQTKTHVCLITDYC 754 (1005)
Q Consensus 679 ~LG~G~~g~Vy~a~~---~~~~~~valK~~~~~~~~~~~~~~~~~~E~~il~~l~-hpnIv~l~~~~~~~~~~~lV~E~~ 754 (1005)
.+|.|+||.|++|.- ...+..|++|+.++......... ....|..++..++ ||++++++..|+.....+++++|.
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~-~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~ 79 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRT-HTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFL 79 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhccccccccccccc-ccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhc
Confidence 379999999998864 34477899999987655444333 4556778888886 999999999999999999999999
Q ss_pred CCCchhhHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCCCCCCCc
Q 001847 755 PGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPT 834 (1005)
Q Consensus 755 ~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~~~~~ 834 (1005)
.||.|+..+... ..+.+...+.+...++-+++++|+.+|+|+|+|++||+++.+|++++.|||+++....
T Consensus 80 rgg~lft~l~~~--~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~-------- 149 (612)
T KOG0603|consen 80 RGGDLFTRLSKE--VMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVK-------- 149 (612)
T ss_pred ccchhhhccccC--CchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeecccCccccCCchhhhHhHh--------
Confidence 999998887654 4478888999999999999999999999999999999999999999999999865321
Q ss_pred chhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHH
Q 001847 835 TNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANIL 914 (1005)
Q Consensus 835 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlGvll~eLltG~~Pf~~~~~~~~~~~i~ 914 (1005)
....|||..|||||++. .+...+|.||||+++++|++|..||.+ +....|+
T Consensus 150 -----------------------~~~~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~----~~~~~Il 200 (612)
T KOG0603|consen 150 -----------------------EKIACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG----DTMKRIL 200 (612)
T ss_pred -----------------------hhhcccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch----HHHHHHh
Confidence 11228999999999988 567899999999999999999999987 6777777
Q ss_pred hCCCCCCCCCCCCHHHHHHHHHccccCcCccCCCh-hcHHHHHcCCCCCCCChhhhhhcCCCCCCCCCC
Q 001847 915 HKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSH-EGANEIKKHPFFKGVNWALVRCMNPPELDAPLF 982 (1005)
Q Consensus 915 ~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~-~~a~elL~hpff~~~~~~~~~~~~~~~~~~p~~ 982 (1005)
+..+..|.. .+..+++++..++..+|.+|.-.. ..+.++++|+||..++|..+..+..+...-|..
T Consensus 201 ~~~~~~p~~--l~~~a~~~~~~l~~r~p~nrLg~~~~~~~eik~h~f~~~i~~~~l~~r~~~~~fkp~~ 267 (612)
T KOG0603|consen 201 KAELEMPRE--LSAEARSLFRQLFKRNPENRLGAGPDGVDEIKQHEFFQSIDWNELEARSRPPPFKPGS 267 (612)
T ss_pred hhccCCchh--hhHHHHHHHHHHHhhCHHHHhccCcchhHHHhccchheeeeHhhHhhcCCCCCCCCcc
Confidence 766555543 678899999999999999999865 578999999999999999887777775544443
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.6e-23 Score=214.58 Aligned_cols=161 Identities=24% Similarity=0.245 Sum_probs=128.2
Q ss_pred CchhhHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCCCCCCCcch
Q 001847 757 GELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTN 836 (1005)
Q Consensus 757 gsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~~~~~~~ 836 (1005)
|+|.+++... +..+++..++.++.||+.||.|||+.+ ||+|||++.++.+|+ ||++.....
T Consensus 1 GsL~~~l~~~-~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~~~~~--fG~~~~~~~---------- 61 (176)
T smart00750 1 VSLADILEVR-GRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWDGLLKL--DGSVAFKTP---------- 61 (176)
T ss_pred CcHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCccceee--ccceEeecc----------
Confidence 6899999754 345999999999999999999999998 999999999999999 998754321
Q ss_pred hhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHcCCCCCCCCChH-HHHHHHHh
Q 001847 837 EKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQ-KTFANILH 915 (1005)
Q Consensus 837 ~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlGvll~eLltG~~Pf~~~~~~-~~~~~i~~ 915 (1005)
....|++.|+|||++.+..++.++|||||||++|+|++|+.||...... ..+..+..
T Consensus 62 ----------------------~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~ 119 (176)
T smart00750 62 ----------------------EQSRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLN 119 (176)
T ss_pred ----------------------ccCCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHH
Confidence 0125889999999999999999999999999999999999999765432 33333333
Q ss_pred CCCCCC-----CCCCCCH--HHHHHHHHccccCcCccCCChhcHHHHHcCCCCC
Q 001847 916 KDLKFP-----SSTPTSL--HAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFK 962 (1005)
Q Consensus 916 ~~~~~~-----~~~~~s~--~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~hpff~ 962 (1005)
...... .....+. .+.+||.+||..+|.+||+ +.++++|+|+.
T Consensus 120 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~----~~~ll~~~~~~ 169 (176)
T smart00750 120 GMPADDPRDRSNLESVSAARSFADFMRVCASRLPQRREA----ANHYLAHCRAL 169 (176)
T ss_pred HhccCCccccccHHHHHhhhhHHHHHHHHHhcccccccC----HHHHHHHHHHH
Confidence 222111 1111222 5899999999999999999 99999999876
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.88 E-value=9.2e-24 Score=252.55 Aligned_cols=261 Identities=24% Similarity=0.387 Sum_probs=200.4
Q ss_pred cccccccccCcEEEEEEEEcCCCeEEEEEEeec---ccccChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEE
Q 001847 675 RPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDK---GVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLIT 751 (1005)
Q Consensus 675 ~~~~~LG~G~~g~Vy~a~~~~~~~~valK~~~~---~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~ 751 (1005)
.....+|.|++|.|+.+......+.++.|.++. ...........+..|..+-..+.|+|++..+..+.+....+-+|
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m 400 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM 400 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence 456789999999999888877666666665542 11122222333667888888899999988777776666566669
Q ss_pred eccCCCchhhHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCCCCC
Q 001847 752 DYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLL 831 (1005)
Q Consensus 752 E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~~ 831 (1005)
|||++ +|+.++... ..++...+..+++||+.||.|||+.||.||||||+|++++.+|.+||+|||.+.......
T Consensus 401 E~~~~-Dlf~~~~~~--~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~--- 474 (601)
T KOG0590|consen 401 EYCPY-DLFSLVMSN--GKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTENGILKIIDFGAASVFRYPW--- 474 (601)
T ss_pred hcccH-HHHHHHhcc--cccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEecCCceEEeecCcceeeccCc---
Confidence 99988 999999774 358889999999999999999999999999999999999999999999999885432111
Q ss_pred CCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCC-hhhHHHHHHHHHHHHcCCCCCCCCChHHHH
Q 001847 832 LPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTS-AVDWWALGILLYEMLYGYTPFRGKTRQKTF 910 (1005)
Q Consensus 832 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~-~sDIwSlGvll~eLltG~~Pf~~~~~~~~~ 910 (1005)
..........+|+..|+|||++.+..|.+ ..||||.|+++..|++|+.||.-....+..
T Consensus 475 --------------------e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~ 534 (601)
T KOG0590|consen 475 --------------------EKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNS 534 (601)
T ss_pred --------------------chhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccc
Confidence 11123455678999999999999998877 789999999999999999999765443322
Q ss_pred -HHHHh-CCC-----CCCCCCCCCHHHHHHHHHccccCcCccCCChhcHHHHHcCCCCCCCC
Q 001847 911 -ANILH-KDL-----KFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVN 965 (1005)
Q Consensus 911 -~~i~~-~~~-----~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~hpff~~~~ 965 (1005)
..... ... +......++...+.+|.+||+++|.+|.| +++|++.+||+.+.
T Consensus 535 ~~~~~~~~~~~~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~t----i~~i~~d~W~~~i~ 592 (601)
T KOG0590|consen 535 FKTNNYSDQRNIFEGPNRLLSLLPRETRIIIYRMLQLDPTKRIT----IEQILNDEWIRSIE 592 (601)
T ss_pred hhhhccccccccccChHHHHHhchhhHHHHHHHHccCChhheec----HHHHhhChHhhhcc
Confidence 11111 111 11111234567789999999999999999 99999999999864
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.7e-21 Score=217.85 Aligned_cols=254 Identities=22% Similarity=0.223 Sum_probs=194.4
Q ss_pred CccccccccccCcEEEEEEEEcCCC-eEEEEEEeecccccChHHHHHHHHHHHHHHhCC----CCCcceEEEEE-EeCCe
Q 001847 673 HFRPIKPLGSGDTGSVHLVELCGSG-QYFAMKAMDKGVMLNRNKVHRACAEREILDMLD----HPFVPALYASF-QTKTH 746 (1005)
Q Consensus 673 ~y~~~~~LG~G~~g~Vy~a~~~~~~-~~valK~~~~~~~~~~~~~~~~~~E~~il~~l~----hpnIv~l~~~~-~~~~~ 746 (1005)
+|++.+.||+|+||.||+|.+..++ ..+|+|......... ...+..|..++..+. .++++.+++.+ ....+
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~---~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~ 95 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSK---PSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDF 95 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCC---CccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCce
Confidence 8999999999999999999997764 688999876542111 115666888888885 36999999999 47788
Q ss_pred EEEEEeccCCCchhhHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecC-----CcEEEEeccCC
Q 001847 747 VCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGN-----GHVSLTDFDLS 821 (1005)
Q Consensus 747 ~~lV~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~~~-----g~vkL~DFG~a 821 (1005)
.|+||+.+ |.+|.++......+.++...+..++.|++.+|.+||+.|++||||||+|+++... ..+.|+|||++
T Consensus 96 ~~iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGla 174 (322)
T KOG1164|consen 96 NFIVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLA 174 (322)
T ss_pred eEEEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEecCCC
Confidence 99999999 9999999877666779999999999999999999999999999999999999865 36999999999
Q ss_pred c--ccCCCCCCCCCcchhhhhcccCCCCCccccccccc-ccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHcCC
Q 001847 822 C--LTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRA-SNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGY 898 (1005)
Q Consensus 822 ~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlGvll~eLltG~ 898 (1005)
+ ......... ..+.+. .....||..|+++.++.+...+.+.|+||++.++.+++.|.
T Consensus 175 r~~~~~~~~~~~--------------------~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~ 234 (322)
T KOG1164|consen 175 RRFKYVGDSGGN--------------------LRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGS 234 (322)
T ss_pred ccccccCCCCcc--------------------cccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCC
Confidence 7 221111000 001111 23456999999999999999999999999999999999999
Q ss_pred CCCCCCChHHHHHHHHhCC--CCCC-CCCCCCHHHHHHHHHccccCcCccCCChh
Q 001847 899 TPFRGKTRQKTFANILHKD--LKFP-SSTPTSLHAKQLMYRLLHRDPKSRLGSHE 950 (1005)
Q Consensus 899 ~Pf~~~~~~~~~~~i~~~~--~~~~-~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~ 950 (1005)
.||.+.........+.... .... .....+..+.+++..+-..+...+|....
T Consensus 235 LPW~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~ 289 (322)
T KOG1164|consen 235 LPWEALEMTDLKSKFEKDPRKLLTDRFGDLKPEEFAKILEYIDSLDYEDKPDYEK 289 (322)
T ss_pred CCCccccccchHHHHHHHhhhhccccccCCChHHHHHHHHHhhccCCcCCCCHHH
Confidence 9997755432222222211 1111 12234567778888888889999999543
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.88 E-value=8.7e-23 Score=241.66 Aligned_cols=242 Identities=39% Similarity=0.649 Sum_probs=186.9
Q ss_pred CCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEE
Q 001847 672 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLIT 751 (1005)
Q Consensus 672 ~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~ 751 (1005)
.+|..++.|..|++|.||.++|+.+.+.+|+|+=+... +.+ .++....+|++|
T Consensus 83 ~df~~IklisngAygavylvrh~~trqrfa~kiNkq~l---------ilR--nilt~a~npfvv---------------- 135 (1205)
T KOG0606|consen 83 SDFNTIKLISNGAYGAVYLVRHKETRQRFAMKINKQNL---------ILR--NILTFAGNPFVV---------------- 135 (1205)
T ss_pred cccceeEeeccCCCCceeeeeccccccchhhcccccch---------hhh--ccccccCCccee----------------
Confidence 47899999999999999999999999999996433221 111 044444555555
Q ss_pred eccCCCchhhHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCCCC-
Q 001847 752 DYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQL- 830 (1005)
Q Consensus 752 E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~- 830 (1005)
|+-..+++.. +.++.+. +.+++|||+-||+|||+||+|++|+.-|++|+.|||++....-....
T Consensus 136 -----gDc~tllk~~--g~lPvdm--------vla~Eylh~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atn 200 (1205)
T KOG0606|consen 136 -----GDCATLLKNI--GPLPVDM--------VLAVEYLHSYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATN 200 (1205)
T ss_pred -----chhhhhcccC--CCCcchh--------hHHhHhhccCCeecCCCCCCcceeeecccccccchhhhhhhhhhccch
Confidence 3334444432 3344333 77899999999999999999999999999999999998653211111
Q ss_pred CCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHcCCCCCCCCChHHHH
Q 001847 831 LLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTF 910 (1005)
Q Consensus 831 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlGvll~eLltG~~Pf~~~~~~~~~ 910 (1005)
.+....++..+ ......++|||.|+|||++....|+..+|-|++|+++|+++.|+.||.+++..+.+
T Consensus 201 l~eg~I~k~t~-------------Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelf 267 (1205)
T KOG0606|consen 201 LKEGHIEKDTH-------------EFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELF 267 (1205)
T ss_pred hhhcchHHHHH-------------HhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHH
Confidence 01111111000 11234579999999999999999999999999999999999999999999999999
Q ss_pred HHHHhCCCCCCCC-CCCCHHHHHHHHHccccCcCccCCChhcHHHHHcCCCCCCCChhhh
Q 001847 911 ANILHKDLKFPSS-TPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVNWALV 969 (1005)
Q Consensus 911 ~~i~~~~~~~~~~-~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~hpff~~~~~~~~ 969 (1005)
..++...+.|++. ..+..+++++|.++|+.+|..|..-- .+-++.+|+||+.++|+-+
T Consensus 268 g~visd~i~wpE~dea~p~Ea~dli~~LL~qnp~~Rlgt~-ga~evk~h~ff~~LDw~~l 326 (1205)
T KOG0606|consen 268 GQVISDDIEWPEEDEALPPEAQDLIEQLLRQNPLCRLGTG-GALEVKQHGFFQLLDWKSL 326 (1205)
T ss_pred hhhhhhhccccccCcCCCHHHHHHHHHHHHhChHhhcccc-hhhhhhhccceeecccchh
Confidence 9999998888876 44678999999999999999998744 6889999999999999944
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.3e-20 Score=209.89 Aligned_cols=262 Identities=36% Similarity=0.555 Sum_probs=205.9
Q ss_pred ccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCC-CcceEEEEEEeCCeEEEEEe
Q 001847 674 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHP-FVPALYASFQTKTHVCLITD 752 (1005)
Q Consensus 674 y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~il~~l~hp-nIv~l~~~~~~~~~~~lV~E 752 (1005)
|.+.+.||.|+|+.||++.+. ..+++|.+.............+.+|+.++..+.|+ +++.+++.+......+++++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 78 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVME 78 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEe
Confidence 788899999999999999996 78899999876544444577888999999999988 79999999988777899999
Q ss_pred ccCCCchhhHHhhCCC-CCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCC-cEEEEeccCCcccCCCCCC
Q 001847 753 YCPGGELFLLLDRQPT-KVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNG-HVSLTDFDLSCLTSCKPQL 830 (1005)
Q Consensus 753 ~~~ggsL~~~l~~~~~-~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~~~g-~vkL~DFG~a~~~~~~~~~ 830 (1005)
++.+++|.+++..... ..++......++.|++.++.|+|+.+++|||+||+||+++..+ .++++|||.+.........
T Consensus 79 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~~ 158 (384)
T COG0515 79 YVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGST 158 (384)
T ss_pred cCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCCCeEEEeccCcceecCCCCcc
Confidence 9999999977765421 2589999999999999999999999999999999999999988 7999999998633211110
Q ss_pred CCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccC---CCCCChhhHHHHHHHHHHHHcCCCCCCCCCh-
Q 001847 831 LLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAG---AGHTSAVDWWALGILLYEMLYGYTPFRGKTR- 906 (1005)
Q Consensus 831 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~---~~~~~~sDIwSlGvll~eLltG~~Pf~~~~~- 906 (1005)
.. .........|+..|++||.+.+ .......|+||+|++++++++|..||.....
T Consensus 159 ~~---------------------~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~ 217 (384)
T COG0515 159 SS---------------------IPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNS 217 (384)
T ss_pred cc---------------------ccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCcc
Confidence 00 0012356689999999999987 5778899999999999999999999877653
Q ss_pred ---HHHHHHHHhCCCC-CCCCCCCC------HHHHHHHHHccccCcCccCCChhcHHHHHcCCCCCC
Q 001847 907 ---QKTFANILHKDLK-FPSSTPTS------LHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKG 963 (1005)
Q Consensus 907 ---~~~~~~i~~~~~~-~~~~~~~s------~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~hpff~~ 963 (1005)
......+...... ........ ..+.+++..|+..+|..|.+ ......++|...
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~----~~~~~~~~~~~~ 280 (384)
T COG0515 218 SATSQTLKIILELPTPSLASPLSPSNPELISKAASDLLKKLLAKDPKNRLS----SSSDLSHDLLAH 280 (384)
T ss_pred ccHHHHHHHHHhcCCcccccccCccccchhhHHHHHHHHHHHhcCchhcCC----HHHHhhchHhhC
Confidence 3434444333322 22221111 46889999999999999999 666666655554
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.87 E-value=8.3e-22 Score=221.67 Aligned_cols=177 Identities=21% Similarity=0.185 Sum_probs=132.7
Q ss_pred cccccCCccccccccccCcEEEEEEEEcC-CCeEEEEEEeecccc--cChHHHHHHHHHHHHHHhCCCCCcce-EEEEEE
Q 001847 667 EQINLQHFRPIKPLGSGDTGSVHLVELCG-SGQYFAMKAMDKGVM--LNRNKVHRACAEREILDMLDHPFVPA-LYASFQ 742 (1005)
Q Consensus 667 ~~i~~~~y~~~~~LG~G~~g~Vy~a~~~~-~~~~valK~~~~~~~--~~~~~~~~~~~E~~il~~l~hpnIv~-l~~~~~ 742 (1005)
.+...++|.+.+.||+|+||+||+|.+.. ++..+|||.+..... ........+.+|+++|++++|+|++. ++++
T Consensus 13 ~~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~-- 90 (365)
T PRK09188 13 IPALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT-- 90 (365)
T ss_pred cccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc--
Confidence 34457899999999999999999999876 678889998753311 12334567889999999999999985 4432
Q ss_pred eCCeEEEEEeccCCCchhhHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCC-CCCcEEEecCCcEEEEeccCC
Q 001847 743 TKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDL-KPENVLLQGNGHVSLTDFDLS 821 (1005)
Q Consensus 743 ~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDL-kP~NILi~~~g~vkL~DFG~a 821 (1005)
+..|+||||++|++|... .. .. ...++.|++.+|.|||++||+|||| ||+|||++.++.+||+|||+|
T Consensus 91 --~~~~LVmE~~~G~~L~~~-~~-----~~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~~~~ikLiDFGlA 159 (365)
T PRK09188 91 --GKDGLVRGWTEGVPLHLA-RP-----HG---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGPDGEAAVIDFQLA 159 (365)
T ss_pred --CCcEEEEEccCCCCHHHh-Cc-----cc---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcCCCCEEEEECccc
Confidence 457999999999999632 11 11 1467899999999999999999999 999999999999999999999
Q ss_pred cccCCCCCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccC
Q 001847 822 CLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAG 875 (1005)
Q Consensus 822 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~ 875 (1005)
.......... . ......-....+++.|+|||.+..
T Consensus 160 ~~~~~~~~~~----------------~---~~~~~d~~~~~~~~~~~~pe~~~~ 194 (365)
T PRK09188 160 SVFRRRGALY----------------R---IAAYEDLRHLLKHKRTYAPDALTP 194 (365)
T ss_pred eecccCcchh----------------h---hhhhhhhhhhhccCccCCcccCCh
Confidence 7653221100 0 000011135678999999999854
|
|
| >PRK11359 cyclic-di-GMP phosphodiesterase; Provisional | Back alignment and domain information |
|---|
Probab=99.85 E-value=4.2e-20 Score=234.54 Aligned_cols=241 Identities=20% Similarity=0.309 Sum_probs=197.7
Q ss_pred chHHHHHHHHHhcCCeEEEEeCCCCCCcEEEccHHHHHHcCCChhhhcCCCCCcCCCCCCChHHHHHHHHHHHcCC----
Q 001847 189 RVSDIVKDALSTFQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKIRETLQNGQ---- 264 (1005)
Q Consensus 189 ~~~~~l~~ile~~~~~i~i~D~~~~dg~I~~vN~a~~~l~Gys~eEllG~~~~~l~~~~~~~~~~~~i~~~l~~g~---- 264 (1005)
.....+..+++.++++++++|. +|+|++||++|++++||+.+|++|+++..+.+++........+......+.
T Consensus 9 ~~~~~~~~~le~~~~~i~~~d~---~g~i~~~N~~~~~l~G~s~eeliG~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 85 (799)
T PRK11359 9 AADGIFFPALEQNMMGAVLINE---NDEVLFFNPAAEKLWGYKREEVIGNNIDMLIPRDLRPAHPEYIRHNREGGKARVE 85 (799)
T ss_pred hhhhhHHHHHHhhcCcEEEEcC---CCeEEEEcHHHHHHhCCCHHHHcCCCHHHhcCccccccchHHHhhhhccCCcccc
Confidence 4455778899999999999998 778999999999999999999999998877777665444444444444432
Q ss_pred cEEEEEEEEecCCcEEEEEEEeeeeecCCCCEEEEEEEEeccchhhHHHHHhhcCCCCCchhhhhHHHHHHHHhhhhHHH
Q 001847 265 SYCGRLLNYKKDGTPFWNLLTIAPIKDDEGKVLKFIGMQVEVSKHTEGAKDKMLRPNGLPESLIRYDARQKEMATSSVTE 344 (1005)
Q Consensus 265 ~~~~e~~~~~kdG~~~wv~~~~~pi~d~~G~v~~~v~~~~DITerk~~E~~L~~~~~~l~~~l~~~~~~~~~~~~~~~~~ 344 (1005)
.+..+++.+++||..+|+.++..++. .+|. .+++++.+|||++++.+++++.
T Consensus 86 ~~~~e~~~~~~dG~~~~v~~~~~~~~-~~g~-~~~~~~~~DiT~~~~~~~~~~~-------------------------- 137 (799)
T PRK11359 86 GMSRELQLEKKDGSKIWTRFALSKVS-AEGK-VYYLALVRDASVEMAQKEQTRQ-------------------------- 137 (799)
T ss_pred ccceeeEEecCCcCEEEEEEEeeeec-cCCc-eEEEEEEeeccchhhhHHHHHH--------------------------
Confidence 24457888999999999999998874 4454 4678999999987766544331
Q ss_pred HHHHccCCCCcccCCCCCcccccCCCCchhhhcccccCCCCCCCCCCCCCCCCCCcccccccccccchhhccccCCcccc
Q 001847 345 LVQAMKKPRSLSESTNRPPIIRKSEGGVEEERAGALGRRKSENVPPPRRNSYGGGCRTSMQRISEVPEKKKQKSGRRSFM 424 (1005)
Q Consensus 345 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 424 (1005)
T Consensus 138 -------------------------------------------------------------------------------- 137 (799)
T PRK11359 138 -------------------------------------------------------------------------------- 137 (799)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred cccccccccCCCCCCccccccccCCCCCCCCCCCCCchhhHHHHHHHhhcccHHHHHHhccccEEEEcCCCCCCCEEeec
Q 001847 425 GLIGRKSQSTDDHDSFENEIIMEGDDDYESDDERPDSVDDKVRQKEMRKGIDLATTLERIEKNFVITDPRLPDNPIIFAS 504 (1005)
Q Consensus 425 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~er~~~e~~l~~~~~l~~i~e~~~~~I~i~D~~G~d~~i~~vN 504 (1005)
+..++++++++++++|.+|. ++++|
T Consensus 138 ----------------------------------------------------~~~~~~~~~~~i~~~d~~g~---i~~~N 162 (799)
T PRK11359 138 ----------------------------------------------------LIIAVDHLDRPVIVLDPERR---IVQCN 162 (799)
T ss_pred ----------------------------------------------------HHHHHhcCCCcEEEEcCCCc---EEEEC
Confidence 55678999999999999888 99999
Q ss_pred HHHHHHcCCChhhhcCCCCCccC-CCCCCHHHHHHHHHHHhcCCcEEEEEEEEecCCcEEEEEEEEeeeeCCCCCEEEEE
Q 001847 505 DSFLELTEYSREEILGRNCRFLQ-GPETDPATVRKIRAAIDNQTDVTVQLINYTKSGKKFWNLFHLQPMRDQKGEVQYFI 583 (1005)
Q Consensus 505 ~a~~~l~Gy~~eEllG~~~~~l~-~~~~~~~~~~~i~~~l~~~~~~~~e~~~~~kdG~~~wv~~~~~pi~d~~G~v~~~v 583 (1005)
+++++++||+.++++|++...+. ++.........+...+..+..+..+++..+++|..+|+.++..|+.+.+|.+.+++
T Consensus 163 ~~~~~l~G~~~~e~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~dG~~~~~~~~~~~v~d~~g~~~~~~ 242 (799)
T PRK11359 163 RAFTEMFGYCISEASGMQPDTLLNIPEFPADNRIRLQQLLWKTARDQDEFLLLTRTGEKIWIKASISPVYDVLAHLQNLV 242 (799)
T ss_pred hhhHhhhCCCHHHHCCCChHHhcCCCCCcHHHHHHHHHhhccCCCCcceeEEeCCCCCEEEEEeeeeeeecCCCceeEEE
Confidence 99999999999999999876554 45555555666777777777788889999999999999999999999999999999
Q ss_pred EEEecCccCccc
Q 001847 584 GVQLDGSEHLEP 595 (1005)
Q Consensus 584 gi~~DITerK~~ 595 (1005)
++.+|||++|+.
T Consensus 243 ~~~~DITerk~~ 254 (799)
T PRK11359 243 MTFSDITEERQI 254 (799)
T ss_pred EEeehhhhHHHH
Confidence 999999999874
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=6e-22 Score=234.29 Aligned_cols=270 Identities=21% Similarity=0.273 Sum_probs=193.1
Q ss_pred CccccccccccCcEEEEEEEEcCCCeEEEEEEeeccc-ccChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEE
Q 001847 673 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGV-MLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLIT 751 (1005)
Q Consensus 673 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~~~~~~-~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~ 751 (1005)
.|...+.||++-|=+|.++++. .| .+++|++-+.. .-.-....+...+++ ...+++||++.+.-+.......|||-
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~-eG-~vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvR 100 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDR-EG-LVVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVR 100 (1431)
T ss_pred ceeeecccCchhhhhhhhccCC-Cc-eEEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHH
Confidence 6889999999999999999983 34 48999987653 223334455555666 56679999999988877888899999
Q ss_pred eccCCCchhhHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCCCCC
Q 001847 752 DYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLL 831 (1005)
Q Consensus 752 E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~~ 831 (1005)
+|+ ..+|+|.+..++. +..-..+.|+.||+.||..+|..||+|||||.+||||++-+.+.|.||...+...-..+.
T Consensus 101 qyv-khnLyDRlSTRPF--L~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDN- 176 (1431)
T KOG1240|consen 101 QYV-KHNLYDRLSTRPF--LVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDN- 176 (1431)
T ss_pred HHH-hhhhhhhhccchH--HHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEeeechhhhhcccccCCccCCCCC-
Confidence 999 7899999987654 888889999999999999999999999999999999999999999999976443211110
Q ss_pred CCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCC----------C-CCChhhHHHHHHHHHHHHc-CCC
Q 001847 832 LPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGA----------G-HTSAVDWWALGILLYEMLY-GYT 899 (1005)
Q Consensus 832 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~----------~-~~~~sDIwSlGvll~eLlt-G~~ 899 (1005)
|. .. .++. ++-.-..+|+|||.+... . .+++.||||+||++.||++ |++
T Consensus 177 -Pa-----------df-~fFF------DTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~P 237 (1431)
T KOG1240|consen 177 -PA-----------DF-TFFF------DTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRP 237 (1431)
T ss_pred -cc-----------cc-eEEE------ecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCC
Confidence 00 00 0111 111234589999988542 1 4678999999999999997 888
Q ss_pred CCCCCChHHHHHHHHhCCCCCC---CCCCCCHHHHHHHHHccccCcCccCCChhcHHHHHcC-------CCCCCCChhhh
Q 001847 900 PFRGKTRQKTFANILHKDLKFP---SSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKH-------PFFKGVNWALV 969 (1005)
Q Consensus 900 Pf~~~~~~~~~~~i~~~~~~~~---~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~h-------pff~~~~~~~~ 969 (1005)
||.-. ++.....+.-..+ .....+..+++||..|++.||.+|.+ |++.|+- .||-.+-+.-+
T Consensus 238 lF~LS----QL~aYr~~~~~~~e~~Le~Ied~~~Rnlil~Mi~rdPs~RlS----AedyL~~yrG~~FP~yFy~FL~~Y~ 309 (1431)
T KOG1240|consen 238 LFTLS----QLLAYRSGNADDPEQLLEKIEDVSLRNLILSMIQRDPSKRLS----AEDYLQKYRGLVFPEYFYSFLYDYL 309 (1431)
T ss_pred cccHH----HHHhHhccCccCHHHHHHhCcCccHHHHHHHHHccCchhccC----HHHHHHhhhccccHHHHHHHHHHHH
Confidence 88311 0111111100000 00112335789999999999999999 8888876 34444444555
Q ss_pred hhcCCCC
Q 001847 970 RCMNPPE 976 (1005)
Q Consensus 970 ~~~~~~~ 976 (1005)
.++.++.
T Consensus 310 ~~~~~~~ 316 (1431)
T KOG1240|consen 310 DRFVPLT 316 (1431)
T ss_pred HhcCCcc
Confidence 6666665
|
|
| >TIGR02938 nifL_nitrog nitrogen fixation negative regulator NifL | Back alignment and domain information |
|---|
Probab=99.84 E-value=3.8e-21 Score=229.44 Aligned_cols=244 Identities=20% Similarity=0.299 Sum_probs=191.5
Q ss_pred HHHHHHHHHhcCCeEEEEeCCCCCCcEEEccHHHHHHcCCChhhhcCCCCCcCCCCCCChHHHHHHHHHHHcCCcEEEEE
Q 001847 191 SDIVKDALSTFQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKIRETLQNGQSYCGRL 270 (1005)
Q Consensus 191 ~~~l~~ile~~~~~i~i~D~~~~dg~I~~vN~a~~~l~Gys~eEllG~~~~~l~~~~~~~~~~~~i~~~l~~g~~~~~e~ 270 (1005)
.+.|+.++++++++++++|. +|+++++|++|++++||++++++|++...+.++.........+.+.+..+..+..++
T Consensus 3 ~~~~~~i~~~~~~~i~~~d~---~g~~~~~N~~~~~~~G~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 79 (494)
T TIGR02938 3 PEAYRQTVDQAPLAISITDL---KANILYANDAFTRITGYTKEEIIGKNESVLSNHTTPPEVYQALWGSLAEQKPWAGKL 79 (494)
T ss_pred hHHHHHHHHhCCceEEEECC---CCcEEEEchhheeecCCCHHHHhCCCchhhcCCCCCHHHHHHHHHHHHhCCccccee
Confidence 46799999999999999998 777999999999999999999999987766666666666777788888888888888
Q ss_pred EEEecCCcEEEEEEEeeeeecCCCCEEEEEEEEeccchhhHHHHHhhcCCCCCchhhhhHHHHHHHHhhhhHHHHHHHcc
Q 001847 271 LNYKKDGTPFWNLLTIAPIKDDEGKVLKFIGMQVEVSKHTEGAKDKMLRPNGLPESLIRYDARQKEMATSSVTELVQAMK 350 (1005)
Q Consensus 271 ~~~~kdG~~~wv~~~~~pi~d~~G~v~~~v~~~~DITerk~~E~~L~~~~~~l~~~l~~~~~~~~~~~~~~~~~l~~~~~ 350 (1005)
..++++|..+|+...+.|+++.+|.+.+++++++|||++|+++++++..
T Consensus 80 ~~~~~~g~~~~~~~~~~~~~~~~g~~~~~~~~~~DIt~~k~~e~~l~~~------------------------------- 128 (494)
T TIGR02938 80 LNRRKDGELYLAELTVAPVLNEAGETTHFLGMHRDITELHRLEQVVANQ------------------------------- 128 (494)
T ss_pred eccCCCccchhhheeeEEEECCCCCEEEEEEehhhhhHHHHHHHHHHHH-------------------------------
Confidence 8889999999999999999999999999999999999999998776520
Q ss_pred CCCCcccCCCCCcccccCCCCchhhhcccccCCCCCCCCCCCCCCCCCCcccccccccccchhhccccCCcccccccccc
Q 001847 351 KPRSLSESTNRPPIIRKSEGGVEEERAGALGRRKSENVPPPRRNSYGGGCRTSMQRISEVPEKKKQKSGRRSFMGLIGRK 430 (1005)
Q Consensus 351 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 430 (1005)
T Consensus 129 -------------------------------------------------------------------------------- 128 (494)
T TIGR02938 129 -------------------------------------------------------------------------------- 128 (494)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred cccCCCCCCccccccccCCCCCCCCCCCCCchhhHHHHHHHhhcccHHHHHHhccccEEEEcCCCCCCCEEeecHHHHHH
Q 001847 431 SQSTDDHDSFENEIIMEGDDDYESDDERPDSVDDKVRQKEMRKGIDLATTLERIEKNFVITDPRLPDNPIIFASDSFLEL 510 (1005)
Q Consensus 431 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~er~~~e~~l~~~~~l~~i~e~~~~~I~i~D~~G~d~~i~~vN~a~~~l 510 (1005)
...++.++++++++|+++|.+|. ++++|++|+++
T Consensus 129 -------------------------------------------~~~~~~~~~~~~~~i~~~d~~~~---i~~~N~~~~~~ 162 (494)
T TIGR02938 129 -------------------------------------------KLLIESVVDAAPVAFVLLDPTGR---VILDNQEYKKL 162 (494)
T ss_pred -------------------------------------------HHHHHHHHhcccceEEEEcCCCC---EEEechhHHHh
Confidence 01178899999999999999888 99999999999
Q ss_pred cCCChhhhcCCCCCccCCCCCCHHHHHHHHHHHhcCCcE-EEEEEEEecCCc-EEEEEEEEeeeeCCCCCE---------
Q 001847 511 TEYSREEILGRNCRFLQGPETDPATVRKIRAAIDNQTDV-TVQLINYTKSGK-KFWNLFHLQPMRDQKGEV--------- 579 (1005)
Q Consensus 511 ~Gy~~eEllG~~~~~l~~~~~~~~~~~~i~~~l~~~~~~-~~e~~~~~kdG~-~~wv~~~~~pi~d~~G~v--------- 579 (1005)
+|+...+..+..+..+.+++.... +......+..+ ..+......+|. .+|+.....++.+..|.+
T Consensus 163 ~g~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (494)
T TIGR02938 163 ATDLRVKEPAHTVLDLLREAWREA----LAENWPQQLAFSNREARFDRGGGRPARWLSCTGSVIGMESDCADSFFCAAEQ 238 (494)
T ss_pred hchhhhhHHHHHHHHHhhHHhhhh----hhhcchhhhccccceeeeccCCCceeeEEEecCceEEeecchhhheeccCCC
Confidence 999988887765444444332222 11111111121 223444455555 789999888887766553
Q ss_pred EEEEEEEecCccCcccccc
Q 001847 580 QYFIGVQLDGSEHLEPLRN 598 (1005)
Q Consensus 580 ~~~vgi~~DITerK~~e~~ 598 (1005)
.+++++++|||++|+++++
T Consensus 239 ~~~~~~~~DITe~k~~ee~ 257 (494)
T TIGR02938 239 PYLLLTIADISNLREEQER 257 (494)
T ss_pred chheehHHHHHHHHHHHHH
Confidence 3456788999999996544
|
NifL is a modulator of the nitrogen fixation positive regulator protein NifA, and is therefore a negative regulator. It binds NifA. NifA and NifL are encoded by adjacent genes. |
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.82 E-value=2.7e-20 Score=195.04 Aligned_cols=176 Identities=16% Similarity=0.144 Sum_probs=135.8
Q ss_pred ccccCCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHH------HHHHHHHHHhCCCCCcceEEEEE
Q 001847 668 QINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHR------ACAEREILDMLDHPFVPALYASF 741 (1005)
Q Consensus 668 ~i~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~------~~~E~~il~~l~hpnIv~l~~~~ 741 (1005)
.+..++|++++.||.|+||.||++.+ ++..+|+|++............. +.+|+..+.++.|++|..+.+++
T Consensus 27 ~~l~~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~ 104 (232)
T PRK10359 27 DFLSYNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFY 104 (232)
T ss_pred HHhhCceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEee
Confidence 34568999999999999999999766 46689999998764444443333 56889999999999999999886
Q ss_pred EeC--------CeEEEEEeccCCCchhhHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcE
Q 001847 742 QTK--------THVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHV 813 (1005)
Q Consensus 742 ~~~--------~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~~~g~v 813 (1005)
... +..++||||++|.+|.++.. +++ ..+.+++.+|..||..|++|||+||+||+++.+| +
T Consensus 105 ~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~------~~~----~~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~~g-i 173 (232)
T PRK10359 105 LLAERKTLRYAHTYIMLIEYIEGVELNDMPE------ISE----DVKAKIKASIESLHQHGMVSGDPHKGNFIVSKNG-L 173 (232)
T ss_pred eecccccccccCCeEEEEEEECCccHHHhhh------ccH----HHHHHHHHHHHHHHHcCCccCCCChHHEEEeCCC-E
Confidence 633 35789999999999988732 333 2456999999999999999999999999999988 9
Q ss_pred EEEeccCCcccCCCCCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHH
Q 001847 814 SLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYE 893 (1005)
Q Consensus 814 kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlGvll~e 893 (1005)
+|+|||.......+.. . .-++....++.++||||||+++..
T Consensus 174 ~liDfg~~~~~~e~~a---------------------------------~------d~~vler~y~~~~di~~lg~~~~~ 214 (232)
T PRK10359 174 RIIDLSGKRCTAQRKA---------------------------------K------DRIDLERHYGIKNEIKDLGYYLLI 214 (232)
T ss_pred EEEECCCcccccchhh---------------------------------H------HHHHHHhHhcccccccceeEeehH
Confidence 9999998743311100 0 002334445678999999999877
Q ss_pred HH
Q 001847 894 ML 895 (1005)
Q Consensus 894 Ll 895 (1005)
+.
T Consensus 215 ~~ 216 (232)
T PRK10359 215 YK 216 (232)
T ss_pred HH
Confidence 64
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.82 E-value=3.5e-20 Score=199.79 Aligned_cols=236 Identities=23% Similarity=0.281 Sum_probs=152.8
Q ss_pred CccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCC----------CCCcceEEEEEE
Q 001847 673 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLD----------HPFVPALYASFQ 742 (1005)
Q Consensus 673 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~il~~l~----------hpnIv~l~~~~~ 742 (1005)
.+.....||.|+++.||.|.|..||+.+|+|++...........+.+.+|.-....+. |-.++..++...
T Consensus 13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~ 92 (288)
T PF14531_consen 13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR 92 (288)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence 4677789999999999999999999999999987665444555666666654443322 223444444332
Q ss_pred e---------C---C-----eEEEEEeccCCCchhhHHhh---CCC--CCCCHHHHHHHHHHHHHHHHHHHHcCcccCCC
Q 001847 743 T---------K---T-----HVCLITDYCPGGELFLLLDR---QPT--KVLKEDAVRFYAAEVVVALEYLHCQGIIYRDL 800 (1005)
Q Consensus 743 ~---------~---~-----~~~lV~E~~~ggsL~~~l~~---~~~--~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDL 800 (1005)
. . . ..+++|+-+ .++|.+++.. ... ..+.......+..|+++.+++||..|++|+||
T Consensus 93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHgdi 171 (288)
T PF14531_consen 93 IPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHGDI 171 (288)
T ss_dssp ETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEEST-
T ss_pred EcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEeccc
Confidence 1 1 1 246788888 7888877652 111 11223333455589999999999999999999
Q ss_pred CCCcEEEecCCcEEEEeccCCcccCCCCCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccC-----
Q 001847 801 KPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAG----- 875 (1005)
Q Consensus 801 kP~NILi~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~----- 875 (1005)
+|+|++++.+|.++|+||+.....+... .....+..|.+||....
T Consensus 172 ~~~nfll~~~G~v~Lg~F~~~~r~g~~~------------------------------~~~~~~~~~~PPe~~~~~~~~~ 221 (288)
T PF14531_consen 172 KPENFLLDQDGGVFLGDFSSLVRAGTRY------------------------------RCSEFPVAFTPPELESCAGQFG 221 (288)
T ss_dssp SGGGEEE-TTS-EEE--GGGEEETTEEE------------------------------EGGGS-TTTS-HHHHHHHTSCH
T ss_pred ceeeEEEcCCCCEEEcChHHHeecCcee------------------------------eccCCCcccCChhhhhhhcccC
Confidence 9999999999999999999764322100 00124467899997643
Q ss_pred ---CCCCChhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHccccCcCcc
Q 001847 876 ---AGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSR 945 (1005)
Q Consensus 876 ---~~~~~~sDIwSlGvll~eLltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~R 945 (1005)
..++.+.|.|+||+++|.|.||..||........... .+......+..++.||..||+++|.+|
T Consensus 222 ~~~~~~t~~~DaW~LG~~ly~lWC~~lPf~~~~~~~~~~~------~f~~C~~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 222 QNNAPYTFATDAWQLGITLYSLWCGRLPFGLSSPEADPEW------DFSRCRDMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp HSEEEE-HHHHHHHHHHHHHHHHHSS-STCCCGGGSTSGG------GGTTSS---HHHHHHHHHHT-SSGGGS
T ss_pred cccceeeeccCHHHHHHHHHHHHHccCCCCCCCccccccc------cchhcCCcCHHHHHHHHHHccCCcccC
Confidence 2467799999999999999999999976543221110 333334678889999999999999988
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.6e-19 Score=187.03 Aligned_cols=141 Identities=16% Similarity=0.173 Sum_probs=109.6
Q ss_pred cccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHH-----------------------HHHHHHHHHHHHhCCCCC
Q 001847 677 IKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNK-----------------------VHRACAEREILDMLDHPF 733 (1005)
Q Consensus 677 ~~~LG~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~-----------------------~~~~~~E~~il~~l~hpn 733 (1005)
...||+|++|.||+|.+. +|+.||+|+++......... ......|+.++..+.+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05147 2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAG 80 (190)
T ss_pred CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCC
Confidence 467999999999999996 89999999998653211110 112235899999998877
Q ss_pred cceEEEEEEeCCeEEEEEeccCCCchhhHHhhCCCCCCCHHHHHHHHHHHHHHHHHH-HHcCcccCCCCCCcEEEecCCc
Q 001847 734 VPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYL-HCQGIIYRDLKPENVLLQGNGH 812 (1005)
Q Consensus 734 Iv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~L-H~~gIvHrDLkP~NILi~~~g~ 812 (1005)
+.....+... . .+|||||++|+++...+... ..++...+..++.||+.+|.+| |+.||+||||||+|||++ ++.
T Consensus 81 v~~p~~~~~~-~-~~iVmE~i~g~~l~~~~~~~--~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~-~~~ 155 (190)
T cd05147 81 IPCPEPILLK-S-HVLVMEFIGDDGWAAPRLKD--APLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYH-DGK 155 (190)
T ss_pred CCCCcEEEec-C-CEEEEEEeCCCCCcchhhhc--CCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEE-CCc
Confidence 7544433222 2 38999999887776553332 4588999999999999999999 799999999999999998 588
Q ss_pred EEEEeccCCcc
Q 001847 813 VSLTDFDLSCL 823 (1005)
Q Consensus 813 vkL~DFG~a~~ 823 (1005)
++|+|||+|..
T Consensus 156 v~LiDFG~a~~ 166 (190)
T cd05147 156 LYIIDVSQSVE 166 (190)
T ss_pred EEEEEcccccc
Confidence 99999999854
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.78 E-value=2.3e-19 Score=182.94 Aligned_cols=244 Identities=19% Similarity=0.301 Sum_probs=199.7
Q ss_pred cccCCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEE
Q 001847 669 INLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVC 748 (1005)
Q Consensus 669 i~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~ 748 (1005)
+...+..++.+|.+.-.|..|++++ .|.-++.|++..... ......+|..|.-.|+...||||+.+++.+.....+.
T Consensus 187 id~~~lnl~tkl~e~hsgelwrgrw--qgndivakil~vr~~-t~risrdfneefp~lrifshpnilpvlgacnsppnlv 263 (448)
T KOG0195|consen 187 IDVSSLNLITKLAESHSGELWRGRW--QGNDIVAKILNVREV-TARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLV 263 (448)
T ss_pred cchhhhhhhhhhccCCCcccccccc--cCcchhhhhhhhhhc-chhhcchhhhhCcceeeecCCchhhhhhhccCCCCce
Confidence 4455677788899999999999999 445677787764432 2333456777888888899999999999999999999
Q ss_pred EEEeccCCCchhhHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcC--cccCCCCCCcEEEecCCcEEEE--eccCCccc
Q 001847 749 LITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQG--IIYRDLKPENVLLQGNGHVSLT--DFDLSCLT 824 (1005)
Q Consensus 749 lV~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~g--IvHrDLkP~NILi~~~g~vkL~--DFG~a~~~ 824 (1005)
++..||+-|+|+.++..+..-..+..++..++.++++|++|||+.. |..--|....++|+++-+.+|+ |--++...
T Consensus 264 ~isq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltarismad~kfsfqe 343 (448)
T KOG0195|consen 264 IISQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARISMADTKFSFQE 343 (448)
T ss_pred EeeeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhheecccceeeeec
Confidence 9999999999999999887777888999999999999999999984 4445788889999998776663 43333111
Q ss_pred CCCCCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCC---ChhhHHHHHHHHHHHHcCCCCC
Q 001847 825 SCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHT---SAVDWWALGILLYEMLYGYTPF 901 (1005)
Q Consensus 825 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~---~~sDIwSlGvll~eLltG~~Pf 901 (1005)
......|.||+||.+...+-+ .++|+|||++++|||.|...||
T Consensus 344 ----------------------------------~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpf 389 (448)
T KOG0195|consen 344 ----------------------------------VGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPF 389 (448)
T ss_pred ----------------------------------cccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhcccccc
Confidence 123457899999999876543 3899999999999999999999
Q ss_pred CCCChHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHccccCcCccCCCh
Q 001847 902 RGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSH 949 (1005)
Q Consensus 902 ~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~ 949 (1005)
..-.+.+.-.+|.-..+....++.++...-+|+.-|+..||.+||.+.
T Consensus 390 adlspmecgmkialeglrv~ippgis~hm~klm~icmnedpgkrpkfd 437 (448)
T KOG0195|consen 390 ADLSPMECGMKIALEGLRVHIPPGISRHMNKLMNICMNEDPGKRPKFD 437 (448)
T ss_pred ccCCchhhhhhhhhccccccCCCCccHHHHHHHHHHhcCCCCcCCCcc
Confidence 999998888888777777777778899999999999999999999964
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.78 E-value=2.6e-18 Score=178.42 Aligned_cols=143 Identities=17% Similarity=0.138 Sum_probs=111.7
Q ss_pred cccccccCcEEEEEEEEcCCCeEEEEEEeecccccCh-----------------------HHHHHHHHHHHHHHhCCCCC
Q 001847 677 IKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNR-----------------------NKVHRACAEREILDMLDHPF 733 (1005)
Q Consensus 677 ~~~LG~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~-----------------------~~~~~~~~E~~il~~l~hpn 733 (1005)
.+.||+|++|.||+|.+. +|+.||||+++....... ........|...+.++.|++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05145 2 NGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAG 80 (190)
T ss_pred CceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCC
Confidence 578999999999999986 899999999986521100 00122357889999999998
Q ss_pred cceEEEEEEeCCeEEEEEeccCCCchhhHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHH-cCcccCCCCCCcEEEecCCc
Q 001847 734 VPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHC-QGIIYRDLKPENVLLQGNGH 812 (1005)
Q Consensus 734 Iv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~-~gIvHrDLkP~NILi~~~g~ 812 (1005)
+.....+.... .|+||||++|+++....... ..++...+..++.|++.+|.+||+ .||+||||||+|||++ ++.
T Consensus 81 i~~p~~~~~~~--~~lVmE~~~g~~~~~~~l~~--~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~-~~~ 155 (190)
T cd05145 81 VPVPEPILLKK--NVLVMEFIGDDGSPAPRLKD--VPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYH-DGK 155 (190)
T ss_pred CCCceEEEecC--CEEEEEEecCCCchhhhhhh--ccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEE-CCC
Confidence 86554443332 48999999887554332222 347888999999999999999999 9999999999999999 899
Q ss_pred EEEEeccCCcccC
Q 001847 813 VSLTDFDLSCLTS 825 (1005)
Q Consensus 813 vkL~DFG~a~~~~ 825 (1005)
++|+|||++....
T Consensus 156 ~~liDFG~a~~~~ 168 (190)
T cd05145 156 PYIIDVSQAVELD 168 (190)
T ss_pred EEEEEcccceecC
Confidence 9999999986543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.78 E-value=8.1e-19 Score=187.74 Aligned_cols=205 Identities=23% Similarity=0.343 Sum_probs=145.8
Q ss_pred CCCCcceEEEEEEe---------------------------CCeEEEEEeccCCCchhhHHhhCCCCCCCHHHHHHHHHH
Q 001847 730 DHPFVPALYASFQT---------------------------KTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAE 782 (1005)
Q Consensus 730 ~hpnIv~l~~~~~~---------------------------~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~q 782 (1005)
+|||||.++.+|.+ +..+|+||..+ ..+|..|+..+. .+....+.++.|
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY-~~tLr~yl~~~~---~s~r~~~~~laQ 349 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRY-RQTLREYLWTRH---RSYRTGRVILAQ 349 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcc-hhhHHHHHhcCC---CchHHHHHHHHH
Confidence 59999999988743 23589999999 889999998753 677888889999
Q ss_pred HHHHHHHHHHcCcccCCCCCCcEEEe--cCC--cEEEEeccCCcccCCCCCCCCCcchhhhhcccCCCCCcccccccccc
Q 001847 783 VVVALEYLHCQGIIYRDLKPENVLLQ--GNG--HVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRAS 858 (1005)
Q Consensus 783 il~aL~~LH~~gIvHrDLkP~NILi~--~~g--~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 858 (1005)
+++|+.|||++||.|||+|.+|||+. +|+ .+.|.|||++-.. +.+. .+-+. ....
T Consensus 350 lLEav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd--~~hG--------------lqlpy-----~S~~ 408 (598)
T KOG4158|consen 350 LLEAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLAD--DNHG--------------LQLPY-----ESDE 408 (598)
T ss_pred HHHHHHHHHHccchhhcccccceEEEecCCCCcEEEEcccceeeec--cccc--------------ccccc-----cccc
Confidence 99999999999999999999999995 333 5889999976321 1111 00000 0011
Q ss_pred cccccCCcccccccccCCCC------CChhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhCCCCCC-CCCCCCHHHH
Q 001847 859 NSFVGTEEYIAPEIIAGAGH------TSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANILHKDLKFP-SSTPTSLHAK 931 (1005)
Q Consensus 859 ~~~~gt~~y~aPE~l~~~~~------~~~sDIwSlGvll~eLltG~~Pf~~~~~~~~~~~i~~~~~~~~-~~~~~s~~l~ 931 (1005)
-..-|...-||||+....+- ..++|.|+.|.+.||++....||.+......-..-.+. -.+| .+..+++.++
T Consensus 409 Vd~GGNa~lmAPEi~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~Yqe-~qLPalp~~vpp~~r 487 (598)
T KOG4158|consen 409 VDLGGNAKLMAPEIATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRTYQE-SQLPALPSRVPPVAR 487 (598)
T ss_pred ccCCCcceecchhhhhcCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchheechhhhhh-hhCCCCcccCChHHH
Confidence 12357778999999865431 23899999999999999999999873332211111111 1222 2334788899
Q ss_pred HHHHHccccCcCccCCChhcHHHHHcCCCC
Q 001847 932 QLMYRLLHRDPKSRLGSHEGANEIKKHPFF 961 (1005)
Q Consensus 932 ~Ll~~~L~~dP~~Rpt~~~~a~elL~hpff 961 (1005)
+|+..+|+.||.+|++.. ++..+|+-..+
T Consensus 488 qlV~~lL~r~pskRvsp~-iAANvl~LsLw 516 (598)
T KOG4158|consen 488 QLVFDLLKRDPSKRVSPN-IAANVLNLSLW 516 (598)
T ss_pred HHHHHHhcCCccccCCcc-HHHhHHHHHHh
Confidence 999999999999999954 45555544333
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.75 E-value=2.1e-17 Score=169.57 Aligned_cols=203 Identities=19% Similarity=0.178 Sum_probs=139.8
Q ss_pred ccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccC-hHHHHHHHHHHHHHHhCC-CCCcceEEEEEEeCCeEEEEE
Q 001847 674 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLN-RNKVHRACAEREILDMLD-HPFVPALYASFQTKTHVCLIT 751 (1005)
Q Consensus 674 y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~-~~~~~~~~~E~~il~~l~-hpnIv~l~~~~~~~~~~~lV~ 751 (1005)
+-+...|++|+||+||.+.. .+.+++.+.+....... .-....+.+|+++|++|. +++|++++++ +..|++|
T Consensus 4 ~~~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvm 77 (218)
T PRK12274 4 PAVNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDR 77 (218)
T ss_pred cccceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEE
Confidence 34567899999999997776 67788877665432111 111225678999999995 5889999886 4469999
Q ss_pred eccCCCchhhHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCC-CCCcEEEecCCcEEEEeccCCcccCCCCCC
Q 001847 752 DYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDL-KPENVLLQGNGHVSLTDFDLSCLTSCKPQL 830 (1005)
Q Consensus 752 E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDL-kP~NILi~~~g~vkL~DFG~a~~~~~~~~~ 830 (1005)
||+.|.+|...... . ...++.|++.+|.++|++||+|||| ||+|||++.+|.++|+|||++.........
T Consensus 78 eyI~G~~L~~~~~~--------~-~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~ 148 (218)
T PRK12274 78 SYLAGAAMYQRPPR--------G-DLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARW 148 (218)
T ss_pred eeecCccHHhhhhh--------h-hHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcchH
Confidence 99999998654321 1 1357889999999999999999999 799999999999999999999643311100
Q ss_pred CCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCC-CCC-ChhhHHHHHHHHHHHHcCCCCCCCCC
Q 001847 831 LLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGA-GHT-SAVDWWALGILLYEMLYGYTPFRGKT 905 (1005)
Q Consensus 831 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~-~~sDIwSlGvll~eLltG~~Pf~~~~ 905 (1005)
. ..-. .+.. ... ...-...++.|++|+.-... ..+ ...+-++.|+-+|.++|+..|+.++.
T Consensus 149 ~--r~L~-~rDl----------~~l-lk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~ 211 (218)
T PRK12274 149 M--RLLA-REDL----------RHL-LKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDN 211 (218)
T ss_pred H--HHHH-HHHH----------HHH-HHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccC
Confidence 0 0000 0000 000 00012357778888753221 222 46788899999999999999886654
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.74 E-value=4.2e-18 Score=207.19 Aligned_cols=197 Identities=25% Similarity=0.360 Sum_probs=159.0
Q ss_pred cccCCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCC---CCCcceEEEEEEeCC
Q 001847 669 INLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLD---HPFVPALYASFQTKT 745 (1005)
Q Consensus 669 i~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~il~~l~---hpnIv~l~~~~~~~~ 745 (1005)
+....|.|-+.||+|+||+||+|.+.. |+.+|||+=+.... -.++--.+++.+|+ -+.|..+..++...+
T Consensus 695 ~~~~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~------WEfYI~~q~~~RLk~~~~~~~~~~~~a~~~~~ 767 (974)
T KOG1166|consen 695 VGGEKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNP------WEFYICLQVMERLKPQMLPSIMHISSAHVFQN 767 (974)
T ss_pred ecceeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCCc------eeeeehHHHHHhhchhhhcchHHHHHHHccCC
Confidence 456789999999999999999999966 99999998765432 23333344555555 234455555556667
Q ss_pred eEEEEEeccCCCchhhHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEec-------CCcEEEEec
Q 001847 746 HVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQG-------NGHVSLTDF 818 (1005)
Q Consensus 746 ~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~~-------~g~vkL~DF 818 (1005)
.-++|+||.+.|+|.+++.. .+.+++..+..+..|++..|+.||..+||||||||+|+|+.. +-.++|+||
T Consensus 768 ~S~lv~ey~~~Gtlld~~N~--~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDf 845 (974)
T KOG1166|consen 768 ASVLVSEYSPYGTLLDLINT--NKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKGLYLIDF 845 (974)
T ss_pred cceeeeeccccccHHHhhcc--CCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccceEEEec
Confidence 77899999999999999984 466999999999999999999999999999999999999952 335999999
Q ss_pred cCCcccCCCCCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHcCC
Q 001847 819 DLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGY 898 (1005)
Q Consensus 819 G~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlGvll~eLltG~ 898 (1005)
|.+.-+..-+ +.......++|-.|-++|...+.++++..|.|.|+.+++-|++|+
T Consensus 846 G~siDm~lfp-------------------------~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~ 900 (974)
T KOG1166|consen 846 GRSIDMKLFP-------------------------DGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGK 900 (974)
T ss_pred ccceeeeEcC-------------------------CCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHH
Confidence 9986543111 112345678999999999999999999999999999999999986
Q ss_pred C
Q 001847 899 T 899 (1005)
Q Consensus 899 ~ 899 (1005)
+
T Consensus 901 y 901 (974)
T KOG1166|consen 901 Y 901 (974)
T ss_pred H
Confidence 3
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.73 E-value=4.1e-17 Score=170.72 Aligned_cols=136 Identities=22% Similarity=0.215 Sum_probs=107.2
Q ss_pred cccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhC-----CCCCcceEEEEEEeCC---e
Q 001847 675 RPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDML-----DHPFVPALYASFQTKT---H 746 (1005)
Q Consensus 675 ~~~~~LG~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~il~~l-----~hpnIv~l~~~~~~~~---~ 746 (1005)
.-...||+|+|+.||. ++.++.. +||++.... ......+.+|+.+++.+ +||||+++++++.++. .
T Consensus 5 ~~~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~---~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~ 78 (210)
T PRK10345 5 SEQSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRG---DGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGY 78 (210)
T ss_pred CCcceecCCCceEEEE--CCCCcCe-EEEEEeccc---cchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeE
Confidence 3456799999999995 7667666 699886532 22346788999999999 5799999999998863 4
Q ss_pred EE-EEEec--cCCCchhhHHhhCCCCCCCHHHHHHHHHHHHHHH-HHHHHcCcccCCCCCCcEEEecC----CcEEEEec
Q 001847 747 VC-LITDY--CPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVAL-EYLHCQGIIYRDLKPENVLLQGN----GHVSLTDF 818 (1005)
Q Consensus 747 ~~-lV~E~--~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL-~~LH~~gIvHrDLkP~NILi~~~----g~vkL~DF 818 (1005)
++ +|||| +.+++|.+++... .+++. ..++.|++.++ +|||+++|+||||||+|||++.. +.++|+||
T Consensus 79 v~~~I~e~~G~~~~tL~~~l~~~---~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg 153 (210)
T PRK10345 79 VYDVIADFDGKPSITLTEFAEQC---RYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDN 153 (210)
T ss_pred EEEEEecCCCCcchhHHHHHHcc---cccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEEC
Confidence 44 78999 4479999999653 25555 35678888887 99999999999999999999743 47999995
Q ss_pred cCC
Q 001847 819 DLS 821 (1005)
Q Consensus 819 G~a 821 (1005)
+-+
T Consensus 154 ~G~ 156 (210)
T PRK10345 154 IGE 156 (210)
T ss_pred CCC
Confidence 433
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.69 E-value=1.3e-16 Score=171.02 Aligned_cols=145 Identities=20% Similarity=0.139 Sum_probs=113.7
Q ss_pred CccccccccccCcEEEEEEE-EcCCCeEEEEEEeecccccC-------------------hH--HHHHHHHHHHHHHhCC
Q 001847 673 HFRPIKPLGSGDTGSVHLVE-LCGSGQYFAMKAMDKGVMLN-------------------RN--KVHRACAEREILDMLD 730 (1005)
Q Consensus 673 ~y~~~~~LG~G~~g~Vy~a~-~~~~~~~valK~~~~~~~~~-------------------~~--~~~~~~~E~~il~~l~ 730 (1005)
.|.+.+.||.|++|.||+|. +..+|+.||+|+++...... .. ....+..|+.++.++.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 58899999999999999999 66789999999997542110 00 1123567999999997
Q ss_pred C--CCcceEEEEEEeCCeEEEEEeccCCCchhhHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcC-cccCCCCCCcEEE
Q 001847 731 H--PFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQG-IIYRDLKPENVLL 807 (1005)
Q Consensus 731 h--pnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~g-IvHrDLkP~NILi 807 (1005)
+ ..+++++++ ...++||||++|++|....... ..+....+..++.||+.+|.+||+.| |+|+||||+||++
T Consensus 109 ~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~--~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~NIli 182 (237)
T smart00090 109 EAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKD--VEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYNILV 182 (237)
T ss_pred hcCCCCCeeeEe----cCceEEEEEecCCccccccccc--CCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhhEEE
Confidence 5 334555543 2348999999988887654332 33666677899999999999999999 9999999999999
Q ss_pred ecCCcEEEEeccCCccc
Q 001847 808 QGNGHVSLTDFDLSCLT 824 (1005)
Q Consensus 808 ~~~g~vkL~DFG~a~~~ 824 (1005)
+ ++.++|+|||.+...
T Consensus 183 ~-~~~i~LiDFg~a~~~ 198 (237)
T smart00090 183 H-DGKVVIIDVSQSVEL 198 (237)
T ss_pred E-CCCEEEEEChhhhcc
Confidence 9 889999999998543
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.66 E-value=3.9e-17 Score=183.00 Aligned_cols=185 Identities=26% Similarity=0.374 Sum_probs=137.8
Q ss_pred CeEEEEEeccCCCchhhHHhh-CCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcc
Q 001847 745 THVCLITDYCPGGELFLLLDR-QPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCL 823 (1005)
Q Consensus 745 ~~~~lV~E~~~ggsL~~~l~~-~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~~~g~vkL~DFG~a~~ 823 (1005)
.++||.|++|.-.+|.+.+.+ ......+......++.|++.++.| +|.+|+|+||.||++..+..+||+|||+...
T Consensus 329 ~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d~q~kIgDFgl~ts 405 (516)
T KOG1033|consen 329 VYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDDDQLKIGDFGLVTS 405 (516)
T ss_pred cchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccccchhhhhhhhhheee
Confidence 368999999999999999974 344457778899999999999999 9999999999999999999999999999865
Q ss_pred cCCCCCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHcCCCCCCC
Q 001847 824 TSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRG 903 (1005)
Q Consensus 824 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlGvll~eLltG~~Pf~~ 903 (1005)
+...... ..........+||..||+||.+.+..|+.++||||||++|+||+. +|..
T Consensus 406 ~~~~~~~---------------------~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~---~f~T 461 (516)
T KOG1033|consen 406 QDKDETV---------------------APAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLI---QFST 461 (516)
T ss_pred cccCCcc---------------------cchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHH---Hhcc
Confidence 4433211 111223455689999999999999999999999999999999996 2222
Q ss_pred CC-hHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHccccCcCccCCChhcHHHHHcCCCC
Q 001847 904 KT-RQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFF 961 (1005)
Q Consensus 904 ~~-~~~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~hpff 961 (1005)
.. ....+..+-.+.++......++ .-..|+.+||...|.+||+ +.+.--|+|.
T Consensus 462 ~~er~~t~~d~r~g~ip~~~~~d~p-~e~~ll~~lls~~p~~RP~----~~~~~~~~~~ 515 (516)
T KOG1033|consen 462 QFERIATLTDIRDGIIPPEFLQDYP-EEYTLLQQLLSPSPEERPS----AIEVALHEFL 515 (516)
T ss_pred HHHHHHhhhhhhcCCCChHHhhcCc-HHHHHHHHhcCCCcccCch----HHHHhhhhhc
Confidence 11 1222233333333311222222 3468999999999999997 5555556554
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.65 E-value=1.2e-15 Score=161.19 Aligned_cols=138 Identities=21% Similarity=0.237 Sum_probs=114.9
Q ss_pred cccccccCcEEEEEEEEcCCCeEEEEEEeecccccCh-----HHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEE
Q 001847 677 IKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNR-----NKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLIT 751 (1005)
Q Consensus 677 ~~~LG~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~-----~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~ 751 (1005)
++.||+|++|.||++.+ .|..+++|.......... .....+.+|+.++..+.|++|+....++......++||
T Consensus 1 ~~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~ 78 (211)
T PRK14879 1 MKLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVM 78 (211)
T ss_pred CcccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEE
Confidence 36789999999999987 677899997664322111 12345778999999999999888777777778889999
Q ss_pred eccCCCchhhHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcc
Q 001847 752 DYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCL 823 (1005)
Q Consensus 752 E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~~~g~vkL~DFG~a~~ 823 (1005)
||++|++|.+++... .. ....++.+++.+|.+||+.|++|+|++|.|||++ ++.++|+|||.+..
T Consensus 79 e~~~G~~L~~~~~~~-----~~-~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 79 EYIEGEPLKDLINSN-----GM-EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred EEeCCcCHHHHHHhc-----cH-HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 999999999998653 12 7888999999999999999999999999999999 88999999998844
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.64 E-value=1.4e-16 Score=189.56 Aligned_cols=298 Identities=34% Similarity=0.550 Sum_probs=222.1
Q ss_pred cCCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEE
Q 001847 671 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLI 750 (1005)
Q Consensus 671 ~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV 750 (1005)
.+.+.+++.+.+|+++.++.+.-..+|...+.|.......-....+.....+-.++-...+|.++...-.|......+++
T Consensus 803 ~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L~ 882 (1205)
T KOG0606|consen 803 PDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPLV 882 (1205)
T ss_pred CccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcchh
Confidence 45788888999999999999988778866666655433221222223333333333333456666555556667788999
Q ss_pred EeccCCCchhhHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCCCC
Q 001847 751 TDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQL 830 (1005)
Q Consensus 751 ~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~ 830 (1005)
++|.++++|...+...+ ..+.+-.+.++..+..+++|||...+.|+|++|.|+++..+|..++.|||.....+.-+..
T Consensus 883 ~~~~~~~~~~Skl~~~~--~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~~p~ 960 (1205)
T KOG0606|consen 883 GHYLNGGDLPSKLHNSG--CLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLIPPT 960 (1205)
T ss_pred hHHhccCCchhhhhcCC--CcccccccchhHHHHhhhhccccchhhcccccccchhhcccCCcccCccccccccccccCc
Confidence 99999999999987653 4777778888999999999999999999999999999999999999999954332211110
Q ss_pred -CC--Ccc-hhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCh
Q 001847 831 -LL--PTT-NEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTR 906 (1005)
Q Consensus 831 -~~--~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlGvll~eLltG~~Pf~~~~~ 906 (1005)
.. +.. ..-.+..+....+..............||+.|.+||.+.+......+|.|++|+++++.++|.+||.....
T Consensus 961 ~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~na~tp 1040 (1205)
T KOG0606|consen 961 TDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFNAETP 1040 (1205)
T ss_pred CCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCCCcch
Confidence 00 000 00001111112222222344556677899999999999999999999999999999999999999999999
Q ss_pred HHHHHHHHhCCCCCCCCCC-CCHHHHHHHHHccccCcCccCCChhcHHHHHcCCCCCCCChhhhhh
Q 001847 907 QKTFANILHKDLKFPSSTP-TSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVNWALVRC 971 (1005)
Q Consensus 907 ~~~~~~i~~~~~~~~~~~~-~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~hpff~~~~~~~~~~ 971 (1005)
...+..|..+.++|+.... .+.++++++..+|..+|.+|..++ ++.+...|+||+.++|+.+.-
T Consensus 1041 q~~f~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~-~~~e~k~~~~~~~~~~~~l~~ 1105 (1205)
T KOG0606|consen 1041 QQIFENILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAK-GAAEVKGHPFFQDVDWENLAL 1105 (1205)
T ss_pred hhhhhccccCCCCCCCCccccChhhhhhhhhhhccCchhccCcc-cccccccCCccCCCCcccccc
Confidence 9999999999999987643 577899999999999999999943 245899999999999998743
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.63 E-value=2.6e-15 Score=157.17 Aligned_cols=133 Identities=19% Similarity=0.218 Sum_probs=107.5
Q ss_pred cccccCcEEEEEEEEcCCCeEEEEEEeecccccC-----hHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEEec
Q 001847 679 PLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLN-----RNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDY 753 (1005)
Q Consensus 679 ~LG~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~-----~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~ 753 (1005)
.||+|++|.||++.. ++..+++|......... .....++.+|+.+++.+.|+++....-++...+..++||||
T Consensus 1 ~ig~G~~~~vy~~~~--~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 78 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF--LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEY 78 (199)
T ss_pred CCCCCceEEEEEeec--CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEE
Confidence 379999999999985 67789999865432111 12235677899999999888766555556666778999999
Q ss_pred cCCCchhhHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcc
Q 001847 754 CPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCL 823 (1005)
Q Consensus 754 ~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~~~g~vkL~DFG~a~~ 823 (1005)
++|++|.+++.... . .++.+++.+|.+||+.|++|+|++|.||+++ ++.++++|||++..
T Consensus 79 ~~g~~l~~~~~~~~------~---~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 79 IEGKPLKDVIEEGN------D---ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred ECCccHHHHHhhcH------H---HHHHHHHHHHHHHHHCCeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 99999998875421 0 7889999999999999999999999999999 89999999998844
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >PF13426 PAS_9: PAS domain; PDB: 3ULF_B 3UE6_E 2Z6D_B 2Z6C_B 3P7N_B 1LL8_A 3MJQ_A 3BWL_A 4EET_B 4EEP_A | Back alignment and domain information |
|---|
Probab=99.62 E-value=5.7e-15 Score=136.27 Aligned_cols=104 Identities=26% Similarity=0.564 Sum_probs=96.2
Q ss_pred CCeEEEEeCCCCCCcEEEccHHHHHHcCCChhhhcCCCCCcCCCCCCChHHHHHHHHHHHcCCcEEEEEEEEecCCcEEE
Q 001847 202 QQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKIRETLQNGQSYCGRLLNYKKDGTPFW 281 (1005)
Q Consensus 202 ~~~i~i~D~~~~dg~I~~vN~a~~~l~Gys~eEllG~~~~~l~~~~~~~~~~~~i~~~l~~g~~~~~e~~~~~kdG~~~w 281 (1005)
|+|++++|. +|+|+++|++|++++||++++++|+++..++++.........+.+.+..+..+..++..++++|+.+|
T Consensus 1 p~~i~i~d~---~g~i~~~N~~~~~~~g~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~g~~~~ 77 (104)
T PF13426_consen 1 PDGIFILDP---DGRILYVNPAFERLFGYSREELIGKSISDFFPEEDRPEFEEQIERALEEGGSWSGEVRLRRKDGETFW 77 (104)
T ss_dssp -SEEEEEET---TSBEEEE-HHHHHHHTS-HHHHTTSBGGGGCSTTSCHHHHHHHHHHHHHTSSEEEEEEEEETTSEEEE
T ss_pred CEEEEEECC---cCcEEehhHHHHHHHCcCHHHHcCCCcccccCcccchhhHHHHHHHHhcCCceeEEEEEEcCCCCEEE
Confidence 689999999 78899999999999999999999999998888887888889999999999999999999999999999
Q ss_pred EEEEeeeeecCCCCEEEEEEEEeccch
Q 001847 282 NLLTIAPIKDDEGKVLKFIGMQVEVSK 308 (1005)
Q Consensus 282 v~~~~~pi~d~~G~v~~~v~~~~DITe 308 (1005)
+.++++|+.+++|++.+++++++|||+
T Consensus 78 ~~~~~~~i~~~~g~~~~~i~~~~DiTe 104 (104)
T PF13426_consen 78 VEVSASPIRDEDGEITGIIGIFRDITE 104 (104)
T ss_dssp EEEEEEEEEETTSSEEEEEEEEEEEHH
T ss_pred EEEEEEEEECCCCCEEEEEEEEEECCC
Confidence 999999999999999999999999996
|
... |
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.62 E-value=3.2e-15 Score=156.38 Aligned_cols=139 Identities=21% Similarity=0.156 Sum_probs=108.6
Q ss_pred CccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccCh-------------------HHHHHHHHHHHHHHhCCCC-
Q 001847 673 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNR-------------------NKVHRACAEREILDMLDHP- 732 (1005)
Q Consensus 673 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~-------------------~~~~~~~~E~~il~~l~hp- 732 (1005)
.|.+.+.||.|+||.||++.+ .+|+.+|||++........ ........|+.++..+.++
T Consensus 16 ~~~~~~~i~~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 94 (198)
T cd05144 16 VESLGNQIGVGKESDVYLALD-PDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEG 94 (198)
T ss_pred hhhcCCccccCcceEEEEEEc-CCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcC
Confidence 388899999999999999988 4799999998765321000 0112356788888888777
Q ss_pred -CcceEEEEEEeCCeEEEEEeccCCCchhhHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCC
Q 001847 733 -FVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNG 811 (1005)
Q Consensus 733 -nIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~~~g 811 (1005)
.++.+++. ...++||||++|++|..+... .....++.+|+.++.++|+.||+|+||||+||+++.++
T Consensus 95 i~v~~~~~~----~~~~lv~e~~~g~~L~~~~~~--------~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill~~~~ 162 (198)
T cd05144 95 FPVPKPIDW----NRHAVVMEYIDGVELYRVRVL--------EDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILVDDDE 162 (198)
T ss_pred CCCCceeec----CCceEEEEEeCCcchhhcccc--------ccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEEcCCC
Confidence 44555432 455899999999998765421 33567889999999999999999999999999999999
Q ss_pred cEEEEeccCCccc
Q 001847 812 HVSLTDFDLSCLT 824 (1005)
Q Consensus 812 ~vkL~DFG~a~~~ 824 (1005)
.++|+|||++...
T Consensus 163 ~~~liDfg~~~~~ 175 (198)
T cd05144 163 KIYIIDWPQMVST 175 (198)
T ss_pred cEEEEECCccccC
Confidence 9999999998543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PF13426 PAS_9: PAS domain; PDB: 3ULF_B 3UE6_E 2Z6D_B 2Z6C_B 3P7N_B 1LL8_A 3MJQ_A 3BWL_A 4EET_B 4EEP_A | Back alignment and domain information |
|---|
Probab=99.60 E-value=8.1e-15 Score=135.23 Aligned_cols=104 Identities=28% Similarity=0.460 Sum_probs=96.5
Q ss_pred cccEEEEcCCCCCCCEEeecHHHHHHcCCChhhhcCCCCCccCCCCCCHHHHHHHHHHHhcCCcEEEEEEEEecCCcEEE
Q 001847 485 EKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIRAAIDNQTDVTVQLINYTKSGKKFW 564 (1005)
Q Consensus 485 ~~~I~i~D~~G~d~~i~~vN~a~~~l~Gy~~eEllG~~~~~l~~~~~~~~~~~~i~~~l~~~~~~~~e~~~~~kdG~~~w 564 (1005)
|+||+++|.+|. |+++|++|++++||++++++|+++..+.+++........+.+.+..+..+..+..+.+++|+.+|
T Consensus 1 p~~i~i~d~~g~---i~~~N~~~~~~~g~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~g~~~~ 77 (104)
T PF13426_consen 1 PDGIFILDPDGR---ILYVNPAFERLFGYSREELIGKSISDFFPEEDRPEFEEQIERALEEGGSWSGEVRLRRKDGETFW 77 (104)
T ss_dssp -SEEEEEETTSB---EEEE-HHHHHHHTS-HHHHTTSBGGGGCSTTSCHHHHHHHHHHHHHTSSEEEEEEEEETTSEEEE
T ss_pred CEEEEEECCcCc---EEehhHHHHHHHCcCHHHHcCCCcccccCcccchhhHHHHHHHHhcCCceeEEEEEEcCCCCEEE
Confidence 689999999888 99999999999999999999999999998888888889999999989889999999999999999
Q ss_pred EEEEEeeeeCCCCCEEEEEEEEecCcc
Q 001847 565 NLFHLQPMRDQKGEVQYFIGVQLDGSE 591 (1005)
Q Consensus 565 v~~~~~pi~d~~G~v~~~vgi~~DITe 591 (1005)
+++++.|+.+++|++.+++++++||||
T Consensus 78 ~~~~~~~i~~~~g~~~~~i~~~~DiTe 104 (104)
T PF13426_consen 78 VEVSASPIRDEDGEITGIIGIFRDITE 104 (104)
T ss_dssp EEEEEEEEEETTSSEEEEEEEEEEEHH
T ss_pred EEEEEEEEECCCCCEEEEEEEEEECCC
Confidence 999999999999999999999999996
|
... |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.59 E-value=1e-14 Score=175.69 Aligned_cols=139 Identities=21% Similarity=0.221 Sum_probs=111.8
Q ss_pred CCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccc-----cChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCe
Q 001847 672 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVM-----LNRNKVHRACAEREILDMLDHPFVPALYASFQTKTH 746 (1005)
Q Consensus 672 ~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~~~~~~~-----~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~ 746 (1005)
..|...+.||+|+||.||++.+... .+++|....... ........+.+|+.+++.++|++++.+..++.....
T Consensus 333 ~~~~~~~~iG~G~~g~Vy~~~~~~~--~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~ 410 (535)
T PRK09605 333 RRKIPDHLIGKGAEADIKKGEYLGR--DAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEE 410 (535)
T ss_pred cccCccceeccCCcEEEEEEeecCc--cceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCC
Confidence 3567789999999999999987443 344443322111 111234567889999999999999988777777777
Q ss_pred EEEEEeccCCCchhhHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcc
Q 001847 747 VCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCL 823 (1005)
Q Consensus 747 ~~lV~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~~~g~vkL~DFG~a~~ 823 (1005)
.++||||++|++|.+++. ....++.|++.+|.+||+.|++||||||+|||+ .++.++|+|||++..
T Consensus 411 ~~lv~E~~~g~~L~~~l~----------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl-~~~~~~liDFGla~~ 476 (535)
T PRK09605 411 KTIVMEYIGGKDLKDVLE----------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIV-RDDRLYLIDFGLGKY 476 (535)
T ss_pred CEEEEEecCCCcHHHHHH----------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEE-ECCcEEEEeCccccc
Confidence 899999999999998875 246789999999999999999999999999999 578999999999855
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.59 E-value=1.3e-16 Score=191.42 Aligned_cols=264 Identities=23% Similarity=0.354 Sum_probs=205.8
Q ss_pred cCCccccccccccCcEEEEEEEEcCC-CeEEEEEEeecccccChHHHHHHHHHHHHHHhCC-CCCcceEEEEEEeCCeEE
Q 001847 671 LQHFRPIKPLGSGDTGSVHLVELCGS-GQYFAMKAMDKGVMLNRNKVHRACAEREILDMLD-HPFVPALYASFQTKTHVC 748 (1005)
Q Consensus 671 ~~~y~~~~~LG~G~~g~Vy~a~~~~~-~~~valK~~~~~~~~~~~~~~~~~~E~~il~~l~-hpnIv~l~~~~~~~~~~~ 748 (1005)
...|.+.+.||+|+|+.|-.+....+ ...+++|.+.... ...........|..+-+.+. |.|++.+++........+
T Consensus 19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~-~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~ 97 (601)
T KOG0590|consen 19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPP-KSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYL 97 (601)
T ss_pred cccccccccccccccchhhhhhhcCCCcceeeccCCCCCC-CccchhhhcCccccccccccccccccccCCccCCCcccc
Confidence 34789999999999999998887433 4567777665432 23334455556777777776 999999999999999999
Q ss_pred EEEeccCCCchhhHHhhCCCCCCCHHHHHHHHHHHHHHHHHHH-HcCcccCCCCCCcEEEecCC-cEEEEeccCCcccCC
Q 001847 749 LITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLH-CQGIIYRDLKPENVLLQGNG-HVSLTDFDLSCLTSC 826 (1005)
Q Consensus 749 lV~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH-~~gIvHrDLkP~NILi~~~g-~vkL~DFG~a~~~~~ 826 (1005)
++++|..|++++..+........+......++.|+..++.|+| ..++.|+||||+|.+++.++ .+++.|||+|.....
T Consensus 98 ~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~ 177 (601)
T KOG0590|consen 98 LSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDESGSALKIADFGLATAYRN 177 (601)
T ss_pred cccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhccCCCcccCCCchhhccccc
Confidence 9999999999999883222224777888899999999999999 99999999999999999999 999999999955432
Q ss_pred CCCCCCCcchhhhhcccCCCCCccccccccccccccc-CCcccccccccCC-CCCChhhHHHHHHHHHHHHcCCCCCCCC
Q 001847 827 KPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVG-TEEYIAPEIIAGA-GHTSAVDWWALGILLYEMLYGYTPFRGK 904 (1005)
Q Consensus 827 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g-t~~y~aPE~l~~~-~~~~~sDIwSlGvll~eLltG~~Pf~~~ 904 (1005)
. .+........+| ++.|+|||.+.+. ...+..|+||+|+++..+++|..|+...
T Consensus 178 ~------------------------~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~ 233 (601)
T KOG0590|consen 178 K------------------------NGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFP 233 (601)
T ss_pred c------------------------CCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccc
Confidence 0 011122344577 9999999999884 4567899999999999999999999765
Q ss_pred ChHHHH-HHHHhC--CCCCCCCCCCCHHHHHHHHHccccCcCccCCChhcHHHHHcCCCCCC
Q 001847 905 TRQKTF-ANILHK--DLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKG 963 (1005)
Q Consensus 905 ~~~~~~-~~i~~~--~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~hpff~~ 963 (1005)
...... ...... ......+...+....+++.+++..+|..|.+ ++++..++|+..
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s----~~~~~~d~~~~~ 291 (601)
T KOG0590|consen 234 SRKDGRYSSWKSNKGRFTQLPWNSISDQAHDLLHKILKENPSNRLS----IEELKLDNWLSS 291 (601)
T ss_pred ccccccceeecccccccccCccccCChhhhhcccccccCCchhccc----cccccccccccc
Confidence 443322 222221 2234445556778889999999999999999 999999999998
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.56 E-value=2.3e-14 Score=148.29 Aligned_cols=138 Identities=20% Similarity=0.220 Sum_probs=99.3
Q ss_pred cccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHH---------------------HHHHHHHHHHhCCCC--C
Q 001847 677 IKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVH---------------------RACAEREILDMLDHP--F 733 (1005)
Q Consensus 677 ~~~LG~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~---------------------~~~~E~~il~~l~hp--n 733 (1005)
.+.||+|+||.||+|.+. ++..||||++............ ....|...+..+.+. .
T Consensus 2 ~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~ 80 (187)
T cd05119 2 GGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVP 80 (187)
T ss_pred CcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCC
Confidence 578999999999999985 7899999998764221111111 113455666666443 3
Q ss_pred cceEEEEEEeCCeEEEEEeccCCCchhh-HHhhCCCCCCCHHHHHHHHHHHHHHHHHHHH-cCcccCCCCCCcEEEecCC
Q 001847 734 VPALYASFQTKTHVCLITDYCPGGELFL-LLDRQPTKVLKEDAVRFYAAEVVVALEYLHC-QGIIYRDLKPENVLLQGNG 811 (1005)
Q Consensus 734 Iv~l~~~~~~~~~~~lV~E~~~ggsL~~-~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~-~gIvHrDLkP~NILi~~~g 811 (1005)
+++++.+ ...++||||++++++.. .+.... . ...++.++.+++.++.++|. .||+|+||||+||+++ ++
T Consensus 81 ~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~---~-~~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~-~~ 151 (187)
T cd05119 81 VPKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR---L-LEDPEELYDQILELMRKLYREAGLVHGDLSEYNILVD-DG 151 (187)
T ss_pred CCceEec----CCCEEEEEEeCCCCccChhhhhhh---h-cccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEE-CC
Confidence 5555543 23589999998854432 121110 1 16678899999999999999 9999999999999999 99
Q ss_pred cEEEEeccCCccc
Q 001847 812 HVSLTDFDLSCLT 824 (1005)
Q Consensus 812 ~vkL~DFG~a~~~ 824 (1005)
.++|+|||.+...
T Consensus 152 ~~~liDfg~a~~~ 164 (187)
T cd05119 152 KVYIIDVPQAVEI 164 (187)
T ss_pred cEEEEECcccccc
Confidence 9999999998544
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.55 E-value=1.7e-14 Score=165.44 Aligned_cols=199 Identities=23% Similarity=0.330 Sum_probs=152.1
Q ss_pred HHhCCCCCcceEEEEEEeCCeEEEEEeccCCCchhhHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCc-ccCCCCCCc
Q 001847 726 LDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGI-IYRDLKPEN 804 (1005)
Q Consensus 726 l~~l~hpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gI-vHrDLkP~N 804 (1005)
|+.+.|.|+.++++.+.++..+++|.+||..|+|.+.+... ...++......++++|+.||.|||...| .|+.++++|
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~-~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~n 79 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNE-DIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSSN 79 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhcc-ccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeecccc
Confidence 35678999999999999999999999999999999999763 3458888889999999999999998755 999999999
Q ss_pred EEEecCCcEEEEeccCCcccCCCCCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCC-------
Q 001847 805 VLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAG------- 877 (1005)
Q Consensus 805 ILi~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~------- 877 (1005)
.+++..+.+||.|||+......... ........-...|.|||.+....
T Consensus 80 Clvd~~w~lklt~~Gl~~~~~~~~~-------------------------~~~~~~~~~~~lw~aPellr~~~~~~~~~~ 134 (484)
T KOG1023|consen 80 CLVDSRWVLKLTDFGLNSLLEETAE-------------------------PEAHHPIRKALLWTAPELLRGALSQSLESA 134 (484)
T ss_pred ceeeeeEEEEechhhhccccccccc-------------------------ccccchhHHHHhccCHHHhccccccccccc
Confidence 9999999999999999855431000 00111122456799999986631
Q ss_pred CCChhhHHHHHHHHHHHHcCCCCCCCCC----hHHHHHHHHh-CCCCCCC----CCCCCHHHHHHHHHccccCcCccCCC
Q 001847 878 HTSAVDWWALGILLYEMLYGYTPFRGKT----RQKTFANILH-KDLKFPS----STPTSLHAKQLMYRLLHRDPKSRLGS 948 (1005)
Q Consensus 878 ~~~~sDIwSlGvll~eLltG~~Pf~~~~----~~~~~~~i~~-~~~~~~~----~~~~s~~l~~Ll~~~L~~dP~~Rpt~ 948 (1005)
.+.+.||||||+++||+++.+.||.... ..+.+..+.+ +...+.. ......++..++..||..+|..||++
T Consensus 135 ~~~~gdiYs~~ii~~ei~~r~~~~~~~~~~~~~~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~ 214 (484)
T KOG1023|consen 135 LTQKGDIYSFGIIMYEILFRSGPFDLRNLVEDPDEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSI 214 (484)
T ss_pred ccccCCeehHHHHHHHHHhccCccccccccCChHHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccH
Confidence 3567999999999999999999997522 2344444444 2211111 11234468899999999999999995
Q ss_pred hh
Q 001847 949 HE 950 (1005)
Q Consensus 949 ~~ 950 (1005)
..
T Consensus 215 ~~ 216 (484)
T KOG1023|consen 215 EQ 216 (484)
T ss_pred HH
Confidence 44
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.53 E-value=8.7e-14 Score=149.48 Aligned_cols=137 Identities=23% Similarity=0.351 Sum_probs=104.8
Q ss_pred cccc-ccCcEEEEEEEEcCCCeEEEEEEeecccc----------cChHHHHHHHHHHHHHHhCCCCCc--ceEEEEEEeC
Q 001847 678 KPLG-SGDTGSVHLVELCGSGQYFAMKAMDKGVM----------LNRNKVHRACAEREILDMLDHPFV--PALYASFQTK 744 (1005)
Q Consensus 678 ~~LG-~G~~g~Vy~a~~~~~~~~valK~~~~~~~----------~~~~~~~~~~~E~~il~~l~hpnI--v~l~~~~~~~ 744 (1005)
..|| .|+.|+||.+.. .+..++||.+..... .......++.+|+.++..|.|++| +.++++....
T Consensus 37 ~~lg~~~g~gtv~~v~~--~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~ 114 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQT--PGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR 114 (239)
T ss_pred ceeecCCCCccEEEEEe--CCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence 4466 888888998887 477899998864221 011234567889999999988775 6777664432
Q ss_pred -C---eEEEEEeccCC-CchhhHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEecc
Q 001847 745 -T---HVCLITDYCPG-GELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFD 819 (1005)
Q Consensus 745 -~---~~~lV~E~~~g-gsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~~~g~vkL~DFG 819 (1005)
. ..++|||+++| .+|.+++... .++... +.||+.+|.+||++||+|+||||.|||++.++.++|+|||
T Consensus 115 ~~~~~~~~lV~e~l~G~~~L~~~l~~~---~l~~~~----~~~i~~~l~~lH~~GI~HrDlkp~NILv~~~~~v~LIDfg 187 (239)
T PRK01723 115 HGLFYRADILIERIEGARDLVALLQEA---PLSEEQ----WQAIGQLIARFHDAGVYHADLNAHNILLDPDGKFWLIDFD 187 (239)
T ss_pred cCcceeeeEEEEecCCCCCHHHHHhcC---CCCHHH----HHHHHHHHHHHHHCCCCCCCCCchhEEEcCCCCEEEEECC
Confidence 2 23599999987 6898887642 355443 5789999999999999999999999999999999999999
Q ss_pred CCcc
Q 001847 820 LSCL 823 (1005)
Q Consensus 820 ~a~~ 823 (1005)
.+..
T Consensus 188 ~~~~ 191 (239)
T PRK01723 188 RGEL 191 (239)
T ss_pred Cccc
Confidence 8844
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.50 E-value=1.8e-13 Score=135.34 Aligned_cols=132 Identities=23% Similarity=0.245 Sum_probs=111.8
Q ss_pred ccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCC--CCcceEEEEEEeCCeEEEEEec
Q 001847 676 PIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDH--PFVPALYASFQTKTHVCLITDY 753 (1005)
Q Consensus 676 ~~~~LG~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~il~~l~h--pnIv~l~~~~~~~~~~~lV~E~ 753 (1005)
+++.||.|.++.||++.+. +..+++|.+..... ...+..|+.+++.+.+ .++++++.++...+..+++|||
T Consensus 2 ~~~~i~~g~~~~v~~~~~~--~~~~~iK~~~~~~~-----~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~ 74 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTK--DEDYVLKINPSREK-----GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEW 74 (155)
T ss_pred cceecccccccceEEEEec--CCeEEEEecCCCCc-----hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEe
Confidence 4678999999999999984 37899998865421 4567889999999976 5899999988888889999999
Q ss_pred cCCCchhhHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHc---CcccCCCCCCcEEEecCCcEEEEeccCCcc
Q 001847 754 CPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQ---GIIYRDLKPENVLLQGNGHVSLTDFDLSCL 823 (1005)
Q Consensus 754 ~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~---gIvHrDLkP~NILi~~~g~vkL~DFG~a~~ 823 (1005)
+.+..+..+ +......++.+++.+|++||.. +++|+|++|+||+++..+.++++|||.+..
T Consensus 75 ~~g~~~~~~---------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 75 IEGETLDEV---------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred cCCeecccC---------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 988777554 4456677889999999999985 799999999999999989999999998854
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >PF08448 PAS_4: PAS fold; InterPro: IPR013656 The PAS fold corresponds to the structural domain that has previously been defined as PAS and PAC motifs [] | Back alignment and domain information |
|---|
Probab=99.49 E-value=2.5e-13 Score=126.73 Aligned_cols=110 Identities=24% Similarity=0.365 Sum_probs=98.9
Q ss_pred HHhcCCeEEEEeCCCCCCcEEEccHHHHHHcCCChhhhcCCCCCcCCCCCCChHHHHHHHHHHHcCCcEEEEEEEEecCC
Q 001847 198 LSTFQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKIRETLQNGQSYCGRLLNYKKDG 277 (1005)
Q Consensus 198 le~~~~~i~i~D~~~~dg~I~~vN~a~~~l~Gys~eEllG~~~~~l~~~~~~~~~~~~i~~~l~~g~~~~~e~~~~~kdG 277 (1005)
|++++++++++|. +|+|+++|+++++++|++.++++|+++..++++.........+.+++.++.....+..... +|
T Consensus 1 l~~~p~~i~v~D~---~~~i~~~N~~~~~~~~~~~~~~~G~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~ 76 (110)
T PF08448_consen 1 LDSSPDGIFVIDP---DGRIVYANQAAAELFGVSPEELIGRSLFDLLPPEDREEFQAALRRALAGGEPVFFEEILLR-DG 76 (110)
T ss_dssp HHHCSSEEEEEET---TSBEEEE-HHHHHHHTSTHHHHTTSBHHHHSCCGCHHHHHHHHHHHHHHTSEEEEEEEECT-TS
T ss_pred CCCCCceeEEECC---CCEEEEEHHHHHHHhCCCHHHHhhccchhccccchhhhhHHHHHHhhccCceEEEEEEEee-cC
Confidence 6899999999999 8889999999999999999999999999888887777788888899998887776665544 99
Q ss_pred cEEEEEEEeeeeecCCCCEEEEEEEEeccchhhH
Q 001847 278 TPFWNLLTIAPIKDDEGKVLKFIGMQVEVSKHTE 311 (1005)
Q Consensus 278 ~~~wv~~~~~pi~d~~G~v~~~v~~~~DITerk~ 311 (1005)
..+|+.+++.|+.|.+|++.|++++++|||++|+
T Consensus 77 ~~~~~~~~~~Pi~~~~g~~~g~~~~~~DiT~~rr 110 (110)
T PF08448_consen 77 EERWFEVSISPIFDEDGEVVGVLVIIRDITERRR 110 (110)
T ss_dssp CEEEEEEEEEEEECTTTCEEEEEEEEEEECCHHH
T ss_pred CcEEEEEEEEEeEcCCCCEEEEEEEEEECchhhC
Confidence 9999999999999999999999999999999985
|
The PAS fold appears in archaea, eubacteria and eukarya. ; PDB: 3K3D_A 3K3C_B 3KX0_X 3FC7_B 3LUQ_D 3MXQ_A 3BWL_C 3FG8_A. |
| >PF00989 PAS: PAS fold; InterPro: IPR013767 PAS domains are involved in many signalling proteins where they are used as a signal sensor domain [] | Back alignment and domain information |
|---|
Probab=99.48 E-value=3.1e-13 Score=126.76 Aligned_cols=112 Identities=21% Similarity=0.385 Sum_probs=95.6
Q ss_pred HHHHHHHHhcCCeEEEEeCCCCCCcEEEccHHHHHHcCCChhhhcCCCCCcCCCCCCChHHHHHHHHHHHcCCcEEE-EE
Q 001847 192 DIVKDALSTFQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKIRETLQNGQSYCG-RL 270 (1005)
Q Consensus 192 ~~l~~ile~~~~~i~i~D~~~~dg~I~~vN~a~~~l~Gys~eEllG~~~~~l~~~~~~~~~~~~i~~~l~~g~~~~~-e~ 270 (1005)
++|++++++++++++++|. +|+|+++|++|++++||+.++++|+++..++++.........+.+.+..+..... +.
T Consensus 1 e~~~~i~~~~~~~i~~~d~---~g~I~~~N~a~~~l~g~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 77 (113)
T PF00989_consen 1 ERYRAILENSPDGIFVIDE---DGRILYVNQAAEELLGYSREELIGKSLFDLIHPEDRRELRERLRQALSQGESGESFEV 77 (113)
T ss_dssp HHHHHHHHCSSSEEEEEET---TSBEEEECHHHHHHHSS-HHHHTTSBGGGGCSGGGHHHHHHHHHHHHHHCCHECEEEE
T ss_pred CHHHHHHhcCCceEEEEeC---cCeEEEECHHHHHHHccCHHHHcCCcHHHhcCchhhHHHHHHHHHHHHcCCCceeEEE
Confidence 5789999999999999998 8889999999999999999999999999887776655677778888877766443 34
Q ss_pred EEEecCCcEEEEEEEeeeeecCCCCEEEEEEEEecc
Q 001847 271 LNYKKDGTPFWNLLTIAPIKDDEGKVLKFIGMQVEV 306 (1005)
Q Consensus 271 ~~~~kdG~~~wv~~~~~pi~d~~G~v~~~v~~~~DI 306 (1005)
....++|..+|+.+..+|+++.+|++.|++++++||
T Consensus 78 ~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~DI 113 (113)
T PF00989_consen 78 RFRLRDGRPRWVEVRASPVRDEDGQIIGILVIFRDI 113 (113)
T ss_dssp EEEETTSCEEEEEEEEEEEEETTEEEEEEEEEEEE-
T ss_pred EEEecCCcEEEEEEEEEEEEeCCCCEEEEEEEEEeC
Confidence 444469999999999999999999999999999997
|
PAS domains appear in archaea, bacteria and eukaryotes. Several PAS-domain proteins are known to detect their signal by way of an associated cofactor. Haeme, flavin, and a 4-hydroxycinnamyl chromophore are used in different proteins. The PAS domain was named after three proteins that it occurs in: Per- period circadian protein Arnt- Ah receptor nuclear translocator protein Sim- single-minded protein. PAS domains are often associated with PAC domains IPR001610 from INTERPRO. It appears that these domains are directly linked, and that together they form the conserved 3D PAS fold. The division between the PAS and PAC domains is caused by major differences in sequences in the region connecting these two motifs []. In human PAS kinase, this region has been shown to be very flexible, and adopts different conformations depending on the bound ligand []. Probably the most surprising identification of a PAS domain was that in EAG-like K+-channels [].; GO: 0006355 regulation of transcription, DNA-dependent; PDB: 2GJ3_A 4F3L_B 1XFN_A 1OTD_A 2PYR_A 1KOU_A 1XFQ_A 2ZOI_A 2ZOH_A 1OTA_A .... |
| >PF08448 PAS_4: PAS fold; InterPro: IPR013656 The PAS fold corresponds to the structural domain that has previously been defined as PAS and PAC motifs [] | Back alignment and domain information |
|---|
Probab=99.47 E-value=2.1e-13 Score=127.21 Aligned_cols=110 Identities=25% Similarity=0.335 Sum_probs=99.7
Q ss_pred HHhccccEEEEcCCCCCCCEEeecHHHHHHcCCChhhhcCCCCCccCCCCCCHHHHHHHHHHHhcCCcEEEEEEEEecCC
Q 001847 481 LERIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIRAAIDNQTDVTVQLINYTKSG 560 (1005)
Q Consensus 481 ~e~~~~~I~i~D~~G~d~~i~~vN~a~~~l~Gy~~eEllG~~~~~l~~~~~~~~~~~~i~~~l~~~~~~~~e~~~~~kdG 560 (1005)
|+++|++|+++|.+|+ |+++|+++++++|++.++++|+++..+.++.........+.+++.++.....+..... +|
T Consensus 1 l~~~p~~i~v~D~~~~---i~~~N~~~~~~~~~~~~~~~G~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~ 76 (110)
T PF08448_consen 1 LDSSPDGIFVIDPDGR---IVYANQAAAELFGVSPEELIGRSLFDLLPPEDREEFQAALRRALAGGEPVFFEEILLR-DG 76 (110)
T ss_dssp HHHCSSEEEEEETTSB---EEEE-HHHHHHHTSTHHHHTTSBHHHHSCCGCHHHHHHHHHHHHHHTSEEEEEEEECT-TS
T ss_pred CCCCCceeEEECCCCE---EEEEHHHHHHHhCCCHHHHhhccchhccccchhhhhHHHHHHhhccCceEEEEEEEee-cC
Confidence 6899999999999888 9999999999999999999999999888888777788889999988887776666655 99
Q ss_pred cEEEEEEEEeeeeCCCCCEEEEEEEEecCccCcc
Q 001847 561 KKFWNLFHLQPMRDQKGEVQYFIGVQLDGSEHLE 594 (1005)
Q Consensus 561 ~~~wv~~~~~pi~d~~G~v~~~vgi~~DITerK~ 594 (1005)
..+|+.+++.|++|.+|.+.+++++++|||++|+
T Consensus 77 ~~~~~~~~~~Pi~~~~g~~~g~~~~~~DiT~~rr 110 (110)
T PF08448_consen 77 EERWFEVSISPIFDEDGEVVGVLVIIRDITERRR 110 (110)
T ss_dssp CEEEEEEEEEEEECTTTCEEEEEEEEEEECCHHH
T ss_pred CcEEEEEEEEEeEcCCCCEEEEEEEEEECchhhC
Confidence 9999999999999999999999999999999875
|
The PAS fold appears in archaea, eubacteria and eukarya. ; PDB: 3K3D_A 3K3C_B 3KX0_X 3FC7_B 3LUQ_D 3MXQ_A 3BWL_C 3FG8_A. |
| >PRK09776 putative diguanylate cyclase; Provisional | Back alignment and domain information |
|---|
Probab=99.46 E-value=8.5e-14 Score=183.06 Aligned_cols=269 Identities=10% Similarity=-0.019 Sum_probs=194.9
Q ss_pred cccccccccccccccccccchHHHHHHHHHhcCCeEEEEeCCCCCCcEEEccHHHHHHcCCChhhhcCCC-CCcCCCCCC
Q 001847 170 SVRSSGEMSDEGGKEKGLPRVSDIVKDALSTFQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRN-CRFLQGAGT 248 (1005)
Q Consensus 170 ~~~~~~dit~~~~~e~~L~~~~~~l~~ile~~~~~i~i~D~~~~dg~I~~vN~a~~~l~Gys~eEllG~~-~~~l~~~~~ 248 (1005)
.+....|||++++++++++++++.++.+++..+++++.+|. +|+++++|+++++++||+.++..+.. +..+.++++
T Consensus 388 ~i~~~~DITerk~~e~~l~~~~~~~~~~~~~~~~~i~~~d~---~~~~~~~n~~~~~l~G~~~~~~~~~~~~~~~~~p~d 464 (1092)
T PRK09776 388 FIAQIEDINELKRTEQVNERLMERITLANEAGGIGIWEWDL---KPNIISWDKRMFELYEIPPHIKPTWQVWYACLHPED 464 (1092)
T ss_pred ehhhHHhhHHHHHHHHHHHHHHHHHHHHHHhcCceEEEEec---CCCeEeeCHHHHHHhCCCcccCCCHHHHHHhcCHhH
Confidence 33445899999999999999999999999999999999999 67799999999999999998854432 223456666
Q ss_pred ChHHHHHHHHHHHcCCcEEEEEEEEecCCcEEEEEEEeeeeecCCCCEEEEEEEEeccchhhHHHHHhhcCCCCCchhhh
Q 001847 249 DPEDVAKIRETLQNGQSYCGRLLNYKKDGTPFWNLLTIAPIKDDEGKVLKFIGMQVEVSKHTEGAKDKMLRPNGLPESLI 328 (1005)
Q Consensus 249 ~~~~~~~i~~~l~~g~~~~~e~~~~~kdG~~~wv~~~~~pi~d~~G~v~~~v~~~~DITerk~~E~~L~~~~~~l~~~l~ 328 (1005)
.......+...+..+..+..+++.+++|| .+|+.....+++|++|.+.+++++.+|||++|+++++++...++
T Consensus 465 ~~~~~~~~~~~~~~~~~~~~e~r~~~~dG-~~w~~~~~~~~~d~~G~~~~~ig~~~DITerk~~e~~L~~~~~~------ 537 (1092)
T PRK09776 465 RQRVEKEIRDALQGRSPFKLEFRIVVKDG-VRHIRALANRVLNKDGEVERLLGINMDMTEVRQLNEALFQEKER------ 537 (1092)
T ss_pred HHHHHHHHHHHHhcCCCeeEEEEEEcCCc-eEEEEEeeEEEECCCCCEEEEEeeeeehhHHHHHHHHHHHHHHH------
Confidence 66666777888888889999999999999 99999999999999999999999999999999999887732110
Q ss_pred hHHHHHHHHhhhhHHHHHHHccCCCCcccCCCCCcccccCCCCchhhhcccccCCCCCCCCCCCCCC-CC-CCcccccc-
Q 001847 329 RYDARQKEMATSSVTELVQAMKKPRSLSESTNRPPIIRKSEGGVEEERAGALGRRKSENVPPPRRNS-YG-GGCRTSMQ- 405 (1005)
Q Consensus 329 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~-~~-~~~~~~~~- 405 (1005)
... .+...-......+..-....+|.......|++.+++.|+...+++....... .. ........
T Consensus 538 -----l~~-------~l~~~~~~i~~~D~~g~i~~~N~a~~~l~G~~~~e~iG~~~~~~~~~~~~~~~~~~~~~~~~~~~ 605 (1092)
T PRK09776 538 -----LHI-------TLDSIGEAVVCTDMAMKVTFMNPVAEKMTGWTQEEALGVPLLTVLHITFGDNGPLMENIYSCLTS 605 (1092)
T ss_pred -----HHH-------HHhccccEEEEECCCCeEEEEcHHHHHHhCCCHHHHcCCCHHHHcccccCCcchhhHHHHHHHhc
Confidence 000 1111112223334444556788888889999999999998877654311110 00 00000000
Q ss_pred ---cccccchhhccccCCcccccccccccccCCCCCCccccccccCCCCCCCCCCCCCchhhHHHHHHHhh
Q 001847 406 ---RISEVPEKKKQKSGRRSFMGLIGRKSQSTDDHDSFENEIIMEGDDDYESDDERPDSVDDKVRQKEMRK 473 (1005)
Q Consensus 406 ---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~er~~~e~~l~~ 473 (1005)
...........++|...|+.....+..+.++...+...+ .+|+|++++.+++++.
T Consensus 606 ~~~~~~~~~~~~~~~~G~~~~~~~~~~pi~~~~g~~~g~v~~-------------~~DITe~k~~e~~L~~ 663 (1092)
T PRK09776 606 RSAAYLEQDVVLHCRSGGSYDVHYSITPLSTLDGENIGSVLV-------------IQDVTESRKMLRQLSY 663 (1092)
T ss_pred CCCccccceEEEEeCCCcEEEEEEEeeeeecCCCCEEEEEEE-------------EEecchHHHHHHHHHh
Confidence 111223334577888888888888887776665443333 5789999999998854
|
|
| >PF00989 PAS: PAS fold; InterPro: IPR013767 PAS domains are involved in many signalling proteins where they are used as a signal sensor domain [] | Back alignment and domain information |
|---|
Probab=99.45 E-value=5.2e-13 Score=125.24 Aligned_cols=111 Identities=22% Similarity=0.331 Sum_probs=95.9
Q ss_pred cHHHHHHhccccEEEEcCCCCCCCEEeecHHHHHHcCCChhhhcCCCCCccCCCCCCHHHHHHHHHHHhcCCcEE-EEEE
Q 001847 476 DLATTLERIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIRAAIDNQTDVT-VQLI 554 (1005)
Q Consensus 476 ~l~~i~e~~~~~I~i~D~~G~d~~i~~vN~a~~~l~Gy~~eEllG~~~~~l~~~~~~~~~~~~i~~~l~~~~~~~-~e~~ 554 (1005)
+|+.++++++++++++|.+|. |+++|++|+++|||+.++++|+++..++++++.......+...+..+.... .+..
T Consensus 2 ~~~~i~~~~~~~i~~~d~~g~---I~~~N~a~~~l~g~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 78 (113)
T PF00989_consen 2 RYRAILENSPDGIFVIDEDGR---ILYVNQAAEELLGYSREELIGKSLFDLIHPEDRRELRERLRQALSQGESGESFEVR 78 (113)
T ss_dssp HHHHHHHCSSSEEEEEETTSB---EEEECHHHHHHHSS-HHHHTTSBGGGGCSGGGHHHHHHHHHHHHHHCCHECEEEEE
T ss_pred HHHHHHhcCCceEEEEeCcCe---EEEECHHHHHHHccCHHHHcCCcHHHhcCchhhHHHHHHHHHHHHcCCCceeEEEE
Confidence 489999999999999999888 999999999999999999999999988888766667777788777766543 4455
Q ss_pred EEecCCcEEEEEEEEeeeeCCCCCEEEEEEEEecC
Q 001847 555 NYTKSGKKFWNLFHLQPMRDQKGEVQYFIGVQLDG 589 (1005)
Q Consensus 555 ~~~kdG~~~wv~~~~~pi~d~~G~v~~~vgi~~DI 589 (1005)
...++|+.+|+.++..|+++.+|.+.+++++++||
T Consensus 79 ~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~DI 113 (113)
T PF00989_consen 79 FRLRDGRPRWVEVRASPVRDEDGQIIGILVIFRDI 113 (113)
T ss_dssp EEETTSCEEEEEEEEEEEEETTEEEEEEEEEEEE-
T ss_pred EEecCCcEEEEEEEEEEEEeCCCCEEEEEEEEEeC
Confidence 55579999999999999999999999999999998
|
PAS domains appear in archaea, bacteria and eukaryotes. Several PAS-domain proteins are known to detect their signal by way of an associated cofactor. Haeme, flavin, and a 4-hydroxycinnamyl chromophore are used in different proteins. The PAS domain was named after three proteins that it occurs in: Per- period circadian protein Arnt- Ah receptor nuclear translocator protein Sim- single-minded protein. PAS domains are often associated with PAC domains IPR001610 from INTERPRO. It appears that these domains are directly linked, and that together they form the conserved 3D PAS fold. The division between the PAS and PAC domains is caused by major differences in sequences in the region connecting these two motifs []. In human PAS kinase, this region has been shown to be very flexible, and adopts different conformations depending on the bound ligand []. Probably the most surprising identification of a PAS domain was that in EAG-like K+-channels [].; GO: 0006355 regulation of transcription, DNA-dependent; PDB: 2GJ3_A 4F3L_B 1XFN_A 1OTD_A 2PYR_A 1KOU_A 1XFQ_A 2ZOI_A 2ZOH_A 1OTA_A .... |
| >PRK13559 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.42 E-value=2.7e-12 Score=147.33 Aligned_cols=143 Identities=38% Similarity=0.717 Sum_probs=117.8
Q ss_pred ccHHHHHHhccccEEEEcCCCCCCCEEeecHHHHHHcCCChhhhcCCCCCccCCCCCCHHHHHHHHHHHhcCCcEEEEEE
Q 001847 475 IDLATTLERIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIRAAIDNQTDVTVQLI 554 (1005)
Q Consensus 475 ~~l~~i~e~~~~~I~i~D~~G~d~~i~~vN~a~~~l~Gy~~eEllG~~~~~l~~~~~~~~~~~~i~~~l~~~~~~~~e~~ 554 (1005)
..|+.++++++++|+++|.+|.+++|+++|++|++++||+.++++|+++..+.++.........+...+..+..+..+..
T Consensus 43 ~~~~~~~e~~~~~i~i~D~~~~~g~i~~~N~a~~~l~G~~~~e~iG~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~e~~ 122 (361)
T PRK13559 43 RLFEQAMEQTRMAMCITDPHQPDLPIVLANQAFLDLTGYAAEEVVGRNCRFLQGAATDPIAVAKIRAAIAAEREIVVELL 122 (361)
T ss_pred hHHHHHHHhCCCcEEEecCCCCCCcEEEEchHHHHHhCCCHHHHcCCChhhhcCCCCCHHHHHHHHHHhccCCceEEEEE
Confidence 34888999999999999986655669999999999999999999999988777777766667777888888888888999
Q ss_pred EEecCCcEEEEEEEEeeeeCCCCCEEEEEEEEecCccCccccccCCchhhHHHHHHHHHHHhhhhhhhh
Q 001847 555 NYTKSGKKFWNLFHLQPMRDQKGEVQYFIGVQLDGSEHLEPLRNSIPEATAEESEKLVKQTAENVNEAV 623 (1005)
Q Consensus 555 ~~~kdG~~~wv~~~~~pi~d~~G~v~~~vgi~~DITerK~~e~~~~~~~~~~e~~~l~~~~~~~v~~~v 623 (1005)
.+++||..+|+..+..|+++.+|.+.+++++++|||++|+.++ .+++..++++.+.|.+++.+
T Consensus 123 ~~~~dG~~~~~~~~~~~i~d~~G~~~~~v~~~~DITerk~~e~------~~~~~~~l~~~l~H~~~n~L 185 (361)
T PRK13559 123 NYRKDGEPFWNALHLGPVYGEDGRLLYFFGSQWDVTDIRAVRA------LEAHERRLAREVDHRSKNVF 185 (361)
T ss_pred EEcCCCCEEEEEEEEEEEEcCCCCEEEeeeeeeehhcchhhHH------HHHHHHHHHHHHHHhhhhHH
Confidence 9999999999999999999999999999999999999998532 22333444455555554443
|
|
| >PRK13557 histidine kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.40 E-value=2e-12 Score=156.50 Aligned_cols=149 Identities=38% Similarity=0.697 Sum_probs=123.4
Q ss_pred ccHHHHHHhccccEEEEcCCCCCCCEEeecHHHHHHcCCChhhhcCCCCCccCCCCCCHHHHHHHHHHHhcCCcEEEEEE
Q 001847 475 IDLATTLERIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIRAAIDNQTDVTVQLI 554 (1005)
Q Consensus 475 ~~l~~i~e~~~~~I~i~D~~G~d~~i~~vN~a~~~l~Gy~~eEllG~~~~~l~~~~~~~~~~~~i~~~l~~~~~~~~e~~ 554 (1005)
..|+.++++++++|+++|.++.+++|+|+|++|++++||+.+|++|+++..+.+++........++..+..+..+..+.+
T Consensus 30 ~~~~~~~~~~~~~i~v~d~~~~~g~i~~~N~a~~~~~G~~~~e~~g~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 109 (540)
T PRK13557 30 DIFFAAVETTRMPMIVTDPNQPDNPIVFANRAFLEMTGYAAEEIIGNNCRFLQGPETDRATVAEVRDAIAERREIATEIL 109 (540)
T ss_pred HHHHHHHHhCcCcEEEEcCCCCCCCEEEEcHHHHHHhCCCHHHhcCCChHhhcCCCCCHHHHHHHHHHHHcCCCceEEEE
Confidence 45999999999999999986556669999999999999999999999998888888877778888888888888888888
Q ss_pred EEecCCcEEEEEEEEeeeeCCCCCEEEEEEEEecCccCccccccCCchhhHHHHHHHHHHHhhhhhhhh
Q 001847 555 NYTKSGKKFWNLFHLQPMRDQKGEVQYFIGVQLDGSEHLEPLRNSIPEATAEESEKLVKQTAENVNEAV 623 (1005)
Q Consensus 555 ~~~kdG~~~wv~~~~~pi~d~~G~v~~~vgi~~DITerK~~e~~~~~~~~~~e~~~l~~~~~~~v~~~v 623 (1005)
..+++|+.+|+.+++.|+++.+|.+++++++.+|||++++.+++.......+.+...+..+.|.+++.+
T Consensus 110 ~~~~~G~~~~~~~~~~~i~~~~g~~~~~~~~~~dit~~~~~e~~l~~~~~~~~l~~~~~~i~h~l~~pl 178 (540)
T PRK13557 110 NYRKDGSSFWNALFVSPVYNDAGDLVYFFGSQLDVSRRRDAEDALRQAQKMEALGQLTGGIAHDFNNLL 178 (540)
T ss_pred EEeCCCCEEEEEEEEEEeECCCCCEEEEEEEecChHHHHHHHHHHHHHHHHHHhhhhhhhhhHHhhhHH
Confidence 899999999999999999999999999999999999999865444333333334444444555555444
|
|
| >PRK13559 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.39 E-value=8.5e-12 Score=143.22 Aligned_cols=129 Identities=40% Similarity=0.748 Sum_probs=114.5
Q ss_pred chHHHHHHHHHhcCCeEEEEeCCCCCCcEEEccHHHHHHcCCChhhhcCCCCCcCCCCCCChHHHHHHHHHHHcCCcEEE
Q 001847 189 RVSDIVKDALSTFQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKIRETLQNGQSYCG 268 (1005)
Q Consensus 189 ~~~~~l~~ile~~~~~i~i~D~~~~dg~I~~vN~a~~~l~Gys~eEllG~~~~~l~~~~~~~~~~~~i~~~l~~g~~~~~ 268 (1005)
.+.+.|+.++++++++|+++|..+.+|+|+++|++|++++||+.+|++|+++..+.++.........+...+..+..+..
T Consensus 40 ~~~~~~~~~~e~~~~~i~i~D~~~~~g~i~~~N~a~~~l~G~~~~e~iG~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 119 (361)
T PRK13559 40 ASGRLFEQAMEQTRMAMCITDPHQPDLPIVLANQAFLDLTGYAAEEVVGRNCRFLQGAATDPIAVAKIRAAIAAEREIVV 119 (361)
T ss_pred hhhhHHHHHHHhCCCcEEEecCCCCCCcEEEEchHHHHHhCCCHHHHcCCChhhhcCCCCCHHHHHHHHHHhccCCceEE
Confidence 45677899999999999999987668889999999999999999999999988777666666666777888888888888
Q ss_pred EEEEEecCCcEEEEEEEeeeeecCCCCEEEEEEEEeccchhhHHHHHhh
Q 001847 269 RLLNYKKDGTPFWNLLTIAPIKDDEGKVLKFIGMQVEVSKHTEGAKDKM 317 (1005)
Q Consensus 269 e~~~~~kdG~~~wv~~~~~pi~d~~G~v~~~v~~~~DITerk~~E~~L~ 317 (1005)
+...+++||..+|+.+++.|+++.+|.+.+++++++|||++|+++++++
T Consensus 120 e~~~~~~dG~~~~~~~~~~~i~d~~G~~~~~v~~~~DITerk~~e~~~~ 168 (361)
T PRK13559 120 ELLNYRKDGEPFWNALHLGPVYGEDGRLLYFFGSQWDVTDIRAVRALEA 168 (361)
T ss_pred EEEEEcCCCCEEEEEEEEEEEEcCCCCEEEeeeeeeehhcchhhHHHHH
Confidence 9998999999999999999999999999999999999999998875543
|
|
| >PRK11091 aerobic respiration control sensor protein ArcB; Provisional | Back alignment and domain information |
|---|
Probab=99.39 E-value=2.3e-12 Score=163.22 Aligned_cols=136 Identities=14% Similarity=0.107 Sum_probs=121.4
Q ss_pred CCCchhhHHHHHHHhhc-ccHHHHHHhccccEEEEcCCCCCCCEEeecHHHHHHcCCChhhhcCCCCCccCCCCCCHHHH
Q 001847 458 RPDSVDDKVRQKEMRKG-IDLATTLERIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATV 536 (1005)
Q Consensus 458 ~~~~~er~~~e~~l~~~-~~l~~i~e~~~~~I~i~D~~G~d~~i~~vN~a~~~l~Gy~~eEllG~~~~~l~~~~~~~~~~ 536 (1005)
..++.+|++.++++++. ..++.++++++++|+++|.+|+ |+++|++|++++||+.++++|+++..+.+++......
T Consensus 137 ~~~i~~r~~~~~~l~~~~~~l~~il~~~~~~i~~~D~~g~---i~~~N~a~~~l~G~~~~eliG~~~~~l~~~~~~~~~~ 213 (779)
T PRK11091 137 KNEIKEREETQIELEQQSSLLRSFLDASPDLVYYRNEDGE---FSGCNRAMELLTGKSEKQLIGLTPKDVYSPEAAEKVI 213 (779)
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHHHhcCcceEEEECCCCc---EEeEcHHHHHHhCcCHHHHcCCChHHhCCHHHHHHHH
Confidence 35677788888888766 6699999999999999999888 9999999999999999999999988888877666666
Q ss_pred HHHHHHHhcCCcEEEEEEEEecCCcEEEEEEEEeeeeCCCCCEEEEEEEEecCccCcccc
Q 001847 537 RKIRAAIDNQTDVTVQLINYTKSGKKFWNLFHLQPMRDQKGEVQYFIGVQLDGSEHLEPL 596 (1005)
Q Consensus 537 ~~i~~~l~~~~~~~~e~~~~~kdG~~~wv~~~~~pi~d~~G~v~~~vgi~~DITerK~~e 596 (1005)
......+..+..+..+.+..++||..+|+.++..|+++.+|.+.+++++++|||++|+.+
T Consensus 214 ~~~~~~~~~~~~~~~e~~~~~~~G~~~~~~~~~~pi~~~~g~~~g~v~~~~DITe~k~~e 273 (779)
T PRK11091 214 ETDEKVFRHNVSLTYEQWLDYPDGRKACFELRKVPFYDRVGKRHGLMGFGRDITERKRYQ 273 (779)
T ss_pred HHHHHHHhcCCCeEEEEEEEcCCCCEEEEEEEeeeEEcCCCCEEEEEEEEeehhHHHHHH
Confidence 666777788888899999999999999999999999999999999999999999999853
|
|
| >PRK13557 histidine kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.39 E-value=3.7e-12 Score=154.14 Aligned_cols=133 Identities=37% Similarity=0.735 Sum_probs=121.0
Q ss_pred ccccchHHHHHHHHHhcCCeEEEEeCCCCCCcEEEccHHHHHHcCCChhhhcCCCCCcCCCCCCChHHHHHHHHHHHcCC
Q 001847 185 KGLPRVSDIVKDALSTFQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKIRETLQNGQ 264 (1005)
Q Consensus 185 ~~L~~~~~~l~~ile~~~~~i~i~D~~~~dg~I~~vN~a~~~l~Gys~eEllG~~~~~l~~~~~~~~~~~~i~~~l~~g~ 264 (1005)
.........|+.++++++++|+++|..+.+|+|+|+|++|++++||+.+|++|+++..+.+++........++..+..+.
T Consensus 23 ~~~~~~~~~~~~~~~~~~~~i~v~d~~~~~g~i~~~N~a~~~~~G~~~~e~~g~~~~~l~~~~~~~~~~~~~~~~~~~~~ 102 (540)
T PRK13557 23 DVSDHRSDIFFAAVETTRMPMIVTDPNQPDNPIVFANRAFLEMTGYAAEEIIGNNCRFLQGPETDRATVAEVRDAIAERR 102 (540)
T ss_pred hhhhhhhHHHHHHHHhCcCcEEEEcCCCCCCCEEEEcHHHHHHhCCCHHHhcCCChHhhcCCCCCHHHHHHHHHHHHcCC
Confidence 33446678999999999999999998777899999999999999999999999999988888777777888888898888
Q ss_pred cEEEEEEEEecCCcEEEEEEEeeeeecCCCCEEEEEEEEeccchhhHHHHHhh
Q 001847 265 SYCGRLLNYKKDGTPFWNLLTIAPIKDDEGKVLKFIGMQVEVSKHTEGAKDKM 317 (1005)
Q Consensus 265 ~~~~e~~~~~kdG~~~wv~~~~~pi~d~~G~v~~~v~~~~DITerk~~E~~L~ 317 (1005)
.+..+++.++++|+.+|+.+++.|+.+.+|.+++++++.+|||+++++++++.
T Consensus 103 ~~~~~~~~~~~~G~~~~~~~~~~~i~~~~g~~~~~~~~~~dit~~~~~e~~l~ 155 (540)
T PRK13557 103 EIATEILNYRKDGSSFWNALFVSPVYNDAGDLVYFFGSQLDVSRRRDAEDALR 155 (540)
T ss_pred CceEEEEEEeCCCCEEEEEEEEEEeECCCCCEEEEEEEecChHHHHHHHHHHH
Confidence 88888888999999999999999999999999999999999999999987765
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.39 E-value=2.7e-13 Score=155.46 Aligned_cols=263 Identities=22% Similarity=0.214 Sum_probs=197.8
Q ss_pred ccCCccccccccc--cCcEEEEEEEE--cCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhC-CCCCcceEEEEEEeC
Q 001847 670 NLQHFRPIKPLGS--GDTGSVHLVEL--CGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPALYASFQTK 744 (1005)
Q Consensus 670 ~~~~y~~~~~LG~--G~~g~Vy~a~~--~~~~~~valK~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~ 744 (1005)
....+.+.+.+|. |.+|.||.+.. ..++..+|+|.-+.... .+.....-.+++.-...+ .|++.++.+..+...
T Consensus 112 ~~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s-~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~ 190 (524)
T KOG0601|consen 112 FDQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFS-PPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGS 190 (524)
T ss_pred hhhhcccccccccCCCCCceeecccCCcccCCcccccccccCCCC-CccccccccchhhcccccCccccccccCcccccC
Confidence 3456788899999 99999999998 88899999997554322 222233344555555555 589999988899999
Q ss_pred CeEEEEEeccCCCchhhHHhhCCCCCCCHHHHHHHHHHHHH----HHHHHHHcCcccCCCCCCcEEEecC-CcEEEEecc
Q 001847 745 THVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVV----ALEYLHCQGIIYRDLKPENVLLQGN-GHVSLTDFD 819 (1005)
Q Consensus 745 ~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~----aL~~LH~~gIvHrDLkP~NILi~~~-g~vkL~DFG 819 (1005)
+..++-+|++ +.+|..+... ....+++..++..+.+... ||.++|+.+++|-|+||.||++..+ ..++++|||
T Consensus 191 ~~lfiqtE~~-~~sl~~~~~~-~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~~~s~~~~df~ 268 (524)
T KOG0601|consen 191 GILFIQTELC-GESLQSYCHT-PCNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSDWTSCKLTDFG 268 (524)
T ss_pred Ccceeeeccc-cchhHHhhhc-ccccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheecccccceeecCCcc
Confidence 9999999999 7888777653 2445889999999999999 9999999999999999999999999 889999999
Q ss_pred CCcccCCCCCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHcCCC
Q 001847 820 LSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYT 899 (1005)
Q Consensus 820 ~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlGvll~eLltG~~ 899 (1005)
+...++...... .........|...|++||.+.+. ++...|||+||.++.+-.+|..
T Consensus 269 ~v~~i~~~~~~~----------------------~~~~~~r~~~~~~Y~~ke~~~~l-~~~~~di~sl~ev~l~~~l~~~ 325 (524)
T KOG0601|consen 269 LVSKISDGNFSS----------------------VFKVSKRPEGDCIYAAKELLNGL-ATFASDIFSLGEVILEAILGSH 325 (524)
T ss_pred eeEEccCCcccc----------------------ceeeeecCCCCceEeChhhhccc-cchHhhhcchhhhhHhhHhhcc
Confidence 987665433211 11111223577889999987554 6789999999999999988776
Q ss_pred CCCCC--ChHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHccccCcCccCCChhcHHHHHcCCCCCCCC
Q 001847 900 PFRGK--TRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVN 965 (1005)
Q Consensus 900 Pf~~~--~~~~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~hpff~~~~ 965 (1005)
++... .....+..+ .++.......+..+...+..|+..+|-.|++ ++.++.|+++..-.
T Consensus 326 ~~~~g~~~~W~~~r~~---~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~----~q~~~~l~~i~s~~ 386 (524)
T KOG0601|consen 326 LPSVGKNSSWSQLRQG---YIPLEFCEGGSSSLRSVTSQMLDEDPRLRLT----AQILTALNVIHSKL 386 (524)
T ss_pred cccCCCCCCccccccc---cCchhhhcCcchhhhhHHHHhcCcchhhhhH----HHHHhccccccchh
Confidence 66443 222222211 1222222334566777999999999999999 99999999998643
|
|
| >PRK11091 aerobic respiration control sensor protein ArcB; Provisional | Back alignment and domain information |
|---|
Probab=99.37 E-value=1.7e-12 Score=164.29 Aligned_cols=141 Identities=13% Similarity=0.126 Sum_probs=128.6
Q ss_pred cccccccccccccccchHHHHHHHHHhcCCeEEEEeCCCCCCcEEEccHHHHHHcCCChhhhcCCCCCcCCCCCCChHHH
Q 001847 174 SGEMSDEGGKEKGLPRVSDIVKDALSTFQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDV 253 (1005)
Q Consensus 174 ~~dit~~~~~e~~L~~~~~~l~~ile~~~~~i~i~D~~~~dg~I~~vN~a~~~l~Gys~eEllG~~~~~l~~~~~~~~~~ 253 (1005)
..+|+++++++++++++++.++.++++++++|+++|. +|+|+++|++|++++||+.++++|+++..++++.......
T Consensus 137 ~~~i~~r~~~~~~l~~~~~~l~~il~~~~~~i~~~D~---~g~i~~~N~a~~~l~G~~~~eliG~~~~~l~~~~~~~~~~ 213 (779)
T PRK11091 137 KNEIKEREETQIELEQQSSLLRSFLDASPDLVYYRNE---DGEFSGCNRAMELLTGKSEKQLIGLTPKDVYSPEAAEKVI 213 (779)
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHHHhcCcceEEEECC---CCcEEeEcHHHHHHhCcCHHHHcCCChHHhCCHHHHHHHH
Confidence 4788999999999999999999999999999999998 7889999999999999999999999988887776655566
Q ss_pred HHHHHHHHcCCcEEEEEEEEecCCcEEEEEEEeeeeecCCCCEEEEEEEEeccchhhHHHHHhh
Q 001847 254 AKIRETLQNGQSYCGRLLNYKKDGTPFWNLLTIAPIKDDEGKVLKFIGMQVEVSKHTEGAKDKM 317 (1005)
Q Consensus 254 ~~i~~~l~~g~~~~~e~~~~~kdG~~~wv~~~~~pi~d~~G~v~~~v~~~~DITerk~~E~~L~ 317 (1005)
......+..+..+..+.+..++||..+|+.++..|+++.+|.+.|++++++|||++|+++++++
T Consensus 214 ~~~~~~~~~~~~~~~e~~~~~~~G~~~~~~~~~~pi~~~~g~~~g~v~~~~DITe~k~~e~~l~ 277 (779)
T PRK11091 214 ETDEKVFRHNVSLTYEQWLDYPDGRKACFELRKVPFYDRVGKRHGLMGFGRDITERKRYQDALE 277 (779)
T ss_pred HHHHHHHhcCCCeEEEEEEEcCCCCEEEEEEEeeeEEcCCCCEEEEEEEEeehhHHHHHHHHHH
Confidence 6667777888888889998999999999999999999999999999999999999999998876
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.34 E-value=3.6e-12 Score=148.72 Aligned_cols=185 Identities=22% Similarity=0.314 Sum_probs=120.0
Q ss_pred CCCCchhhhccCCcccCCCCCCCCCCchhhHHhhccc--ccccc--cCCccccccccccCcEEEEEEEEcCCCeEEEEEE
Q 001847 629 ANLTPEDLWANHSKVVHPKPHRKDSPPWKAIQKILDS--GEQIN--LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKA 704 (1005)
Q Consensus 629 ~~~~p~~~~an~s~~~~~~~~~~~~~~~~~~~~~~~~--~~~i~--~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~ 704 (1005)
..+-|+++...-+++....|+.. +....+++.. |.++. ...|. .+.||.|++|+||+|.. .+|+.||||+
T Consensus 75 ~dllp~~~~~~L~~Lqd~v~p~~----~~~~~~~l~~elg~~~~~~F~~fd-~~plasaSigQVh~A~l-~~G~~VaVKv 148 (437)
T TIGR01982 75 ADLLPADIAEELSLLQDRVPPFD----FKVARKVIEAALGGPLEELFAEFE-EKPLAAASIAQVHRARL-VDGKEVAVKV 148 (437)
T ss_pred cccCCHHHHHHHHHHhcCCCCCC----HHHHHHHHHHHhCcCHHHHHhhCC-CcceeeeehhheEEEEe-cCCCEEEEEe
Confidence 34557778888888777776443 4433333332 12221 12333 36799999999999997 5789999999
Q ss_pred eecccccChH---------------------------H----------HHHHHHHHHHHHhC----C-CCCc--ceEEEE
Q 001847 705 MDKGVMLNRN---------------------------K----------VHRACAEREILDML----D-HPFV--PALYAS 740 (1005)
Q Consensus 705 ~~~~~~~~~~---------------------------~----------~~~~~~E~~il~~l----~-hpnI--v~l~~~ 740 (1005)
.+++....-. . .-++.+|+..+.++ . +++| ++++.
T Consensus 149 ~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~~Ea~n~~~~~~~~~~~~~v~vP~v~~- 227 (437)
T TIGR01982 149 LRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLRREAANASELGENFKNDPGVYVPEVYW- 227 (437)
T ss_pred eCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHHHHHHHHHHHHHhcCCCCCEEeCCEeh-
Confidence 8764211000 0 00233455555444 2 3433 33332
Q ss_pred EEeCCeEEEEEeccCCCchhhHHhhCCCCCCCHHHHHHHHHHHHH-HHHHHHHcCcccCCCCCCcEEEecCCcEEEEecc
Q 001847 741 FQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVV-ALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFD 819 (1005)
Q Consensus 741 ~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~-aL~~LH~~gIvHrDLkP~NILi~~~g~vkL~DFG 819 (1005)
......++||||++|++|.++......+ .+ ...++.+++. .+..+|..|++|+|+||.||+++.+|.++|+|||
T Consensus 228 -~~~~~~vLvmE~i~G~~L~~~~~~~~~~-~~---~~~ia~~~~~~~l~ql~~~g~~H~D~hPgNilv~~~g~i~liDfG 302 (437)
T TIGR01982 228 -DRTSERVLTMEWIDGIPLSDIAALDEAG-LD---RKALAENLARSFLNQVLRDGFFHADLHPGNIFVLKDGKIIALDFG 302 (437)
T ss_pred -hhcCCceEEEEeECCcccccHHHHHhcC-CC---HHHHHHHHHHHHHHHHHhCCceeCCCCcccEEECCCCcEEEEeCC
Confidence 2234568999999999998876532111 22 3445666665 4788999999999999999999999999999999
Q ss_pred CCcccC
Q 001847 820 LSCLTS 825 (1005)
Q Consensus 820 ~a~~~~ 825 (1005)
++...+
T Consensus 303 ~~~~l~ 308 (437)
T TIGR01982 303 IVGRLS 308 (437)
T ss_pred CeeECC
Confidence 986553
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.31 E-value=1.3e-12 Score=154.02 Aligned_cols=209 Identities=16% Similarity=0.190 Sum_probs=125.0
Q ss_pred hhHHHHHHHHHHHhhhhhhhhccCCCCCCCchhhhccCCcccCCCCCCCCCCchhhHHhhcccccccccCCccccccccc
Q 001847 603 ATAEESEKLVKQTAENVNEAVKELPDANLTPEDLWANHSKVVHPKPHRKDSPPWKAIQKILDSGEQINLQHFRPIKPLGS 682 (1005)
Q Consensus 603 ~~~~e~~~l~~~~~~~v~~~v~~l~~~~~~p~~~~an~s~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~y~~~~~LG~ 682 (1005)
.+++++.-..-++-+.++.. ..+-|+++...-+++....|+.........+..-++....-....|.. +.||+
T Consensus 57 ~aLe~LGp~fIKlGQ~LStR------~DllP~~~~~eL~~Lqd~vpp~~~~~~~~~ie~elG~~~~~~F~~fd~-~Plas 129 (537)
T PRK04750 57 LALEELGPIFVKFGQMLSTR------RDLFPPDIADELALLQDRVPPFDGALARAIIEKALGGPVEEWFDDFDI-KPLAS 129 (537)
T ss_pred HHHHHcCcHHHHHHHHHHcC------cccCCHHHHHHHHHHHcCCCCCCHHHHHHHHHHHhCCCHHHHHHhcCh-hhhcC
Confidence 34555554444444444422 445577777777777776664332222222222222111111356777 89999
Q ss_pred cCcEEEEEEEEcCCCeEEEEEEeecccccC---------------------------h----HHHH------HHHHHHHH
Q 001847 683 GDTGSVHLVELCGSGQYFAMKAMDKGVMLN---------------------------R----NKVH------RACAEREI 725 (1005)
Q Consensus 683 G~~g~Vy~a~~~~~~~~valK~~~~~~~~~---------------------------~----~~~~------~~~~E~~i 725 (1005)
|++|+||+|..+.+|+.||||+.+++.... . +... ++.+|+..
T Consensus 130 aSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~ElD~~~Ea~N 209 (537)
T PRK04750 130 ASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLHDELDLMREAAN 209 (537)
T ss_pred CCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHHHhhCHHHHHHH
Confidence 999999999998889999999998652110 0 0011 12234444
Q ss_pred HHhC----CCCCcceEEEEEE-eCCeEEEEEeccCCCchhhHHhhCCCC----CCCHHHHHHHHHHHHHHHHHHHHcCcc
Q 001847 726 LDML----DHPFVPALYASFQ-TKTHVCLITDYCPGGELFLLLDRQPTK----VLKEDAVRFYAAEVVVALEYLHCQGII 796 (1005)
Q Consensus 726 l~~l----~hpnIv~l~~~~~-~~~~~~lV~E~~~ggsL~~~l~~~~~~----~l~~~~i~~i~~qil~aL~~LH~~gIv 796 (1005)
+.++ .+...+.+-.+|. .....++||||+.|+.+.++..-...+ .+....+..++.|+ +..|++
T Consensus 210 ~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qi-------f~~Gff 282 (537)
T PRK04750 210 ASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQV-------FRDGFF 282 (537)
T ss_pred HHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHH-------HhCCee
Confidence 4443 2333333323332 245678999999999998753211111 23334444444444 458999
Q ss_pred cCCCCCCcEEEecCC----cEEEEeccCCcccC
Q 001847 797 YRDLKPENVLLQGNG----HVSLTDFDLSCLTS 825 (1005)
Q Consensus 797 HrDLkP~NILi~~~g----~vkL~DFG~a~~~~ 825 (1005)
|+|+||.||+++.+| .++++|||++...+
T Consensus 283 HaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~ 315 (537)
T PRK04750 283 HADMHPGNIFVSYDPPENPRYIALDFGIVGSLN 315 (537)
T ss_pred eCCCChHHeEEecCCCCCCeEEEEecceEEECC
Confidence 999999999999888 99999999986553
|
|
| >PRK13558 bacterio-opsin activator; Provisional | Back alignment and domain information |
|---|
Probab=99.27 E-value=5.8e-11 Score=147.74 Aligned_cols=128 Identities=39% Similarity=0.741 Sum_probs=115.2
Q ss_pred HHHHHHHHHhcCCeEEEEeCCCCCCcEEEccHHHHHHcCCChhhhcCCCCCcCCCCCCChHHHHHHHHHHHcCCcEEEEE
Q 001847 191 SDIVKDALSTFQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKIRETLQNGQSYCGRL 270 (1005)
Q Consensus 191 ~~~l~~ile~~~~~i~i~D~~~~dg~I~~vN~a~~~l~Gys~eEllG~~~~~l~~~~~~~~~~~~i~~~l~~g~~~~~e~ 270 (1005)
..+++.+++++++++++.|..+.+|+|+++|++|++++||+.++++|+++..+.++.........+...+..+..+..++
T Consensus 147 ~r~~~~~~~~~~~gi~~~d~~~~dg~i~~~N~~~~~l~G~~~eel~g~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~e~ 226 (665)
T PRK13558 147 RRLKERALDEAPVGITIADATLPDEPLIYINDAFERITGYSPDEVLGRNCRFLQGEDTNEERVAELREAIDEERPTSVEL 226 (665)
T ss_pred hHHHHHHHhcCCccEEEEcCCCCCCcEEEEcHHHHHHhCcCHHHHcCCCHHHhcCCCccHHHHHHHHHHHhcCCCeEEEE
Confidence 34567899999999999986666889999999999999999999999998877777766666677788888888889999
Q ss_pred EEEecCCcEEEEEEEeeeeecCCCCEEEEEEEEeccchhhHHHHHhhc
Q 001847 271 LNYKKDGTPFWNLLTIAPIKDDEGKVLKFIGMQVEVSKHTEGAKDKML 318 (1005)
Q Consensus 271 ~~~~kdG~~~wv~~~~~pi~d~~G~v~~~v~~~~DITerk~~E~~L~~ 318 (1005)
+.+++||..+|+.++..|+.+.+|.+.+++++++|||++|++|++++.
T Consensus 227 ~~~~~dG~~~~~~~~~~pi~d~~G~~~~~vgi~~DITerk~~E~~L~~ 274 (665)
T PRK13558 227 RNYRKDGSTFWNQVDIAPIRDEDGTVTHYVGFQTDVTERKEAELALQR 274 (665)
T ss_pred EEECCCCCEEEEEEEEEEEECCCCCEEEEEEEEEeCcHHHHHHHHHHH
Confidence 999999999999999999999999999999999999999999998874
|
|
| >TIGR02040 PpsR-CrtJ transcriptional regulator PpsR | Back alignment and domain information |
|---|
Probab=99.26 E-value=6.7e-12 Score=148.23 Aligned_cols=255 Identities=9% Similarity=-0.007 Sum_probs=163.2
Q ss_pred ccccccccccccc-----------cc---cccchHHHHHHHHHhcCCeEEEEeCCCCCCcEEEccHHHHHHcCCChhhhc
Q 001847 171 VRSSGEMSDEGGK-----------EK---GLPRVSDIVKDALSTFQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVV 236 (1005)
Q Consensus 171 ~~~~~dit~~~~~-----------e~---~L~~~~~~l~~ile~~~~~i~i~D~~~~dg~I~~vN~a~~~l~Gys~eEll 236 (1005)
+...+|||++++. |+ +|+++++.|+.++++++++|+++|.. +|+|+++|++|++++||+.+|++
T Consensus 98 ~~i~rDi~~~~~~~~~l~~~~~~~e~~~~~l~~~e~r~~~l~e~~~~~i~~~d~~--~g~i~~~N~a~~~l~G~~~~el~ 175 (442)
T TIGR02040 98 LALGRDLRAVAELQQQLVAAQQAMERDYWTLREMETRYRVVLEVSSDAVLLVDMS--TGRIVEANSAAAALLGGVGQSLV 175 (442)
T ss_pred EEEecccHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhhCCceEEEEECC--CCEEEEEcHHHHHHhCcCHHHHc
Confidence 3445888765543 22 66777889999999999999999962 56799999999999999999999
Q ss_pred CCCCCcCCCCCCChHHHHHHHHHHHcCCcEEEEEEEEecCCcEEEEEEEeeeeecCCCCEEEEEEEEeccchhhHHHHHh
Q 001847 237 GRNCRFLQGAGTDPEDVAKIRETLQNGQSYCGRLLNYKKDGTPFWNLLTIAPIKDDEGKVLKFIGMQVEVSKHTEGAKDK 316 (1005)
Q Consensus 237 G~~~~~l~~~~~~~~~~~~i~~~l~~g~~~~~e~~~~~kdG~~~wv~~~~~pi~d~~G~v~~~v~~~~DITerk~~E~~L 316 (1005)
|+++..++++.........+......+.....++. .++|...| .+.++++.. +|. ..+++.++|||+++++++++
T Consensus 176 g~~~~~~~~~~~~~~~~~~l~~~~~~g~~~~~~~~--~~~~~~~~-~~~~~~~~~-~~~-~~~l~~~~dit~~~~~e~~~ 250 (442)
T TIGR02040 176 GRAFPQEFEGRRREELMLTLRNVRATGSAAPVRIL--LRRSQKRL-LVVVSVFRQ-DGE-SLFLCQLSPAGATQPVGDEL 250 (442)
T ss_pred CCCHHHhCCHHHHHHHHHHHHHHHhcCCCcceEEE--EcCCCeEE-EEEEEEEEe-CCc-eEEEEEEcccchhhhhhHHH
Confidence 99988777776666566667777777765555544 33443344 445666654 333 35778899999998877553
Q ss_pred hcCCCCCchhhhhHHHHHHHHhhhhHHHHHHHccCCCCcccCCCCCcccccCCCCchhh-hcccccCCCCCCCCCCCCCC
Q 001847 317 MLRPNGLPESLIRYDARQKEMATSSVTELVQAMKKPRSLSESTNRPPIIRKSEGGVEEE-RAGALGRRKSENVPPPRRNS 395 (1005)
Q Consensus 317 ~~~~~~l~~~l~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~g~~~~~~~~~~~~~~ 395 (1005)
.. .. ..-+..+-....-.+..-....+|..+...+|++ .+++.|++...+++......
T Consensus 251 ~~--------------~~-------~~l~e~~~d~I~v~D~~G~I~~~N~a~~~l~G~~~~~~l~G~~~~~~~~~~~~~~ 309 (442)
T TIGR02040 251 SE--------------NL-------ARLYHEAPDAIVFSDADGTIRGANEAFLELTDSSSLEAVRGRTLDRWLGRGGVDL 309 (442)
T ss_pred HH--------------HH-------HHHHHhCCceEEEEcCCCcEEehhHHHHHHhCCCChHHHcCCCHHHHhCCCcccH
Confidence 30 00 1111222223333444455667888889999997 47799998877654321110
Q ss_pred C-CCCcccccccccccchhhccccCCcccccccccccccCCCCCCccccccccCCCCCCCCCCCCCchhhHHHH
Q 001847 396 Y-GGGCRTSMQRISEVPEKKKQKSGRRSFMGLIGRKSQSTDDHDSFENEIIMEGDDDYESDDERPDSVDDKVRQ 468 (1005)
Q Consensus 396 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~er~~~e 468 (1005)
. .............+......++|+.+|+.++..+....++.. .+. ..+|+|+|++.+
T Consensus 310 ~~~~~~~~~~g~~~~~~~~~~~~~G~~~~ve~s~~~i~~~~~~~-~~~--------------v~rDITeR~~~~ 368 (442)
T TIGR02040 310 RVLLSNVRRTGQVRLYATTLTGEFGAQTEVEISAAWVDQGERPL-IVL--------------VIRDISRRLTMR 368 (442)
T ss_pred HHHHHHHhhcCceEEEEEEEEcCCCCEEEEEEEEEEeccCCceE-EEE--------------EEecchhhccCC
Confidence 0 000000011122234445688999999999988877644422 222 247788877664
|
This model represents the transcriptional regulator PpsR which is strictly associated with photosynthetic proteobacteria and found in photosynthetic operons. PpsR has been reported to be a repressor. These proteins contain a Helix-Turn_Helix motif of the "fis" type (pfam02954). |
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.26 E-value=6.3e-12 Score=132.77 Aligned_cols=210 Identities=21% Similarity=0.254 Sum_probs=146.5
Q ss_pred HHHhCCCCCcceEEEEEEeC-----CeEEEEEeccCCCchhhHHhhC--CCCCCCHHHHHHHHHHHHHHHHHHHHc--Cc
Q 001847 725 ILDMLDHPFVPALYASFQTK-----THVCLITDYCPGGELFLLLDRQ--PTKVLKEDAVRFYAAEVVVALEYLHCQ--GI 795 (1005)
Q Consensus 725 il~~l~hpnIv~l~~~~~~~-----~~~~lV~E~~~ggsL~~~l~~~--~~~~l~~~~i~~i~~qil~aL~~LH~~--gI 795 (1005)
-+-++-|.|+|+++.|+.+. ..+.++.|||..|+|..+|++- -...+.....++|+.||+.||.|||+. -|
T Consensus 120 nllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~Ppi 199 (458)
T KOG1266|consen 120 NLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPPI 199 (458)
T ss_pred HHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCcc
Confidence 45556799999999988654 3578999999999999999742 124588888999999999999999998 49
Q ss_pred ccCCCCCCcEEEecCCcEEEEeccCCcccCCCCCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccC
Q 001847 796 IYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAG 875 (1005)
Q Consensus 796 vHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~ 875 (1005)
+|+++..+-|++..+|-+|+.--.-... .+.... ..........+-++|.+||.=..
T Consensus 200 ihgnlTc~tifiq~ngLIkig~~ap~s~---h~s~~~--------------------~~~~Ek~~~~~~~g~~a~~sg~~ 256 (458)
T KOG1266|consen 200 IHGNLTCDTIFIQHNGLIKIGSVAPDST---HPSVNS--------------------TREAEKSVNTSLPGFSAPESGTT 256 (458)
T ss_pred ccCCcchhheeecCCceEEecccCcccc---chhhhh--------------------hhHhhhhccccCCccccCCcCcc
Confidence 9999999999999998888753332211 100000 00011122346789999997655
Q ss_pred CCCCChhhHHHHHHHHHHHHcCCCCCCCCCh-HHHHHHHHhCCCCCCCCCCCCHHHHHHHHHccccCcCccCCChhcHHH
Q 001847 876 AGHTSAVDWWALGILLYEMLYGYTPFRGKTR-QKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANE 954 (1005)
Q Consensus 876 ~~~~~~sDIwSlGvll~eLltG~~Pf~~~~~-~~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~e 954 (1005)
...+.++|||+||...++|..+..--..... ...-..+..- +. ....+ .-.+++.+||...|+.||+ ++.
T Consensus 257 tn~~~a~dIy~fgmcAlemailEiq~tnseS~~~~ee~ia~~-i~-~len~---lqr~~i~kcl~~eP~~rp~----ar~ 327 (458)
T KOG1266|consen 257 TNTTGASDIYKFGMCALEMAILEIQSTNSESKVEVEENIANV-II-GLENG---LQRGSITKCLEGEPNGRPD----ARL 327 (458)
T ss_pred cccccchhhhhhhHHHHHHHHheeccCCCcceeehhhhhhhh-ee-eccCc---cccCcCcccccCCCCCCcc----hhh
Confidence 5666799999999999999887654322221 1111112111 11 11111 1246899999999999999 999
Q ss_pred HHcCCCCCCCCh
Q 001847 955 IKKHPFFKGVNW 966 (1005)
Q Consensus 955 lL~hpff~~~~~ 966 (1005)
+|.||-+-.+.-
T Consensus 328 llfHpllfeVhs 339 (458)
T KOG1266|consen 328 LLFHPLLFEVHS 339 (458)
T ss_pred hhcCceeeecch
Confidence 999998877543
|
|
| >PRK10060 RNase II stability modulator; Provisional | Back alignment and domain information |
|---|
Probab=99.26 E-value=5.1e-11 Score=147.32 Aligned_cols=158 Identities=13% Similarity=0.134 Sum_probs=121.8
Q ss_pred ccccccccccccchHHHHHHHHHhcCCeEEEEeCCCCCCcEEEccHHHHHHcCCChhhhcCCCCCcC-CCCCCChHHHHH
Q 001847 177 MSDEGGKEKGLPRVSDIVKDALSTFQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFL-QGAGTDPEDVAK 255 (1005)
Q Consensus 177 it~~~~~e~~L~~~~~~l~~ile~~~~~i~i~D~~~~dg~I~~vN~a~~~l~Gys~eEllG~~~~~l-~~~~~~~~~~~~ 255 (1005)
+++.....+.+.....+++.+++.++++|+++|. +|+|+++|++|++++||+.+|++|+++..+ .++.........
T Consensus 96 ~~~~~~~~~~~~~~~~~~~~v~~~~~~gI~i~D~---~g~I~~~N~a~~~l~Gy~~~eliG~~~~~l~~~~~~~~~~~~~ 172 (663)
T PRK10060 96 WHDTPSVARDLSHGLSFAEQVVSEANSVIVILDS---RGNIQRFNRLCEEYTGLKEHDVIGQSVFKLFMSRREAAASRRN 172 (663)
T ss_pred HHHHHHHHHHHHHHHHHHHHHHhhCCceEEEEeC---CCCEEEEcHHHHHHHCcCHHHHcCCCHHHHhCChhhHHHHHHH
Confidence 3333444455667778889999999999999999 778999999999999999999999997644 344444555666
Q ss_pred HHHHHHcCCcEEEEEEEEecCCcEEEEEEEeeeeecCCCCEEEEEEEEeccchhhHHHHHhhcC-----CCCCchhhhhH
Q 001847 256 IRETLQNGQSYCGRLLNYKKDGTPFWNLLTIAPIKDDEGKVLKFIGMQVEVSKHTEGAKDKMLR-----PNGLPESLIRY 330 (1005)
Q Consensus 256 i~~~l~~g~~~~~e~~~~~kdG~~~wv~~~~~pi~d~~G~v~~~v~~~~DITerk~~E~~L~~~-----~~~l~~~l~~~ 330 (1005)
+...+..+..|.++.+..+++|..+|+.....+..+.++...+++++.+|||++|+++++++.. +++|++|-...
T Consensus 173 ~~~~~~~~~~~~~e~~~~~~~G~~~~~~~~~~~~~~~g~~~~~~i~~~~DITe~k~~e~~l~~~a~~D~LTGL~NR~~f~ 252 (663)
T PRK10060 173 IRGFFRSGNAYEVERWIKTRKGQRLFLFRNKFVHSGSGKNEIFLICSGTDITEERRAQERLRILANTDSITGLPNRNAIQ 252 (663)
T ss_pred HHHHHhcCCceEEEEEEEeCCCCEEEEEeeeEEEcCCCCceEEEEEEEEechHHHHHHHHHHHHhhcCccCCCcCHHHHH
Confidence 7777888888999999999999999987665443333334567889999999999999887653 67788876555
Q ss_pred HHHHHHH
Q 001847 331 DARQKEM 337 (1005)
Q Consensus 331 ~~~~~~~ 337 (1005)
+.....+
T Consensus 253 ~~l~~~l 259 (663)
T PRK10060 253 ELIDHAI 259 (663)
T ss_pred HHHHHHH
Confidence 5554433
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.23 E-value=9e-11 Score=115.47 Aligned_cols=146 Identities=19% Similarity=0.211 Sum_probs=113.6
Q ss_pred ccccccccCcEEEEEEEEcCCCeEEEEEEe-----ecccccChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEE
Q 001847 676 PIKPLGSGDTGSVHLVELCGSGQYFAMKAM-----DKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLI 750 (1005)
Q Consensus 676 ~~~~LG~G~~g~Vy~a~~~~~~~~valK~~-----~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV 750 (1005)
.+..|.+|+-+.|+++.+ .|+.++||.- +...+..+-...+..+|+.+|.++.--.|.-..-+|.+...-+|+
T Consensus 11 ~l~likQGAEArv~~~~~--~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ 88 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSF--SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIY 88 (229)
T ss_pred cceeeeccceeeEeeecc--CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEE
Confidence 567889999999999997 7888888743 333344455567778899999998655665555566666777899
Q ss_pred EeccCC-CchhhHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCC---cEEEEeccCCcc
Q 001847 751 TDYCPG-GELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNG---HVSLTDFDLSCL 823 (1005)
Q Consensus 751 ~E~~~g-gsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~~~g---~vkL~DFG~a~~ 823 (1005)
|||++| .++.+++...-...........++++|-..+.-||.++|||+||..+||++.++| .+.|+|||++..
T Consensus 89 ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 89 MEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred EEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEEeecchhc
Confidence 999966 5888888764334344555578999999999999999999999999999998765 358999999843
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.22 E-value=2.1e-10 Score=118.15 Aligned_cols=140 Identities=15% Similarity=0.122 Sum_probs=101.8
Q ss_pred cccccccCcEEEEEEEEcC------CCeEEEEEEeeccccc-------------------ChHHHHHHH----HHHHHHH
Q 001847 677 IKPLGSGDTGSVHLVELCG------SGQYFAMKAMDKGVML-------------------NRNKVHRAC----AEREILD 727 (1005)
Q Consensus 677 ~~~LG~G~~g~Vy~a~~~~------~~~~valK~~~~~~~~-------------------~~~~~~~~~----~E~~il~ 727 (1005)
...||.|--+.||.|.... .+..+|||+++-.... .......+. +|+..|+
T Consensus 2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~ 81 (197)
T cd05146 2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK 81 (197)
T ss_pred CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence 3578999999999998643 3579999988642110 011122333 7888999
Q ss_pred hCCC--CCcceEEEEEEeCCeEEEEEeccCCCchhh-HHhhCCCCCCCHHHHHHHHHHHHHHHHHH-HHcCcccCCCCCC
Q 001847 728 MLDH--PFVPALYASFQTKTHVCLITDYCPGGELFL-LLDRQPTKVLKEDAVRFYAAEVVVALEYL-HCQGIIYRDLKPE 803 (1005)
Q Consensus 728 ~l~h--pnIv~l~~~~~~~~~~~lV~E~~~ggsL~~-~l~~~~~~~l~~~~i~~i~~qil~aL~~L-H~~gIvHrDLkP~ 803 (1005)
++.. -+++.++.+ ..-+|||||+.++.+.. .++. ..++......++.+++.+|..| |+.||||+||+|.
T Consensus 82 rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd---~~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs~~ 154 (197)
T cd05146 82 RMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKD---AKLNDEEMKNAYYQVLSMMKQLYKECNLVHADLSEY 154 (197)
T ss_pred HHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhc---cccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCCHH
Confidence 8843 567777764 44679999996654422 2221 2355667778889999999999 8999999999999
Q ss_pred cEEEecCCcEEEEeccCCccc
Q 001847 804 NVLLQGNGHVSLTDFDLSCLT 824 (1005)
Q Consensus 804 NILi~~~g~vkL~DFG~a~~~ 824 (1005)
|||+. ++.+.|+|||.+...
T Consensus 155 NIL~~-~~~v~iIDF~qav~~ 174 (197)
T cd05146 155 NMLWH-DGKVWFIDVSQSVEP 174 (197)
T ss_pred HEEEE-CCcEEEEECCCceeC
Confidence 99997 578999999988544
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.21 E-value=6e-11 Score=120.56 Aligned_cols=127 Identities=24% Similarity=0.291 Sum_probs=95.8
Q ss_pred cccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCC-cceEEEEEEeCCeEEEEEeccC
Q 001847 677 IKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPF-VPALYASFQTKTHVCLITDYCP 755 (1005)
Q Consensus 677 ~~~LG~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~il~~l~hpn-Iv~l~~~~~~~~~~~lV~E~~~ 755 (1005)
++.|+.|.++.||++.. .+..|++|....... ....+..|+.+++.+.+.+ +++++.+.. ...++||||++
T Consensus 3 ~~~l~~G~~~~vy~~~~--~~~~~~lK~~~~~~~----~~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~~~lv~e~i~ 74 (170)
T cd05151 3 ISPLKGGMTNKNYRVEV--ANKKYVVRIPGNGTE----LLINRENEAENSKLAAEAGIGPKLYYFDP--ETGVLITEFIE 74 (170)
T ss_pred eeecCCcccCceEEEEE--CCeEEEEEeCCCCcc----cccCHHHHHHHHHHHHHhCCCCceEEEeC--CCCeEEEEecC
Confidence 46789999999999997 478899998765421 1224567888888885443 456665543 23479999999
Q ss_pred CCchhhHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCc-----ccCCCCCCcEEEecCCcEEEEeccCCc
Q 001847 756 GGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGI-----IYRDLKPENVLLQGNGHVSLTDFDLSC 822 (1005)
Q Consensus 756 ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gI-----vHrDLkP~NILi~~~g~vkL~DFG~a~ 822 (1005)
|.++.... . ....++.+++.+|+.||..++ +|+|++|+||+++ ++.++++|||.+.
T Consensus 75 G~~l~~~~-------~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~ 135 (170)
T cd05151 75 GSELLTED-------F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG 135 (170)
T ss_pred CCcccccc-------c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence 98876430 1 113456899999999999985 9999999999999 6789999999884
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.20 E-value=1.8e-10 Score=133.39 Aligned_cols=240 Identities=17% Similarity=0.160 Sum_probs=155.5
Q ss_pred CccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEEe
Q 001847 673 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITD 752 (1005)
Q Consensus 673 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E 752 (1005)
.|.+ ....-++.+..-.+.-+.++.++.+..++... ........+-++-|+.++||||+++++.++..+.+|||+|
T Consensus 14 pY~l-e~~~~~~~a~~~~~t~k~~~~~vsVF~~~~~~---~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTE 89 (690)
T KOG1243|consen 14 PYDL-EETAFSSEALWPDGTRKADGGPVSVFVYKRSN---GEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTE 89 (690)
T ss_pred Cccc-ccccCCCcccccccceeccCCceEEEEEeCCC---chhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEee
Confidence 3555 33333333322234555678888888877542 2345566677888999999999999999999999999999
Q ss_pred ccCCCchhhHHhhCCCCCCCHHHHHHHHHHHHHHHHHHH-HcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCCCCC
Q 001847 753 YCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLH-CQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLL 831 (1005)
Q Consensus 753 ~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH-~~gIvHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~~ 831 (1005)
.+ ..|..+++. +....+..-+.||+.||.||| +++++|++|.-+.|+|+..|.-||++|.++........
T Consensus 90 rV--~Pl~~~lk~-----l~~~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~-- 160 (690)
T KOG1243|consen 90 RV--RPLETVLKE-----LGKEEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA-- 160 (690)
T ss_pred cc--ccHHHHHHH-----hHHHHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc--
Confidence 98 456666665 345667777899999999998 66999999999999999999999999998744321110
Q ss_pred CCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHcCCCCCCCCChHHHHH
Q 001847 832 LPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFA 911 (1005)
Q Consensus 832 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlGvll~eLltG~~Pf~~~~~~~~~~ 911 (1005)
.......--.|..|+.+.... -..|.|.|||++++++.|..+- ......
T Consensus 161 -------------------------~~~~~~~~~s~~~P~~~~~s~--~s~D~~~Lg~li~el~ng~~~~--~~~~~~-- 209 (690)
T KOG1243|consen 161 -------------------------PAKSLYLIESFDDPEEIDPSE--WSIDSWGLGCLIEELFNGSLLT--KTDLSN-- 209 (690)
T ss_pred -------------------------ccccchhhhcccChhhcCccc--cchhhhhHHHHHHHHhCcccCc--chhhhc--
Confidence 001111222356665443222 3469999999999999983322 111000
Q ss_pred HHHhCCCCCCCCCCCCHHHHHHHHHccccCcCccCCChhcHHHHHc-CCCCCCCChh
Q 001847 912 NILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKK-HPFFKGVNWA 967 (1005)
Q Consensus 912 ~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~-hpff~~~~~~ 967 (1005)
.+ .++.....+..+-+.-.+..||.....+..++. |+||++--..
T Consensus 210 ---~~--------~ipk~~~~~~~k~~~~~~~~r~n~~~~~~~~~~~~gff~n~fvd 255 (690)
T KOG1243|consen 210 ---TG--------KIPKALIELYCKKLGATELKRPNKLRFILECRLLGGFFRNDFVD 255 (690)
T ss_pred ---cC--------ccchhHHHHHHHHhccccccccchhhHHHHHHhccccccchHHH
Confidence 00 112223334444444555666663344555554 8888874443
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.20 E-value=9.9e-12 Score=142.74 Aligned_cols=253 Identities=21% Similarity=0.266 Sum_probs=185.6
Q ss_pred ccccCCccccccccccCcEEEEEEEEc-CCCeEEEEEEeecccccChHHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCC
Q 001847 668 QINLQHFRPIKPLGSGDTGSVHLVELC-GSGQYFAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPALYASFQTKT 745 (1005)
Q Consensus 668 ~i~~~~y~~~~~LG~G~~g~Vy~a~~~-~~~~~valK~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~ 745 (1005)
.....+|..+..||.|.|+.|+.+.-. .++..|++|.+............. ..|..+...+ .|.+++.++..+....
T Consensus 261 s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~s-l~ev~l~~~l~~~~~~~g~~~~W~~~r 339 (524)
T KOG0601|consen 261 SCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFS-LGEVILEAILGSHLPSVGKNSSWSQLR 339 (524)
T ss_pred eeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcc-hhhhhHhhHhhcccccCCCCCCccccc
Confidence 455678999999999999999998765 678899999888765444443332 3355555555 6889998888888888
Q ss_pred eEEEEEeccCCCchhhHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecC-CcEEEEeccCCccc
Q 001847 746 HVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGN-GHVSLTDFDLSCLT 824 (1005)
Q Consensus 746 ~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~~~-g~vkL~DFG~a~~~ 824 (1005)
..|+-.|||.++++...... ...+.+...+.+..|++.++.++|++.++|+|+||+||++..+ +..+++|||....+
T Consensus 340 ~~~ip~e~~~~~s~~l~~~~--~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~ 417 (524)
T KOG0601|consen 340 QGYIPLEFCEGGSSSLRSVT--SQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDGFFSKLGDFGCWTRL 417 (524)
T ss_pred cccCchhhhcCcchhhhhHH--HHhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccchhhhhcccccccccc
Confidence 88899999999888766532 2347788899999999999999999999999999999999976 78899999987432
Q ss_pred CCCCCCCCCcchhhhhcccCCCCCcccccccccccccccCCccc--ccccccCCCCCChhhHHHHHHHHHHHHcCCCCCC
Q 001847 825 SCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYI--APEIIAGAGHTSAVDWWALGILLYEMLYGYTPFR 902 (1005)
Q Consensus 825 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~--aPE~l~~~~~~~~sDIwSlGvll~eLltG~~Pf~ 902 (1005)
.... ....+..+++ ++..+....+..+.|++|||..+++.++|...-.
T Consensus 418 ~~~~------------------------------~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~ 467 (524)
T KOG0601|consen 418 AFSS------------------------------GVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSE 467 (524)
T ss_pred ceec------------------------------ccccccccccccchhhccccccccccccccccccccccccCcccCc
Confidence 1111 1112333444 4444455677889999999999999999875443
Q ss_pred CCChHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHccccCcCccCCChhcHHHHHcCCCCC
Q 001847 903 GKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFK 962 (1005)
Q Consensus 903 ~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~Rpt~~~~a~elL~hpff~ 962 (1005)
.... ...+..+.. +........++.+.+.++..++..|+. +.++..|.-|.
T Consensus 468 ~~~~---~~~i~~~~~--p~~~~~~~~~q~~~kv~~~~~~~~~~l----~~~l~~~~~~~ 518 (524)
T KOG0601|consen 468 SGVQ---SLTIRSGDT--PNLPGLKLQLQVLLKVMINPDRKRRPS----AVELSLHSEFY 518 (524)
T ss_pred cccc---ceeeecccc--cCCCchHHhhhhhhhhhcCCccccchh----hhhhcccchhh
Confidence 3222 222333322 222233467888999999999999998 77777776554
|
|
| >PRK13558 bacterio-opsin activator; Provisional | Back alignment and domain information |
|---|
Probab=99.18 E-value=3e-10 Score=141.36 Aligned_cols=121 Identities=40% Similarity=0.759 Sum_probs=107.5
Q ss_pred HHHHHHhccccEEEEcCCCCCCCEEeecHHHHHHcCCChhhhcCCCCCccCCCCCCHHHHHHHHHHHhcCCcEEEEEEEE
Q 001847 477 LATTLERIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIRAAIDNQTDVTVQLINY 556 (1005)
Q Consensus 477 l~~i~e~~~~~I~i~D~~G~d~~i~~vN~a~~~l~Gy~~eEllG~~~~~l~~~~~~~~~~~~i~~~l~~~~~~~~e~~~~ 556 (1005)
++.+++.++.++++.|..+.++.|+++|+++++++||+.++++|+++..+.+++........+...+..+..+..+++.+
T Consensus 150 ~~~~~~~~~~gi~~~d~~~~dg~i~~~N~~~~~l~G~~~eel~g~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~ 229 (665)
T PRK13558 150 KERALDEAPVGITIADATLPDEPLIYINDAFERITGYSPDEVLGRNCRFLQGEDTNEERVAELREAIDEERPTSVELRNY 229 (665)
T ss_pred HHHHHhcCCccEEEEcCCCCCCcEEEEcHHHHHHhCcCHHHHcCCCHHHhcCCCccHHHHHHHHHHHhcCCCeEEEEEEE
Confidence 57789999999999986444555999999999999999999999998888877776666677778888888889999999
Q ss_pred ecCCcEEEEEEEEeeeeCCCCCEEEEEEEEecCccCccccc
Q 001847 557 TKSGKKFWNLFHLQPMRDQKGEVQYFIGVQLDGSEHLEPLR 597 (1005)
Q Consensus 557 ~kdG~~~wv~~~~~pi~d~~G~v~~~vgi~~DITerK~~e~ 597 (1005)
++||..+|+.++..|+++.+|.+.+++++++|||++|+.++
T Consensus 230 ~~dG~~~~~~~~~~pi~d~~G~~~~~vgi~~DITerk~~E~ 270 (665)
T PRK13558 230 RKDGSTFWNQVDIAPIRDEDGTVTHYVGFQTDVTERKEAEL 270 (665)
T ss_pred CCCCCEEEEEEEEEEEECCCCCEEEEEEEEEeCcHHHHHHH
Confidence 99999999999999999999999999999999999999543
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.17 E-value=2.6e-10 Score=113.15 Aligned_cols=134 Identities=21% Similarity=0.217 Sum_probs=101.7
Q ss_pred ccccccCcEEEEEEEEcCCCeEEEEEEeecc-----cccChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEEe
Q 001847 678 KPLGSGDTGSVHLVELCGSGQYFAMKAMDKG-----VMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITD 752 (1005)
Q Consensus 678 ~~LG~G~~g~Vy~a~~~~~~~~valK~~~~~-----~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E 752 (1005)
..+++|+-+.+|.+.. -|..+++|.=.+. .+..+-...+-.+|+.++.++..-.|....=++.+.+...|+||
T Consensus 2 ~~i~~GAEa~i~~~~~--~g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me 79 (204)
T COG3642 2 DLIKQGAEAIIYLTDF--LGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVME 79 (204)
T ss_pred chhhCCcceeEEeeec--cCcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEE
Confidence 4578999999999976 4445777754332 22223334566689999999866566555555666677789999
Q ss_pred ccCCCchhhHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcc
Q 001847 753 YCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCL 823 (1005)
Q Consensus 753 ~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~~~g~vkL~DFG~a~~ 823 (1005)
|++|..|.+++... ...+++.+-.-+.-||..||||+||.++||++.++ .+.++|||++..
T Consensus 80 ~I~G~~lkd~l~~~---------~~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~~-~i~~IDfGLg~~ 140 (204)
T COG3642 80 YIEGELLKDALEEA---------RPDLLREVGRLVGKLHKAGIVHGDLTTSNIILSGG-RIYFIDFGLGEF 140 (204)
T ss_pred EeCChhHHHHHHhc---------chHHHHHHHHHHHHHHhcCeecCCCccceEEEeCC-cEEEEECCcccc
Confidence 99999999998763 14567778888899999999999999999999955 499999999853
|
|
| >TIGR02938 nifL_nitrog nitrogen fixation negative regulator NifL | Back alignment and domain information |
|---|
Probab=99.13 E-value=1.5e-10 Score=138.25 Aligned_cols=132 Identities=23% Similarity=0.418 Sum_probs=112.4
Q ss_pred HHHHHHhccccEEEEcCCCCCCCEEeecHHHHHHcCCChhhhcCCCCCccCCCCCCHHHHHHHHHHHhcCCcEEEEEEEE
Q 001847 477 LATTLERIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIRAAIDNQTDVTVQLINY 556 (1005)
Q Consensus 477 l~~i~e~~~~~I~i~D~~G~d~~i~~vN~a~~~l~Gy~~eEllG~~~~~l~~~~~~~~~~~~i~~~l~~~~~~~~e~~~~ 556 (1005)
|+.++++++++++++|.+|+ ++++|+++++++||++++++|++...+.++.........+.+.+..+..+..+....
T Consensus 6 ~~~i~~~~~~~i~~~d~~g~---~~~~N~~~~~~~G~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 82 (494)
T TIGR02938 6 YRQTVDQAPLAISITDLKAN---ILYANDAFTRITGYTKEEIIGKNESVLSNHTTPPEVYQALWGSLAEQKPWAGKLLNR 82 (494)
T ss_pred HHHHHHhCCceEEEECCCCc---EEEEchhheeecCCCHHHHhCCCchhhcCCCCCHHHHHHHHHHHHhCCcccceeecc
Confidence 89999999999999999888 999999999999999999999987777766666667777778888888888888889
Q ss_pred ecCCcEEEEEEEEeeeeCCCCCEEEEEEEEecCccCccccccCCchhhHHHHHHHHHHHhh
Q 001847 557 TKSGKKFWNLFHLQPMRDQKGEVQYFIGVQLDGSEHLEPLRNSIPEATAEESEKLVKQTAE 617 (1005)
Q Consensus 557 ~kdG~~~wv~~~~~pi~d~~G~v~~~vgi~~DITerK~~e~~~~~~~~~~e~~~l~~~~~~ 617 (1005)
+++|+.+|+..+..|+++.+|.+.+++++++|||++|+.+ +.+++.+.+++.+..
T Consensus 83 ~~~g~~~~~~~~~~~~~~~~g~~~~~~~~~~DIt~~k~~e------~~l~~~~~~~~~~~~ 137 (494)
T TIGR02938 83 RKDGELYLAELTVAPVLNEAGETTHFLGMHRDITELHRLE------QVVANQKLLIESVVD 137 (494)
T ss_pred CCCccchhhheeeEEEECCCCCEEEEEEehhhhhHHHHHH------HHHHHHHHHHHHHHh
Confidence 9999999999999999999999999999999999999842 233444444444443
|
NifL is a modulator of the nitrogen fixation positive regulator protein NifA, and is therefore a negative regulator. It binds NifA. NifA and NifL are encoded by adjacent genes. |
| >PRK10060 RNase II stability modulator; Provisional | Back alignment and domain information |
|---|
Probab=99.12 E-value=7e-10 Score=137.26 Aligned_cols=115 Identities=17% Similarity=0.178 Sum_probs=95.1
Q ss_pred HHHHHHhccccEEEEcCCCCCCCEEeecHHHHHHcCCChhhhcCCCCCccC-CCCCCHHHHHHHHHHHhcCCcEEEEEEE
Q 001847 477 LATTLERIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQ-GPETDPATVRKIRAAIDNQTDVTVQLIN 555 (1005)
Q Consensus 477 l~~i~e~~~~~I~i~D~~G~d~~i~~vN~a~~~l~Gy~~eEllG~~~~~l~-~~~~~~~~~~~i~~~l~~~~~~~~e~~~ 555 (1005)
++.+++.++++|+++|.+|+ |+++|++|++++||+.+|++|+++..+. ++++.......+...+..+..+..|.+.
T Consensus 113 ~~~v~~~~~~gI~i~D~~g~---I~~~N~a~~~l~Gy~~~eliG~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~ 189 (663)
T PRK10060 113 AEQVVSEANSVIVILDSRGN---IQRFNRLCEEYTGLKEHDVIGQSVFKLFMSRREAAASRRNIRGFFRSGNAYEVERWI 189 (663)
T ss_pred HHHHHhhCCceEEEEeCCCC---EEEEcHHHHHHHCcCHHHHcCCCHHHHhCChhhHHHHHHHHHHHHhcCCceEEEEEE
Confidence 67899999999999999888 9999999999999999999999975544 5554455566777778888889999999
Q ss_pred EecCCcEEEEEEEEeeeeCCCCC-EEEEEEEEecCccCccc
Q 001847 556 YTKSGKKFWNLFHLQPMRDQKGE-VQYFIGVQLDGSEHLEP 595 (1005)
Q Consensus 556 ~~kdG~~~wv~~~~~pi~d~~G~-v~~~vgi~~DITerK~~ 595 (1005)
.+++|..+|+..... +.+..|. ..+++++.+|||++|+.
T Consensus 190 ~~~~G~~~~~~~~~~-~~~~~g~~~~~~i~~~~DITe~k~~ 229 (663)
T PRK10060 190 KTRKGQRLFLFRNKF-VHSGSGKNEIFLICSGTDITEERRA 229 (663)
T ss_pred EeCCCCEEEEEeeeE-EEcCCCCceEEEEEEEEechHHHHH
Confidence 999999999876644 4444554 46788999999999884
|
|
| >TIGR00229 sensory_box PAS domain S-box | Back alignment and domain information |
|---|
Probab=99.12 E-value=8.2e-10 Score=100.47 Aligned_cols=120 Identities=20% Similarity=0.409 Sum_probs=97.2
Q ss_pred HHHHHHHHhcCCeEEEEeCCCCCCcEEEccHHHHHHcCCChhhhcCCCCCcCCCCCCChHHHHHHHHHHHcC-CcEEEEE
Q 001847 192 DIVKDALSTFQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKIRETLQNG-QSYCGRL 270 (1005)
Q Consensus 192 ~~l~~ile~~~~~i~i~D~~~~dg~I~~vN~a~~~l~Gys~eEllG~~~~~l~~~~~~~~~~~~i~~~l~~g-~~~~~e~ 270 (1005)
+.++.++++++++++++|. +|+++++|+++++++|++.++++|..+..+.++.........+...+..+ .....+.
T Consensus 3 ~~~~~~~~~~~~~~~~~d~---~~~i~~~n~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 79 (124)
T TIGR00229 3 ERYRAIFESSPDAIIVIDL---EGNILYVNPAFEEIFGYSAEELIGRNVLELIPEEDREEVRERIERLLEGEREPVSEER 79 (124)
T ss_pred hHHHHHHhhCCceEEEEcC---CCcEEEEchHHHHHhCCChHHhcCcchhhhcChhhhHHHHHHHHHHHcCCCCCcceEe
Confidence 5678899999999999998 77799999999999999999999999877666655554445555555533 2233445
Q ss_pred EEEecCCcEEEEEEEeeeeecCCCCEEEEEEEEeccchhhHHHHH
Q 001847 271 LNYKKDGTPFWNLLTIAPIKDDEGKVLKFIGMQVEVSKHTEGAKD 315 (1005)
Q Consensus 271 ~~~~kdG~~~wv~~~~~pi~d~~G~v~~~v~~~~DITerk~~E~~ 315 (1005)
....++|..+|+.....|+. .+|...++++++.|||++++++++
T Consensus 80 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~dit~~~~~~~~ 123 (124)
T TIGR00229 80 RVRRKDGSEIWVEVSVSPIR-TNGGELGVVGIVRDITERKQAEEA 123 (124)
T ss_pred eeEcCCCCEEEEEEEEeehh-hCCCeeEEEEEeeehhHHHHHHhc
Confidence 55588999999999999998 788899999999999999988765
|
The PAS domain was previously described. This sensory box, or S-box domain occupies the central portion of the PAS domain but is more widely distributed. It is often tandemly repeated. Known prosthetic groups bound in the S-box domain include heme in the oxygen sensor FixL, FAD in the redox potential sensor NifL, and a 4-hydroxycinnamyl chromophore in photoactive yellow protein. Proteins containing the domain often contain other regulatory domains such as response regulator or sensor histidine kinase domains. Other S-box proteins include phytochromes and the aryl hydrocarbon receptor nuclear translocator. |
| >PRK11359 cyclic-di-GMP phosphodiesterase; Provisional | Back alignment and domain information |
|---|
Probab=99.07 E-value=6.8e-10 Score=141.34 Aligned_cols=141 Identities=14% Similarity=0.183 Sum_probs=117.4
Q ss_pred cccccccccccccccccccchHHHHHHHHHhcCCeEEEEeCCCCCCcEEEccHHHHHHcCCChhhhcCCCCCcCC-CCCC
Q 001847 170 SVRSSGEMSDEGGKEKGLPRVSDIVKDALSTFQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQ-GAGT 248 (1005)
Q Consensus 170 ~~~~~~dit~~~~~e~~L~~~~~~l~~ile~~~~~i~i~D~~~~dg~I~~vN~a~~~l~Gys~eEllG~~~~~l~-~~~~ 248 (1005)
.+....|||++++.++ ..+.+..++++++++++++|. +|+|+++|+++++++||+.++++|+++..+. ++..
T Consensus 118 ~~~~~~DiT~~~~~~~----~~~~~~~~~~~~~~~i~~~d~---~g~i~~~N~~~~~l~G~~~~e~~g~~~~~~~~~~~~ 190 (799)
T PRK11359 118 YLALVRDASVEMAQKE----QTRQLIIAVDHLDRPVIVLDP---ERRIVQCNRAFTEMFGYCISEASGMQPDTLLNIPEF 190 (799)
T ss_pred EEEEEeeccchhhhHH----HHHHHHHHHhcCCCcEEEEcC---CCcEEEEChhhHhhhCCCHHHHCCCChHHhcCCCCC
Confidence 4555689998766544 456677889999999999998 7779999999999999999999999877544 4445
Q ss_pred ChHHHHHHHHHHHcCCcEEEEEEEEecCCcEEEEEEEeeeeecCCCCEEEEEEEEeccchhhHHHHHhh
Q 001847 249 DPEDVAKIRETLQNGQSYCGRLLNYKKDGTPFWNLLTIAPIKDDEGKVLKFIGMQVEVSKHTEGAKDKM 317 (1005)
Q Consensus 249 ~~~~~~~i~~~l~~g~~~~~e~~~~~kdG~~~wv~~~~~pi~d~~G~v~~~v~~~~DITerk~~E~~L~ 317 (1005)
.......+...+..+..+..+++..+++|..+|+.++..|+.+.+|.+.+++++.+|||++|++++..+
T Consensus 191 ~~~~~~~~~~~~~~~~~~~~e~~~~~~dG~~~~~~~~~~~v~d~~g~~~~~~~~~~DITerk~~e~~~~ 259 (799)
T PRK11359 191 PADNRIRLQQLLWKTARDQDEFLLLTRTGEKIWIKASISPVYDVLAHLQNLVMTFSDITEERQIRQLEG 259 (799)
T ss_pred cHHHHHHHHHhhccCCCCcceeEEeCCCCCEEEEEeeeeeeecCCCceeEEEEEeehhhhHHHHHHHHH
Confidence 555566677777777778888888999999999999999999999999999999999999998875543
|
|
| >PF08447 PAS_3: PAS fold; InterPro: IPR013655 The PAS fold corresponds to the structural domain that has previously been defined as PAS and PAC motifs [] | Back alignment and domain information |
|---|
Probab=99.04 E-value=9.5e-10 Score=99.21 Aligned_cols=86 Identities=29% Similarity=0.408 Sum_probs=74.7
Q ss_pred EEeecHHHHHHcCCChhhhcCCC----CCccCCCCCCHHHHHHHHH-HHhcCCcEEEEEEEEecCCcEEEEEEEEeeeeC
Q 001847 500 IIFASDSFLELTEYSREEILGRN----CRFLQGPETDPATVRKIRA-AIDNQTDVTVQLINYTKSGKKFWNLFHLQPMRD 574 (1005)
Q Consensus 500 i~~vN~a~~~l~Gy~~eEllG~~----~~~l~~~~~~~~~~~~i~~-~l~~~~~~~~e~~~~~kdG~~~wv~~~~~pi~d 574 (1005)
|+|||+++++++||+++++ +.. +..++||++...+.+.+.. .+..+..+..+++++++||+.+|++.++.+++|
T Consensus 1 ~i~~s~~~~~i~G~~~~~~-~~~~~~~~~~~ihpdD~~~~~~~~~~~~~~~~~~~~~e~R~~~~~G~~~wi~~~~~~~~d 79 (91)
T PF08447_consen 1 IIYWSDNFYEIFGYSPEEI-GKPDFEEWLERIHPDDRERVRQAIQQAALQNGEPFEIEYRIRRKDGEYRWIEVRGRPIFD 79 (91)
T ss_dssp -EEE-THHHHHHTS-HHHH-TCBEHHHHHHHB-TTTHHHHHHHHHHHHHHTT-EEEEEEEEEGTTSTEEEEEEEEEEEET
T ss_pred CEEEeHHHHHHhCCCHHHh-ccCCHHHHHhhcCHHHHHHHHHHHHHHhhccCcceEEEEEEECCCCCEEEEEEEEEEEEC
Confidence 6899999999999999999 766 7778999999999999999 778888999999999999999999999999999
Q ss_pred CCCCEEEEEEEE
Q 001847 575 QKGEVQYFIGVQ 586 (1005)
Q Consensus 575 ~~G~v~~~vgi~ 586 (1005)
++|+++.++|++
T Consensus 80 ~~g~~~~~~Gv~ 91 (91)
T PF08447_consen 80 ENGKPIRIIGVI 91 (91)
T ss_dssp TTS-EEEEEEEE
T ss_pred CCCCEEEEEEEC
Confidence 999999999984
|
The PAS fold appears in archaea, eubacteria and eukarya. The PAS domain contains a sensory box, or S-box domain that occupies the central portion of the PAS domain but is more widely distributed. It is often tandemly repeated. Known prosthetic groups bound in the S-box domain include haem in the oxygen sensor FixL [], FAD in the redox potential sensor NifL [], and a 4-hydroxycinnamyl chromophore in photoactive yellow protein []. Proteins containing the domain often contain other regulatory domains such as response regulator or sensor histidine kinase domains. Other S-box proteins include phytochromes and the aryl hydrocarbon receptor nuclear translocator. This domain has been found in the gene product of the madA gene of the filamentous zygomycete fungus Phycomyces blakesleeanus. It has been shown that MadA encodes a blue-light photoreceptor for phototropism and other light responses. The gene is involved in the phototropic responses associated with sporangiophore growth; they exhibit phototropism by bending toward near-UV and blue wavelengths and away from far-UV wavelengths in a manner that is physiologically similar to plant phototropic responses [].; GO: 0005515 protein binding; PDB: 3NJA_D 3H9W_A 3GDI_B 3ICY_A 3EEH_A 3MR0_B. |
| >TIGR00229 sensory_box PAS domain S-box | Back alignment and domain information |
|---|
Probab=99.02 E-value=2.5e-09 Score=97.16 Aligned_cols=115 Identities=22% Similarity=0.351 Sum_probs=95.7
Q ss_pred HHHHHHhccccEEEEcCCCCCCCEEeecHHHHHHcCCChhhhcCCCCCccCCCCCCHHHHHHHHHHHhcC-CcEEEEEEE
Q 001847 477 LATTLERIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIRAAIDNQ-TDVTVQLIN 555 (1005)
Q Consensus 477 l~~i~e~~~~~I~i~D~~G~d~~i~~vN~a~~~l~Gy~~eEllG~~~~~l~~~~~~~~~~~~i~~~l~~~-~~~~~e~~~ 555 (1005)
++.++++++++++++|.+|. ++++|+++++++|++.++++|..+..+.++.........+...+..+ .....+..+
T Consensus 5 ~~~~~~~~~~~~~~~d~~~~---i~~~n~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 81 (124)
T TIGR00229 5 YRAIFESSPDAIIVIDLEGN---ILYVNPAFEEIFGYSAEELIGRNVLELIPEEDREEVRERIERLLEGEREPVSEERRV 81 (124)
T ss_pred HHHHHhhCCceEEEEcCCCc---EEEEchHHHHHhCCChHHhcCcchhhhcChhhhHHHHHHHHHHHcCCCCCcceEeee
Confidence 78899999999999999888 99999999999999999999999877777666555555555555533 234455555
Q ss_pred EecCCcEEEEEEEEeeeeCCCCCEEEEEEEEecCccCccc
Q 001847 556 YTKSGKKFWNLFHLQPMRDQKGEVQYFIGVQLDGSEHLEP 595 (1005)
Q Consensus 556 ~~kdG~~~wv~~~~~pi~d~~G~v~~~vgi~~DITerK~~ 595 (1005)
..++|..+|+.....|+. .+|...+++++++|||++++.
T Consensus 82 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~dit~~~~~ 120 (124)
T TIGR00229 82 RRKDGSEIWVEVSVSPIR-TNGGELGVVGIVRDITERKQA 120 (124)
T ss_pred EcCCCCEEEEEEEEeehh-hCCCeeEEEEEeeehhHHHHH
Confidence 688999999999999998 788899999999999999874
|
The PAS domain was previously described. This sensory box, or S-box domain occupies the central portion of the PAS domain but is more widely distributed. It is often tandemly repeated. Known prosthetic groups bound in the S-box domain include heme in the oxygen sensor FixL, FAD in the redox potential sensor NifL, and a 4-hydroxycinnamyl chromophore in photoactive yellow protein. Proteins containing the domain often contain other regulatory domains such as response regulator or sensor histidine kinase domains. Other S-box proteins include phytochromes and the aryl hydrocarbon receptor nuclear translocator. |
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.00 E-value=1.2e-08 Score=114.56 Aligned_cols=205 Identities=18% Similarity=0.232 Sum_probs=145.5
Q ss_pred cEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceEEEEEEe----CCeEEEEEeccCC-Cch
Q 001847 685 TGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQT----KTHVCLITDYCPG-GEL 759 (1005)
Q Consensus 685 ~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~----~~~~~lV~E~~~g-gsL 759 (1005)
..+.|++....+|..|++|.++........ ....-.++++++.|+|||.+.++|.. ...+++|++|+++ ++|
T Consensus 289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~n---k~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL 365 (655)
T KOG3741|consen 289 SITTYKATSNVDGNAYVLKRLHGDRDQSTN---KDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTL 365 (655)
T ss_pred cceeEeeeeccCCceeeeeeeccccccCcc---cchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchH
Confidence 458899999999999999999544322222 22234678999999999999999873 4578999999975 577
Q ss_pred hhHHhh-------------CCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCC
Q 001847 760 FLLLDR-------------QPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSC 826 (1005)
Q Consensus 760 ~~~l~~-------------~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~~~g~vkL~DFG~a~~~~~ 826 (1005)
.++.-. ..+...++..+|.++.||..||.++|+.|+..+-|.|.+|+++.+-+++|...|.......
T Consensus 366 ~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~ 445 (655)
T KOG3741|consen 366 YDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVTGKMRIRISGCGIMDVLQE 445 (655)
T ss_pred HHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEeeCcceEEEecccceeeecC
Confidence 665321 1223578899999999999999999999999999999999999888899987776533221
Q ss_pred CCCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHcCCCCC-CCCC
Q 001847 827 KPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPF-RGKT 905 (1005)
Q Consensus 827 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDIwSlGvll~eLltG~~Pf-~~~~ 905 (1005)
++ . +.+.. -.+-|.=-||.+++.|.||..-- ....
T Consensus 446 d~---------------------------------------~--~~le~---~Qq~D~~~lG~ll~aLAt~~~ns~~~d~ 481 (655)
T KOG3741|consen 446 DP---------------------------------------T--EPLES---QQQNDLRDLGLLLLALATGTENSNRTDS 481 (655)
T ss_pred CC---------------------------------------C--cchhH---HhhhhHHHHHHHHHHHhhcccccccccc
Confidence 11 0 11111 13678999999999999996542 1222
Q ss_pred hHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHccccCcCc
Q 001847 906 RQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKS 944 (1005)
Q Consensus 906 ~~~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~~L~~dP~~ 944 (1005)
........+. ..++.++.++|..+...++++
T Consensus 482 ~~~s~~~~I~--------~~yS~D~rn~v~yl~s~~~~~ 512 (655)
T KOG3741|consen 482 TQSSHLTRIT--------TTYSTDLRNVVEYLESLNFRE 512 (655)
T ss_pred hHHHHHHHhh--------hhhhHHHHHHHHHHHhcCccc
Confidence 2222111111 125667788888888888774
|
|
| >PF08447 PAS_3: PAS fold; InterPro: IPR013655 The PAS fold corresponds to the structural domain that has previously been defined as PAS and PAC motifs [] | Back alignment and domain information |
|---|
Probab=98.96 E-value=3.3e-09 Score=95.68 Aligned_cols=86 Identities=28% Similarity=0.453 Sum_probs=73.3
Q ss_pred EEEccHHHHHHcCCChhhhcCCC----CCcCCCCCCChHHHHHHHH-HHHcCCcEEEEEEEEecCCcEEEEEEEeeeeec
Q 001847 217 IMYASAGFFKMTGYTSKEVVGRN----CRFLQGAGTDPEDVAKIRE-TLQNGQSYCGRLLNYKKDGTPFWNLLTIAPIKD 291 (1005)
Q Consensus 217 I~~vN~a~~~l~Gys~eEllG~~----~~~l~~~~~~~~~~~~i~~-~l~~g~~~~~e~~~~~kdG~~~wv~~~~~pi~d 291 (1005)
|+|||++|++++||+++++ |.. +..+++|++.......+.. .+..+..+..+++.+++||+.+|++.+..+++|
T Consensus 1 ~i~~s~~~~~i~G~~~~~~-~~~~~~~~~~~ihpdD~~~~~~~~~~~~~~~~~~~~~e~R~~~~~G~~~wi~~~~~~~~d 79 (91)
T PF08447_consen 1 IIYWSDNFYEIFGYSPEEI-GKPDFEEWLERIHPDDRERVRQAIQQAALQNGEPFEIEYRIRRKDGEYRWIEVRGRPIFD 79 (91)
T ss_dssp -EEE-THHHHHHTS-HHHH-TCBEHHHHHHHB-TTTHHHHHHHHHHHHHHTT-EEEEEEEEEGTTSTEEEEEEEEEEEET
T ss_pred CEEEeHHHHHHhCCCHHHh-ccCCHHHHHhhcCHHHHHHHHHHHHHHhhccCcceEEEEEEECCCCCEEEEEEEEEEEEC
Confidence 6899999999999999999 766 6677889888888888888 788888999999999999999999999999999
Q ss_pred CCCCEEEEEEEE
Q 001847 292 DEGKVLKFIGMQ 303 (1005)
Q Consensus 292 ~~G~v~~~v~~~ 303 (1005)
++|++.+++|+.
T Consensus 80 ~~g~~~~~~Gv~ 91 (91)
T PF08447_consen 80 ENGKPIRIIGVI 91 (91)
T ss_dssp TTS-EEEEEEEE
T ss_pred CCCCEEEEEEEC
Confidence 999999999874
|
The PAS fold appears in archaea, eubacteria and eukarya. The PAS domain contains a sensory box, or S-box domain that occupies the central portion of the PAS domain but is more widely distributed. It is often tandemly repeated. Known prosthetic groups bound in the S-box domain include haem in the oxygen sensor FixL [], FAD in the redox potential sensor NifL [], and a 4-hydroxycinnamyl chromophore in photoactive yellow protein []. Proteins containing the domain often contain other regulatory domains such as response regulator or sensor histidine kinase domains. Other S-box proteins include phytochromes and the aryl hydrocarbon receptor nuclear translocator. This domain has been found in the gene product of the madA gene of the filamentous zygomycete fungus Phycomyces blakesleeanus. It has been shown that MadA encodes a blue-light photoreceptor for phototropism and other light responses. The gene is involved in the phototropic responses associated with sporangiophore growth; they exhibit phototropism by bending toward near-UV and blue wavelengths and away from far-UV wavelengths in a manner that is physiologically similar to plant phototropic responses [].; GO: 0005515 protein binding; PDB: 3NJA_D 3H9W_A 3GDI_B 3ICY_A 3EEH_A 3MR0_B. |
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=98.95 E-value=4.6e-09 Score=111.45 Aligned_cols=140 Identities=24% Similarity=0.320 Sum_probs=107.0
Q ss_pred ccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCC--CCcceEEEEEEeC---CeEEEEEe
Q 001847 678 KPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDH--PFVPALYASFQTK---THVCLITD 752 (1005)
Q Consensus 678 ~~LG~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~il~~l~h--pnIv~l~~~~~~~---~~~~lV~E 752 (1005)
+.|+.|.++.||++.... |..|++|........ .....+..|..+++.+.+ ..+++++.+.... +..++|||
T Consensus 4 ~~l~~G~~n~~~~v~~~~-g~~~ilK~~~~~~~~--~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e 80 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGG-GRRLVLRRPPPGALL--PSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVME 80 (223)
T ss_pred eecCCCccceEEEEEecC-CcceEEEeCCCcccC--cccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEE
Confidence 568999999999998733 678999987654221 134567889999999965 4467787776653 36789999
Q ss_pred ccCCCchhhHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHH----------------------------------------
Q 001847 753 YCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHC---------------------------------------- 792 (1005)
Q Consensus 753 ~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~---------------------------------------- 792 (1005)
|++|.++.+.+.. ..++......++.+++.+|.+||+
T Consensus 81 ~i~G~~l~~~~~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (223)
T cd05154 81 RVDGRVLRDRLLR---PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAM 157 (223)
T ss_pred EeCCEecCCCCCC---CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHH
Confidence 9999988776532 236777777788888888888874
Q ss_pred ----------------cCcccCCCCCCcEEEec--CCcEEEEeccCCcc
Q 001847 793 ----------------QGIIYRDLKPENVLLQG--NGHVSLTDFDLSCL 823 (1005)
Q Consensus 793 ----------------~gIvHrDLkP~NILi~~--~g~vkL~DFG~a~~ 823 (1005)
..++|+|++|+||+++. ++.+.|+||+.+..
T Consensus 158 ~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 158 ERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 23699999999999998 56789999998854
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.87 E-value=4.9e-08 Score=106.27 Aligned_cols=134 Identities=19% Similarity=0.064 Sum_probs=94.5
Q ss_pred EEEEEEEcCCCeEEEEEEeeccccc---C-----hHHHHHHHHHHHHHHhCCCCCc--ceEEEEEEe-----CCeEEEEE
Q 001847 687 SVHLVELCGSGQYFAMKAMDKGVML---N-----RNKVHRACAEREILDMLDHPFV--PALYASFQT-----KTHVCLIT 751 (1005)
Q Consensus 687 ~Vy~a~~~~~~~~valK~~~~~~~~---~-----~~~~~~~~~E~~il~~l~hpnI--v~l~~~~~~-----~~~~~lV~ 751 (1005)
.|+++.. .|+.|.||........ . ........+|...+.+|..-+| +.+..++.. ...-++||
T Consensus 37 rvvr~~~--~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVt 114 (268)
T PRK15123 37 RTLRFEL--AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIIT 114 (268)
T ss_pred eEEEEEE--CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEE
Confidence 4556655 6778999976432210 0 0111136678888877743333 344445432 23478999
Q ss_pred eccCCC-chhhHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEec-------CCcEEEEeccCCc
Q 001847 752 DYCPGG-ELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQG-------NGHVSLTDFDLSC 822 (1005)
Q Consensus 752 E~~~gg-sL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~~-------~g~vkL~DFG~a~ 822 (1005)
|++++. +|.+++........+......++.+++..+..||..||+|+|++|+|||++. ++.+.|+||+.+.
T Consensus 115 e~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~ 193 (268)
T PRK15123 115 EDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQ 193 (268)
T ss_pred eeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEEEEECCccc
Confidence 999875 8999886422234567778899999999999999999999999999999985 4679999999874
|
|
| >COG3829 RocR Transcriptional regulator containing PAS, AAA-type ATPase, and DNA-binding domains [Transcription / Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.84 E-value=3.5e-08 Score=112.57 Aligned_cols=221 Identities=17% Similarity=0.182 Sum_probs=153.0
Q ss_pred HHHHHhcCCeEEEEeCCCCCCcEEEccHHHHHHcCCChhhhcCCCCCcCCCCCCChHHHHHHHHHHHcCCcEEEEEEEEe
Q 001847 195 KDALSTFQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKIRETLQNGQSYCGRLLNYK 274 (1005)
Q Consensus 195 ~~ile~~~~~i~i~D~~~~dg~I~~vN~a~~~l~Gys~eEllG~~~~~l~~~~~~~~~~~~i~~~l~~g~~~~~e~~~~~ 274 (1005)
+.+++.+.++++++|. ...|..+|..+..+++-....++|+++..+.+....+.. . .+..+........
T Consensus 4 ~~~l~~~~~~~~vi~~---~~~~~~~~~~a~~~~~~~~~~~i~~~~~~i~~~~~~~~v-------~-~~~~~~~~~~~~~ 72 (560)
T COG3829 4 EGILKSILDGPVVIDK---NTGIDVANALALAKRQKNAEAVIGRPLREILETLGMERV-------E-QSRDKELTERLKL 72 (560)
T ss_pred hhhhhhcccceEEEEc---CCceeeechHHHHhhhcceEEEecccceeeccccCccee-------e-ccCccceeeeeec
Confidence 4589999999999998 445999999999999999999999998866655433221 1 2222222222223
Q ss_pred cCCcEEEEEEEeeeeecCCCCEEEEEEEEeccchhhHHHHHhhcCCCCCchhhhhHHHHHHHHhhhhHHHHHHHccCCCC
Q 001847 275 KDGTPFWNLLTIAPIKDDEGKVLKFIGMQVEVSKHTEGAKDKMLRPNGLPESLIRYDARQKEMATSSVTELVQAMKKPRS 354 (1005)
Q Consensus 275 kdG~~~wv~~~~~pi~d~~G~v~~~v~~~~DITerk~~E~~L~~~~~~l~~~l~~~~~~~~~~~~~~~~~l~~~~~~~~~ 354 (1005)
+ + .. ..+...++.++.|+++|++.++.|+++..+.-.+..
T Consensus 73 ~-~-~~-~~~~~~~~~~~~~~~~g~~~~~~~~~e~~~~~~~~l------------------------------------- 112 (560)
T COG3829 73 K-V-KR-IVVVGKTPVDEQGRVVGVLEVFLDISEALELIEENL------------------------------------- 112 (560)
T ss_pred c-c-ee-EEEcCCceeecCCceeeeehhhhhhHHHHHHHHHHH-------------------------------------
Confidence 3 3 22 333444556788999999999999998443322210
Q ss_pred cccCCCCCcccccCCCCchhhhcccccCCCCCCCCCCCCCCCCCCcccccccccccchhhccccCCcccccccccccccC
Q 001847 355 LSESTNRPPIIRKSEGGVEEERAGALGRRKSENVPPPRRNSYGGGCRTSMQRISEVPEKKKQKSGRRSFMGLIGRKSQST 434 (1005)
Q Consensus 355 ~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 434 (1005)
T Consensus 113 -------------------------------------------------------------------------------- 112 (560)
T COG3829 113 -------------------------------------------------------------------------------- 112 (560)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CCCCCccccccccCCCCCCCCCCCCCchhhHHHHHHHhhcccHHHHHHhccccEEEEcCCCCCCCEEeecHHHHHHcCCC
Q 001847 435 DDHDSFENEIIMEGDDDYESDDERPDSVDDKVRQKEMRKGIDLATTLERIEKNFVITDPRLPDNPIIFASDSFLELTEYS 514 (1005)
Q Consensus 435 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~er~~~e~~l~~~~~l~~i~e~~~~~I~i~D~~G~d~~i~~vN~a~~~l~Gy~ 514 (1005)
.... ..|+.+++.+.++++++|.+|. ++++|.++..++|++
T Consensus 113 -------------------------------~~~~-----~~l~~il~~~~~~l~vvD~~G~---~i~~N~~~~~~~gl~ 153 (560)
T COG3829 113 -------------------------------RQLR-----QRLEAILDSIDDGLLVVDEDGI---IIYYNKAYAKLLGLS 153 (560)
T ss_pred -------------------------------HHHH-----HHHHHHHhhccCceEEEcCCCc---EEEEcHHHHHHhCCC
Confidence 0000 1289999999999999999999 999999999999999
Q ss_pred hhhhcCCCCCccCCCCCCHHHHHHHHHHHhcCCcEEEEEEEEecCCcEEEEEEEEeeeeCCCCCEEEEEEEEecCccCcc
Q 001847 515 REEILGRNCRFLQGPETDPATVRKIRAAIDNQTDVTVQLINYTKSGKKFWNLFHLQPMRDQKGEVQYFIGVQLDGSEHLE 594 (1005)
Q Consensus 515 ~eEllG~~~~~l~~~~~~~~~~~~i~~~l~~~~~~~~e~~~~~kdG~~~wv~~~~~pi~d~~G~v~~~vgi~~DITerK~ 594 (1005)
.++++|+++.++...... ......+..+.+.......+..++. ..+..|++ .+|.+.|.+++++|+++-+.
T Consensus 154 ~e~~~gk~~~~v~~~~~~----s~~l~vl~~~kp~~~~~~~~~~~~~----i~~~~pv~-~~g~l~G~v~~~~~~~~l~~ 224 (560)
T COG3829 154 PEEVLGKHLLDVVSAGED----STLLEVLRTGKPIRDVVQTYNGNKI----IVNVAPVY-ADGQLIGVVGISKDVSELER 224 (560)
T ss_pred HHHHcCCcHHHHHhccCC----ceehhhhhcCCcceeeeeeecCCce----eEeeccEe-cCCcEEEEEEeecchHHHHH
Confidence 999999997666411111 1234556677765554443333332 34556766 46799999999999998766
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.83 E-value=2.4e-08 Score=102.55 Aligned_cols=127 Identities=24% Similarity=0.207 Sum_probs=82.5
Q ss_pred EEEEEEEcCCCeEEEEEEeeccccc-----------------------ChHHHHHHHHHHHHHHhCCCC--CcceEEEEE
Q 001847 687 SVHLVELCGSGQYFAMKAMDKGVML-----------------------NRNKVHRACAEREILDMLDHP--FVPALYASF 741 (1005)
Q Consensus 687 ~Vy~a~~~~~~~~valK~~~~~~~~-----------------------~~~~~~~~~~E~~il~~l~hp--nIv~l~~~~ 741 (1005)
.||.|.. ..|..+|+|+.+..... .........+|...|.++..- ++++++.+.
T Consensus 1 ~Vy~~~~-~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~ 79 (188)
T PF01163_consen 1 DVYHAID-PDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN 79 (188)
T ss_dssp EEEEEEE-CTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE
T ss_pred CEEEEEC-CCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe
Confidence 3888887 56889999988742110 001123456799999999765 577777542
Q ss_pred EeCCeEEEEEeccC--CCchhhHHhhCCCCCCCHHHHHHHHHHHHHHHHH-HHHcCcccCCCCCCcEEEecCCcEEEEec
Q 001847 742 QTKTHVCLITDYCP--GGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEY-LHCQGIIYRDLKPENVLLQGNGHVSLTDF 818 (1005)
Q Consensus 742 ~~~~~~~lV~E~~~--ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~-LH~~gIvHrDLkP~NILi~~~g~vkL~DF 818 (1005)
.-+|||||++ |..+..+.... ++......++.+++..+.. +|..||+||||.+.|||++.+ .+.|+||
T Consensus 80 ----~~~ivME~I~~~G~~~~~l~~~~----~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~~~-~~~iIDf 150 (188)
T PF01163_consen 80 ----RNVIVMEYIGEDGVPLPRLKDVD----LSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVDDG-KVYIIDF 150 (188)
T ss_dssp ----TTEEEEE--EETTEEGGCHHHCG----GGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEETT-CEEE--G
T ss_pred ----CCEEEEEecCCCccchhhHHhcc----ccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEeecc-eEEEEec
Confidence 3369999997 65555443321 2234567778888885555 679999999999999999966 9999999
Q ss_pred cCCcc
Q 001847 819 DLSCL 823 (1005)
Q Consensus 819 G~a~~ 823 (1005)
|.+..
T Consensus 151 ~qav~ 155 (188)
T PF01163_consen 151 GQAVD 155 (188)
T ss_dssp TTEEE
T ss_pred Cccee
Confidence 98844
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >cd00130 PAS PAS domain; PAS motifs appear in archaea, eubacteria and eukarya | Back alignment and domain information |
|---|
Probab=98.79 E-value=1.4e-07 Score=81.33 Aligned_cols=103 Identities=27% Similarity=0.422 Sum_probs=89.2
Q ss_pred ccccEEEEcCCCCCCCEEeecHHHHHHcCCChhhhcCCCCCccCCCCCCHHHHHHHHHHHhcCCcEEEEEEEEecCCcEE
Q 001847 484 IEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIRAAIDNQTDVTVQLINYTKSGKKF 563 (1005)
Q Consensus 484 ~~~~I~i~D~~G~d~~i~~vN~a~~~l~Gy~~eEllG~~~~~l~~~~~~~~~~~~i~~~l~~~~~~~~e~~~~~kdG~~~ 563 (1005)
++++++++|.+|. ++++|+++++++|++.++++|..+..+.+++........+...+..+.....+......+|..+
T Consensus 1 ~~~~i~~~d~~~~---~~~~n~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 77 (103)
T cd00130 1 LPDGVIVLDLDGR---ILYANPAAEQLLGYSPEELIGKSLLDLIHPEDREELRERLENLLSGGEPVTLEVRLRRKDGSVI 77 (103)
T ss_pred CCceEEEECCCCc---EEEECHHHHHHhCCCHHHHcCccHHHhcCCccchHHHHHHHHHHhcCcCeEEEEEEEccCCCEE
Confidence 3678999999888 9999999999999999999999987777777776666666666666667778888888999999
Q ss_pred EEEEEEeeeeCCCCCEEEEEEEEecC
Q 001847 564 WNLFHLQPMRDQKGEVQYFIGVQLDG 589 (1005)
Q Consensus 564 wv~~~~~pi~d~~G~v~~~vgi~~DI 589 (1005)
|+.....++.+..|...+++++.+||
T Consensus 78 ~~~~~~~~~~~~~~~~~~~~~~~~di 103 (103)
T cd00130 78 WVLVSLTPIRDEGGEVIGLLGVVRDI 103 (103)
T ss_pred EEEEEEEEEecCCCCEEEEEEEEecC
Confidence 99999999999888999999999986
|
Probably the most surprising identification of a PAS domain was that in EAG-like K+-channels. PAS domains have been found to bind ligands, and to act as sensors for light and oxygen in signal transduction. |
| >PRK11073 glnL nitrogen regulation protein NR(II); Provisional | Back alignment and domain information |
|---|
Probab=98.79 E-value=2e-08 Score=114.65 Aligned_cols=136 Identities=13% Similarity=0.163 Sum_probs=97.7
Q ss_pred cHHHHHHhccccEEEEcCCCCCCCEEeecHHHHHHcCCChhhhcCCCCCccCCCCCCHHHHHHHHHHHhcCCcEEEEEEE
Q 001847 476 DLATTLERIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIRAAIDNQTDVTVQLIN 555 (1005)
Q Consensus 476 ~l~~i~e~~~~~I~i~D~~G~d~~i~~vN~a~~~l~Gy~~eEllG~~~~~l~~~~~~~~~~~~i~~~l~~~~~~~~e~~~ 555 (1005)
.++.+++++++|++++|.+|. |+++|+++++++||+.++++|+++..+.+... .....+...+..+..+..+...
T Consensus 8 ~~~~il~~~~~gi~~~d~~~~---i~~~N~a~~~~~g~~~~~~~g~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~ 82 (348)
T PRK11073 8 DAGQILNSLINSILLLDDDLA---IHYANPAAQQLLAQSSRKLFGTPLPELLSYFS--LNIELMRESLQAGQGFTDNEVT 82 (348)
T ss_pred hHHHHHhcCcCeEEEECCCCe---EeeEcHHHHHHhCCCHHHHcCCCHHHHcCcch--hhHHHHHHHHHcCCcccccceE
Confidence 389999999999999999888 99999999999999999999999877765432 2233445566666555444455
Q ss_pred EecCCcEEEEEEEEeeeeCCCCCEEEEEEEEecCccCccccccCCchhhHHHHHHHHHHHhhhhhh
Q 001847 556 YTKSGKKFWNLFHLQPMRDQKGEVQYFIGVQLDGSEHLEPLRNSIPEATAEESEKLVKQTAENVNE 621 (1005)
Q Consensus 556 ~~kdG~~~wv~~~~~pi~d~~G~v~~~vgi~~DITerK~~e~~~~~~~~~~e~~~l~~~~~~~v~~ 621 (1005)
..+||..+|+.++..|+. . .+++..++|||++++.++++..+.........+..++|.+.+
T Consensus 83 ~~~~g~~~~~~~~~~~~~--~---~~~~~~~~dit~~~~~~~~~~~~~~~~~~~~~~~~iaHelr~ 143 (348)
T PRK11073 83 LVIDGRSHILSLTAQRLP--E---GMILLEMAPMDNQRRLSQEQLQHAQQVAARDLVRGLAHEIKN 143 (348)
T ss_pred EEECCceEEEEEEEEEcc--C---ceeEEEEechhHHHHHHHHHHHHHHHHHHHHHHHhhhHhhcC
Confidence 667999999999999997 2 245677899999988544433222222333344444444443
|
|
| >cd00130 PAS PAS domain; PAS motifs appear in archaea, eubacteria and eukarya | Back alignment and domain information |
|---|
Probab=98.77 E-value=1.8e-07 Score=80.57 Aligned_cols=103 Identities=24% Similarity=0.479 Sum_probs=86.6
Q ss_pred cCCeEEEEeCCCCCCcEEEccHHHHHHcCCChhhhcCCCCCcCCCCCCChHHHHHHHHHHHcCCcEEEEEEEEecCCcEE
Q 001847 201 FQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKIRETLQNGQSYCGRLLNYKKDGTPF 280 (1005)
Q Consensus 201 ~~~~i~i~D~~~~dg~I~~vN~a~~~l~Gys~eEllG~~~~~l~~~~~~~~~~~~i~~~l~~g~~~~~e~~~~~kdG~~~ 280 (1005)
++++++++|. +|.++++|+++++++|++.++++|+.+..+.++.........+...+..+..+..++.....+|..+
T Consensus 1 ~~~~i~~~d~---~~~~~~~n~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 77 (103)
T cd00130 1 LPDGVIVLDL---DGRILYANPAAEQLLGYSPEELIGKSLLDLIHPEDREELRERLENLLSGGEPVTLEVRLRRKDGSVI 77 (103)
T ss_pred CCceEEEECC---CCcEEEECHHHHHHhCCCHHHHcCccHHHhcCCccchHHHHHHHHHHhcCcCeEEEEEEEccCCCEE
Confidence 3578899998 7779999999999999999999999987676666665566666666666666777888888899999
Q ss_pred EEEEEeeeeecCCCCEEEEEEEEecc
Q 001847 281 WNLLTIAPIKDDEGKVLKFIGMQVEV 306 (1005)
Q Consensus 281 wv~~~~~pi~d~~G~v~~~v~~~~DI 306 (1005)
|+.+...++.+..|...+++++.+||
T Consensus 78 ~~~~~~~~~~~~~~~~~~~~~~~~di 103 (103)
T cd00130 78 WVLVSLTPIRDEGGEVIGLLGVVRDI 103 (103)
T ss_pred EEEEEEEEEecCCCCEEEEEEEEecC
Confidence 99999999999888999999999886
|
Probably the most surprising identification of a PAS domain was that in EAG-like K+-channels. PAS domains have been found to bind ligands, and to act as sensors for light and oxygen in signal transduction. |
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.76 E-value=4.3e-09 Score=122.58 Aligned_cols=171 Identities=19% Similarity=0.329 Sum_probs=124.0
Q ss_pred HHHHHHHHHHHHHc-CcccCCCCCCcEEEecCCcEEEEeccCCcccCCCCCCCCCcchhhhhcccCCCCCcccccccccc
Q 001847 780 AAEVVVALEYLHCQ-GIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRAS 858 (1005)
Q Consensus 780 ~~qil~aL~~LH~~-gIvHrDLkP~NILi~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 858 (1005)
+.+.+.|+.|+|.. ++||++|.|++|.++.+|..||+.|+++............ .......
T Consensus 105 l~~v~dgl~flh~sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~------------------~yd~~lp 166 (700)
T KOG2137|consen 105 LGNVADGLAFLHRSAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFS------------------EYDPPLP 166 (700)
T ss_pred hhcccchhhhhccCcceeecccchhheeeccCcceeeccchhhhccCCCCccccc------------------cCCCCCC
Confidence 34555999999975 9999999999999999999999999987543321111000 0111112
Q ss_pred cccccCCcccccccccCCCCCChhhHHHHHHHHHHHH-cCCCCCCCCChHHHHHHHHhC--C-CCCCCCCCCCHHHHHHH
Q 001847 859 NSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEML-YGYTPFRGKTRQKTFANILHK--D-LKFPSSTPTSLHAKQLM 934 (1005)
Q Consensus 859 ~~~~gt~~y~aPE~l~~~~~~~~sDIwSlGvll~eLl-tG~~Pf~~~~~~~~~~~i~~~--~-~~~~~~~~~s~~l~~Ll 934 (1005)
....-...|.|||++.....+.++|+|||||++|.+. .|+..+........+ ..... + ..+.....++.++++=|
T Consensus 167 ~~~~~~~~f~apE~~~~~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~-~~~~~~~~~~~~~~s~~~p~el~~~l 245 (700)
T KOG2137|consen 167 LLLQPHLNFLAPEYLLGTTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSY-SFSRNLLNAGAFGYSNNLPSELRESL 245 (700)
T ss_pred hhhccCcccccchhhccccccccccceeeeeEEEEEecCCcchhhccCCcchh-hhhhcccccccccccccCcHHHHHHH
Confidence 2233466899999999988889999999999999999 566666544332222 22211 1 12223356788999999
Q ss_pred HHccccCcCccCCChhcHHHHHcCCCCCCCChhhhhhcC
Q 001847 935 YRLLHRDPKSRLGSHEGANEIKKHPFFKGVNWALVRCMN 973 (1005)
Q Consensus 935 ~~~L~~dP~~Rpt~~~~a~elL~hpff~~~~~~~~~~~~ 973 (1005)
.+++..++.-||+ +.+++..|||...-...+++..
T Consensus 246 ~k~l~~~~~~rp~----~~~l~~~~ff~D~~~~aLrfLD 280 (700)
T KOG2137|consen 246 KKLLNGDSAVRPT----LDLLLSIPFFSDPGLKALRFLD 280 (700)
T ss_pred HHHhcCCcccCcc----hhhhhcccccCCchhhhhhhcc
Confidence 9999999999998 9999999999998888887643
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.75 E-value=2e-07 Score=102.35 Aligned_cols=238 Identities=19% Similarity=0.243 Sum_probs=155.1
Q ss_pred ccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhC-CCCCcceEEEE------EEeCC-eE
Q 001847 676 PIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPALYAS------FQTKT-HV 747 (1005)
Q Consensus 676 ~~~~LG~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~------~~~~~-~~ 747 (1005)
..+.||+|+-+.+|-+.... -.+-|++..... .... +....|... .||-+..-+.| ..... .+
T Consensus 15 ~gr~LgqGgea~ly~l~e~~---d~VAKIYh~Ppp---a~~a---qk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~i 85 (637)
T COG4248 15 PGRPLGQGGEADLYTLGEVR---DQVAKIYHAPPP---AAQA---QKVAELAATPDAPLLNYRVAWPQATLHGGRRGKVI 85 (637)
T ss_pred CCccccCCccceeeecchhh---chhheeecCCCc---hHHH---HHHHHhccCCCCcchhhhhcccHHHhhCCCcccee
Confidence 34779999999999776432 367788876422 1111 122233333 56655431111 11222 26
Q ss_pred EEEEeccCCC-chhhHH----hhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCc
Q 001847 748 CLITDYCPGG-ELFLLL----DRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSC 822 (1005)
Q Consensus 748 ~lV~E~~~gg-sL~~~l----~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~~~g~vkL~DFG~a~ 822 (1005)
.++|..+.|. ....++ +++......+..+...++.|+.+.+.||..|.+-+|++++|+|+++++.|.|+|-....
T Consensus 86 GflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~~~V~LVdsDsfq 165 (637)
T COG4248 86 GFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDDSKVVLVDSDSFQ 165 (637)
T ss_pred EEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecCceEEEEccccee
Confidence 7888888664 222222 23445567888999999999999999999999999999999999999999999876432
Q ss_pred ccCCCCCCCCCcchhhhhcccCCCCCcccccccccccccccCCccccccccc-----CCCCCChhhHHHHHHHHHHHHcC
Q 001847 823 LTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIA-----GAGHTSAVDWWALGILLYEMLYG 897 (1005)
Q Consensus 823 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~-----~~~~~~~sDIwSlGvll~eLltG 897 (1005)
.. .+.......+|.+.|.+||.-. +..-+...|-|.||+++++|+.|
T Consensus 166 i~----------------------------~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~g 217 (637)
T COG4248 166 IN----------------------------ANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFG 217 (637)
T ss_pred ec----------------------------cCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhc
Confidence 21 1222334568999999999754 23345679999999999999985
Q ss_pred -CCCCCCCCh----HHHHH-HHHhC-----------CCCCCCC---CCCCHHHHHHHHHccccC--cCccCCChh
Q 001847 898 -YTPFRGKTR----QKTFA-NILHK-----------DLKFPSS---TPTSLHAKQLMYRLLHRD--PKSRLGSHE 950 (1005)
Q Consensus 898 -~~Pf~~~~~----~~~~~-~i~~~-----------~~~~~~~---~~~s~~l~~Ll~~~L~~d--P~~Rpt~~~ 950 (1005)
+.||.|... ...++ .|..+ ..+.|.. .-+++.++.|+.+|+... +.-||+...
T Consensus 218 grHPysGI~~~~~ap~p~E~~Ia~g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~a 292 (637)
T COG4248 218 GRHPYSGIPLISDAPNPLETDIAHGRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKA 292 (637)
T ss_pred CCCCCCcccccCCCCCcchhhhhcceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHH
Confidence 999976221 11111 22222 1122222 235678889999999763 567999654
|
|
| >PRK11360 sensory histidine kinase AtoS; Provisional | Back alignment and domain information |
|---|
Probab=98.73 E-value=8.7e-08 Score=117.42 Aligned_cols=141 Identities=16% Similarity=0.129 Sum_probs=106.3
Q ss_pred cHHHHHHhccccEEEEcCCCCCCCEEeecHHHHHHcCCChhhhcCCCCCccCCCCCCHHHHHHHHHHHhcCCc-EEEEEE
Q 001847 476 DLATTLERIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIRAAIDNQTD-VTVQLI 554 (1005)
Q Consensus 476 ~l~~i~e~~~~~I~i~D~~G~d~~i~~vN~a~~~l~Gy~~eEllG~~~~~l~~~~~~~~~~~~i~~~l~~~~~-~~~e~~ 554 (1005)
.++.++++++++++++|.+|. ++++|+++++++||+.++++|+++..+.+++. .....+...+..+.. ...+..
T Consensus 263 ~~~~i~~~~~~~i~~~d~~g~---i~~~N~~~~~l~g~~~~~~~g~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~ 337 (607)
T PRK11360 263 LNELILESIADGVIAIDRQGK---ITTMNPAAEVITGLQRHELVGKPYSELFPPNT--PFASPLLDTLEHGTEHVDLEIS 337 (607)
T ss_pred HHHHHHHhccCeEEEEcCCCC---EEEECHHHHHHhCCChHHhcCCcHHHHcCCch--hHHHHHHHHHhcCCCccceEEE
Confidence 378899999999999999888 99999999999999999999999877776542 233344555554443 445667
Q ss_pred EEecCCcEEEEEEEEeeeeCCCCCEEEEEEEEecCccCccccccCCchhhHHHHHHHHHHHhhhhhhh
Q 001847 555 NYTKSGKKFWNLFHLQPMRDQKGEVQYFIGVQLDGSEHLEPLRNSIPEATAEESEKLVKQTAENVNEA 622 (1005)
Q Consensus 555 ~~~kdG~~~wv~~~~~pi~d~~G~v~~~vgi~~DITerK~~e~~~~~~~~~~e~~~l~~~~~~~v~~~ 622 (1005)
..+++|..+ +.++..|+.+.+|.+.+++++++|||++|+.+.+.........+.+.+..+.|.+.+.
T Consensus 338 ~~~~~~~~~-~~~~~~~i~~~~g~~~~~i~~~~Dite~~~~e~~l~~~~~~~~l~~~~~~~~hel~~~ 404 (607)
T PRK11360 338 FPGRDRTIE-LSVSTSLLHNTHGEMIGALVIFSDLTERKRLQRRVARQERLAALGELVAGVAHEIRNP 404 (607)
T ss_pred EEcCCCcEE-EEEEEeeEEcCCCCEEEEEEEEeechHHHHHHHHHHHHHHHHHHHHHHHHHHHHhhhH
Confidence 778888876 8999999999999999999999999999996554443333333334444455554443
|
|
| >TIGR02966 phoR_proteo phosphate regulon sensor kinase PhoR | Back alignment and domain information |
|---|
Probab=98.72 E-value=4.8e-08 Score=110.09 Aligned_cols=114 Identities=14% Similarity=0.114 Sum_probs=89.1
Q ss_pred cchHHHHHHHHHhcCCeEEEEeCCCCCCcEEEccHHHHHHcCCChhhhcCCCCCcCCCCCCChHHHHHHHHHHHcCCcEE
Q 001847 188 PRVSDIVKDALSTFQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKIRETLQNGQSYC 267 (1005)
Q Consensus 188 ~~~~~~l~~ile~~~~~i~i~D~~~~dg~I~~vN~a~~~l~Gys~eEllG~~~~~l~~~~~~~~~~~~i~~~l~~g~~~~ 267 (1005)
....+.|+.++++++++|+++|. +|+|+++|++|++++||+.++++|+++..+..+ ..+...+..+.. .
T Consensus 2 ~~~~~~l~~~~~~~~~~i~~~d~---~g~i~~~N~~~~~~~g~~~~~~~g~~~~~~~~~-------~~~~~~l~~~~~-~ 70 (333)
T TIGR02966 2 SALLSRFRAAAQALPDAVVVLDE---EGQIEWCNPAAERLLGLRWPDDLGQRITNLIRH-------PEFVEYLAAGRF-S 70 (333)
T ss_pred hhHHHHHHHHHHhCcCcEEEECC---CCcEEEEcHHHHHHhCCChHHHcCCcHHHHccC-------HHHHHHHHhccc-C
Confidence 45667899999999999999999 777999999999999999999999998766443 123334443332 2
Q ss_pred EEEEEEecCCcEEEEEEEeeeeecCCCCEEEEEEEEeccchhhHHHHHhh
Q 001847 268 GRLLNYKKDGTPFWNLLTIAPIKDDEGKVLKFIGMQVEVSKHTEGAKDKM 317 (1005)
Q Consensus 268 ~e~~~~~kdG~~~wv~~~~~pi~d~~G~v~~~v~~~~DITerk~~E~~L~ 317 (1005)
.......++|..+|+.+.+.|+.+.+ ++++++|||++++.++.++
T Consensus 71 ~~~~~~~~~~~~~~~~~~~~p~~~~~-----~~~~~~dit~~~~~~~~~~ 115 (333)
T TIGR02966 71 EPLELPSPINSERVLEIRIAPYGEEQ-----KLLVARDVTRLRRLEQMRR 115 (333)
T ss_pred CCeEeecCCCCceEEEEEEEEcCCCc-----eEEEEeCchHHHHHHHHHH
Confidence 23455568899999999999987642 6788999999998876644
|
Members of this protein family are the regulatory histidine kinase PhoR associated with the phosphate ABC transporter in most Proteobacteria. Related proteins from Gram-positive organisms are not included in this model. The phoR gene usually is adjacent to the response regulator phoB gene (TIGR02154). |
| >TIGR02966 phoR_proteo phosphate regulon sensor kinase PhoR | Back alignment and domain information |
|---|
Probab=98.68 E-value=8.1e-08 Score=108.24 Aligned_cols=103 Identities=11% Similarity=0.026 Sum_probs=81.8
Q ss_pred cHHHHHHhccccEEEEcCCCCCCCEEeecHHHHHHcCCChhhhcCCCCCccCCCCCCHHHHHHHHHHHhcCCcEEEEEEE
Q 001847 476 DLATTLERIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIRAAIDNQTDVTVQLIN 555 (1005)
Q Consensus 476 ~l~~i~e~~~~~I~i~D~~G~d~~i~~vN~a~~~l~Gy~~eEllG~~~~~l~~~~~~~~~~~~i~~~l~~~~~~~~e~~~ 555 (1005)
.|+.+++++++||+++|.+|. |+++|++|++++||++++++|+++..+.+++ . +...+..+.. ......
T Consensus 7 ~l~~~~~~~~~~i~~~d~~g~---i~~~N~~~~~~~g~~~~~~~g~~~~~~~~~~---~----~~~~l~~~~~-~~~~~~ 75 (333)
T TIGR02966 7 RFRAAAQALPDAVVVLDEEGQ---IEWCNPAAERLLGLRWPDDLGQRITNLIRHP---E----FVEYLAAGRF-SEPLEL 75 (333)
T ss_pred HHHHHHHhCcCcEEEECCCCc---EEEEcHHHHHHhCCChHHHcCCcHHHHccCH---H----HHHHHHhccc-CCCeEe
Confidence 389999999999999999988 9999999999999999999999977775542 2 2333333222 223555
Q ss_pred EecCCcEEEEEEEEeeeeCCCCCEEEEEEEEecCccCcc
Q 001847 556 YTKSGKKFWNLFHLQPMRDQKGEVQYFIGVQLDGSEHLE 594 (1005)
Q Consensus 556 ~~kdG~~~wv~~~~~pi~d~~G~v~~~vgi~~DITerK~ 594 (1005)
..++|..+|+.+...|+.+.. ++++++|||++++
T Consensus 76 ~~~~~~~~~~~~~~~p~~~~~-----~~~~~~dit~~~~ 109 (333)
T TIGR02966 76 PSPINSERVLEIRIAPYGEEQ-----KLLVARDVTRLRR 109 (333)
T ss_pred ecCCCCceEEEEEEEEcCCCc-----eEEEEeCchHHHH
Confidence 568899999999999997643 6788999999887
|
Members of this protein family are the regulatory histidine kinase PhoR associated with the phosphate ABC transporter in most Proteobacteria. Related proteins from Gram-positive organisms are not included in this model. The phoR gene usually is adjacent to the response regulator phoB gene (TIGR02154). |
| >PRK11073 glnL nitrogen regulation protein NR(II); Provisional | Back alignment and domain information |
|---|
Probab=98.67 E-value=2e-07 Score=106.34 Aligned_cols=117 Identities=17% Similarity=0.213 Sum_probs=92.7
Q ss_pred HHHHHHHHHhcCCeEEEEeCCCCCCcEEEccHHHHHHcCCChhhhcCCCCCcCCCCCCChHHHHHHHHHHHcCCcEEEEE
Q 001847 191 SDIVKDALSTFQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKIRETLQNGQSYCGRL 270 (1005)
Q Consensus 191 ~~~l~~ile~~~~~i~i~D~~~~dg~I~~vN~a~~~l~Gys~eEllG~~~~~l~~~~~~~~~~~~i~~~l~~g~~~~~e~ 270 (1005)
...+.++++++++|++++|. +|+|+++|+++++++||+.++++|+++..+.+... .....+...+..+..+..+.
T Consensus 6 ~~~~~~il~~~~~gi~~~d~---~~~i~~~N~a~~~~~g~~~~~~~g~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~ 80 (348)
T PRK11073 6 LPDAGQILNSLINSILLLDD---DLAIHYANPAAQQLLAQSSRKLFGTPLPELLSYFS--LNIELMRESLQAGQGFTDNE 80 (348)
T ss_pred cchHHHHHhcCcCeEEEECC---CCeEeeEcHHHHHHhCCCHHHHcCCCHHHHcCcch--hhHHHHHHHHHcCCcccccc
Confidence 35678999999999999998 78899999999999999999999999887765432 22344556666666555444
Q ss_pred EEEecCCcEEEEEEEeeeeecCCCCEEEEEEEEeccchhhHHHHHhh
Q 001847 271 LNYKKDGTPFWNLLTIAPIKDDEGKVLKFIGMQVEVSKHTEGAKDKM 317 (1005)
Q Consensus 271 ~~~~kdG~~~wv~~~~~pi~d~~G~v~~~v~~~~DITerk~~E~~L~ 317 (1005)
..+.+||..+|+.++.+|+. . .+++..++|||++++.++++.
T Consensus 81 ~~~~~~g~~~~~~~~~~~~~--~---~~~~~~~~dit~~~~~~~~~~ 122 (348)
T PRK11073 81 VTLVIDGRSHILSLTAQRLP--E---GMILLEMAPMDNQRRLSQEQL 122 (348)
T ss_pred eEEEECCceEEEEEEEEEcc--C---ceeEEEEechhHHHHHHHHHH
Confidence 55678999999999999986 2 246778999999998877654
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.64 E-value=1.6e-07 Score=98.84 Aligned_cols=137 Identities=22% Similarity=0.204 Sum_probs=102.2
Q ss_pred ccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccC------h-------------HHHHHHHHHHHHHHhCCCC--
Q 001847 674 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLN------R-------------NKVHRACAEREILDMLDHP-- 732 (1005)
Q Consensus 674 y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~------~-------------~~~~~~~~E~~il~~l~hp-- 732 (1005)
+.+...||-|--|.||.|.+ ..|.++|||.-+.+...= . .......+|.++|..|...
T Consensus 93 e~iG~~IGvGKEsdVY~~~~-~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~ 171 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAID-PKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGV 171 (304)
T ss_pred HhhccccccCccceEEEEEC-CCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCC
Confidence 45567899999999999998 478999999765431110 0 1122345788999999665
Q ss_pred CcceEEEEEEeCCeEEEEEeccCCCchhhHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCc
Q 001847 733 FVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGH 812 (1005)
Q Consensus 733 nIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~~~g~ 812 (1005)
.|++.+++ +.-++||||++|-.|...- ++......++..|+.-+..+-..|+||+|+.+-||+++.+|.
T Consensus 172 ~VP~P~~~----nRHaVvMe~ieG~eL~~~r-------~~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV~~dg~ 240 (304)
T COG0478 172 KVPKPIAW----NRHAVVMEYIEGVELYRLR-------LDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILVTEDGD 240 (304)
T ss_pred CCCCcccc----ccceeeeehcccceeeccc-------CcccCHHHHHHHHHHHHHHHHHcCccccCCchheEEEecCCC
Confidence 78888765 5568999999887775543 233445556666676666666899999999999999999999
Q ss_pred EEEEeccCCc
Q 001847 813 VSLTDFDLSC 822 (1005)
Q Consensus 813 vkL~DFG~a~ 822 (1005)
+.++||--+.
T Consensus 241 ~~vIDwPQ~v 250 (304)
T COG0478 241 IVVIDWPQAV 250 (304)
T ss_pred EEEEeCcccc
Confidence 9999999663
|
|
| >PRK11360 sensory histidine kinase AtoS; Provisional | Back alignment and domain information |
|---|
Probab=98.64 E-value=1.9e-07 Score=114.42 Aligned_cols=128 Identities=13% Similarity=0.121 Sum_probs=105.2
Q ss_pred ccccchHHHHHHHHHhcCCeEEEEeCCCCCCcEEEccHHHHHHcCCChhhhcCCCCCcCCCCCCChHHHHHHHHHHHcCC
Q 001847 185 KGLPRVSDIVKDALSTFQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKIRETLQNGQ 264 (1005)
Q Consensus 185 ~~L~~~~~~l~~ile~~~~~i~i~D~~~~dg~I~~vN~a~~~l~Gys~eEllG~~~~~l~~~~~~~~~~~~i~~~l~~g~ 264 (1005)
..+...+..++.++++++++++++|. +|+|+++|+++++++||+.++++|+++..++++.. .....+...+..+.
T Consensus 255 ~~l~~~~~~~~~i~~~~~~~i~~~d~---~g~i~~~N~~~~~l~g~~~~~~~g~~~~~~~~~~~--~~~~~~~~~~~~~~ 329 (607)
T PRK11360 255 QALRETRSLNELILESIADGVIAIDR---QGKITTMNPAAEVITGLQRHELVGKPYSELFPPNT--PFASPLLDTLEHGT 329 (607)
T ss_pred HHHHHHHHHHHHHHHhccCeEEEEcC---CCCEEEECHHHHHHhCCChHHhcCCcHHHHcCCch--hHHHHHHHHHhcCC
Confidence 34666778889999999999999998 77799999999999999999999999887766542 23344555565554
Q ss_pred cE-EEEEEEEecCCcEEEEEEEeeeeecCCCCEEEEEEEEeccchhhHHHHHhhc
Q 001847 265 SY-CGRLLNYKKDGTPFWNLLTIAPIKDDEGKVLKFIGMQVEVSKHTEGAKDKML 318 (1005)
Q Consensus 265 ~~-~~e~~~~~kdG~~~wv~~~~~pi~d~~G~v~~~v~~~~DITerk~~E~~L~~ 318 (1005)
.. ..++....++|..+ +.++..|+.+.+|.+.+++++++|||+++++|++++.
T Consensus 330 ~~~~~~~~~~~~~~~~~-~~~~~~~i~~~~g~~~~~i~~~~Dite~~~~e~~l~~ 383 (607)
T PRK11360 330 EHVDLEISFPGRDRTIE-LSVSTSLLHNTHGEMIGALVIFSDLTERKRLQRRVAR 383 (607)
T ss_pred CccceEEEEEcCCCcEE-EEEEEeeEEcCCCCEEEEEEEEeechHHHHHHHHHHH
Confidence 43 34566678888776 8999999999999999999999999999999988763
|
|
| >KOG0501 consensus K+-channel KCNQ [Inorganic ion transport and metabolism] | Back alignment and domain information |
|---|
Probab=98.64 E-value=9.5e-08 Score=107.00 Aligned_cols=119 Identities=27% Similarity=0.600 Sum_probs=104.8
Q ss_pred HHHHHHhcc---ccEEEEcCCCCCCCEEeecHHHHHHcCCChhhhcCCC--CCccCCCCCCHHHHHHHHHHHhcCCcEEE
Q 001847 477 LATTLERIE---KNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRN--CRFLQGPETDPATVRKIRAAIDNQTDVTV 551 (1005)
Q Consensus 477 l~~i~e~~~---~~I~i~D~~G~d~~i~~vN~a~~~l~Gy~~eEllG~~--~~~l~~~~~~~~~~~~i~~~l~~~~~~~~ 551 (1005)
++.++..+. ..+++.+++-.|++|+|+|+.||++.||.+.|++.++ +.+++++-.+....+.+++.+.+.+.-++
T Consensus 16 LENiiRRsn~~dtsFlL~NAQiVD~PiVY~NdgFcKlsGY~RAevMQKs~tc~FMyGEltdk~ti~k~~~t~eN~~~~qf 95 (971)
T KOG0501|consen 16 LENIIRRSNNADTSFLLANAQIVDWPIVYCNDGFCKLSGYHRAEVMQKSCTCSFMYGELTDKGTIEKVRQTLENYETNQF 95 (971)
T ss_pred HHHHHhhccCCCcceeeccceeeccceEEecCcchhccCccHHHHhcccceeeeeeccccchhhHHHHHHHHHhhhhcce
Confidence 566665444 4455556666699999999999999999999999888 56778888888888999999999999999
Q ss_pred EEEEEecCCcEEEEEEEEeeeeCCCCCEEEEEEEEecCccCccc
Q 001847 552 QLINYTKSGKKFWNLFHLQPMRDQKGEVQYFIGVQLDGSEHLEP 595 (1005)
Q Consensus 552 e~~~~~kdG~~~wv~~~~~pi~d~~G~v~~~vgi~~DITerK~~ 595 (1005)
|.-++.|+.+.+|..+.+.||+++...++.|++.+.|||.-||+
T Consensus 96 EillyKKN~TPvW~~vqiAPIrNe~d~VVLfLctFkDIT~~KQP 139 (971)
T KOG0501|consen 96 EILLYKKNRTPVWLLVQIAPIRNEKDKVVLFLCTFKDITALKQP 139 (971)
T ss_pred eeEeeecCCCceEEEEEeecccCCCceEEEEEeecccchhhcCC
Confidence 99999999999999999999999999999999999999999996
|
|
| >PF13596 PAS_10: PAS domain; PDB: 3CAX_A 2QKP_D | Back alignment and domain information |
|---|
Probab=98.64 E-value=1.6e-07 Score=87.60 Aligned_cols=106 Identities=16% Similarity=0.304 Sum_probs=74.4
Q ss_pred HHHHHHhcCCeEEEEeCCCCCCcEEEccHHHHHHcCCChhhhcCCCCCcCCCCCCChHHHHHHHHHHHcCCcEEEEEEEE
Q 001847 194 VKDALSTFQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKIRETLQNGQSYCGRLLNY 273 (1005)
Q Consensus 194 l~~ile~~~~~i~i~D~~~~dg~I~~vN~a~~~l~Gys~eEllG~~~~~l~~~~~~~~~~~~i~~~l~~g~~~~~e~~~~ 273 (1005)
++.++++++.+++++|. +++|.++|+++.++++... ..+|+++..+.++.... ....+.+.+..|+....+...
T Consensus 1 L~~il~s~~~~i~~vD~---~~~I~~~n~~a~~~f~~~~-~~iGr~l~~~~~~~~~~-~l~~~i~~~~~~~~~~~~~~~- 74 (106)
T PF13596_consen 1 LNNILDSMPIGIIFVDR---NLRIRYFNPAAARLFNLSP-SDIGRPLFDIHPPLSYP-NLKKIIEQVRSGKEEEFEIVI- 74 (106)
T ss_dssp HHHHHHHSSSEEEEEET---TSBEEEE-SCGC-SS---G-GGTTSBCCCSS-HHHHH-HHHHHHHHHHTTSBSEEEEEE-
T ss_pred ChHHHhcCCCCEEEEcC---CCeEEEeChhHhhhcCCCh-HHCCCCHHHcCCccchH-HHHHHHHHHHcCCCceEEEEe-
Confidence 46899999999999999 8889999999999999764 56899999887663333 333444555666653333332
Q ss_pred ecCCcEEEEEEEeeeeecCCCCEEEEEEEEeccc
Q 001847 274 KKDGTPFWNLLTIAPIKDDEGKVLKFIGMQVEVS 307 (1005)
Q Consensus 274 ~kdG~~~wv~~~~~pi~d~~G~v~~~v~~~~DIT 307 (1005)
..+|. |+.+++.|+++.+|+..|++.++.|||
T Consensus 75 ~~~~~--~~~~~~~P~~~~~g~~~G~v~~~~DIT 106 (106)
T PF13596_consen 75 PNGGR--WYLVRYRPYRDEDGEYAGAVITFQDIT 106 (106)
T ss_dssp EETTE--EEEEEEEEEE-TTS-EEEEEEEEEE-G
T ss_pred cCCCE--EEEEEEEEEECCCCCEEEEEEEEEecC
Confidence 35554 678899999999999999999999998
|
|
| >PF12860 PAS_7: PAS fold | Back alignment and domain information |
|---|
Probab=98.58 E-value=2.1e-07 Score=88.15 Aligned_cols=105 Identities=21% Similarity=0.297 Sum_probs=74.8
Q ss_pred HHhcCCeEEEEeCCCCCCcEEEccHHHHHHcCCChhhh-cCCCCCcCC---------CCCCChHHHHHHHHHHHcCCcEE
Q 001847 198 LSTFQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEV-VGRNCRFLQ---------GAGTDPEDVAKIRETLQNGQSYC 267 (1005)
Q Consensus 198 le~~~~~i~i~D~~~~dg~I~~vN~a~~~l~Gys~eEl-lG~~~~~l~---------~~~~~~~~~~~i~~~l~~g~~~~ 267 (1005)
++++++||++.|. +|+++++|++|.+++|++.+.+ .|.++..+. .+.............+.......
T Consensus 1 Ld~l~~Gv~v~D~---~~rl~~~N~~~~~l~~~~~~~~~~G~~~~~l~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~ 77 (115)
T PF12860_consen 1 LDSLPQGVAVFDS---DGRLVFWNQRFRELFGLPPEMLRPGASFRDLLRRLAERGEFPPGDPEAWVRQRLARLRRRQPRS 77 (115)
T ss_pred CCCcCceEEEEcC---CCeEEeEcHHHHHHhCCCHHHhcCCCCHHHHHHHHHHcCCCCCCCHHHHHHHHHHHHhcCCCce
Confidence 4789999999999 8889999999999999999998 788865332 11222233333333344444433
Q ss_pred EEEEEEecCCcEEEEEEEeeeeecCCCCEEEEEEEEeccchhhHHHH
Q 001847 268 GRLLNYKKDGTPFWNLLTIAPIKDDEGKVLKFIGMQVEVSKHTEGAK 314 (1005)
Q Consensus 268 ~e~~~~~kdG~~~wv~~~~~pi~d~~G~v~~~v~~~~DITerk~~E~ 314 (1005)
.+. ...||. |++++..|+ ++| |+|.++.|||+++++|+
T Consensus 78 ~~~--~~~dgr--~l~~~~~~~--~~G---g~v~~~~DVT~~~~~E~ 115 (115)
T PF12860_consen 78 FEL--RLPDGR--WLEVRAQPL--PDG---GFVLTFTDVTERRRAEE 115 (115)
T ss_pred eEE--ECCCCE--EEEEEeEEC--CCC---CEEEEEEeCCHHHHhcC
Confidence 333 468886 678888888 445 57789999999999874
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.57 E-value=7.7e-07 Score=91.98 Aligned_cols=140 Identities=14% Similarity=0.151 Sum_probs=102.5
Q ss_pred cccCcEEEEEEEEcCCCeEEEEEEeecccccC---hHHHHHHHHHHHHHHhCCCC--CcceEEEEEE-e----CCeEEEE
Q 001847 681 GSGDTGSVHLVELCGSGQYFAMKAMDKGVMLN---RNKVHRACAEREILDMLDHP--FVPALYASFQ-T----KTHVCLI 750 (1005)
Q Consensus 681 G~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~---~~~~~~~~~E~~il~~l~hp--nIv~l~~~~~-~----~~~~~lV 750 (1005)
|.||.|.|+.... .|+.|-+|.-....... +.....+.+|...+.+|..- .++++. ++. . .-..+||
T Consensus 27 ~rgG~SgV~r~~~--~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LV 103 (216)
T PRK09902 27 RRNGMSGVQCVER--NGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLV 103 (216)
T ss_pred CCCCcceEEEEEe--CCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEE
Confidence 6789999999886 44468888664211111 33456788898888888432 255555 332 1 1246799
Q ss_pred EeccCC-CchhhHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCc--EEEEeccCCcc
Q 001847 751 TDYCPG-GELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGH--VSLTDFDLSCL 823 (1005)
Q Consensus 751 ~E~~~g-gsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~~~g~--vkL~DFG~a~~ 823 (1005)
+|-+.| .+|.+++....-...+......++.+++.++.-||+.|+.|+|+.+.||+++.+|. +.++||.-++.
T Consensus 104 Te~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 104 TEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred EEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 997743 68888876543345677888899999999999999999999999999999987777 99999997643
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.57 E-value=9e-07 Score=91.75 Aligned_cols=143 Identities=21% Similarity=0.269 Sum_probs=95.2
Q ss_pred ccccccCCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHH------HHHHHHHHHhC---CCCCcce
Q 001847 666 GEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHR------ACAEREILDML---DHPFVPA 736 (1005)
Q Consensus 666 ~~~i~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~------~~~E~~il~~l---~hpnIv~ 736 (1005)
+.-+....|.+.+.+.......|.+..- .|+.|++|..+....-....... ..+.+..+.++ .......
T Consensus 25 ~~~i~~~~~~~~kv~k~~~r~~ValIei--~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~ 102 (229)
T PF06176_consen 25 GEKILDNNYKIIKVFKNTKRNYVALIEI--DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPAD 102 (229)
T ss_pred HHHHHhCCceEEEeecCCCccEEEEEEE--CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCcccccc
Confidence 3445567899999999999888888876 77899999887542111111111 11233333333 2222223
Q ss_pred EEEEE-----EeCCeEEEEEeccCCCchhhHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCC
Q 001847 737 LYASF-----QTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNG 811 (1005)
Q Consensus 737 l~~~~-----~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvHrDLkP~NILi~~~g 811 (1005)
++-+. ......+++|||++|..|.++.. +++ .+...|..++.-||+.|+.|+|.+|+|++++. +
T Consensus 103 ~yl~~ekk~~~~~~~~~ll~EYIeG~~l~d~~~------i~e----~~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~~-~ 171 (229)
T PF06176_consen 103 PYLAAEKKIFRYTSSYVLLMEYIEGVELNDIED------IDE----DLAEKIVEAIKQLHKHGFYHGDPHPGNFLVSN-N 171 (229)
T ss_pred ceeeeeeeeccceeEEEEEEEEecCeecccchh------cCH----HHHHHHHHHHHHHHHcCCccCCCCcCcEEEEC-C
Confidence 22222 22345578999999988877642 232 24466778899999999999999999999995 4
Q ss_pred cEEEEeccCC
Q 001847 812 HVSLTDFDLS 821 (1005)
Q Consensus 812 ~vkL~DFG~a 821 (1005)
.++++||+..
T Consensus 172 ~i~iID~~~k 181 (229)
T PF06176_consen 172 GIRIIDTQGK 181 (229)
T ss_pred cEEEEECccc
Confidence 5999999965
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.54 E-value=1e-06 Score=92.71 Aligned_cols=106 Identities=27% Similarity=0.286 Sum_probs=83.0
Q ss_pred HHHHHHHHHHHHhCCCC--CcceEEEEEEeC----CeEEEEEeccCC-CchhhHHhhCCCCCCCHHHHHHHHHHHHHHHH
Q 001847 716 VHRACAEREILDMLDHP--FVPALYASFQTK----THVCLITDYCPG-GELFLLLDRQPTKVLKEDAVRFYAAEVVVALE 788 (1005)
Q Consensus 716 ~~~~~~E~~il~~l~hp--nIv~l~~~~~~~----~~~~lV~E~~~g-gsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~ 788 (1005)
..+..+|...+..|..- .++.++.+.... ...++|+|++++ .+|.+++..... ++......++.+++..++
T Consensus 55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~--~~~~~~~~ll~~l~~~i~ 132 (206)
T PF06293_consen 55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ--LDPSQRRELLRALARLIA 132 (206)
T ss_pred chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc--cchhhHHHHHHHHHHHHH
Confidence 34566777777777433 345666665542 245899999987 489999876322 667778899999999999
Q ss_pred HHHHcCcccCCCCCCcEEEecCC---cEEEEeccCCcc
Q 001847 789 YLHCQGIIYRDLKPENVLLQGNG---HVSLTDFDLSCL 823 (1005)
Q Consensus 789 ~LH~~gIvHrDLkP~NILi~~~g---~vkL~DFG~a~~ 823 (1005)
-||.+||+|+|++|.|||++.++ .+.|+||+.+..
T Consensus 133 ~lH~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 133 KLHDAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF 170 (206)
T ss_pred HHHHCcCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence 99999999999999999999887 899999997744
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >KOG0501 consensus K+-channel KCNQ [Inorganic ion transport and metabolism] | Back alignment and domain information |
|---|
Probab=98.51 E-value=3.6e-07 Score=102.50 Aligned_cols=121 Identities=31% Similarity=0.634 Sum_probs=103.3
Q ss_pred HHHHHHHHhcC--C-eEEEEeCCCCCCcEEEccHHHHHHcCCChhhhcCCCCC--cCCCCCCChHHHHHHHHHHHcCCcE
Q 001847 192 DIVKDALSTFQ--Q-TFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCR--FLQGAGTDPEDVAKIRETLQNGQSY 266 (1005)
Q Consensus 192 ~~l~~ile~~~--~-~i~i~D~~~~dg~I~~vN~a~~~l~Gys~eEllG~~~~--~l~~~~~~~~~~~~i~~~l~~g~~~ 266 (1005)
..++.++..+. | .+++.+..-.|..|+|+|..||++.||.+.|+..+++. +++++..+....+.+++.++..+..
T Consensus 14 TFLENiiRRsn~~dtsFlL~NAQiVD~PiVY~NdgFcKlsGY~RAevMQKs~tc~FMyGEltdk~ti~k~~~t~eN~~~~ 93 (971)
T KOG0501|consen 14 TFLENIIRRSNNADTSFLLANAQIVDWPIVYCNDGFCKLSGYHRAEVMQKSCTCSFMYGELTDKGTIEKVRQTLENYETN 93 (971)
T ss_pred hHHHHHHhhccCCCcceeeccceeeccceEEecCcchhccCccHHHHhcccceeeeeeccccchhhHHHHHHHHHhhhhc
Confidence 34455554433 3 44444555558889999999999999999999999865 7788888999999999999999988
Q ss_pred EEEEEEEecCCcEEEEEEEeeeeecCCCCEEEEEEEEeccchhhHH
Q 001847 267 CGRLLNYKKDGTPFWNLLTIAPIKDDEGKVLKFIGMQVEVSKHTEG 312 (1005)
Q Consensus 267 ~~e~~~~~kdG~~~wv~~~~~pi~d~~G~v~~~v~~~~DITerk~~ 312 (1005)
+.|+..++|+-..+|+.+.+.||+++...++-|+++++|||..|+-
T Consensus 94 qfEillyKKN~TPvW~~vqiAPIrNe~d~VVLfLctFkDIT~~KQP 139 (971)
T KOG0501|consen 94 QFEILLYKKNRTPVWLLVQIAPIRNEKDKVVLFLCTFKDITALKQP 139 (971)
T ss_pred ceeeEeeecCCCceEEEEEeecccCCCceEEEEEeecccchhhcCC
Confidence 9999999999999999999999999999999999999999998874
|
|
| >PF13596 PAS_10: PAS domain; PDB: 3CAX_A 2QKP_D | Back alignment and domain information |
|---|
Probab=98.49 E-value=4.7e-07 Score=84.41 Aligned_cols=106 Identities=20% Similarity=0.317 Sum_probs=73.8
Q ss_pred HHHHHHhccccEEEEcCCCCCCCEEeecHHHHHHcCCChhhhcCCCCCccCCCCCCHHHHHHHHHHHhcCCcEEEEEEEE
Q 001847 477 LATTLERIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIRAAIDNQTDVTVQLINY 556 (1005)
Q Consensus 477 l~~i~e~~~~~I~i~D~~G~d~~i~~vN~a~~~l~Gy~~eEllG~~~~~l~~~~~~~~~~~~i~~~l~~~~~~~~e~~~~ 556 (1005)
++.++++++.++.++|.++. |.+.|+++.++|+.. ...+|+++..+.++.........+ +.+..+.....+...
T Consensus 1 L~~il~s~~~~i~~vD~~~~---I~~~n~~a~~~f~~~-~~~iGr~l~~~~~~~~~~~l~~~i-~~~~~~~~~~~~~~~- 74 (106)
T PF13596_consen 1 LNNILDSMPIGIIFVDRNLR---IRYFNPAAARLFNLS-PSDIGRPLFDIHPPLSYPNLKKII-EQVRSGKEEEFEIVI- 74 (106)
T ss_dssp HHHHHHHSSSEEEEEETTSB---EEEE-SCGC-SS----GGGTTSBCCCSS-HHHHHHHHHHH-HHHHTTSBSEEEEEE-
T ss_pred ChHHHhcCCCCEEEEcCCCe---EEEeChhHhhhcCCC-hHHCCCCHHHcCCccchHHHHHHH-HHHHcCCCceEEEEe-
Confidence 46789999999999999888 999999999999976 466899998887664444444444 444455443333333
Q ss_pred ecCCcEEEEEEEEeeeeCCCCCEEEEEEEEecCc
Q 001847 557 TKSGKKFWNLFHLQPMRDQKGEVQYFIGVQLDGS 590 (1005)
Q Consensus 557 ~kdG~~~wv~~~~~pi~d~~G~v~~~vgi~~DIT 590 (1005)
..+|. |+.++..|+++++|...|++.++.|||
T Consensus 75 ~~~~~--~~~~~~~P~~~~~g~~~G~v~~~~DIT 106 (106)
T PF13596_consen 75 PNGGR--WYLVRYRPYRDEDGEYAGAVITFQDIT 106 (106)
T ss_dssp EETTE--EEEEEEEEEE-TTS-EEEEEEEEEE-G
T ss_pred cCCCE--EEEEEEEEEECCCCCEEEEEEEEEecC
Confidence 35565 667899999999999999999999998
|
|
| >PF12860 PAS_7: PAS fold | Back alignment and domain information |
|---|
Probab=98.47 E-value=5e-07 Score=85.55 Aligned_cols=104 Identities=22% Similarity=0.284 Sum_probs=73.2
Q ss_pred HHhccccEEEEcCCCCCCCEEeecHHHHHHcCCChhhh-cCCCCCccC---------CCCCCHHHHHHHHHHHhcCCcEE
Q 001847 481 LERIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEI-LGRNCRFLQ---------GPETDPATVRKIRAAIDNQTDVT 550 (1005)
Q Consensus 481 ~e~~~~~I~i~D~~G~d~~i~~vN~a~~~l~Gy~~eEl-lG~~~~~l~---------~~~~~~~~~~~i~~~l~~~~~~~ 550 (1005)
+++++.||++.|.+|+ ++++|++|.+++|++.+.+ .|.++..++ .+.....................
T Consensus 1 Ld~l~~Gv~v~D~~~r---l~~~N~~~~~l~~~~~~~~~~G~~~~~l~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~ 77 (115)
T PF12860_consen 1 LDSLPQGVAVFDSDGR---LVFWNQRFRELFGLPPEMLRPGASFRDLLRRLAERGEFPPGDPEAWVRQRLARLRRRQPRS 77 (115)
T ss_pred CCCcCceEEEEcCCCe---EEeEcHHHHHHhCCCHHHhcCCCCHHHHHHHHHHcCCCCCCCHHHHHHHHHHHHhcCCCce
Confidence 4678999999999888 9999999999999999998 788854332 22222223333333333333333
Q ss_pred EEEEEEecCCcEEEEEEEEeeeeCCCCCEEEEEEEEecCccCcccc
Q 001847 551 VQLINYTKSGKKFWNLFHLQPMRDQKGEVQYFIGVQLDGSEHLEPL 596 (1005)
Q Consensus 551 ~e~~~~~kdG~~~wv~~~~~pi~d~~G~v~~~vgi~~DITerK~~e 596 (1005)
.+ ....||. |+.++..|+ .+| ++|.++.|||+++++|
T Consensus 78 ~~--~~~~dgr--~l~~~~~~~--~~G---g~v~~~~DVT~~~~~E 114 (115)
T PF12860_consen 78 FE--LRLPDGR--WLEVRAQPL--PDG---GFVLTFTDVTERRRAE 114 (115)
T ss_pred eE--EECCCCE--EEEEEeEEC--CCC---CEEEEEEeCCHHHHhc
Confidence 33 4568886 677888888 456 5778999999999853
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST 
Original result of BLAST against Protein Data Bank
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() | |
| Query | 1005 | ||||
| 2v1a_A | 144 | N- And C-Terminal Helices Of Oat Lov2 (404-546) Are | 2e-67 | ||
| 2v0u_A | 146 | N- And C-terminal Helices Of Oat Lov2 (404-546) Are | 2e-67 | ||
| 2wkp_A | 332 | Structure Of A Photoactivatable Rac1 Containing Lov | 6e-67 | ||
| 2wkq_A | 332 | Structure Of A Photoactivatable Rac1 Containing The | 8e-66 | ||
| 2wkr_A | 332 | Structure Of A Photoactivatable Rac1 Containing The | 1e-65 | ||
| 2z6c_A | 129 | Crystal Structure Of Lov1 Domain Of Phototropin1 Fr | 2e-63 | ||
| 2z6c_A | 129 | Crystal Structure Of Lov1 Domain Of Phototropin1 Fr | 4e-25 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 1e-55 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 2e-55 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 2e-55 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 2e-55 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 3e-55 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 4e-55 | ||
| 2z6d_A | 130 | Crystal Structure Of Lov1 Domain Of Phototropin2 Fr | 6e-55 | ||
| 2z6d_A | 130 | Crystal Structure Of Lov1 Domain Of Phototropin2 Fr | 4e-26 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 8e-55 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 9e-55 | ||
| 4eep_A | 115 | Crystal Structure Of Lov2 Domain Of Arabidopsis Tha | 1e-54 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 2e-54 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 5e-54 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 6e-54 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 8e-54 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 8e-54 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 8e-54 | ||
| 4eer_A | 115 | Crystal Structure Of Lov2 Domain Of Arabidopsis Tha | 8e-54 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 8e-54 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 1e-53 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 1e-53 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 2e-53 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 2e-53 | ||
| 4ees_A | 115 | Crystal Structure Of Ilov Length = 115 | 6e-52 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 2e-51 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 9e-49 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 1e-48 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 1e-48 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 2e-48 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 2e-48 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 2e-48 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 2e-48 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 2e-48 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 3e-48 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 3e-48 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 3e-48 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 3e-48 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 3e-48 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 3e-48 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 3e-48 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 4e-48 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 4e-48 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 5e-48 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 5e-48 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 6e-48 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 6e-48 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 6e-48 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 6e-48 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 6e-48 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 7e-48 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 7e-48 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 7e-48 | ||
| 4eeu_A | 118 | Crystal Structure Of Philov2.1 Length = 118 | 8e-48 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 8e-48 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 8e-48 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 8e-48 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 9e-48 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 9e-48 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 1e-47 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 2e-47 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 2e-47 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 2e-47 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 2e-47 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 2e-47 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 3e-47 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 3e-47 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 3e-47 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 3e-47 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 3e-47 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 3e-47 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 4e-47 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 4e-47 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 4e-47 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 4e-47 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 4e-47 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 4e-47 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 4e-47 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 5e-47 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 6e-47 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 7e-47 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 7e-47 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 9e-47 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 2e-46 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 2e-46 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 3e-46 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 3e-46 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 2e-44 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 2e-44 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 5e-44 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 8e-44 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 3e-43 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 6e-43 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 7e-43 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 8e-43 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 8e-43 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 8e-43 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 1e-42 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 1e-42 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 1e-42 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 1e-42 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 2e-42 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 2e-42 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 2e-42 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 2e-42 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 2e-42 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 3e-42 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 3e-42 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 3e-42 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 3e-42 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 4e-42 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 4e-42 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 5e-42 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 5e-42 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 9e-42 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 1e-41 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 1e-41 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 1e-41 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 7e-41 | ||
| 1g28_A | 104 | Structure Of A Flavin-Binding Domain, Lov2, From Th | 2e-40 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 2e-39 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 2e-38 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 2e-38 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 8e-38 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 1e-37 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 5e-36 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 7e-36 | ||
| 1n9l_A | 109 | Crystal Structure Of The Phot-lov1 Domain From Chla | 2e-35 | ||
| 1n9l_A | 109 | Crystal Structure Of The Phot-lov1 Domain From Chla | 2e-24 | ||
| 3ulf_A | 170 | The Light State Structure Of The Blue-light Photore | 1e-32 | ||
| 3ue6_A | 166 | The Dark Structure Of The Blue-light Photoreceptor | 2e-32 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 4e-31 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 5e-31 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 6e-31 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 7e-31 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 7e-31 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 7e-31 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 1e-30 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 2e-30 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 3e-30 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 3e-30 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 4e-30 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 4e-30 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 4e-30 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 5e-30 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 6e-30 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 6e-30 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 6e-30 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 6e-30 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 7e-30 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 7e-30 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 7e-30 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 7e-30 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 7e-30 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 9e-30 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 1e-29 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 1e-29 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 1e-29 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 1e-29 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 1e-29 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 1e-29 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 2e-29 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 2e-29 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-29 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 2e-29 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 3e-29 | ||
| 3t50_A | 128 | X-Ray Structure Of The Lov Domain From The Lov-Hk S | 4e-29 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 5e-29 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 1e-28 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 2e-28 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 2e-26 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 2e-26 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 2e-26 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 4e-26 | ||
| 2pr5_A | 132 | Structural Basis For Light-dependent Signaling In T | 7e-26 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 2e-25 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 7e-25 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 7e-25 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 1e-24 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 1e-24 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-24 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-24 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-24 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 5e-24 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 6e-24 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 6e-24 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 6e-24 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 7e-24 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 8e-24 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 9e-24 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 9e-24 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 9e-24 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 1e-23 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 1e-23 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-23 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 1e-23 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 1e-23 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 2e-23 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 2e-23 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 2e-23 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 2e-23 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 2e-23 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-23 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 2e-23 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 2e-23 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-23 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 2e-23 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 2e-23 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 3e-23 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 3e-23 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 3e-23 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 4e-23 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 4e-23 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 5e-23 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 5e-23 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 6e-23 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 6e-23 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 7e-23 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 7e-23 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 7e-23 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 7e-23 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 1e-22 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 3e-22 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 3e-22 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 3e-22 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 4e-22 | ||
| 3p7n_A | 258 | Crystal Structure Of Light Activated Transcription | 5e-22 | ||
| 3p7n_A | 258 | Crystal Structure Of Light Activated Transcription | 6e-20 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 5e-22 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 6e-22 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 6e-22 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 7e-22 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 7e-22 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 7e-22 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 1e-21 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 2e-21 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 2e-21 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 3e-21 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 3e-21 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 3e-21 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 3e-21 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 4e-21 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 4e-21 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 4e-21 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 4e-21 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 4e-21 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 4e-21 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 5e-21 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 5e-21 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 7e-21 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 7e-21 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 8e-21 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 8e-21 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 8e-21 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 8e-21 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 8e-21 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 9e-21 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 9e-21 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 1e-20 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 1e-20 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 1e-20 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 1e-20 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 2e-20 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 2e-20 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 2e-20 | ||
| 3rh8_B | 148 | Crystal Structure Of The Light-State Dimer Of Funga | 2e-20 | ||
| 3hjk_A | 154 | 2.0 Angstrom Structure Of The Ile74val Variant Of V | 2e-20 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-20 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 3e-20 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 3e-20 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 3e-20 | ||
| 3hji_A | 154 | 1.8 Angstrom Crystal Structure Of The I74v:i85v Var | 3e-20 | ||
| 3is2_B | 154 | 2.3 Angstrom Crystal Structure Of A Cys71 Sulfenic | 3e-20 | ||
| 3is2_A | 154 | 2.3 Angstrom Crystal Structure Of A Cys71 Sulfenic | 3e-20 | ||
| 2pd7_A | 149 | 2.0 Angstrom Crystal Structure Of The Fungal Blue-L | 3e-20 | ||
| 2pd8_A | 149 | 1.8 Angstrom Crystal Structure Of The Cys71ser Muta | 3e-20 | ||
| 3d72_A | 149 | 1.65 Angstrom Crystal Structure Of The Cys71val Var | 4e-20 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 5e-20 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 7e-20 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 9e-20 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 1e-19 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 2e-19 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 2e-19 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 2e-19 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 2e-19 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 3e-19 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 3e-19 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 4e-19 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 5e-19 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 6e-19 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 6e-19 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 6e-19 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 7e-19 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 7e-19 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 8e-19 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 1e-18 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 2e-18 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 2e-18 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 2e-18 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 2e-18 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 2e-18 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 2e-18 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 2e-18 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-18 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 4e-18 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 6e-18 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 6e-18 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 8e-18 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-17 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 1e-17 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 1e-17 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 2e-17 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 2e-17 | ||
| 3sw1_A | 162 | Structure Of A Full-Length Bacterial Lov Protein Le | 2e-17 | ||
| 3sw1_A | 162 | Structure Of A Full-Length Bacterial Lov Protein Le | 2e-13 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 5e-17 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 7e-17 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 9e-17 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 1e-16 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 2e-16 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-16 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 2e-16 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-16 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 3e-16 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 3e-16 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 4e-16 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 4e-16 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 4e-16 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 4e-16 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 5e-16 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 5e-16 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 5e-16 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 8e-16 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-15 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-15 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-15 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-15 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 2e-15 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 2e-15 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 2e-15 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 2e-15 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-15 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-15 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 2e-15 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 3e-15 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 3e-15 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 3e-15 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-15 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 3e-15 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 3e-15 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 3e-15 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 4e-15 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 4e-15 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 4e-15 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 5e-15 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 5e-15 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 6e-15 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 9e-15 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-14 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 1e-14 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 1e-14 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-14 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-14 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-14 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 1e-14 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 1e-14 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 1e-14 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 1e-14 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 2e-14 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 2e-14 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 2e-14 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 2e-14 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-14 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 2e-14 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-14 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 3e-14 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 3e-14 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 3e-14 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 3e-14 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 4e-14 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 4e-14 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 5e-14 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 5e-14 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 5e-14 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 5e-14 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 5e-14 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 7e-14 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 9e-14 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 1e-13 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 1e-13 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 1e-13 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-13 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 1e-13 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-13 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 1e-13 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 2e-13 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-13 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 2e-13 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 2e-13 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 2e-13 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 2e-13 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 2e-13 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 2e-13 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 2e-13 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 2e-13 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 2e-13 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 3e-13 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 4e-13 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 4e-13 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 5e-13 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 5e-13 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 5e-13 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 6e-13 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 6e-13 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 6e-13 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 6e-13 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 7e-13 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 7e-13 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 7e-13 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 7e-13 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 7e-13 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 8e-13 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 8e-13 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 8e-13 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 9e-13 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 9e-13 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 9e-13 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 9e-13 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 9e-13 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 9e-13 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 9e-13 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 1e-12 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 1e-12 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 1e-12 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 2e-12 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 2e-12 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-12 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 2e-12 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 2e-12 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 3e-12 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 3e-12 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 3e-12 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 3e-12 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 3e-12 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 3e-12 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 4e-12 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 4e-12 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 4e-12 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 4e-12 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 4e-12 | ||
| 3k2l_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 5e-12 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 5e-12 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 5e-12 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 5e-12 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 5e-12 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 5e-12 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 5e-12 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 5e-12 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 5e-12 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 5e-12 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 5e-12 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 5e-12 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 5e-12 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 5e-12 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 5e-12 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 5e-12 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 6e-12 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 6e-12 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 6e-12 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 6e-12 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 6e-12 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 6e-12 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 6e-12 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 6e-12 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 6e-12 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 6e-12 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 6e-12 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 7e-12 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 7e-12 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 7e-12 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 7e-12 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 7e-12 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 7e-12 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 7e-12 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 7e-12 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 7e-12 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 8e-12 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 8e-12 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 8e-12 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 8e-12 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 8e-12 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 8e-12 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 8e-12 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 8e-12 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 9e-12 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 1e-11 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 1e-11 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 1e-11 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 1e-11 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 1e-11 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-11 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-11 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 1e-11 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 1e-11 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 1e-11 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 2e-11 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-11 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 2e-11 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 2e-11 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 2e-11 | ||
| 4hia_A | 176 | Crystal Structure Of Rhodobacter Sphaeroides Lov Pr | 2e-11 | ||
| 4hia_A | 176 | Crystal Structure Of Rhodobacter Sphaeroides Lov Pr | 1e-10 | ||
| 4hj3_A | 176 | Crystal Structure Of Rhodobacter Sphaeroides Lov Pr | 2e-11 | ||
| 4hj3_A | 176 | Crystal Structure Of Rhodobacter Sphaeroides Lov Pr | 1e-10 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 2e-11 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 2e-11 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 3e-11 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 3e-11 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 3e-11 | ||
| 4hj6_A | 178 | Crystal Structure Of Rhodobacter Sphaeroides Lov Pr | 3e-11 | ||
| 4hj6_A | 178 | Crystal Structure Of Rhodobacter Sphaeroides Lov Pr | 2e-10 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 3e-11 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 3e-11 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 3e-11 | ||
| 4hj4_A | 177 | Crystal Structure Of Rhodobacter Sphaeroides Lov Pr | 3e-11 | ||
| 4hj4_A | 177 | Crystal Structure Of Rhodobacter Sphaeroides Lov Pr | 2e-10 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 3e-11 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 3e-11 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 3e-11 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 3e-11 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 3e-11 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 3e-11 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 4e-11 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 4e-11 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 5e-11 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 5e-11 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 5e-11 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 5e-11 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 5e-11 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 5e-11 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 5e-11 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 6e-11 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 6e-11 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 6e-11 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 6e-11 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 6e-11 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 6e-11 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 6e-11 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 6e-11 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 6e-11 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 7e-11 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 7e-11 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 7e-11 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 7e-11 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 7e-11 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 7e-11 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 7e-11 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 7e-11 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 7e-11 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 8e-11 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 8e-11 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 8e-11 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 9e-11 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 9e-11 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 9e-11 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 9e-11 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 9e-11 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 1e-10 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 1e-10 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 1e-10 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 1e-10 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 1e-10 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 1e-10 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 1e-10 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 1e-10 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 1e-10 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 1e-10 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-10 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 1e-10 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 1e-10 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 1e-10 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-10 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-10 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 1e-10 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 1e-10 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 1e-10 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 1e-10 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 1e-10 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 1e-10 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 1e-10 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 1e-10 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 1e-10 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 1e-10 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-10 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 1e-10 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 1e-10 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 1e-10 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 1e-10 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 1e-10 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 1e-10 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 1e-10 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 1e-10 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 1e-10 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 1e-10 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-10 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 1e-10 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 1e-10 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-10 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 1e-10 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 1e-10 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 1e-10 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 1e-10 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 1e-10 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 2e-10 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 2e-10 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 2e-10 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 2e-10 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 2e-10 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 2e-10 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-10 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 2e-10 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 2e-10 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 2e-10 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 2e-10 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 2e-10 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 2e-10 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 2e-10 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 2e-10 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-10 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 2e-10 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 2e-10 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 2e-10 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 2e-10 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 2e-10 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 2e-10 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 2e-10 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 2e-10 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 2e-10 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 2e-10 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 2e-10 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 2e-10 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 2e-10 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 2e-10 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-10 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-10 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 2e-10 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 2e-10 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 2e-10 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-10 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 2e-10 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 2e-10 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 2e-10 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 2e-10 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-10 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 2e-10 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 2e-10 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 2e-10 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 2e-10 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 2e-10 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 2e-10 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 3e-10 | ||
| 3llt_A | 360 | Crystal Structure Of Pf14_0431, Kinase Domain Lengt | 3e-10 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 3e-10 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 3e-10 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 3e-10 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 3e-10 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 3e-10 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 3e-10 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 3e-10 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 3e-10 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 4e-10 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 4e-10 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 4e-10 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 4e-10 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 4e-10 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 4e-10 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 4e-10 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 4e-10 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 5e-10 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 5e-10 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 5e-10 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 5e-10 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 5e-10 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 5e-10 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 5e-10 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 6e-10 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 6e-10 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 6e-10 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 6e-10 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 6e-10 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 7e-10 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 7e-10 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 7e-10 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 7e-10 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 7e-10 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 7e-10 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 7e-10 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 7e-10 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 7e-10 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 8e-10 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 8e-10 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 8e-10 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 8e-10 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 8e-10 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 9e-10 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 9e-10 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 1e-09 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 1e-09 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-09 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 1e-09 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 1e-09 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 1e-09 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 1e-09 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 1e-09 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 1e-09 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 1e-09 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 1e-09 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 1e-09 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 2e-09 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 2e-09 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-09 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 2e-09 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 2e-09 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 2e-09 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 2e-09 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-09 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 2e-09 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 2e-09 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 2e-09 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-09 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 2e-09 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 2e-09 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 2e-09 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-09 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 2e-09 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 2e-09 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 2e-09 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 2e-09 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 2e-09 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-09 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 3e-09 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 3e-09 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 3e-09 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 3e-09 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 3e-09 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 3e-09 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 3e-09 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 3e-09 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 3e-09 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 4e-09 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 4e-09 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 4e-09 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 4e-09 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 4e-09 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 4e-09 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 4e-09 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 4e-09 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 5e-09 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 5e-09 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 5e-09 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 5e-09 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 5e-09 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 5e-09 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 5e-09 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 5e-09 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 5e-09 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 6e-09 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 6e-09 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 6e-09 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 6e-09 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 6e-09 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 7e-09 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 7e-09 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 7e-09 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 7e-09 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 7e-09 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 7e-09 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 8e-09 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 8e-09 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 8e-09 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 9e-09 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 1e-08 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 1e-08 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 1e-08 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 1e-08 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 1e-08 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 1e-08 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 1e-08 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 1e-08 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 1e-08 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 1e-08 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 1e-08 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 1e-08 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 2e-08 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 2e-08 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 2e-08 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 2e-08 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 2e-08 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 2e-08 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 2e-08 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 3e-08 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 3e-08 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 3e-08 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 3e-08 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 3e-08 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 3e-08 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 3e-08 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 4e-08 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-08 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 4e-08 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 4e-08 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 4e-08 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 4e-08 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 4e-08 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 4e-08 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 4e-08 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 4e-08 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 5e-08 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 5e-08 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 5e-08 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-08 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 5e-08 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 6e-08 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 6e-08 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 6e-08 | ||
| 2l0w_A | 138 | Solution Nmr Structure Of The N-Terminal Pas Domain | 6e-08 | ||
| 2l4r_A | 135 | Nmr Solution Structure Of The N-Terminal Pas Domain | 6e-08 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 6e-08 | ||
| 2l1m_A | 150 | Solution Structure Of The Eag Domain Of The Herg (K | 6e-08 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 7e-08 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 7e-08 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 7e-08 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 7e-08 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 8e-08 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 9e-08 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 1e-07 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 1e-07 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 1e-07 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-07 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 1e-07 | ||
| 3eb0_A | 383 | Crystal Structure Of Cgd4_240 From Cryptosporidium | 1e-07 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 1e-07 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 1e-07 | ||
| 2gj3_A | 120 | Crystal Structure Of The Fad-Containing Pas Domain | 1e-07 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-07 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 2e-07 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 2e-07 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 2e-07 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 2e-07 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 2e-07 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 2e-07 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 2e-07 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 2e-07 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 2e-07 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 2e-07 | ||
| 4f99_A | 361 | Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti | 3e-07 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 3e-07 | ||
| 1byw_A | 110 | Structure Of The N-Terminal Domain Of The Human-Erg | 3e-07 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 3e-07 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 3e-07 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 3e-07 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 4e-07 | ||
| 3juh_A | 335 | Crystal Structure Of A Mutant Of Human Protein Kina | 4e-07 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 4e-07 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 4e-07 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 5e-07 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 5e-07 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 5e-07 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 5e-07 | ||
| 3ofm_A | 350 | Structure Of A Human Ck2alpha Prime, The Paralog Is | 6e-07 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 6e-07 | ||
| 3e3b_X | 339 | Crystal Structure Of Catalytic Subunit Of Human Pro | 6e-07 | ||
| 2r7i_A | 335 | Crystal Structure Of Catalytic Subunit Of Protein K | 6e-07 | ||
| 1z57_A | 339 | Crystal Structure Of Human Clk1 In Complex With 10z | 6e-07 | ||
| 3h30_A | 334 | Crystal Structure Of The Catalytic Subunit Of Human | 6e-07 | ||
| 3u87_A | 349 | Structure Of A Chimeric Construct Of Human Ck2alpha | 6e-07 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 6e-07 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 6e-07 | ||
| 3bqc_A | 335 | High Ph-Value Crystal Structure Of Emodin In Comple | 6e-07 | ||
| 3nga_A | 333 | Human Ck2 Catalytic Domain In Complex With Cx-4945 | 7e-07 | ||
| 1jwh_A | 337 | Crystal Structure Of Human Protein Kinase Ck2 Holoe | 7e-07 | ||
| 4dgl_C | 335 | Crystal Structure Of The Ck2 Tetrameric Holoenzyme | 7e-07 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 7e-07 | ||
| 1pjk_A | 334 | Crystal Structure Of A C-terminal Deletion Mutant O | 7e-07 | ||
| 3q04_A | 328 | Crystal Structure Of The Apo-Form Of Human Ck2 Alph | 7e-07 | ||
| 3q9w_A | 336 | Crystal Structure Of Human Ck2 Alpha In Complex Wit | 7e-07 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 7e-07 | ||
| 3nsz_A | 330 | Human Ck2 Catalytic Domain In Complex With Amppn Le | 7e-07 | ||
| 3mb6_A | 331 | Human Ck2 Catalytic Domain In Complex With A Difura | 7e-07 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 7e-07 | ||
| 2zjw_A | 340 | Crystal Structure Of Human Ck2 Alpha Complexed With | 7e-07 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 8e-07 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 8e-07 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 9e-07 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 9e-07 | ||
| 2wu6_A | 381 | Crystal Structure Of The Human Clk3 In Complex With | 1e-06 | ||
| 2exe_A | 357 | Crystal Structure Of The Phosphorylated Clk3 Length | 1e-06 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 1e-06 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 1e-06 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 1e-06 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 1e-06 | ||
| 2eu9_A | 355 | Crystal Structure Of Clk3 Length = 355 | 1e-06 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 1e-06 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 1e-06 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 1e-06 | ||
| 3ewk_A | 227 | Structure Of The Redox Sensor Domain Of Methylococc | 1e-06 | ||
| 3ewk_A | 227 | Structure Of The Redox Sensor Domain Of Methylococc | 3e-04 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 1e-06 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 1e-06 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 2e-06 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 2e-06 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 2e-06 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 2e-06 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 2e-06 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 2e-06 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 2e-06 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 2e-06 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 2e-06 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 2e-06 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 2e-06 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 2e-06 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 2e-06 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 2e-06 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 2e-06 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 2e-06 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 2e-06 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 2e-06 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 2e-06 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 2e-06 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 2e-06 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 2e-06 | ||
| 3kga_A | 299 | Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe | 2e-06 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 2e-06 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 2e-06 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-06 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 2e-06 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 2e-06 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-06 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-06 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 2e-06 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 2e-06 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 2e-06 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 2e-06 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 2e-06 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 2e-06 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-06 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 2e-06 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 2e-06 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 2e-06 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 2e-06 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 2e-06 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 2e-06 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 3e-06 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 3e-06 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 3e-06 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 3e-06 | ||
| 3nr9_A | 368 | Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length | 3e-06 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 3e-06 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 3e-06 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 3e-06 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 3e-06 | ||
| 3anq_A | 368 | Human Dyrk1aINHIBITOR COMPLEX Length = 368 | 3e-06 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 3e-06 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 3e-06 | ||
| 2vx3_A | 382 | Crystal Structure Of The Human Dual Specificity Tyr | 4e-06 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 4e-06 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 4e-06 | ||
| 2vag_A | 339 | Crystal Structure Of Di-Phosphorylated Human Clk1 I | 4e-06 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 4e-06 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 5e-06 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 5e-06 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 5e-06 | ||
| 4aze_A | 382 | Human Dyrk1a In Complex With Leucettine L41 Length | 6e-06 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 6e-06 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 7e-06 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 8e-06 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 8e-06 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 8e-06 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 8e-06 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 8e-06 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 9e-06 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 1e-05 | ||
| 2wtk_B | 373 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 1e-05 | ||
| 2cmw_A | 310 | Structure Of Human Casein Kinase 1 Gamma-1 In Compl | 1e-05 | ||
| 3gni_B | 389 | Structure Of Strad And Mo25 Length = 389 | 1e-05 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 1e-05 | ||
| 4hgl_A | 330 | Crystal Structure Of Ck1g3 With Compound 1 Length = | 1e-05 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 2e-05 | ||
| 2izr_A | 330 | Structure Of Casein Kinase Gamma 3 In Complex With | 2e-05 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 2e-05 | ||
| 2chl_A | 351 | Structure Of Casein Kinase 1 Gamma 3 Length = 351 | 2e-05 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 3e-05 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 3e-05 | ||
| 2c47_A | 313 | Structure Of Casein Kinase 1 Gamma 2 Length = 313 | 3e-05 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-05 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 3e-05 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 3e-05 | ||
| 3pvg_A | 331 | Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C | 3e-05 | ||
| 2qc6_A | 332 | Protein Kinase Ck2 In Complex With Dbc Length = 332 | 3e-05 | ||
| 2pvh_A | 352 | Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri | 3e-05 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-05 | ||
| 1ds5_A | 332 | Dimeric Crystal Structure Of The Alpha Subunit In C | 4e-05 | ||
| 4anm_A | 335 | Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | 4e-05 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 4e-05 |
| >pdb|2V1A|A Chain A, N- And C-Terminal Helices Of Oat Lov2 (404-546) Are Involved In Light-Induced Signal Transduction (Room Temperature (293k) Dark Structure Of Lov2 (404-546)) Length = 144 | Back alignment and structure |
|
| >pdb|2V0U|A Chain A, N- And C-terminal Helices Of Oat Lov2 (404-546) Are Involved In Light-induced Signal Transduction (cryo Dark Structure Of Lov2 (404-546)) Length = 146 | Back alignment and structure |
|
| >pdb|2WKP|A Chain A, Structure Of A Photoactivatable Rac1 Containing Lov2 Wildtype Length = 332 | Back alignment and structure |
|
| >pdb|2WKQ|A Chain A, Structure Of A Photoactivatable Rac1 Containing The Lov2 C450a Mutant Length = 332 | Back alignment and structure |
|
| >pdb|2WKR|A Chain A, Structure Of A Photoactivatable Rac1 Containing The Lov2 C450m Mutant Length = 332 | Back alignment and structure |
|
| >pdb|2Z6C|A Chain A, Crystal Structure Of Lov1 Domain Of Phototropin1 From Arabidopsis Thaliana Length = 129 | Back alignment and structure |
|
| >pdb|2Z6C|A Chain A, Crystal Structure Of Lov1 Domain Of Phototropin1 From Arabidopsis Thaliana Length = 129 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|2Z6D|A Chain A, Crystal Structure Of Lov1 Domain Of Phototropin2 From Arabidopsis Thaliana Length = 130 | Back alignment and structure |
|
| >pdb|2Z6D|A Chain A, Crystal Structure Of Lov1 Domain Of Phototropin2 From Arabidopsis Thaliana Length = 130 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|4EEP|A Chain A, Crystal Structure Of Lov2 Domain Of Arabidopsis Thaliana Phototropin 2 Length = 115 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|4EER|A Chain A, Crystal Structure Of Lov2 Domain Of Arabidopsis Thaliana Phototropin 2 C426a Mutant Length = 115 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|4EES|A Chain A, Crystal Structure Of Ilov Length = 115 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|4EEU|A Chain A, Crystal Structure Of Philov2.1 Length = 118 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|1G28|A Chain A, Structure Of A Flavin-Binding Domain, Lov2, From The Chimeric PhytochromePHOTOTROPIN PHOTORECEPTOR PHY3 Length = 104 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|1N9L|A Chain A, Crystal Structure Of The Phot-lov1 Domain From Chlamydomonas Reinhardtii In The Dark State. Length = 109 | Back alignment and structure |
|
| >pdb|1N9L|A Chain A, Crystal Structure Of The Phot-lov1 Domain From Chlamydomonas Reinhardtii In The Dark State. Length = 109 | Back alignment and structure |
|
| >pdb|3ULF|A Chain A, The Light State Structure Of The Blue-light Photoreceptor Aureochrome1 Lov Length = 170 | Back alignment and structure |
|
| >pdb|3UE6|A Chain A, The Dark Structure Of The Blue-light Photoreceptor Aureochrome1 Lov Length = 166 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3T50|A Chain A, X-Ray Structure Of The Lov Domain From The Lov-Hk Sensory Protein From Brucella Abortus (Dark State). Length = 128 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|2PR5|A Chain A, Structural Basis For Light-dependent Signaling In The Dimeric Lov Photosensor Ytva (dark Structure) Length = 132 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|3P7N|A Chain A, Crystal Structure Of Light Activated Transcription Factor El222 From Erythrobacter Litoralis Length = 258 | Back alignment and structure |
|
| >pdb|3P7N|A Chain A, Crystal Structure Of Light Activated Transcription Factor El222 From Erythrobacter Litoralis Length = 258 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3RH8|B Chain B, Crystal Structure Of The Light-State Dimer Of Fungal Blue-Light Photoreceptor Vivid Length = 148 | Back alignment and structure |
|
| >pdb|3HJK|A Chain A, 2.0 Angstrom Structure Of The Ile74val Variant Of Vivid (Vvd). Length = 154 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|3HJI|A Chain A, 1.8 Angstrom Crystal Structure Of The I74v:i85v Variant Of Vivid (Vvd). Length = 154 | Back alignment and structure |
|
| >pdb|3IS2|B Chain B, 2.3 Angstrom Crystal Structure Of A Cys71 Sulfenic Acid Form Of Vivid Length = 154 | Back alignment and structure |
|
| >pdb|3IS2|A Chain A, 2.3 Angstrom Crystal Structure Of A Cys71 Sulfenic Acid Form Of Vivid Length = 154 | Back alignment and structure |
|
| >pdb|2PD7|A Chain A, 2.0 Angstrom Crystal Structure Of The Fungal Blue-Light Photoreceptor Vivid Length = 149 | Back alignment and structure |
|
| >pdb|2PD8|A Chain A, 1.8 Angstrom Crystal Structure Of The Cys71ser Mutant Of Vivid Length = 149 | Back alignment and structure |
|
| >pdb|3D72|A Chain A, 1.65 Angstrom Crystal Structure Of The Cys71val Variant In The Fungal Photoreceptor Vvd Length = 149 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|3SW1|A Chain A, Structure Of A Full-Length Bacterial Lov Protein Length = 162 | Back alignment and structure |
|
| >pdb|3SW1|A Chain A, Structure Of A Full-Length Bacterial Lov Protein Length = 162 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4HIA|A Chain A, Crystal Structure Of Rhodobacter Sphaeroides Lov Protein Length = 176 | Back alignment and structure |
|
| >pdb|4HIA|A Chain A, Crystal Structure Of Rhodobacter Sphaeroides Lov Protein Length = 176 | Back alignment and structure |
|
| >pdb|4HJ3|A Chain A, Crystal Structure Of Rhodobacter Sphaeroides Lov Protein Length = 176 | Back alignment and structure |
|
| >pdb|4HJ3|A Chain A, Crystal Structure Of Rhodobacter Sphaeroides Lov Protein Length = 176 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|4HJ6|A Chain A, Crystal Structure Of Rhodobacter Sphaeroides Lov Protein Length = 178 | Back alignment and structure |
|
| >pdb|4HJ6|A Chain A, Crystal Structure Of Rhodobacter Sphaeroides Lov Protein Length = 178 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|4HJ4|A Chain A, Crystal Structure Of Rhodobacter Sphaeroides Lov Protein Length = 177 | Back alignment and structure |
|
| >pdb|4HJ4|A Chain A, Crystal Structure Of Rhodobacter Sphaeroides Lov Protein Length = 177 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3LLT|A Chain A, Crystal Structure Of Pf14_0431, Kinase Domain Length = 360 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|2L0W|A Chain A, Solution Nmr Structure Of The N-Terminal Pas Domain Of Herg Potassium Channel Length = 138 | Back alignment and structure |
|
| >pdb|2L4R|A Chain A, Nmr Solution Structure Of The N-Terminal Pas Domain Of Herg Length = 135 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|2L1M|A Chain A, Solution Structure Of The Eag Domain Of The Herg (Kv11.1) K+ Channel Length = 150 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2GJ3|A Chain A, Crystal Structure Of The Fad-Containing Pas Domain Of The Protein Nifl From Azotobacter Vinelandii. Length = 120 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|1BYW|A Chain A, Structure Of The N-Terminal Domain Of The Human-Erg Potassium Channel Length = 110 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339 | Back alignment and structure |
|
| >pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334 | Back alignment and structure |
|
| >pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333 | Back alignment and structure |
|
| >pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337 | Back alignment and structure |
|
| >pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334 | Back alignment and structure |
|
| >pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328 | Back alignment and structure |
|
| >pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330 | Back alignment and structure |
|
| >pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|2WU6|A Chain A, Crystal Structure Of The Human Clk3 In Complex With Dki Length = 381 | Back alignment and structure |
|
| >pdb|2EXE|A Chain A, Crystal Structure Of The Phosphorylated Clk3 Length = 357 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|2EU9|A Chain A, Crystal Structure Of Clk3 Length = 355 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|3EWK|A Chain A, Structure Of The Redox Sensor Domain Of Methylococcus Capsulatus (Bath) Mmos Length = 227 | Back alignment and structure |
|
| >pdb|3EWK|A Chain A, Structure Of The Redox Sensor Domain Of Methylococcus Capsulatus (Bath) Mmos Length = 227 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|3NR9|A Chain A, Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length = 368 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|2VAG|A Chain A, Crystal Structure Of Di-Phosphorylated Human Clk1 In Complex With A Novel Substituted Indole Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|2WTK|B Chain B, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 373 | Back alignment and structure |
|
| >pdb|2CMW|A Chain A, Structure Of Human Casein Kinase 1 Gamma-1 In Complex With 2-(2-Hydroxyethylamino)-6-(3-Chloroanilino)-9- Isopropylpurine (Casp Target) Length = 310 | Back alignment and structure |
|
| >pdb|3GNI|B Chain B, Structure Of Strad And Mo25 Length = 389 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|4HGL|A Chain A, Crystal Structure Of Ck1g3 With Compound 1 Length = 330 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|2IZR|A Chain A, Structure Of Casein Kinase Gamma 3 In Complex With Inhibitor Length = 330 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|2CHL|A Chain A, Structure Of Casein Kinase 1 Gamma 3 Length = 351 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|2C47|A Chain A, Structure Of Casein Kinase 1 Gamma 2 Length = 313 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331 | Back alignment and structure |
|
| >pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332 | Back alignment and structure |
|
| >pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332 | Back alignment and structure |
|
| >pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST 
Original result of RPS-BLAST against PDB70 database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| Query | 1005 | |||
| 1uu3_A | 310 | HPDK1, 3-phosphoinositide dependent protein kinase | 1e-119 | |
| 3g51_A | 325 | Ribosomal protein S6 kinase alpha-3; N-terminal ki | 1e-113 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 1e-112 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 1e-112 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 1e-112 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 1e-112 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 1e-111 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 1e-110 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 1e-109 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 1e-109 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 1e-108 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 1e-108 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 1e-108 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 1e-106 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 1e-106 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 1e-106 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 1e-105 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 1e-104 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 1e-104 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 1e-103 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 1e-103 | |
| 3pvu_A | 695 | Beta-adrenergic receptor kinase 1; transferase, se | 4e-99 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 3e-86 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 1e-85 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 2e-73 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 2e-71 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 9e-69 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 2e-68 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 5e-67 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 1e-66 | |
| 2wkq_A | 332 | NPH1-1, RAS-related C3 botulinum toxin substrate 1 | 1e-65 | |
| 2wkq_A | 332 | NPH1-1, RAS-related C3 botulinum toxin substrate 1 | 3e-40 | |
| 2v0u_A | 146 | NPH1-1, LOV2; kinase, transferase, ATP-binding, se | 1e-64 | |
| 2v0u_A | 146 | NPH1-1, LOV2; kinase, transferase, ATP-binding, se | 4e-54 | |
| 4apc_A | 350 | Serine/threonine-protein kinase NEK1; transferase; | 1e-62 | |
| 2z6d_A | 130 | Phototropin-2; PAS-fold, LOV-fold, alternative spl | 3e-62 | |
| 2z6d_A | 130 | Phototropin-2; PAS-fold, LOV-fold, alternative spl | 1e-56 | |
| 4eet_B | 115 | Phototropin-2; LOV, blue light photoreceptor, sign | 2e-59 | |
| 4eet_B | 115 | Phototropin-2; LOV, blue light photoreceptor, sign | 9e-55 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 4e-59 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 7e-59 | |
| 3ue6_A | 166 | Aureochrome1; PAS/LOV domain, FMN-binding blue-lig | 7e-59 | |
| 3ue6_A | 166 | Aureochrome1; PAS/LOV domain, FMN-binding blue-lig | 4e-54 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 1e-58 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 4e-58 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 5e-58 | |
| 1n9l_A | 109 | PHOT-LOV1, putative blue light receptor; phototrop | 5e-58 | |
| 1n9l_A | 109 | PHOT-LOV1, putative blue light receptor; phototrop | 1e-55 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 6e-58 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 2e-57 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 2e-57 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 3e-57 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 4e-57 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 4e-57 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 6e-57 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 7e-57 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 9e-57 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 1e-56 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 1e-56 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 2e-56 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 2e-56 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 3e-56 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 3e-56 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 4e-56 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 5e-56 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 7e-56 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 7e-56 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 8e-56 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 1e-55 | |
| 3p7n_A | 258 | Sensor histidine kinase; LOV domain, light-activat | 1e-55 | |
| 3p7n_A | 258 | Sensor histidine kinase; LOV domain, light-activat | 5e-54 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 3e-55 | |
| 3t50_A | 128 | Blue-light-activated histidine kinase; PAS superfa | 4e-55 | |
| 3t50_A | 128 | Blue-light-activated histidine kinase; PAS superfa | 9e-53 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 4e-55 | |
| 2l0w_A | 138 | Potassium voltage-gated channel, subfamily H (EAG | 6e-55 | |
| 2l0w_A | 138 | Potassium voltage-gated channel, subfamily H (EAG | 3e-52 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 6e-55 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 6e-55 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 8e-55 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 9e-55 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 2e-54 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 2e-54 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 4e-54 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 5e-54 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 2e-53 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 2e-53 | |
| 3sw1_A | 162 | Sensory box protein; light-oxygen-voltage, LOV, PA | 2e-53 | |
| 3sw1_A | 162 | Sensory box protein; light-oxygen-voltage, LOV, PA | 3e-53 | |
| 1byw_A | 110 | Protein (human ERG potassium channel); PAS domain, | 3e-53 | |
| 1byw_A | 110 | Protein (human ERG potassium channel); PAS domain, | 2e-52 | |
| 2pr5_A | 132 | Blue-light photoreceptor; light-oxygen-voltage, LO | 5e-53 | |
| 2pr5_A | 132 | Blue-light photoreceptor; light-oxygen-voltage, LO | 3e-50 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 6e-53 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 2e-52 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 2e-52 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 2e-52 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 2e-52 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 2e-52 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 3e-52 | |
| 3d72_A | 149 | Vivid PAS protein VVD; circadian, photoreceptor, b | 8e-52 | |
| 3d72_A | 149 | Vivid PAS protein VVD; circadian, photoreceptor, b | 5e-49 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 9e-52 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 1e-50 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 1e-50 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 2e-50 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 2e-50 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 3e-50 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 7e-50 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 2e-49 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 3e-49 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 7e-49 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 2e-48 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 7e-48 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 1e-47 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 5e-47 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 6e-47 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 3e-46 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 3e-46 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 3e-06 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 3e-46 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 6e-44 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 5e-43 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 6e-41 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 6e-41 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 5e-36 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 2e-35 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 2e-35 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 3e-35 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 3e-35 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 4e-35 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 5e-35 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 7e-35 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 1e-34 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 1e-34 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 2e-34 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 5e-34 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 9e-34 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 2e-33 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 3e-33 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 3e-33 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 5e-33 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 9e-33 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 1e-32 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 2e-32 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 2e-31 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 3e-31 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 5e-31 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 1e-30 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 3e-30 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 2e-26 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 4e-26 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 8e-26 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 2e-25 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 4e-25 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 1e-24 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 3e-24 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 1e-23 | |
| 3ewk_A | 227 | Sensor protein; PAS domain, alpha/beta fold, kinas | 3e-23 | |
| 3ewk_A | 227 | Sensor protein; PAS domain, alpha/beta fold, kinas | 5e-23 | |
| 3ewk_A | 227 | Sensor protein; PAS domain, alpha/beta fold, kinas | 4e-22 | |
| 3ewk_A | 227 | Sensor protein; PAS domain, alpha/beta fold, kinas | 3e-19 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 5e-23 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 9e-23 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 1e-22 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 1e-22 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 2e-22 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 2e-22 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 3e-22 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 4e-22 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 6e-22 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 7e-22 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 2e-21 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 2e-21 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 3e-21 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 5e-21 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 7e-21 | |
| 2gj3_A | 120 | Nitrogen fixation regulatory protein; PAS domain, | 8e-21 | |
| 2gj3_A | 120 | Nitrogen fixation regulatory protein; PAS domain, | 5e-16 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 1e-20 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 2e-20 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 2e-20 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 5e-20 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 7e-20 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 7e-20 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 1e-19 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 1e-19 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 1e-19 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 2e-19 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 2e-19 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 2e-19 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 2e-19 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 2e-19 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 3e-19 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 3e-19 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 3e-19 | |
| 3lyx_A | 124 | Sensory BOX/ggdef domain protein; structural genom | 3e-19 | |
| 3lyx_A | 124 | Sensory BOX/ggdef domain protein; structural genom | 3e-17 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 4e-19 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 4e-19 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 5e-19 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 6e-19 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 7e-19 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 9e-19 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 1e-18 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 1e-18 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 2e-18 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 2e-18 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 2e-18 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 3e-18 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 4e-18 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 8e-18 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 9e-18 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 9e-18 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 1e-17 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 1e-17 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 2e-17 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 3e-17 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 3e-17 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 5e-17 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 5e-17 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 5e-17 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 6e-17 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 7e-17 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 8e-17 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 1e-16 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 2e-16 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 3e-16 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 3e-16 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 4e-16 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 7e-16 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 7e-16 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 9e-16 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 2e-15 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 2e-15 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 3e-15 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 4e-15 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 5e-15 | |
| 1vt4_I | 1221 | APAF-1 related killer DARK; drosophila apoptosome, | 7e-15 | |
| 1vt4_I | 1221 | APAF-1 related killer DARK; drosophila apoptosome, | 8e-09 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 1e-14 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 3e-14 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 6e-14 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 7e-14 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 9e-14 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 6e-13 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 1e-12 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 2e-12 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 2e-12 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 2e-12 | |
| 3v5q_A | 297 | NT-3 growth factor receptor; kinase domain, kinase | 3e-12 | |
| 3mqq_A | 120 | Transcriptional regulator, LUXR family; PAS domain | 5e-12 | |
| 3mqq_A | 120 | Transcriptional regulator, LUXR family; PAS domain | 7e-10 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 9e-12 | |
| 3zzw_A | 289 | Tyrosine-protein kinase transmembrane receptor RO; | 1e-11 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 1e-11 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 4e-11 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 6e-11 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 7e-11 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 8e-11 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 9e-11 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 4e-10 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 6e-10 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 8e-10 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 8e-10 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 1e-09 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 3e-09 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 4e-08 | |
| 3luq_A | 114 | Sensor protein; PAS, histidine, kinase, PSI, MCSG, | 5e-08 | |
| 3luq_A | 114 | Sensor protein; PAS, histidine, kinase, PSI, MCSG, | 8e-05 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 8e-08 | |
| 3b33_A | 115 | Sensor protein; structural genomics, PAS domain, n | 1e-07 | |
| 3b33_A | 115 | Sensor protein; structural genomics, PAS domain, n | 5e-05 | |
| 2r78_A | 117 | Sensor protein; sensory box sensor histidine kinas | 1e-07 | |
| 2r78_A | 117 | Sensor protein; sensory box sensor histidine kinas | 4e-07 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 2e-07 | |
| 2vlg_A | 111 | Sporulation kinase A; histidine kinase, two-compon | 5e-07 | |
| 2vlg_A | 111 | Sporulation kinase A; histidine kinase, two-compon | 3e-04 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 5e-07 | |
| 3bwl_A | 126 | Sensor protein; structural genomics, APC87707.1, P | 6e-07 | |
| 3bwl_A | 126 | Sensor protein; structural genomics, APC87707.1, P | 8e-07 | |
| 3mjq_A | 126 | Uncharacterized protein; NESG, structural genomics | 5e-06 | |
| 3mjq_A | 126 | Uncharacterized protein; NESG, structural genomics | 3e-05 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 8e-06 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 1e-05 | |
| 3olo_A | 118 | Two-component sensor histidine kinase; structural | 1e-05 | |
| 3olo_A | 118 | Two-component sensor histidine kinase; structural | 4e-05 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 2e-05 | |
| 3fc7_A | 125 | HTR-like protein, sensor protein; APC87712.1, HTR- | 2e-05 | |
| 3fc7_A | 125 | HTR-like protein, sensor protein; APC87712.1, HTR- | 3e-04 | |
| 3eeh_A | 125 | Putative light and redox sensing histidine kinase; | 3e-05 | |
| 3icy_A | 118 | Sensor protein; sensory box histidine kinase/respo | 3e-05 | |
| 3icy_A | 118 | Sensor protein; sensory box histidine kinase/respo | 2e-04 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 6e-05 |
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 366 bits (943), Expect = e-119
Identities = 104/315 (33%), Positives = 155/315 (49%), Gaps = 31/315 (9%)
Query: 667 EQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREIL 726
+ + F+ K LG G +V L + + +A+K ++K ++ NKV ER+++
Sbjct: 25 RKKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVM 84
Query: 727 DMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVA 786
LDHPF LY +FQ + Y GEL + + E RFY AE+V A
Sbjct: 85 SRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKI--GSFDETCTRFYTAEIVSA 142
Query: 787 LEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQ 846
LEYLH +GII+RDLKPEN+LL + H+ +TDF K +L +++ R
Sbjct: 143 LEYLHGKGIIHRDLKPENILLNEDMHIQITDFGT-----AK---VLSPESKQAR------ 188
Query: 847 NPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTR 906
+NSFVGT +Y++PE++ + D WALG ++Y+++ G PFR
Sbjct: 189 -----------ANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNE 237
Query: 907 QKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGS--HEGANEIKKHPFFKGV 964
F I+ + FP A+ L+ +LL D RLG EG +K HPFF+ V
Sbjct: 238 YLIFQKIIKLEYDFPEK--FFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESV 295
Query: 965 NWALVRCMNPPELDA 979
W + PP+L A
Sbjct: 296 TWENLHQQTPPKLTA 310
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 350 bits (900), Expect = e-113
Identities = 118/322 (36%), Positives = 176/322 (54%), Gaps = 38/322 (11%)
Query: 660 QKILDSGEQINLQHFRPIKPLGSGDTGSVHLVELC---GSGQYFAMKAMDKGVMLNRNKV 716
+ + E+ + F +K LG G G V LV+ + Q +AMK + K + R++V
Sbjct: 12 HHVKEGHEKADPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRV 71
Query: 717 HRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAV 776
ER+IL ++HPF+ L+ +FQT+ + LI D+ GG+LF L ++ + E+ V
Sbjct: 72 R-TKMERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKE--VMFTEEDV 128
Query: 777 RFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTN 836
+FY AE+ +AL++LH GIIYRDLKPEN+LL GH+ LTDF L K +
Sbjct: 129 KFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGL-----SKESIDHEKK- 182
Query: 837 EKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY 896
+ SF GT EY+APE++ GHT + DWW+ G+L++EML
Sbjct: 183 ---------------------AYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLT 221
Query: 897 GYTPFRGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSH-EGANEI 955
G PF+GK R++T IL L P S A+ L+ L R+P +RLG+ +G EI
Sbjct: 222 GTLPFQGKDRKETMTMILKAKLGMPQF--LSPEAQSLLRMLFKRNPANRLGAGPDGVEEI 279
Query: 956 KKHPFFKGVNWALV--RCMNPP 975
K+H FF ++W + R ++PP
Sbjct: 280 KRHSFFSTIDWNKLYRREIHPP 301
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 348 bits (896), Expect = e-112
Identities = 123/323 (38%), Positives = 174/323 (53%), Gaps = 38/323 (11%)
Query: 660 QKILDSGEQINLQHFRPIKPLGSGDTGSVHLVELC---GSGQYFAMKAMDKGVMLNRNK- 715
+ E+I + F ++ LG G G V V +G+ FAMK + K +++ K
Sbjct: 5 TSVNRGPEKIRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKD 64
Query: 716 VHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDA 775
AER IL+ + HPF+ L +FQT + LI +Y GGELF+ L+R+ + ED
Sbjct: 65 TAHTKAERNILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLERE--GIFMEDT 122
Query: 776 VRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTT 835
FY AE+ +AL +LH +GIIYRDLKPEN++L GHV LTDF L CK
Sbjct: 123 ACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGL-----CK-------- 169
Query: 836 NEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEML 895
+ + ++F GT EY+APEI+ +GH AVDWW+LG L+Y+ML
Sbjct: 170 -------------ESIHDGTVT-HTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDML 215
Query: 896 YGYTPFRGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHE-GANE 954
G PF G+ R+KT IL L P + A+ L+ +LL R+ SRLG+ A E
Sbjct: 216 TGAPPFTGENRKKTIDKILKCKLNLPPY--LTQEARDLLKKLLKRNAASRLGAGPGDAGE 273
Query: 955 IKKHPFFKGVNWALV--RCMNPP 975
++ HPFF+ +NW + R + PP
Sbjct: 274 VQAHPFFRHINWEELLARKVEPP 296
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 348 bits (895), Expect = e-112
Identities = 120/349 (34%), Positives = 182/349 (52%), Gaps = 46/349 (13%)
Query: 668 QINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILD 727
+ +LQ F+ ++ LG+G G VHL+ +G+Y+AMK + K +++ +V ER +L
Sbjct: 2 KYSLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLS 61
Query: 728 MLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVAL 787
++ HPF+ ++ +FQ + +I DY GGELF LL + + +FYAAEV +AL
Sbjct: 62 IVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKS--QRFPNPVAKFYAAEVCLAL 119
Query: 788 EYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQN 847
EYLH + IIYRDLKPEN+LL NGH+ +TDF K
Sbjct: 120 EYLHSKDIIYRDLKPENILLDKNGHIKITDFGF-----AK-------------------- 154
Query: 848 PVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQ 907
+ + GT +YIAPE+++ + ++DWW+ GIL+YEML GYTPF
Sbjct: 155 -----YVPDVTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTM 209
Query: 908 KTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGS-HEGANEIKKHPFFKGVNW 966
KT+ IL+ +L+FP + K L+ RL+ RD RLG+ G ++K HP+FK V W
Sbjct: 210 KTYEKILNAELRFPPF--FNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVVW 267
Query: 967 ALV--RCMNPP--------ELDAPLFATDTEKEYKVVDPGMQDLQQNVF 1005
+ R + P + D F E++ G +D ++F
Sbjct: 268 EKLLSRNIETPYEPPIQQGQGDTSQFDKYPEEDINYGVQG-EDPYADLF 315
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 349 bits (897), Expect = e-112
Identities = 113/329 (34%), Positives = 162/329 (49%), Gaps = 34/329 (10%)
Query: 650 RKDSPPWKAIQKILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGV 709
P + I S F +K +G G G V L ++A+K + K
Sbjct: 16 APPPAPSQQINLGPSSNPHAKPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKA 75
Query: 710 MLNRNKVHRACAEREILDM-LDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPT 768
+L + + +ER +L + HPF+ L+ SFQT + + DY GGELF L R+
Sbjct: 76 ILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRE-- 133
Query: 769 KVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKP 828
+ E RFYAAE+ AL YLH I+YRDLKPEN+LL GH+ LTDF L CK
Sbjct: 134 RCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGL-----CKE 188
Query: 829 QLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALG 888
+ +T +++F GT EY+APE++ + VDWW LG
Sbjct: 189 NIEHNST----------------------TSTFCGTPEYLAPEVLHKQPYDRTVDWWCLG 226
Query: 889 ILLYEMLYGYTPFRGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGS 948
+LYEMLYG PF + + + NIL+K L+ + + A+ L+ LL +D RLG+
Sbjct: 227 AVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPN--ITNSARHLLEGLLQKDRTKRLGA 284
Query: 949 HEGANEIKKHPFFKGVNWALV--RCMNPP 975
+ EIK H FF +NW + + + PP
Sbjct: 285 KDDFMEIKSHVFFSLINWDDLINKKITPP 313
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 350 bits (900), Expect = e-112
Identities = 108/356 (30%), Positives = 167/356 (46%), Gaps = 49/356 (13%)
Query: 668 QINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILD 727
++ + + +K +G G G V LV + + +AMK + K M+ R+ ER+I+
Sbjct: 65 RMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMA 124
Query: 728 MLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVAL 787
+ P+V L+ +FQ ++ ++ +Y PGG+L L+ + E RFY AEVV+AL
Sbjct: 125 FANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYD---VPEKWARFYTAEVVLAL 181
Query: 788 EYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQN 847
+ +H G I+RD+KP+N+LL +GH+ L DF K +G
Sbjct: 182 DAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTC----------------MKMNKEGMVR 225
Query: 848 PVFMAEPMRASNSFVGTEEYIAPEIIAGAG----HTSAVDWWALGILLYEMLYGYTPFRG 903
++ VGT +YI+PE++ G + DWW++G+ LYEML G TPF
Sbjct: 226 ----------CDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYA 275
Query: 904 KTRQKTFANILH--KDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFF 961
+ T++ I++ L FP S AK L+ L D + RLG + G EIK+H FF
Sbjct: 276 DSLVGTYSKIMNHKNSLTFPDDNDISKEAKNLICAFL-TDREVRLGRN-GVEEIKRHLFF 333
Query: 962 KGVNWA--LVRCMNPP-------ELDAPLF---ATDTEKEYKVVDPGMQDLQQNVF 1005
K WA +R P ++D F D +E P Q F
Sbjct: 334 KNDQWAWETLRDTVAPVVPDLSSDIDTSNFDDLEEDKGEEETFPIPKAFVGNQLPF 389
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 347 bits (893), Expect = e-111
Identities = 113/311 (36%), Positives = 170/311 (54%), Gaps = 34/311 (10%)
Query: 668 QINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILD 727
++ + F +K LG G G V LV +G+Y+AMK + K V++ +++V E +L
Sbjct: 1 KVTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQ 60
Query: 728 MLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVAL 787
HPF+ AL +FQT +C + +Y GGELF L R+ +V E+ RFY AE+V AL
Sbjct: 61 NTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRE--RVFTEERARFYGAEIVSAL 118
Query: 788 EYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQN 847
EYLH + ++YRD+K EN++L +GH+ +TDF L CK +
Sbjct: 119 EYLHSRDVVYRDIKLENLMLDKDGHIKITDFGL-----CKEGI----------------- 156
Query: 848 PVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQ 907
+F GT EY+APE++ + AVDWW LG+++YEM+ G PF + +
Sbjct: 157 -----SDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE 211
Query: 908 KTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHE-GANEIKKHPFFKGVNW 966
+ F IL ++++FP + S AK L+ LL +DPK RLG A E+ +H FF +NW
Sbjct: 212 RLFELILMEEIRFPRT--LSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINW 269
Query: 967 ALV--RCMNPP 975
V + + PP
Sbjct: 270 QDVVQKKLLPP 280
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 347 bits (893), Expect = e-110
Identities = 102/318 (32%), Positives = 159/318 (50%), Gaps = 39/318 (12%)
Query: 668 QINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILD 727
++ F +K +G G V +V++ +GQ +AMK M+K ML R +V ER++L
Sbjct: 57 RLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLV 116
Query: 728 MLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVAL 787
D ++ L+ +FQ + ++ L+ +Y GG+L LL + + + + RFY AE+V+A+
Sbjct: 117 NGDRRWITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFGER-IPAEMARFYLAEIVMAI 175
Query: 788 EYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQN 847
+ +H G ++RD+KP+N+LL GH+ L DF K R G
Sbjct: 176 DSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSC----------------LKLRADGTVR 219
Query: 848 PVFMAEPMRASNSFVGTEEYIAPEIIAGAG-------HTSAVDWWALGILLYEMLYGYTP 900
S VGT +Y++PEI+ G + DWWALG+ YEM YG TP
Sbjct: 220 ----------SLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTP 269
Query: 901 FRGKTRQKTFANILHKD--LKFPSSTPT-SLHAKQLMYRLLHRDPKSRLGSHEGANEIKK 957
F + +T+ I+H L P A+ + RLL P++RLG GA + +
Sbjct: 270 FYADSTAETYGKIVHYKEHLSLPLVDEGVPEEARDFIQRLL-CPPETRLGRG-GAGDFRT 327
Query: 958 HPFFKGVNWALVRCMNPP 975
HPFF G++W +R PP
Sbjct: 328 HPFFFGLDWDGLRDSVPP 345
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 342 bits (879), Expect = e-109
Identities = 101/315 (32%), Positives = 160/315 (50%), Gaps = 35/315 (11%)
Query: 665 SGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAERE 724
+ +++ L F + LG G G V L E G+ + +A+K + K V++ + V E+
Sbjct: 13 NRDRMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKR 72
Query: 725 ILDMLD-HPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEV 783
+L + PF+ L++ FQT + + +Y GG+L + + KE FYAAE+
Sbjct: 73 VLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQV--GRFKEPHAVFYAAEI 130
Query: 784 VVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHK 843
+ L +L +GIIYRDLK +NV+L GH+ + DF + CK + T
Sbjct: 131 AIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGM-----CKENIWDGVT-------- 177
Query: 844 GQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRG 903
+ +F GT +YIAPEIIA + +VDWWA G+LLYEML G PF G
Sbjct: 178 --------------TKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEG 223
Query: 904 KTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHE-GANEIKKHPFFK 962
+ + F +I+ ++ +P S S A + L+ + P RLG G +IK+H FF+
Sbjct: 224 EDEDELFQSIMEHNVAYPKS--MSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFR 281
Query: 963 GVNWALV--RCMNPP 975
++W + + + PP
Sbjct: 282 YIDWEKLERKEIQPP 296
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 344 bits (883), Expect = e-109
Identities = 102/317 (32%), Positives = 165/317 (52%), Gaps = 37/317 (11%)
Query: 667 EQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREIL 726
+++ + F +K +G G G V +V+L + + FAMK ++K ML R + ER++L
Sbjct: 69 MRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVL 128
Query: 727 DMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVA 786
D ++ L+ +FQ ++ L+ DY GG+L LL + + L E+ RFY AE+V+A
Sbjct: 129 VNGDSKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDR-LPEEMARFYLAEMVIA 187
Query: 787 LEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQ 846
++ +H ++RD+KP+N+L+ NGH+ L DF C
Sbjct: 188 IDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGS-----CLK------------------ 224
Query: 847 NPVFMAEPMRASNSFVGTEEYIAPEIIAG-----AGHTSAVDWWALGILLYEMLYGYTPF 901
M + S+ VGT +YI+PEI+ + DWW+LG+ +YEMLYG TPF
Sbjct: 225 ---LMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPF 281
Query: 902 RGKTRQKTFANILHK--DLKFPSSTPT-SLHAKQLMYRLLHRDPKSRLGSHEGANEIKKH 958
++ +T+ I++ +FP+ S +AK L+ RL+ RLG + G + KKH
Sbjct: 282 YAESLVETYGKIMNHKERFQFPTQVTDVSENAKDLIRRLICSREH-RLGQN-GIEDFKKH 339
Query: 959 PFFKGVNWALVRCMNPP 975
PFF G++W +R P
Sbjct: 340 PFFSGIDWDNIRNCEAP 356
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 339 bits (872), Expect = e-108
Identities = 107/316 (33%), Positives = 163/316 (51%), Gaps = 36/316 (11%)
Query: 665 SGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAERE 724
S ++ + +F I+ LG G G V L + +G +A+K + K V+L + V E+
Sbjct: 16 SSNRLGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKR 75
Query: 725 IL-DMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEV 783
IL +HPF+ L+ FQT + + ++ GG+L + + + E RFYAAE+
Sbjct: 76 ILSLARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKS--RRFDEARARFYAAEI 133
Query: 784 VVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHK 843
+ AL +LH +GIIYRDLK +NVLL GH L DF + CK + T
Sbjct: 134 ISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGM-----CKEGICNGVT-------- 180
Query: 844 GQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRG 903
+ +F GT +YIAPEI+ + AVDWWA+G+LLYEML G+ PF
Sbjct: 181 --------------TATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEA 226
Query: 904 KTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHE--GANEIKKHPFF 961
+ F IL+ ++ +P+ A ++ + ++P RLGS G + I +HPFF
Sbjct: 227 ENEDDLFEAILNDEVVYPTW--LHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRHPFF 284
Query: 962 KGVNWALV--RCMNPP 975
K ++WA + R + PP
Sbjct: 285 KEIDWAQLNHRQIEPP 300
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 339 bits (871), Expect = e-108
Identities = 102/314 (32%), Positives = 168/314 (53%), Gaps = 37/314 (11%)
Query: 665 SGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAERE 724
++ ++ F K LG G G V L E + Q+FA+KA+ K V+L + V E+
Sbjct: 10 LQIKLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKR 69
Query: 725 ILDM-LDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEV 783
+L + +HPF+ ++ +FQTK ++ + +Y GG+L + FYAAE+
Sbjct: 70 VLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSC--HKFDLSRATFYAAEI 127
Query: 784 VVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHK 843
++ L++LH +GI+YRDLK +N+LL +GH+ + DF + CK +L
Sbjct: 128 ILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGM-----CKENMLGDAK-------- 174
Query: 844 GQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRG 903
+N+F GT +YIAPEI+ G + +VDWW+ G+LLYEML G +PF G
Sbjct: 175 --------------TNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHG 220
Query: 904 KTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKG 963
+ ++ F +I + +P AK L+ +L R+P+ RLG +I++HP F+
Sbjct: 221 QDEEELFHSIRMDNPFYPRW--LEKEAKDLLVKLFVREPEKRLGVRG---DIRQHPLFRE 275
Query: 964 VNWALV--RCMNPP 975
+NW + + ++PP
Sbjct: 276 INWEELERKEIDPP 289
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 338 bits (868), Expect = e-108
Identities = 111/351 (31%), Positives = 163/351 (46%), Gaps = 47/351 (13%)
Query: 665 SGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAERE 724
S L F IK LG+G G V LV+ SG ++AMK +DK ++ ++ E+
Sbjct: 34 SQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKR 93
Query: 725 ILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVV 784
IL ++ PF+ L SF+ +++ ++ +Y GGE+F L R E RFYAA++V
Sbjct: 94 ILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRI--GRFSEPHARFYAAQIV 151
Query: 785 VALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKG 844
+ EYLH +IYRDLKPEN+L+ G++ +TDF K
Sbjct: 152 LTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGF-----AK----------------- 189
Query: 845 QQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGK 904
+ + GT E +APEII G+ AVDWWALG+L+YEM GY PF
Sbjct: 190 --------RVKGRTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFAD 241
Query: 905 TRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGS-HEGANEIKKHPFFKG 963
+ + I+ ++FPS S K L+ LL D R G+ G N+IK H +F
Sbjct: 242 QPIQIYEKIVSGKVRFPSH--FSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFAT 299
Query: 964 VNWALV--RCMNPP-------ELDAPLFATDTEKEYKVVDPGMQDLQQNVF 1005
+W + R + P D F E+E + + + F
Sbjct: 300 TDWIAIYQRKVEAPFIPKFKGPGDTSNFDDYEEEE---IRVSINEKCGKEF 347
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 338 bits (868), Expect = e-106
Identities = 123/366 (33%), Positives = 184/366 (50%), Gaps = 36/366 (9%)
Query: 614 QTAENVNEAVKELPDANLTPEDLWANHSKVVHPKPHRKDSPPWKAIQKILDSGEQINLQH 673
+T E E + + A P +S + + ++ +
Sbjct: 91 ETPEEREEWTTAIQTVADGLKKQAAAEMDFRSGSP-SDNSGAEEMEVSLAKPKHRVTMNE 149
Query: 674 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPF 733
F +K LG G G V LV+ +G+Y+AMK + K V++ +++V E +L HPF
Sbjct: 150 FEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPF 209
Query: 734 VPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQ 793
+ AL SFQT +C + +Y GGELF L R+ +V ED RFY AE+V AL+YLH +
Sbjct: 210 LTALKYSFQTHDRLCFVMEYANGGELFFHLSRE--RVFSEDRARFYGAEIVSALDYLHSE 267
Query: 794 -GIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMA 852
++YRDLK EN++L +GH+ +TDF L CK + T
Sbjct: 268 KNVVYRDLKLENLMLDKDGHIKITDFGL-----CKEGIKDGAT----------------- 305
Query: 853 EPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFAN 912
+F GT EY+APE++ + AVDWW LG+++YEM+ G PF + +K F
Sbjct: 306 -----MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFEL 360
Query: 913 ILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHE-GANEIKKHPFFKGVNWALV-- 969
IL ++++FP + AK L+ LL +DPK RLG A EI +H FF G+ W V
Sbjct: 361 ILMEEIRFPRT--LGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIVWQHVYE 418
Query: 970 RCMNPP 975
+ ++PP
Sbjct: 419 KKLSPP 424
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 333 bits (857), Expect = e-106
Identities = 110/325 (33%), Positives = 174/325 (53%), Gaps = 45/325 (13%)
Query: 665 SGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAERE 724
+ + + LQ F ++ +G G V LV L + + +AMK + K ++ + + E+
Sbjct: 2 AMDPLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKH 61
Query: 725 ILDM-LDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEV 783
+ + +HPF+ L++ FQT++ + + +Y GG+L + RQ + L E+ RFY+AE+
Sbjct: 62 VFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQ--RKLPEEHARFYSAEI 119
Query: 784 VVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHK 843
+AL YLH +GIIYRDLK +NVLL GH+ LTD+ + CK L
Sbjct: 120 SLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGM-----CKEGL------------- 161
Query: 844 GQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPF-- 901
P +++F GT YIAPEI+ G + +VDWWALG+L++EM+ G +PF
Sbjct: 162 ---------RPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDI 212
Query: 902 -------RGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHE--GA 952
T F IL K ++ P S S+ A ++ L++DPK RLG H G
Sbjct: 213 VGSSDNPDQNTEDYLFQVILEKQIRIPRS--LSVKAASVLKSFLNKDPKERLGCHPQTGF 270
Query: 953 NEIKKHPFFKGVNWALV--RCMNPP 975
+I+ HPFF+ V+W ++ + + PP
Sbjct: 271 ADIQGHPFFRNVDWDMMEQKQVVPP 295
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 333 bits (857), Expect = e-106
Identities = 120/325 (36%), Positives = 177/325 (54%), Gaps = 44/325 (13%)
Query: 665 SGEQINLQHFRPIKPLGSGDTGSVHLVELC---GSGQYFAMKAMDKGVMLNRNK-VHRAC 720
E++ +++F +K LG+G G V LV +G+ +AMK + K ++ + K
Sbjct: 47 HAEKVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTR 106
Query: 721 AEREILDMLDH-PFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFY 779
ER++L+ + PF+ L+ +FQT+T + LI DY GGELF L ++ + E V+ Y
Sbjct: 107 TERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQR--ERFTEHEVQIY 164
Query: 780 AAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKK 839
E+V+ALE+LH GIIYRD+K EN+LL NGHV LTDF L K
Sbjct: 165 VGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGL-----SK------------ 207
Query: 840 RRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGA--GHTSAVDWWALGILLYEMLYG 897
F+A+ + F GT EY+AP+I+ G GH AVDWW+LG+L+YE+L G
Sbjct: 208 ---------EFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTG 258
Query: 898 YTPF----RGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSH-EGA 952
+PF ++ + IL + +P S AK L+ RLL +DPK RLG A
Sbjct: 259 ASPFTVDGEKNSQAEISRRILKSEPPYPQE--MSALAKDLIQRLLMKDPKKRLGCGPRDA 316
Query: 953 NEIKKHPFFKGVNWALV--RCMNPP 975
+EIK+H FF+ +NW + + + P
Sbjct: 317 DEIKEHLFFQKINWDDLAAKKVPAP 341
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 333 bits (856), Expect = e-105
Identities = 93/322 (28%), Positives = 160/322 (49%), Gaps = 43/322 (13%)
Query: 662 ILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACA 721
+ D E +N HF ++ +G G G V +V+ + + +AMK M+K + RN+V
Sbjct: 5 VFDENEDVNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFK 64
Query: 722 EREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAA 781
E +I+ L+HPF+ L+ SFQ + + ++ D GG+L L + KE+ V+ +
Sbjct: 65 ELQIMQGLEHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQN--VHFKEETVKLFIC 122
Query: 782 EVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRR 841
E+V+AL+YL Q II+RD+KP+N+LL +GHV +TDF++
Sbjct: 123 ELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNI-----AA-------------- 163
Query: 842 HKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIA---GAGHTSAVDWWALGILLYEMLYGY 898
M + GT+ Y+APE+ + GAG++ AVDWW+LG+ YE+L G
Sbjct: 164 ---------MLPRETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGR 214
Query: 899 TPFRGKT---RQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEI 955
P+ ++ ++ + +PS+ S L+ +LL +P R +++
Sbjct: 215 RPYHIRSSTSSKEIVHTFETTVVTYPSA--WSQEMVSLLKKLLEPNPDQRFS---QLSDV 269
Query: 956 KKHPFFKGVNWALV--RCMNPP 975
+ P+ +NW V + + P
Sbjct: 270 QNFPYMNDINWDAVFQKRLIPG 291
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 331 bits (851), Expect = e-104
Identities = 110/363 (30%), Positives = 178/363 (49%), Gaps = 45/363 (12%)
Query: 627 PDANLTPEDLWANHSKVVHPKPHRKDSPPWKAIQKILDSGEQINLQHFRPIKPLGSGDTG 686
+ N ++ ++ + + LQ F ++ +G G
Sbjct: 7 HHHHDYDIPTTENLYFQGAMGSGIEEEKEAMNTRESGKASSSLGLQDFDLLRVIGRGSYA 66
Query: 687 SVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREIL-DMLDHPFVPALYASFQTKT 745
V LV L + + +AM+ + K ++ + + E+ + +HPF+ L++ FQT++
Sbjct: 67 KVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTES 126
Query: 746 HVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENV 805
+ + +Y GG+L + RQ + L E+ RFY+AE+ +AL YLH +GIIYRDLK +NV
Sbjct: 127 RLFFVIEYVNGGDLMFHMQRQ--RKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNV 184
Query: 806 LLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTE 865
LL GH+ LTD+ + CK L P +++F GT
Sbjct: 185 LLDSEGHIKLTDYGM-----CKEGL----------------------RPGDTTSTFCGTP 217
Query: 866 EYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPF---------RGKTRQKTFANILHK 916
YIAPEI+ G + +VDWWALG+L++EM+ G +PF T F IL K
Sbjct: 218 NYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEK 277
Query: 917 DLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHE--GANEIKKHPFFKGVNWALV--RCM 972
++ P S S+ A ++ L++DPK RLG H G +I+ HPFF+ V+W ++ + +
Sbjct: 278 QIRIPRS--LSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWDMMEQKQV 335
Query: 973 NPP 975
PP
Sbjct: 336 VPP 338
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 338 bits (869), Expect = e-104
Identities = 114/460 (24%), Positives = 199/460 (43%), Gaps = 44/460 (9%)
Query: 529 PETDPATVRKIRAAIDNQTDVTVQLINYTKSGKKFWNLFHLQPMRDQKGEVQYFIGVQLD 588
P K++ D +++ + S WN +++ + + + +
Sbjct: 189 PNGLSDPYVKLKLIPDPKSESKQKTKTIKSSLNPEWNETFRFQLKESDKDRRLSVEIWDW 248
Query: 589 GSEHLEPLRNSIPEATAEESEKLVKQTAENVNEAVKELPDANLTPED---------LWAN 639
S+ +E + V + +++ E + + PE +
Sbjct: 249 DLTSRNDFMGSLSFGISELQKAGVDGWFKLLSQEEGEYFNVPVPPEGSEGNEELRQKFER 308
Query: 640 HSKVVHPKPHRKDSPPWKAIQKILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQY 699
K + + + + +++ L F + LG G G V L E G+ +
Sbjct: 309 AKIGQGTKAPEEKTANTISKFDNNGNRDRMKLTDFNFLMVLGKGSFGKVMLSERKGTDEL 368
Query: 700 FAMKAMDKGVMLNRNKVHRACAEREILDM-LDHPFVPALYASFQTKTHVCLITDYCPGGE 758
+A+K + K V++ + V E+ +L + PF+ L++ FQT + + +Y GG+
Sbjct: 369 YAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGD 428
Query: 759 LFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDF 818
L + + KE FYAAE+ + L +L +GIIYRDLK +NV+L GH+ + DF
Sbjct: 429 LMYHIQQV--GRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADF 486
Query: 819 DLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGH 878
+ CK + T + +F GT +YIAPEIIA +
Sbjct: 487 GM-----CKENIWDGVT----------------------TKTFCGTPDYIAPEIIAYQPY 519
Query: 879 TSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLL 938
+VDWWA G+LLYEML G PF G+ + F +I+ ++ +P S S A + L+
Sbjct: 520 GKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKS--MSKEAVAICKGLM 577
Query: 939 HRDPKSRLGSHE-GANEIKKHPFFKGVNWALV--RCMNPP 975
+ P RLG G +IK+H FF+ ++W + + + PP
Sbjct: 578 TKHPGKRLGCGPEGERDIKEHAFFRYIDWEKLERKEIQPP 617
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 333 bits (856), Expect = e-103
Identities = 96/422 (22%), Positives = 170/422 (40%), Gaps = 49/422 (11%)
Query: 598 NSIPEATAEESEKLVKQTAENVNEAVKELPDANLTPEDLWANHSKVVHPKPHRKDSPPWK 657
+ + V + + + + P L + + WK
Sbjct: 117 PQAQLFCSFLDAETVARARAGAGDGLFQ-PLLRAVLAHLGQAPFQEFLDSLYFLRFLQWK 175
Query: 658 AIQKILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVH 717
++ + + F + LG G G V ++ +G+ +A K ++K + R
Sbjct: 176 WLEA-----QPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQ 230
Query: 718 RACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELF--LLLDRQPTKVLKEDA 775
A E++IL + F+ +L +F+TKT +CL+ GG++ + + +E
Sbjct: 231 GAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPR 290
Query: 776 VRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTT 835
FY A++V LE+LH + IIYRDLKPENVLL +G+V ++D L+
Sbjct: 291 AIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVE------------ 338
Query: 836 NEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEML 895
A + + GT ++APE++ G + +VD++ALG+ LYEM+
Sbjct: 339 --------------LKAGQTKT-KGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMI 383
Query: 896 YGYTPFRGK----TRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHE- 950
PFR + ++ +L + + +P S +K LL +DP+ RLG +
Sbjct: 384 AARGPFRARGEKVENKELKQRVLEQAVTYPDK--FSPASKDFCEALLQKDPEKRLGFRDG 441
Query: 951 GANEIKKHPFFKGVNW-ALVRCMNPPELDAPLFA------TDTEKEYKVVDPGMQDLQQN 1003
+ ++ HP F+ ++W L M P D V +
Sbjct: 442 SCDGLRTHPLFRDISWRQLEAGMLTPPFVPDSRTVYAKNIQDVGAFSTVKGVAFEKADTE 501
Query: 1004 VF 1005
F
Sbjct: 502 FF 503
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 334 bits (858), Expect = e-103
Identities = 114/431 (26%), Positives = 187/431 (43%), Gaps = 58/431 (13%)
Query: 596 LRNSIPEATAEESEKLVKQTAENVNEAVKELPDANLTPEDLWANHSKV-VHPKPHRKDSP 654
+N + + ++ +Q N + +++ P +L E H + V P DS
Sbjct: 106 TQNFLSHTGPDLIPEVPRQLVTNCTQRLEQGPCKDLFQELTRLTHEYLSVAPFADYLDSI 165
Query: 655 ------PWKAIQKILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKG 708
WK +++ + + FR + LG G G V ++ +G+ +A K ++K
Sbjct: 166 YFNRFLQWKWLER-----QPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKK 220
Query: 709 VMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPT 768
+ R A E++IL+ ++ FV +L +++TK +CL+ GG+L +
Sbjct: 221 RIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQ 280
Query: 769 KVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKP 828
E FYAAE+ LE LH + I+YRDLKPEN+LL +GH+ ++D L
Sbjct: 281 AGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGL-----AVH 335
Query: 829 QLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALG 888
+ E VGT Y+APE++ +T + DWWALG
Sbjct: 336 ----------------------VPEGQTI-KGRVGTVGYMAPEVVKNERYTFSPDWWALG 372
Query: 889 ILLYEMLYGYTPFRGK----TRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKS 944
LLYEM+ G +PF+ + R++ + ++ S A+ L +LL +DP
Sbjct: 373 CLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYSER--FSPQARSLCSQLLCKDPAE 430
Query: 945 RLGSHE-GANEIKKHPFFKGVNW-ALVRCMNPP----------ELDAPLFATDTEKEYKV 992
RLG A E+K+HP FK +N+ L M P D + +
Sbjct: 431 RLGCRGGSAREVKEHPLFKKLNFKRLGAGMLEPPFKPDPQAIYCKDVLDIEQFSTVKGVE 490
Query: 993 VDPGMQDLQQN 1003
++P QD Q
Sbjct: 491 LEPTDQDFYQK 501
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 326 bits (837), Expect = 4e-99
Identities = 105/387 (27%), Positives = 181/387 (46%), Gaps = 47/387 (12%)
Query: 601 PEATAEESEKLVKQTAENVNEAVKELPDANLTP--EDLWANHSKVVHPKPHRKDSPPWKA 658
+ S+ ++ ++ + K++P P E++ N V K D
Sbjct: 118 LACSHPFSKSAIEHVQGHLVK--KQVPPDLFQPYIEEICQNLRGDVFQKFIESDKFTRFC 175
Query: 659 IQKILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHR 718
K ++ + + F + +G G G V+ +G+ +AMK +DK + +
Sbjct: 176 QWKNVELNIHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETL 235
Query: 719 ACAEREILDML---DHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDA 775
A ER +L ++ D PF+ + +F T + I D GG+L L + V E
Sbjct: 236 ALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQH--GVFSEAD 293
Query: 776 VRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTT 835
+RFYAAE+++ LE++H + ++YRDLKP N+LL +GHV ++D L+
Sbjct: 294 MRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLA-------------- 339
Query: 836 NEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIA-GAGHTSAVDWWALGILLYEM 894
K + ++ VGT Y+APE++ G + S+ DW++LG +L+++
Sbjct: 340 ---CDFSKKK------------PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKL 384
Query: 895 LYGYTPFRG---KTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSH-E 950
L G++PFR K + + L ++ P S S + L+ LL RD RLG
Sbjct: 385 LRGHSPFRQHKTKDKHEIDRMTLTMAVELPDS--FSPELRSLLEGLLQRDVNRRLGCLGR 442
Query: 951 GANEIKKHPFFKGVNWALV--RCMNPP 975
GA E+K+ PFF+ ++W +V + PP
Sbjct: 443 GAQEVKESPFFRSLDWQMVFLQKYPPP 469
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 277 bits (712), Expect = 3e-86
Identities = 92/306 (30%), Positives = 129/306 (42%), Gaps = 37/306 (12%)
Query: 668 QINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILD 727
Q L+ F +PLG G G+V+L S A+K + K + H+ E EI
Sbjct: 5 QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 64
Query: 728 MLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVAL 787
L HP + LY F T V LI +Y P G ++ L + E Y E+ AL
Sbjct: 65 HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKL--SKFDEQRTATYITELANAL 122
Query: 788 EYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQN 847
Y H + +I+RD+KPEN+LL G + + DF S RR
Sbjct: 123 SYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHA------------PSSRRT----- 165
Query: 848 PVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQ 907
GT +Y+ PE+I G H VD W+LG+L YE L G PF T Q
Sbjct: 166 ------------DLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQ 213
Query: 908 KTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVNWA 967
+T+ I + FP + A+ L+ RLL +P R E+ +HP+ +
Sbjct: 214 ETYKRISRVEFTFPDF--VTEGARDLISRLLKHNPSQRPMLR----EVLEHPWITANSSK 267
Query: 968 LVRCMN 973
C N
Sbjct: 268 PSNCQN 273
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 276 bits (708), Expect = 1e-85
Identities = 83/295 (28%), Positives = 127/295 (43%), Gaps = 37/295 (12%)
Query: 668 QINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILD 727
+ + F +PLG G G+V+L + A+K + K + H+ E EI
Sbjct: 10 KFTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQS 69
Query: 728 MLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVAL 787
L HP + +Y F + + L+ ++ P GEL+ L + E + E+ AL
Sbjct: 70 HLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKH--GRFDEQRSATFMEELADAL 127
Query: 788 EYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQN 847
Y H + +I+RD+KPEN+L+ G + + DF S RR
Sbjct: 128 HYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHA------------PSLRRR----- 170
Query: 848 PVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQ 907
+ GT +Y+ PE+I G H VD W G+L YE L G PF +
Sbjct: 171 ------------TMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHT 218
Query: 908 KTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFK 962
+T I++ DLKFP S +K L+ +LL P RL + +HP+ K
Sbjct: 219 ETHRRIVNVDLKFPPF--LSDGSKDLISKLLRYHPPQRL----PLKGVMEHPWVK 267
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 245 bits (628), Expect = 2e-73
Identities = 71/378 (18%), Positives = 137/378 (36%), Gaps = 90/378 (23%)
Query: 634 EDLWANHSKVVHPKPHRKDSPPWKAIQKILDSGEQINLQHFRPIKPLGSGDTGSVHLVEL 693
+D+ +N+S +++ + K+ + + +R I+ L G + L E
Sbjct: 7 KDILSNYSNLIYLNKYVKE--------------KDKYINDYRIIRTLNQGKFNKIILCE- 51
Query: 694 CGSGQYFAMKAMDKGVMLNRNKVHRACA--------------EREILDMLDHPFVPALYA 739
+++A+K +K ++ + ++ E +I+ + + +
Sbjct: 52 -KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCEG 110
Query: 740 SFQTKTHVCLITDYCPGGELF------LLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQ 793
V +I +Y + +LD+ T + ++ V+ + Y+H +
Sbjct: 111 IITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNE 170
Query: 794 -GIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMA 852
I +RD+KP N+L+ NG V L+DF S K+
Sbjct: 171 KNICHRDVKPSNILMDKNGRVKLSDFGESEYM------------VDKKIK---------- 208
Query: 853 EPMRASNSFVGTEEYIAPEIIAGAG--HTSAVDWWALGILLYEMLYGYTPFRGK-TRQKT 909
GT E++ PE + + + VD W+LGI LY M Y PF K + +
Sbjct: 209 -------GSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVEL 261
Query: 910 FANILHKDLKFPSSTPT-----------------SLHAKQLMYRLLHRDPKSRLGSHEGA 952
F NI K++++P S + L ++P R+ S
Sbjct: 262 FNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSE--- 318
Query: 953 NEIKKHPFFKGVNWALVR 970
+ KH + N +R
Sbjct: 319 -DALKHEWLADTNIEDLR 335
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 238 bits (609), Expect = 2e-71
Identities = 71/308 (23%), Positives = 124/308 (40%), Gaps = 40/308 (12%)
Query: 671 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLD 730
F I LG G G V +Y+A+K + K+ +E +L L+
Sbjct: 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRH----TEEKLSTILSEVMLLASLN 60
Query: 731 HPFVPALYASFQ-------------TKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVR 777
H +V YA++ K+ + + +YC G L+ L+ + + D
Sbjct: 61 HQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLN-QQRDEYW 119
Query: 778 FYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNE 837
+++ AL Y+H QGII+RDLKP N+ + + +V + DF L+ N
Sbjct: 120 RLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLA-------------KNV 166
Query: 838 KKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGH-TSAVDWWALGILLYEMLY 896
+ + + + S +GT Y+A E++ G GH +D ++LGI+ +EM+Y
Sbjct: 167 HRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY 226
Query: 897 GYTPFRGKTRQKTFANILHKDLKFPS--STPTSLHAKQLMYRLLHRDPKSRLGSHEGANE 954
G R + ++FP K+++ L+ DP R GA
Sbjct: 227 P--FSTGMERVNILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRP----GART 280
Query: 955 IKKHPFFK 962
+ +
Sbjct: 281 LLNSGWLP 288
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 231 bits (591), Expect = 9e-69
Identities = 72/338 (21%), Positives = 124/338 (36%), Gaps = 45/338 (13%)
Query: 630 NLTPEDLWANHSKVVHPKPHRKDSPPWKAIQKIL---DSGEQINLQHFRPIKPLGSGDTG 686
+L E+L+ + P+ + +Q E Q F+ + LG G G
Sbjct: 12 DLGTENLYFQSMHQLQPRRVSFRGEASETLQSPGYDPSRPESFFQQSFQRLSRLGHGSYG 71
Query: 687 SVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREIL-DMLDHPFVPALYASFQTKT 745
V V G+ +A+K +++ AE + HP L +++
Sbjct: 72 EVFKVRSKEDGRLYAVKRSMSPFRGPKDRAR-KLAEVGSHEKVGQHPCCVRLEQAWEEGG 130
Query: 746 HVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENV 805
+ L T+ C G L + L E V Y + ++AL +LH QG+++ D+KP N+
Sbjct: 131 ILYLQTELC-GPSLQQHCEAWG-ASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANI 188
Query: 806 LLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTE 865
L G L DF L V + G
Sbjct: 189 FLGPRGRCKLGDFGLL---------------------------VELGTAGAG-EVQEGDP 220
Query: 866 EYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYT-PFRGKTRQKTFANILHKDLKFPSST 924
Y+APE++ G + +A D ++LG+ + E+ P G+ Q+ L +F +
Sbjct: 221 RYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEGWQQLRQGYLP--PEFTAG- 276
Query: 925 PTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFK 962
S + ++ +L DPK R A + P +
Sbjct: 277 -LSSELRSVLVMMLEPDPKLRA----TAEALLALPVLR 309
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 229 bits (586), Expect = 2e-68
Identities = 80/292 (27%), Positives = 125/292 (42%), Gaps = 34/292 (11%)
Query: 671 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLD 730
++ F+ LG G V+ E +G A+K +DK M V R E +I L
Sbjct: 10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLK 69
Query: 731 HPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYL 790
HP + LY F+ +V L+ + C GE+ L + K E+ R + +++ + YL
Sbjct: 70 HPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRV-KPFSENEARHFMHQIITGMLYL 128
Query: 791 HCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVF 850
H GI++RDL N+LL N ++ + DF L+ +
Sbjct: 129 HSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKH------------------- 169
Query: 851 MAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTF 910
+ GT YI+PEI + H D W+LG + Y +L G PF T + T
Sbjct: 170 --------YTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTL 221
Query: 911 ANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFK 962
++ D + PS AK L+++LL R+P RL + + HPF
Sbjct: 222 NKVVLADYEMPSFLSIE--AKDLIHQLLRRNPADRL----SLSSVLDHPFMS 267
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 227 bits (581), Expect = 5e-67
Identities = 78/331 (23%), Positives = 130/331 (39%), Gaps = 37/331 (11%)
Query: 632 TPEDLWANHSKVVHPKPHRKDSPPWKAIQKILDSGEQINLQHFRPIKPLGSGDTGSVHLV 691
P D V +PP K I ++L + + + + LG G +
Sbjct: 3 APADPGKAGVPGVAAPGAPAAAPPAKEIPEVLVDPR--SRRRYVRGRFLGKGGFAKCFEI 60
Query: 692 ELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLIT 751
+ + FA K + K ++L ++ + E I L H V + F+ V ++
Sbjct: 61 SDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVL 120
Query: 752 DYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNG 811
+ C L L R+ K L E R+Y ++V+ +YLH +I+RDLK N+ L +
Sbjct: 121 ELCRRRSLLELHKRR--KALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDL 178
Query: 812 HVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPE 871
V + DF L+ + GT YIAPE
Sbjct: 179 EVKIGDFGLATKVEYDGERK---------------------------KVLCGTPNYIAPE 211
Query: 872 IIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANILHKDLKFPSSTPTSLHAK 931
+++ GH+ VD W++G ++Y +L G PF ++T+ I + P A
Sbjct: 212 VLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPV--AA 269
Query: 932 QLMYRLLHRDPKSRLGSHEGANEIKKHPFFK 962
L+ ++L DP +R NE+ FF
Sbjct: 270 SLIQKMLQTDPTARP----TINELLNDEFFT 296
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 224 bits (574), Expect = 1e-66
Identities = 70/293 (23%), Positives = 119/293 (40%), Gaps = 35/293 (11%)
Query: 670 NLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDML 729
+ + + + LG G + + + FA K + K ++L ++ + E I L
Sbjct: 13 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSL 72
Query: 730 DHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEY 789
H V + F+ V ++ + C L L R+ K L E R+Y ++V+ +Y
Sbjct: 73 AHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRR--KALTEPEARYYLRQIVLGCQY 130
Query: 790 LHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPV 849
LH +I+RDLK N+ L + V + DF L+ +
Sbjct: 131 LHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERK--KV-------------- 174
Query: 850 FMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKT 909
GT YIAPE+++ GH+ VD W++G ++Y +L G PF ++T
Sbjct: 175 -----------LCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKET 223
Query: 910 FANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFK 962
+ I + P A L+ ++L DP +R NE+ FF
Sbjct: 224 YLRIKKNEYSIPKHINPV--AASLIQKMLQTDPTARP----TINELLNDEFFT 270
|
| >2wkq_A NPH1-1, RAS-related C3 botulinum toxin substrate 1; transferase, cell adhesion, nucleotide-binding, protein engineering, RAS superfamily LOV2; HET: GTP FMN; 1.60A {Avena sativa} PDB: 2wkr_A* 2wkp_A* Length = 332 | Back alignment and structure |
|---|
Score = 223 bits (569), Expect = 1e-65
Identities = 120/236 (50%), Positives = 150/236 (63%), Gaps = 15/236 (6%)
Query: 468 QKEMRKGIDLATTLERIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQ 527
LATTLERIEKNFVITDPRLPDNPIIFASDSFL+LTEYSREEILGRN RFLQ
Sbjct: 4 SHHHHHHGSLATTLERIEKNFVITDPRLPDNPIIFASDSFLQLTEYSREEILGRNARFLQ 63
Query: 528 GPETDPATVRKIRAAIDNQTDVTVQLINYTKSGKKFWNLFHLQPMRDQKGEVQYFIGVQL 587
GPETD ATVRKIR AIDNQT+VTVQLINYTKSGKKFWNLFHLQPMRDQKG+VQYFIGVQL
Sbjct: 64 GPETDRATVRKIRDAIDNQTEVTVQLINYTKSGKKFWNLFHLQPMRDQKGDVQYFIGVQL 123
Query: 588 DGSEHLEPLRNSIPEATAEESEKLVKQTAENVNEAVKELPDANLTPEDLWANHSKVVHPK 647
DG+EH+ +++ + + + A+ + + + D + L +++ P
Sbjct: 124 DGTEHVRDAAEREGVMLIKKTAENIDEAAKELIK-CVVVGDGAVGKTCLLISYTTNAFPG 182
Query: 648 PHRKDSPPW-KAIQKILDSGEQINLQ--------HFRPIKPLGSGDTGSVHLVELC 694
+ + ++ G+ +NL + ++PL T + +C
Sbjct: 183 EYI--PTVFDNYSANVMVDGKPVNLGLWDTAGLEDYDRLRPLSYPQT---DVFLIC 233
|
| >2wkq_A NPH1-1, RAS-related C3 botulinum toxin substrate 1; transferase, cell adhesion, nucleotide-binding, protein engineering, RAS superfamily LOV2; HET: GTP FMN; 1.60A {Avena sativa} PDB: 2wkr_A* 2wkp_A* Length = 332 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 3e-40
Identities = 48/130 (36%), Positives = 76/130 (58%)
Query: 188 PRVSDIVKDALSTFQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGAG 247
+ L ++ FV++D PD PI++AS F ++T Y+ +E++GRN RFLQG
Sbjct: 7 HHHHGSLATTLERIEKNFVITDPRLPDNPIIFASDSFLQLTEYSREEILGRNARFLQGPE 66
Query: 248 TDPEDVAKIRETLQNGQSYCGRLLNYKKDGTPFWNLLTIAPIKDDEGKVLKFIGMQVEVS 307
TD V KIR+ + N +L+NY K G FWNL + P++D +G V FIG+Q++ +
Sbjct: 67 TDRATVRKIRDAIDNQTEVTVQLINYTKSGKKFWNLFHLQPMRDQKGDVQYFIGVQLDGT 126
Query: 308 KHTEGAKDKM 317
+H A ++
Sbjct: 127 EHVRDAAERE 136
|
| >2v0u_A NPH1-1, LOV2; kinase, transferase, ATP-binding, serine/threonine-protein kinase, light-induced signal trans phototropin1, nucleotide-binding; HET: FMN; 1.40A {Avena sativa} PDB: 2v0w_A* 2v1b_A* 2v1a_A* 1jnu_A* 1g28_A* Length = 146 | Back alignment and structure |
|---|
Score = 213 bits (545), Expect = 1e-64
Identities = 123/150 (82%), Positives = 133/150 (88%), Gaps = 7/150 (4%)
Query: 477 LATTLERIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATV 536
LATTLERIEKNFVITDPRLPDNPIIFASDSFL+LTEYSREEILGRNCRFLQGPETD ATV
Sbjct: 4 LATTLERIEKNFVITDPRLPDNPIIFASDSFLQLTEYSREEILGRNCRFLQGPETDRATV 63
Query: 537 RKIRAAIDNQTDVTVQLINYTKSGKKFWNLFHLQPMRDQKGEVQYFIGVQLDGSEHLEPL 596
RKIR AIDNQT+VTVQLINYTKSGKKFWNLFHLQPMRDQKG+VQYFIGVQLDG+EH+
Sbjct: 64 RKIRDAIDNQTEVTVQLINYTKSGKKFWNLFHLQPMRDQKGDVQYFIGVQLDGTEHVR-- 121
Query: 597 RNSIPEATAEESEKLVKQTAENVNEAVKEL 626
+A E L+K+TAEN++EA KEL
Sbjct: 122 -----DAAEREGVMLIKKTAENIDEAAKEL 146
|
| >2v0u_A NPH1-1, LOV2; kinase, transferase, ATP-binding, serine/threonine-protein kinase, light-induced signal trans phototropin1, nucleotide-binding; HET: FMN; 1.40A {Avena sativa} PDB: 2v0w_A* 2v1b_A* 2v1a_A* 1jnu_A* 1g28_A* Length = 146 | Back alignment and structure |
|---|
Score = 183 bits (468), Expect = 4e-54
Identities = 53/154 (34%), Positives = 85/154 (55%), Gaps = 9/154 (5%)
Query: 192 DIVKDALSTFQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPE 251
+ + L ++ FV++D PD PI++AS F ++T Y+ +E++GRNCRFLQG TD
Sbjct: 2 EFLATTLERIEKNFVITDPRLPDNPIIFASDSFLQLTEYSREEILGRNCRFLQGPETDRA 61
Query: 252 DVAKIRETLQNGQSYCGRLLNYKKDGTPFWNLLTIAPIKDDEGKVLKFIGMQVEVSKHTE 311
V KIR+ + N +L+NY K G FWNL + P++D +G V FIG+Q++ ++H
Sbjct: 62 TVRKIRDAIDNQTEVTVQLINYTKSGKKFWNLFHLQPMRDQKGDVQYFIGVQLDGTEHVR 121
Query: 312 GAKDKMLRPNGLPESLIRYDARQKEMATSSVTEL 345
A ++ E ++ E + EL
Sbjct: 122 DAAER--------EGVMLIKKTA-ENIDEAAKEL 146
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 215 bits (550), Expect = 1e-62
Identities = 68/319 (21%), Positives = 138/319 (43%), Gaps = 38/319 (11%)
Query: 644 VHPKPHRKDSPPWKAIQKILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMK 703
+H H + ++ +++ + ++ +G G G LV+ G+ + +K
Sbjct: 1 MHHHHHHS-----SGVDLGTENLYFQSMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIK 55
Query: 704 AMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLL 763
++ M ++ + + E +L + HP + SF+ + ++ DYC GG+LF +
Sbjct: 56 EINISRMSSKER-EESRREVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRI 114
Query: 764 DRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCL 823
+ Q + +ED + + ++ +AL+++H + I++RD+K +N+ L +G V L DF ++ +
Sbjct: 115 NAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARV 174
Query: 824 TSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVD 883
+ +L + +GT Y++PEI + + D
Sbjct: 175 LNSTVELA---------------------------RACIGTPYYLSPEICENKPYNNKSD 207
Query: 884 WWALGILLYEMLYGYTPFRGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPK 943
WALG +LYE+ F + + I+ P S S + L+ +L R+P+
Sbjct: 208 IWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFP-PVSLHYSYDLRSLVSQLFKRNPR 266
Query: 944 SRLGSHEGANEIKKHPFFK 962
R N I + F
Sbjct: 267 DRP----SVNSILEKGFIA 281
|
| >2z6d_A Phototropin-2; PAS-fold, LOV-fold, alternative splicing, ATP-binding, chromophore, flavoprotein, FMN, kinase, membrane, nucleotide-binding; HET: FMN; 2.00A {Arabidopsis thaliana} PDB: 2z6c_A* Length = 130 | Back alignment and structure |
|---|
Score = 206 bits (526), Expect = 3e-62
Identities = 97/130 (74%), Positives = 112/130 (86%)
Query: 187 LPRVSDIVKDALSTFQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGA 246
PRVS +K ALST QQTFVVSDAT+P PI+YAS+GFF MTGY+SKE+VGRNCRFLQG
Sbjct: 1 FPRVSQELKTALSTLQQTFVVSDATQPHCPIVYASSGFFTMTGYSSKEIVGRNCRFLQGP 60
Query: 247 GTDPEDVAKIRETLQNGQSYCGRLLNYKKDGTPFWNLLTIAPIKDDEGKVLKFIGMQVEV 306
TD +VAKIR+ ++NG+SYCGRLLNYKKDGTPFWNLLT+ PIKDD+G +KFIGMQVEV
Sbjct: 61 DTDKNEVAKIRDCVKNGKSYCGRLLNYKKDGTPFWNLLTVTPIKDDQGNTIKFIGMQVEV 120
Query: 307 SKHTEGAKDK 316
SK+TEG DK
Sbjct: 121 SKYTEGVNDK 130
|
| >2z6d_A Phototropin-2; PAS-fold, LOV-fold, alternative splicing, ATP-binding, chromophore, flavoprotein, FMN, kinase, membrane, nucleotide-binding; HET: FMN; 2.00A {Arabidopsis thaliana} PDB: 2z6c_A* Length = 130 | Back alignment and structure |
|---|
Score = 190 bits (485), Expect = 1e-56
Identities = 53/127 (41%), Positives = 79/127 (62%)
Query: 472 RKGIDLATTLERIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPET 531
R +L T L +++ FV++D P PI++AS F +T YS +EI+GRNCRFLQGP+T
Sbjct: 3 RVSQELKTALSTLQQTFVVSDATQPHCPIVYASSGFFTMTGYSSKEIVGRNCRFLQGPDT 62
Query: 532 DPATVRKIRAAIDNQTDVTVQLINYTKSGKKFWNLFHLQPMRDQKGEVQYFIGVQLDGSE 591
D V KIR + N +L+NY K G FWNL + P++D +G FIG+Q++ S+
Sbjct: 63 DKNEVAKIRDCVKNGKSYCGRLLNYKKDGTPFWNLLTVTPIKDDQGNTIKFIGMQVEVSK 122
Query: 592 HLEPLRN 598
+ E + +
Sbjct: 123 YTEGVND 129
|
| >4eet_B Phototropin-2; LOV, blue light photoreceptor, signaling protein, flavoprote; HET: FMN; 1.20A {Arabidopsis thaliana} PDB: 4ees_A* 4eer_A* 4eep_A* 4eeu_A* 1jnu_A* 1g28_A* Length = 115 | Back alignment and structure |
|---|
Score = 197 bits (504), Expect = 2e-59
Identities = 96/113 (84%), Positives = 103/113 (91%)
Query: 481 LERIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIR 540
E IEKNFVITDPRLPDNPIIFASD FLELTEYSREEILGRN RFLQGPETD ATV+KIR
Sbjct: 3 PEFIEKNFVITDPRLPDNPIIFASDGFLELTEYSREEILGRNARFLQGPETDQATVQKIR 62
Query: 541 AAIDNQTDVTVQLINYTKSGKKFWNLFHLQPMRDQKGEVQYFIGVQLDGSEHL 593
AI +Q + TVQLINYTKSGKKFWNL HLQP+RDQKGE+QYFIGVQLDGS+H+
Sbjct: 63 DAIRDQRETTVQLINYTKSGKKFWNLLHLQPVRDQKGELQYFIGVQLDGSDHV 115
|
| >4eet_B Phototropin-2; LOV, blue light photoreceptor, signaling protein, flavoprote; HET: FMN; 1.20A {Arabidopsis thaliana} PDB: 4ees_A* 4eer_A* 4eep_A* 4eeu_A* 1jnu_A* 1g28_A* Length = 115 | Back alignment and structure |
|---|
Score = 184 bits (469), Expect = 9e-55
Identities = 47/113 (41%), Positives = 76/113 (67%)
Query: 197 ALSTFQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKI 256
+ ++ FV++D PD PI++AS GF ++T Y+ +E++GRN RFLQG TD V KI
Sbjct: 2 SPEFIEKNFVITDPRLPDNPIIFASDGFLELTEYSREEILGRNARFLQGPETDQATVQKI 61
Query: 257 RETLQNGQSYCGRLLNYKKDGTPFWNLLTIAPIKDDEGKVLKFIGMQVEVSKH 309
R+ +++ + +L+NY K G FWNLL + P++D +G++ FIG+Q++ S H
Sbjct: 62 RDAIRDQRETTVQLINYTKSGKKFWNLLHLQPVRDQKGELQYFIGVQLDGSDH 114
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 205 bits (524), Expect = 4e-59
Identities = 72/304 (23%), Positives = 120/304 (39%), Gaps = 47/304 (15%)
Query: 672 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAERE--ILDML 729
+ + +G G V +GQ FA+K +D + + +RE I ML
Sbjct: 24 DVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHML 83
Query: 730 DHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDR-----QPTKVLKEDAVRFYAAEVV 784
HP + L ++ + + ++ ++ G +L V E Y +++
Sbjct: 84 KHPHIVELLETYSSDGMLYMVFEFMDGADLC---FEIVKRADAGFVYSEAVASHYMRQIL 140
Query: 785 VALEYLHCQGIIYRDLKPENVLLQG---NGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRR 841
AL Y H II+RD+KP VLL + V L F ++
Sbjct: 141 EALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVA-------------------- 180
Query: 842 HKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPF 901
+ + E + VGT ++APE++ + VD W G++L+ +L G PF
Sbjct: 181 -------IQLGESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPF 233
Query: 902 RGKTRQKTFANILHKDLKFPSS--TPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHP 959
G T+++ F I+ K + S AK L+ R+L DP R+ E HP
Sbjct: 234 YG-TKERLFEGIIKGKYKMNPRQWSHISESAKDLVRRMLMLDPAERI----TVYEALNHP 288
Query: 960 FFKG 963
+ K
Sbjct: 289 WLKE 292
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 202 bits (517), Expect = 7e-59
Identities = 79/310 (25%), Positives = 138/310 (44%), Gaps = 44/310 (14%)
Query: 660 QKILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKG-VMLNRNKVHR 718
++ L I+ F + LGSG G VHLVE SG +K ++K + ++
Sbjct: 11 RENLYFQGTID-DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEA 69
Query: 719 ACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELF--LLLDRQPTKVLKEDAV 776
E E+L LDHP + ++ F+ ++ ++ + C GGEL ++ + K L E V
Sbjct: 70 ---EIEVLKSLDHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYV 126
Query: 777 RFYAAEVVVALEYLHCQGIIYRDLKPENVLLQG---NGHVSLTDFDLSCLTSCKPQLLLP 833
+++ AL Y H Q ++++DLKPEN+L Q + + + DF L+
Sbjct: 127 AELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLA------------ 174
Query: 834 TTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYE 893
+ S + GT Y+APE+ T D W+ G+++Y
Sbjct: 175 ---------------ELF-KSDEHSTNAAGTALYMAPEVFKR-DVTFKCDIWSAGVVMYF 217
Query: 894 MLYGYTPFRGKTRQKTFANILHKDLKFPSS-TPTSLHAKQLMYRLLHRDPKSRLGSHEGA 952
+L G PF G + ++ +K+ + P + A L+ ++L +DP+ R A
Sbjct: 218 LLTGCLPFTGTSLEEVQQKATYKEPNYAVECRPLTPQAVDLLKQMLTKDPERRP----SA 273
Query: 953 NEIKKHPFFK 962
++ H +FK
Sbjct: 274 AQVLHHEWFK 283
|
| >3ue6_A Aureochrome1; PAS/LOV domain, FMN-binding blue-light photoreceptor, signal protein; HET: FMN; 2.75A {Vaucheria frigida} PDB: 3ulf_A* Length = 166 | Back alignment and structure |
|---|
Score = 198 bits (505), Expect = 7e-59
Identities = 67/155 (43%), Positives = 91/155 (58%), Gaps = 3/155 (1%)
Query: 443 EIIMEGDDDYESDDERPDSVDDKVRQKEMRKGIDLATTLERIEKNFVITDPRLPDNPIIF 502
+I + + ++ S +++ + L L+ ++NFVITD LPDNPI++
Sbjct: 6 SLIAQCSPEADTLLTDNPSKANRILEDPDYS---LVKALQMAQQNFVITDASLPDNPIVY 62
Query: 503 ASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIRAAIDNQTDVTVQLINYTKSGKK 562
AS FL LT YS ++ILGRNCRFLQGPETDP V KIR AI D +V L+NY + G
Sbjct: 63 ASRGFLTLTGYSLDQILGRNCRFLQGPETDPRAVDKIRNAITKGVDTSVCLLNYRQDGTT 122
Query: 563 FWNLFHLQPMRDQKGEVQYFIGVQLDGSEHLEPLR 597
FWNLF + +RD KG + ++GVQ SE L
Sbjct: 123 FWNLFFVAGLRDSKGNIVNYVGVQSKVSEDYAKLL 157
|
| >3ue6_A Aureochrome1; PAS/LOV domain, FMN-binding blue-light photoreceptor, signal protein; HET: FMN; 2.75A {Vaucheria frigida} PDB: 3ulf_A* Length = 166 | Back alignment and structure |
|---|
Score = 184 bits (470), Expect = 4e-54
Identities = 56/143 (39%), Positives = 84/143 (58%)
Query: 169 NSVRSSGEMSDEGGKEKGLPRVSDIVKDALSTFQQTFVVSDATKPDYPIMYASAGFFKMT 228
+ + + + L + AL QQ FV++DA+ PD PI+YAS GF +T
Sbjct: 12 SPEADTLLTDNPSKANRILEDPDYSLVKALQMAQQNFVITDASLPDNPIVYASRGFLTLT 71
Query: 229 GYTSKEVVGRNCRFLQGAGTDPEDVAKIRETLQNGQSYCGRLLNYKKDGTPFWNLLTIAP 288
GY+ +++GRNCRFLQG TDP V KIR + G LLNY++DGT FWNL +A
Sbjct: 72 GYSLDQILGRNCRFLQGPETDPRAVDKIRNAITKGVDTSVCLLNYRQDGTTFWNLFFVAG 131
Query: 289 IKDDEGKVLKFIGMQVEVSKHTE 311
++D +G ++ ++G+Q +VS+
Sbjct: 132 LRDSKGNIVNYVGVQSKVSEDYA 154
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 204 bits (520), Expect = 1e-58
Identities = 78/365 (21%), Positives = 129/365 (35%), Gaps = 76/365 (20%)
Query: 644 VHPKPHRKDSPPWKAIQKILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMK 703
+H H + + S ++ + + +G G G V + + A+K
Sbjct: 1 MHHHHHHSSGR--ENLYFQGGSLLELQ-KKYHLKGAIGQGSYGVVRVAIENQTRAIRAIK 57
Query: 704 AMDKGVMLNRNKVHRACAERE--ILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELF- 760
M+K + N + E ++ L HP + LY ++ + ++CL+ + C GG L
Sbjct: 58 IMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLD 117
Query: 761 -------------------------------------LLLDRQPTKVLKEDAVRFYAAEV 783
V +E + ++
Sbjct: 118 KLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQI 177
Query: 784 VVALEYLHCQGIIYRDLKPENVLLQ--GNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRR 841
AL YLH QGI +RD+KPEN L + + L DF LS K+
Sbjct: 178 FSALHYLHNQGICHRDIKPENFLFSTNKSFEIKLVDFGLS----------------KEFY 221
Query: 842 HKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGH--TSAVDWWALGILLYEMLYGYT 899
M GT ++APE++ D W+ G+LL+ +L G
Sbjct: 222 KLNNGEYYGMTT-------KAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGAV 274
Query: 900 PFRGKTRQKTFANILHKDLKFPSS--TPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKK 957
PF G T + +L+K L F + S A+ L+ LL+R+ R A +
Sbjct: 275 PFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERF----DAMRALQ 330
Query: 958 HPFFK 962
HP+
Sbjct: 331 HPWIS 335
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 200 bits (512), Expect = 4e-58
Identities = 88/337 (26%), Positives = 133/337 (39%), Gaps = 58/337 (17%)
Query: 650 RKDSPPWKAIQKILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGV 709
R + P S +++ P + LG G + V + + +A+K +D
Sbjct: 2 RDAALPGS------HSTHGFY-ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTG 54
Query: 710 MLNRNKVH----RACAERE--ILDMLD-HPFVPALYASFQTKTHVCLITDYCPGGELFLL 762
+ + R +E IL + HP + L +++T T L+ D GELF
Sbjct: 55 GGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELF-- 112
Query: 763 LDRQPTKV-LKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLS 821
D KV L E R ++ + LH I++RDLKPEN+LL + ++ LTDF S
Sbjct: 113 -DYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFS 171
Query: 822 CLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGA----- 876
C P L GT Y+APEII +
Sbjct: 172 CQ--LDPGEKLREV--------------------------CGTPSYLAPEIIECSMNDNH 203
Query: 877 -GHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANILHKDLKFPSS--TPTSLHAKQL 933
G+ VD W+ G+++Y +L G PF + + I+ + +F S S K L
Sbjct: 204 PGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDDYSDTVKDL 263
Query: 934 MYRLLHRDPKSRLGSHEGANEIKKHPFFKGVNWALVR 970
+ R L P+ R A E HPFF+ VR
Sbjct: 264 VSRFLVVQPQKRY----TAEEALAHPFFQQYVVEEVR 296
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 200 bits (510), Expect = 5e-58
Identities = 78/298 (26%), Positives = 129/298 (43%), Gaps = 45/298 (15%)
Query: 672 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDH 731
Q++ +G G G V + G+ A K + K + + ++ + E EI+ LDH
Sbjct: 9 QYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQ---EIEIMKSLDH 65
Query: 732 PFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKV-LKEDAVRFYAAEVVVALEYL 790
P + LY +F+ T + L+ + C GGELF +R K +E +V+ A+ Y
Sbjct: 66 PNIIRLYETFEDNTDIYLVMELCTGGELF---ERVVHKRVFRESDAARIMKDVLSAVAYC 122
Query: 791 HCQGIIYRDLKPENVLLQGNGHVS---LTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQN 847
H + +RDLKPEN L + S L DF L+
Sbjct: 123 HKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLA-------------------------- 156
Query: 848 PVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQ 907
+P + + VGT Y++P+++ G + D W+ G+++Y +L GY PF T
Sbjct: 157 -ARF-KPGKMMRTKVGTPYYVSPQVLEG-LYGPECDEWSAGVMMYVLLCGYPPFSAPTDS 213
Query: 908 KTFANILHKDLKFPSS--TPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKG 963
+ I FP S A+ L+ RLL + PK R+ + + +H +F+
Sbjct: 214 EVMLKIREGTFTFPEKDWLNVSPQAESLIRRLLTKSPKQRI----TSLQALEHEWFEK 267
|
| >1n9l_A PHOT-LOV1, putative blue light receptor; phototropin, flavin, electron transport; HET: FMN; 1.90A {Chlamydomonas reinhardtii} SCOP: d.110.3.6 PDB: 1n9n_A* 1n9o_A* Length = 109 | Back alignment and structure |
|---|
Score = 193 bits (493), Expect = 5e-58
Identities = 65/107 (60%), Positives = 86/107 (80%)
Query: 201 FQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKIRETL 260
+ TFVV+DAT PD P++YAS GF+ MTGY EV+G NCRFLQG GTDP++V KIR+ +
Sbjct: 2 LRHTFVVADATLPDCPLVYASEGFYAMTGYGPDEVLGHNCRFLQGEGTDPKEVQKIRDAI 61
Query: 261 QNGQSYCGRLLNYKKDGTPFWNLLTIAPIKDDEGKVLKFIGMQVEVS 307
+ G++ RLLNY+KDGTPFWNLLT+ PIK +G+V KF+G+QV+V+
Sbjct: 62 KKGEACSVRLLNYRKDGTPFWNLLTVTPIKTPDGRVSKFVGVQVDVT 108
|
| >1n9l_A PHOT-LOV1, putative blue light receptor; phototropin, flavin, electron transport; HET: FMN; 1.90A {Chlamydomonas reinhardtii} SCOP: d.110.3.6 PDB: 1n9n_A* 1n9o_A* Length = 109 | Back alignment and structure |
|---|
Score = 186 bits (476), Expect = 1e-55
Identities = 49/102 (48%), Positives = 66/102 (64%)
Query: 487 NFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIRAAIDNQ 546
FV+ D LPD P+++AS+ F +T Y +E+LG NCRFLQG TDP V+KIR AI
Sbjct: 5 TFVVADATLPDCPLVYASEGFYAMTGYGPDEVLGHNCRFLQGEGTDPKEVQKIRDAIKKG 64
Query: 547 TDVTVQLINYTKSGKKFWNLFHLQPMRDQKGEVQYFIGVQLD 588
+V+L+NY K G FWNL + P++ G V F+GVQ+D
Sbjct: 65 EACSVRLLNYRKDGTPFWNLLTVTPIKTPDGRVSKFVGVQVD 106
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 200 bits (510), Expect = 6e-58
Identities = 87/296 (29%), Positives = 133/296 (44%), Gaps = 45/296 (15%)
Query: 678 KPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLN-RNKVHRACAERE--ILDMLDHPFV 734
+ LGSG V G+G+ +A K + K + + R V R ERE IL + HP +
Sbjct: 11 EELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNI 70
Query: 735 PALYASFQTKTHVCLITDYCPGGELFLLLDRQPTK-VLKEDAVRFYAAEVVVALEYLHCQ 793
L+ F+ KT V LI + GGELF D K L ED + +++ + YLH +
Sbjct: 71 ITLHDIFENKTDVVLILELVSGGELF---DFLAEKESLTEDEATQFLKQILDGVHYLHSK 127
Query: 794 GIIYRDLKPENVLLQ----GNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPV 849
I + DLKPEN++L N + L DF ++ +
Sbjct: 128 RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIA--HKIEAG-------------------- 165
Query: 850 FMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKT 909
+ + GT E++APEI+ D W++G++ Y +L G +PF G+T+Q+T
Sbjct: 166 ---NEFK---NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQET 219
Query: 910 FANILHKDLKFPSST--PTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKG 963
NI + F TS AK + RLL +DPK R+ + +H + K
Sbjct: 220 LTNISAVNYDFDEEYFSNTSELAKDFIRRLLVKDPKRRM----TIAQSLEHSWIKA 271
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 204 bits (522), Expect = 2e-57
Identities = 76/300 (25%), Positives = 121/300 (40%), Gaps = 42/300 (14%)
Query: 672 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDH 731
++ + LG G G V L + +GQ A+K + K + + E ++L LDH
Sbjct: 26 DRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDH 85
Query: 732 PFVPALYASFQTKTHVCLITDYCPGGELFLLLDR-QPTKVLKEDAVRFYAAEVVVALEYL 790
P + LY F+ K + L+ + GGELF D K E +V+ + Y+
Sbjct: 86 PNIMKLYEFFEDKGYFYLVGEVYTGGELF---DEIISRKRFSEVDAARIIRQVLSGITYM 142
Query: 791 HCQGIIYRDLKPENVLLQ---GNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQN 847
H I++RDLKPEN+LL+ + ++ + DF LS
Sbjct: 143 HKNKIVHRDLKPENLLLESKSKDANIRIIDFGLST------------------------- 177
Query: 848 PVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQ 907
E + +GT YIAPE++ G + D W+ G++LY +L G PF G
Sbjct: 178 ---HFEASKKMKDKIGTAYYIAPEVLHGT-YDEKCDVWSTGVILYILLSGCPPFNGANEY 233
Query: 908 KTFANILHKDLKFPSST--PTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVN 965
+ F S AK L+ ++L P R+ A + H + +
Sbjct: 234 DILKKVEKGKYTFELPQWKKVSESAKDLIRKMLTYVPSMRI----SARDALDHEWIQTYT 289
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 199 bits (508), Expect = 2e-57
Identities = 70/304 (23%), Positives = 119/304 (39%), Gaps = 35/304 (11%)
Query: 668 QINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILD 727
I+ +H+ I+ LG G V LVE G ++A+K + +R + R E ++
Sbjct: 25 IIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQR---EADMHR 81
Query: 728 MLDHPFVPALYASFQTKT----HVCLITDYCPGGELFLLLDRQPTKV--LKEDAVRFYAA 781
+ +HP + L A + L+ + G L+ ++R K L ED + +
Sbjct: 82 LFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLL 141
Query: 782 EVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRR 841
+ LE +H +G +RDLKP N+LL G L D S + + +
Sbjct: 142 GICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLG-----SMNQACIHVEGSRQ--- 193
Query: 842 HKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGH---TSAVDWWALGILLYEMLYGY 898
A ++ + T Y APE+ + H D W+LG +LY M++G
Sbjct: 194 ----------ALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGE 243
Query: 899 TPFRGKTRQ-KTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKK 957
P+ ++ + A + L P S S QL+ ++ DP R +
Sbjct: 244 GPYDMVFQKGDSVALAVQNQLSIPQSPRHSSALWQLLNSMMTVDPHQRP----HIPLLLS 299
Query: 958 HPFF 961
Sbjct: 300 QLEA 303
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 199 bits (509), Expect = 3e-57
Identities = 81/332 (24%), Positives = 136/332 (40%), Gaps = 43/332 (12%)
Query: 644 VHPKPHRKDSPPWKAIQKILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMK 703
+H H S E N + K LG G V +GQ +A K
Sbjct: 1 MHHHHHHSSGVDLGTENLYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAK 60
Query: 704 AMDKGVMLNRNKVHRACAERE--ILDMLDH-PFVPALYASFQTKTHVCLITDYCPGGELF 760
+ K R + RA E +L++ P V L+ ++ + + LI +Y GGE+F
Sbjct: 61 FLKKR---RRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGGEIF 117
Query: 761 LLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQ---GNGHVSLTD 817
L + +++ E+ V +++ + YLH I++ DLKP+N+LL G + + D
Sbjct: 118 SLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVD 177
Query: 818 FDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAG 877
F +S +R +GT EY+APEI+
Sbjct: 178 FGMS--RKIGHA-----------------------CELR---EIMGTPEYLAPEILNYDP 209
Query: 878 HTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANILHKDLKFPSST--PTSLHAKQLMY 935
T+A D W +GI+ Y +L +PF G+ Q+T+ NI ++ + T S A +
Sbjct: 210 ITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSEETFSSVSQLATDFIQ 269
Query: 936 RLLHRDPKSRLGSHEGANEIKKHPFFKGVNWA 967
LL ++P+ R A H + + ++
Sbjct: 270 SLLVKNPEKRP----TAEICLSHSWLQQWDFE 297
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 199 bits (507), Expect = 4e-57
Identities = 81/302 (26%), Positives = 126/302 (41%), Gaps = 45/302 (14%)
Query: 672 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVH-RACAERE--ILDM 728
+ + LGSG V +G +A K + K + R ERE IL
Sbjct: 12 DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQ 71
Query: 729 LDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTK-VLKEDAVRFYAAEVVVAL 787
+ H V L+ ++ +T V LI + GGELF D K L E+ + +++ +
Sbjct: 72 VLHHNVITLHDVYENRTDVVLILELVSGGELF---DFLAQKESLSEEEATSFIKQILDGV 128
Query: 788 EYLHCQGIIYRDLKPENVLLQ----GNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHK 843
YLH + I + DLKPEN++L H+ L DF L+ +
Sbjct: 129 NYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA--HEIEDG-------------- 172
Query: 844 GQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRG 903
+ + GT E++APEI+ D W++G++ Y +L G +PF G
Sbjct: 173 ---------VEFK---NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLG 220
Query: 904 KTRQKTFANILHKDLKFPSST--PTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFF 961
T+Q+T ANI F TS AK + +LL ++ + RL E +HP+
Sbjct: 221 DTKQETLANITSVSYDFDEEFFSHTSELAKDFIRKLLVKETRKRL----TIQEALRHPWI 276
Query: 962 KG 963
Sbjct: 277 TP 278
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 198 bits (506), Expect = 4e-57
Identities = 70/333 (21%), Positives = 124/333 (37%), Gaps = 50/333 (15%)
Query: 644 VHPKPHRKDSPPWKAIQKILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMK 703
+H H S + + + +K +GSG + V V L Q +A+K
Sbjct: 1 MHHHHHHSSGVDLGTENLYFQS-MSVKGRIYSILKQIGSGGSSKVFQV-LNEKKQIYAIK 58
Query: 704 AMDKGVMLNRNKVHRACAEREILDMLDHP--FVPALYASFQTKTHVCLITDYCPGGELFL 761
++ + + E L+ L + LY T ++ ++ + +L
Sbjct: 59 YVNLE-EADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECG-NIDLNS 116
Query: 762 LLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLS 821
L ++ K + + Y ++ A+ +H GI++ DLKP N L+ +G + L DF ++
Sbjct: 117 WLKKK--KSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIA 173
Query: 822 CLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAG---- 877
+ P T + +S VGT Y+ PE I
Sbjct: 174 -------NQMQPDTTSVVK------------------DSQVGTVNYMPPEAIKDMSSSRE 208
Query: 878 -------HTSAVDWWALGILLYEMLYGYTPFRGKTRQ-KTFANILHKDLKFPSSTPTSLH 929
+ D W+LG +LY M YG TPF+ Q I+ + +
Sbjct: 209 NGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPEKD 268
Query: 930 AKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFK 962
+ ++ L RDPK R+ E+ HP+ +
Sbjct: 269 LQDVLKCCLKRDPKQRI----SIPELLAHPYVQ 297
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 198 bits (505), Expect = 6e-57
Identities = 87/298 (29%), Positives = 133/298 (44%), Gaps = 45/298 (15%)
Query: 672 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDH 731
+ F ++ LGSG V LV+ +G+ FA+K + K + + E +L + H
Sbjct: 9 KTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLEN---EIAVLKKIKH 65
Query: 732 PFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKV-LKEDAVRFYAAEVVVALEYL 790
+ L +++ TH L+ GGELF DR + E +V+ A++YL
Sbjct: 66 ENIVTLEDIYESTTHYYLVMQLVSGGELF---DRILERGVYTEKDASLVIQQVLSAVKYL 122
Query: 791 HCQGIIYRDLKPENVLLQG---NGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQN 847
H GI++RDLKPEN+L N + +TDF LS K +QN
Sbjct: 123 HENGIVHRDLKPENLLYLTPEENSKIMITDFGLS---------------------KMEQN 161
Query: 848 PVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQ 907
+ + GT Y+APE++A ++ AVD W++G++ Y +L GY PF +T
Sbjct: 162 GIMS--------TACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETES 213
Query: 908 KTFANILHKDLKFPSS--TPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKG 963
K F I +F S S AK + LL +DP R + HP+ G
Sbjct: 214 KLFEKIKEGYYEFESPFWDDISESAKDFICHLLEKDPNERY----TCEKALSHPWIDG 267
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 198 bits (506), Expect = 7e-57
Identities = 85/296 (28%), Positives = 129/296 (43%), Gaps = 45/296 (15%)
Query: 678 KPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLN-RNKVHRACAERE--ILDMLDHPFV 734
+ LGSG V +G +A K + K + R V R ERE IL + HP V
Sbjct: 17 EELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNV 76
Query: 735 PALYASFQTKTHVCLITDYCPGGELFLLLDRQPTK-VLKEDAVRFYAAEVVVALEYLHCQ 793
L+ ++ KT V LI + GGELF D K L E+ + +++ + YLH
Sbjct: 77 ITLHEVYENKTDVILILELVAGGELF---DFLAEKESLTEEEATEFLKQILNGVYYLHSL 133
Query: 794 GIIYRDLKPENVLLQ----GNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPV 849
I + DLKPEN++L + + DF L+
Sbjct: 134 QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA--HKIDFG-------------------- 171
Query: 850 FMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKT 909
+ + GT E++APEI+ D W++G++ Y +L G +PF G T+Q+T
Sbjct: 172 ---NEFK---NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQET 225
Query: 910 FANILHKDLKFPSST--PTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKG 963
AN+ + +F TS AK + RLL +DPK R+ + +HP+ K
Sbjct: 226 LANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRM----TIQDSLQHPWIKP 277
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 196 bits (501), Expect = 9e-57
Identities = 77/300 (25%), Positives = 128/300 (42%), Gaps = 46/300 (15%)
Query: 672 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRN--KVHRACAEREILDML 729
++ + LG G V +G FA K ++ + R+ K+ R E I L
Sbjct: 6 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLER---EARICRKL 62
Query: 730 DHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKV-LKEDAVRFYAAEVVVALE 788
HP + L+ S Q ++ L+ D GGELF + + E +++ ++
Sbjct: 63 QHPNIVRLHDSIQEESFHYLVFDLVTGGELF---EDIVAREFYSEADASHCIQQILESIA 119
Query: 789 YLHCQGIIYRDLKPENVLLQG---NGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQ 845
Y H GI++R+LKPEN+LL V L DF L+
Sbjct: 120 YCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLA------------------------ 155
Query: 846 QNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKT 905
+ + A + F GT Y++PE++ ++ VD WA G++LY +L GY PF +
Sbjct: 156 ---IEV-NDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDED 211
Query: 906 RQKTFANILHKDLKFPSS--TPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKG 963
+ + +A I +PS + AK L+ +L +PK R+ A++ K P+
Sbjct: 212 QHRLYAQIKAGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRI----TADQALKVPWICN 267
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 199 bits (509), Expect = 1e-56
Identities = 78/292 (26%), Positives = 126/292 (43%), Gaps = 44/292 (15%)
Query: 678 KPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPAL 737
+ LGSG G VH +G+ F K ++ L++ V E I++ L HP + L
Sbjct: 57 EELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKN---EISIMNQLHHPKLINL 113
Query: 738 YASFQTKTHVCLITDYCPGGELFLLLDRQPTK--VLKEDAVRFYAAEVVVALEYLHCQGI 795
+ +F+ K + LI ++ GGELF DR + + E V Y + L+++H I
Sbjct: 114 HDAFEDKYEMVLILEFLSGGELF---DRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSI 170
Query: 796 IYRDLKPENVLLQ--GNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAE 853
++ D+KPEN++ + V + DF L+
Sbjct: 171 VHLDIKPENIMCETKKASSVKIIDFGLAT----------------------------KLN 202
Query: 854 PMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANI 913
P T E+ APEI+ D WA+G+L Y +L G +PF G+ +T N+
Sbjct: 203 PDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNV 262
Query: 914 LHKDLKFPSST--PTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKG 963
D +F S AK + LL ++P+ RL ++ +HP+ KG
Sbjct: 263 KRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRL----TVHDALEHPWLKG 310
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 197 bits (502), Expect = 1e-56
Identities = 85/327 (25%), Positives = 136/327 (41%), Gaps = 62/327 (18%)
Query: 664 DSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACA-- 721
SG+ + L + +G G G V L Y+AMK + K ++ + R
Sbjct: 5 SSGDCVQLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPR 64
Query: 722 -------------------EREI--LDMLDHPFVPALY--ASFQTKTHVCLITDYCPGGE 758
+EI L LDHP V L + H+ ++ + G
Sbjct: 65 GTRPAPGGCIQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGP 124
Query: 759 LFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDF 818
+ + +P L ED RFY +++ +EYLH Q II+RD+KP N+L+ +GH+ + DF
Sbjct: 125 VMEVPTLKP---LSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADF 181
Query: 819 DLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGH 878
+S LL T VGT ++APE ++
Sbjct: 182 GVSNEFK-GSDALLSNT--------------------------VGTPAFMAPESLSETRK 214
Query: 879 T---SAVDWWALGILLYEMLYGYTPFRGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMY 935
A+D WA+G+ LY ++G PF + + I + L+FP + K L+
Sbjct: 215 IFSGKALDVWAMGVTLYCFVFGQCPFMDERIMCLHSKIKSQALEFPDQPDIAEDLKDLIT 274
Query: 936 RLLHRDPKSRLGSHEGANEIKKHPFFK 962
R+L ++P+SR+ EIK HP+
Sbjct: 275 RMLDKNPESRI----VVPEIKLHPWVT 297
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 197 bits (502), Expect = 2e-56
Identities = 66/337 (19%), Positives = 116/337 (34%), Gaps = 76/337 (22%)
Query: 667 EQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREIL 726
+ + + LG G T +V +G FA+K + L V E E+L
Sbjct: 4 QSTSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLR--PVDVQMREFEVL 61
Query: 727 DMLDHPFVPALYASFQTKT--HVCLITDYCPGGELF-LLLDRQPTKVLKEDAVRFYAAEV 783
L+H + L+A + T H LI ++CP G L+ +L + L E +V
Sbjct: 62 KKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDV 121
Query: 784 VVALEYLHCQGIIYRDLKPENVLLQ----GNGHVSLTDFDLSCLTSCKPQLLLPTTNEKK 839
V + +L GI++R++KP N++ G LTDF +
Sbjct: 122 VGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA------------------ 163
Query: 840 RRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGA--------GHTSAVDWWALGILL 891
+ ++ S GTEEY+ P++ A + + VD W++G+
Sbjct: 164 ---RELEDDEQFV-------SLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTF 213
Query: 892 YEMLYGYTPFRGKTRQKTFANILHK-------------------DLKFPSSTPTSLH--- 929
Y G PFR + +++K + + P S
Sbjct: 214 YHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSR 273
Query: 930 -----AKQLMYRLLHRDPKSRLGSHEGANEIKKHPFF 961
++ +L D + G ++
Sbjct: 274 GLQVLLTPVLANILEADQEKCW----GFDQFFAETSD 306
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 198 bits (506), Expect = 2e-56
Identities = 83/302 (27%), Positives = 129/302 (42%), Gaps = 45/302 (14%)
Query: 672 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDK-GVMLNRNKVHRACAERE--ILDM 728
+ + LGSG V +G +A K + K +R V R ERE IL
Sbjct: 12 DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQ 71
Query: 729 LDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKV-LKEDAVRFYAAEVVVAL 787
+ HP + L+ ++ +T V LI + GGELF D K L E+ + +++ +
Sbjct: 72 VLHPNIITLHDVYENRTDVVLILELVSGGELF---DFLAQKESLSEEEATSFIKQILDGV 128
Query: 788 EYLHCQGIIYRDLKPENVLLQ----GNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHK 843
YLH + I + DLKPEN++L H+ L DF L+ +
Sbjct: 129 NYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA--HEIEDG-------------- 172
Query: 844 GQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRG 903
+ + GT E++APEI+ D W++G++ Y +L G +PF G
Sbjct: 173 ---------VEFK---NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLG 220
Query: 904 KTRQKTFANILHKDLKFPSST--PTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFF 961
T+Q+T ANI F TS AK + +LL ++ + RL E +HP+
Sbjct: 221 DTKQETLANITAVSYDFDEEFFSQTSELAKDFIRKLLVKETRKRL----TIQEALRHPWI 276
Query: 962 KG 963
Sbjct: 277 TP 278
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 195 bits (498), Expect = 3e-56
Identities = 61/308 (19%), Positives = 111/308 (36%), Gaps = 61/308 (19%)
Query: 671 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLD 730
F+ I+ +GSG G V + G+ + +K + N K R E + L LD
Sbjct: 10 GMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKY----NNEKAER---EVKALAKLD 62
Query: 731 HPFVPALYASFQ----------------TKTHVCLITDYCPGGELFLLLDRQPTKVLKED 774
H + + + + ++C G L ++++ + L +
Sbjct: 63 HVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKV 122
Query: 775 AVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPT 834
++ ++Y+H + +I RDLKP N+ L V + DF L L
Sbjct: 123 LALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVT--------SLKN 174
Query: 835 TNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEM 894
++ GT Y++PE I+ + VD +ALG++L E+
Sbjct: 175 DGKRT--------------------RSKGTLRYMSPEQISSQDYGKEVDLYALGLILAEL 214
Query: 895 LYGYTPFRGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANE 954
L+ K F ++ +D K L+ +LL + P+ R +E
Sbjct: 215 LHV--CDTAFETSKFFTDL--RDGIISDI--FDKKEKTLLQKLLSKKPEDRP----NTSE 264
Query: 955 IKKHPFFK 962
I +
Sbjct: 265 ILRTLTVW 272
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 194 bits (496), Expect = 3e-56
Identities = 67/301 (22%), Positives = 119/301 (39%), Gaps = 42/301 (13%)
Query: 671 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLD 730
+ + + +G+G G + G+ K +D G M K +E +L L
Sbjct: 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEK-QMLVSEVNLLRELK 63
Query: 731 HPFVPALYASFQTKT--HVCLITDYCPGGELFLLLDRQPTK--VLKEDAVRFYAAEVVVA 786
HP + Y +T + ++ +YC GG+L ++ + + L E+ V ++ +A
Sbjct: 64 HPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLA 123
Query: 787 LEYLH-----CQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRR 841
L+ H +++RDLKP NV L G +V L DF L+
Sbjct: 124 LKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLA-------------------- 163
Query: 842 HKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPF 901
+ + A +FVGT Y++PE + + D W+LG LLYE+ PF
Sbjct: 164 -RILNHDTSFA------KTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPF 216
Query: 902 RGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFF 961
++++ I + S +++ R+L+ R EI ++P
Sbjct: 217 TAFSQKELAGKIREGKFR-RIPYRYSDELNEIITRMLNLKDYHRP----SVEEILENPLI 271
Query: 962 K 962
Sbjct: 272 L 272
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 197 bits (504), Expect = 4e-56
Identities = 87/383 (22%), Positives = 153/383 (39%), Gaps = 53/383 (13%)
Query: 589 GSEHLEPLRNSIPEATAEESEKLVKQTAENVNEAVKELPDANLTPEDLWANHSKVVHPKP 648
G+E+L S + + + + +P + L + P
Sbjct: 15 GTENLYFQSMKNSGDQDSRSGHNEAKEVWSNADLTERMPVKSKRTSALAVDIPAPPAPFD 74
Query: 649 HRKDSPPWKAIQKILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKG 708
HR + A+ + + LG G G VH E +G A K +
Sbjct: 75 HRIVTAKQGAVNSFYTVSKT---------EILGGGRFGQVHKCEETATGLKLAAKIIKTR 125
Query: 709 VMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPT 768
M ++ +V E +++ LDH + LY +F++K + L+ +Y GGELF DR
Sbjct: 126 GMKDKEEVKN---EISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELF---DRIID 179
Query: 769 K--VLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLL--QGNGHVSLTDFDLSCLT 824
+ L E + ++ + ++H I++ DLKPEN+L + + + DF L+
Sbjct: 180 ESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLA--- 236
Query: 825 SCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDW 884
RR+K + E ++ GT E++APE++ + D
Sbjct: 237 ---------------RRYKPR-------EKLK---VNFGTPEFLAPEVVNYDFVSFPTDM 271
Query: 885 WALGILLYEMLYGYTPFRGKTRQKTFANILHKDLKFPSST--PTSLHAKQLMYRLLHRDP 942
W++G++ Y +L G +PF G +T NIL S AK+ + +LL ++
Sbjct: 272 WSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEEFQDISEEAKEFISKLLIKEK 331
Query: 943 KSRLGSHEGANEIKKHPFFKGVN 965
R+ A+E KHP+
Sbjct: 332 SWRI----SASEALKHPWLSDHK 350
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 195 bits (499), Expect = 5e-56
Identities = 73/292 (25%), Positives = 128/292 (43%), Gaps = 45/292 (15%)
Query: 678 KPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPAL 737
+ LG G+ G VH S + + K + ++ V + E IL++ H + L
Sbjct: 11 EDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGT-DQVLVKK---EISILNIARHRNILHL 66
Query: 738 YASFQTKTHVCLITDYCPGGELFLLLDRQPTK--VLKEDAVRFYAAEVVVALEYLHCQGI 795
+ SF++ + +I ++ G ++F +R T L E + Y +V AL++LH I
Sbjct: 67 HESFESMEELVMIFEFISGLDIF---ERINTSAFELNEREIVSYVHQVCEALQFLHSHNI 123
Query: 796 IYRDLKPENVLLQ--GNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAE 853
+ D++PEN++ Q + + + +F + KP +
Sbjct: 124 GHFDIRPENIIYQTRRSSTIKIIEFGQARQ--LKPG-----------------------D 158
Query: 854 PMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANI 913
R EY APE+ ++A D W+LG L+Y +L G PF +T Q+ NI
Sbjct: 159 NFR---LLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENI 215
Query: 914 LHKDLKFPSST--PTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKG 963
++ + F S+ A + RLL ++ KSR+ A+E +HP+ K
Sbjct: 216 MNAEYTFDEEAFKEISIEAMDFVDRLLVKERKSRM----TASEALQHPWLKQ 263
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 197 bits (502), Expect = 7e-56
Identities = 78/327 (23%), Positives = 136/327 (41%), Gaps = 47/327 (14%)
Query: 645 HPKPHRKDSPPWKAIQKILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKA 704
H + + ++++ + + ++ + LG G V +G FA K
Sbjct: 3 HMASMTGGQQMGRGSEFMMNASTKFS-DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKI 61
Query: 705 MDKGVMLNR--NKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLL 762
++ + R K+ R E I L HP + L+ S Q ++ L+ D GGELF
Sbjct: 62 INTKKLSARDFQKLER---EARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELF-- 116
Query: 763 LDRQPTKV-LKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQG---NGHVSLTDF 818
+ + E +++ ++ Y H GI++R+LKPEN+LL V L DF
Sbjct: 117 -EDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADF 175
Query: 819 DLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGH 878
L+ + + A + F GT Y++PE++ +
Sbjct: 176 GLA---------------------------IEV-NDSEAWHGFAGTPGYLSPEVLKKDPY 207
Query: 879 TSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANILHKDLKFPSS--TPTSLHAKQLMYR 936
+ VD WA G++LY +L GY PF + + + +A I +PS + AK L+
Sbjct: 208 SKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLIDS 267
Query: 937 LLHRDPKSRLGSHEGANEIKKHPFFKG 963
+L +PK R+ A++ K P+
Sbjct: 268 MLTVNPKKRI----TADQALKVPWICN 290
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 200 bits (511), Expect = 7e-56
Identities = 87/352 (24%), Positives = 143/352 (40%), Gaps = 55/352 (15%)
Query: 644 VHPKPHRKDSPPWKAIQKILDSGEQINL--------QHFRPIKPLGSGDTGSVHLVELCG 695
+H H Q L + + + + ++ +K LGSG G V L
Sbjct: 1 MHHHHHHSSGRENLYFQGDLQATPGMFITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKV 60
Query: 696 SGQYFAMKAMDKGVMLNRN--KVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDY 753
+ A+K + K + + K+ E +L +LDHP + LY F+ K + L+ +
Sbjct: 61 THVERAIKIIRKTSVSTSSNSKLLE---EVAVLKLLDHPNIMKLYDFFEDKRNYYLVMEC 117
Query: 754 CPGGELFLLLDR-QPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQ---G 809
GGELF D E +V+ + YLH I++RDLKPEN+LL+
Sbjct: 118 YKGGELF---DEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEK 174
Query: 810 NGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIA 869
+ + + DF LS + E + +GT YIA
Sbjct: 175 DALIKIVDFGLSA----------------------------VFENQKKMKERLGTAYYIA 206
Query: 870 PEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANILHKDLKFPSST--PTS 927
PE++ + D W++G++L+ +L GY PF G+T Q+ + F S S
Sbjct: 207 PEVLRK-KYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKNVS 265
Query: 928 LHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVNWALVRCMNPPELDA 979
AK L+ ++L D + R+ A + +HP+ K + + P L
Sbjct: 266 EGAKDLIKQMLQFDSQRRI----SAQQALEHPWIKEMCSKKESGIELPSLAN 313
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 200 bits (511), Expect = 8e-56
Identities = 76/316 (24%), Positives = 128/316 (40%), Gaps = 47/316 (14%)
Query: 672 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRN--KVHRACAEREILDML 729
+ + + LG G G V + + Q +A+K ++K N++ + R E E+L L
Sbjct: 22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILR---EVELLKKL 78
Query: 730 DHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDR-QPTKVLKEDAVRFYAAEVVVALE 788
DHP + L+ + + ++ + GGELF D K E +V +
Sbjct: 79 DHPNIMKLFEILEDSSSFYIVGELYTGGELF---DEIIKRKRFSEHDAARIIKQVFSGIT 135
Query: 789 YLHCQGIIYRDLKPENVLLQ---GNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQ 845
Y+H I++RDLKPEN+LL+ + + + DF LS
Sbjct: 136 YMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCF--------------------- 174
Query: 846 QNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKT 905
+ +GT YIAPE++ G + D W+ G++LY +L G PF GK
Sbjct: 175 -------QQNTKMKDRIGTAYYIAPEVLRGT-YDEKCDVWSAGVILYILLSGTPPFYGKN 226
Query: 906 RQKTFANILHKDLKFPSST--PTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKG 963
+ F S AK L+ ++L P R+ A + +HP+ +
Sbjct: 227 EYDILKRVETGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRI----TATQCLEHPWIQK 282
Query: 964 VNWALVRCMNPPELDA 979
+ + P L++
Sbjct: 283 YSSETPTISDLPSLES 298
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 195 bits (498), Expect = 1e-55
Identities = 66/309 (21%), Positives = 119/309 (38%), Gaps = 49/309 (15%)
Query: 668 QINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILD 727
+ + + +K +GSG + V V L Q +A+K ++ + + E L+
Sbjct: 5 SVKGRIYSILKQIGSGGSSKVFQV-LNEKKQIYAIKYVNLE-EADNQTLDSYRNEIAYLN 62
Query: 728 MLDHP--FVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVV 785
L + LY T ++ ++ + +L L ++ K + + Y ++
Sbjct: 63 KLQQHSDKIIRLYDYEITDQYIYMVMECG-NIDLNSWLKKK--KSIDPWERKSYWKNMLE 119
Query: 786 ALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQ 845
A+ +H GI++ DLKP N L+ +G + L DF ++ + +
Sbjct: 120 AVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIA------------------NQMQPD 160
Query: 846 QNPVFMAEPMRASNSFVGTEEYIAPEIIAGAG-----------HTSAVDWWALGILLYEM 894
V +S VGT Y+ PE I + D W+LG +LY M
Sbjct: 161 TTSVVK-------DSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYM 213
Query: 895 LYGYTPFRGKTRQ-KTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGAN 953
YG TPF+ Q I+ + + + ++ L RDPK R+
Sbjct: 214 TYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRI----SIP 269
Query: 954 EIKKHPFFK 962
E+ HP+ +
Sbjct: 270 ELLAHPYVQ 278
|
| >3p7n_A Sensor histidine kinase; LOV domain, light-activated transcription factor, DNA bindin; HET: FMN; 2.10A {Erythrobacter litoralis} Length = 258 | Back alignment and structure |
|---|
Score = 192 bits (489), Expect = 1e-55
Identities = 66/238 (27%), Positives = 101/238 (42%), Gaps = 21/238 (8%)
Query: 427 IGRKSQSTDDHDSFENEIIMEGDDDYESDDERPDSVDDKVRQKEMRKGIDLATTLERIEK 486
+GR DD D G D P + D +V + + + +E
Sbjct: 21 MGRDLYDDDDKDHP----FTMGQDRPIDGSGAPGADDTRVEVQPPAQ--WVLDLIEASPI 74
Query: 487 NFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIRAAIDNQ 546
V++DPRL DNP+I + +F +LT YS EE +GRNCRFL G T+P KIR +
Sbjct: 75 ASVVSDPRLADNPLIAINQAFTDLTGYSEEECVGRNCRFLAGSGTEPWLTDKIRQGVREH 134
Query: 547 TDVTVQLINYTKSGKKFWNLFHLQPMRDQKGEVQYFIGVQLDGSEHLEPLRNSIPEATAE 606
V V+++NY K G F N + P+ D E+ YF+G Q++ + +
Sbjct: 135 KPVLVEILNYKKDGTPFRNAVLVAPIYDDDDELLYFLGSQVEVDDDQPNM-----GMARR 189
Query: 607 ESEKLVKQTAENVNEAVKELPDANLTPEDLWAN----------HSKVVHPKPHRKDSP 654
E + +T V L + L +++ A H +V K + K S
Sbjct: 190 ERAAEMLKTLSPRQLEVTTLVASGLRNKEVAARLGLSEKTVKMHRGLVMEKLNLKTSA 247
|
| >3p7n_A Sensor histidine kinase; LOV domain, light-activated transcription factor, DNA bindin; HET: FMN; 2.10A {Erythrobacter litoralis} Length = 258 | Back alignment and structure |
|---|
Score = 188 bits (478), Expect = 5e-54
Identities = 62/203 (30%), Positives = 91/203 (44%), Gaps = 14/203 (6%)
Query: 147 VARTSGGDDPNGKPGTSRRNSNNSVRSSGEMSDEGGKEKGLPRVSDIVKDALSTFQQTFV 206
+ R DD P T ++ + D + + V D + V
Sbjct: 21 MGRDLYDDDDKDHPFTMGQDRPIDGSGAPGADDT---RVEVQPPAQWVLDLIEASPIASV 77
Query: 207 VSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKIRETLQNGQSY 266
VSD D P++ + F +TGY+ +E VGRNCRFL G+GT+P KIR+ ++ +
Sbjct: 78 VSDPRLADNPLIAINQAFTDLTGYSEEECVGRNCRFLAGSGTEPWLTDKIRQGVREHKPV 137
Query: 267 CGRLLNYKKDGTPFWNLLTIAPIKDDEGKVLKFIGMQVEVSKHTEGAKDKMLRPNGLP-- 324
+LNYKKDGTPF N + +API DD+ ++L F+G QVEV
Sbjct: 138 LVEILNYKKDGTPFRNAVLVAPIYDDDDELLYFLGSQVEVDDDQPNMGMARRERAAEMLK 197
Query: 325 ---------ESLIRYDARQKEMA 338
+L+ R KE+A
Sbjct: 198 TLSPRQLEVTTLVASGLRNKEVA 220
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 192 bits (490), Expect = 3e-55
Identities = 73/298 (24%), Positives = 120/298 (40%), Gaps = 43/298 (14%)
Query: 672 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDH 731
+ + + LG G G V + + Q +A+K ++K N++ E E+L LDH
Sbjct: 22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKD-TSTILREVELLKKLDH 80
Query: 732 PFVPALYASFQTKTHVCLITDYCPGGELFLLLDR-QPTKVLKEDAVRFYAAEVVVALEYL 790
P + L+ + + ++ + GGELF D K E +V + Y+
Sbjct: 81 PNIMKLFEILEDSSSFYIVGELYTGGELF---DEIIKRKRFSEHDAARIIKQVFSGITYM 137
Query: 791 HCQGIIYRDLKPENVLLQ---GNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQN 847
H I++RDLKPEN+LL+ + + + DF LS
Sbjct: 138 HKHNIVHRDLKPENILLESKEKDCDIKIIDFGLS-------------------------- 171
Query: 848 PVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQ 907
+ +GT YIAPE++ G + D W+ G++LY +L G PF GK
Sbjct: 172 -TCF-QQNTKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEY 228
Query: 908 KTFANILHKDLKFPSS--TPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKG 963
+ F S AK L+ ++L P R+ A + +HP+ +
Sbjct: 229 DILKRVETGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRI----TATQCLEHPWIQK 282
|
| >3t50_A Blue-light-activated histidine kinase; PAS superfamily, blue-light photoreceptor, FMN binding, TRAN; HET: FMN; 1.64A {Brucella melitensis} Length = 128 | Back alignment and structure |
|---|
Score = 186 bits (474), Expect = 4e-55
Identities = 54/114 (47%), Positives = 77/114 (67%)
Query: 481 LERIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIR 540
E +IT+P LPDNPI+FA+ +FL+LT Y +E++GRNCRFLQG TDPA VR I+
Sbjct: 3 SEFTLMPMLITNPHLPDNPIVFANPAFLKLTGYEADEVMGRNCRFLQGHGTDPAHVRAIK 62
Query: 541 AAIDNQTDVTVQLINYTKSGKKFWNLFHLQPMRDQKGEVQYFIGVQLDGSEHLE 594
+AI + + + +INY KSG+ FWN H+ P+ + G +Q+F+ QLD + L
Sbjct: 63 SAIAAEKPIDIDIINYKKSGEAFWNRLHISPVHNANGRLQHFVSSQLDVTLELV 116
|
| >3t50_A Blue-light-activated histidine kinase; PAS superfamily, blue-light photoreceptor, FMN binding, TRAN; HET: FMN; 1.64A {Brucella melitensis} Length = 128 | Back alignment and structure |
|---|
Score = 179 bits (456), Expect = 9e-53
Identities = 43/113 (38%), Positives = 67/113 (59%)
Query: 197 ALSTFQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKI 256
A ++++ PD PI++A+ F K+TGY + EV+GRNCRFLQG GTDP V I
Sbjct: 2 ASEFTLMPMLITNPHLPDNPIVFANPAFLKLTGYEADEVMGRNCRFLQGHGTDPAHVRAI 61
Query: 257 RETLQNGQSYCGRLLNYKKDGTPFWNLLTIAPIKDDEGKVLKFIGMQVEVSKH 309
+ + + ++NYKK G FWN L I+P+ + G++ F+ Q++V+
Sbjct: 62 KSAIAAEKPIDIDIINYKKSGEAFWNRLHISPVHNANGRLQHFVSSQLDVTLE 114
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 193 bits (493), Expect = 4e-55
Identities = 76/300 (25%), Positives = 115/300 (38%), Gaps = 54/300 (18%)
Query: 678 KPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLD-HPFVPA 736
KPLG G S Q FA+K + K E L + + HP +
Sbjct: 17 KPLGEGSFSICRKCVHKKSNQAFAVKIISK------RMEANTQKEITALKLCEGHPNIVK 70
Query: 737 LYASFQTKTHVCLITDYCPGGELFLLLDR-QPTKVLKEDAVRFYAAEVVVALEYLHCQGI 795
L+ F + H L+ + GGELF +R + K E + ++V A+ ++H G+
Sbjct: 71 LHEVFHDQLHTFLVMELLNGGELF---ERIKKKKHFSETEASYIMRKLVSAVSHMHDVGV 127
Query: 796 IYRDLKPENVLLQGNGHVS---LTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMA 852
++RDLKPEN+L + DF + R K N
Sbjct: 128 VHRDLKPENLLFTDENDNLEIKIIDFGFA-------------------RLKPPDNQPLK- 167
Query: 853 EPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKT--- 909
+ T Y APE++ G+ + D W+LG++LY ML G PF+ R T
Sbjct: 168 -------TPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTS 220
Query: 910 ----FANILHKDLKFPSS--TPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKG 963
I D F S AK L+ LL DP RL + ++ + + +
Sbjct: 221 AVEIMKKIKKGDFSFEGEAWKNVSQEAKDLIQGLLTVDPNKRL----KMSGLRYNEWLQD 276
|
| >2l0w_A Potassium voltage-gated channel, subfamily H (EAG member 2, isoform CRA_B; HERG, PAS domain, voltage-gated potassium channel, membrane; NMR {Homo sapiens} PDB: 2l1m_A 2l4r_A Length = 138 | Back alignment and structure |
|---|
Score = 185 bits (473), Expect = 6e-55
Identities = 37/130 (28%), Positives = 59/130 (45%), Gaps = 5/130 (3%)
Query: 467 RQKEMRKGIDLATTLERIEK---NFVITDPRLPDNPIIFASDSFLELTEYSREEILGR-- 521
R + L T + + E F+I + R+ + +I+ +D F EL YSR E++ R
Sbjct: 8 RGHVAPQNTFLDTIIRKFEGQSRKFIIANARVENCAVIYCNDGFCELCGYSRAEVMQRPC 67
Query: 522 NCRFLQGPETDPATVRKIRAAIDNQTDVTVQLINYTKSGKKFWNLFHLQPMRDQKGEVQY 581
C FL GP T +I A+ + V++ Y K G F L + P++++ G V
Sbjct: 68 TCDFLHGPRTQRRAAAQIAQALLGAEERKVEIAFYRKDGSCFLCLVDVVPVKNEDGAVIM 127
Query: 582 FIGVQLDGSE 591
FI E
Sbjct: 128 FILNFEVVME 137
|
| >2l0w_A Potassium voltage-gated channel, subfamily H (EAG member 2, isoform CRA_B; HERG, PAS domain, voltage-gated potassium channel, membrane; NMR {Homo sapiens} PDB: 2l1m_A 2l4r_A Length = 138 | Back alignment and structure |
|---|
Score = 178 bits (453), Expect = 3e-52
Identities = 32/118 (27%), Positives = 59/118 (50%), Gaps = 2/118 (1%)
Query: 192 DIVKDALSTFQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGR--NCRFLQGAGTD 249
D + + F++++A + ++Y + GF ++ GY+ EV+ R C FL G T
Sbjct: 19 DTIIRKFEGQSRKFIIANARVENCAVIYCNDGFCELCGYSRAEVMQRPCTCDFLHGPRTQ 78
Query: 250 PEDVAKIRETLQNGQSYCGRLLNYKKDGTPFWNLLTIAPIKDDEGKVLKFIGMQVEVS 307
A+I + L + + Y+KDG+ F L+ + P+K+++G V+ FI V
Sbjct: 79 RRAAAQIAQALLGAEERKVEIAFYRKDGSCFLCLVDVVPVKNEDGAVIMFILNFEVVM 136
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 198 bits (505), Expect = 6e-55
Identities = 77/343 (22%), Positives = 122/343 (35%), Gaps = 59/343 (17%)
Query: 644 VHPKPHRKDSPPWKAIQKILDSGEQINLQHFRPI-------KPLGSGDTGSVHLVELCGS 696
+H H Q I + + I + LGSG G V L +
Sbjct: 1 MHHHHHHSSGRENLYFQGIAINPGMYVRKKEGKIGESYFKVRKLGSGAYGEVLLCKEKNG 60
Query: 697 GQYFAMKAMDKGVMLNRNKVHRACA----------EREILDMLDHPFVPALYASFQTKTH 746
A+K + K E +L LDHP + L+ F+ K +
Sbjct: 61 HSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKY 120
Query: 747 VCLITDYCPGGELFLLLDR-QPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENV 805
L+T++ GGELF ++ E +++ + YLH I++RD+KPEN+
Sbjct: 121 FYLVTEFYEGGELF---EQIINRHKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENI 177
Query: 806 LLQ---GNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFV 862
LL+ ++ + DF LS +
Sbjct: 178 LLENKNSLLNIKIVDFGLSS----------------------------FFSKDYKLRDRL 209
Query: 863 GTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANILHKDLKFPS 922
GT YIAPE++ + D W+ G+++Y +L GY PF G+ Q + F
Sbjct: 210 GTAYYIAPEVLKK-KYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYFDF 268
Query: 923 ST--PTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKG 963
+ S AK+L+ +L D R A E + K
Sbjct: 269 NDWKNISDEAKELIKLMLTYDYNKRC----TAEEALNSRWIKK 307
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 200 bits (509), Expect = 6e-55
Identities = 80/378 (21%), Positives = 146/378 (38%), Gaps = 57/378 (15%)
Query: 594 EPLRNSIPEATAEESEKLVKQTAENVNEAVKELPDANLTPEDLWANHSKVVHPKPHRKDS 653
+P + P + K ++ +V+E K + + + +
Sbjct: 92 KPCEPTAPVLIPGDERK--RRRGYDVDEQGKIVRGKGTVSSNYDNYVFDIWKQYYPQPVE 149
Query: 654 PPWKAIQKILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNR 713
+ D E+ LG+G G VH V +G FA K + ++
Sbjct: 150 IKHDHVLDHYDIHEE-----------LGTGAFGVVHRVTERATGNNFAAKFVMTPHESDK 198
Query: 714 NKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTK--VL 771
V + E + + +L HP + L+ +F+ + +I ++ GGELF ++ + +
Sbjct: 199 ETVRK---EIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELF---EKVADEHNKM 252
Query: 772 KEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQ--GNGHVSLTDFDLSCLTSCKPQ 829
ED Y +V L ++H ++ DLKPEN++ + + L DF L+
Sbjct: 253 SEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTA------- 305
Query: 830 LLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGI 889
+P ++ GT E+ APE+ G D W++G+
Sbjct: 306 ---------------------HLDPKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGV 344
Query: 890 LLYEMLYGYTPFRGKTRQKTFANILHKDLKFPSS--TPTSLHAKQLMYRLLHRDPKSRLG 947
L Y +L G +PF G+ +T N+ D S + S K + +LL DP +R+
Sbjct: 345 LSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDFIRKLLLADPNTRM- 403
Query: 948 SHEGANEIKKHPFFKGVN 965
++ +HP+ N
Sbjct: 404 ---TIHQALEHPWLTPGN 418
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 196 bits (500), Expect = 8e-55
Identities = 75/298 (25%), Positives = 124/298 (41%), Gaps = 41/298 (13%)
Query: 672 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDH 731
+ ++ + LG G V +GQ +A ++ L+ + E I +L H
Sbjct: 11 EEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINT-KKLSARDHQKLEREARICRLLKH 69
Query: 732 PFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKV-LKEDAVRFYAAEVVVALEYL 790
P + L+ S + H LI D GGELF + + E +++ A+ +
Sbjct: 70 PNIVRLHDSISEEGHHYLIFDLVTGGELF---EDIVAREYYSEADASHCIQQILEAVLHC 126
Query: 791 HCQGIIYRDLKPENVLLQG---NGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQN 847
H G+++R+LKPEN+LL V L DF L+
Sbjct: 127 HQMGVVHRNLKPENLLLASKLKGAAVKLADFGLA-------------------------- 160
Query: 848 PVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQ 907
+ + +A F GT Y++PE++ + VD WA G++LY +L GY PF + +
Sbjct: 161 -IEVEGEQQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQH 219
Query: 908 KTFANILHKDLKFPSS--TPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKG 963
+ + I FPS + AK L+ ++L +P R+ A E KHP+
Sbjct: 220 RLYQQIKAGAYDFPSPEWDTVTPEAKDLINKMLTINPSKRI----TAAEALKHPWISH 273
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 191 bits (487), Expect = 9e-55
Identities = 73/311 (23%), Positives = 131/311 (42%), Gaps = 43/311 (13%)
Query: 671 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVM-LNRNKVHRACAEREILDML 729
L F PI+ LG G G V + +A+K + L R KV R E + L L
Sbjct: 4 LTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMR---EVKALAKL 60
Query: 730 DHPFVPALYASFQTKT------------HVCLITDYCPGGELFLLLDRQPTKVLKEDA-V 776
+HP + + ++ K ++ + C L ++ + T +E +
Sbjct: 61 EHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVC 120
Query: 777 RFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTN 836
++ A+E+LH +G+++RDLKP N+ + V + DF L +
Sbjct: 121 LHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVT--------AMDQDE 172
Query: 837 EKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY 896
E++ VGT+ Y++PE I G ++ VD ++LG++L+E+LY
Sbjct: 173 EEQTVLTPMPAYARH-------TGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY 225
Query: 897 GYTPFRGKT-RQKTFANILHKDLKFPS-STPTSLHAKQLMYRLLHRDPKSRLGSHEGANE 954
PF + R +T ++ ++LKFP T ++ +L P R A
Sbjct: 226 ---PFSTQMERVRTLTDV--RNLKFPPLFTQKYPCEYVMVQDMLSPSPMERP----EAIN 276
Query: 955 IKKHPFFKGVN 965
I ++ F+ ++
Sbjct: 277 IIENAVFEDLD 287
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 193 bits (491), Expect = 2e-54
Identities = 95/384 (24%), Positives = 151/384 (39%), Gaps = 54/384 (14%)
Query: 598 NSIPEATAEESEKLVKQTAENVNEAVKELPDANLTPEDLWANHSKVVHPKPHRKDSPPWK 657
N E L E ++ L D +L A K+ +P ++ ++
Sbjct: 16 NKERRRARREIRHLPNLNREQRRAFIRSLRDDPSQSANLLAEAKKLNDAQPKGTENLYFQ 75
Query: 658 AIQKILDSGEQINLQHFRPI----KPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNR 713
++ + + + F +G G + V +G FA+K M+
Sbjct: 76 SMGPEDELPDWAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLS 135
Query: 714 NKVHRACAER-----EILDML-DHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQP 767
+ E IL + HP + L S+++ + + L+ D GELF D
Sbjct: 136 PEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELF---DYLT 192
Query: 768 TKV-LKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSC 826
KV L E R ++ A+ +LH I++RDLKPEN+LL N + L+DF SC
Sbjct: 193 EKVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCH--L 250
Query: 827 KPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGA------GHTS 880
+P L GT Y+APEI+ + G+
Sbjct: 251 EPGEKLRE--------------------------LCGTPGYLAPEILKCSMDETHPGYGK 284
Query: 881 AVDWWALGILLYEMLYGYTPFRGKTRQKTFANILHKDLKFPSS--TPTSLHAKQLMYRLL 938
VD WA G++L+ +L G PF + + I+ +F S S K L+ RLL
Sbjct: 285 EVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQFSSPEWDDRSSTVKDLISRLL 344
Query: 939 HRDPKSRLGSHEGANEIKKHPFFK 962
DP++RL A + +HPFF+
Sbjct: 345 QVDPEARL----TAEQALQHPFFE 364
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 193 bits (492), Expect = 2e-54
Identities = 67/343 (19%), Positives = 118/343 (34%), Gaps = 72/343 (20%)
Query: 665 SGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAERE 724
+ + + LG G T +V +G FA+K + L V E E
Sbjct: 2 GSQSTSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLR--PVDVQMREFE 59
Query: 725 ILDMLDHPFVPALYASFQTKT--HVCLITDYCPGGELF-LLLDRQPTKVLKEDAVRFYAA 781
+L L+H + L+A + T H LI ++CP G L+ +L + L E
Sbjct: 60 VLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLR 119
Query: 782 EVVVALEYLHCQGIIYRDLKPENVLLQ----GNGHVSLTDFDLSCLTSCKPQLLLPTTNE 837
+VV + +L GI++R++KP N++ G LTDF +
Sbjct: 120 DVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA---------------- 163
Query: 838 KKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGA--------GHTSAVDWWALGI 889
+ ++ S GTEEY+ P++ A + + VD W++G+
Sbjct: 164 -----RELEDDEQF-------VSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGV 211
Query: 890 LLYEMLYGYTPFRGKTRQKTFANILHK-------------------DLKFPSSTPTSLH- 929
Y G PFR + +++K + + P S
Sbjct: 212 TFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSL 271
Query: 930 -------AKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVN 965
++ +L D + G + E ++
Sbjct: 272 SRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHRMVIH 314
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 190 bits (484), Expect = 4e-54
Identities = 76/319 (23%), Positives = 124/319 (38%), Gaps = 38/319 (11%)
Query: 646 PKPHRKDSPPWKAIQKILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAM 705
P P KA++ + L +FR K +G G V+ G A+K +
Sbjct: 9 QGPPVPQFQPQKALRPDMGYNT---LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKV 65
Query: 706 DKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLL-- 763
+++ E ++L L+HP V YASF + ++ + G+L ++
Sbjct: 66 QIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKH 125
Query: 764 DRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCL 823
++ +++ E V Y ++ ALE++H + +++RD+KP NV + G V L D L
Sbjct: 126 FKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRF 185
Query: 824 TSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVD 883
S K +S VGT Y++PE I G+ D
Sbjct: 186 FSSKTTAA---------------------------HSLVGTPYYMSPERIHENGYNFKSD 218
Query: 884 WWALGILLYEMLYGYTPFRGKTRQKT--FANILHKDLKFPSSTPTSLHAKQLMYRLLHRD 941
W+LG LLYEM +PF G I D S S +QL+ ++ D
Sbjct: 219 IWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELRQLVNMCINPD 278
Query: 942 PKSRLGSHEGANEIKKHPF 960
P+ R +
Sbjct: 279 PEKRP----DVTYVYDVAK 293
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 190 bits (485), Expect = 5e-54
Identities = 82/333 (24%), Positives = 140/333 (42%), Gaps = 49/333 (14%)
Query: 665 SGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVM--LNRNKVHRACAE 722
+ EQ ++ ++R +K +G G+ V L +G+ A+K +DK + + K+ R E
Sbjct: 8 ADEQPHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFR---E 64
Query: 723 REILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAE 782
I+ +L+HP + L+ +T+ + LI +Y GGE+F L +KE R +
Sbjct: 65 VRIMKILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAH--GRMKEKEARSKFRQ 122
Query: 783 VVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRH 842
+V A++Y H + I++RDLK EN+LL + ++ + DF S L
Sbjct: 123 IVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNE--FTVGGKLDA-------- 172
Query: 843 KGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHT-SAVDWWALGILLYEMLYGYTPF 901
F G Y APE+ G + VD W+LG++LY ++ G PF
Sbjct: 173 ------------------FCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPF 214
Query: 902 RGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFF 961
G+ ++ +L + P S + L+ R L +P R +I K +
Sbjct: 215 DGQNLKELRERVLRGKYRIPFY--MSTDCENLLKRFLVLNPIKRG----TLEQIMKDRWI 268
Query: 962 KGVNWALVRCMNPPELDAPLFATDTEKEYKVVD 994
EL + + K +D
Sbjct: 269 N-------AGHEEDELKPFVEPELDISDQKRID 294
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 189 bits (483), Expect = 2e-53
Identities = 86/295 (29%), Positives = 131/295 (44%), Gaps = 47/295 (15%)
Query: 678 KPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPAL 737
LG G T V+ + G+ + +A+K + K E +L L HP + L
Sbjct: 59 SELGRGATSIVYRCKQKGTQKPYALKVLKK-----TVDKKIVRTEIGVLLRLSHPNIIKL 113
Query: 738 YASFQTKTHVCLITDYCPGGELFLLLDRQPTKV-LKEDAVRFYAAEVVVALEYLHCQGII 796
F+T T + L+ + GGELF DR K E +++ A+ YLH GI+
Sbjct: 114 KEIFETPTEISLVLELVTGGELF---DRIVEKGYYSERDAADAVKQILEAVAYLHENGIV 170
Query: 797 YRDLKPENVLLQ---GNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAE 853
+RDLKPEN+L + + + DF LS + + Q+L+ T
Sbjct: 171 HRDLKPENLLYATPAPDAPLKIADFGLSKI--VEHQVLMKT------------------- 209
Query: 854 PMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQK-TFAN 912
GT Y APEI+ G + VD W++GI+ Y +L G+ PF + + F
Sbjct: 210 -------VCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRR 262
Query: 913 ILHKDLKFPSS--TPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVN 965
IL+ + F S SL+AK L+ +L+ DPK RL + +HP+ G
Sbjct: 263 ILNCEYYFISPWWDEVSLNAKDLVRKLIVLDPKKRL----TTFQALQHPWVTGKA 313
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 189 bits (481), Expect = 2e-53
Identities = 79/322 (24%), Positives = 125/322 (38%), Gaps = 52/322 (16%)
Query: 653 SPPWKAIQKILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLN 712
+ +I + L + + +G G + FA+K +DK +
Sbjct: 3 TVGVHSIVQQLHRNSIQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDK----S 58
Query: 713 RNKVHRACAEREILDML-DHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDR-QPTKV 770
+ E EIL HP + L + +V ++T+ GGEL D+ K
Sbjct: 59 KRDPTE---EIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELL---DKILRQKF 112
Query: 771 LKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQ----GNGHVSLTDFDLSCLTSC 826
E + +EYLH QG+++RDLKP N+L + + DF +
Sbjct: 113 FSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFA----- 167
Query: 827 KPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWA 886
K+ R + + P T ++APE++ G+ +A D W+
Sbjct: 168 -----------KQLRAENG----LLMTP-------CYTANFVAPEVLERQGYDAACDIWS 205
Query: 887 LGILLYEMLYGYTPFRGK---TRQKTFANILHKDLKFPSS--TPTSLHAKQLMYRLLHRD 941
LG+LLY ML GYTPF T ++ A I S AK L+ ++LH D
Sbjct: 206 LGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYWNSVSDTAKDLVSKMLHVD 265
Query: 942 PKSRLGSHEGANEIKKHPFFKG 963
P RL A + +HP+
Sbjct: 266 PHQRL----TAALVLRHPWIVH 283
|
| >3sw1_A Sensory box protein; light-oxygen-voltage, LOV, PAS, signaling protein; HET: FMN; 2.63A {Pseudomonas putida} Length = 162 | Back alignment and structure |
|---|
Score = 182 bits (464), Expect = 2e-53
Identities = 41/135 (30%), Positives = 63/135 (46%), Gaps = 3/135 (2%)
Query: 460 DSVDDKVRQKEMRKGIDLATTLERIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEIL 519
V + L + ++ V+ + D +I+ + +F LT YSR+EIL
Sbjct: 13 GLVPRGSHMINAQL---LQSMVDASNDGIVVAEKEGDDTILIYVNAAFEYLTGYSRDEIL 69
Query: 520 GRNCRFLQGPETDPATVRKIRAAIDNQTDVTVQLINYTKSGKKFWNLFHLQPMRDQKGEV 579
++CRFLQG + D +IR A+ L NY K G FWN + P++ +
Sbjct: 70 YQDCRFLQGDDRDQLGRARIRKAMAEGRPCREVLRNYRKDGSAFWNELSITPVKSDFDQR 129
Query: 580 QYFIGVQLDGSEHLE 594
YFIG+Q D S +E
Sbjct: 130 TYFIGIQKDVSRQVE 144
|
| >3sw1_A Sensory box protein; light-oxygen-voltage, LOV, PAS, signaling protein; HET: FMN; 2.63A {Pseudomonas putida} Length = 162 | Back alignment and structure |
|---|
Score = 182 bits (463), Expect = 3e-53
Identities = 42/115 (36%), Positives = 66/115 (57%)
Query: 197 ALSTFQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKI 256
+ VV++ D ++Y +A F +TGY+ E++ ++CRFLQG D A+I
Sbjct: 30 MVDASNDGIVVAEKEGDDTILIYVNAAFEYLTGYSRDEILYQDCRFLQGDDRDQLGRARI 89
Query: 257 RETLQNGQSYCGRLLNYKKDGTPFWNLLTIAPIKDDEGKVLKFIGMQVEVSKHTE 311
R+ + G+ L NY+KDG+ FWN L+I P+K D + FIG+Q +VS+ E
Sbjct: 90 RKAMAEGRPCREVLRNYRKDGSAFWNELSITPVKSDFDQRTYFIGIQKDVSRQVE 144
|
| >1byw_A Protein (human ERG potassium channel); PAS domain, potassium channel domain, membrane protein; 2.60A {Homo sapiens} SCOP: d.110.3.6 Length = 110 | Back alignment and structure |
|---|
Score = 180 bits (458), Expect = 3e-53
Identities = 33/107 (30%), Positives = 52/107 (48%), Gaps = 2/107 (1%)
Query: 487 NFVITDPRLPDNPIIFASDSFLELTEYSREEILGR--NCRFLQGPETDPATVRKIRAAID 544
F+I + R+ + +I+ +D F EL YSR E++ R C FL GP T +I A+
Sbjct: 3 KFIIANARVENCAVIYCNDGFCELCGYSRAEVMQRPCTCDFLHGPCTQRRAAAQIAQALL 62
Query: 545 NQTDVTVQLINYTKSGKKFWNLFHLQPMRDQKGEVQYFIGVQLDGSE 591
+ V++ Y K G F L + P++++ G V FI E
Sbjct: 63 GAEERKVEIAFYRKDGSCFLCLVDVVPVKNEDGAVIMFILNFEVVME 109
|
| >1byw_A Protein (human ERG potassium channel); PAS domain, potassium channel domain, membrane protein; 2.60A {Homo sapiens} SCOP: d.110.3.6 Length = 110 | Back alignment and structure |
|---|
Score = 178 bits (453), Expect = 2e-52
Identities = 31/107 (28%), Positives = 57/107 (53%), Gaps = 2/107 (1%)
Query: 203 QTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGR--NCRFLQGAGTDPEDVAKIRETL 260
+ F++++A + ++Y + GF ++ GY+ EV+ R C FL G T A+I + L
Sbjct: 2 RKFIIANARVENCAVIYCNDGFCELCGYSRAEVMQRPCTCDFLHGPCTQRRAAAQIAQAL 61
Query: 261 QNGQSYCGRLLNYKKDGTPFWNLLTIAPIKDDEGKVLKFIGMQVEVS 307
+ + Y+KDG+ F L+ + P+K+++G V+ FI V
Sbjct: 62 LGAEERKVEIAFYRKDGSCFLCLVDVVPVKNEDGAVIMFILNFEVVM 108
|
| >2pr5_A Blue-light photoreceptor; light-oxygen-voltage, LOV, PER-ARNT-SIM, PAS, flavoprotein, protein; HET: FMN; 1.45A {Bacillus subtilis} PDB: 2pr6_A* Length = 132 | Back alignment and structure |
|---|
Score = 180 bits (459), Expect = 5e-53
Identities = 58/128 (45%), Positives = 80/128 (62%), Gaps = 5/128 (3%)
Query: 481 LERIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIR 540
L+ + VITDP L DNPI++ + F+++T Y EEILG+NCRFLQG TDPA V IR
Sbjct: 5 LDHVRVGVVITDPALEDNPIVYVNQGFVQMTGYETEEILGKNCRFLQGKHTDPAEVDNIR 64
Query: 541 AAIDNQTDVTVQLINYTKSGKKFWNLFHLQPMRDQKGEVQYFIGVQLDGSEHL---EPLR 597
A+ N+ VTVQ+ NY K G FWN ++ PM + YF+G+Q D ++ + L
Sbjct: 65 TALQNKEPVTVQIQNYKKDGTMFWNELNIDPMEI--EDKTYFVGIQNDITKQKEYEKLLE 122
Query: 598 NSIPEATA 605
+S+ E TA
Sbjct: 123 DSLTEITA 130
|
| >2pr5_A Blue-light photoreceptor; light-oxygen-voltage, LOV, PER-ARNT-SIM, PAS, flavoprotein, protein; HET: FMN; 1.45A {Bacillus subtilis} PDB: 2pr6_A* Length = 132 | Back alignment and structure |
|---|
Score = 172 bits (438), Expect = 3e-50
Identities = 49/115 (42%), Positives = 73/115 (63%), Gaps = 2/115 (1%)
Query: 197 ALSTFQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKI 256
L + V++D D PI+Y + GF +MTGY ++E++G+NCRFLQG TDP +V I
Sbjct: 4 MLDHVRVGVVITDPALEDNPIVYVNQGFVQMTGYETEEILGKNCRFLQGKHTDPAEVDNI 63
Query: 257 RETLQNGQSYCGRLLNYKKDGTPFWNLLTIAPIKDDEGKVLKFIGMQVEVSKHTE 311
R LQN + ++ NYKKDGT FWN L I P++ ++ F+G+Q +++K E
Sbjct: 64 RTALQNKEPVTVQIQNYKKDGTMFWNELNIDPMEIEDKTY--FVGIQNDITKQKE 116
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 187 bits (476), Expect = 6e-53
Identities = 87/307 (28%), Positives = 128/307 (41%), Gaps = 51/307 (16%)
Query: 672 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAER-----EIL 726
+ K LGSG G V L + + A+K + K + A EIL
Sbjct: 10 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEIL 69
Query: 727 DMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKV-LKEDAVRFYAAEVVV 785
L+HP + + F + ++ + GGELF D+ LKE + Y ++++
Sbjct: 70 KKLNHPCIIKIKNFFDAE-DYYIVLELMEGGELF---DKVVGNKRLKEATCKLYFYQMLL 125
Query: 786 ALEYLHCQGIIYRDLKPENVLLQG---NGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRH 842
A++YLH GII+RDLKPENVLL + + +TDF S
Sbjct: 126 AVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHS--------------------- 164
Query: 843 KGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAG---AGHTSAVDWWALGILLYEMLYGYT 899
K M + GT Y+APE++ AG+ AVD W+LG++L+ L GY
Sbjct: 165 KILGETSLM-------RTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYP 217
Query: 900 PFRGKTRQKT-FANILHKDLKFPSS--TPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIK 956
PF Q + I F S A L+ +LL DPK+R E
Sbjct: 218 PFSEHRTQVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARF----TTEEAL 273
Query: 957 KHPFFKG 963
+HP+ +
Sbjct: 274 RHPWLQD 280
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 188 bits (479), Expect = 2e-52
Identities = 72/353 (20%), Positives = 129/353 (36%), Gaps = 50/353 (14%)
Query: 624 KELPDANLTPEDLWANHSKVVHPKPHRKDSPPWKAIQKILDSGEQINLQHFRPIKPLGSG 683
+P + E A + P KA + + + + +K +GSG
Sbjct: 9 GLVPRGSGMKETAAAKFERQHMDSPDLGTDDDDKASSSANEC-ISVKGRIYSILKQIGSG 67
Query: 684 DTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHP--FVPALYASF 741
+ V V L Q +A+K ++ + + E L+ L + LY
Sbjct: 68 GSSKVFQV-LNEKKQIYAIKYVNLE-EADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYE 125
Query: 742 QTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLK 801
T ++ ++ + +L L ++ K + + Y ++ A+ +H GI++ DLK
Sbjct: 126 ITDQYIYMVMECG-NIDLNSWLKKK--KSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLK 182
Query: 802 PENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSF 861
P N L+ +G + L DF ++ + P T + +S
Sbjct: 183 PANFLIV-DGMLKLIDFGIA-------NQMQPDTTSVVK------------------DSQ 216
Query: 862 VGTEEYIAPEIIAGAG-----------HTSAVDWWALGILLYEMLYGYTPFRGKTRQ-KT 909
VG Y+ PE I + D W+LG +LY M YG TPF+ Q
Sbjct: 217 VGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISK 276
Query: 910 FANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFK 962
I+ + + + ++ L RDPK R+ E+ HP+ +
Sbjct: 277 LHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRI----SIPELLAHPYVQ 325
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 187 bits (477), Expect = 2e-52
Identities = 46/329 (13%), Positives = 89/329 (27%), Gaps = 83/329 (25%)
Query: 678 KPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREIL----------- 726
LG D + +G+ F + N + + E L
Sbjct: 79 TVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQ 138
Query: 727 -----------DMLDHPFVPALYASFQTKTHVCLITDY-------CPGGELFLLLDRQPT 768
D++ P + + + +++ + +L +
Sbjct: 139 AKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSS 198
Query: 769 --KVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSC 826
K L A +V+ L LH G+++ L+P +++L G V LT F+
Sbjct: 199 THKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDG- 257
Query: 827 KPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAG--------- 877
A + + PE+ A
Sbjct: 258 ------------------------------ARVVSSVSRGFEPPELEARRATISYHRDRR 287
Query: 878 --HTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMY 935
T + D WALG+++Y + P I P + L+
Sbjct: 288 TLMTFSFDAWALGLVIYWIWCADLPITKDAALGGSEWIFRSCKNIPQP------VRALLE 341
Query: 936 RLLHRDPKSRLGSHEGANEIKKHPFFKGV 964
L + RL + + P ++ +
Sbjct: 342 GFLRYPKEDRL----LPLQAMETPEYEQL 366
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 184 bits (469), Expect = 2e-52
Identities = 76/297 (25%), Positives = 126/297 (42%), Gaps = 37/297 (12%)
Query: 667 EQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREIL 726
++ + H+ LG G G V + E +G A+K +++ + + + V + E + L
Sbjct: 6 GRVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNL 65
Query: 727 DMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVA 786
+ HP + LY T T ++ +Y GGELF + + ++E R +++ A
Sbjct: 66 KLFRHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKH--GRVEEMEARRLFQQILSA 123
Query: 787 LEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQ 846
++Y H +++RDLKPENVLL + + + DF LS + L T
Sbjct: 124 VDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMM--SDGEFLRT------------ 169
Query: 847 NPVFMAEPMRASNSFVGTEEYIAPEIIAGAG-HTSAVDWWALGILLYEMLYGYTPFRGKT 905
G+ Y APE+I+G VD W+ G++LY +L G PF +
Sbjct: 170 --------------SCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEH 215
Query: 906 RQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFK 962
F I P S L+ +L DP R +I++H +FK
Sbjct: 216 VPTLFKKIRGGVFYIPEYLNRS--VATLLMHMLQVDPLKRATIK----DIREHEWFK 266
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 186 bits (474), Expect = 2e-52
Identities = 71/359 (19%), Positives = 131/359 (36%), Gaps = 56/359 (15%)
Query: 652 DSPPWKAIQKILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVML 711
+ PP + L + E Q + + PLGSG G V + +K + K +L
Sbjct: 4 EEPPKAVELEGLAACEGEYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVL 63
Query: 712 NRNKVHRACAER-----EILDMLDHPFVPALYASFQTKTHVCLITD-YCPGGELFLLLDR 765
+ + IL ++H + + F+ + L+ + + G +LF +DR
Sbjct: 64 EDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDR 123
Query: 766 QPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTS 825
P L E + ++V A+ YL + II+RD+K EN+++ + + L DF +
Sbjct: 124 HPR--LDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYL- 180
Query: 826 CKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHT-SAVDW 884
+ L T F GT EY APE++ G + ++
Sbjct: 181 -ERGKLFYT--------------------------FCGTIEYCAPEVLMGNPYRGPELEM 213
Query: 885 WALGILLYEMLYGYTPFRGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKS 944
W+LG+ LY +++ PF + + P S L+ LL P+
Sbjct: 214 WSLGVTLYTLVFEENPFCE------LEETVEAAIHPPY--LVSKELMSLVSGLLQPVPER 265
Query: 945 RLGSHEGANEIKKHPFFKGVNWALVRCMNPPELDAPLFATDTEKEYKVVDPGMQDLQQN 1003
R ++ P+ + +N + + E V+ ++
Sbjct: 266 RT----TLEKLVTDPWVT-------QPVNLADYTWEEVFRVNKPESGVLSAASLEMGNR 313
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 188 bits (480), Expect = 2e-52
Identities = 87/307 (28%), Positives = 129/307 (42%), Gaps = 51/307 (16%)
Query: 672 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAER-----EIL 726
+ K LGSG G V L + + A++ + K + A EIL
Sbjct: 135 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEIL 194
Query: 727 DMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDR-QPTKVLKEDAVRFYAAEVVV 785
L+HP + + F + ++ + GGELF D+ K LKE + Y ++++
Sbjct: 195 KKLNHPCIIKIKNFFDAE-DYYIVLELMEGGELF---DKVVGNKRLKEATCKLYFYQMLL 250
Query: 786 ALEYLHCQGIIYRDLKPENVLLQG---NGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRH 842
A++YLH GII+RDLKPENVLL + + +TDF S
Sbjct: 251 AVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHS--------------------- 289
Query: 843 KGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAG---AGHTSAVDWWALGILLYEMLYGYT 899
K M + GT Y+APE++ AG+ AVD W+LG++L+ L GY
Sbjct: 290 KILGETSLM-------RTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYP 342
Query: 900 PFRGKTRQKT-FANILHKDLKFPSS--TPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIK 956
PF Q + I F S A L+ +LL DPK+R E
Sbjct: 343 PFSEHRTQVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARF----TTEEAL 398
Query: 957 KHPFFKG 963
+HP+ +
Sbjct: 399 RHPWLQD 405
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 183 bits (467), Expect = 3e-52
Identities = 70/297 (23%), Positives = 125/297 (42%), Gaps = 41/297 (13%)
Query: 671 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLN-RNKVHRACAEREILDML 729
++ + ++ LG G G V L + + A+K +D ++ + + E I ML
Sbjct: 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKK---EICINKML 62
Query: 730 DHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKV-LKEDAVRFYAAEVVVALE 788
+H V Y + L +YC GGELF DR + + E + + +++ +
Sbjct: 63 NHENVVKFYGHRREGNIQYLFLEYCSGGELF---DRIEPDIGMPEPDAQRFFHQLMAGVV 119
Query: 789 YLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQL-LLPTTNEKKRRHKGQQN 847
YLH GI +RD+KPEN+LL ++ ++DF L+ + + LL
Sbjct: 120 YLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKM------------ 167
Query: 848 PVFMAEPMRASNSFVGTEEYIAPEIIAGAG-HTSAVDWWALGILLYEMLYGYTPFRGKTR 906
GT Y+APE++ H VD W+ GI+L ML G P+ +
Sbjct: 168 --------------CGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSD 213
Query: 907 -QKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFK 962
+ +++ K L++++L +P +R+ +IKK ++
Sbjct: 214 SCQEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARI----TIPDIKKDRWYN 266
|
| >3d72_A Vivid PAS protein VVD; circadian, photoreceptor, blue-light, LOV, signaling protein; HET: FAD; 1.65A {Neurospora crassa} PDB: 3is2_A* 2pd8_A* 3hjk_A* 2pdr_A* 2pd7_A* 2pdt_A* 3hji_A* 3rh8_B* Length = 149 | Back alignment and structure |
|---|
Score = 177 bits (451), Expect = 8e-52
Identities = 48/141 (34%), Positives = 76/141 (53%), Gaps = 26/141 (18%)
Query: 474 GIDLATTLERI--EKN-------------FVITDPRLPDNPIIFASDSFLELTEYSREEI 518
G D+ L +I N ++ D + D PI++AS++FL +T YS E+
Sbjct: 9 GYDIMGYLIQIMNRPNPQVELGPVDTSVALILCDLKQKDTPIVYASEAFLYMTGYSNAEV 68
Query: 519 LGRNCRFLQGPE-----------TDPATVRKIRAAIDNQTDVTVQLINYTKSGKKFWNLF 567
LGRNCRFLQ P+ D T+ +R AID +V V+++N+ K+G++F N
Sbjct: 69 LGRNCRFLQSPDGMVKPKSTRKYVDSNTINTMRKAIDRNAEVQVEVVNFKKNGQRFVNFL 128
Query: 568 HLQPMRDQKGEVQYFIGVQLD 588
+ P+RD+ GE +Y +G Q +
Sbjct: 129 TMIPVRDETGEYRYSMGFQCE 149
|
| >3d72_A Vivid PAS protein VVD; circadian, photoreceptor, blue-light, LOV, signaling protein; HET: FAD; 1.65A {Neurospora crassa} PDB: 3is2_A* 2pd8_A* 3hjk_A* 2pdr_A* 2pd7_A* 2pdt_A* 3hji_A* 3rh8_B* Length = 149 | Back alignment and structure |
|---|
Score = 169 bits (431), Expect = 5e-49
Identities = 38/112 (33%), Positives = 59/112 (52%), Gaps = 11/112 (9%)
Query: 205 FVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGAG-----------TDPEDV 253
++ D + D PI+YAS F MTGY++ EV+GRNCRFLQ D +
Sbjct: 38 LILCDLKQKDTPIVYASEAFLYMTGYSNAEVLGRNCRFLQSPDGMVKPKSTRKYVDSNTI 97
Query: 254 AKIRETLQNGQSYCGRLLNYKKDGTPFWNLLTIAPIKDDEGKVLKFIGMQVE 305
+R+ + ++N+KK+G F N LT+ P++D+ G+ +G Q E
Sbjct: 98 NTMRKAIDRNAEVQVEVVNFKKNGQRFVNFLTMIPVRDETGEYRYSMGFQCE 149
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 183 bits (467), Expect = 9e-52
Identities = 80/313 (25%), Positives = 124/313 (39%), Gaps = 57/313 (18%)
Query: 678 KPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPA 736
LG G V + Q +A+K ++K R++V R E E+L H V
Sbjct: 19 DVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFR---EVEMLYQCQGHRNVLE 75
Query: 737 LYASFQTKTHVCLITDYCPGGELFLLLDR-QPTKVLKEDAVRFYAAEVVVALEYLHCQGI 795
L F+ + L+ + GG + + E +V AL++LH +GI
Sbjct: 76 LIEFFEEEDRFYLVFEKMRGGSIL---SHIHKRRHFNELEASVVVQDVASALDFLHNKGI 132
Query: 796 IYRDLKPENVLLQGNGHVS---LTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMA 852
+RDLKPEN+L + VS + DFDL
Sbjct: 133 AHRDLKPENILCEHPNQVSPVKICDFDLG-----------------SGIKLNGDCSPIST 175
Query: 853 EPMRASNSFVGTEEYIAPEIIAGAGHTS-----AVDWWALGILLYEMLYGYTPFRGK--- 904
+ + G+ EY+APE++ + D W+LG++LY +L GY PF G+
Sbjct: 176 PELL---TPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGS 232
Query: 905 ------------TRQKTFANILHKDLKFPSS--TPTSLHAKQLMYRLLHRDPKSRLGSHE 950
+ F +I +FP S AK L+ +LL RD K RL
Sbjct: 233 DCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRL---- 288
Query: 951 GANEIKKHPFFKG 963
A ++ +HP+ +G
Sbjct: 289 SAAQVLQHPWVQG 301
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 180 bits (460), Expect = 1e-50
Identities = 69/296 (23%), Positives = 124/296 (41%), Gaps = 39/296 (13%)
Query: 671 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLN-RNKVHRACAEREILDML 729
++ + ++ LG G G V L + + A+K +D ++ + + E I ML
Sbjct: 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKK---EICINKML 62
Query: 730 DHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKV-LKEDAVRFYAAEVVVALE 788
+H V Y + L +YC GGELF DR + + E + + +++ +
Sbjct: 63 NHENVVKFYGHRREGNIQYLFLEYCSGGELF---DRIEPDIGMPEPDAQRFFHQLMAGVV 119
Query: 789 YLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNP 848
YLH GI +RD+KPEN+LL ++ ++DF L+ + + L
Sbjct: 120 YLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK------------- 166
Query: 849 VFMAEPMRASNSFVGTEEYIAPEIIAGAG-HTSAVDWWALGILLYEMLYGYTPFRGKTR- 906
GT Y+APE++ H VD W+ GI+L ML G P+ +
Sbjct: 167 ------------MCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDS 214
Query: 907 QKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFK 962
+ +++ K L++++L +P +R+ +IKK ++
Sbjct: 215 CQEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARI----TIPDIKKDRWYN 266
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 181 bits (462), Expect = 1e-50
Identities = 81/310 (26%), Positives = 119/310 (38%), Gaps = 45/310 (14%)
Query: 660 QKILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRA 719
LD + + +K +GSG+ G L+ + + A+K +++G V R
Sbjct: 8 TGPLDMPIMHDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERG-AAIDENVQR- 65
Query: 720 CAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFY 779
E L HP + T TH+ +I +Y GGEL+ + ED RF+
Sbjct: 66 --EIINHRSLRHPNIVRFKEVILTPTHLAIIMEYASGGELYERICNA--GRFSEDEARFF 121
Query: 780 AAEVVVALEYLHCQGIIYRDLKPENVLLQGN--GHVSLTDFDLSCLTSCKPQLLLPTTNE 837
+++ + Y H I +RDLK EN LL G+ + + DF S S +T
Sbjct: 122 FQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYS--KSSVLHSQPKST-- 177
Query: 838 KKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAG-HTSAVDWWALGILLYEMLY 896
VGT YIAPE++ D W+ G+ LY ML
Sbjct: 178 ------------------------VGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLV 213
Query: 897 GYTPFRGKTR----QKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGA 952
G PF +KT IL P S L+ R+ DP +R+
Sbjct: 214 GAYPFEDPEEPRDYRKTIQRILSVKYSIPDDIRISPECCHLISRIFVADPATRI----SI 269
Query: 953 NEIKKHPFFK 962
EIK H +F
Sbjct: 270 PEIKTHSWFL 279
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 179 bits (456), Expect = 2e-50
Identities = 73/313 (23%), Positives = 112/313 (35%), Gaps = 50/313 (15%)
Query: 678 KPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRN----KVHRACAEREILDMLDHPF 733
LG G G V V + A+K + K + V + E ++L L H
Sbjct: 11 DLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKK---EIQLLRRLRHKN 67
Query: 734 VPALY--ASFQTKTHVCLITDYCPGG--ELFLLLDRQPTKVLKEDAVRFYAAEVVVALEY 789
V L + K + ++ +YC G E+ D P K Y +++ LEY
Sbjct: 68 VIQLVDVLYNEEKQKMYMVMEYCVCGMQEML---DSVPEKRFPVCQAHGYFCQLIDGLEY 124
Query: 790 LHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSC-KPQLLLPTTNEKKRRHKGQQNP 848
LH QGI+++D+KP N+LL G + ++ ++ T+
Sbjct: 125 LHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTS------------- 171
Query: 849 VFMAEPMRASNSFVGTEEYIAPEIIAGAG--HTSAVDWWALGILLYEMLYGYTPFRGKTR 906
G+ + PEI G VD W+ G+ LY + G PF G
Sbjct: 172 -------------QGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNI 218
Query: 907 QKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFF-KGVN 965
K F NI P L+ +L +P R +I++H +F K
Sbjct: 219 YKLFENIGKGSYAIPGDCGPP--LSDLLKGMLEYEPAKRFSIR----QIRQHSWFRKKHP 272
Query: 966 WALVRCMNPPELD 978
A PP D
Sbjct: 273 PAEAPVPIPPSPD 285
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 180 bits (459), Expect = 3e-50
Identities = 52/357 (14%), Positives = 107/357 (29%), Gaps = 68/357 (19%)
Query: 641 SKVVHPKPHRKDSPPWKAIQKILDSGEQINL--QHFRPIKPLGSGDTGSVHLVE-----L 693
S + P ++ W+ + + L + LG G V+
Sbjct: 32 SGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLND 91
Query: 694 CGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDY 753
+ Q F +K N + + E L Y++ + L+ +
Sbjct: 92 AKNKQKFVLKVQKPA---NPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGEL 148
Query: 754 CPGGELFLLLDR---QPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQG- 809
G L ++ P KV+ + V +A ++ +E +H II+ D+KP+N +L
Sbjct: 149 YSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNG 208
Query: 810 ----------NGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASN 859
+ ++L D S P+ +F
Sbjct: 209 FLEQDDEDDLSAGLALIDLGQSIDMKLFPK-----------------GTIF--------T 243
Query: 860 SFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTP--------------FRGKT 905
+ T + E+++ +D++ + +Y ML+G FR
Sbjct: 244 AKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLP 303
Query: 906 RQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFK 962
+ H L P L + L+ + L + + + ++
Sbjct: 304 HLDMWNEFFHVMLNIPD--CHHLPSLDLLRQKLKKVFQQHYTNK---IRALRNRLIV 355
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 179 bits (455), Expect = 7e-50
Identities = 68/305 (22%), Positives = 112/305 (36%), Gaps = 65/305 (21%)
Query: 678 KPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDML---DHPFV 734
+ LG G G V +GQ A+K + A +E+ P +
Sbjct: 35 QVLGLGVNGKVLECFHRRTGQKCALKLLYD----------SPKARQEVDHHWQASGGPHI 84
Query: 735 PALYASFQTKTH----VCLITDYCPGGELFLLLDR---QPTKVLKEDAVRFYAAEVVVAL 787
+ ++ H + +I + GGELF R + + E ++ A+
Sbjct: 85 VCILDVYENMHHGKRCLLIIMECMEGGELF---SRIQERGDQAFTEREAAEIMRDIGTAI 141
Query: 788 EYLHCQGIIYRDLKPENVLLQGNGHVS---LTDFDLSCLTSCKPQLLLPTTNEKKRRHKG 844
++LH I +RD+KPEN+L + LTDF + K
Sbjct: 142 QFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFA---------------------KE 180
Query: 845 QQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGK 904
+ T Y+APE++ + + D W+LG+++Y +L G+ PF
Sbjct: 181 TTQNALQ--------TPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSN 232
Query: 905 TRQKTFANILHK----DLKFPSS--TPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKH 958
T Q + + FP+ + S AKQL+ LL DP RL + H
Sbjct: 233 TGQAISPGMKRRIRLGQYGFPNPEWSEVSEDAKQLIRLLLKTDPTERL----TITQFMNH 288
Query: 959 PFFKG 963
P+
Sbjct: 289 PWINQ 293
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 181 bits (462), Expect = 2e-49
Identities = 79/330 (23%), Positives = 132/330 (40%), Gaps = 49/330 (14%)
Query: 667 EQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREIL 726
++ + H+ LG G G V + + +G A+K +++ + + + V + E + L
Sbjct: 11 GRVKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNL 70
Query: 727 DMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVA 786
+ HP + LY T + + ++ +Y GGELF + + L E R +++
Sbjct: 71 KLFRHPHIIKLYQVISTPSDIFMVMEYVSGGELFDYICKN--GRLDEKESRRLFQQILSG 128
Query: 787 LEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQ 846
++Y H +++RDLKPENVLL + + + DF LS + L T
Sbjct: 129 VDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMM--SDGEFLRT------------ 174
Query: 847 NPVFMAEPMRASNSFVGTEEYIAPEIIAGAG-HTSAVDWWALGILLYEMLYGYTPFRGKT 905
G+ Y APE+I+G VD W+ G++LY +L G PF
Sbjct: 175 --------------SCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDH 220
Query: 906 RQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVN 965
F I P S L+ +L DP R +I++H +FK
Sbjct: 221 VPTLFKKICDGIFYTPQYLNPS--VISLLKHMLQVDPMKRATIK----DIREHEWFK--- 271
Query: 966 WALVRCMNPPELDAPLFATDTEKEYKVVDP 995
+L LF D ++D
Sbjct: 272 ---------QDLPKYLFPEDPSYSSTMIDD 292
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 178 bits (452), Expect = 3e-49
Identities = 62/410 (15%), Positives = 117/410 (28%), Gaps = 94/410 (22%)
Query: 592 HLEPLRNSIPEATAEESEKLVKQTAENVNEAVKELPDANLTPEDLWANHSKVVHPKPHRK 651
H+E + + + E E + E + E + +W +++ +
Sbjct: 3 HMEAGDSFMRDLLKREEELIGYCREEALKEPAAMV---EAVTATVWPQNAETTVDSLLSQ 59
Query: 652 DSPPWKAIQKILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVML 711
+ + ++PL GD V LV + FA+K G
Sbjct: 60 GE------------------RKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAEN 101
Query: 712 NRNKVHRACAEREILDMLDHPFVPALYASFQ--------------------------TKT 745
+R+++ R L +
Sbjct: 102 SRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVA 161
Query: 746 HVCLITDYCPG--GELFLLLDRQPTK--VLKEDAVRFYAAEVVVALEYLHCQGIIYRDLK 801
+ L+ LF LD A+ A+++ L +G+++
Sbjct: 162 NYLLLMPAASVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFT 221
Query: 802 PENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSF 861
P+N+ + +G + L D + +
Sbjct: 222 PDNLFIMPDGRLMLGDVSAL------------------------------WKVGTRGPAS 251
Query: 862 VGTEEYIAPEII--AGAGHTSAVDWWALGILLYEMLYGYTPFRGKT-------RQKTFAN 912
Y E + + A T A++ W LG+ +Y + + PF T ++ +
Sbjct: 252 SVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKGSWKRPSLRV 311
Query: 913 ILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFK 962
L F S TP K L+ R L+ D + RL E + P F
Sbjct: 312 PGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRL----LPLEAMETPEFL 357
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 178 bits (452), Expect = 7e-49
Identities = 48/339 (14%), Positives = 91/339 (26%), Gaps = 72/339 (21%)
Query: 678 KPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREIL----------- 726
LG D + +G+ F + N + + E L
Sbjct: 84 TVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQ 143
Query: 727 -----------DMLDHPFVPALYASFQTKTHVCLITDY-------CPGGELFLLLDRQPT 768
D++ P + + + +++ + +L +
Sbjct: 144 AKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSS 203
Query: 769 --KVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSC 826
K L A +V+ L LH G+++ L+P +++L G V LT F+
Sbjct: 204 THKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLV---- 259
Query: 827 KPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGH-----TSA 881
A + E A ++ H T A
Sbjct: 260 ----------------------RDGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFA 297
Query: 882 VDWWALGILLYEMLYGYTPFRGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRD 941
D W LG+ +Y + P I P + L+ L
Sbjct: 298 FDTWTLGLAIYWIWCADLPNTDDAALGGSEWIFRSCKNIPQP------VRALLEGFLRYP 351
Query: 942 PKSRLGSHEGANEIKKHPFFKGVNWALVRCMNPPELDAP 980
+ RL + + P ++ + L + + D
Sbjct: 352 KEDRL----LPLQAMETPEYEQLRTELSAALPLYQTDGE 386
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 174 bits (444), Expect = 2e-48
Identities = 85/301 (28%), Positives = 132/301 (43%), Gaps = 42/301 (13%)
Query: 665 SGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAERE 724
+ + ++ + + LG G G V L + Q A+K + + ++ + R ERE
Sbjct: 2 AISKRHIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRV--ERE 59
Query: 725 I--LDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAE 782
I L +L HP + LY T T + ++ +Y GGELF + + K + ED R + +
Sbjct: 60 ISYLKLLRHPHIIKLYDVITTPTDIVMVIEYA-GGELFDYIVEK--KRMTEDEGRRFFQQ 116
Query: 783 VVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRH 842
++ A+EY H I++RDLKPEN+LL N +V + DF LS + L T
Sbjct: 117 IICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIM--TDGNFLKT-------- 166
Query: 843 KGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAG-HTSAVDWWALGILLYEMLYGYTPF 901
G+ Y APE+I G VD W+ GI+LY ML G PF
Sbjct: 167 ------------------SCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPF 208
Query: 902 RGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFF 961
+ F + P A+ L+ R++ DP R+ EI++ P+F
Sbjct: 209 DDEFIPNLFKKVNSCVYVMPDFLSPG--AQSLIRRMIVADPMQRI----TIQEIRRDPWF 262
Query: 962 K 962
Sbjct: 263 N 263
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 175 bits (445), Expect = 7e-48
Identities = 69/338 (20%), Positives = 118/338 (34%), Gaps = 64/338 (18%)
Query: 645 HPKPHRKDSPPWKAIQKILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKA 704
P P + P + + I + + LG G G V + + + FA+K
Sbjct: 35 PPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKM 94
Query: 705 MDKGVMLNRNKVHRACAEREI---LDMLDHPFVPALYASFQT----KTHVCLITDYCPGG 757
+ A RE+ P + + ++ + + ++ + GG
Sbjct: 95 LQD----------CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGG 144
Query: 758 ELFLLLDR---QPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVS 814
ELF R + + E + A++YLH I +RD+KPEN+L +
Sbjct: 145 ELF---SRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNA 201
Query: 815 ---LTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPE 871
LTDF + T+ L + T Y+APE
Sbjct: 202 ILKLTDFGFAKETTSHNSL----------------------------TTPCYTPYYVAPE 233
Query: 872 IIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKT----FANILHKDLKFPSS--TP 925
++ + + D W+LG+++Y +L GY PF I +FP+ +
Sbjct: 234 VLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSE 293
Query: 926 TSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKG 963
S K L+ LL +P R+ E HP+
Sbjct: 294 VSEEVKMLIRNLLKTEPTQRM----TITEFMNHPWIMQ 327
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 172 bits (438), Expect = 1e-47
Identities = 70/343 (20%), Positives = 116/343 (33%), Gaps = 44/343 (12%)
Query: 668 QINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILD 727
++ R + L G V+ + GSG+ +A+K + + + E +
Sbjct: 24 ELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQ---EVCFMK 80
Query: 728 ML-DHPFVPALYASFQTKTH--------VCLITDYCPGGELFLLLDRQPTKVLKEDAVRF 778
L HP + ++ L+T+ C G + L + L D V
Sbjct: 81 KLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLK 140
Query: 779 YAAEVVVALEYLHCQG--IIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTN 836
+ A++++H Q II+RDLK EN+LL G + L DF + S P
Sbjct: 141 IFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQR 200
Query: 837 EKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGH---TSAVDWWALGILLYE 893
+ +N T Y PEII + D WALG +LY
Sbjct: 201 RALVEEEITRN---------------TTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYL 245
Query: 894 MLYGYTPFRGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGAN 953
+ + PF + + I++ P L+ +L +P+ RL
Sbjct: 246 LCFRQHPFEDGAKLR----IVNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERL----SIA 297
Query: 954 EIKKHPFFKGVNWALVRCMNPPELDAPLFATDTEKEYKVVDPG 996
E+ A R +NP L + + G
Sbjct: 298 EVVHQLQ----EIAAARNVNPKSPITELLEQNGGYGSATLSRG 336
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 178 bits (453), Expect = 5e-47
Identities = 73/325 (22%), Positives = 122/325 (37%), Gaps = 66/325 (20%)
Query: 673 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHP 732
+ + LG+G G V +G+ A+K + L+ R C E +I+ L+HP
Sbjct: 15 PWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQ--ELSPKNRERWCLEIQIMKKLNHP 72
Query: 733 FVPALYASFQTKTHV------CLITDYCPGGELF-LLLDRQPTKVLKEDAVRFYAAEVVV 785
V + + L +YC GG+L L + LKE +R +++
Sbjct: 73 NVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISS 132
Query: 786 ALEYLHCQGIIYRDLKPENVLLQGNGHVS---LTDFDLSCLTSCKPQLLLPTTNEKKRRH 842
AL YLH II+RDLKPEN++LQ + D + L
Sbjct: 133 ALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYA--KELDQGELCTE-------- 182
Query: 843 KGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFR 902
FVGT +Y+APE++ +T VD+W+ G L +E + G+ PF
Sbjct: 183 ------------------FVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFL 224
Query: 903 GKTRQKTFANILHK--------------DLKFPSSTPTSLH--------AKQLMYRLLHR 940
+ + + + +KF S PT H ++ + +L
Sbjct: 225 PNWQPVQWHGKVREKSNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMW 284
Query: 941 DPKSRLGSHEGANEIKKHPFFKGVN 965
+ R + F+ ++
Sbjct: 285 HQRQRGTDP----QNPNVGCFQALD 305
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 169 bits (431), Expect = 6e-47
Identities = 76/327 (23%), Positives = 118/327 (36%), Gaps = 53/327 (16%)
Query: 646 PKPHRKDSPPWKAIQKILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAM 705
+PP + +R LG G G+V A+K +
Sbjct: 5 KPLQGPPAPPGTPTPPPGGKDREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVI 64
Query: 706 DKGVMLNRNKVHRACA-EREI--LDMLD----HPFVPALYASFQTKTHVCLITDY-CPGG 757
+ +L + + + E+ L + HP V L F+T+ L+ + P
Sbjct: 65 PRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQ 124
Query: 758 ELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLL-QGNGHVSLT 816
+LF + + L E R + +VV A+++ H +G+++RD+K EN+L+ G L
Sbjct: 125 DLFDYITEK--GPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLI 182
Query: 817 DFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGA 876
DF L + F GT Y PE I+
Sbjct: 183 DFGSGALL--HDEPY---------------------------TDFDGTRVYSPPEWISRH 213
Query: 877 G-HTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMY 935
H W+LGILLY+M+ G PF IL +L FP+ S L+
Sbjct: 214 QYHALPATVWSLGILLYDMVCGDIPFERDQE------ILEAELHFPAH--VSPDCCALIR 265
Query: 936 RLLHRDPKSRLGSHEGANEIKKHPFFK 962
R L P SR EI P+ +
Sbjct: 266 RCLAPKPSSRP----SLEEILLDPWMQ 288
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 171 bits (435), Expect = 3e-46
Identities = 62/311 (19%), Positives = 113/311 (36%), Gaps = 48/311 (15%)
Query: 664 DSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAER 723
S + F P LG G G++ + + A+K + A E
Sbjct: 16 TSVVIVGKISFCPKDVLGHGAEGTIVYRGMF-DNRDVAVKRILP------ECFSFADREV 68
Query: 724 EILDMLD-HPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAE 782
++L D HP V + + + + + + C L ++ Q +
Sbjct: 69 QLLRESDEHPNVIRYFCTEKDRQFQYIAIELC-AATLQEYVE-QKDFAHLGLEPITLLQQ 126
Query: 783 VVVALEYLHCQGIIYRDLKPENVLLQGNGH-----VSLTDFDLSCLTSCKPQLLLPTTNE 837
L +LH I++RDLKP N+L+ ++DF L
Sbjct: 127 TTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLC---------------- 170
Query: 838 KKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAG---AGHTSAVDWWALGILLYEM 894
K+ G+ + + GTE +IAPE+++ T VD ++ G + Y +
Sbjct: 171 -KKLAVGRHSFSRR-------SGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYV 222
Query: 895 L-YGYTPFRGKTRQKTFANILHKDLKFPSSTPT-SLHAKQLMYRLLHRDPKSRLGSHEGA 952
+ G PF +++ + L + A++L+ +++ DP+ R A
Sbjct: 223 ISEGSHPFGKSLQRQANILLGACSLDCLHPEKHEDVIARELIEKMIAMDPQKRP----SA 278
Query: 953 NEIKKHPFFKG 963
+ KHPFF
Sbjct: 279 KHVLKHPFFWS 289
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 168 bits (427), Expect = 3e-46
Identities = 52/296 (17%), Positives = 114/296 (38%), Gaps = 26/296 (8%)
Query: 671 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLD 730
L+H ++ + + + ++ D + + + + + +D
Sbjct: 61 LEHPGIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLS-SPSPMDAPSVKIRRMDPFS 119
Query: 731 HPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQ-PTKVLKEDAVRFYAAEVVVALEY 789
K ++ + C L ++R+ + + ++ A+E+
Sbjct: 120 TKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEF 179
Query: 790 LHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPV 849
LH +G+++RDLKP N+ + V + DF L + E++
Sbjct: 180 LHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVT--------AMDQDEEEQTVLTPM---- 227
Query: 850 FMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKT 909
VGT+ Y++PE I G ++ VD ++LG++L+E+LY ++ R +
Sbjct: 228 ---PAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFST--QMERVRI 282
Query: 910 FANILHKDLKFPS-STPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGV 964
++ ++LKFP T ++ +L P R A +I ++ F+ +
Sbjct: 283 ITDV--RNLKFPLLFTQKYPQEHMMVQDMLSPSPTERP----EATDIIENAIFENL 332
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 49.1 bits (117), Expect = 3e-06
Identities = 20/85 (23%), Positives = 33/85 (38%), Gaps = 4/85 (4%)
Query: 671 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVM-LNRNKVHRACAEREILDML 729
L F PI+ +G G G V + +A+K + L R KV R E + L L
Sbjct: 5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMR---EVKALAKL 61
Query: 730 DHPFVPALYASFQTKTHVCLITDYC 754
+HP + + ++ +
Sbjct: 62 EHPGIVRYFNAWLETPPEKWQEEMD 86
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 167 bits (426), Expect = 3e-46
Identities = 74/333 (22%), Positives = 123/333 (36%), Gaps = 51/333 (15%)
Query: 641 SKVVHPKPHRKDSPPWKAIQKILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYF 700
S +V H A + ++ ++ LGSG GSV+
Sbjct: 12 SGLVPRGSHMAPCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPV 71
Query: 701 AMKAMDKGVMLNRNKV-HRACAEREI--LDMLDH--PFVPALYASFQTKTHVCLITDYC- 754
A+K ++K + + ++ + E+ L + V L F+ LI +
Sbjct: 72 AIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPE 131
Query: 755 PGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGN-GHV 813
P +LF + + L+E+ R + +V+ A+ + H G+++RD+K EN+L+ N G +
Sbjct: 132 PVQDLFDFITER--GALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGEL 189
Query: 814 SLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEII 873
L DF L K + F GT Y PE I
Sbjct: 190 KLIDFGSGALL--KDTVY---------------------------TDFDGTRVYSPPEWI 220
Query: 874 AGAG-HTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANILHKDLKFPSSTPTSLHAKQ 932
H + W+LGILLY+M+ G PF I+ + F + +
Sbjct: 221 RYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIRGQVFFRQRVSSE--CQH 272
Query: 933 LMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVN 965
L+ L P R EI+ HP+ + V
Sbjct: 273 LIRWCLALRPSDRPTFE----EIQNHPWMQDVL 301
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 164 bits (417), Expect = 6e-44
Identities = 72/335 (21%), Positives = 126/335 (37%), Gaps = 69/335 (20%)
Query: 663 LDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAE 722
+ + EQ K LG G +G+V G+ A+K M + A E
Sbjct: 6 IPNFEQSLKNLVVSEKILGYGSSGTVVFQGSF-QGRPVAVKRMLI------DFCDIALME 58
Query: 723 REILDMLD-HPFVPALYASFQTKTHVCLITDYCPGGELFLLLDR-----QPTKVLKEDAV 776
++L D HP V Y S T + + + C L L++ + K+ KE
Sbjct: 59 IKLLTESDDHPNVIRYYCSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNP 117
Query: 777 RFYAAEVVVALEYLHCQGIIYRDLKPENVLL-------------QGNGHVSLTDFDLSCL 823
++ + +LH II+RDLKP+N+L+ N + ++DF L
Sbjct: 118 ISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLC-- 175
Query: 824 TSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGH----- 878
K+ GQ + N+ GT + APE++ + +
Sbjct: 176 ---------------KKLDSGQSS------FRTNLNNPSGTSGWRAPELLEESNNLQTKR 214
Query: 879 --TSAVDWWALGILLYEML-YGYTPFRGKTRQKTFANILHKDLKFPSSTPT-----SLHA 930
T ++D +++G + Y +L G PF K ++ +NI+ A
Sbjct: 215 RLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE--SNIIRGIFSLDEMKCLHDRSLIAEA 272
Query: 931 KQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVN 965
L+ +++ DP R A ++ +HP F +
Sbjct: 273 TDLISQMIDHDPLKRP----TAMKVLRHPLFWPKS 303
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 157 bits (400), Expect = 5e-43
Identities = 55/303 (18%), Positives = 105/303 (34%), Gaps = 39/303 (12%)
Query: 671 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREI---LD 727
F ++ +GSG+ GSV G +A+K K + V A RE+
Sbjct: 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLA---GSVDEQNALREVYAHAV 66
Query: 728 MLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLD--RQPTKVLKEDAVRFYAAEVVV 785
+ H V ++++ H+ + +YC GG L + + KE ++ +V
Sbjct: 67 LGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGR 126
Query: 786 ALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHK-- 843
L Y+H +++ D+KP N+ + + + +++ K
Sbjct: 127 GLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMF----------KIG 176
Query: 844 --GQQNPVFMAEPMRASNSFVGTEEYIAPEIIAG-AGHTSAVDWWALGILLYEMLYGYTP 900
G + + G ++A E++ H D +AL + +
Sbjct: 177 DLG------HVTRISSPQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPL 230
Query: 901 FRGKTRQKTFANILHKDL-KFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHP 959
R + I L + P S +L+ ++H DP+ R A + KH
Sbjct: 231 PRNG---DQWHEIRQGRLPRIPQV--LSQEFTELLKVMIHPDPERRP----SAMALVKHS 281
Query: 960 FFK 962
Sbjct: 282 VLL 284
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 153 bits (388), Expect = 6e-41
Identities = 65/328 (19%), Positives = 118/328 (35%), Gaps = 38/328 (11%)
Query: 637 WANHSKVVHPKPHRKDSPPWKAIQKILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGS 696
+ + + P+ + K +D + + +G G G VH ++ +
Sbjct: 23 GSAKLQRLGPETEDNEGVLLTEKLKPVDYEYREEVHWMTHQPRVGRGSFGEVHRMKDKQT 82
Query: 697 GQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPG 756
G A+K + V E L P + LY + + V + + G
Sbjct: 83 GFQCAVKKVRLEVFRVE--------ELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEG 134
Query: 757 GELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNG-HVSL 815
G L L+ + L ED +Y + + LEYLH + I++ D+K +NVLL +G +L
Sbjct: 135 GSLGQLI--KQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAAL 192
Query: 816 TDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAG 875
DF + P + + + + GTE ++APE++ G
Sbjct: 193 CDFGHA----------------------LCLQPDGLGKSLLTGDYIPGTETHMAPEVVMG 230
Query: 876 AGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANILHKD-LKFPSSTPTSLHAKQLM 934
+ VD W+ ++ ML G P+ R I + + Q +
Sbjct: 231 KPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIREIPPSCAPLTAQAI 290
Query: 935 YRLLHRDPKSRLGSHEGANEIKKHPFFK 962
L ++P R A E+++
Sbjct: 291 QEGLRKEPVHRA----SAMELRRKVGKA 314
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 152 bits (385), Expect = 6e-41
Identities = 61/305 (20%), Positives = 100/305 (32%), Gaps = 85/305 (27%)
Query: 678 KPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREI---LDMLDHPFV 734
+ LG G G V + + + FA+K + A RE+ P +
Sbjct: 24 QVLGLGINGKVLQIFNKRTQEKFALKMLQD----------CPKARREVELHWRASQCPHI 73
Query: 735 PALYASFQT----KTHVCLITDYCPGGELFLLLDR---QPTKVLKEDAVRFYAAEVVVAL 787
+ ++ + + ++ + GGELF R + + E + A+
Sbjct: 74 VRIVDVYENLYAGRKCLLIVMECLDGGELF---SRIQDRGDQAFTEREASEIMKSIGEAI 130
Query: 788 EYLHCQGIIYRDLKPENVLLQ---GNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKG 844
+YLH I +RD+KPEN+L N + LTDF
Sbjct: 131 QYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGF------------------------ 166
Query: 845 QQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGK 904
A E + + D W+LG+++Y +L GY PF
Sbjct: 167 ------------------------AKETTGE-KYDKSCDMWSLGVIMYILLCGYPPFYSN 201
Query: 905 TRQKT----FANILHKDLKFPSS--TPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKH 958
I +FP+ + S K L+ LL +P R+ E H
Sbjct: 202 HGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRM----TITEFMNH 257
Query: 959 PFFKG 963
P+
Sbjct: 258 PWIMQ 262
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 5e-36
Identities = 62/280 (22%), Positives = 107/280 (38%), Gaps = 22/280 (7%)
Query: 669 INLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDM 728
+ LG G G V +G+ MK + + + + E +++
Sbjct: 7 FRPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLK---EVKVMRC 63
Query: 729 LDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALE 788
L+HP V + IT+Y GG L ++ ++ V F A ++ +
Sbjct: 64 LEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSF-AKDIASGMA 122
Query: 789 YLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNP 848
YLH II+RDL N L++ N +V + DF L+ L+ + + + P
Sbjct: 123 YLHSMNIIHRDLNSHNCLVRENKNVVVADFGLAR--------LMVDEKTQPEGLRSLKKP 174
Query: 849 VFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKT-RQ 907
+ + VG ++APE+I G + VD ++ GI+L E++ R
Sbjct: 175 DR-----KKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRT 229
Query: 908 KTFANILHK--DLKFPSSTPTSLHAKQLMYRLLHRDPKSR 945
F + D P + P S + R DP+ R
Sbjct: 230 MDFGLNVRGFLDRYCPPNCPPSFF--PITVRCCDLDPEKR 267
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 2e-35
Identities = 61/289 (21%), Positives = 110/289 (38%), Gaps = 49/289 (16%)
Query: 665 SGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAERE 724
S I+ + + +G G G V + + A+K + + ++ E
Sbjct: 1 SLHMIDYKEIEVEEVVGRGAFGVVCKAKWRA--KDVAIK-----QIESESERKAFIVELR 53
Query: 725 ILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELF-LLLDRQPTKVLKEDAVRFYAAEV 783
L ++HP + LY + VCL+ +Y GG L+ +L +P + +
Sbjct: 54 QLSRVNHPNIVKLYGA--CLNPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQC 111
Query: 784 VVALEYLHC---QGIIYRDLKPENVLLQGNGHVS-LTDFDLSCLTSCKPQLLLPTTNEKK 839
+ YLH + +I+RDLKP N+LL G V + DF +C
Sbjct: 112 SQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTAC----------------- 154
Query: 840 RRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYT 899
+ M + G+ ++APE+ G+ ++ D ++ GI+L+E++
Sbjct: 155 ----------DIQTHM---TNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRK 201
Query: 900 PFRG-KTRQKTFANILHKDL--KFPSSTPTSLHAKQLMYRLLHRDPKSR 945
PF +H + P + + LM R +DP R
Sbjct: 202 PFDEIGGPAFRIMWAVHNGTRPPLIKNLPKPI--ESLMTRCWSKDPSQR 248
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 2e-35
Identities = 78/312 (25%), Positives = 124/312 (39%), Gaps = 49/312 (15%)
Query: 669 INLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDM 728
IN + + +GSG T V + A+K ++ L + + +EI M
Sbjct: 12 INRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRIN----LEKCQTSMDELLKEIQAM 67
Query: 729 --LDHPFVPALYASFQTKTHVCLITDYCPGGELFLLL------DRQPTKVLKEDAVRFYA 780
HP + + Y SF K + L+ GG + ++ + VL E +
Sbjct: 68 SQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATIL 127
Query: 781 AEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLS-CLTSCKPQLLLPTTNEKK 839
EV+ LEYLH G I+RD+K N+LL +G V + DF +S L + T K
Sbjct: 128 REVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATG-----GDITRNKV 182
Query: 840 RRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIA-GAGHTSAVDWWALGILLYEMLYGY 898
R +FVGT ++APE++ G+ D W+ GI E+ G
Sbjct: 183 R------------------KTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGA 224
Query: 899 TPFRGKTRQKTFANILHKD---LKFPSSTPTSLHA-----KQLMYRLLHRDPKSRLGSHE 950
P+ K L D L+ L ++++ L +DP+ R
Sbjct: 225 APYHKYPPMKVLMLTLQNDPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRP---- 280
Query: 951 GANEIKKHPFFK 962
A E+ +H FF+
Sbjct: 281 TAAELLRHKFFQ 292
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 3e-35
Identities = 70/288 (24%), Positives = 110/288 (38%), Gaps = 39/288 (13%)
Query: 680 LGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYA 739
LG G G V+ + A+K + + E + L H +
Sbjct: 30 LGKGTYGIVYAGRDLSNQVRIAIKEIP---ERDSRYSQPLHEEIALHKHLKHKNIVQYLG 86
Query: 740 SFQTKTHVCLITDYCPGGELFLLLDRQPTKV-LKEDAVRFYAAEVVVALEYLHCQGIIYR 798
SF + + + PGG L LL + + E + FY +++ L+YLH I++R
Sbjct: 87 SFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHR 146
Query: 799 DLKPENVLL-QGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRA 857
D+K +NVL+ +G + ++DF S KR +A
Sbjct: 147 DIKGDNVLINTYSGVLKISDFGTS-----------------KR----------LAGINPC 179
Query: 858 SNSFVGTEEYIAPEIIAGA--GHTSAVDWWALGILLYEMLYGYTPFRG-KTRQKTFANIL 914
+ +F GT +Y+APEII G+ A D W+LG + EM G PF Q +
Sbjct: 180 TETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVG 239
Query: 915 HKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFK 962
+ S AK + + DP R AN++ F K
Sbjct: 240 MFKVHPEIPESMSAEAKAFILKCFEPDPDKRA----CANDLLVDEFLK 283
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 3e-35
Identities = 65/300 (21%), Positives = 118/300 (39%), Gaps = 37/300 (12%)
Query: 652 DSPPWKAIQKILDSGE---QINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKG 708
D K ++ L + ++ F I LG+G+ G V V SG A K +
Sbjct: 10 DEQQRKRLEAFLTQKQKVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIH-- 67
Query: 709 VMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPT 768
+ + ++ E ++L + P++ Y +F + + + ++ GG L +L +
Sbjct: 68 LEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKK--A 125
Query: 769 KVLKEDAVRFYAAEVVVALEYLHCQG-IIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCK 827
+ E + + V+ L YL + I++RD+KP N+L+ G + L DF +S
Sbjct: 126 GRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVS------ 179
Query: 828 PQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWAL 887
GQ + + M NSFVGT Y++PE + G ++ D W++
Sbjct: 180 ----------------GQ-----LIDSMA--NSFVGTRSYMSPERLQGTHYSVQSDIWSM 216
Query: 888 GILLYEMLYGYTPFRGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLG 947
G+ L EM G P ++ + + TP D + +
Sbjct: 217 GLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDSRPPMA 276
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 4e-35
Identities = 63/313 (20%), Positives = 113/313 (36%), Gaps = 39/313 (12%)
Query: 640 HSKVVHPKPHRKDSPPWKAIQKILDSGEQ--INLQHFRPIKPLGSGDTGSVHLVELCGSG 697
H HP + G+ I + +G+G G+VH E G
Sbjct: 3 HHHHHHPMSDYDIPTTENLYFQGAMDGDDMDIPWCDLNIKEKIGAGSFGTVHRAEWHG-- 60
Query: 698 QYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGG 757
A+K + + +V+ E I+ L HP + + ++ ++T+Y G
Sbjct: 61 SDVAVKIL-MEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRG 119
Query: 758 ELF-LLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQG--IIYRDLKPENVLLQGNGHVS 814
L+ LL + L E A +V + YLH + I++R+LK N+L+ V
Sbjct: 120 SLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVK 179
Query: 815 LTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIA 874
+ DF LS A +S S GT E++APE++
Sbjct: 180 VCDFGLSR---------------------------LKASTFLSSKSAAGTPEWMAPEVLR 212
Query: 875 GAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANILHKDLK--FPSSTPTSLHAKQ 932
D ++ G++L+E+ P+ + A + K + P + +
Sbjct: 213 DEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIPRNLNPQV--AA 270
Query: 933 LMYRLLHRDPKSR 945
++ +P R
Sbjct: 271 IIEGCWTNEPWKR 283
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 5e-35
Identities = 62/292 (21%), Positives = 116/292 (39%), Gaps = 47/292 (16%)
Query: 680 LGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYA 739
+G G +V+ + A + L +++ R E E+L L HP + Y
Sbjct: 34 IGRGSFKTVYKGLDTETTVEVAWCELQDR-KLTKSERQRFKEEAEMLKGLQHPNIVRFYD 92
Query: 740 SF----QTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQG- 794
S+ + K + L+T+ G L L R KV+K +R + +++ L++LH +
Sbjct: 93 SWESTVKGKKCIVLVTELMTSGTLKTYLKR--FKVMKIKVLRSWCRQILKGLQFLHTRTP 150
Query: 795 -IIYRDLKPENVLLQG-NGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMA 852
II+RDLK +N+ + G G V + D L+ L
Sbjct: 151 PIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS------------------------- 185
Query: 853 EPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFAN 912
+ + +GT E++APE+ + +VD +A G+ + EM P+
Sbjct: 186 ----FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYR 240
Query: 913 ILHKDLKFPSSTP--TSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFK 962
+ +K P+S K+++ + ++ R ++ H FF+
Sbjct: 241 RVTSGVK-PASFDKVAIPEVKEIIEGCIRQNKDERY----SIKDLLNHAFFQ 287
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 7e-35
Identities = 79/298 (26%), Positives = 125/298 (41%), Gaps = 51/298 (17%)
Query: 672 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDM--L 729
+ F ++ +G G G V + + A+K +D L + ++EI +
Sbjct: 22 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIID----LEEAEDEIEDIQQEITVLSQC 77
Query: 730 DHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEY 789
D P+V Y S+ T + +I +Y GG LL+ L E + E++ L+Y
Sbjct: 78 DSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLE---PGPLDETQIATILREILKGLDY 134
Query: 790 LHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPV 849
LH + I+RD+K NVLL +G V L DF ++ QL T+ + +R
Sbjct: 135 LHSEKKIHRDIKAANVLLSEHGEVKLADFGVAG------QL----TDTQIKR-------- 176
Query: 850 FMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKT 909
N+FVGT ++APE+I + + S D W+LGI E+ G P K
Sbjct: 177 ---------NTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKV 227
Query: 910 FANILHKDLKFPSSTPT-----SLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFK 962
I + PT S K+ + L+++P R A E+ KH F
Sbjct: 228 LFLIPKNN------PPTLEGNYSKPLKEFVEACLNKEPSFRP----TAKELLKHKFIL 275
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 1e-34
Identities = 76/294 (25%), Positives = 128/294 (43%), Gaps = 42/294 (14%)
Query: 672 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDH 731
+G G TG V L SG+ A+K MD + + + E I+ H
Sbjct: 45 LLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMD---LRKQQRRELLFNEVVIMRDYQH 101
Query: 732 PFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLH 791
V +Y S+ + ++ ++ GG L ++ + L E+ + V+ AL YLH
Sbjct: 102 FNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQVR---LNEEQIATVCEAVLQALAYLH 158
Query: 792 CQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFM 851
QG+I+RD+K +++LL +G V L+DF Q+ + + +R
Sbjct: 159 AQGVIHRDIKSDSILLTLDGRVKLSDFGFCA------QI----SKDVPKR---------- 198
Query: 852 AEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFA 911
S VGT ++APE+I+ + + + VD W+LGI++ EM+ G P+ + +
Sbjct: 199 -------KSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMK 251
Query: 912 NILHKD---LKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFK 962
+ LK L + + R+L RDP+ R A E+ HPF
Sbjct: 252 RLRDSPPPKLKNSHKVSPVL--RDFLERMLVRDPQER----ATAQELLDHPFLL 299
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 1e-34
Identities = 71/316 (22%), Positives = 117/316 (37%), Gaps = 54/316 (17%)
Query: 662 ILDSGEQ---INLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHR 718
L G Q + + +GSG G V + +G A+K M + NK
Sbjct: 12 YLTIGGQRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMR----RSGNKEEN 67
Query: 719 ACAEREI---LDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDA 775
++ L D P++ + +F T T V + + L ++ + E
Sbjct: 68 KRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELMGTC--AEKLKKRMQGPIPERI 125
Query: 776 VRFYAAEVVVALEYLHCQ-GIIYRDLKPENVLLQGNGHVSLTDFDLS-CLTSCKPQLLLP 833
+ +V AL YL + G+I+RD+KP N+LL G + L DF +S L
Sbjct: 126 LGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVD-------- 177
Query: 834 TTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEII-----AGAGHTSAVDWWALG 888
+A + G Y+APE I + D W+LG
Sbjct: 178 ---------------------DKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLG 216
Query: 889 ILLYEMLYGYTPFRG-KTRQKTFANILHKDL-KFPSSTPTSLHAKQLMYRLLHRDPKSRL 946
I L E+ G P++ KT + +L ++ P S + + L +D + R
Sbjct: 217 ISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLLPGHMGFSGDFQSFVKDCLTKDHRKRP 276
Query: 947 GSHEGANEIKKHPFFK 962
N++ +H F K
Sbjct: 277 ----KYNKLLEHSFIK 288
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 2e-34
Identities = 68/294 (23%), Positives = 124/294 (42%), Gaps = 42/294 (14%)
Query: 672 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDH 731
+ + + +G G +G+V+ +GQ A++ M+ + + K E ++ +
Sbjct: 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMN---LQQQPKKELIINEILVMRENKN 76
Query: 732 PFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLH 791
P + S+ + ++ +Y GG L ++ + E + E + ALE+LH
Sbjct: 77 PNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETC---MDEGQIAAVCRECLQALEFLH 133
Query: 792 CQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFM 851
+I+RD+K +N+LL +G V LTDF Q+ T E+ +R
Sbjct: 134 SNQVIHRDIKSDNILLGMDGSVKLTDFGFCA------QI----TPEQSKR---------- 173
Query: 852 AEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFA 911
++ VGT ++APE++ + VD W+LGI+ EM+ G P+ + +
Sbjct: 174 -------STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALY 226
Query: 912 NILHKD---LKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFK 962
I L+ P + + R L D + R A E+ +H F K
Sbjct: 227 LIATNGTPELQNPEKLSAIF--RDFLNRCLEMDVEKR----GSAKELLQHQFLK 274
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 5e-34
Identities = 60/294 (20%), Positives = 107/294 (36%), Gaps = 52/294 (17%)
Query: 669 INLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAE--RE-- 724
+ K +G G G VH L A+K++ G ++ E RE
Sbjct: 16 LADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVF 75
Query: 725 ILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVV 784
I+ L+HP + LY ++ ++ P G+L+ L + + +R ++
Sbjct: 76 IMSNLNHPNIVKLYGL--MHNPPRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRL-MLDIA 132
Query: 785 VALEYLHCQG--IIYRDLKPENVLL-----QGNGHVSLTDFDLSCLTSCKPQLLLPTTNE 837
+ +EY+ Q I++RDL+ N+ L + DF LS +
Sbjct: 133 LGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSV------------ 180
Query: 838 KKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAG--HTSAVDWWALGILLYEML 895
+ + +G +++APE I +T D ++ ++LY +L
Sbjct: 181 ------------------HSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTIL 222
Query: 896 YGYTPFRGKTRQK--TFANILHKDL--KFPSSTPTSLHAKQLMYRLLHRDPKSR 945
G PF + K I + L P P L + ++ DPK R
Sbjct: 223 TGEGPFDEYSYGKIKFINMIREEGLRPTIPEDCPPRL--RNVIELCWSGDPKKR 274
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 9e-34
Identities = 69/303 (22%), Positives = 119/303 (39%), Gaps = 42/303 (13%)
Query: 668 QINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREI-L 726
++ PI LG G G V + SGQ A+K + +N + R + +I +
Sbjct: 3 EVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIR--ATVNSQEQKRLLMDLDISM 60
Query: 727 DMLDHPFVPALYASFQTKTHVCLITDYCPGG-ELFLLLDRQPTKVLKEDAVRFYAAEVVV 785
+D PF Y + + V + + + F + + ED + A +V
Sbjct: 61 RTVDCPFTVTFYGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVK 120
Query: 786 ALEYLHCQG-IIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKG 844
ALE+LH + +I+RD+KP NVL+ G V + DF +S G
Sbjct: 121 ALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGIS----------------------G 158
Query: 845 QQNPVFMAEPMRASNSFVGTEEYIAPEIIAG----AGHTSAVDWWALGILLYEMLYGYTP 900
+ + + A + G + Y+APE I G++ D W+LGI + E+ P
Sbjct: 159 Y-----LVDDV-AKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFP 212
Query: 901 FRG-KTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHP 959
+ T + ++ + + S + L ++ K R E+ +HP
Sbjct: 213 YDSWGTPFQQLKQVVEEPSPQLPADKFSAEFVDFTSQCLKKNSKERP----TYPELMQHP 268
Query: 960 FFK 962
FF
Sbjct: 269 FFT 271
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 2e-33
Identities = 77/317 (24%), Positives = 131/317 (41%), Gaps = 43/317 (13%)
Query: 650 RKDSPPWKAIQKILDSGEQIN-LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKG 708
+ +PP + ++K+ + + F ++ LG G GSV+ +GQ A+K +
Sbjct: 6 QLRNPPRRQLKKLDEDSLTKQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVP-- 63
Query: 709 VMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPT 768
+ + E I+ D P V Y S+ T + ++ +YC G + ++ +
Sbjct: 64 ---VESDLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRN- 119
Query: 769 KVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKP 828
K L ED + + LEYLH I+RD+K N+LL GH L DF ++
Sbjct: 120 KTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAG------ 173
Query: 829 QLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALG 888
QL T+ +R N+ +GT ++APE+I G+ D W+LG
Sbjct: 174 QL----TDTMAKR-----------------NTVIGTPFWMAPEVIQEIGYNCVADIWSLG 212
Query: 889 ILLYEMLYGYTPFRGKTRQKTFANILHKD---LKFPSSTPTSLHAKQLMYRLLHRDPKSR 945
I EM G P+ + I + P S + + + L + P+ R
Sbjct: 213 ITAIEMAEGKPPYADIHPMRAIFMIPTNPPPTFRKPEL--WSDNFTDFVKQCLVKSPEQR 270
Query: 946 LGSHEGANEIKKHPFFK 962
A ++ +HPF +
Sbjct: 271 A----TATQLLQHPFVR 283
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 3e-33
Identities = 62/308 (20%), Positives = 109/308 (35%), Gaps = 49/308 (15%)
Query: 650 RKDSPPWKAIQKILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYF---AMKAMD 706
+ + D E I + +GSG G+V+ G++ A+K ++
Sbjct: 3 KGHHHHHHGSRDAADDWE-IPDGQITVGQRIGSGSFGTVYK------GKWHGDVAVKMLN 55
Query: 707 KGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQ 766
++ E +L H + T + ++T +C G L+ L
Sbjct: 56 VTAP-TPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVTQWCEGSSLYHHLHAS 113
Query: 767 PTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSC 826
TK + + A + ++YLH + II+RDLK N+ L + V + DF L+ S
Sbjct: 114 ETKFEMKKLIDI-ARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKS- 171
Query: 827 KPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGH---TSAVD 883
G+ ++APE+I + D
Sbjct: 172 ------------------------RWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSD 207
Query: 884 WWALGILLYEMLYGYTPFRGKT-RQKTFANILHKDLK-----FPSSTPTSLHAKQLMYRL 937
+A GI+LYE++ G P+ R + + L S+ P + K+LM
Sbjct: 208 VYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRSNCPKRM--KRLMAEC 265
Query: 938 LHRDPKSR 945
L + R
Sbjct: 266 LKKKRDER 273
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 3e-33
Identities = 59/368 (16%), Positives = 124/368 (33%), Gaps = 82/368 (22%)
Query: 645 HPKPHRKDSPPWKAIQKILDSGEQINLQHFRPIKPLGSG--DTGSVHLVELCGSGQYFAM 702
H H ++ ++ + L G + + +G G D +V+L +G+Y +
Sbjct: 3 HHHHHHMENLYFQGMSSFLPEGG-----CYELLTVIGKGFEDLMTVNLARYKPTGEYVTV 57
Query: 703 KAMDKGVMLNRNKVHRACAEREILDM--LDHPFVPALYASFQTKTHVCLITDYCPGGELF 760
+ ++ + + + E+ +HP + A+F + ++T + G
Sbjct: 58 RRIN---LEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAK 114
Query: 761 LLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDL 820
L+ + E A+ + V+ AL+Y+H G ++R +K ++L+ +G V L+
Sbjct: 115 DLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRS 174
Query: 821 SCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIA--GAGH 878
+ + + +R+ P V +++PE++ G+
Sbjct: 175 NL------SM----ISHGQRQRVVHDFP----------KYSVKVLPWLSPEVLQQNLQGY 214
Query: 879 TSAVDWWALGILLYEMLYGYTPF------------------------------------- 901
+ D +++GI E+ G+ PF
Sbjct: 215 DAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTSTIPAEELTMSPSR 274
Query: 902 -------RGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANE 954
T P S H + + L R+P +R A+
Sbjct: 275 SVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARP----SAST 330
Query: 955 IKKHPFFK 962
+ H FFK
Sbjct: 331 LLNHSFFK 338
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 5e-33
Identities = 68/292 (23%), Positives = 114/292 (39%), Gaps = 50/292 (17%)
Query: 668 QINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRA-CAEREIL 726
+I+ + +G G G V+ G A+KA + ++ E ++
Sbjct: 3 EIDFAELTLEEIIGIGGFGKVYRAFWIG--DEVAVKAARHDPDEDISQTIENVRQEAKLF 60
Query: 727 DMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVA 786
ML HP + AL + ++CL+ ++ GG L +L + + D + +A ++
Sbjct: 61 AMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGKR---IPPDILVNWAVQIARG 117
Query: 787 LEYLHCQG---IIYRDLKPENVLL--------QGNGHVSLTDFDLSCLTSCKPQLLLPTT 835
+ YLH + II+RDLK N+L+ N + +TDF L+
Sbjct: 118 MNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRT-------- 169
Query: 836 NEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEML 895
S G ++APE+I + + D W+ G+LL+E+L
Sbjct: 170 ---------------------TKMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELL 208
Query: 896 YGYTPFRGKTRQKTFANILHKD--LKFPSSTPTSLHAKQLMYRLLHRDPKSR 945
G PFRG + L PS+ P +LM + DP SR
Sbjct: 209 TGEVPFRGIDGLAVAYGVAMNKLALPIPSTCPEPF--AKLMEDCWNPDPHSR 258
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 9e-33
Identities = 70/301 (23%), Positives = 128/301 (42%), Gaps = 45/301 (14%)
Query: 672 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDH 731
+ + + LG G G V+ + +G A K ++ + ++ E EIL DH
Sbjct: 19 EVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIE---TKSEEELEDYIVEIEILATCDH 75
Query: 732 PFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLH 791
P++ L ++ + ++ ++CPGG + ++ + L E ++ +++ AL +LH
Sbjct: 76 PYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELD-RGLTEPQIQVVCRQMLEALNFLH 134
Query: 792 CQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFM 851
+ II+RDLK NVL+ G + L DF +S + ++R
Sbjct: 135 SKRIIHRDLKAGNVLMTLEGDIRLADFGVSA------KN----LKTLQKR---------- 174
Query: 852 AEPMRASNSFVGTEEYIAPEIIA-----GAGHTSAVDWWALGILLYEMLYGYTPFRGKTR 906
+SF+GT ++APE++ + D W+LGI L EM P
Sbjct: 175 -------DSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNP 227
Query: 907 QKTFANILHKD---LKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKG 963
+ I D L PS S+ + + L ++P++R A ++ +HPF
Sbjct: 228 MRVLLKIAKSDPPTLLTPSK--WSVEFRDFLKIALDKNPETRP----SAAQLLEHPFVSS 281
Query: 964 V 964
+
Sbjct: 282 I 282
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 2e-32
Identities = 63/309 (20%), Positives = 107/309 (34%), Gaps = 50/309 (16%)
Query: 668 QINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREI-- 725
+ + + +G G GSV+ + SGQ A+K + ++ + ++
Sbjct: 18 DFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIR----STVDEKEQKQLLMDLDV 73
Query: 726 -LDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLD--RQPTKVLKEDAVRFYAAE 782
+ D P++ Y + + + + V+ E+ +
Sbjct: 74 VMRSSDCPYIVQFYGALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLA 133
Query: 783 VVVALEYLHCQG-IIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRR 841
V AL +L II+RD+KP N+LL +G++ L DF +S QL + +
Sbjct: 134 TVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGIS------GQL----VDSIAKT 183
Query: 842 HKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAG----AGHTSAVDWWALGILLYEMLYG 897
G Y+APE I G+ D W+LGI LYE+ G
Sbjct: 184 R------------------DAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATG 225
Query: 898 YTPFRG-KTRQKTFANILHKD---LKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGAN 953
P+ + ++ D L S + L +D R
Sbjct: 226 RFPYPKWNSVFDQLTQVVKGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRP----KYK 281
Query: 954 EIKKHPFFK 962
E+ KHPF
Sbjct: 282 ELLKHPFIL 290
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 2e-31
Identities = 75/310 (24%), Positives = 121/310 (39%), Gaps = 61/310 (19%)
Query: 672 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREIL-DMLD 730
F ++ +G+G G V+ +GQ A+K MD + ++ E +L
Sbjct: 24 GIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMD----VTGDEEEEIKQEINMLKKYSH 79
Query: 731 HPFVPALYASFQTKTHVC------LITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVV 784
H + Y +F K L+ ++C G + L+ LKE+ + + E++
Sbjct: 80 HRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREIL 139
Query: 785 VALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKG 844
L +LH +I+RD+K +NVLL N V L DF +S QL RR
Sbjct: 140 RGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSA------QL----DRTVGRR--- 186
Query: 845 QQNPVFMAEPMRASNSFVGTEEYIAPEIIA-----GAGHTSAVDWWALGILLYEMLYGYT 899
N+F+GT ++APE+IA A + D W+LGI EM G
Sbjct: 187 --------------NTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAP 232
Query: 900 PFRGKTRQKTFANILHKDLKFPSSTPTSLHAKQL-------MYRLLHRDPKSRLGSHEGA 952
P + I P + L +K+ + L ++ R
Sbjct: 233 PLCDMHPMRALFLI-------PRNPAPRLKSKKWSKKFQSFIESCLVKNHSQRP----AT 281
Query: 953 NEIKKHPFFK 962
++ KHPF +
Sbjct: 282 EQLMKHPFIR 291
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 3e-31
Identities = 58/292 (19%), Positives = 106/292 (36%), Gaps = 49/292 (16%)
Query: 669 INLQHFRPIKPLGSGDTGSVHLVELCGSGQYF---AMKAMDKGVMLNRNKVHRACAEREI 725
I + + +G G G V+ G++ A++ +D N +++ E
Sbjct: 30 IPFEQLEIGELIGKGRFGQVY------HGRWHGEVAIRLIDIERD-NEDQLKAFKREVMA 82
Query: 726 LDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVV 785
H V + + H+ +IT C G L+ ++ R VL + R A E+V
Sbjct: 83 YRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVV-RDAKIVLDVNKTRQIAQEIVK 141
Query: 786 ALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQ 845
+ YLH +GI+++DLK +NV NG V +TDF L + +
Sbjct: 142 GMGYLHAKGILHKDLKSKNVFY-DNGKVVITDFGLFSI---------------SGVLQAG 185
Query: 846 QNPVFMAEPMRASNSFVGTEEYIAPEIIAGAG---------HTSAVDWWALGILLYEMLY 896
+ + G ++APEII + D +ALG + YE+
Sbjct: 186 RREDKLRIQ-------NGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHA 238
Query: 897 GYTPFRGKTRQKTFANILHKDLKF---PSSTPTSLHAKQLMYRLLHRDPKSR 945
PF+ + + + +K + ++ + + R
Sbjct: 239 REWPFKTQPAEAIIWQM-GTGMKPNLSQIGMGKEI--SDILLFCWAFEQEER 287
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 1e-30
Identities = 45/292 (15%), Positives = 95/292 (32%), Gaps = 46/292 (15%)
Query: 663 LDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAE 722
++ I+ + + L +G + G +K + + K E
Sbjct: 1 MNKHSGIDFKQLNFLTKLNENHSGELWKGRWQG--NDIVVKVLKVR-DWSTRKSRDFNEE 57
Query: 723 REILDMLDHPFVPALYASFQT--KTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYA 780
L + HP V + + Q+ H LIT + P G L+ +L V+ + +A
Sbjct: 58 CPRLRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFA 117
Query: 781 AEVVVALEYLHCQG--IIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEK 838
++ + +LH I L +V++ + ++ D+
Sbjct: 118 LDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQSP----------- 166
Query: 839 KRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAG---HTSAVDWWALGILLYEML 895
+ ++APE + + + D W+ +LL+E++
Sbjct: 167 ---------------------GRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELV 205
Query: 896 YGYTPFRGKTRQKTFANILHKDL--KFPSSTPTSLHAKQLMYRLLHRDPKSR 945
PF + + + + L P + +LM ++ DP R
Sbjct: 206 TREVPFADLSNMEIGMKVALEGLRPTIPPGISPHV--SKLMKICMNEDPAKR 255
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 3e-30
Identities = 68/328 (20%), Positives = 111/328 (33%), Gaps = 56/328 (17%)
Query: 645 HPKPHRKDSPPWKAIQKILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKA 704
P R S + ++ + + F ++ +G G G+V+ + + A+K
Sbjct: 29 MPAGGRAGSLKDPDVAELFFKDD--PEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKK 86
Query: 705 MDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLD 764
M + K E L L HP + + L+ +YC G LL
Sbjct: 87 MSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEV 146
Query: 765 RQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLT 824
+ K L+E + + L YLH +I+RD+K N+LL G V L DF +
Sbjct: 147 HK--KPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSAS-- 202
Query: 825 SCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAG---AGHTSA 881
+ NSFVGT ++APE+I +
Sbjct: 203 ----IM-------APA------------------NSFVGTPYWMAPEVILAMDEGQYDGK 233
Query: 882 VDWWALGILLYEMLYGYTPFRGKTRQKTFANILHKDLKFPSSTPTSLHAKQL-------M 934
VD W+LGI E+ P +I + +L + +
Sbjct: 234 VDVWSLGITCIELAERKPPLFNMNAMSALYHI-------AQNESPALQSGHWSEYFRNFV 286
Query: 935 YRLLHRDPKSRLGSHEGANEIKKHPFFK 962
L + P+ R + + KH F
Sbjct: 287 DSCLQKIPQDRP----TSEVLLKHRFVL 310
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 111 bits (278), Expect = 4e-26
Identities = 55/285 (19%), Positives = 102/285 (35%), Gaps = 44/285 (15%)
Query: 666 GEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHR--ACAER 723
G+ N + I+ LG G +V L ++ AMK ++ + + A E
Sbjct: 32 GDLFN-GRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMK------VVKSAEHYTETALDEI 84
Query: 724 EILDML-----DHP---FVPALYASFQTK----THVCLITDYCPGGE-LFLLLDRQPTKV 770
+L + + P V L F+ TH+C++ + G L + + +
Sbjct: 85 RLLKSVRNSDPNDPNREMVVQLLDDFKISGVNGTHICMVFE--VLGHHLLKWIIKSNYQG 142
Query: 771 LKEDAVRFYAAEVVVALEYLHCQ-GIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQ 829
L V+ +V+ L+YLH + II+ D+KPEN+LL N +
Sbjct: 143 LPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGA 202
Query: 830 LLLPTTNEKKRRHKGQQNPVFMAEPMRAS-------------------NSFVGTEEYIAP 870
+ V EP A + T +Y +
Sbjct: 203 PPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTRQYRSL 262
Query: 871 EIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANILH 915
E++ G+G+ + D W+ + +E+ G F + ++ + H
Sbjct: 263 EVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDH 307
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 113 bits (283), Expect = 8e-26
Identities = 51/238 (21%), Positives = 82/238 (34%), Gaps = 50/238 (21%)
Query: 716 VHRACAEREILDMLDHPFVPALYASFQTKTHVC-----LITDYCPGGELFLLLDRQPTKV 770
A AER+ L + HP + ++ + ++ +Y G L ++
Sbjct: 123 QAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQK---- 178
Query: 771 LKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQL 830
L Y E++ AL YLH G++Y DLKPEN++L + L D
Sbjct: 179 LPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEEQ-LKLIDLGA---------- 227
Query: 831 LLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGIL 890
+ + GT + APEI+ G T A D + +G
Sbjct: 228 ---------------------VSRINSFGYLYGTPGFQAPEIVRT-GPTVATDIYTVGRT 265
Query: 891 LYEMLYGYTPFRGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGS 948
L + G+ L +D T S L+ R + DP+ R +
Sbjct: 266 LAALTLDLPTRNGRYVDG-----LPEDDPVL-KTYDSYGR--LLRRAIDPDPRQRFTT 315
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 2e-25
Identities = 67/321 (20%), Positives = 118/321 (36%), Gaps = 78/321 (24%)
Query: 677 IKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREI--LDMLDHPFV 734
+ +G G G V + G + A+K + + + E EI ML H +
Sbjct: 47 QESIGKGRFGEVWRGKWRG--EEVAVK------IFSSREERSWFREAEIYQTVMLRHENI 98
Query: 735 PALYAS----FQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYL 790
A+ T T + L++DY G LF L+R V E ++ A L +L
Sbjct: 99 LGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTV--EGMIKL-ALSTASGLAHL 155
Query: 791 HCQ--------GIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRH 842
H + I +RDLK +N+L++ NG + D L+ RH
Sbjct: 156 HMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA------------------VRH 197
Query: 843 KGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTS------AVDWWALGILLYEMLY 896
+ + + A N VGT+ Y+APE++ + + D +A+G++ +E+
Sbjct: 198 DSATDTIDI-----APNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIAR 252
Query: 897 GYT----------PFRGKT-RQKTFANI----LHKDL--KFPS---STPTSLHAKQLMYR 936
+ P+ + + + L P+ S ++M
Sbjct: 253 RCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRE 312
Query: 937 LLHRDPKSRLGSHEGANEIKK 957
+ + +RL A IKK
Sbjct: 313 CWYANGAARL----TALRIKK 329
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 4e-25
Identities = 72/334 (21%), Positives = 115/334 (34%), Gaps = 89/334 (26%)
Query: 667 EQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREI- 725
I L + +G G G V G + A+K + + E E+
Sbjct: 8 RDITLL-----ECVGKGRYGEVWRGSWQG--ENVAVK------IFSSRDEKSWFRETELY 54
Query: 726 -LDMLDHP----FVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYA 780
ML H F+ + S + T + LIT Y G L+ L +R
Sbjct: 55 NTVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDT--VSCLRI-V 111
Query: 781 AEVVVALEYLHCQ--------GIIYRDLKPENVLLQGNGHVSLTDFDLSCL-TSCKPQLL 831
+ L +LH + I +RDLK +N+L++ NG + D L+ + + QL
Sbjct: 112 LSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLD 171
Query: 832 LPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSA------VDWW 885
+ VGT+ Y+APE++ VD W
Sbjct: 172 VGNNPR------------------------VGTKRYMAPEVLDETIQVDCFDSYKRVDIW 207
Query: 886 ALGILLYEMLYGYT----------PFRGKT-RQKTFANI----LHKDL--KFPSS----- 923
A G++L+E+ PF +F ++ P+
Sbjct: 208 AFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDP 267
Query: 924 TPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKK 957
T TSL +LM +++P +RL A IKK
Sbjct: 268 TLTSL--AKLMKECWYQNPSARL----TALRIKK 295
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 1e-24
Identities = 64/331 (19%), Positives = 120/331 (36%), Gaps = 74/331 (22%)
Query: 667 EQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREI- 725
++ + + +K +G G G V + + G + A+K V + E EI
Sbjct: 32 QRTIAKQIQMVKQIGKGRYGEVWMGKWRG--EKVAVK-----VFFTTEE-ASWFRETEIY 83
Query: 726 -LDMLDHPFVPALYAS----FQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYA 780
++ H + A+ + T + LITDY G L+ L + + ++ A
Sbjct: 84 QTVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKSTT--LDAKSMLKL-A 140
Query: 781 AEVVVALEYLHCQ--------GIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLL 832
V L +LH + I +RDLK +N+L++ NG + D L+
Sbjct: 141 YSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA----------- 189
Query: 833 PTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTS------AVDWWA 886
+ N V + N+ VGT+ Y+ PE++ + + + D ++
Sbjct: 190 -------VKFISDTNEVDI-----PPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYS 237
Query: 887 LGILLYEMLYGYT----------PFRGKT-RQKTFANI----LHKDL-----KFPSSTPT 926
G++L+E+ P+ ++ ++ K L SS
Sbjct: 238 FGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDEC 297
Query: 927 SLHAKQLMYRLLHRDPKSRLGSHEGANEIKK 957
+LM +P SRL + + K
Sbjct: 298 LRQMGKLMTECWAHNPASRLTALRVKKTLAK 328
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 3e-24
Identities = 57/257 (22%), Positives = 95/257 (36%), Gaps = 53/257 (20%)
Query: 669 INLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREI--L 726
++L + + ++ +G G G+V+ L + A+K NR E+ I +
Sbjct: 10 LDLDNLKLLELIGRGRYGAVYKGSLDE--RPVAVKVFSFA---NRQNFIN---EKNIYRV 61
Query: 727 DMLDHPFVPALYA-----SFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAA 781
+++H + + + L+ +Y P G L L + A
Sbjct: 62 PLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHT---SDWVSSCRLAH 118
Query: 782 EVVVALEYLHCQ---------GIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLL 832
V L YLH + I +RDL NVL++ +G ++DF LS
Sbjct: 119 SVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMR--------- 169
Query: 833 PTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGA-------GHTSAVDWW 885
V E A+ S VGT Y+APE++ GA VD +
Sbjct: 170 ----------LTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMY 219
Query: 886 ALGILLYEMLYGYTPFR 902
ALG++ +E+ T
Sbjct: 220 ALGLIYWEIFMRCTDLF 236
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 1e-23
Identities = 62/326 (19%), Positives = 121/326 (37%), Gaps = 59/326 (18%)
Query: 674 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPF 733
++ + LG G +V+L E A+KA+ + R E L H
Sbjct: 13 YKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQN 72
Query: 734 VPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQ 793
+ ++ + L+ +Y G L ++ L D + +++ +++ H
Sbjct: 73 IVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESH--GPLSVDTAINFTNQILDGIKHAHDM 130
Query: 794 GIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAE 853
I++RD+KP+N+L+ N + + DF ++ S
Sbjct: 131 RIVHRDIKPQNILIDSNKTLKIFDFGIAKALS--------------------------ET 164
Query: 854 PMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKT------RQ 907
+ +N +GT +Y +PE G D +++GI+LYEML G PF G+T +
Sbjct: 165 SLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKH 224
Query: 908 KTFANILHKDLKFPSST-----PTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFK 962
+ + ++ P SL ++ R +D +R + E+K
Sbjct: 225 ------IQDSVPNVTTDVRKDIPQSLSN--VILRATEKDKANRYKT---IQEMKD----- 268
Query: 963 GVNWALVRCMNPPELDAPLFATDTEK 988
L ++ + ++ D K
Sbjct: 269 ----DLSSVLHENRANEDVYELDKMK 290
|
| >3ewk_A Sensor protein; PAS domain, alpha/beta fold, kinase, phosphoprotein, transfe flavoprotein; HET: FAD; 2.34A {Methylococcus capsulatus} Length = 227 | Back alignment and structure |
|---|
Score = 98.6 bits (246), Expect = 3e-23
Identities = 27/101 (26%), Positives = 51/101 (50%)
Query: 211 TKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKIRETLQNGQSYCGRL 270
T I+YA+ F ++ Y +E+VG++ R + + + T+ G + G
Sbjct: 5 TDLQGRILYANDNFCAVSRYGREELVGQDHRIVNSGYHGKAYIRDMWRTISRGNIWQGEF 64
Query: 271 LNYKKDGTPFWNLLTIAPIKDDEGKVLKFIGMQVEVSKHTE 311
N +KDGT +W TI P+ D+ GK ++I ++ +++ E
Sbjct: 65 CNRRKDGTRYWVDSTIVPLMDNAGKPRQYISIRRDITAQKE 105
|
| >3ewk_A Sensor protein; PAS domain, alpha/beta fold, kinase, phosphoprotein, transfe flavoprotein; HET: FAD; 2.34A {Methylococcus capsulatus} Length = 227 | Back alignment and structure |
|---|
Score = 97.9 bits (244), Expect = 5e-23
Identities = 37/186 (19%), Positives = 75/186 (40%), Gaps = 15/186 (8%)
Query: 489 VITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIRAAIDNQTD 548
ITD I++A+D+F ++ Y REE++G++ R + A +R + I
Sbjct: 3 SITDL---QGRILYANDNFCAVSRYGREELVGQDHRIVNSGYHGKAYIRDMWRTISRGNI 59
Query: 549 VTVQLINYTKSGKKFWNLFHLQPMRDQKGEVQYFIGVQLDGSE------HLEPLRNSIPE 602
+ N K G ++W + P+ D G+ + +I ++ D + L L+ ++
Sbjct: 60 WQGEFCNRRKDGTRYWVDSTIVPLMDNAGKPRQYISIRRDITAQKEAEAQLARLKQAMDA 119
Query: 603 ATAEESEKLVKQTAENVNEAVKELPDANLTPEDLW-ANHSKVVHPKPHRKDSPPWKAIQK 661
+ N A+ + + +L + S + P D A+Q+
Sbjct: 120 NSEMILLTDRAGRIIYANPALCRF--SGMAEGELLGQSPSILDSP---LADQETLAAMQE 174
Query: 662 ILDSGE 667
L +G+
Sbjct: 175 ALQAGQ 180
|
| >3ewk_A Sensor protein; PAS domain, alpha/beta fold, kinase, phosphoprotein, transfe flavoprotein; HET: FAD; 2.34A {Methylococcus capsulatus} Length = 227 | Back alignment and structure |
|---|
Score = 95.2 bits (237), Expect = 4e-22
Identities = 27/99 (27%), Positives = 49/99 (49%), Gaps = 6/99 (6%)
Query: 211 TKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKIRETLQNGQSYCGRL 270
T I+YA+ + +G E++G++ L D E +A ++E LQ GQ + GRL
Sbjct: 127 TDRAGRIIYANPALCRFSGMAEGELLGQSPSILDSPLADQETLAAMQEALQAGQPWSGRL 186
Query: 271 LNYKK------DGTPFWNLLTIAPIKDDEGKVLKFIGMQ 303
LN ++ D +W ++ PI D ++ ++ +Q
Sbjct: 187 LNRRRTGPAPHDAEDYWAEISTTPIHTDGNGLVGYVQIQ 225
|
| >3ewk_A Sensor protein; PAS domain, alpha/beta fold, kinase, phosphoprotein, transfe flavoprotein; HET: FAD; 2.34A {Methylococcus capsulatus} Length = 227 | Back alignment and structure |
|---|
Score = 87.1 bits (216), Expect = 3e-19
Identities = 21/128 (16%), Positives = 53/128 (41%), Gaps = 9/128 (7%)
Query: 467 RQKEMRKGIDLATTLERIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFL 526
+++ + L ++ + ++TD II+A+ + + + E+LG++ L
Sbjct: 103 QKEAEAQLARLKQAMDANSEMILLTDR---AGRIIYANPALCRFSGMAEGELLGQSPSIL 159
Query: 527 QGPETDPATVRKIRAAIDNQTDVTVQLINYTKSGKK------FWNLFHLQPMRDQKGEVQ 580
P D T+ ++ A+ + +L+N ++G +W P+ +
Sbjct: 160 DSPLADQETLAAMQEALQAGQPWSGRLLNRRRTGPAPHDAEDYWAEISTTPIHTDGNGLV 219
Query: 581 YFIGVQLD 588
++ +Q D
Sbjct: 220 GYVQIQHD 227
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 99 bits (250), Expect = 5e-23
Identities = 76/324 (23%), Positives = 120/324 (37%), Gaps = 68/324 (20%)
Query: 674 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREI--LDMLDH 731
+ I +G G G V +GQ A+K K + + V + A REI L L H
Sbjct: 5 YEKIGKIGEGSYGVVFKCRNRDTGQIVAIK---KFLESEDDPVIKKIALREIRMLKQLKH 61
Query: 732 PFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLH 791
P + L F+ K + L+ +YC + LDR + + E V+ + + A+ + H
Sbjct: 62 PNLVNLLEVFRRKRRLHLVFEYCDH-TVLHELDRYQ-RGVPEHLVKSITWQTLQAVNFCH 119
Query: 792 CQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFM 851
I+RD+KPEN+L+ + + L DF + R + +
Sbjct: 120 KHNCIHRDVKPENILITKHSVIKLCDFGFA-------------------RLLTGPSDYYD 160
Query: 852 AEPMRASNSFVGTEEYIAPEIIAGAGH-TSAVDWWALGILLYEMLYGYTPFRGKTR---- 906
E V T Y +PE++ G VD WA+G + E+L G + GK+
Sbjct: 161 DE--------VATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQL 212
Query: 907 QKTF---------------ANILHKDLKFPSSTPT----------SLHAKQLMYRLLHRD 941
N +K P S A L+ LH D
Sbjct: 213 YLIRKTLGDLIPRHQQVFSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMD 272
Query: 942 PKSRLGSHEGANEIKKHPFFKGVN 965
P RL ++ HP+F+ +
Sbjct: 273 PTERL----TCEQLLHHPYFENIR 292
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 99.2 bits (248), Expect = 9e-23
Identities = 50/222 (22%), Positives = 92/222 (41%), Gaps = 31/222 (13%)
Query: 729 LDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALE 788
L P V ++ + + + G +L +L RQ + AV ++ AL+
Sbjct: 91 LQEPHVVPIHDFGEIDGQLYVDMRLINGVDLAAMLRRQ-GPLAPPRAVA-IVRQIGSALD 148
Query: 789 YLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNP 848
H G +RD+KPEN+L+ + L DF ++ T+
Sbjct: 149 AAHAAGATHRDVKPENILVSADDFAYLVDFGIASATT----------------------- 185
Query: 849 VFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQK 908
E + + VGT Y+APE + + T D +AL +LYE L G P++G
Sbjct: 186 ---DEKLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLSV 242
Query: 909 TFANILHKDLKFPSSTPTSLHAK--QLMYRLLHRDPKSRLGS 948
A+ +++ + PS+ + ++ R + ++P+ R +
Sbjct: 243 MGAH-INQAIPRPSTVRPGIPVAFDAVIARGMAKNPEDRYVT 283
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 99.0 bits (247), Expect = 1e-22
Identities = 56/321 (17%), Positives = 103/321 (32%), Gaps = 78/321 (24%)
Query: 668 QINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREI-- 725
+ ++ G G V +L +Y A+K ++ E E+
Sbjct: 20 YFQSMPLQLLEVKARGRFGCVWKAQLLN--EYVAVKIFPIQ---DKQSWQN---EYEVYS 71
Query: 726 LDMLDHP----FVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAA 781
L + H F+ A + LIT + G L L + + + A
Sbjct: 72 LPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKANV---VSWNELCHIAE 128
Query: 782 EVVVALEYLHCQ----------GIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLL 831
+ L YLH I +RD+K +NVLL+ N + DF L+
Sbjct: 129 TMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLA---------- 178
Query: 832 LPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSA-----VDWWA 886
+ + ++ + VGT Y+APE++ GA + +D +A
Sbjct: 179 --------LKFEAGKSAGDT-------HGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYA 223
Query: 887 LGILLYEMLYGYTPFRGKT------------RQKTFANIL------HKDLKFPSSTPTSL 928
+G++L+E+ T G + + ++ K
Sbjct: 224 MGLVLWELASRCTAADGPVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHA 283
Query: 929 HAK---QLMYRLLHRDPKSRL 946
+ + D ++RL
Sbjct: 284 GMAMLCETIEECWDHDAEARL 304
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 98.8 bits (247), Expect = 1e-22
Identities = 76/369 (20%), Positives = 138/369 (37%), Gaps = 84/369 (22%)
Query: 671 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMK--AMDK--GVMLNRNKVHRACAEREI- 725
++ + + LG G +V+ + + A+K ++ G A RE+
Sbjct: 1 METYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCT--------AIREVS 52
Query: 726 -LDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVV 784
L L H + L+ T+ + L+ +Y +L LD + V+ + +++
Sbjct: 53 LLKDLKHANIVTLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNI-INMHNVKLFLFQLL 110
Query: 785 VALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKG 844
L Y H Q +++RDLKP+N+L+ G + L DF L+ R K
Sbjct: 111 RGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLA-------------------RAKS 151
Query: 845 QQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGH-TSAVDWWALGILLYEMLYGYTPFRG 903
P + ++ V T Y P+I+ G+ ++ +D W +G + YEM G F G
Sbjct: 152 --------IPTKTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPG 203
Query: 904 KTR----QKTFANIL----------------HKDLKFPSSTPTSL---------HAKQLM 934
T F IL K +P +L L+
Sbjct: 204 STVEEQLHFIF-RILGTPTEETWPGILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLL 262
Query: 935 YRLLHRDPKSRLGSHEGANEIKKHPFFKGVNWALVRCMNPPELDAPLFATDTEKEYKVVD 994
+LL + ++R+ A + KHPFF +L ++ +FA + K +
Sbjct: 263 TKLLQFEGRNRI----SAEDAMKHPFF----LSLGERIHKLPDTTSIFALKEIQLQK--E 312
Query: 995 PGMQDLQQN 1003
++ +
Sbjct: 313 ASLRSAHHH 321
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 99.8 bits (249), Expect = 2e-22
Identities = 62/367 (16%), Positives = 116/367 (31%), Gaps = 109/367 (29%)
Query: 666 GEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHR-ACAERE 724
GE + ++ LG G +V L + + + AMK ++ A E +
Sbjct: 13 GEPYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMK-----IVRGDKVYTEAAEDEIK 67
Query: 725 ILDML-----------DHPFVPALYASFQTK----THVCLITDYCPGGELFLLLDRQPTK 769
+L + + L F K HV ++ + G L L+ + +
Sbjct: 68 LLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHR 126
Query: 770 VLKEDAVRFYAAEVVVALEYLHCQ-GIIYRDLKPENVLL------QGNGHVSLTDFDLSC 822
+ V+ + ++++ L+Y+H + GII+ D+KPENVL+ + + + D +C
Sbjct: 127 GIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNAC 186
Query: 823 LTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAV 882
+ + + T EY +PE++ GA
Sbjct: 187 WYD--------------EHY----------------TNSIQTREYRSPEVLLGAPWGCGA 216
Query: 883 DWWALGILLYEMLYGYTPFRGKTRQKTFANILH--------------------------- 915
D W+ L++E++ G F + H
Sbjct: 217 DIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFN 276
Query: 916 ---KDLKFPSSTPTSLH-------------AKQ---LMYRLLHRDPKSRLGSHEGANEIK 956
L AK+ + +L DP+ R A +
Sbjct: 277 SRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRA----DAGGLV 332
Query: 957 KHPFFKG 963
HP+ K
Sbjct: 333 NHPWLKD 339
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 98.1 bits (245), Expect = 2e-22
Identities = 61/274 (22%), Positives = 110/274 (40%), Gaps = 60/274 (21%)
Query: 729 LDHPFVPALY----ASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVV 784
L+HP + A+Y A ++ +Y G L ++ + + A+
Sbjct: 69 LNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTE--GPMTPKRAIEVIADAC 126
Query: 785 VALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKG 844
AL + H GII+RD+KP N+++ V + DF ++ R
Sbjct: 127 QALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIA-------------------RAIA 167
Query: 845 QQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGK 904
+ + + +GT +Y++PE G + D ++LG +LYE+L G PF G
Sbjct: 168 DS-----GNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGD 222
Query: 905 T------RQKTFANILHKDLKFPSST----PTSLHAKQLMYRLLHRDPKSRLGSHEGANE 954
+ + + +D PS+ L A ++ + L ++P++R + A E
Sbjct: 223 SPVSVAYQH------VREDPIPPSARHEGLSADLDA--VVLKALAKNPENRYQT---AAE 271
Query: 955 IKKHPFFKGVNWALVRCMNPPELDAPLFATDTEK 988
++ LVR N +AP TD E+
Sbjct: 272 MRA---------DLVRVHNGEPPEAPKVLTDAER 296
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 98.1 bits (245), Expect = 3e-22
Identities = 76/340 (22%), Positives = 121/340 (35%), Gaps = 71/340 (20%)
Query: 674 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREI--LDMLDH 731
+ + +G G G V +G+ A+K K + + +K+ + A REI L L H
Sbjct: 27 YENLGLVGEGSYGMVMKCRNKDTGRIVAIK---KFLESDDDKMVKKIAMREIKLLKQLRH 83
Query: 732 PFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLH 791
+ L + K L+ ++ + L+ P L V+ Y +++ + + H
Sbjct: 84 ENLVNLLEVCKKKKRWYLVFEFVDH-TILDDLELFPNG-LDYQVVQKYLFQIINGIGFCH 141
Query: 792 CQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFM 851
II+RD+KPEN+L+ +G V L DF + R V+
Sbjct: 142 SHNIIHRDIKPENILVSQSGVVKLCDFGFA-------------------RTLAAPGEVYD 182
Query: 852 AEPMRASNSFVGTEEYIAPEIIAGAGH-TSAVDWWALGILLYEMLYGYTPFRGKTRQKTF 910
E V T Y APE++ G AVD WA+G L+ EM G F G +
Sbjct: 183 DE--------VATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQL 234
Query: 911 ANILH-------------------KDLKFPSSTPT----------SLHAKQLMYRLLHRD 941
+I+ ++ P S L + LH D
Sbjct: 235 YHIMMCLGNLIPRHQELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHID 294
Query: 942 PKSRLGSHEGANEIKKHPFFKGVNWALVRCMNPPELDAPL 981
P R E+ H FF+ + EL +
Sbjct: 295 PDKRP----FCAELLHHDFFQMDGF---AERFSQELQLKV 327
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 98.1 bits (245), Expect = 6e-22
Identities = 60/316 (18%), Positives = 116/316 (36%), Gaps = 35/316 (11%)
Query: 632 TPEDLWANHSKVVHPKPHRKDSPPWKAIQKILDSGEQINLQHFRPIKPLGSGDTGSVHLV 691
+ L + P + +A+ K D +N + + +G G+ G V
Sbjct: 77 SIPLLIDHLLSTQQPLTKKSGVVLHRAVPK--DKWV-LNHEDLVLGEQIGRGNFGEVFSG 133
Query: 692 ELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLIT 751
L A+K+ + + + + E IL HP + L K + ++
Sbjct: 134 RLRADNTLVAVKSCRETLP--PDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVM 191
Query: 752 DYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNG 811
+ GG+ L + ++ + ++ + +EYL + I+RDL N L+
Sbjct: 192 ELVQGGDFLTFLRTEGARLRVKTLLQM-VGDAAAGMEYLESKCCIHRDLAARNCLVTEKN 250
Query: 812 HVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPE 871
+ ++DF +S + +Q PV ++ APE
Sbjct: 251 VLKISDFGMSREEA---------DGVYAASGGLRQVPV----------------KWTAPE 285
Query: 872 IIAGAGHTSAVDWWALGILLYEML-YGYTPFRGKTRQKTFANILHKD-LKFPSSTPTSLH 929
+ ++S D W+ GILL+E G +P+ + Q+T + L P P ++
Sbjct: 286 ALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGGRLPCPELCPDAVF 345
Query: 930 AKQLMYRLLHRDPKSR 945
+LM + +P R
Sbjct: 346 --RLMEQCWAYEPGQR 359
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 98.6 bits (246), Expect = 7e-22
Identities = 84/361 (23%), Positives = 138/361 (38%), Gaps = 80/361 (22%)
Query: 642 KVVHPKPHRKDSPPWKAIQKILDSGEQINLQ---HFRPIKPLGSGDTGSVHLVELCGSGQ 698
+D K + G+ + + K +G+G G V+ +LC SG+
Sbjct: 21 SAFGSMKVSRDKDGSKVTTVVATPGQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGE 80
Query: 699 YFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKT------HVCLITD 752
A+K K V+ ++ +R E +I+ LDH + L F + ++ L+ D
Sbjct: 81 LVAIK---K-VLQDKRFKNR---ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLD 133
Query: 753 YCPGGELFLLLDRQP--TKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGN 810
Y P ++ + + L V+ Y ++ +L Y+H GI +RD+KP+N+LL +
Sbjct: 134 YVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPD 192
Query: 811 -GHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIA 869
+ L DF + + L+ EP S++ + Y A
Sbjct: 193 TAVLKLCDFGSA-------KQLVRG------------------EPNV---SYICSRYYRA 224
Query: 870 PEIIAGAGH-TSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANIL-------------- 914
PE+I GA TS++D W+ G +L E+L G F G + I+
Sbjct: 225 PELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREM 284
Query: 915 ---HKDLKFPSSTPTSLH----------AKQLMYRLLHRDPKSRLGSHEGANEIKKHPFF 961
+ + KFP A L RLL P +RL E H FF
Sbjct: 285 NPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARL----TPLEACAHSFF 340
Query: 962 K 962
Sbjct: 341 D 341
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 94.9 bits (237), Expect = 2e-21
Identities = 62/276 (22%), Positives = 108/276 (39%), Gaps = 65/276 (23%)
Query: 721 AEREI--LDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRF 778
REI L L H + LY TK + L+ ++ +L LLD L+ +
Sbjct: 47 TIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQ-DLKKLLDVCEGG-LESVTAKS 104
Query: 779 YAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEK 838
+ +++ + Y H + +++RDLKP+N+L+ G + + DF L+
Sbjct: 105 FLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLA----------------- 147
Query: 839 KRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGH-TSAVDWWALGILLYEMLYG 897
R G P+R + T Y AP+++ G+ ++ +D W++G + EM+ G
Sbjct: 148 --RAFG--------IPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNG 197
Query: 898 YTPFRGKTR----QKTFANIL----------HKDL-----KFPSSTPTSL---------H 929
F G + + F IL +L F P
Sbjct: 198 TPLFPGVSEADQLMRIF-RILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDES 256
Query: 930 AKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVN 965
L+ ++L DP R+ A + +H +FK N
Sbjct: 257 GIDLLSKMLKLDPNQRI----TAKQALEHAYFKENN 288
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 94.9 bits (237), Expect = 2e-21
Identities = 65/275 (23%), Positives = 113/275 (41%), Gaps = 66/275 (24%)
Query: 723 REI--LDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYA 780
REI L L HP + +L ++ + L+ ++ +L +LD T L++ ++ Y
Sbjct: 68 REISLLKELHHPNIVSLIDVIHSERCLTLVFEFMEK-DLKKVLDENKTG-LQDSQIKIYL 125
Query: 781 AEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKR 840
+++ + + H I++RDLKP+N+L+ +G + L DF L+
Sbjct: 126 YQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLA------------------- 166
Query: 841 RHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGH-TSAVDWWALGILLYEMLYGYT 899
R G P+R+ V T Y AP+++ G+ +++VD W++G + EM+ G
Sbjct: 167 RAFG--------IPVRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKP 218
Query: 900 PFRGKTR----QKTFANIL----------------HKDLKFPSSTPTSL---------HA 930
F G T K F +IL K F
Sbjct: 219 LFPGVTDDDQLPKIF-SILGTPNPREWPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEG 277
Query: 931 KQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVN 965
L+ +L DP R+ A + HP+FK ++
Sbjct: 278 IDLLSNMLCFDPNKRI----SARDAMNHPYFKDLD 308
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 95.8 bits (239), Expect = 3e-21
Identities = 66/362 (18%), Positives = 122/362 (33%), Gaps = 86/362 (23%)
Query: 645 HPKPHRKDSPPWKAIQKILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKA 704
H H + + + + + + +G G G V + A+K
Sbjct: 1 HHHHHHMAAAAAAGPEMVRGQVFDV-GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKK 59
Query: 705 MDKGVMLNRNKVHRACAEREI--LDMLDHP--------FVPALYASFQTKTHVCLITDYC 754
+ ++ + REI L H + V ++ D
Sbjct: 60 ISP----FEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMK---DVYIVQDLM 112
Query: 755 PGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVS 814
+L+ LL Q L D + ++ +++ L+Y+H +++RDLKP N+LL +
Sbjct: 113 -ETDLYKLLKTQH---LSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLK 168
Query: 815 LTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIA 874
+ DF L+ + + F+ E +V T Y APEI+
Sbjct: 169 ICDFGLARVAD-----------------PDHDHTGFLTE-------YVATRWYRAPEIML 204
Query: 875 GAGH-TSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANILH------------------ 915
+ T ++D W++G +L EML F GK +IL
Sbjct: 205 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKA 264
Query: 916 ------------KDLK--FPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFF 961
FP++ +L L+ ++L +P R+ + HP+
Sbjct: 265 RNYLLSLPHKNKVPWNRLFPNADSKALD---LLDKMLTFNPHKRI----EVEQALAHPYL 317
Query: 962 KG 963
+
Sbjct: 318 EQ 319
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 95.5 bits (238), Expect = 5e-21
Identities = 88/373 (23%), Positives = 149/373 (39%), Gaps = 80/373 (21%)
Query: 647 KPHRKDSPPWKAIQKILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMD 706
P + K + +GEQ + + K +G+G G V +L S + A+K
Sbjct: 16 NPLDDPNKVIKVLASDGKTGEQREIA-YTNCKVIGNGSFGVVFQAKLVESDE-VAIK--- 70
Query: 707 KGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTH------VCLITDYCPGGELF 760
K V+ ++ +R E +I+ ++ HP V L A F + + L+ +Y P ++
Sbjct: 71 K-VLQDKRFKNR---ELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPE-TVY 125
Query: 761 LLLD--RQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGN-GHVSLTD 817
+ + + ++ Y +++ +L Y+H GI +RD+KP+N+LL G + L D
Sbjct: 126 RASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLID 185
Query: 818 FDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAG 877
F + + + S++ + Y APE+I GA
Sbjct: 186 FGSA-------------------KI---------LIAGEPNVSYICSRYYRAPELIFGAT 217
Query: 878 H-TSAVDWWALGILLYEMLYGYTPFRGKT-----------------RQKTFANILHKDLK 919
+ T+ +D W+ G ++ E++ G F G++ Q N + + K
Sbjct: 218 NYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTMNPNYMEHK 277
Query: 920 FPSSTPTSLH----------AKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVNWALV 969
FP P A L+ RLL P +RL A E HPFF +
Sbjct: 278 FPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARL----TAIEALCHPFFDELRTGEA 333
Query: 970 RCMNPPELDAPLF 982
R N EL PLF
Sbjct: 334 RMPNGRELP-PLF 345
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 93.4 bits (233), Expect = 7e-21
Identities = 59/275 (21%), Positives = 98/275 (35%), Gaps = 68/275 (24%)
Query: 723 REI-----LDMLDHPFVPALY-----ASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLK 772
RE+ L+ +HP V L + + V L+ ++ +L LD+ P L
Sbjct: 60 REVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLP 118
Query: 773 EDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLL 832
+ ++ + + L++LH I++RDLKPEN+L+ G V L DF L+
Sbjct: 119 AETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLA----------- 167
Query: 833 PTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLY 892
R M + V T Y APE++ + + + VD W++G +
Sbjct: 168 --------RIYS--------YQMALTPVVV-TLWYRAPEVLLQSTYATPVDMWSVGCIFA 210
Query: 893 EMLYGYTPFRGKTRQKTFANILH----------------KDLKFPSSTPTSL-------- 928
EM F G + I FP P +
Sbjct: 211 EMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEME 270
Query: 929 -HAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFK 962
QL+ +L +P R+ A +H +
Sbjct: 271 ESGAQLLLEMLTFNPHKRI----SAFRALQHSYLH 301
|
| >2gj3_A Nitrogen fixation regulatory protein; PAS domain, FAD, redox sensor, atomic resolution, transferase; HET: FAD; 1.04A {Azotobacter vinelandii} Length = 120 | Back alignment and structure |
|---|
Score = 87.9 bits (219), Expect = 8e-21
Identities = 29/92 (31%), Positives = 51/92 (55%)
Query: 217 IMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKIRETLQNGQSYCGRLLNYKKD 276
I+YA+ F +TGY S+EV+G+N L T + L + + G L+N +KD
Sbjct: 27 ILYANRAFRTITGYGSEEVLGKNESILSNGTTPRLVYQALWGRLAQKKPWSGVLVNRRKD 86
Query: 277 GTPFWNLLTIAPIKDDEGKVLKFIGMQVEVSK 308
T + LT+AP+ ++ G+ + ++GM + S+
Sbjct: 87 KTLYLAELTVAPVLNEAGETIYYLGMHRDTSE 118
|
| >2gj3_A Nitrogen fixation regulatory protein; PAS domain, FAD, redox sensor, atomic resolution, transferase; HET: FAD; 1.04A {Azotobacter vinelandii} Length = 120 | Back alignment and structure |
|---|
Score = 74.1 bits (183), Expect = 5e-16
Identities = 29/116 (25%), Positives = 50/116 (43%), Gaps = 5/116 (4%)
Query: 477 LATTLERIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATV 536
T+E ITD I++A+ +F +T Y EE+LG+N L T
Sbjct: 7 FRQTVEHAPIAISITDL---KANILYANRAFRTITGYGSEEVLGKNESILSNGTTPRLVY 63
Query: 537 RKIRAAIDNQTDV-TVQLINYTKSGKKFWNLFHLQPMRDQKGEVQYFIGVQLDGSE 591
+ + + Q + L+N K + + P+ ++ GE Y++G+ D SE
Sbjct: 64 QALWGRL-AQKKPWSGVLVNRRKDKTLYLAELTVAPVLNEAGETIYYLGMHRDTSE 118
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 1e-20
Identities = 75/332 (22%), Positives = 123/332 (37%), Gaps = 85/332 (25%)
Query: 672 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREI--LDML 729
+ ++ + P+GSG GSV +G A+K K ++ +H RE+ L +
Sbjct: 29 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK---KLSRPFQSIIHAKRTYRELRLLKHM 85
Query: 730 DHPFVPALY------ASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEV 783
H V L S + V L+T G +L ++ Q L +D V+F ++
Sbjct: 86 KHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQK---LTDDHVQFLIYQI 141
Query: 784 VVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHK 843
+ L+Y+H II+RDLKP N+ + + + + DF L+ RH
Sbjct: 142 LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA-------------------RHT 182
Query: 844 GQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGH-TSAVDWWALGILLYEMLYGYTPFR 902
M +V T Y APEI+ H VD W++G ++ E+L G T F
Sbjct: 183 AD----EMTG-------YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFP 231
Query: 903 GKTRQKTFANILH------------------------------KDLK--FPSSTPTSLHA 930
G IL + F + P ++
Sbjct: 232 GTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVD- 290
Query: 931 KQLMYRLLHRDPKSRLGSHEGANEIKKHPFFK 962
L+ ++L D R+ A + H +F
Sbjct: 291 --LLEKMLVLDSDKRI----TAAQALAHAYFA 316
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 93.1 bits (232), Expect = 2e-20
Identities = 69/337 (20%), Positives = 118/337 (35%), Gaps = 79/337 (23%)
Query: 671 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREI--LDM 728
F+ LG G G V +G+ A+K ++ + REI L
Sbjct: 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIE--PF--DKPLFALRTLREIKILKH 65
Query: 729 LDHP--------FVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYA 780
H P + +F V +I + +L ++ Q L +D ++++
Sbjct: 66 FKHENIITIFNIQRPDSFENFN---EVYIIQELM-QTDLHRVISTQM---LSDDHIQYFI 118
Query: 781 AEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKR 840
+ + A++ LH +I+RDLKP N+L+ N + + DF L+ +
Sbjct: 119 YQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIID----------ESAAD 168
Query: 841 RHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGH-TSAVDWWALGILLYEMLYGYT 899
+ M E FV T Y APE++ + + A+D W+ G +L E+
Sbjct: 169 NSEPTGQQSGMVE-------FVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRP 221
Query: 900 PFRGK----------------TRQKTFANIL---------------HKDLK--FPSSTPT 926
F G+ I L+ FP P
Sbjct: 222 IFPGRDYRHQLLLIFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPK 281
Query: 927 SLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKG 963
+ L+ R+L DP R+ A E +HP+ +
Sbjct: 282 GID---LLQRMLVFDPAKRI----TAKEALEHPYLQT 311
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 92.7 bits (231), Expect = 2e-20
Identities = 62/303 (20%), Positives = 114/303 (37%), Gaps = 74/303 (24%)
Query: 723 REI-----LDMLDHPFVPALY-----ASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLK 772
RE+ L+ +HP V L+ + +T + L+ ++ +L LD+ P +
Sbjct: 60 REVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVP 118
Query: 773 EDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLL 832
+ ++ +++ L++LH +++RDLKP+N+L+ +G + L DF L+
Sbjct: 119 TETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLA----------- 167
Query: 833 PTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLY 892
R M ++ V T Y APE++ + + + VD W++G +
Sbjct: 168 --------RIYS--------FQMALTSVVV-TLWYRAPEVLLQSSYATPVDLWSVGCIFA 210
Query: 893 EMLYGYTPFRGKTRQKTFANILH----------------KDLKFPSSTPTSL-------- 928
EM FRG + IL F S + +
Sbjct: 211 EMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDID 270
Query: 929 -HAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVNWALVRCMNPPELDAPLFATDTE 987
K L+ + L +P R+ A HP+F+ + LD+ L +
Sbjct: 271 ELGKDLLLKCLTFNPAKRI----SAYSALSHPYFQDLE------RCKENLDSHLPPSQNT 320
Query: 988 KEY 990
E
Sbjct: 321 SEL 323
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 93.7 bits (233), Expect = 5e-20
Identities = 64/302 (21%), Positives = 113/302 (37%), Gaps = 36/302 (11%)
Query: 647 KPHRKDSPPWKAIQKILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMD 706
P K + P ++ LG G G V+ A+K +
Sbjct: 195 YPAPKRNKPTIYGVSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK 254
Query: 707 KGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELF-LLLDR 765
+ M +V E ++ + HP + L + +IT++ G L L +
Sbjct: 255 EDTM----EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLREC 310
Query: 766 QPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTS 825
+V + A ++ A+EYL + I+R+L N L+ N V + DF LS
Sbjct: 311 NRQEVSAVVLLYM-ATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLS---- 365
Query: 826 CKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWW 885
+L+ T + H G + P+ + APE +A + D W
Sbjct: 366 ---RLM---TGDTYTAHAGAKFPIK----------------WTAPESLAYNKFSIKSDVW 403
Query: 886 ALGILLYEML-YGYTPFRGKTRQKTFANILHKD-LKFPSSTPTSLHAKQLMYRLLHRDPK 943
A G+LL+E+ YG +P+ G + + + ++ P P ++ +LM +P
Sbjct: 404 AFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVY--ELMRACWQWNPS 461
Query: 944 SR 945
R
Sbjct: 462 DR 463
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 90.7 bits (226), Expect = 7e-20
Identities = 61/281 (21%), Positives = 110/281 (39%), Gaps = 71/281 (25%)
Query: 721 AEREI--LDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKV----LKED 774
A REI + L H + LY T+ + L+ ++ +L +D + L+ +
Sbjct: 50 AIREISLMKELKHENIVRLYDVIHTENKLTLVFEFMDN-DLKKYMDSRTVGNTPRGLELN 108
Query: 775 AVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPT 834
V+++ +++ L + H I++RDLKP+N+L+ G + L DF L+
Sbjct: 109 LVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLA------------- 155
Query: 835 TNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGH-TSAVDWWALGILLYE 893
R G P+ +S V T Y AP+++ G+ ++++D W+ G +L E
Sbjct: 156 ------RAFG--------IPVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAE 201
Query: 894 MLYGYTPFRGKT--------------------------------RQKTFANILHKDLKFP 921
M+ G F G Q+ L + L+
Sbjct: 202 MITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTKLPKYNPNIQQRPPRDLRQVLQPH 261
Query: 922 SSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFK 962
+ P + ++ LL +P RL A + HP+F
Sbjct: 262 TKEPLDGNLMDFLHGLLQLNPDMRL----SAKQALHHPWFA 298
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 91.1 bits (227), Expect = 7e-20
Identities = 65/322 (20%), Positives = 124/322 (38%), Gaps = 62/322 (19%)
Query: 667 EQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYF----AMKAMDKGVMLNRNKVHRACAE 722
+ F+ IK LGSG G+V+ G+ A+K + + E
Sbjct: 10 RILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATS--PKANKEILDE 67
Query: 723 REILDMLDHPFVPALYASFQTKTHVCLITDYCPGGEL--FLLLDRQPTKVLKEDAVRFYA 780
++ +D+P V L + V LIT P G L ++ R+ + + +
Sbjct: 68 AYVMASVDNPHVCRLLG-ICLTSTVQLITQLMPFGCLLDYV---REHKDNIGSQYLLNWC 123
Query: 781 AEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKR 840
++ + YL + +++RDL NVL++ HV +TDF L+ +LL EK+
Sbjct: 124 VQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLA-------KLL--GAEEKEY 174
Query: 841 RHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEML-YGYT 899
+G + P+ +++A E I +T D W+ G+ ++E++ +G
Sbjct: 175 HAEGGKVPI----------------KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSK 218
Query: 900 PFRGKTRQKTFANI-----LHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANE 954
P+ G + + + L + P ++ +M + D SR
Sbjct: 219 PYDGIPASEISSILEKGERLPQ----PPICTIDVY--MIMRKCWMIDADSR--------- 263
Query: 955 IKKHPFFKGVNWALVRCMNPPE 976
P F+ + + P+
Sbjct: 264 ----PKFRELIIEFSKMARDPQ 281
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 92.5 bits (230), Expect = 1e-19
Identities = 69/318 (21%), Positives = 121/318 (38%), Gaps = 41/318 (12%)
Query: 634 EDLWANHSKVVHPKPHRKDSPPW---KAIQKILDSGEQINLQHFRPIKPLGSGDTGSVHL 690
+ L A +SK HR + Q + +I + R LG G G V +
Sbjct: 143 QQLVAYYSKHADGLCHRLTTVCPTSKPQTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWM 202
Query: 691 VELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLI 750
G+ + A+K + G M E +++ L H + LYA ++ + ++
Sbjct: 203 GTWNGTTR-VAIKTLKPGTM----SPEAFLQEAQVMKKLRHEKLVQLYAVV-SEEPIYIV 256
Query: 751 TDYCPGGELF-LLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQG 809
T+Y G L L + V AA++ + Y+ ++RDL+ N+L+
Sbjct: 257 TEYMSKGSLLDFLKGETGKYLRLPQLVDM-AAQIASGMAYVERMNYVHRDLRAANILVGE 315
Query: 810 NGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIA 869
N + DF L+ +L+ + + +G + P+ + A
Sbjct: 316 NLVCKVADFGLA-------RLI---EDNEYTARQGAKFPIK----------------WTA 349
Query: 870 PEIIAGAGHTSAVDWWALGILLYEML-YGYTPFRGKTRQKTFANILHKD-LKFPSSTPTS 927
PE T D W+ GILL E+ G P+ G ++ + + P P S
Sbjct: 350 PEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPES 409
Query: 928 LHAKQLMYRLLHRDPKSR 945
LH LM + ++P+ R
Sbjct: 410 LH--DLMCQCWRKEPEER 425
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 89.6 bits (223), Expect = 1e-19
Identities = 68/333 (20%), Positives = 117/333 (35%), Gaps = 58/333 (17%)
Query: 655 PWKAIQKILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYF---AMKAMDKGVML 711
P +++ ++ + + L ++ LG G G V E A+K + V+
Sbjct: 7 PLQSLTCLIGE-KDLRL-----LEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLS 60
Query: 712 NRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGEL--FLLLDRQPTK 769
+ E + LDH + LY + ++T+ P G L L R+
Sbjct: 61 QPEAMDDFIREVNAMHSLDHRNLIRLYG-VVLTPPMKMVTELAPLGSLLDRL---RKHQG 116
Query: 770 VLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQ 829
+ YA +V + YL + I+RDL N+LL V + DF L
Sbjct: 117 HFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLM-------- 168
Query: 830 LLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGI 889
LP ++ + ++ P + APE + + A D W G+
Sbjct: 169 RALPQNDDHYVMQEHRKVPF----------------AWCAPESLKTRTFSHASDTWMFGV 212
Query: 890 LLYEML-YGYTPFRGKTRQKTFANILHKD--LKFPSSTPTSLHAKQLMYRLLHRDPKSRL 946
L+EM YG P+ G + I + L P P ++ +M + P+ R
Sbjct: 213 TLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQDIY--NVMVQCWAHKPEDR- 269
Query: 947 GSHEGANEIKKHPFFKGVNWALVRCMNPPELDA 979
P F + L+ P ++ A
Sbjct: 270 ------------PTFVALRDFLLE-AQPTDMRA 289
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 90.8 bits (226), Expect = 1e-19
Identities = 63/342 (18%), Positives = 117/342 (34%), Gaps = 91/342 (26%)
Query: 672 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLN------RNKVHRACAEREI 725
+ + + SG G+V + G A+K + V + REI
Sbjct: 22 SPYTVQRFISSGSYGAVCAG-VDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREI 80
Query: 726 --LDMLDHP--------FVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDA 775
L+ HP FV + + L+T+ +L ++ V+
Sbjct: 81 RLLNHFHHPNILGLRDIFVHFEEPAMH---KLYLVTELM-RTDLAQVI-HDQRIVISPQH 135
Query: 776 VRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTT 835
++++ +++ L LH G+++RDL P N+LL N +++ DF+L+
Sbjct: 136 IQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNLA-------------- 181
Query: 836 NEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGH-TSAVDWWALGILLYEM 894
R +V Y APE++ T VD W+ G ++ EM
Sbjct: 182 -----REDTADA--NKTH-------YVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEM 227
Query: 895 LYGYTPFRGKTRQKTFANILH-------------------------------KDLK--FP 921
FRG T I+ + P
Sbjct: 228 FNRKALFRGSTFYNQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVP 287
Query: 922 SSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKG 963
++ P +L L+ ++L +P+ R+ + +HP+F+
Sbjct: 288 TADPVALD---LIAKMLEFNPQRRI----STEQALRHPYFES 322
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 90.5 bits (225), Expect = 2e-19
Identities = 78/363 (21%), Positives = 122/363 (33%), Gaps = 90/363 (24%)
Query: 662 ILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHR-AC 720
G +N F I+ +G G G V L + + +Y+A+K V+ N K R A
Sbjct: 26 SWKKGMLLN-NAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVK-----VVRNIKKYTRSAK 79
Query: 721 AEREILDML------DHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKED 774
E +IL + ++ V + F H+CLI + G L+ ++ R +
Sbjct: 80 IEADILKKIQNDDINNNNIV-KYHGKFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIE 137
Query: 775 AVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPT 834
++ Y E++ AL YL + + DLKPEN+LL K Q+
Sbjct: 138 DIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTK 197
Query: 835 TNEKK-----------RRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVD 883
+ K H S + T +Y APE+I G + D
Sbjct: 198 STGIKLIDFGCATFKSDYH----------------GSIINTRQYRAPEVILNLGWDVSSD 241
Query: 884 WWALGILLYEMLYGYTPFRG--------------------------KTRQKTFANILHKD 917
W+ G +L E+ G FR KT + N
Sbjct: 242 MWSFGCVLAELYTGSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELK 301
Query: 918 LKFPSSTPTSLHAKQ------------------LMYRLLHRDPKSRLGSHEGANEIKKHP 959
L +P + + K +Y +L DP R E+ KH
Sbjct: 302 LAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSILQIDPTLRP----SPAELLKHK 357
Query: 960 FFK 962
F +
Sbjct: 358 FLE 360
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 89.1 bits (222), Expect = 2e-19
Identities = 60/277 (21%), Positives = 109/277 (39%), Gaps = 66/277 (23%)
Query: 721 AEREI--LDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRF 778
A REI L L H + L+ + + L+ ++C +L D L + V+
Sbjct: 48 ALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDSCNGD-LDPEIVKS 105
Query: 779 YAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEK 838
+ +++ L + H + +++RDLKP+N+L+ NG + L +F L+
Sbjct: 106 FLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLA----------------- 148
Query: 839 KRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGH-TSAVDWWALGILLYEMLYG 897
R G P+R ++ V T Y P+++ GA ++++D W+ G + E+
Sbjct: 149 --RAFGI--------PVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANA 198
Query: 898 YTP-FRGKTR----QKTFANIL----------HKDL----KFPSSTPT----------SL 928
P F G ++ F +L L +P T +
Sbjct: 199 GRPLFPGNDVDDQLKRIF-RLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNA 257
Query: 929 HAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVN 965
+ L+ LL +P R+ A E +HP+F
Sbjct: 258 TGRDLLQNLLKCNPVQRI----SAEEALQHPYFSDFC 290
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 90.1 bits (224), Expect = 2e-19
Identities = 74/333 (22%), Positives = 130/333 (39%), Gaps = 85/333 (25%)
Query: 672 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREI--LDML 729
+R ++P+GSG G+V +G A+K + + ++++ A RE+ L +
Sbjct: 25 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYR---PFQSELFAKRAYRELRLLKHM 81
Query: 730 DHPFVPALY------ASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEV 783
H V L + T L+ + G +L L+ + L ED ++F ++
Sbjct: 82 RHENVIGLLDVFTPDETLDDFTDFYLVMPFM-GTDLGKLMKHEK---LGEDRIQFLVYQM 137
Query: 784 VVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHK 843
+ L Y+H GII+RDLKP N+ + + + + DF L+ R
Sbjct: 138 LKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLA-------------------RQA 178
Query: 844 GQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGH-TSAVDWWALGILLYEMLYGYTPFR 902
M +V T Y APE+I T VD W++G ++ EM+ G T F+
Sbjct: 179 DS----EMTG-------YVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFK 227
Query: 903 GKTRQKTFANILH------------------------------KDLK--FPSSTPTSLHA 930
G I+ KD +++P +++
Sbjct: 228 GSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVN- 286
Query: 931 KQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKG 963
L+ ++L D + R+ A E HP+F+
Sbjct: 287 --LLEKMLVLDAEQRV----TAGEALAHPYFES 313
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 90.0 bits (224), Expect = 2e-19
Identities = 74/333 (22%), Positives = 128/333 (38%), Gaps = 86/333 (25%)
Query: 672 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREI--LDML 729
+ + +GSG GSV SG+ A+K + + ++++ A RE+ L +
Sbjct: 24 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSR---PFQSEIFAKRAYRELLLLKHM 80
Query: 730 DHPFVPALY------ASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEV 783
H V L +S + L+ + +L ++ E+ +++ ++
Sbjct: 81 QHENVIGLLDVFTPASSLRNFYDFYLVMPFM-QTDLQKIM-GLK---FSEEKIQYLVYQM 135
Query: 784 VVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHK 843
+ L+Y+H G+++RDLKP N+ + + + + DF L+ RH
Sbjct: 136 LKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLA-------------------RHA 176
Query: 844 GQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGH-TSAVDWWALGILLYEMLYGYTPFR 902
+ M +V T Y APE+I H VD W++G ++ EML G T F+
Sbjct: 177 DAE----MTG-------YVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFK 225
Query: 903 GKTRQKTFANILH------------------------------KDLK--FPSSTPTSLHA 930
GK IL KD FP ++P +
Sbjct: 226 GKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAAD- 284
Query: 931 KQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKG 963
L+ ++L D RL A + HPFF+
Sbjct: 285 --LLEKMLELDVDKRL----TAAQALTHPFFEP 311
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 89.9 bits (224), Expect = 2e-19
Identities = 76/299 (25%), Positives = 111/299 (37%), Gaps = 68/299 (22%)
Query: 721 AEREI--LDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRF 778
A REI L L HP + L +F K+++ L+ D+ +L +++ L ++
Sbjct: 59 ALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMET-DLEVIIKDNSLV-LTPSHIKA 116
Query: 779 YAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEK 838
Y + LEYLH I++RDLKP N+LL NG + L DF L+
Sbjct: 117 YMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLA----------------- 159
Query: 839 KRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGH-TSAVDWWALGILLYEMLYG 897
+ G P RA V T Y APE++ GA VD WA+G +L E+L
Sbjct: 160 --KSFG--------SPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLR 209
Query: 898 YTPFRGKTR----QKTFANIL----------HKDL----KFPSSTPTSLHAK-------- 931
G + + F L L F S LH
Sbjct: 210 VPFLPGDSDLDQLTRIF-ETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDL 268
Query: 932 -QLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVNWALVRCMNPPELDAPLFATDTEKE 989
L+ L +P +R+ A + K +F +L P +T KE
Sbjct: 269 LDLIQGLFLFNPCARI----TATQALKMKYF----SNRPGPTPGCQLPRPNCPVETLKE 319
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 3e-19
Identities = 60/307 (19%), Positives = 114/307 (37%), Gaps = 65/307 (21%)
Query: 668 QINLQHFRPIKPLGSGDTGSVHLVELCG----SGQYFAMKAMDKGVMLNRNKVHRACAER 723
Q +H + ++ LG G+ GSV + +G+ A+K + + R E
Sbjct: 6 QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFER---EI 62
Query: 724 EILDMLDHPFVPALYA--SFQTKTHVCLITDYCPGGEL--FLLLDRQPTKVLKEDAVRFY 779
EIL L H + + ++ LI +Y P G L +L ++ + + + Y
Sbjct: 63 EILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL---QKHKERIDHIKLLQY 119
Query: 780 AAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKK 839
+++ +EYL + I+RDL N+L++ V + DF L+ +LP E
Sbjct: 120 TSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLT--------KVLPQDKEFF 171
Query: 840 RRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEML---- 895
+ + ++P+F + APE + + + A D W+ G++LYE+
Sbjct: 172 KVKEPGESPIF----------------WYAPESLTESKFSVASDVWSFGVVLYELFTYIE 215
Query: 896 ------------YGYTPFRGKTRQKTFANI-----LHKDLKFPSSTPTSLHAKQLMYRLL 938
G + L + P P ++ +M
Sbjct: 216 KSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPR----PDGCPDEIY--MIMTECW 269
Query: 939 HRDPKSR 945
+ + R
Sbjct: 270 NNNVNQR 276
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 88.6 bits (220), Expect = 3e-19
Identities = 46/309 (14%), Positives = 82/309 (26%), Gaps = 73/309 (23%)
Query: 646 PKPHRKDSPPWKAIQKILDSGEQINLQHFRPIKPLGSGDTGSVHL---VELCGSGQYFAM 702
+P R+ S P +Q L G +I +R + G L + A+
Sbjct: 7 REPDRESSAPPDDVQ--LVPGARIANGRYRLLIFHGGVPPLQFWQALDTAL---DRQVAL 61
Query: 703 KAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLL 762
+D +L + + + L +D P V + T+ ++ ++ GG L +
Sbjct: 62 TFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVAEWIRGGSLQEV 121
Query: 763 LDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSC 822
D P+ A+R + A + H G+ P V + +G V L
Sbjct: 122 ADTSPSP---VGAIR-AMQSLAAAADAAHRAGVALSIDHPSRVRVSIDGDVVLAYP---- 173
Query: 823 LTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAV 882
+
Sbjct: 174 -------------------------------------------ATMPDA-------NPQD 183
Query: 883 DWWALGILLYEMLYGYTPFRGKTRQKTFANILHKDLKFPSSTPTSLHAK------QLMYR 936
D +G LY +L P + A +D P + + R
Sbjct: 184 DIRGIGASLYALLVNRWPLPEAGVRSGLA-PAERDTAGQPIEPADIDRDIPFQISAVAAR 242
Query: 937 LLHRDPKSR 945
+ D R
Sbjct: 243 SVQGDGGIR 251
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 91.9 bits (228), Expect = 3e-19
Identities = 69/318 (21%), Positives = 121/318 (38%), Gaps = 41/318 (12%)
Query: 634 EDLWANHSKVVHPKPHRKDSPPWK---AIQKILDSGEQINLQHFRPIKPLGSGDTGSVHL 690
+ L A +SK HR + Q + +I + R LG G G V +
Sbjct: 226 QQLVAYYSKHADGLCHRLTTVCPTSKPQTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWM 285
Query: 691 VELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLI 750
G+ + A+K + G M E +++ L H + LYA ++ + ++
Sbjct: 286 GTWNGTTR-VAIKTLKPGTM----SPEAFLQEAQVMKKLRHEKLVQLYAVV-SEEPIYIV 339
Query: 751 TDYCPGGELF-LLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQG 809
T+Y G L L + V AA++ + Y+ ++RDL+ N+L+
Sbjct: 340 TEYMSKGSLLDFLKGETGKYLRLPQLVDM-AAQIASGMAYVERMNYVHRDLRAANILVGE 398
Query: 810 NGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIA 869
N + DF L+ +L+ + + +G + P+ + A
Sbjct: 399 NLVCKVADFGLA-------RLI---EDNEYTARQGAKFPIK----------------WTA 432
Query: 870 PEIIAGAGHTSAVDWWALGILLYEML-YGYTPFRGKTRQKTFANILHKD-LKFPSSTPTS 927
PE T D W+ GILL E+ G P+ G ++ + + P P S
Sbjct: 433 PEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPES 492
Query: 928 LHAKQLMYRLLHRDPKSR 945
LH LM + ++P+ R
Sbjct: 493 LH--DLMCQCWRKEPEER 508
|
| >3lyx_A Sensory BOX/ggdef domain protein; structural genomics, PSI- 2, protein structure initiative, northeast structural genomics consortium; 2.00A {Colwellia psychrerythraea} Length = 124 | Back alignment and structure |
|---|
Score = 83.7 bits (208), Expect = 3e-19
Identities = 16/86 (18%), Positives = 37/86 (43%)
Query: 217 IMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKIRETLQNGQSYCGRLLNYKKD 276
I+ + G + GY+ ++ +G+ L G +++ ++N + G + KD
Sbjct: 29 IIDWNKGSETLYGYSKEQAIGQPVNMLHVPGDTEHITSEVISAVENQGKWTGEIRMLHKD 88
Query: 277 GTPFWNLLTIAPIKDDEGKVLKFIGM 302
G W PI + +++ +G+
Sbjct: 89 GHIGWIESMCVPIYGENYQMVGALGI 114
|
| >3lyx_A Sensory BOX/ggdef domain protein; structural genomics, PSI- 2, protein structure initiative, northeast structural genomics consortium; 2.00A {Colwellia psychrerythraea} Length = 124 | Back alignment and structure |
|---|
Score = 77.5 bits (192), Expect = 3e-17
Identities = 22/103 (21%), Positives = 43/103 (41%), Gaps = 3/103 (2%)
Query: 489 VITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIRAAIDNQTD 548
V+TD II + L YS+E+ +G+ L P ++ +A++NQ
Sbjct: 21 VVTDL---QGFIIDWNKGSETLYGYSKEQAIGQPVNMLHVPGDTEHITSEVISAVENQGK 77
Query: 549 VTVQLINYTKSGKKFWNLFHLQPMRDQKGEVQYFIGVQLDGSE 591
T ++ K G W P+ + ++ +G+ D ++
Sbjct: 78 WTGEIRMLHKDGHIGWIESMCVPIYGENYQMVGALGINRDITK 120
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 89.0 bits (221), Expect = 4e-19
Identities = 61/336 (18%), Positives = 121/336 (36%), Gaps = 66/336 (19%)
Query: 639 NHSKVVHPKPHRKDSPPWKAIQKILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCG--- 695
+H + + + + D + +H + ++ LG G+ GSV +
Sbjct: 9 HHDYDIPTTENLYFQGAMGSAFEDRDPTQ-FEERHLKFLQQLGKGNFGSVEMCRYDPLQD 67
Query: 696 -SGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYA--SFQTKTHVCLITD 752
+G+ A+K + + R E EIL L H + + ++ LI +
Sbjct: 68 NTGEVVAVKKLQHSTEEHLRDFER---EIEILKSLQHDNIVKYKGVCYSAGRRNLKLIME 124
Query: 753 YCPGGEL--FLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGN 810
Y P G L +L ++ + + + Y +++ +EYL + I+RDL N+L++
Sbjct: 125 YLPYGSLRDYL---QKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENE 181
Query: 811 GHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAP 870
V + DF L+ +LP E + + ++P+F + AP
Sbjct: 182 NRVKIGDFGLT--------KVLPQDKEYYKVKEPGESPIF----------------WYAP 217
Query: 871 EIIAGAGHTSAVDWWALGILLYEML----------------YGYTPFRGKTRQKTFANI- 913
E + + + A D W+ G++LYE+ G +
Sbjct: 218 ESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLK 277
Query: 914 ----LHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSR 945
L + P P ++ +M + + R
Sbjct: 278 NNGRLPR----PDGCPDEIY--MIMTECWNNNVNQR 307
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 89.8 bits (223), Expect = 4e-19
Identities = 58/256 (22%), Positives = 101/256 (39%), Gaps = 50/256 (19%)
Query: 662 ILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHR-AC 720
I+ +GE+ + +G G G V ++ A+K ++ N+ A
Sbjct: 45 IVKNGEKWM-DRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIK-----IIKNKKAFLNQAQ 98
Query: 721 AEREILDML-------DHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKE 773
E +L+++ + V L F + H+CL+ + L+ LL + +
Sbjct: 99 IEVRLLELMNKHDTEMKYYIVH-LKRHFMFRNHLCLVFEML-SYNLYDLLRNTNFRGVSL 156
Query: 774 DAVRFYAAEVVVALEYLHCQ--GIIYRDLKPENVLL--QGNGHVSLTDFDLSCLTSCKPQ 829
+ R +A ++ AL +L II+ DLKPEN+LL + + DF SC
Sbjct: 157 NLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSC------- 209
Query: 830 LLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGI 889
GQ+ ++ + Y +PE++ G + A+D W+LG
Sbjct: 210 ------------QLGQR-----------IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGC 246
Query: 890 LLYEMLYGYTPFRGKT 905
+L EM G F G
Sbjct: 247 ILVEMHTGEPLFSGAN 262
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 90.3 bits (224), Expect = 5e-19
Identities = 68/341 (19%), Positives = 127/341 (37%), Gaps = 88/341 (25%)
Query: 671 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREI--LDM 728
L+ ++ +KP+GSG G V + A+K K +N+ H A RE+ +
Sbjct: 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIK---KLSRPFQNQTHAKRAYRELVLMKC 117
Query: 729 LDHPFVPALY------ASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAE 782
++H + +L + + V L+ + L ++ + L + + + +
Sbjct: 118 VNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLCQVI-QME---LDHERMSYLLYQ 172
Query: 783 VVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRH 842
++ +++LH GII+RDLKP N++++ + + + DF L+
Sbjct: 173 MLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA--------------------- 211
Query: 843 KGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFR 902
+ M +V T Y APE+I G G+ VD W++G ++ EM+ F
Sbjct: 212 RTAGTSFMMTP-------YVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFP 264
Query: 903 GK-------------------------------------TRQKTFANILHKDLKFPSSTP 925
G+ TF + L S
Sbjct: 265 GRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEH 324
Query: 926 TSLHAKQ---LMYRLLHRDPKSRLGSHEGANEIKKHPFFKG 963
L A Q L+ ++L DP R+ ++ +HP+
Sbjct: 325 NKLKASQARDLLSKMLVIDPAKRI----SVDDALQHPYINV 361
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 88.2 bits (219), Expect = 6e-19
Identities = 64/301 (21%), Positives = 108/301 (35%), Gaps = 56/301 (18%)
Query: 669 INLQHFRPIKPLGSGDTGSVHLVELCGSGQYF----AMKAMDKGVMLNRNKVHRACAERE 724
+H + I LG G+ GSV L G A+K + + R E +
Sbjct: 20 FEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQR---EIQ 76
Query: 725 ILDMLDHPFVPALYA-SFQTKTH-VCLITDYCPGGEL--FLLLDRQPTKVLKEDAVRFYA 780
IL L F+ S+ + L+ +Y P G L FL ++ L + Y+
Sbjct: 77 ILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFL---QRHRARLDASRLLLYS 133
Query: 781 AEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKR 840
+++ +EYL + ++RDL N+L++ HV + DF L+ LLP +
Sbjct: 134 SQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLA--------KLLPLDKDYYV 185
Query: 841 RHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEML-YGYT 899
+ Q+P+F + APE ++ + D W+ G++LYE+ Y
Sbjct: 186 VREPGQSPIF----------------WYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDK 229
Query: 900 PFRGKTRQKTFANILHKDLKF---------------PSSTPTSLHAKQLMYRLLHRDPKS 944
P + P +H +LM P+
Sbjct: 230 SCSPSAEFLRMMGCERDVPALSRLLELLEEGQRLPAPPACPAEVH--ELMKLCWAPSPQD 287
Query: 945 R 945
R
Sbjct: 288 R 288
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 89.4 bits (222), Expect = 7e-19
Identities = 60/254 (23%), Positives = 105/254 (41%), Gaps = 48/254 (18%)
Query: 662 ILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHR-AC 720
+ + + + + +K +G G G V Q+ A+K ++ N + HR A
Sbjct: 88 VQVPHDHVAYR-YEVLKVIGKGSFGQVVKAYDHKVHQHVALK-----MVRNEKRFHRQAA 141
Query: 721 AEREILDML-------DHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKE 773
E IL+ L + + +F + H+C+ + L+ L+ + +
Sbjct: 142 EEIRILEHLRKQDKDNTMNVIH-MLENFTFRNHICMTFELL-SMNLYELIKKNKFQGFSL 199
Query: 774 DAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGH--VSLTDFDLSCLTSCKPQLL 831
VR +A ++ L+ LH II+ DLKPEN+LL+ G + + DF SC
Sbjct: 200 PLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEH------ 253
Query: 832 LPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILL 891
V+ +++ + Y APE+I GA + +D W+LG +L
Sbjct: 254 ---------------QRVY---------TYIQSRFYRAPEVILGARYGMPIDMWSLGCIL 289
Query: 892 YEMLYGYTPFRGKT 905
E+L GY G+
Sbjct: 290 AELLTGYPLLPGED 303
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 88.2 bits (219), Expect = 9e-19
Identities = 74/369 (20%), Positives = 115/369 (31%), Gaps = 104/369 (28%)
Query: 662 ILDSGEQINLQHFRPIKPLGSGDTGSVHLVE---LCGSGQYFAMKAMDKGVMLNRNKVHR 718
+ G+ + + + + LG G G V VE A+K ++ N K
Sbjct: 10 VCRIGDWLQ-ERYEIVGNLGEGTFGKV--VECLDHARGKSQVALK-----IIRNVGKYRE 61
Query: 719 -ACAEREILDML-------DHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKV 770
A E +L + V + F H+C+ + G F L +
Sbjct: 62 AARLEINVLKKIKEKDKENKFLCV-LMSDWFNFHGHMCIAFELL-GKNTFEFLKENNFQP 119
Query: 771 LKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQL 830
VR A ++ AL +LH + + DLKPEN+L +
Sbjct: 120 YPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILF------------------VNSEF 161
Query: 831 LLPTTNEKKRRHKGQQNPV----------FMAEPMRASNSFVGTEEYIAPEIIAGAGHTS 880
K K +N F E + V T Y PE+I G
Sbjct: 162 ETLYNEHKSCEEKSVKNTSIRVADFGSATFDHEHH---TTIVATRHYRPPEVILELGWAQ 218
Query: 881 AVDWWALGILLYEMLYGYTPFRGKT------------------------RQKTFANILHK 916
D W++G +L+E G+T F+ +QK F
Sbjct: 219 PCDVWSIGCILFEYYRGFTLFQTHENREHLVMMEKILGPIPSHMIHRTRKQKYFY---KG 275
Query: 917 DLKFPSSTPTSLHAKQ---------------------LMYRLLHRDPKSRLGSHEGANEI 955
L + ++ + K+ LM R+L DP R+ E
Sbjct: 276 GLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRI----TLAEA 331
Query: 956 KKHPFFKGV 964
HPFF G+
Sbjct: 332 LLHPFFAGL 340
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 89.4 bits (222), Expect = 1e-18
Identities = 68/308 (22%), Positives = 124/308 (40%), Gaps = 44/308 (14%)
Query: 641 SKVVHPKPHRKDSPPWKAIQKILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYF 700
K+ P K PW+ +I + + K LG+G G V + +
Sbjct: 163 QKLSVPCMSSKPQKPWEKDAW------EIPRESLKLEKKLGAGQFGEVWMATYNKHTK-V 215
Query: 701 AMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELF 760
A+K M G M V AE ++ L H + L+A TK + +IT++ G L
Sbjct: 216 AVKTMKPGSM----SVEAFLAEANVMKTLQHDKLVKLHAVV-TKEPIYIITEFMAKGSLL 270
Query: 761 -LLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFD 819
L + +K + F +A++ + ++ + I+RDL+ N+L+ + + DF
Sbjct: 271 DFLKSDEGSKQPLPKLIDF-SAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFG 329
Query: 820 LSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHT 879
L+ +++ + + +G + P+ ++ APE I T
Sbjct: 330 LA-------RVI---EDNEYTAREGAKFPI----------------KWTAPEAINFGSFT 363
Query: 880 SAVDWWALGILLYEML-YGYTPFRGKTRQKTFANILHKD-LKFPSSTPTSLHAKQLMYRL 937
D W+ GILL E++ YG P+ G + + + + P + P L+ +M R
Sbjct: 364 IKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENCPEELY--NIMMRC 421
Query: 938 LHRDPKSR 945
P+ R
Sbjct: 422 WKNRPEER 429
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 88.2 bits (219), Expect = 1e-18
Identities = 68/341 (19%), Positives = 125/341 (36%), Gaps = 88/341 (25%)
Query: 671 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREI--LDM 728
L+ ++ +KP+GSG G V + A+K K +N+ H A RE+ +
Sbjct: 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIK---KLSRPFQNQTHAKRAYRELVLMKC 80
Query: 729 LDHPFVPALY------ASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAE 782
++H + L S + V ++ + L ++ + L + + + +
Sbjct: 81 VNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM-DANLCQVI-QME---LDHERMSYLLYQ 135
Query: 783 VVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRH 842
++ +++LH GII+RDLKP N++++ + + + DF L+
Sbjct: 136 MLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA--------------------- 174
Query: 843 KGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFR 902
+ M +V T Y APE+I G G+ VD W++G ++ EM+ G F
Sbjct: 175 RTAGTSFMMTP-------YVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFP 227
Query: 903 GK-------------------------------------TRQKTFANILHKDLKFPSSTP 925
G +F + L S
Sbjct: 228 GTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEH 287
Query: 926 TSLHAKQ---LMYRLLHRDPKSRLGSHEGANEIKKHPFFKG 963
L A Q L+ ++L D R+ +E +HP+
Sbjct: 288 NKLKASQARDLLSKMLVIDASKRI----SVDEALQHPYINV 324
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 86.9 bits (216), Expect = 2e-18
Identities = 70/338 (20%), Positives = 120/338 (35%), Gaps = 92/338 (27%)
Query: 672 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDML-D 730
++ ++ LG G V + + +K +L K + E +IL+ L
Sbjct: 36 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVK------ILKPVKKKKIKREIKILENLRG 89
Query: 731 HPFVPALYA---SFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVAL 787
P + L ++T L+ ++ + L L + +RFY E++ AL
Sbjct: 90 GPNIITLADIVKDPVSRTPA-LVFEHVNNTDFKQLYQT-----LTDYDIRFYMYEILKAL 143
Query: 788 EYLHCQGIIYRDLKPENVLL-QGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQ 846
+Y H GI++RD+KP NV++ + + L D+ L
Sbjct: 144 DYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGL-------------------------- 177
Query: 847 NPVFMAE---PMRASNSFVGTEEYIAPEIIAGAGH-TSAVDWWALGILLYEMLYGYTP-F 901
AE P + N V + + PE++ ++D W+LG +L M++ P F
Sbjct: 178 -----AEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFF 232
Query: 902 RGK---------------------------TRQKTFANIL----HKDLK--FPSSTPTSL 928
G F +IL K + S +
Sbjct: 233 HGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLV 292
Query: 929 H--AKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGV 964
A + +LL D +SRL A E +HP+F V
Sbjct: 293 SPEALDFLDKLLRYDHQSRL----TAREAMEHPYFYTV 326
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 87.3 bits (217), Expect = 2e-18
Identities = 70/342 (20%), Positives = 120/342 (35%), Gaps = 94/342 (27%)
Query: 671 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKV--HRACAEREI--- 725
+ F+ + G G G+V L + +G A+K KV RE+
Sbjct: 22 MDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIK-----------KVIQDPRFRNRELQIM 70
Query: 726 --LDMLDHPFVPALYASFQTKTH-------VCLITDYCPGGELFLLLDRQPTK--VLKED 774
L +L HP + L + F T + ++ +Y P L +
Sbjct: 71 QDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPI 129
Query: 775 AVRFYAAEVVVALEYLHCQ--GIIYRDLKPENVLL-QGNGHVSLTDFDLSCLTSCKPQLL 831
++ + +++ ++ LH + +RD+KP NVL+ + +G + L DF +
Sbjct: 130 LIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSA---------- 179
Query: 832 LPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGH-TSAVDWWALGIL 890
+ P + +++ + Y APE+I G H T+AVD W++G +
Sbjct: 180 --------K----------KLSPSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCI 221
Query: 891 LYEMLYGYTPFRGKT-----------------RQKTFANILHKDLKFPSSTPTSLH---- 929
EM+ G FRG N H D+ +S
Sbjct: 222 FAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFS 281
Query: 930 ---------AKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFK 962
A L+ LL P+ R+ E HP+F
Sbjct: 282 DHSLKDAKEAYDLLSALLQYLPEERM----KPYEALCHPYFD 319
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 88.0 bits (218), Expect = 2e-18
Identities = 68/367 (18%), Positives = 125/367 (34%), Gaps = 43/367 (11%)
Query: 641 SKVVHPKPHRKDSPPWKAIQKILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYF 700
S+ + + S A S QI + +G+G G V +
Sbjct: 23 SQQEGQQRKQHHSSKPTASMPRPHSDWQI-PDRYEIRHLIGTGSYGHVCEAYDKLEKRVV 81
Query: 701 AMKAMDKGVMLNRNKVHRACAEREI--LDMLDHPFVPALYASFQTKTHVCLITDYCPGGE 758
A+K + + + + + REI L+ L+H V + + + D E
Sbjct: 82 AIKKILR---VFEDLIDCKRILREIAILNRLNHDHVVKVL-------DIVIPKDVEKFDE 131
Query: 759 LFLLLDRQPT---------KVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQG 809
L+++L+ + L E ++ ++V ++Y+H GI++RDLKP N L+
Sbjct: 132 LYVVLEIADSDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQ 191
Query: 810 NGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIA 869
+ V + DF L+ + R V T Y A
Sbjct: 192 DCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRA 251
Query: 870 PEIIAGAGH-TSAVDWWALGILLYEMLYGYTP-----------FRGKTRQKTFANILHKD 917
PE+I + T A+D W++G + E+L F G + F +
Sbjct: 252 PELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYHADRGPLFPGSS---CFPLSPDQK 308
Query: 918 LKFPSSTPTSLHAKQL--MYRLL---HRDPKSRLGSHEGANEIKKHPFFKGVNWA-LVRC 971
T + QL ++ +L + L + I+ P +G + A
Sbjct: 309 AGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAERFPA 368
Query: 972 MNPPELD 978
+ +
Sbjct: 369 SSADAIH 375
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 86.6 bits (215), Expect = 3e-18
Identities = 73/366 (19%), Positives = 127/366 (34%), Gaps = 98/366 (26%)
Query: 662 ILDSGEQINLQHFRPIKPLGSGDTGSVHLVE---LCGSGQYFAMKAMDKGVMLNRNKVHR 718
I SG+ ++ + + LG G G V VE G++ A+K ++ N ++
Sbjct: 5 ICQSGDVLS-ARYEIVDTLGEGAFGKV--VECIDHKAGGRHVAVK-----IVKNVDRYCE 56
Query: 719 -ACAEREILDML-------DHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKV 770
A +E ++L+ L V + F+ H+C++ + G + +
Sbjct: 57 AARSEIQVLEHLNTTDPNSTFRCV-QMLEWFEHHGHICIVFELL-GLSTYDFIKENGFLP 114
Query: 771 LKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQL 830
+ D +R A ++ ++ +LH + + DLKPEN+L +
Sbjct: 115 FRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILF------------------VQSDY 156
Query: 831 LLPTTNEKKRRHKGQQNPV----------FMAEPMRASNSFVGTEEYIAPEIIAGAGHTS 880
+ KR + NP + E ++ V T Y APE+I G +
Sbjct: 157 TEAYNPKIKRDERTLINPDIKVVDFGSATYDDEHH---STLVSTRHYRAPEVILALGWSQ 213
Query: 881 AVDWWALGILLYEMLYGYTPFRGKT------------------------RQKTFANIL-- 914
D W++G +L E G+T F ++K F +
Sbjct: 214 PCDVWSIGCILIEYYLGFTVFPTHDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLD 273
Query: 915 --------------HKDLK--FPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKH 958
K LK S L+ ++L DP R+ E KH
Sbjct: 274 WDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRI----TLREALKH 329
Query: 959 PFFKGV 964
PFF +
Sbjct: 330 PFFDLL 335
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 86.3 bits (214), Expect = 4e-18
Identities = 72/364 (19%), Positives = 131/364 (35%), Gaps = 107/364 (29%)
Query: 666 GEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREI 725
G + + + + K LG+G G V V SG+ FA+K K V+ + +R E +I
Sbjct: 1 GLETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALK---K-VLQDPRYKNR---ELDI 53
Query: 726 LDMLDHPFVPALYASFQTKTHVCLITDYCPGG--------------------------EL 759
+ +LDH + L F T P L
Sbjct: 54 MKVLDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYL 113
Query: 760 FLLLDRQPT-------------KVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVL 806
++++ P + + + + Y ++ A+ ++H GI +RD+KP+N+L
Sbjct: 114 NVIMEYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLL 173
Query: 807 LQGN-GHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTE 865
+ + L DF + + P S +++ +
Sbjct: 174 VNSKDNTLKLCDFGSA-------------------KK---------LIPSEPSVAYICSR 205
Query: 866 EYIAPEIIAGAGH-TSAVDWWALGILLYEMLYGYTPFRGKTR-----------------Q 907
Y APE++ GA T ++D W++G + E++ G F G+T Q
Sbjct: 206 FYRAPELMLGATEYTPSIDLWSIGCVFGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQ 265
Query: 908 KTFANILHKDLKFPSSTPTSLH----------AKQLMYRLLHRDPKSRLGSHEGANEIKK 957
N + +++FP+ A L+ ++L +P R+ E
Sbjct: 266 MIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRI----NPYEAMA 321
Query: 958 HPFF 961
HPFF
Sbjct: 322 HPFF 325
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 84.2 bits (209), Expect = 8e-18
Identities = 61/281 (21%), Positives = 108/281 (38%), Gaps = 36/281 (12%)
Query: 668 QINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILD 727
++ LG G G V+ A+K + + M +V E ++
Sbjct: 9 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMK 64
Query: 728 MLDHPFVPALYASFQTKTHVCLITDYCPGGELF-LLLDRQPTKVLKEDAVRFYAAEVVVA 786
+ HP + L + +IT++ G L L + +V + A ++ A
Sbjct: 65 EIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYM-ATQISSA 123
Query: 787 LEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQ 846
+EYL + I+RDL N L+ N V + DF LS L + + H G +
Sbjct: 124 MEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT----------GDTYTAHAGAK 173
Query: 847 NPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEML-YGYTPFRGKT 905
P+ ++ APE +A + D WA G+LL+E+ YG +P+ G
Sbjct: 174 FPI----------------KWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID 217
Query: 906 RQKTFANILHKD-LKFPSSTPTSLHAKQLMYRLLHRDPKSR 945
+ + + ++ P P ++ +LM +P R
Sbjct: 218 LSQVYELLEKDYRMERPEGCPEKVY--ELMRACWQWNPSDR 256
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 85.5 bits (212), Expect = 9e-18
Identities = 59/241 (24%), Positives = 103/241 (42%), Gaps = 21/241 (8%)
Query: 671 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREIL---D 727
L+ + +K LG G G V +G+ A+K K +N REI+ +
Sbjct: 8 LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVK---KIFDAFQNSTDAQRTFREIMILTE 64
Query: 728 MLDHPFVPALYASFQTKT--HVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVV 785
+ H + L + V L+ DY +L ++ L+ ++ +++
Sbjct: 65 LSGHENIVNLLNVLRADNDRDVYLVFDYM-ETDLHAVIRANI---LEPVHKQYVVYQLIK 120
Query: 786 ALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLS-CLTSCKPQLLLPTTNEKKRRHKG 844
++YLH G+++RD+KP N+LL HV + DF LS + + + +
Sbjct: 121 VIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENF 180
Query: 845 QQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGH-TSAVDWWALGILLYEMLYGYTPFRG 903
+ + + +V T Y APEI+ G+ T +D W+LG +L E+L G F G
Sbjct: 181 DDDQPILTD-------YVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPG 233
Query: 904 K 904
Sbjct: 234 S 234
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 84.7 bits (210), Expect = 9e-18
Identities = 74/315 (23%), Positives = 119/315 (37%), Gaps = 42/315 (13%)
Query: 640 HSKVVHPKPHRKDSPPWKAIQKILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQY 699
K+ P+ + + + + +I K +GSGD+G V L GQ
Sbjct: 17 QGKLPEPQFYAEPHTYEEPGRAGRSFTREIEASRIHIEKIIGSGDSGEVCYGRLRVPGQR 76
Query: 700 F---AMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPG 756
A+KA+ G + + +E I+ DHP + L ++T+Y
Sbjct: 77 DVPVAIKALKAGYTERQRR--DFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMEN 134
Query: 757 GELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLT 816
G L L + V V + YL G ++RDL NVL+ N ++
Sbjct: 135 GSLDTFLRTHDGQFTIMQLVGM-LRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVS 193
Query: 817 DFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGA 876
DF LS +L + G + P+ + APE IA
Sbjct: 194 DFGLSR--------VLEDDPDAAYTTTGGKIPI----------------RWTAPEAIAFR 229
Query: 877 GHTSAVDWWALGILLYEML-YGYTPFRGKTRQKTFANI-----LHKDLKFPSSTPTSLHA 930
+SA D W+ G++++E+L YG P+ T + +++ L P P +LH
Sbjct: 230 TFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGYRLPA----PMGCPHALH- 284
Query: 931 KQLMYRLLHRDPKSR 945
QLM H+D R
Sbjct: 285 -QLMLDCWHKDRAQR 298
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 84.2 bits (209), Expect = 1e-17
Identities = 63/338 (18%), Positives = 116/338 (34%), Gaps = 81/338 (23%)
Query: 671 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREI--LDM 728
+ +KPLG G G V + A+K K ++ + A REI +
Sbjct: 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIK---K--IVLTDPQSVKHALREIKIIRR 64
Query: 729 LDHPFVPALYASF--QTKTHVCLITDYCPGGELFLLLDRQPT--------KVLKEDAVRF 778
LDH + ++ + ++++ + T L E+ R
Sbjct: 65 LDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPLLEEHARL 124
Query: 779 YAAEVVVALEYLHCQGIIYRDLKPENVLL-QGNGHVSLTDFDLSCLTSCKPQLLLPTTNE 837
+ +++ L+Y+H +++RDLKP N+ + + + + DF L+ +
Sbjct: 125 FMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLARIMD------------ 172
Query: 838 KKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGH-TSAVDWWALGILLYEMLY 896
+ ++E + T+ Y +P ++ + T A+D WA G + EML
Sbjct: 173 -----PHYSHKGHLSE-------GLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLT 220
Query: 897 GYTPFRGKTRQKTFANILH-----------------------------KDLK--FPSSTP 925
G T F G + IL K L P +
Sbjct: 221 GKTLFAGAHELEQMQLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISR 280
Query: 926 TSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKG 963
++ + ++L P RL A E HP+
Sbjct: 281 EAVD---FLEQILTFSPMDRL----TAEEALSHPYMSI 311
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 84.3 bits (209), Expect = 1e-17
Identities = 62/287 (21%), Positives = 117/287 (40%), Gaps = 41/287 (14%)
Query: 667 EQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYF----AMKAMDKGVMLNRNKVHRACAE 722
+ F+ IK LGSG G+V+ G+ A+K + + E
Sbjct: 10 RILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATS--PKANKEILDE 67
Query: 723 REILDMLDHPFVPALYASFQTKTHVCLITDYCPGGEL--FLLLDRQPTKVLKEDAVRFYA 780
++ +D+P V L + V LIT P G L ++ R+ + + +
Sbjct: 68 AYVMASVDNPHVCRLLG-ICLTSTVQLITQLMPFGCLLDYV---REHKDNIGSQYLLNWC 123
Query: 781 AEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKR 840
++ + YL + +++RDL NVL++ HV +TDF L+ +LL EK+
Sbjct: 124 VQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLA-------KLL--GAEEKEY 174
Query: 841 RHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEML-YGYT 899
+G + P+ +++A E I +T D W+ G+ ++E++ +G
Sbjct: 175 HAEGGKVPI----------------KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSK 218
Query: 900 PFRGKTRQKTFANILHKD-LKFPSSTPTSLHAKQLMYRLLHRDPKSR 945
P+ G + + + + L P ++ +M + D SR
Sbjct: 219 PYDGIPASEISSILEKGERLPQPPICTIDVY--MIMVKCWMIDADSR 263
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 83.8 bits (208), Expect = 2e-17
Identities = 60/279 (21%), Positives = 103/279 (36%), Gaps = 72/279 (25%)
Query: 721 AEREI--LDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRF 778
A RE+ L L H + L + + LI +Y +L +D+ P + ++
Sbjct: 80 AIREVSLLKELQHRNIIELKSVIHHNHRLHLIFEYAEN-DLKKYMDKNP--DVSMRVIKS 136
Query: 779 YAAEVVVALEYLHCQGIIYRDLKPENVLL-----QGNGHVSLTDFDLSCLTSCKPQLLLP 833
+ +++ + + H + ++RDLKP+N+LL + + DF L+
Sbjct: 137 FLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLA------------ 184
Query: 834 TTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGH-TSAVDWWALGILLY 892
R G P+R + T Y PEI+ G+ H +++VD W++ +
Sbjct: 185 -------RAFG--------IPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWA 229
Query: 893 EMLYGYTPFRGKTR----QKTFANIL----------HKDL-----KFPSSTPTSL----- 928
EML F G + K F +L L FP +L
Sbjct: 230 EMLMKTPLFPGDSEIDQLFKIF-EVLGLPDDTTWPGVTALPDWKQSFPKFRGKTLKRVLG 288
Query: 929 -----HAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFK 962
L+ +L DP R+ A +HP+F
Sbjct: 289 ALLDDEGLDLLTAMLEMDPVKRI----SAKNALEHPYFS 323
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 84.4 bits (209), Expect = 3e-17
Identities = 60/341 (17%), Positives = 122/341 (35%), Gaps = 58/341 (17%)
Query: 671 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREI--LDM 728
++ +G G G V+L + + A+K +++ + + + REI L+
Sbjct: 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNR---MFEDLIDCKRILREITILNR 81
Query: 729 LDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPT---------KVLKEDAVRFY 779
L ++ LY + + D EL+++L+ + L E+ ++
Sbjct: 82 LKSDYIIRLY-------DLIIPDDLLKFDELYIVLEIADSDLKKLFKTPIFLTEEHIKTI 134
Query: 780 AAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDL--SCLTSCKPQLLLPTTNE 837
+++ ++H GII+RDLKP N LL + V + DF L + + ++
Sbjct: 135 LYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEEN 194
Query: 838 KKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGH-TSAVDWWALGILLYEMLY 896
++ + + V T Y APE+I + T ++D W+ G + E+L
Sbjct: 195 EEPGPHNKNLKKQLTS-------HVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLN 247
Query: 897 GYTPFRGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPK------------- 943
+ L FP S+ L + ++ + +
Sbjct: 248 MLQSHINDPTNR-------FPL-FPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTP 299
Query: 944 -----SRLGSHEGANEIKKHPFFKGVNWA-LVRCMNPPELD 978
+ E IK P K +N ++ ++
Sbjct: 300 TEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSISDDGIN 340
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 82.3 bits (204), Expect = 3e-17
Identities = 61/274 (22%), Positives = 109/274 (39%), Gaps = 38/274 (13%)
Query: 678 KPLGSGDTGSVHLVELCGSGQYF--AMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVP 735
K LGSG+ G+V A+K + + AE ++ LD+P++
Sbjct: 23 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAN-DPALKDELLAEANVMQQLDNPYIV 81
Query: 736 ALYASFQTKTHVCLITDYCPGGEL--FLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQ 793
+ L+ + G L +L +R +K+ + +V + ++YL
Sbjct: 82 RMIG-ICEAESWMLVMEMAELGPLNKYLQQNRH----VKDKNIIELVHQVSMGMKYLEES 136
Query: 794 GIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAE 853
++RDL NVLL + ++DF LS + L N K + G+
Sbjct: 137 NFVHRDLAARNVLLVTQHYAKISDFGLS-------KALRADENYYKAQTHGKW------- 182
Query: 854 PMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEML-YGYTPFRGKTRQKTFAN 912
P++ + APE I +S D W+ G+L++E YG P+RG + A
Sbjct: 183 PVK----------WYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAM 232
Query: 913 ILH-KDLKFPSSTPTSLHAKQLMYRLLHRDPKSR 945
+ + + P+ P ++ LM D ++R
Sbjct: 233 LEKGERMGCPAGCPREMY--DLMNLCWTYDVENR 264
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 82.0 bits (203), Expect = 5e-17
Identities = 61/305 (20%), Positives = 104/305 (34%), Gaps = 61/305 (20%)
Query: 668 QINLQHFRPIKPLGSGDTGSVHLVELCGSGQYF----AMKAM--DKGVMLNRNKVHRACA 721
+ + I+ LG G G V L G A+K++ + G +
Sbjct: 17 HFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLK----K 72
Query: 722 EREILDMLDHPFVPALYA--SFQTKTHVCLITDYCPGGEL--FLLLDRQPTKVLKEDAVR 777
E EIL L H + + + LI ++ P G L +L + +
Sbjct: 73 EIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYL---PKNKNKINLKQQL 129
Query: 778 FYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNE 837
YA ++ ++YL + ++RDL NVL++ V + DF L+ + T E
Sbjct: 130 KYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLT--------KAIETDKE 181
Query: 838 KKRRHKGQQNPVF-MAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEML- 895
+ +PVF APE + + A D W+ G+ L+E+L
Sbjct: 182 YYTVKDDRDSPVFWY-----------------APECLMQSKFYIASDVWSFGVTLHELLT 224
Query: 896 YGYTPFRGKTRQKTFANILHKDLKF---------------PSSTPTSLHAKQLMYRLLHR 940
Y + H + P + P ++ QLM +
Sbjct: 225 YCDSDSSPMALFLKMIGPTHGQMTVTRLVNTLKEGKRLPCPPNCPDEVY--QLMRKCWEF 282
Query: 941 DPKSR 945
P +R
Sbjct: 283 QPSNR 287
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 82.8 bits (205), Expect = 5e-17
Identities = 68/343 (19%), Positives = 124/343 (36%), Gaps = 52/343 (15%)
Query: 640 HSKVVHPKPHRKDSPPWKAIQKILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQY 699
++ ++ + P Q +L +I+ K +G+G+ G V+ L S
Sbjct: 16 TTENLYFQGAMGSDPN----QAVLKFTTEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGK 71
Query: 700 F----AMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCP 755
A+K + G + E I+ H + L + +IT+Y
Sbjct: 72 KEVPVAIKTLKAGYTEKQRV--DFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYME 129
Query: 756 GGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSL 815
G L L + + V + ++YL ++RDL N+L+ N +
Sbjct: 130 NGALDKFLREKDGEFSVLQLVGM-LRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKV 188
Query: 816 TDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAG 875
+DF LS +L E G + P+ + APE I+
Sbjct: 189 SDFGLSR--------VLEDDPEATYTTSGGKIPI----------------RWTAPEAISY 224
Query: 876 AGHTSAVDWWALGILLYEML-YGYTPFRGKTRQKTFANILHKD-LKFPSSTPTSLHAKQL 933
TSA D W+ GI+++E++ YG P+ + + I L P P++++ QL
Sbjct: 225 RKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDCPSAIY--QL 282
Query: 934 MYRLLHRDPKSRLGSHEGANEIKKHPFFKGVNWALVRCMNPPE 976
M + ++ R P F + L + + P+
Sbjct: 283 MMQCWQQERARR-------------PKFADIVSILDKLIRAPD 312
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 5e-17
Identities = 63/309 (20%), Positives = 120/309 (38%), Gaps = 49/309 (15%)
Query: 642 KVVHPKPHRKDSPPWKAIQKILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFA 701
+++ PK + SG +N++ + ++ +G G+ G V L G Y
Sbjct: 166 RLIKPKVMEGTVAAQDEFYR---SGWALNMKELKLLQTIGKGEFGDVML------GDYRG 216
Query: 702 MKAMDKGVMLNRNKVHRA-CAEREILDMLDHPFVPALYA-SFQTKTHVCLITDYCPGGEL 759
K K + + +A AE ++ L H + L + K + ++T+Y G L
Sbjct: 217 NKVAVK--CIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSL 274
Query: 760 F-LLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDF 818
L R + + + ++F + +V A+EYL ++RDL NVL+ + ++DF
Sbjct: 275 VDYLRSRGRSVLGGDCLLKF-SLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDF 333
Query: 819 DLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGH 878
L+ E + PV ++ APE +
Sbjct: 334 GLTK--------------EASSTQDTGKLPV----------------KWTAPEALREKKF 363
Query: 879 TSAVDWWALGILLYEML-YGYTPFRGKTRQKTFANILHKD-LKFPSSTPTSLHAKQLMYR 936
++ D W+ GILL+E+ +G P+ + + + P P +++ +M
Sbjct: 364 STKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVY--DVMKN 421
Query: 937 LLHRDPKSR 945
H D +R
Sbjct: 422 CWHLDAATR 430
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 82.8 bits (205), Expect = 6e-17
Identities = 75/363 (20%), Positives = 131/363 (36%), Gaps = 61/363 (16%)
Query: 647 KPHRKDSPPWKAIQKILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYF---AMK 703
PH + P Q + + ++++ + K +G+G+ G V L + A+K
Sbjct: 24 DPHTFEDP----TQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIK 79
Query: 704 AMDKGVML-NRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLL 762
+ G R E I+ DHP + L V ++T+Y G L
Sbjct: 80 TLKVGYTEKQRRDFLG---EASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSF 136
Query: 763 LDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSC 822
L + + V + ++YL G ++RDL N+L+ N ++DF L
Sbjct: 137 LRKHDAQFTVIQLVGM-LRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGR 195
Query: 823 LTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAV 882
+L E +G + P+ + +PE IA TSA
Sbjct: 196 --------VLEDDPEAAYTTRGGKIPI----------------RWTSPEAIAYRKFTSAS 231
Query: 883 DWWALGILLYEML-YGYTPFRGKTRQKTFANI-----LHKDLKFPSSTPTSLHAKQLMYR 936
D W+ GI+L+E++ YG P+ + Q + L P P +L+ QLM
Sbjct: 232 DVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPP----PMDCPAALY--QLMLD 285
Query: 937 LLHRDPKSRLGSHEGANEIKKHPFFKGVNWALVRCMNPPELDAPLFATDTEKEYKVVDPG 996
+D +R P F+ + L + + P + + ++D
Sbjct: 286 CWQKDRNNR-------------PKFEQIVSILDKLIRNPGSLKIITSAAARPSNLLLDQS 332
Query: 997 MQD 999
D
Sbjct: 333 NVD 335
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 84.2 bits (208), Expect = 7e-17
Identities = 64/318 (20%), Positives = 117/318 (36%), Gaps = 35/318 (11%)
Query: 633 PEDLWANHSKVVHPKPHRKDSPPWKAIQKILDSGEQINLQHFRPIKP-LGSGDTGSVHLV 691
P + + P P+ +++ D + + LG G+ GSV
Sbjct: 296 PARITSPDKPRPMPMDTSVFESPFSDPEELKDKKLFLKRDNLLIADIELGCGNFGSVRQG 355
Query: 692 ELCGSGQYF--AMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCL 749
+ A+K + +G + E +I+ LD+P++ L + L
Sbjct: 356 VYRMRKKQIDVAIKVLKQGTEKADTE--EMMREAQIMHQLDNPYIVRLIG-VCQAEALML 412
Query: 750 ITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQG 809
+ + GG L L + + V +V + ++YL + ++R+L NVLL
Sbjct: 413 VMEMAGGGPLHKFL-VGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVN 471
Query: 810 NGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIA 869
+ ++DF LS + L + R G+ P++ + A
Sbjct: 472 RHYAKISDFGLS-------KALGADDSYYTARSAGKW-------PLK----------WYA 507
Query: 870 PEIIAGAGHTSAVDWWALGILLYEML-YGYTPFRGKTRQKTFANILH-KDLKFPSSTPTS 927
PE I +S D W+ G+ ++E L YG P++ + A I K ++ P P
Sbjct: 508 PECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPPE 567
Query: 928 LHAKQLMYRLLHRDPKSR 945
L+ LM + R
Sbjct: 568 LY--ALMSDCWIYKWEDR 583
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 80.7 bits (200), Expect = 8e-17
Identities = 61/284 (21%), Positives = 115/284 (40%), Gaps = 44/284 (15%)
Query: 668 QINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILD 727
I+ ++ +GSG G VHL + A+K + +G M E E++
Sbjct: 4 VIDPSELTFVQEIGSGQFGLVHLGYWLNKDK-VAIKTIREGAM----SEEDFIEEAEVMM 58
Query: 728 MLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVAL 787
L HP + LY + +CL+T++ G L L Q E + +V +
Sbjct: 59 KLSHPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGM-CLDVCEGM 117
Query: 788 EYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQN 847
YL +I+RDL N L+ N + ++DF ++ +++ G +
Sbjct: 118 AYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRF----------VLDDQYTSSTGTKF 167
Query: 848 PVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEML-YGYTPFRGKTR 906
PV ++ +PE+ + + ++S D W+ G+L++E+ G P+ ++
Sbjct: 168 PV----------------KWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN 211
Query: 907 QKTFANI-----LHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSR 945
+ +I L+K P T ++ Q+M P+ R
Sbjct: 212 SEVVEDISTGFRLYK----PRLASTHVY--QIMNHCWRERPEDR 249
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 81.2 bits (201), Expect = 1e-16
Identities = 70/340 (20%), Positives = 110/340 (32%), Gaps = 76/340 (22%)
Query: 668 QINLQHFRPIKPLGSGDTGSVHLVELCGSGQYF----AMKAM--DKGVMLNRNKVHRACA 721
+ ++ + I+ LG G G V L + A+KA+ D G
Sbjct: 27 VFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWK----Q 82
Query: 722 EREILDMLDHPFVPALYA--SFQTKTHVCLITDYCPGGEL--FLLLDRQPTKVLKEDAVR 777
E +IL L H + + L+ +Y P G L +L L
Sbjct: 83 EIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHSIGLAQLLL---- 138
Query: 778 FYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNE 837
+A ++ + YLH Q I+RDL NVLL + V + DF L+ +P +E
Sbjct: 139 -FAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLA--------KAVPEGHE 189
Query: 838 KKRRHKGQQNPVF-MAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEML- 895
R + +PVF APE + A D W+ G+ LYE+L
Sbjct: 190 YYRVREDGDSPVFWY-----------------APECLKEYKFYYASDVWSFGVTLYELLT 232
Query: 896 YGYTPFRGKTRQKTFANILHKDLKF---------------PSSTPTSLHAKQLMYRLLHR 940
+ + T+ I + P P ++ LM
Sbjct: 233 HCDSSQSPPTKFLELIGIAQGQMTVLRLTELLERGERLPRPDKCPAEVY--HLMKNCWET 290
Query: 941 DPKSRLGSHEGANEIKKHPFFKGVNWALVRCMNPPELDAP 980
+ R P F+ + L + AP
Sbjct: 291 EASFR-------------PTFENLIPILKTVHEKYQGQAP 317
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 79.9 bits (198), Expect = 2e-16
Identities = 68/302 (22%), Positives = 122/302 (40%), Gaps = 51/302 (16%)
Query: 647 KPHRKDSPPWKAIQKILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMD 706
KP +D W ++ + + ++ LG+G G V + G + A+K++
Sbjct: 1 KPWWEDE--W-----------EVPRETLKLVERLGAGQFGEVWMGYYNGHTK-VAVKSLK 46
Query: 707 KGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLL-DR 765
+G M + AE ++ L H + LYA T+ + +IT+Y G L L
Sbjct: 47 QGSMSPDAFL----AEANLMKQLQHQRLVRLYAVV-TQEPIYIITEYMENGSLVDFLKTP 101
Query: 766 QPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTS 825
K+ + AA++ + ++ + I+RDL+ N+L+ + DF L+
Sbjct: 102 SGIKLTINKLLDM-AAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLA---- 156
Query: 826 CKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWW 885
+L+ +G + P+ ++ APE I T D W
Sbjct: 157 ---RLIEDNEYT---AREGAKFPI----------------KWTAPEAINYGTFTIKSDVW 194
Query: 886 ALGILLYEML-YGYTPFRGKTRQKTFANILHKD-LKFPSSTPTSLHAKQLMYRLLHRDPK 943
+ GILL E++ +G P+ G T + N+ + P + P L+ QLM P+
Sbjct: 195 SFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELY--QLMRLCWKERPE 252
Query: 944 SR 945
R
Sbjct: 253 DR 254
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 80.1 bits (198), Expect = 3e-16
Identities = 56/287 (19%), Positives = 106/287 (36%), Gaps = 45/287 (15%)
Query: 669 INLQHFRPIKPLGSGDTGSVHLVELCGSGQYF----AMKAM--DKGVMLNRNKVHRACAE 722
R +K LGSG G+VH G+ +K + G +
Sbjct: 10 FKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVT----DH 65
Query: 723 REILDMLDHPFVPALYASFQTKTHVCLITDYCPGGEL--FLLLDRQPTKVLKEDAVRFYA 780
+ LDH + L + + L+T Y P G L + RQ L + +
Sbjct: 66 MLAIGSLDHAHIVRLLG-LCPGSSLQLVTQYLPLGSLLDHV---RQHRGALGPQLLLNWG 121
Query: 781 AEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKR 840
++ + YL G+++R+L NVLL+ V + DF ++ L ++K+
Sbjct: 122 VQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLP---------PDDKQL 172
Query: 841 RHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEML-YGYT 899
+ + P+ +++A E I +T D W+ G+ ++E++ +G
Sbjct: 173 LYSEAKTPI----------------KWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAE 216
Query: 900 PFRGKTRQKTFANILHKD-LKFPSSTPTSLHAKQLMYRLLHRDPKSR 945
P+ G + + + L P ++ +M + D R
Sbjct: 217 PYAGLRLAEVPDLLEKGERLAQPQICTIDVY--MVMVKCWMIDENIR 261
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 79.2 bits (196), Expect = 3e-16
Identities = 74/316 (23%), Positives = 120/316 (37%), Gaps = 54/316 (17%)
Query: 668 QINLQHFRPIKPLGSGDTGSVHLVELCGSGQYF---AMKAMDKGVMLNRNKVHRACAERE 724
+I + + +G G G VH A+K + + + E
Sbjct: 11 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVRE--KFLQEAL 68
Query: 725 ILDMLDHPFVPALYASFQTKTHVCLITDYCPGGEL--FLLLDRQPTKVLKEDAVRFYAAE 782
+ DHP + L T+ V +I + C GEL FL + L ++ YA +
Sbjct: 69 TMRQFDHPHIVKLIGVI-TENPVWIIMELCTLGELRSFL---QVRKYSLDLASLILYAYQ 124
Query: 783 VVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRH 842
+ AL YL + ++RD+ NVL+ N V L DF LS + + +T K +
Sbjct: 125 LSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLS-------RYMEDSTYYKASKG 177
Query: 843 KGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEML-YGYTPF 901
K P++ ++APE I TSA D W G+ ++E+L +G PF
Sbjct: 178 K---------LPIK----------WMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPF 218
Query: 902 RGKTRQKTFANILHKD-LKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPF 960
+G I + + L P + P +L+ LM + DP R P
Sbjct: 219 QGVKNNDVIGRIENGERLPMPPNCPPTLY--SLMTKCWAYDPSRR-------------PR 263
Query: 961 FKGVNWALVRCMNPPE 976
F + L + +
Sbjct: 264 FTELKAQLSTILEEEK 279
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 81.8 bits (202), Expect = 4e-16
Identities = 75/317 (23%), Positives = 121/317 (38%), Gaps = 54/317 (17%)
Query: 668 QINLQHFRPIKPLGSGDTGSVHLVELCGSGQYF---AMKAMDKGVMLNRNKVHRACAERE 724
+I + + +G G G VH A+K + + + E
Sbjct: 386 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVRE--KFLQEAL 443
Query: 725 ILDMLDHPFVPALYASFQTKTHVCLITDYCPGGEL--FLLLDRQPTKVLKEDAVRFYAAE 782
+ DHP + L T+ V +I + C GEL FL + L ++ YA +
Sbjct: 444 TMRQFDHPHIVKLIGVI-TENPVWIIMELCTLGELRSFL---QVRKFSLDLASLILYAYQ 499
Query: 783 VVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRH 842
+ AL YL + ++RD+ NVL+ N V L DF LS + + +T K +
Sbjct: 500 LSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLS-------RYMEDSTYYKASKG 552
Query: 843 KGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEML-YGYTPF 901
K P++ ++APE I TSA D W G+ ++E+L +G PF
Sbjct: 553 K---------LPIK----------WMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPF 593
Query: 902 RGKTRQKTFANILHKD-LKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPF 960
+G I + + L P + P +L+ LM + DP R P
Sbjct: 594 QGVKNNDVIGRIENGERLPMPPNCPPTLY--SLMTKCWAYDPSRR-------------PR 638
Query: 961 FKGVNWALVRCMNPPEL 977
F + L + +L
Sbjct: 639 FTELKAQLSTILEEEKL 655
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 78.0 bits (193), Expect = 7e-16
Identities = 59/280 (21%), Positives = 107/280 (38%), Gaps = 36/280 (12%)
Query: 668 QINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILD 727
++ + +K LGSG G V L + G A+K + +G M E + +
Sbjct: 4 ELKREEITLLKELGSGQFGVVKLGKWKGQ-YDVAVKMIKEGSM----SEDEFFQEAQTMM 58
Query: 728 MLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVAL 787
L HP + Y + + ++T+Y G L L + + +V +
Sbjct: 59 KLSHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEM-CYDVCEGM 117
Query: 788 EYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQN 847
+L I+RDL N L+ + V ++DF ++ +++ G +
Sbjct: 118 AFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRY----------VLDDQYVSSVGTKF 167
Query: 848 PVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEML-YGYTPFRGKTR 906
PV ++ APE+ ++S D WA GIL++E+ G P+ T
Sbjct: 168 PV----------------KWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTN 211
Query: 907 QKTFANILHKD-LKFPSSTPTSLHAKQLMYRLLHRDPKSR 945
+ + L P +++ Q+MY H P+ R
Sbjct: 212 SEVVLKVSQGHRLYRPHLASDTIY--QIMYSCWHELPEKR 249
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 7e-16
Identities = 58/281 (20%), Positives = 107/281 (38%), Gaps = 46/281 (16%)
Query: 677 IKPLGSGDTGSVH---LVELCGSGQYFAMKAMDKGVMLNRNKVHRACA----EREILDML 729
+ +G G G V+ L++ G + A+K LNR + E I+
Sbjct: 30 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVK------SLNRITDIGEVSQFLTEGIIMKDF 83
Query: 730 DHPFVPALYA-SFQTKTHVCLITDYCPGGEL--FLLLDRQPTKVLKEDAVRFYAAEVVVA 786
HP V +L +++ ++ Y G+L F+ + V +D + F +V
Sbjct: 84 SHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV--KDLIGF-GLQVAKG 140
Query: 787 LEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQ 846
++YL + ++RDL N +L V + DF L+ + + G +
Sbjct: 141 MKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLA-------RDMYDKEYYSVHNKTGAK 193
Query: 847 NPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEML-YGYTPFRGKT 905
PV +++A E + T+ D W+ G+LL+E++ G P+
Sbjct: 194 LPV----------------KWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVN 237
Query: 906 RQKTFANILHKD-LKFPSSTPTSLHAKQLMYRLLHRDPKSR 945
+L L P P L+ ++M + H + R
Sbjct: 238 TFDITVYLLQGRRLLQPEYCPDPLY--EVMLKCWHPKAEMR 276
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 9e-16
Identities = 60/271 (22%), Positives = 106/271 (39%), Gaps = 36/271 (13%)
Query: 680 LGSGDTGSVHLVELCGSGQYF--AMKAMDKGVMLNRNKVHRA-CAEREILDMLDHPFVPA 736
LG G+ GSV + A+K + +G E +I+ LD+P++
Sbjct: 18 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTE---KADTEEMMREAQIMHQLDNPYIVR 74
Query: 737 LYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGII 796
L Q + + L+ + GG L L + ++ + +V + ++YL + +
Sbjct: 75 LIGVCQAEA-LMLVMEMAGGGPLHKFLVGKREEIPVSNVAEL-LHQVSMGMKYLEEKNFV 132
Query: 797 YRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMR 856
+RDL NVLL + ++DF LS + L + R G+ P++
Sbjct: 133 HRDLAARNVLLVNRHYAKISDFGLS-------KALGADDSYYTARSAGKW-------PLK 178
Query: 857 ASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEML-YGYTPFRGKTRQKTFANILH 915
+ APE I +S D W+ G+ ++E L YG P++ + A I
Sbjct: 179 ----------WYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQ 228
Query: 916 KD-LKFPSSTPTSLHAKQLMYRLLHRDPKSR 945
++ P P L+ LM + R
Sbjct: 229 GKRMECPPECPPELY--ALMSDCWIYKWEDR 257
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 78.4 bits (194), Expect = 2e-15
Identities = 63/284 (22%), Positives = 99/284 (34%), Gaps = 72/284 (25%)
Query: 721 AEREI--LDMLDHPFVPALY--------ASFQTKTHVCLITDYCPGGELFLLLDRQPTKV 770
A REI L +L H V L + K + L+ D+C +L LL K
Sbjct: 63 ALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVK- 120
Query: 771 LKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLS-CLTSCKPQ 829
++ ++ L Y+H I++RD+K NVL+ +G + L DF L+ + K
Sbjct: 121 FTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNS 180
Query: 830 LLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGH-TSAVDWWALG 888
TN V T Y PE++ G +D W G
Sbjct: 181 QPNRYTNR------------------------VVTLWYRPPELLLGERDYGPPIDLWGAG 216
Query: 889 ILLYEMLYGYTPFRGKTRQKTFANI-------------------LHKDLKFPSSTPTSL- 928
++ EM +G T Q A I L++ L+ +
Sbjct: 217 CIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVK 276
Query: 929 ----------HAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFK 962
+A L+ +LL DP R+ +++ H FF
Sbjct: 277 DRLKAYVRDPYALDLIDKLLVLDPAQRI----DSDDALNHDFFW 316
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 78.3 bits (193), Expect = 2e-15
Identities = 57/281 (20%), Positives = 108/281 (38%), Gaps = 46/281 (16%)
Query: 677 IKPLGSGDTGSVH---LVELCGSGQYFAMKAMDKGVMLNRNKVHRACA----EREILDML 729
+ +G G G V+ L++ G + A+K LNR + E I+
Sbjct: 94 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVK------SLNRITDIGEVSQFLTEGIIMKDF 147
Query: 730 DHPFVPALYA-SFQTKTHVCLITDYCPGGEL--FLLLDRQPTKVLKEDAVRFYAAEVVVA 786
HP V +L +++ ++ Y G+L F+ + V +D + F +V
Sbjct: 148 SHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV--KDLIGF-GLQVAKG 204
Query: 787 LEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQ 846
+++L + ++RDL N +L V + DF L+ + + + G +
Sbjct: 205 MKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLA-------RDMYDKEFDSVHNKTGAK 257
Query: 847 NPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEML-YGYTPFRGKT 905
PV +++A E + T+ D W+ G+LL+E++ G P+
Sbjct: 258 LPV----------------KWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVN 301
Query: 906 RQKTFANILHKD-LKFPSSTPTSLHAKQLMYRLLHRDPKSR 945
+L L P P L+ ++M + H + R
Sbjct: 302 TFDITVYLLQGRRLLQPEYCPDPLY--EVMLKCWHPKAEMR 340
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 76.1 bits (188), Expect = 3e-15
Identities = 62/293 (21%), Positives = 116/293 (39%), Gaps = 44/293 (15%)
Query: 657 KAIQKILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKV 716
A + SG +N++ + ++ +G G+ G V L + G A+K + +
Sbjct: 6 AAQDEFYRSGWALNMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVK------CIKNDAT 57
Query: 717 HRA-CAEREILDMLDHPFVPALYAS-FQTKTHVCLITDYCPGGELFLLLDRQPTKVLKED 774
+A AE ++ L H + L + K + ++T+Y G L L + VL D
Sbjct: 58 AQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGD 117
Query: 775 AVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPT 834
+ ++ +V A+EYL ++RDL NVL+ + ++DF L+
Sbjct: 118 CLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLT------------- 164
Query: 835 TNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEM 894
E + PV ++ APE + ++ D W+ GILL+E+
Sbjct: 165 -KEASSTQDTGKLPV----------------KWTAPEALREKKFSTKSDVWSFGILLWEI 207
Query: 895 L-YGYTPFRGKTRQKTFANILH-KDLKFPSSTPTSLHAKQLMYRLLHRDPKSR 945
+G P+ + + + P P +++ ++M H D R
Sbjct: 208 YSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVY--EVMKNCWHLDAAMR 258
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 76.5 bits (189), Expect = 4e-15
Identities = 69/306 (22%), Positives = 119/306 (38%), Gaps = 49/306 (16%)
Query: 652 DSPPWKAIQKILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYF---AMKAMDKG 708
DS ++ +L E++ + +G G G V+ E Q A+K
Sbjct: 4 DSALLAEVKDVLIPHERVVTHS---DRVIGKGHFGVVYHGEYIDQAQNRIQCAIK----- 55
Query: 709 VMLNRNKVHRACA----EREILDMLDHPFVPALYA-SFQTKTHVCLITDYCPGGEL--FL 761
L+R + E ++ L+HP V AL + ++ Y G+L F+
Sbjct: 56 -SLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFI 114
Query: 762 LLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLS 821
++ V +D + F +V +EYL Q ++RDL N +L + V + DF L+
Sbjct: 115 RSPQRNPTV--KDLISF-GLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLA 171
Query: 822 CLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSA 881
+ +L ++H+ + PV ++ A E + T+
Sbjct: 172 -------RDILDREYYSVQQHRHARLPV----------------KWTALESLQTYRFTTK 208
Query: 882 VDWWALGILLYEML-YGYTPFRGKTRQKTFANILHKD-LKFPSSTPTSLHAKQLMYRLLH 939
D W+ G+LL+E+L G P+R + L P P SL+ Q+M +
Sbjct: 209 SDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGRRLPQPEYCPDSLY--QVMQQCWE 266
Query: 940 RDPKSR 945
DP R
Sbjct: 267 ADPAVR 272
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 75.7 bits (187), Expect = 5e-15
Identities = 63/280 (22%), Positives = 109/280 (38%), Gaps = 36/280 (12%)
Query: 668 QINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILD 727
+I+ + +K LG+G G V + G A+K + +G M E +++
Sbjct: 20 EIDPKDLTFLKELGTGQFGVVKYGKWRGQYD-VAIKMIKEGSM----SEDEFIEEAKVMM 74
Query: 728 MLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVAL 787
L H + LY + + +IT+Y G L L + + + +V A+
Sbjct: 75 NLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEM-CKDVCEAM 133
Query: 788 EYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQN 847
EYL + ++RDL N L+ G V ++DF LS + +L G +
Sbjct: 134 EYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLS-------RYVLDDEYT---SSVGSKF 183
Query: 848 PVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEML-YGYTPFRGKTR 906
PV + PE++ + +S D WA G+L++E+ G P+ T
Sbjct: 184 PV----------------RWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTN 227
Query: 907 QKTFANILHKD-LKFPSSTPTSLHAKQLMYRLLHRDPKSR 945
+T +I L P ++ +MY H R
Sbjct: 228 SETAEHIAQGLRLYRPHLASEKVY--TIMYSCWHEKADER 265
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 78.7 bits (193), Expect = 7e-15
Identities = 114/691 (16%), Positives = 190/691 (27%), Gaps = 232/691 (33%)
Query: 195 KDALSTFQQTFV-------VSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGAG 247
KD LS F+ FV V D K I+ + +E+
Sbjct: 19 KDILSVFEDAFVDNFDCKDVQDMPKS---IL------------SKEEI------------ 51
Query: 248 TDPEDVAKIRETLQNGQSYCGRLLNYKKDGTPFWNLLTIAPIKDDEGKVLKFIGMQVEVS 307
+ + ++ + + RL FW LL+ K +E V KF+
Sbjct: 52 ---DHIIMSKDAVS--GTL--RL---------FWTLLS----KQEEM-VQKFVE------ 84
Query: 308 KHTEGAKDKMLRPN-GLPESLIRYDARQKEMATSSVTELVQAMKK-PRSLSE-STNRPPI 364
++LR N S I+ + RQ M T E + + ++ + +R
Sbjct: 85 --------EVLRINYKFLMSPIKTEQRQPSMMTRMYIEQRDRLYNDNQVFAKYNVSRLQP 136
Query: 365 IRKSEGGVEEERA-------GALGRRKS-------ENVPPPRRNSYG------GGCRTSM 404
K + E R G LG K+ + + + C +
Sbjct: 137 YLKLRQALLELRPAKNVLIDGVLGSGKTWVALDVCLSYKVQCKMDFKIFWLNLKNCNSPE 196
Query: 405 QRISEVPEKKKQKSGRRSFMGLIGRKSQSTDDHDS---FENEIIMEGDDDYESDDERPDS 461
+ + QK + I S DH S I +
Sbjct: 197 TVL-----EMLQK-----LLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYENC 246
Query: 462 ---VDDKVRQKEMRKGID-----LATTLERIEKNFVITDPRLPDNPIIFASDSFLE-LTE 512
+ + V+ + + L TT + +TD + D LT
Sbjct: 247 LLVLLN-VQNAKAWNAFNLSCKILLTT-----RFKQVTDFLSAATTTHISLDHHSMTLTP 300
Query: 513 YSREEILGR--NCRFLQGPE----TDPATVRKIRAAIDNQTDVTVQLINYTKSGKKFWNL 566
+ +L + +CR P T+P + I +I + G W+
Sbjct: 301 DEVKSLLLKYLDCRPQDLPREVLTTNPRRLSIIAESI--------------RDGLATWDN 346
Query: 567 FHLQPMRDQKGEVQYFIGVQLDGSEHLEP--LRNS------------IPEAT-------- 604
+ D+ + I L LEP R IP
Sbjct: 347 W-KHVNCDKLTTI---IESSL---NVLEPAEYRKMFDRLSVFPPSAHIPTILLSLIWFDV 399
Query: 605 -AEESE----KLVKQT--AENVNEAVKELPDANL----TPEDLWANHSKVVHPKPHRKDS 653
+ KL K + + E+ +P L E+ +A H +V K
Sbjct: 400 IKSDVMVVVNKLHKYSLVEKQPKESTISIPSIYLELKVKLENEYALHRSIVDHYNIPKTF 459
Query: 654 PPWKAIQKILDSGEQIN--LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVML 711
I LD H +G HL + + M V L
Sbjct: 460 DSDDLIPPYLD-----QYFYSH------IGH------HLKN-IEHPERMTLFRM---VFL 498
Query: 712 N----RNKVHRA----CAEREILDML-DHPFVPALYASFQTKTH------VCLITDYCPG 756
+ K+ A IL+ L F Y + V I D+ P
Sbjct: 499 DFRFLEQKIRHDSTAWNASGSILNTLQQLKF----YKPYICDNDPKYERLVNAILDFLPK 554
Query: 757 GELFLLLDR----------QPTKVLKEDAVR 777
E L+ + + + E+A +
Sbjct: 555 IEENLICSKYTDLLRIALMAEDEAIFEEAHK 585
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 59.1 bits (142), Expect = 8e-09
Identities = 68/489 (13%), Positives = 140/489 (28%), Gaps = 145/489 (29%)
Query: 563 FWNLFHLQPMRDQKGEVQYFIGVQLDGSEHLEPLRNSIPEATAEESEKLVKQTAENVNEA 622
FW L + Q+ VQ F+ E L + E +Q +
Sbjct: 68 FWTL-----LSKQEEMVQKFVE------EVLRINYKFLMSPIKTEQ----RQPSMMTRMY 112
Query: 623 VKELPDANLTPEDLWANHSKVVHPKPHRKDSPPWKAIQKILDSGEQINLQHFRPIKPL-- 680
+++ + L+ N ++V K + P+ +++ L RP K +
Sbjct: 113 IEQR-------DRLY-NDNQVF-AKYNVSRLQPYLKLRQ--------ALLELRPAKNVLI 155
Query: 681 -GSGDTG-SVHLVELCGSGQYFAMKAMDKGVM-LNRNKVHRACAEREILDMLDHPFVPAL 737
G +G + +++C S Y MD + LN + +L+ML L
Sbjct: 156 DGVLGSGKTWVALDVCLS--YKVQCKMDFKIFWLNLKNCNS---PETVLEMLQ-----KL 205
Query: 738 YASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIY 797
++ + + + ++ + R ++ Y +C ++
Sbjct: 206 LYQIDP--------NWTSRSDHSSNI-KLRIHSIQAELRRLLKSK-----PYENCL-LVL 250
Query: 798 RDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEK---------KRRHK--GQQ 846
+++ F+LSC ++LL TT K H
Sbjct: 251 LNVQNAKAW---------NAFNLSC------KILL-TTRFKQVTDFLSAATTTHISLDHH 294
Query: 847 NPVFM-AEPMRASNSFVGTEEY--------IAPEIIAGAG-----HTSAVDWW------A 886
+ E ++ P ++ + D W
Sbjct: 295 SMTLTPDEVKSLLLKYLDCRPQDLPREVLTTNPRRLSIIAESIRDGLATWDNWKHVNCDK 354
Query: 887 LGILL---YEMLYGYTPFRGKTRQKTFANILHKDLKFPSSTPTSL-----------HAKQ 932
L ++ +L P + + + P+ + + +
Sbjct: 355 LTTIIESSLNVL---EPAEYRKMFDRLS-VFPPSAHIPTILLSLIWFDVIKSDVMVVVNK 410
Query: 933 LM-YRLLHRDPK-SRLGSH--------EGANEIKKHPFFKGVNWALVRCMNPPE-LDAPL 981
L Y L+ + PK S + + NE H ++V N P+ D+
Sbjct: 411 LHKYSLVEKQPKESTISIPSIYLELKVKLENEYALHR-------SIVDHYNIPKTFDSDD 463
Query: 982 FATDTEKEY 990
+Y
Sbjct: 464 LIPPYLDQY 472
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 74.5 bits (184), Expect = 1e-14
Identities = 67/298 (22%), Positives = 101/298 (33%), Gaps = 67/298 (22%)
Query: 668 QINLQHFRPIKPLGSGDTGSVHLVELCGSGQYF---AMKAMDKGVML-NRNKVHRACAER 723
I + + LG G G V+ A+K K L N+ K E
Sbjct: 8 GIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMS---EA 64
Query: 724 EILDMLDHPFVPALYASFQTKTHVCLITDYCPGGEL--FLLLDRQPTKVLKEDAVRFYAA 781
I+ LDHP + L + +I + P GEL +L + LK + Y+
Sbjct: 65 VIMKNLDHPHIVKLIGII-EEEPTWIIMELYPYGELGHYL---ERNKNSLKVLTLVLYSL 120
Query: 782 EVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRR 841
++ A+ YL ++RD+ N+L+ V L DF LS
Sbjct: 121 QICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLS-------------------- 160
Query: 842 HKGQQNPVFMAEPMRASNSFVGTEEYI------------APEIIAGAGHTSAVDWWALGI 889
R + E+Y +PE I T+A D W +
Sbjct: 161 --------------RY----IEDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAV 202
Query: 890 LLYEML-YGYTPFRGKTRQKTFANILHKD-LKFPSSTPTSLHAKQLMYRLLHRDPKSR 945
++E+L +G PF + + D L P P L+ LM R DP R
Sbjct: 203 CMWEILSFGKQPFFWLENKDVIGVLEKGDRLPKPDLCPPVLY--TLMTRCWDYDPSDR 258
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 3e-14
Identities = 49/324 (15%), Positives = 95/324 (29%), Gaps = 68/324 (20%)
Query: 668 QINLQHFRPIKPLGSGDTGSVHLVELCGSGQYF-------AMKAMDKGVMLNRNKVHRAC 720
+I + + LG G + G Y +K +DK
Sbjct: 4 KIRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFE-- 61
Query: 721 AEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYA 780
++ L H + Y L+ ++ G L L + + + A
Sbjct: 62 -AASMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEV-A 119
Query: 781 AEVVVALEYLHCQGIIYRDLKPENVLLQG--------NGHVSLTDFDLSCLTSCKPQLLL 832
++ A+ +L +I+ ++ +N+LL + L+D +S +L
Sbjct: 120 KQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGIS-------ITVL 172
Query: 833 PTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGH-TSAVDWWALGILL 891
P ++ + ++ PE I + A D W+ G L
Sbjct: 173 PKDILQE--------------RIP----------WVPPECIENPKNLNLATDKWSFGTTL 208
Query: 892 YEML-YGYTPFRGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHE 950
+E+ G P Q+ + P+ L L+ + +P R
Sbjct: 209 WEICSGGDKPLSALDSQRKLQFY-EDRHQLPAPKAAELA--NLINNCMDYEPDHR----- 260
Query: 951 GANEIKKHPFFKGVNWALVRCMNP 974
P F+ + L P
Sbjct: 261 --------PSFRAIIRDLNSLFTP 276
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 6e-14
Identities = 67/295 (22%), Positives = 118/295 (40%), Gaps = 50/295 (16%)
Query: 667 EQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYF---AMKAMDKGVMLNRNKVHRACAER 723
+Q L + LG G+ GSV +L F A+K + ++ + + E
Sbjct: 23 QQFTL-----GRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADII-ASSDIEEFLREA 76
Query: 724 EILDMLDHPFVPALYA------SFQTKTHVCLITDYCPGGEL--FLLLDR---QPTKVLK 772
+ DHP V L + +I + G+L FLL R P +
Sbjct: 77 ACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPL 136
Query: 773 EDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLL 832
+ VRF ++ +EYL + I+RDL N +L + V + DF LS +
Sbjct: 137 QTLVRF-MVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVADFGLS--------RKI 187
Query: 833 PTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLY 892
+ + ++ + P++ ++A E +A +T D WA G+ ++
Sbjct: 188 YSGDYYRQGCASKL-------PVK----------WLALESLADNLYTVHSDVWAFGVTMW 230
Query: 893 EML-YGYTPFRGKTRQKTFANILHKD-LKFPSSTPTSLHAKQLMYRLLHRDPKSR 945
E++ G TP+ G + + ++ + LK P ++ LMY+ DPK R
Sbjct: 231 EIMTRGQTPYAGIENAEIYNYLIGGNRLKQPPECMEEVY--DLMYQCWSADPKQR 283
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 73.7 bits (181), Expect = 7e-14
Identities = 70/354 (19%), Positives = 119/354 (33%), Gaps = 93/354 (26%)
Query: 695 GSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTH--VCLITD 752
+ +A+K ++ + AC E +L L HP V +L F + V L+ D
Sbjct: 46 KDDKDYALKQIEGTGIS-----MSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFD 100
Query: 753 YCPGGELFLLLDRQPTKVLKEDAVRFYAAEV-------VVALEYLHCQGIIYRDLKPENV 805
Y +L+ ++ + V+ V + + YLH +++RDLKP N+
Sbjct: 101 YAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANI 159
Query: 806 LLQG----NGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSF 861
L+ G G V + D + R +P+ +P+ +
Sbjct: 160 LVMGEGPERGRVKIADMGFA-------------------RLFN--SPL---KPLADLDPV 195
Query: 862 VGTEEYIAPEIIAGAGH-TSAVDWWALGILLYEMLYGYTPFRGKT--------------- 905
V T Y APE++ GA H T A+D WA+G + E+L F +
Sbjct: 196 VVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLD 255
Query: 906 ------------------------------RQKTFANILHKDLKFPSSTPTSLHAKQLMY 935
R+ T+ N A L+
Sbjct: 256 RIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQ 315
Query: 936 RLLHRDPKSRLGSHEGANEIKKHPFFKGVNWALVRCMNPPELDAPLFATDTEKE 989
+LL DP R+ + + + P+F ++ P TE+E
Sbjct: 316 KLLTMDPIKRI----TSEQAMQDPYFLEDPLPTSDVFAGCQIPYPKREFLTEEE 365
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 72.0 bits (177), Expect = 9e-14
Identities = 54/260 (20%), Positives = 103/260 (39%), Gaps = 42/260 (16%)
Query: 673 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDH- 731
+R + +GSG G ++L +G+ A+K + K + E +I M+
Sbjct: 10 RYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECV-----KTKHPQLHIESKIYKMMQGG 64
Query: 732 PFVPALYASFQTKTHVCLITDYCPGG----ELFLLLDRQPTKVLKEDAVRFYAAEVVVAL 787
+P + + ++ + G +LF R+ + LK V A +++ +
Sbjct: 65 VGIPTIRWCGAEGDYNVMVMELL--GPSLEDLFNFCSRKFS--LK--TVLLLADQMISRI 118
Query: 788 EYLHCQGIIYRDLKPENVLLQGNGH---VSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKG 844
EY+H + I+RD+KP+N L+ V + DF L+ + + +H
Sbjct: 119 EYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK----------KYRDARTHQHI- 167
Query: 845 QQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRG- 903
P R + + GT Y + G + D +LG +L G P++G
Sbjct: 168 ---------PYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGL 218
Query: 904 --KTRQKTFANILHKDLKFP 921
T+++ + I K + P
Sbjct: 219 KAATKRQKYERISEKKMSTP 238
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 69.7 bits (171), Expect = 6e-13
Identities = 55/263 (20%), Positives = 101/263 (38%), Gaps = 46/263 (17%)
Query: 673 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDH- 731
H++ + +G G G + + Q A+K + R+ + E +L
Sbjct: 11 HYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPR-----RSDAPQLRDEYRTYKLLAGC 65
Query: 732 PFVPALYASFQTKTHVCLITDYCPG---GELFLLLDRQPTKVLKEDAVRFYAAEVVVALE 788
+P +Y Q H L+ D G +L L R+ + +K V A +++ ++
Sbjct: 66 TGIPNVYYFGQEGLHNVLVIDLL-GPSLEDLLDLCGRKFS--VK--TVAMAAKQMLARVQ 120
Query: 789 YLHCQGIIYRDLKPENVLL-QGNGH----VSLTDFDLSCLTSCKPQLLLPTTNEKKRRHK 843
+H + ++YRD+KP+N L+ + N + + DF + K R
Sbjct: 121 SIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMV----------------KFYRDP 164
Query: 844 GQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAV--DWWALGILLYEMLYGYTPF 901
+ + P R + GT Y++ I G + D ALG + L G P+
Sbjct: 165 VTKQHI----PYREKKNLSGTARYMS--INTHLGREQSRRDDLEALGHVFMYFLRGSLPW 218
Query: 902 RG---KTRQKTFANILHKDLKFP 921
+G T ++ + I K P
Sbjct: 219 QGLKAATNKQKYERIGEKKQSTP 241
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 69.2 bits (170), Expect = 1e-12
Identities = 65/321 (20%), Positives = 113/321 (35%), Gaps = 65/321 (20%)
Query: 677 IKPLGSGDTGSVHLVELCGSGQYF-----AMKAMDKGVMLNRNKVHRACAEREILDMLDH 731
LG G G V L E A+KA+ + R R E E+L ML H
Sbjct: 46 KWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQR---EAELLTMLQH 102
Query: 732 PFVPALYASFQTKTHVCLITDYCPGGEL--FL------------LLDRQPTKVLKEDAVR 777
+ + + ++ +Y G+L FL D P + +
Sbjct: 103 QHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLA 162
Query: 778 FYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNE 837
A++V + YL ++RDL N L+ V + DF +S + +T+
Sbjct: 163 V-ASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMS--------RDIYSTDY 213
Query: 838 KKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEML-Y 896
+ + P+R ++ PE I T+ D W+ G++L+E+ Y
Sbjct: 214 YRVGGRTML-------PIR----------WMPPESILYRKFTTESDVWSFGVVLWEIFTY 256
Query: 897 GYTPFRGKTRQKTFANILH-KDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEI 955
G P+ + + I ++L+ P + P ++ +M R+P+ R
Sbjct: 257 GKQPWYQLSNTEAIDCITQGRELERPRACPPEVY--AIMRGCWQREPQQR---------- 304
Query: 956 KKHPFFKGVNWALVRCMNPPE 976
K V+ L P
Sbjct: 305 ---HSIKDVHARLQALAQAPP 322
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 68.5 bits (168), Expect = 2e-12
Identities = 69/321 (21%), Positives = 123/321 (38%), Gaps = 49/321 (15%)
Query: 640 HSKVVHPKPHRKDSPPWKAIQKILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQY 699
H R ++ ++ + L K LG G+ GSV L
Sbjct: 7 HHHHSSGLVPRGSEELQNKLEDVVIDRNLLIL-----GKILGEGEFGSVMEGNLKQEDGT 61
Query: 700 F---AMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYA-----SFQTKTHVCLIT 751
A+K M ++ ++ +E + HP V L S Q +I
Sbjct: 62 SLKVAVKTMKLDNS-SQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVIL 120
Query: 752 DYCPGGEL--FLLLDR---QPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVL 806
+ G+L +LL R P + + ++F ++ + +EYL + ++RDL N +
Sbjct: 121 PFMKYGDLHTYLLYSRLETGPKHIPLQTLLKF-MVDIALGMEYLSNRNFLHRDLAARNCM 179
Query: 807 LQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEE 866
L+ + V + DF LS + + + ++ + P++
Sbjct: 180 LRDDMTVCVADFGLS--------KKIYSGDYYRQGRIAKM-------PVK---------- 214
Query: 867 YIAPEIIAGAGHTSAVDWWALGILLYEML-YGYTPFRGKTRQKTFANILHKD-LKFPSST 924
+IA E +A +TS D WA G+ ++E+ G TP+ G + + +LH LK P
Sbjct: 215 WIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHGHRLKQPEDC 274
Query: 925 PTSLHAKQLMYRLLHRDPKSR 945
L+ ++MY DP R
Sbjct: 275 LDELY--EIMYSCWRTDPLDR 293
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 68.5 bits (168), Expect = 2e-12
Identities = 58/328 (17%), Positives = 117/328 (35%), Gaps = 59/328 (17%)
Query: 677 IKPLGSGDTGSVHLVELCGSGQYF-----AMKAMDKGVMLN-RNKVHRACAEREILDMLD 730
+ LG G G V+ G + A+K +++ + R + E ++ +
Sbjct: 30 SRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLN---EASVMKEFN 86
Query: 731 HPFVPALYASFQTKTHVCLITDYCPGGEL--FLLLDRQPTKVLKEDAVR------FYAAE 782
V L +I + G+L +L R A A E
Sbjct: 87 CHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGE 146
Query: 783 VVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRH 842
+ + YL+ ++RDL N ++ + V + DF ++ + T+ ++
Sbjct: 147 IADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMT--------RDIYETDYYRKGG 198
Query: 843 KGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEML-YGYTPF 901
KG P+R +++PE + T+ D W+ G++L+E+ P+
Sbjct: 199 KGLL-------PVR----------WMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPY 241
Query: 902 RGKTRQKTFANILH-KDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPF 960
+G + ++ ++ L P + P L +LM +PK R P
Sbjct: 242 QGLSNEQVLRFVMEGGLLDKPDNCPDMLF--ELMRMCWQYNPKMR-------------PS 286
Query: 961 FKGVNWALVRCMNPPELDAPLFATDTEK 988
F + ++ M P + + ++ K
Sbjct: 287 FLEIISSIKEEMEPGFREVSFYYSEENK 314
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 68.1 bits (167), Expect = 2e-12
Identities = 61/324 (18%), Positives = 116/324 (35%), Gaps = 64/324 (19%)
Query: 677 IKPLGSGDTGSVHLVELCGSGQYF-----AMKAMDKGVMLN-RNKVHRACAEREILDMLD 730
I+ LG G G V+ ++ G A+K + + E I+ +
Sbjct: 35 IRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLM---EALIISKFN 91
Query: 731 HPFVPALYA-SFQTKTHVCLITDYCPGGEL--FLLLDR----QPTKVLKEDAVRFYAAEV 783
H + S Q+ ++ + GG+L FL R QP+ + D + A ++
Sbjct: 92 HQNIVRCIGVSLQSLP-RFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHV-ARDI 149
Query: 784 VVALEYLHCQGIIYRDLKPENVLLQGNGH---VSLTDFDLSCLTSCKPQLLLPTTNEKKR 840
+YL I+RD+ N LL G + DF ++ + + ++
Sbjct: 150 ACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMA--------RDIYRASYYRK 201
Query: 841 RHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEML-YGYT 899
P++ ++ PE TS D W+ G+LL+E+ GY
Sbjct: 202 GGCAML-------PVK----------WMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYM 244
Query: 900 PFRGKTRQKTFANILH-KDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKH 958
P+ K+ Q+ + + P + P ++ ++M + P+ R
Sbjct: 245 PYPSKSNQEVLEFVTSGGRMDPPKNCPGPVY--RIMTQCWQHQPEDR------------- 289
Query: 959 PFFKGVNWALVRCM-NPPELDAPL 981
P F + + C +P ++ L
Sbjct: 290 PNFAIILERIEYCTQDPDVINTAL 313
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 67.6 bits (166), Expect = 3e-12
Identities = 62/291 (21%), Positives = 107/291 (36%), Gaps = 53/291 (18%)
Query: 677 IKPLGSGDTGSVHLVELCGSGQYF-----AMKAMDKGVMLNRNKVHRACAEREILDMLDH 731
+ LG G G V L E A+KA+ + R R E E+L L H
Sbjct: 20 KRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQR---EAELLTNLQH 76
Query: 732 PFVPALYA-SFQTKTHVCLITDYCPGGEL--FLLLDRQPTKVLKEDAVR----------- 777
+ Y + ++ +Y G+L FL +L + R
Sbjct: 77 EHIVKFYGVCGDGDP-LIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQM 135
Query: 778 -FYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTN 836
A+++ + YL Q ++RDL N L+ N V + DF +S + +T+
Sbjct: 136 LHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMS--------RDVYSTD 187
Query: 837 EKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEML- 895
+ P+R ++ PE I T+ D W+ G++L+E+
Sbjct: 188 YYRVGGHTML-------PIR----------WMPPESIMYRKFTTESDVWSFGVILWEIFT 230
Query: 896 YGYTPFRGKTRQKTFANILH-KDLKFPSSTPTSLHAKQLMYRLLHRDPKSR 945
YG P+ + + I + L+ P P ++ +M R+P+ R
Sbjct: 231 YGKQPWFQLSNTEVIECITQGRVLERPRVCPKEVY--DVMLGCWQREPQQR 279
|
| >3mqq_A Transcriptional regulator, LUXR family; PAS domain, PSI, MCSG, structural genomics, center for structural genomics; 1.65A {Burkholderia thailandensis} PDB: 3mqo_A Length = 120 | Back alignment and structure |
|---|
Score = 63.0 bits (154), Expect = 5e-12
Identities = 13/87 (14%), Positives = 30/87 (34%), Gaps = 2/87 (2%)
Query: 217 IMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAK-IRETLQNGQSYCGRLLNYKK 275
I + + +++GR+ L + + E + + I + SY + +
Sbjct: 24 IEDCNDELAAIFRCARADLIGRSFEVLYPSSDEFERIGERISPVMIAHGSYADDRIMKRA 83
Query: 276 DGTPFWNLLTIAPIKDDEGKVLKFIGM 302
G FW +T + D + +
Sbjct: 84 GGELFWCHVTGRAL-DRTAPLAAGVWT 109
|
| >3mqq_A Transcriptional regulator, LUXR family; PAS domain, PSI, MCSG, structural genomics, center for structural genomics; 1.65A {Burkholderia thailandensis} PDB: 3mqo_A Length = 120 | Back alignment and structure |
|---|
Score = 56.8 bits (138), Expect = 7e-10
Identities = 14/95 (14%), Positives = 30/95 (31%), Gaps = 2/95 (2%)
Query: 495 LPDNPIIFASDSFLELTEYSREEILGRNCRFLQ-GPETDPATVRKIRAAIDNQTDVTVQL 553
D I +D + +R +++GR+ L + +I +
Sbjct: 19 SRDRVIEDCNDELAAIFRCARADLIGRSFEVLYPSSDEFERIGERISPVMIAHGSYADDR 78
Query: 554 INYTKSGKKFWNLFHLQPMRDQKGEVQYFIGVQLD 588
I G+ FW + + D+ + + D
Sbjct: 79 IMKRAGGELFWCHVTGRAL-DRTAPLAAGVWTFED 112
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 67.0 bits (164), Expect = 9e-12
Identities = 59/323 (18%), Positives = 112/323 (34%), Gaps = 62/323 (19%)
Query: 677 IKPLGSGDTGSVHLVELCGSGQYF-----AMKAMDKGVMLN-RNKVHRACAEREILDMLD 730
I+ LG G G V+ ++ G A+K + + E I+ +
Sbjct: 76 IRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLM---EALIISKFN 132
Query: 731 HPFVPALYASFQTKTHVCLITDYCPGGEL--FLLLDR----QPTKVLKEDAVRFYAAEVV 784
H + ++ + GG+L FL R QP+ + D + A ++
Sbjct: 133 HQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHV-ARDIA 191
Query: 785 VALEYLHCQGIIYRDLKPENVLLQGNGH---VSLTDFDLSCLTSCKPQLLLPTTNEKKRR 841
+YL I+RD+ N LL G + DF ++ + ++
Sbjct: 192 CGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMA--------RDIYRAGYYRKG 243
Query: 842 HKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEML-YGYTP 900
P++ ++ PE TS D W+ G+LL+E+ GY P
Sbjct: 244 GCAML-------PVK----------WMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP 286
Query: 901 FRGKTRQKTFANILH-KDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHP 959
+ K+ Q+ + + P + P ++ ++M + P+ R P
Sbjct: 287 YPSKSNQEVLEFVTSGGRMDPPKNCPGPVY--RIMTQCWQHQPEDR-------------P 331
Query: 960 FFKGVNWALVRCM-NPPELDAPL 981
F + + C +P ++ L
Sbjct: 332 NFAIILERIEYCTQDPDVINTAL 354
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 65.7 bits (161), Expect = 1e-11
Identities = 62/291 (21%), Positives = 104/291 (35%), Gaps = 52/291 (17%)
Query: 677 IKPLGSGDTGSVHLVELCGSGQYF-----AMKAMDKGVMLN-RNKVHRACAEREILDMLD 730
++ LG G V+ L G A+K + R + E + L
Sbjct: 14 MEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRH---EAMLRARLQ 70
Query: 731 HPFVPALYASFQTKTHVCLITDYCPGGEL--FLLLDRQPTKVLKEDAVRF---------- 778
HP V L + +I YC G+L FL++ + V D R
Sbjct: 71 HPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDF 130
Query: 779 --YAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTN 836
A++ +EYL ++++DL NVL+ +V ++D L + +
Sbjct: 131 VHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLF--------REVYAAD 182
Query: 837 EKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEML- 895
K P+R ++APE I + D W+ G++L+E+
Sbjct: 183 YYKLLGNSLL-------PIR----------WMAPEAIMYGKFSIDSDIWSYGVVLWEVFS 225
Query: 896 YGYTPFRGKTRQKTFANILH-KDLKFPSSTPTSLHAKQLMYRLLHRDPKSR 945
YG P+ G + Q I + + L P P ++ LM + P R
Sbjct: 226 YGLQPYCGYSNQDVVEMIRNRQVLPCPDDCPAWVY--ALMIECWNEFPSRR 274
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 66.3 bits (162), Expect = 1e-11
Identities = 49/286 (17%), Positives = 97/286 (33%), Gaps = 42/286 (14%)
Query: 639 NHSKVVHPKPHRKDSPPWKAIQKILDSGEQ---INLQHFRPIKPLGSGDTGSVHLVELCG 695
+HS V + L +G + + ++ + G ++
Sbjct: 6 HHSSGVDLGTENLYFQSMTTSLEALPTGTVLTDKSGRQWKLKSFQTRDNQGILYEAAPTS 65
Query: 696 SG--------QYFAMK--AMDKGVMLNRNKVHRACAEREI-----LDMLDHPFVPALYAS 740
+ Q F++K A D + +N RA ++ L +P
Sbjct: 66 TLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNKWKKLYSTPLLAIPTCMGF 125
Query: 741 -FQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRD 799
+ L+ G L LD P VL E +V A ++ ALE+LH ++ +
Sbjct: 126 GVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGN 184
Query: 800 LKPENVLL--QGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRA 857
+ EN+ + + V+L + + + G+ +
Sbjct: 185 VTAENIFVDPEDQSQVTLAGYGFA----------------FRYCPSGKHVA----YVEGS 224
Query: 858 SNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRG 903
+ G E+I+ ++ G G + D +LG + + LYG+ P+
Sbjct: 225 RSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTN 270
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 64.7 bits (158), Expect = 4e-11
Identities = 59/262 (22%), Positives = 105/262 (40%), Gaps = 44/262 (16%)
Query: 673 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDH- 731
+FR K +G G+ G + L + + +Y A+K + +++ + E L
Sbjct: 10 NFRVGKKIGCGNFGELRLGKNLYTNEYVAIK-----LEPMKSRAPQLHLEYRFYKQLGSG 64
Query: 732 PFVPALYASFQTKTHVCLITDYCPGG----ELFLLLDRQPTKVLKEDAVRFYAAEVVVAL 787
+P +Y + ++ + G +LF L DR + LK V A +++ +
Sbjct: 65 DGIPQVYYFGPCGKYNAMVLELL--GPSLEDLFDLCDRTFS--LK--TVLMIAIQLISRM 118
Query: 788 EYLHCQGIIYRDLKPENVLLQGNGH-----VSLTDFDLSCLTSCKPQLLLPTTNEKKRRH 842
EY+H + +IYRD+KPEN L+ G+ + + DF L+ K+
Sbjct: 119 EYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALA----------------KEYID 162
Query: 843 KGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFR 902
+ + P R S GT Y++ G + D ALG + L G P++
Sbjct: 163 PETKKHI----PYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQ 218
Query: 903 G---KTRQKTFANILHKDLKFP 921
G T ++ + I P
Sbjct: 219 GLKADTLKERYQKIGDTKRATP 240
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 65.0 bits (158), Expect = 6e-11
Identities = 48/235 (20%), Positives = 92/235 (39%), Gaps = 31/235 (13%)
Query: 673 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDML-DH 731
FR + +GSG G ++L + + A+K + + K + E +I +L
Sbjct: 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENV-----KTKHPQLLYESKIYRILQGG 62
Query: 732 PFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLH 791
+P + + L+ D G L L + K+ + + A +++ +E++H
Sbjct: 63 TGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLML-ADQMINRVEFVH 120
Query: 792 CQGIIYRDLKPENVLLQGNGH---VSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNP 848
+ ++RD+KP+N L+ V + DF L+ + +H
Sbjct: 121 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK----------KYRDTSTHQHI----- 165
Query: 849 VFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRG 903
P R + + GT Y + G + D +LG +L L G P++G
Sbjct: 166 -----PYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQG 215
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 64.0 bits (156), Expect = 7e-11
Identities = 50/285 (17%), Positives = 92/285 (32%), Gaps = 44/285 (15%)
Query: 645 HPKPHRKDSPPWKAIQKI-LDSGEQINL---QHFRPIKPLGSGDTGSVHLVELCGSGQYF 700
H Q + G+ ++ + K +GSG G ++L +
Sbjct: 6 HHSSGVDLGTENLYFQSMPFPEGKVLDDMEGNQWVLGKKIGSGGFGLIYLAFPTNKPEKD 65
Query: 701 AMKAM-----DKGVMLNRNKV-HRACAEREILDM-----LDHPFVPALYAS----FQTKT 745
A + + G + + K R + I LD+ +P Y S F+ ++
Sbjct: 66 ARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGSGLTEFKGRS 125
Query: 746 HVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENV 805
+ ++ + G +L + + T V ++ LEY+H ++ D+K N+
Sbjct: 126 YRFMVMERL-GIDLQKISGQNGTFKKS--TVLQLGIRMLDVLEYIHENEYVHGDIKAANL 182
Query: 806 LL-QGNGH-VSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVG 863
LL N V L D+ LS + G G
Sbjct: 183 LLGYKNPDQVYLADYGLS----------------YRYCPNGNHKQY----QENPRKGHNG 222
Query: 864 TEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQK 908
T E+ + + G + D LG + L G P+ +
Sbjct: 223 TIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDP 267
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 63.5 bits (155), Expect = 8e-11
Identities = 73/322 (22%), Positives = 122/322 (37%), Gaps = 61/322 (18%)
Query: 645 HPKPHRKDSPPWKAIQKILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYF--AM 702
H H + P I +LD I Q +G G+ G V + G A+
Sbjct: 4 HHHHHHGKNNPDPTIYPVLDW-NDIKFQ-----DVIGEGNFGQVLKARIKKDGLRMDAAI 57
Query: 703 KAMDKGVMLNRNKVHRA-CAEREILDML-DHPFVPALYASFQTKTHVCLITDYCPGGEL- 759
K M + HR E E+L L HP + L + + + ++ L +Y P G L
Sbjct: 58 KRMKEYAS---KDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLL 114
Query: 760 -FLLLDRQPTKVLK-------------EDAVRFYAAEVVVALEYLHCQGIIYRDLKPENV 805
FL R + + F AA+V ++YL + I+RDL N+
Sbjct: 115 DFLRKSRVLETDPAFAIANSTASTLSSQQLLHF-AADVARGMDYLSQKQFIHRDLAARNI 173
Query: 806 LLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTE 865
L+ N + DF LS ++ G+ P+R
Sbjct: 174 LVGENYVAKIADFGLS-----------RGQEVYVKKTMGRL-------PVR--------- 206
Query: 866 EYIAPEIIAGAGHTSAVDWWALGILLYEML-YGYTPFRGKTRQKTFANILH-KDLKFPSS 923
++A E + + +T+ D W+ G+LL+E++ G TP+ G T + + + L+ P +
Sbjct: 207 -WMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKPLN 265
Query: 924 TPTSLHAKQLMYRLLHRDPKSR 945
++ LM + P R
Sbjct: 266 CDDEVY--DLMRQCWREKPYER 285
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 63.6 bits (155), Expect = 9e-11
Identities = 52/284 (18%), Positives = 99/284 (34%), Gaps = 44/284 (15%)
Query: 647 KPHRKDSPPWKAIQKILDSGEQINL---QHFRPIKPLGSGDTGSVHLVEL-----CGSGQ 698
+ S + + + GE I ++ P+G G G ++L ++ GS
Sbjct: 7 AQAGRQSSAKRHLAEQFAVGEIITDMAAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDA 66
Query: 699 YFAMKAM--DKGVMLNRNKVHRACAEREILDM------LDHPFVPALYAS----FQTKTH 746
+K D G + K ++ A+ E + L + VP + S K++
Sbjct: 67 PCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSY 126
Query: 747 VCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVL 806
+I D G +L + + + V + ++ LEY+H ++ D+K N+L
Sbjct: 127 RFMIMDRF-GSDLQKIYEANAKR-FSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLL 184
Query: 807 L-QGNGH-VSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGT 864
L N V L D+ L+ + +G GT
Sbjct: 185 LNYKNPDQVYLVDYGLA----------------YRYCPEGVHKAY----AADPKRCHDGT 224
Query: 865 EEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQK 908
E+ + + G + D LG + + L G+ P+ +
Sbjct: 225 IEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDP 268
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 61.5 bits (150), Expect = 4e-10
Identities = 48/248 (19%), Positives = 98/248 (39%), Gaps = 51/248 (20%)
Query: 722 EREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGEL--FLLLDRQPTKVLKEDAVRF- 778
E +L ++HP V LY + + LI +Y G L FL R+
Sbjct: 76 EFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRN 135
Query: 779 -------------------YAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFD 819
+A ++ ++YL +++RDL N+L+ + ++DF
Sbjct: 136 SSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFG 195
Query: 820 LSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHT 879
LS + + +R +G+ P++ ++A E + +T
Sbjct: 196 LS--------RDVYEEDSYVKRSQGR-------IPVK----------WMAIESLFDHIYT 230
Query: 880 SAVDWWALGILLYEML-YGYTPFRGKTRQKTFANILH-KDLKFPSSTPTSLHAKQLMYRL 937
+ D W+ G+LL+E++ G P+ G ++ F + ++ P + ++ +LM +
Sbjct: 231 TQSDVWSFGVLLWEIVTLGGNPYPGIPPERLFNLLKTGHRMERPDNCSEEMY--RLMLQC 288
Query: 938 LHRDPKSR 945
++P R
Sbjct: 289 WKQEPDKR 296
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 61.2 bits (149), Expect = 6e-10
Identities = 63/296 (21%), Positives = 112/296 (37%), Gaps = 59/296 (19%)
Query: 677 IKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGV-MLNRNKVHRACAEREILDML------ 729
KPLG G G V + E G + +A+ V ML + E+++ D++
Sbjct: 40 GKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDD-----ATEKDLSDLVSEMEMM 94
Query: 730 ----DHPFVPALYASFQTKTHVCLITDYCPGGEL--FLLLDRQPTKVLKEDAVRF----- 778
H + L + + +I +Y G L +L R P D R
Sbjct: 95 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 779 -------YAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLL 831
++ +EYL Q I+RDL NVL+ N + + DF L+
Sbjct: 155 TFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLA--------RD 206
Query: 832 LPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILL 891
+ + K+ G+ P++ ++APE + +T D W+ G+L+
Sbjct: 207 INNIDYYKKTTNGR-------LPVK----------WMAPEALFDRVYTHQSDVWSFGVLM 249
Query: 892 YEML-YGYTPFRGKTRQKTFANILH-KDLKFPSSTPTSLHAKQLMYRLLHRDPKSR 945
+E+ G +P+ G ++ F + + P++ L+ +M H P R
Sbjct: 250 WEIFTLGGSPYPGIPVEELFKLLKEGHRMDKPANCTNELY--MMMRDCWHAVPSQR 303
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 60.8 bits (148), Expect = 8e-10
Identities = 66/330 (20%), Positives = 111/330 (33%), Gaps = 73/330 (22%)
Query: 677 IKPLGSGDTGSVHLVELCGSGQYF-----AMKAMDKGVMLN-RNKVHRACAEREILDMLD 730
++ +G G G V G Y A+K + + + + R E ++ D
Sbjct: 52 VRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQR---EAALMAEFD 108
Query: 731 HPFVPALYASFQTKTHVCLITDYCPGGEL--FLLLDRQPTKVLKEDAVRFY--------- 779
+P + L +CL+ +Y G+L FL T +
Sbjct: 109 NPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGP 168
Query: 780 -----------AAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKP 828
A +V + YL + ++RDL N L+ N V + DF LS
Sbjct: 169 PPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLS------- 221
Query: 829 QLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALG 888
+ + + K P+R ++ PE I +T+ D WA G
Sbjct: 222 -RNIYSADYYKADGNDAI-------PIR----------WMPPESIFYNRYTTESDVWAYG 263
Query: 889 ILLYEML-YGYTPFRGKTRQKTFANILH-KDLKFPSSTPTSLHAKQLMYRLLHRDPKSRL 946
++L+E+ YG P+ G ++ + L P + P L+ LM + P R
Sbjct: 264 VVLWEIFSYGLQPYYGMAHEEVIYYVRDGNILACPENCPLELY--NLMRLCWSKLPADR- 320
Query: 947 GSHEGANEIKKHPFFKGVNWALVRCMNPPE 976
P F ++ L R E
Sbjct: 321 ------------PSFCSIHRILQRMCERAE 338
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 60.8 bits (148), Expect = 8e-10
Identities = 71/355 (20%), Positives = 122/355 (34%), Gaps = 75/355 (21%)
Query: 677 IKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGV-MLNRNKVHRACAEREILDML------ 729
KPLG G G V L E G + + V ML + E+++ D++
Sbjct: 74 GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSD-----ATEKDLSDLISEMEMM 128
Query: 730 ----DHPFVPALYASFQTKTHVCLITDYCPGGEL--FLLLDRQPTKVLKEDAVRF----- 778
H + L + + +I +Y G L +L R P +
Sbjct: 129 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 188
Query: 779 -------YAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLL 831
A +V +EYL + I+RDL NVL+ + + + DF L+
Sbjct: 189 SSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIH------ 242
Query: 832 LPTTNEKKRRHKGQQNPV-FMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGIL 890
+ ++ + PV +M APE + +T D W+ G+L
Sbjct: 243 ---HIDYYKKTTNGRLPVKWM-----------------APEALFDRIYTHQSDVWSFGVL 282
Query: 891 LYEML-YGYTPFRGKTRQKTFANILH-KDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGS 948
L+E+ G +P+ G ++ F + + PS+ L+ +M H P R
Sbjct: 283 LWEIFTLGGSPYPGVPVEELFKLLKEGHRMDKPSNCTNELY--MMMRDCWHAVPSQR--- 337
Query: 949 HEGANEIKKHPFFKGVNWALVRCMNPPELDAPLFATDTEKEYKVVDPGMQDLQQN 1003
P FK + L R + + + + P ++L N
Sbjct: 338 ----------PTFKQLVEDLDRIVALTS-NQEMGYYHHHHHHDYDIPTTENLYFN 381
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 60.0 bits (146), Expect = 1e-09
Identities = 54/243 (22%), Positives = 93/243 (38%), Gaps = 46/243 (18%)
Query: 722 EREILDMLD-HPFVPALY-ASFQTKTHVCLITDYCPGGEL--FLLLDRQPTKVLKEDAVR 777
E +IL + H V L A + + +I ++C G L +L R K
Sbjct: 80 ELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPED 139
Query: 778 F------------YAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTS 825
Y+ +V +E+L + I+RDL N+LL V + DF L+
Sbjct: 140 LYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLA---- 195
Query: 826 CKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWW 885
+ + R+ + P++ ++APE I +T D W
Sbjct: 196 ----RDIYKDPDYVRKGDAR-------LPLK----------WMAPETIFDRVYTIQSDVW 234
Query: 886 ALGILLYEML-YGYTPFRGKTRQKTFANILHKD--LKFPSSTPTSLHAKQLMYRLLHRDP 942
+ G+LL+E+ G +P+ G + F L + ++ P T ++ Q M H +P
Sbjct: 235 SFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMY--QTMLDCWHGEP 292
Query: 943 KSR 945
R
Sbjct: 293 SQR 295
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 59.3 bits (144), Expect = 3e-09
Identities = 63/296 (21%), Positives = 112/296 (37%), Gaps = 59/296 (19%)
Query: 677 IKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGV-MLNRNKVHRACAEREILDML------ 729
KPLG G G V + E G + +A+ V ML + E+++ D++
Sbjct: 86 GKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDD-----ATEKDLSDLVSEMEMM 140
Query: 730 ----DHPFVPALYASFQTKTHVCLITDYCPGGEL--FLLLDRQPTKVLKEDAVRF----- 778
H + L + + +I +Y G L +L R P D R
Sbjct: 141 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 200
Query: 779 -------YAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLL 831
++ +EYL Q I+RDL NVL+ N + + DF L+
Sbjct: 201 TFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLA--------RD 252
Query: 832 LPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILL 891
+ + K+ G+ P++ ++APE + +T D W+ G+L+
Sbjct: 253 INNIDYYKKTTNGR-------LPVK----------WMAPEALFDRVYTHQSDVWSFGVLM 295
Query: 892 YEML-YGYTPFRGKTRQKTFANILH-KDLKFPSSTPTSLHAKQLMYRLLHRDPKSR 945
+E+ G +P+ G ++ F + + P++ L+ +M H P R
Sbjct: 296 WEIFTLGGSPYPGIPVEELFKLLKEGHRMDKPANCTNELY--MMMRDCWHAVPSQR 349
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 55.3 bits (134), Expect = 4e-08
Identities = 49/226 (21%), Positives = 86/226 (38%), Gaps = 42/226 (18%)
Query: 680 LGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRA-CAEREILDMLDHPFVPALY 738
+G G G V+ + + A+K + V + ++ + E +++ H + L
Sbjct: 39 MGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELL 96
Query: 739 ASFQTKTHVCLITDYCPGGEL-FLLLDRQPTKVLKED-AVRFY----AAEVVVALEYLHC 792
+CL+ Y P G L L T L +R AA + +LH
Sbjct: 97 GFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPL--SWHMRCKIAQGAAN---GINFLHE 151
Query: 793 QGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMA 852
I+RD+K N+LL ++DF L+ + Q +
Sbjct: 152 NHHIHRDIKSANILLDEAFTAKISDFGLA-----R---ASEK---------FAQTVM--- 191
Query: 853 EPMRASNSFVGTEEYIAPEIIAGAGH-TSAVDWWALGILLYEMLYG 897
++ VGT Y+APE + G T D ++ G++L E++ G
Sbjct: 192 -----TSRIVGTTAYMAPEAL--RGEITPKSDIYSFGVVLLEIITG 230
|
| >3luq_A Sensor protein; PAS, histidine, kinase, PSI, MCSG, structural genomics, midwest center for structural genomics; HET: PGE; 2.49A {Geobacter sulfurreducens} Length = 114 | Back alignment and structure |
|---|
Score = 51.1 bits (123), Expect = 5e-08
Identities = 14/88 (15%), Positives = 29/88 (32%), Gaps = 1/88 (1%)
Query: 501 IFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIRAAIDNQTDVTVQLINYTKSG 560
+ S + E +ILG + + PE R + + + G
Sbjct: 26 LAVSRRWREDYGLGDGDILGMSHYDI-FPEIGEEWKSVHRRGLAGEVIRVEEDCFVRADG 84
Query: 561 KKFWNLFHLQPMRDQKGEVQYFIGVQLD 588
+ W + ++P + +G V + D
Sbjct: 85 RTQWLRWEVRPWYEGEGRVGGVVIFTED 112
|
| >3luq_A Sensor protein; PAS, histidine, kinase, PSI, MCSG, structural genomics, midwest center for structural genomics; HET: PGE; 2.49A {Geobacter sulfurreducens} Length = 114 | Back alignment and structure |
|---|
Score = 42.2 bits (100), Expect = 8e-05
Identities = 13/93 (13%), Positives = 27/93 (29%), Gaps = 17/93 (18%)
Query: 218 MYASAGFFKMTGYTSKEVVGRNCRFLQGAGTD----PEDVAKIRET----LQNGQSYCGR 269
+ S + + G +++G + PE + + L
Sbjct: 26 LAVSRRWREDYGLGDGDILGM---------SHYDIFPEIGEEWKSVHRRGLAGEVIRVEE 76
Query: 270 LLNYKKDGTPFWNLLTIAPIKDDEGKVLKFIGM 302
+ DG W + P + EG+V +
Sbjct: 77 DCFVRADGRTQWLRWEVRPWYEGEGRVGGVVIF 109
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 54.6 bits (131), Expect = 8e-08
Identities = 48/263 (18%), Positives = 94/263 (35%), Gaps = 34/263 (12%)
Query: 690 LVELCGSG--QYFAMKAMDKGVMLNRNKVHRACAER--EILDMLDHPFVPALYASFQTKT 745
+VE C G + ++ V + + + + ++ +S + +
Sbjct: 105 IVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSAS 164
Query: 746 HVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENV 805
+ E + L + + Y+ +V +E+L + I+RDL N+
Sbjct: 165 SGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNI 224
Query: 806 LLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTE 865
LL V + DF L+ + R + P+
Sbjct: 225 LLSEKNVVKICDFGLARDI---------YKDPDYVRKGDARLPL---------------- 259
Query: 866 EYIAPEIIAGAGHTSAVDWWALGILLYEML-YGYTPFRGKTRQKTFANILHKD--LKFPS 922
+++APE I +T D W+ G+LL+E+ G +P+ G + F L + ++ P
Sbjct: 260 KWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPD 319
Query: 923 STPTSLHAKQLMYRLLHRDPKSR 945
T ++ Q M H +P R
Sbjct: 320 YTTPEMY--QTMLDCWHGEPSQR 340
|
| >3b33_A Sensor protein; structural genomics, PAS domain, nitrogen regulation protein APC91440.4, PSI-2; HET: MSE; 1.83A {Vibrio parahaemolyticus rimd 2210633} Length = 115 | Back alignment and structure |
|---|
Score = 50.2 bits (120), Expect = 1e-07
Identities = 20/81 (24%), Positives = 37/81 (45%), Gaps = 2/81 (2%)
Query: 217 IMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKIRETLQNGQSYCGRLLNYKKD 276
I YA+ + ++K +V ++ Q D+A + + LQ+GQS + + D
Sbjct: 29 IRYANPAAELLFSQSAKRIVEQSLS--QLIQHASLDLALLTQPLQSGQSITDSDVTFVVD 86
Query: 277 GTPFWNLLTIAPIKDDEGKVL 297
G P +T++PI +L
Sbjct: 87 GRPLMLEVTVSPITWQRQLML 107
|
| >3b33_A Sensor protein; structural genomics, PAS domain, nitrogen regulation protein APC91440.4, PSI-2; HET: MSE; 1.83A {Vibrio parahaemolyticus rimd 2210633} Length = 115 | Back alignment and structure |
|---|
Score = 42.5 bits (100), Expect = 5e-05
Identities = 14/92 (15%), Positives = 35/92 (38%), Gaps = 7/92 (7%)
Query: 489 VITDPRLPDNPIIFASDSFLELTEYSREEILGRNC-RFLQGPETDPATVRKIRAAIDNQT 547
+I D I +A+ + L S + I+ ++ + +Q D A + + +
Sbjct: 21 LILDD---GLAIRYANPAAELLFSQSAKRIVEQSLSQLIQHASLDLAL---LTQPLQSGQ 74
Query: 548 DVTVQLINYTKSGKKFWNLFHLQPMRDQKGEV 579
+T + + G+ + P+ Q+ +
Sbjct: 75 SITDSDVTFVVDGRPLMLEVTVSPITWQRQLM 106
|
| >2r78_A Sensor protein; sensory box sensor histidine kinase/response regulator, structural genomics, PSI, MCSG; 1.60A {Geobacter sulfurreducens pca} Length = 117 | Back alignment and structure |
|---|
Score = 49.9 bits (120), Expect = 1e-07
Identities = 13/93 (13%), Positives = 28/93 (30%), Gaps = 12/93 (12%)
Query: 213 PDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKIRETLQ---NGQSYCGR 269
+ + + GYT E + + L + D +L G+
Sbjct: 29 AEGHYLDVNPAICSAIGYTRDEFLALDWGVL----SRGVDSGWAAASLARIVGGEPLREE 84
Query: 270 LLNYKKDGTPFWNLLTIAPIKDDEGKVLKFIGM 302
+ ++G L+ + D K +G+
Sbjct: 85 RTVWTRNGDQLTVELSAHLLPDG-----KILGI 112
|
| >2r78_A Sensor protein; sensory box sensor histidine kinase/response regulator, structural genomics, PSI, MCSG; 1.60A {Geobacter sulfurreducens pca} Length = 117 | Back alignment and structure |
|---|
Score = 48.7 bits (117), Expect = 4e-07
Identities = 10/86 (11%), Positives = 28/86 (32%), Gaps = 6/86 (6%)
Query: 500 IIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIRAAIDNQTDVTVQLINYTKS 559
+ + + Y+R+E L + L + + + + + +T++
Sbjct: 33 YLDVNPAICSAIGYTRDEFLALDWGVLSRGVDSGWAAASLARIVGGEP-LREERTVWTRN 91
Query: 560 GKKFWNLFHLQPMRDQKGEVQYFIGV 585
G + + D K +G+
Sbjct: 92 GDQLTVELSAHLLPDGK-----ILGI 112
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 53.0 bits (128), Expect = 2e-07
Identities = 52/246 (21%), Positives = 87/246 (35%), Gaps = 49/246 (19%)
Query: 721 AEREILDML-DHPFVPALYASFQTKTHVCLITDYCPGGEL--FLLLDRQPTKVLKEDAVR 777
+E ++L L +H + L + +IT+YC G+L FL R K
Sbjct: 75 SELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAI 134
Query: 778 F--------------YAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCL 823
++ +V + +L + I+RDL N+LL + DF L+
Sbjct: 135 MEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLA-- 192
Query: 824 TSCKPQLLLPTTNEKKRRHKGQQNPV-FMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAV 882
+ + + + PV +M APE I +T
Sbjct: 193 ------RDIKNDSNYVVKGNA-RLPVKWM-----------------APESIFNCVYTFES 228
Query: 883 DWWALGILLYEML-YGYTPFRG-KTRQKTFANILH-KDLKFPSSTPTSLHAKQLMYRLLH 939
D W+ GI L+E+ G +P+ G K + I + P P ++ +M
Sbjct: 229 DVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMY--DIMKTCWD 286
Query: 940 RDPKSR 945
DP R
Sbjct: 287 ADPLKR 292
|
| >2vlg_A Sporulation kinase A; histidine kinase, two-component regulatory system, two-component signal transduction, transferase, phosphorylation, SCOD; 1.7A {Bacillus subtilis} Length = 111 | Back alignment and structure |
|---|
Score = 48.2 bits (115), Expect = 5e-07
Identities = 19/99 (19%), Positives = 35/99 (35%), Gaps = 9/99 (9%)
Query: 213 PDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKIRETLQNGQSYCG---R 269
+ I+Y SA GY E++G + ED + N R
Sbjct: 17 SNGRIIYISANSKLHLGYLQGEMIGSFLKTF----LHEEDQFLVESYFYNEHHLMPCTFR 72
Query: 270 LLNYKKDGTPFWNLLTIAPIKDDEGKVLKFIGMQVEVSK 308
+ KKD T W + + + + I ++++V +
Sbjct: 73 FI--KKDHTIVWVEAAVEIVTTRAERTEREIILKMKVLE 109
|
| >2vlg_A Sporulation kinase A; histidine kinase, two-component regulatory system, two-component signal transduction, transferase, phosphorylation, SCOD; 1.7A {Bacillus subtilis} Length = 111 | Back alignment and structure |
|---|
Score = 40.5 bits (95), Expect = 3e-04
Identities = 15/96 (15%), Positives = 32/96 (33%), Gaps = 3/96 (3%)
Query: 496 PDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIRAAIDNQTDVTVQLIN 555
+ II+ S + Y + E++G + E D V + T + I
Sbjct: 17 SNGRIIYISANSKLHLGYLQGEMIGSFLKTFLHEE-DQFLVESYFYNEHHLMPCTFRFI- 74
Query: 556 YTKSGKKFWNLFHLQPMRDQKGEVQYFIGVQLDGSE 591
K W ++ + + + I +++ E
Sbjct: 75 -KKDHTIVWVEAAVEIVTTRAERTEREIILKMKVLE 109
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 51.9 bits (125), Expect = 5e-07
Identities = 52/242 (21%), Positives = 91/242 (37%), Gaps = 47/242 (19%)
Query: 722 EREILDMLD-HPFVPALYASFQTKTHVCLITDYCPGGEL--FLLLDRQPTKVLK------ 772
E +I+ L H + L + V +IT+YC G+L FL + +
Sbjct: 99 ELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIAN 158
Query: 773 -----EDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCK 827
D + F +++V + +L + I+RD+ NVLL + DF L+
Sbjct: 159 STASTRDLLHF-SSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLA------ 211
Query: 828 PQLLLPTTNEKKRRHKGQQNPV-FMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWA 886
+ + + + PV +M APE I +T D W+
Sbjct: 212 --RDIMNDSNYIVKGNARL-PVKWM-----------------APESIFDCVYTVQSDVWS 251
Query: 887 LGILLYEML-YGYTPFRG-KTRQKTFANILH-KDLKFPSSTPTSLHAKQLMYRLLHRDPK 943
GILL+E+ G P+ G K + + + P+ P +++ +M +P
Sbjct: 252 YGILLWEIFSLGLNPYPGILVNSKFYKLVKDGYQMAQPAFAPKNIY--SIMQACWALEPT 309
Query: 944 SR 945
R
Sbjct: 310 HR 311
|
| >3bwl_A Sensor protein; structural genomics, APC87707.1, PAS domain, HTR-like protei protein structure initiative; HET: MSE I3A; 1.73A {Haloarcula marismortui atcc 43049} Length = 126 | Back alignment and structure |
|---|
Score = 48.3 bits (116), Expect = 6e-07
Identities = 15/98 (15%), Positives = 26/98 (26%), Gaps = 6/98 (6%)
Query: 488 FVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIRAAIDNQT 547
+ D D I + F Y E+LGR+ D V+ +
Sbjct: 30 IDVLDA---DGTICEVNQRFCAELGYDESEVLGRSIWEF-DLMFDAEDVQTQLSGFSVDE 85
Query: 548 DVTVQLINYTKSGKKFWNLFHLQPMRDQKGEVQYFIGV 585
+ + + G HL F+ +
Sbjct: 86 RRKFEGLYERRDGSTMSVEVHLLRFNL--EGEDRFLAI 121
|
| >3bwl_A Sensor protein; structural genomics, APC87707.1, PAS domain, HTR-like protei protein structure initiative; HET: MSE I3A; 1.73A {Haloarcula marismortui atcc 43049} Length = 126 | Back alignment and structure |
|---|
Score = 48.3 bits (116), Expect = 8e-07
Identities = 15/81 (18%), Positives = 25/81 (30%), Gaps = 1/81 (1%)
Query: 217 IMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKIRETLQNGQSYCGRLLNYKKD 276
I + F GY EV+GR+ D EDV + L ++D
Sbjct: 39 ICEVNQRFCAELGYDESEVLGRSIWEF-DLMFDAEDVQTQLSGFSVDERRKFEGLYERRD 97
Query: 277 GTPFWNLLTIAPIKDDEGKVL 297
G+ + + +
Sbjct: 98 GSTMSVEVHLLRFNLEGEDRF 118
|
| >3mjq_A Uncharacterized protein; NESG, structural genomics, PSI-2, protein structure initiati northeast structural genomics consortium; 2.60A {Desulfitobacterium hafniense} Length = 126 | Back alignment and structure |
|---|
Score = 45.7 bits (109), Expect = 5e-06
Identities = 12/98 (12%), Positives = 32/98 (32%), Gaps = 6/98 (6%)
Query: 488 FVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIRAAIDNQT 547
+I + + +++A+ + + Y+ EE++ + + A KI A +
Sbjct: 12 ILIINR---EGRLLYANTAVPKKLGYTHEELMSMHILTIT-SAGKMAEGEKILAELFAGK 67
Query: 548 DVTVQLINYTKSGKKFWNLFHLQPMRDQKGEVQYFIGV 585
++ L K G + + +
Sbjct: 68 KESLPLSLEKKEGTSIPAKARIWQGKW--HNEPCLFAI 103
|
| >3mjq_A Uncharacterized protein; NESG, structural genomics, PSI-2, protein structure initiati northeast structural genomics consortium; 2.60A {Desulfitobacterium hafniense} Length = 126 | Back alignment and structure |
|---|
Score = 43.7 bits (104), Expect = 3e-05
Identities = 19/81 (23%), Positives = 31/81 (38%), Gaps = 1/81 (1%)
Query: 217 IMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKIRETLQNGQSYCGRLLNYKKD 276
++YA+ K GYT +E++ + + + + KI L G+ L KK+
Sbjct: 21 LLYANTAVPKKLGYTHEELMSMHILTIT-SAGKMAEGEKILAELFAGKKESLPLSLEKKE 79
Query: 277 GTPFWNLLTIAPIKDDEGKVL 297
GT I K L
Sbjct: 80 GTSIPAKARIWQGKWHNEPCL 100
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 48.0 bits (115), Expect = 8e-06
Identities = 56/241 (23%), Positives = 85/241 (35%), Gaps = 50/241 (20%)
Query: 674 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRA----CAEREILDML 729
F LG G G V+ L G A+K L + E E++ M
Sbjct: 32 FSNKNILGRGGFGKVYKGRL-ADGTLVAVK------RLKEERTQGGELQFQTEVEMISMA 84
Query: 730 DHPFVPALYASFQTKTHVCLITDYCPGGEL-FLLLDRQPTKVLKEDAVRFY----AAEVV 784
H + L T T L+ Y G + L +R ++ + R +A
Sbjct: 85 VHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSAR-- 142
Query: 785 VALEYLHCQG---IIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRR 841
L YLH II+RD+K N+LL + DF L+ K L+ +
Sbjct: 143 -GLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLA-----K---LMDYKDT---- 189
Query: 842 HKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGH-TSAVDWWALGILLYEMLYGYTP 900
H + + GT +IAPE G + D + G++L E++ G
Sbjct: 190 H--------------VTTAVRGTIGHIAPE-YLSTGKSSEKTDVFGYGVMLLELITGQRA 234
Query: 901 F 901
F
Sbjct: 235 F 235
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 47.6 bits (114), Expect = 1e-05
Identities = 17/35 (48%), Positives = 23/35 (65%)
Query: 787 LEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLS 821
L YLH + II+RD+K N+LL N +TDF +S
Sbjct: 152 LHYLHTRAIIHRDVKSINILLDENFVPKITDFGIS 186
|
| >3olo_A Two-component sensor histidine kinase; structural genomics, PSI-2, protein structure initiative, MI center for structural genomics, MCSG, TRA; 2.09A {Nostoc SP} Length = 118 | Back alignment and structure |
|---|
Score = 44.1 bits (105), Expect = 1e-05
Identities = 18/98 (18%), Positives = 37/98 (37%), Gaps = 10/98 (10%)
Query: 488 FVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIRAAIDNQT 547
+ ++ +D+ +TEYSRE++L N + + D I +
Sbjct: 26 SFCLGD---NWQFLYVNDATCRMTEYSREQLLSMNLQDI-----DVDFALHDWEEIRQKN 77
Query: 548 DVTVQLINYTKSGKKFWNLFHLQPMRDQKGEVQYFIGV 585
+ T + ++SG+ F L + DQ+ +
Sbjct: 78 NYTFKTRYRSQSGRIFLVEMSLTFLEDQERR--FSCVF 113
|
| >3olo_A Two-component sensor histidine kinase; structural genomics, PSI-2, protein structure initiative, MI center for structural genomics, MCSG, TRA; 2.09A {Nostoc SP} Length = 118 | Back alignment and structure |
|---|
Score = 43.0 bits (102), Expect = 4e-05
Identities = 12/81 (14%), Positives = 34/81 (41%), Gaps = 5/81 (6%)
Query: 217 IMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKIRETLQNGQSYCGRLLNYKKD 276
+Y + +MT Y+ ++++ N + + D + E ++ +Y + +
Sbjct: 35 FLYVNDATCRMTEYSREQLLSMNLQDI-----DVDFALHDWEEIRQKNNYTFKTRYRSQS 89
Query: 277 GTPFWNLLTIAPIKDDEGKVL 297
G F +++ ++D E +
Sbjct: 90 GRIFLVEMSLTFLEDQERRFS 110
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 46.5 bits (111), Expect = 2e-05
Identities = 47/249 (18%), Positives = 90/249 (36%), Gaps = 52/249 (20%)
Query: 722 EREILDML-DHPFVPALYASFQTKTHVCLITDYCPGGEL--FLLLDRQPTKVLKEDAVRF 778
E +++ L H + L + + LI +YC G+L +L R+ + +
Sbjct: 98 ELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQ 157
Query: 779 -------------------YAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFD 819
+A +V +E+L + ++RDL NVL+ V + DF
Sbjct: 158 KRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFG 217
Query: 820 LSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHT 879
L+ + + + R + P++ ++APE + +T
Sbjct: 218 LA--------RDIMSDSNYVVRGNAR-------LPVK----------WMAPESLFEGIYT 252
Query: 880 SAVDWWALGILLYEML-YGYTPFRG-KTRQKTFANILH-KDLKFPSSTPTSLHAKQLMYR 936
D W+ GILL+E+ G P+ G + I + + P ++ +M
Sbjct: 253 IKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLIQNGFKMDQPFYATEEIY--IIMQS 310
Query: 937 LLHRDPKSR 945
D + R
Sbjct: 311 CWAFDSRKR 319
|
| >3fc7_A HTR-like protein, sensor protein; APC87712.1, HTR-like protein,haloarcula marismortui ATCC 430 structural genomics, PSI-2; 2.65A {Haloarcula marismortui} Length = 125 | Back alignment and structure |
|---|
Score = 43.8 bits (104), Expect = 2e-05
Identities = 12/86 (13%), Positives = 30/86 (34%), Gaps = 6/86 (6%)
Query: 500 IIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIRAAIDNQTDVTVQLINYTKS 559
I+ + S + ++G+ + E + ++A++N T +
Sbjct: 41 ILSVNPSMAGRLGADPDTLVGQQLSAVMDSEAANQRLEAGKSAVENGTATRSE---DAVG 97
Query: 560 GKKFWNLFHLQPMRDQKGEVQYFIGV 585
G+ + N + P+ + F V
Sbjct: 98 GRHYHNQYI--PVDSH-RKSDTFQLV 120
|
| >3fc7_A HTR-like protein, sensor protein; APC87712.1, HTR-like protein,haloarcula marismortui ATCC 430 structural genomics, PSI-2; 2.65A {Haloarcula marismortui} Length = 125 | Back alignment and structure |
|---|
Score = 40.4 bits (95), Expect = 3e-04
Identities = 12/86 (13%), Positives = 27/86 (31%), Gaps = 6/86 (6%)
Query: 217 IMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKIRETLQNGQSYCGRLLNYKKD 276
I+ + G +VG+ + + + + + ++NG +
Sbjct: 41 ILSVNPSMAGRLGADPDTLVGQQLSAVMDSEAANQRLEAGKSAVENGTA---TRSEDAVG 97
Query: 277 GTPFWNLLTIAPIKDDEGKVLKFIGM 302
G + N P+ D K F +
Sbjct: 98 GRHYHN--QYIPV-DSHRKSDTFQLV 120
|
| >3eeh_A Putative light and redox sensing histidine kinase; structural genomic MCSG, protein structure initiative, midwest center for STRU genomics; HET: PG5; 1.95A {Haloarcula marismortui} Length = 125 | Back alignment and structure |
|---|
Score = 43.7 bits (104), Expect = 3e-05
Identities = 18/90 (20%), Positives = 40/90 (44%), Gaps = 9/90 (10%)
Query: 217 IMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKIRETLQ---NGQSYCG--RLL 271
++ ++ + + G + ++ FL G PED +++T+Q +G+S R+
Sbjct: 34 VLVINSAYEDIWGRSVAKLRENPHDFLNG--IHPEDRELMKDTMQSLMDGESADVECRVN 91
Query: 272 NYKKDGTPFWNLLTIAPIKDDEGKVLKFIG 301
+ W + PI +D G+ ++ G
Sbjct: 92 A--TEEYQRWVWIQGEPITNDAGETVRVAG 119
|
| >3icy_A Sensor protein; sensory box histidine kinase/response regulator domain, kinase, chlorobium tepidum TLS, PSI-2; 2.68A {Chlorobaculum tepidum} Length = 118 | Back alignment and structure |
|---|
Score = 43.4 bits (103), Expect = 3e-05
Identities = 16/99 (16%), Positives = 28/99 (28%), Gaps = 12/99 (12%)
Query: 496 PDNPIIFASDSFLELTEYSREEILGRNCRFLQG--PETDPATVRK-IRAAIDNQTDVTVQ 552
I F +FL+ E L + D + + + +T+
Sbjct: 24 GQATIRFRPPAFLKT--LVSEHAGTTRLNTLSMIHHD-DRHMLSNAYSKLREAKHSLTLV 80
Query: 553 LINY---TKSGKKFWNLFHLQPMRDQKGEVQYFIGVQLD 588
Y T GK W H++ G G+ +
Sbjct: 81 ---YRIVTPEGKLHWIEDHMRSSFSDDGLFSGIDGILCE 116
|
| >3icy_A Sensor protein; sensory box histidine kinase/response regulator domain, kinase, chlorobium tepidum TLS, PSI-2; 2.68A {Chlorobaculum tepidum} Length = 118 | Back alignment and structure |
|---|
Score = 40.7 bits (96), Expect = 2e-04
Identities = 12/95 (12%), Positives = 21/95 (22%), Gaps = 12/95 (12%)
Query: 213 PDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKIRETLQ----NGQSYCG 268
I + F K N + +D + S
Sbjct: 24 GQATIRFRPPAFLKTLVSEHAGTTRLNTL----SMIHHDDRHMLSNAYSKLREAKHSLTL 79
Query: 269 --RLLNYKKDGTPFWNLLTIAPIKDDEGKVLKFIG 301
R++ +G W + D+G G
Sbjct: 80 VYRIVT--PEGKLHWIEDHMRSSFSDDGLFSGIDG 112
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 45.3 bits (106), Expect = 6e-05
Identities = 27/225 (12%), Positives = 64/225 (28%), Gaps = 23/225 (10%)
Query: 740 SFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQ-GIIYR 798
F + ++ ++ GG L++ TK+ + ++ +L +R
Sbjct: 130 DFFKDDQLFIVLEFEFGGID---LEQMRTKLSSLATAKSILHQLTASLAVAEASLRFEHR 186
Query: 799 DLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPV--FMAEPMR 856
DL NVLL+ L G Q + + +
Sbjct: 187 DLHWGNVLLKKTSLKKLHYTLNG--------------KSSTIPSCGLQVSIIDYTLSRLE 232
Query: 857 ASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANILHK 916
V + + ++ G G + + Y P+ + + K
Sbjct: 233 RDGIVVFCDVSMDEDLFTGDGDYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLK 292
Query: 917 DLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFF 961
+ F + T + + R + ++ + + A ++
Sbjct: 293 QMTFKTKCNTPAMKQ--IKRKI-QEFHRTMLNFSSATDLLCQHSL 334
|
Structure Templates Detected by HHsearch 
Original result of HHsearch against PDB70 database
No hit with probability above 80.00
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST 
Original result of RPS-BLAST against SCOP70(version1.75) database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| 1005 | ||||
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 3e-79 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 2e-71 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 4e-69 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 2e-68 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 7e-68 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 4e-67 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 1e-66 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 2e-65 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 7e-65 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 4e-64 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 5e-63 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 5e-63 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 6e-63 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 1e-62 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 2e-62 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 2e-62 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 4e-62 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 5e-61 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 1e-60 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 2e-60 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 4e-58 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 6e-56 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 6e-53 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 1e-52 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 2e-52 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 1e-51 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 3e-51 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 4e-51 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 6e-51 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 3e-50 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 2e-49 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 1e-48 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 4e-48 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 9e-48 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 1e-47 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 1e-47 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 1e-47 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 2e-47 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 5e-47 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 6e-47 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 1e-46 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 3e-45 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 1e-44 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 2e-44 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 2e-44 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 6e-44 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 1e-43 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 2e-43 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 2e-43 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 3e-43 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 9e-43 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 2e-42 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 2e-42 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 3e-42 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 2e-40 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 3e-40 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 3e-40 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 9e-40 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 2e-39 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 9e-39 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 1e-35 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 1e-30 | |
| d1n9la_ | 109 | d.110.3.6 (A:) Putative blue light receptor, phot- | 2e-24 | |
| d1n9la_ | 109 | d.110.3.6 (A:) Putative blue light receptor, phot- | 2e-24 | |
| d1jnua_ | 104 | d.110.3.6 (A:) Photoreceptor phy3 flavin-binding d | 5e-23 | |
| d1jnua_ | 104 | d.110.3.6 (A:) Photoreceptor phy3 flavin-binding d | 6e-21 | |
| d1bywa_ | 110 | d.110.3.6 (A:) Erg potassium channel, N-terminal d | 6e-16 | |
| d1bywa_ | 110 | d.110.3.6 (A:) Erg potassium channel, N-terminal d | 1e-12 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 3e-13 | |
| d1xj3a1 | 106 | d.110.3.2 (A:154-259) Histidine kinase FixL heme d | 1e-06 | |
| d1xj3a1 | 106 | d.110.3.2 (A:154-259) Histidine kinase FixL heme d | 1e-05 | |
| d1ew0a_ | 130 | d.110.3.2 (A:) Histidine kinase FixL heme domain { | 9e-06 | |
| d1ew0a_ | 130 | d.110.3.2 (A:) Histidine kinase FixL heme domain { | 4e-05 | |
| d1ll8a_ | 114 | d.110.3.5 (A:) N-terminal PAS domain of Pas kinase | 9e-05 | |
| d1p97a_ | 114 | d.110.3.7 (A:) Hypoxia-inducible factor Hif2a, C-t | 4e-04 | |
| d1p97a_ | 114 | d.110.3.7 (A:) Hypoxia-inducible factor Hif2a, C-t | 0.001 | |
| d1mzua_ | 110 | d.110.3.1 (A:) PYP domain of sensor histidine kina | 0.001 |
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 258 bits (659), Expect = 3e-79
Identities = 102/309 (33%), Positives = 150/309 (48%), Gaps = 31/309 (10%)
Query: 673 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHP 732
F+ K LG G +V L + + +A+K ++K ++ NKV ER+++ LDHP
Sbjct: 9 DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 68
Query: 733 FVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHC 792
F LY +FQ + Y GEL + + E RFY AE+V ALEYLH
Sbjct: 69 FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKI--GSFDETCTRFYTAEIVSALEYLHG 126
Query: 793 QGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMA 852
+GII+RDLKPEN+LL + H+ +TDF + + S +
Sbjct: 127 KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPE------------------------- 161
Query: 853 EPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFAN 912
+NSFVGT +Y++PE++ + D WALG ++Y+++ G PFR F
Sbjct: 162 SKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQK 221
Query: 913 ILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHE--GANEIKKHPFFKGVNWALVR 970
I+ + FP A+ L+ +LL D RLG E G +K HPFF+ V W +
Sbjct: 222 IIKLEYDFPEK--FFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENLH 279
Query: 971 CMNPPELDA 979
PP+L A
Sbjct: 280 QQTPPKLTA 288
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 235 bits (601), Expect = 2e-71
Identities = 88/293 (30%), Positives = 124/293 (42%), Gaps = 37/293 (12%)
Query: 671 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLD 730
L+ F +PLG G G+V+L S A+K + K + H+ E EI L
Sbjct: 5 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR 64
Query: 731 HPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYL 790
HP + LY F T V LI +Y P G ++ L + E Y E+ AL Y
Sbjct: 65 HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKL--SKFDEQRTATYITELANALSYC 122
Query: 791 HCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVF 850
H + +I+RD+KPEN+LL G + + DF S
Sbjct: 123 HSKRVIHRDIKPENLLLGSAGELKIADFGWSVHA-------------------------- 156
Query: 851 MAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTF 910
P + GT +Y+ PE+I G H VD W+LG+L YE L G PF T Q+T+
Sbjct: 157 ---PSSRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETY 213
Query: 911 ANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKG 963
I + FP A+ L+ RLL +P R E+ +HP+
Sbjct: 214 KRISRVEFTFPDFVTEG--ARDLISRLLKHNPSQRP----MLREVLEHPWITA 260
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 231 bits (590), Expect = 4e-69
Identities = 105/349 (30%), Positives = 173/349 (49%), Gaps = 48/349 (13%)
Query: 671 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDM-L 729
++ F K LG G G V L E + Q+FA+KA+ K V+L + V E+ +L +
Sbjct: 1 IEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAW 60
Query: 730 DHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEY 789
+HPF+ ++ +FQTK ++ + +Y GG+L + FYAAE+++ L++
Sbjct: 61 EHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSC--HKFDLSRATFYAAEIILGLQF 118
Query: 790 LHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPV 849
LH +GI+YRDLK +N+LL +GH+ + DF +
Sbjct: 119 LHSKGIVYRDLKLDNILLDKDGHIKIADFGMCK--------------------------- 151
Query: 850 FMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKT 909
+N+F GT +YIAPEI+ G + +VDWW+ G+LLYEML G +PF G+ ++
Sbjct: 152 ENMLGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEEL 211
Query: 910 FANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVNWALV 969
F +I + +P AK L+ +L R+P+ RLG +I++HP F+ +NW +
Sbjct: 212 FHSIRMDNPFYPRWLEKE--AKDLLVKLFVREPEKRLGV---RGDIRQHPLFREINWEEL 266
Query: 970 --RCMNPP-------ELDAPLFATDTEKEYKVVDPG----MQDLQQNVF 1005
+ ++PP D F + E + + + QN+F
Sbjct: 267 ERKEIDPPFRPKVKSPFDCSNFDKEFLNEKPRLSFADRALINSMDQNMF 315
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 229 bits (584), Expect = 2e-68
Identities = 120/346 (34%), Positives = 176/346 (50%), Gaps = 46/346 (13%)
Query: 671 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLD 730
LQ F+ ++ LG+G G VHL+ +G+Y+AMK + K +++ +V ER +L ++
Sbjct: 3 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVT 62
Query: 731 HPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYL 790
HPF+ ++ +FQ + +I DY GGELF LL + +FYAAEV +ALEYL
Sbjct: 63 HPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRF--PNPVAKFYAAEVCLALEYL 120
Query: 791 HCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVF 850
H + IIYRDLKPEN+LL NGH+ +TDF +
Sbjct: 121 HSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVT---------------------- 158
Query: 851 MAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTF 910
+ GT +YIAPE+++ + ++DWW+ GIL+YEML GYTPF KT+
Sbjct: 159 --------YTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTY 210
Query: 911 ANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGS-HEGANEIKKHPFFKGVNWA-- 967
IL+ +L+FP K L+ RL+ RD RLG+ G ++K HP+FK V W
Sbjct: 211 EKILNAELRFPPFFNED--VKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVVWEKL 268
Query: 968 LVRCMNPP--------ELDAPLFATDTEKEYKVVDPGMQDLQQNVF 1005
L R + P + D F E++ G D ++F
Sbjct: 269 LSRNIETPYEPPIQQGQGDTSQFDKYPEEDINYGVQGE-DPYADLF 313
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 228 bits (582), Expect = 7e-68
Identities = 113/347 (32%), Positives = 173/347 (49%), Gaps = 41/347 (11%)
Query: 669 INLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDM 728
+ + F +K LG G G V LV +G+Y+AMK + K V++ +++V E +L
Sbjct: 2 VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQN 61
Query: 729 LDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALE 788
HPF+ AL +FQT +C + +Y GGELF L R+ E+ RFY AE+V ALE
Sbjct: 62 TRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERV--FTEERARFYGAEIVSALE 119
Query: 789 YLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNP 848
YLH + ++YRD+K EN++L +GH+ +TDF L
Sbjct: 120 YLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCK-------------------------- 153
Query: 849 VFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQK 908
+F GT EY+APE++ + AVDWW LG+++YEM+ G PF + ++
Sbjct: 154 -EGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER 212
Query: 909 TFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHE-GANEIKKHPFFKGVNWA 967
F IL ++++FP + AK L+ LL +DPK RLG A E+ +H FF +NW
Sbjct: 213 LFELILMEEIRFPRTLSPE--AKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQ 270
Query: 968 LV--RCMNPP-------ELDAPLFATDTEKEYKVVDPGMQDLQQNVF 1005
V + + PP E+D F + + + P + +
Sbjct: 271 DVVQKKLLPPFKPQVTSEVDTRYFDDEFTAQSITITPPDRYDSLGLL 317
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 226 bits (578), Expect = 4e-67
Identities = 76/322 (23%), Positives = 134/322 (41%), Gaps = 40/322 (12%)
Query: 671 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLD 730
L H+ + LG+G G VH V +G FA K + ++ V + E + + +L
Sbjct: 25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRK---EIQTMSVLR 81
Query: 731 HPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYL 790
HP + L+ +F+ + +I ++ GGELF + + K + ED Y +V L ++
Sbjct: 82 HPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNK-MSEDEAVEYMRQVCKGLCHM 140
Query: 791 HCQGIIYRDLKPENVLL--QGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNP 848
H ++ DLKPEN++ + + + L DF L+
Sbjct: 141 HENNYVHLDLKPENIMFTTKRSNELKLIDFGLTA-------------------------- 174
Query: 849 VFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQK 908
+P ++ GT E+ APE+ G D W++G+L Y +L G +PF G+ +
Sbjct: 175 --HLDPKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDE 232
Query: 909 TFANILHKDLKFPSSTPTSL--HAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVNW 966
T N+ D S + + K + +LL DP +R+ ++ +HP+ N
Sbjct: 233 TLRNVKSCDWNMDDSAFSGISEDGKDFIRKLLLADPNTRM----TIHQALEHPWLTPGNA 288
Query: 967 ALVRCMNPPELDAPLFATDTEK 988
P + + K
Sbjct: 289 PGRDSQIPSSRYTKIRDSIKTK 310
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 225 bits (575), Expect = 1e-66
Identities = 78/312 (25%), Positives = 136/312 (43%), Gaps = 40/312 (12%)
Query: 671 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLD 730
++ ++ LGSG G VH +G+ F K ++ L++ V E I++ L
Sbjct: 28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKN---EISIMNQLH 84
Query: 731 HPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYL 790
HP + L+ +F+ K + LI ++ GGELF + + K + E V Y + L+++
Sbjct: 85 HPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYK-MSEAEVINYMRQACEGLKHM 143
Query: 791 HCQGIIYRDLKPENVLL--QGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNP 848
H I++ D+KPEN++ + V + DF L+ +
Sbjct: 144 HEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLN----------------------- 180
Query: 849 VFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQK 908
P T E+ APEI+ D WA+G+L Y +L G +PF G+ +
Sbjct: 181 -----PDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLE 235
Query: 909 TFANILHKDLKFPSSTPTSL--HAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVNW 966
T N+ D +F +S+ AK + LL ++P+ RL ++ +HP+ KG +
Sbjct: 236 TLQNVKRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRL----TVHDALEHPWLKGDHS 291
Query: 967 ALVRCMNPPELD 978
L + +
Sbjct: 292 NLTSRIPSSRYN 303
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 219 bits (560), Expect = 2e-65
Identities = 64/297 (21%), Positives = 118/297 (39%), Gaps = 41/297 (13%)
Query: 673 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHP 732
+ I LG G G V+ + + A K +D + ++ E +IL DHP
Sbjct: 13 FWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTK---SEEELEDYMVEIDILASCDHP 69
Query: 733 FVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHC 792
+ L +F + ++ ++ ++C GG + ++ + L E ++ + + AL YLH
Sbjct: 70 NIVKLLDAFYYENNLWILIEFCAGGAVDAVMLEL-ERPLTESQIQVVCKQTLDALNYLHD 128
Query: 793 QGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMA 852
II+RDLK N+L +G + L DF +S
Sbjct: 129 NKIIHRDLKAGNILFTLDGDIKLADFGVSA---------------------------KNT 161
Query: 853 EPMRASNSFVGTEEYIAPEIIAG-----AGHTSAVDWWALGILLYEMLYGYTPFRGKTRQ 907
++ +SF+GT ++APE++ + D W+LGI L EM P
Sbjct: 162 RTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPM 221
Query: 908 KTFANILHKD-LKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKG 963
+ I + + S + K + + L ++ +R +++ +HPF
Sbjct: 222 RVLLKIAKSEPPTLAQPSRWSSNFKDFLKKCLEKNVDARW----TTSQLLQHPFVTV 274
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 221 bits (563), Expect = 7e-65
Identities = 103/356 (28%), Positives = 167/356 (46%), Gaps = 54/356 (15%)
Query: 669 INLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDM 728
+ + F + +G G G V+ +G+ +AMK +DK + + A ER +L +
Sbjct: 1 LTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSL 60
Query: 729 L---DHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVV 785
+ D PF+ + +F T + I D GG+L L + E +RFYAAE+++
Sbjct: 61 VSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVF--SEADMRFYAAEIIL 118
Query: 786 ALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQ 845
LE++H + ++YRDLKP N+LL +GHV ++D L+C S K
Sbjct: 119 GLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK----------------- 161
Query: 846 QNPVFMAEPMRASNSFVGTEEYIAPEIIA-GAGHTSAVDWWALGILLYEMLYGYTPFRGK 904
++ VGT Y+APE++ G + S+ DW++LG +L+++L G++PFR
Sbjct: 162 ------------PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQH 209
Query: 905 TRQKTFANILHKDLKFPSSTPTSL--HAKQLMYRLLHRDPKSRLGS-HEGANEIKKHPFF 961
+ I L P S + L+ LL RD RLG GA E+K+ PFF
Sbjct: 210 KTKDKH-EIDRMTLTMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFF 268
Query: 962 KGVNWALV--RCMNPP------------ELDAPLFATDTEKEYKVVDPGMQDLQQN 1003
+ ++W +V + PP D F + K K++D Q+L +N
Sbjct: 269 RSLDWQMVFLQKYPPPLIPPRGEVNAADAFDIGSFDEEDTKGIKLLDS-DQELYRN 323
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 217 bits (553), Expect = 4e-64
Identities = 67/294 (22%), Positives = 106/294 (36%), Gaps = 40/294 (13%)
Query: 672 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDH 731
+ F ++ +G G G+V+ + + A+K M + K E L L H
Sbjct: 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRH 74
Query: 732 PFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLH 791
P + + L+ +YC G LL + K L+E + + L YLH
Sbjct: 75 PNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHK--KPLQEVEIAAVTHGALQGLAYLH 132
Query: 792 CQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFM 851
+I+RD+K N+LL G V L DF + +
Sbjct: 133 SHNMIHRDVKAGNILLSEPGLVKLGDFGSASI---------------------------- 164
Query: 852 AEPMRASNSFVGTEEYIAPEIIAGAGH---TSAVDWWALGILLYEMLYGYTPFRGKTRQK 908
M +NSFVGT ++APE+I VD W+LGI E+ P
Sbjct: 165 ---MAPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS 221
Query: 909 TFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFK 962
+I + S S + + + L + P+ R + + KH F
Sbjct: 222 ALYHIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRP----TSEVLLKHRFVL 271
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 213 bits (542), Expect = 5e-63
Identities = 79/306 (25%), Positives = 125/306 (40%), Gaps = 49/306 (16%)
Query: 672 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNK------VHRACAEREI 725
+++ P + LG G + V + + +A+K +D + + E +I
Sbjct: 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 62
Query: 726 LDML-DHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVV 784
L + HP + L +++T T L+ D GELF L + T L E R ++
Sbjct: 63 LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVT--LSEKETRKIMRALL 120
Query: 785 VALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKG 844
+ LH I++RDLKPEN+LL + ++ LTDF SC
Sbjct: 121 EVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQ--------------------- 159
Query: 845 QQNPVFMAEPMRASNSFVGTEEYIAPEIIAGA------GHTSAVDWWALGILLYEMLYGY 898
+P GT Y+APEII + G+ VD W+ G+++Y +L G
Sbjct: 160 -------LDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGS 212
Query: 899 TPFRGKTRQKTFANILHKDLKFPSSTPTSL--HAKQLMYRLLHRDPKSRLGSHEGANEIK 956
PF + + I+ + +F S K L+ R L P+ R A E
Sbjct: 213 PPFWHRKQMLMLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRY----TAEEAL 268
Query: 957 KHPFFK 962
HPFF+
Sbjct: 269 AHPFFQ 274
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 214 bits (546), Expect = 5e-63
Identities = 122/325 (37%), Positives = 176/325 (54%), Gaps = 38/325 (11%)
Query: 661 KILDSGEQINLQHFRPIKPLGSGDTGSVHLVELC---GSGQYFAMKAMDKGVMLNRNK-V 716
+ E++ +++F +K LG+G G V LV +G+ +AMK + K ++ + K
Sbjct: 13 NLTGHAEKVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTT 72
Query: 717 HRACAEREILDMLDH-PFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDA 775
ER++L+ + PF+ L+ +FQT+T + LI DY GGELF L ++ E
Sbjct: 73 EHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRER--FTEHE 130
Query: 776 VRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTT 835
V+ Y E+V+ALE+LH GIIYRD+K EN+LL NGHV LTDF LS
Sbjct: 131 VQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSK------------- 177
Query: 836 NEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAG--AGHTSAVDWWALGILLYE 893
F+A+ + F GT EY+AP+I+ G +GH AVDWW+LG+L+YE
Sbjct: 178 -------------EFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYE 224
Query: 894 MLYGYTPFRGKTRQKTFANILHKDLKFPSSTPT--SLHAKQLMYRLLHRDPKSRLGS-HE 950
+L G +PF + + A I + LK P S AK L+ RLL +DPK RLG
Sbjct: 225 LLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPR 284
Query: 951 GANEIKKHPFFKGVNWALVRCMNPP 975
A+EIK+H FF+ +NW + P
Sbjct: 285 DADEIKEHLFFQKINWDDLAAKKVP 309
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 213 bits (544), Expect = 6e-63
Identities = 82/316 (25%), Positives = 134/316 (42%), Gaps = 49/316 (15%)
Query: 656 WKAIQKILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNK 715
WK + I D + LG+G V L E + + A+K + K + K
Sbjct: 1 WKQAEDIRD--------IYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKAL--EGK 50
Query: 716 VHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDA 775
E +L + HP + AL +++ H+ LI GGELF + + E
Sbjct: 51 EGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEK--GFYTERD 108
Query: 776 VRFYAAEVVVALEYLHCQGIIYRDLKPENVLL---QGNGHVSLTDFDLSCLTSCKPQLLL 832
+V+ A++YLH GI++RDLKPEN+L + + ++DF LS +
Sbjct: 109 ASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMED------- 161
Query: 833 PTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLY 892
P ++ GT Y+APE++A ++ AVD W++G++ Y
Sbjct: 162 ---------------------PGSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAY 200
Query: 893 EMLYGYTPFRGKTRQKTFANILHKDLKFPSSTPTSL--HAKQLMYRLLHRDPKSRLGSHE 950
+L GY PF + K F IL + +F S + AK + L+ +DP+ R
Sbjct: 201 ILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAKDFIRHLMEKDPEKRF---- 256
Query: 951 GANEIKKHPFFKGVNW 966
+ +HP+ G
Sbjct: 257 TCEQALQHPWIAGDTA 272
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 213 bits (543), Expect = 1e-62
Identities = 67/345 (19%), Positives = 120/345 (34%), Gaps = 80/345 (23%)
Query: 668 QINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILD 727
++ F I LG+G+ G V V SG A K + + ++ E ++L
Sbjct: 2 ELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLE--IKPAIRNQIIRELQVLH 59
Query: 728 MLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVAL 787
+ P++ Y +F + + + ++ GG L +L + + E + + V+ L
Sbjct: 60 ECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKA--GRIPEQILGKVSIAVIKGL 117
Query: 788 EYLH-CQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQ 846
YL I++RD+KP N+L+ G + L DF +S
Sbjct: 118 TYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL---------------------- 155
Query: 847 NPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTR 906
+NSFVGT Y++PE + G ++ D W++G+ L EM G P
Sbjct: 156 -------IDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDA 208
Query: 907 QKTFANILHKDLKFPSSTPT---------------------------------------- 926
++ + + TP
Sbjct: 209 KELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSG 268
Query: 927 --SLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVNWALV 969
SL + + + L ++P R ++ H F K + V
Sbjct: 269 VFSLEFQDFVNKCLIKNPAERA----DLKQLMVHAFIKRSDAEEV 309
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 211 bits (537), Expect = 2e-62
Identities = 68/294 (23%), Positives = 123/294 (41%), Gaps = 35/294 (11%)
Query: 671 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLD 730
++ + ++ LG G G V L + + A+K +D ++ + E I ML+
Sbjct: 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPE--NIKKEICINKMLN 61
Query: 731 HPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYL 790
H V Y + L +YC GGELF ++ + E + + +++ + YL
Sbjct: 62 HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPD--IGMPEPDAQRFFHQLMAGVVYL 119
Query: 791 HCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVF 850
H GI +RD+KPEN+LL ++ ++DF L+ + +
Sbjct: 120 HGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR--------------------- 158
Query: 851 MAEPMRASNSFVGTEEYIAPEIIAGAG-HTSAVDWWALGILLYEMLYGYTPFRGKTRQ-K 908
R N GT Y+APE++ H VD W+ GI+L ML G P+ + +
Sbjct: 159 ----ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ 214
Query: 909 TFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFK 962
+++ K L++++L +P +R+ +IKK ++
Sbjct: 215 EYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARI----TIPDIKKDRWYN 264
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 211 bits (539), Expect = 2e-62
Identities = 63/294 (21%), Positives = 117/294 (39%), Gaps = 42/294 (14%)
Query: 672 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDH 731
+ + + +G G +G+V+ +GQ A++ M+ + + E ++ +
Sbjct: 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIIN---EILVMRENKN 76
Query: 732 PFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLH 791
P + S+ + ++ +Y GG L ++ E + E + ALE+LH
Sbjct: 77 PNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMD---EGQIAAVCRECLQALEFLH 133
Query: 792 CQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFM 851
+I+RD+K +N+LL +G V LTDF +
Sbjct: 134 SNQVIHRDIKSDNILLGMDGSVKLTDFGFCA---------------------------QI 166
Query: 852 AEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFA 911
++ VGT ++APE++ + VD W+LGI+ EM+ G P+ + +
Sbjct: 167 TPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALY 226
Query: 912 NILHK---DLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFK 962
I +L+ P + + R L D + R A E+ +H F K
Sbjct: 227 LIATNGTPELQNPEKLSAI--FRDFLNRCLDMDVEKRG----SAKELLQHQFLK 274
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 213 bits (542), Expect = 4e-62
Identities = 107/334 (32%), Positives = 159/334 (47%), Gaps = 44/334 (13%)
Query: 668 QINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILD 727
L F IK LG+G G V LV+ SG ++AMK +DK ++ ++ E+ IL
Sbjct: 37 TAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQ 96
Query: 728 MLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVAL 787
++ PF+ L SF+ +++ ++ +Y GGE+F L R E RFYAA++V+
Sbjct: 97 AVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRI--GRFSEPHARFYAAQIVLTF 154
Query: 788 EYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQN 847
EYLH +IYRDLKPEN+L+ G++ +TDF +
Sbjct: 155 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK------------------------- 189
Query: 848 PVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQ 907
+ + GT E +APEII G+ AVDWWALG+L+YEM GY PF
Sbjct: 190 -----RVKGRTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI 244
Query: 908 KTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGS-HEGANEIKKHPFFKGVNW 966
+ + I+ ++FPS + K L+ LL D R G+ G N+IK H +F +W
Sbjct: 245 QIYEKIVSGKVRFPSHFSSD--LKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDW 302
Query: 967 ALV--RCMNPP-------ELDAPLFATDTEKEYK 991
+ R + P D F E+E +
Sbjct: 303 IAIYQRKVEAPFIPKFKGPGDTSNFDDYEEEEIR 336
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 208 bits (529), Expect = 5e-61
Identities = 87/317 (27%), Positives = 139/317 (43%), Gaps = 45/317 (14%)
Query: 673 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVML-NRNKVHRACAERE--ILDML 729
++ + LGSG V +G +A K + K +R V R ERE IL +
Sbjct: 11 YYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEI 70
Query: 730 DHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEY 789
HP V L+ ++ KT V LI + GGELF L + + L E+ + +++ + Y
Sbjct: 71 QHPNVITLHEVYENKTDVILILELVAGGELFDFLAEK--ESLTEEEATEFLKQILNGVYY 128
Query: 790 LHCQGIIYRDLKPENVLLQGNG----HVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQ 845
LH I + DLKPEN++L + + DF L+
Sbjct: 129 LHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH----------------------- 165
Query: 846 QNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKT 905
+ + GT E++APEI+ D W++G++ Y +L G +PF G T
Sbjct: 166 -----KIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDT 220
Query: 906 RQKTFANILHKDLKFPSSTP--TSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKG 963
+Q+T AN+ + +F TS AK + RLL +DPK R+ + +HP+ K
Sbjct: 221 KQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRM----TIQDSLQHPWIKP 276
Query: 964 VNW--ALVRCMNPPELD 978
+ AL + P+ +
Sbjct: 277 KDTQQALSSAWSHPQFE 293
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 205 bits (524), Expect = 1e-60
Identities = 66/296 (22%), Positives = 120/296 (40%), Gaps = 42/296 (14%)
Query: 674 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPF 733
+ + +G+G G + G+ K +D G M + +E +L L HP
Sbjct: 6 YEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSM-TEAEKQMLVSEVNLLRELKHPN 64
Query: 734 VPALYASF--QTKTHVCLITDYCPGGELFLLLDR--QPTKVLKEDAVRFYAAEVVVALEY 789
+ Y +T T + ++ +YC GG+L ++ + + + L E+ V ++ +AL+
Sbjct: 65 IVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKE 124
Query: 790 LHCQG-----IIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKG 844
H + +++RDLKP NV L G +V L DF L+
Sbjct: 125 CHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR---------------------- 162
Query: 845 QQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGK 904
+ + +FVGT Y++PE + + D W+LG LLYE+ PF
Sbjct: 163 -----ILNHDTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAF 217
Query: 905 TRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPF 960
++++ I + S +++ R+L+ R EI ++P
Sbjct: 218 SQKELAGKIREGKFRRIPYR-YSDELNEIITRMLNLKDYHRP----SVEEILENPL 268
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 207 bits (527), Expect = 2e-60
Identities = 67/294 (22%), Positives = 121/294 (41%), Gaps = 41/294 (13%)
Query: 673 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHP 732
+ + LG G+ G VH S + + K + E IL++ H
Sbjct: 6 KYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKV----KGTDQVLVKKEISILNIARHR 61
Query: 733 FVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHC 792
+ L+ SF++ + +I ++ G ++F ++ + L E + Y +V AL++LH
Sbjct: 62 NILHLHESFESMEELVMIFEFISGLDIFERINTSAFE-LNEREIVSYVHQVCEALQFLHS 120
Query: 793 QGIIYRDLKPENVLLQ--GNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVF 850
I + D++PEN++ Q + + + +F +
Sbjct: 121 HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNF-------------------- 160
Query: 851 MAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTF 910
EY APE+ ++A D W+LG L+Y +L G PF +T Q+
Sbjct: 161 --------RLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQII 212
Query: 911 ANILHKDLKFPSSTPT--SLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFK 962
NI++ + F S+ A + RLL ++ KSR+ A+E +HP+ K
Sbjct: 213 ENIMNAEYTFDEEAFKEISIEAMDFVDRLLVKERKSRM----TASEALQHPWLK 262
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 199 bits (506), Expect = 4e-58
Identities = 60/305 (19%), Positives = 119/305 (39%), Gaps = 45/305 (14%)
Query: 666 GEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREI 725
G + + + +G G +V+ + A + L +++ R E E+
Sbjct: 3 GMSNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDR-KLTKSERQRFKEEAEM 61
Query: 726 LDMLDHPFVPALYASFQT----KTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAA 781
L L HP + Y S+++ K + L+T+ G L L R KV+K +R +
Sbjct: 62 LKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRF--KVMKIKVLRSWCR 119
Query: 782 EVVVALEYLHCQG--IIYRDLKPENVLLQG-NGHVSLTDFDLSCLTSCKPQLLLPTTNEK 838
+++ L++LH + II+RDLK +N+ + G G V + D L+ L
Sbjct: 120 QILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL--------------- 164
Query: 839 KRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGY 898
+ + + +GT E++APE+ + +VD +A G+ + EM
Sbjct: 165 --------------KRASFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSE 209
Query: 899 TPFRGK-TRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKK 957
P+ + + + K+++ + ++ R ++
Sbjct: 210 YPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERY----SIKDLLN 265
Query: 958 HPFFK 962
H FF+
Sbjct: 266 HAFFQ 270
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 193 bits (490), Expect = 6e-56
Identities = 58/282 (20%), Positives = 115/282 (40%), Gaps = 32/282 (11%)
Query: 673 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHP 732
+ + LG G VHL + A+K + + + + R E + L+HP
Sbjct: 8 RYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHP 67
Query: 733 FVPALYASFQTKTH----VCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALE 788
+ A+Y + + +T ++ +Y G L ++ + + A+ AL
Sbjct: 68 AIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTE--GPMTPKRAIEVIADACQALN 125
Query: 789 YLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNP 848
+ H GII+RD+KP N+++ V + DF ++ +
Sbjct: 126 FSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGN------------------- 166
Query: 849 VFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQK 908
+ + + +GT +Y++PE G + D ++LG +LYE+L G PF G +
Sbjct: 167 -----SVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVS 221
Query: 909 TFANILHKDLKFPSSTPTSL--HAKQLMYRLLHRDPKSRLGS 948
+ +D PS+ L ++ + L ++P++R +
Sbjct: 222 VAYQHVREDPIPPSARHEGLSADLDAVVLKALAKNPENRYQT 263
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (468), Expect = 6e-53
Identities = 57/284 (20%), Positives = 106/284 (37%), Gaps = 38/284 (13%)
Query: 669 INLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDM 728
I + +GSG G+V+ + G A+K ++ ++ E +L
Sbjct: 5 IPDGQITVGQRIGSGSFGTVYKGKWHGD---VAVKMLNVTAP-TPQQLQAFKNEVGVLRK 60
Query: 729 LDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALE 788
H + + T + ++T +C G L+ L TK + + A + ++
Sbjct: 61 TRHVNILLFMG-YSTAPQLAIVTQWCEGSSLYHHLHIIETK-FEMIKLIDIARQTAQGMD 118
Query: 789 YLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNP 848
YLH + II+RDLK N+ L + V + DF L+ + S
Sbjct: 119 YLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKS----------------------- 155
Query: 849 VFMAEPMRASNSFVGTEEYIAPEIIAGAG---HTSAVDWWALGILLYEMLYGYTPFRGKT 905
G+ ++APE+I ++ D +A GI+LYE++ G P+
Sbjct: 156 --RWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNIN 213
Query: 906 RQKTFANILHKDLKFPSSTPTSLH----AKQLMYRLLHRDPKSR 945
+ ++ + P + + K+LM L + R
Sbjct: 214 NRDQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDER 257
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 183 bits (465), Expect = 1e-52
Identities = 66/299 (22%), Positives = 109/299 (36%), Gaps = 49/299 (16%)
Query: 673 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVH---RACAEREILDML 729
++ LGSG GSV+ A+K ++K + + ++ R E +L +
Sbjct: 5 QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 64
Query: 730 D--HPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVAL 787
V L F+ LI + + + L+E+ R + +V+ A+
Sbjct: 65 SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITER-GALQEELARSFFWQVLEAV 123
Query: 788 EYLHCQGIIYRDLKPENVLLQGN-GHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQ 846
+ H G+++RD+K EN+L+ N G + L DF L
Sbjct: 124 RHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY----------------- 166
Query: 847 NPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTS-AVDWWALGILLYEMLYGYTPFRGKT 905
F GT Y PE I + + W+LGILLY+M+ G PF
Sbjct: 167 ------------TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE 214
Query: 906 RQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGV 964
I+ + F + + L+ L P R EI+ HP+ + V
Sbjct: 215 ------EIIRGQVFFRQRVSSE--CQHLIRWCLALRPSDRP----TFEEIQNHPWMQDV 261
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 185 bits (470), Expect = 2e-52
Identities = 61/299 (20%), Positives = 109/299 (36%), Gaps = 54/299 (18%)
Query: 678 KPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREIL-DMLDHPFVPA 736
+ LG G G V + + + FA+K + R E E+ P +
Sbjct: 18 QVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARR--------EVELHWRASQCPHIVR 69
Query: 737 LYASFQT----KTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHC 792
+ ++ + + ++ + GGELF + + + E + A++YLH
Sbjct: 70 IVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS 129
Query: 793 QGIIYRDLKPENVLL---QGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPV 849
I +RD+KPEN+L + N + LTDF +
Sbjct: 130 INIAHRDVKPENLLYTSKRPNAILKLTDFGFAK--------------------------- 162
Query: 850 FMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKT 909
+ + T Y+APE++ + + D W+LG+++Y +L GY PF
Sbjct: 163 -ETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI 221
Query: 910 FANILHK------DLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFK 962
+ + + P + S K L+ LL +P R+ E HP+
Sbjct: 222 SPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRM----TITEFMNHPWIM 276
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 180 bits (458), Expect = 1e-51
Identities = 59/293 (20%), Positives = 110/293 (37%), Gaps = 35/293 (11%)
Query: 678 KPLGSGDTGSVHLVELC--GSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVP 735
K LGSG+ G+V + A+K + + AE ++ LD+P++
Sbjct: 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAN-DPALKDELLAEANVMQQLDNPYIV 71
Query: 736 ALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGI 795
+ + ++ L+ + G L L + +K+ + +V + ++YL
Sbjct: 72 RMIGICEAESW-MLVMEMAELGPLNKYLQQNRH--VKDKNIIELVHQVSMGMKYLEESNF 128
Query: 796 IYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPM 855
++RDL NVLL + ++DF LS
Sbjct: 129 VHRDLAARNVLLVTQHYAKISDFGLSKALRADEN------------------------YY 164
Query: 856 RASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEML-YGYTPFRGKTRQKTFANIL 914
+A ++ APE I +S D W+ G+L++E YG P+RG + A +
Sbjct: 165 KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLE 224
Query: 915 H-KDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVNW 966
+ + P+ P + LM D ++R G ++ ++ VN
Sbjct: 225 KGERMGCPAGCPREM--YDLMNLCWTYDVENRPGFAA-VELRLRNYYYDVVNE 274
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 179 bits (455), Expect = 3e-51
Identities = 59/281 (20%), Positives = 93/281 (33%), Gaps = 30/281 (10%)
Query: 669 INLQHFRPIKPLGSGDTGSVHLVELC---GSGQYFAMKAMDKGVMLNRNKVHRACAEREI 725
I + R ++ LG G G V E G A+K + V+ + E
Sbjct: 5 IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNA 64
Query: 726 LDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVV 785
+ LDH + LY T + ++T+ P G L L + + YA +V
Sbjct: 65 MHSLDHRNLIRLYGVVLTP-PMKMVTELAPLGSLLDRLRKHQGH-FLLGTLSRYAVQVAE 122
Query: 786 ALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQ 845
+ YL + I+RDL N+LL V + DF L
Sbjct: 123 GMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQN------------------ 164
Query: 846 QNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEML-YGYTPFRGK 904
+ + APE + + A D W G+ L+EM YG P+ G
Sbjct: 165 ------DDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGL 218
Query: 905 TRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSR 945
+ I + + P +M + P+ R
Sbjct: 219 NGSQILHKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDR 259
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 178 bits (453), Expect = 4e-51
Identities = 60/298 (20%), Positives = 110/298 (36%), Gaps = 43/298 (14%)
Query: 666 GEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREI 725
G +N++ + ++ +G G+ G V L + G A+K + AE +
Sbjct: 1 GWALNMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKN-----DATAQAFLAEASV 53
Query: 726 LDMLDHPFVPALYASF-QTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVV 784
+ L H + L + K + ++T+Y G L L + VL D + ++ +V
Sbjct: 54 MTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVC 113
Query: 785 VALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKG 844
A+EYL ++RDL NVL+ + ++DF L+ S
Sbjct: 114 EAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST----------------- 156
Query: 845 QQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEML-YGYTPFRG 903
++ ++ APE + ++ D W+ GILL+E+ +G P+
Sbjct: 157 -------------QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPR 203
Query: 904 KTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGAN---EIKKH 958
+ + K K + ++M H D R + IK H
Sbjct: 204 IPLKDVVPRVE-KGYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTH 260
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 179 bits (454), Expect = 6e-51
Identities = 74/327 (22%), Positives = 111/327 (33%), Gaps = 62/327 (18%)
Query: 677 IKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAERE--ILDMLDHPFV 734
+ LG G +V+ + Q A+K + G A RE +L L HP +
Sbjct: 3 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNI 62
Query: 735 PALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQG 794
L +F K+++ L+ D+ ++ D VL ++ Y + LEYLH
Sbjct: 63 IGLLDAFGHKSNISLVFDFMETDLEVIIKDNS--LVLTPSHIKAYMLMTLQGLEYLHQHW 120
Query: 795 IIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEP 854
I++RDLKP N+LL NG + L DF L+ P
Sbjct: 121 ILHRDLKPNNLLLDENGVLKLADFGLAK---------------------------SFGSP 153
Query: 855 MRASNSFVGTEEYIAPEIIAGA-GHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANI 913
RA V T Y APE++ GA + VD WA+G +L E+L G + I
Sbjct: 154 NRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRI 213
Query: 914 LHKDLKFPSST--------------------------PTSLHAKQLMYRLLHRDPKSRLG 947
L+ L +P +R+
Sbjct: 214 FETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARI- 272
Query: 948 SHEGANEIKKHPFFKGVNWALVRCMNP 974
A + K +F C P
Sbjct: 273 ---TATQALKMKYFSNRPGPTPGCQLP 296
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 176 bits (446), Expect = 3e-50
Identities = 60/278 (21%), Positives = 105/278 (37%), Gaps = 34/278 (12%)
Query: 669 INLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDM 728
I+ + +K LG+G G V + G A+K + +G M E +++
Sbjct: 1 IDPKDLTFLKELGTGQFGVVKYGKWRG-QYDVAIKMIKEGSMSED----EFIEEAKVMMN 55
Query: 729 LDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALE 788
L H + LY + + +IT+Y G L L + + + +V A+E
Sbjct: 56 LSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHR-FQTQQLLEMCKDVCEAME 114
Query: 789 YLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNP 848
YL + ++RDL N L+ G V ++DF LS
Sbjct: 115 YLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRY------------------------- 149
Query: 849 VFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEML-YGYTPFRGKTRQ 907
+ + +S + PE++ + +S D WA G+L++E+ G P+ T
Sbjct: 150 -VLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNS 208
Query: 908 KTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSR 945
+T +I + L+ S +MY H R
Sbjct: 209 ETAEHIA-QGLRLYRPHLASEKVYTIMYSCWHEKADER 245
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 174 bits (443), Expect = 2e-49
Identities = 58/287 (20%), Positives = 103/287 (35%), Gaps = 35/287 (12%)
Query: 680 LGSGDTGSVHLVELC--GSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPAL 737
LG G+ GSV A+K + +G + E +I+ LD+P++ L
Sbjct: 17 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT--EKADTEEMMREAQIMHQLDNPYIVRL 74
Query: 738 YASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIY 797
Q + + L+ + GG L L + + V +V + ++YL + ++
Sbjct: 75 IGVCQAE-ALMLVMEMAGGGPLHKFL-VGKREEIPVSNVAELLHQVSMGMKYLEEKNFVH 132
Query: 798 RDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRA 857
RDL NVLL + ++DF LS +
Sbjct: 133 RDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARS---------------------- 170
Query: 858 SNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEML-YGYTPFRGKTRQKTFANILH- 915
+ ++ APE I +S D W+ G+ ++E L YG P++ + A I
Sbjct: 171 --AGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQG 228
Query: 916 KDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFK 962
K ++ P P L LM + R + + ++
Sbjct: 229 KRMECPPECPPEL--YALMSDCWIYKWEDRPDFLT-VEQRMRACYYS 272
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 172 bits (437), Expect = 1e-48
Identities = 69/323 (21%), Positives = 118/323 (36%), Gaps = 61/323 (18%)
Query: 671 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLD 730
+++F+ ++ +G G G V+ +G+ A+K + A E +L L+
Sbjct: 1 MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE-TEGVPSTAIREISLLKELN 59
Query: 731 HPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYL 790
HP + L T+ + L+ ++ L +D + ++ Y +++ L +
Sbjct: 60 HPNIVKLLDVIHTENKLYLVFEFLHQD-LKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 118
Query: 791 HCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVF 850
H +++RDLKP+N+L+ G + L DF L+
Sbjct: 119 HSHRVLHRDLKPQNLLINTEGAIKLADFGLAR---------------------------A 151
Query: 851 MAEPMRASNSFVGTEEYIAPEIIAGAGHTS-AVDWWALGILLYEMLYGYTPFRGKTRQKT 909
P+R V T Y APEI+ G + S AVD W+LG + EM+ F G +
Sbjct: 152 FGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQ 211
Query: 910 FANILHKDLKFPSST---------------------------PTSLHAKQLMYRLLHRDP 942
I P + L+ ++LH DP
Sbjct: 212 LFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDP 271
Query: 943 KSRLGSHEGANEIKKHPFFKGVN 965
R+ A HPFF+ V
Sbjct: 272 NKRI----SAKAALAHPFFQDVT 290
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 171 bits (434), Expect = 4e-48
Identities = 64/300 (21%), Positives = 111/300 (37%), Gaps = 33/300 (11%)
Query: 667 EQINLQHFRPIKPLGSGDTGSVHLVELCGSGQ---YFAMKAMDKGVMLNRNKVHRACAER 723
++I++ + + +G+G+ G V L G+ + A+K + G + +E
Sbjct: 21 KEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY--TEKQRRDFLSEA 78
Query: 724 EILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEV 783
I+ DHP V L T V +IT++ G L RQ + +
Sbjct: 79 SIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSF-LRQNDGQFTVIQLVGMLRGI 137
Query: 784 VVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHK 843
++YL ++RDL N+L+ N ++DF LS
Sbjct: 138 AAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSD------------- 184
Query: 844 GQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEML-YGYTPFR 902
++ + APE I TSA D W+ GI+++E++ YG P+
Sbjct: 185 ---------PTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYW 235
Query: 903 GKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGAN---EIKKHP 959
T Q I +D + P QLM +D R + N ++ ++P
Sbjct: 236 DMTNQDVINAIE-QDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRNP 294
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 171 bits (435), Expect = 9e-48
Identities = 79/351 (22%), Positives = 130/351 (37%), Gaps = 76/351 (21%)
Query: 674 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPF 733
+ K +G+G G V+ +LC SG+ A+K + + E +I+ LDH
Sbjct: 22 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR-------ELQIMRKLDHCN 74
Query: 734 VPALYASFQT------KTHVCLITDYCPGGELFLLLDR-QPTKVLKEDAVRFYAAEVVVA 786
+ L F + + ++ L+ DY P + + + L V+ Y ++ +
Sbjct: 75 IVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRS 134
Query: 787 LEYLHCQGIIYRDLKPENVLLQGNGHVS-LTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQ 845
L Y+H GI +RD+KP+N+LL + V L DF +
Sbjct: 135 LAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV-------------------- 174
Query: 846 QNPVFMAEPMRASNSFVGTEEYIAP-EIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGK 904
+ S++ + Y AP I +TS++D W+ G +L E+L G F G
Sbjct: 175 --------RGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGD 226
Query: 905 TRQKTFANIL-----------------HKDLKFPSSTP----------TSLHAKQLMYRL 937
+ I+ + + KFP T A L RL
Sbjct: 227 SGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRL 286
Query: 938 LHRDPKSRLGSHEGANEIKKHPFFKGVNWALVRCMNPPELDAPLFATDTEK 988
L P +RL E H FF + V+ N + LF T++
Sbjct: 287 LEYTPTARL----TPLEACAHSFFDELRDPNVKLPNGRDTP-ALFNFTTQE 332
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 169 bits (429), Expect = 1e-47
Identities = 69/319 (21%), Positives = 118/319 (36%), Gaps = 55/319 (17%)
Query: 647 KPHRKDSPPWKAIQKILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMD 706
KP +D W ++ + + ++ LG+G G V + G A+K++
Sbjct: 1 KPWWEDE--W-----------EVPRETLKLVERLGAGQFGEVWMGYYNG-HTKVAVKSLK 46
Query: 707 KGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQ 766
+G M AE ++ L H + LYA T+ + +IT+Y G L L
Sbjct: 47 QGSM----SPDAFLAEANLMKQLQHQRLVRLYA-VVTQEPIYIITEYMENGSLVDFLKTP 101
Query: 767 PTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSC 826
L + + AA++ + ++ + I+RDL+ N+L+ + DF L+ L
Sbjct: 102 SGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARL--- 158
Query: 827 KPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWA 886
A ++ APE I T D W+
Sbjct: 159 -----------------------IEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWS 195
Query: 887 LGILLYEML-YGYTPFRGKTRQKTFANILH-KDLKFPSSTPTSLHAKQLMYRLLHRDPKS 944
GILL E++ +G P+ G T + N+ + P + P L QLM P+
Sbjct: 196 FGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEEL--YQLMRLCWKERPED 253
Query: 945 RLGSHEGANEIKK--HPFF 961
R + ++ FF
Sbjct: 254 RP----TFDYLRSVLEDFF 268
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 171 bits (433), Expect = 1e-47
Identities = 57/305 (18%), Positives = 104/305 (34%), Gaps = 55/305 (18%)
Query: 669 INLQHFRPIKPLGSGDTGSVHLVELCGSGQ-----YFAMKAMDKGVMLNRNKVHRACAER 723
++ K LGSG G V G + A+K + + + ++ +E
Sbjct: 34 FPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA--DSSEREALMSEL 91
Query: 724 EILDML-DHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTK------------- 769
+++ L H + L + + LI +YC G+L L + K
Sbjct: 92 KMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKR 151
Query: 770 --------VLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLS 821
VL + + +A +V +E+L + ++RDL NVL+ V + DF L+
Sbjct: 152 LEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLA 211
Query: 822 CLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSA 881
++ +++APE + +T
Sbjct: 212 RDIMSDSNYVVRGN-------------------------ARLPVKWMAPESLFEGIYTIK 246
Query: 882 VDWWALGILLYEML-YGYTPFRGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHR 940
D W+ GILL+E+ G P+ G F ++ K + +M
Sbjct: 247 SDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAF 306
Query: 941 DPKSR 945
D + R
Sbjct: 307 DSRKR 311
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 170 bits (431), Expect = 1e-47
Identities = 68/329 (20%), Positives = 122/329 (37%), Gaps = 68/329 (20%)
Query: 672 QHFRPIKPLGSGDTGSVHLV-ELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDML- 729
Q + + +G G G V +L G++ A+K + E +L L
Sbjct: 7 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTG-EEGMPLSTIREVAVLRHLE 65
Query: 730 --DHPFVPALYASFQT-----KTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAE 782
+HP V L+ +T + L+ ++ L D+ P + + ++ +
Sbjct: 66 TFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYL-DKVPEPGVPTETIKDMMFQ 124
Query: 783 VVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRH 842
++ L++LH +++RDLKP+N+L+ +G + L DF L+ + S
Sbjct: 125 LLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYS----------------- 167
Query: 843 KGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFR 902
A S V T Y APE++ + + + VD W++G + EM FR
Sbjct: 168 -----------FQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFR 216
Query: 903 GKTRQKTFANILH-----------KDLKFPSS--------------TPTSLHAKQLMYRL 937
G + IL +D+ P T K L+ +
Sbjct: 217 GSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKC 276
Query: 938 LHRDPKSRLGSHEGANEIKKHPFFKGVNW 966
L +P R+ A HP+F+ +
Sbjct: 277 LTFNPAKRI----SAYSALSHPYFQDLER 301
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 169 bits (428), Expect = 2e-47
Identities = 54/278 (19%), Positives = 93/278 (33%), Gaps = 30/278 (10%)
Query: 668 QINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILD 727
++ LG G G V+ A+K + + + +V E ++
Sbjct: 13 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE----DTMEVEEFLKEAAVMK 68
Query: 728 MLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVAL 787
+ HP + L + +IT++ G L L + + + + A ++ A+
Sbjct: 69 EIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAM 128
Query: 788 EYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQN 847
EYL + I+RDL N L+ N V + DF LS L
Sbjct: 129 EYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRL------------------------ 164
Query: 848 PVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQ 907
+ A ++ APE +A + D WA G+LL+E+
Sbjct: 165 --MTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL 222
Query: 908 KTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSR 945
+L KD + +LM +P R
Sbjct: 223 SQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDR 260
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 167 bits (423), Expect = 5e-47
Identities = 51/277 (18%), Positives = 102/277 (36%), Gaps = 32/277 (11%)
Query: 669 INLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDM 728
I+ ++ +GSG G VHL + A+K + +G M + + E E++
Sbjct: 2 IDPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEEDFIE----EAEVMMK 56
Query: 729 LDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALE 788
L HP + LY + +CL+ ++ G L R + + + +V +
Sbjct: 57 LSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDY-LRTQRGLFAAETLLGMCLDVCEGMA 115
Query: 789 YLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNP 848
YL +I+RDL N L+ N + ++DF ++
Sbjct: 116 YLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRF------------------------- 150
Query: 849 VFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQK 908
+ + +S ++ +PE+ + + ++S D W+ G+L++E+
Sbjct: 151 -VLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS 209
Query: 909 TFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSR 945
+ + S H Q+M P+ R
Sbjct: 210 EVVEDISTGFRLYKPRLASTHVYQIMNHCWKERPEDR 246
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (426), Expect = 6e-47
Identities = 65/329 (19%), Positives = 105/329 (31%), Gaps = 69/329 (20%)
Query: 673 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHP 732
+ + +G G G V +GQ A+K + A E +IL +L H
Sbjct: 11 KYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLME-NEKEGFPITALREIKILQLLKHE 69
Query: 733 FVPALYASFQTKT--------HVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVV 784
V L +TK + L+ D+C LL + ++ ++
Sbjct: 70 NVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVL--VKFTLSEIKRVMQMLL 127
Query: 785 VALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKG 844
L Y+H I++RD+K NVL+ +G + L DF L+ S
Sbjct: 128 NGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKN--------------- 172
Query: 845 QQNPVFMAEPMRASNSFVGTEEYIAPEIIAGA-GHTSAVDWWALGILLYEMLYGYTPFRG 903
+ V T Y PE++ G + +D W G ++ EM +G
Sbjct: 173 --------SQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQG 224
Query: 904 KTRQKTFANILHKDLKFPSSTP------------------------------TSLHAKQL 933
T Q A I +A L
Sbjct: 225 NTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDL 284
Query: 934 MYRLLHRDPKSRLGSHEGANEIKKHPFFK 962
+ +LL DP R+ +++ H FF
Sbjct: 285 IDKLLVLDPAQRI----DSDDALNHDFFW 309
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (422), Expect = 1e-46
Identities = 59/297 (19%), Positives = 106/297 (35%), Gaps = 40/297 (13%)
Query: 669 INLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDM 728
I + R LG G G V + G+ + A+K + G M E +++
Sbjct: 14 IPRESLRLEVKLGQGCFGEVWMGTWNGTTRV-AIKTLKPGTMSPE----AFLQEAQVMKK 68
Query: 729 LDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALE 788
L H + LYA ++ + ++T+Y G L L + K L+ + AA++ +
Sbjct: 69 LRHEKLVQLYA-VVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMA 127
Query: 789 YLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNP 848
Y+ ++RDL+ N+L+ N + DF L+ L
Sbjct: 128 YVERMNYVHRDLRAANILVGENLVCKVADFGLARL------------------------- 162
Query: 849 VFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEML-YGYTPFRGKTRQ 907
A ++ APE T D W+ GILL E+ G P+ G +
Sbjct: 163 -IEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR 221
Query: 908 KTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKK--HPFFK 962
+ + + + P LM + ++P+ R ++ +F
Sbjct: 222 EVLDQVE-RGYRMPCPPECPESLHDLMCQCWRKEPEERP----TFEYLQAFLEDYFT 273
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 162 bits (411), Expect = 3e-45
Identities = 60/320 (18%), Positives = 117/320 (36%), Gaps = 63/320 (19%)
Query: 671 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLD 730
++ + ++ +G G G V+ + G+ FA+K + + E IL L
Sbjct: 1 MEKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLE-KEDEGIPSTTIREISILKELK 58
Query: 731 HPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYL 790
H + LY TK + L+ ++ LL + L+ + + +++ + Y
Sbjct: 59 HSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCE--GGLESVTAKSFLLQLLNGIAYC 116
Query: 791 HCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVF 850
H + +++RDLKP+N+L+ G + + DF L+
Sbjct: 117 HDRRVLHRDLKPQNLLINREGELKIADFGLAR---------------------------A 149
Query: 851 MAEPMRASNSFVGTEEYIAPEIIAGAG-HTSAVDWWALGILLYEMLYGYTPFRGKTRQKT 909
P+R + T Y AP+++ G+ +++ +D W++G + EM+ G F G +
Sbjct: 150 FGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQ 209
Query: 910 FANILHKDLKFPSSTP---------------------------TSLHAKQLMYRLLHRDP 942
I S L+ ++L DP
Sbjct: 210 LMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDP 269
Query: 943 KSRLGSHEGANEIKKHPFFK 962
R+ A + +H +FK
Sbjct: 270 NQRI----TAKQALEHAYFK 285
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 163 bits (412), Expect = 1e-44
Identities = 66/351 (18%), Positives = 120/351 (34%), Gaps = 67/351 (19%)
Query: 673 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHP 732
+ + +G G G V + A+K + ++ R E +IL H
Sbjct: 9 RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISP--FEHQTYCQRTLREIKILLRFRHE 66
Query: 733 FVPALYASFQTKTHV----CLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALE 788
+ + + T + + G +L+ LL Q L D + ++ +++ L+
Sbjct: 67 NIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQH---LSNDHICYFLYQILRGLK 123
Query: 789 YLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNP 848
Y+H +++RDLKP N+LL + + DF L+ +
Sbjct: 124 YIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDH-------------------- 163
Query: 849 VFMAEPMRASNSFVGTEEYIAPEIIA-GAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQ 907
+ +V T Y APEI+ G+T ++D W++G +L EML F GK
Sbjct: 164 ----DHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYL 219
Query: 908 KTFANIL--------------------HKDLKFPSSTPTSLH---------AKQLMYRLL 938
+IL + L P + A L+ ++L
Sbjct: 220 DQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKML 279
Query: 939 HRDPKSRLGSHEGANEIKKHPFFKGVNWALVRCMNPPELDAPLFATDTEKE 989
+P R+ + HP+ + + + D KE
Sbjct: 280 TFNPHKRI----EVEQALAHPYLEQYYDPSDEPIAEAPFKFDMELDDLPKE 326
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 161 bits (409), Expect = 2e-44
Identities = 69/367 (18%), Positives = 125/367 (34%), Gaps = 87/367 (23%)
Query: 641 SKVVHPKPHRKDSPPWKAIQKILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYF 700
++V + W +++ G N ++ ++ LG G V + +
Sbjct: 7 ARVYTDVNTHRPREYWDYESHVVEWG---NQDDYQLVRKLGRGKYSEVFEAINITNNEKV 63
Query: 701 AMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPALYASFQTKTH--VCLITDYCPGG 757
+K + K + E +IL+ L P + L + L+ ++
Sbjct: 64 VVKILKP------VKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNT 117
Query: 758 ELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQG-NGHVSLT 816
+ L L + +RFY E++ AL+Y H GI++RD+KP NV++ + + L
Sbjct: 118 DFKQLYQT-----LTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLI 172
Query: 817 DFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGA 876
D+ L+ P + N V + + PE++
Sbjct: 173 DWGLAE----------------------------FYHPGQEYNVRVASRYFKGPELLVDY 204
Query: 877 -GHTSAVDWWALGILLYEMLYGYTPFR-GKTRQKTFANI-----------------LHKD 917
+ ++D W+LG +L M++ PF G I + D
Sbjct: 205 QMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELD 264
Query: 918 LKFPSSTPT------------------SLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHP 959
+F S A + +LL D +SRL A E +HP
Sbjct: 265 PRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLT----AREAMEHP 320
Query: 960 FFKGVNW 966
+F V
Sbjct: 321 YFYTVVK 327
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (404), Expect = 2e-44
Identities = 58/321 (18%), Positives = 116/321 (36%), Gaps = 63/321 (19%)
Query: 671 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLD 730
+Q + ++ +G G G+V + + + A+K + + A E +L L
Sbjct: 1 MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD-DEGVPSSALREICLLKELK 59
Query: 731 HPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYL 790
H + L+ + + L+ ++C L + V+ + +++ L +
Sbjct: 60 HKNIVRLHDVLHSDKKLTLVFEFCDQDLKKY--FDSCNGDLDPEIVKSFLFQLLKGLGFC 117
Query: 791 HCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVF 850
H + +++RDLKP+N+L+ NG + L +F L+
Sbjct: 118 HSRNVLHRDLKPQNLLINRNGELKLANFGLARA--------------------------- 150
Query: 851 MAEPMRASNSFVGTEEYIAPEIIAGAG-HTSAVDWWALGILLYEMLYGYTP-FRGKTRQK 908
P+R ++ V T Y P+++ GA +++++D W+ G + E+ P F G
Sbjct: 151 FGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDD 210
Query: 909 TFANILHKDLKFPSSTPTSLH---------------------------AKQLMYRLLHRD 941
I S+ + L+ LL +
Sbjct: 211 QLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCN 270
Query: 942 PKSRLGSHEGANEIKKHPFFK 962
P R+ A E +HP+F
Sbjct: 271 PVQRI----SAEEALQHPYFS 287
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (403), Expect = 6e-44
Identities = 54/294 (18%), Positives = 99/294 (33%), Gaps = 45/294 (15%)
Query: 668 QINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILD 727
++ + +G G+ G V + G +++ E E+L
Sbjct: 6 VLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLC 65
Query: 728 ML-DHPFVPALYASFQTKTHVCLITDYCPGGELFLLL--------------DRQPTKVLK 772
L HP + L + + + ++ L +Y P G L L L
Sbjct: 66 KLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLS 125
Query: 773 EDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLL 832
+ +AA+V ++YL + I+RDL N+L+ N + DF LS
Sbjct: 126 SQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLS----------- 174
Query: 833 PTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLY 892
E ++A E + + +T+ D W+ G+LL+
Sbjct: 175 -----------------RGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLW 217
Query: 893 EML-YGYTPFRGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSR 945
E++ G TP+ G T + + + + + LM + P R
Sbjct: 218 EIVSLGGTPYCGMTCAELYEKLP-QGYRLEKPLNCDDEVYDLMRQCWREKPYER 270
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 158 bits (400), Expect = 1e-43
Identities = 57/307 (18%), Positives = 102/307 (33%), Gaps = 58/307 (18%)
Query: 668 QINLQHFRPIKPLGSGDTGSVHLVELCG-----SGQYFAMKAMDKGVMLNRNKVHRACAE 722
+ + ++ +G G G V G A+K + + + + E
Sbjct: 9 EYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQRE 66
Query: 723 REILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQ---------------- 766
++ D+P + L +CL+ +Y G+L L
Sbjct: 67 AALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTR 126
Query: 767 ------PTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDL 820
L A +V + YL + ++RDL N L+ N V + DF L
Sbjct: 127 ARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGL 186
Query: 821 SCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTS 880
S ++ A+ +A + ++ PE I +T+
Sbjct: 187 SRN-------------------------IYSADYYKADGNDAIPIRWMPPESIFYNRYTT 221
Query: 881 AVDWWALGILLYEML-YGYTPFRGKTRQKTFANILHKD-LKFPSSTPTSLHAKQLMYRLL 938
D WA G++L+E+ YG P+ G ++ + + L P + P L LM
Sbjct: 222 ESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYYVRDGNILACPENCPLEL--YNLMRLCW 279
Query: 939 HRDPKSR 945
+ P R
Sbjct: 280 SKLPADR 286
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 157 bits (398), Expect = 2e-43
Identities = 49/300 (16%), Positives = 100/300 (33%), Gaps = 38/300 (12%)
Query: 673 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHP 732
+R + +GSG G ++L +G+ A+K + + K + E +I M+
Sbjct: 8 RYRLGRKIGSGSFGDIYLGTDIAAGEEVAIK-----LECVKTKHPQLHIESKIYKMMQGG 62
Query: 733 -FVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLH 791
+P + + ++ + L ++ V A +++ +EY+H
Sbjct: 63 VGIPTIRWCGAEGDYNVMVMELLGPSLEDL--FNFCSRKFSLKTVLLLADQMISRIEYIH 120
Query: 792 CQGIIYRDLKPENVLLQ---GNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNP 848
+ I+RD+KP+N L+ V + DF L+ K +
Sbjct: 121 SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK--------------------KYRDAR 160
Query: 849 VFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQK 908
P R + + GT Y + G + D +LG +L G P++G
Sbjct: 161 THQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAAT 220
Query: 909 TFANILHKDLKFPSSTPTSLH------AKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFK 962
K S+ L + + + ++ ++ F +
Sbjct: 221 KRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKP-DYSYLRQLFRNLFHR 279
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 158 bits (399), Expect = 2e-43
Identities = 57/309 (18%), Positives = 101/309 (32%), Gaps = 50/309 (16%)
Query: 660 QKILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCG-----SGQYFAMKAMDKGVMLNRN 714
Q D + K LG+G G V G + A+K + +
Sbjct: 11 QLPYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA--HLT 68
Query: 715 KVHRACAEREILDML-DHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQ------- 766
+ +E ++L L +H + L + +IT+YC G+L L R+
Sbjct: 69 EREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICS 128
Query: 767 ---------PTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTD 817
L + + ++ +V + +L + I+RDL N+LL + D
Sbjct: 129 KTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICD 188
Query: 818 FDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAG 877
F L+ + +++APE I
Sbjct: 189 FGLARDIKND-------------------------SNYVVKGNARLPVKWMAPESIFNCV 223
Query: 878 HTSAVDWWALGILLYEML-YGYTPFRGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYR 936
+T D W+ GI L+E+ G +P+ G F ++ + + S +M
Sbjct: 224 YTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKT 283
Query: 937 LLHRDPKSR 945
DP R
Sbjct: 284 CWDADPLKR 292
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 158 bits (399), Expect = 3e-43
Identities = 75/345 (21%), Positives = 128/345 (37%), Gaps = 42/345 (12%)
Query: 658 AIQKILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNK-- 715
A+ +IL E F+ IK LGSG G+V+ G+ + K + +
Sbjct: 1 ALLRILKETE------FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA 54
Query: 716 VHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDA 775
E ++ +D+P V L T T LIT P G L + +
Sbjct: 55 NKEILDEAYVMASVDNPHVCRLLGICLTSTV-QLITQLMPFGCLLDYVREHKDNI-GSQY 112
Query: 776 VRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTT 835
+ + ++ + YL + +++RDL NVL++ HV +TDF L+ L +
Sbjct: 113 LLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE-------- 164
Query: 836 NEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEML 895
E + +++A E I +T D W+ G+ ++E++
Sbjct: 165 -----------------EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELM 207
Query: 896 -YGYTPFRGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANE 954
+G P+ G + +IL K + P ++ +M + D SR E E
Sbjct: 208 TFGSKPYDGIPASEIS-SILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIE 266
Query: 955 ---IKKHPFFKGVNWALVRCMNPPELDAPLFA--TDTEKEYKVVD 994
+ + P V R P D+ + D E VVD
Sbjct: 267 FSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVD 311
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (392), Expect = 9e-43
Identities = 68/295 (23%), Positives = 107/295 (36%), Gaps = 41/295 (13%)
Query: 669 INLQHFRPIKPLGSGDTGSVHLVELC---GSGQYFAMKAMDKGVMLNRNKVHRACAEREI 725
I + + +G G G VH A+K + + + E
Sbjct: 4 IQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKN--CTSDSVREKFLQEALT 61
Query: 726 LDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVV 785
+ DHP + L T+ V +I + C GEL L + L ++ YA ++
Sbjct: 62 MRQFDHPHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKYS-LDLASLILYAYQLST 119
Query: 786 ALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQ 845
AL YL + ++RD+ NVL+ N V L DF LS
Sbjct: 120 ALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYME-------------------- 159
Query: 846 QNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEML-YGYTPFRGK 904
++ +++APE I TSA D W G+ ++E+L +G PF+G
Sbjct: 160 ------DSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGV 213
Query: 905 TRQKTFANILHKD-LKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKH 958
I + + L P + P +L LM + DP R E+K
Sbjct: 214 KNNDVIGRIENGERLPMPPNCPPTL--YSLMTKCWAYDPSRRP----RFTELKAQ 262
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (396), Expect = 2e-42
Identities = 71/328 (21%), Positives = 120/328 (36%), Gaps = 67/328 (20%)
Query: 672 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDH 731
+R ++P+GSG G+V +G A+K + + + RA E +L + H
Sbjct: 18 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQ-SELFAKRAYRELRLLKHMRH 76
Query: 732 PFVPALYASFQTKTHVCLITDYCPGGEL--FLLLDRQPTKVLKEDAVRFYAAEVVVALEY 789
V L F + TD+ L + L ED ++F +++ L Y
Sbjct: 77 ENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRY 136
Query: 790 LHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPV 849
+H GII+RDLKP N+ + + + + DF L+ +
Sbjct: 137 IHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSE---------------------- 174
Query: 850 FMAEPMRASNSFVGTEEYIAPEIIAGAG-HTSAVDWWALGILLYEMLYGYTPFRGKTRQK 908
+V T Y APE+I +T VD W++G ++ EM+ G T F+G
Sbjct: 175 --------MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLD 226
Query: 909 TFANILHKDLKFPSSTP-----------------------------TSLHAKQLMYRLLH 939
I+ P+ S A L+ ++L
Sbjct: 227 QLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLV 286
Query: 940 RDPKSRLGSHEGANEIKKHPFFKGVNWA 967
D + R+ A E HP+F+ ++
Sbjct: 287 LDAEQRV----TAGEALAHPYFESLHDT 310
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 154 bits (390), Expect = 2e-42
Identities = 49/285 (17%), Positives = 92/285 (32%), Gaps = 39/285 (13%)
Query: 673 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDH- 731
H++ + +G G G + + Q A+K + R+ + E +L
Sbjct: 6 HYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPR-----RSDAPQLRDEYRTYKLLAGC 60
Query: 732 PFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLH 791
+P +Y Q H L+ D LL + V A +++ ++ +H
Sbjct: 61 TGIPNVYYFGQEGLHNVLVIDLLGPSLEDLL--DLCGRKFSVKTVAMAAKQMLARVQSIH 118
Query: 792 CQGIIYRDLKPENVLL-----QGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQ 846
+ ++YRD+KP+N L+ + + + DF +
Sbjct: 119 EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYR--------------------D 158
Query: 847 NPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTR 906
P R + GT Y++ G + D ALG + L G P++G
Sbjct: 159 PVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKA 218
Query: 907 QKTFANILHKDLKFPSSTPTSLHA------KQLMYRLLHRDPKSR 945
K S+ L A + M+ + +
Sbjct: 219 ATNKQKYERIGEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDAT 263
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (394), Expect = 3e-42
Identities = 69/369 (18%), Positives = 135/369 (36%), Gaps = 86/369 (23%)
Query: 671 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLD 730
L+ ++ +KP+GSG G V + A+K + + N+ RA E ++ ++
Sbjct: 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQ-NQTHAKRAYRELVLMKCVN 74
Query: 731 HPFVPALYASFQTK------THVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVV 784
H + +L F + V L+ + ++ + + + +++
Sbjct: 75 HKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELD-----HERMSYLLYQML 129
Query: 785 VALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKG 844
+++LH GII+RDLKP N++++ + + + DF L+ +
Sbjct: 130 CGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM-------------- 175
Query: 845 QQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGK 904
+V T Y APE+I G G+ VD W++G ++ EM+ F G+
Sbjct: 176 --------------TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGR 221
Query: 905 TRQKTFANIL---------------------------HKDLKFPSSTPTSLH-------- 929
+ ++ + L FP P SL
Sbjct: 222 DYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNK 281
Query: 930 -----AKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVNWALVRCMNPPELDAPLF-- 982
A+ L+ ++L DP R+ ++ +HP+ PP++
Sbjct: 282 LKASQARDLLSKMLVIDPAKRI----SVDDALQHPYINVWYDPAEVEAPPPQIYDKQLDE 337
Query: 983 ATDTEKEYK 991
T +E+K
Sbjct: 338 REHTIEEWK 346
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (376), Expect = 2e-40
Identities = 60/301 (19%), Positives = 105/301 (34%), Gaps = 53/301 (17%)
Query: 669 INLQHFRPIKPLGSGDTGSVHLVELCG-------SGQYFAMKAMDKGVMLNRNKVHRACA 721
+ KPLG G G V L E G A+K + + +
Sbjct: 10 LPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA--TEKDLSDLIS 67
Query: 722 EREILDML-DHPFVPALYASFQTKTHVCLITDYCPGGELFLLL--------------DRQ 766
E E++ M+ H + L + + +I +Y G L L
Sbjct: 68 EMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHN 127
Query: 767 PTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSC 826
P + L + A +V +EYL + I+RDL NVL+ + + + DF L+
Sbjct: 128 PEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIH- 186
Query: 827 KPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWA 886
+ + + + +++APE + +T D W+
Sbjct: 187 ------------------------HIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWS 222
Query: 887 LGILLYEML-YGYTPFRGKTRQKTFANILHKD-LKFPSSTPTSLHAKQLMYRLLHRDPKS 944
G+LL+E+ G +P+ G ++ F + + PS+ L +M H P
Sbjct: 223 FGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHRMDKPSNCTNEL--YMMMRDCWHAVPSQ 280
Query: 945 R 945
R
Sbjct: 281 R 281
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (375), Expect = 3e-40
Identities = 51/314 (16%), Positives = 105/314 (33%), Gaps = 46/314 (14%)
Query: 669 INLQHFRPIKPLGSGDTGSVHLVELCG-----SGQYFAMKAMDKGVMLNRNKVHRACAER 723
+ + + LG G G V+ G A+K +++ + E
Sbjct: 17 VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERI--EFLNEA 74
Query: 724 EILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLL--------DRQPTKVLKEDA 775
++ + V L +I + G+L L +
Sbjct: 75 SVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSK 134
Query: 776 VRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTT 835
+ A E+ + YL+ ++RDL N ++ + V +
Sbjct: 135 MIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIG------------------- 175
Query: 836 NEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEML 895
G ++ + R + +++PE + T+ D W+ G++L+E+
Sbjct: 176 ------DFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIA 229
Query: 896 -YGYTPFRGKTRQKTFANILHKD-LKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGAN 953
P++G + ++ ++ L P + P L +LM +PK R E +
Sbjct: 230 TLAEQPYQGLSNEQVLRFVMEGGLLDKPDNCPDML--FELMRMCWQYNPKMRPSFLEIIS 287
Query: 954 EIKK--HPFFKGVN 965
IK+ P F+ V+
Sbjct: 288 SIKEEMEPGFREVS 301
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (373), Expect = 3e-40
Identities = 51/282 (18%), Positives = 95/282 (33%), Gaps = 31/282 (10%)
Query: 668 QINLQHFRPIKPLGSGDTGSVHLVELCGSGQ----YFAMKAMDKGVMLNRNKVHRACAER 723
+I+ K +G+G+ G V+ L S A+K + G + E
Sbjct: 3 EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAG--YTEKQRVDFLGEA 60
Query: 724 EILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEV 783
I+ H + L + +IT+Y G R+ + +
Sbjct: 61 GIMGQFSHHNIIRLEGVISKYKPMMIITEYMENG-ALDKFLREKDGEFSVLQLVGMLRGI 119
Query: 784 VVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHK 843
++YL ++RDL N+L+ N ++DF LS + P+ T+
Sbjct: 120 AAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTS-------- 171
Query: 844 GQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRG 903
+ APE I+ TSA D W+ GI+++E++
Sbjct: 172 ----------------GGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYW 215
Query: 904 KTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSR 945
+ ++ + P+ QLM + ++ R
Sbjct: 216 ELSNHEVMKAINDGFRLPTPMDCPSAIYQLMMQCWQQERARR 257
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (371), Expect = 9e-40
Identities = 62/313 (19%), Positives = 114/313 (36%), Gaps = 53/313 (16%)
Query: 668 QINLQHFRPIKPLGSGDTGSVHLVELCG-----SGQYFAMKAMDKGVMLNRNKVHRACAE 722
+ + KPLG G G V + G + + A+K + +G + ++ + E
Sbjct: 9 EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMS--E 66
Query: 723 REILDMLDHPF--VPALYASFQTKTHVCLITDYCPGGELFLLLDRQ-------------- 766
+IL + H V L A + + +I ++C G L L +
Sbjct: 67 LKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDL 126
Query: 767 PTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSC 826
L + + Y+ +V +E+L + I+RDL N+LL V + DF L+
Sbjct: 127 YKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARD--- 183
Query: 827 KPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWA 886
++ +++APE I +T D W+
Sbjct: 184 ----------------------IYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWS 221
Query: 887 LGILLYEMLYGY-TPFRGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSR 945
G+LL+E+ +P+ G + F L + + + T+ Q M H +P R
Sbjct: 222 FGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQR 281
Query: 946 LGSHEGANEIKKH 958
+E+ +H
Sbjct: 282 P----TFSELVEH 290
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (370), Expect = 2e-39
Identities = 57/308 (18%), Positives = 118/308 (38%), Gaps = 37/308 (12%)
Query: 644 VHPKPHRKDSPPWKAIQKILDSGEQINLQHFRPIKPLGSGDTGSVHLVELC---GSGQYF 700
VH + +A+Q ++ + + HF + +G G G V+ L G +
Sbjct: 2 VHIDLSALNPELVQAVQHVVIGPSSLIV-HFNEV--IGRGHFGCVYHGTLLDNDGKKIHC 58
Query: 701 AMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALY-ASFQTKTHVCLITDYCPGGEL 759
A+K++++ + + +V + E I+ HP V +L +++ ++ Y G+L
Sbjct: 59 AVKSLNR--ITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDL 116
Query: 760 FLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFD 819
+ + +D + F +V +++L + ++RDL N +L V + DF
Sbjct: 117 RNFIRNETHNPTVKDLIGF-GLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFG 175
Query: 820 LSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHT 879
L+ K + + +++A E + T
Sbjct: 176 LARDMYDK-----------------------EFDSVHNKTGAKLPVKWMALESLQTQKFT 212
Query: 880 SAVDWWALGILLYEML-YGYTPFRGKTRQKTFANILH-KDLKFPSSTPTSLHAKQLMYRL 937
+ D W+ G+LL+E++ G P+ +L + L P P L ++M +
Sbjct: 213 TKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPL--YEVMLKC 270
Query: 938 LHRDPKSR 945
H + R
Sbjct: 271 WHPKAEMR 278
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (367), Expect = 9e-39
Identities = 70/354 (19%), Positives = 122/354 (34%), Gaps = 73/354 (20%)
Query: 673 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHP 732
++ + P+GSG GSV +G A+K + + + R E +L + H
Sbjct: 19 RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ-SIIHAKRTYRELRLLKHMKHE 77
Query: 733 FVPALYASFQTKTHVC-----LITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVAL 787
V L F + + + G +L ++ Q L +D V+F +++ L
Sbjct: 78 NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK---LTDDHVQFLIYQILRGL 134
Query: 788 EYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQN 847
+Y+H II+RDLKP N+ + + + + DF L+ T +
Sbjct: 135 KYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM------------------- 175
Query: 848 PVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTS-AVDWWALGILLYEMLYGYTPFRGKTR 906
+V T Y APEI+ H + VD W++G ++ E+L G T F G
Sbjct: 176 -----------TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDH 224
Query: 907 QKTFANILHKDLKFPSSTP-----------------------------TSLHAKQLMYRL 937
IL + + A L+ ++
Sbjct: 225 IDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKM 284
Query: 938 LHRDPKSRLGSHEGANEIKKHPFFKGVNWALVRCMNPPELDAPLFATDTEKEYK 991
L D R+ A + H +F + + P + E+K
Sbjct: 285 LVLDSDKRI----TAAQALAHAYFAQYHDPDDEPVADPYDQSFESRDLLIDEWK 334
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (341), Expect = 1e-35
Identities = 57/309 (18%), Positives = 103/309 (33%), Gaps = 74/309 (23%)
Query: 678 KPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDM--LDHPFVP 735
+ +G G G V + G+ A+K + + + E EI L H +
Sbjct: 9 ESIGKGRFGEVWRGKW--RGEEVAVK------IFSSREERSWFREAEIYQTVMLRHENIL 60
Query: 736 ALYASFQ----TKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLH 791
A+ T T + L++DY G LF L+R + + + A L +LH
Sbjct: 61 GFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT---VTVEGMIKLALSTASGLAHLH 117
Query: 792 CQ--------GIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHK 843
+ I +RDLK +N+L++ NG + D L+ +
Sbjct: 118 MEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTI------------ 165
Query: 844 GQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGH------TSAVDWWALGILLYEMLYG 897
A N VGT+ Y+APE++ + + D +A+G++ +E+
Sbjct: 166 -----------DIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARR 214
Query: 898 YTPFRGKTRQKTFANILHK-----------------DLKFP---SSTPTSLHAKQLMYRL 937
+ + L P S ++M
Sbjct: 215 CSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMREC 274
Query: 938 LHRDPKSRL 946
+ + +RL
Sbjct: 275 WYANGAARL 283
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 122 bits (306), Expect = 1e-30
Identities = 57/357 (15%), Positives = 110/357 (30%), Gaps = 87/357 (24%)
Query: 666 GEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREI 725
GE + ++ LG G +V L + + + AMK + + + +
Sbjct: 7 GEPYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRV 66
Query: 726 -------LDMLDHPFVPALYASFQTKT---HVCLITDYCPGGELFLLLDRQPTKVLKEDA 775
D + + L F K ++ G L L+ + + +
Sbjct: 67 NDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIY 126
Query: 776 VRFYAAEVVVALEYLHCQ-GIIYRDLKPENVLLQGNGHVS-LTDFDLSCLTSCKPQLLLP 833
V+ + ++++ L+Y+H + GII+ D+KPENVL++ L ++ L +
Sbjct: 127 VKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNAC------ 180
Query: 834 TTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYE 893
+ + T EY +PE++ GA D W+ L++E
Sbjct: 181 -------------------WYDEHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFE 221
Query: 894 MLYGYTPFRGKTRQKTFANILH-------------------------------------- 915
++ G F + H
Sbjct: 222 LITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKL 281
Query: 916 --------KDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGV 964
K+ S + + +L DP+ R A + HP+ K
Sbjct: 282 KFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRA----DAGGLVNHPWLKDT 334
|
| >d1n9la_ d.110.3.6 (A:) Putative blue light receptor, phot-lov1 domain {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} Length = 109 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Profilin-like superfamily: PYP-like sensor domain (PAS domain) family: Flavin-binding PAS domain domain: Putative blue light receptor, phot-lov1 domain species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Score = 96.9 bits (240), Expect = 2e-24
Identities = 65/107 (60%), Positives = 86/107 (80%)
Query: 201 FQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKIRETL 260
+ TFVV+DAT PD P++YAS GF+ MTGY EV+G NCRFLQG GTDP++V KIR+ +
Sbjct: 2 LRHTFVVADATLPDCPLVYASEGFYAMTGYGPDEVLGHNCRFLQGEGTDPKEVQKIRDAI 61
Query: 261 QNGQSYCGRLLNYKKDGTPFWNLLTIAPIKDDEGKVLKFIGMQVEVS 307
+ G++ RLLNY+KDGTPFWNLLT+ PIK +G+V KF+G+QV+V+
Sbjct: 62 KKGEACSVRLLNYRKDGTPFWNLLTVTPIKTPDGRVSKFVGVQVDVT 108
|
| >d1n9la_ d.110.3.6 (A:) Putative blue light receptor, phot-lov1 domain {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} Length = 109 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Profilin-like superfamily: PYP-like sensor domain (PAS domain) family: Flavin-binding PAS domain domain: Putative blue light receptor, phot-lov1 domain species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Score = 96.9 bits (240), Expect = 2e-24
Identities = 49/105 (46%), Positives = 67/105 (63%)
Query: 484 IEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIRAAI 543
+ FV+ D LPD P+++AS+ F +T Y +E+LG NCRFLQG TDP V+KIR AI
Sbjct: 2 LRHTFVVADATLPDCPLVYASEGFYAMTGYGPDEVLGHNCRFLQGEGTDPKEVQKIRDAI 61
Query: 544 DNQTDVTVQLINYTKSGKKFWNLFHLQPMRDQKGEVQYFIGVQLD 588
+V+L+NY K G FWNL + P++ G V F+GVQ+D
Sbjct: 62 KKGEACSVRLLNYRKDGTPFWNLLTVTPIKTPDGRVSKFVGVQVD 106
|
| >d1jnua_ d.110.3.6 (A:) Photoreceptor phy3 flavin-binding domain, lov2 {Maidenhair fern (Adiantum capillus-veneris) [TaxId: 13818]} Length = 104 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Profilin-like superfamily: PYP-like sensor domain (PAS domain) family: Flavin-binding PAS domain domain: Photoreceptor phy3 flavin-binding domain, lov2 species: Maidenhair fern (Adiantum capillus-veneris) [TaxId: 13818]
Score = 92.3 bits (228), Expect = 5e-23
Identities = 75/103 (72%), Positives = 86/103 (83%)
Query: 486 KNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIRAAIDN 545
K+FVITDPRLPDNPIIFASD FLELTEY+REE+LG NCRFLQG TD V+ IR A+
Sbjct: 1 KSFVITDPRLPDNPIIFASDRFLELTEYTREEVLGNNCRFLQGRGTDRKAVQLIRDAVKE 60
Query: 546 QTDVTVQLINYTKSGKKFWNLFHLQPMRDQKGEVQYFIGVQLD 588
Q DVTVQ++NYTK G+ FWNLFHLQ MRD+ G+VQYFIGVQ +
Sbjct: 61 QRDVTVQVLNYTKGGRAFWNLFHLQVMRDENGDVQYFIGVQQE 103
|
| >d1jnua_ d.110.3.6 (A:) Photoreceptor phy3 flavin-binding domain, lov2 {Maidenhair fern (Adiantum capillus-veneris) [TaxId: 13818]} Length = 104 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Profilin-like superfamily: PYP-like sensor domain (PAS domain) family: Flavin-binding PAS domain domain: Photoreceptor phy3 flavin-binding domain, lov2 species: Maidenhair fern (Adiantum capillus-veneris) [TaxId: 13818]
Score = 86.5 bits (213), Expect = 6e-21
Identities = 46/104 (44%), Positives = 69/104 (66%)
Query: 203 QTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKIRETLQN 262
++FV++D PD PI++AS F ++T YT +EV+G NCRFLQG GTD + V IR+ ++
Sbjct: 1 KSFVITDPRLPDNPIIFASDRFLELTEYTREEVLGNNCRFLQGRGTDRKAVQLIRDAVKE 60
Query: 263 GQSYCGRLLNYKKDGTPFWNLLTIAPIKDDEGKVLKFIGMQVEV 306
+ ++LNY K G FWNL + ++D+ G V FIG+Q E+
Sbjct: 61 QRDVTVQVLNYTKGGRAFWNLFHLQVMRDENGDVQYFIGVQQEM 104
|
| >d1bywa_ d.110.3.6 (A:) Erg potassium channel, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 110 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Profilin-like superfamily: PYP-like sensor domain (PAS domain) family: Flavin-binding PAS domain domain: Erg potassium channel, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 72.4 bits (176), Expect = 6e-16
Identities = 33/108 (30%), Positives = 53/108 (49%), Gaps = 2/108 (1%)
Query: 486 KNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNC--RFLQGPETDPATVRKIRAAI 543
+ F+I + R+ + +I+ +D F EL YSR E++ R C FL GP T +I A+
Sbjct: 2 RKFIIANARVENCAVIYCNDGFCELCGYSRAEVMQRPCTCDFLHGPCTQRRAAAQIAQAL 61
Query: 544 DNQTDVTVQLINYTKSGKKFWNLFHLQPMRDQKGEVQYFIGVQLDGSE 591
+ V++ Y K G F L + P++++ G V FI E
Sbjct: 62 LGAEERKVEIAFYRKDGSCFLCLVDVVPVKNEDGAVIMFILNFEVVME 109
|
| >d1bywa_ d.110.3.6 (A:) Erg potassium channel, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 110 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Profilin-like superfamily: PYP-like sensor domain (PAS domain) family: Flavin-binding PAS domain domain: Erg potassium channel, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 63.6 bits (153), Expect = 1e-12
Identities = 31/107 (28%), Positives = 57/107 (53%), Gaps = 2/107 (1%)
Query: 203 QTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNC--RFLQGAGTDPEDVAKIRETL 260
+ F++++A + ++Y + GF ++ GY+ EV+ R C FL G T A+I + L
Sbjct: 2 RKFIIANARVENCAVIYCNDGFCELCGYSRAEVMQRPCTCDFLHGPCTQRRAAAQIAQAL 61
Query: 261 QNGQSYCGRLLNYKKDGTPFWNLLTIAPIKDDEGKVLKFIGMQVEVS 307
+ + Y+KDG+ F L+ + P+K+++G V+ FI V
Sbjct: 62 LGAEERKVEIAFYRKDGSCFLCLVDVVPVKNEDGAVIMFILNFEVVM 108
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 67.1 bits (163), Expect = 3e-13
Identities = 25/159 (15%), Positives = 46/159 (28%), Gaps = 30/159 (18%)
Query: 678 KPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRN-KVHRACAERE------------ 724
K +G G +V +K G + K R +
Sbjct: 6 KLMGEGKESAVFNCY-SEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNE 64
Query: 725 --ILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAE 782
L L VP +YA ++ + ++ +
Sbjct: 65 FRALQKLQGLAVPKVYAWEGN----AVLMELIDAK---------ELYRVRVENPDEVLDM 111
Query: 783 VVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLS 821
++ + + +GI++ DL NVL+ G + DF S
Sbjct: 112 ILEEVAKFYHRGIVHGDLSQYNVLVSEEGIW-IIDFPQS 149
|
| >d1xj3a1 d.110.3.2 (A:154-259) Histidine kinase FixL heme domain {Bradyrhizobium japonicum [TaxId: 375]} Length = 106 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Profilin-like superfamily: PYP-like sensor domain (PAS domain) family: Heme-binding PAS domain domain: Histidine kinase FixL heme domain species: Bradyrhizobium japonicum [TaxId: 375]
Score = 45.9 bits (107), Expect = 1e-06
Identities = 20/108 (18%), Positives = 34/108 (31%), Gaps = 9/108 (8%)
Query: 489 VITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKI----RAAID 544
++ D I S + L +S E +G+N L I +
Sbjct: 4 IVIDG---HGIIQLFSTAAERLFGWSELEAIGQNVNILMPEPDRSRHDSYISRYRTTSDP 60
Query: 545 NQTDVTVQLINYTKSGKKFWNLFHLQPMRDQKGEVQYFIGVQLDGSEH 592
+ + + + G F + M+ G YF G D +EH
Sbjct: 61 HIIGIGRIVTGKRRDGTTFPMHLSIGEMQS--GGEPYFTGFVRDLTEH 106
|
| >d1xj3a1 d.110.3.2 (A:154-259) Histidine kinase FixL heme domain {Bradyrhizobium japonicum [TaxId: 375]} Length = 106 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Profilin-like superfamily: PYP-like sensor domain (PAS domain) family: Heme-binding PAS domain domain: Histidine kinase FixL heme domain species: Bradyrhizobium japonicum [TaxId: 375]
Score = 43.2 bits (100), Expect = 1e-05
Identities = 17/103 (16%), Positives = 36/103 (34%), Gaps = 6/103 (5%)
Query: 211 TKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKI----RETLQNGQSY 266
I S ++ G++ E +G+N L + I + +
Sbjct: 6 IDGHGIIQLFSTAAERLFGWSELEAIGQNVNILMPEPDRSRHDSYISRYRTTSDPHIIGI 65
Query: 267 CGRLLNYKKDGTPFWNLLTIAPIKDDEGKVLKFIGMQVEVSKH 309
+ ++DGT F L+I ++ F G ++++H
Sbjct: 66 GRIVTGKRRDGTTFPMHLSIGEMQSGGEPY--FTGFVRDLTEH 106
|
| >d1ew0a_ d.110.3.2 (A:) Histidine kinase FixL heme domain {Rhizobium meliloti [TaxId: 382]} Length = 130 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Profilin-like superfamily: PYP-like sensor domain (PAS domain) family: Heme-binding PAS domain domain: Histidine kinase FixL heme domain species: Rhizobium meliloti [TaxId: 382]
Score = 43.9 bits (102), Expect = 9e-06
Identities = 20/101 (19%), Positives = 41/101 (40%), Gaps = 6/101 (5%)
Query: 211 TKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKIRETLQNGQ----SY 266
+ D I+ +A + GY +EV+G+N R L E ++ + G+
Sbjct: 32 SATDGTIVSFNAAAVRQFGYAEEEVIGQNLRILMPEPYRHEHDGYLQRYMATGEKRIIGI 91
Query: 267 CGRLLNYKKDGTPFWNLLTIAPIKDDEGKVLKFIGMQVEVS 307
+ +KDG+ F L + ++ + F G +++
Sbjct: 92 DRVVSGQRKDGSTFPMKLAVGEMRSGGERF--FTGFIRDLT 130
|
| >d1ew0a_ d.110.3.2 (A:) Histidine kinase FixL heme domain {Rhizobium meliloti [TaxId: 382]} Length = 130 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Profilin-like superfamily: PYP-like sensor domain (PAS domain) family: Heme-binding PAS domain domain: Histidine kinase FixL heme domain species: Rhizobium meliloti [TaxId: 382]
Score = 42.0 bits (97), Expect = 4e-05
Identities = 27/129 (20%), Positives = 48/129 (37%), Gaps = 13/129 (10%)
Query: 464 DKVRQKEMRKGIDLATTLERIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNC 523
D VR ++ L + L+ + V++ D I+ + + + Y+ EE++G+N
Sbjct: 9 DVVRARDAH----LRSILDTVPDATVVSAT---DGTIVSFNAAAVRQFGYAEEEVIGQNL 61
Query: 524 RFLQG----PETDPATVRKIRAAIDNQTDVTVQLINYTKSGKKFWNLFHLQPMRDQKGEV 579
R L E D R + + + K G F + MR G
Sbjct: 62 RILMPEPYRHEHDGYLQRYMATGEKRIIGIDRVVSGQRKDGSTFPMKLAVGEMRS--GGE 119
Query: 580 QYFIGVQLD 588
++F G D
Sbjct: 120 RFFTGFIRD 128
|
| >d1ll8a_ d.110.3.5 (A:) N-terminal PAS domain of Pas kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 114 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Profilin-like superfamily: PYP-like sensor domain (PAS domain) family: N-terminal PAS domain of Pas kinase domain: N-terminal PAS domain of Pas kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.5 bits (94), Expect = 9e-05
Identities = 15/101 (14%), Positives = 34/101 (33%), Gaps = 8/101 (7%)
Query: 489 VITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIRAAIDNQTD 548
D + I+ A+D L YS ++++G+ ++
Sbjct: 12 FTVDAK--TTEILVANDKACGLLGYSSQDLIGQKLTQFFLRSDSDVVEALSEEHMEADGH 69
Query: 549 VTV----QLINYTKSGKKFWNLFHLQPMRDQKGEVQYFIGV 585
V + ++SG+K ++ MR ++ + V
Sbjct: 70 AAVVFGTVVDIISRSGEKIPVSVWMKRMRQERRL--CCVVV 108
|
| >d1p97a_ d.110.3.7 (A:) Hypoxia-inducible factor Hif2a, C-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 114 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Profilin-like superfamily: PYP-like sensor domain (PAS domain) family: Hypoxia-inducible factor Hif2a, C-terminal domain domain: Hypoxia-inducible factor Hif2a, C-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.9 bits (89), Expect = 4e-04
Identities = 19/97 (19%), Positives = 30/97 (30%), Gaps = 1/97 (1%)
Query: 496 PDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIRAAIDNQTDVTVQLIN 555
D + D EL Y EE+LGR+ + + V+ Q
Sbjct: 14 MDMKFTYCDDRITELIGYHPEELLGRSAYEFYHALDSENMTKSHQNLCTKGQVVSGQYRM 73
Query: 556 YTKSGKKFWNLFHLQPMRDQK-GEVQYFIGVQLDGSE 591
K G W + + + + Q + V SE
Sbjct: 74 LAKHGGYVWLETQGTVIYNPRNLQPQCIMCVNYVLSE 110
|
| >d1p97a_ d.110.3.7 (A:) Hypoxia-inducible factor Hif2a, C-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 114 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Profilin-like superfamily: PYP-like sensor domain (PAS domain) family: Hypoxia-inducible factor Hif2a, C-terminal domain domain: Hypoxia-inducible factor Hif2a, C-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 37.3 bits (85), Expect = 0.001
Identities = 18/107 (16%), Positives = 33/107 (30%), Gaps = 3/107 (2%)
Query: 202 QQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKIRETLQ 261
+TF+ D Y ++ GY +E++GR+ A +
Sbjct: 5 SKTFLSR--HSMDMKFTYCDDRITELIGYHPEELLGRSAYEFYHALDSENMTKSHQNLCT 62
Query: 262 NGQSYCGRLLNYKKDGTPFWNLLTIAPIKDDE-GKVLKFIGMQVEVS 307
GQ G+ K G W I + + + + +S
Sbjct: 63 KGQVVSGQYRMLAKHGGYVWLETQGTVIYNPRNLQPQCIMCVNYVLS 109
|
| >d1mzua_ d.110.3.1 (A:) PYP domain of sensor histidine kinase Ppr {Rhodospirillum centenum [TaxId: 34018]} Length = 110 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Profilin-like superfamily: PYP-like sensor domain (PAS domain) family: PYP-like domain: PYP domain of sensor histidine kinase Ppr species: Rhodospirillum centenum [TaxId: 34018]
Score = 37.0 bits (85), Expect = 0.001
Identities = 12/96 (12%), Positives = 25/96 (26%), Gaps = 5/96 (5%)
Query: 489 VITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVR-KIRAAIDNQT 547
+ D I + + L+ E ++GRN P T+ + + + T
Sbjct: 17 IQVDG---SGVIHRYNRTESRLSGRIPERVIGRNFFTEVAPCTNIPAFSGRFMDGVTSGT 73
Query: 548 DVTVQLINYTKSGKKFWNLFHLQPMRDQKGEVQYFI 583
+ +Q F+
Sbjct: 74 LDARFDFVFDFQMAPVRVQIRMQNAGVP-DRYWIFV 108
|
Homologous Domains Detected by HHsearch 
Original result of HHsearch against SCOP70(version1.75) database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 1005 | |||
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.92 | |
| d1n9la_ | 109 | Putative blue light receptor, phot-lov1 domain {Gr | 99.86 | |
| d1n9la_ | 109 | Putative blue light receptor, phot-lov1 domain {Gr | 99.82 | |
| d1bywa_ | 110 | Erg potassium channel, N-terminal domain {Human (H | 99.81 | |
| d1jnua_ | 104 | Photoreceptor phy3 flavin-binding domain, lov2 {Ma | 99.79 | |
| d1bywa_ | 110 | Erg potassium channel, N-terminal domain {Human (H | 99.79 | |
| d1ew0a_ | 130 | Histidine kinase FixL heme domain {Rhizobium melil | 99.79 | |
| d1ew0a_ | 130 | Histidine kinase FixL heme domain {Rhizobium melil | 99.76 | |
| d1jnua_ | 104 | Photoreceptor phy3 flavin-binding domain, lov2 {Ma | 99.74 | |
| d1p97a_ | 114 | Hypoxia-inducible factor Hif2a, C-terminal domain | 99.67 | |
| d1p97a_ | 114 | Hypoxia-inducible factor Hif2a, C-terminal domain | 99.67 | |
| d1v9ya_ | 113 | Direct oxygen sensor protein, DOS {Escherichia col | 99.63 | |
| d1xj3a1 | 106 | Histidine kinase FixL heme domain {Bradyrhizobium | 99.6 | |
| d1v9ya_ | 113 | Direct oxygen sensor protein, DOS {Escherichia col | 99.59 | |
| d1xj3a1 | 106 | Histidine kinase FixL heme domain {Bradyrhizobium | 99.58 | |
| d1nwza_ | 125 | Photoactive yellow protein, PYP {Ectothiorhodospir | 99.49 | |
| d1mzua_ | 110 | PYP domain of sensor histidine kinase Ppr {Rhodosp | 99.46 | |
| d1nwza_ | 125 | Photoactive yellow protein, PYP {Ectothiorhodospir | 99.45 | |
| d1mzua_ | 110 | PYP domain of sensor histidine kinase Ppr {Rhodosp | 99.36 | |
| d1ll8a_ | 114 | N-terminal PAS domain of Pas kinase {Human (Homo s | 99.35 | |
| d1ll8a_ | 114 | N-terminal PAS domain of Pas kinase {Human (Homo s | 99.26 | |
| d1oj5a_ | 109 | PAS domain of steroid receptor coactivator 1A, NCo | 99.03 | |
| d1oj5a_ | 109 | PAS domain of steroid receptor coactivator 1A, NCo | 99.0 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.9 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 98.62 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.51 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 98.13 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 97.68 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 97.48 | |
| d2oola2 | 114 | Sensor protein PhyB2 {Rhodopseudomonas palustris [ | 96.81 | |
| d2oola2 | 114 | Sensor protein PhyB2 {Rhodopseudomonas palustris [ | 96.78 | |
| d2veaa3 | 127 | Phytochrome-like protein Cph1 {Synechocystis sp. p | 93.64 | |
| d2veaa3 | 127 | Phytochrome-like protein Cph1 {Synechocystis sp. p | 93.54 | |
| d2o9ca2 | 127 | Bacteriophytochrome BphP {Deinococcus radiodurans | 93.25 | |
| d2o9ca2 | 127 | Bacteriophytochrome BphP {Deinococcus radiodurans | 92.58 |
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=421.88 Aligned_cols=278 Identities=40% Similarity=0.761 Sum_probs=246.1
Q ss_pred CCCCCCCCCCCCCCCCCEEEEEEEECCCCEEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEE
Q ss_conf 34688432331166693899999990799199999940531237578999999999999579998453789987078189
Q 001847 669 INLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVC 748 (1005)
Q Consensus 669 i~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~ 748 (1005)
+.+++|++++.||+|+||.||+|.++.+++.||+|++.+...........+.+|+.+++.++||||++++++|.+.+.+|
T Consensus 2 i~l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~ 81 (337)
T d1o6la_ 2 VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLC 81 (337)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEE
T ss_pred CCHHHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCCCC
T ss_conf 84474289889831768499999998999899999981565449799999999999998679998877876403564211
Q ss_pred EEEECCCCCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEEECCCCEEEEECCCCCCCCCCC
Q ss_conf 99960589835667731799999899999999999999999998594317899996898069928998516775458898
Q 001847 749 LITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKP 828 (1005)
Q Consensus 749 iV~E~~~g~sL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvH~DLkP~NIli~~~g~ikL~DFG~a~~~~~~~ 828 (1005)
+|||||+||+|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+|+.....
T Consensus 82 iv~ey~~gg~L~~~~~~~--~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~- 158 (337)
T d1o6la_ 82 FVMEYANGGELFFHLSRE--RVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD- 158 (337)
T ss_dssp EEEECCTTCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT-
T ss_pred CCEECCCCCCHHHHHHCC--CCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHEEECCCCCEEEEECCCCCCCCCC-
T ss_conf 100035798605555325--67759999999999965211343159622464777847658998888205652003567-
Q ss_pred CCCCCCCHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCHHH
Q ss_conf 77788512332114699997432356665655556876335200038888883059999999999990999999999689
Q 001847 829 QLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQK 908 (1005)
Q Consensus 829 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDIwSLG~il~eLltG~~Pf~~~~~~~ 908 (1005)
.......+||+.|+|||++.+..++.++|||||||++|+|++|++||.+.+..+
T Consensus 159 --------------------------~~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~ 212 (337)
T d1o6la_ 159 --------------------------GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER 212 (337)
T ss_dssp --------------------------TCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred --------------------------CCCCCCCEECHHHHHHHHCCCCCCCHHHCCCCHHHHHHHHHHCCCCCCCCCHHH
T ss_conf --------------------------862055100889966665048988833310223067889987899999969999
Q ss_pred HHHHHHHCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHH-CHHHHHCCCCCCCCCHHHHH--HCCCCCC
Q ss_conf 999998289999999988798999999801039276699824-09999819997799811335--0599988
Q 001847 909 TFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHE-GANEIKKHPFFKGVNWALVR--CMNPPEL 977 (1005)
Q Consensus 909 ~~~~i~~~~~~~~~~~~~s~~l~~Ll~~mL~~dP~~Rpt~~~-~a~elL~hpff~~~~~~~~~--~~~~~~~ 977 (1005)
.+..+....+.+|. .++.++.+||.+||+.||.+|++... .+.++++||||++++|..+. ...||..
T Consensus 213 ~~~~i~~~~~~~p~--~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~Hp~f~~i~~~~l~~~~~~~p~~ 282 (337)
T d1o6la_ 213 LFELILMEEIRFPR--TLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQDVVQKKLLPPFK 282 (337)
T ss_dssp HHHHHHHCCCCCCT--TSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCCHHHHHTTCSCCSCC
T ss_pred HHHHHHCCCCCCCC--CCCHHHHHHHHHHCCCCCHHHCCCCCCCHHHHHCCCCCCCCCHHHHHHCCCCCCCC
T ss_conf 99998528998986--68999999998666389344225652349999729150369999998478998978
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=426.08 Aligned_cols=279 Identities=36% Similarity=0.652 Sum_probs=246.9
Q ss_pred CCCCCCCCCCCCCCCEEEEEEEECCCCEEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEEEE
Q ss_conf 68843233116669389999999079919999994053123757899999999999957999845378998707818999
Q 001847 671 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLI 750 (1005)
Q Consensus 671 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~iV 750 (1005)
.++|++.+.||+|+||.||+|.+..+++.||||++.+....+......+.+|+.++++++||||+++++++.+.+.+|+|
T Consensus 7 p~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~iv 86 (288)
T d1uu3a_ 7 PEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFG 86 (288)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEE
T ss_pred CCCCEEEEEEEECCCEEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCEEEEE
T ss_conf 98778988985087909999999899979999998657755777899999999999876888861799999989988999
Q ss_pred EECCCCCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEEECCCCEEEEECCCCCCCCCCCCC
Q ss_conf 96058983566773179999989999999999999999999859431789999689806992899851677545889877
Q 001847 751 TDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQL 830 (1005)
Q Consensus 751 ~E~~~g~sL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvH~DLkP~NIli~~~g~ikL~DFG~a~~~~~~~~~ 830 (1005)
|||++||+|.+++... +.+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||+|........
T Consensus 87 mEy~~gg~L~~~~~~~--~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~- 163 (288)
T d1uu3a_ 87 LSYAKNGELLKYIRKI--GSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESK- 163 (288)
T ss_dssp ECCCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECC-----
T ss_pred EECCCCCCHHHHHHCC--CCCCHHHHHHHHHHHHHHHHHHCCCCEECCCCCCCCCCCCCCCEEEECCCCCCEECCCCCC-
T ss_conf 9704898777765315--9999999999999999999762165088476774123668885388603210242256776-
Q ss_pred CCCCCHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCHHHHH
Q ss_conf 78851233211469999743235666565555687633520003888888305999999999999099999999968999
Q 001847 831 LLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTF 910 (1005)
Q Consensus 831 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDIwSLG~il~eLltG~~Pf~~~~~~~~~ 910 (1005)
.......+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+....+
T Consensus 164 ------------------------~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~ 219 (288)
T d1uu3a_ 164 ------------------------QARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIF 219 (288)
T ss_dssp ------------------------------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH
T ss_pred ------------------------CCCCCCCCCCCCCCCCEEECCCCCCCCCCEEHHHHHHHHHHHCCCCCCCCCHHHHH
T ss_conf ------------------------43335556775525844002689896662304569999980388998995999999
Q ss_pred HHHHHCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHH--CHHHHHCCCCCCCCCHHHHHHCCCCCCC
Q ss_conf 9998289999999988798999999801039276699824--0999981999779981133505999889
Q 001847 911 ANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHE--GANEIKKHPFFKGVNWALVRCMNPPELD 978 (1005)
Q Consensus 911 ~~i~~~~~~~~~~~~~s~~l~~Ll~~mL~~dP~~Rpt~~~--~a~elL~hpff~~~~~~~~~~~~~~~~~ 978 (1005)
..+......++. .++.++.+||.+||..||.+|||+.+ ....+++||||++++|..+....||.|+
T Consensus 220 ~~i~~~~~~~p~--~~s~~~~~li~~~L~~dP~~R~t~~e~~~~~~i~~Hpff~~i~w~~l~~~~pP~l~ 287 (288)
T d1uu3a_ 220 QKIIKLEYDFPE--KFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENLHQQTPPKLT 287 (288)
T ss_dssp HHHHTTCCCCCT--TCCHHHHHHHHTTSCSSGGGSTTSGGGTCHHHHHTSGGGTTCCCTTGGGSCCCCCC
T ss_pred HHHHCCCCCCCC--CCCHHHHHHHHHHCCCCHHHCCCHHHHCCCHHHHCCCCCCCCCHHHHHCCCCCCCC
T ss_conf 999718999985--47999999999985579768919789737789876976478998896157999999
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=0 Score=414.14 Aligned_cols=281 Identities=37% Similarity=0.679 Sum_probs=245.6
Q ss_pred CCCCCCCCCCCCCCCEEEEEEEECCCCEEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEEEE
Q ss_conf 68843233116669389999999079919999994053123757899999999999957999845378998707818999
Q 001847 671 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLI 750 (1005)
Q Consensus 671 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~iV 750 (1005)
+++|++++.||+|+||.||+|.++.+++.||||++.+....+......+.+|+.+++.++||||+++++++.....+++|
T Consensus 40 ld~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v 119 (350)
T d1rdqe_ 40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV 119 (350)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCCEEEEEEEECCCCCEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCCCCCCCC
T ss_conf 23708988961176808999999899989999998267745889999999999999974877274034444322222322
Q ss_pred EECCCCCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEEECCCCEEEEECCCCCCCCCCCCC
Q ss_conf 96058983566773179999989999999999999999999859431789999689806992899851677545889877
Q 001847 751 TDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQL 830 (1005)
Q Consensus 751 ~E~~~g~sL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvH~DLkP~NIli~~~g~ikL~DFG~a~~~~~~~~~ 830 (1005)
|||+.+|+|..++... +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|.....
T Consensus 120 ~e~~~~g~l~~~l~~~--~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~---- 193 (350)
T d1rdqe_ 120 MEYVAGGEMFSHLRRI--GRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG---- 193 (350)
T ss_dssp EECCTTCBHHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSS----
T ss_pred CCCCCCCCHHHHHHHC--CCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHCCCCCCCCEEEEECEEEEECCC----
T ss_conf 2233466226667515--8989999999999999989999859986176799993607789788610103332256----
Q ss_pred CCCCCHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCHHHHH
Q ss_conf 78851233211469999743235666565555687633520003888888305999999999999099999999968999
Q 001847 831 LLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTF 910 (1005)
Q Consensus 831 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDIwSLG~il~eLltG~~Pf~~~~~~~~~ 910 (1005)
.....+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+....+
T Consensus 194 --------------------------~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~ 247 (350)
T d1rdqe_ 194 --------------------------RTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIY 247 (350)
T ss_dssp --------------------------CBCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH
T ss_pred --------------------------CCCCCCCCCCCCCHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCHHHHH
T ss_conf --------------------------664336763567889971799885331145007899997588998995999999
Q ss_pred HHHHHCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCC-CCHHCHHHHHCCCCCCCCCHHHHH--HCCCCCCCCCCCCCCCC
Q ss_conf 999828999999998879899999980103927669-982409999819997799811335--05999889998887311
Q 001847 911 ANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRL-GSHEGANEIKKHPFFKGVNWALVR--CMNPPELDAPLFATDTE 987 (1005)
Q Consensus 911 ~~i~~~~~~~~~~~~~s~~l~~Ll~~mL~~dP~~Rp-t~~~~a~elL~hpff~~~~~~~~~--~~~~~~~~~~~~~~~~~ 987 (1005)
..+......++. .++.++.+||.+||..||.+|+ +.++.++++++||||++++|..+. ...+|.+ |-+..+.+
T Consensus 248 ~~i~~~~~~~p~--~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~Hp~f~~~~~~~~~~~~~~~p~~--p~~~~~~d 323 (350)
T d1rdqe_ 248 EKIVSGKVRFPS--HFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAPFI--PKFKGPGD 323 (350)
T ss_dssp HHHHHCCCCCCT--TCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTCCHHHHHTTCSCCSCC--CCCCSTTC
T ss_pred HHHHCCCCCCCC--CCCHHHHHHHHHHHHHCHHHCCCCCCCCHHHHHCCCCCCCCCHHHHHHCCCCCCCC--CCCCCCCH
T ss_conf 998617988976--68999999999983409986065534549999719051589989998367896936--88899211
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=0 Score=411.63 Aligned_cols=273 Identities=41% Similarity=0.801 Sum_probs=241.3
Q ss_pred CCCCCCCCCCCCCCCEEEEEEEECCCCEEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEEEE
Q ss_conf 68843233116669389999999079919999994053123757899999999999957999845378998707818999
Q 001847 671 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLI 750 (1005)
Q Consensus 671 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~iV 750 (1005)
+++|++++.||+|+||.||+|.++.+++.||+|++.+...........+.+|+.+++.++||||+++++++...+.+|+|
T Consensus 3 l~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv 82 (316)
T d1fota_ 3 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI 82 (316)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred HHHEEEEEEEECCCCCEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCHHHEEEEEEECCEEEEE
T ss_conf 54708888972076808999999899979999998457754889999999999999863696753303568528800567
Q ss_pred EECCCCCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEEECCCCEEEEECCCCCCCCCCCCC
Q ss_conf 96058983566773179999989999999999999999999859431789999689806992899851677545889877
Q 001847 751 TDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQL 830 (1005)
Q Consensus 751 ~E~~~g~sL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvH~DLkP~NIli~~~g~ikL~DFG~a~~~~~~~~~ 830 (1005)
||||.||+|..++... ..+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+|.....
T Consensus 83 mE~~~gg~l~~~~~~~--~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~---- 156 (316)
T d1fota_ 83 MDYIEGGELFSLLRKS--QRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD---- 156 (316)
T ss_dssp ECCCCSCBHHHHHHHT--SSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSS----
T ss_pred EEECCCCCCCCCCCCC--CCCCCCHHHHHHHHHHHHHHHHCCCCEECCCCCCHHEEECCCCCEEEECCCCCEEECC----
T ss_conf 6503786322343222--2111007999999998765541247677055681050386899889831752167124----
Q ss_pred CCCCCHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCHHHHH
Q ss_conf 78851233211469999743235666565555687633520003888888305999999999999099999999968999
Q 001847 831 LLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTF 910 (1005)
Q Consensus 831 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDIwSLG~il~eLltG~~Pf~~~~~~~~~ 910 (1005)
...+.+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+..
T Consensus 157 --------------------------~~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~ 210 (316)
T d1fota_ 157 --------------------------VTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTY 210 (316)
T ss_dssp --------------------------CBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHH
T ss_pred --------------------------CCCCCCCCCCCCCHHHHCCCCCCCHHHCCCCCHHHHHHHHCCCCCCCCCHHHHH
T ss_conf --------------------------564345763435999983899980430465333689997598999996999999
Q ss_pred HHHHHCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCH-HCHHHHHCCCCCCCCCHHHHH--HCCCCCC
Q ss_conf 999828999999998879899999980103927669982-409999819997799811335--0599988
Q 001847 911 ANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSH-EGANEIKKHPFFKGVNWALVR--CMNPPEL 977 (1005)
Q Consensus 911 ~~i~~~~~~~~~~~~~s~~l~~Ll~~mL~~dP~~Rpt~~-~~a~elL~hpff~~~~~~~~~--~~~~~~~ 977 (1005)
..+..+...++. .++.++.+++.+||..||.+|++.. +.++++|+||||++++|..+. ...+|..
T Consensus 211 ~~i~~~~~~~p~--~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~Hp~f~~i~~~~l~~~~~~~p~~ 278 (316)
T d1fota_ 211 EKILNAELRFPP--FFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVVWEKLLSRNIETPYE 278 (316)
T ss_dssp HHHHHCCCCCCT--TSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSCCHHHHHTTCSCCSCC
T ss_pred HHHHCCCCCCCC--CCCHHHHHHHHHHHHHCHHHCCCCCHHHHHHHHCCCCCCCCCHHHHHHCCCCCCCC
T ss_conf 999708988997--78999999999995449976664310219999819351467989998378996988
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=0 Score=406.75 Aligned_cols=263 Identities=28% Similarity=0.461 Sum_probs=233.2
Q ss_pred CCCCCCCCCCCCCCCEEEEEEEECCCCEEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEEEE
Q ss_conf 68843233116669389999999079919999994053123757899999999999957999845378998707818999
Q 001847 671 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLI 750 (1005)
Q Consensus 671 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~iV 750 (1005)
+++|++++.||+|+||.||+|.+..+++.||+|++... .......+.+|+.++++++||||+++++++...+.+|+|
T Consensus 25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~---~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv 101 (350)
T d1koaa2 25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTP---HESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMI 101 (350)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCC---SHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEE
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCC---CHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCEEEEE
T ss_conf 65758988984076819999998899989999998452---431699999999999867997999299999989999999
Q ss_pred EECCCCCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEEEC--CCCEEEEECCCCCCCCCCC
Q ss_conf 96058983566773179999989999999999999999999859431789999689806--9928998516775458898
Q 001847 751 TDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQG--NGHVSLTDFDLSCLTSCKP 828 (1005)
Q Consensus 751 ~E~~~g~sL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvH~DLkP~NIli~~--~g~ikL~DFG~a~~~~~~~ 828 (1005)
||||+||+|.+++... .+.+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||+|......
T Consensus 102 mE~~~gg~L~~~l~~~-~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~- 179 (350)
T d1koaa2 102 YEFMSGGELFEKVADE-HNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK- 179 (350)
T ss_dssp ECCCCSCBHHHHHTCT-TSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTT-
T ss_pred EECCCCCCHHHHHHHH-CCCCCHHHHHHHHHHHHHHHHHHHHCCCEEEEECHHHEEECCCCCCEEEEEECCHHEECCCC-
T ss_conf 9857998899999762-37899999999999999999999756976000154673641688986999545210442565-
Q ss_pred CCCCCCCHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCHHH
Q ss_conf 77788512332114699997432356665655556876335200038888883059999999999990999999999689
Q 001847 829 QLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQK 908 (1005)
Q Consensus 829 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDIwSLG~il~eLltG~~Pf~~~~~~~ 908 (1005)
......+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+
T Consensus 180 ---------------------------~~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~ 232 (350)
T d1koaa2 180 ---------------------------QSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDE 232 (350)
T ss_dssp ---------------------------SCEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred ---------------------------CCCCEECCCCCCCCHHHHCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCHHH
T ss_conf ---------------------------43200068624218899758998726765546599999985989989979999
Q ss_pred HHHHHHHCCCCCCCC--CCCCHHHHHHHHHCCCCCCCCCCCCHHCHHHHHCCCCCCCCCHHHH
Q ss_conf 999998289999999--9887989999998010392766998240999981999779981133
Q 001847 909 TFANILHKDLKFPSS--TPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVNWALV 969 (1005)
Q Consensus 909 ~~~~i~~~~~~~~~~--~~~s~~l~~Ll~~mL~~dP~~Rpt~~~~a~elL~hpff~~~~~~~~ 969 (1005)
.+..+......++.. ..++..+.+||.+||..||.+||| +.|+|+||||+..++...
T Consensus 233 ~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t----~~eil~hp~~~~~~~~~~ 291 (350)
T d1koaa2 233 TLRNVKSCDWNMDDSAFSGISEDGKDFIRKLLLADPNTRMT----IHQALEHPWLTPGNAPGR 291 (350)
T ss_dssp HHHHHHHTCCCSCCGGGGGCCHHHHHHHHHHCCSSGGGSCC----HHHHHHSTTTSCTTCCSC
T ss_pred HHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCC----HHHHHCCCCCCCCCCCCC
T ss_conf 99999847889894223589999999999975689667908----999862913288988875
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=404.74 Aligned_cols=265 Identities=25% Similarity=0.412 Sum_probs=229.8
Q ss_pred HHHCCCCCCCCCCCCCCCCCCCCCCCEEEEEEEECCCCEEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEE
Q ss_conf 75304544434688432331166693899999990799199999940531237578999999999999579998453789
Q 001847 660 QKILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYA 739 (1005)
Q Consensus 660 ~~~~~~~~~i~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~ 739 (1005)
+.+...+.+ .++|++++.||+|+||.||+|.+..+++.||+|.+...... ..+.+.+|+.+++.++||||+++++
T Consensus 10 ~~~~~~~dp--~~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~---~~~~~~~E~~il~~l~HpnIv~~~~ 84 (293)
T d1yhwa1 10 RSIVSVGDP--KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP---KKELIINEILVMRENKNPNIVNYLD 84 (293)
T ss_dssp HHHSBSSCT--TTTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCS---CHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred HCCCCCCCC--CCCCEEEEEEECCCCCEEEEEEECCCCCEEEEEEEECCCCH---HHHHHHHHHHHHHHCCCCCEEEEEE
T ss_conf 533789995--10538878981285829999999899989999998430172---7999999999998679998805857
Q ss_pred EEEECCEEEEEEECCCCCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEEECCCCEEEEECC
Q ss_conf 98707818999960589835667731799999899999999999999999998594317899996898069928998516
Q 001847 740 SFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFD 819 (1005)
Q Consensus 740 ~~~~~~~~~iV~E~~~g~sL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvH~DLkP~NIli~~~g~ikL~DFG 819 (1005)
++...+.+|+|||||+||+|.+++... .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||
T Consensus 85 ~~~~~~~~~ivmEy~~gg~L~~~~~~~---~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~vkl~DFG 161 (293)
T d1yhwa1 85 SYLVGDELWVVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFG 161 (293)
T ss_dssp EEEETTEEEEEEECCTTCBHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCT
T ss_pred EEEECCEEEEEEEECCCCCHHHHHHCC---CCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHEEECCCCCEEECCCH
T ss_conf 798899989999703798089886415---99999999999999999999998797226776888688789968642515
Q ss_pred CCCCCCCCCCCCCCCCHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCCCC
Q ss_conf 77545889877788512332114699997432356665655556876335200038888883059999999999990999
Q 001847 820 LSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYT 899 (1005)
Q Consensus 820 ~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDIwSLG~il~eLltG~~ 899 (1005)
+|...... .......+||+.|+|||++.+..++.++|||||||++|+|++|++
T Consensus 162 ~a~~~~~~---------------------------~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~ 214 (293)
T d1yhwa1 162 FCAQITPE---------------------------QSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEP 214 (293)
T ss_dssp TCEECCST---------------------------TCCBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSC
T ss_pred HHEEECCC---------------------------CCCCCCCCCCCCCCCHHHHCCCCCCCHHCEEHHHHHHHHHHHCCC
T ss_conf 64132136---------------------------664444444777368266447998801203137299999804889
Q ss_pred CCCCCCHHHHHHHHHHCC-CCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHCHHHHHCCCCCCC
Q ss_conf 999999689999998289-9999999887989999998010392766998240999981999779
Q 001847 900 PFRGKTRQKTFANILHKD-LKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKG 963 (1005)
Q Consensus 900 Pf~~~~~~~~~~~i~~~~-~~~~~~~~~s~~l~~Ll~~mL~~dP~~Rpt~~~~a~elL~hpff~~ 963 (1005)
||.+.+.......+.... ..+..+..++..+.+||.+||..||.+||| +.|+|+||||+.
T Consensus 215 Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s----~~eil~Hp~~~~ 275 (293)
T d1yhwa1 215 PYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLDMDVEKRGS----AKELLQHQFLKI 275 (293)
T ss_dssp TTTTSCHHHHHHHHHHHCSCCCSSGGGSCHHHHHHHHHHTCSSTTTSCC----HHHHTTCGGGGG
T ss_pred CCCCCCHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCC----HHHHHCCHHHCC
T ss_conf 9899799999999985799988885537999999999986699668909----999964996577
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=407.78 Aligned_cols=256 Identities=34% Similarity=0.571 Sum_probs=231.1
Q ss_pred CCCCCCCCCCCCCCCEEEEEEEECCCCEEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEEEE
Q ss_conf 68843233116669389999999079919999994053123757899999999999957999845378998707818999
Q 001847 671 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLI 750 (1005)
Q Consensus 671 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~iV 750 (1005)
+++|++.+.||+|+||.||+|.++.+++.||+|++.+....+......+.+|+.+++.++||||+++++++.+.+.+|+|
T Consensus 5 l~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~iv 84 (263)
T d2j4za1 5 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI 84 (263)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred HHHEEEEEEEECCCCCEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEEEE
T ss_conf 53769988985177858999999899949999998168856768999999999999856888888599999989998999
Q ss_pred EECCCCCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEEECCCCEEEEECCCCCCCCCCCCC
Q ss_conf 96058983566773179999989999999999999999999859431789999689806992899851677545889877
Q 001847 751 TDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQL 830 (1005)
Q Consensus 751 ~E~~~g~sL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvH~DLkP~NIli~~~g~ikL~DFG~a~~~~~~~~~ 830 (1005)
||||++|+|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|.....
T Consensus 85 mEy~~~g~L~~~l~~~--~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~---- 158 (263)
T d2j4za1 85 LEYAPLGTVYRELQKL--SKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS---- 158 (263)
T ss_dssp EECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCC----
T ss_pred EEECCCCCHHHHHHHC--CCCCHHHHHHHHHHHHHHHHHHHHCCEEEEEECCCCCEECCCCCEEECCCCEEEECCC----
T ss_conf 8504798589887504--8999999999999999999999988946522023441466899871155563354488----
Q ss_pred CCCCCHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCHHHHH
Q ss_conf 78851233211469999743235666565555687633520003888888305999999999999099999999968999
Q 001847 831 LLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTF 910 (1005)
Q Consensus 831 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDIwSLG~il~eLltG~~Pf~~~~~~~~~ 910 (1005)
......+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+.+
T Consensus 159 -------------------------~~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~ 213 (263)
T d2j4za1 159 -------------------------SRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETY 213 (263)
T ss_dssp -------------------------CCCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHH
T ss_pred -------------------------CCCCCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCHHHHH
T ss_conf -------------------------8523557887634999975899893144046759999983299998889999999
Q ss_pred HHHHHCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHCHHHHHCCCCCCC
Q ss_conf 99982899999999887989999998010392766998240999981999779
Q 001847 911 ANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKG 963 (1005)
Q Consensus 911 ~~i~~~~~~~~~~~~~s~~l~~Ll~~mL~~dP~~Rpt~~~~a~elL~hpff~~ 963 (1005)
..+......++. .++.++.+||.+||..||.+||| +.|+|+||||++
T Consensus 214 ~~i~~~~~~~p~--~~s~~~~~li~~~L~~dp~~R~t----~~eil~hp~~~~ 260 (263)
T d2j4za1 214 KRISRVEFTFPD--FVTEGARDLISRLLKHNPSQRPM----LREVLEHPWITA 260 (263)
T ss_dssp HHHHTTCCCCCT--TSCHHHHHHHHHHTCSSGGGSCC----HHHHHTCHHHHH
T ss_pred HHHHCCCCCCCC--CCCHHHHHHHHHHCCCCHHHCCC----HHHHHCCCCCCC
T ss_conf 999718999986--68999999999976479768909----999971907078
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=0 Score=404.79 Aligned_cols=277 Identities=32% Similarity=0.582 Sum_probs=226.3
Q ss_pred CCCCCCCCCCCCCCCCEEEEEEEECCCCEEEEEEEEECCCCCCHHHHHHHHH---HHHHHHHCCCCCCCEEEEEEEECCE
Q ss_conf 4688432331166693899999990799199999940531237578999999---9999995799984537899870781
Q 001847 670 NLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACA---EREILDMLDHPFVPALYASFQTKTH 746 (1005)
Q Consensus 670 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~---E~~il~~l~hpnIv~l~~~~~~~~~ 746 (1005)
.+++|++.+.||+|+||.||+|.+..+++.||+|++.+...........+.+ ++.+++.++||||++++++|...+.
T Consensus 2 slddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~ 81 (364)
T d1omwa3 2 TMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDK 81 (364)
T ss_dssp CSTTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSE
T ss_pred CHHHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEEECCE
T ss_conf 77768510188428890999999999997999999845875426679999999999999850899858899999998998
Q ss_pred EEEEEECCCCCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEEECCCCEEEEECCCCCCCCC
Q ss_conf 89999605898356677317999998999999999999999999985943178999968980699289985167754588
Q 001847 747 VCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSC 826 (1005)
Q Consensus 747 ~~iV~E~~~g~sL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvH~DLkP~NIli~~~g~ikL~DFG~a~~~~~ 826 (1005)
+|+|||||+||+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+....
T Consensus 82 ~~ivmE~~~gg~L~~~l~~~--~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~ 159 (364)
T d1omwa3 82 LSFILDLMNGGDLHYHLSQH--GVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSK 159 (364)
T ss_dssp EEEEECCCCSCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSSSCEEECCCTTCEECSS
T ss_pred EEEEEEECCCCCHHHHHHHC--CCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCEEEECCCCCEEEEEECEEEECCC
T ss_conf 89999914898389998732--5532789999999999999999977962204442216785889679822010233378
Q ss_pred CCCCCCCCCHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC-CCCCCHHHHHHHHHHHHHHHCCCCCCCCCC
Q ss_conf 9877788512332114699997432356665655556876335200038-888883059999999999990999999999
Q 001847 827 KPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAG-AGHTSAVDWWALGILLYEMLYGYTPFRGKT 905 (1005)
Q Consensus 827 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~l~~-~~~~~~sDIwSLG~il~eLltG~~Pf~~~~ 905 (1005)
. .....+||+.|+|||++.. ..++.++|||||||++|+|++|+.||.+.+
T Consensus 160 ~-----------------------------~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~ 210 (364)
T d1omwa3 160 K-----------------------------KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHK 210 (364)
T ss_dssp S-----------------------------CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSC
T ss_pred C-----------------------------CCCCCCCCCCCCHHHHHHCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCC
T ss_conf 8-----------------------------64331134554216876038999844104677899999985999888899
Q ss_pred HHHHHHHHHH-CCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCH-HCHHHHHCCCCCCCCCHHHHHH--CCCCCC
Q ss_conf 6899999982-8999999998879899999980103927669982-4099998199977998113350--599988
Q 001847 906 RQKTFANILH-KDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSH-EGANEIKKHPFFKGVNWALVRC--MNPPEL 977 (1005)
Q Consensus 906 ~~~~~~~i~~-~~~~~~~~~~~s~~l~~Ll~~mL~~dP~~Rpt~~-~~a~elL~hpff~~~~~~~~~~--~~~~~~ 977 (1005)
.......... .......+..++.++.+||.+||..||.+|||.. ..|+++++||||++++|..+.. ..+|.+
T Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~Hp~f~~i~~~~~~~~~~~~p~~ 286 (364)
T d1omwa3 211 TKDKHEIDRMTLTMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMVFLQKYPPPLI 286 (364)
T ss_dssp SSCHHHHHHHSSSCCCCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTSGGGTTCCHHHHHTTCSCCSCC
T ss_pred HHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCHHHHCCCCCCCHHHHHCCCCCCCCCHHHHHCCCCCCCCC
T ss_conf 8999999986046888788778999999999985669888088743579999749102378987996288995937
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=0 Score=402.66 Aligned_cols=258 Identities=28% Similarity=0.465 Sum_probs=230.1
Q ss_pred CCCCCCCCCCCCCCCEEEEEEEECCCCEEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEEEE
Q ss_conf 68843233116669389999999079919999994053123757899999999999957999845378998707818999
Q 001847 671 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLI 750 (1005)
Q Consensus 671 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~iV 750 (1005)
.++|++++.||+|+||.||+|.+..+++.||+|++.... ......+.+|+.++++++||||++++++|...+.+|+|
T Consensus 28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~---~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv 104 (352)
T d1koba_ 28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY---PLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLI 104 (352)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS---HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEE
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCCC---HHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCEEEEE
T ss_conf 403599899931778299999998999799999988726---46799999999999867997989199999989999999
Q ss_pred EECCCCCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEEE--CCCCEEEEECCCCCCCCCCC
Q ss_conf 9605898356677317999998999999999999999999985943178999968980--69928998516775458898
Q 001847 751 TDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQ--GNGHVSLTDFDLSCLTSCKP 828 (1005)
Q Consensus 751 ~E~~~g~sL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvH~DLkP~NIli~--~~g~ikL~DFG~a~~~~~~~ 828 (1005)
||||+||+|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||+|......
T Consensus 105 mE~~~gg~L~~~~~~~-~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~- 182 (352)
T d1koba_ 105 LEFLSGGELFDRIAAE-DYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD- 182 (352)
T ss_dssp EECCCCCBHHHHTTCT-TCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT-
T ss_pred EECCCCCHHHHHHHHC-CCCCCHHHHHHHHHHHHHHHHHHHHCCEEECCCCCCCCCCCCCCCCEEEEEECCCCEECCCC-
T ss_conf 9828998088889863-89989999999999999999999977926513144553113467884899525630343788-
Q ss_pred CCCCCCCHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCHHH
Q ss_conf 77788512332114699997432356665655556876335200038888883059999999999990999999999689
Q 001847 829 QLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQK 908 (1005)
Q Consensus 829 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDIwSLG~il~eLltG~~Pf~~~~~~~ 908 (1005)
.......||+.|+|||++.+..++.++|||||||++|+|++|++||.+.+...
T Consensus 183 ---------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~ 235 (352)
T d1koba_ 183 ---------------------------EIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLE 235 (352)
T ss_dssp ---------------------------SCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHH
T ss_pred ---------------------------CCEEECCCCCCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCHHH
T ss_conf ---------------------------72010047645348999747998976333898999999996889989979999
Q ss_pred HHHHHHHCCCCCCCC--CCCCHHHHHHHHHCCCCCCCCCCCCHHCHHHHHCCCCCCCC
Q ss_conf 999998289999999--98879899999980103927669982409999819997799
Q 001847 909 TFANILHKDLKFPSS--TPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGV 964 (1005)
Q Consensus 909 ~~~~i~~~~~~~~~~--~~~s~~l~~Ll~~mL~~dP~~Rpt~~~~a~elL~hpff~~~ 964 (1005)
.+..+......++.. ..++.++.+||.+||..||.+||| +.|+|+||||++.
T Consensus 236 ~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s----~~eil~Hp~~~~~ 289 (352)
T d1koba_ 236 TLQNVKRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLT----VHDALEHPWLKGD 289 (352)
T ss_dssp HHHHHHHCCCCCCSSTTTTSCHHHHHHHHTTSCSSGGGSCC----HHHHHTSTTTSSC
T ss_pred HHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCC----HHHHHCCHHHCCC
T ss_conf 99999847889893002479999999999975699668918----9999609734888
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=403.80 Aligned_cols=266 Identities=36% Similarity=0.740 Sum_probs=233.4
Q ss_pred CCCCCCCCCCCCCCCEEEEEEEECCCCEEEEEEEEECCCCCCHHHHHHHHHHHHHHH-HCCCCCCCEEEEEEEECCEEEE
Q ss_conf 688432331166693899999990799199999940531237578999999999999-5799984537899870781899
Q 001847 671 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILD-MLDHPFVPALYASFQTKTHVCL 749 (1005)
Q Consensus 671 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~-~l~hpnIv~l~~~~~~~~~~~i 749 (1005)
+++|++.+.||+|+||.||+|.+..+++.||+|++.+...........+..|..++. .++||||+++++++...+.+|+
T Consensus 1 iddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yi 80 (320)
T d1xjda_ 1 IEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFF 80 (320)
T ss_dssp CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred CCCEEEEEEEECCCCCEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCCEEE
T ss_conf 99718865894087828999999999989999998055533848999999999999984799968789889704983167
Q ss_pred EEECCCCCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEEECCCCEEEEECCCCCCCCCCCC
Q ss_conf 99605898356677317999998999999999999999999985943178999968980699289985167754588987
Q 001847 750 ITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQ 829 (1005)
Q Consensus 750 V~E~~~g~sL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvH~DLkP~NIli~~~g~ikL~DFG~a~~~~~~~~ 829 (1005)
||||+++|+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 81 vmEy~~~g~L~~~i~~~--~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~-- 156 (320)
T d1xjda_ 81 VMEYLNGGDLMYHIQSC--HKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLG-- 156 (320)
T ss_dssp EEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT--
T ss_pred EEEECCCCCHHHHHHCC--CCCCHHHHHHHHHHHHHHHHHHHHCCEEECCCCCCCEEECCCCCEECCCCCHHHHCCCC--
T ss_conf 77503798089986404--78999999999999999999998689340347654044448996301555302323566--
Q ss_pred CCCCCCHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCHHHH
Q ss_conf 77885123321146999974323566656555568763352000388888830599999999999909999999996899
Q 001847 830 LLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKT 909 (1005)
Q Consensus 830 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDIwSLG~il~eLltG~~Pf~~~~~~~~ 909 (1005)
.......+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+....
T Consensus 157 -------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~ 211 (320)
T d1xjda_ 157 -------------------------DAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEEL 211 (320)
T ss_dssp -------------------------TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred -------------------------CCCCCCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHH
T ss_conf -------------------------5334545787776899998279988323201122789898738899999899999
Q ss_pred HHHHHHCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHCHH-HHHCCCCCCCCCHHHHHH
Q ss_conf 99998289999999988798999999801039276699824099-998199977998113350
Q 001847 910 FANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGAN-EIKKHPFFKGVNWALVRC 971 (1005)
Q Consensus 910 ~~~i~~~~~~~~~~~~~s~~l~~Ll~~mL~~dP~~Rpt~~~~a~-elL~hpff~~~~~~~~~~ 971 (1005)
...+....+.++. .++..+.+||.+||..||.+||+ +. ++++||||++++|..+..
T Consensus 212 ~~~i~~~~~~~p~--~~s~~~~dli~~~L~~dP~~R~s----~~~~l~~hpff~~~~~~~l~~ 268 (320)
T d1xjda_ 212 FHSIRMDNPFYPR--WLEKEAKDLLVKLFVREPEKRLG----VRGDIRQHPLFREINWEELER 268 (320)
T ss_dssp HHHHHHCCCCCCT--TSCHHHHHHHHHHSCSSGGGSBT----TBSCGGGSGGGTTCCHHHHHT
T ss_pred HHHHHCCCCCCCC--CCCHHHHHHHHHHCCCCCCCCCC----HHHHHHHCCHHCCCCHHHHHH
T ss_conf 9999718998975--67999999999965448987838----899998090131589999983
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=409.74 Aligned_cols=265 Identities=25% Similarity=0.405 Sum_probs=223.3
Q ss_pred CCCCCCCCCCCCCCCCCCEEEEEEEECCCCEEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEE
Q ss_conf 43468843233116669389999999079919999994053123757899999999999957999845378998707818
Q 001847 668 QINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHV 747 (1005)
Q Consensus 668 ~i~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 747 (1005)
++..++|++++.||+|+||.||+|.+..+++.||+|.++... .......+.+|+.+++.++||||++++++|...+.+
T Consensus 2 el~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~--~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 79 (322)
T d1s9ja_ 2 ELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEI 79 (322)
T ss_dssp CCCGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCC--CTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEE
T ss_pred CCCCCCCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHH--CHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCEE
T ss_conf 787568889789712778099999998999699999987540--978999999999999867999999499999989999
Q ss_pred EEEEECCCCCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHH-CCCCCCCCCCCCEEEECCCCEEEEECCCCCCCCC
Q ss_conf 999960589835667731799999899999999999999999998-5943178999968980699289985167754588
Q 001847 748 CLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHC-QGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSC 826 (1005)
Q Consensus 748 ~iV~E~~~g~sL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~-~gIvH~DLkP~NIli~~~g~ikL~DFG~a~~~~~ 826 (1005)
|+||||++||+|.+++.+. +.+++..++.++.||+.||.|||+ +||+||||||+|||++.++.+||+|||+|.....
T Consensus 80 ~iVmEy~~gg~L~~~l~~~--~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~ 157 (322)
T d1s9ja_ 80 SICMEHMDGGSLDQVLKKA--GRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 157 (322)
T ss_dssp EEEEECCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHH
T ss_pred EEEEECCCCCCHHHHHHHC--CCCCHHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEECCCCCEEEEECCCCCCCCC
T ss_conf 9999767998689987424--99999999999999999999999859997144577994687899899954877625678
Q ss_pred CCCCCCCCCHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCH
Q ss_conf 98777885123321146999974323566656555568763352000388888830599999999999909999999996
Q 001847 827 KPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTR 906 (1005)
Q Consensus 827 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDIwSLG~il~eLltG~~Pf~~~~~ 906 (1005)
....+.+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+.
T Consensus 158 -----------------------------~~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~ 208 (322)
T d1s9ja_ 158 -----------------------------SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDA 208 (322)
T ss_dssp -----------------------------HTC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCT
T ss_pred -----------------------------CCCCCCCCCCCCCCCHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCH
T ss_conf -----------------------------862111377141194687589989488899899999999988899899887
Q ss_pred HHHH------------------------------------------HHHHHCCCCCCCCCCCCHHHHHHHHHCCCCCCCC
Q ss_conf 8999------------------------------------------9998289999999988798999999801039276
Q 001847 907 QKTF------------------------------------------ANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKS 944 (1005)
Q Consensus 907 ~~~~------------------------------------------~~i~~~~~~~~~~~~~s~~l~~Ll~~mL~~dP~~ 944 (1005)
.... ..+.....+.......+.++.+||.+||..||.+
T Consensus 209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~ 288 (322)
T d1s9ja_ 209 KELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAE 288 (322)
T ss_dssp THHHHHC------------------------------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTT
T ss_pred HHHHHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCHHH
T ss_conf 89999998875177545774212333221111222354134778876650268766764448999999999986899467
Q ss_pred CCCCHHCHHHHHCCCCCCCCCHHHH
Q ss_conf 6998240999981999779981133
Q 001847 945 RLGSHEGANEIKKHPFFKGVNWALV 969 (1005)
Q Consensus 945 Rpt~~~~a~elL~hpff~~~~~~~~ 969 (1005)
||| +.|+|+||||++.++...
T Consensus 289 R~t----a~e~L~Hpf~~~~~~~~~ 309 (322)
T d1s9ja_ 289 RAD----LKQLMVHAFIKRSDAEEV 309 (322)
T ss_dssp SCC----HHHHHTSHHHHHHHHSCC
T ss_pred CCC----HHHHHHCHHHCCCCCCCC
T ss_conf 908----999960986476982313
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=399.59 Aligned_cols=265 Identities=30% Similarity=0.463 Sum_probs=234.4
Q ss_pred CCCCCCCCCCCCCCCEEEEEEEECCCCEEEEEEEEECCCCCC---HHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEE
Q ss_conf 688432331166693899999990799199999940531237---57899999999999957999845378998707818
Q 001847 671 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLN---RNKVHRACAEREILDMLDHPFVPALYASFQTKTHV 747 (1005)
Q Consensus 671 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~---~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 747 (1005)
.++|++.+.||+|+||.||+|.++.+++.||+|++.+..... ......+.+|+.++++++||||+++++++.+.+.+
T Consensus 9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 88 (293)
T d1jksa_ 9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 88 (293)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCEE
T ss_conf 56779827981178959999999999989999998756632134068999999999999867998999388999979989
Q ss_pred EEEEECCCCCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEEECCC----CEEEEECCCCCC
Q ss_conf 9999605898356677317999998999999999999999999985943178999968980699----289985167754
Q 001847 748 CLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNG----HVSLTDFDLSCL 823 (1005)
Q Consensus 748 ~iV~E~~~g~sL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvH~DLkP~NIli~~~g----~ikL~DFG~a~~ 823 (1005)
|+|||||+||+|.+++... +.+++..++.++.|++.||+|||+++|+||||||+|||++.++ .+||+|||+|..
T Consensus 89 ~iv~E~~~gg~L~~~i~~~--~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~ 166 (293)
T d1jksa_ 89 ILILELVAGGELFDFLAEK--ESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK 166 (293)
T ss_dssp EEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCCTTCEE
T ss_pred EEEEECCCCCCCCCHHCCC--CCCCHHHHHHHHHHHHHHHHHHHHCCEEECCCCCCEEEEECCCCCCCCEEECCHHHHHH
T ss_conf 9999867786431001035--64215578999999999987666254221133301279825898666469643344210
Q ss_pred CCCCCCCCCCCCHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCC
Q ss_conf 58898777885123321146999974323566656555568763352000388888830599999999999909999999
Q 001847 824 TSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRG 903 (1005)
Q Consensus 824 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDIwSLG~il~eLltG~~Pf~~ 903 (1005)
.... .......|++.|+|||++.+..++.++|||||||++|+|++|+.||.+
T Consensus 167 ~~~~----------------------------~~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~ 218 (293)
T d1jksa_ 167 IDFG----------------------------NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLG 218 (293)
T ss_dssp CTTS----------------------------CBCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred CCCC----------------------------CCCCCCCCCCCCCCHHHHCCCCCCCCCCCHHHHHHHHHHHCCCCCCCC
T ss_conf 5777----------------------------631224777743099998189999766522140999999708899889
Q ss_pred CCHHHHHHHHHHCCCCCCCC--CCCCHHHHHHHHHCCCCCCCCCCCCHHCHHHHHCCCCCCCCCHHHH
Q ss_conf 99689999998289999999--9887989999998010392766998240999981999779981133
Q 001847 904 KTRQKTFANILHKDLKFPSS--TPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVNWALV 969 (1005)
Q Consensus 904 ~~~~~~~~~i~~~~~~~~~~--~~~s~~l~~Ll~~mL~~dP~~Rpt~~~~a~elL~hpff~~~~~~~~ 969 (1005)
.+..+.+..+......++.. ..++..+.+||.+||..||.+||| ++++|+||||+..+|...
T Consensus 219 ~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s----~~eil~hp~~~~~~~~~~ 282 (293)
T d1jksa_ 219 DTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMT----IQDSLQHPWIKPKDTQQA 282 (293)
T ss_dssp SSHHHHHHHHHTTCCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCC----HHHHHHSTTTCC------
T ss_pred CCHHHHHHHHHHCCCCCCCHHCCCCCHHHHHHHHHHCCCCHHHCCC----HHHHHCCCCCCCCCHHHH
T ss_conf 9999999999816888870104788999999999986389668919----999961904188870576
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=0 Score=401.60 Aligned_cols=255 Identities=26% Similarity=0.373 Sum_probs=229.5
Q ss_pred CCCCCCCCCCCCCCEEEEEEEECCCCEEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEEEEE
Q ss_conf 88432331166693899999990799199999940531237578999999999999579998453789987078189999
Q 001847 672 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLIT 751 (1005)
Q Consensus 672 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~iV~ 751 (1005)
..|++++.||+|+||.||+|.+..+++.||||++......+......+.+|+.++++++||||+++++++...+.+|+||
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~ 94 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (309)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCEEEEEE
T ss_conf 85676279701888099999998999399999984444358899999999999999778999823899999899889999
Q ss_pred ECCCCCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEEECCCCEEEEECCCCCCCCCCCCCC
Q ss_conf 60589835667731799999899999999999999999998594317899996898069928998516775458898777
Q 001847 752 DYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLL 831 (1005)
Q Consensus 752 E~~~g~sL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvH~DLkP~NIli~~~g~ikL~DFG~a~~~~~~~~~~ 831 (1005)
|||.+|+|..++... +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|....
T Consensus 95 E~~~~g~l~~~~~~~--~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~------ 166 (309)
T d1u5ra_ 95 EYCLGSASDLLEVHK--KPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMA------ 166 (309)
T ss_dssp ECCSEEHHHHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSS------
T ss_pred EECCCCCHHHHHHHC--CCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCCCEEEECCCCCEEEEECCCCCCCC------
T ss_conf 806999457899737--999999999999999999999986897666788421798799978984436533467------
Q ss_pred CCCCHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC---CCCCCHHHHHHHHHHHHHHHCCCCCCCCCCHHH
Q ss_conf 88512332114699997432356665655556876335200038---888883059999999999990999999999689
Q 001847 832 LPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAG---AGHTSAVDWWALGILLYEMLYGYTPFRGKTRQK 908 (1005)
Q Consensus 832 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~l~~---~~~~~~sDIwSLG~il~eLltG~~Pf~~~~~~~ 908 (1005)
.....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+...
T Consensus 167 -------------------------~~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~ 221 (309)
T d1u5ra_ 167 -------------------------PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS 221 (309)
T ss_dssp -------------------------SBCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH
T ss_pred -------------------------CCCCCCCCCCCCCHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHH
T ss_conf -------------------------7873134766368899834678886721454558999999987889999979999
Q ss_pred HHHHHHHCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHCHHHHHCCCCCCC
Q ss_conf 9999982899999999887989999998010392766998240999981999779
Q 001847 909 TFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKG 963 (1005)
Q Consensus 909 ~~~~i~~~~~~~~~~~~~s~~l~~Ll~~mL~~dP~~Rpt~~~~a~elL~hpff~~ 963 (1005)
.+..+..+..+......++..+.+||.+||..||.+||| +.++|+||||+.
T Consensus 222 ~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt----~~ell~Hp~~~~ 272 (309)
T d1u5ra_ 222 ALYHIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPT----SEVLLKHRFVLR 272 (309)
T ss_dssp HHHHHHHSCCCCCSCTTSCHHHHHHHHHHTCSSGGGSCC----HHHHTTCHHHHS
T ss_pred HHHHHHHCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCC----HHHHHHCHHHCC
T ss_conf 999998289998887888999999999977379657918----999971997537
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=0 Score=400.95 Aligned_cols=258 Identities=30% Similarity=0.491 Sum_probs=228.5
Q ss_pred CCCCCCCCCCCCCCCEEEEEEEECCCCEEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEEEE
Q ss_conf 68843233116669389999999079919999994053123757899999999999957999845378998707818999
Q 001847 671 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLI 750 (1005)
Q Consensus 671 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~iV 750 (1005)
.+.|++.+.||+|+||.||+|.++.+++.||+|++.+..... ....+.+|+.+++.++||||+++++++...+.+|+|
T Consensus 8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~--~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv 85 (307)
T d1a06a_ 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEG--KEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLI 85 (307)
T ss_dssp GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC------------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCCEEEEEEEEECCCEEEEEEEECCCCCEEEEEEECHHHHHH--HHHHHHHHHHHHHHCCCCCCCCEEEEEEECCEEEEE
T ss_conf 666699889940658399999999999899999981577312--899999999999867998999198999989988898
Q ss_pred EECCCCCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEEE---CCCCEEEEECCCCCCCCCC
Q ss_conf 9605898356677317999998999999999999999999985943178999968980---6992899851677545889
Q 001847 751 TDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQ---GNGHVSLTDFDLSCLTSCK 827 (1005)
Q Consensus 751 ~E~~~g~sL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvH~DLkP~NIli~---~~g~ikL~DFG~a~~~~~~ 827 (1005)
||||+||+|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||+. .++.+||+|||+|......
T Consensus 86 mE~~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~ 163 (307)
T d1a06a_ 86 MQLVSGGELFDRIVEK--GFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPG 163 (307)
T ss_dssp ECCCCSCBHHHHHHTC--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC---------
T ss_pred EECCCCCCHHHHHHCC--CCCCHHHHHHHHHHHHHHHHHHHHCEEEEEEECCCCEEECCCCCCCEEEEECCCEEEECCCC
T ss_conf 8526898488865303--67887899999999999987524130556870463001104688824998315435872589
Q ss_pred CCCCCCCCHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCHH
Q ss_conf 87778851233211469999743235666565555687633520003888888305999999999999099999999968
Q 001847 828 PQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQ 907 (1005)
Q Consensus 828 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDIwSLG~il~eLltG~~Pf~~~~~~ 907 (1005)
......+||+.|+|||++.+..++.++|||||||++|+|++|++||.+....
T Consensus 164 ----------------------------~~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~ 215 (307)
T d1a06a_ 164 ----------------------------SVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDA 215 (307)
T ss_dssp -------------------------------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred ----------------------------CEEEEEEECCCCCCCHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHH
T ss_conf ----------------------------7044003284225918873799980787345159999998597999998999
Q ss_pred HHHHHHHHCCCCCCC--CCCCCHHHHHHHHHCCCCCCCCCCCCHHCHHHHHCCCCCCCC
Q ss_conf 999999828999999--998879899999980103927669982409999819997799
Q 001847 908 KTFANILHKDLKFPS--STPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGV 964 (1005)
Q Consensus 908 ~~~~~i~~~~~~~~~--~~~~s~~l~~Ll~~mL~~dP~~Rpt~~~~a~elL~hpff~~~ 964 (1005)
.....+......++. ...++.++.+||.+||..||.+||| +.|+|+||||++.
T Consensus 216 ~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s----~~eil~hp~~~~~ 270 (307)
T d1a06a_ 216 KLFEQILKAEYEFDSPYWDDISDSAKDFIRHLMEKDPEKRFT----CEQALQHPWIAGD 270 (307)
T ss_dssp HHHHHHHTTCCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCC----HHHHHHSTTTTSS
T ss_pred HHHHHHHCCCCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCC----HHHHHCCHHHCCC
T ss_conf 999998616877787666678999999999976089757918----9998629844799
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=401.89 Aligned_cols=260 Identities=26% Similarity=0.420 Sum_probs=221.9
Q ss_pred CCCCCCCCCCCCCCCEEEEEEEECCCCEEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEEEE
Q ss_conf 68843233116669389999999079919999994053123757899999999999957999845378998707818999
Q 001847 671 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLI 750 (1005)
Q Consensus 671 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~iV 750 (1005)
.++|++++.||+|+||.||+|.++.+++.||+|++..... ......+.+|+.++++++||||+++++++...+.+|+|
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~--~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~iv 81 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA--VDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLF 81 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC---------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEHHHC--CHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCEEEEE
T ss_conf 7460899897217480999999999997999999845664--12799999999999857998884696540467436798
Q ss_pred EECCCCCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEEECCCCEEEEECCCCCCCCCCCCC
Q ss_conf 96058983566773179999989999999999999999999859431789999689806992899851677545889877
Q 001847 751 TDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQL 830 (1005)
Q Consensus 751 ~E~~~g~sL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvH~DLkP~NIli~~~g~ikL~DFG~a~~~~~~~~~ 830 (1005)
||||++|+|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|.......
T Consensus 82 mEy~~gg~L~~~l~~~--~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~-- 157 (271)
T d1nvra_ 82 LEYCSGGELFDRIEPD--IGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNN-- 157 (271)
T ss_dssp EECCTTEEGGGGSBTT--TBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECEETT--
T ss_pred EECCCCCCHHHHHHCC--CCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHEEECCCCCEEECCCHHHEEECCCC--
T ss_conf 8645898089997537--999999999999999999999997598357546899788789987983231422404688--
Q ss_pred CCCCCHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC-CCHHHHHHHHHHHHHHHCCCCCCCCCCHHHH
Q ss_conf 788512332114699997432356665655556876335200038888-8830599999999999909999999996899
Q 001847 831 LLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGH-TSAVDWWALGILLYEMLYGYTPFRGKTRQKT 909 (1005)
Q Consensus 831 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~-~~~sDIwSLG~il~eLltG~~Pf~~~~~~~~ 909 (1005)
........+||+.|+|||++.+..+ +.++|||||||++|+|++|++||.+......
T Consensus 158 -----------------------~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~ 214 (271)
T d1nvra_ 158 -----------------------RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ 214 (271)
T ss_dssp -----------------------EECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSH
T ss_pred -----------------------CCCCCCCEEECCCCCCHHHHCCCCCCCCCEEEEHHHHHHHHHHHCCCCCCCCCHHHH
T ss_conf -----------------------653111325574742872861899999710161737999999829978888985999
Q ss_pred -HHHHHHCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHCHHHHHCCCCCCC
Q ss_conf -999982899999999887989999998010392766998240999981999779
Q 001847 910 -FANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKG 963 (1005)
Q Consensus 910 -~~~i~~~~~~~~~~~~~s~~l~~Ll~~mL~~dP~~Rpt~~~~a~elL~hpff~~ 963 (1005)
+..+............++.++.+||.+||..||.+||| +.|+|+||||+.
T Consensus 215 ~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t----~~eil~hpwf~~ 265 (271)
T d1nvra_ 215 EYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARIT----IPDIKKDRWYNK 265 (271)
T ss_dssp HHHHHHTTCTTSTTGGGSCHHHHHHHHHHSCSSTTTSCC----HHHHTTCTTTTC
T ss_pred HHHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCC----HHHHHCCHHHCC
T ss_conf 999986388878864469999999999976799668909----999961984585
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=399.37 Aligned_cols=258 Identities=25% Similarity=0.410 Sum_probs=225.5
Q ss_pred CCCCCCCCCCCCCCEEEEEEEECCCCEEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEEEEE
Q ss_conf 88432331166693899999990799199999940531237578999999999999579998453789987078189999
Q 001847 672 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLIT 751 (1005)
Q Consensus 672 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~iV~ 751 (1005)
+.|++++.||+|+||.||+|.+..++..||+|++.... ......+.+|+.++++++||||+++++++...+.+|+||
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~---~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvm 88 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKS---EEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILI 88 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSS---SGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred CCEEEEEEEEECCCCEEEEEEECCCCEEEEEEEECCCC---HHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEEEEE
T ss_conf 37598479930778199999999999399999987289---999999999999998679999884988980099589999
Q ss_pred ECCCCCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEEECCCCEEEEECCCCCCCCCCCCCC
Q ss_conf 60589835667731799999899999999999999999998594317899996898069928998516775458898777
Q 001847 752 DYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLL 831 (1005)
Q Consensus 752 E~~~g~sL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvH~DLkP~NIli~~~g~ikL~DFG~a~~~~~~~~~~ 831 (1005)
|||++|+|.+++... .+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|.....
T Consensus 89 Ey~~~g~L~~~~~~~-~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~----- 162 (288)
T d2jfla1 89 EFCAGGAVDAVMLEL-ERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTR----- 162 (288)
T ss_dssp ECCTTEEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECHH-----
T ss_pred ECCCCCCHHHHHHHC-CCCCCHHHHHHHHHHHHHHHHHHHHCCEEEEECCHHHEEECCCCCEEEEECHHHHCCCC-----
T ss_conf 627998188999862-89999999999999999999999988988714070031487899989971612303577-----
Q ss_pred CCCCHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC-----CCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCH
Q ss_conf 8851233211469999743235666565555687633520003-----88888830599999999999909999999996
Q 001847 832 LPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIA-----GAGHTSAVDWWALGILLYEMLYGYTPFRGKTR 906 (1005)
Q Consensus 832 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~l~-----~~~~~~~sDIwSLG~il~eLltG~~Pf~~~~~ 906 (1005)
........+||+.|+|||++. ...++.++|||||||++|+|++|++||.+.+.
T Consensus 163 ----------------------~~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~ 220 (288)
T d2jfla1 163 ----------------------TIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNP 220 (288)
T ss_dssp ----------------------HHHHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCG
T ss_pred ----------------------CCCCCCCCCCCCCCCCHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCH
T ss_conf ----------------------8641001025626479999832025788888066578789999998208899999899
Q ss_pred HHHHHHHHHCCCCC-CCCCCCCHHHHHHHHHCCCCCCCCCCCCHHCHHHHHCCCCCCCC
Q ss_conf 89999998289999-99998879899999980103927669982409999819997799
Q 001847 907 QKTFANILHKDLKF-PSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGV 964 (1005)
Q Consensus 907 ~~~~~~i~~~~~~~-~~~~~~s~~l~~Ll~~mL~~dP~~Rpt~~~~a~elL~hpff~~~ 964 (1005)
.+.+..+.....+. .....++.++.+||.+||..||.+||| +.|+|+||||+.-
T Consensus 221 ~~~~~~i~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t----~~ell~hp~~~~~ 275 (288)
T d2jfla1 221 MRVLLKIAKSEPPTLAQPSRWSSNFKDFLKKCLEKNVDARWT----TSQLLQHPFVTVD 275 (288)
T ss_dssp GGHHHHHHHSCCCCCSSGGGSCHHHHHHHHHHSCSSTTTSCC----HHHHTTSGGGCCC
T ss_pred HHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCC----HHHHHCCCCCCCC
T ss_conf 999999970799877765669999999999976699668919----9999629231889
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=393.19 Aligned_cols=257 Identities=25% Similarity=0.456 Sum_probs=225.4
Q ss_pred CCCCCCCCCCCCCCEEEEEEEECCCCEEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEE--CCEEEE
Q ss_conf 884323311666938999999907991999999405312375789999999999995799984537899870--781899
Q 001847 672 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQT--KTHVCL 749 (1005)
Q Consensus 672 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~--~~~~~i 749 (1005)
++|++++.||+|+||.||+|.++.+++.||+|.+..... +......+.+|+.++++++||||+++++++.+ .+.+|+
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~i 82 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSM-TEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 82 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTS-CHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEE
T ss_pred HHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHC-CHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCEEEE
T ss_conf 337996798308891999999999997999999874657-9799999999999999778999824899999178998999
Q ss_pred EEECCCCCCHHHHHHHC--CCCCCCHHHHHHHHHHHHHHHHHHHHCC-----CCCCCCCCCCEEEECCCCEEEEECCCCC
Q ss_conf 99605898356677317--9999989999999999999999999859-----4317899996898069928998516775
Q 001847 750 ITDYCPGGELFLLLDRQ--PTKVLKEDAVRFYAAEVVVALEYLHCQG-----IIYRDLKPENVLLQGNGHVSLTDFDLSC 822 (1005)
Q Consensus 750 V~E~~~g~sL~~~l~~~--~~~~l~~~~i~~i~~qil~aL~~LH~~g-----IvH~DLkP~NIli~~~g~ikL~DFG~a~ 822 (1005)
|||||++|+|.+++... ....+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+|.
T Consensus 83 vmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~ 162 (269)
T d2java1 83 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR 162 (269)
T ss_dssp EEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHH
T ss_pred EEECCCCCCHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCHHHCCCCCCCCEEEEECCCEE
T ss_conf 99568999389999851545789999999999999999999999716778878858676542574788857980010003
Q ss_pred CCCCCCCCCCCCCHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCC
Q ss_conf 45889877788512332114699997432356665655556876335200038888883059999999999990999999
Q 001847 823 LTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFR 902 (1005)
Q Consensus 823 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDIwSLG~il~eLltG~~Pf~ 902 (1005)
...... ......+||+.|+|||++.+..++.++|||||||++|+|++|+.||.
T Consensus 163 ~~~~~~---------------------------~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~ 215 (269)
T d2java1 163 ILNHDT---------------------------SFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFT 215 (269)
T ss_dssp HC--------------------------------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCC
T ss_pred ECCCCC---------------------------CCCCCCCCCCCCCCHHHHCCCCCCHHHHHHHHCHHHHHHHHCCCCCC
T ss_conf 224577---------------------------75566778823279999839999938988752789999801889989
Q ss_pred CCCHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHCHHHHHCCCCC
Q ss_conf 99968999999828999999998879899999980103927669982409999819997
Q 001847 903 GKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFF 961 (1005)
Q Consensus 903 ~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~mL~~dP~~Rpt~~~~a~elL~hpff 961 (1005)
+.+..+....+..+.... .+..++.++.+||.+||..||.+||| +.|+|+|||+
T Consensus 216 ~~~~~~~~~~i~~~~~~~-~~~~~s~~l~~li~~~L~~dp~~Rps----~~ell~hp~i 269 (269)
T d2java1 216 AFSQKELAGKIREGKFRR-IPYRYSDELNEIITRMLNLKDYHRPS----VEEILENPLI 269 (269)
T ss_dssp CSSHHHHHHHHHHTCCCC-CCTTSCHHHHHHHHHHTCSSGGGSCC----HHHHHTSTTC
T ss_pred CCCHHHHHHHHHCCCCCC-CCCCCCHHHHHHHHHHCCCCHHHCCC----HHHHHHCCCC
T ss_conf 989999999997189988-97435999999999976799557918----9999729819
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=387.23 Aligned_cols=257 Identities=22% Similarity=0.357 Sum_probs=215.6
Q ss_pred CCCCCCCCCCCCCCCCCEEEEEEEECCCCEEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEE----C
Q ss_conf 346884323311666938999999907991999999405312375789999999999995799984537899870----7
Q 001847 669 INLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQT----K 744 (1005)
Q Consensus 669 i~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~----~ 744 (1005)
.+..-|++.+.||+|+||.||+|.+..++..||+|.+..... .......+.+|++++++++||||+++++++.. .
T Consensus 6 ~~gry~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~-~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ 84 (270)
T d1t4ha_ 6 NDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKL-TKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGK 84 (270)
T ss_dssp TTSCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSC
T ss_pred CCCCEEEEEEEEECCCCCEEEEEEECCCCEEEEEEEECHHHC-CHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCC
T ss_conf 788778851697008284999999999995999999851227-9899999999999998579998506999984033458
Q ss_pred CEEEEEEECCCCCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--CCCCCCCCCCEEEE-CCCCEEEEECCCC
Q ss_conf 81899996058983566773179999989999999999999999999859--43178999968980-6992899851677
Q 001847 745 THVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQG--IIYRDLKPENVLLQ-GNGHVSLTDFDLS 821 (1005)
Q Consensus 745 ~~~~iV~E~~~g~sL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~g--IvH~DLkP~NIli~-~~g~ikL~DFG~a 821 (1005)
..+|+||||+++|+|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||+|
T Consensus 85 ~~~~ivmE~~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla 162 (270)
T d1t4ha_ 85 KCIVLVTELMTSGTLKTYLKRF--KVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLA 162 (270)
T ss_dssp EEEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGG
T ss_pred CEEEEEEECCCCCCHHHHHHCC--CCCCHHHHHHHHHHHHHHHHHHHHCCCCEEECCCCHHHCEEECCCCCEEEEECCCC
T ss_conf 8899999578989489997513--55469999999999999999999789979968767435116679998898005765
Q ss_pred CCCCCCCCCCCCCCHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCC
Q ss_conf 54588987778851233211469999743235666565555687633520003888888305999999999999099999
Q 001847 822 CLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPF 901 (1005)
Q Consensus 822 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDIwSLG~il~eLltG~~Pf 901 (1005)
..... ......+||+.|+|||++.+ .++.++|||||||++|+|++|+.||
T Consensus 163 ~~~~~-----------------------------~~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf 212 (270)
T d1t4ha_ 163 TLKRA-----------------------------SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPY 212 (270)
T ss_dssp GGCCT-----------------------------TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTT
T ss_pred EECCC-----------------------------CCCCCCCCCCCCCCHHHHCC-CCCCCCCHHHHHHHHHHHHHCCCCC
T ss_conf 42368-----------------------------76677553813008988478-9998671100799999998788999
Q ss_pred CCCCHHHHH-HHHHHCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHCHHHHHCCCCCC
Q ss_conf 999968999-9998289999999988798999999801039276699824099998199977
Q 001847 902 RGKTRQKTF-ANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFK 962 (1005)
Q Consensus 902 ~~~~~~~~~-~~i~~~~~~~~~~~~~s~~l~~Ll~~mL~~dP~~Rpt~~~~a~elL~hpff~ 962 (1005)
.+......+ ..+..+..+.......+.++.+||.+||..||++||| +.|+|+||||+
T Consensus 213 ~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s----~~ell~Hp~fk 270 (270)
T d1t4ha_ 213 SECQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYS----IKDLLNHAFFQ 270 (270)
T ss_dssp TTCSSHHHHHHHHTTTCCCGGGGGCCCHHHHHHHHHHSCSSGGGSCC----HHHHHTSGGGC
T ss_pred CCCCCHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCC----HHHHHCCCCCC
T ss_conf 87655999999997389986567557899999999976379758929----99996775409
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=388.10 Aligned_cols=256 Identities=26% Similarity=0.416 Sum_probs=227.6
Q ss_pred CCCCCCCCCCCCCCCEEEEEEEECCCCEEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEEEE
Q ss_conf 68843233116669389999999079919999994053123757899999999999957999845378998707818999
Q 001847 671 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLI 750 (1005)
Q Consensus 671 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~iV 750 (1005)
.++|++++.||+|+||.||+|.+..+++.||+|.++... .....+.+|+.+|+.++||||++++++|...+.+|+|
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~----~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lv 79 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG----TDQVLVKKEISILNIARHRNILHLHESFESMEELVMI 79 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT----HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEE
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCCC----CCHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEEEE
T ss_conf 010588789831778399999998999699999975786----6599999999999857997989098999889988999
Q ss_pred EECCCCCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEEECC--CCEEEEECCCCCCCCCCC
Q ss_conf 960589835667731799999899999999999999999998594317899996898069--928998516775458898
Q 001847 751 TDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGN--GHVSLTDFDLSCLTSCKP 828 (1005)
Q Consensus 751 ~E~~~g~sL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvH~DLkP~NIli~~~--g~ikL~DFG~a~~~~~~~ 828 (1005)
||||+|++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++.+ ..+||+|||++.....
T Consensus 80 mE~~~gg~L~~~i~~~-~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~-- 156 (321)
T d1tkia_ 80 FEFISGLDIFERINTS-AFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP-- 156 (321)
T ss_dssp ECCCCCCBHHHHHTSS-SCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCT--
T ss_pred EECCCCCCHHHHHHHC-CCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCEEEEECCCCHHHCCCC--
T ss_conf 9538998088998753-8999999999999999999999987699751355444344378851899764411100346--
Q ss_pred CCCCCCCHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCHHH
Q ss_conf 77788512332114699997432356665655556876335200038888883059999999999990999999999689
Q 001847 829 QLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQK 908 (1005)
Q Consensus 829 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDIwSLG~il~eLltG~~Pf~~~~~~~ 908 (1005)
.......+|++.|+|||.+.+..++.++|||||||++|+|++|..||.+.+...
T Consensus 157 --------------------------~~~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~ 210 (321)
T d1tkia_ 157 --------------------------GDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQ 210 (321)
T ss_dssp --------------------------TCEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHH
T ss_pred --------------------------CCCCCCCCCCCCCCCCHHCCCCCCCCHHHCCCHHHHHHHHHHCCCCCCCCCHHH
T ss_conf --------------------------775321223322234021048777840113027999999982899999989999
Q ss_pred HHHHHHHCCCCCCCC--CCCCHHHHHHHHHCCCCCCCCCCCCHHCHHHHHCCCCCCC
Q ss_conf 999998289999999--9887989999998010392766998240999981999779
Q 001847 909 TFANILHKDLKFPSS--TPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKG 963 (1005)
Q Consensus 909 ~~~~i~~~~~~~~~~--~~~s~~l~~Ll~~mL~~dP~~Rpt~~~~a~elL~hpff~~ 963 (1005)
.+..+......++.. ..++.++.+||.+||..||.+||| +.|+|+||||++
T Consensus 211 ~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s----~~eil~hp~~~~ 263 (321)
T d1tkia_ 211 IIENIMNAEYTFDEEAFKEISIEAMDFVDRLLVKERKSRMT----ASEALQHPWLKQ 263 (321)
T ss_dssp HHHHHHHTCCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCC----HHHHHHSHHHHS
T ss_pred HHHHHHHCCCCCCHHHCCCCCHHHHHHHHHHCCCCHHHCCC----HHHHHCCHHHCC
T ss_conf 99999838999880223678999999999986699668909----999963996566
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=0 Score=380.09 Aligned_cols=260 Identities=30% Similarity=0.455 Sum_probs=227.8
Q ss_pred CCCCCCCCCCCCCCCEEEEEEEECCCCEEEEEEEEECCCCCC------HHHHHHHHHHHHHHHHCC-CCCCCEEEEEEEE
Q ss_conf 688432331166693899999990799199999940531237------578999999999999579-9984537899870
Q 001847 671 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLN------RNKVHRACAEREILDMLD-HPFVPALYASFQT 743 (1005)
Q Consensus 671 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~------~~~~~~~~~E~~il~~l~-hpnIv~l~~~~~~ 743 (1005)
.++|++.+.||+|+||.||+|++..+++.||+|++.+..... ......+.+|+.++++++ ||||+++++++.+
T Consensus 2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 81 (277)
T d1phka_ 2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 81 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred CCCCEECEEEECCCCEEEEEEEECCCCCEEEEEEEECCCCCCHHHHHHHHHHHHHHHHHHHHHHHCCCCCEEEEEEECCC
T ss_conf 66388852884176849999999999989999999624464114788899999999999999985079974799762146
Q ss_pred CCEEEEEEECCCCCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEEECCCCEEEEECCCCCC
Q ss_conf 78189999605898356677317999998999999999999999999985943178999968980699289985167754
Q 001847 744 KTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCL 823 (1005)
Q Consensus 744 ~~~~~iV~E~~~g~sL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvH~DLkP~NIli~~~g~ikL~DFG~a~~ 823 (1005)
++.+|+||||+++|+|.+++..+ +.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++..
T Consensus 82 ~~~~~ivmE~~~~g~L~~~l~~~--~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~ 159 (277)
T d1phka_ 82 NTFFFLVFDLMKKGELFDYLTEK--VTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQ 159 (277)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred CCCEEEEEECCCCCHHHHHHHHC--CCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCEEEECCCCCEEECCCHHEEE
T ss_conf 76059999768986689999865--9999999999999999999999875994323462548986899838712403167
Q ss_pred CCCCCCCCCCCCHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC------CCCCCHHHHHHHHHHHHHHHCC
Q ss_conf 5889877788512332114699997432356665655556876335200038------8888830599999999999909
Q 001847 824 TSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAG------AGHTSAVDWWALGILLYEMLYG 897 (1005)
Q Consensus 824 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~l~~------~~~~~~sDIwSLG~il~eLltG 897 (1005)
.... ......+||+.|+|||++.+ ..++.++||||+||++|+|++|
T Consensus 160 ~~~~----------------------------~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g 211 (277)
T d1phka_ 160 LDPG----------------------------EKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAG 211 (277)
T ss_dssp CCTT----------------------------CCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHS
T ss_pred CCCC----------------------------CCEEEEECCCCCCCHHHHHCCCCCCCCCCCCHHEECCCCHHHHHHCCC
T ss_conf 2688----------------------------721345246788898886053445678899233185656023103228
Q ss_pred CCCCCCCCHHHHHHHHHHCCCCCCC--CCCCCHHHHHHHHHCCCCCCCCCCCCHHCHHHHHCCCCCCCC
Q ss_conf 9999999968999999828999999--998879899999980103927669982409999819997799
Q 001847 898 YTPFRGKTRQKTFANILHKDLKFPS--STPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGV 964 (1005)
Q Consensus 898 ~~Pf~~~~~~~~~~~i~~~~~~~~~--~~~~s~~l~~Ll~~mL~~dP~~Rpt~~~~a~elL~hpff~~~ 964 (1005)
+.||.+.+.......+..+...++. ...+|.++.+||.+||..||.+||| +.++|+||||+..
T Consensus 212 ~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~p~~R~s----~~eil~h~~~~~~ 276 (277)
T d1phka_ 212 SPPFWHRKQMLMLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYT----AEEALAHPFFQQY 276 (277)
T ss_dssp SCSSCCSSHHHHHHHHHHTCCCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCC----HHHHTTSGGGCTT
T ss_pred CCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCC----HHHHHCCHHHHHH
T ss_conf 8898899999999999818988898543468999999999976589668919----9999739787975
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=385.14 Aligned_cols=268 Identities=27% Similarity=0.366 Sum_probs=219.4
Q ss_pred CCCCCCCCCCEEEEEEEECCCCEEEEEEEEECCCCCCH--HHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEEEEEEC
Q ss_conf 23311666938999999907991999999405312375--7899999999999957999845378998707818999960
Q 001847 676 PIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNR--NKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDY 753 (1005)
Q Consensus 676 ~~~~LG~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~--~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~iV~E~ 753 (1005)
.++.||+|+||.||+|.+..+++.||||++........ .....+.+|+.+++.++||||+++++++...+.+|+||||
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~ 81 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF 81 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred CCEEECCCCCEEEEEEEECCCCCEEEEEEEEHHHHHHHHHHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCCEEEHHHH
T ss_conf 56385127282999999999996999999842021245679999999999999867999986898542258740220455
Q ss_pred CCCCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEEECCCCEEEEECCCCCCCCCCCCCCCC
Q ss_conf 58983566773179999989999999999999999999859431789999689806992899851677545889877788
Q 001847 754 CPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLP 833 (1005)
Q Consensus 754 ~~g~sL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvH~DLkP~NIli~~~g~ikL~DFG~a~~~~~~~~~~~~ 833 (1005)
+.++++..+... ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|......
T Consensus 82 ~~~~~~~~~~~~--~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~------ 153 (299)
T d1ua2a_ 82 METDLEVIIKDN--SLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSP------ 153 (299)
T ss_dssp CSEEHHHHHTTC--CSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSC------
T ss_pred HCCHHHHHHHHC--CCCCCHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCEEEECCCCCCCCCCCCCCCCCCCC------
T ss_conf 345077655412--667789999999999999998863163550357762588537784114657610005787------
Q ss_pred CCHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC-CCCCHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHH
Q ss_conf 5123321146999974323566656555568763352000388-888830599999999999909999999996899999
Q 001847 834 TTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGA-GHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFAN 912 (1005)
Q Consensus 834 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~-~~~~~sDIwSLG~il~eLltG~~Pf~~~~~~~~~~~ 912 (1005)
.......+||+.|+|||++... .++.++|||||||++|+|++|.+||.+.+..+.+..
T Consensus 154 ---------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~ 212 (299)
T d1ua2a_ 154 ---------------------NRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTR 212 (299)
T ss_dssp ---------------------CCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH
T ss_pred ---------------------CCCCCCEECCHHHCCHHHHCCCCCCCHHHHHHHCCHHHHHHHHCCCCCCCCCHHHHHHH
T ss_conf ---------------------55433020473336399972677888056436304289999859699999999999999
Q ss_pred HHHCCCC-----C---------------CC------CCCCCHHHHHHHHHCCCCCCCCCCCCHHCHHHHHCCCCCCCCCH
Q ss_conf 9828999-----9---------------99------99887989999998010392766998240999981999779981
Q 001847 913 ILHKDLK-----F---------------PS------STPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVNW 966 (1005)
Q Consensus 913 i~~~~~~-----~---------------~~------~~~~s~~l~~Ll~~mL~~dP~~Rpt~~~~a~elL~hpff~~~~~ 966 (1005)
+...... + +. ....+.++.+||.+||+.||.+||| |.|+|+||||++...
T Consensus 213 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~s----a~e~L~Hp~f~~~p~ 288 (299)
T d1ua2a_ 213 IFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARIT----ATQALKMKYFSNRPG 288 (299)
T ss_dssp HHHHHCCCCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCC----HHHHHTSGGGTSSSC
T ss_pred HHHHCCCCCHHHCCCHHCCCHHHHHCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCC----HHHHHCCHHHCCCCC
T ss_conf 9985189972545210002134430347898867856568999999999976389456908----999967996578999
Q ss_pred HHHHHCCCCCCCCC
Q ss_conf 13350599988999
Q 001847 967 ALVRCMNPPELDAP 980 (1005)
Q Consensus 967 ~~~~~~~~~~~~~~ 980 (1005)
+.- +.++|.|
T Consensus 289 p~~----~~~~p~p 298 (299)
T d1ua2a_ 289 PTP----GCQLPRP 298 (299)
T ss_dssp CCC----SSSSCCC
T ss_pred CCC----CCCCCCC
T ss_conf 989----8889999
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=383.30 Aligned_cols=253 Identities=25% Similarity=0.435 Sum_probs=213.2
Q ss_pred CCCCCCCC-CCCCCCCEEEEEEEECCCCEEEEEEEEECCCCCCHHHHHHHHHHHHHHHH-CCCCCCCEEEEEEEE----C
Q ss_conf 68843233-11666938999999907991999999405312375789999999999995-799984537899870----7
Q 001847 671 LQHFRPIK-PLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDM-LDHPFVPALYASFQT----K 744 (1005)
Q Consensus 671 ~~~y~~~~-~LG~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~-l~hpnIv~l~~~~~~----~ 744 (1005)
.++|+++. .||+|+||.||+|.+..+++.||||++... ....+|+.++.+ ++||||++++++|.+ .
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~--------~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~ 81 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYENLYAGR 81 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTE
T ss_pred CCCEEEEEEEEEECCCEEEEEEEECCCCCEEEEEEECCC--------HHHHHHHHHHHHHCCCCCCCEEEEEEEECCCCC
T ss_conf 148798107965454869999998899989999998974--------779999999998669999782989995034689
Q ss_pred CEEEEEEECCCCCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEEEC---CCCEEEEECCCC
Q ss_conf 81899996058983566773179999989999999999999999999859431789999689806---992899851677
Q 001847 745 THVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQG---NGHVSLTDFDLS 821 (1005)
Q Consensus 745 ~~~~iV~E~~~g~sL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvH~DLkP~NIli~~---~g~ikL~DFG~a 821 (1005)
..+|+|||||+||+|.+++.......+++..++.++.||+.||+|||++||+||||||+|||++. ++.+||+|||+|
T Consensus 82 ~~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a 161 (335)
T d2ozaa1 82 KCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFA 161 (335)
T ss_dssp EEEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred CEEEEEEECCCCCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEE
T ss_conf 78999997789984999998627877579999999999999999999769864441002201135555663113545512
Q ss_pred CCCCCCCCCCCCCCHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCC
Q ss_conf 54588987778851233211469999743235666565555687633520003888888305999999999999099999
Q 001847 822 CLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPF 901 (1005)
Q Consensus 822 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDIwSLG~il~eLltG~~Pf 901 (1005)
...... ......+||+.|+|||++.+..++.++|||||||++|+|++|++||
T Consensus 162 ~~~~~~----------------------------~~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf 213 (335)
T d2ozaa1 162 KETTSH----------------------------NSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPF 213 (335)
T ss_dssp EECCCC----------------------------CCCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSC
T ss_pred EECCCC----------------------------CCCCCCCCCCCCCCCHHHCCCCCCHHHHHHHHCHHHHHHHHCCCCC
T ss_conf 333688----------------------------8643226775637927774898888888876451677886588998
Q ss_pred CCCCHHHHHHHHHH----CCCCCCCC--CCCCHHHHHHHHHCCCCCCCCCCCCHHCHHHHHCCCCCCC
Q ss_conf 99996899999982----89999999--9887989999998010392766998240999981999779
Q 001847 902 RGKTRQKTFANILH----KDLKFPSS--TPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKG 963 (1005)
Q Consensus 902 ~~~~~~~~~~~i~~----~~~~~~~~--~~~s~~l~~Ll~~mL~~dP~~Rpt~~~~a~elL~hpff~~ 963 (1005)
.+.+.......+.. ....++.. ..++.++.+||.+||..||.+||| +.|+|+||||+.
T Consensus 214 ~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s----~~eil~hp~~~~ 277 (335)
T d2ozaa1 214 YSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMT----ITEFMNHPWIMQ 277 (335)
T ss_dssp EETTCC--------CCCSCSSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCC----HHHHHHSHHHHT
T ss_pred CCCCHHHHHHHHHHHHHCCCCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCC----HHHHHCCHHHHC
T ss_conf 8988778899999998538888898543469999999999975699657909----999970987617
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=378.59 Aligned_cols=261 Identities=26% Similarity=0.451 Sum_probs=220.3
Q ss_pred CCCCCCCCCCCCCCCEEEEEEEECCCCEEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEEEE
Q ss_conf 68843233116669389999999079919999994053123757899999999999957999845378998707818999
Q 001847 671 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLI 750 (1005)
Q Consensus 671 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~iV 750 (1005)
+++|++++.||+|+||.||+|.+..+++.||+|++..... .......+.+|+.++++++||||+++++++...+.+|+|
T Consensus 1 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv 79 (298)
T d1gz8a_ 1 MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE-TEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLV 79 (298)
T ss_dssp CTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC--------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred CCCCEECCEEECCCCEEEEEEEECCCCCEEEEEEEEHHHC-CHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCCCCEEEE
T ss_conf 9997765177237680999999999997999999802225-758999999999999867998388744533224320378
Q ss_pred EECCCCCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEEECCCCEEEEECCCCCCCCCCCCC
Q ss_conf 96058983566773179999989999999999999999999859431789999689806992899851677545889877
Q 001847 751 TDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQL 830 (1005)
Q Consensus 751 ~E~~~g~sL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvH~DLkP~NIli~~~g~ikL~DFG~a~~~~~~~~~ 830 (1005)
|||+ ++++.+++.......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||.|......
T Consensus 80 ~e~~-~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~--- 155 (298)
T d1gz8a_ 80 FEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP--- 155 (298)
T ss_dssp EECC-SEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCC---
T ss_pred EEEC-CCCHHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHCCCEECCCCCCHHEEECCCCCCEECCCCCCEECCCC---
T ss_conf 8623-774455544202568888999999999999999865288992135711401134676210357861343688---
Q ss_pred CCCCCHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC-CCHHHHHHHHHHHHHHHCCCCCCCCCCHHHH
Q ss_conf 788512332114699997432356665655556876335200038888-8830599999999999909999999996899
Q 001847 831 LLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGH-TSAVDWWALGILLYEMLYGYTPFRGKTRQKT 909 (1005)
Q Consensus 831 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~-~~~sDIwSLG~il~eLltG~~Pf~~~~~~~~ 909 (1005)
........||+.|+|||++....+ +.++|||||||++|+|++|+.||.+.+....
T Consensus 156 ------------------------~~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~ 211 (298)
T d1gz8a_ 156 ------------------------VRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQ 211 (298)
T ss_dssp ------------------------SBCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH
T ss_pred ------------------------CCCCEEECCCCEEEEHHHHCCCCCCCCCCCCCCCCHHHHHHHHCCCCCCCCCHHHH
T ss_conf ------------------------64100103652154112213665777422103333134279668799898899999
Q ss_pred HHHHHHCCCC------------------CCC---------CCCCCHHHHHHHHHCCCCCCCCCCCCHHCHHHHHCCCCCC
Q ss_conf 9999828999------------------999---------9988798999999801039276699824099998199977
Q 001847 910 FANILHKDLK------------------FPS---------STPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFK 962 (1005)
Q Consensus 910 ~~~i~~~~~~------------------~~~---------~~~~s~~l~~Ll~~mL~~dP~~Rpt~~~~a~elL~hpff~ 962 (1005)
...+...... ++. ....+.++.+||.+||..||.+||| +.|+|+||||+
T Consensus 212 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t----~~ell~H~ff~ 287 (298)
T d1gz8a_ 212 LFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRIS----AKAALAHPFFQ 287 (298)
T ss_dssp HHHHHHHHCCCCTTTSTTGGGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCC----HHHHHTSGGGT
T ss_pred HHHHHHHCCCCCHHHCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCC----HHHHHCCHHHC
T ss_conf 99999832898333144422242124345432222044416678999999999976399557918----99996787014
Q ss_pred CC
Q ss_conf 99
Q 001847 963 GV 964 (1005)
Q Consensus 963 ~~ 964 (1005)
++
T Consensus 288 ~~ 289 (298)
T d1gz8a_ 288 DV 289 (298)
T ss_dssp TC
T ss_pred CC
T ss_conf 69
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=0 Score=373.55 Aligned_cols=258 Identities=22% Similarity=0.266 Sum_probs=220.8
Q ss_pred CCCCCCCCCCCCCCCCCCCCEEEEEEEECCCCEEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECC
Q ss_conf 44434688432331166693899999990799199999940531237578999999999999579998453789987078
Q 001847 666 GEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKT 745 (1005)
Q Consensus 666 ~~~i~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~ 745 (1005)
.|.+..++|++.+.||+|+||.||+|.+..+++.||+|+++... .....+.+|+.++++++||||+++++++...+
T Consensus 11 ~wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~----~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~ 86 (287)
T d1opja_ 11 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT----MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREP 86 (287)
T ss_dssp TTBCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC----SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred CCEECHHHEEEEEEEEECCCEEEEEEEECCCCEEEEEEEECCCC----CHHHHHHHHHHHHHHCCCCCEECCCCCEEECC
T ss_conf 51745799398659820888089999999999699999977761----03999999999998679998826775274578
Q ss_pred EEEEEEECCCCCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEEECCCCEEEEECCCCCCCC
Q ss_conf 18999960589835667731799999899999999999999999998594317899996898069928998516775458
Q 001847 746 HVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTS 825 (1005)
Q Consensus 746 ~~~iV~E~~~g~sL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvH~DLkP~NIli~~~g~ikL~DFG~a~~~~ 825 (1005)
.+|+|||||++|+|.+++.......+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+...
T Consensus 87 ~~~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~ 166 (287)
T d1opja_ 87 PFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT 166 (287)
T ss_dssp SCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCCTTTCC
T ss_pred EEEEEEECCCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCEEEECCCCCEEECCCCCEEECC
T ss_conf 54787631467606777530355415799999999999997888987893057604576899899928983244546537
Q ss_pred CCCCCCCCCCHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCC
Q ss_conf 89877788512332114699997432356665655556876335200038888883059999999999990999999999
Q 001847 826 CKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKT 905 (1005)
Q Consensus 826 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDIwSLG~il~eLltG~~Pf~~~~ 905 (1005)
.... .......|++.|+|||++.+..++.++|||||||++|+|++|..||....
T Consensus 167 ~~~~--------------------------~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~ 220 (287)
T d1opja_ 167 GDTY--------------------------TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI 220 (287)
T ss_dssp SSSS--------------------------EEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred CCCC--------------------------EEECCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCC
T ss_conf 8872--------------------------21035566546669278727999810430217899999986799887742
Q ss_pred HHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHCHHHHHC
Q ss_conf 6899999982899999999887989999998010392766998240999981
Q 001847 906 RQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKK 957 (1005)
Q Consensus 906 ~~~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~mL~~dP~~Rpt~~~~a~elL~ 957 (1005)
....+..++......+.+..++..+.+|+.+||..||.+||| +.++++
T Consensus 221 ~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps----~~ei~~ 268 (287)
T d1opja_ 221 DLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPS----FAEIHQ 268 (287)
T ss_dssp CHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCC----HHHHHH
T ss_pred HHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHCCCCHHHCCC----HHHHHH
T ss_conf 599999998558888887433099999999975779768939----999999
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=371.16 Aligned_cols=263 Identities=24% Similarity=0.381 Sum_probs=213.9
Q ss_pred CCCCCCCCCCCCCCCCEEEEEEEECCC-CEEEEEEEEECCCCCCHHHHHHHHHHHHHHHHC---CCCCCCEEEEEEEE--
Q ss_conf 468843233116669389999999079-919999994053123757899999999999957---99984537899870--
Q 001847 670 NLQHFRPIKPLGSGDTGSVHLVELCGS-GQYFAMKAMDKGVMLNRNKVHRACAEREILDML---DHPFVPALYASFQT-- 743 (1005)
Q Consensus 670 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~-~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l---~hpnIv~l~~~~~~-- 743 (1005)
..++|++++.||+|+||.||+|.+..+ ++.||||++....... .......+|+.+++.+ +||||++++++|..
T Consensus 5 ~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~-~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~ 83 (305)
T d1blxa_ 5 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEE-GMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSR 83 (305)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTT-SCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEE
T ss_pred CCCCEEEEEEEECCCCEEEEEEEEECCCCEEEEEEEEEHHHCCC-HHHHHHHHHHHHHHHHHHCCCCCCCEEEEEECCCC
T ss_conf 75897988899215586999999988899899999980232451-67999999999999874258988023663221466
Q ss_pred ---CCEEEEEEECCCCCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEEECCCCEEEEECCC
Q ss_conf ---78189999605898356677317999998999999999999999999985943178999968980699289985167
Q 001847 744 ---KTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDL 820 (1005)
Q Consensus 744 ---~~~~~iV~E~~~g~sL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvH~DLkP~NIli~~~g~ikL~DFG~ 820 (1005)
...++++||++.++.+..... .....+++..++.++.|++.||+|||+++|+||||||+|||++.++.+||+|||+
T Consensus 84 ~~~~~~~~~~~e~~~~~~~~~~~~-~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~~~~~kl~dfg~ 162 (305)
T d1blxa_ 84 TDRETKLTLVFEHVDQDLTTYLDK-VPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGL 162 (305)
T ss_dssp CSSEEEEEEEEECCSCBHHHHHHH-SCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCS
T ss_pred CCCCCEEEEEEEECCCCCHHHHHH-CCCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECCCCCCEEEECCCCCEEECCHHH
T ss_conf 666746999997405871444443-0378999899999999999999999758898357986278985899754210001
Q ss_pred CCCCCCCCCCCCCCCHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCC
Q ss_conf 75458898777885123321146999974323566656555568763352000388888830599999999999909999
Q 001847 821 SCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTP 900 (1005)
Q Consensus 821 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDIwSLG~il~eLltG~~P 900 (1005)
+..... ........||+.|+|||++.+..++.++|||||||++|+|++|++|
T Consensus 163 ~~~~~~----------------------------~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~p 214 (305)
T d1blxa_ 163 ARIYSF----------------------------QMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPL 214 (305)
T ss_dssp CCCCCG----------------------------GGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCS
T ss_pred HHHHCC----------------------------CCCCCCCCCCHHHCCCCHHCCCCCCHHEHHHCHHHHHHHHHHCCCC
T ss_conf 011002----------------------------3457776548511483100179888111000328999999878799
Q ss_pred CCCCCHHHHHHHHHHCCCC-----C--------------------CCCCCCCHHHHHHHHHCCCCCCCCCCCCHHCHHHH
Q ss_conf 9999968999999828999-----9--------------------99998879899999980103927669982409999
Q 001847 901 FRGKTRQKTFANILHKDLK-----F--------------------PSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEI 955 (1005)
Q Consensus 901 f~~~~~~~~~~~i~~~~~~-----~--------------------~~~~~~s~~l~~Ll~~mL~~dP~~Rpt~~~~a~el 955 (1005)
|.+.+..+.+..+...... + ......+..+.+||.+||..||.+||| +.|+
T Consensus 215 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~s----a~e~ 290 (305)
T d1blxa_ 215 FRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRIS----AYSA 290 (305)
T ss_dssp CCCSSHHHHHHHHHHHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCC----HHHH
T ss_pred CCCCCHHHHHHHHHHHHCCCCHHCCCCCCCCHHHHHCCCCCCCHHHCCCCCCHHHHHHHHHHCCCCHHHCCC----HHHH
T ss_conf 899898999999998407996110532111103330223456454404458999999999987489667918----9999
Q ss_pred HCCCCCCCCCH
Q ss_conf 81999779981
Q 001847 956 KKHPFFKGVNW 966 (1005)
Q Consensus 956 L~hpff~~~~~ 966 (1005)
|+||||++++.
T Consensus 291 L~Hpff~~i~~ 301 (305)
T d1blxa_ 291 LSHPYFQDLER 301 (305)
T ss_dssp HTSGGGTTCCC
T ss_pred HCCHHHCCCHH
T ss_conf 66963407521
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=372.02 Aligned_cols=259 Identities=28% Similarity=0.433 Sum_probs=220.0
Q ss_pred CCCCCCCCCCCCCCCEEEEEEEECCCCEEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECC-----
Q ss_conf 688432331166693899999990799199999940531237578999999999999579998453789987078-----
Q 001847 671 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKT----- 745 (1005)
Q Consensus 671 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~----- 745 (1005)
.++|++++.||+|+||.||+|.+..+++.||||++++.. ........+.+|+.+|+.++||||++++++|...+
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~-~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~ 95 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPF-QSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF 95 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTT-SSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHH-CCHHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCCCCCC
T ss_conf 771899889801778199999999999899999985222-5969999999999999866898754799986357655554
Q ss_pred -EEEEEEECCCCCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEEECCCCEEEEECCCCCCC
Q ss_conf -1899996058983566773179999989999999999999999999859431789999689806992899851677545
Q 001847 746 -HVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLT 824 (1005)
Q Consensus 746 -~~~iV~E~~~g~sL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvH~DLkP~NIli~~~g~ikL~DFG~a~~~ 824 (1005)
.+|+||||+ +.+|..+.+. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|...
T Consensus 96 ~~~~lv~e~~-~~~l~~~~~~---~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~ 171 (346)
T d1cm8a_ 96 TDFYLVMPFM-GTDLGKLMKH---EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQA 171 (346)
T ss_dssp CCCEEEEECC-SEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred CEEEEEEECC-CCCHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHCCCCCCCCCCCCCCEECC
T ss_conf 1599998405-5218999874---02269999999999999999987378764566851111210012211343102206
Q ss_pred CCCCCCCCCCCHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC-CCCCHHHHHHHHHHHHHHHCCCCCCCC
Q ss_conf 8898777885123321146999974323566656555568763352000388-888830599999999999909999999
Q 001847 825 SCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGA-GHTSAVDWWALGILLYEMLYGYTPFRG 903 (1005)
Q Consensus 825 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~-~~~~~sDIwSLG~il~eLltG~~Pf~~ 903 (1005)
.. ......||+.|+|||++.+. .++.++|||||||++|+|++|++||.+
T Consensus 172 ~~------------------------------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~ 221 (346)
T d1cm8a_ 172 DS------------------------------EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKG 221 (346)
T ss_dssp CS------------------------------SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCC
T ss_pred CC------------------------------CCCCCCCCCCCCCHHHHCCCCCCCCCCHHHCCHHHHHHHHHCCCCCCC
T ss_conf 87------------------------------631024553335889981787899650103003899999978699888
Q ss_pred CCHHHHHHHHHHCCCC-----------------------C------CCCCCCCHHHHHHHHHCCCCCCCCCCCCHHCHHH
Q ss_conf 9968999999828999-----------------------9------9999887989999998010392766998240999
Q 001847 904 KTRQKTFANILHKDLK-----------------------F------PSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANE 954 (1005)
Q Consensus 904 ~~~~~~~~~i~~~~~~-----------------------~------~~~~~~s~~l~~Ll~~mL~~dP~~Rpt~~~~a~e 954 (1005)
.+....+..+...... . ......+..+.+||.+||..||.+||| +.|
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~t----a~e 297 (346)
T d1cm8a_ 222 SDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVT----AGE 297 (346)
T ss_dssp SSHHHHHHHHHHHHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCC----HHH
T ss_pred CCHHHHHHHHHHCCCCCCHHHHHHHCCHHHHHHHCCCCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCC----HHH
T ss_conf 9768999999850378848888653000344331157866655667755689999999999977299557929----999
Q ss_pred HHCCCCCCCCCHHH
Q ss_conf 98199977998113
Q 001847 955 IKKHPFFKGVNWAL 968 (1005)
Q Consensus 955 lL~hpff~~~~~~~ 968 (1005)
+|+||||+++....
T Consensus 298 iL~Hp~f~~~~~~~ 311 (346)
T d1cm8a_ 298 ALAHPYFESLHDTE 311 (346)
T ss_dssp HHHSGGGTTTC---
T ss_pred HHCCHHHCCCCCCC
T ss_conf 96396237587766
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=373.44 Aligned_cols=263 Identities=21% Similarity=0.304 Sum_probs=223.9
Q ss_pred CCCCCCCCCCCCCCCCCCCCCEEEEEEEECCCC-----EEEEEEEEECCCCCCHHHHHHHHHHHHHHHHC-CCCCCCEEE
Q ss_conf 544434688432331166693899999990799-----19999994053123757899999999999957-999845378
Q 001847 665 SGEQINLQHFRPIKPLGSGDTGSVHLVELCGSG-----QYFAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPALY 738 (1005)
Q Consensus 665 ~~~~i~~~~y~~~~~LG~G~~g~Vy~~~~~~~~-----~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~ 738 (1005)
..|.+..++|++.+.||+|+||.||+|.+..++ ..||+|.+.... .......+.+|+.++.++ +||||++++
T Consensus 30 ~kwei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~HpnIv~l~ 107 (325)
T d1rjba_ 30 LKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA--DSSEREALMSELKMMTQLGSHENIVNLL 107 (325)
T ss_dssp GGGBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC--------CHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred CCCCCCHHHEEEEEEEEECCCEEEEEEEECCCCCCCCEEEEEEEEECCCC--CHHHHHHHHHHHHHHHHHCCCCCEEEEE
T ss_conf 44657789939701983078819999998578855420499999966335--8789999999999999715899686877
Q ss_pred EEEEECCEEEEEEECCCCCCHHHHHHHCCC---------------------CCCCHHHHHHHHHHHHHHHHHHHHCCCCC
Q ss_conf 998707818999960589835667731799---------------------99989999999999999999999859431
Q 001847 739 ASFQTKTHVCLITDYCPGGELFLLLDRQPT---------------------KVLKEDAVRFYAAEVVVALEYLHCQGIIY 797 (1005)
Q Consensus 739 ~~~~~~~~~~iV~E~~~g~sL~~~l~~~~~---------------------~~l~~~~i~~i~~qil~aL~~LH~~gIvH 797 (1005)
+++...+.+|+|||||++|+|.+++..... ..+++..++.++.||+.||+|||+++|+|
T Consensus 108 ~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiH 187 (325)
T d1rjba_ 108 GACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVH 187 (325)
T ss_dssp EEECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEE
T ss_pred EEEEECCEEEEEEECCCCCCHHHHHHHCCCCCCCHHHHHCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEEE
T ss_conf 88862995899997279995999998625777510221000012220012577899999999999999999997399050
Q ss_pred CCCCCCCEEEECCCCEEEEECCCCCCCCCCCCCCCCCCHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC
Q ss_conf 78999968980699289985167754588987778851233211469999743235666565555687633520003888
Q 001847 798 RDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAG 877 (1005)
Q Consensus 798 ~DLkP~NIli~~~g~ikL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~ 877 (1005)
|||||+|||++.++.+||+|||+|+....... ........||+.|+|||++.+..
T Consensus 188 RDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~-------------------------~~~~~~~~gt~~y~aPE~l~~~~ 242 (325)
T d1rjba_ 188 RDLAARNVLVTHGKVVKICDFGLARDIMSDSN-------------------------YVVRGNARLPVKWMAPESLFEGI 242 (325)
T ss_dssp TTCSGGGEEEETTTEEEECCCGGGSCGGGCTT-------------------------SEEETTEEECGGGCCHHHHHHCC
T ss_pred CCCCHHCCCCCCCCEEEEEECCCCCCCCCCCC-------------------------EEEECCCCCCCCCCCHHHHCCCC
T ss_conf 52703214434598289851422220457786-------------------------15623435787657838872799
Q ss_pred CCCHHHHHHHHHHHHHHHC-CCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHCHHHHH
Q ss_conf 8883059999999999990-999999999689999998289999999988798999999801039276699824099998
Q 001847 878 HTSAVDWWALGILLYEMLY-GYTPFRGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIK 956 (1005)
Q Consensus 878 ~~~~sDIwSLG~il~eLlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~mL~~dP~~Rpt~~~~a~elL 956 (1005)
++.++|||||||++|+|++ |++||.+.+....+..++.....++.+..++.++.+|+.+||..||++||| +++++
T Consensus 243 ~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~~~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt----~~ei~ 318 (325)
T d1rjba_ 243 YTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPS----FPNLT 318 (325)
T ss_dssp CCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCC----HHHHH
T ss_pred CCCCEECCCHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCC----HHHHH
T ss_conf 99633030003999999838999999989899999998569989988767899999999975889668939----99999
Q ss_pred CC
Q ss_conf 19
Q 001847 957 KH 958 (1005)
Q Consensus 957 ~h 958 (1005)
+|
T Consensus 319 ~~ 320 (325)
T d1rjba_ 319 SF 320 (325)
T ss_dssp HH
T ss_pred HH
T ss_conf 99
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=374.86 Aligned_cols=289 Identities=41% Similarity=0.727 Sum_probs=234.5
Q ss_pred CCCCCCCCCCCCCCCCCEEEEEEEEC---CCCEEEEEEEEECCCCC-CHHHHHHHHHHHHHHHHCCC-CCCCEEEEEEEE
Q ss_conf 34688432331166693899999990---79919999994053123-75789999999999995799-984537899870
Q 001847 669 INLQHFRPIKPLGSGDTGSVHLVELC---GSGQYFAMKAMDKGVML-NRNKVHRACAEREILDMLDH-PFVPALYASFQT 743 (1005)
Q Consensus 669 i~~~~y~~~~~LG~G~~g~Vy~~~~~---~~~~~vaiK~i~~~~~~-~~~~~~~~~~E~~il~~l~h-pnIv~l~~~~~~ 743 (1005)
+.+++|++++.||+|+||.||+|.+. .+++.||+|.+.+.... +......+.+|+.++++++| |||+++++++..
T Consensus 21 ~~l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~ 100 (322)
T d1vzoa_ 21 VGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQT 100 (322)
T ss_dssp CCGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEE
T ss_pred CCHHCEEEEEEEECCCCEEEEEEEECCCCCCCCEEEEEEEEHHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECC
T ss_conf 45102599989832878399999987658879489999983677210168999999999999864679839996200024
Q ss_pred CCEEEEEEECCCCCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEEECCCCEEEEECCCCCC
Q ss_conf 78189999605898356677317999998999999999999999999985943178999968980699289985167754
Q 001847 744 KTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCL 823 (1005)
Q Consensus 744 ~~~~~iV~E~~~g~sL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvH~DLkP~NIli~~~g~ikL~DFG~a~~ 823 (1005)
...++++|||+.+++|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..
T Consensus 101 ~~~~~~v~e~~~~~~L~~~i~~~--~~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~~~vkL~DFG~a~~ 178 (322)
T d1vzoa_ 101 ETKLHLILDYINGGELFTHLSQR--ERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKE 178 (322)
T ss_dssp TTEEEEEECCCCSCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEE
T ss_pred CCCEEEEEECCCCCHHHHHHHHC--CCCCHHHHHHHHHHHHHHHHHHHCCCEEECCCCCCCEEECCCCCEEEEECCCHHH
T ss_conf 87300123123411799998730--4543788888899999999885149989654773201246999888741320222
Q ss_pred CCCCCCCCCCCCHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC--CCCCHHHHHHHHHHHHHHHCCCCCC
Q ss_conf 58898777885123321146999974323566656555568763352000388--8888305999999999999099999
Q 001847 824 TSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGA--GHTSAVDWWALGILLYEMLYGYTPF 901 (1005)
Q Consensus 824 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~--~~~~~sDIwSLG~il~eLltG~~Pf 901 (1005)
..... ........|++.|++||.+.+. .++.++|||||||++|+|++|+.||
T Consensus 179 ~~~~~--------------------------~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF 232 (322)
T d1vzoa_ 179 FVADE--------------------------TERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPF 232 (322)
T ss_dssp CCGGG--------------------------GGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTT
T ss_pred HCCCC--------------------------CCCCCCCCCCCCCCHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHCCCCC
T ss_conf 03444--------------------------4322122233333106876057768871325177779999997689998
Q ss_pred CCCCHHHHHHHH----HHCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCH-HCHHHHHCCCCCCCCCHHHHHHCCCCC
Q ss_conf 999968999999----828999999998879899999980103927669982-409999819997799811335059998
Q 001847 902 RGKTRQKTFANI----LHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSH-EGANEIKKHPFFKGVNWALVRCMNPPE 976 (1005)
Q Consensus 902 ~~~~~~~~~~~i----~~~~~~~~~~~~~s~~l~~Ll~~mL~~dP~~Rpt~~-~~a~elL~hpff~~~~~~~~~~~~~~~ 976 (1005)
.+.+.......+ ......++ ..++..+.+||.+||..||.+||+.. ..|+|+|+||||++++|..+.....|.
T Consensus 233 ~~~~~~~~~~~i~~~~~~~~~~~~--~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff~~i~~~~l~~~~~~~ 310 (322)
T d1vzoa_ 233 TVDGEKNSQAEISRRILKSEPPYP--QEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINWDDLAAKKVPA 310 (322)
T ss_dssp SCTTSCCCHHHHHHHHHHCCCCCC--TTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCCHHHHHTTCSCC
T ss_pred CCCCHHHHHHHHHHHCCCCCCCCC--CCCCHHHHHHHHHHCCCCHHHCCCCCCCCHHHHHCCHHHCCCCHHHHHHCCCCC
T ss_conf 888777799999983356899886--547999999999974458988199974509999749723489988997378985
Q ss_pred CCCCCCCCCCC
Q ss_conf 89998887311
Q 001847 977 LDAPLFATDTE 987 (1005)
Q Consensus 977 ~~~~~~~~~~~ 987 (1005)
-.+|.+..+.+
T Consensus 311 p~~p~~~~~~~ 321 (322)
T d1vzoa_ 311 PFKPVIRDELD 321 (322)
T ss_dssp SCCCCCCC-CC
T ss_pred CCCCCCCCCCC
T ss_conf 98999999777
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=0 Score=363.29 Aligned_cols=254 Identities=24% Similarity=0.370 Sum_probs=209.3
Q ss_pred CCCCCCCCCCCCCCCEEEEEEEECCCCEEEEEEEEECCCCCCHHHHHHHHHHHHHHHHC-CCCCCCEEEEEEEE--CCEE
Q ss_conf 68843233116669389999999079919999994053123757899999999999957-99984537899870--7818
Q 001847 671 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPALYASFQT--KTHV 747 (1005)
Q Consensus 671 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~--~~~~ 747 (1005)
.++|++++.||+|+||.||+|.+..+++.||+|++++. ....+.+|+.+++.+ +||||++++++|.. ...+
T Consensus 34 ~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~------~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~ 107 (328)
T d3bqca1 34 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV------KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTP 107 (328)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS------CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSE
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHH------HHHHHHHHHHHHHHCCCCCCCCEEEEEEEECCCCCE
T ss_conf 86718978983174819999998899979999998889------999999999999851579987679999981687712
Q ss_pred EEEEECCCCCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEEECCC-CEEEEECCCCCCCCC
Q ss_conf 9999605898356677317999998999999999999999999985943178999968980699-289985167754588
Q 001847 748 CLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNG-HVSLTDFDLSCLTSC 826 (1005)
Q Consensus 748 ~iV~E~~~g~sL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvH~DLkP~NIli~~~g-~ikL~DFG~a~~~~~ 826 (1005)
|+||||+.+++|..+.+ .+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+|.....
T Consensus 108 ~~v~e~~~~~~L~~~~~-----~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~ 182 (328)
T d3bqca1 108 ALVFEHVNNTDFKQLYQ-----TLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP 182 (328)
T ss_dssp EEEEECCCSCBGGGTTT-----SCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCGGGCEECCT
T ss_pred EEEEEECCCCCHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCEEEECCCCCCEECCC
T ss_conf 68886317985899746-----8999999999999999998876433443456441237748998366415654266468
Q ss_pred CCCCCCCCCHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC-CCCCHHHHHHHHHHHHHHHCCCCCCCCCC
Q ss_conf 98777885123321146999974323566656555568763352000388-88883059999999999990999999999
Q 001847 827 KPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGA-GHTSAVDWWALGILLYEMLYGYTPFRGKT 905 (1005)
Q Consensus 827 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~-~~~~~sDIwSLG~il~eLltG~~Pf~~~~ 905 (1005)
. ......+||+.|+|||.+.+. .++.++||||+||++|+|++|+.||....
T Consensus 183 ~----------------------------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~ 234 (328)
T d3bqca1 183 G----------------------------QEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGH 234 (328)
T ss_dssp T----------------------------CCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCS
T ss_pred C----------------------------CCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCC
T ss_conf 8----------------------------744432248642476102688888845232335455587604889998876
Q ss_pred H-HHHHHHHHH-------------CCC----------------------CCCCCCCCCHHHHHHHHHCCCCCCCCCCCCH
Q ss_conf 6-899999982-------------899----------------------9999998879899999980103927669982
Q 001847 906 R-QKTFANILH-------------KDL----------------------KFPSSTPTSLHAKQLMYRLLHRDPKSRLGSH 949 (1005)
Q Consensus 906 ~-~~~~~~i~~-------------~~~----------------------~~~~~~~~s~~l~~Ll~~mL~~dP~~Rpt~~ 949 (1005)
. ......+.. ... .......++.++.+||.+||..||.+|||
T Consensus 235 ~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~t-- 312 (328)
T d3bqca1 235 DNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLT-- 312 (328)
T ss_dssp SHHHHHHHHHHHHCHHHHHHHHHHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCC--
T ss_pred HHHHHHHHHHHHHCCCHHHHHHHHCCCCCCCCCCHHCCCCCCCCHHHCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCC--
T ss_conf 018999999998788415555542254447430000033343311211552112448999999999986699568908--
Q ss_pred HCHHHHHCCCCCCCCCHH
Q ss_conf 409999819997799811
Q 001847 950 EGANEIKKHPFFKGVNWA 967 (1005)
Q Consensus 950 ~~a~elL~hpff~~~~~~ 967 (1005)
|+|+|+||||+++.|.
T Consensus 313 --a~e~L~Hp~F~~v~~~ 328 (328)
T d3bqca1 313 --AREAMEHPYFYTVVKD 328 (328)
T ss_dssp --HHHHHTSGGGTTSCCC
T ss_pred --HHHHHCCCCCCCCCCC
T ss_conf --9999649355887979
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=0 Score=366.15 Aligned_cols=261 Identities=23% Similarity=0.360 Sum_probs=223.9
Q ss_pred CCCCCCCCCCCCCCCEEEEEEEECCCCEEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECC----E
Q ss_conf 688432331166693899999990799199999940531237578999999999999579998453789987078----1
Q 001847 671 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKT----H 746 (1005)
Q Consensus 671 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~----~ 746 (1005)
.++|++.+.||+|+||.||+|.+..+++.||+|++.+....+......+.+|+.+++.++||||+++++++...+ .
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~ 85 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 85 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred CCEEEEEEEEEECCCEEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCEEEECCCCCCE
T ss_conf 62069868996089929999999999989999998556646989999999999999856999887311435432688766
Q ss_pred EEEEEECCCCCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEEECCCCEEEEECCCCCCCCC
Q ss_conf 89999605898356677317999998999999999999999999985943178999968980699289985167754588
Q 001847 747 VCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSC 826 (1005)
Q Consensus 747 ~~iV~E~~~g~sL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvH~DLkP~NIli~~~g~ikL~DFG~a~~~~~ 826 (1005)
+|+||||++|++|..++... +.+++..++.++.||+.||.|||++||+||||||+|||++.++.++++|||.+.....
T Consensus 86 ~~lvmE~~~g~~L~~~~~~~--~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~~ 163 (277)
T d1o6ya_ 86 PYIVMEYVDGVTLRDIVHTE--GPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIAD 163 (277)
T ss_dssp EEEEEECCCEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTSCEEECCCTTCEECC-
T ss_pred EEEEEECCCCCEEHHHHCCC--CCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCCCCCEEEHHHHHHHHCC
T ss_conf 99999778898710112035--8999999999999999999999857952763467556657543201003444322123
Q ss_pred CCCCCCCCCHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCH
Q ss_conf 98777885123321146999974323566656555568763352000388888830599999999999909999999996
Q 001847 827 KPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTR 906 (1005)
Q Consensus 827 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDIwSLG~il~eLltG~~Pf~~~~~ 906 (1005)
... ........+||+.|+|||++.+..++.++|||||||++|+|++|++||.+.+.
T Consensus 164 ~~~------------------------~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~ 219 (277)
T d1o6ya_ 164 SGN------------------------SVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSP 219 (277)
T ss_dssp ---------------------------------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred CCC------------------------CCCCCCCCCCCCCCCCHHHHCCCCCCCCEECCCCHHHHHHHHHCCCCCCCCCH
T ss_conf 544------------------------33334642576243699998399999663202652899999769799899699
Q ss_pred HHHHHHHHHCCCCCC--CCCCCCHHHHHHHHHCCCCCCCCCCCCHHCHHHHHCCCCC
Q ss_conf 899999982899999--9998879899999980103927669982409999819997
Q 001847 907 QKTFANILHKDLKFP--SSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFF 961 (1005)
Q Consensus 907 ~~~~~~i~~~~~~~~--~~~~~s~~l~~Ll~~mL~~dP~~Rpt~~~~a~elL~hpff 961 (1005)
.+....+.......+ ....+|..+.+||.+||..||.+||++ ++++ .|+|+
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~~s---a~~l-~~~l~ 272 (277)
T d1o6ya_ 220 VSVAYQHVREDPIPPSARHEGLSADLDAVVLKALAKNPENRYQT---AAEM-RADLV 272 (277)
T ss_dssp HHHHHHHHHCCCCCGGGTSSSCCHHHHHHHHHHTCSSGGGSCSS---HHHH-HHHHH
T ss_pred HHHHHHHHHCCCCCCCHHCCCCCHHHHHHHHHHCCCCHHHCHHH---HHHH-HHHHH
T ss_conf 99999998469999710034789999999999866797677739---9999-99999
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=365.80 Aligned_cols=269 Identities=23% Similarity=0.426 Sum_probs=221.2
Q ss_pred CCCCCCCCCCCCCCCEEEEEEEECCCCEEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEE------C
Q ss_conf 6884323311666938999999907991999999405312375789999999999995799984537899870------7
Q 001847 671 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQT------K 744 (1005)
Q Consensus 671 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~------~ 744 (1005)
.++|++++.||+|+||+||+|.+..+++.||||++.+.. ........+.+|+.++++++||||++++++|.. .
T Consensus 16 ~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~-~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~ 94 (355)
T d2b1pa1 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPF-QNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEF 94 (355)
T ss_dssp ETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTT-SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTC
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHH-CCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCCCCCC
T ss_conf 377599889621758599999999999899999988233-6979999999999999864898764899897025643457
Q ss_pred CEEEEEEECCCCCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEEECCCCEEEEECCCCCCC
Q ss_conf 81899996058983566773179999989999999999999999999859431789999689806992899851677545
Q 001847 745 THVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLT 824 (1005)
Q Consensus 745 ~~~~iV~E~~~g~sL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvH~DLkP~NIli~~~g~ikL~DFG~a~~~ 824 (1005)
.++|+||||+.+ ++...+. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.++++|||++...
T Consensus 95 ~~~~iv~Ey~~~-~l~~~~~----~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~~~~~kl~df~~~~~~ 169 (355)
T d2b1pa1 95 QDVYLVMELMDA-NLCQVIQ----MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA 169 (355)
T ss_dssp CEEEEEEECCSE-EHHHHHT----SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred CEEEEEEECCCH-HHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCCCCEEEECHHHHHCC
T ss_conf 626999841446-7787650----38999999999999999998865221124567763211365443132010232114
Q ss_pred CCCCCCCCCCCHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCC
Q ss_conf 88987778851233211469999743235666565555687633520003888888305999999999999099999999
Q 001847 825 SCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGK 904 (1005)
Q Consensus 825 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDIwSLG~il~eLltG~~Pf~~~ 904 (1005)
... ......+||+.|+|||++.+..++.++||||+||++|+|++|++||.+.
T Consensus 170 ~~~----------------------------~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~ 221 (355)
T d2b1pa1 170 GTS----------------------------FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGR 221 (355)
T ss_dssp ---------------------------------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred CCC----------------------------CCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCCHHHHHHHCCCCCCCC
T ss_conf 666----------------------------5533221465555813314777787743335662578986598998889
Q ss_pred CHHHHHHHHHHC----------------------CCCCCCC------------------CCCCHHHHHHHHHCCCCCCCC
Q ss_conf 968999999828----------------------9999999------------------988798999999801039276
Q 001847 905 TRQKTFANILHK----------------------DLKFPSS------------------TPTSLHAKQLMYRLLHRDPKS 944 (1005)
Q Consensus 905 ~~~~~~~~i~~~----------------------~~~~~~~------------------~~~s~~l~~Ll~~mL~~dP~~ 944 (1005)
+.......+... ....... ...+.++.+||.+||..||++
T Consensus 222 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~ 301 (355)
T d2b1pa1 222 DYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAK 301 (355)
T ss_dssp SHHHHHHHHHHHHCCCCHHHHTTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTT
T ss_pred CHHHHHHHHHHHCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHCCCCHHH
T ss_conf 77889999997205898799987656677776417543566642126433354321013337999999999987699457
Q ss_pred CCCCHHCHHHHHCCCCCCCCCHHHHHHCCCCCC
Q ss_conf 699824099998199977998113350599988
Q 001847 945 RLGSHEGANEIKKHPFFKGVNWALVRCMNPPEL 977 (1005)
Q Consensus 945 Rpt~~~~a~elL~hpff~~~~~~~~~~~~~~~~ 977 (1005)
||| |+|+|+||||+..-+..-....+|++
T Consensus 302 R~t----a~elL~Hpw~~~~~~~~~~~~~~~~~ 330 (355)
T d2b1pa1 302 RIS----VDDALQHPYINVWYDPAEVEAPPPQI 330 (355)
T ss_dssp SCC----HHHHHTSTTTGGGCCHHHHTCCCC--
T ss_pred CCC----HHHHHCCCCCCCCCCCCCCCCCCCCC
T ss_conf 908----99996694208788810045899987
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=361.94 Aligned_cols=256 Identities=29% Similarity=0.439 Sum_probs=209.3
Q ss_pred CCCCCCCCCCCCCCEEEEEEEECCCCEEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEE------CC
Q ss_conf 884323311666938999999907991999999405312375789999999999995799984537899870------78
Q 001847 672 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQT------KT 745 (1005)
Q Consensus 672 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~------~~ 745 (1005)
.+|..++.||+|+||+||+|.+..+++.||||++..... ...+|+.++++++||||++++++|.. ..
T Consensus 20 ~~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~-------~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~ 92 (350)
T d1q5ka_ 20 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-------FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEV 92 (350)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS-------SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCC
T ss_pred CCCEEEEEEEECCCEEEEEEEECCCCCEEEEEEECCCCH-------HHHHHHHHHHHCCCCCCCCEEEEEEECCCCCCCE
T ss_conf 776751698217683999999999997999999881606-------8999999998668989873878997447657731
Q ss_pred EEEEEEECCCCCCHHHHHH-HCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEEECCC-CEEEEECCCCCC
Q ss_conf 1899996058983566773-17999998999999999999999999985943178999968980699-289985167754
Q 001847 746 HVCLITDYCPGGELFLLLD-RQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNG-HVSLTDFDLSCL 823 (1005)
Q Consensus 746 ~~~iV~E~~~g~sL~~~l~-~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvH~DLkP~NIli~~~g-~ikL~DFG~a~~ 823 (1005)
++|+|||||+++.+..+.. ......+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||++..
T Consensus 93 ~~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~ 172 (350)
T d1q5ka_ 93 YLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ 172 (350)
T ss_dssp EEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTTCCEEECCCTTCEE
T ss_pred EEEEEEECCCCCCHHHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCEEEEECCCCCEEEECCCCHHH
T ss_conf 89999841688607888863103689999999999999999999998668764578860378735897116733660544
Q ss_pred CCCCCCCCCCCCHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC-CCCCCHHHHHHHHHHHHHHHCCCCCCC
Q ss_conf 5889877788512332114699997432356665655556876335200038-888883059999999999990999999
Q 001847 824 TSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAG-AGHTSAVDWWALGILLYEMLYGYTPFR 902 (1005)
Q Consensus 824 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~l~~-~~~~~~sDIwSLG~il~eLltG~~Pf~ 902 (1005)
.... ....+.+|++.|+|||.+.+ ..++.++|||||||++|+|++|++||.
T Consensus 173 ~~~~----------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~ 224 (350)
T d1q5ka_ 173 LVRG----------------------------EPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFP 224 (350)
T ss_dssp CCTT----------------------------SCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSC
T ss_pred CCCC----------------------------CCCCCCCCCCCCCCHHHHHCCCCCCCCEEECCCCEEEEEHHHCCCCCC
T ss_conf 0477----------------------------653200255555682776404688821000246527785502879989
Q ss_pred CCCHHHHHHHHHHC-----------------CCCCC----------CCCCCCHHHHHHHHHCCCCCCCCCCCCHHCHHHH
Q ss_conf 99968999999828-----------------99999----------9998879899999980103927669982409999
Q 001847 903 GKTRQKTFANILHK-----------------DLKFP----------SSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEI 955 (1005)
Q Consensus 903 ~~~~~~~~~~i~~~-----------------~~~~~----------~~~~~s~~l~~Ll~~mL~~dP~~Rpt~~~~a~el 955 (1005)
+.+....+..+... ...++ .....+.++.+||.+||..||.+||| |.|+
T Consensus 225 ~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~t----a~e~ 300 (350)
T d1q5ka_ 225 GDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLT----PLEA 300 (350)
T ss_dssp CSSHHHHHHHHHHHHCCCCHHHHHHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCC----HHHH
T ss_pred CCCHHHHHHHHHHHHCCCHHHHHHHHCCCHHHCCCCCCCCCCHHHHCCCCCCHHHHHHHHHHCCCCHHHCCC----HHHH
T ss_conf 879999999999974898177654306210110355445674444315689999999999976589557929----9999
Q ss_pred HCCCCCCCCCH
Q ss_conf 81999779981
Q 001847 956 KKHPFFKGVNW 966 (1005)
Q Consensus 956 L~hpff~~~~~ 966 (1005)
|+||||+.+.-
T Consensus 301 L~Hp~f~~~~~ 311 (350)
T d1q5ka_ 301 CAHSFFDELRD 311 (350)
T ss_dssp HTSGGGGGGGC
T ss_pred HCCHHHCCCCC
T ss_conf 66984524667
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=367.32 Aligned_cols=253 Identities=27% Similarity=0.372 Sum_probs=213.0
Q ss_pred CCCCCCCCCCCCCCCEEEEEEEECCCCEEEEEEEEECCCCCCHH---HHHHHHHHHHHHHHCC--CCCCCEEEEEEEECC
Q ss_conf 68843233116669389999999079919999994053123757---8999999999999579--998453789987078
Q 001847 671 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRN---KVHRACAEREILDMLD--HPFVPALYASFQTKT 745 (1005)
Q Consensus 671 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~---~~~~~~~E~~il~~l~--hpnIv~l~~~~~~~~ 745 (1005)
.++|++.+.||+|+||.||+|.+..+++.||+|.+.+....+.. ....+.+|+.++++++ ||||+++++++...+
T Consensus 3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~ 82 (273)
T d1xwsa_ 3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD 82 (273)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred CCEEEEEEEEEECCCEEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEEECC
T ss_conf 88379967984087839999999999979999998568844334556799999999999974358988127999983099
Q ss_pred EEEEEEECCCC-CCHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEEECC-CCEEEEECCCCCC
Q ss_conf 18999960589-835667731799999899999999999999999998594317899996898069-9289985167754
Q 001847 746 HVCLITDYCPG-GELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGN-GHVSLTDFDLSCL 823 (1005)
Q Consensus 746 ~~~iV~E~~~g-~sL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvH~DLkP~NIli~~~-g~ikL~DFG~a~~ 823 (1005)
.+|+||||+.+ +++.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.+ +.+||+|||+|..
T Consensus 83 ~~~lv~e~~~~~~~l~~~~~~~--~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~~~~vkl~DFG~a~~ 160 (273)
T d1xwsa_ 83 SFVLILERPEPVQDLFDFITER--GALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGAL 160 (273)
T ss_dssp EEEEEEECCSSEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred EEEEEEEECCCCCHHHHHHHCC--CCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEEECCCCEEEECCCCCCEE
T ss_conf 6899998336862289998615--89999999999999999999998779755667611147744788489775465353
Q ss_pred CCCCCCCCCCCCHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC-CCHHHHHHHHHHHHHHHCCCCCCC
Q ss_conf 5889877788512332114699997432356665655556876335200038888-883059999999999990999999
Q 001847 824 TSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGH-TSAVDWWALGILLYEMLYGYTPFR 902 (1005)
Q Consensus 824 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~-~~~sDIwSLG~il~eLltG~~Pf~ 902 (1005)
... ......+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.
T Consensus 161 ~~~-----------------------------~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~ 211 (273)
T d1xwsa_ 161 LKD-----------------------------TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFE 211 (273)
T ss_dssp CCS-----------------------------SCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCC
T ss_pred CCC-----------------------------CCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCEEEEHHHHHCCCCCC
T ss_conf 244-----------------------------455665658774799998489978865332554034536756889988
Q ss_pred CCCHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHCHHHHHCCCCCCCCCH
Q ss_conf 9996899999982899999999887989999998010392766998240999981999779981
Q 001847 903 GKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVNW 966 (1005)
Q Consensus 903 ~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~mL~~dP~~Rpt~~~~a~elL~hpff~~~~~ 966 (1005)
+. ..+......++. .+|.++.+||.+||..||.+||| ++|+|+||||+++-.
T Consensus 212 ~~------~~i~~~~~~~~~--~~s~~~~~li~~~L~~dp~~R~s----~~eil~hp~~~~~~~ 263 (273)
T d1xwsa_ 212 HD------EEIIRGQVFFRQ--RVSSECQHLIRWCLALRPSDRPT----FEEIQNHPWMQDVLL 263 (273)
T ss_dssp SH------HHHHHCCCCCSS--CCCHHHHHHHHHHTCSSGGGSCC----HHHHHTSGGGSSCCC
T ss_pred CC------HHHHHCCCCCCC--CCCHHHHHHHHHHCCCCHHHCCC----HHHHHCCHHHCCCCC
T ss_conf 73------677615447787--79999999999976089758939----999853986678878
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=362.63 Aligned_cols=258 Identities=21% Similarity=0.288 Sum_probs=213.2
Q ss_pred CCCCCCCCCCCCCCCCCCCCEEEEEEEECCCCEEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECC
Q ss_conf 44434688432331166693899999990799199999940531237578999999999999579998453789987078
Q 001847 666 GEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKT 745 (1005)
Q Consensus 666 ~~~i~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~ 745 (1005)
.|.+..++|++.+.||+|+||.||+|... ..||||+++.... +......+.+|+.++++++||||+++++++.. +
T Consensus 2 dwei~~~~~~~~~~lG~G~fg~Vy~~~~~---~~vAvK~~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~ 76 (276)
T d1uwha_ 2 DWEIPDGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAP-TPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-P 76 (276)
T ss_dssp CCBCCTTCCCCCSEEEECSSCEEEEEESS---SEEEEEECCCSSC-CTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-S
T ss_pred CCCCCCCCEEEEEEEEECCCCEEEEEEEC---CEEEEEEEECCCC-CHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEC-C
T ss_conf 71315451899889830788589999999---9899999973469-98999999999999984799878645679715-5
Q ss_pred EEEEEEECCCCCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEEECCCCEEEEECCCCCCCC
Q ss_conf 18999960589835667731799999899999999999999999998594317899996898069928998516775458
Q 001847 746 HVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTS 825 (1005)
Q Consensus 746 ~~~iV~E~~~g~sL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvH~DLkP~NIli~~~g~ikL~DFG~a~~~~ 825 (1005)
.+|+|||||++|+|.+++.... ..+++..+..++.||+.||+|||+++|+||||||+|||++.++.+||+|||+|....
T Consensus 77 ~~~lv~Ey~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~ 155 (276)
T d1uwha_ 77 QLAIVTQWCEGSSLYHHLHIIE-TKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKS 155 (276)
T ss_dssp SCEEEEECCCEEEHHHHHHTSC-CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTSSEEECCCCCSCC--
T ss_pred EEEEEEECCCCCCHHHHHHHCC-CCCCHHHHHHHHHHHHHHHHHHHCCCEECCCCCHHHEEECCCCCEEECCCCCEEECC
T ss_conf 8999996589988899985235-789999999999999999888750999516147899798189978875002213335
Q ss_pred CCCCCCCCCCHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC---CCCCHHHHHHHHHHHHHHHCCCCCCC
Q ss_conf 898777885123321146999974323566656555568763352000388---88883059999999999990999999
Q 001847 826 CKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGA---GHTSAVDWWALGILLYEMLYGYTPFR 902 (1005)
Q Consensus 826 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~---~~~~~sDIwSLG~il~eLltG~~Pf~ 902 (1005)
.... ........||+.|+|||++.+. .++.++|||||||++|+|++|+.||.
T Consensus 156 ~~~~-------------------------~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~ 210 (276)
T d1uwha_ 156 RWSG-------------------------SHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYS 210 (276)
T ss_dssp -----------------------------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTT
T ss_pred CCCC-------------------------CCCCCCCCCCCCCCCHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCC
T ss_conf 5677-------------------------631256655743179999950568999953151635999999997889989
Q ss_pred CCCHHHHHHHHHHCCCCCC----CCCCCCHHHHHHHHHCCCCCCCCCCCCHHCHHHHHCC
Q ss_conf 9996899999982899999----9998879899999980103927669982409999819
Q 001847 903 GKTRQKTFANILHKDLKFP----SSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKH 958 (1005)
Q Consensus 903 ~~~~~~~~~~i~~~~~~~~----~~~~~s~~l~~Ll~~mL~~dP~~Rpt~~~~a~elL~h 958 (1005)
+.+....+..........+ ....++..+.+|+.+||..||.+||| +.+++++
T Consensus 211 ~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~l~~li~~cl~~dp~~RPt----~~~il~~ 266 (276)
T d1uwha_ 211 NINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPL----FPQILAS 266 (276)
T ss_dssp TCCCHHHHHHHHHHTSCCCCGGGSCTTCCHHHHHHHHHHTCSSGGGSCC----HHHHHHH
T ss_pred CCCHHHHHHHHHHCCCCCCCCHHCCCCCHHHHHHHHHHHCCCCHHHCCC----HHHHHHH
T ss_conf 9896999999996588898600036555499999999975889768929----9999999
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=359.96 Aligned_cols=263 Identities=25% Similarity=0.370 Sum_probs=214.2
Q ss_pred CCCCCCCCCCCCCCCEEEEEEEECCCCEEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECC-----
Q ss_conf 688432331166693899999990799199999940531237578999999999999579998453789987078-----
Q 001847 671 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKT----- 745 (1005)
Q Consensus 671 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~----- 745 (1005)
.++|++++.||+|+||+||+|.+..+++.||||++.+.. .......+.+|+.+++.++||||+++++++....
T Consensus 7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~ 84 (345)
T d1pmea_ 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE--HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMK 84 (345)
T ss_dssp CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTT--CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCC
T ss_pred CCCEEEEEEEEECCCEEEEEEEECCCCCEEEEEEEEHHC--CHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCCCCCC
T ss_conf 898599789940648099999999999499999980310--958999999999999976898988588899505645541
Q ss_pred EEEEEEECCCCCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEEECCCCEEEEECCCCCCCC
Q ss_conf 18999960589835667731799999899999999999999999998594317899996898069928998516775458
Q 001847 746 HVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTS 825 (1005)
Q Consensus 746 ~~~iV~E~~~g~sL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvH~DLkP~NIli~~~g~ikL~DFG~a~~~~ 825 (1005)
.+|++++ +.+++|.+++... .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 85 ~~~l~~~-~~~g~L~~~l~~~---~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~ 160 (345)
T d1pmea_ 85 DVYLVTH-LMGADLYKLLKTQ---HLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVAD 160 (345)
T ss_dssp CEEEEEE-CCCEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEEEEEE-ECCCCHHHHHHCC---CCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCEEEECCCCCEEECCCCCEEECC
T ss_conf 4999996-2598656644058---99999999999999999999997898677787643788799977875457056504
Q ss_pred CCCCCCCCCCHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC-CCCCCHHHHHHHHHHHHHHHCCCCCCCCC
Q ss_conf 89877788512332114699997432356665655556876335200038-88888305999999999999099999999
Q 001847 826 CKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAG-AGHTSAVDWWALGILLYEMLYGYTPFRGK 904 (1005)
Q Consensus 826 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~l~~-~~~~~~sDIwSLG~il~eLltG~~Pf~~~ 904 (1005)
..... .......+|++.|+|||++.. ..++.++||||+||++|+|++|+.||.+.
T Consensus 161 ~~~~~------------------------~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~ 216 (345)
T d1pmea_ 161 PDHDH------------------------TGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGK 216 (345)
T ss_dssp GGGCB------------------------CCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred CCCCC------------------------CEEECCCCCCCEECHHHHHHCCCCCCCHHHHHCCCCEEHHHHHCCCCCCCC
T ss_conf 77764------------------------101011026520003878604788874101004670133776697997888
Q ss_pred CHHHHHHHHHHCC----------------------CCCC-------CCCCCCHHHHHHHHHCCCCCCCCCCCCHHCHHHH
Q ss_conf 9689999998289----------------------9999-------9998879899999980103927669982409999
Q 001847 905 TRQKTFANILHKD----------------------LKFP-------SSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEI 955 (1005)
Q Consensus 905 ~~~~~~~~i~~~~----------------------~~~~-------~~~~~s~~l~~Ll~~mL~~dP~~Rpt~~~~a~el 955 (1005)
+............ .+.. .....+..+.+||.+||..||.+||| +.++
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t----a~e~ 292 (345)
T d1pmea_ 217 HYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIE----VEQA 292 (345)
T ss_dssp SHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCC----HHHH
T ss_pred CHHHHHHHHHHHCCCCCHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCC----HHHH
T ss_conf 889999987652069975664234332222024467755778777837899999999999976489567908----9998
Q ss_pred HCCCCCCCCCHH
Q ss_conf 819997799811
Q 001847 956 KKHPFFKGVNWA 967 (1005)
Q Consensus 956 L~hpff~~~~~~ 967 (1005)
|+||||+.....
T Consensus 293 L~hpf~~~~~~~ 304 (345)
T d1pmea_ 293 LAHPYLEQYYDP 304 (345)
T ss_dssp HTSGGGTTTCCG
T ss_pred HCCHHHCCCCCC
T ss_conf 619865558897
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=0 Score=361.19 Aligned_cols=261 Identities=23% Similarity=0.326 Sum_probs=218.0
Q ss_pred CCCCCCCCCCCCCCCCCCEEEEEEEECCCCE---EEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEEC
Q ss_conf 4346884323311666938999999907991---9999994053123757899999999999957999845378998707
Q 001847 668 QINLQHFRPIKPLGSGDTGSVHLVELCGSGQ---YFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTK 744 (1005)
Q Consensus 668 ~i~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~---~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~ 744 (1005)
.+..+.|++.+.||+|+||.||+|.++.+++ .+|+|.+.... .......+.+|+.++++++||||+++++++...
T Consensus 22 ~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~ 99 (299)
T d1jpaa_ 22 EIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY--TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKS 99 (299)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS
T ss_pred HHCHHHCEEEEEEEECCCEEEEEEEEECCCCEEEEEEEEEECCCC--CHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEEC
T ss_conf 208004278569802788299999995799788999999978445--989999999999999857998886189999628
Q ss_pred CEEEEEEECCCCCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEEECCCCEEEEECCCCCCC
Q ss_conf 81899996058983566773179999989999999999999999999859431789999689806992899851677545
Q 001847 745 THVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLT 824 (1005)
Q Consensus 745 ~~~~iV~E~~~g~sL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvH~DLkP~NIli~~~g~ikL~DFG~a~~~ 824 (1005)
+.+|+|||||++|+|.+++... .+.+++..+..++.||+.||.|||+++|+||||||+|||++.++.+||+|||+|...
T Consensus 100 ~~~~iv~Ey~~~g~L~~~~~~~-~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~ 178 (299)
T d1jpaa_ 100 TPVMIITEFMENGSLDSFLRQN-DGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFL 178 (299)
T ss_dssp SSCEEEEECCTTEEHHHHHHTT-TTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC------
T ss_pred CEEEEEEEECCCCCCEEEECCC-CCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCEEEECCCCCEEECCCCCCEEC
T ss_conf 8779999722798530021045-679999999999999999889885279835761504489889991998884431575
Q ss_pred CCCCCCCCCCCHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHC-CCCCCCC
Q ss_conf 889877788512332114699997432356665655556876335200038888883059999999999990-9999999
Q 001847 825 SCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY-GYTPFRG 903 (1005)
Q Consensus 825 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDIwSLG~il~eLlt-G~~Pf~~ 903 (1005)
...... ..........||+.|+|||++.+..++.++|||||||++|+|++ |+.||.+
T Consensus 179 ~~~~~~----------------------~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~ 236 (299)
T d1jpaa_ 179 EDDTSD----------------------PTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWD 236 (299)
T ss_dssp ---------------------------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTT
T ss_pred CCCCCC----------------------CEEEECCCCCCCCCCCCHHHHHCCCCCCCCCCCCCHHHHHHHHHCCCCCCCC
T ss_conf 677776----------------------5365025666883003878883699786121445357899998679999999
Q ss_pred CCHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHCHHHHHCC
Q ss_conf 9968999999828999999998879899999980103927669982409999819
Q 001847 904 KTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKH 958 (1005)
Q Consensus 904 ~~~~~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~mL~~dP~~Rpt~~~~a~elL~h 958 (1005)
.+..+....+..+ ...+.+..++..+.+|+.+||..||.+||| +.+++++
T Consensus 237 ~~~~~~~~~i~~~-~~~~~~~~~~~~l~~li~~cl~~~P~~RPs----~~ei~~~ 286 (299)
T d1jpaa_ 237 MTNQDVINAIEQD-YRLPPPMDCPSALHQLMLDCWQKDRNHRPK----FGQIVNT 286 (299)
T ss_dssp CCHHHHHHHHHTT-CCCCCCTTCCHHHHHHHHHHTCSSTTTSCC----HHHHHHH
T ss_pred CCHHHHHHHHHCC-CCCCCCCCCHHHHHHHHHHHCCCCHHHCCC----HHHHHHH
T ss_conf 9999999999737-889997422699999999975879768929----9999999
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=0 Score=362.90 Aligned_cols=258 Identities=23% Similarity=0.377 Sum_probs=216.6
Q ss_pred CCCCCCCCCCCCCCCEEEEEEEECCCCEEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEEEE
Q ss_conf 68843233116669389999999079919999994053123757899999999999957999845378998707818999
Q 001847 671 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLI 750 (1005)
Q Consensus 671 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~iV 750 (1005)
+++|+++++||+|+||.||+|.+ .+++.||+|++..... .......+.+|+.++++++||||+++++++...+..|++
T Consensus 1 ~~~Y~~~~~iG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~ 78 (286)
T d1ob3a_ 1 MEKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKE-DEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLV 78 (286)
T ss_dssp CCSEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSG-GGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEE
T ss_pred CCCCEECCEEECCCCCEEEEEEE-CCCCEEEEEEEEHHHC-CHHHHHHHHHHHHHHHHCCCCCEEEEEEECCCCCCEEEE
T ss_conf 99963431872277818999996-8999999999812326-858999999999999867998687660120467731589
Q ss_pred EECCCCCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEEECCCCEEEEECCCCCCCCCCCCC
Q ss_conf 96058983566773179999989999999999999999999859431789999689806992899851677545889877
Q 001847 751 TDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQL 830 (1005)
Q Consensus 751 ~E~~~g~sL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvH~DLkP~NIli~~~g~ikL~DFG~a~~~~~~~~~ 830 (1005)
|+++.++.+..+.... +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||.|......
T Consensus 79 ~e~~~~~~~~~~~~~~--~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~--- 153 (286)
T d1ob3a_ 79 FEHLDQDLKKLLDVCE--GGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIP--- 153 (286)
T ss_dssp EECCSEEHHHHHHTST--TCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC----
T ss_pred EEEEHHHHHHHHHHHC--CCCCHHHHHHHHHHHHHHHHHHCCCCEEECCCCCCEEEECCCCCEEECCCCCCEECCCC---
T ss_conf 9740045678998604--77514456899999999999860574882678775056868997873236643011467---
Q ss_pred CCCCCHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC-CCCCHHHHHHHHHHHHHHHCCCCCCCCCCHHHH
Q ss_conf 7885123321146999974323566656555568763352000388-888830599999999999909999999996899
Q 001847 831 LLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGA-GHTSAVDWWALGILLYEMLYGYTPFRGKTRQKT 909 (1005)
Q Consensus 831 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~-~~~~~sDIwSLG~il~eLltG~~Pf~~~~~~~~ 909 (1005)
........|++.|+|||.+.+. .++.++|||||||++|+|++|++||.+.+..+.
T Consensus 154 ------------------------~~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~ 209 (286)
T d1ob3a_ 154 ------------------------VRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQ 209 (286)
T ss_dssp --------------------------------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH
T ss_pred ------------------------CCCCCEECCCCHHHHHHHHHCCCCCCCCEEEHHCCCHHHHHHHCCCCCCCCCHHHH
T ss_conf ------------------------65410102431101378871788888410021117589999779799898898999
Q ss_pred HHHHHHCCCC------------------C---------CCCCCCCHHHHHHHHHCCCCCCCCCCCCHHCHHHHHCCCCCC
Q ss_conf 9999828999------------------9---------999988798999999801039276699824099998199977
Q 001847 910 FANILHKDLK------------------F---------PSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFK 962 (1005)
Q Consensus 910 ~~~i~~~~~~------------------~---------~~~~~~s~~l~~Ll~~mL~~dP~~Rpt~~~~a~elL~hpff~ 962 (1005)
+..+...... . ......+..+.+||.+||..||++||| +.|+|+||||+
T Consensus 210 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s----~~ell~Hp~f~ 285 (286)
T d1ob3a_ 210 LMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRIT----AKQALEHAYFK 285 (286)
T ss_dssp HHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCC----HHHHHTSGGGG
T ss_pred HHHHHHHHCCCCHHHCCCHHHHHHCCCCCCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCC----HHHHHCCCCCC
T ss_conf 99999863899711042123332214333335676466651258999999999986689668909----99985692207
Q ss_pred C
Q ss_conf 9
Q 001847 963 G 963 (1005)
Q Consensus 963 ~ 963 (1005)
+
T Consensus 286 ~ 286 (286)
T d1ob3a_ 286 E 286 (286)
T ss_dssp C
T ss_pred C
T ss_conf 4
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=365.29 Aligned_cols=264 Identities=22% Similarity=0.339 Sum_probs=220.3
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCEEEEEEEECCCCEEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEE
Q ss_conf 04544434688432331166693899999990799199999940531237578999999999999579998453789987
Q 001847 663 LDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQ 742 (1005)
Q Consensus 663 ~~~~~~i~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~ 742 (1005)
....|.+..++|++.+.||+|+||.||+|.+ .++..||||.+.... ...+.+.+|+.++++++||||+++++++.
T Consensus 4 ~~~~wei~~~~~~~~~~iG~G~fg~Vy~~~~-~~~~~vAvK~~~~~~----~~~~~~~~E~~~l~~l~HpnIv~~~g~~~ 78 (272)
T d1qpca_ 4 WEDEWEVPRETLKLVERLGAGQFGEVWMGYY-NGHTKVAVKSLKQGS----MSPDAFLAEANLMKQLQHQRLVRLYAVVT 78 (272)
T ss_dssp TTCTTBCCGGGEEEEEEEEEETTEEEEEEEE-TTTEEEEEEEECTTS----SCHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred CCCCEECCHHHEEEEEEEECCCCCEEEEEEE-CCCCEEEEEEECCCC----CCHHHHHHHHHHHHHCCCCCEEEEEEEEC
T ss_conf 9877003889938867981079828999999-999999999986476----88899999999998679998857873104
Q ss_pred ECCEEEEEEECCCCCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEEECCCCEEEEECCCCC
Q ss_conf 07818999960589835667731799999899999999999999999998594317899996898069928998516775
Q 001847 743 TKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSC 822 (1005)
Q Consensus 743 ~~~~~~iV~E~~~g~sL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvH~DLkP~NIli~~~g~ikL~DFG~a~ 822 (1005)
. +.+|+||||+++|+|.+++.......+++..+..++.||+.||.|||+++|+||||||+|||++.++.+||+|||+|.
T Consensus 79 ~-~~~~iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~~~~~Kl~DFGla~ 157 (272)
T d1qpca_ 79 Q-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLAR 157 (272)
T ss_dssp S-SSCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCE
T ss_pred C-CCEEEEEEECCCCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHEEEECCCCEEECCCCCEE
T ss_conf 5-976999995789828888751478988788999999999999999974895467564225156202440423410147
Q ss_pred CCCCCCCCCCCCCHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHC-CCCCC
Q ss_conf 45889877788512332114699997432356665655556876335200038888883059999999999990-99999
Q 001847 823 LTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY-GYTPF 901 (1005)
Q Consensus 823 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDIwSLG~il~eLlt-G~~Pf 901 (1005)
...... ........|++.|+|||++....++.++|||||||++|+|++ |.+||
T Consensus 158 ~~~~~~--------------------------~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~ 211 (272)
T d1qpca_ 158 LIEDNE--------------------------YTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPY 211 (272)
T ss_dssp ECSSSC--------------------------EECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSS
T ss_pred ECCCCC--------------------------CCCCCCCCCCCCCCCHHHHHCCCCCCHHHHHHHHHHHHHHHHCCCCCC
T ss_conf 735886--------------------------442035677444458289837999824564525799999996898888
Q ss_pred CCCCHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHCHHHHHC--CCCCCC
Q ss_conf 99996899999982899999999887989999998010392766998240999981--999779
Q 001847 902 RGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKK--HPFFKG 963 (1005)
Q Consensus 902 ~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~mL~~dP~~Rpt~~~~a~elL~--hpff~~ 963 (1005)
...+..+....+..+ ...+.+..++..+.+|+.+||..||++||| +.++++ |+||..
T Consensus 212 ~~~~~~~~~~~i~~~-~~~~~p~~~~~~l~~li~~cl~~~P~~Rpt----~~ei~~~L~~~fts 270 (272)
T d1qpca_ 212 PGMTNPEVIQNLERG-YRMVRPDNCPEELYQLMRLCWKERPEDRPT----FDYLRSVLEDFFTA 270 (272)
T ss_dssp TTCCHHHHHHHHHTT-CCCCCCTTCCHHHHHHHHHHTCSSGGGSCC----HHHHHHHHHHHHHH
T ss_pred CCCCHHHHHHHHHHC-CCCCCCCCCHHHHHHHHHHHCCCCHHHCCC----HHHHHHHHHHHHHC
T ss_conf 888999999999706-888896557199999999975889768939----99999986113213
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=359.75 Aligned_cols=263 Identities=25% Similarity=0.320 Sum_probs=214.5
Q ss_pred CCCCCCCCCCCCCCCEEEEEEEECCCCEEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEE-------
Q ss_conf 6884323311666938999999907991999999405312375789999999999995799984537899870-------
Q 001847 671 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQT------- 743 (1005)
Q Consensus 671 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~------- 743 (1005)
.++|++++.||+|+||+||+|.+..+++.||||++..... .......+.+|+.+++.++||||+++++++..
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~ 87 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENE-KEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNR 87 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----C-TTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC-------
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEHHHC-CHHHHHHHHHHHHHHHHHCCCCCCCEEEEEECCCCCCCC
T ss_conf 2798899997227482999999989997999999842224-637899999999999983599966067654024654444
Q ss_pred -CCEEEEEEECCCCCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEEECCCCEEEEECCCCC
Q ss_conf -7818999960589835667731799999899999999999999999998594317899996898069928998516775
Q 001847 744 -KTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSC 822 (1005)
Q Consensus 744 -~~~~~iV~E~~~g~sL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvH~DLkP~NIli~~~g~ikL~DFG~a~ 822 (1005)
.+.+|+||||+.++.+..+... ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.
T Consensus 88 ~~~~~~iv~e~~~~~~~~~~~~~--~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~~~~~kl~dfg~~~ 165 (318)
T d3blha1 88 CKGSIYLVFDFCEHDLAGLLSNV--LVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLAR 165 (318)
T ss_dssp ---CEEEEEECCCEEHHHHHTCT--TCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCE
T ss_pred CCCEEEEEEECCCCCCCCHHHHC--CCCCCCHHHHHHHHHHHHHHHHHCCCCEEECCCCCHHEEECCCCCEEEEECCEEE
T ss_conf 57638999853578741012220--3443308999999999999988522998856767222036689968763135002
Q ss_pred CCCCCCCCCCCCCHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC-CCCCHHHHHHHHHHHHHHHCCCCCC
Q ss_conf 458898777885123321146999974323566656555568763352000388-8888305999999999999099999
Q 001847 823 LTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGA-GHTSAVDWWALGILLYEMLYGYTPF 901 (1005)
Q Consensus 823 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~-~~~~~sDIwSLG~il~eLltG~~Pf 901 (1005)
....... .........+||+.|+|||++.+. .++.++|||||||++|+|++|++||
T Consensus 166 ~~~~~~~-----------------------~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf 222 (318)
T d3blha1 166 AFSLAKN-----------------------SQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIM 222 (318)
T ss_dssp ECCC----------------------------CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSC
T ss_pred ECCCCCC-----------------------CCCCCCCCEECCHHHHHHHHHCCCCCCCCHHHCCCCCCEEEEHHHCCCCC
T ss_conf 2355444-----------------------32113566024978742899707999891787006786466174487998
Q ss_pred CCCCHHHHHHHHHHCCCCCCCC------------------------------CCCCHHHHHHHHHCCCCCCCCCCCCHHC
Q ss_conf 9999689999998289999999------------------------------9887989999998010392766998240
Q 001847 902 RGKTRQKTFANILHKDLKFPSS------------------------------TPTSLHAKQLMYRLLHRDPKSRLGSHEG 951 (1005)
Q Consensus 902 ~~~~~~~~~~~i~~~~~~~~~~------------------------------~~~s~~l~~Ll~~mL~~dP~~Rpt~~~~ 951 (1005)
.+.+.......+.......+.. ...+..+.+||.+||..||++|||
T Consensus 223 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~s---- 298 (318)
T d3blha1 223 QGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRID---- 298 (318)
T ss_dssp CCSSHHHHHHHHHHHHCCCCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCC----
T ss_pred CCCCHHHHHHHHHHHCCCCCHHHCCCCCHHHHHHHHCCCCCCCCCCHHHHCCCCCCHHHHHHHHHHCCCCHHHCCC----
T ss_conf 9989999999999841899825534432034443320133445550334044459989999999987389658909----
Q ss_pred HHHHHCCCCCCC
Q ss_conf 999981999779
Q 001847 952 ANEIKKHPFFKG 963 (1005)
Q Consensus 952 a~elL~hpff~~ 963 (1005)
|.|+|+||||+.
T Consensus 299 a~elL~Hpff~~ 310 (318)
T d3blha1 299 SDDALNHDFFWS 310 (318)
T ss_dssp HHHHHHSGGGSS
T ss_pred HHHHHCCHHHCC
T ss_conf 999974950156
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=360.82 Aligned_cols=257 Identities=26% Similarity=0.382 Sum_probs=216.3
Q ss_pred CCCCCCCCCCCCCCCEEEEEEEECCCCEEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEEC-----C
Q ss_conf 68843233116669389999999079919999994053123757899999999999957999845378998707-----8
Q 001847 671 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTK-----T 745 (1005)
Q Consensus 671 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~-----~ 745 (1005)
.++|++++.||+|+||.||+|.+..+++.||||++.+.. .+......+.+|+.+++.++||||+++++++... .
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~-~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~ 95 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 95 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTT-SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTC
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCHH-CCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCCCC
T ss_conf 987188889831788399999999999799999988200-2868999999999999866898742599999634645668
Q ss_pred EEEEEEECCCCCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEEECCCCEEEEECCCCCCCC
Q ss_conf 18999960589835667731799999899999999999999999998594317899996898069928998516775458
Q 001847 746 HVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTS 825 (1005)
Q Consensus 746 ~~~iV~E~~~g~sL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvH~DLkP~NIli~~~g~ikL~DFG~a~~~~ 825 (1005)
..+++|+++.+++|.+++.. +.+++..++.++.||+.||+|||++||+||||||+|||++.++.+|++|||.+....
T Consensus 96 ~~~~i~~~~~gg~L~~~~~~---~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~~~~~kl~dfg~a~~~~ 172 (348)
T d2gfsa1 96 NDVYLVTHLMGADLNNIVKC---QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD 172 (348)
T ss_dssp CCCEEEEECCSEEHHHHHTT---CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCC----CCT
T ss_pred CEEEEEEEECCCCHHHHCCC---CCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCHHCCCC
T ss_conf 64999996258862320022---453099999999999999999973887651667763345543220013210001257
Q ss_pred CCCCCCCCCCHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC-CCCHHHHHHHHHHHHHHHCCCCCCCCC
Q ss_conf 8987778851233211469999743235666565555687633520003888-888305999999999999099999999
Q 001847 826 CKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAG-HTSAVDWWALGILLYEMLYGYTPFRGK 904 (1005)
Q Consensus 826 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~-~~~~sDIwSLG~il~eLltG~~Pf~~~ 904 (1005)
.......|++.|+|||++.+.. ++.++|||||||++|+|++|++||.+.
T Consensus 173 ------------------------------~~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~ 222 (348)
T d2gfsa1 173 ------------------------------DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 222 (348)
T ss_dssp ------------------------------GGGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred ------------------------------CCCCCCCCCCCCCCCHHHCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCC
T ss_conf ------------------------------54444345435558355337756785512432058999997688997889
Q ss_pred CHHHHHHHHHHCCCCC-----------------------CC------CCCCCHHHHHHHHHCCCCCCCCCCCCHHCHHHH
Q ss_conf 9689999998289999-----------------------99------998879899999980103927669982409999
Q 001847 905 TRQKTFANILHKDLKF-----------------------PS------STPTSLHAKQLMYRLLHRDPKSRLGSHEGANEI 955 (1005)
Q Consensus 905 ~~~~~~~~i~~~~~~~-----------------------~~------~~~~s~~l~~Ll~~mL~~dP~~Rpt~~~~a~el 955 (1005)
+.......+....... +. ....+..+++||.+||..||.+||| |.|+
T Consensus 223 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~t----a~el 298 (348)
T d2gfsa1 223 DHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRIT----AAQA 298 (348)
T ss_dssp SHHHHHHHHHHHHCCCCHHHHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCC----HHHH
T ss_pred CHHHHHHHHHHHCCCCCHHHHHHCCCHHHHHHHHHCCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCC----HHHH
T ss_conf 889999999973079975773200102445444303557875556626789999999999977588345938----9998
Q ss_pred HCCCCCCCCC
Q ss_conf 8199977998
Q 001847 956 KKHPFFKGVN 965 (1005)
Q Consensus 956 L~hpff~~~~ 965 (1005)
|+||||++..
T Consensus 299 L~Hp~f~~~~ 308 (348)
T d2gfsa1 299 LAHAYFAQYH 308 (348)
T ss_dssp HTSGGGTTTC
T ss_pred HCCHHHCCCC
T ss_conf 5599548799
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=356.99 Aligned_cols=264 Identities=20% Similarity=0.280 Sum_probs=217.7
Q ss_pred CCCCCCCCCCC-CCCCCCEEEEEEEECC--CCEEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECC
Q ss_conf 34688432331-1666938999999907--99199999940531237578999999999999579998453789987078
Q 001847 669 INLQHFRPIKP-LGSGDTGSVHLVELCG--SGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKT 745 (1005)
Q Consensus 669 i~~~~y~~~~~-LG~G~~g~Vy~~~~~~--~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~ 745 (1005)
+..++|.+... ||+|+||.||+|.++. ++..||||.++... .......+.+|+.++++++||||+++++++.. +
T Consensus 5 l~~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~ 81 (285)
T d1u59a_ 5 LKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT--EKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-E 81 (285)
T ss_dssp CCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-S
T ss_pred ECCCCEEECCCEEECCCCEEEEEEEEECCCCCEEEEEEEECHHC--CHHHHHHHHHHHHHHHHCCCCCEEEEEEEECC-C
T ss_conf 54447188784873060809999999608976899999988203--97899999999999986799888068656036-8
Q ss_pred EEEEEEECCCCCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEEECCCCEEEEECCCCCCCC
Q ss_conf 18999960589835667731799999899999999999999999998594317899996898069928998516775458
Q 001847 746 HVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTS 825 (1005)
Q Consensus 746 ~~~iV~E~~~g~sL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvH~DLkP~NIli~~~g~ikL~DFG~a~~~~ 825 (1005)
.+|+||||+++|+|.+++... ...+++..+..++.||+.||.|||+++|+||||||+|||++.++.+||+|||+|....
T Consensus 82 ~~~lvmE~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~ 160 (285)
T d1u59a_ 82 ALMLVMEMAGGGPLHKFLVGK-REEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALG 160 (285)
T ss_dssp SEEEEEECCTTEEHHHHHTTC-TTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECT
T ss_pred EEEEEEEECCCCCHHHHHHCC-CCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEECCCCCEEECCCHHHHCCC
T ss_conf 079999807899689975212-5699999999999999998789986881057676466045468854203313421155
Q ss_pred CCCCCCCCCCHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHC-CCCCCCCC
Q ss_conf 89877788512332114699997432356665655556876335200038888883059999999999990-99999999
Q 001847 826 CKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY-GYTPFRGK 904 (1005)
Q Consensus 826 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDIwSLG~il~eLlt-G~~Pf~~~ 904 (1005)
..... ........||+.|+|||++....++.++|||||||++|+|++ |+.||.+.
T Consensus 161 ~~~~~------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~ 216 (285)
T d1u59a_ 161 ADDSY------------------------YTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKM 216 (285)
T ss_dssp TCSCE------------------------ECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred CCCCC------------------------CCCCCCCCCCCCCCCHHHHHCCCCCCCCHHHCCHHHHHHHHHCCCCCCCCC
T ss_conf 43432------------------------113562113743358688727999954123220178999993899999997
Q ss_pred CHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHCHHHHHCCCCCC
Q ss_conf 9689999998289999999988798999999801039276699824099998199977
Q 001847 905 TRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFK 962 (1005)
Q Consensus 905 ~~~~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~mL~~dP~~Rpt~~~~a~elL~hpff~ 962 (1005)
+..+....+..+.. .+.+..++.++.+|+.+||..||++|||+.+ +.+.|+|+|+.
T Consensus 217 ~~~~~~~~i~~~~~-~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~-i~~~L~~~~~~ 272 (285)
T d1u59a_ 217 KGPEVMAFIEQGKR-MECPPECPPELYALMSDCWIYKWEDRPDFLT-VEQRMRACYYS 272 (285)
T ss_dssp CTHHHHHHHHTTCC-CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHH-HHHHHHHHHHH
T ss_pred CHHHHHHHHHCCCC-CCCCCCCCHHHHHHHHHHCCCCHHHCCCHHH-HHHHHHHHHHH
T ss_conf 99999999981899-9999767899999999975779768909999-99999999998
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=356.08 Aligned_cols=253 Identities=22% Similarity=0.364 Sum_probs=215.3
Q ss_pred CCCCCCCCCCCCCCCCCEEEEEEEECCCCEEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEE
Q ss_conf 34688432331166693899999990799199999940531237578999999999999579998453789987078189
Q 001847 669 INLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVC 748 (1005)
Q Consensus 669 i~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~ 748 (1005)
|+.++|++.+.||+|+||.||+|.+. ++..||||.+..... ....+.+|+.++++++||||+++++++...+.+|
T Consensus 2 idp~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~----~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~ 76 (263)
T d1sm2a_ 2 IDPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAM----SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPIC 76 (263)
T ss_dssp BCCSCEEEEEEEECCSSCCEEEEEET-TTEEEEEEECCSSSS----CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred CCHHHCEEEEEEEECCCEEEEEEEEC-CCCEEEEEEECCCCC----CHHHHHHHHHHHHHCCCCCCCCCCCEECCCCCEE
T ss_conf 89699588889820888299999988-999999999878867----6899999999999668997565352431599337
Q ss_pred EEEECCCCCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEEECCCCEEEEECCCCCCCCCCC
Q ss_conf 99960589835667731799999899999999999999999998594317899996898069928998516775458898
Q 001847 749 LITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKP 828 (1005)
Q Consensus 749 iV~E~~~g~sL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvH~DLkP~NIli~~~g~ikL~DFG~a~~~~~~~ 828 (1005)
+||||+++|+|.+++... ...+++..+..++.|++.||.|||+++|+||||||+|||++.++.+||+|||++.......
T Consensus 77 lv~E~~~~g~L~~~l~~~-~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~ 155 (263)
T d1sm2a_ 77 LVFEFMEHGCLSDYLRTQ-RGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ 155 (263)
T ss_dssp EEEECCTTCBHHHHHHTT-TTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECGGGCEEECSCC---------
T ss_pred EEEEECCCCCHHHHHHCC-CCCCCHHHHHHHHHHHHHHHHHHHCCCEEECCCCHHHEEECCCCCEEECCCCHHEECCCCC
T ss_conf 999836999189975201-3478899999999999998776531643104431532666688776865532100236887
Q ss_pred CCCCCCCHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHC-CCCCCCCCCHH
Q ss_conf 77788512332114699997432356665655556876335200038888883059999999999990-99999999968
Q 001847 829 QLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY-GYTPFRGKTRQ 907 (1005)
Q Consensus 829 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDIwSLG~il~eLlt-G~~Pf~~~~~~ 907 (1005)
. .......||+.|+|||++.+..++.++|||||||++|+|++ |.+||.+.+..
T Consensus 156 ~--------------------------~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~ 209 (263)
T d1sm2a_ 156 Y--------------------------TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS 209 (263)
T ss_dssp -----------------------------------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHH
T ss_pred C--------------------------EEECCEECCCCCCCHHHHCCCCCCCHHHHCCHHHHHHHHHHCCCCCCCCCCHH
T ss_conf 3--------------------------35043001766678578607999840332105999999987898887789999
Q ss_pred HHHHHHHHCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHCHHHHHCC
Q ss_conf 999999828999999998879899999980103927669982409999819
Q 001847 908 KTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKH 958 (1005)
Q Consensus 908 ~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~mL~~dP~~Rpt~~~~a~elL~h 958 (1005)
+....+..+. ....+..++.++.+|+.+||..||++||| ++++++|
T Consensus 210 ~~~~~i~~~~-~~~~p~~~~~~l~~li~~cl~~~p~~Rps----~~~il~~ 255 (263)
T d1sm2a_ 210 EVVEDISTGF-RLYKPRLASTHVYQIMNHCWKERPEDRPA----FSRLLRQ 255 (263)
T ss_dssp HHHHHHHHTC-CCCCCTTSCHHHHHHHHHHTCSSGGGSCC----HHHHHHH
T ss_pred HHHHHHHHCC-CCCCCCCCCHHHHHHHHHHCCCCHHHCCC----HHHHHHH
T ss_conf 9999998068-88995436799999999976579768919----9999999
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=351.75 Aligned_cols=260 Identities=21% Similarity=0.347 Sum_probs=217.7
Q ss_pred CCCCCCCCCCCCCCCEEEEEEEECCCCEEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEEEE
Q ss_conf 68843233116669389999999079919999994053123757899999999999957999845378998707818999
Q 001847 671 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLI 750 (1005)
Q Consensus 671 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~iV 750 (1005)
+++|++++.||+|+||.||+|.+..+++.||||+++... ........+.+|+.+++.++||||+++++++......+++
T Consensus 1 ~~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv 79 (292)
T d1unla_ 1 MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDD-DDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLV 79 (292)
T ss_dssp CCSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSC-SSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCCCEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEHHH-CCHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCCCCEEEE
T ss_conf 999786269712868199999999999699999980321-7868999999999999856757888213544444311588
Q ss_pred EECCCCCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEEECCCCEEEEECCCCCCCCCCCCC
Q ss_conf 96058983566773179999989999999999999999999859431789999689806992899851677545889877
Q 001847 751 TDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQL 830 (1005)
Q Consensus 751 ~E~~~g~sL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvH~DLkP~NIli~~~g~ikL~DFG~a~~~~~~~~~ 830 (1005)
++++.+++|..++... +.+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||.+.......
T Consensus 80 ~~~~~~~~l~~~~~~~--~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~-- 155 (292)
T d1unla_ 80 FEFCDQDLKKYFDSCN--GDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPV-- 155 (292)
T ss_dssp EECCSEEHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSCC--
T ss_pred EEECCCCCCCCCCCCC--CCCCHHHHHHHHHHHHHHHHHHHCCCEEEECCCCCCCCCCCCCCEEEEECCHHHCCCCCC--
T ss_conf 6302332221121235--654036789999999999877433998600146761211337826652046011046887--
Q ss_pred CCCCCHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC-CCCHHHHHHHHHHHHHHHCCCCCCCC-CCHHH
Q ss_conf 78851233211469999743235666565555687633520003888-88830599999999999909999999-99689
Q 001847 831 LLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAG-HTSAVDWWALGILLYEMLYGYTPFRG-KTRQK 908 (1005)
Q Consensus 831 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~-~~~~sDIwSLG~il~eLltG~~Pf~~-~~~~~ 908 (1005)
.......+++.|+|||++.... ++.++|||||||++|+|++|+.||.. .+..+
T Consensus 156 -------------------------~~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~ 210 (292)
T d1unla_ 156 -------------------------RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDD 210 (292)
T ss_dssp -------------------------SCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHH
T ss_pred -------------------------CCCEEECCCCCHHHHHHHCCCCCCCCHHHCCCCCHHHHHHHHCCCCCCCCCCHHH
T ss_conf -------------------------5100103443101466750698888044402654188998518999988999999
Q ss_pred HHHHHHHCCC---------------------------CCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHCHHHHHCCCCC
Q ss_conf 9999982899---------------------------9999998879899999980103927669982409999819997
Q 001847 909 TFANILHKDL---------------------------KFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFF 961 (1005)
Q Consensus 909 ~~~~i~~~~~---------------------------~~~~~~~~s~~l~~Ll~~mL~~dP~~Rpt~~~~a~elL~hpff 961 (1005)
.+..+..... ........+..+.+||.+||+.||.+||| |+|+|+||||
T Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~s----a~e~L~Hp~f 286 (292)
T d1unla_ 211 QLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRIS----AEEALQHPYF 286 (292)
T ss_dssp HHHHHHHHHCCCCTTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCC----HHHHTTSGGG
T ss_pred HHHHHHHHCCCCCHHHHHHHHHCCCCCCCCCCCCCCHHHHCCCCCCHHHHHHHHHHCCCCHHHCCC----HHHHHCCHHH
T ss_conf 999998611899735513443222113344454431043306568999999999986499668909----9999649534
Q ss_pred CCC
Q ss_conf 799
Q 001847 962 KGV 964 (1005)
Q Consensus 962 ~~~ 964 (1005)
+++
T Consensus 287 ~~~ 289 (292)
T d1unla_ 287 SDF 289 (292)
T ss_dssp SSC
T ss_pred CCC
T ss_conf 079
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=351.95 Aligned_cols=253 Identities=23% Similarity=0.340 Sum_probs=218.3
Q ss_pred CCCCCCCCCCCCCCCCCEEEEEEEECCCCEEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEE
Q ss_conf 34688432331166693899999990799199999940531237578999999999999579998453789987078189
Q 001847 669 INLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVC 748 (1005)
Q Consensus 669 i~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~ 748 (1005)
++.++|++.+.||+|+||.||+|.+ .++..||||.+++... ....+.+|+.++++++||||+++++++...+.++
T Consensus 1 ~~~~~~~~~~~iG~G~fg~Vy~~~~-~~~~~vAvK~l~~~~~----~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~ 75 (258)
T d1k2pa_ 1 IDPKDLTFLKELGTGQFGVVKYGKW-RGQYDVAIKMIKEGSM----SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIF 75 (258)
T ss_dssp CCCCCCCCCCCCCEETTEEEEEEEE-TTTEEEEEEEEESSSS----CHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEE
T ss_pred CCHHHCEEEEEEECCCCEEEEEEEE-CCCCEEEEEEECCCCC----CHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCEE
T ss_conf 9969979968982078839999998-8998999999874757----7899999999999668986015889985078169
Q ss_pred EEEECCCCCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEEECCCCEEEEECCCCCCCCCCC
Q ss_conf 99960589835667731799999899999999999999999998594317899996898069928998516775458898
Q 001847 749 LITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKP 828 (1005)
Q Consensus 749 iV~E~~~g~sL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvH~DLkP~NIli~~~g~ikL~DFG~a~~~~~~~ 828 (1005)
+||||+++|+|..++... ...+++..++.++.|++.||.|||++||+|+||||+||+++.++.+||+|||++.......
T Consensus 76 iv~Ey~~~g~l~~~~~~~-~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~ 154 (258)
T d1k2pa_ 76 IITEYMANGCLLNYLREM-RHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE 154 (258)
T ss_dssp EEEECCTTEEHHHHHHSG-GGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSS
T ss_pred EEEECCCCCCHHHHHHCC-CCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCEEEEECCCCCEEECCCHHHEECCCCC
T ss_conf 999704899388864102-4677689999999999999998754684346654135887699847988614420235787
Q ss_pred CCCCCCCHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHC-CCCCCCCCCHH
Q ss_conf 77788512332114699997432356665655556876335200038888883059999999999990-99999999968
Q 001847 829 QLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY-GYTPFRGKTRQ 907 (1005)
Q Consensus 829 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDIwSLG~il~eLlt-G~~Pf~~~~~~ 907 (1005)
. .......||+.|+|||++.+..++.++|||||||++|+|++ |+.||.+.+..
T Consensus 155 ~--------------------------~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~ 208 (258)
T d1k2pa_ 155 Y--------------------------TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNS 208 (258)
T ss_dssp C--------------------------CCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHH
T ss_pred C--------------------------EEECCCCCCCCCCCCHHHCCCCCCCCEEECCCCHHHHHHHHCCCCCCCCCCHH
T ss_conf 2--------------------------25246578877578078637998852103364324673975599998899999
Q ss_pred HHHHHHHHCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHCHHHHHCC
Q ss_conf 999999828999999998879899999980103927669982409999819
Q 001847 908 KTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKH 958 (1005)
Q Consensus 908 ~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~mL~~dP~~Rpt~~~~a~elL~h 958 (1005)
+....+..+. ..+.+...+..+.+|+.+||+.||++||| +.++++|
T Consensus 209 ~~~~~i~~~~-~~~~p~~~~~~l~~li~~cl~~dP~~RPt----~~eil~~ 254 (258)
T d1k2pa_ 209 ETAEHIAQGL-RLYRPHLASEKVYTIMYSCWHEKADERPT----FKILLSN 254 (258)
T ss_dssp HHHHHHHTTC-CCCCCTTCCHHHHHHHHHTTCSSGGGSCC----HHHHHHH
T ss_pred HHHHHHHHCC-CCCCCCCCCHHHHHHHHHHCCCCHHHCCC----HHHHHHH
T ss_conf 9999998079-78996546599999999976689768939----9999987
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=356.04 Aligned_cols=264 Identities=22% Similarity=0.338 Sum_probs=219.7
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCEEEEEEEECCCCEEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEE
Q ss_conf 45444346884323311666938999999907991999999405312375789999999999995799984537899870
Q 001847 664 DSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQT 743 (1005)
Q Consensus 664 ~~~~~i~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~ 743 (1005)
...|.+..++|++.+.||+|+||.||+|.+.. +..||||.+..... ....+.+|+.++++++||||+++++++..
T Consensus 9 ~~~~~i~~~~~~i~~~iG~G~fg~Vy~~~~~~-~~~vAiK~l~~~~~----~~~~~~~E~~~l~~l~h~nIv~~~g~~~~ 83 (285)
T d1fmka3 9 KDAWEIPRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTM----SPEAFLQEAQVMKKLRHEKLVQLYAVVSE 83 (285)
T ss_dssp TTCSBCCGGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTSS----CHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred CCCEECCHHHEEEEEEEEECCCEEEEEEEECC-CCEEEEEEECCCCC----CHHHHHHHHHHHHHCCCCCEEEEEEEEEC
T ss_conf 75607477997984699307980999999999-99999999880448----88999999999986666788689999823
Q ss_pred CCEEEEEEECCCCCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEEECCCCEEEEECCCCCC
Q ss_conf 78189999605898356677317999998999999999999999999985943178999968980699289985167754
Q 001847 744 KTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCL 823 (1005)
Q Consensus 744 ~~~~~iV~E~~~g~sL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvH~DLkP~NIli~~~g~ikL~DFG~a~~ 823 (1005)
+.+++||||+++|+|..++.......+++..+..++.||+.||+|||++||+|+||||+|||++.++.+||+|||++..
T Consensus 84 -~~~~lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~~~~~kl~DfGla~~ 162 (285)
T d1fmka3 84 -EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARL 162 (285)
T ss_dssp -SSCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC-
T ss_pred -CCEEEEEEECCCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHHHHEECCCCCCEEEEECCCCCEEECCCCHHHH
T ss_conf -9759999944799435420000355305999999999999999987541143353123079998999299844255542
Q ss_pred CCCCCCCCCCCCHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCC-CCCCC
Q ss_conf 58898777885123321146999974323566656555568763352000388888830599999999999909-99999
Q 001847 824 TSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYG-YTPFR 902 (1005)
Q Consensus 824 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDIwSLG~il~eLltG-~~Pf~ 902 (1005)
...... .......|++.|+|||++....++.++|||||||++|+|++| .+|+.
T Consensus 163 ~~~~~~--------------------------~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~ 216 (285)
T d1fmka3 163 IEDNEY--------------------------TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYP 216 (285)
T ss_dssp ---------------------------------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSST
T ss_pred CCCCCC--------------------------EEECCCCCCCCCCCHHHHHCCCCCCHHHHHCCHHHHHHHHHCCCCCCC
T ss_conf 568873--------------------------352454556654580898379989177413235899999868999998
Q ss_pred CCCHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHCHHHHHC--CCCCCCC
Q ss_conf 9996899999982899999999887989999998010392766998240999981--9997799
Q 001847 903 GKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKK--HPFFKGV 964 (1005)
Q Consensus 903 ~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~mL~~dP~~Rpt~~~~a~elL~--hpff~~~ 964 (1005)
+....+.+..+..+ ...+....++..+.+|+.+||..||++||+ +.+++. ++||+..
T Consensus 217 ~~~~~~~~~~i~~~-~~~~~~~~~~~~l~~li~~cl~~dP~~Rps----~~~i~~~L~~~~~~~ 275 (285)
T d1fmka3 217 GMVNREVLDQVERG-YRMPCPPECPESLHDLMCQCWRKEPEERPT----FEYLQAFLEDYFTST 275 (285)
T ss_dssp TCCHHHHHHHHHTT-CCCCCCTTSCHHHHHHHHHHTCSSGGGSCC----HHHHHHHHHTTTSCS
T ss_pred CCCHHHHHHHHHHC-CCCCCCCCCCHHHHHHHHHHCCCCHHHCCC----HHHHHHHHHHHHCCC
T ss_conf 88899999999826-899998323799999999975669758919----999999876662389
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=355.07 Aligned_cols=255 Identities=22% Similarity=0.315 Sum_probs=212.1
Q ss_pred CCCCCCCCEEEEEEEECC--CCEEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEEEEEECCC
Q ss_conf 311666938999999907--991999999405312375789999999999995799984537899870781899996058
Q 001847 678 KPLGSGDTGSVHLVELCG--SGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCP 755 (1005)
Q Consensus 678 ~~LG~G~~g~Vy~~~~~~--~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~iV~E~~~ 755 (1005)
++||+|+||.||+|.+.. +++.||+|.++... .+......+.+|+.++++++||||+++++++.. +..|+||||++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~ 90 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEA-NDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAE 90 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC------CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCT
T ss_pred CCCCCCCCEEEEEEEECCCCCCEEEEEEEECHHH-CCHHHHHHHHHHHHHHHHCCCCCCCEEEEEECC-CCEEEEEECCC
T ss_conf 7834587829999998169738599999988010-898999999999999986799898527777505-97799997478
Q ss_pred CCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEEECCCCEEEEECCCCCCCCCCCCCCCCCC
Q ss_conf 98356677317999998999999999999999999985943178999968980699289985167754588987778851
Q 001847 756 GGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTT 835 (1005)
Q Consensus 756 g~sL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvH~DLkP~NIli~~~g~ikL~DFG~a~~~~~~~~~~~~~~ 835 (1005)
+|+|.+++... ..+++..+..++.||+.||.|||+++|+||||||+|||++.++.+||+|||++........
T Consensus 91 ~g~L~~~l~~~--~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~------ 162 (277)
T d1xbba_ 91 LGPLNKYLQQN--RHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN------ 162 (277)
T ss_dssp TEEHHHHHHHC--TTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCS------
T ss_pred CCCHHHHHHHC--CCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHCCCCCCCCCCCCHHHHHHCCCCCC------
T ss_conf 89689997522--5789999999999999997668747955677761131023567512341345331343234------
Q ss_pred HHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHC-CCCCCCCCCHHHHHHHHH
Q ss_conf 2332114699997432356665655556876335200038888883059999999999990-999999999689999998
Q 001847 836 NEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY-GYTPFRGKTRQKTFANIL 914 (1005)
Q Consensus 836 ~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDIwSLG~il~eLlt-G~~Pf~~~~~~~~~~~i~ 914 (1005)
.........||+.|+|||++.+..++.++|||||||++|+|++ |++||.+.+..+....+.
T Consensus 163 ------------------~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~ 224 (277)
T d1xbba_ 163 ------------------YYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLE 224 (277)
T ss_dssp ------------------EEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHH
T ss_pred ------------------CCCCCCCCCCCCEECCCHHHCCCCCCCHHHHCCCHHHHHHHHHCCCCCCCCCCHHHHHHHHH
T ss_conf ------------------43224456778420391665379998434430340313289658999999989999999998
Q ss_pred HCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHCHHHH---HCCCCCCCCC
Q ss_conf 28999999998879899999980103927669982409999---8199977998
Q 001847 915 HKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEI---KKHPFFKGVN 965 (1005)
Q Consensus 915 ~~~~~~~~~~~~s~~l~~Ll~~mL~~dP~~Rpt~~~~a~el---L~hpff~~~~ 965 (1005)
.+. ..+.+..++.++.+|+.+||..||.+||| +.++ |+|+|+.-++
T Consensus 225 ~~~-~~~~p~~~~~~~~~li~~cl~~dp~~RPs----~~~i~~~L~~~~~~~~~ 273 (277)
T d1xbba_ 225 KGE-RMGCPAGCPREMYDLMNLCWTYDVENRPG----FAAVELRLRNYYYDVVN 273 (277)
T ss_dssp TTC-CCCCCTTCCHHHHHHHHHHTCSSTTTSCC----HHHHHHHHHHHHHHHHH
T ss_pred CCC-CCCCCCCCCHHHHHHHHHHCCCCHHHCCC----HHHHHHHHHCHHHHCCC
T ss_conf 289-99998656799999999975889768909----89999985288750479
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=347.09 Aligned_cols=258 Identities=21% Similarity=0.278 Sum_probs=212.8
Q ss_pred CCCCCCCCCCCCCCCCCCEEEEEEEECCCC----EEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEE
Q ss_conf 434688432331166693899999990799----1999999405312375789999999999995799984537899870
Q 001847 668 QINLQHFRPIKPLGSGDTGSVHLVELCGSG----QYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQT 743 (1005)
Q Consensus 668 ~i~~~~y~~~~~LG~G~~g~Vy~~~~~~~~----~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~ 743 (1005)
.|....|.+.+.||+|+||.||+|.+..++ ..||||.+.... .......+.+|+.++++++||||+++++++..
T Consensus 3 ei~~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~ 80 (283)
T d1mqba_ 3 EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY--TEKQRVDFLGEAGIMGQFSHHNIIRLEGVISK 80 (283)
T ss_dssp BCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred CCCHHHEEEEEEEEECCCEEEEEEEEECCCCEEEEEEEEEEECCCC--CHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEC
T ss_conf 5788996861598117790999999968998787999999988445--96899999999999985689878323677833
Q ss_pred CCEEEEEEECCCCCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEEECCCCEEEEECCCCCC
Q ss_conf 78189999605898356677317999998999999999999999999985943178999968980699289985167754
Q 001847 744 KTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCL 823 (1005)
Q Consensus 744 ~~~~~iV~E~~~g~sL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvH~DLkP~NIli~~~g~ikL~DFG~a~~ 823 (1005)
.+..++||||+.++++.+++... ...+++..+..++.||+.||.|||+++|+||||||+|||++.++.+||+|||+++.
T Consensus 81 ~~~~~~v~e~~~~~~l~~~~~~~-~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~ 159 (283)
T d1mqba_ 81 YKPMMIITEYMENGALDKFLREK-DGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRV 159 (283)
T ss_dssp SSSEEEEEECCTTEEHHHHHHHT-TTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred CCCEEEEEEECCCCCCHHHHHCC-CCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCEEEECCCCEEEECCCCHHHC
T ss_conf 88038999721357402221023-45420899999999999854121212342576564427888998499845510300
Q ss_pred CCCCCCCCCCCCHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCC-CCCCC
Q ss_conf 58898777885123321146999974323566656555568763352000388888830599999999999909-99999
Q 001847 824 TSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYG-YTPFR 902 (1005)
Q Consensus 824 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDIwSLG~il~eLltG-~~Pf~ 902 (1005)
....... ........||+.|+|||++.+..++.++|||||||++|+|+++ .+||.
T Consensus 160 ~~~~~~~------------------------~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~ 215 (283)
T d1mqba_ 160 LEDDPEA------------------------TYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYW 215 (283)
T ss_dssp --------------------------------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTT
T ss_pred CCCCCCC------------------------CEEECCCCCCCCCCCHHHHCCCCCCCCCCCCCCHHHHHHHHHCCCCCCC
T ss_conf 3578765------------------------2674267777343488887049999735563448989999967988655
Q ss_pred CCCHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHCHHHHHC
Q ss_conf 9996899999982899999999887989999998010392766998240999981
Q 001847 903 GKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKK 957 (1005)
Q Consensus 903 ~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~mL~~dP~~Rpt~~~~a~elL~ 957 (1005)
+.+..+....+.. ....+.+..++..+.+|+.+||..||++||| +.++++
T Consensus 216 ~~~~~~~~~~i~~-~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt----~~eil~ 265 (283)
T d1mqba_ 216 ELSNHEVMKAIND-GFRLPTPMDCPSAIYQLMMQCWQQERARRPK----FADIVS 265 (283)
T ss_dssp TCCHHHHHHHHHT-TCCCCCCTTCBHHHHHHHHHHTCSSTTTSCC----HHHHHH
T ss_pred CCCHHHHHHHHHC-CCCCCCCHHHHHHHHHHHHHHCCCCHHHCCC----HHHHHH
T ss_conf 6899999999863-5789985045799999999977679768939----999999
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=350.72 Aligned_cols=257 Identities=25% Similarity=0.355 Sum_probs=218.4
Q ss_pred CCCCCCCCCCCCCCCCCCCEEEEEEEECCC---CEEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEE
Q ss_conf 443468843233116669389999999079---91999999405312375789999999999995799984537899870
Q 001847 667 EQINLQHFRPIKPLGSGDTGSVHLVELCGS---GQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQT 743 (1005)
Q Consensus 667 ~~i~~~~y~~~~~LG~G~~g~Vy~~~~~~~---~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~ 743 (1005)
|.+..++|++.+.||+|+||.||+|.+..+ +..+|+|.++.. ........+.+|+.++++++||||+++++++.
T Consensus 2 ~ei~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~--~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~- 78 (273)
T d1mp8a_ 2 YEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNC--TSDSVREKFLQEALTMRQFDHPHIVKLIGVIT- 78 (273)
T ss_dssp CBCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTT--TSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-
T ss_pred CCCCHHHEEEEEEEEECCCCEEEEEEEECCCCEEEEEEEEEECCC--CCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEE-
T ss_conf 976889969877993078829999999369964499999993656--68799999999999998689999856988995-
Q ss_pred CCEEEEEEECCCCCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEEECCCCEEEEECCCCCC
Q ss_conf 78189999605898356677317999998999999999999999999985943178999968980699289985167754
Q 001847 744 KTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCL 823 (1005)
Q Consensus 744 ~~~~~iV~E~~~g~sL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvH~DLkP~NIli~~~g~ikL~DFG~a~~ 823 (1005)
.+.+|+||||+++|+|.+++... ...+++..++.++.||+.||.|||+++|+||||||+||+++.++.+||+|||+|..
T Consensus 79 ~~~~~iv~E~~~~g~l~~~~~~~-~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~ 157 (273)
T d1mp8a_ 79 ENPVWIIMELCTLGELRSFLQVR-KYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRY 157 (273)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHT-TTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC------
T ss_pred CCEEEEEEEECCCCCHHHHHHCC-CCCCCHHHHHHHHHHHHHHHHHHCCCCEECCCCCHHHEEECCCCCEEECCCHHHEE
T ss_conf 37479999840698077654224-78999999999999998775230226744141026553206789678765034213
Q ss_pred CCCCCCCCCCCCHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHC-CCCCCC
Q ss_conf 5889877788512332114699997432356665655556876335200038888883059999999999990-999999
Q 001847 824 TSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY-GYTPFR 902 (1005)
Q Consensus 824 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDIwSLG~il~eLlt-G~~Pf~ 902 (1005)
..... ........||+.|+|||++.+..++.++|||||||++|+|++ |.+||.
T Consensus 158 ~~~~~--------------------------~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~ 211 (273)
T d1mp8a_ 158 MEDST--------------------------YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQ 211 (273)
T ss_dssp ---------------------------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTT
T ss_pred CCCCC--------------------------CEECCCEECCCCCCHHHHHCCCCCCCCCCCCCCHHHHHHHHHCCCCCCC
T ss_conf 36776--------------------------2330540058310326675169988745244424789999826999988
Q ss_pred CCCHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHCHHHHHCC
Q ss_conf 99968999999828999999998879899999980103927669982409999819
Q 001847 903 GKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKH 958 (1005)
Q Consensus 903 ~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~mL~~dP~~Rpt~~~~a~elL~h 958 (1005)
+.+..+....+..+.. .+.+..++..+.+||.+||..||.+||| +.++++|
T Consensus 212 ~~~~~~~~~~i~~~~~-~~~~~~~~~~~~~li~~cl~~dp~~Rps----~~ei~~~ 262 (273)
T d1mp8a_ 212 GVKNNDVIGRIENGER-LPMPPNCPPTLYSLMTKCWAYDPSRRPR----FTELKAQ 262 (273)
T ss_dssp TCCGGGHHHHHHTTCC-CCCCTTCCHHHHHHHHHHTCSSGGGSCC----HHHHHHH
T ss_pred CCCHHHHHHHHHCCCC-CCCCCCCCHHHHHHHHHHCCCCHHHCCC----HHHHHHH
T ss_conf 8999999999981899-9898777999999999976879768929----9999999
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=348.93 Aligned_cols=262 Identities=24% Similarity=0.343 Sum_probs=214.4
Q ss_pred CCCCCCCCCCCCCCCCCCCCEEEEEEEECCC-----CEEEEEEEEECCCCCCHHHHHHHHHHHHHHHHC-CCCCCCEEEE
Q ss_conf 4443468843233116669389999999079-----919999994053123757899999999999957-9998453789
Q 001847 666 GEQINLQHFRPIKPLGSGDTGSVHLVELCGS-----GQYFAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPALYA 739 (1005)
Q Consensus 666 ~~~i~~~~y~~~~~LG~G~~g~Vy~~~~~~~-----~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~ 739 (1005)
.|.+..++|++.+.||+|+||.||+|.+... ++.||+|.+.... .......+..|..++.++ .|+||+.+++
T Consensus 7 ~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~--~~~~~~~~~~e~~~l~~~~~h~~iv~~~~ 84 (299)
T d1ywna1 7 KWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLG 84 (299)
T ss_dssp HHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC------CHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred CCCCCHHHEEEEEEEEECCCEEEEEEEECCCCCCCCCEEEEEEEECCCC--CCHHHHHHHHHHHHHHHHCCCCEEEEEEE
T ss_conf 5261679979844984167839999998677755578399999986001--71789999999999886149984997411
Q ss_pred EEEE-CCEEEEEEECCCCCCHHHHHHHCC--------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCC
Q ss_conf 9870-781899996058983566773179--------------9999899999999999999999998594317899996
Q 001847 740 SFQT-KTHVCLITDYCPGGELFLLLDRQP--------------TKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPEN 804 (1005)
Q Consensus 740 ~~~~-~~~~~iV~E~~~g~sL~~~l~~~~--------------~~~l~~~~i~~i~~qil~aL~~LH~~gIvH~DLkP~N 804 (1005)
++.. ...+++|||||++|+|.+++.... ...+++..+..++.||+.||.|||+++|+||||||+|
T Consensus 85 ~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~N 164 (299)
T d1ywna1 85 ACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARN 164 (299)
T ss_dssp EECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGG
T ss_pred EECCCCCEEEEEEEECCCCCHHHHHHHCCCCCCCCCCCHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCC
T ss_conf 54047975799998458992999998536666653222023321468999999999999999998873797178677310
Q ss_pred EEEECCCCEEEEECCCCCCCCCCCCCCCCCCHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHH
Q ss_conf 89806992899851677545889877788512332114699997432356665655556876335200038888883059
Q 001847 805 VLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDW 884 (1005)
Q Consensus 805 Ili~~~g~ikL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDI 884 (1005)
||++.++.+||+|||+|+....... ........||+.|+|||++.+..++.++||
T Consensus 165 ILl~~~~~~Kl~DFGla~~~~~~~~-------------------------~~~~~~~~gt~~y~APE~l~~~~~~~~sDi 219 (299)
T d1ywna1 165 ILLSEKNVVKICDFGLARDIYKDPD-------------------------YVRKGDARLPLKWMAPETIFDRVYTIQSDV 219 (299)
T ss_dssp EEECGGGCEEECC------CCSCTT-------------------------SCCTTSCCCGGGGCCHHHHHHCCCCHHHHH
T ss_pred EEECCCCCEEECCCCCHHHCCCCCC-------------------------CCCCCCEEECCCCCCHHHHHCCCCCCCCCE
T ss_conf 6577998289845752001135665-------------------------222475166721020368646889966322
Q ss_pred HHHHHHHHHHHCC-CCCCCCCCHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHCHHHHHCC
Q ss_conf 9999999999909-9999999968999999828999999998879899999980103927669982409999819
Q 001847 885 WALGILLYEMLYG-YTPFRGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKH 958 (1005)
Q Consensus 885 wSLG~il~eLltG-~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~mL~~dP~~Rpt~~~~a~elL~h 958 (1005)
|||||++|+|++| .+||.+......+..++......+.+..++.++.+|+.+||..||.+||| +.++++|
T Consensus 220 wS~Gvil~ellt~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt----~~eil~~ 290 (299)
T d1ywna1 220 WSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPT----FSELVEH 290 (299)
T ss_dssp HHHHHHHHHHHTTSCCSSTTCCCSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCC----HHHHHHH
T ss_pred EEHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCC----HHHHHHH
T ss_conf 1367899999868899998999899999999638988888657899999999976779667919----9999999
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=347.21 Aligned_cols=254 Identities=22% Similarity=0.315 Sum_probs=212.5
Q ss_pred CCCCCCCCCCCCCCCEEEEEEEECCCCE----EEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCE
Q ss_conf 6884323311666938999999907991----999999405312375789999999999995799984537899870781
Q 001847 671 LQHFRPIKPLGSGDTGSVHLVELCGSGQ----YFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTH 746 (1005)
Q Consensus 671 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~----~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~ 746 (1005)
..+|++++.||+|+||.||+|.+..+++ .||+|.+.... .......+.+|+.++++++||||+++++++... .
T Consensus 8 ~~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~ 84 (317)
T d1xkka_ 8 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASVDNPHVCRLLGICLTS-T 84 (317)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC------CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-S
T ss_pred HHHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEEEECCCC--CHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECC-C
T ss_conf 8999783198208992999999958998898999999965134--979999999999999867998881589999619-8
Q ss_pred EEEEEECCCCCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEEECCCCEEEEECCCCCCCCC
Q ss_conf 89999605898356677317999998999999999999999999985943178999968980699289985167754588
Q 001847 747 VCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSC 826 (1005)
Q Consensus 747 ~~iV~E~~~g~sL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvH~DLkP~NIli~~~g~ikL~DFG~a~~~~~ 826 (1005)
.+++++++.+++|.+++... ...+++..++.++.||+.||.|||+++|+||||||+|||++.++.+||+|||+|.....
T Consensus 85 ~~~v~e~~~~~~l~~~~~~~-~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~ 163 (317)
T d1xkka_ 85 VQLITQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 163 (317)
T ss_dssp EEEEEECCTTCBHHHHHHHT-SSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCCSHHHHTTT
T ss_pred EEEEEEECCCCCCCCCCCCC-CCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCHHHCCEECCCCCEEEECCCCCEECCC
T ss_conf 36999842687401011133-45799999999999999999999876950476212031167998758602552223354
Q ss_pred CCCCCCCCCHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHC-CCCCCCCCC
Q ss_conf 9877788512332114699997432356665655556876335200038888883059999999999990-999999999
Q 001847 827 KPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY-GYTPFRGKT 905 (1005)
Q Consensus 827 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDIwSLG~il~eLlt-G~~Pf~~~~ 905 (1005)
... ........||+.|+|||++.+..++.++|||||||++|+|++ |.+||.+.+
T Consensus 164 ~~~-------------------------~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~ 218 (317)
T d1xkka_ 164 EEK-------------------------EYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP 218 (317)
T ss_dssp TCC---------------------------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSC
T ss_pred CCC-------------------------CCCCCCCCCCCCCCCHHHHHCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCC
T ss_conf 445-------------------------3223651058644670887469998356544079999999977999999999
Q ss_pred HHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHCHHHHHCC
Q ss_conf 68999999828999999998879899999980103927669982409999819
Q 001847 906 RQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKH 958 (1005)
Q Consensus 906 ~~~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~mL~~dP~~Rpt~~~~a~elL~h 958 (1005)
..+....+..+. .++.+..++..+.+|+.+||..||.+||| +.+++.|
T Consensus 219 ~~~~~~~i~~~~-~~~~p~~~~~~~~~li~~cl~~dP~~RPs----~~eil~~ 266 (317)
T d1xkka_ 219 ASEISSILEKGE-RLPQPPICTIDVYMIMVKCWMIDADSRPK----FRELIIE 266 (317)
T ss_dssp GGGHHHHHHHTC-CCCCCTTBCHHHHHHHHHHTCSSGGGSCC----HHHHHHH
T ss_pred HHHHHHHHHCCC-CCCCCCCCCHHHHHHHHHHCCCCHHHCCC----HHHHHHH
T ss_conf 899999997599-89998556899999999847899346919----9999999
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=348.47 Aligned_cols=258 Identities=22% Similarity=0.314 Sum_probs=222.3
Q ss_pred CCCCCCCCCCCCCCCCCEEEEEEEECCC---CEEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECC
Q ss_conf 3468843233116669389999999079---9199999940531237578999999999999579998453789987078
Q 001847 669 INLQHFRPIKPLGSGDTGSVHLVELCGS---GQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKT 745 (1005)
Q Consensus 669 i~~~~y~~~~~LG~G~~g~Vy~~~~~~~---~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~ 745 (1005)
|+.++|++++.||+|+||.||+|..... ...||+|++.+...........+.+|+.++++++||||+++++++.. .
T Consensus 5 i~~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~ 83 (273)
T d1u46a_ 5 IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-P 83 (273)
T ss_dssp CCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-S
T ss_pred ECHHHEEEEEEEECCCCEEEEEEEEECCCCCEEEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEE-C
T ss_conf 864891997898038883999999988999079999999983555798999999999999986899998789877740-1
Q ss_pred EEEEEEECCCCCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEEECCCCEEEEECCCCCCCC
Q ss_conf 18999960589835667731799999899999999999999999998594317899996898069928998516775458
Q 001847 746 HVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTS 825 (1005)
Q Consensus 746 ~~~iV~E~~~g~sL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvH~DLkP~NIli~~~g~ikL~DFG~a~~~~ 825 (1005)
.+++||||+++++|.+++..+. +.+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++....
T Consensus 84 ~~~lv~e~~~~~~l~~~~~~~~-~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~ 162 (273)
T d1u46a_ 84 PMKMVTELAPLGSLLDRLRKHQ-GHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALP 162 (273)
T ss_dssp SCEEEEECCTTCBHHHHHHHHG-GGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECC
T ss_pred CHHEEEEEECCCCHHHHHHCCC-CCCCHHHHHHHHHHHHHHHHHHHHCCEEEEEECHHHHCCCCCCCEEECCCHHHHHCC
T ss_conf 0011465423861254442126-899999999999999999987521787520566888156556543325611555303
Q ss_pred CCCCCCCCCCHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHC-CCCCCCCC
Q ss_conf 89877788512332114699997432356665655556876335200038888883059999999999990-99999999
Q 001847 826 CKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY-GYTPFRGK 904 (1005)
Q Consensus 826 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDIwSLG~il~eLlt-G~~Pf~~~ 904 (1005)
..... ........|+..|+|||++.+..++.++|||||||++|+|++ |..||.+.
T Consensus 163 ~~~~~------------------------~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~ 218 (273)
T d1u46a_ 163 QNDDH------------------------YVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGL 218 (273)
T ss_dssp C-CCE------------------------EEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred CCCCC------------------------CEECCCCCCCCCCCCHHHHHCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCC
T ss_conf 58875------------------------265476325731079999837999942156614899999996899999996
Q ss_pred CHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHCHHHHH
Q ss_conf 9689999998289999999988798999999801039276699824099998
Q 001847 905 TRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIK 956 (1005)
Q Consensus 905 ~~~~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~mL~~dP~~Rpt~~~~a~elL 956 (1005)
+..+....+.+....++....++..+.+|+.+||..||.+||| +.+++
T Consensus 219 ~~~~~~~~i~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt----~~ei~ 266 (273)
T d1u46a_ 219 NGSQILHKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPT----FVALR 266 (273)
T ss_dssp CHHHHHHHHHTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCC----HHHHH
T ss_pred CHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCC----HHHHH
T ss_conf 9999999998479999985445399999999976889667929----99999
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=342.40 Aligned_cols=261 Identities=21% Similarity=0.317 Sum_probs=220.1
Q ss_pred CCCCCCCCCCCCCCCCCCCCCEEEEEEEECCCC-------EEEEEEEEECCCCCCHHHHHHHHHHHHHHHHC-CCCCCCE
Q ss_conf 544434688432331166693899999990799-------19999994053123757899999999999957-9998453
Q 001847 665 SGEQINLQHFRPIKPLGSGDTGSVHLVELCGSG-------QYFAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPA 736 (1005)
Q Consensus 665 ~~~~i~~~~y~~~~~LG~G~~g~Vy~~~~~~~~-------~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~ 736 (1005)
+.|.+..++|++.+.||+|+||.||+|.+..++ ..||+|.+++.. .......+.+|...+.++ +||||++
T Consensus 6 ~~~~i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~~e~~~l~~~~~HpnIv~ 83 (299)
T d1fgka_ 6 PRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA--TEKDLSDLISEMEMMKMIGKHKNIIN 83 (299)
T ss_dssp TTTBCCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTC--CHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred CCCCCCHHHEEEEEEEEECCCCEEEEEEECCCCCCCCCCCEEEEEEEECCCC--CHHHHHHHHHHHHHHHHHCCCCEEEE
T ss_conf 7672258996970098516782899999857875556675499999988112--86889999999999998139996973
Q ss_pred EEEEEEECCEEEEEEECCCCCCHHHHHHHCC--------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCC
Q ss_conf 7899870781899996058983566773179--------------99998999999999999999999985943178999
Q 001847 737 LYASFQTKTHVCLITDYCPGGELFLLLDRQP--------------TKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKP 802 (1005)
Q Consensus 737 l~~~~~~~~~~~iV~E~~~g~sL~~~l~~~~--------------~~~l~~~~i~~i~~qil~aL~~LH~~gIvH~DLkP 802 (1005)
+++++..++.+++||||+.+|+|.+++.... ...+++..+..++.||+.||+|||+++|+||||||
T Consensus 84 ~~~~~~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiKp 163 (299)
T d1fgka_ 84 LLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAA 163 (299)
T ss_dssp EEEEECSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSG
T ss_pred CCCCCCCCCEEEEEEECCCCCCHHHHHHHHCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEEEECC
T ss_conf 46522018868999973699909999986067764322233457434679999999999999999876637978630221
Q ss_pred CCEEEECCCCEEEEECCCCCCCCCCCCCCCCCCHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHH
Q ss_conf 96898069928998516775458898777885123321146999974323566656555568763352000388888830
Q 001847 803 ENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAV 882 (1005)
Q Consensus 803 ~NIli~~~g~ikL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~s 882 (1005)
+|||++.++.+||+|||++....... .........|++.|+|||++.+..++.++
T Consensus 164 ~NiLl~~~~~~kl~dfg~~~~~~~~~-------------------------~~~~~~~~~~~~~y~aPE~l~~~~y~~k~ 218 (299)
T d1fgka_ 164 RNVLVTEDNVMKIADFGLARDIHHID-------------------------YYKKTTNGRLPVKWMAPEALFDRIYTHQS 218 (299)
T ss_dssp GGEEECTTCCEEECSTTCCCCGGGCC-------------------------TTCCCTTSCCGGGGSCHHHHHHCCCCHHH
T ss_pred CCEEECCCCCEEECCCHHHCCCCCCC-------------------------CCCCCCCCCCCHHHHHHHHHCCCCCCCHH
T ss_conf 02245478976762211101135555-------------------------54314667888466326675179888255
Q ss_pred HHHHHHHHHHHHHC-CCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHCHHHHHC
Q ss_conf 59999999999990-9999999996899999982899999999887989999998010392766998240999981
Q 001847 883 DWWALGILLYEMLY-GYTPFRGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKK 957 (1005)
Q Consensus 883 DIwSLG~il~eLlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~mL~~dP~~Rpt~~~~a~elL~ 957 (1005)
|||||||++|+|++ |.+||.+.+.......+..+ ..++.+..++..+.+|+.+||..||.+||| +.++++
T Consensus 219 DiwS~Gvvl~ell~~g~~p~~~~~~~~~~~~i~~~-~~~~~p~~~~~~l~~li~~cl~~dP~~Rps----~~eil~ 289 (299)
T d1fgka_ 219 DVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEG-HRMDKPSNCTNELYMMMRDCWHAVPSQRPT----FKQLVE 289 (299)
T ss_dssp HHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTT-CCCCCCSSCCHHHHHHHHHHTCSSGGGSCC----HHHHHH
T ss_pred HHHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHCC-CCCCCCCCCHHHHHHHHHHHCCCCHHHCCC----HHHHHH
T ss_conf 54775888887401798989999999999999728-888987435299999999976679767939----999999
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=341.42 Aligned_cols=262 Identities=21% Similarity=0.312 Sum_probs=222.1
Q ss_pred CCCCCCCCCCCCCCCCCCCCCEEEEEEEEC-----CCCEEEEEEEEECCCCCCHHHHHHHHHHHHHHHHC-CCCCCCEEE
Q ss_conf 544434688432331166693899999990-----79919999994053123757899999999999957-999845378
Q 001847 665 SGEQINLQHFRPIKPLGSGDTGSVHLVELC-----GSGQYFAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPALY 738 (1005)
Q Consensus 665 ~~~~i~~~~y~~~~~LG~G~~g~Vy~~~~~-----~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~ 738 (1005)
..|.+..++|++.+.||+|+||.||+|.+. .+++.||+|.++... .......+.+|+.++..+ +||||++++
T Consensus 16 ~~~~~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~~E~~~~~~l~~HpnIv~~~ 93 (311)
T d1t46a_ 16 HKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA--HLTEREALMSELKVLSYLGNHMNIVNLL 93 (311)
T ss_dssp GGGBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred CCCCCCHHHEEEEEEEEECCCEEEEEEEEECCCCCCCCEEEEEEEECCCC--CHHHHHHHHHHHHHHHHCCCCCCEEEEE
T ss_conf 02637789969854982068829999998066447788699999987424--8779999999999987626999887899
Q ss_pred EEEEECCEEEEEEECCCCCCHHHHHHHCC----------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCC
Q ss_conf 99870781899996058983566773179----------------99998999999999999999999985943178999
Q 001847 739 ASFQTKTHVCLITDYCPGGELFLLLDRQP----------------TKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKP 802 (1005)
Q Consensus 739 ~~~~~~~~~~iV~E~~~g~sL~~~l~~~~----------------~~~l~~~~i~~i~~qil~aL~~LH~~gIvH~DLkP 802 (1005)
+++...+.+|+|||||++|+|.+++.... ...+++..+..++.||+.||+|||+++++||||||
T Consensus 94 g~~~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLKp 173 (311)
T d1t46a_ 94 GACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAA 173 (311)
T ss_dssp EEECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSG
T ss_pred EEEEECCEEEEEEECCCCCCHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECCCCC
T ss_conf 89831997899997379987999998535665444445332223345889999999999999999988757926662410
Q ss_pred CCEEEECCCCEEEEECCCCCCCCCCCCCCCCCCHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHH
Q ss_conf 96898069928998516775458898777885123321146999974323566656555568763352000388888830
Q 001847 803 ENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAV 882 (1005)
Q Consensus 803 ~NIli~~~g~ikL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~s 882 (1005)
+||+++.++.+|++|||.+........ .......+||+.|+|||++....++.++
T Consensus 174 ~NIl~~~~~~~ki~DfG~~~~~~~~~~-------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~ 228 (311)
T d1t46a_ 174 RNILLTHGRITKICDFGLARDIKNDSN-------------------------YVVKGNARLPVKWMAPESIFNCVYTFES 228 (311)
T ss_dssp GGEEEETTTEEEECCCGGGSCTTSCTT-------------------------SEECSSSEECGGGCCHHHHHHCCCCHHH
T ss_pred CCCCCCCCCCCCCCCCCHHEECCCCCC-------------------------CEEEEECCCCHHHCCHHHHCCCCCCCCC
T ss_conf 210000257521023401023367886-------------------------1586201359687677886179999740
Q ss_pred HHHHHHHHHHHHHC-CCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHCHHHHHC
Q ss_conf 59999999999990-9999999996899999982899999999887989999998010392766998240999981
Q 001847 883 DWWALGILLYEMLY-GYTPFRGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKK 957 (1005)
Q Consensus 883 DIwSLG~il~eLlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~mL~~dP~~Rpt~~~~a~elL~ 957 (1005)
|||||||++|+|++ |.+||.+.+....+..++............+..+.+||.+||..||.+||| +.++++
T Consensus 229 DIwS~G~~l~ellt~g~p~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs----~~~il~ 300 (311)
T d1t46a_ 229 DVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPT----FKQIVQ 300 (311)
T ss_dssp HHHHHHHHHHHHHTTTCCSSTTCCSSHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCC----HHHHHH
T ss_pred CCCCHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCC----HHHHHH
T ss_conf 010258999999858998877899899999998668988985436599999999975779657929----999999
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=344.58 Aligned_cols=256 Identities=22% Similarity=0.311 Sum_probs=217.0
Q ss_pred CCCCCCCCCCCCCCCCCCEEEEEEEECCCCEE--EEEEEEECCCCCCHHHHHHHHHHHHHHHHC-CCCCCCEEEEEEEEC
Q ss_conf 43468843233116669389999999079919--999994053123757899999999999957-999845378998707
Q 001847 668 QINLQHFRPIKPLGSGDTGSVHLVELCGSGQY--FAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPALYASFQTK 744 (1005)
Q Consensus 668 ~i~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~--vaiK~i~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~ 744 (1005)
.|+.++|++.+.||+|+||.||+|.+..++.. +|||.+.... .......+.+|+.++.++ +||||+++++++...
T Consensus 6 ~i~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~ 83 (309)
T d1fvra_ 6 VLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA--SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHR 83 (309)
T ss_dssp BCCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC--------CHHHHHHHHHTTCCCCTTBCCEEEEEEET
T ss_pred CCCHHHCEEEEEEEECCCCEEEEEEECCCCEEEEEEEEEECCCC--CHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEECC
T ss_conf 66879968877982078828999999899969999999978233--8579999999999998622899883678888418
Q ss_pred CEEEEEEECCCCCCHHHHHHHC--------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEEECC
Q ss_conf 8189999605898356677317--------------99999899999999999999999998594317899996898069
Q 001847 745 THVCLITDYCPGGELFLLLDRQ--------------PTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGN 810 (1005)
Q Consensus 745 ~~~~iV~E~~~g~sL~~~l~~~--------------~~~~l~~~~i~~i~~qil~aL~~LH~~gIvH~DLkP~NIli~~~ 810 (1005)
+.+++||||+++|+|.+++... ....+++..+..++.||+.||.|||+++|+||||||+|||++.+
T Consensus 84 ~~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~~~~ 163 (309)
T d1fvra_ 84 GYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGEN 163 (309)
T ss_dssp TEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGG
T ss_pred CEEEEEEEECCCCCHHHHHHHCCCCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEEECCC
T ss_conf 73699998028986999986403555551231012345789999999999999999876630895455505204898688
Q ss_pred CCEEEEECCCCCCCCCCCCCCCCCCHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHH
Q ss_conf 92899851677545889877788512332114699997432356665655556876335200038888883059999999
Q 001847 811 GHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGIL 890 (1005)
Q Consensus 811 g~ikL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDIwSLG~i 890 (1005)
+.+||+|||++...... .......||..|+|||.+....++.++|||||||+
T Consensus 164 ~~~kl~DfG~a~~~~~~----------------------------~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvi 215 (309)
T d1fvra_ 164 YVAKIADFGLSRGQEVY----------------------------VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVL 215 (309)
T ss_dssp GCEEECCTTCEESSCEE----------------------------CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHH
T ss_pred CCEEECCCCCCCCCCCC----------------------------CCCCCEECCCCCCCHHHHCCCCCCCCCEEEHHHHH
T ss_conf 76387434432244422----------------------------34553013775555387526999962215313889
Q ss_pred HHHHHCC-CCCCCCCCHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHCHHHHHCC
Q ss_conf 9999909-9999999968999999828999999998879899999980103927669982409999819
Q 001847 891 LYEMLYG-YTPFRGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKH 958 (1005)
Q Consensus 891 l~eLltG-~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~mL~~dP~~Rpt~~~~a~elL~h 958 (1005)
+|+|++| .+||.+.+..+....+..+. .++.+..++.++.+||.+||..||++||| +.++++|
T Consensus 216 l~ell~~~~~p~~~~~~~~~~~~i~~~~-~~~~~~~~~~~~~~li~~cl~~dP~~RPs----~~eil~~ 279 (309)
T d1fvra_ 216 LWEIVSLGGTPYCGMTCAELYEKLPQGY-RLEKPLNCDDEVYDLMRQCWREKPYERPS----FAQILVS 279 (309)
T ss_dssp HHHHHTTSCCTTTTCCHHHHHHHGGGTC-CCCCCTTBCHHHHHHHHHHTCSSGGGSCC----HHHHHHH
T ss_pred HHHHHHCCCCCCCCCCHHHHHHHHHHCC-CCCCCCCCCHHHHHHHHHHCCCCHHHCCC----HHHHHHH
T ss_conf 9999836899999999999999998268-88887667899999999976789668949----9999999
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=347.72 Aligned_cols=251 Identities=22% Similarity=0.377 Sum_probs=215.3
Q ss_pred CCCCCCCCCCCCCCCCCCCCEEEEEEEECCCCEEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEE-C
Q ss_conf 444346884323311666938999999907991999999405312375789999999999995799984537899870-7
Q 001847 666 GEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQT-K 744 (1005)
Q Consensus 666 ~~~i~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~ 744 (1005)
||.+..++|++.+.||+|+||.||+|.+ ++..||+|.++.. ...+.+.+|+.++++++||||+++++++.. .
T Consensus 1 ~w~i~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~i~~~-----~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~ 73 (262)
T d1byga_ 1 GWALNMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKND-----ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEK 73 (262)
T ss_dssp CCBCCGGGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCC-----C--HHHHHTHHHHTTCCCTTBCCEEEEECCC-
T ss_pred CCCCCHHHEEEEEEEECCCCEEEEEEEE--CCEEEEEEEECCH-----HHHHHHHHHHHHHHHCCCCCEEEEEEEEEECC
T ss_conf 9955789948857982079808999999--9909999998857-----77999999999998678989854987887238
Q ss_pred CEEEEEEECCCCCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEEECCCCEEEEECCCCCCC
Q ss_conf 81899996058983566773179999989999999999999999999859431789999689806992899851677545
Q 001847 745 THVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLT 824 (1005)
Q Consensus 745 ~~~~iV~E~~~g~sL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvH~DLkP~NIli~~~g~ikL~DFG~a~~~ 824 (1005)
+.+|+||||+++|+|.+++.......+++..++.++.||+.||.|||+++|+|+||||+|||++.++.+||+|||++...
T Consensus 74 ~~~~lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~ 153 (262)
T d1byga_ 74 GGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEA 153 (262)
T ss_dssp -CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC----
T ss_pred CCEEEEEECCCCCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHCCCCCCCCEECCCCCHHHHEECCCCCEEECCCCCCEEC
T ss_conf 92899996369998999987457888899999999999985232113376553666567601468997763245600344
Q ss_pred CCCCCCCCCCCHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHC-CCCCCCC
Q ss_conf 889877788512332114699997432356665655556876335200038888883059999999999990-9999999
Q 001847 825 SCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY-GYTPFRG 903 (1005)
Q Consensus 825 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDIwSLG~il~eLlt-G~~Pf~~ 903 (1005)
.. ......++..|+|||++.+..++.++|||||||++|+|++ |++||.+
T Consensus 154 ~~------------------------------~~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~ 203 (262)
T d1byga_ 154 SS------------------------------TQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPR 203 (262)
T ss_dssp --------------------------------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTT
T ss_pred CC------------------------------CCCCCCCCCCCCCHHHHHCCCCCHHHHHHHHHHHHHHHHHCCCCCCCC
T ss_conf 78------------------------------776556664677817872798885887775799999999789999999
Q ss_pred CCHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHCHHHHHCC
Q ss_conf 9968999999828999999998879899999980103927669982409999819
Q 001847 904 KTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKH 958 (1005)
Q Consensus 904 ~~~~~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~mL~~dP~~Rpt~~~~a~elL~h 958 (1005)
.+..+....+..+ ...+.+...+..+.+|+.+||..||.+||| +.+++++
T Consensus 204 ~~~~~~~~~i~~~-~~~~~~~~~~~~~~~li~~cl~~dP~~Rps----~~~l~~~ 253 (262)
T d1byga_ 204 IPLKDVVPRVEKG-YKMDAPDGCPPAVYEVMKNCWHLDAAMRPS----FLQLREQ 253 (262)
T ss_dssp SCGGGHHHHHTTT-CCCCCCTTCCHHHHHHHHHHTCSSGGGSCC----HHHHHHH
T ss_pred CCHHHHHHHHHCC-CCCCCCCCCCHHHHHHHHHHCCCCHHHCCC----HHHHHHH
T ss_conf 9999999999808-999997657999999999975669768939----9999999
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=341.56 Aligned_cols=270 Identities=18% Similarity=0.237 Sum_probs=225.2
Q ss_pred CCCCCCCCCCCCCCCCCCCCCEEEEEEEECC-----CCEEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEE
Q ss_conf 5444346884323311666938999999907-----99199999940531237578999999999999579998453789
Q 001847 665 SGEQINLQHFRPIKPLGSGDTGSVHLVELCG-----SGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYA 739 (1005)
Q Consensus 665 ~~~~i~~~~y~~~~~LG~G~~g~Vy~~~~~~-----~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~ 739 (1005)
..|.+..++|.+.+.||+|+||.||+|.+.. ++..||||.++... .......+.+|+.++++++||||+++++
T Consensus 13 ~~~ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~--~~~~~~~~~~E~~il~~l~h~nIv~~~~ 90 (308)
T d1p4oa_ 13 DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA--SMRERIEFLNEASVMKEFNCHHVVRLLG 90 (308)
T ss_dssp CTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS--CHHHHHHHHHHHHHGGGCCCTTBCCEEE
T ss_pred CCEEECHHHEEEEEEEEECCCEEEEEEEECCCCCCCCCCEEEEEEECCCC--CHHHHHHHHHHHHHHHHCCCCCEEEEEE
T ss_conf 10042689918835982078818999998786447789689999987012--8689999999999999769998841254
Q ss_pred EEEECCEEEEEEECCCCCCHHHHHHHC--------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEEECCC
Q ss_conf 987078189999605898356677317--------999998999999999999999999985943178999968980699
Q 001847 740 SFQTKTHVCLITDYCPGGELFLLLDRQ--------PTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNG 811 (1005)
Q Consensus 740 ~~~~~~~~~iV~E~~~g~sL~~~l~~~--------~~~~l~~~~i~~i~~qil~aL~~LH~~gIvH~DLkP~NIli~~~g 811 (1005)
++......++||||+++|+|.+++... ....++...+..++.|++.||.|||+++|+||||||+|||++.++
T Consensus 91 ~~~~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLld~~~ 170 (308)
T d1p4oa_ 91 VVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDF 170 (308)
T ss_dssp EECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTC
T ss_pred EEECCCCEEEEEEECCCCCHHHHHHHCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECEECCCCEEECCCC
T ss_conf 78428810677760489988999875033211344468879999999999999999987647965432867754035996
Q ss_pred CEEEEECCCCCCCCCCCCCCCCCCHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHH
Q ss_conf 28998516775458898777885123321146999974323566656555568763352000388888830599999999
Q 001847 812 HVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILL 891 (1005)
Q Consensus 812 ~ikL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDIwSLG~il 891 (1005)
.+||+|||+|....... .........|++.|+|||.+.+..++.++|||||||++
T Consensus 171 ~~Kl~DFGla~~~~~~~-------------------------~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il 225 (308)
T d1p4oa_ 171 TVKIGDFGMTRDIYETD-------------------------YYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVL 225 (308)
T ss_dssp CEEECCTTCCCGGGGGG-------------------------CEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHH
T ss_pred EEEEEECCCCEECCCCC-------------------------CEEECCCEECCCCCCCHHHHCCCCCCCCCCCCCHHHHH
T ss_conf 49994245420235776-------------------------30313402316323788887369988333444378999
Q ss_pred HHHHCC-CCCCCCCCHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHCHHHHHC------CCCCCCC
Q ss_conf 999909-999999996899999982899999999887989999998010392766998240999981------9997799
Q 001847 892 YEMLYG-YTPFRGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKK------HPFFKGV 964 (1005)
Q Consensus 892 ~eLltG-~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~mL~~dP~~Rpt~~~~a~elL~------hpff~~~ 964 (1005)
|+|++| .+||.+.+..+.+..+..+.. .+....++..+.+|+.+||..+|++||| +.++++ +|+|+.+
T Consensus 226 ~El~t~~~~p~~~~~~~~~~~~i~~~~~-~~~p~~~~~~l~~li~~cl~~~P~~RPs----~~~il~~L~~~~~~~~~~~ 300 (308)
T d1p4oa_ 226 WEIATLAEQPYQGLSNEQVLRFVMEGGL-LDKPDNCPDMLFELMRMCWQYNPKMRPS----FLEIISSIKEEMEPGFREV 300 (308)
T ss_dssp HHHHHTSCCTTTTSCHHHHHHHHHTTCC-CCCCTTCCHHHHHHHHHHTCSSGGGSCC----HHHHHHHHGGGSCTTHHHH
T ss_pred HHHHHCCCCCCCCCCHHHHHHHHHHCCC-CCCCCCCHHHHHHHHHHHCCCCHHHCCC----HHHHHHHHHHHCCCCCCCC
T ss_conf 9999689999999899999999980888-8886335399999999975779658939----9999999787617787577
Q ss_pred CH
Q ss_conf 81
Q 001847 965 NW 966 (1005)
Q Consensus 965 ~~ 966 (1005)
++
T Consensus 301 ~~ 302 (308)
T d1p4oa_ 301 SF 302 (308)
T ss_dssp CS
T ss_pred CC
T ss_conf 88
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=0 Score=339.65 Aligned_cols=258 Identities=20% Similarity=0.281 Sum_probs=217.1
Q ss_pred CCCCCCCCCCCCCCCCCCEEEEEEEECC-----CCEEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEE
Q ss_conf 4346884323311666938999999907-----99199999940531237578999999999999579998453789987
Q 001847 668 QINLQHFRPIKPLGSGDTGSVHLVELCG-----SGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQ 742 (1005)
Q Consensus 668 ~i~~~~y~~~~~LG~G~~g~Vy~~~~~~-----~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~ 742 (1005)
++..++|++.+.||+|+||.||+|++.. ++..||||.+.... .......+.+|+.+++.++||||+++++++.
T Consensus 9 e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~~E~~il~~l~h~niv~~~~~~~ 86 (301)
T d1lufa_ 9 EYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMAEFDNPNIVKLLGVCA 86 (301)
T ss_dssp BCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred CCCHHHCEEEEEEEECCCEEEEEEEECCCCCCCCCEEEEEEEECHHC--CHHHHHHHHHHHHHHHHCCCCCCCCCEEEEC
T ss_conf 38988938867982078839999998887657788299999988210--8579999999999999668997655246660
Q ss_pred ECCEEEEEEECCCCCCHHHHHHHCC----------------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCC
Q ss_conf 0781899996058983566773179----------------------999989999999999999999999859431789
Q 001847 743 TKTHVCLITDYCPGGELFLLLDRQP----------------------TKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDL 800 (1005)
Q Consensus 743 ~~~~~~iV~E~~~g~sL~~~l~~~~----------------------~~~l~~~~i~~i~~qil~aL~~LH~~gIvH~DL 800 (1005)
..+..+++|||+++|+|.+++.... ...++...+..++.|++.||+|||+++|+||||
T Consensus 87 ~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivHrDl 166 (301)
T d1lufa_ 87 VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDL 166 (301)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCC
T ss_pred CCCCEEEEEEECCCCCHHHHHHHCCCCCCCCCCCCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCEEEEEE
T ss_conf 59803899981589929999985275542100001110012103467889899999999999999855413578685488
Q ss_pred CCCCEEEECCCCEEEEECCCCCCCCCCCCCCCCCCHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC
Q ss_conf 99968980699289985167754588987778851233211469999743235666565555687633520003888888
Q 001847 801 KPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTS 880 (1005)
Q Consensus 801 kP~NIli~~~g~ikL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~ 880 (1005)
||+|||++.++.+||+|||+|....... ......+..|++.|+|||++.+..++.
T Consensus 167 Kp~NILld~~~~~Kl~DFGls~~~~~~~-------------------------~~~~~~~~~~~~~y~aPE~~~~~~~t~ 221 (301)
T d1lufa_ 167 ATRNCLVGENMVVKIADFGLSRNIYSAD-------------------------YYKADGNDAIPIRWMPPESIFYNRYTT 221 (301)
T ss_dssp SGGGEEECGGGCEEECCCSCHHHHTGGG-------------------------CBC----CCBCGGGCCHHHHHHCCCCH
T ss_pred CCCCEEECCCCCEEECCCHHHEECCCCC-------------------------CCCCCCCCCCCCCCCCHHHHCCCCCCH
T ss_conf 4011689899928983314421136776-------------------------411157777676767989972688980
Q ss_pred HHHHHHHHHHHHHHHCCC-CCCCCCCHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHCHHHHHC
Q ss_conf 305999999999999099-99999996899999982899999999887989999998010392766998240999981
Q 001847 881 AVDWWALGILLYEMLYGY-TPFRGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKK 957 (1005)
Q Consensus 881 ~sDIwSLG~il~eLltG~-~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~Ll~~mL~~dP~~Rpt~~~~a~elL~ 957 (1005)
++|||||||++|+|++|. +||.+.+..+....+..+.. .+.+..++.++.+|+.+||..+|.+||| +.++++
T Consensus 222 ksDVwS~Gvvl~ell~~~~~p~~~~~~~e~~~~v~~~~~-~~~p~~~~~~~~~li~~cl~~~P~~RPt----~~ev~~ 294 (301)
T d1lufa_ 222 ESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYYVRDGNI-LACPENCPLELYNLMRLCWSKLPADRPS----FCSIHR 294 (301)
T ss_dssp HHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCC-CCCCTTCCHHHHHHHHHHTCSSGGGSCC----HHHHHH
T ss_pred HHHHCCCHHHHHHHHCCCCCCCCCCCHHHHHHHHHCCCC-CCCCCCCHHHHHHHHHHHCCCCHHHCCC----HHHHHH
T ss_conf 563025236299998068999999899999999973997-8887325299999999974889657939----999999
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=325.79 Aligned_cols=253 Identities=18% Similarity=0.215 Sum_probs=205.4
Q ss_pred CCCCCCCCCCCEEEEEEEECCC---CEEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEE-CCEEEEE
Q ss_conf 3233116669389999999079---91999999405312375789999999999995799984537899870-7818999
Q 001847 675 RPIKPLGSGDTGSVHLVELCGS---GQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQT-KTHVCLI 750 (1005)
Q Consensus 675 ~~~~~LG~G~~g~Vy~~~~~~~---~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~~iV 750 (1005)
...+.||+|+||.||+|.+..+ ...||||.++.. .+......+.+|++++++++||||+++++++.. ++..++|
T Consensus 30 ~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~--~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv 107 (311)
T d1r0pa_ 30 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI--TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV 107 (311)
T ss_dssp EEEEEEEEETTEEEEEEEECC----CEEEEEEEECCC--CCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEE
T ss_pred CCCEEEEECCCEEEEEEEEECCCCEEEEEEEEEECCC--CCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCEEEE
T ss_conf 2666981368809999999779987999999998843--69789999999999998678999867867898069943899
Q ss_pred EECCCCCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEEECCCCEEEEECCCCCCCCCCCCC
Q ss_conf 96058983566773179999989999999999999999999859431789999689806992899851677545889877
Q 001847 751 TDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQL 830 (1005)
Q Consensus 751 ~E~~~g~sL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvH~DLkP~NIli~~~g~ikL~DFG~a~~~~~~~~~ 830 (1005)
||||++++|.+++... ...++...+..++.|++.||.|||+.+|+||||||+|||++.++.+||+|||++.........
T Consensus 108 ~E~~~~g~l~~~~~~~-~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~ 186 (311)
T d1r0pa_ 108 LPYMKHGDLRNFIRNE-THNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFD 186 (311)
T ss_dssp EECCTTCBHHHHHHCT-TCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCC
T ss_pred EEEEECCCHHHHHCCC-CCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHEEECCCCCEEEECCCCHHHCCCCCCC
T ss_conf 9874067414421013-454048999999999887652003367625776687576779998899106523225566555
Q ss_pred CCCCCHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCC-HHHH
Q ss_conf 788512332114699997432356665655556876335200038888883059999999999990999999999-6899
Q 001847 831 LLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKT-RQKT 909 (1005)
Q Consensus 831 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDIwSLG~il~eLltG~~Pf~~~~-~~~~ 909 (1005)
.........||+.|+|||++....++.++||||||+++|+|++|..||.... ..+.
T Consensus 187 -----------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~ 243 (311)
T d1r0pa_ 187 -----------------------SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDI 243 (311)
T ss_dssp -----------------------CTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC------C
T ss_pred -----------------------CCEECCCCCCCCCCCCHHHHHCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCHHHH
T ss_conf -----------------------310025655564556768874379997457466199999999789999888999999
Q ss_pred HHHHHHCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHCHHHHHCC
Q ss_conf 9999828999999998879899999980103927669982409999819
Q 001847 910 FANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKH 958 (1005)
Q Consensus 910 ~~~i~~~~~~~~~~~~~s~~l~~Ll~~mL~~dP~~Rpt~~~~a~elL~h 958 (1005)
...+..+. ....+..++..+.+|+.+||..||.+||+ +.++++|
T Consensus 244 ~~~i~~g~-~~~~p~~~~~~l~~li~~cl~~dP~~RPs----~~ei~~~ 287 (311)
T d1r0pa_ 244 TVYLLQGR-RLLQPEYCPDPLYEVMLKCWHPKAEMRPS----FSELVSR 287 (311)
T ss_dssp HHHHHTTC-CCCCCTTCCHHHHHHHHHHTCSSGGGSCC----HHHHHHH
T ss_pred HHHHHCCC-CCCCCCCCCHHHHHHHHHHCCCCHHHCCC----HHHHHHH
T ss_conf 99998089-88996447599999999976889768939----9999999
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=0 Score=328.14 Aligned_cols=264 Identities=18% Similarity=0.210 Sum_probs=205.9
Q ss_pred CCCCCCCCCCCCCCCEEEEEEEECCCCEEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCC-CCEEEEEEEECCEEEE
Q ss_conf 688432331166693899999990799199999940531237578999999999999579998-4537899870781899
Q 001847 671 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPF-VPALYASFQTKTHVCL 749 (1005)
Q Consensus 671 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpn-Iv~l~~~~~~~~~~~i 749 (1005)
.++|++.+.||+|+||.||+|.+..+++.||||++..... ...+..|+++++.++|++ |+.+..++...+..++
T Consensus 6 g~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~-----~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~i 80 (299)
T d1ckia_ 6 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK-----HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVM 80 (299)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT-----SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEE
T ss_pred CCEEEEEEEEEECCCCEEEEEEECCCCCEEEEEEECHHCC-----CHHHHHHHHHHHHCCCCCCCCEEEEEEECCCEEEE
T ss_conf 8889996898507880999999988998999999721005-----88899999999970389960179999951987789
Q ss_pred EEECCCCCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEEEC---CCCEEEEECCCCCCCCC
Q ss_conf 996058983566773179999989999999999999999999859431789999689806---99289985167754588
Q 001847 750 ITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQG---NGHVSLTDFDLSCLTSC 826 (1005)
Q Consensus 750 V~E~~~g~sL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvH~DLkP~NIli~~---~g~ikL~DFG~a~~~~~ 826 (1005)
||||+ +++|...+... ...+++..+..++.|++.||.|||++||+||||||+|||++. +..++|+|||+|.....
T Consensus 81 vme~~-~~~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~ 158 (299)
T d1ckia_ 81 VMELL-GPSLEDLFNFC-SRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD 158 (299)
T ss_dssp EEECC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBC
T ss_pred EEEEC-CCCHHHHHHHC-CCCCCHHHHHHHHHHHHHHHHHHHHCCEEECCCCHHHCCCCCCCCCCEEEEECCCCCEECCC
T ss_conf 99873-87133324430-68876899999999999999999979944266787660643357776156504675134255
Q ss_pred CCCCCCCCCHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCH
Q ss_conf 98777885123321146999974323566656555568763352000388888830599999999999909999999996
Q 001847 827 KPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTR 906 (1005)
Q Consensus 827 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDIwSLG~il~eLltG~~Pf~~~~~ 906 (1005)
.... ...+.......+||+.|+|||++.+..++.++|||||||++|+|++|..||.+...
T Consensus 159 ~~~~--------------------~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~ 218 (299)
T d1ckia_ 159 ARTH--------------------QHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKA 218 (299)
T ss_dssp TTTC--------------------CBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-
T ss_pred CCCC--------------------CCEECCCCCCCCCCCCCCCHHHHHCCCCCCHHHEEECCHHHHHHHHCCCCCCCCCH
T ss_conf 4455--------------------41000135776787353299999189989832188617789999849876655305
Q ss_pred HHHHHHHH---HCC--CCCC-CCCCCCHHHHHHHHHCCCCCCCCCCCCHHCHHHHHCCCCCC
Q ss_conf 89999998---289--9999-99988798999999801039276699824099998199977
Q 001847 907 QKTFANIL---HKD--LKFP-SSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFK 962 (1005)
Q Consensus 907 ~~~~~~i~---~~~--~~~~-~~~~~s~~l~~Ll~~mL~~dP~~Rpt~~~~a~elL~hpff~ 962 (1005)
......+. ... .+.+ ....++.++.+|+.+||..+|++||++.. +.++|+|+|.+
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~-i~~~l~~~~~~ 279 (299)
T d1ckia_ 219 ATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSY-LRQLFRNLFHR 279 (299)
T ss_dssp ------HHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHH-HHHHHHHHHHH
T ss_pred HHHHHHHHHHHCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHH-HHHHHHHHHHH
T ss_conf 77999999852356789835753478899999999984399557919999-99999999997
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=0 Score=315.84 Aligned_cols=253 Identities=20% Similarity=0.234 Sum_probs=203.7
Q ss_pred CCCCCCCCCCCCCCCCEEEEEEEECCCCEEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCC-CCCCEEEEEEEECCEEE
Q ss_conf 46884323311666938999999907991999999405312375789999999999995799-98453789987078189
Q 001847 670 NLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDH-PFVPALYASFQTKTHVC 748 (1005)
Q Consensus 670 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h-pnIv~l~~~~~~~~~~~ 748 (1005)
..++|++.+.||+|+||.||+|.+..+++.||+|++..... ...+.+|++.+..+.| +|++.+++++......|
T Consensus 3 ig~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~-----~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~ 77 (293)
T d1csna_ 3 VGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD-----APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNV 77 (293)
T ss_dssp ETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT-----SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEE
T ss_pred CCCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCCCC-----CHHHHHHHHHHHHHCCCCCCCEEEEEEECCCCCE
T ss_conf 89806997998417882999999988997999999750258-----2999999999999648999877999960188117
Q ss_pred EEEECCCCCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEEEC-----CCCEEEEECCCCCC
Q ss_conf 9996058983566773179999989999999999999999999859431789999689806-----99289985167754
Q 001847 749 LITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQG-----NGHVSLTDFDLSCL 823 (1005)
Q Consensus 749 iV~E~~~g~sL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvH~DLkP~NIli~~-----~g~ikL~DFG~a~~ 823 (1005)
+||||+ +++|.+++... ...++...+..++.|++.||.|||++||+||||||+|||++. ++.+||+|||+|+.
T Consensus 78 ~vme~~-~~~l~~~~~~~-~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~ 155 (293)
T d1csna_ 78 LVIDLL-GPSLEDLLDLC-GRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF 155 (293)
T ss_dssp EEEECC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred EEEEEC-CCCHHHHHHHH-CCCHHHHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCEEECCCCCCCCCCEEECCCCEEEE
T ss_conf 999964-88879999752-0311068999999999999999997796626677131523475434479568723660577
Q ss_pred CCCCCCCCCCCCHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCC
Q ss_conf 58898777885123321146999974323566656555568763352000388888830599999999999909999999
Q 001847 824 TSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRG 903 (1005)
Q Consensus 824 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDIwSLG~il~eLltG~~Pf~~ 903 (1005)
........ ..+.......+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+
T Consensus 156 ~~~~~~~~--------------------~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~ 215 (293)
T d1csna_ 156 YRDPVTKQ--------------------HIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQG 215 (293)
T ss_dssp SBCTTTCC--------------------BCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSS
T ss_pred CCCCCCCC--------------------CEEECCCCCEEECHHHCCHHHHCCCCCCHHHHHHHHHHHHHHHHHCCCCCCC
T ss_conf 14676654--------------------1110246762775102679896488888699989831999999869876788
Q ss_pred CCH---HHHHHHHHHCCCCCC---CCCCCCHHHHHHHHHCCCCCCCCCCCCH
Q ss_conf 996---899999982899999---9998879899999980103927669982
Q 001847 904 KTR---QKTFANILHKDLKFP---SSTPTSLHAKQLMYRLLHRDPKSRLGSH 949 (1005)
Q Consensus 904 ~~~---~~~~~~i~~~~~~~~---~~~~~s~~l~~Ll~~mL~~dP~~Rpt~~ 949 (1005)
... ......+.......+ ....++.++.+++..|+..+|++||+..
T Consensus 216 ~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~ 267 (293)
T d1csna_ 216 LKAATNKQKYERIGEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYD 267 (293)
T ss_dssp CCSCCHHHHHHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHH
T ss_pred CCCHHHHHHHHHHHHCCCCCCHHHHCCCCCHHHHHHHHHHHCCCCCCCCCHH
T ss_conf 5302199999999705679995896579989999999998439930085999
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=0 Score=320.57 Aligned_cols=264 Identities=23% Similarity=0.366 Sum_probs=203.5
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCEEEEEEEECCCCEEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCC-----------CC
Q ss_conf 4544434688432331166693899999990799199999940531237578999999999999579-----------99
Q 001847 664 DSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLD-----------HP 732 (1005)
Q Consensus 664 ~~~~~i~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~-----------hp 732 (1005)
..|+.+..++|++++.||+|+||+||+|++..+++.||||++.+. ........+|+.+++.+. |+
T Consensus 5 ~~g~~~~~~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~----~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~ 80 (362)
T d1q8ya_ 5 FKGEPYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD----KVYTEAAEDEIKLLQRVNDADNTKEDSMGAN 80 (362)
T ss_dssp CTTCEETTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC----HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHT
T ss_pred CCCCCCCCCCEEEEEEEEECCCEEEEEEEECCCCCEEEEEEEECC----CCCHHHHHHHHHHHHHHCCHHHHHHHHCCCC
T ss_conf 888884478579989975077818999999999979999998343----1336899999999998401455555422767
Q ss_pred CCCEEEEEEEE--CCEEEEEEECCCCCC-HHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHH-CCCCCCCCCCCCEEEE
Q ss_conf 84537899870--781899996058983-5667731799999899999999999999999998-5943178999968980
Q 001847 733 FVPALYASFQT--KTHVCLITDYCPGGE-LFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHC-QGIIYRDLKPENVLLQ 808 (1005)
Q Consensus 733 nIv~l~~~~~~--~~~~~iV~E~~~g~s-L~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~-~gIvH~DLkP~NIli~ 808 (1005)
||+++++++.. ....+++|.++..+. ............+++..++.++.||+.||.|||+ .||+||||||+|||++
T Consensus 81 ~iv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~ 160 (362)
T d1q8ya_ 81 HILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLME 160 (362)
T ss_dssp TBCCCCEEEEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEE
T ss_pred CEEEEEEEEEECCCCCEEEEEEECCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHEEEE
T ss_conf 64789987631256520234320003542000001223467868999999999999988876405864656770570563
Q ss_pred CCC------CEEEEECCCCCCCCCCCCCCCCCCHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHH
Q ss_conf 699------28998516775458898777885123321146999974323566656555568763352000388888830
Q 001847 809 GNG------HVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAV 882 (1005)
Q Consensus 809 ~~g------~ikL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~s 882 (1005)
.++ .++++|||.+..... .....+||+.|+|||++....++.++
T Consensus 161 ~~~~~~~~~~~kl~dfg~s~~~~~------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~ 210 (362)
T d1q8ya_ 161 IVDSPENLIQIKIADLGNACWYDE------------------------------HYTNSIQTREYRSPEVLLGAPWGCGA 210 (362)
T ss_dssp EEETTTTEEEEEECCCTTCEETTB------------------------------CCCSCCSCGGGCCHHHHHTCCCCTHH
T ss_pred CCCCCCCCCEEEEEECCCCCCCCC------------------------------CCCCCCCCCCCCCHHHCCCCCCCCCC
T ss_conf 057656443056753144212344------------------------------54223665210571321466777643
Q ss_pred HHHHHHHHHHHHHCCCCCCCCCCHH------HHHHHHHH--CC------------------------CCC----------
Q ss_conf 5999999999999099999999968------99999982--89------------------------999----------
Q 001847 883 DWWALGILLYEMLYGYTPFRGKTRQ------KTFANILH--KD------------------------LKF---------- 920 (1005)
Q Consensus 883 DIwSLG~il~eLltG~~Pf~~~~~~------~~~~~i~~--~~------------------------~~~---------- 920 (1005)
||||+||++++|++|+.||...... ........ +. ...
T Consensus 211 DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (362)
T d1q8ya_ 211 DIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVL 290 (362)
T ss_dssp HHHHHHHHHHHHHHSSCCC---------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHH
T ss_pred CCCCHHHHHHHHHHCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCHHHHHCCCCCCCCCCCCHHHHCCCCCCCCCHHHHC
T ss_conf 20123789999987889989875543210268999999983799878862453220001320122024323577644421
Q ss_pred ----CCCCCCCHHHHHHHHHCCCCCCCCCCCCHHCHHHHHCCCCCCCCC
Q ss_conf ----999988798999999801039276699824099998199977998
Q 001847 921 ----PSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVN 965 (1005)
Q Consensus 921 ----~~~~~~s~~l~~Ll~~mL~~dP~~Rpt~~~~a~elL~hpff~~~~ 965 (1005)
......+..+.+||.+||..||.+||| |+|+|+||||+.+-
T Consensus 291 ~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpt----a~e~L~Hp~f~~~~ 335 (362)
T d1q8ya_ 291 TEKYKFSKDEAKEISDFLSPMLQLDPRKRAD----AGGLVNHPWLKDTL 335 (362)
T ss_dssp HHTTCCCHHHHHHHHHHHGGGGCSSTTTCBC----HHHHHTCGGGTTCT
T ss_pred CCCCCCCCCCCHHHHHHHHHHCCCCHHHCCC----HHHHHCCCCCCCCC
T ss_conf 0001567435899999999987799457908----99996693407898
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=314.33 Aligned_cols=248 Identities=23% Similarity=0.306 Sum_probs=188.8
Q ss_pred CCCCCCCCCCCCCCEEEEEEEECCCCEEEEEEEEECCCCCCHHHHHHHHH--HHHHHHHCCCCCCCEEEEEEEECC----
Q ss_conf 88432331166693899999990799199999940531237578999999--999999579998453789987078----
Q 001847 672 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACA--EREILDMLDHPFVPALYASFQTKT---- 745 (1005)
Q Consensus 672 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~--E~~il~~l~hpnIv~l~~~~~~~~---- 745 (1005)
.+|.+.+.||+|+||.||+|.+ ++..||||.+.... ...... |+..+..++||||+++++++...+
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~--~g~~vAvK~~~~~~------~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~ 74 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSRE------ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWT 74 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE--TTEEEEEEEECGGG------HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSE
T ss_pred CEEEEEEEEEECCCEEEEEEEE--CCEEEEEEEECCCC------HHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCCCCE
T ss_conf 6899988982078819999999--99899999987200------467999999999962799868326889983798604
Q ss_pred EEEEEEECCCCCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHH--------CCCCCCCCCCCCEEEECCCCEEEEE
Q ss_conf 18999960589835667731799999899999999999999999998--------5943178999968980699289985
Q 001847 746 HVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHC--------QGIIYRDLKPENVLLQGNGHVSLTD 817 (1005)
Q Consensus 746 ~~~iV~E~~~g~sL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~--------~gIvH~DLkP~NIli~~~g~ikL~D 817 (1005)
.+|+||||+++|+|.+++++. .+++..+..++.|++.||.|+|+ +||+||||||+|||++.++.+||+|
T Consensus 75 ~~~lv~Ey~~~g~L~~~l~~~---~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~D 151 (303)
T d1vjya_ 75 QLWLVSDYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIAD 151 (303)
T ss_dssp EEEEEEECCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECC
T ss_pred EEEEEEECCCCCCHHHHHHCC---CCCHHHHHHHHHHHHHHHHHHHHHHHHHCCCCCEECCCCCCCCEEECCCCCEEEEE
T ss_conf 899999646698989998658---99989999999999999999887665204689866153173135786887768876
Q ss_pred CCCCCCCCCCCCCCCCCCHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC------CCCHHHHHHHHHHH
Q ss_conf 167754588987778851233211469999743235666565555687633520003888------88830599999999
Q 001847 818 FDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAG------HTSAVDWWALGILL 891 (1005)
Q Consensus 818 FG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~------~~~~sDIwSLG~il 891 (1005)
||++......... ........+||+.|+|||++.+.. ++.++|||||||++
T Consensus 152 FGl~~~~~~~~~~-----------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl 208 (303)
T d1vjya_ 152 LGLAVRHDSATDT-----------------------IDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVF 208 (303)
T ss_dssp CTTCEEEETTTTE-----------------------ECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHH
T ss_pred CCCCCCCCCCCCC-----------------------EECCCCCEECCCCCCCHHHCCCCCCCCCCCCCCCHHHHHHHHHH
T ss_conf 3866234677762-----------------------00135525035476782210565454677767501220159999
Q ss_pred HHHHCCCCCCCCC--------------CHHHHHHHHH-HCCCC--CCCC---CCCCHHHHHHHHHCCCCCCCCCCCCHHC
Q ss_conf 9999099999999--------------9689999998-28999--9999---9887989999998010392766998240
Q 001847 892 YEMLYGYTPFRGK--------------TRQKTFANIL-HKDLK--FPSS---TPTSLHAKQLMYRLLHRDPKSRLGSHEG 951 (1005)
Q Consensus 892 ~eLltG~~Pf~~~--------------~~~~~~~~i~-~~~~~--~~~~---~~~s~~l~~Ll~~mL~~dP~~Rpt~~~~ 951 (1005)
|+|++|..||... .......... ..... ++.. ......+.+|+.+||..||.+|||
T Consensus 209 ~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps---- 284 (303)
T d1vjya_ 209 WEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLT---- 284 (303)
T ss_dssp HHHHHTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCC----
T ss_pred HHHHHCCCCCCCCCCCCCCHHHCCCCCCHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCHHHCCC----
T ss_conf 9996289988766311241012255643099999987502468887765577689999999999976069858959----
Q ss_pred HHHHHC
Q ss_conf 999981
Q 001847 952 ANEIKK 957 (1005)
Q Consensus 952 a~elL~ 957 (1005)
+.|+++
T Consensus 285 ~~ei~~ 290 (303)
T d1vjya_ 285 ALRIKK 290 (303)
T ss_dssp HHHHHH
T ss_pred HHHHHH
T ss_conf 999999
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.92 E-value=6.3e-25 Score=166.59 Aligned_cols=136 Identities=19% Similarity=0.142 Sum_probs=105.6
Q ss_pred CCCCCCCCCCCCEEEEEEEECCCCEEEEEEEEECCCCC---------------CHHHHHHHHHHHHHHHHCCCCCCCEEE
Q ss_conf 43233116669389999999079919999994053123---------------757899999999999957999845378
Q 001847 674 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVML---------------NRNKVHRACAEREILDMLDHPFVPALY 738 (1005)
Q Consensus 674 y~~~~~LG~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~---------------~~~~~~~~~~E~~il~~l~hpnIv~l~ 738 (1005)
+-+.++||+|+||.||+|.+ .+++.||||+++..... ..........|...+.++.+.+++..+
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~-~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~ 80 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVY 80 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEE
T ss_pred CHHCCEEEECCCEEEEEEEC-CCCCEEEEEEEECCCCHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHCCCCCCCEEE
T ss_conf 02277802485659999997-99999999998604434666556563000888999999778999999981699914499
Q ss_pred EEEEECCEEEEEEECCCCCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEEECCCCEEEEEC
Q ss_conf 99870781899996058983566773179999989999999999999999999859431789999689806992899851
Q 001847 739 ASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDF 818 (1005)
Q Consensus 739 ~~~~~~~~~~iV~E~~~g~sL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIvH~DLkP~NIli~~~g~ikL~DF 818 (1005)
+... .+++|||+++..+.. ++...+..++.|++.+|.|||++||+|+||||+|||++. +.++|+||
T Consensus 81 ~~~~----~~lvme~~~~~~~~~---------l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~-~~~~liDF 146 (191)
T d1zara2 81 AWEG----NAVLMELIDAKELYR---------VRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSE-EGIWIIDF 146 (191)
T ss_dssp EEET----TEEEEECCCCEEGGG---------CCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEET-TEEEECCC
T ss_pred EECC----CEEEEEEECCCCCCC---------HHHHHHHHHHHHHHHHHHHHHHCCEEECCCCHHHEEEEC-CCEEEEEC
T ss_conf 8628----889999504565420---------015789999999999999982688898368903611428-98999877
Q ss_pred CCCCCC
Q ss_conf 677545
Q 001847 819 DLSCLT 824 (1005)
Q Consensus 819 G~a~~~ 824 (1005)
|.|...
T Consensus 147 G~a~~~ 152 (191)
T d1zara2 147 PQSVEV 152 (191)
T ss_dssp TTCEET
T ss_pred CCCCCC
T ss_conf 884308
|
| >d1n9la_ d.110.3.6 (A:) Putative blue light receptor, phot-lov1 domain {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Profilin-like superfamily: PYP-like sensor domain (PAS domain) family: Flavin-binding PAS domain domain: Putative blue light receptor, phot-lov1 domain species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=99.86 E-value=7.3e-21 Score=141.70 Aligned_cols=108 Identities=60% Similarity=1.139 Sum_probs=99.2
Q ss_pred CCCEEEEEECCCCCCCEEECCHHHHHHCCCCHHHHCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCEEEEEEEEECCCCEE
Q ss_conf 48709999378999858981578899809994555399987677999995899999999974993999999982399689
Q 001847 201 FQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKIRETLQNGQSYCGRLLNYKKDGTPF 280 (1005)
Q Consensus 201 ~~~~i~i~D~~~~dg~Ii~vN~af~~l~Gys~eEliG~~~~~l~~~~~~~~~~~~i~~~l~~g~~~~~e~~~~~kdG~~~ 280 (1005)
+.++++++|+..+||+|+|||++|++++||+++|++|+++..+.+++......+.++.++..+..+.+|++.++|||+.+
T Consensus 2 i~~~~vi~Da~~pdg~Ii~vN~a~~~~~Gy~~~El~G~~~~~l~~~~~~~~~~~~~~~~l~~~~~~~~e~~~~~kdG~~~ 81 (109)
T d1n9la_ 2 LRHTFVVADATLPDCPLVYASEGFYAMTGYGPDEVLGHNCRFLQGEGTDPKEVQKIRDAIKKGEACSVRLLNYRKDGTPF 81 (109)
T ss_dssp CSCEEEEEETTSTTCCEEEECHHHHHHHCCCHHHHTTSCGGGGCCTTCCHHHHHHHHHHHHHTCCEEEEEEEECTTSCEE
T ss_pred CCCEEEEEECCCCCCEEEEECHHHHHHHCCCHHHHCCCCCEEEECCCCCHHHHHHHHHHHHCCCCEEEEEEEEECCCEEE
T ss_conf 66569999598998969999589999888699998587300311355787784223457653985031278870688399
Q ss_pred EEEEEEEEEECCCCCEEEEEEEEECCCH
Q ss_conf 9988865666699988999999952403
Q 001847 281 WNLLTIAPIKDDEGKVLKFIGMQVEVSK 308 (1005)
Q Consensus 281 wv~~~ispi~d~~G~v~~~i~~~~DITe 308 (1005)
|++++++|++|++|.+.+++++++|||.
T Consensus 82 w~~~~~~pi~d~~G~v~~~v~~~~DITa 109 (109)
T d1n9la_ 82 WNLLTVTPIKTPDGRVSKFVGVQVDVTS 109 (109)
T ss_dssp EEEEEEEEEECTTSCEEEEEEEEEECCC
T ss_pred EEEEEEEEEECCCCCEEEEEEEEEECCC
T ss_conf 9998998899999999999999997799
|
| >d1n9la_ d.110.3.6 (A:) Putative blue light receptor, phot-lov1 domain {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Profilin-like superfamily: PYP-like sensor domain (PAS domain) family: Flavin-binding PAS domain domain: Putative blue light receptor, phot-lov1 domain species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=99.82 E-value=3.2e-19 Score=131.67 Aligned_cols=108 Identities=45% Similarity=0.912 Sum_probs=99.6
Q ss_pred CCCCEEEECCCCCCCCEEEECHHHHHHCCCCHHHHCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCEEEEEEEEECCCCEE
Q ss_conf 15529999488999987850488899819996656499988668999998899999999965992999999994599699
Q 001847 484 IEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIRAAIDNQTDVTVQLINYTKSGKKF 563 (1005)
Q Consensus 484 ~~d~i~i~d~~G~d~~i~~vN~a~~~l~Gys~eEllG~~~~~l~~~~~~~~~~~~l~~~l~~g~~~~~e~~~~~kdG~~~ 563 (1005)
..++++++|+..+|++|+|||++|++++||+++|++|+++..+.+++......+.+.+.+..+..+..|+++++|||+.+
T Consensus 2 i~~~~vi~Da~~pdg~Ii~vN~a~~~~~Gy~~~El~G~~~~~l~~~~~~~~~~~~~~~~l~~~~~~~~e~~~~~kdG~~~ 81 (109)
T d1n9la_ 2 LRHTFVVADATLPDCPLVYASEGFYAMTGYGPDEVLGHNCRFLQGEGTDPKEVQKIRDAIKKGEACSVRLLNYRKDGTPF 81 (109)
T ss_dssp CSCEEEEEETTSTTCCEEEECHHHHHHHCCCHHHHTTSCGGGGCCTTCCHHHHHHHHHHHHHTCCEEEEEEEECTTSCEE
T ss_pred CCCEEEEEECCCCCCEEEEECHHHHHHHCCCHHHHCCCCCEEEECCCCCHHHHHHHHHHHHCCCCEEEEEEEEECCCEEE
T ss_conf 66569999598998969999589999888699998587300311355787784223457653985031278870688399
Q ss_pred EEEEEEEEEECCCCCEEEEEEEEECCCC
Q ss_conf 9999996210799988999999964865
Q 001847 564 WNLFHLQPMRDQKGEVQYFIGVQLDGSE 591 (1005)
Q Consensus 564 wv~~~~~pi~d~~G~v~~~igi~rDITe 591 (1005)
|+.++..|++|++|.+.+++++.+|||.
T Consensus 82 w~~~~~~pi~d~~G~v~~~v~~~~DITa 109 (109)
T d1n9la_ 82 WNLLTVTPIKTPDGRVSKFVGVQVDVTS 109 (109)
T ss_dssp EEEEEEEEEECTTSCEEEEEEEEEECCC
T ss_pred EEEEEEEEEECCCCCEEEEEEEEEECCC
T ss_conf 9998998899999999999999997799
|
| >d1bywa_ d.110.3.6 (A:) Erg potassium channel, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Profilin-like superfamily: PYP-like sensor domain (PAS domain) family: Flavin-binding PAS domain domain: Erg potassium channel, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.81 E-value=7.3e-19 Score=129.46 Aligned_cols=107 Identities=29% Similarity=0.579 Sum_probs=89.3
Q ss_pred CEEEEEECCCCCCCEEECCHHHHHHCCCCHHHHCCCCCC--CCCCCCCCHHHHHHHHHHHHCCCCEEEEEEEEECCCCEE
Q ss_conf 709999378999858981578899809994555399987--677999995899999999974993999999982399689
Q 001847 203 QTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCR--FLQGAGTDPEDVAKIRETLQNGQSYCGRLLNYKKDGTPF 280 (1005)
Q Consensus 203 ~~i~i~D~~~~dg~Ii~vN~af~~l~Gys~eEliG~~~~--~l~~~~~~~~~~~~i~~~l~~g~~~~~e~~~~~kdG~~~ 280 (1005)
..++++|....|+.|+|+|++|++++||+++|++|+++. ++.+++........+..++..+..+..+++.++++|..+
T Consensus 2 ~~f~i~~~~~~d~~I~~~N~a~~~l~G~~~~eiiG~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~e~~~~~~~g~~~ 81 (110)
T d1bywa_ 2 RKFIIANARVENCAVIYCNDGFCELCGYSRAEVMQRPCTCDFLHGPCTQRRAAAQIAQALLGAEERKVEIAFYRKDGSCF 81 (110)
T ss_dssp CEEEEEETTSSSCBEEEECHHHHHHHTCCHHHHTTSBTTCGGGCCTTCCHHHHHHHHHHHHTTCCEEEEEEEECTTSCEE
T ss_pred CEEEEECCCCCCCEEEEECHHHHHHHCCCHHHHCCCCCCCCCCEEEHEECCCCCCCCHHHCCCCCCCCEEEEEECCCCEE
T ss_conf 61999759899998999948999985998889533674311210100000000010000001211111000220132201
Q ss_pred EEEEEEEEEECCCCCEEEEEEEEECCCHH
Q ss_conf 99888656666999889999999524031
Q 001847 281 WNLLTIAPIKDDEGKVLKFIGMQVEVSKH 309 (1005)
Q Consensus 281 wv~~~ispi~d~~G~v~~~i~~~~DITer 309 (1005)
|+.++++|++|++|.+.+++++++|||||
T Consensus 82 w~~~~~~pi~d~~G~v~~~i~~~~DITer 110 (110)
T d1bywa_ 82 LCLVDVVPVKNEDGAVIMFILNFEVVMEK 110 (110)
T ss_dssp EEEEEEEEEECTTCCEEEEEEEEEEEEEC
T ss_pred EEEEEEEEEECCCCCEEEEEEEEEECCCC
T ss_conf 12336778998999999999999978899
|
| >d1jnua_ d.110.3.6 (A:) Photoreceptor phy3 flavin-binding domain, lov2 {Maidenhair fern (Adiantum capillus-veneris) [TaxId: 13818]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Profilin-like superfamily: PYP-like sensor domain (PAS domain) family: Flavin-binding PAS domain domain: Photoreceptor phy3 flavin-binding domain, lov2 species: Maidenhair fern (Adiantum capillus-veneris) [TaxId: 13818]
Probab=99.79 E-value=1.8e-18 Score=127.04 Aligned_cols=103 Identities=45% Similarity=0.866 Sum_probs=93.1
Q ss_pred EEEEEECCCCCCCEEECCHHHHHHCCCCHHHHCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCEEEEEEEEECCCCEEEEE
Q ss_conf 09999378999858981578899809994555399987677999995899999999974993999999982399689998
Q 001847 204 TFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKIRETLQNGQSYCGRLLNYKKDGTPFWNL 283 (1005)
Q Consensus 204 ~i~i~D~~~~dg~Ii~vN~af~~l~Gys~eEliG~~~~~l~~~~~~~~~~~~i~~~l~~g~~~~~e~~~~~kdG~~~wv~ 283 (1005)
.++++|+..+||+|+|+|++|++++||+.+|++|+++..+.++.........+...+..+..+.+|++.+++||+.+|++
T Consensus 2 ~fvi~d~~~pd~~I~y~N~a~~~~~G~s~~e~~G~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~dg~~~~~~ 81 (104)
T d1jnua_ 2 SFVITDPRLPDNPIIFASDRFLELTEYTREEVLGNNCRFLQGRGTDRKAVQLIRDAVKEQRDVTVQVLNYTKGGRAFWNL 81 (104)
T ss_dssp EEEEECTTSTTCCEEEECHHHHHHHTCCHHHHTTSCGGGGCCTTSCHHHHHHHHHHHHHTCCEEEEEEEECTTSCEEEEE
T ss_pred EEEEECCCCCCCEEEEECHHHHHHHCCCHHHHCCCCCEECCCCCCCHHHHHHHHHHHHCCCEEEEEEEEEECCCCEEEEE
T ss_conf 59998599998989999689999888698997786210010110016777642356525963576899996055428988
Q ss_pred EEEEEEECCCCCEEEEEEEEECC
Q ss_conf 88656666999889999999524
Q 001847 284 LTIAPIKDDEGKVLKFIGMQVEV 306 (1005)
Q Consensus 284 ~~ispi~d~~G~v~~~i~~~~DI 306 (1005)
++++|++|++|++.+++++.+||
T Consensus 82 ~~~~pi~d~~G~v~~~i~i~~DI 104 (104)
T d1jnua_ 82 FHLQVMRDENGDVQYFIGVQQEM 104 (104)
T ss_dssp EEEEEECTTTSSCCEEEEEEEEC
T ss_pred EEEEEEECCCCCEEEEEEEEECC
T ss_conf 78888999999999999999829
|
| >d1bywa_ d.110.3.6 (A:) Erg potassium channel, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Profilin-like superfamily: PYP-like sensor domain (PAS domain) family: Flavin-binding PAS domain domain: Erg potassium channel, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.79 E-value=3.4e-18 Score=125.37 Aligned_cols=107 Identities=30% Similarity=0.527 Sum_probs=97.6
Q ss_pred CCEEEECCCCCCCCEEEECHHHHHHCCCCHHHHCCCCCCC--CCCCCCCHHHHHHHHHHHHCCCCEEEEEEEEECCCCEE
Q ss_conf 5299994889999878504888998199966564999886--68999998899999999965992999999994599699
Q 001847 486 KNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRF--LQGPETDPATVRKIRAAIDNQTDVTVQLINYTKSGKKF 563 (1005)
Q Consensus 486 d~i~i~d~~G~d~~i~~vN~a~~~l~Gys~eEllG~~~~~--l~~~~~~~~~~~~l~~~l~~g~~~~~e~~~~~kdG~~~ 563 (1005)
..++++|+++.|++|+|+|++|++++||+.+|++|++... +.+++........+...+..+..+..++++++++|+.+
T Consensus 2 ~~f~i~~~~~~d~~I~~~N~a~~~l~G~~~~eiiG~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~e~~~~~~~g~~~ 81 (110)
T d1bywa_ 2 RKFIIANARVENCAVIYCNDGFCELCGYSRAEVMQRPCTCDFLHGPCTQRRAAAQIAQALLGAEERKVEIAFYRKDGSCF 81 (110)
T ss_dssp CEEEEEETTSSSCBEEEECHHHHHHHTCCHHHHTTSBTTCGGGCCTTCCHHHHHHHHHHHHTTCCEEEEEEEECTTSCEE
T ss_pred CEEEEECCCCCCCEEEEECHHHHHHHCCCHHHHCCCCCCCCCCEEEHEECCCCCCCCHHHCCCCCCCCEEEEEECCCCEE
T ss_conf 61999759899998999948999985998889533674311210100000000010000001211111000220132201
Q ss_pred EEEEEEEEEECCCCCEEEEEEEEECCCCC
Q ss_conf 99999962107999889999999648657
Q 001847 564 WNLFHLQPMRDQKGEVQYFIGVQLDGSEH 592 (1005)
Q Consensus 564 wv~~~~~pi~d~~G~v~~~igi~rDITer 592 (1005)
|+.++..|++|++|++.+++++++|||||
T Consensus 82 w~~~~~~pi~d~~G~v~~~i~~~~DITer 110 (110)
T d1bywa_ 82 LCLVDVVPVKNEDGAVIMFILNFEVVMEK 110 (110)
T ss_dssp EEEEEEEEEECTTCCEEEEEEEEEEEEEC
T ss_pred EEEEEEEEEECCCCCEEEEEEEEEECCCC
T ss_conf 12336778998999999999999978899
|
| >d1ew0a_ d.110.3.2 (A:) Histidine kinase FixL heme domain {Rhizobium meliloti [TaxId: 382]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Profilin-like superfamily: PYP-like sensor domain (PAS domain) family: Heme-binding PAS domain domain: Histidine kinase FixL heme domain species: Rhizobium meliloti [TaxId: 382]
Probab=99.79 E-value=3e-19 Score=131.78 Aligned_cols=124 Identities=21% Similarity=0.263 Sum_probs=72.7
Q ss_pred CCCCCCCCCCCHHHHHHHHHHHCCCEEEEEECCCCCCCEEECCHHHHHHCCCCHHHHCCCCCCCCCCCCCCHHHHHHHHH
Q ss_conf 22111125523399999999834870999937899985898157889980999455539998767799999589999999
Q 001847 179 DEGGKEKGLPRVSDIVKDALSTFQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKIRE 258 (1005)
Q Consensus 179 ~~~~~e~~L~~~~~~l~~ile~~~~~i~i~D~~~~dg~Ii~vN~af~~l~Gys~eEliG~~~~~l~~~~~~~~~~~~i~~ 258 (1005)
+..+++++|++++++|++++++++++|+++|. +|+|++||+++++++||+++|++|+++..++++.........+..
T Consensus 3 ~l~~~e~~l~~~e~~~~~i~~~~~~~i~~~d~---~g~i~~~N~~~~~l~Gy~~~el~g~~~~~~~~~~~~~~~~~~~~~ 79 (130)
T d1ew0a_ 3 HMLETEDVVRARDAHLRSILDTVPDATVVSAT---DGTIVSFNAAAVRQFGYAEEEVIGQNLRILMPEPYRHEHDGYLQR 79 (130)
T ss_dssp HHHHHHHHHHHHTSCHHHHHTTCSSEEEEEET---TSBEEEECHHHHHHHCCCHHHHTTSBGGGGSCTTTGGGHHHHHHH
T ss_pred HHHHHHHHHHHHHHHHHHHHHCCCCEEEEEEC---CCCEEEEHHHHHHHHCCCHHHHCCCCCCCCCCCCHHHHHHHHHHH
T ss_conf 69999999999999999999719772999908---964998788877751699889628752233331026778899999
Q ss_pred HHHCCCC----EEEEEEEEECCCCEEEEEEEEEEEECCCCCEEEEEEEEECCC
Q ss_conf 9974993----999999982399689998886566669998899999995240
Q 001847 259 TLQNGQS----YCGRLLNYKKDGTPFWNLLTIAPIKDDEGKVLKFIGMQVEVS 307 (1005)
Q Consensus 259 ~l~~g~~----~~~e~~~~~kdG~~~wv~~~ispi~d~~G~v~~~i~~~~DIT 307 (1005)
.+..+.. ...++...++||..+|++++++|+.+.++ ..++++++|||
T Consensus 80 ~~~~~~~~~~~~~~e~~~~~~dG~~~~v~~~~~~i~~~~~--~~~~~i~rDIT 130 (130)
T d1ew0a_ 80 YMATGEKRIIGIDRVVSGQRKDGSTFPMKLAVGEMRSGGE--RFFTGFIRDLT 130 (130)
T ss_dssp HHHHCCCSSTTSCEEEEEECTTSCEEEEEEEEEEEEETTE--EEEEEEEEECC
T ss_pred HHHHCCCCCCCCEEEEEEECCCCCEEEEEEEEEEEEECCE--EEEEEEEEECC
T ss_conf 9971887544410158898589979999999999997993--89999999787
|
| >d1ew0a_ d.110.3.2 (A:) Histidine kinase FixL heme domain {Rhizobium meliloti [TaxId: 382]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Profilin-like superfamily: PYP-like sensor domain (PAS domain) family: Heme-binding PAS domain domain: Histidine kinase FixL heme domain species: Rhizobium meliloti [TaxId: 382]
Probab=99.76 E-value=6.7e-18 Score=123.54 Aligned_cols=124 Identities=16% Similarity=0.204 Sum_probs=105.7
Q ss_pred HHHHHHHHHHHHC-CCHHHHHHHCCCCEEEECCCCCCCCEEEECHHHHHHCCCCHHHHCCCCCCCCCCCCCCHHHHHHHH
Q ss_conf 3368988977300-109999985155299994889999878504888998199966564999886689999988999999
Q 001847 462 VDDKVRQKEMRKG-IDLATTLERIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIR 540 (1005)
Q Consensus 462 ~er~~~e~~l~~~-~~l~~i~e~~~d~i~i~d~~G~d~~i~~vN~a~~~l~Gys~eEllG~~~~~l~~~~~~~~~~~~l~ 540 (1005)
++.+..+++++++ .+|+.++++++++|+++|.+|. |+++|+++++++||++++++|+++..+.++.........+.
T Consensus 2 s~l~~~e~~l~~~e~~~~~i~~~~~~~i~~~d~~g~---i~~~N~~~~~l~Gy~~~el~g~~~~~~~~~~~~~~~~~~~~ 78 (130)
T d1ew0a_ 2 SHMLETEDVVRARDAHLRSILDTVPDATVVSATDGT---IVSFNAAAVRQFGYAEEEVIGQNLRILMPEPYRHEHDGYLQ 78 (130)
T ss_dssp CHHHHHHHHHHHHTSCHHHHHTTCSSEEEEEETTSB---EEEECHHHHHHHCCCHHHHTTSBGGGGSCTTTGGGHHHHHH
T ss_pred CHHHHHHHHHHHHHHHHHHHHHCCCCEEEEEECCCC---EEEEHHHHHHHHCCCHHHHCCCCCCCCCCCCHHHHHHHHHH
T ss_conf 769999999999999999999719772999908964---99878887775169988962875223333102677889999
Q ss_pred HHHHCCCC----EEEEEEEEECCCCEEEEEEEEEEEECCCCCEEEEEEEEECCC
Q ss_conf 99965992----999999994599699999999621079998899999996486
Q 001847 541 AAIDNQTD----VTVQLINYTKSGKKFWNLFHLQPMRDQKGEVQYFIGVQLDGS 590 (1005)
Q Consensus 541 ~~l~~g~~----~~~e~~~~~kdG~~~wv~~~~~pi~d~~G~v~~~igi~rDIT 590 (1005)
..+..+.. ...++...++||..+|+.++..++.++.+ ..++++++|||
T Consensus 79 ~~~~~~~~~~~~~~~e~~~~~~dG~~~~v~~~~~~i~~~~~--~~~~~i~rDIT 130 (130)
T d1ew0a_ 79 RYMATGEKRIIGIDRVVSGQRKDGSTFPMKLAVGEMRSGGE--RFFTGFIRDLT 130 (130)
T ss_dssp HHHHHCCCSSTTSCEEEEEECTTSCEEEEEEEEEEEEETTE--EEEEEEEEECC
T ss_pred HHHHHCCCCCCCCEEEEEEECCCCCEEEEEEEEEEEEECCE--EEEEEEEEECC
T ss_conf 99971887544410158898589979999999999997993--89999999787
|
| >d1jnua_ d.110.3.6 (A:) Photoreceptor phy3 flavin-binding domain, lov2 {Maidenhair fern (Adiantum capillus-veneris) [TaxId: 13818]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Profilin-like superfamily: PYP-like sensor domain (PAS domain) family: Flavin-binding PAS domain domain: Photoreceptor phy3 flavin-binding domain, lov2 species: Maidenhair fern (Adiantum capillus-veneris) [TaxId: 13818]
Probab=99.74 E-value=3.4e-17 Score=119.21 Aligned_cols=103 Identities=72% Similarity=1.188 Sum_probs=96.4
Q ss_pred CEEEECCCCCCCCEEEECHHHHHHCCCCHHHHCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCEEEEEEEEECCCCEEEEE
Q ss_conf 29999488999987850488899819996656499988668999998899999999965992999999994599699999
Q 001847 487 NFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIRAAIDNQTDVTVQLINYTKSGKKFWNL 566 (1005)
Q Consensus 487 ~i~i~d~~G~d~~i~~vN~a~~~l~Gys~eEllG~~~~~l~~~~~~~~~~~~l~~~l~~g~~~~~e~~~~~kdG~~~wv~ 566 (1005)
.++++|+...|++|+|+|++|++++||+.+|++|+++..+.+++......+.+...+..+..+..|+++++++|+.+|++
T Consensus 2 ~fvi~d~~~pd~~I~y~N~a~~~~~G~s~~e~~G~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~dg~~~~~~ 81 (104)
T d1jnua_ 2 SFVITDPRLPDNPIIFASDRFLELTEYTREEVLGNNCRFLQGRGTDRKAVQLIRDAVKEQRDVTVQVLNYTKGGRAFWNL 81 (104)
T ss_dssp EEEEECTTSTTCCEEEECHHHHHHHTCCHHHHTTSCGGGGCCTTSCHHHHHHHHHHHHHTCCEEEEEEEECTTSCEEEEE
T ss_pred EEEEECCCCCCCEEEEECHHHHHHHCCCHHHHCCCCCEECCCCCCCHHHHHHHHHHHHCCCEEEEEEEEEECCCCEEEEE
T ss_conf 59998599998989999689999888698997786210010110016777642356525963576899996055428988
Q ss_pred EEEEEEECCCCCEEEEEEEEECC
Q ss_conf 99962107999889999999648
Q 001847 567 FHLQPMRDQKGEVQYFIGVQLDG 589 (1005)
Q Consensus 567 ~~~~pi~d~~G~v~~~igi~rDI 589 (1005)
+++.|++|++|++.+++++.+||
T Consensus 82 ~~~~pi~d~~G~v~~~i~i~~DI 104 (104)
T d1jnua_ 82 FHLQVMRDENGDVQYFIGVQQEM 104 (104)
T ss_dssp EEEEEECTTTSSCCEEEEEEEEC
T ss_pred EEEEEEECCCCCEEEEEEEEECC
T ss_conf 78888999999999999999829
|
| >d1p97a_ d.110.3.7 (A:) Hypoxia-inducible factor Hif2a, C-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Profilin-like superfamily: PYP-like sensor domain (PAS domain) family: Hypoxia-inducible factor Hif2a, C-terminal domain domain: Hypoxia-inducible factor Hif2a, C-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.67 E-value=1.4e-16 Score=115.52 Aligned_cols=104 Identities=17% Similarity=0.144 Sum_probs=48.2
Q ss_pred EEEECCCCCCCCEEEECHHHHHHCCCCHHHHCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCEEEEEEEEECCCCEEEEEE
Q ss_conf 99994889999878504888998199966564999886689999988999999999659929999999945996999999
Q 001847 488 FVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIRAAIDNQTDVTVQLINYTKSGKKFWNLF 567 (1005)
Q Consensus 488 i~i~d~~G~d~~i~~vN~a~~~l~Gys~eEllG~~~~~l~~~~~~~~~~~~l~~~l~~g~~~~~e~~~~~kdG~~~wv~~ 567 (1005)
|+..|++|+ |+|+|+++++++||+.+|++|+++..+++|++.....+.+...+.++..+..+++++++||+.+|+.+
T Consensus 9 i~r~~~dG~---i~~~N~~~~~~~G~~~~el~g~~~~~~~~~ed~~~~~~~~~~~~~~~~~~~~e~~~~~kdG~~~wv~~ 85 (114)
T d1p97a_ 9 LSRHSMDMK---FTYCDDRITELIGYHPEELLGRSAYEFYHALDSENMTKSHQNLCTKGQVVSGQYRMLAKHGGYVWLET 85 (114)
T ss_dssp EEEECTTTS---CSEECTTHHHHTSSCHHHHTTSCHHHHSCSSSHHHHHHHHHHHTTTSEEEEEEEEEECTTSCEEEEEE
T ss_pred EEEECCCCC---EEEECHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCEEEEEECCCCCCEEECCEEEEEECCCCEEEEE
T ss_conf 999979995---99998799977499713055200000000012431100100001111100011000000476517999
Q ss_pred EEEEEECC-CCCEEEEEEEEECCCCCCC
Q ss_conf 99621079-9988999999964865742
Q 001847 568 HLQPMRDQ-KGEVQYFIGVQLDGSEHLE 594 (1005)
Q Consensus 568 ~~~pi~d~-~G~v~~~igi~rDITerk~ 594 (1005)
+..|++|. +|.+.+++++.+||||+|+
T Consensus 86 ~~~~~~~~~~~~~~~ii~~~~dite~k~ 113 (114)
T d1p97a_ 86 QGTVIYNPRNLQPQCIMCVNYVLSEIEK 113 (114)
T ss_dssp EEEEEECTTTCSEEEEEEEEEEEEEEEC
T ss_pred EEEEEEECCCCCEEEEEEEEEECCHHHC
T ss_conf 9889996899989999999998972423
|
| >d1p97a_ d.110.3.7 (A:) Hypoxia-inducible factor Hif2a, C-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Profilin-like superfamily: PYP-like sensor domain (PAS domain) family: Hypoxia-inducible factor Hif2a, C-terminal domain domain: Hypoxia-inducible factor Hif2a, C-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.67 E-value=9.5e-17 Score=116.49 Aligned_cols=107 Identities=15% Similarity=0.174 Sum_probs=92.7
Q ss_pred CCEEEE--EECCCCCCCEEECCHHHHHHCCCCHHHHCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCEEEEEEEEECCCCE
Q ss_conf 870999--937899985898157889980999455539998767799999589999999997499399999998239968
Q 001847 202 QQTFVV--SDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKIRETLQNGQSYCGRLLNYKKDGTP 279 (1005)
Q Consensus 202 ~~~i~i--~D~~~~dg~Ii~vN~af~~l~Gys~eEliG~~~~~l~~~~~~~~~~~~i~~~l~~g~~~~~e~~~~~kdG~~ 279 (1005)
....++ .|. ||+|+|+|+++++++||+.+|++|+++..+.++++.....+.+...+..+..+..+++.+++||+.
T Consensus 4 d~~~fi~r~~~---dG~i~~~N~~~~~~~G~~~~el~g~~~~~~~~~ed~~~~~~~~~~~~~~~~~~~~e~~~~~kdG~~ 80 (114)
T d1p97a_ 4 DSKTFLSRHSM---DMKFTYCDDRITELIGYHPEELLGRSAYEFYHALDSENMTKSHQNLCTKGQVVSGQYRMLAKHGGY 80 (114)
T ss_dssp CCEEEEEEECT---TTSCSEECTTHHHHTSSCHHHHTTSCHHHHSCSSSHHHHHHHHHHHTTTSEEEEEEEEEECTTSCE
T ss_pred CCCEEEEEECC---CCCEEEECHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCEEEEEECCCCCCEEECCEEEEEECCCC
T ss_conf 76779999979---995999987999774997130552000000000124311001000011111000110000004765
Q ss_pred EEEEEEEEEEECC-CCCEEEEEEEEECCCHHHH
Q ss_conf 9998886566669-9988999999952403159
Q 001847 280 FWNLLTIAPIKDD-EGKVLKFIGMQVEVSKHTE 311 (1005)
Q Consensus 280 ~wv~~~ispi~d~-~G~v~~~i~~~~DITerk~ 311 (1005)
+|++++.+|++++ +|.+.+++++.+|||++|+
T Consensus 81 ~wv~~~~~~~~~~~~~~~~~ii~~~~dite~k~ 113 (114)
T d1p97a_ 81 VWLETQGTVIYNPRNLQPQCIMCVNYVLSEIEK 113 (114)
T ss_dssp EEEEEEEEEEECTTTCSEEEEEEEEEEEEEEEC
T ss_pred EEEEEEEEEEEECCCCCEEEEEEEEEECCHHHC
T ss_conf 179999889996899989999999998972423
|
| >d1v9ya_ d.110.3.2 (A:) Direct oxygen sensor protein, DOS {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Profilin-like superfamily: PYP-like sensor domain (PAS domain) family: Heme-binding PAS domain domain: Direct oxygen sensor protein, DOS species: Escherichia coli [TaxId: 562]
Probab=99.63 E-value=1.3e-15 Score=109.50 Aligned_cols=108 Identities=21% Similarity=0.358 Sum_probs=72.0
Q ss_pred HHHHHHHHCCCEEEEEECCCCCCCEEECCHHHHHHCCCCHHHHCCCCCCCCCCCCCCHHHHHHHHHHHHCCC----CEEE
Q ss_conf 999999834870999937899985898157889980999455539998767799999589999999997499----3999
Q 001847 193 IVKDALSTFQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKIRETLQNGQ----SYCG 268 (1005)
Q Consensus 193 ~l~~ile~~~~~i~i~D~~~~dg~Ii~vN~af~~l~Gys~eEliG~~~~~l~~~~~~~~~~~~i~~~l~~g~----~~~~ 268 (1005)
+|.+++++++++|+++|. +|+|+++|++|++++||+++|++|+++..+.++.........+...+..+. ....
T Consensus 2 ~~~~~~e~~~d~i~~~d~---~g~i~~~N~~~~~l~Gy~~~e~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 78 (113)
T d1v9ya_ 2 IFFPALEQNMMGAVLINE---NDEVMFFNPAAEKLWGYKREEVIGNNIDMLIPRDLRPAHPEYIRHNREGGKARVEGMSR 78 (113)
T ss_dssp CHHHHHHTCSSEEEEECT---TSBEEEECHHHHHHHSCCGGGTTTSBGGGGSCGGGTTTHHHHHHHHHC----------C
T ss_pred HHHHHHHCCCCCEEEEEC---CCCEEEECHHHHHHHCCCHHHHCCCCEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCE
T ss_conf 789998708471899929---99999986168665201366653752000332111111000001100124320011000
Q ss_pred EEEEEECCCCEEEEEEEEEEEECCCCCEEEEEEEEEC
Q ss_conf 9999823996899988865666699988999999952
Q 001847 269 RLLNYKKDGTPFWNLLTIAPIKDDEGKVLKFIGMQVE 305 (1005)
Q Consensus 269 e~~~~~kdG~~~wv~~~ispi~d~~G~v~~~i~~~~D 305 (1005)
+...+++||+.+|++++++|+.+++| .+++++++|
T Consensus 79 e~~~~~~dG~~~~v~~~~~~i~~~~~--~~~~~v~rD 113 (113)
T d1v9ya_ 79 ELQLEKKDGSKIWTRFALSKVSAEGK--VYYLALVRD 113 (113)
T ss_dssp EEEEECTTSCEEEEEEEEEEEEETTE--EEEEEEEEC
T ss_pred EEEECCCCCEEEEEEEEEEEEEECCE--EEEEEEEEC
T ss_conf 24410245416999999999998990--899999999
|
| >d1xj3a1 d.110.3.2 (A:154-259) Histidine kinase FixL heme domain {Bradyrhizobium japonicum [TaxId: 375]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Profilin-like superfamily: PYP-like sensor domain (PAS domain) family: Heme-binding PAS domain domain: Histidine kinase FixL heme domain species: Bradyrhizobium japonicum [TaxId: 375]
Probab=99.60 E-value=4.3e-15 Score=106.38 Aligned_cols=102 Identities=19% Similarity=0.262 Sum_probs=71.9
Q ss_pred CEEEEEECCCCCCCEEECCHHHHHHCCCCHHHHCCCCCCCCCCCCCCHHHHHHHHHHHHCCCC----EEEEEEEEECCCC
Q ss_conf 709999378999858981578899809994555399987677999995899999999974993----9999999823996
Q 001847 203 QTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKIRETLQNGQS----YCGRLLNYKKDGT 278 (1005)
Q Consensus 203 ~~i~i~D~~~~dg~Ii~vN~af~~l~Gys~eEliG~~~~~l~~~~~~~~~~~~i~~~l~~g~~----~~~e~~~~~kdG~ 278 (1005)
+||+++|. +|+|+++|++|++++||+.+|++|+++..++++.........+...+..... ...+...+++||.
T Consensus 1 dgi~~~D~---~G~I~~~N~a~~~l~Gy~~~el~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~dg~ 77 (106)
T d1xj3a1 1 DAMIVIDG---HGIIQLFSTAAERLFGWSELEAIGQNVNILMPEPDRSRHDSYISRYRTTSDPHIIGIGRIVTGKRRDGT 77 (106)
T ss_dssp CCEEEEET---TSBEEEECHHHHHHHCCCHHHHTTSBGGGGSCTTHHHHHHHHHHHHHHHCCCSSTTTCEEEEEECTTSC
T ss_pred CEEEEECC---CCCEEEECHHHHHHHHHCHHHHCCCCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCEEEEEECCCE
T ss_conf 98999979---993997738999876434186618974224221210001122234443023211111100013301436
Q ss_pred EEEEEEEEEEEECCCCCEEEEEEEEECCCHH
Q ss_conf 8999888656666999889999999524031
Q 001847 279 PFWNLLTIAPIKDDEGKVLKFIGMQVEVSKH 309 (1005)
Q Consensus 279 ~~wv~~~ispi~d~~G~v~~~i~~~~DITer 309 (1005)
.+|++++++|+.++++ .+++++++||||.
T Consensus 78 ~~~v~~~~~~~~~~~~--~~~~~~~~DITE~ 106 (106)
T d1xj3a1 78 TFPMHLSIGEMQSGGE--PYFTGFVRDLTEH 106 (106)
T ss_dssp EEEEEEEEEEEEETTE--EEEEEEEEECHHH
T ss_pred EEEEEEEEEEEEECCE--EEEEEEEEECCCC
T ss_conf 9988899999997993--7999999968898
|
| >d1v9ya_ d.110.3.2 (A:) Direct oxygen sensor protein, DOS {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Profilin-like superfamily: PYP-like sensor domain (PAS domain) family: Heme-binding PAS domain domain: Direct oxygen sensor protein, DOS species: Escherichia coli [TaxId: 562]
Probab=99.59 E-value=7.9e-15 Score=104.75 Aligned_cols=107 Identities=23% Similarity=0.366 Sum_probs=88.2
Q ss_pred HHHHHHHCCCCEEEECCCCCCCCEEEECHHHHHHCCCCHHHHCCCCCCCCCCCCCCHHHHHHHHHHHHCC----CCEEEE
Q ss_conf 9999985155299994889999878504888998199966564999886689999988999999999659----929999
Q 001847 477 LATTLERIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIRAAIDNQ----TDVTVQ 552 (1005)
Q Consensus 477 l~~i~e~~~d~i~i~d~~G~d~~i~~vN~a~~~l~Gys~eEllG~~~~~l~~~~~~~~~~~~l~~~l~~g----~~~~~e 552 (1005)
|.+++++++++|+++|.+|+ |+++|+++++++||+++|++|++...+.++.........+...+..+ .....+
T Consensus 3 ~~~~~e~~~d~i~~~d~~g~---i~~~N~~~~~l~Gy~~~e~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e 79 (113)
T d1v9ya_ 3 FFPALEQNMMGAVLINENDE---VMFFNPAAEKLWGYKREEVIGNNIDMLIPRDLRPAHPEYIRHNREGGKARVEGMSRE 79 (113)
T ss_dssp HHHHHHTCSSEEEEECTTSB---EEEECHHHHHHHSCCGGGTTTSBGGGGSCGGGTTTHHHHHHHHHC----------CE
T ss_pred HHHHHHCCCCCEEEEECCCC---EEEECHHHHHHHCCCHHHHCCCCEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEE
T ss_conf 89998708471899929999---999861686652013666537520003321111110000011001243200110002
Q ss_pred EEEEECCCCEEEEEEEEEEEECCCCCEEEEEEEEEC
Q ss_conf 999945996999999996210799988999999964
Q 001847 553 LINYTKSGKKFWNLFHLQPMRDQKGEVQYFIGVQLD 588 (1005)
Q Consensus 553 ~~~~~kdG~~~wv~~~~~pi~d~~G~v~~~igi~rD 588 (1005)
...+++||+.+|+++++.|+.++.| ..+++++||
T Consensus 80 ~~~~~~dG~~~~v~~~~~~i~~~~~--~~~~~v~rD 113 (113)
T d1v9ya_ 80 LQLEKKDGSKIWTRFALSKVSAEGK--VYYLALVRD 113 (113)
T ss_dssp EEEECTTSCEEEEEEEEEEEEETTE--EEEEEEEEC
T ss_pred EEECCCCCEEEEEEEEEEEEEECCE--EEEEEEEEC
T ss_conf 4410245416999999999998990--899999999
|
| >d1xj3a1 d.110.3.2 (A:154-259) Histidine kinase FixL heme domain {Bradyrhizobium japonicum [TaxId: 375]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Profilin-like superfamily: PYP-like sensor domain (PAS domain) family: Heme-binding PAS domain domain: Histidine kinase FixL heme domain species: Bradyrhizobium japonicum [TaxId: 375]
Probab=99.58 E-value=4.7e-15 Score=106.12 Aligned_cols=102 Identities=19% Similarity=0.205 Sum_probs=85.4
Q ss_pred CCEEEECCCCCCCCEEEECHHHHHHCCCCHHHHCCCCCCCCCCCCCCHHHHHHHHHHHHCCC----CEEEEEEEEECCCC
Q ss_conf 52999948899998785048889981999665649998866899999889999999996599----29999999945996
Q 001847 486 KNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIRAAIDNQT----DVTVQLINYTKSGK 561 (1005)
Q Consensus 486 d~i~i~d~~G~d~~i~~vN~a~~~l~Gys~eEllG~~~~~l~~~~~~~~~~~~l~~~l~~g~----~~~~e~~~~~kdG~ 561 (1005)
|||+++|.+|+ |+++|+++++++||+.+|++|+++..+.++.........+...+.... ....+...+++||.
T Consensus 1 dgi~~~D~~G~---I~~~N~a~~~l~Gy~~~el~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~dg~ 77 (106)
T d1xj3a1 1 DAMIVIDGHGI---IQLFSTAAERLFGWSELEAIGQNVNILMPEPDRSRHDSYISRYRTTSDPHIIGIGRIVTGKRRDGT 77 (106)
T ss_dssp CCEEEEETTSB---EEEECHHHHHHHCCCHHHHTTSBGGGGSCTTHHHHHHHHHHHHHHHCCCSSTTTCEEEEEECTTSC
T ss_pred CEEEEECCCCC---EEEECHHHHHHHHHCHHHHCCCCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCEEEEEECCCE
T ss_conf 98999979993---997738999876434186618974224221210001122234443023211111100013301436
Q ss_pred EEEEEEEEEEEECCCCCEEEEEEEEECCCCC
Q ss_conf 9999999962107999889999999648657
Q 001847 562 KFWNLFHLQPMRDQKGEVQYFIGVQLDGSEH 592 (1005)
Q Consensus 562 ~~wv~~~~~pi~d~~G~v~~~igi~rDITer 592 (1005)
.+|+++++.|+.++++ .+++++++||||+
T Consensus 78 ~~~v~~~~~~~~~~~~--~~~~~~~~DITE~ 106 (106)
T d1xj3a1 78 TFPMHLSIGEMQSGGE--PYFTGFVRDLTEH 106 (106)
T ss_dssp EEEEEEEEEEEEETTE--EEEEEEEEECHHH
T ss_pred EEEEEEEEEEEEECCE--EEEEEEEEECCCC
T ss_conf 9988899999997993--7999999968898
|
| >d1nwza_ d.110.3.1 (A:) Photoactive yellow protein, PYP {Ectothiorhodospira halophila [TaxId: 1053]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Profilin-like superfamily: PYP-like sensor domain (PAS domain) family: PYP-like domain: Photoactive yellow protein, PYP species: Ectothiorhodospira halophila [TaxId: 1053]
Probab=99.49 E-value=9.4e-14 Score=98.16 Aligned_cols=108 Identities=19% Similarity=0.124 Sum_probs=71.9
Q ss_pred HHHHHHHHHCCCEEEEEECCCCCCCEEECCHHHHHHCCCCHHHHCCCCCCCCC-CCCCCHHHHHHHHHHHHCCCCEEEEE
Q ss_conf 99999998348709999378999858981578899809994555399987677-99999589999999997499399999
Q 001847 192 DIVKDALSTFQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQ-GAGTDPEDVAKIRETLQNGQSYCGRL 270 (1005)
Q Consensus 192 ~~l~~ile~~~~~i~i~D~~~~dg~Ii~vN~af~~l~Gys~eEliG~~~~~l~-~~~~~~~~~~~i~~~l~~g~~~~~e~ 270 (1005)
.++..+++++++|++++|. +|+|+++|+++++++||+++|++|+++..++ |+.........+.+++..|.....+.
T Consensus 17 ~~~d~~ld~~p~gi~~lD~---~G~i~~~N~a~~~l~G~~~~e~iG~~~~~~~~p~~~~~~~~~~~~~~~~~g~~~~~~~ 93 (125)
T d1nwza_ 17 KMDDGQLDGLAFGAIQLDG---DGNILQYNAAEGDITGRDPKQVIGKNFFKDVAPCTDSPEFYGKFKEGVASGNLNTMFE 93 (125)
T ss_dssp TCCHHHHTTCSSEEEEEET---TCBEEEECHHHHHHHCCCHHHHTTSBCCCCCCGGGCSTTTHHHHHHHHHHTCCEEEEE
T ss_pred HHHHHHHHCCCCCEEEEEC---CCCEEEECHHHHHHHCCCHHHHCCCCHHHCCCCHHHHHHEEEECEEEEECCCCCEEEE
T ss_conf 9999998578752999908---9989998179997624562766399777726956661002000000210477545888
Q ss_pred EEEECCCCEEEEEEEEEEEECCCCCEEEEEEEEECC
Q ss_conf 998239968999888656666999889999999524
Q 001847 271 LNYKKDGTPFWNLLTIAPIKDDEGKVLKFIGMQVEV 306 (1005)
Q Consensus 271 ~~~~kdG~~~wv~~~ispi~d~~G~v~~~i~~~~DI 306 (1005)
..++++|..+|+++++.+..+ |+-. ..+++||
T Consensus 94 ~~~~~~G~~~~v~v~l~~~~~--g~~~--~v~V~di 125 (125)
T d1nwza_ 94 YTFDYQMTPTKVKVHMKKALS--GDSY--WVFVKRV 125 (125)
T ss_dssp EEECTTSCCEEEEEEEEECSS--SSEE--EEEEEEC
T ss_pred EEECCCCCEEEEEEEEEEECC--CCEE--EEEEEEC
T ss_conf 874037947999999999469--9989--9999989
|
| >d1mzua_ d.110.3.1 (A:) PYP domain of sensor histidine kinase Ppr {Rhodospirillum centenum [TaxId: 34018]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Profilin-like superfamily: PYP-like sensor domain (PAS domain) family: PYP-like domain: PYP domain of sensor histidine kinase Ppr species: Rhodospirillum centenum [TaxId: 34018]
Probab=99.46 E-value=4.3e-13 Score=94.10 Aligned_cols=96 Identities=10% Similarity=0.065 Sum_probs=67.1
Q ss_pred HHHHHHHHCCCEEEEEECCCCCCCEEECCHHHHHHCCCCHHHHCCCCCC-CCCCCCCCHHHHHHHHHHHHCCCCEEEEEE
Q ss_conf 9999998348709999378999858981578899809994555399987-677999995899999999974993999999
Q 001847 193 IVKDALSTFQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCR-FLQGAGTDPEDVAKIRETLQNGQSYCGRLL 271 (1005)
Q Consensus 193 ~l~~ile~~~~~i~i~D~~~~dg~Ii~vN~af~~l~Gys~eEliG~~~~-~l~~~~~~~~~~~~i~~~l~~g~~~~~e~~ 271 (1005)
.+.+++|++|+||+++|. +|+|++||+++++++||+++|++|+++. .+.|+.........+.+.+.+|........
T Consensus 4 ~~~A~ld~~p~gvi~~D~---~G~I~~~N~aa~~~~G~~~eellG~~~~~~~~p~~~~~~~~~~~~~~~~~g~~~~~~~~ 80 (110)
T d1mzua_ 4 MGTAEFDALPVGAIQVDG---SGVIHRYNRTESRLSGRIPERVIGRNFFTEVAPCTNIPAFSGRFMDGVTSGTLDARFDF 80 (110)
T ss_dssp --CTTGGGCSSEEEEEET---TCBEEEECHHHHHHHCCCHHHHTTSBCCCCCCGGGCSTTTHHHHHHHHHTSCCEEEEEE
T ss_pred HHHHHHHCCCCEEEEECC---CCCEEEEHHHHHHHHCCCHHHHCCCCHHHHCCCHHHHHHHHHHHHHHHHCCCCCCCEEE
T ss_conf 779998478937999969---99999857789998867999985997899649864668999999999865565741379
Q ss_pred EEECCCCEEEEEEEEEEEEC
Q ss_conf 98239968999888656666
Q 001847 272 NYKKDGTPFWNLLTIAPIKD 291 (1005)
Q Consensus 272 ~~~kdG~~~wv~~~ispi~d 291 (1005)
.++++|..++++++..+..+
T Consensus 81 ~l~~~G~~~~v~v~~~~~~~ 100 (110)
T d1mzua_ 81 VFDFQMAPVRVQIRMQNAGV 100 (110)
T ss_dssp EEECSSCEEEEEEEEEECSS
T ss_pred EEECCCCEEEEEEEEEEECC
T ss_conf 99307963899999999347
|
| >d1nwza_ d.110.3.1 (A:) Photoactive yellow protein, PYP {Ectothiorhodospira halophila [TaxId: 1053]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Profilin-like superfamily: PYP-like sensor domain (PAS domain) family: PYP-like domain: Photoactive yellow protein, PYP species: Ectothiorhodospira halophila [TaxId: 1053]
Probab=99.45 E-value=6.1e-13 Score=93.19 Aligned_cols=108 Identities=11% Similarity=0.010 Sum_probs=88.2
Q ss_pred CCHHHHHHHCCCCEEEECCCCCCCCEEEECHHHHHHCCCCHHHHCCCCCCCCCCCC-CCHHHHHHHHHHHHCCCCEEEEE
Q ss_conf 10999998515529999488999987850488899819996656499988668999-99889999999996599299999
Q 001847 475 IDLATTLERIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPE-TDPATVRKIRAAIDNQTDVTVQL 553 (1005)
Q Consensus 475 ~~l~~i~e~~~d~i~i~d~~G~d~~i~~vN~a~~~l~Gys~eEllG~~~~~l~~~~-~~~~~~~~l~~~l~~g~~~~~e~ 553 (1005)
..+..+++++|+|++++|.+|+ |+++|+++++++||++++++|+++..+++|+ ....+...+.+.+..+.....+.
T Consensus 17 ~~~d~~ld~~p~gi~~lD~~G~---i~~~N~a~~~l~G~~~~e~iG~~~~~~~~p~~~~~~~~~~~~~~~~~g~~~~~~~ 93 (125)
T d1nwza_ 17 KMDDGQLDGLAFGAIQLDGDGN---ILQYNAAEGDITGRDPKQVIGKNFFKDVAPCTDSPEFYGKFKEGVASGNLNTMFE 93 (125)
T ss_dssp TCCHHHHTTCSSEEEEEETTCB---EEEECHHHHHHHCCCHHHHTTSBCCCCCCGGGCSTTTHHHHHHHHHHTCCEEEEE
T ss_pred HHHHHHHHCCCCCEEEEECCCC---EEEECHHHHHHHCCCHHHHCCCCHHHCCCCHHHHHHEEEECEEEEECCCCCEEEE
T ss_conf 9999998578752999908998---9998179997624562766399777726956661002000000210477545888
Q ss_pred EEEECCCCEEEEEEEEEEEECCCCCEEEEEEEEECC
Q ss_conf 999459969999999962107999889999999648
Q 001847 554 INYTKSGKKFWNLFHLQPMRDQKGEVQYFIGVQLDG 589 (1005)
Q Consensus 554 ~~~~kdG~~~wv~~~~~pi~d~~G~v~~~igi~rDI 589 (1005)
...+++|..+|+.+++.+..+ |+-+ ..+++||
T Consensus 94 ~~~~~~G~~~~v~v~l~~~~~--g~~~--~v~V~di 125 (125)
T d1nwza_ 94 YTFDYQMTPTKVKVHMKKALS--GDSY--WVFVKRV 125 (125)
T ss_dssp EEECTTSCCEEEEEEEEECSS--SSEE--EEEEEEC
T ss_pred EEECCCCCEEEEEEEEEEECC--CCEE--EEEEEEC
T ss_conf 874037947999999999469--9989--9999989
|
| >d1mzua_ d.110.3.1 (A:) PYP domain of sensor histidine kinase Ppr {Rhodospirillum centenum [TaxId: 34018]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Profilin-like superfamily: PYP-like sensor domain (PAS domain) family: PYP-like domain: PYP domain of sensor histidine kinase Ppr species: Rhodospirillum centenum [TaxId: 34018]
Probab=99.36 E-value=3.9e-12 Score=88.20 Aligned_cols=96 Identities=11% Similarity=-0.032 Sum_probs=79.2
Q ss_pred HHHHHHHCCCCEEEECCCCCCCCEEEECHHHHHHCCCCHHHHCCCCCCCCCC-CCCCHHHHHHHHHHHHCCCCEEEEEEE
Q ss_conf 9999985155299994889999878504888998199966564999886689-999988999999999659929999999
Q 001847 477 LATTLERIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQG-PETDPATVRKIRAAIDNQTDVTVQLIN 555 (1005)
Q Consensus 477 l~~i~e~~~d~i~i~d~~G~d~~i~~vN~a~~~l~Gys~eEllG~~~~~l~~-~~~~~~~~~~l~~~l~~g~~~~~e~~~ 555 (1005)
+.++++++|+||+++|.+|+ |+++|+++++++||+++|++|+++..++. +.....+...+.+.+..|.........
T Consensus 5 ~~A~ld~~p~gvi~~D~~G~---I~~~N~aa~~~~G~~~eellG~~~~~~~~p~~~~~~~~~~~~~~~~~g~~~~~~~~~ 81 (110)
T d1mzua_ 5 GTAEFDALPVGAIQVDGSGV---IHRYNRTESRLSGRIPERVIGRNFFTEVAPCTNIPAFSGRFMDGVTSGTLDARFDFV 81 (110)
T ss_dssp -CTTGGGCSSEEEEEETTCB---EEEECHHHHHHHCCCHHHHTTSBCCCCCCGGGCSTTTHHHHHHHHHTSCCEEEEEEE
T ss_pred HHHHHHCCCCEEEEECCCCC---EEEEHHHHHHHHCCCHHHHCCCCHHHHCCCHHHHHHHHHHHHHHHHCCCCCCCEEEE
T ss_conf 79998478937999969999---998577899988679999859978996498646689999999998655657413799
Q ss_pred EECCCCEEEEEEEEEEEECC
Q ss_conf 94599699999999621079
Q 001847 556 YTKSGKKFWNLFHLQPMRDQ 575 (1005)
Q Consensus 556 ~~kdG~~~wv~~~~~pi~d~ 575 (1005)
.+++|..+++.++.....+.
T Consensus 82 l~~~G~~~~v~v~~~~~~~~ 101 (110)
T d1mzua_ 82 FDFQMAPVRVQIRMQNAGVP 101 (110)
T ss_dssp EECSSCEEEEEEEEEECSST
T ss_pred EECCCCEEEEEEEEEEECCC
T ss_conf 93079638999999993479
|
| >d1ll8a_ d.110.3.5 (A:) N-terminal PAS domain of Pas kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Profilin-like superfamily: PYP-like sensor domain (PAS domain) family: N-terminal PAS domain of Pas kinase domain: N-terminal PAS domain of Pas kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.35 E-value=2.4e-13 Score=95.64 Aligned_cols=106 Identities=12% Similarity=0.149 Sum_probs=72.1
Q ss_pred HHHCCCEEEEEECCCCCCCEEECCHHHHHHCCCCHHHHCCCCCCCCCCCCCCHHHHHHHHHHHHCCCC----EEEEEEEE
Q ss_conf 98348709999378999858981578899809994555399987677999995899999999974993----99999998
Q 001847 198 LSTFQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKIRETLQNGQS----YCGRLLNY 273 (1005)
Q Consensus 198 le~~~~~i~i~D~~~~dg~Ii~vN~af~~l~Gys~eEliG~~~~~l~~~~~~~~~~~~i~~~l~~g~~----~~~e~~~~ 273 (1005)
-+.+.++|+++|.. +|+|+++|+++++++||+.+|++|+++..+.++.........+...+..+.. +..++..+
T Consensus 4 ~~~~n~AI~~id~~--~G~I~~~N~a~~~l~Gy~~~el~g~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~ 81 (114)
T d1ll8a_ 4 DPEFNKAIFTVDAK--TTEILVANDKACGLLGYSSQDLIGQKLTQFFLRSDSDVVEALSEEHMEADGHAAVVFGTVVDII 81 (114)
T ss_dssp STTTTCEEEEEETT--TCBEEEECTTHHHHHTCCTTTTTTSBGGGGSSCTTTHHHHHTTSSTTSSSSCSSCCCSSSEEEC
T ss_pred CHHCCCEEEEEECC--CCEEEEECHHHHHHHCCCHHHHCCCCEEEECCCCCHHHHHHHHHHHHHCCCCCCCEEEEEEEEE
T ss_conf 01009689999999--9999997789997546897898399722142810499999999999856777310036788888
Q ss_pred ECCCCEEEEEEEEEEEECCCCCEEEEEEEEECCC
Q ss_conf 2399689998886566669998899999995240
Q 001847 274 KKDGTPFWNLLTIAPIKDDEGKVLKFIGMQVEVS 307 (1005)
Q Consensus 274 ~kdG~~~wv~~~ispi~d~~G~v~~~i~~~~DIT 307 (1005)
+++|..+|++++++++..++ .. .++++++||+
T Consensus 82 ~~~G~~~pvevs~~~i~~~~-~~-~~l~vi~dV~ 113 (114)
T d1ll8a_ 82 SRSGEKIPVSVWMKRMRQER-RL-CCVVVLEPVE 113 (114)
T ss_dssp CTTCCCEEEECCEECCBSSS-SB-EEEEEEEECC
T ss_pred CCCCCEEEEEEEEEEEEECC-EE-EEEEEEEECC
T ss_conf 04991999999999999999-67-9999999775
|
| >d1ll8a_ d.110.3.5 (A:) N-terminal PAS domain of Pas kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Profilin-like superfamily: PYP-like sensor domain (PAS domain) family: N-terminal PAS domain of Pas kinase domain: N-terminal PAS domain of Pas kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.26 E-value=1.1e-12 Score=91.71 Aligned_cols=104 Identities=14% Similarity=0.155 Sum_probs=83.4
Q ss_pred HHCCCCEEEECC-CCCCCCEEEECHHHHHHCCCCHHHHCCCCCCCCCCCCCCHHHHHHHHHHHHCCCC----EEEEEEEE
Q ss_conf 851552999948-8999987850488899819996656499988668999998899999999965992----99999999
Q 001847 482 ERIEKNFVITDP-RLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIRAAIDNQTD----VTVQLINY 556 (1005)
Q Consensus 482 e~~~d~i~i~d~-~G~d~~i~~vN~a~~~l~Gys~eEllG~~~~~l~~~~~~~~~~~~l~~~l~~g~~----~~~e~~~~ 556 (1005)
+...++|+++|. +|. |+++|++++++|||+++|++|+++..+.++.+.......+...+..+.. +..+...+
T Consensus 5 ~~~n~AI~~id~~~G~---I~~~N~a~~~l~Gy~~~el~g~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~ 81 (114)
T d1ll8a_ 5 PEFNKAIFTVDAKTTE---ILVANDKACGLLGYSSQDLIGQKLTQFFLRSDSDVVEALSEEHMEADGHAAVVFGTVVDII 81 (114)
T ss_dssp TTTTCEEEEEETTTCB---EEEECTTHHHHHTCCTTTTTTSBGGGGSSCTTTHHHHHTTSSTTSSSSCSSCCCSSSEEEC
T ss_pred HHCCCEEEEEECCCCE---EEEECHHHHHHHCCCHHHHCCCCEEEECCCCCHHHHHHHHHHHHHCCCCCCCEEEEEEEEE
T ss_conf 1009689999999999---9997789997546897898399722142810499999999999856777310036788888
Q ss_pred ECCCCEEEEEEEEEEEECCCCCEEEEEEEEECCC
Q ss_conf 4599699999999621079998899999996486
Q 001847 557 TKSGKKFWNLFHLQPMRDQKGEVQYFIGVQLDGS 590 (1005)
Q Consensus 557 ~kdG~~~wv~~~~~pi~d~~G~v~~~igi~rDIT 590 (1005)
+++|+.+|++++++++..+ |+. .++++++||+
T Consensus 82 ~~~G~~~pvevs~~~i~~~-~~~-~~l~vi~dV~ 113 (114)
T d1ll8a_ 82 SRSGEKIPVSVWMKRMRQE-RRL-CCVVVLEPVE 113 (114)
T ss_dssp CTTCCCEEEECCEECCBSS-SSB-EEEEEEEECC
T ss_pred CCCCCEEEEEEEEEEEEEC-CEE-EEEEEEEECC
T ss_conf 0499199999999999999-967-9999999775
|
| >d1oj5a_ d.110.3.8 (A:) PAS domain of steroid receptor coactivator 1A, NCo-A1 {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Profilin-like superfamily: PYP-like sensor domain (PAS domain) family: PAS domain of steroid receptor coactivator 1A, NCo-A1 domain: PAS domain of steroid receptor coactivator 1A, NCo-A1 species: Mouse (Mus musculus) [TaxId: 10090]
Probab=99.03 E-value=9.8e-11 Score=79.67 Aligned_cols=82 Identities=11% Similarity=0.032 Sum_probs=43.1
Q ss_pred CCCEEECCHHHHHHCCCCH-HHHCCCCCCCCCCCCCCH--HHHHHHHHHHHCCCCEEEEEEEEECCCCEEEEEEEEEEEE
Q ss_conf 9858981578899809994-555399987677999995--8999999999749939999999823996899988865666
Q 001847 214 DYPIMYASAGFFKMTGYTS-KEVVGRNCRFLQGAGTDP--EDVAKIRETLQNGQSYCGRLLNYKKDGTPFWNLLTIAPIK 290 (1005)
Q Consensus 214 dg~Ii~vN~af~~l~Gys~-eEliG~~~~~l~~~~~~~--~~~~~i~~~l~~g~~~~~e~~~~~kdG~~~wv~~~ispi~ 290 (1005)
+|+|+++|+++++++||.+ +|++|+++..++||++.. .........+..|.....++|.++|||+.+|++.+..+++
T Consensus 11 ~g~~~~vd~~~~~~~gy~~~eelig~s~~~f~HPeD~~~~~~~~~~~~~~~~g~~~~~~yR~~~kdG~~vWv~t~~~~~~ 90 (109)
T d1oj5a_ 11 TGKIISIDTSSLRAAGRTGWEDLVRKCIYAFFQPQGREPSYARQLFQEVMTRGTASSPSYRFILNDGTMLSAHTRCKLCY 90 (109)
T ss_dssp TCCEEEEECHHHHTTCCSCHHHHHHHHHHHHTSCBTTBCCHHHHHHHHHHHHSEEECCCEEEECTTSCEEEEEEEEEEEC
T ss_pred CCEEEEECHHHHHHHHCCCHHHHCCCCHHHEECCCCCHHHHHHHHHHHHHHHCCCCHHHHHHHHCCCCEEEEEEEEEEEE
T ss_conf 96299998789667533787898597598849801332777667899887302223055644023683899999999999
Q ss_pred CCCCC
Q ss_conf 69998
Q 001847 291 DDEGK 295 (1005)
Q Consensus 291 d~~G~ 295 (1005)
++.|+
T Consensus 91 ~~~~~ 95 (109)
T d1oj5a_ 91 PQSPD 95 (109)
T ss_dssp C----
T ss_pred CCCCC
T ss_conf 99999
|
| >d1oj5a_ d.110.3.8 (A:) PAS domain of steroid receptor coactivator 1A, NCo-A1 {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Profilin-like superfamily: PYP-like sensor domain (PAS domain) family: PAS domain of steroid receptor coactivator 1A, NCo-A1 domain: PAS domain of steroid receptor coactivator 1A, NCo-A1 species: Mouse (Mus musculus) [TaxId: 10090]
Probab=99.00 E-value=1.3e-10 Score=79.00 Aligned_cols=95 Identities=12% Similarity=0.104 Sum_probs=77.9
Q ss_pred EEEECCCCCCCCEEEECHHHHHHCCCCH-HHHCCCCCCCCCCCCCCHH--HHHHHHHHHHCCCCEEEEEEEEECCCCEEE
Q ss_conf 9999488999987850488899819996-6564999886689999988--999999999659929999999945996999
Q 001847 488 FVITDPRLPDNPIIFASDSFLELTEYSR-EEILGRNCRFLQGPETDPA--TVRKIRAAIDNQTDVTVQLINYTKSGKKFW 564 (1005)
Q Consensus 488 i~i~d~~G~d~~i~~vN~a~~~l~Gys~-eEllG~~~~~l~~~~~~~~--~~~~l~~~l~~g~~~~~e~~~~~kdG~~~w 564 (1005)
+...|++|+ |+++|+++++++||.+ +|++|+++..++||++... ........+..|.....++++++|||.++|
T Consensus 5 ~trh~~~g~---~~~vd~~~~~~~gy~~~eelig~s~~~f~HPeD~~~~~~~~~~~~~~~~g~~~~~~yR~~~kdG~~vW 81 (109)
T d1oj5a_ 5 MTKQDTTGK---IISIDTSSLRAAGRTGWEDLVRKCIYAFFQPQGREPSYARQLFQEVMTRGTASSPSYRFILNDGTMLS 81 (109)
T ss_dssp EEEECTTCC---EEEEECHHHHTTCCSCHHHHHHHHHHHHTSCBTTBCCHHHHHHHHHHHHSEEECCCEEEECTTSCEEE
T ss_pred EEEECCCCE---EEEECHHHHHHHHCCCHHHHCCCCHHHEECCCCCHHHHHHHHHHHHHHHCCCCHHHHHHHHCCCCEEE
T ss_conf 999879962---99998789667533787898597598849801332777667899887302223055644023683899
Q ss_pred EEEEEEEEECCCCC-EEEEEEE
Q ss_conf 99999621079998-8999999
Q 001847 565 NLFHLQPMRDQKGE-VQYFIGV 585 (1005)
Q Consensus 565 v~~~~~pi~d~~G~-v~~~igi 585 (1005)
+..+..++++..|. +.+++|+
T Consensus 82 v~t~~~~~~~~~~~~~~~Ii~~ 103 (109)
T d1oj5a_ 82 AHTRCKLCYPQSPDMQPFIMGI 103 (109)
T ss_dssp EEEEEEEECC----CCCEEEEE
T ss_pred EEEEEEEEECCCCCCCCEEEEE
T ss_conf 9999999999999963589999
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.90 E-value=9.8e-09 Score=67.41 Aligned_cols=139 Identities=12% Similarity=0.061 Sum_probs=93.1
Q ss_pred CCCCCCCCCCCCCCEEEEEEEECCCCEEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCC-CCCCCEEEEEEEECCEEEEE
Q ss_conf 88432331166693899999990799199999940531237578999999999999579-99845378998707818999
Q 001847 672 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLD-HPFVPALYASFQTKTHVCLI 750 (1005)
Q Consensus 672 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~-hpnIv~l~~~~~~~~~~~iV 750 (1005)
..|+.++..+.+..+.||++.. ++..+++|......... ...+.+|...+..+. +--+++++.+....+..++|
T Consensus 14 ~~~~~~~~~~G~s~~~v~rv~~--~~~~~vlk~~~~~~~~~---~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv 88 (263)
T d1j7la_ 14 EKYRCVKDTEGMSPAKVYKLVG--ENENLYLKMTDSRYKGT---TYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLL 88 (263)
T ss_dssp TTSEEEECSCCCSSSEEEEEEC--SSCEEEEEEECGGGTTS---TTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEE
T ss_pred HCEEEEECCCCCCCCCEEEEEE--CCCEEEEEECCCCCCCC---HHHHHHHHHHHHHHHCCCCCCCEEEEEECCCCEEEE
T ss_conf 3527997678998771899990--89869999848876532---556999999999876069987289997508964999
Q ss_pred EECCCCCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHC-------------------------------------
Q ss_conf 9605898356677317999998999999999999999999985-------------------------------------
Q 001847 751 TDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQ------------------------------------- 793 (1005)
Q Consensus 751 ~E~~~g~sL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~------------------------------------- 793 (1005)
|++.+|.++....... .. ...++.++...++.||+.
T Consensus 89 ~~~l~G~~~~~~~~~~----~~---~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (263)
T d1j7la_ 89 MSEADGVLCSEEYEDE----QS---PEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEED 161 (263)
T ss_dssp EECCSSEEHHHHTTTC----SC---HHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTT
T ss_pred EEECCCCCCCCCCCCC----CC---HHHHHHHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHHHCCCCC
T ss_conf 9860433435433440----26---9999998999999985568421435764465655577899877655554303323
Q ss_pred ----------------------CCCCCCCCCCCEEEECCCCEEEEECCCCC
Q ss_conf ----------------------94317899996898069928998516775
Q 001847 794 ----------------------GIIYRDLKPENVLLQGNGHVSLTDFDLSC 822 (1005)
Q Consensus 794 ----------------------gIvH~DLkP~NIli~~~g~ikL~DFG~a~ 822 (1005)
.++|+|+.|.||+++.++.+.|+||+.+.
T Consensus 162 ~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T d1j7la_ 162 TPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp CSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred CCCHHHHHHHHHHHHCCCCCCCEEEEEECCCCCEEECCCCEEEEEECHHCC
T ss_conf 200579999999984498678178986004764236499659996023144
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=98.62 E-value=1.7e-07 Score=59.83 Aligned_cols=81 Identities=15% Similarity=0.130 Sum_probs=53.4
Q ss_pred CCCCCCCCCEEEEEEEECCCCEEEEEEEEECCCCCC----HHHHHHHHHHHHHHHHCC-C--CCCCEEEEEEEECCEEEE
Q ss_conf 331166693899999990799199999940531237----578999999999999579-9--984537899870781899
Q 001847 677 IKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLN----RNKVHRACAEREILDMLD-H--PFVPALYASFQTKTHVCL 749 (1005)
Q Consensus 677 ~~~LG~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~----~~~~~~~~~E~~il~~l~-h--pnIv~l~~~~~~~~~~~i 749 (1005)
.+.+|.|....||++.+..+++.+++|...+..... +....+...|...++.+. + ..+++++.+ +....++
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l 108 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 108 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEEECCCCEEEEEEEEECCCCEEEEEECCCCHHCCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCEEEEE--CCCCCEE
T ss_conf 99807985276899995799848999617713034677788877899999999998650579885528998--5988779
Q ss_pred EEECCCCCCH
Q ss_conf 9960589835
Q 001847 750 ITDYCPGGEL 759 (1005)
Q Consensus 750 V~E~~~g~sL 759 (1005)
|||++.+..+
T Consensus 109 vmE~L~~~~~ 118 (392)
T d2pula1 109 VMEDLSHLKI 118 (392)
T ss_dssp EECCCTTSEE
T ss_pred EEECCCCCCC
T ss_conf 8713577653
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.51 E-value=6.7e-07 Score=56.15 Aligned_cols=142 Identities=13% Similarity=0.087 Sum_probs=82.7
Q ss_pred CCCCCCCCCCCC-CEEEEEEEECCCCEEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCC--CCCCCEEEEEEEECCEEEE
Q ss_conf 843233116669-3899999990799199999940531237578999999999999579--9984537899870781899
Q 001847 673 HFRPIKPLGSGD-TGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLD--HPFVPALYASFQTKTHVCL 749 (1005)
Q Consensus 673 ~y~~~~~LG~G~-~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~--hpnIv~l~~~~~~~~~~~i 749 (1005)
.++.. .+..|. .+.||++.. ..+..+++|....... ..+..|...++.+. .-.+++++.+....+..++
T Consensus 12 g~~~~-~~~~G~s~~~v~r~~~-~~~~~~vlK~~~~~~~------~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~ 83 (255)
T d1nd4a_ 12 GYDWA-QQTIGCSDAAVFRLSA-QGRPVLFVKTDLSGAL------NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWL 83 (255)
T ss_dssp TCEEE-ECSCTTSSCEEEEEEC-TTSCCEEEEEECSCTT------SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEE
T ss_pred CCCEE-ECCCCCCCCEEEEEEE-CCCCEEEEEECCCCCH------HHHHHHHHHHHHHHHCCCCCCCEEEECCCCCCEEE
T ss_conf 98358-7678654775899993-8987899995896677------68999999999998659998861322245661599
Q ss_pred EEECCCCCCHHHH--------------HHH-CC----CCCCC--HH-HHHHHHH-------------------HHHHHHH
Q ss_conf 9960589835667--------------731-79----99998--99-9999999-------------------9999999
Q 001847 750 ITDYCPGGELFLL--------------LDR-QP----TKVLK--ED-AVRFYAA-------------------EVVVALE 788 (1005)
Q Consensus 750 V~E~~~g~sL~~~--------------l~~-~~----~~~l~--~~-~i~~i~~-------------------qil~aL~ 788 (1005)
||++++|.++... +.+ +. ...+. .. .+..... .....+.
T Consensus 84 v~~~i~G~~~~~~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (255)
T d1nd4a_ 84 LLGEVPGQDLLSSHLAPAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFA 163 (255)
T ss_dssp EEECCSSEETTTSCCCHHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHH
T ss_pred EEEEEECCCCCCCCCCHHHHHHHHHHHHHHHCCCCHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCHHHHHHHHHHHH
T ss_conf 98744135543221268999999999999873688544887554124688999999875411011340112137999999
Q ss_pred HHHHC-------CCCCCCCCCCCEEEECCCCEEEEECCCCC
Q ss_conf 99985-------94317899996898069928998516775
Q 001847 789 YLHCQ-------GIIYRDLKPENVLLQGNGHVSLTDFDLSC 822 (1005)
Q Consensus 789 ~LH~~-------gIvH~DLkP~NIli~~~g~ikL~DFG~a~ 822 (1005)
.+... .++|+|+.|.||+++.++.+-|+||+.+.
T Consensus 164 ~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~ 204 (255)
T d1nd4a_ 164 RLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 204 (255)
T ss_dssp HHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred HHHHHCCCCCCCEEEECCCCCCCEEEECCCEEEEEECHHCC
T ss_conf 99871876579567867888763577379658999853326
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=98.13 E-value=1.3e-05 Score=48.19 Aligned_cols=77 Identities=22% Similarity=0.363 Sum_probs=52.2
Q ss_pred CCCCCCCCCCCCCEEEEEEEECC-------CCEEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCC-CCCCCEEEEEEEEC
Q ss_conf 84323311666938999999907-------99199999940531237578999999999999579-99845378998707
Q 001847 673 HFRPIKPLGSGDTGSVHLVELCG-------SGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLD-HPFVPALYASFQTK 744 (1005)
Q Consensus 673 ~y~~~~~LG~G~~g~Vy~~~~~~-------~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~-hpnIv~l~~~~~~~ 744 (1005)
.++ ++.|+.|-...+|++.... ....+++++.... .......+|..+++.+. +.-.++++.++.+
T Consensus 44 ~l~-v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~-----~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~- 116 (395)
T d1nw1a_ 44 HLR-ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP-----ETESHLVAESVIFTLLSERHLGPKLYGIFSG- 116 (395)
T ss_dssp GEE-EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC-----CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT-
T ss_pred CEE-EEECCCCCCCCEEEEEECCCCCCCCCCCCCEEEEECCCC-----CHHHHHHHHHHHHHHHHHCCCCCEEEEECCC-
T ss_conf 169-999178533434899968877544578981799965996-----1165899999999999757999808998189-
Q ss_pred CEEEEEEECCCCCCH
Q ss_conf 818999960589835
Q 001847 745 THVCLITDYCPGGEL 759 (1005)
Q Consensus 745 ~~~~iV~E~~~g~sL 759 (1005)
.+||+|++|.+|
T Consensus 117 ---g~I~efi~g~~l 128 (395)
T d1nw1a_ 117 ---GRLEEYIPSRPL 128 (395)
T ss_dssp ---EEEECCCCEEEC
T ss_pred ---CEEEEEECCCCC
T ss_conf ---569997345548
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=97.68 E-value=0.00011 Score=42.52 Aligned_cols=29 Identities=21% Similarity=0.200 Sum_probs=23.3
Q ss_pred CCCCCCCCCCCCEEEECCCCEEEEECCCCCC
Q ss_conf 5943178999968980699289985167754
Q 001847 793 QGIIYRDLKPENVLLQGNGHVSLTDFDLSCL 823 (1005)
Q Consensus 793 ~gIvH~DLkP~NIli~~~g~ikL~DFG~a~~ 823 (1005)
.++||+|+.|.|||++ ++ ..++||+.++.
T Consensus 192 ~~liHgDlh~~NvL~~-~~-~~~IDFdd~~~ 220 (325)
T d1zyla1 192 VLRLHGDCHAGNILWR-DG-PMFVDLDDARN 220 (325)
T ss_dssp CEECCSSCSGGGEEES-SS-EEECCCTTCCE
T ss_pred CEEECCCCCCCCEEEE-CC-CEEEECHHCCC
T ss_conf 1202478880428783-89-35886520146
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=97.48 E-value=0.00061 Score=38.05 Aligned_cols=31 Identities=35% Similarity=0.620 Sum_probs=27.1
Q ss_pred CCCCCCCCCCCCEEEECCCCEEEEECCCCCC
Q ss_conf 5943178999968980699289985167754
Q 001847 793 QGIIYRDLKPENVLLQGNGHVSLTDFDLSCL 823 (1005)
Q Consensus 793 ~gIvH~DLkP~NIli~~~g~ikL~DFG~a~~ 823 (1005)
.|+||+|+.++||+++.+..+-++||+.++.
T Consensus 183 ~giIHgDl~~dNvl~~~~~v~gvIDF~~~~~ 213 (316)
T d2ppqa1 183 AGVIHADLFQDNVFFLGDELSGLIDFYFACN 213 (316)
T ss_dssp EEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred CCCCCCCCCHHHHHCCCCCCEEEECCCCCCC
T ss_conf 5033378636564020454126742221236
|
| >d2oola2 d.110.3.9 (A:26-139) Sensor protein PhyB2 {Rhodopseudomonas palustris [TaxId: 1076]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Profilin-like superfamily: PYP-like sensor domain (PAS domain) family: BphP N-terminal domain-like domain: Sensor protein PhyB2 species: Rhodopseudomonas palustris [TaxId: 1076]
Probab=96.81 E-value=0.00053 Score=38.40 Aligned_cols=31 Identities=13% Similarity=0.051 Sum_probs=15.1
Q ss_pred EEEECHHHHHHCCCCHHHHCCCCCCCCCCCC
Q ss_conf 7850488899819996656499988668999
Q 001847 500 IIFASDSFLELTEYSREEILGRNCRFLQGPE 530 (1005)
Q Consensus 500 i~~vN~a~~~l~Gys~eEllG~~~~~l~~~~ 530 (1005)
|++++++...++|+++++++|+++..+++++
T Consensus 30 I~~vS~N~~~lLG~~~~~llG~~l~dll~~~ 60 (114)
T d2oola2 30 IASVSANVEDLLRQPPASLLNVPIAHYLTAA 60 (114)
T ss_dssp EEEEETTHHHHHSSCGGGGTTCBGGGGBCHH
T ss_pred EEEECCCHHHHHCCCHHHHCCCCHHHHCCHH
T ss_conf 9999488899848892887599889968998
|
| >d2oola2 d.110.3.9 (A:26-139) Sensor protein PhyB2 {Rhodopseudomonas palustris [TaxId: 1076]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Profilin-like superfamily: PYP-like sensor domain (PAS domain) family: BphP N-terminal domain-like domain: Sensor protein PhyB2 species: Rhodopseudomonas palustris [TaxId: 1076]
Probab=96.78 E-value=0.00058 Score=38.18 Aligned_cols=73 Identities=19% Similarity=0.180 Sum_probs=46.5
Q ss_pred EEEEEECCCCCCCEEECCHHHHHHCCCCHHHHCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCE---EEEEEEEECCC-CE
Q ss_conf 099993789998589815788998099945553999876779999958999999999749939---99999982399-68
Q 001847 204 TFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKIRETLQNGQSY---CGRLLNYKKDG-TP 279 (1005)
Q Consensus 204 ~i~i~D~~~~dg~Ii~vN~af~~l~Gys~eEliG~~~~~l~~~~~~~~~~~~i~~~l~~g~~~---~~e~~~~~kdG-~~ 279 (1005)
.++++|. .+|+|++++++...++|+++++++|+++..+++++. ...++..+...... ...+.....+| ..
T Consensus 19 ~Llvld~--~d~~I~~vS~N~~~lLG~~~~~llG~~l~dll~~~~----~~~i~~~l~~~~~~~~~~~~~~~~~~~~~~~ 92 (114)
T d2oola2 19 YLFVVSE--TDLRIASVSANVEDLLRQPPASLLNVPIAHYLTAAS----AARLTHALHGGDPAAINPIRLDVVTPDGERA 92 (114)
T ss_dssp EEEEECT--TTCBEEEEETTHHHHHSSCGGGGTTCBGGGGBCHHH----HHHHHHHHCC----CCCSEEEEEEETTEEEE
T ss_pred EEEEEEC--CCCEEEEECCCHHHHHCCCHHHHCCCCHHHHCCHHH----HHHHHHHHHCCCCCCCCCEEEEEECCCCCEE
T ss_conf 8999988--999899994888998488928875998899689989----9999998742794447878999752799868
Q ss_pred EEE
Q ss_conf 999
Q 001847 280 FWN 282 (1005)
Q Consensus 280 ~wv 282 (1005)
+++
T Consensus 93 ~~~ 95 (114)
T d2oola2 93 FNG 95 (114)
T ss_dssp EEE
T ss_pred EEE
T ss_conf 999
|
| >d2veaa3 d.110.3.9 (A:4-130) Phytochrome-like protein Cph1 {Synechocystis sp. pcc 6803 [TaxId: 1148]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Profilin-like superfamily: PYP-like sensor domain (PAS domain) family: BphP N-terminal domain-like domain: Phytochrome-like protein Cph1 species: Synechocystis sp. pcc 6803 [TaxId: 1148]
Probab=93.64 E-value=0.036 Score=27.15 Aligned_cols=33 Identities=21% Similarity=0.136 Sum_probs=17.5
Q ss_pred CEEEECHHHHHHCCCCHHHHCCCCCCCCCCCCC
Q ss_conf 878504888998199966564999886689999
Q 001847 499 PIIFASDSFLELTEYSREEILGRNCRFLQGPET 531 (1005)
Q Consensus 499 ~i~~vN~a~~~l~Gys~eEllG~~~~~l~~~~~ 531 (1005)
.|..++.....++|.++++++|+++..+++++.
T Consensus 38 ~I~~aS~N~~~~lG~~~~~lLG~~l~~ll~~~~ 70 (127)
T d2veaa3 38 TISQISANCTGILGRSPEDLLGRTLGEVFDSFQ 70 (127)
T ss_dssp EEEEEETTHHHHTSCCTTTSSTTTTTTTSBCC-
T ss_pred EEEEECCCHHHHHCCCHHHHCCCCHHHHCCHHH
T ss_conf 899985798988485969983999889879899
|
| >d2veaa3 d.110.3.9 (A:4-130) Phytochrome-like protein Cph1 {Synechocystis sp. pcc 6803 [TaxId: 1148]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Profilin-like superfamily: PYP-like sensor domain (PAS domain) family: BphP N-terminal domain-like domain: Phytochrome-like protein Cph1 species: Synechocystis sp. pcc 6803 [TaxId: 1148]
Probab=93.54 E-value=0.028 Score=27.85 Aligned_cols=45 Identities=22% Similarity=0.225 Sum_probs=36.0
Q ss_pred EEEEECCCCCCCEEECCHHHHHHCCCCHHHHCCCCCCCCCCCCCCHH
Q ss_conf 99993789998589815788998099945553999876779999958
Q 001847 205 FVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPE 251 (1005)
Q Consensus 205 i~i~D~~~~dg~Ii~vN~af~~l~Gys~eEliG~~~~~l~~~~~~~~ 251 (1005)
++++|. .+++|+.++.....++|+++++++|+++..++++.....
T Consensus 29 LLald~--~~~~I~~aS~N~~~~lG~~~~~lLG~~l~~ll~~~~~~~ 73 (127)
T d2veaa3 29 VVVLQE--PDLTISQISANCTGILGRSPEDLLGRTLGEVFDSFQIDP 73 (127)
T ss_dssp EEEEET--TTTEEEEEETTHHHHTSCCTTTSSTTTTTTTSBCC----
T ss_pred EEEEEC--CCCEEEEECCCHHHHHCCCHHHHCCCCHHHHCCHHHHHH
T ss_conf 999988--999899985798988485969983999889879899999
|
| >d2o9ca2 d.110.3.9 (A:4-130) Bacteriophytochrome BphP {Deinococcus radiodurans [TaxId: 1299]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Profilin-like superfamily: PYP-like sensor domain (PAS domain) family: BphP N-terminal domain-like domain: Bacteriophytochrome BphP species: Deinococcus radiodurans [TaxId: 1299]
Probab=93.25 E-value=0.13 Score=23.78 Aligned_cols=31 Identities=10% Similarity=-0.007 Sum_probs=16.6
Q ss_pred CCEEEECHHHHHHCCCCHHHHCCCCCCCCCC
Q ss_conf 9878504888998199966564999886689
Q 001847 498 NPIIFASDSFLELTEYSREEILGRNCRFLQG 528 (1005)
Q Consensus 498 ~~i~~vN~a~~~l~Gys~eEllG~~~~~l~~ 528 (1005)
+.|..++.....++|+++++++|++...+.+
T Consensus 46 ~~I~~~S~N~~~~lG~~~~~llG~~l~~ll~ 76 (127)
T d2o9ca2 46 GEVLQMSLNAATFLGQEPTVLRGQTLAALLP 76 (127)
T ss_dssp CBEEEEETTHHHHHSSCHHHHTTCBHHHHCT
T ss_pred CEEEEECCCHHHHHCCCHHHHCCCCHHHHCC
T ss_conf 9799987898998387968984999899888
|
| >d2o9ca2 d.110.3.9 (A:4-130) Bacteriophytochrome BphP {Deinococcus radiodurans [TaxId: 1299]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Profilin-like superfamily: PYP-like sensor domain (PAS domain) family: BphP N-terminal domain-like domain: Bacteriophytochrome BphP species: Deinococcus radiodurans [TaxId: 1299]
Probab=92.58 E-value=0.16 Score=23.28 Aligned_cols=77 Identities=10% Similarity=-0.003 Sum_probs=48.1
Q ss_pred CCEE-EEEECCCCCCCEEECCHHHHHHCCCCHHHHCCCCCCCCCCCCCCHHHHHHHHHHHHCCCC--EEEEEEEEECCCC
Q ss_conf 8709-999378999858981578899809994555399987677999995899999999974993--9999999823996
Q 001847 202 QQTF-VVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKIRETLQNGQS--YCGRLLNYKKDGT 278 (1005)
Q Consensus 202 ~~~i-~i~D~~~~dg~Ii~vN~af~~l~Gys~eEliG~~~~~l~~~~~~~~~~~~i~~~l~~g~~--~~~e~~~~~kdG~ 278 (1005)
+.|+ +++|.. ++.|+.++....+++|+++++++|+++..+++.. ...+...+..... ..........+|.
T Consensus 34 phG~LLald~~--~~~I~~~S~N~~~~lG~~~~~llG~~l~~ll~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 106 (127)
T d2o9ca2 34 PHGALLTADGH--SGEVLQMSLNAATFLGQEPTVLRGQTLAALLPEQ-----WPALQAALPPGCPDALQYRATLDWPAAG 106 (127)
T ss_dssp TTSEEEEEETT--TCBEEEEETTHHHHHSSCHHHHTTCBHHHHCTTT-----HHHHHHHSCTTCCTTCCEEEEECCSSSS
T ss_pred CCEEEEEEECC--CCEEEEECCCHHHHHCCCHHHHCCCCHHHHCCHH-----HHHHHHHHHHCCCCCCCCEEEEECCCCC
T ss_conf 88489999889--9979998789899838796898499989988888-----9999998653586322230354068993
Q ss_pred EEEEEEE
Q ss_conf 8999888
Q 001847 279 PFWNLLT 285 (1005)
Q Consensus 279 ~~wv~~~ 285 (1005)
.+|+.+.
T Consensus 107 ~f~~~~H 113 (127)
T d2o9ca2 107 HLSLTVH 113 (127)
T ss_dssp EEEEEEE
T ss_pred EEEEEEE
T ss_conf 6999999
|